sampleid	sample_name	run_prefix	experimental_strategy	cgc_base_name	filename	analyte_amount	analyte_A260A280Ratio	aliquot_concentration	cgc_id	cgc_filename	vital_status	gender	race	ethnicity	disease_type	data_subtype	tcga_sample_id	cgc_case_uuid	sample_type	cgc_platform	gdc_file_uuid	primary_site	age_at_diagnosis	cgc_sample_uuid	cgc_aliquot_uuid	tcga_aliquot_id	reference_genome	tcga_case_id	investigation	days_to_death	knightlabID	data_submitting_center_label	tissue_source_site_label	country_of_sample_procurement	portion_is_ffpe	pathologic_t_label	pathologic_n_label	histological_diagnosis_label	pathologic_stage_label	PlateCenter	PlateCenterFlag
13767.58cfa83ae4b0c9d6adf7169b	58cfa83ae4b0c9d6adf7169b	UNCID_2391582.2bbec916-3c74-45b7-9eab-76022899fe7d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2391582.2bbec916-3c74-45b7-9eab-76022899fe7d.sorted_genome_alignments	UNCID_2391582.2bbec916-3c74-45b7-9eab-76022899fe7d.sorted_genome_alignments.bam	48.19	1.8	0.17	58cfa83ae4b0c9d6adf7169b	UNCID_2391582.2bbec916-3c74-45b7-9eab-76022899fe7d.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-J4-A83J-01A	98240F19-BCA7-4001-8AA2-4D790C7C4C53	Primary Tumor	Illumina HiSeq	10BF70D8-C8E7-45B4-910B-60EF957B0A11	Prostate	68.0	2426F010-6122-410C-95FD-9EE4A185F4ED	2BBEC916-3C74-45B7-9EAB-76022899FE7D	TCGA-J4-A83J-01A-11R-A36G-07	HG19	TCGA-J4-A83J	TCGA-PRAD		s3892	University of North Carolina	ABS - Lahey Clinic	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		A36G-07	True
13767.58cfa838e4b0c9d6adf70832	58cfa838e4b0c9d6adf70832	UNCID_2034744.ad229cea-5cac-422d-a773-370ed37152e9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2034744.ad229cea-5cac-422d-a773-370ed37152e9.sorted_genome_alignments	UNCID_2034744.ad229cea-5cac-422d-a773-370ed37152e9.sorted_genome_alignments.bam	66.56	1.83	0.17	58cfa838e4b0c9d6adf70832	UNCID_2034744.ad229cea-5cac-422d-a773-370ed37152e9.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-KJ-A3U4-01A	1A36D5DE-A097-4323-90E9-F1B924A8A5D8	Primary Tumor	Illumina HiSeq	1358363D-EAF0-4096-9E07-7ED2041AC996	Uterus	55.0	7FCBD3E2-4A71-4EF2-96DF-D4BE66352D9E	AD229CEA-5CAC-422D-A773-370ED37152E9	TCGA-KJ-A3U4-01A-11R-A22K-07	HG19	TCGA-KJ-A3U4	TCGA-UCEC		s4704	University of North Carolina	University of Miami	United States	NO			Serous endometrial adenocarcinoma		A22K-07	True
13767.58cfa833e4b0c9d6adf6d8a0	58cfa833e4b0c9d6adf6d8a0	UNCID_1089940.b4a82c9e-4b14-42ed-8d33-6494ec475827.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1089940.b4a82c9e-4b14-42ed-8d33-6494ec475827.sorted_genome_alignments	UNCID_1089940.b4a82c9e-4b14-42ed-8d33-6494ec475827.sorted_genome_alignments.bam	48.2		0.15	58cfa833e4b0c9d6adf6d8a0	UNCID_1089940.b4a82c9e-4b14-42ed-8d33-6494ec475827.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-55-7281-01A	659668E8-F0D9-4FF2-BBC8-9246F2EF49AB	Primary Tumor	Illumina HiSeq	8AE48D0F-FCED-4967-8BB4-09B73F1F3090	Lung	70.0	AFEC3B25-C3F7-4E48-8FB0-6FB4DD581081	B4A82C9E-4B14-42ED-8D33-6494EC475827	TCGA-55-7281-01A-11R-2039-07	HG19	TCGA-55-7281	TCGA-LUAD		s10676	University of North Carolina	International Genomics Consortium	United States	NO	T1b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2039-07	True
13722.58cfa832e4b0c9d6adf6cfff	58cfa832e4b0c9d6adf6cfff	TCGA-G3-A25W-11A-12D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A25W-11A-12D-A16V-10_wgs_Illumina	TCGA-G3-A25W-11A-12D-A16V-10_wgs_Illumina.bam	46.92	1.81	0.09	58cfa832e4b0c9d6adf6cfff	TCGA-G3-A25W-11A-12D-A16V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A25W-11A	06AC44E9-1226-4202-828B-6F224766D7AC	Solid Tissue Normal	Illumina HiSeq	56292a1a-0d0d-48e0-b27b-27a059f5cd34	Liver	79.0	1467D6A9-E66E-49DC-A1EF-161BA83C4432	FDC8E770-343E-4C4E-BC1D-99375EA94DE4	TCGA-G3-A25W-11A-12D-A16V-10	GRCh37-lite	TCGA-G3-A25W	TCGA-LIHC		s16596	Baylor College of Medicine	Alberta Health Services	Canada	NO	T3b	N0	Hepatocellular Carcinoma	Stage III	A16V-10	True
13722.58cfa830e4b0c9d6adf6c2a8	58cfa830e4b0c9d6adf6c2a8	TCGA-BR-4184-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-4184-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_3_rg.sorted	TCGA-BR-4184-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_3_rg.sorted.bam	257.9	1.9	0.15	58cfa830e4b0c9d6adf6c2a8	TCGA-BR-4184-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4184-01A	0D4D23BA-066B-4244-A3A5-922CDCAAA28F	Primary Tumor	Illumina HiSeq	efa9bef0-628c-4883-8eea-34f0690acc42	Stomach	70.0	5DB02C36-DCF0-4311-AD90-754E4EC579EE	501F74C8-6E77-429C-99BD-739D45A74ED1	TCGA-BR-4184-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4184	TCGA-STAD		s15102	Harvard Medical School	Asterand	Russia	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1128-02	True
13722.58cfa82ee4b0c9d6adf6ad3e	58cfa82ee4b0c9d6adf6ad3e	G39020.TCGA-D7-5579-01A-01D-1600-08.2.filtered.	WGS	G39020.TCGA-D7-5579-01A-01D-1600-08.2	G39020.TCGA-D7-5579-01A-01D-1600-08.2.bam	84.7	1.89	0.05	58cfa82ee4b0c9d6adf6ad3e	G39020.TCGA-D7-5579-01A-01D-1600-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-5579-01A	8B5746F9-DBEE-40BD-9141-1081960CF286	Primary Tumor	Illumina HiSeq	9296203d-9b4e-42bc-b596-e5d928afb7fc	Stomach	74.0	633DCE5B-7A88-46DC-AD06-8897A609675B	3DB3B7B1-DA1D-4B9C-A92A-C60FECF4328C	TCGA-D7-5579-01A-01D-1600-08	HG19_Broad_variant	TCGA-D7-5579	TCGA-STAD		s15098	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T3	N2	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage III	1600-08	True
13767.58cfa837e4b0c9d6adf701a2	58cfa837e4b0c9d6adf701a2	UNCID_1844849.8fe3cf69-3d71-4d77-aa05-60e619708e06.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1844849.8fe3cf69-3d71-4d77-aa05-60e619708e06.sorted_genome_alignments	UNCID_1844849.8fe3cf69-3d71-4d77-aa05-60e619708e06.sorted_genome_alignments.bam	53.2		0.13	58cfa837e4b0c9d6adf701a2	UNCID_1844849.8fe3cf69-3d71-4d77-aa05-60e619708e06.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HW-8320-01A	E3ED0C19-6ACC-4BE1-AAE2-73FE73CC9F24	Primary Tumor	Illumina HiSeq	7C419F86-532F-4C06-BCF9-61B8C1003823	Brain	36.0	246FE972-5E77-4FFF-BD49-3F1CF7C71D97	8FE3CF69-3D71-4D77-AA05-60E619708E06	TCGA-HW-8320-01A-11R-2404-07	HG19	TCGA-HW-8320	TCGA-LGG		s8211	University of North Carolina	MSKCC	United States	NO			Astrocytoma		2404-07	True
13767.58cfa83ae4b0c9d6adf7178e	58cfa83ae4b0c9d6adf7178e	UNCID_2414694.916cf47a-0100-4e01-a912-2e884777186f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2414694.916cf47a-0100-4e01-a912-2e884777186f.sorted_genome_alignments	UNCID_2414694.916cf47a-0100-4e01-a912-2e884777186f.sorted_genome_alignments.bam	98.62	1.92	0.17	58cfa83ae4b0c9d6adf7178e	UNCID_2414694.916cf47a-0100-4e01-a912-2e884777186f.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-E6-A8L9-01A	EB642568-30D4-4805-A295-BDA314CCAAAF	Primary Tumor	Illumina HiSeq	A3D94EC5-F94F-4D29-AE0C-C192CBC982A8	Uterus	61.0	04225AB6-5A39-4694-BAB3-423F95D60421	916CF47A-0100-4E01-A912-2E884777186F	TCGA-E6-A8L9-01A-21R-A37O-07	HG19	TCGA-E6-A8L9	TCGA-UCEC		s5130	University of North Carolina	Roswell Park	United States	NO			Serous endometrial adenocarcinoma		A37O-07	True
13767.58cfa838e4b0c9d6adf70507	58cfa838e4b0c9d6adf70507	UNCID_1965787.1eee1136-f567-482b-b64d-a4761e615170.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1965787.1eee1136-f567-482b-b64d-a4761e615170.sorted_genome_alignments	UNCID_1965787.1eee1136-f567-482b-b64d-a4761e615170.sorted_genome_alignments.bam	42.2	1.7	0.14	58cfa838e4b0c9d6adf70507	UNCID_1965787.1eee1136-f567-482b-b64d-a4761e615170.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-6649-01A	39B6AE01-C97B-4234-8A28-208FDF170432	Primary Tumor	Illumina HiSeq	8A53C466-5E08-435F-B809-D910FBE9A7C4	Colorectal	66.0	CB16E564-E613-4F02-9F74-E807A51DD512	1EEE1136-F567-482B-B64D-A4761E615170	TCGA-A6-6649-01A-11R-1774-07	HG19	TCGA-A6-6649	TCGA-COAD		s13775	University of North Carolina	Christiana Healthcare	United States	NO	T3	N1b	Colon Adenocarcinoma	Stage III	1774-07	True
13767.58cfa83be4b0c9d6adf71f8c	58cfa83be4b0c9d6adf71f8c	UNCID_2542908.81741a67-7bfd-46c5-8784-a4c87eb71c5e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2542908.81741a67-7bfd-46c5-8784-a4c87eb71c5e.sorted_genome_alignments	UNCID_2542908.81741a67-7bfd-46c5-8784-a4c87eb71c5e.sorted_genome_alignments.bam	55.15	1.9	0.17	58cfa83be4b0c9d6adf71f8c	UNCID_2542908.81741a67-7bfd-46c5-8784-a4c87eb71c5e.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-AA6U-01A	104C8E20-1B29-4D77-9633-359A35BE48FB	Primary Tumor	Illumina HiSeq	8BCB8110-392B-43DE-BB20-FB12D71EBE0A	Bladder	64.0	CCFEE146-E91D-413A-8466-33EFB4502990	81741A67-7BFD-46C5-8784-A4C87EB71C5E	TCGA-DK-AA6U-01A-11R-A39I-07	HG19	TCGA-DK-AA6U	TCGA-BLCA		s3386	University of North Carolina	Memorial Sloan Kettering	United States	NO		N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A39I-07	True
13722.58cfa830e4b0c9d6adf6bc8e	58cfa830e4b0c9d6adf6bc8e	TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina	TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina.bam	510.89	1.9	0.15	58cfa830e4b0c9d6adf6bc8e	TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina.bam	Alive	FEMALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3901-01A	1586CB0A-081A-4364-9470-46F9D0F0167D	Primary Tumor	Illumina HiSeq	51acbe73-78d9-48e4-b937-42a159dfb5a5	Colorectal	67.0	93B755E6-5D6E-4542-8BAE-2121F44F590C	7D59205A-65EC-4341-9748-28639D82ED29	TCGA-AG-3901-01A-01D-1989-10	GRCh37-lite	TCGA-AG-3901	TCGA-READ		s2160	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Rectal Mucinous Adenocarcinoma	Stage III	1989-10	True
13722.58cfa832e4b0c9d6adf6d648	58cfa832e4b0c9d6adf6d648	TCGA-LN-A49Y-10A-01D-A267_131120_SN1222_0229_AD2FDGACXX_s_6_rg.sorted.filtered.	WGS	TCGA-LN-A49Y-10A-01D-A267_131120_SN1222_0229_AD2FDGACXX_s_6_rg.sorted	TCGA-LN-A49Y-10A-01D-A267_131120_SN1222_0229_AD2FDGACXX_s_6_rg.sorted.bam	70.65		0.15	58cfa832e4b0c9d6adf6d648	TCGA-LN-A49Y-10A-01D-A267_131120_SN1222_0229_AD2FDGACXX_s_6_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49Y-10A	87FABA0E-28E7-4A7E-A7E1-12582EC68FAC	Blood Derived Normal	Illumina HiSeq	90238e0b-cf44-4a8a-bb0e-2f034e197c58	Esophagus	77.0	DD3C843E-95D4-43F7-93FF-052777F0E65E	2911715B-5518-44A7-B7D7-54B4C413EB54	TCGA-LN-A49Y-10A-01D-A267-26	HG19_Broad_variant	TCGA-LN-A49Y	TCGA-ESCA		s1872	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0		Stage II	A267-26	True
13767.58cfa82ee4b0c9d6adf6b188	58cfa82ee4b0c9d6adf6b188	TCGA-13-1505-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-1505-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-13-1505-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	332.0	1.8	0.15	58cfa82ee4b0c9d6adf6b188	TCGA-13-1505-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1505-01A	914F84BF-578B-4F4D-93CB-378228EA58F6	Primary Tumor	Illumina HiSeq	37DB25F6-D5D4-4CAD-BFE4-4EB87C839C40	Ovary	63.0	4FB10554-1573-44D5-99DD-D7ABEF42E373	7774B7D4-2935-4B9B-BF76-312A625629E1	TCGA-13-1505-01A-01R-1565-13	GRCh37-lite	TCGA-13-1505	TCGA-OV		s17870	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa82fe4b0c9d6adf6b9af	58cfa82fe4b0c9d6adf6b9af	TCGA-57-1584-01A-01R-1566-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-57-1584-01A-01R-1566-13_GRCh37-lite_rnaseq	TCGA-57-1584-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	583.0	1.8	0.14	58cfa82fe4b0c9d6adf6b9af	TCGA-57-1584-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-57-1584-01A	ED21615C-0DE3-421C-9E8D-8996026C4431	Primary Tumor	Illumina HiSeq	572C013D-4296-4D23-BABB-692EEF4C0A9E	Ovary	47.0	99287CBC-E4D4-4D24-B373-7865B7905727	E92B95DF-BACB-4083-B2DE-78E540EC0E68	TCGA-57-1584-01A-01R-1566-13	GRCh37-lite	TCGA-57-1584	TCGA-OV		s18008	Canada's Michael Smith Genome Sciences Centre	International Genomics Consortium	None	NO			Serous Cystadenocarcinoma		1566-13	True
13722.58cfa832e4b0c9d6adf6cf28	58cfa832e4b0c9d6adf6cf28	TCGA-H2-A3RI-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_4_rg.sorted.filtered.	WGS	TCGA-H2-A3RI-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_4_rg.sorted	TCGA-H2-A3RI-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_4_rg.sorted.bam	30.6		0.16	58cfa832e4b0c9d6adf6cf28	TCGA-H2-A3RI-11A-11D-A221_120611_SN1222_0115_BD141KACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-H2-A3RI-11A	BF193C4F-FBAC-41BC-B1AF-19B6CE856F0F	Solid Tissue Normal	Illumina HiSeq	4eb6cb87-95fa-472d-8586-3243852bee0d	Thyroid	29.0	44098BAB-EF64-4695-918C-501874BEC9E4	82A3F4E9-87A9-411E-B3C0-CA8D497432F5	TCGA-H2-A3RI-11A-11D-A221-26	HG19_Broad_variant	TCGA-H2-A3RI	TCGA-THCA		s12534	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A221-26	True
13722.58cfa82fe4b0c9d6adf6b94c	58cfa82fe4b0c9d6adf6b94c	TCGA-AA-3518-10A-01D-1525-10_hg19_wgs_Illumina.filtered.	WGS	TCGA-AA-3518-10A-01D-1525-10_hg19_wgs_Illumina	TCGA-AA-3518-10A-01D-1525-10_hg19_wgs_Illumina.bam	117.86	1.9	0.05	58cfa82fe4b0c9d6adf6b94c	TCGA-AA-3518-10A-01D-1525-10_hg19_wgs_Illumina.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-3518-10A	C5C4A0A5-900D-483D-9282-475654D63265	Blood Derived Normal	Illumina HiSeq	de1036e1-ef2b-4b1e-a47f-556789ce4266	Colorectal	81.0	DA5D09FA-0582-45EC-BC71-B8461A0FB13D	A8761858-4C07-4277-A857-5A1861A99C52	TCGA-AA-3518-10A-01D-1525-10	GRCh37-lite	TCGA-AA-3518	TCGA-COAD		s13662	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1525-10	True
13767.58cfa834e4b0c9d6adf6e4c8	58cfa834e4b0c9d6adf6e4c8	UNCID_1195405.c43207c0-edd2-4a86-a8c0-afc179996389.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1195405.c43207c0-edd2-4a86-a8c0-afc179996389.sorted_genome_alignments	UNCID_1195405.c43207c0-edd2-4a86-a8c0-afc179996389.sorted_genome_alignments.bam	104.3	1.8	0.14	58cfa834e4b0c9d6adf6e4c8	UNCID_1195405.c43207c0-edd2-4a86-a8c0-afc179996389.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4971-01A	E173C4BA-9C08-4CE6-B46C-1673B5AF9E2D	Primary Tumor	Illumina HiSeq	B170CBF9-9162-432A-AFF5-603944281AC7	Kidney	40.0	1CA70C1E-A4B9-41AA-AAA8-F55296AAE041	C43207C0-EDD2-4A86-A8C0-AFC179996389	TCGA-BP-4971-01A-01R-1334-07	HG19	TCGA-BP-4971	TCGA-KIRC		s9810	University of North Carolina	MSKCC	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1334-07	True
13767.58cfa838e4b0c9d6adf70f9e	58cfa838e4b0c9d6adf70f9e	UNCID_2122804.20179843-10c8-48ea-bffe-6a9e756be0ac.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2122804.20179843-10c8-48ea-bffe-6a9e756be0ac.sorted_genome_alignments	UNCID_2122804.20179843-10c8-48ea-bffe-6a9e756be0ac.sorted_genome_alignments.bam	28.59	1.9	0.17	58cfa838e4b0c9d6adf70f9e	UNCID_2122804.20179843-10c8-48ea-bffe-6a9e756be0ac.sorted_genome_alignments.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Carcinosarcoma	Aligned reads	TCGA-ND-A4W6-01A	605E9E51-270C-48FB-B198-46B5512B29DA	Primary Tumor	Illumina HiSeq	BCBA3373-24F8-4665-A8C9-18BA742CFBF3	Uterus	67.0	8EFBA839-2630-42C0-899C-217A3BC64078	20179843-10C8-48EA-BFFE-6A9E756BE0AC	TCGA-ND-A4W6-01A-11R-A28V-07	HG19	TCGA-ND-A4W6	TCGA-UCS	317.0	s72	University of North Carolina	Cedars Sinai	United States	NO					A28V-07	True
13767.58cfa835e4b0c9d6adf6f2c2	58cfa835e4b0c9d6adf6f2c2	UNCID_1531847.fca6dae9-687d-418d-bf8b-61bbf6927f61.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1531847.fca6dae9-687d-418d-bf8b-61bbf6927f61.sorted_genome_alignments	UNCID_1531847.fca6dae9-687d-418d-bf8b-61bbf6927f61.sorted_genome_alignments.bam	131.2	1.7	0.16	58cfa835e4b0c9d6adf6f2c2	UNCID_1531847.fca6dae9-687d-418d-bf8b-61bbf6927f61.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-6692-01A	5F10CD91-1E03-4016-B35A-8629A1A8FCC9	Primary Tumor	Illumina HiSeq	31917027-BD97-4442-A12B-ED4161B2AA03	Brain	63.0	FDDB3709-5F1C-40C8-A39A-48329DFE9C97	FCA6DAE9-687D-418D-BF8B-61BBF6927F61	TCGA-FG-6692-01A-11R-1896-07	HG19	TCGA-FG-6692	TCGA-LGG		s8395	University of North Carolina	Case Western	United States	NO			Oligodendroglioma		1896-07	True
13767.58cfa83ce4b0c9d6adf72ccc	58cfa83ce4b0c9d6adf72ccc	UNCID_407763.039a7b01-3a1f-40d4-a636-09e2819db256.110614_UNC11-SN627_0104_AD0CV3ABXX.2.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_407763.039a7b01-3a1f-40d4-a636-09e2819db256.110614_UNC11-SN627_0104_AD0CV3ABXX.2.trimmed.annotated.translated_to_genomic	UNCID_407763.039a7b01-3a1f-40d4-a636-09e2819db256.110614_UNC11-SN627_0104_AD0CV3ABXX.2.trimmed.annotated.translated_to_genomic.bam	36.3	1.8	0.17	58cfa83ce4b0c9d6adf72ccc	UNCID_407763.039a7b01-3a1f-40d4-a636-09e2819db256.110614_UNC11-SN627_0104_AD0CV3ABXX.2.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5077-01A	03B2AC94-05A3-49A7-B68F-51D045395B07	Primary Tumor	Illumina HiSeq	40087060-BF76-4546-984B-AF39DA5FB915	Kidney	77.0	6920B9DA-05B6-45A1-9872-AA7D2954CF74	039A7B01-3A1F-40D4-A636-09E2819DB256	TCGA-B0-5077-01A-01R-1334-07	HG19	TCGA-B0-5077	TCGA-KIRC	1317.0	s8986	University of North Carolina	University of Pittsburgh	None	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13722.58cfa830e4b0c9d6adf6baba	58cfa830e4b0c9d6adf6baba	TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina	TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina.bam	89.57	1.8	0.07	58cfa830e4b0c9d6adf6baba	TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01S-01A	84E34CF2-B3BB-4A1A-8FB7-6C2C604C4008	Primary Tumor	Illumina HiSeq	02f49f2b-40ad-427b-bb81-6ef0c6efc46d	Colorectal	47.0	5743700C-CBD3-4F87-8109-6349A96EB605	A64000DF-16E5-4B88-865F-5C680ADF60EB	TCGA-AA-A01S-01A-21D-A17O-10	GRCh37-lite	TCGA-AA-A01S	TCGA-COAD		s12877	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	A17O-10	True
13767.58cfa833e4b0c9d6adf6db03	58cfa833e4b0c9d6adf6db03	UNCID_1109420.d27e254c-1ccb-4b13-97f3-48d1e427d130.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1109420.d27e254c-1ccb-4b13-97f3-48d1e427d130.sorted_genome_alignments	UNCID_1109420.d27e254c-1ccb-4b13-97f3-48d1e427d130.sorted_genome_alignments.bam	87.2	1.8	0.15	58cfa833e4b0c9d6adf6db03	UNCID_1109420.d27e254c-1ccb-4b13-97f3-48d1e427d130.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5072-01A	1575148B-0F63-44EE-86FD-93AE1A02BE0B	Primary Tumor	Illumina HiSeq	378ABC02-7064-4376-96E6-B789A63288B1	Lung	74.0	AEB9E1BC-A9D2-4AA3-8CDD-CC4EDBF5EDF9	D27E254C-1CCB-4B13-97F3-48D1E427D130	TCGA-50-5072-01A-21R-1858-07	HG19	TCGA-50-5072	TCGA-LUAD		s11565	University of North Carolina	University of Pittsburgh	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1858-07	True
13767.58cfa833e4b0c9d6adf6df90	58cfa833e4b0c9d6adf6df90	UNCID_1139184.d2e1fdf7-1ac9-49e9-a611-b15c90772bf6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1139184.d2e1fdf7-1ac9-49e9-a611-b15c90772bf6.sorted_genome_alignments	UNCID_1139184.d2e1fdf7-1ac9-49e9-a611-b15c90772bf6.sorted_genome_alignments.bam	20.07	1.97	0.18	58cfa833e4b0c9d6adf6df90	UNCID_1139184.d2e1fdf7-1ac9-49e9-a611-b15c90772bf6.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A24T-01A	9E3DE467-FB0D-4021-89F8-B34968A7C7BC	Primary Tumor	Illumina HiSeq	C823363C-2441-4565-92A7-4921BA680E02	Breast	46.0	3CF5C205-2A3B-4F17-8E56-2078E88F615C	D2E1FDF7-1AC9-49E9-A611-B15C90772BF6	TCGA-AR-A24T-01A-11R-A169-07	HG19	TCGA-AR-A24T	TCGA-BRCA		s6828	University of North Carolina	Mayo	United States	NO	T3	N3	Infiltrating Lobular Carcinoma	Stage III	A169-07	True
13722.58cfa832e4b0c9d6adf6d1ec	58cfa832e4b0c9d6adf6d1ec	TCGA-HT-7604-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_2_rg.sorted.filtered.	WGS	TCGA-HT-7604-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_2_rg.sorted	TCGA-HT-7604-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_2_rg.sorted.bam	135.0		0.13	58cfa832e4b0c9d6adf6d1ec	TCGA-HT-7604-10A-01D-2088_130910_SN208_0494_AC2A1DACXX_s_2_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7604-10A	019C5DE9-74FD-48B7-95A3-227532E16C5A	Blood Derived Normal	Illumina HiSeq	b43b5074-d9bd-4d06-b367-bebab284ebfe	Brain	50.0	2D4653B8-97BC-4074-8BCB-670897CEB16A	17624312-479E-4C9B-9C97-65D8C13B0217	TCGA-HT-7604-10A-01D-2088-02	HG19_Broad_variant	TCGA-HT-7604	TCGA-LGG		s8576	Harvard Medical School	Case Western - St Joes	United States	NO			Astrocytoma		2088-02	False
13767.58cfa834e4b0c9d6adf6e735	58cfa834e4b0c9d6adf6e735	UNCID_1211934.f4463436-536d-412e-824c-0c623a244da5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1211934.f4463436-536d-412e-824c-0c623a244da5.sorted_genome_alignments	UNCID_1211934.f4463436-536d-412e-824c-0c623a244da5.sorted_genome_alignments.bam	129.8	1.8	0.15	58cfa834e4b0c9d6adf6e735	UNCID_1211934.f4463436-536d-412e-824c-0c623a244da5.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5508-01A	BD18DD01-D894-4BDD-9CE2-E25705A52A57	Primary Tumor	Illumina HiSeq	80B2D7DD-B744-46F1-98B0-370671A4F186	Prostate	65.0	E3969BF5-B0CC-49E3-B8CB-3D9E98F1676D	F4463436-536D-412E-824C-0C623A244DA5	TCGA-EJ-5508-01A-02R-1580-07	HG19	TCGA-EJ-5508	TCGA-PRAD		s3819	University of North Carolina	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1580-07	True
13767.58cfa833e4b0c9d6adf6d8c1	58cfa833e4b0c9d6adf6d8c1	UNCID_1089357.68663b98-823a-4dd1-950b-caa33793eafb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1089357.68663b98-823a-4dd1-950b-caa33793eafb.sorted_genome_alignments	UNCID_1089357.68663b98-823a-4dd1-950b-caa33793eafb.sorted_genome_alignments.bam	125.3	1.7	0.15	58cfa833e4b0c9d6adf6d8c1	UNCID_1089357.68663b98-823a-4dd1-950b-caa33793eafb.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5175-01A	265F1D03-FA56-4F9A-A1D2-33F123558729	Primary Tumor	Illumina HiSeq	20F194F6-D292-4A7B-9AB9-7940D2C7687A	Kidney	60.0	0463EF8A-DFC4-4365-8A69-7BCD72AB4DDC	68663B98-823A-4DD1-950B-CAA33793EAFB	TCGA-BP-5175-01A-01R-1426-07	HG19	TCGA-BP-5175	TCGA-KIRC		s9746	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1426-07	True
13722.58cfa82ee4b0c9d6adf6aa3c	58cfa82ee4b0c9d6adf6aa3c	G23081.TCGA_CV_6961_01A_21D_2268_08.2.filtered.	WGS	G23081.TCGA_CV_6961_01A_21D_2268_08.2	G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam	52.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa3c	G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6961-01A	4075717B-2240-4842-A00A-0C4DBCB910C4	Primary Tumor	Illumina HiSeq	4b9344a0-a7c6-453a-b184-87e94c97920a	Head and Neck	61.0	BE0A6A2B-A306-4AC6-8BF8-EA6AF16EAA5A	DFA20D2D-1BA3-476A-B4B9-21D21470BEE2	TCGA-CV-6961-01A-21D-2268-08	HG19_Broad_variant	TCGA-CV-6961	TCGA-HNSC	76.0	s15744	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2268-08	True
13767.58cfa83ce4b0c9d6adf7302c	58cfa83ce4b0c9d6adf7302c	_1_TCGA-HU-A4H4-01A-21R-A251-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-HU-A4H4-01A-21R-A251-31_rnaseq	_1_TCGA-HU-A4H4-01A-21R-A251-31_rnaseq.bam	59.78	1.79	0.17	58cfa83ce4b0c9d6adf7302c	_1_TCGA-HU-A4H4-01A-21R-A251-31_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4H4-01A	00FDF96D-C48A-47E0-B91D-576C52E6819C	Primary Tumor	Illumina HiSeq	6CEC32B7-9BF8-4C21-A00C-807E7E80C675	Stomach	53.0	F8DF5FD6-BB50-473B-804A-F934DD266866	F0C78332-67DA-4C6F-AE33-7FF78362F02F	TCGA-HU-A4H4-01A-21R-A251-31	GRCh37-lite	TCGA-HU-A4H4	TCGA-STAD		s14954	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage II	A251-31	True
13767.58cfa82fe4b0c9d6adf6b269	58cfa82fe4b0c9d6adf6b269	TCGA-23-1109-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-23-1109-01A-01R-1564-13_rnaseq	TCGA-23-1109-01A-01R-1564-13_rnaseq.bam	218.0	1.8	0.15	58cfa82fe4b0c9d6adf6b269	TCGA-23-1109-01A-01R-1564-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1109-01A	7C466A5F-A6B4-4D1A-A0F5-DDCD7EF90FF1	Primary Tumor	Illumina HiSeq	9FDA313B-D2C9-417A-B4A4-FAAD1DCEA416	Ovary	62.0	146F9463-DE59-4418-9099-2425A6F86A0F	D47E074A-F78E-40C5-8AF4-F737CE010041	TCGA-23-1109-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-23-1109	TCGA-OV	1562.0	s17297	Canada's Michael Smith Genome Sciences Centre	Cedars Sinai	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa832e4b0c9d6adf6d0c4	58cfa832e4b0c9d6adf6d0c4	TCGA-IC-A6RE-11A-12R-A336-31_rnaseq.filtered.	RNA-Seq	TCGA-IC-A6RE-11A-12R-A336-31_rnaseq	TCGA-IC-A6RE-11A-12R-A336-31_rnaseq.bam	33.12	1.96	0.18	58cfa832e4b0c9d6adf6d0c4	TCGA-IC-A6RE-11A-12R-A336-31_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IC-A6RE-11A	64AA95B2-CCF7-4BFA-8D4F-98DE09F03E71	Solid Tissue Normal	Illumina HiSeq	28358E5F-F3C4-4810-81ED-DB4EE09312A5	Esophagus	59.0	C43EE0D1-3683-43D5-9250-5010FA7A03AC	6E85CBE2-F41B-45FC-8EBB-F9024E465C9C	TCGA-IC-A6RE-11A-12R-A336-31	GRCh37-lite	TCGA-IC-A6RE	TCGA-ESCA		s1913	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	United States	NO	T1	N1		Stage II	A336-31	True
13722.58cfa830e4b0c9d6adf6bf3d	58cfa830e4b0c9d6adf6bf3d	TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted	TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted.bam	138.9	1.9	0.15	58cfa830e4b0c9d6adf6bf3d	TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4187-01A	12071070-D06B-4C7B-A7B1-77C84963ABE6	Primary Tumor	Illumina HiSeq	1da3a244-39ae-4b4d-baed-e4d9b312f777	Stomach	56.0	144FB4ED-63BB-4908-B678-6026E09566A3	57CF858D-FF3F-4528-96DB-5A820C9B78DE	TCGA-BR-4187-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4187	TCGA-STAD		s15046	Harvard Medical School	Asterand	Russia	NO	TX	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)		1128-02	True
13767.58cfa835e4b0c9d6adf6eb2c	58cfa835e4b0c9d6adf6eb2c	UNCID_1235023.5f75a7a1-a36b-4ddc-adc7-7de26854f0b2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1235023.5f75a7a1-a36b-4ddc-adc7-7de26854f0b2.sorted_genome_alignments	UNCID_1235023.5f75a7a1-a36b-4ddc-adc7-7de26854f0b2.sorted_genome_alignments.bam	42.48	1.86	0.18	58cfa835e4b0c9d6adf6eb2c	UNCID_1235023.5f75a7a1-a36b-4ddc-adc7-7de26854f0b2.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2GI-06A	B4079A49-BB11-430A-9A1E-19BD46D87FBE	Metastatic	Illumina HiSeq	6237CA5E-2072-40EC-AAD3-921300BDFDCD	Skin	39.0	46799FCF-E072-43B0-A5C1-73EA38EC6570	5F75A7A1-A36B-4DDC-ADC7-7DE26854F0B2	TCGA-EE-A2GI-06A-11R-A18T-07	HG19	TCGA-EE-A2GI	TCGA-SKCM		s7908	University of North Carolina	University of Sydney	Australia	NO	T1a	N0		Stage I	A18T-07	True
13767.58cfa837e4b0c9d6adf6fe5c	58cfa837e4b0c9d6adf6fe5c	UNCID_1726295.182a5fad-d6f5-4656-b198-aceb2ac081d1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1726295.182a5fad-d6f5-4656-b198-aceb2ac081d1.sorted_genome_alignments	UNCID_1726295.182a5fad-d6f5-4656-b198-aceb2ac081d1.sorted_genome_alignments.bam	69.2		0.15	58cfa837e4b0c9d6adf6fe5c	UNCID_1726295.182a5fad-d6f5-4656-b198-aceb2ac081d1.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8345-01A	452E96B0-DD23-4F5A-BC05-625763B0EE12	Primary Tumor	Illumina HiSeq	CBB034BE-227E-40B0-9CB3-36983DA0DD86	Kidney	75.0	F1E4BBD2-F053-49F1-867C-0B27E68BB55F	182A5FAD-D6F5-4656-B198-ACEB2AC081D1	TCGA-KL-8345-01A-11R-2315-07	HG19	TCGA-KL-8345	TCGA-KICH		s16418	University of North Carolina	MSKCC	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2315-07	True
13767.58cfa838e4b0c9d6adf70e55	58cfa838e4b0c9d6adf70e55	UNCID_2195521.55b5dd8f-9e80-4084-9cb2-c04ccf558802.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2195521.55b5dd8f-9e80-4084-9cb2-c04ccf558802.sorted_genome_alignments	UNCID_2195521.55b5dd8f-9e80-4084-9cb2-c04ccf558802.sorted_genome_alignments.bam	55.51	1.86	0.18	58cfa838e4b0c9d6adf70e55	UNCID_2195521.55b5dd8f-9e80-4084-9cb2-c04ccf558802.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-PG-A6IB-01A	E8C7195B-A26B-4D98-B1C5-0AA18385E9C8	Primary Tumor	Illumina HiSeq	098751D2-9A87-4B4C-A852-DBB90FB4FF90	Uterus	68.0	C9C01AE7-BFDF-4077-B9D7-5D3698AFD32F	55B5DD8F-9E80-4084-9CB2-C04CCF558802	TCGA-PG-A6IB-01A-21R-A31O-07	HG19	TCGA-PG-A6IB	TCGA-UCEC		s4346	University of North Carolina	Montefiore Medical Center	United States	NO			Serous endometrial adenocarcinoma		A31O-07	True
13767.58cfa839e4b0c9d6adf71437	58cfa839e4b0c9d6adf71437	UNCID_2314179.caee83ab-8805-45e2-817c-0cef5f71c292.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2314179.caee83ab-8805-45e2-817c-0cef5f71c292.sorted_genome_alignments	UNCID_2314179.caee83ab-8805-45e2-817c-0cef5f71c292.sorted_genome_alignments.bam	93.4	1.92	0.16	58cfa839e4b0c9d6adf71437	UNCID_2314179.caee83ab-8805-45e2-817c-0cef5f71c292.sorted_genome_alignments.bam	Alive	MALE	ASIAN		Pancreatic Adenocarcinoma	Aligned reads	TCGA-HV-A7OP-01A	5C51FBFE-153C-4CD2-97BD-E444DAA0B20F	Primary Tumor	Illumina HiSeq	B4963F18-C89C-42F4-8813-2B1B80AD56CF	Pancreas	72.0	4A004132-335F-4299-88CD-95F473523ED3	CAEE83AB-8805-45E2-817C-0CEF5F71C292	TCGA-HV-A7OP-01A-11R-A33R-07	HG19	TCGA-HV-A7OP	TCGA-PAAD		s807	University of North Carolina	National Cancer Center Korea	Korea South	NO	T3	N1	Pancreas-Adenocarcinoma-Other Subtype	Stage II	A33R-07	True
13767.58cfa83ce4b0c9d6adf72d32	58cfa83ce4b0c9d6adf72d32	UNCID_609955.04a943a3-4942-482b-b70d-cc190bc2008c.111025_UNC9-SN296_0252_AD0F59ABXX.4.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_609955.04a943a3-4942-482b-b70d-cc190bc2008c.111025_UNC9-SN296_0252_AD0F59ABXX.4.trimmed.annotated.translated_to_genomic	UNCID_609955.04a943a3-4942-482b-b70d-cc190bc2008c.111025_UNC9-SN296_0252_AD0F59ABXX.4.trimmed.annotated.translated_to_genomic.bam	28.8	1.6	0.14	58cfa83ce4b0c9d6adf72d32	UNCID_609955.04a943a3-4942-482b-b70d-cc190bc2008c.111025_UNC9-SN296_0252_AD0F59ABXX.4.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5982-01A	A43401AE-14CD-4F57-946B-9A9C073F2A47	Primary Tumor	Illumina HiSeq	82DA6A54-9D7B-4023-9259-1E4EF6BF7EAD	Kidney	59.0	2AB4C680-809C-4FB9-8959-73DBA6ED2BAA	04A943A3-4942-482B-B70D-CC190BC2008C	TCGA-CZ-5982-01A-11R-1672-07	HG19	TCGA-CZ-5982	TCGA-KIRC		s9922	University of North Carolina	Harvard	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1672-07	True
13722.58cfa831e4b0c9d6adf6cd65	58cfa831e4b0c9d6adf6cd65	TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted	TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.bam	72.56	2.05	0.18	58cfa831e4b0c9d6adf6cd65	TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A232-01A	5EB0D577-223B-4409-89D1-5C5D196AFFC3	Primary Tumor	Illumina HiSeq	ca8aaa05-1546-46a2-aee9-1ad97cadf087	Thyroid	44.0	213BE6EE-1E61-4FA0-9B73-66B696086397	AD42DF5B-2665-4CA1-8049-943F684B6BFD	TCGA-FE-A232-01A-11D-A14U-02	HG19_Broad_variant	TCGA-FE-A232	TCGA-THCA		s12530	Harvard Medical School	Ohio State University	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	True
13767.58cfa836e4b0c9d6adf6fc30	58cfa836e4b0c9d6adf6fc30	UNCID_1664075.22dcbc1b-95f2-4343-b1e4-18daacd66e28.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1664075.22dcbc1b-95f2-4343-b1e4-18daacd66e28.sorted_genome_alignments	UNCID_1664075.22dcbc1b-95f2-4343-b1e4-18daacd66e28.sorted_genome_alignments.bam	82.2		0.14	58cfa836e4b0c9d6adf6fc30	UNCID_1664075.22dcbc1b-95f2-4343-b1e4-18daacd66e28.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7677-01A	00B18AD6-FF70-41FE-8F4D-0763AC8F28B9	Primary Tumor	Illumina HiSeq	5F967E6C-6BE2-4BD4-9CB3-665805C8C587	Brain	53.0	441D4146-FF65-486C-957B-1CECB3552BEC	22DCBC1B-95F2-4343-B1E4-18DAACD66E28	TCGA-HT-7677-01A-11R-2256-07	HG19	TCGA-HT-7677	TCGA-LGG		s8194	University of North Carolina	Case Western - St Joes	United States	NO			Oligodendroglioma		2256-07	True
13722.58cfa831e4b0c9d6adf6c924	58cfa831e4b0c9d6adf6c924	TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted	TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted.bam	579.0		0.15	58cfa831e4b0c9d6adf6c924	TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6996-10A	49B94421-FE82-4F24-8EF2-820674142418	Blood Derived Normal	Illumina HiSeq	ca0120d2-68ba-4605-a647-eb86ed714611	Head and Neck	58.0	91A53555-ECB3-4FF6-B56F-8AC5021BB5A8	F268F2F5-1BE4-454B-809B-C509F1454D8E	TCGA-CN-6996-10A-01D-1911-02	HG19_Broad_variant	TCGA-CN-6996	TCGA-HNSC		s15505	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IV	1911-02	True
13767.58cfa837e4b0c9d6adf6fd56	58cfa837e4b0c9d6adf6fd56	UNCID_1676901.128a925c-6b94-44ed-aa40-97d1ce11715f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1676901.128a925c-6b94-44ed-aa40-97d1ce11715f.sorted_genome_alignments	UNCID_1676901.128a925c-6b94-44ed-aa40-97d1ce11715f.sorted_genome_alignments.bam	82.2		0.15	58cfa837e4b0c9d6adf6fd56	UNCID_1676901.128a925c-6b94-44ed-aa40-97d1ce11715f.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-IB-7893-01A	0944CE65-A89A-4916-B90A-F674B334281E	Primary Tumor	Illumina HiSeq	04E19B0D-2AE9-49DF-88E2-E1A5ABCE09CE	Pancreas	64.0	CED8751E-3265-4CFE-8289-D2C66DD0139C	128A925C-6B94-44ED-AA40-97D1CE11715F	TCGA-IB-7893-01A-11R-2204-07	HG19	TCGA-IB-7893	TCGA-PAAD	117.0	s754	University of North Carolina	Alberta Health Services	Canada	NO	T3	N0	Pancreas-Adenocarcinoma Ductal Type	Stage II	2204-07	True
13767.58cfa83be4b0c9d6adf7284d	58cfa83be4b0c9d6adf7284d	UNCID_351756.TCGA-B8-5158-01A-01R-1420-07.110512_UNC9-SN296_0181_BD0C6RABXX.4.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_351756.TCGA-B8-5158-01A-01R-1420-07.110512_UNC9-SN296_0181_BD0C6RABXX.4.trimmed.annotated.translated_to_genomic	UNCID_351756.TCGA-B8-5158-01A-01R-1420-07.110512_UNC9-SN296_0181_BD0C6RABXX.4.trimmed.annotated.translated_to_genomic.bam	63.3	1.7	0.15	58cfa83be4b0c9d6adf7284d	UNCID_351756.TCGA-B8-5158-01A-01R-1420-07.110512_UNC9-SN296_0181_BD0C6RABXX.4.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B8-5158-01A	E7AFC830-FA22-4562-A1F3-0F4F5A34EACD	Primary Tumor	Illumina HiSeq	0880C064-B597-421F-93CA-D8531B5808C6	Kidney	56.0	5E11DAF8-523B-42E5-A9B5-A16BFFC4299C	DA5862A3-A56B-4B67-9F53-3B36AC7F023F	TCGA-B8-5158-01A-01R-1420-07	HG19	TCGA-B8-5158	TCGA-KIRC		s8932	University of North Carolina	UNC	None	NO	T3a	N1	Kidney Clear Cell Renal Carcinoma	Stage III	1420-07	True
13767.58cfa832e4b0c9d6adf6d0fe	58cfa832e4b0c9d6adf6d0fe	TCGA-IG-A3I8-11A-11R-A24K-31_rnaseq.filtered.	RNA-Seq	TCGA-IG-A3I8-11A-11R-A24K-31_rnaseq	TCGA-IG-A3I8-11A-11R-A24K-31_rnaseq.bam	7.07	1.74	0.18	58cfa832e4b0c9d6adf6d0fe	TCGA-IG-A3I8-11A-11R-A24K-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A3I8-11A	7BF3F18B-A013-48D2-A743-26A57FDBE4C4	Solid Tissue Normal	Illumina HiSeq	AD3F4BA3-C3DE-4B28-8828-A083520C116C	Esophagus	51.0	E843C89C-0AC4-4F98-A7BF-2D354CDD3A33	03615F64-600C-4C08-BB17-E5FD9B45A7DF	TCGA-IG-A3I8-11A-11R-A24K-31	GRCh37-lite	TCGA-IG-A3I8	TCGA-ESCA		s1728	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T3	N0		Stage II	A24K-31	True
13722.58cfa830e4b0c9d6adf6c23c	58cfa830e4b0c9d6adf6c23c	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.bam	51.24		0.18	58cfa830e4b0c9d6adf6c23c	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LB-01A	D17A5AB1-3789-4652-AFF5-D8F4F2291F9C	Primary Tumor	Illumina HiSeq	de67212f-594e-409c-bd19-3d40f013b89a	Bladder	73.0	7C6178A6-6D4C-4DEF-B4AC-A064AB4A6C8A	FAD087E0-3752-4144-960B-659B59312C92	TCGA-BT-A2LB-01A-11D-A18D-02	HG19_Broad_variant	TCGA-BT-A2LB	TCGA-BLCA		s3087	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A18D-02	True
13767.58cfa83be4b0c9d6adf72a9c	58cfa83be4b0c9d6adf72a9c	UNCID_359780.TCGA-BP-4349-01A-01R-1289-07.110506_UNC9-SN296_0178_BC02MGABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_359780.TCGA-BP-4349-01A-01R-1289-07.110506_UNC9-SN296_0178_BC02MGABXX.5.trimmed.annotated.translated_to_genomic	UNCID_359780.TCGA-BP-4349-01A-01R-1289-07.110506_UNC9-SN296_0178_BC02MGABXX.5.trimmed.annotated.translated_to_genomic.bam	17.3	1.8	0.14	58cfa83be4b0c9d6adf72a9c	UNCID_359780.TCGA-BP-4349-01A-01R-1289-07.110506_UNC9-SN296_0178_BC02MGABXX.5.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4349-01A	F72DEFB3-87CA-4EFD-9DC7-D2068533FD98	Primary Tumor	Illumina HiSeq	92DE86BF-AB90-4B15-A4D5-C73E4D02B95A	Kidney	68.0	45B17CB6-94C7-4E9C-A025-76E6DAE5ABBC	0E104CA3-C25F-4393-88A2-887D84A03E87	TCGA-BP-4349-01A-01R-1289-07	HG19	TCGA-BP-4349	TCGA-KIRC		s9403	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1289-07	True
13767.58cfa836e4b0c9d6adf6f8a4	58cfa836e4b0c9d6adf6f8a4	UNCID_1643025.6058cfd7-abc1-451e-a445-7c9833b512d7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1643025.6058cfd7-abc1-451e-a445-7c9833b512d7.sorted_genome_alignments	UNCID_1643025.6058cfd7-abc1-451e-a445-7c9833b512d7.sorted_genome_alignments.bam	234.2		0.16	58cfa836e4b0c9d6adf6f8a4	UNCID_1643025.6058cfd7-abc1-451e-a445-7c9833b512d7.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-HZ-7924-01A	AD220F0D-06B7-4DAD-A87D-36DFF31C8623	Primary Tumor	Illumina HiSeq	4FEF2A8D-A980-4201-98DA-FC6839242E76	Pancreas	60.0	E749BABB-81D9-4B12-B7C7-D9C5E4926D1B	6058CFD7-ABC1-451E-A445-7C9833B512D7	TCGA-HZ-7924-01A-11R-2156-07	HG19	TCGA-HZ-7924	TCGA-PAAD		s750	University of North Carolina	International Genomics Consortium	United States	NO	T3	N0	Pancreas-Adenocarcinoma Ductal Type	Stage II	2156-07	True
13767.58cfa838e4b0c9d6adf7055c	58cfa838e4b0c9d6adf7055c	UNCID_1911607.b32d8bea-966a-4640-9a23-e20cd465771c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1911607.b32d8bea-966a-4640-9a23-e20cd465771c.sorted_genome_alignments	UNCID_1911607.b32d8bea-966a-4640-9a23-e20cd465771c.sorted_genome_alignments.bam	292.2		0.15	58cfa838e4b0c9d6adf7055c	UNCID_1911607.b32d8bea-966a-4640-9a23-e20cd465771c.sorted_genome_alignments.bam	Dead	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-8150-01A	7CC8892E-4BA5-4CF5-BE76-9E5CB4891D25	Primary Tumor	Illumina HiSeq	D14B94D2-C727-434C-906A-785098C49AA5	Lung	64.0	B85ADAF2-0884-41F6-AADA-B38D9759A6D1	B32D8BEA-966A-4640-9A23-E20CD465771C	TCGA-77-8150-01A-11R-2247-07	HG19	TCGA-77-8150	TCGA-LUSC	1655.0	s10561	University of North Carolina	Prince Charles Hospital	Australia	NO	T3	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	2247-07	True
13767.58cfa83ce4b0c9d6adf72bba	58cfa83ce4b0c9d6adf72bba	UNCID_425446.6bb98c7f-6a92-4947-86d7-06b65e0dfc73.110819_UNC11-SN627_0140_BB01T2ABXX.6.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_425446.6bb98c7f-6a92-4947-86d7-06b65e0dfc73.110819_UNC11-SN627_0140_BB01T2ABXX.6.trimmed.annotated.translated_to_genomic	UNCID_425446.6bb98c7f-6a92-4947-86d7-06b65e0dfc73.110819_UNC11-SN627_0140_BB01T2ABXX.6.trimmed.annotated.translated_to_genomic.bam	52.8	1.7	0.15	58cfa83ce4b0c9d6adf72bba	UNCID_425446.6bb98c7f-6a92-4947-86d7-06b65e0dfc73.110819_UNC11-SN627_0140_BB01T2ABXX.6.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5469-01A	6205C2D8-D431-4C4C-8AC6-EE407170E833	Primary Tumor	Illumina HiSeq	7B03EAA0-0F5B-4EA7-BCAE-A4F17C3159F0	Kidney	41.0	2C46A26A-3454-4966-AC59-AF6E0A11D1E9	6BB98C7F-6A92-4947-86D7-06B65E0DFC73	TCGA-CZ-5469-01A-01R-1503-07	HG19	TCGA-CZ-5469	TCGA-KIRC	946.0	s9138	University of North Carolina	Harvard	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage II	1503-07	True
13767.58cfa837e4b0c9d6adf701aa	58cfa837e4b0c9d6adf701aa	UNCID_1864063.fecdc742-c116-479c-8660-03b122543662.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1864063.fecdc742-c116-479c-8660-03b122543662.sorted_genome_alignments	UNCID_1864063.fecdc742-c116-479c-8660-03b122543662.sorted_genome_alignments.bam	31.2	1.8	0.14	58cfa837e4b0c9d6adf701aa	UNCID_1864063.fecdc742-c116-479c-8660-03b122543662.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-6652-01A	96AC1F4B-79B0-4517-8CAF-FC05ABCAAF4F	Primary Tumor	Illumina HiSeq	C1A7E33A-9D49-46FB-BC85-4629258D5211	Colorectal	59.0	E10CA275-47DB-4D0B-8CC1-6680AAD968B2	FECDC742-C116-479C-8660-03B122543662	TCGA-A6-6652-01A-11R-1774-07	HG19	TCGA-A6-6652	TCGA-COAD		s13452	University of North Carolina	Christiana Healthcare	United States	NO	T3	N0	Colon Adenocarcinoma	Stage IV	1774-07	True
13722.58cfa82ee4b0c9d6adf6aa6e	58cfa82ee4b0c9d6adf6aa6e	G32523.TCGA-DJ-A2Q2-10A-01D-A19M-08.2.filtered.	WGS	G32523.TCGA-DJ-A2Q2-10A-01D-A19M-08.2	G32523.TCGA-DJ-A2Q2-10A-01D-A19M-08.2.bam	91.75		0.09	58cfa82ee4b0c9d6adf6aa6e	G32523.TCGA-DJ-A2Q2-10A-01D-A19M-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q2-10A	A00DA907-E527-45F9-9AFB-2FAD2C7B0940	Blood Derived Normal	Illumina HiSeq	795a8bdf-4587-42b2-a974-d0651e0e972e	Thyroid	57.0	33167ED2-2095-4ADA-A7E6-246A3E312ED9	A78604A5-9AA0-4D49-B007-24C54F34EA21	TCGA-DJ-A2Q2-10A-01D-A19M-08	HG19_Broad_variant	TCGA-DJ-A2Q2	TCGA-THCA		s12083	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A19M-08	False
13767.58cfa83be4b0c9d6adf71f82	58cfa83be4b0c9d6adf71f82	UNCID_2538606.be27b78a-f543-497a-96d8-44e21898b502.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2538606.be27b78a-f543-497a-96d8-44e21898b502.sorted_genome_alignments	UNCID_2538606.be27b78a-f543-497a-96d8-44e21898b502.sorted_genome_alignments.bam	17.84	1.89	0.17	58cfa83be4b0c9d6adf71f82	UNCID_2538606.be27b78a-f543-497a-96d8-44e21898b502.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EL-01A	8DE236F1-C029-44DF-A2A9-319145488BAA	Primary Tumor	Illumina HiSeq	56EBE49D-42B0-469A-817E-98120B63B677	Eye	60.0	DB91E719-82B1-4E9A-AB28-AC67B726340B	BE27B78A-F543-497A-96D8-44E21898B502	TCGA-V4-A9EL-01A-11R-A405-07	HG19	TCGA-V4-A9EL	TCGA-UVM		s296	University of North Carolina	Institut Curie	France	NO	T4a	N0		Stage III	A405-07	True
13722.58cfa831e4b0c9d6adf6c3ba	58cfa831e4b0c9d6adf6c3ba	TCGA-CC-5261-10A-01D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-CC-5261-10A-01D-A12Z-10_wgs_Illumina	TCGA-CC-5261-10A-01D-A12Z-10_wgs_Illumina.bam	77.6	1.95	0.08	58cfa831e4b0c9d6adf6c3ba	TCGA-CC-5261-10A-01D-A12Z-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-5261-10A	1AD7F17E-B3B8-40E9-AAB8-5A17E0AEC408	Blood Derived Normal	Illumina HiSeq	59883362-cc79-4771-8824-7cc42fa91622	Liver	44.0	6FA15D13-FA7E-4974-843A-982C934047A9	5AD24CF2-DB35-428A-A10F-50B2DECBE482	TCGA-CC-5261-10A-01D-A12Z-10	GRCh37-lite	TCGA-CC-5261	TCGA-LIHC		s16583	Baylor College of Medicine	ILSbio	None	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A12Z-10	True
13767.58cfa838e4b0c9d6adf709a0	58cfa838e4b0c9d6adf709a0	UNCID_2035281.6b961695-40e4-4c88-976a-8fb6c99b4f0f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2035281.6b961695-40e4-4c88-976a-8fb6c99b4f0f.sorted_genome_alignments	UNCID_2035281.6b961695-40e4-4c88-976a-8fb6c99b4f0f.sorted_genome_alignments.bam	29.53	1.84	0.16	58cfa838e4b0c9d6adf709a0	UNCID_2035281.6b961695-40e4-4c88-976a-8fb6c99b4f0f.sorted_genome_alignments.bam					Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-FL-A3WE-11A	50EDD97A-F440-40AF-B94C-D88ECA55D845	Solid Tissue Normal	Illumina HiSeq	E7959238-D2CF-4BFD-83B5-62AFE937F233	Uterus		70C3B243-D83A-4D15-B803-999BDD1576A8	6B961695-40E4-4C88-976A-8FB6C99B4F0F	TCGA-FL-A3WE-11A-11R-A22K-07	HG19	TCGA-FL-A3WE	TCGA-UCEC		s4893	University of North Carolina	University of Hawaii - Normal Study	United States	NO					A22K-07	True
13767.58cfa837e4b0c9d6adf70256	58cfa837e4b0c9d6adf70256	UNCID_1880805.9f492497-0039-460c-b408-192cc194baf6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1880805.9f492497-0039-460c-b408-192cc194baf6.sorted_genome_alignments	UNCID_1880805.9f492497-0039-460c-b408-192cc194baf6.sorted_genome_alignments.bam	15.96	1.85	0.17	58cfa837e4b0c9d6adf70256	UNCID_1880805.9f492497-0039-460c-b408-192cc194baf6.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Thyroid Carcinoma	Aligned reads	TCGA-KS-A4IC-01A	4D30606F-3AB6-4EF0-9991-8897CDB9960B	Primary Tumor	Illumina HiSeq	65A2A9F8-1BEC-40D4-81D8-4BCF1C0C29DE	Thyroid	45.0	88AD3801-2464-4327-A72E-291794FDA877	9F492497-0039-460C-B408-192CC194BAF6	TCGA-KS-A4IC-01A-11R-A250-07	HG19	TCGA-KS-A4IC	TCGA-THCA		s12713	University of North Carolina	University of Michigan	United States	NO	T1b	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A250-07	True
13722.58cfa832e4b0c9d6adf6d4a7	58cfa832e4b0c9d6adf6d4a7	TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted	TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted.bam	39.6		0.17	58cfa832e4b0c9d6adf6d4a7	TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted.bam	Alive	MALE			Uveal Melanoma	Aligned reads	TCGA-VD-A8KH-01A	39AF6E0F-908C-4B2B-97B8-A4D1966E47E1	Primary Tumor	Illumina HiSeq	c1aaf5dd-316d-42b5-9471-88f8c886efd8	Eye	69.0	98A73F7B-83C7-4160-944E-7A19B07AD696	4A25E140-632B-481F-8D50-49433ECEF545	TCGA-VD-A8KH-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KH	TCGA-UVM		s251	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T4b	NX		Stage III	A40D-26	True
13767.58cfa835e4b0c9d6adf6ec88	58cfa835e4b0c9d6adf6ec88	UNCID_1358589.2ae16d20-e82e-49de-90fd-cad0c6b900ad.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1358589.2ae16d20-e82e-49de-90fd-cad0c6b900ad.sorted_genome_alignments	UNCID_1358589.2ae16d20-e82e-49de-90fd-cad0c6b900ad.sorted_genome_alignments.bam	29.88	1.8	0.17	58cfa835e4b0c9d6adf6ec88	UNCID_1358589.2ae16d20-e82e-49de-90fd-cad0c6b900ad.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A39N-01A	87858089-1BAD-4E5D-80ED-04F846DA9CA4	Primary Tumor	Illumina HiSeq	0B02E1BC-FAF5-4B8F-8A80-1AB4F1BEBDB3	Thyroid	35.0	B3CF7E11-9204-4201-BF32-1AFE0233A85E	2AE16D20-E82E-49DE-90FD-CAD0C6B900AD	TCGA-ET-A39N-01A-11R-A19O-07	HG19	TCGA-ET-A39N	TCGA-THCA		s12423	University of North Carolina	Johns Hopkins	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19O-07	True
13767.58cfa839e4b0c9d6adf71142	58cfa839e4b0c9d6adf71142	UNCID_2266614.9d5f0b9f-ff36-4a80-8472-412d0ec803c5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2266614.9d5f0b9f-ff36-4a80-8472-412d0ec803c5.sorted_genome_alignments	UNCID_2266614.9d5f0b9f-ff36-4a80-8472-412d0ec803c5.sorted_genome_alignments.bam	11.35	1.81	0.16	58cfa839e4b0c9d6adf71142	UNCID_2266614.9d5f0b9f-ff36-4a80-8472-412d0ec803c5.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-KK-A7B2-01A	000D566C-96C7-4F1C-B36E-FA2222467983	Primary Tumor	Illumina HiSeq	A1E4CC7A-6C20-473E-AC6E-6D58A0C6D195	Prostate	68.0	BCCB7F9D-8DDE-45B7-A50D-6C7233239CEB	9D5F0B9F-FF36-4A80-8472-412D0EC803C5	TCGA-KK-A7B2-01A-12R-A32O-07	HG19	TCGA-KK-A7B2	TCGA-PRAD		s3881	University of North Carolina	MD Anderson Cancer Center	United States	NO	T3a	N1	Prostate Adenocarcinoma Acinar Type		A32O-07	True
13722.58cfa831e4b0c9d6adf6c401	58cfa831e4b0c9d6adf6c401	TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted	TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted.bam	145.7	2.0	0.17	58cfa831e4b0c9d6adf6c401	TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5791-01A	829BED0C-C40D-44FD-AEE8-6C7589DB60F9	Primary Tumor	Illumina HiSeq	e2778c71-6feb-40df-8b1e-8d8f0e889beb	Prostate	72.0	C14B5C15-994B-4739-870B-A50984D274A1	500F071A-6697-4880-BBD0-9054CCAE108A	TCGA-CH-5791-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5791	TCGA-PRAD		s3417	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1572-02	True
13767.58cfa838e4b0c9d6adf70838	58cfa838e4b0c9d6adf70838	UNCID_2033679.835b36a5-39ab-4c39-ae0a-50d235b19b93.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2033679.835b36a5-39ab-4c39-ae0a-50d235b19b93.sorted_genome_alignments	UNCID_2033679.835b36a5-39ab-4c39-ae0a-50d235b19b93.sorted_genome_alignments.bam	15.05	1.92	0.18	58cfa838e4b0c9d6adf70838	UNCID_2033679.835b36a5-39ab-4c39-ae0a-50d235b19b93.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A4F5-06A	87DC5C05-3121-46BF-ADBA-061F45CECF27	Metastatic	Illumina HiSeq	6C4926BF-CAB9-42D6-86CA-A8CC27A97ACE	Skin	77.0	881CFCC8-BFCF-4404-8742-5BE9BE653412	835B36A5-39AB-4C39-AE0A-50D235B19B93	TCGA-FS-A4F5-06A-11R-A266-07	HG19	TCGA-FS-A4F5	TCGA-SKCM	874.0	s7768	University of North Carolina	Essen	Germany	NO	T2a	N0		Stage I	A266-07	True
13767.58cfa834e4b0c9d6adf6e890	58cfa834e4b0c9d6adf6e890	UNCID_1229292.47bb130b-c5cc-40ba-b72f-7d337080c62f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1229292.47bb130b-c5cc-40ba-b72f-7d337080c62f.sorted_genome_alignments	UNCID_1229292.47bb130b-c5cc-40ba-b72f-7d337080c62f.sorted_genome_alignments.bam	190.2	1.8	0.14	58cfa834e4b0c9d6adf6e890	UNCID_1229292.47bb130b-c5cc-40ba-b72f-7d337080c62f.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-51-4081-11A	3F43C83E-C2A2-4224-9DA0-0757B9C7D4CA	Solid Tissue Normal	Illumina HiSeq	42B2349B-9C33-4C52-B590-7633B7F2AD59	Lung	55.0	F44B5AEE-7B92-45CC-8FAB-5B3D42CB6AD3	47BB130B-C5CC-40BA-B72F-7D337080C62F	TCGA-51-4081-11A-01R-1758-07	HG19	TCGA-51-4081	TCGA-LUSC		s10211	University of North Carolina	UNC	United States	NO	T2a	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	1758-07	True
13767.58cfa83be4b0c9d6adf72130	58cfa83be4b0c9d6adf72130	UNCID_2588951.29605016-26f0-4146-a99d-b4d0381c9dc2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2588951.29605016-26f0-4146-a99d-b4d0381c9dc2.sorted_genome_alignments	UNCID_2588951.29605016-26f0-4146-a99d-b4d0381c9dc2.sorted_genome_alignments.bam	34.25	1.8	0.17	58cfa83be4b0c9d6adf72130	UNCID_2588951.29605016-26f0-4146-a99d-b4d0381c9dc2.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thymoma	Aligned reads	TCGA-ZB-A96L-01A	CFFD89D3-0D36-4B30-A676-E9D66E2C764B	Primary Tumor	Illumina HiSeq	B5B921D4-7ACA-4B97-9710-5F3CA0E6ABBB	Thymus	70.0	6011C29D-219A-4001-8AFD-F374FDB8DDFD	29605016-26F0-4146-A99D-B4D0381C9DC2	TCGA-ZB-A96L-01A-11R-A42S-07	HG19	TCGA-ZB-A96L	TCGA-THYM		s536	University of North Carolina	Thoraxklinik	Germany	NO					A42S-07	True
13767.58cfa83ce4b0c9d6adf72fa2	58cfa83ce4b0c9d6adf72fa2	_1_TCGA-BR-8295-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-8295-01A-11R-2343-13_rnaseq	_1_TCGA-BR-8295-01A-11R-2343-13_rnaseq.bam	628.2		0.13	58cfa83ce4b0c9d6adf72fa2	_1_TCGA-BR-8295-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8295-01A	62D32D19-EC93-4359-AB17-DC32E599B29A	Primary Tumor	Illumina HiSeq	B33BF27E-61A4-40E8-BE71-F4F2362CE050	Stomach	60.0	EFCA85B6-CAC4-4DF0-9B83-84CC8669A053	9C2721CF-CA2E-4A60-91C1-1F45CB49BF91	TCGA-BR-8295-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8295	TCGA-STAD		s15274	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4a	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2343-13	True
13767.58cfa833e4b0c9d6adf6deda	58cfa833e4b0c9d6adf6deda	UNCID_1145731.4808bc63-000a-4a49-a25b-4b817ca5ea54.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1145731.4808bc63-000a-4a49-a25b-4b817ca5ea54.sorted_genome_alignments	UNCID_1145731.4808bc63-000a-4a49-a25b-4b817ca5ea54.sorted_genome_alignments.bam	49.1	1.74	0.16	58cfa833e4b0c9d6adf6deda	UNCID_1145731.4808bc63-000a-4a49-a25b-4b817ca5ea54.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J4-01A	A9B7D7FE-BE31-4F71-AFEE-C1BFDF511888	Primary Tumor	Illumina HiSeq	841306CB-0CD1-4A7C-A768-E66389097D9A	Breast	41.0	CF11642A-EB96-4B37-B914-371C71F8E0CA	4808BC63-000A-4A49-A25B-4B817CA5EA54	TCGA-AO-A0J4-01A-11R-A034-07	HG19	TCGA-AO-A0J4	TCGA-BRCA		s5869	University of North Carolina	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A034-07	True
13767.58cfa834e4b0c9d6adf6e722	58cfa834e4b0c9d6adf6e722	UNCID_1212134.c862a72f-d317-4419-905f-bf42adb784d9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1212134.c862a72f-d317-4419-905f-bf42adb784d9.sorted_genome_alignments	UNCID_1212134.c862a72f-d317-4419-905f-bf42adb784d9.sorted_genome_alignments.bam	14.01	1.73	0.15	58cfa834e4b0c9d6adf6e722	UNCID_1212134.c862a72f-d317-4419-905f-bf42adb784d9.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2MD-06A	D28B2D64-2399-4CE1-9C9A-7538DABAB862	Metastatic	Illumina HiSeq	262539F4-B675-4891-BF2F-C15A76A43BC6	Skin	52.0	FE5CCE9F-6DBD-4532-8926-BBF6BD850E71	C862A72F-D317-4419-905F-BF42ADB784D9	TCGA-EE-A2MD-06A-11R-A18T-07	HG19	TCGA-EE-A2MD	TCGA-SKCM	1438.0	s7881	University of North Carolina	University of Sydney	Australia	NO	T3a	N0		Stage II	A18T-07	True
13767.58cfa83ae4b0c9d6adf71a63	58cfa83ae4b0c9d6adf71a63	UNCID_2443505.2dc97660-d26f-49a4-9e47-3678a3768724.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2443505.2dc97660-d26f-49a4-9e47-3678a3768724.sorted_genome_alignments	UNCID_2443505.2dc97660-d26f-49a4-9e47-3678a3768724.sorted_genome_alignments.bam	17.01	1.91	0.15	58cfa83ae4b0c9d6adf71a63	UNCID_2443505.2dc97660-d26f-49a4-9e47-3678a3768724.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-RY-A843-01A	1F2F3BF6-ACDD-4A72-8C33-230DE40910EB	Primary Tumor	Illumina HiSeq	436ED1E5-ED65-4EDF-998D-7657230AA8F5	Brain	30.0	91E1C815-BDF7-4F20-A7C4-E683E89953B2	2DC97660-D26F-49A4-9E47-3678A3768724	TCGA-RY-A843-01A-11R-A36H-07	HG19	TCGA-RY-A843	TCGA-LGG		s8829	University of North Carolina	University of California San Francisco	United States	NO			Astrocytoma		A36H-07	True
13767.58cfa832e4b0c9d6adf6d850	58cfa832e4b0c9d6adf6d850	TCGA-VQ-A8PM-01A-21R-A414-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-A8PM-01A-21R-A414-31_rnaseq	TCGA-VQ-A8PM-01A-21R-A414-31_rnaseq.bam	53.01	1.86	0.18	58cfa832e4b0c9d6adf6d850	TCGA-VQ-A8PM-01A-21R-A414-31_rnaseq.bam	Dead	MALE	WHITE		Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-A8PM-01A	BAB53C56-82F1-4D63-98F5-4608EA7B5F4E	Primary Tumor	Illumina HiSeq	142D552E-E20B-47EA-82DB-42049859426A	Stomach	56.0	47924478-6EEE-4958-A585-CA6EBAE55132	61295C91-AA67-4A4D-B1A3-17D91CF60896	TCGA-VQ-A8PM-01A-21R-A414-31	GRCh37-lite	TCGA-VQ-A8PM	TCGA-STAD	57.0	s15147	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T4	N3	Stomach Adenocarcinoma  Signet Ring Type	Stage IV	A414-31	True
13767.58cfa83ce4b0c9d6adf72d8c	58cfa83ce4b0c9d6adf72d8c	UNCID_624035.54ef8e19-fd0b-417a-a083-3892bb8d651b.110823_UNC10-SN254_0269_AC019UABXX.4.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_624035.54ef8e19-fd0b-417a-a083-3892bb8d651b.110823_UNC10-SN254_0269_AC019UABXX.4.trimmed.annotated.translated_to_genomic	UNCID_624035.54ef8e19-fd0b-417a-a083-3892bb8d651b.110823_UNC10-SN254_0269_AC019UABXX.4.trimmed.annotated.translated_to_genomic.bam	34.8	1.2	0.16	58cfa83ce4b0c9d6adf72d8c	UNCID_624035.54ef8e19-fd0b-417a-a083-3892bb8d651b.110823_UNC10-SN254_0269_AC019UABXX.4.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5402-01A	D7AB7EC0-3DE7-4FFD-A5AC-F75579355B2A	Primary Tumor	Illumina HiSeq	41A70BC5-DA4A-49B1-88A0-16D6C3622B0A	Kidney	64.0	B1DFBA29-3616-4686-8A92-9DDD918F35C5	54EF8E19-FD0B-417A-A083-3892BB8D651B	TCGA-B0-5402-01A-01R-1503-07	HG19	TCGA-B0-5402	TCGA-KIRC		s9439	University of North Carolina	University of Pittsburgh	None	NO	T4	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1503-07	True
13767.58cfa834e4b0c9d6adf6e7a8	58cfa834e4b0c9d6adf6e7a8	UNCID_1224366.eb5b988d-308e-4afb-b21b-8bdd45010c72.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1224366.eb5b988d-308e-4afb-b21b-8bdd45010c72.sorted_genome_alignments	UNCID_1224366.eb5b988d-308e-4afb-b21b-8bdd45010c72.sorted_genome_alignments.bam	35.83	1.94	0.17	58cfa834e4b0c9d6adf6e7a8	UNCID_1224366.eb5b988d-308e-4afb-b21b-8bdd45010c72.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-H4-A2HO-01A	86D1E388-B30F-48FD-9647-3848EB6134F1	Primary Tumor	Illumina HiSeq	05FF61D5-8993-42F6-A5BE-9E90685AEC1B	Bladder	53.0	708501D2-B376-49EA-94ED-3E0AB73AF619	EB5B988D-308E-4AFB-B21B-8BDD45010C72	TCGA-H4-A2HO-01A-11R-A180-07	HG19	TCGA-H4-A2HO	TCGA-BLCA		s2758	University of North Carolina	Medical College of Georgia	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A180-07	True
13767.58cfa83ce4b0c9d6adf731fe	58cfa83ce4b0c9d6adf731fe	_1_TCGA-HU-8608-01A-11R-2402-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-HU-8608-01A-11R-2402-13_rnaseq	_1_TCGA-HU-8608-01A-11R-2402-13_rnaseq.bam	181.2		0.16	58cfa83ce4b0c9d6adf731fe	_1_TCGA-HU-8608-01A-11R-2402-13_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-8608-01A	C6316FB5-99A7-4ADF-832F-DCE44DDCD3AA	Primary Tumor	Illumina HiSeq	16BCE79A-7544-4BAB-85F0-69EB45DAD6D6	Stomach	70.0	E70FE3AD-F9FA-4097-B472-86606C241D26	52739598-8083-45B3-B89E-4D841CB15D7A	TCGA-HU-8608-01A-11R-2402-13	GRCh37-lite	TCGA-HU-8608	TCGA-STAD		s14952	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage III	2402-13	True
13722.58cfa82fe4b0c9d6adf6b790	58cfa82fe4b0c9d6adf6b790	TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.filtered.	WGS	TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted	TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.bam	72.0	1.9	0.16	58cfa82fe4b0c9d6adf6b790	TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6146-01A	0C0B610E-FE4C-406D-A5ED-5CC3B11DABF5	Primary Tumor	Illumina HiSeq	99148000-be38-4da1-aeaa-4b0271725662	Lung	64.0	AD66185F-983D-4416-B705-25D3D4D8B5A5	2D5C6425-E3F4-4389-9DDF-FDE694B4227E	TCGA-44-6146-01A-11D-1751-02	HG19_Broad_variant	TCGA-44-6146	TCGA-LUAD		s11337	Harvard Medical School	Christiana Healthcare	United States	NO	T3	N0	Lung Mucinous Adenocarcinoma	Stage II	1751-02	True
13767.58cfa837e4b0c9d6adf6fcb2	58cfa837e4b0c9d6adf6fcb2	UNCID_1669196.5A2EBAB3-98A8-4226-987C-3009B2E0D062.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1669196.5A2EBAB3-98A8-4226-987C-3009B2E0D062.sorted_genome_alignments	UNCID_1669196.5A2EBAB3-98A8-4226-987C-3009B2E0D062.sorted_genome_alignments.bam	6.22	1.81	0.17	58cfa837e4b0c9d6adf6fcb2	UNCID_1669196.5A2EBAB3-98A8-4226-987C-3009B2E0D062.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A3VM-01A	1EBD5834-56B8-498A-8F34-C0031FCFD856	Primary Tumor	Illumina HiSeq	1F21558E-77F0-4002-BC71-0A9C2E3DB033	Thyroid	68.0	20D9CA9B-DEDC-428A-A0F0-9332E4BB68AA	5A2EBAB3-98A8-4226-987C-3009B2E0D062	TCGA-DJ-A3VM-01A-11R-A23N-07	HG19	TCGA-DJ-A3VM	TCGA-THCA		s12709	University of North Carolina	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A23N-07	True
13767.58cfa830e4b0c9d6adf6c09d	58cfa830e4b0c9d6adf6c09d	TCGA-BR-8372-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-8372-01A-11R-2343-13_rnaseq	TCGA-BR-8372-01A-11R-2343-13_rnaseq.bam	323.5		0.17	58cfa830e4b0c9d6adf6c09d	TCGA-BR-8372-01A-11R-2343-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8372-01A	5B52F882-DF12-42EC-A000-FF3B428BA05B	Primary Tumor	Illumina HiSeq	F69871BF-22A0-4C77-9496-0F7AA2E84560	Stomach	63.0	FAE10552-1D8A-4970-B733-5AA0F498FBC8	82A70DA7-F6EC-4F02-81EF-A4BDADF258FD	TCGA-BR-8372-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8372	TCGA-STAD		s14822	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4b	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2343-13	True
13767.58cfa834e4b0c9d6adf6e872	58cfa834e4b0c9d6adf6e872	UNCID_1233798.40eb0b4a-3863-403f-a90b-919bfa24237e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1233798.40eb0b4a-3863-403f-a90b-919bfa24237e.sorted_genome_alignments	UNCID_1233798.40eb0b4a-3863-403f-a90b-919bfa24237e.sorted_genome_alignments.bam	96.3	1.8	0.15	58cfa834e4b0c9d6adf6e872	UNCID_1233798.40eb0b4a-3863-403f-a90b-919bfa24237e.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5763-01A	18E79A01-07A2-4CD5-B700-71D41724E041	Primary Tumor	Illumina HiSeq	697F5428-D5B3-40B4-8674-93945297F61D	Prostate	66.0	F4192448-E5B3-4A9F-8354-9FE28503017A	40EB0B4A-3863-403F-A90B-919BFA24237E	TCGA-CH-5763-01A-11R-1580-07	HG19	TCGA-CH-5763	TCGA-PRAD		s3991	University of North Carolina	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1580-07	True
13767.58cfa830e4b0c9d6adf6c301	58cfa830e4b0c9d6adf6c301	TCGA-BR-7717-11A-01R-2055-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-7717-11A-01R-2055-13_rnaseq	TCGA-BR-7717-11A-01R-2055-13_rnaseq.bam	182.2		0.13	58cfa830e4b0c9d6adf6c301	TCGA-BR-7717-11A-01R-2055-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7717-11A	93A337AE-2BD3-4464-B38F-93DFF92D3FDE	Solid Tissue Normal	Illumina HiSeq	62D80DD8-F801-4A1C-B2EA-0C8DF063C018	Stomach	63.0	1E95C987-3EB2-4B36-B4EE-96EC57BB88E6	F4291BC0-4D5D-48AD-9901-6CFF010B281F	TCGA-BR-7717-11A-01R-2055-13	GRCh37-lite	TCGA-BR-7717	TCGA-STAD		s15112	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	2055-13	True
13767.58cfa836e4b0c9d6adf6fbf5	58cfa836e4b0c9d6adf6fbf5	UNCID_1657816.2D1871C3-4AD4-4AF6-8E36-125A385CC899.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1657816.2D1871C3-4AD4-4AF6-8E36-125A385CC899.sorted_genome_alignments	UNCID_1657816.2D1871C3-4AD4-4AF6-8E36-125A385CC899.sorted_genome_alignments.bam	62.92	2.12	0.16	58cfa836e4b0c9d6adf6fbf5	UNCID_1657816.2D1871C3-4AD4-4AF6-8E36-125A385CC899.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T1-01A	97D0E1BB-1459-4124-B25A-48195F2AD8B5	Primary Tumor	Illumina HiSeq	A2E02BD7-CA89-4A7A-B84A-2B359E9A269C	Thyroid	38.0	62114ABF-0F25-4521-9CF2-CA591F931B4F	2D1871C3-4AD4-4AF6-8E36-125A385CC899	TCGA-EL-A3T1-01A-11R-A22L-07	HG19	TCGA-EL-A3T1	TCGA-THCA		s12456	University of North Carolina	MD Anderson	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22L-07	True
13767.58cfa832e4b0c9d6adf6d7e6	58cfa832e4b0c9d6adf6d7e6	UNCID_1031684.d16a7dea-99ca-455e-80c7-4f182b25d382.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1031684.d16a7dea-99ca-455e-80c7-4f182b25d382.sorted_genome_alignments	UNCID_1031684.d16a7dea-99ca-455e-80c7-4f182b25d382.sorted_genome_alignments.bam	48.2	1.7	0.15	58cfa832e4b0c9d6adf6d7e6	UNCID_1031684.d16a7dea-99ca-455e-80c7-4f182b25d382.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-7142-11A	37A0AB12-44AF-4815-B7CC-961D44851470	Solid Tissue Normal	Illumina HiSeq	35C0597E-011A-4487-9AC7-820365DB7E4E	Lung	59.0	8B0C5F64-54DF-47B2-8147-2E89520889BC	D16A7DEA-99CA-455E-80C7-4F182B25D382	TCGA-77-7142-11A-01R-2045-07	HG19	TCGA-77-7142	TCGA-LUSC		s10168	University of North Carolina	Prince Charles Hospital	Australia	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2045-07	True
13722.58cfa82ee4b0c9d6adf6aee7	58cfa82ee4b0c9d6adf6aee7	TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted	TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted.bam	182.7	1.9	0.16	58cfa82ee4b0c9d6adf6aee7	TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4410-01A	D28E465C-E553-4C53-8BB7-3D8199B9A8A5	Primary Tumor	Illumina HiSeq	bdcc8e9a-8d27-4167-ae6f-3c41b38c6c51	Lung	62.0	F8961F5C-E28B-44A2-8E4E-B5759FE2D849	51E2038A-2D9D-481D-A3B6-D5D5D6B33E4F	TCGA-05-4410-01A-21D-1853-02	HG19_Broad_variant	TCGA-05-4410	TCGA-LUAD		s10773	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	1853-02	True
13767.58cfa835e4b0c9d6adf6ef06	58cfa835e4b0c9d6adf6ef06	UNCID_1474278.41836F0E-F807-4AFA-AE39-C0EB16FA6B54.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1474278.41836F0E-F807-4AFA-AE39-C0EB16FA6B54.sorted_genome_alignments	UNCID_1474278.41836F0E-F807-4AFA-AE39-C0EB16FA6B54.sorted_genome_alignments.bam	33.23	1.84	0.16	58cfa835e4b0c9d6adf6ef06	UNCID_1474278.41836F0E-F807-4AFA-AE39-C0EB16FA6B54.sorted_genome_alignments.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SN-01A	0FB043D3-D86B-4CD8-8C01-9E2B3E965BB0	Primary Tumor	Illumina HiSeq	3A822CC6-01A9-46BB-B217-FFE6E4BD4660	Bladder	79.0	127892ED-8A7A-41CB-8ABE-353E09E6D327	41836F0E-F807-4AFA-AE39-C0EB16FA6B54	TCGA-FD-A3SN-01A-12R-A22U-07	HG19	TCGA-FD-A3SN	TCGA-BLCA		s3335	University of North Carolina	BLN - University Of Chicago	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A22U-07	True
13722.58cfa82ee4b0c9d6adf6ad2c	58cfa82ee4b0c9d6adf6ad2c	G49538.TCGA-14-1402-10A-01D-1493-08.3.filtered.	WGS	G49538.TCGA-14-1402-10A-01D-1493-08.3	G49538.TCGA-14-1402-10A-01D-1493-08.3.bam	133.3	1.9	0.05	58cfa82ee4b0c9d6adf6ad2c	G49538.TCGA-14-1402-10A-01D-1493-08.3.bam	Dead	FEMALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-14-1402-10A	BF339349-062F-4EA9-A0B2-D87D3A21099E	Blood Derived Normal	Illumina HiSeq	b83634d5-24f0-480f-8719-3fa10ee45090	Brain	58.0	5FDA351B-DFA5-4DBB-825A-8A7EC84ECAED	0D9BBE68-41A0-488A-B5EE-8EDBB6DCFD63	TCGA-14-1402-10A-01D-1493-08	HG19_Broad_variant	TCGA-14-1402	TCGA-GBM	975.0	s14174	Broad Institute of MIT and Harvard	Emory University	None	NO			Untreated primary (de novo) GBM		1493-08	False
13767.58cfa83be4b0c9d6adf7258b	58cfa83be4b0c9d6adf7258b	UNCID_2667315.ceba19ee-6da0-4917-a4ba-e9bd20ad7f10.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2667315.ceba19ee-6da0-4917-a4ba-e9bd20ad7f10.sorted_genome_alignments	UNCID_2667315.ceba19ee-6da0-4917-a4ba-e9bd20ad7f10.sorted_genome_alignments.bam	65.56	1.8	0.16	58cfa83be4b0c9d6adf7258b	UNCID_2667315.ceba19ee-6da0-4917-a4ba-e9bd20ad7f10.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A05W-01A	87E44856-EB9A-475F-96B1-047B7F77B0DA	Primary Tumor	Illumina HiSeq	C92C53F5-3A86-48A4-B236-63ADE1F91374	Uterus	60.0	DBDF67E1-E4C2-499C-B701-F1F322242E84	CEBA19EE-6DA0-4917-A4BA-E9BD20AD7F10	TCGA-AX-A05W-01A-21R-A466-07	HG19	TCGA-AX-A05W	TCGA-UCEC		s4551	University of North Carolina	Gynecologic Oncology Group	None	NO			Endometrioid endometrial adenocarcinoma		A466-07	False
13722.58cfa831e4b0c9d6adf6c64e	58cfa831e4b0c9d6adf6c64e	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.bam	215.7	1.9	0.14	58cfa831e4b0c9d6adf6c64e	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4741-01A	277B02E9-DED5-4980-845D-AF53690000AC	Primary Tumor	Illumina HiSeq	cd19ee2f-be9d-446a-9045-e7bfcafb49aa	Head and Neck	75.0	03C9108A-5139-4BAC-9641-C7DBBEDEF420	FAA30C0B-E008-4313-A2AB-1D641F98E2B9	TCGA-CN-4741-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4741	TCGA-HNSC		s15760	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IV	1431-02	True
13767.58cfa82ee4b0c9d6adf6a7ac	58cfa82ee4b0c9d6adf6a7ac	G17782.TCGA-26-5136-01B-01R-1850-01.4.filtered.	RNA-Seq	G17782.TCGA-26-5136-01B-01R-1850-01.4	G17782.TCGA-26-5136-01B-01R-1850-01.4.bam	141.7	1.8	0.16	58cfa82ee4b0c9d6adf6a7ac	G17782.TCGA-26-5136-01B-01R-1850-01.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-26-5136-01B	34F216FB-09DC-48AF-9E09-7D12CC07C1F7	Primary Tumor	Illumina HiSeq	99A64C80-DA3A-4218-A7FF-602880C6205F	Brain	78.0	7CC02E7F-2000-42B7-90F5-5CB00CA33D42	39B5A7B5-E2EC-442D-94C4-BA938EE79B97	TCGA-26-5136-01B-01R-1850-01	HG19_Broad_variant	TCGA-26-5136	TCGA-GBM		s13941	Broad Institute of MIT and Harvard	University of Florida	None	NO			Untreated primary (de novo) GBM		1850-01	True
13767.58cfa837e4b0c9d6adf7010d	58cfa837e4b0c9d6adf7010d	UNCID_1874153.a57dad4d-e09e-4ad2-9db1-1fea79435706.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1874153.a57dad4d-e09e-4ad2-9db1-1fea79435706.sorted_genome_alignments	UNCID_1874153.a57dad4d-e09e-4ad2-9db1-1fea79435706.sorted_genome_alignments.bam	46.2	1.8	0.15	58cfa837e4b0c9d6adf7010d	UNCID_1874153.a57dad4d-e09e-4ad2-9db1-1fea79435706.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4323-01A	C59D90A6-9CDA-426D-B8EA-41F0A87033D5	Primary Tumor	Illumina HiSeq	B0D78199-B4A8-4B45-9CF5-E3CEEB983AC9	Colorectal	37.0	1CD9614D-C2EB-4146-A4FF-ADEFCDAD7315	A57DAD4D-E09E-4AD2-9DB1-1FEA79435706	TCGA-AZ-4323-01A-21R-1839-07	HG19	TCGA-AZ-4323	TCGA-COAD	43.0	s13611	University of North Carolina	University of Pittsburgh	None	NO	T4	N2	Colon Adenocarcinoma	Stage IV	1839-07	True
13722.58cfa831e4b0c9d6adf6c956	58cfa831e4b0c9d6adf6c956	TCGA-DJ-A1QQ-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DJ-A1QQ-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_7_rg.sorted	TCGA-DJ-A1QQ-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_7_rg.sorted.bam	25.11	0.18	0.16	58cfa831e4b0c9d6adf6c956	TCGA-DJ-A1QQ-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_7_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QQ-10A	99EF2FEC-5A3C-4E42-8F78-7EAF9877E26D	Blood Derived Normal	Illumina HiSeq	90c167bf-1373-46c1-bb08-0bdd5f44a2a4	Thyroid	43.0	3BBBC8D3-799A-4D4E-A43C-E7A8B449492A	C8A4F7A1-2E2F-4485-8201-9CB104D276E8	TCGA-DJ-A1QQ-10A-01D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QQ	TCGA-THCA		s12516	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	True
13767.58cfa835e4b0c9d6adf6ec64	58cfa835e4b0c9d6adf6ec64	UNCID_1322541.ff7a84e6-f49c-4832-9e60-7d64cbbf7c2c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1322541.ff7a84e6-f49c-4832-9e60-7d64cbbf7c2c.sorted_genome_alignments	UNCID_1322541.ff7a84e6-f49c-4832-9e60-7d64cbbf7c2c.sorted_genome_alignments.bam	27.11	1.79	0.17	58cfa835e4b0c9d6adf6ec64	UNCID_1322541.ff7a84e6-f49c-4832-9e60-7d64cbbf7c2c.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3CP-01A	3585DDAB-FE5E-4A5A-92C7-3CBAFF52AF57	Primary Tumor	Illumina HiSeq	2E4156DB-7AC3-43CB-A3D5-11633AB34896	Thyroid	50.0	309937A5-20BC-459F-B0F7-7A2428005561	FF7A84E6-F49C-4832-9E60-7D64CBBF7C2C	TCGA-EL-A3CP-01A-11R-A19O-07	HG19	TCGA-EL-A3CP	TCGA-THCA		s12419	University of North Carolina	MD Anderson	United States	NO	T1	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		A19O-07	True
13767.58cfa832e4b0c9d6adf6d21e	58cfa832e4b0c9d6adf6d21e	TCGA-IN-A6RR-01A-12R-A32D-31_rnaseq.filtered.	RNA-Seq	TCGA-IN-A6RR-01A-12R-A32D-31_rnaseq	TCGA-IN-A6RR-01A-12R-A32D-31_rnaseq.bam	31.58	1.87	0.17	58cfa832e4b0c9d6adf6d21e	TCGA-IN-A6RR-01A-12R-A32D-31_rnaseq.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-IN-A6RR-01A	7AB5A708-803F-4D8C-9B25-645F06851A26	Primary Tumor	Illumina HiSeq	12C35546-FA6F-405E-A8A1-810B7616F66B	Stomach	84.0	236E195A-1563-43DF-BA4B-D42F803B98D3	6299A2EF-F97A-429A-9FE6-3C5B01A9200F	TCGA-IN-A6RR-01A-12R-A32D-31	GRCh37-lite	TCGA-IN-A6RR	TCGA-STAD	205.0	s15264	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	United States	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	A32D-31	False
13767.58cfa839e4b0c9d6adf7149c	58cfa839e4b0c9d6adf7149c	UNCID_2314856.b9eab491-6fa4-4eee-a2f6-ef923935845e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2314856.b9eab491-6fa4-4eee-a2f6-ef923935845e.sorted_genome_alignments	UNCID_2314856.b9eab491-6fa4-4eee-a2f6-ef923935845e.sorted_genome_alignments.bam	20.32	2.24	0.18	58cfa839e4b0c9d6adf7149c	UNCID_2314856.b9eab491-6fa4-4eee-a2f6-ef923935845e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DH-A7UR-01A	B37ABDC8-B9E3-4F1A-B16D-2E59442DB335	Primary Tumor	Illumina HiSeq	78842F47-9750-438D-B502-EB88F5ED3336	Brain	59.0	3F4D540A-5D6D-4C80-BC3F-32A679BD1302	B9EAB491-6FA4-4EEE-A2F6-EF923935845E	TCGA-DH-A7UR-01A-11R-A33Z-07	HG19	TCGA-DH-A7UR	TCGA-LGG		s8472	University of North Carolina	University of Florida	United States	NO			Oligodendroglioma		A33Z-07	True
13767.58cfa837e4b0c9d6adf7006e	58cfa837e4b0c9d6adf7006e	UNCID_1898975.93ec9ca7-cb63-48a3-809f-6222f506fc07.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1898975.93ec9ca7-cb63-48a3-809f-6222f506fc07.sorted_genome_alignments	UNCID_1898975.93ec9ca7-cb63-48a3-809f-6222f506fc07.sorted_genome_alignments.bam	338.4	1.8	0.15	58cfa837e4b0c9d6adf7006e	UNCID_1898975.93ec9ca7-cb63-48a3-809f-6222f506fc07.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-DC-4749-01A	BF65C2CD-8348-488F-8485-9196BA42D17E	Primary Tumor	Illumina HiSeq	9058F18B-50A4-43C1-A772-4BED0FCD916B	Colorectal	57.0	9C11C1D9-288D-4928-8D0D-AEFBF063BC3D	93EC9CA7-CB63-48A3-809F-6222F506FC07	TCGA-DC-4749-01A-01R-1736-07	HG19	TCGA-DC-4749	TCGA-READ		s2251	University of North Carolina	MSKCC	None	NO	T2	N0	Rectal Adenocarcinoma	Stage I	1736-07	True
13722.58cfa83ce4b0c9d6adf73168	58cfa83ce4b0c9d6adf73168	f31cfe2ad0117626a14c5b0dea28c02d.filtered.	WGS	f31cfe2ad0117626a14c5b0dea28c02d	f31cfe2ad0117626a14c5b0dea28c02d.bam	91.48	2.08	0.08	58cfa83ce4b0c9d6adf73168	f31cfe2ad0117626a14c5b0dea28c02d.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LF-01A	748E38B1-2EAD-4A0A-8881-D640617B856B	Primary Tumor	Illumina HiSeq	edd786b0-5020-470f-a33f-28c99bef68c0	Uterus	82.0	902E2DD8-81E5-4949-A57B-92B3EFD86C63	460F7427-EBCF-404B-9E9E-E0278D0BCA95	TCGA-AP-A0LF-01A-11D-A122-09	GRCh37-lite	TCGA-AP-A0LF	TCGA-UCEC		s5374	Washington University School of Medicine	MSKCC	None	NO			Endometrioid endometrial adenocarcinoma		A122-09	True
13767.58cfa838e4b0c9d6adf708dc	58cfa838e4b0c9d6adf708dc	UNCID_2061749.fef94ae2-4cd8-4e24-9220-3fa17ef1230a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2061749.fef94ae2-4cd8-4e24-9220-3fa17ef1230a.sorted_genome_alignments	UNCID_2061749.fef94ae2-4cd8-4e24-9220-3fa17ef1230a.sorted_genome_alignments.bam	63.63	1.92	0.16	58cfa838e4b0c9d6adf708dc	UNCID_2061749.fef94ae2-4cd8-4e24-9220-3fa17ef1230a.sorted_genome_alignments.bam	Alive	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-JW-A5VJ-01A	F0BB0D18-1190-463D-A0BA-839C2C776794	Primary Tumor	Illumina HiSeq	2F03E51A-858E-486F-92B0-300368D4A67A	Cervix	56.0	0FC6E478-1FA9-430C-96EA-B14FB2101181	FEF94AE2-4CD8-4E24-9220-3FA17EF1230A	TCGA-JW-A5VJ-01A-11R-A28H-07	HG19	TCGA-JW-A5VJ	TCGA-CESC		s1436	University of North Carolina	BLN - Baylor	United States	NO	T2b	NX	Cervical Squamous Cell Carcinoma		A28H-07	True
13767.58cfa839e4b0c9d6adf71018	58cfa839e4b0c9d6adf71018	UNCID_2232181.ea6f7f61-d66c-47c9-a67a-e0d65af36815.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2232181.ea6f7f61-d66c-47c9-a67a-e0d65af36815.sorted_genome_alignments	UNCID_2232181.ea6f7f61-d66c-47c9-a67a-e0d65af36815.sorted_genome_alignments.bam	67.52	1.9	0.17	58cfa839e4b0c9d6adf71018	UNCID_2232181.ea6f7f61-d66c-47c9-a67a-e0d65af36815.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A73F-01A	870C86E7-D6E1-4F9D-BB0B-BD1C66D6BCDE	Primary Tumor	Illumina HiSeq	C2CDB9F0-04BC-48BC-A3AA-EC749D7E0514	Liver	77.0	A15CF382-8456-4096-96A6-F211DEA6BA78	EA6F7F61-D66C-47C9-A67A-E0D65AF36815	TCGA-DD-A73F-01A-11R-A32O-07	HG19	TCGA-DD-A73F	TCGA-LIHC		s16729	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A32O-07	True
13767.58cfa83be4b0c9d6adf7200e	58cfa83be4b0c9d6adf7200e	UNCID_2553062.abd6f1e5-2772-4baf-809b-58209f8d525f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2553062.abd6f1e5-2772-4baf-809b-58209f8d525f.sorted_genome_alignments	UNCID_2553062.abd6f1e5-2772-4baf-809b-58209f8d525f.sorted_genome_alignments.bam	15.28	1.8	0.16	58cfa83be4b0c9d6adf7200e	UNCID_2553062.abd6f1e5-2772-4baf-809b-58209f8d525f.sorted_genome_alignments.bam	Alive	MALE	WHITE		Mesothelioma	Aligned reads	TCGA-3U-A98D-01A	C5D4D4B4-2C9E-4865-8860-68327356D461	Primary Tumor	Illumina HiSeq	BCAB4B74-CCB7-4594-9E22-36A3BAA8667E	Mesothelium	80.0	51B1915D-B527-4248-862A-C4596F7C8B6C	ABD6F1E5-2772-4BAF-809B-58209F8D525F	TCGA-3U-A98D-01A-12R-A40A-07	HG19	TCGA-3U-A98D	TCGA-MESO		s429	University of North Carolina	University of Chicago	United States	NO	T2	N2		Stage III	A40A-07	True
13767.58cfa834e4b0c9d6adf6e5ea	58cfa834e4b0c9d6adf6e5ea	UNCID_1203137.13e20aec-d506-4fa0-a6e1-121e76dcedc4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1203137.13e20aec-d506-4fa0-a6e1-121e76dcedc4.sorted_genome_alignments	UNCID_1203137.13e20aec-d506-4fa0-a6e1-121e76dcedc4.sorted_genome_alignments.bam	59.2	1.8	0.15	58cfa834e4b0c9d6adf6e5ea	UNCID_1203137.13e20aec-d506-4fa0-a6e1-121e76dcedc4.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-6972-01A	C4D1E105-28B7-48DF-ABEF-FBE09782FDB2	Primary Tumor	Illumina HiSeq	2527E3F8-E2F6-48E9-A749-30F6D3DBB509	Lung	72.0	38C83B40-FBA4-48D4-AD6E-93768CB6139F	13E20AEC-D506-4FA0-A6E1-121E76DCEDC4	TCGA-55-6972-01A-11R-1949-07	HG19	TCGA-55-6972	TCGA-LUAD		s10935	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Lung Papillary Adenocarcinoma	Stage I	1949-07	True
13722.58cfa832e4b0c9d6adf6cf9c	58cfa832e4b0c9d6adf6cf9c	TCGA-GC-A3RD-10B-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_8_rg.sorted.filtered.	WGS	TCGA-GC-A3RD-10B-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_8_rg.sorted	TCGA-GC-A3RD-10B-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_8_rg.sorted.bam	64.89		0.15	58cfa832e4b0c9d6adf6cf9c	TCGA-GC-A3RD-10B-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3RD-10B	6A2155B3-915C-41B1-B730-32E55E0C1FBD	Blood Derived Normal	Illumina HiSeq	b81dceea-a960-49fc-9cfc-00d61570a8b0	Bladder	83.0	623992FA-E316-4AEF-9B0E-6C7EAA5121A5	E5267C53-6EEA-47F5-A7E2-EC228507E6E1	TCGA-GC-A3RD-10B-01D-A233-26	HG19_Broad_variant	TCGA-GC-A3RD	TCGA-BLCA		s2728	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	True
13767.58cfa835e4b0c9d6adf6ee1e	58cfa835e4b0c9d6adf6ee1e	UNCID_1362076.27357b4d-5d44-4c5e-bb80-0d5f68c3db8e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1362076.27357b4d-5d44-4c5e-bb80-0d5f68c3db8e.sorted_genome_alignments	UNCID_1362076.27357b4d-5d44-4c5e-bb80-0d5f68c3db8e.sorted_genome_alignments.bam	233.2	1.8	0.15	58cfa835e4b0c9d6adf6ee1e	UNCID_1362076.27357b4d-5d44-4c5e-bb80-0d5f68c3db8e.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6366-01A	DF3ABB97-C790-4FF6-A726-6645B3058D72	Primary Tumor	Illumina HiSeq	FB435267-8316-48B4-A0CB-9A391DB49BE0	Prostate	61.0	34D7178F-CFC8-463A-9E04-F0BB0E3E5154	27357B4D-5D44-4C5E-BB80-0D5F68C3DB8E	TCGA-G9-6366-01A-11R-2118-07	HG19	TCGA-G9-6366	TCGA-PRAD		s3836	University of North Carolina	Roswell Park	United States	NO	T3b		Prostate Adenocarcinoma Acinar Type		2118-07	True
13767.58cfa836e4b0c9d6adf6fabe	58cfa836e4b0c9d6adf6fabe	UNCID_1656884.6434CAA0-3816-472B-9A2A-6238C10131F7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1656884.6434CAA0-3816-472B-9A2A-6238C10131F7.sorted_genome_alignments	UNCID_1656884.6434CAA0-3816-472B-9A2A-6238C10131F7.sorted_genome_alignments.bam	20.1	2.12	0.15	58cfa836e4b0c9d6adf6fabe	UNCID_1656884.6434CAA0-3816-472B-9A2A-6238C10131F7.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T8-01A	989E9202-C08E-4BBF-85B3-1E278A475CB7	Primary Tumor	Illumina HiSeq	9EEF292A-32CF-4E3E-BB0F-00E24A47E790	Thyroid	36.0	6961DFA4-A986-4ED0-96DD-675177A4FEE2	6434CAA0-3816-472B-9A2A-6238C10131F7	TCGA-EL-A3T8-01A-21R-A22L-07	HG19	TCGA-EL-A3T8	TCGA-THCA		s12452	University of North Carolina	MD Anderson	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22L-07	True
13722.58cfa82de4b0c9d6adf6a490	58cfa82de4b0c9d6adf6a490	1df2bf9cb438141bbe76b4a18e708e91.filtered.	WGS	1df2bf9cb438141bbe76b4a18e708e91	1df2bf9cb438141bbe76b4a18e708e91.bam	23.68	2.05	0.08	58cfa82de4b0c9d6adf6a490	1df2bf9cb438141bbe76b4a18e708e91.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A11G-10A	D2AA7D70-A25F-4A9E-9D52-37E372461824	Blood Derived Normal	Illumina HiSeq	92b1160b-6674-4c07-a4bf-560479bf5567	Uterus	71.0	4AA60E62-A361-4BEE-AC7E-97CC480C9985	BAC2CF85-BE6D-4D68-91BF-83DAAB5EA3A6	TCGA-B5-A11G-10A-01D-A122-09	GRCh37-lite	TCGA-B5-A11G	TCGA-UCEC		s5188	Washington University School of Medicine	Duke	United States	NO			Endometrioid endometrial adenocarcinoma		A122-09	True
13767.58cfa836e4b0c9d6adf6f892	58cfa836e4b0c9d6adf6f892	UNCID_1642737.ce2a4f0a-e77f-446b-9412-432daaf5d351.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1642737.ce2a4f0a-e77f-446b-9412-432daaf5d351.sorted_genome_alignments	UNCID_1642737.ce2a4f0a-e77f-446b-9412-432daaf5d351.sorted_genome_alignments.bam	58.8	1.8	0.16	58cfa836e4b0c9d6adf6f892	UNCID_1642737.ce2a4f0a-e77f-446b-9412-432daaf5d351.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DH-5142-01A	5B744051-7355-4E15-B035-0621E709A5D7	Primary Tumor	Illumina HiSeq	24638C9D-98A1-4E2E-8F8B-737771117D99	Brain	29.0	9DBFE00B-FAE8-4765-BF20-4F3CC45880E9	CE2A4F0A-E77F-446B-9412-432DAAF5D351	TCGA-DH-5142-01A-01R-1470-07	HG19	TCGA-DH-5142	TCGA-LGG		s8616	University of North Carolina	University of Florida	United States	NO			Astrocytoma		1470-07	True
13767.58cfa833e4b0c9d6adf6d8b6	58cfa833e4b0c9d6adf6d8b6	UNCID_1089942.2d12d6c7-a3b8-4a0e-a501-a291f1e86eb9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1089942.2d12d6c7-a3b8-4a0e-a501-a291f1e86eb9.sorted_genome_alignments	UNCID_1089942.2d12d6c7-a3b8-4a0e-a501-a291f1e86eb9.sorted_genome_alignments.bam	102.3	1.7	0.15	58cfa833e4b0c9d6adf6d8b6	UNCID_1089942.2d12d6c7-a3b8-4a0e-a501-a291f1e86eb9.sorted_genome_alignments.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5183-01A	64AA0DD1-A80E-401E-96DF-60D121D2CBEC	Primary Tumor	Illumina HiSeq	BAC0298C-0271-48C8-9A80-30A383FC1618	Kidney	57.0	583F4290-C8CF-4D90-882D-25E459A12C26	2D12D6C7-A3B8-4A0E-A501-A291F1E86EB9	TCGA-BP-5183-01A-01R-1426-07	HG19	TCGA-BP-5183	TCGA-KIRC		s9311	University of North Carolina	MSKCC	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1426-07	True
13767.58cfa834e4b0c9d6adf6e6bc	58cfa834e4b0c9d6adf6e6bc	UNCID_1190415.3178484a-1651-4e2a-95ec-5c3ff91bf1f8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1190415.3178484a-1651-4e2a-95ec-5c3ff91bf1f8.sorted_genome_alignments	UNCID_1190415.3178484a-1651-4e2a-95ec-5c3ff91bf1f8.sorted_genome_alignments.bam	67.3	1.8	0.15	58cfa834e4b0c9d6adf6e6bc	UNCID_1190415.3178484a-1651-4e2a-95ec-5c3ff91bf1f8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-5581-11A	2D0F6D4F-ACB9-4B45-A69D-C9A3F68C3732	Solid Tissue Normal	Illumina HiSeq	FFB9321A-0BFD-427C-B9AC-A5D399A75378	Kidney	44.0	F44454F4-282B-41F6-B242-319903D3C9E5	3178484A-1651-4E2A-95EC-5C3FF91BF1F8	TCGA-CW-5581-11A-01R-1541-07	HG19	TCGA-CW-5581	TCGA-KIRC		s9213	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa82fe4b0c9d6adf6b21c	58cfa82fe4b0c9d6adf6b21c	TCGA-13-1499-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-1499-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-13-1499-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	359.0	1.8	0.15	58cfa82fe4b0c9d6adf6b21c	TCGA-13-1499-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1499-01A	B25570ED-BACA-4E3F-87C6-2EF18119BA49	Primary Tumor	Illumina HiSeq	CC56CB6F-6EC6-49BD-BC93-72953EE81972	Ovary	56.0	16220EED-5BA3-4067-9DCF-D7327A44C05D	1F677D4C-6FEB-4A3A-9F12-BA1D43920A80	TCGA-13-1499-01A-01R-1565-13	GRCh37-lite	TCGA-13-1499	TCGA-OV		s18102	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13722.58cfa830e4b0c9d6adf6befa	58cfa830e4b0c9d6adf6befa	TCGA-BJ-A28W-10A-01D-A16N_120805_SN208_0421_AC11HPACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BJ-A28W-10A-01D-A16N_120805_SN208_0421_AC11HPACXX_s_4_rg.sorted	TCGA-BJ-A28W-10A-01D-A16N_120805_SN208_0421_AC11HPACXX_s_4_rg.sorted.bam	62.61	1.87	0.17	58cfa830e4b0c9d6adf6befa	TCGA-BJ-A28W-10A-01D-A16N_120805_SN208_0421_AC11HPACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28W-10A	A6D37F61-BECA-46EA-A59A-62257475AC77	Blood Derived Normal	Illumina HiSeq	341f9656-c88d-4835-910f-e6e4ed9b7ad3	Thyroid	32.0	5961BC0B-0B25-426E-8318-6E04406630A1	1038A255-2A5F-4804-BCFB-F9E6701B5BFB	TCGA-BJ-A28W-10A-01D-A16N-02	HG19_Broad_variant	TCGA-BJ-A28W	TCGA-THCA		s12631	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	True
13722.58cfa832e4b0c9d6adf6d440	58cfa832e4b0c9d6adf6d440	TCGA-V4-A9F0-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_8_rg.sorted.filtered.	WGS	TCGA-V4-A9F0-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_8_rg.sorted	TCGA-V4-A9F0-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_8_rg.sorted.bam	14.63		0.14	58cfa832e4b0c9d6adf6d440	TCGA-V4-A9F0-10A-01D-A40E_140714_SN1440_0192_AC3RUUACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F0-10A	92FCA97D-6123-46A7-9C34-7A6F877FE612	Blood Derived Normal	Illumina HiSeq	f1cef754-8998-4ec4-a0df-7dc28a3c599e	Eye	59.0	0344ECE0-33DF-40B0-B120-F29C8F4290F0	0D77B5D5-25EC-4411-B800-26FBF24A4418	TCGA-V4-A9F0-10A-01D-A40E-26	HG19_Broad_variant	TCGA-V4-A9F0	TCGA-UVM		s228	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4b	N0		Stage III	A40E-26	True
13767.58cfa833e4b0c9d6adf6dec6	58cfa833e4b0c9d6adf6dec6	UNCID_1095171.8c957960-d5a3-4d07-a3aa-6c13b16fff0e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1095171.8c957960-d5a3-4d07-a3aa-6c13b16fff0e.sorted_genome_alignments	UNCID_1095171.8c957960-d5a3-4d07-a3aa-6c13b16fff0e.sorted_genome_alignments.bam	97.2	1.7	0.15	58cfa833e4b0c9d6adf6dec6	UNCID_1095171.8c957960-d5a3-4d07-a3aa-6c13b16fff0e.sorted_genome_alignments.bam	Dead	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-78-7147-01A	E7D30BC2-42E8-49C5-A5B3-9F58411B007A	Primary Tumor	Illumina HiSeq	D2FD91FF-EFAC-486D-9D74-1C7B996FD0B3	Lung	67.0	5D0E7B83-5577-450A-B1A5-59CA03FC3BC5	8C957960-D5A3-4D07-A3AA-6C13B16FFF0E	TCGA-78-7147-01A-11R-2039-07	HG19	TCGA-78-7147	TCGA-LUAD	586.0	s11469	University of North Carolina	Prince Charles Hospital	Australia	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	2039-07	True
13722.58cfa831e4b0c9d6adf6c62e	58cfa831e4b0c9d6adf6c62e	TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted	TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted.bam	112.4	1.9	0.13	58cfa831e4b0c9d6adf6c62e	TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5361-10A	044579EF-16A6-4F00-B951-EDC423D8A14F	Blood Derived Normal	Illumina HiSeq	34ee605a-e704-413f-91ff-81dbaef22fb7	Head and Neck	80.0	5B2581D8-C087-4CAA-B9CE-BC0168FBFEFA	2B747573-FEA7-4404-937E-5D7D74772776	TCGA-CN-5361-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5361	TCGA-HNSC		s15624	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2a	Head and Neck Squamous Cell Carcinoma	Stage IV	1431-02	True
13722.58cfa832e4b0c9d6adf6ce6c	58cfa832e4b0c9d6adf6ce6c	TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina	TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina.bam	43.11		0.08	58cfa832e4b0c9d6adf6ce6c	TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A3CK-01A	39EB1DB0-2722-4AF4-8254-D0E10256C64D	Primary Tumor	Illumina HiSeq	210fd1fb-0012-410b-bfc8-bf53607bfe12	Liver	61.0	2F38C711-639F-4611-9076-DC99A1DB8239	1127B561-EA40-4D5E-95DF-DAA0A5EBC1E4	TCGA-G3-A3CK-01A-11D-A20W-10	GRCh37-lite	TCGA-G3-A3CK	TCGA-LIHC		s16988	Baylor College of Medicine	Alberta Health Services	Canada	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A20W-10	False
13767.58cfa83ce4b0c9d6adf72f67	58cfa83ce4b0c9d6adf72f67	_1_TCGA-D7-6528-01A-11R-1802-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-D7-6528-01A-11R-1802-13_rnaseq	_1_TCGA-D7-6528-01A-11R-1802-13_rnaseq.bam	252.2	1.8	0.14	58cfa83ce4b0c9d6adf72f67	_1_TCGA-D7-6528-01A-11R-1802-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6528-01A	35496E4E-598F-4FFC-B11E-8EDAEB676079	Primary Tumor	Illumina HiSeq	765B93F0-8AD1-46BD-8B50-E073AE047F86	Stomach	70.0	DF817250-9A2C-42E8-AD90-0D9E13FE37B3	8B425D92-11E6-4DCE-914E-5A2F00603719	TCGA-D7-6528-01A-11R-1802-13	GRCh37-lite	TCGA-D7-6528	TCGA-STAD		s15288	Canada's Michael Smith Genome Sciences Centre	Greater Poland Cancer Center	Poland	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage I	1802-13	True
13722.58cfa830e4b0c9d6adf6c126	58cfa830e4b0c9d6adf6c126	TCGA-BS-A0TJ-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BS-A0TJ-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_6_rg.sorted	TCGA-BS-A0TJ-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_6_rg.sorted.bam	11.22	1.88	0.16	58cfa830e4b0c9d6adf6c126	TCGA-BS-A0TJ-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_6_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TJ-10A	F74DA4C6-4291-46D2-ABD4-7D7F6EF03B00	Blood Derived Normal	Illumina HiSeq	5cdf9afa-86d9-4e53-a76a-8223c971f668	Uterus	59.0	B3FA5912-FFE9-4CC6-A973-FDF611415B50	E127BE60-BC96-4B16-AADA-98C546F2FE78	TCGA-BS-A0TJ-10A-01D-A101-02	HG19_Broad_variant	TCGA-BS-A0TJ	TCGA-UCEC		s4609	Harvard Medical School	University of Hawaii	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa82fe4b0c9d6adf6b4be	58cfa82fe4b0c9d6adf6b4be	TCGA-24-1603-01A-01R-1566-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-1603-01A-01R-1566-13_GRCh37-lite_rnaseq	TCGA-24-1603-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	522.0	1.8	0.14	58cfa82fe4b0c9d6adf6b4be	TCGA-24-1603-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1603-01A	19427350-619B-4B9C-A3BA-37F667BB2843	Primary Tumor	Illumina HiSeq	F7319145-3BBC-4E20-9FFE-14E6C0C1D23D	Ovary	53.0	BB14A720-4899-48D9-A57B-E1FD2AA9D8EC	F4187F4F-9C52-4065-818B-C884183A5A70	TCGA-24-1603-01A-01R-1566-13	GRCh37-lite	TCGA-24-1603	TCGA-OV	2742.0	s17676	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa839e4b0c9d6adf711e0	58cfa839e4b0c9d6adf711e0	UNCID_2264077.a8ed4489-1005-488c-9e8e-274b2cfd8a83.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2264077.a8ed4489-1005-488c-9e8e-274b2cfd8a83.sorted_genome_alignments	UNCID_2264077.a8ed4489-1005-488c-9e8e-274b2cfd8a83.sorted_genome_alignments.bam	456.2	1.8	0.14	58cfa839e4b0c9d6adf711e0	UNCID_2264077.a8ed4489-1005-488c-9e8e-274b2cfd8a83.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-G8-6906-01A	3F5A897D-1EAA-4D4C-8324-27AC07C90927	Primary Tumor	Illumina HiSeq	23429DE0-DED8-4376-A251-A3A5BC0DEE0D	Lymph Nodes	58.0	857DC870-58B4-41AA-A0F1-A39DE29B924B	A8ED4489-1005-488C-9E8E-274B2CFD8A83	TCGA-G8-6906-01A-11R-2213-07	HG19	TCGA-G8-6906	TCGA-DLBC	6425.0	s1140	University of North Carolina	Roswell Park	United States	NO			Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)		2213-07	True
13767.58cfa82fe4b0c9d6adf6b4e0	58cfa82fe4b0c9d6adf6b4e0	TCGA-25-1324-01A-01R-1565-13_rnaseq.filtered.	RNA-Seq	TCGA-25-1324-01A-01R-1565-13_rnaseq	TCGA-25-1324-01A-01R-1565-13_rnaseq.bam	507.0	1.8	0.15	58cfa82fe4b0c9d6adf6b4e0	TCGA-25-1324-01A-01R-1565-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1324-01A	C73244FD-D486-439F-A94F-FB0BD4E9AC8F	Primary Tumor	Illumina HiSeq	CE13CD72-552E-4544-B258-3F25C8D4CE6E	Ovary	74.0	FEDFB74C-A7CD-4900-BDCB-93BDBD095C89	790C6D79-9F7D-4E9A-89DB-43B26FE16816	TCGA-25-1324-01A-01R-1565-13	NCBI36_BCCAGSC_variant	TCGA-25-1324	TCGA-OV	1035.0	s17523	Canada's Michael Smith Genome Sciences Centre	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa832e4b0c9d6adf6d5c0	58cfa832e4b0c9d6adf6d5c0	TCGA-LN-A7HY-01A-12R-A354-31_rnaseq.filtered.	RNA-Seq	TCGA-LN-A7HY-01A-12R-A354-31_rnaseq	TCGA-LN-A7HY-01A-12R-A354-31_rnaseq.bam	50.6	1.8	0.17	58cfa832e4b0c9d6adf6d5c0	TCGA-LN-A7HY-01A-12R-A354-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A7HY-01A	7A32847F-69BB-4592-8FEB-CFD5D355ADA9	Primary Tumor	Illumina HiSeq	BC040672-8A4A-40C5-8E4E-138BB8EE1A61	Esophagus	50.0	FBFA044C-A1DC-42E4-976D-E43B0EE59FC7	FDA5CA3B-23B2-476F-BAEA-1881B52929AB	TCGA-LN-A7HY-01A-12R-A354-31	GRCh37-lite	TCGA-LN-A7HY	TCGA-ESCA		s1884	Canada's Michael Smith Genome Sciences Centre	ILSbio	Vietnam	NO	T3	N1		Stage III	A354-31	True
13722.58cfa82fe4b0c9d6adf6b762	58cfa82fe4b0c9d6adf6b762	TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted	TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted.bam	628.4	1.9	0.15	58cfa82fe4b0c9d6adf6b762	TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-75-5125-01A	205759A6-6391-491B-9857-0080C3A5871E	Primary Tumor	Illumina HiSeq	0a5ee83a-046b-41b4-9551-40372fa70b7d	Lung		73A77977-FAB0-486F-8D15-BE8B30C8808A	02DE68CC-AD50-45FD-BB4D-819D6E0F55F5	TCGA-75-5125-01A-01D-1751-02	HG19_Broad_variant	TCGA-75-5125	TCGA-LUAD		s11362	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1751-02	True
13767.58cfa82ee4b0c9d6adf6a932	58cfa82ee4b0c9d6adf6a932	G17205.TCGA-06-0745-01A-01R-1849-01.2.filtered.	RNA-Seq	G17205.TCGA-06-0745-01A-01R-1849-01.2	G17205.TCGA-06-0745-01A-01R-1849-01.2.bam	37.6	1.95	0.18	58cfa82ee4b0c9d6adf6a932	G17205.TCGA-06-0745-01A-01R-1849-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0745-01A	386B629E-FAB1-4033-B088-45D6EEB4A13E	Primary Tumor	Illumina HiSeq	56C108E3-9E72-4E73-AE20-713947731C9C	Brain	59.0	6EB5B7FF-1797-4C31-AB5B-6DB2B2641C5B	616011AA-5AAD-4078-85A6-E61F98D83363	TCGA-06-0745-01A-01R-1849-01	HG19_Broad_variant	TCGA-06-0745	TCGA-GBM	239.0	s14284	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13767.58cfa832e4b0c9d6adf6d783	58cfa832e4b0c9d6adf6d783	UNCID_1033396.7828187d-3fbc-4139-8546-c6d92fef3e0f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1033396.7828187d-3fbc-4139-8546-c6d92fef3e0f.sorted_genome_alignments	UNCID_1033396.7828187d-3fbc-4139-8546-c6d92fef3e0f.sorted_genome_alignments.bam	132.2		0.14	58cfa832e4b0c9d6adf6d783	UNCID_1033396.7828187d-3fbc-4139-8546-c6d92fef3e0f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-92-7340-01A	86B165C2-D0E6-4A4F-84ED-AA95E3133627	Primary Tumor	Illumina HiSeq	3589B00A-196A-4D1C-A36D-09ACA8901B8E	Lung	45.0	D254D457-F42F-42A1-88FF-1E05158C554E	7828187D-3FBC-4139-8546-C6D92FEF3E0F	TCGA-92-7340-01A-21R-2045-07	HG19	TCGA-92-7340	TCGA-LUSC		s10374	University of North Carolina	Washington University - St. Louis	United States	NO	T2a	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	2045-07	True
13722.58cfa830e4b0c9d6adf6bf5c	58cfa830e4b0c9d6adf6bf5c	TCGA-BR-4292-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BR-4292-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_4_rg.sorted	TCGA-BR-4292-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_4_rg.sorted.bam	193.3	1.9	0.15	58cfa830e4b0c9d6adf6bf5c	TCGA-BR-4292-11A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4292-11A	703D3E86-32F4-44AE-BD88-C02378FC2269	Solid Tissue Normal	Illumina HiSeq	763db891-de7a-4a7f-8608-d70ab806e102	Stomach	73.0	1351C1B9-3E15-4FE6-A8D4-F3376E3561B4	94341BBF-538A-498F-860C-0A5B2F1872AB	TCGA-BR-4292-11A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4292	TCGA-STAD		s14878	Harvard Medical School	Asterand	Russia	NO	T1	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)		1128-02	True
13722.58cfa831e4b0c9d6adf6c8fa	58cfa831e4b0c9d6adf6c8fa	TCGA-CU-A0YO-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CU-A0YO-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_6_rg.sorted	TCGA-CU-A0YO-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_6_rg.sorted.bam	20.75	1.95	0.16	58cfa831e4b0c9d6adf6c8fa	TCGA-CU-A0YO-10A-01D-A10R_120926_SN590_0182_BD1EAGACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YO-10A	4A9EF220-922C-49CF-BBED-D173B214ED31	Blood Derived Normal	Illumina HiSeq	d9b681f1-ebb5-4f97-8585-796e6ae8fb6d	Bladder	84.0	ABD9CFE7-EF6B-4A64-8733-0637581A0FC4	16A7AF6E-660A-49F8-8291-BACDA29FB3E1	TCGA-CU-A0YO-10A-01D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YO	TCGA-BLCA	149.0	s3275	Harvard Medical School	UNC	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A10R-02	True
13767.58cfa83be4b0c9d6adf71fb0	58cfa83be4b0c9d6adf71fb0	UNCID_2542823.8b6e8309-2206-4269-8b92-0f42702cbc3d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2542823.8b6e8309-2206-4269-8b92-0f42702cbc3d.sorted_genome_alignments	UNCID_2542823.8b6e8309-2206-4269-8b92-0f42702cbc3d.sorted_genome_alignments.bam	15.53	1.86	0.18	58cfa83be4b0c9d6adf71fb0	UNCID_2542823.8b6e8309-2206-4269-8b92-0f42702cbc3d.sorted_genome_alignments.bam	Dead	MALE	WHITE		Uveal Melanoma	Aligned reads	TCGA-V4-A9E7-01A	B5C516BA-4785-41DC-BD07-B129D47808DD	Primary Tumor	Illumina HiSeq	EDCAE1FA-D1AF-4DFF-B430-5ECF4A091A10	Eye	76.0	76AF65DC-CCCD-4257-8D05-38334D3110DA	8B6E8309-2206-4269-8B92-0F42702CBC3D	TCGA-V4-A9E7-01A-11R-A405-07	HG19	TCGA-V4-A9E7	TCGA-UVM	415.0	s297	University of North Carolina	Institut Curie	France	NO	T4a	N0		Stage III	A405-07	True
13767.58cfa838e4b0c9d6adf70ca7	58cfa838e4b0c9d6adf70ca7	UNCID_2158037.fee1bb5e-af08-43f5-a313-ebe56ceb6a37.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2158037.fee1bb5e-af08-43f5-a313-ebe56ceb6a37.sorted_genome_alignments	UNCID_2158037.fee1bb5e-af08-43f5-a313-ebe56ceb6a37.sorted_genome_alignments.bam	67.89	1.86	0.18	58cfa838e4b0c9d6adf70ca7	UNCID_2158037.fee1bb5e-af08-43f5-a313-ebe56ceb6a37.sorted_genome_alignments.bam	Alive	MALE		NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E5-A4U1-01A	1C28F311-E0B0-4292-B29A-C6757665A4A4	Primary Tumor	Illumina HiSeq	6016169C-0763-43C8-951D-E33F8AA1BBD5	Bladder	72.0	59E8792A-4A68-419D-B30C-3D16FC42A6CA	FEE1BB5E-AF08-43F5-A313-EBE56CEB6A37	TCGA-E5-A4U1-01A-11R-A31N-07	HG19	TCGA-E5-A4U1	TCGA-BLCA		s3357	University of North Carolina	Roswell Park	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A31N-07	True
13722.58cfa82de4b0c9d6adf6a4ee	58cfa82de4b0c9d6adf6a4ee	2548c39fc92627580ce126914f9e541c.filtered.	WGS	2548c39fc92627580ce126914f9e541c	2548c39fc92627580ce126914f9e541c.bam	10.66	1.96	0.09	58cfa82de4b0c9d6adf6a4ee	2548c39fc92627580ce126914f9e541c.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RU-10B	6956473B-92E5-4069-A26B-B48E280E76F2	Blood Derived Normal	Illumina HiSeq	a29cdc57-52ec-48f1-87d6-5f2a56480a48	Breast	40.0	53CA1040-ECA4-4ACA-B437-EEDEB89062D3	B7759C1C-44BA-4C57-A975-C98EED1A9C76	TCGA-B6-A0RU-10B-01D-A12L-09	GRCh37-lite	TCGA-B6-A0RU	TCGA-BRCA		s6758	Washington University School of Medicine	Duke	United States	NO	T1c	N0 (i-)	Other  specify	Stage I	A12L-09	False
13767.58cfa83be4b0c9d6adf71f62	58cfa83be4b0c9d6adf71f62	UNCID_2544221.9192d03e-87ee-424a-90fa-7e66c3b6abe3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2544221.9192d03e-87ee-424a-90fa-7e66c3b6abe3.sorted_genome_alignments	UNCID_2544221.9192d03e-87ee-424a-90fa-7e66c3b6abe3.sorted_genome_alignments.bam	56.26	1.81	0.16	58cfa83be4b0c9d6adf71f62	UNCID_2544221.9192d03e-87ee-424a-90fa-7e66c3b6abe3.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-AA3C-01A	C04CC413-95B0-4B56-AF55-9596A5EAD4A6	Primary Tumor	Illumina HiSeq	29F12F82-3133-4E4F-8FCB-76FC0D4C280A	Bladder	66.0	83D4E9E9-7910-4686-9ED4-17C7D85127EB	9192D03E-87EE-424A-90FA-7E66C3B6ABE3	TCGA-G2-AA3C-01A-21R-A39I-07	HG19	TCGA-G2-AA3C	TCGA-BLCA	211.0	s3231	University of North Carolina	MD Anderson	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A39I-07	True
13767.58cfa833e4b0c9d6adf6ddf8	58cfa833e4b0c9d6adf6ddf8	UNCID_1131242.6ccc37a2-f073-4050-bfcd-de106d86236b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1131242.6ccc37a2-f073-4050-bfcd-de106d86236b.sorted_genome_alignments	UNCID_1131242.6ccc37a2-f073-4050-bfcd-de106d86236b.sorted_genome_alignments.bam	162.8	1.8	0.15	58cfa833e4b0c9d6adf6ddf8	UNCID_1131242.6ccc37a2-f073-4050-bfcd-de106d86236b.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-5782-01A	E21964B8-47C7-4A5F-BFA7-7206222883D2	Primary Tumor	Illumina HiSeq	A69E879A-F7B3-4059-8090-F295E628A1B6	Lung	68.0	9ABF3A20-B34D-429B-9C13-0468DFC20700	6CCC37A2-F073-4050-BFCD-DE106D86236B	TCGA-21-5782-01A-01R-1635-07	HG19	TCGA-21-5782	TCGA-LUSC	962.0	s10305	University of North Carolina	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1635-07	True
13767.58cfa82fe4b0c9d6adf6b2b8	58cfa82fe4b0c9d6adf6b2b8	TCGA-09-2054-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-09-2054-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-09-2054-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	405.0	1.8	0.16	58cfa82fe4b0c9d6adf6b2b8	TCGA-09-2054-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-2054-01A	CBD87697-7708-4B69-9E50-9EE474FEABE1	Primary Tumor	Illumina HiSeq	C054309E-F490-4847-B9DA-EA1B473DBA55	Ovary	58.0	E2A7621D-3C1D-4B7C-9494-0C02DF363ECB	5CD7FAA0-323A-4EA3-A658-859D0336E0AC	TCGA-09-2054-01A-01R-1568-13	GRCh37-lite	TCGA-09-2054	TCGA-OV	637.0	s17355	Canada's Michael Smith Genome Sciences Centre	UCSF	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa837e4b0c9d6adf6fd66	58cfa837e4b0c9d6adf6fd66	UNCID_1676690.f09a51df-011a-419e-b90a-7cd2037c5690.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1676690.f09a51df-011a-419e-b90a-7cd2037c5690.sorted_genome_alignments	UNCID_1676690.f09a51df-011a-419e-b90a-7cd2037c5690.sorted_genome_alignments.bam	100.2	1.8	0.15	58cfa837e4b0c9d6adf6fd66	UNCID_1676690.f09a51df-011a-419e-b90a-7cd2037c5690.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-6186-01A	9EE6E821-3AF2-42D7-9D14-F0CA455F338C	Primary Tumor	Illumina HiSeq	C3659252-0627-4EA1-9B57-C7F42BE888A8	Brain	58.0	5F73FA4E-FC7D-4FC0-8436-2241E57B9B69	F09A51DF-011A-419E-B90A-7CD2037C5690	TCGA-CS-6186-01A-12R-2027-07	HG19	TCGA-CS-6186	TCGA-LGG	538.0	s8425	University of North Carolina	Thomas Jefferson University	United States	NO			Oligoastrocytoma		2027-07	True
13722.58cfa832e4b0c9d6adf6d2de	58cfa832e4b0c9d6adf6d2de	TCGA-KL-8340-11A-01D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8340-11A-01D-2310-10_wgs_Illumina	TCGA-KL-8340-11A-01D-2310-10_wgs_Illumina.bam	209.3		0.05	58cfa832e4b0c9d6adf6d2de	TCGA-KL-8340-11A-01D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8340-11A	3129E869-BB2F-423A-BD20-D0DAAE33B11A	Solid Tissue Normal	Illumina HiSeq	2ea28763-5451-41c6-831e-6e763250abe6	Kidney	34.0	502BEE65-1050-4753-9304-F677AB2EB00D	44123123-63E3-46BD-85EE-C66A37C942A3	TCGA-KL-8340-11A-01D-2310-10	GRCh37-lite	TCGA-KL-8340	TCGA-KICH		s16398	Baylor College of Medicine	MSKCC	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	True
13767.58cfa839e4b0c9d6adf714b7	58cfa839e4b0c9d6adf714b7	UNCID_2314230.0ec4c319-53cc-41d8-8a80-210462506a28.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2314230.0ec4c319-53cc-41d8-8a80-210462506a28.sorted_genome_alignments	UNCID_2314230.0ec4c319-53cc-41d8-8a80-210462506a28.sorted_genome_alignments.bam	27.11	1.85	0.16	58cfa839e4b0c9d6adf714b7	UNCID_2314230.0ec4c319-53cc-41d8-8a80-210462506a28.sorted_genome_alignments.bam	Alive	MALE	ASIAN		Pancreatic Adenocarcinoma	Aligned reads	TCGA-HV-A7OL-01A	2E0701E1-E16F-457F-B939-7B1128F4A58B	Primary Tumor	Illumina HiSeq	0F42420C-8C59-440E-9213-DD23E538B7E7	Pancreas	70.0	34154B8B-1867-432C-9EB4-9F55C76CAA40	0EC4C319-53CC-41D8-8A80-210462506A28	TCGA-HV-A7OL-01A-11R-A33R-07	HG19	TCGA-HV-A7OL	TCGA-PAAD		s808	University of North Carolina	National Cancer Center Korea	Korea South	NO	T3	N0	Pancreas-Adenocarcinoma Ductal Type	Stage II	A33R-07	True
13722.58cfa83ce4b0c9d6adf72f0b	58cfa83ce4b0c9d6adf72f0b	bd84b1b4e53170c8c0a48eda107e6317.filtered.	WGS	bd84b1b4e53170c8c0a48eda107e6317	bd84b1b4e53170c8c0a48eda107e6317.bam	30.29	2.07	0.07	58cfa83ce4b0c9d6adf72f0b	bd84b1b4e53170c8c0a48eda107e6317.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LL-10A	D17668C4-5D66-4E16-8B70-B54616581AAE	Blood Derived Normal	Illumina HiSeq	f1e0e257-a16b-4a00-b0c1-605ee9458570	Uterus	56.0	ACC43C62-1C62-4BA1-ABFA-D8F4872E8D8B	EA5EE522-CAB3-4F66-9E55-AE5C1A1A6E0F	TCGA-AP-A0LL-10A-01D-A10B-09	GRCh37-lite	TCGA-AP-A0LL	TCGA-UCEC		s5183	Washington University School of Medicine	MSKCC	None	NO			Endometrioid endometrial adenocarcinoma		A10B-09	True
13767.58cfa837e4b0c9d6adf70249	58cfa837e4b0c9d6adf70249	UNCID_1900177.4c893780-d86b-4b01-a423-ca099e4fc007.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1900177.4c893780-d86b-4b01-a423-ca099e4fc007.sorted_genome_alignments	UNCID_1900177.4c893780-d86b-4b01-a423-ca099e4fc007.sorted_genome_alignments.bam	234.7		0.13	58cfa837e4b0c9d6adf70249	UNCID_1900177.4c893780-d86b-4b01-a423-ca099e4fc007.sorted_genome_alignments.bam	Dead	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-78-8662-01A	16E64A1E-08B0-4C27-8C69-FA64551F8CA4	Primary Tumor	Illumina HiSeq	73CD85D4-CCEA-4446-B6FE-D08CEDA5292A	Lung	53.0	CFFEEA21-61C8-4F86-B8D3-E67B019768CC	4C893780-D86B-4B01-A423-CA099E4FC007	TCGA-78-8662-01A-11R-2403-07	HG19	TCGA-78-8662	TCGA-LUAD	3361.0	s11067	University of North Carolina	Prince Charles Hospital	Australia	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2403-07	True
13767.58cfa835e4b0c9d6adf6ec90	58cfa835e4b0c9d6adf6ec90	UNCID_1359082.955f7278-0d9c-4a27-8ca2-f05714e4bf48.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1359082.955f7278-0d9c-4a27-8ca2-f05714e4bf48.sorted_genome_alignments	UNCID_1359082.955f7278-0d9c-4a27-8ca2-f05714e4bf48.sorted_genome_alignments.bam	28.72	1.77	0.16	58cfa835e4b0c9d6adf6ec90	UNCID_1359082.955f7278-0d9c-4a27-8ca2-f05714e4bf48.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q2-01A	A00DA907-E527-45F9-9AFB-2FAD2C7B0940	Primary Tumor	Illumina HiSeq	43883C55-9FB0-4CC1-825D-AB9764943428	Thyroid	57.0	A2E3CA88-9FF0-44AD-8C5A-CA4C7B404DE6	955F7278-0D9C-4A27-8CA2-F05714E4BF48	TCGA-DJ-A2Q2-01A-11R-A19O-07	HG19	TCGA-DJ-A2Q2	TCGA-THCA		s12426	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A19O-07	True
13767.58cfa832e4b0c9d6adf6d7d8	58cfa832e4b0c9d6adf6d7d8	UNCID_1033806.432b9ce2-3ef5-4343-896f-bc91c59035fd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1033806.432b9ce2-3ef5-4343-896f-bc91c59035fd.sorted_genome_alignments	UNCID_1033806.432b9ce2-3ef5-4343-896f-bc91c59035fd.sorted_genome_alignments.bam	165.2		0.15	58cfa832e4b0c9d6adf6d7d8	UNCID_1033806.432b9ce2-3ef5-4343-896f-bc91c59035fd.sorted_genome_alignments.bam	Alive	MALE	WHITE		Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-7465-01A	188FE74B-A62B-47A0-9069-5C3A2837EE05	Primary Tumor	Illumina HiSeq	AD1B53FC-DB85-47E9-BB7E-B97E77365D39	Lung	58.0	A2BD3774-B4B4-4419-83A4-D935C285419C	432B9CE2-3EF5-4343-896F-BC91C59035FD	TCGA-77-7465-01A-11R-2045-07	HG19	TCGA-77-7465	TCGA-LUSC		s10265	University of North Carolina	Prince Charles Hospital	Australia	NO	T2a	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	2045-07	True
13767.58cfa83ae4b0c9d6adf71d36	58cfa83ae4b0c9d6adf71d36	UNCID_2506549.7be99ebf-8822-45dc-af84-37b36fcc7619.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2506549.7be99ebf-8822-45dc-af84-37b36fcc7619.sorted_genome_alignments	UNCID_2506549.7be99ebf-8822-45dc-af84-37b36fcc7619.sorted_genome_alignments.bam	33.93	1.86	0.17	58cfa83ae4b0c9d6adf71d36	UNCID_2506549.7be99ebf-8822-45dc-af84-37b36fcc7619.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-IB-AAUN-01A	638B1A6A-C222-414C-96BC-F259F0AFB278	Primary Tumor	Illumina HiSeq	ABDB11EF-3497-4DEF-9617-FDE180DB7A64	Pancreas	74.0	71E44D9E-5F8C-4549-A33D-F785A301F152	7BE99EBF-8822-45DC-AF84-37B36FCC7619	TCGA-IB-AAUN-01A-12R-A38C-07	HG19	TCGA-IB-AAUN	TCGA-PAAD	144.0	s857	University of North Carolina	Alberta Health Services	Canada	NO	T2	N0	Pancreas-Adenocarcinoma Ductal Type	Stage I	A38C-07	True
13767.58cfa82ee4b0c9d6adf6b022	58cfa82ee4b0c9d6adf6b022	TCGA-13-0720-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0720-01A-01R-1564-13_rnaseq	TCGA-13-0720-01A-01R-1564-13_rnaseq.bam	260.0	1.8	0.16	58cfa82ee4b0c9d6adf6b022	TCGA-13-0720-01A-01R-1564-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0720-01A	0D23FA5B-95F8-4626-A4D2-C72AD3CC553B	Primary Tumor	Illumina HiSeq	D26D00A1-4C94-4825-8838-0DB776961138	Ovary	48.0	5C315F82-D4AC-40FD-9CC2-C4BC61286F8E	1FE43034-DF2B-4BEF-BE77-07DBB68083A4	TCGA-13-0720-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-13-0720	TCGA-OV	1355.0	s17660	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa832e4b0c9d6adf6cf55	58cfa832e4b0c9d6adf6cf55	TCGA-IG-A50L-01A-11R-A260-31_rnaseq.filtered.	RNA-Seq	TCGA-IG-A50L-01A-11R-A260-31_rnaseq	TCGA-IG-A50L-01A-11R-A260-31_rnaseq.bam	38.49	1.84	0.16	58cfa832e4b0c9d6adf6cf55	TCGA-IG-A50L-01A-11R-A260-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A50L-01A	9E54A27F-D0FA-4A5B-91BC-13E27FED2A3D	Primary Tumor	Illumina HiSeq	09A5D44C-0DB1-4B57-AC41-F8E040082B15	Esophagus	58.0	5B30B4D1-4FC6-4712-92B4-E3BE5131551E	54D09E0C-B5F0-4B0D-98EB-200B29A6458E	TCGA-IG-A50L-01A-11R-A260-31	GRCh37-lite	TCGA-IG-A50L	TCGA-ESCA		s1625	Canada's Michael Smith Genome Sciences Centre	Asterand	Vietnam	NO	T3	N1		Stage III	A260-31	True
13722.58cfa831e4b0c9d6adf6c680	58cfa831e4b0c9d6adf6c680	TCGA-CG-4455-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CG-4455-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_3_rg.sorted	TCGA-CG-4455-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_3_rg.sorted.bam	67.9	1.9	0.16	58cfa831e4b0c9d6adf6c680	TCGA-CG-4455-10A-01D-1154_121026_SN1120_0198_BC188JACXX_s_3_rg.sorted.bam	Alive	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4455-10A	8A173D98-20A1-4C84-86C1-97818E1C665A	Blood Derived Normal	Illumina HiSeq	b2384b4a-3f8b-482e-baa3-8ce2f162c4fb	Stomach	72.0	DDD0129D-79B1-497A-BB38-60745BD9DEB4	7E88B22D-C19E-45C9-AD0C-4951B5A361A0	TCGA-CG-4455-10A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4455	TCGA-STAD		s15244	Harvard Medical School	Indivumed	Germany	NO	T2b	N1	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage II	1154-02	True
13722.58cfa830e4b0c9d6adf6c1a6	58cfa830e4b0c9d6adf6c1a6	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.bam	58.9	2.0	0.14	58cfa830e4b0c9d6adf6c1a6	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HB-01A	0C1023C0-D2CE-4940-8047-7642F1DC3965	Primary Tumor	Illumina HiSeq	c9a434dc-8ce3-485f-88aa-a2373f6cdfac	Breast	55.0	19193B8F-1E1B-448C-B934-93F25E60D45B	49556237-D73F-4DE9-B5D9-7169DB7A53C5	TCGA-BH-A0HB-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0HB	TCGA-BRCA		s6275	Harvard Medical School	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A060-02	True
13767.58cfa838e4b0c9d6adf70a2e	58cfa838e4b0c9d6adf70a2e	UNCID_2055335.f2249fe9-e838-4895-9e46-98fa8f30655e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2055335.f2249fe9-e838-4895-9e46-98fa8f30655e.sorted_genome_alignments	UNCID_2055335.f2249fe9-e838-4895-9e46-98fa8f30655e.sorted_genome_alignments.bam	22.58	1.85	0.18	58cfa838e4b0c9d6adf70a2e	UNCID_2055335.f2249fe9-e838-4895-9e46-98fa8f30655e.sorted_genome_alignments.bam	Alive	FEMALE			Brain Lower Grade Glioma	Aligned reads	TCGA-DB-A64Q-01A	887DEF39-E212-490D-8849-2BC932FCEFF0	Primary Tumor	Illumina HiSeq	DCB4BCCF-27B8-477D-B40F-1761BA067AEE	Brain	31.0	4B48540F-D137-4CB8-B303-50568883E807	F2249FE9-E838-4895-9E46-98FA8F30655E	TCGA-DB-A64Q-01A-11R-A29R-07	HG19	TCGA-DB-A64Q	TCGA-LGG		s8238	University of North Carolina	Mayo Clinic - Rochester	United States	NO			Oligoastrocytoma		A29R-07	True
13722.58cfa832e4b0c9d6adf6d14a	58cfa832e4b0c9d6adf6d14a	TCGA-FS-A1ZM-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FS-A1ZM-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_7_rg.sorted	TCGA-FS-A1ZM-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_7_rg.sorted.bam	46.64		0.17	58cfa832e4b0c9d6adf6d14a	TCGA-FS-A1ZM-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZM-10A	9937259A-9D47-483C-8773-B3C60E02A653	Blood Derived Normal	Illumina HiSeq	802e023c-a4de-478e-8d5a-10bd9d163dec	Skin	74.0	D2AA13F1-D13B-43CC-95E1-1FA3A611F1CC	99346D7E-B398-4886-BCFB-29876B53964D	TCGA-FS-A1ZM-10A-01D-A190-02	HG19_Broad_variant	TCGA-FS-A1ZM	TCGA-SKCM		s7539	Harvard Medical School	Essen	Germany	NO	T2	N2c		Stage III	A190-02	True
13767.58cfa837e4b0c9d6adf70167	58cfa837e4b0c9d6adf70167	UNCID_1873895.19cc121b-759b-4368-8a98-b0bd8cf7269a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1873895.19cc121b-759b-4368-8a98-b0bd8cf7269a.sorted_genome_alignments	UNCID_1873895.19cc121b-759b-4368-8a98-b0bd8cf7269a.sorted_genome_alignments.bam	72.2	1.8	0.15	58cfa837e4b0c9d6adf70167	UNCID_1873895.19cc121b-759b-4368-8a98-b0bd8cf7269a.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-6603-11A	56D5B0B9-9093-4286-A2C6-7FAA9A1680F5	Solid Tissue Normal	Illumina HiSeq	E40153C3-DF92-40D6-824B-CB927A8BAD4B	Colorectal	77.0	E5C26212-CCFC-40CF-A38F-C0C2D78A2036	19CC121B-759B-4368-8A98-B0BD8CF7269A	TCGA-AZ-6603-11A-02R-1839-07	HG19	TCGA-AZ-6603	TCGA-COAD	899.0	s13282	University of North Carolina	University of Pittsburgh	United States	NO	T2	N1	Colon Adenocarcinoma		1839-07	True
13767.58cfa833e4b0c9d6adf6d90b	58cfa833e4b0c9d6adf6d90b	TCGA-VQ-A91Y-01A-11R-A414-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-A91Y-01A-11R-A414-31_rnaseq	TCGA-VQ-A91Y-01A-11R-A414-31_rnaseq.bam	22.86	1.86	0.16	58cfa833e4b0c9d6adf6d90b	TCGA-VQ-A91Y-01A-11R-A414-31_rnaseq.bam	Dead	MALE	WHITE		Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-A91Y-01A	807BEA1D-975A-4D01-98C5-2748D832235B	Primary Tumor	Illumina HiSeq	05360B71-685A-4426-925E-055BF1DC4551	Stomach	67.0	A9BC482E-8506-462F-98AC-78D9DEB2F63C	149972A7-AE69-40F9-B5C5-98F97BC5B273	TCGA-VQ-A91Y-01A-11R-A414-31	GRCh37-lite	TCGA-VQ-A91Y	TCGA-STAD	296.0	s15148	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T4a	N3b	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	A414-31	True
13767.58cfa838e4b0c9d6adf706c0	58cfa838e4b0c9d6adf706c0	UNCID_1981720.c026a9de-ad2b-4959-89c0-484f9d622dd9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1981720.c026a9de-ad2b-4959-89c0-484f9d622dd9.sorted_genome_alignments	UNCID_1981720.c026a9de-ad2b-4959-89c0-484f9d622dd9.sorted_genome_alignments.bam	28.48	1.83	0.17	58cfa838e4b0c9d6adf706c0	UNCID_1981720.c026a9de-ad2b-4959-89c0-484f9d622dd9.sorted_genome_alignments.bam	Alive	MALE	WHITE		Brain Lower Grade Glioma	Aligned reads	TCGA-HW-A5KJ-01A	8996DC64-8C5E-4E07-8ED8-2EB11C03626B	Primary Tumor	Illumina HiSeq	E23C94DA-C6E8-49D8-88E9-5CB6C82B4749	Brain	68.0	AA607767-D21D-4E66-99F4-5E8D0FDB08A0	C026A9DE-AD2B-4959-89C0-484F9D622DD9	TCGA-HW-A5KJ-01A-12R-A27Q-07	HG19	TCGA-HW-A5KJ	TCGA-LGG		s8653	University of North Carolina	MSKCC	United States	NO			Oligodendroglioma		A27Q-07	True
13767.58cfa83be4b0c9d6adf72ab0	58cfa83be4b0c9d6adf72ab0	UNCID_371033.TCGA-BP-4169-01A-02R-1289-07.110429_SN851_0036_BB0BGLABXX.2.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_371033.TCGA-BP-4169-01A-02R-1289-07.110429_SN851_0036_BB0BGLABXX.2.trimmed.annotated.translated_to_genomic	UNCID_371033.TCGA-BP-4169-01A-02R-1289-07.110429_SN851_0036_BB0BGLABXX.2.trimmed.annotated.translated_to_genomic.bam	36.3	1.7	0.14	58cfa83be4b0c9d6adf72ab0	UNCID_371033.TCGA-BP-4169-01A-02R-1289-07.110429_SN851_0036_BB0BGLABXX.2.trimmed.annotated.translated_to_genomic.bam	Dead	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4169-01A	3F05A719-E81E-4F0C-A5C1-F1733B7ABA11	Primary Tumor	Illumina HiSeq	F40C726E-D3F4-45FD-91AE-33A7E4E05FF3	Kidney	76.0	56C6E5E0-C731-4DBC-A470-FD91E0C83AF7	340B79DC-CB8C-4765-B9DF-0B171D99250B	TCGA-BP-4169-01A-02R-1289-07	HG19	TCGA-BP-4169	TCGA-KIRC	701.0	s9536	University of North Carolina	MSKCC	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage II	1289-07	True
13722.58cfa82fe4b0c9d6adf6b9ca	58cfa82fe4b0c9d6adf6b9ca	TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	232.95	1.72	0.15	58cfa82fe4b0c9d6adf6b9ca	TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00U-01A	091E3084-04EE-4497-893C-D46226DEC78F	Primary Tumor	Illumina HiSeq	95f8b5f7-db6e-4a69-959f-dde28a98d4ed	Colorectal	50.0	2FC854D7-4F80-4C39-BD92-397E94FEE4A0	6765593B-17DC-4B0F-A20B-7F0FF67DFF64	TCGA-AA-A00U-01A-01D-A077-02	HG18	TCGA-AA-A00U	TCGA-COAD		s13682	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	A077-02	True
13767.58cfa834e4b0c9d6adf6e6a7	58cfa834e4b0c9d6adf6e6a7	UNCID_1197705.3497c0d8-c7b0-43ca-92a2-30ea6cd61bde.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1197705.3497c0d8-c7b0-43ca-92a2-30ea6cd61bde.sorted_genome_alignments	UNCID_1197705.3497c0d8-c7b0-43ca-92a2-30ea6cd61bde.sorted_genome_alignments.bam	76.04	1.9	0.15	58cfa834e4b0c9d6adf6e6a7	UNCID_1197705.3497c0d8-c7b0-43ca-92a2-30ea6cd61bde.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BC-A10T-11A	8A9CDE9A-C38C-423E-BC14-354EE26468C9	Solid Tissue Normal	Illumina HiSeq	8D4D67F8-80D5-467D-9BF0-E72C7C6F2479	Liver	76.0	055E602F-5D95-432D-AFCC-627F1F032464	3497C0D8-C7B0-43CA-92A2-30EA6CD61BDE	TCGA-BC-A10T-11A-11R-A131-07	HG19	TCGA-BC-A10T	TCGA-LIHC	837.0	s16603	University of North Carolina	UNC	United States	NO	T4	NX	Hepatocellular Carcinoma		A131-07	True
13722.58cfa831e4b0c9d6adf6c8f2	58cfa831e4b0c9d6adf6c8f2	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.bam	135.0	1.9	0.15	58cfa831e4b0c9d6adf6c8f2	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5976-01A	23062172-7361-4E61-8EE6-B0A613D72A24	Primary Tumor	Illumina HiSeq	ef7745ae-17be-41bc-a3a5-c24eeda89075	Head and Neck	50.0	EEF68956-D624-4CD0-9C48-28FAF052C5F9	2581BC16-0DEF-40BC-8A97-54A1AE577E26	TCGA-CV-5976-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5976	TCGA-HNSC		s16041	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IV	1681-02	True
13767.58cfa83be4b0c9d6adf724b8	58cfa83be4b0c9d6adf724b8	UNCID_2615098.d2f9c79e-127a-4e53-869d-3ff6b2baf0aa.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2615098.d2f9c79e-127a-4e53-869d-3ff6b2baf0aa.sorted_genome_alignments	UNCID_2615098.d2f9c79e-127a-4e53-869d-3ff6b2baf0aa.sorted_genome_alignments.bam	41.16	1.85	0.17	58cfa83be4b0c9d6adf724b8	UNCID_2615098.d2f9c79e-127a-4e53-869d-3ff6b2baf0aa.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-V1-A9OT-01A	18B8AD7F-0F39-4853-AE13-5B13AA5E6F7D	Primary Tumor	Illumina HiSeq	6D7F4010-1006-4B96-93BC-C26C501DE7FA	Prostate	61.0	3E3BAEF3-4686-41D5-BA55-4456DF023975	D2F9C79E-127A-4E53-869D-3FF6B2BAF0AA	TCGA-V1-A9OT-01A-11R-A41O-07	HG19	TCGA-V1-A9OT	TCGA-PRAD		s3748	University of North Carolina	University of California San Francisco	United States	NO	T2c		Prostate Adenocarcinoma Acinar Type		A41O-07	True
13722.58cfa82de4b0c9d6adf6a44b	58cfa82de4b0c9d6adf6a44b	064d2f15569ea353626d7b59f5bfd25d.filtered.	WGS	064d2f15569ea353626d7b59f5bfd25d	064d2f15569ea353626d7b59f5bfd25d.bam	9.5		0.07	58cfa82de4b0c9d6adf6a44b	064d2f15569ea353626d7b59f5bfd25d.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LU-10A	E786DE34-4C21-460F-89AB-008DE4347049	Blood Derived Normal	Illumina HiSeq	44b7172e-b9bd-4e78-a20c-693216b575a9	Mesenchymal	60.0	A8EE2E8A-DEBD-45DF-99D3-600BB0B236FF	97A68A03-DC99-4BA9-8B81-1B40F2CE32EA	TCGA-DX-A3LU-10A-01D-A21Q-09	GRCh37-lite	TCGA-DX-A3LU	TCGA-SARC		s2328	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO					A21Q-09	True
13767.58cfa837e4b0c9d6adf702c8	58cfa837e4b0c9d6adf702c8	UNCID_1942476.4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1942476.4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3.sorted_genome_alignments	UNCID_1942476.4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3.sorted_genome_alignments.bam	239.2		0.16	58cfa837e4b0c9d6adf702c8	UNCID_1942476.4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-58-8392-01A	45AA07C3-CEA4-456E-8000-B4572A2163A8	Primary Tumor	Illumina HiSeq	7D305766-18D1-4FE8-B673-24B6CB971A4C	Lung	70.0	F00E664D-4418-4C3E-B904-ABE0D0C91617	4A3692A0-D9DE-4CD3-9C4A-BBB087AA67C3	TCGA-58-8392-01A-11R-2326-07	HG19	TCGA-58-8392	TCGA-LUSC	501.0	s10045	University of North Carolina	Thoraxklinik at University Hospital Heidelberg	Germany	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2326-07	True
13722.58cfa82de4b0c9d6adf6a4cc	58cfa82de4b0c9d6adf6a4cc	1e9af460376762c5d489a2b820834e3f.filtered.	WGS	1e9af460376762c5d489a2b820834e3f	1e9af460376762c5d489a2b820834e3f.bam	15.12	1.95	0.08	58cfa82de4b0c9d6adf6a4cc	1e9af460376762c5d489a2b820834e3f.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15H-10A	5580B21A-2CDB-4777-AD79-6E06654144F5	Blood Derived Normal	Illumina HiSeq	b2b05078-b11f-488e-afc8-2d70b062609e	Breast	38.0	09644A32-44EA-4FAC-AFB9-448810B90EED	CCC8619F-C4AC-4CD9-9DAB-83FAAA59AFC5	TCGA-E2-A15H-10A-01D-A19H-09	GRCh37-lite	TCGA-E2-A15H	TCGA-BRCA		s6911	Washington University School of Medicine	Roswell Park	None	NO	T1c	N1mi	Infiltrating Ductal Carcinoma	Stage II	A19H-09	True
13767.58cfa82fe4b0c9d6adf6b38c	58cfa82fe4b0c9d6adf6b38c	TCGA-24-2254-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-2254-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-24-2254-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	516.0	1.8	0.16	58cfa82fe4b0c9d6adf6b38c	TCGA-24-2254-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-2254-01A	9AF2248A-D86A-4277-93B4-8EBA5A39BD3C	Primary Tumor	Illumina HiSeq	3D7E2429-3F6B-4239-A63A-A2A37EDC7698	Ovary	66.0	C2699551-32D9-46AD-9C41-04730EF6A8A4	E496319B-DF71-44A0-BFA6-90F50AE54654	TCGA-24-2254-01A-01R-1568-13	GRCh37-lite	TCGA-24-2254	TCGA-OV	1736.0	s17623	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa838e4b0c9d6adf70a14	58cfa838e4b0c9d6adf70a14	UNCID_2087447.32b29d34-5d28-4b68-9d64-61290448fca5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2087447.32b29d34-5d28-4b68-9d64-61290448fca5.sorted_genome_alignments	UNCID_2087447.32b29d34-5d28-4b68-9d64-61290448fca5.sorted_genome_alignments.bam	90.79	1.85	0.18	58cfa838e4b0c9d6adf70a14	UNCID_2087447.32b29d34-5d28-4b68-9d64-61290448fca5.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EY-A548-01A	56BDB68C-A647-4ABA-94AC-9CD52BB5344A	Primary Tumor	Illumina HiSeq	C780C28F-7265-47B9-8CE6-6E511E9666CC	Uterus	83.0	081AC69B-8390-42B1-917A-D7CD231C0156	32B29D34-5D28-4B68-9D64-61290448FCA5	TCGA-EY-A548-01A-11R-A27V-07	HG19	TCGA-EY-A548	TCGA-UCEC		s5321	University of North Carolina	University of North Carolina	United States	NO			Endometrioid endometrial adenocarcinoma		A27V-07	True
13722.58cfa832e4b0c9d6adf6ce7a	58cfa832e4b0c9d6adf6ce7a	TCGA-G3-A25Y-10A-01D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A25Y-10A-01D-A16V-10_wgs_Illumina	TCGA-G3-A25Y-10A-01D-A16V-10_wgs_Illumina.bam	166.26	1.85	0.09	58cfa832e4b0c9d6adf6ce7a	TCGA-G3-A25Y-10A-01D-A16V-10_wgs_Illumina.bam	Dead	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A25Y-10A	239B4298-B090-480A-A19F-9758A827AA30	Blood Derived Normal	Illumina HiSeq	8dbbb564-d7b7-489d-a37f-e9db39f15430	Liver	52.0	0FC499E8-F6A5-44C0-9C99-AFE097B15BEF	9CFC4ADF-3FD0-4F1F-B9E1-5F7A6E1469DF	TCGA-G3-A25Y-10A-01D-A16V-10	GRCh37-lite	TCGA-G3-A25Y	TCGA-LIHC	452.0	s17063	Baylor College of Medicine	Alberta Health Services	Canada	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A16V-10	True
13767.58cfa833e4b0c9d6adf6db02	58cfa833e4b0c9d6adf6db02	UNCID_1121565.62b06301-531d-4fc1-bb00-ede8e507e8f4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1121565.62b06301-531d-4fc1-bb00-ede8e507e8f4.sorted_genome_alignments	UNCID_1121565.62b06301-531d-4fc1-bb00-ede8e507e8f4.sorted_genome_alignments.bam	64.14	1.75	0.15	58cfa833e4b0c9d6adf6db02	UNCID_1121565.62b06301-531d-4fc1-bb00-ede8e507e8f4.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A1HF-01A	A2453BCB-90F2-4505-949D-A89CF4BFC9B8	Primary Tumor	Illumina HiSeq	885D1336-D170-44F5-AE3E-B7C3CC605514	Breast	48.0	F2A49AA7-B756-4EAA-A6FD-00F56C7E7851	62B06301-531D-4FC1-BB00-EDE8E507E8F4	TCGA-C8-A1HF-01A-11R-A137-07	HG19	TCGA-C8-A1HF	TCGA-BRCA		s6141	University of North Carolina	ILSbio	Vietnam	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A137-07	True
13767.58cfa83be4b0c9d6adf722e0	58cfa83be4b0c9d6adf722e0	UNCID_2580954.fc64c379-1064-4bcd-a40e-305f2da1f1f7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2580954.fc64c379-1064-4bcd-a40e-305f2da1f1f7.sorted_genome_alignments	UNCID_2580954.fc64c379-1064-4bcd-a40e-305f2da1f1f7.sorted_genome_alignments.bam	55.48	1.92	0.18	58cfa83be4b0c9d6adf722e0	UNCID_2580954.fc64c379-1064-4bcd-a40e-305f2da1f1f7.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-5P-A9K2-01A	72CC3423-D214-4035-B934-0D4E4B806B6C	Primary Tumor	Illumina HiSeq	C8B147C2-33F3-45DE-A994-DE32372F477C	Kidney	62.0	E490028C-E8F6-4C5D-AE9C-274334A8E86C	FC64C379-1064-4BCD-A40E-305F2DA1F1F7	TCGA-5P-A9K2-01A-11R-A42S-07	HG19	TCGA-5P-A9K2	TCGA-KIRP		s11841	University of North Carolina	University Hospital Erlangen	Germany	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma		A42S-07	True
13767.58cfa838e4b0c9d6adf705bb	58cfa838e4b0c9d6adf705bb	UNCID_1905563.9d7459be-af93-4bf3-8d54-df569a16ee12.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1905563.9d7459be-af93-4bf3-8d54-df569a16ee12.sorted_genome_alignments	UNCID_1905563.9d7459be-af93-4bf3-8d54-df569a16ee12.sorted_genome_alignments.bam	136.2		0.14	58cfa838e4b0c9d6adf705bb	UNCID_1905563.9d7459be-af93-4bf3-8d54-df569a16ee12.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-8619-01A	772324A5-5513-454D-AD6B-605798F69B73	Primary Tumor	Illumina HiSeq	860E5B09-1F4E-4148-8569-0A974E03FE8A	Lung	72.0	0DEED408-8ACB-43CE-84A3-143AABD23312	9D7459BE-AF93-4BF3-8D54-DF569A16EE12	TCGA-55-8619-01A-11R-2403-07	HG19	TCGA-55-8619	TCGA-LUAD		s11070	University of North Carolina	International Genomics Consortium	United States	NO	T3	N0	Mucinous (Colloid) Carcinoma	Stage II	2403-07	True
13767.58cfa82fe4b0c9d6adf6b26a	58cfa82fe4b0c9d6adf6b26a	TCGA-09-2051-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-09-2051-01A-01R-1568-13_rnaseq	TCGA-09-2051-01A-01R-1568-13_rnaseq.bam	435.0	1.8	0.14	58cfa82fe4b0c9d6adf6b26a	TCGA-09-2051-01A-01R-1568-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-2051-01A	02594E5E-8751-47C1-9245-90C66984B665	Primary Tumor	Illumina HiSeq	B0B64F8A-099E-4C2C-A6F6-55171172E5DD	Ovary	42.0	C46D2ADE-620C-44A6-93BA-8EDDA9909C1B	6BC296B8-AC74-4FF9-872D-5F7E4A3D011A	TCGA-09-2051-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-09-2051	TCGA-OV		s17552	Canada's Michael Smith Genome Sciences Centre	UCSF	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa832e4b0c9d6adf6d52c	58cfa832e4b0c9d6adf6d52c	TCGA-L5-A43I-11A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-L5-A43I-11A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_6_rg.sorted	TCGA-L5-A43I-11A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_6_rg.sorted.bam	22.84		0.16	58cfa832e4b0c9d6adf6d52c	TCGA-L5-A43I-11A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A43I-11A	22EE75E0-5D61-41F4-AACD-B4E09C70D2C3	Solid Tissue Normal	Illumina HiSeq	293ca156-99a1-4a10-805c-5a09fa0ff255	Esophagus	77.0	C6347711-A7B8-4195-B25C-9EB58822989B	2C9090C6-C4E1-4C0E-BB0A-E5DA04FBE9E7	TCGA-L5-A43I-11A-11D-A248-26	HG19_Broad_variant	TCGA-L5-A43I	TCGA-ESCA	556.0	s1736	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T3	N1		Stage III	A248-26	True
13722.58cfa82de4b0c9d6adf6a55c	58cfa82de4b0c9d6adf6a55c	2b3e58fa7d731b844fe92dfbeb9a597e.filtered.	WGS	2b3e58fa7d731b844fe92dfbeb9a597e	2b3e58fa7d731b844fe92dfbeb9a597e.bam	38.4	1.33	0.07	58cfa82de4b0c9d6adf6a55c	2b3e58fa7d731b844fe92dfbeb9a597e.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DT-11A	74F31744-0AED-4633-BEEC-4E203315F0B7	Solid Tissue Normal	Illumina HiSeq	fafbdaae-4f36-4715-85b5-8cc9be96343c	Breast	41.0	A9CE148B-AD26-4257-8F5C-295FD2DCB1D7	03C623E2-04D7-43EA-ADE1-5F5A619CD5C8	TCGA-BH-A0DT-11A-12D-A12B-09	GRCh37-lite	TCGA-BH-A0DT	TCGA-BRCA		s5475	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage II	A12B-09	False
13722.58cfa831e4b0c9d6adf6c7c8	58cfa831e4b0c9d6adf6c7c8	TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted	TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.bam	56.36	1.95	0.15	58cfa831e4b0c9d6adf6c7c8	TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17K-01A	5C22C8D6-5805-455C-8E1C-E6B8006738E4	Primary Tumor	Illumina HiSeq	312dd86a-5fc1-4446-bfd6-fe867e3617f2	Uterus	74.0	CA213835-EFC5-4216-A762-A6B320B516BF	3E67F5BD-C5A6-4CDD-8D71-78038D316447	TCGA-D1-A17K-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A17K	TCGA-UCEC		s4617	Harvard Medical School	Mayo Clinic	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13767.58cfa838e4b0c9d6adf70883	58cfa838e4b0c9d6adf70883	UNCID_2043768.c3db032d-a822-4eca-8891-2c4d13a5866a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2043768.c3db032d-a822-4eca-8891-2c4d13a5866a.sorted_genome_alignments	UNCID_2043768.c3db032d-a822-4eca-8891-2c4d13a5866a.sorted_genome_alignments.bam	52.75	1.85	0.17	58cfa838e4b0c9d6adf70883	UNCID_2043768.c3db032d-a822-4eca-8891-2c4d13a5866a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A4BA-01A	9E79059F-3453-4AA6-9849-55A267C711A4	Primary Tumor	Illumina HiSeq	0FFA1110-1C64-4E8E-A15F-699C06A0528E	Cervix	49.0	26CF8464-C376-4C53-8E41-35E9AB326F0E	C3DB032D-A822-4ECA-8891-2C4D13A5866A	TCGA-EA-A4BA-01A-21R-A26T-07	HG19	TCGA-EA-A4BA	TCGA-CESC		s1430	University of North Carolina	Asterand	Ukraine	NO	T1b2	N0	Endocervical Type of Adenocarcinoma		A26T-07	True
13722.58cfa82fe4b0c9d6adf6b6b7	58cfa82fe4b0c9d6adf6b6b7	TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted	TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted.bam	555.7	1.9	0.15	58cfa82fe4b0c9d6adf6b6b7	TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-5781-01A	41C4C704-825E-49F5-9D54-DBD7D30725E0	Primary Tumor	Illumina HiSeq	901f4776-2659-4626-abec-5a9323e6f75e	Lung	55.0	B32F509D-91E5-4601-B8B3-4B0A5212C22B	69DEF564-A4D8-4820-9ED6-F17AF2CAB0A7	TCGA-64-5781-01A-01D-1623-02	HG19_Broad_variant	TCGA-64-5781	TCGA-LUAD		s11352	Harvard Medical School	Fox Chase	United States	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	1623-02	True
13722.58cfa831e4b0c9d6adf6ca88	58cfa831e4b0c9d6adf6ca88	TCGA-DU-5852-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-DU-5852-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_8_rg.sorted	TCGA-DU-5852-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_8_rg.sorted.bam	93.0	1.8	0.14	58cfa831e4b0c9d6adf6ca88	TCGA-DU-5852-10A-01D-1703_130806_SN1222_0209_AD2AW0ACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5852-10A	9ED5AF0E-C87F-46FF-81E7-9D3041B4034E	Blood Derived Normal	Illumina HiSeq	6d9e6678-64e1-4fa4-b57d-338f163a62a1	Brain	61.0	5A82BD3E-7E2F-4D14-95F8-B85C684A3B7D	73074E40-BF47-4433-BA0E-FFEBFE1ED4C2	TCGA-DU-5852-10A-01D-1703-02	HG19_Broad_variant	TCGA-DU-5852	TCGA-LGG	205.0	s8560	Harvard Medical School	Henry Ford Hospital	United States	NO			Oligoastrocytoma		1703-02	True
13767.58cfa835e4b0c9d6adf6ecbe	58cfa835e4b0c9d6adf6ecbe	UNCID_1352894.9893b949-598f-4664-a72c-8495d0047bf0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1352894.9893b949-598f-4664-a72c-8495d0047bf0.sorted_genome_alignments	UNCID_1352894.9893b949-598f-4664-a72c-8495d0047bf0.sorted_genome_alignments.bam	23.72	1.78	0.17	58cfa835e4b0c9d6adf6ecbe	UNCID_1352894.9893b949-598f-4664-a72c-8495d0047bf0.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q3-01A	ACBA8D76-999A-4F6D-B3A4-8D7DD0F2BB52	Primary Tumor	Illumina HiSeq	68768F2B-03D2-4A1E-98A7-7ECC991E152E	Thyroid	61.0	7949D5BD-F0F0-4B11-BC49-DADE6C57BCB1	9893B949-598F-4664-A72C-8495D0047BF0	TCGA-DJ-A2Q3-01A-11R-A18C-07	HG19	TCGA-DJ-A2Q3	TCGA-THCA		s12153	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage III	A18C-07	True
13767.58cfa837e4b0c9d6adf6fd93	58cfa837e4b0c9d6adf6fd93	UNCID_1721243.06c5b3d6-24c7-4d53-8871-7a9b19377c20.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1721243.06c5b3d6-24c7-4d53-8871-7a9b19377c20.sorted_genome_alignments	UNCID_1721243.06c5b3d6-24c7-4d53-8871-7a9b19377c20.sorted_genome_alignments.bam	54.26	1.86	0.17	58cfa837e4b0c9d6adf6fd93	UNCID_1721243.06c5b3d6-24c7-4d53-8871-7a9b19377c20.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-DM-A1D7-01A	FAC2C617-8149-45BB-B766-FBE13DC3C425	Primary Tumor	Illumina HiSeq	99EB5A78-26A1-4391-A817-7E5863F7D73F	Colorectal	82.0	18364FCC-5F9C-4E3F-8A9E-56ED18AC893E	06C5B3D6-24C7-4D53-8871-7A9B19377C20	TCGA-DM-A1D7-01A-11R-A155-07	HG19	TCGA-DM-A1D7	TCGA-COAD	0.0	s13254	University of North Carolina	University of Michigan	None	NO	T3	N0		Stage II	A155-07	True
13722.58cfa832e4b0c9d6adf6ced7	58cfa832e4b0c9d6adf6ced7	TCGA-EM-A1YE-11A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EM-A1YE-11A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_6_rg.sorted	TCGA-EM-A1YE-11A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_6_rg.sorted.bam	43.93	1.89	0.17	58cfa832e4b0c9d6adf6ced7	TCGA-EM-A1YE-11A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_6_rg.sorted.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A1YE-11A	E632B443-CF6A-4592-96C6-C3493EC86FEA	Solid Tissue Normal	Illumina HiSeq	48d31326-3565-4dff-ae01-be3fd0b5ca6c	Thyroid	47.0	B3126B21-FD84-4E3D-BB16-B7834044D5BE	57CCBCC4-DF14-48CB-9F31-BF776D712E32	TCGA-EM-A1YE-11A-11D-A14U-02	HG19_Broad_variant	TCGA-EM-A1YE	TCGA-THCA		s12520	Harvard Medical School	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14U-02	True
13722.58cfa82fe4b0c9d6adf6b694	58cfa82fe4b0c9d6adf6b694	TCGA-49-4486-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4486-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4486-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	176.53	1.9	0.16	58cfa82fe4b0c9d6adf6b694	TCGA-49-4486-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4486-11A	61C655EC-52B5-453F-A6CC-B2ABA445B027	Solid Tissue Normal	Illumina HiSeq	20f65a1e-78a9-454e-a05c-5c944d95f215	Lung	72.0	5AF4A67E-13EF-41DD-945C-18669C7D2701	C0F67DA7-7FC7-4C97-9D1D-EA984206252B	TCGA-49-4486-11A-01D-1203-02	GRCh37	TCGA-49-4486	TCGA-LUAD	2318.0	s10654	Harvard Medical School	Johns Hopkins	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1203-02	True
13767.58cfa839e4b0c9d6adf7123a	58cfa839e4b0c9d6adf7123a	UNCID_2307359.69b30673-9ec0-4c05-b75c-12bcb1f7268f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2307359.69b30673-9ec0-4c05-b75c-12bcb1f7268f.sorted_genome_alignments	UNCID_2307359.69b30673-9ec0-4c05-b75c-12bcb1f7268f.sorted_genome_alignments.bam	34.59	1.83	0.17	58cfa839e4b0c9d6adf7123a	UNCID_2307359.69b30673-9ec0-4c05-b75c-12bcb1f7268f.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A72E-01A	AE080E88-82DA-480C-BD13-AE214DA0463C	Primary Tumor	Illumina HiSeq	3DC629A8-292A-4628-A04A-DDC304741B58	Bladder	76.0	26543A29-59AB-4EBA-B00F-E45C4C6E9A3E	69B30673-9EC0-4C05-B75C-12BCB1F7268F	TCGA-CU-A72E-01A-12R-A33J-07	HG19	TCGA-CU-A72E	TCGA-BLCA		s3016	University of North Carolina	UNC	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A33J-07	True
13767.58cfa82fe4b0c9d6adf6b4a0	58cfa82fe4b0c9d6adf6b4a0	TCGA-24-1550-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-24-1550-01A-01R-1566-13_rnaseq	TCGA-24-1550-01A-01R-1566-13_rnaseq.bam	255.0	1.8	0.15	58cfa82fe4b0c9d6adf6b4a0	TCGA-24-1550-01A-01R-1566-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1550-01A	1858B58F-FDF4-413C-9C29-96AE85B88A74	Primary Tumor	Illumina HiSeq	B52EDFD4-64A2-43E4-A39B-2FE844473996	Ovary	49.0	2726ED05-AC38-41D6-85F3-35AB0BCBC47A	648CB96F-DF1C-48C1-BB15-C37A2784A9DB	TCGA-24-1550-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-24-1550	TCGA-OV	1249.0	s17875	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa835e4b0c9d6adf6eace	58cfa835e4b0c9d6adf6eace	UNCID_1285038.533156e6-19df-4bef-9d3f-e78c6361b4da.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1285038.533156e6-19df-4bef-9d3f-e78c6361b4da.sorted_genome_alignments	UNCID_1285038.533156e6-19df-4bef-9d3f-e78c6361b4da.sorted_genome_alignments.bam	11.31	1.84	0.18	58cfa835e4b0c9d6adf6eace	UNCID_1285038.533156e6-19df-4bef-9d3f-e78c6361b4da.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A19C-06A	D5F8B18C-8AE7-457A-AA3E-C4BD77B276AB	Metastatic	Illumina HiSeq	0E373453-7449-45B0-AC96-700676C02A9A	Skin	77.0	CB807921-54D5-411E-8087-7EC7973BEA7D	533156E6-19DF-4BEF-9D3F-E78C6361B4DA	TCGA-ER-A19C-06A-11R-A18S-07	HG19	TCGA-ER-A19C	TCGA-SKCM	1487.0	s7592	University of North Carolina	University of Pittsburgh	United States	NO	T2a	NX		Stage I	A18S-07	True
13767.58cfa833e4b0c9d6adf6ddb5	58cfa833e4b0c9d6adf6ddb5	UNCID_1124247.b5c8962b-15d5-45ba-9a5a-a75dfacbaad9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1124247.b5c8962b-15d5-45ba-9a5a-a75dfacbaad9.sorted_genome_alignments	UNCID_1124247.b5c8962b-15d5-45ba-9a5a-a75dfacbaad9.sorted_genome_alignments.bam	45.33	1.86	0.15	58cfa833e4b0c9d6adf6ddb5	UNCID_1124247.b5c8962b-15d5-45ba-9a5a-a75dfacbaad9.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1EX-01A	7B892055-C59D-4550-8688-AD039790AF3D	Primary Tumor	Illumina HiSeq	11AE5E1A-4411-4B9F-8A71-F77993D2FFDF	Breast	67.0	F713031B-B8EE-4195-91B1-AC9CF63D76A4	B5C8962B-15D5-45BA-9A5A-A75DFACBAAD9	TCGA-BH-A1EX-01A-11R-A13Q-07	HG19	TCGA-BH-A1EX	TCGA-BRCA	1508.0	s5655	University of North Carolina	University of Pittsburgh	None	NO	T2	N1b	Infiltrating Ductal Carcinoma	Stage II	A13Q-07	True
13722.58cfa831e4b0c9d6adf6cb48	58cfa831e4b0c9d6adf6cb48	TCGA-EE-A29S-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EE-A29S-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_5_rg.sorted	TCGA-EE-A29S-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_5_rg.sorted.bam	34.67		0.17	58cfa831e4b0c9d6adf6cb48	TCGA-EE-A29S-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A29S-06A	5DEC1B6A-5D60-463C-9655-FC7ED79CA19D	Metastatic	Illumina HiSeq	b6eef3eb-6a3c-4010-a637-48540f303a1c	Skin	79.0	4EA37293-D9B4-4231-A283-6839810566D9	512F2D57-71FC-4050-AD4F-FBCC6EA2E687	TCGA-EE-A29S-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-EE-A29S	TCGA-SKCM		s7675	Harvard Medical School	University of Sydney	Australia	NO	T3a	N0		Stage II	A18Y-02	True
13722.58cfa831e4b0c9d6adf6cc98	58cfa831e4b0c9d6adf6cc98	TCGA-EE-A2MI-06A-11D-A18Y_120724_SN208_0418_BD13N7ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EE-A2MI-06A-11D-A18Y_120724_SN208_0418_BD13N7ACXX_s_7_rg.sorted	TCGA-EE-A2MI-06A-11D-A18Y_120724_SN208_0418_BD13N7ACXX_s_7_rg.sorted.bam	23.06		0.17	58cfa831e4b0c9d6adf6cc98	TCGA-EE-A2MI-06A-11D-A18Y_120724_SN208_0418_BD13N7ACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2MI-06A	C061AE6C-7A02-47C3-AECD-A56487C01603	Metastatic	Illumina HiSeq	535ded66-253b-4519-b2d3-4e45793d2ee6	Skin	43.0	3C7442C7-5655-4D38-AE50-41D4E531CE12	779F841E-DB02-429D-A5A8-39CEFC074719	TCGA-EE-A2MI-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-EE-A2MI	TCGA-SKCM	6225.0	s7685	Harvard Medical School	University of Sydney	Australia	NO	T4	N0		Stage II	A18Y-02	True
13767.58cfa82fe4b0c9d6adf6b374	58cfa82fe4b0c9d6adf6b374	TCGA-24-1847-01A-01R-1566-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-1847-01A-01R-1566-13_GRCh37-lite_rnaseq	TCGA-24-1847-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	667.0	1.8	0.15	58cfa82fe4b0c9d6adf6b374	TCGA-24-1847-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1847-01A	21966708-4E66-4211-ADD0-F1515B09E362	Primary Tumor	Illumina HiSeq	E58BA235-8154-4171-A2B4-25229850892C	Ovary	45.0	F1989BF4-C884-430D-A075-679F7B4A4B07	83354694-078E-411E-89D2-029649708528	TCGA-24-1847-01A-01R-1566-13	GRCh37-lite	TCGA-24-1847	TCGA-OV		s17514	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa833e4b0c9d6adf6db4e	58cfa833e4b0c9d6adf6db4e	UNCID_1100335.2f16ddcc-8a98-4734-9878-645ff102fb14.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1100335.2f16ddcc-8a98-4734-9878-645ff102fb14.sorted_genome_alignments	UNCID_1100335.2f16ddcc-8a98-4734-9878-645ff102fb14.sorted_genome_alignments.bam	5.2	1.7	0.15	58cfa833e4b0c9d6adf6db4e	UNCID_1100335.2f16ddcc-8a98-4734-9878-645ff102fb14.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6147-11A	889AEC8E-14BA-48D9-8FE1-F2416E82B333	Solid Tissue Normal	Illumina HiSeq	964064EA-1DFE-4A74-A256-62D48FCC1334	Lung	67.0	D990632B-B55A-4893-9C3D-5AC0FB6BB6F8	2F16DDCC-8A98-4734-9878-645FF102FB14	TCGA-44-6147-11A-01R-1858-07	HG19	TCGA-44-6147	TCGA-LUAD		s11476	University of North Carolina	Christiana Healthcare	United States	NO	T1b	NX	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1858-07	True
13767.58cfa83be4b0c9d6adf72a35	58cfa83be4b0c9d6adf72a35	UNCID_368999.TCGA-AK-3440-01A-02R-1277-07.110415_UNC9-SN296_0171_BB07RHABXX.6.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_368999.TCGA-AK-3440-01A-02R-1277-07.110415_UNC9-SN296_0171_BB07RHABXX.6.trimmed.annotated.translated_to_genomic	UNCID_368999.TCGA-AK-3440-01A-02R-1277-07.110415_UNC9-SN296_0171_BB07RHABXX.6.trimmed.annotated.translated_to_genomic.bam	102.63	1.8	0.17	58cfa83be4b0c9d6adf72a35	UNCID_368999.TCGA-AK-3440-01A-02R-1277-07.110415_UNC9-SN296_0171_BB07RHABXX.6.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-AK-3440-01A	3C5F27E9-DB2F-4963-9240-94815808D32F	Primary Tumor	Illumina HiSeq	C059375E-C783-476E-8D19-AA766CAA4139	Kidney	58.0	A1F24FC5-19A7-474C-952E-940F92734C02	7C4EE68B-D39F-4762-B39F-A40787413AF6	TCGA-AK-3440-01A-02R-1277-07	HG19	TCGA-AK-3440	TCGA-KIRC		s9695	University of North Carolina	Fox Chase	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1277-07	True
13767.58cfa837e4b0c9d6adf6fde6	58cfa837e4b0c9d6adf6fde6	UNCID_1703953.4d3c1834-7351-4aaa-aa2c-70e0c06ebbce.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1703953.4d3c1834-7351-4aaa-aa2c-70e0c06ebbce.sorted_genome_alignments	UNCID_1703953.4d3c1834-7351-4aaa-aa2c-70e0c06ebbce.sorted_genome_alignments.bam	82.2		0.15	58cfa837e4b0c9d6adf6fde6	UNCID_1703953.4d3c1834-7351-4aaa-aa2c-70e0c06ebbce.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8432-11A	AF1111AF-9384-4E37-9B16-227D38007EBD	Solid Tissue Normal	Illumina HiSeq	9A2CD652-BE4C-4169-BE66-D5AAC075384F	Kidney	86.0	6A5BAAC8-C270-45F7-8911-592D987E3FBE	4D3C1834-7351-4AAA-AA2C-70E0C06EBBCE	TCGA-KN-8432-11A-01R-2315-07	HG19	TCGA-KN-8432	TCGA-KICH		s16541	University of North Carolina	Harvard	United States	NO	T2b	NX	Kidney Chromophobe	Stage II	2315-07	True
13767.58cfa83ce4b0c9d6adf72db6	58cfa83ce4b0c9d6adf72db6	UNCID_573635.7f47cd71-b62a-4f65-8479-ceec8261aaa9.110919_UNC13-SN749_0114_BB007YABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_573635.7f47cd71-b62a-4f65-8479-ceec8261aaa9.110919_UNC13-SN749_0114_BB007YABXX.7.trimmed.annotated.translated_to_genomic	UNCID_573635.7f47cd71-b62a-4f65-8479-ceec8261aaa9.110919_UNC13-SN749_0114_BB007YABXX.7.trimmed.annotated.translated_to_genomic.bam	40.8	1.8	0.14	58cfa83ce4b0c9d6adf72db6	UNCID_573635.7f47cd71-b62a-4f65-8479-ceec8261aaa9.110919_UNC13-SN749_0114_BB007YABXX.7.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5675-01A	CEB7CD9A-9CB1-42F2-A4AB-0B4381E2B85B	Primary Tumor	Illumina HiSeq	920CD220-24D0-479E-82EF-707AF77B658E	Kidney	70.0	26F77108-C3B0-4833-9A1A-DF457D7415A9	7F47CD71-B62A-4F65-8479-CEEC8261AAA9	TCGA-CJ-5675-01A-11R-1541-07	HG19	TCGA-CJ-5675	TCGA-KIRC		s9146	University of North Carolina	MD Anderson Cancer Center	None	NO	T2a	NX	Kidney Clear Cell Renal Carcinoma	Stage II	1541-07	True
13767.58cfa83ce4b0c9d6adf72d20	58cfa83ce4b0c9d6adf72d20	UNCID_597424.1d3af406-750e-4b1f-97e2-bd2979f78c5b.111019_UNC14-SN744_0180_AB01RFABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_597424.1d3af406-750e-4b1f-97e2-bd2979f78c5b.111019_UNC14-SN744_0180_AB01RFABXX.7.trimmed.annotated.translated_to_genomic	UNCID_597424.1d3af406-750e-4b1f-97e2-bd2979f78c5b.111019_UNC14-SN744_0180_AB01RFABXX.7.trimmed.annotated.translated_to_genomic.bam	30.8	1.7	0.13	58cfa83ce4b0c9d6adf72d20	UNCID_597424.1d3af406-750e-4b1f-97e2-bd2979f78c5b.111019_UNC14-SN744_0180_AB01RFABXX.7.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5710-01A	BB4A6123-5851-4E49-B859-606FFD2A4D11	Primary Tumor	Illumina HiSeq	4721C2EA-C748-4055-B826-DDD08E70736D	Kidney	57.0	A94BA305-AEC8-4C11-AF83-8F19A3AFAD07	1D3AF406-750E-4B1F-97E2-BD2979F78C5B	TCGA-B0-5710-01A-11R-1672-07	HG19	TCGA-B0-5710	TCGA-KIRC		s9143	University of North Carolina	University of Pittsburgh	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1672-07	True
13722.58cfa831e4b0c9d6adf6c34c	58cfa831e4b0c9d6adf6c34c	TCGA-CG-4476-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_8_rg.sorted.filtered.	WGS	TCGA-CG-4476-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_8_rg.sorted	TCGA-CG-4476-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_8_rg.sorted.bam	67.9	1.9	0.16	58cfa831e4b0c9d6adf6c34c	TCGA-CG-4476-10A-01D-1154_130815_VM001_0006_VMR0006CXX_s_8_rg.sorted.bam	Alive	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4476-10A	442D7415-D095-4962-8296-A14390BAD40A	Blood Derived Normal	Illumina HiSeq	a6ccc4b9-9b2d-4960-900b-4e637c691eee	Stomach	69.0	15D8F5B3-63C4-400A-83C3-49B0A68CA1EF	E6AEDF0B-5818-444A-A4F0-D374F531BDB5	TCGA-CG-4476-10A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4476	TCGA-STAD		s14829	Harvard Medical School	Indivumed	Germany	NO	T4b	N3a	Stomach  Adenocarcinoma  Diffuse Type	Stage III	1154-02	True
13767.58cfa82ee4b0c9d6adf6b100	58cfa82ee4b0c9d6adf6b100	TCGA-13-0801-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-0801-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-13-0801-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	309.0	1.8	0.17	58cfa82ee4b0c9d6adf6b100	TCGA-13-0801-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0801-01A	B8C3D99C-429B-42A3-B486-6FBCB90CC2E0	Primary Tumor	Illumina HiSeq	4ED4B8D7-672E-4DB9-8F4E-1349FC024A2C	Ovary	46.0	DFAF19B4-03B4-49D3-B39F-01AAEB897A2A	C51DEE3C-5047-4DDE-B454-2474DE5CF025	TCGA-13-0801-01A-01R-1564-13	GRCh37-lite	TCGA-13-0801	TCGA-OV		s17915	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13722.58cfa832e4b0c9d6adf6d47e	58cfa832e4b0c9d6adf6d47e	TCGA-V4-A9F4-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-V4-A9F4-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_8_rg.sorted	TCGA-V4-A9F4-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_8_rg.sorted.bam	11.51		0.15	58cfa832e4b0c9d6adf6d47e	TCGA-V4-A9F4-10A-01D-A40E_140715_SN1440_0193_BC4K41ACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F4-10A	4B9FD822-17AA-4A22-8E17-175A72931D5D	Blood Derived Normal	Illumina HiSeq	6e4d47f8-ee26-4117-9c28-2815eb3d97f8	Eye	41.0	C35C6BF5-3F7A-46F6-A9E0-626450A4B645	3263B1FD-DD80-4509-8F1E-02C0543A8030	TCGA-V4-A9F4-10A-01D-A40E-26	HG19_Broad_variant	TCGA-V4-A9F4	TCGA-UVM		s237	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0		Stage III	A40E-26	True
13767.58cfa836e4b0c9d6adf6f46b	58cfa836e4b0c9d6adf6f46b	UNCID_1565334.ba53832f-dfbc-4581-b7b1-cdc476174d72.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1565334.ba53832f-dfbc-4581-b7b1-cdc476174d72.sorted_genome_alignments	UNCID_1565334.ba53832f-dfbc-4581-b7b1-cdc476174d72.sorted_genome_alignments.bam	51.2		0.16	58cfa836e4b0c9d6adf6f46b	UNCID_1565334.ba53832f-dfbc-4581-b7b1-cdc476174d72.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HW-7495-01A	49967A57-7C12-46BB-8D71-CEBBB17C9935	Primary Tumor	Illumina HiSeq	D370D66A-2DDE-4C00-848D-C23FBCF3FEC2	Brain	45.0	1CCC7965-99A5-420A-B5AB-F9853B50E3B1	BA53832F-DFBC-4581-B7B1-CDC476174D72	TCGA-HW-7495-01A-11R-2027-07	HG19	TCGA-HW-7495	TCGA-LGG		s8174	University of North Carolina	MSKCC	United States	NO			Oligodendroglioma		2027-07	True
13767.58cfa82ee4b0c9d6adf6b1ca	58cfa82ee4b0c9d6adf6b1ca	TCGA-13-1507-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-1507-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-13-1507-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	231.0	1.8	0.15	58cfa82ee4b0c9d6adf6b1ca	TCGA-13-1507-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1507-01A	502E8D02-2953-4514-A2E1-6179DD94DA73	Primary Tumor	Illumina HiSeq	5A7C898A-A764-477E-ABCB-7F4F17B91AB6	Ovary	77.0	FCE7A055-F6EA-4DC3-A42F-51B8ED236CA7	41A5FA6B-4594-4EF8-B841-FE75C17A13C2	TCGA-13-1507-01A-01R-1565-13	GRCh37-lite	TCGA-13-1507	TCGA-OV		s17429	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa836e4b0c9d6adf6fc1b	58cfa836e4b0c9d6adf6fc1b	UNCID_1664788.40EA4BB8-CD20-4475-B9D2-4A611975AEB8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1664788.40EA4BB8-CD20-4475-B9D2-4A611975AEB8.sorted_genome_alignments	UNCID_1664788.40EA4BB8-CD20-4475-B9D2-4A611975AEB8.sorted_genome_alignments.bam	44.28	1.8	0.16	58cfa836e4b0c9d6adf6fc1b	UNCID_1664788.40EA4BB8-CD20-4475-B9D2-4A611975AEB8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A2MX-01A	59681E8F-CF57-47B4-82E1-6BE8EAD9583E	Primary Tumor	Illumina HiSeq	87AF5F16-28ED-4571-AB90-F4D827876B0F	Thyroid	27.0	A7B8C025-BDD4-4FD2-B3FD-47E5C0432F90	40EA4BB8-CD20-4475-B9D2-4A611975AEB8	TCGA-ET-A2MX-01A-11R-A23N-07	HG19	TCGA-ET-A2MX	TCGA-THCA		s12470	University of North Carolina	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23N-07	True
13722.58cfa82fe4b0c9d6adf6b8fe	58cfa82fe4b0c9d6adf6b8fe	TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted.filtered.	WGS	TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted	TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted.bam	62.7	1.9	0.15	58cfa82fe4b0c9d6adf6b8fe	TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-49-6744-01A	15340DD3-84AE-49FB-989A-EB212F3E73DA	Primary Tumor	Illumina HiSeq	8290093a-0193-41fa-8e87-71960e0e640e	Lung	64.0	A9D69D7E-298C-4AB6-B64F-1EDC58832CCD	7455D0A5-45DB-461F-9026-5A0FE3D55A6A	TCGA-49-6744-01A-11D-1853-02	HG19_Broad_variant	TCGA-49-6744	TCGA-LUAD		s10656	Harvard Medical School	Johns Hopkins	United States	NO	T2a	N1	Lung Adenocarcinoma Mixed Subtype	Stage II	1853-02	True
13767.58cfa837e4b0c9d6adf7013c	58cfa837e4b0c9d6adf7013c	UNCID_1797877.92c0e4e0-e7a5-486b-82f9-ba7621a10b83.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1797877.92c0e4e0-e7a5-486b-82f9-ba7621a10b83.sorted_genome_alignments	UNCID_1797877.92c0e4e0-e7a5-486b-82f9-ba7621a10b83.sorted_genome_alignments.bam	50.88	1.85	0.16	58cfa837e4b0c9d6adf7013c	UNCID_1797877.92c0e4e0-e7a5-486b-82f9-ba7621a10b83.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BC-A10X-01A	3DC48EA9-A3C6-437F-AF5A-88FEB300CC5F	Primary Tumor	Illumina HiSeq	575AA000-E315-4264-ABBD-89E2487FA677	Liver	52.0	1AE03BC9-DE5A-417C-A617-7256C8D2D9B8	92C0E4E0-E7A5-486B-82F9-BA7621A10B83	TCGA-BC-A10X-01A-11R-A131-07	HG19	TCGA-BC-A10X	TCGA-LIHC	770.0	s16703	University of North Carolina	UNC	United States	NO	T3a	N0	Hepatocellular Carcinoma	Stage III	A131-07	True
13767.58cfa838e4b0c9d6adf70ff6	58cfa838e4b0c9d6adf70ff6	UNCID_2193697.4ede0aec-1fdd-439f-800f-9ba681271b9a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2193697.4ede0aec-1fdd-439f-800f-9ba681271b9a.sorted_genome_alignments	UNCID_2193697.4ede0aec-1fdd-439f-800f-9ba681271b9a.sorted_genome_alignments.bam	13.09	1.87	0.15	58cfa838e4b0c9d6adf70ff6	UNCID_2193697.4ede0aec-1fdd-439f-800f-9ba681271b9a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-KV-A6GD-01A	E6831884-67A2-4CE4-BDFA-49E5E208EAE8	Primary Tumor	Illumina HiSeq	0E3CAF20-07D2-48E0-8408-B75D95AFC2A9	Kidney	85.0	FBCA0CCD-965C-489A-8DE7-F78D64B0ABF5	4EDE0AEC-1FDD-439F-800F-9BA681271B9A	TCGA-KV-A6GD-01A-11R-A31O-07	HG19	TCGA-KV-A6GD	TCGA-KIRP		s11618	University of North Carolina	Hartford	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A31O-07	True
13767.58cfa832e4b0c9d6adf6d668	58cfa832e4b0c9d6adf6d668	TCGA-Z6-A8JD-01A-11R-A36D-31_rnaseq.filtered.	RNA-Seq	TCGA-Z6-A8JD-01A-11R-A36D-31_rnaseq	TCGA-Z6-A8JD-01A-11R-A36D-31_rnaseq.bam	57.05	1.88	0.17	58cfa832e4b0c9d6adf6d668	TCGA-Z6-A8JD-01A-11R-A36D-31_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-Z6-A8JD-01A	B997D486-8C71-4926-9DF1-D2AFDAF2785F	Primary Tumor	Illumina HiSeq	81BB90A3-1D39-4E5E-AD71-2BD8A5A7F9F4	Esophagus	53.0	49C76C05-0274-457D-8710-56F28E1863CF	BD6C5D79-5F03-476A-BA01-03834083C7FF	TCGA-Z6-A8JD-01A-11R-A36D-31	GRCh37-lite	TCGA-Z6-A8JD	TCGA-ESCA		s1898	Canada's Michael Smith Genome Sciences Centre	Cureline	Russia	NO	T3	N0		Stage II	A36D-31	True
13767.58cfa83be4b0c9d6adf72a87	58cfa83be4b0c9d6adf72a87	UNCID_339035.TCGA-B0-4701-01A-01R-1277-07.110331_UNC11-SN627_0072_AB05NMABXX.6.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_339035.TCGA-B0-4701-01A-01R-1277-07.110331_UNC11-SN627_0072_AB05NMABXX.6.trimmed.annotated.translated_to_genomic	UNCID_339035.TCGA-B0-4701-01A-01R-1277-07.110331_UNC11-SN627_0072_AB05NMABXX.6.trimmed.annotated.translated_to_genomic.bam	69.3	1.8	0.15	58cfa83be4b0c9d6adf72a87	UNCID_339035.TCGA-B0-4701-01A-01R-1277-07.110331_UNC11-SN627_0072_AB05NMABXX.6.trimmed.annotated.translated_to_genomic.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4701-01A	6A7A0F51-336A-445D-8A05-8B8811894037	Primary Tumor	Illumina HiSeq	425B5155-EE4E-4048-9075-FE4575610E05	Kidney	66.0	227CD50A-F96C-4894-81B3-DF97DF98EB6E	485298B8-9432-4F8B-AC0F-20073CF82DFD	TCGA-B0-4701-01A-01R-1277-07	HG19	TCGA-B0-4701	TCGA-KIRC	238.0	s9248	University of North Carolina	University of Pittsburgh	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1277-07	True
13767.58cfa838e4b0c9d6adf7061c	58cfa838e4b0c9d6adf7061c	UNCID_1942235.cf069f54-b570-43ff-9f85-ababd06ddddd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1942235.cf069f54-b570-43ff-9f85-ababd06ddddd.sorted_genome_alignments	UNCID_1942235.cf069f54-b570-43ff-9f85-ababd06ddddd.sorted_genome_alignments.bam	156.2		0.15	58cfa838e4b0c9d6adf7061c	UNCID_1942235.cf069f54-b570-43ff-9f85-ababd06ddddd.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-8353-01A	4DB53B4C-2E5C-45EA-8577-4360C114E0C1	Primary Tumor	Illumina HiSeq	83D6A1B8-774F-4DA3-980D-11D89E53C8B4	Lung	72.0	42906E73-5225-4529-B8E1-5D11FB3248E8	CF069F54-B570-43FF-9F85-ABABD06DDDDD	TCGA-85-8353-01A-21R-2296-07	HG19	TCGA-85-8353	TCGA-LUSC		s10572	University of North Carolina	Asterand	Russia	NO	T3	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	2296-07	True
13767.58cfa837e4b0c9d6adf6ffac	58cfa837e4b0c9d6adf6ffac	UNCID_1809843.f8243dda-830f-4c7e-bde2-20bad21725d0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1809843.f8243dda-830f-4c7e-bde2-20bad21725d0.sorted_genome_alignments	UNCID_1809843.f8243dda-830f-4c7e-bde2-20bad21725d0.sorted_genome_alignments.bam	51.2		0.15	58cfa837e4b0c9d6adf6ffac	UNCID_1809843.f8243dda-830f-4c7e-bde2-20bad21725d0.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-68-7756-01A	C6DEBFBB-DE60-4D0D-AEC2-D8D514C1F313	Primary Tumor	Illumina HiSeq	F16E5D85-9B8C-4C2F-A084-B999B6D44D62	Lung	84.0	46227D4E-2EC4-42CC-9B59-82043699E9EE	F8243DDA-830F-4C7E-BDE2-20BAD21725D0	TCGA-68-7756-01A-11R-2125-07	HG19	TCGA-68-7756	TCGA-LUSC		s10437	University of North Carolina	Washington University - Cleveland Clinic	United States	NO	T4	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	2125-07	True
13722.58cfa82ee4b0c9d6adf6afbe	58cfa82ee4b0c9d6adf6afbe	TCGA-05-4427-10A-01D-1853_120228_SN1120_0117_BC0DKWACXX_s_2_rg.sorted.filtered.	WGS	TCGA-05-4427-10A-01D-1853_120228_SN1120_0117_BC0DKWACXX_s_2_rg.sorted	TCGA-05-4427-10A-01D-1853_120228_SN1120_0117_BC0DKWACXX_s_2_rg.sorted.bam	112.0	1.9	0.14	58cfa82ee4b0c9d6adf6afbe	TCGA-05-4427-10A-01D-1853_120228_SN1120_0117_BC0DKWACXX_s_2_rg.sorted.bam	Alive	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4427-10A	78A24C56-576C-4245-BB42-6603B3D19897	Blood Derived Normal	Illumina HiSeq	9d47bafd-adc4-4120-b715-fe1ecbf86b82	Lung	65.0	3F3A0974-5AAD-4895-8153-B95D0D46595D	D161ED6B-FA73-4243-BFFD-921D92DB4E13	TCGA-05-4427-10A-01D-1853-02	HG19_Broad_variant	TCGA-05-4427	TCGA-LUAD		s10985	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage II	1853-02	True
13767.58cfa83ae4b0c9d6adf71836	58cfa83ae4b0c9d6adf71836	UNCID_2349755.635c048b-b3a3-4321-985d-4896ec4af74c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2349755.635c048b-b3a3-4321-985d-4896ec4af74c.sorted_genome_alignments	UNCID_2349755.635c048b-b3a3-4321-985d-4896ec4af74c.sorted_genome_alignments.bam	32.24	1.85	0.18	58cfa83ae4b0c9d6adf71836	UNCID_2349755.635c048b-b3a3-4321-985d-4896ec4af74c.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Mesothelioma	Aligned reads	TCGA-LK-A4O5-01A	9AD7575D-2AD4-4FDA-8176-55145396F04A	Primary Tumor	Illumina HiSeq	8EC62E84-1F9A-40D9-836A-FB703647008C	Mesothelium	68.0	2EAE8928-E40E-4E07-A032-C69B2D6023FE	635C048B-B3A3-4321-985D-4896EC4AF74C	TCGA-LK-A4O5-01A-11R-A34F-07	HG19	TCGA-LK-A4O5	TCGA-MESO		s396	University of North Carolina	University of Pittsburgh	United States	NO	T3	N0		Stage III	A34F-07	True
13767.58cfa83ce4b0c9d6adf72cb6	58cfa83ce4b0c9d6adf72cb6	UNCID_554515.52917ca9-123b-4366-a852-99bcb5982284.111006_UNC11-SN627_0158_BB01Y8ABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_554515.52917ca9-123b-4366-a852-99bcb5982284.111006_UNC11-SN627_0158_BB01Y8ABXX.5.trimmed.annotated.translated_to_genomic	UNCID_554515.52917ca9-123b-4366-a852-99bcb5982284.111006_UNC11-SN627_0158_BB01Y8ABXX.5.trimmed.annotated.translated_to_genomic.bam	89.3	1.8	0.15	58cfa83ce4b0c9d6adf72cb6	UNCID_554515.52917ca9-123b-4366-a852-99bcb5982284.111006_UNC11-SN627_0158_BB01Y8ABXX.5.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4816-01A	44130745-0B09-4201-829F-CC634F462D3B	Primary Tumor	Illumina HiSeq	4B261A54-071B-4CB4-ADB6-FC393FBDC111	Kidney	49.0	D05C3419-4164-4A69-8B11-CE1F5C29B5D4	52917CA9-123B-4366-A852-99BCB5982284	TCGA-B0-4816-01A-01R-1503-07	HG19	TCGA-B0-4816	TCGA-KIRC	1371.0	s9916	University of North Carolina	University of Pittsburgh	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage II	1503-07	True
13767.58cfa833e4b0c9d6adf6dc82	58cfa833e4b0c9d6adf6dc82	UNCID_1119234.9efdba02-2752-4c89-bb53-e8018f5aa7bf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1119234.9efdba02-2752-4c89-bb53-e8018f5aa7bf.sorted_genome_alignments	UNCID_1119234.9efdba02-2752-4c89-bb53-e8018f5aa7bf.sorted_genome_alignments.bam	38.92	1.85	0.15	58cfa833e4b0c9d6adf6dc82	UNCID_1119234.9efdba02-2752-4c89-bb53-e8018f5aa7bf.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A1-A0SQ-01A	08DE63A2-7B76-43C3-80DC-DF748B1D81BC	Primary Tumor	Illumina HiSeq	0444ED2D-5D87-40F9-8442-208AEBDFB257	Breast	45.0	58D073A2-68B8-4F48-BA5E-020258ABEF71	9EFDBA02-2752-4C89-BB53-E8018F5AA7BF	TCGA-A1-A0SQ-01A-21R-A144-07	HG19	TCGA-A1-A0SQ	TCGA-BRCA		s6486	University of North Carolina	UCSF	United States	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A144-07	True
13722.58cfa832e4b0c9d6adf6d0c9	58cfa832e4b0c9d6adf6d0c9	TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted	TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted.bam	34.41		0.15	58cfa832e4b0c9d6adf6d0c9	TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A3YB-01A	A1A233EA-5DDA-4EEB-BD92-6667E8B3EF57	Primary Tumor	Illumina HiSeq	6b51ea9f-5ca3-4973-bc0f-8df5ae95abbd	Esophagus	61.0	F936DE42-1441-4C4C-882A-DC67D332C125	335AAD40-B278-4EEC-BEE6-FC4F77C63370	TCGA-IG-A3YB-01A-11D-A248-26	HG19_Broad_variant	TCGA-IG-A3YB	TCGA-ESCA		s1911	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T3	N1		Stage III	A248-26	True
13767.58cfa834e4b0c9d6adf6e488	58cfa834e4b0c9d6adf6e488	UNCID_1206017.4a74dbdf-f817-47ce-a162-415535183bf4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1206017.4a74dbdf-f817-47ce-a162-415535183bf4.sorted_genome_alignments	UNCID_1206017.4a74dbdf-f817-47ce-a162-415535183bf4.sorted_genome_alignments.bam	16.44	1.69	0.16	58cfa834e4b0c9d6adf6e488	UNCID_1206017.4a74dbdf-f817-47ce-a162-415535183bf4.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A2JK-06A	D7F251C3-8312-47D8-A9CC-2917D2284CC3	Metastatic	Illumina HiSeq	7527B67E-8E3F-4987-B4DE-6501B780115A	Skin	24.0	2236F8D1-C74B-4CC7-ACF0-F98A995E0432	4A74DBDF-F817-47CE-A162-415535183BF4	TCGA-D3-A2JK-06A-11R-A18S-07	HG19	TCGA-D3-A2JK	TCGA-SKCM	368.0	s7714	University of North Carolina	MD Anderson	United States	NO	T4b	N2b		Stage III	A18S-07	True
13767.58cfa836e4b0c9d6adf6fc68	58cfa836e4b0c9d6adf6fc68	UNCID_1664755.854C8055-70C4-404E-A0B7-1D6084430B0B.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1664755.854C8055-70C4-404E-A0B7-1D6084430B0B.sorted_genome_alignments	UNCID_1664755.854C8055-70C4-404E-A0B7-1D6084430B0B.sorted_genome_alignments.bam	13.24	1.82	0.16	58cfa836e4b0c9d6adf6fc68	UNCID_1664755.854C8055-70C4-404E-A0B7-1D6084430B0B.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Thyroid Carcinoma	Aligned reads	TCGA-KS-A41J-11A	23AD7900-4E99-4ABF-82FF-71EDEAA8A51C	Solid Tissue Normal	Illumina HiSeq	9ED17E70-B030-4F8C-AC45-3A51CEDAEA3A	Thyroid	28.0	5C837324-73A6-402F-9F67-CB8D13AFBB9D	854C8055-70C4-404E-A0B7-1D6084430B0B	TCGA-KS-A41J-11A-12R-A23N-07	HG19	TCGA-KS-A41J	TCGA-THCA		s12707	University of North Carolina	University of Michigan	United States	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23N-07	True
13767.58cfa833e4b0c9d6adf6d858	58cfa833e4b0c9d6adf6d858	UNCID_1072523.b6cbe950-44d8-4da9-ba79-116f25015278.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1072523.b6cbe950-44d8-4da9-ba79-116f25015278.sorted_genome_alignments	UNCID_1072523.b6cbe950-44d8-4da9-ba79-116f25015278.sorted_genome_alignments.bam	265.3	1.8	0.15	58cfa833e4b0c9d6adf6d858	UNCID_1072523.b6cbe950-44d8-4da9-ba79-116f25015278.sorted_genome_alignments.bam	Dead	MALE	WHITE		Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-5477-01A	BD15F523-45C4-4D7C-A3CC-4FB56ABB0E54	Primary Tumor	Illumina HiSeq	69F9C36D-0D35-4B94-AD64-EF3CE2B261C1	Lung	65.0	F9D568B1-6951-4EAF-8867-4C86BDAEAA04	B6CBE950-44D8-4DA9-BA79-116F25015278	TCGA-22-5477-01A-01R-1635-07	HG19	TCGA-22-5477	TCGA-LUSC	1346.0	s10114	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1635-07	True
13767.58cfa82ee4b0c9d6adf6b0a7	58cfa82ee4b0c9d6adf6b0a7	TCGA-13-1405-01A-01R-1565-13_rnaseq.filtered.	RNA-Seq	TCGA-13-1405-01A-01R-1565-13_rnaseq	TCGA-13-1405-01A-01R-1565-13_rnaseq.bam	610.0	1.8	0.17	58cfa82ee4b0c9d6adf6b0a7	TCGA-13-1405-01A-01R-1565-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1405-01A	29DCCD25-4C4A-463B-A353-38A193337F38	Primary Tumor	Illumina HiSeq	EB4EDF25-0FD3-4C87-8267-76BB0F740AB4	Ovary	49.0	D900CEBF-8795-4385-8F57-77209178FF43	044D949F-0EB4-44C9-8327-90226936FC7C	TCGA-13-1405-01A-01R-1565-13	NCBI36_BCCAGSC_variant	TCGA-13-1405	TCGA-OV		s18098	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa839e4b0c9d6adf71570	58cfa839e4b0c9d6adf71570	UNCID_2357355.b53cf9af-aa70-416e-b430-1271660c6841.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2357355.b53cf9af-aa70-416e-b430-1271660c6841.sorted_genome_alignments	UNCID_2357355.b53cf9af-aa70-416e-b430-1271660c6841.sorted_genome_alignments.bam	40.55	1.83	0.17	58cfa839e4b0c9d6adf71570	UNCID_2357355.b53cf9af-aa70-416e-b430-1271660c6841.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-PR-A5PF-01A	F36583AF-CC6B-4985-8D11-307970D11008	Primary Tumor	Illumina HiSeq	9539F86B-D2DC-403A-BA3B-B5DFEDDD855C	Nervous System	62.0	0DA6422B-90E0-4D14-99DD-55DB30DE5D61	B53CF9AF-AA70-416E-B430-1271660C6841	TCGA-PR-A5PF-01A-11R-A35K-07	HG19	TCGA-PR-A5PF	TCGA-PCPG		s922	University of North Carolina	Roswell Park	United States	NO					A35K-07	True
13767.58cfa838e4b0c9d6adf70f96	58cfa838e4b0c9d6adf70f96	UNCID_2191919.84dff8b1-e381-4f41-a05c-04524aca78b3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2191919.84dff8b1-e381-4f41-a05c-04524aca78b3.sorted_genome_alignments	UNCID_2191919.84dff8b1-e381-4f41-a05c-04524aca78b3.sorted_genome_alignments.bam	46.73	1.89	0.18	58cfa838e4b0c9d6adf70f96	UNCID_2191919.84dff8b1-e381-4f41-a05c-04524aca78b3.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-A5W7-01A	F0446AED-9B4B-4E77-8708-88F239F2B671	Primary Tumor	Illumina HiSeq	F7D1B167-C248-4F18-8FA5-B0791F4B1FF7	Kidney	47.0	551CB44F-38F6-4C7E-AA9A-A8D95175F2F6	84DFF8B1-E381-4F41-A05C-04524ACA78B3	TCGA-B9-A5W7-01A-11R-A31O-07	HG19	TCGA-B9-A5W7	TCGA-KIRP		s11617	University of North Carolina	UNC	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A31O-07	True
13722.58cfa832e4b0c9d6adf6ced3	58cfa832e4b0c9d6adf6ced3	TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted	TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted.bam	188.7	1.9	0.15	58cfa832e4b0c9d6adf6ced3	TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5527-01A	BA0C9096-5F35-4F0A-AE98-EE1A695B55F0	Primary Tumor	Illumina HiSeq	62c0aaa3-44c3-4b25-b1cb-8e6196d66189	Prostate	69.0	15A638FE-4DFD-4280-AD40-5E0D5FDE3812	AE85C536-0580-4A34-B686-161D337E7951	TCGA-EJ-5527-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5527	TCGA-PRAD		s3443	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1572-02	True
13722.58cfa832e4b0c9d6adf6d2d2	58cfa832e4b0c9d6adf6d2d2	TCGA-KL-8346-11A-01D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8346-11A-01D-2310-10_wgs_Illumina	TCGA-KL-8346-11A-01D-2310-10_wgs_Illumina.bam	187.8		0.05	58cfa832e4b0c9d6adf6d2d2	TCGA-KL-8346-11A-01D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8346-11A	A122D361-835E-4CF2-850F-AF7864AA112C	Solid Tissue Normal	Illumina HiSeq	7912daa1-e634-487d-ad82-43698738c0b0	Kidney	62.0	9D387257-A798-4CAB-9EAB-1FA285D618A8	684B307D-9053-47DC-B223-A5B491327703	TCGA-KL-8346-11A-01D-2310-10	GRCh37-lite	TCGA-KL-8346	TCGA-KICH		s16482	Baylor College of Medicine	MSKCC	United States	NO	T2b	N0	Kidney Chromophobe	Stage II	2310-10	True
13767.58cfa83ce4b0c9d6adf72d4e	58cfa83ce4b0c9d6adf72d4e	UNCID_618678.14c027ea-836d-4402-b0c4-9feb68e523fa.110926_UNC10-SN254_0279_AD0E60ABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_618678.14c027ea-836d-4402-b0c4-9feb68e523fa.110926_UNC10-SN254_0279_AD0E60ABXX.7.trimmed.annotated.translated_to_genomic	UNCID_618678.14c027ea-836d-4402-b0c4-9feb68e523fa.110926_UNC10-SN254_0279_AD0E60ABXX.7.trimmed.annotated.translated_to_genomic.bam	41.8	1.7	0.14	58cfa83ce4b0c9d6adf72d4e	UNCID_618678.14c027ea-836d-4402-b0c4-9feb68e523fa.110926_UNC10-SN254_0279_AD0E60ABXX.7.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-5584-01A	09C4EA05-928D-49B7-B7FB-30CFF3481B14	Primary Tumor	Illumina HiSeq	E00E9ADC-2B59-4EFD-8AF4-A4F8AFA30124	Kidney	74.0	509069C7-21FC-41FB-80DD-99F1BCDDE5A8	14C027EA-836D-4402-B0C4-9FEB68E523FA	TCGA-CW-5584-01A-01R-1541-07	HG19	TCGA-CW-5584	TCGA-KIRC	164.0	s9557	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T3b	N1	Kidney Clear Cell Renal Carcinoma	Stage III	1541-07	True
13767.58cfa839e4b0c9d6adf710be	58cfa839e4b0c9d6adf710be	UNCID_2250213.327c179d-b8d0-4e9b-9e0a-54d1b2e649b2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2250213.327c179d-b8d0-4e9b-9e0a-54d1b2e649b2.sorted_genome_alignments	UNCID_2250213.327c179d-b8d0-4e9b-9e0a-54d1b2e649b2.sorted_genome_alignments.bam	9.18	1.87	0.17	58cfa839e4b0c9d6adf710be	UNCID_2250213.327c179d-b8d0-4e9b-9e0a-54d1b2e649b2.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FR-A726-01A	49F961AF-1126-431D-93CD-18941C1738F3	Primary Tumor	Illumina HiSeq	8C24AEA1-1110-4B71-BAA5-C16E1075FF35	Skin	90.0	010D3625-4234-49A2-8864-A4D3809AF628	327C179D-B8D0-4E9B-9E0A-54D1B2E649B2	TCGA-FR-A726-01A-11R-A32P-07	HG19	TCGA-FR-A726	TCGA-SKCM		s7627	University of North Carolina	University of North Carolina	United States	NO	T4b	N0		Stage II	A32P-07	True
13767.58cfa835e4b0c9d6adf6ebf8	58cfa835e4b0c9d6adf6ebf8	UNCID_1281705.d02d5b10-3d8e-4ecb-a644-b8fb547e6cf4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1281705.d02d5b10-3d8e-4ecb-a644-b8fb547e6cf4.sorted_genome_alignments	UNCID_1281705.d02d5b10-3d8e-4ecb-a644-b8fb547e6cf4.sorted_genome_alignments.bam	19.8	1.8	0.15	58cfa835e4b0c9d6adf6ebf8	UNCID_1281705.d02d5b10-3d8e-4ecb-a644-b8fb547e6cf4.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-BQ-5878-11A	C793250D-1553-48E1-B6B2-AAFFDFE5D39B	Solid Tissue Normal	Illumina HiSeq	82D579CC-B344-4BC1-8FB4-CE5A1ECDFBAD	Kidney	79.0	F4A921B0-3672-4401-A17D-042CC4D0D124	D02D5B10-3D8E-4ECB-A644-B8FB547E6CF4	TCGA-BQ-5878-11A-01R-1592-07	HG19	TCGA-BQ-5878	TCGA-KIRP		s11883	University of North Carolina	MSKCC	None	NO	T3a	N1	Kidney Papillary Renal Cell Carcinoma	Stage III	1592-07	True
13767.58cfa83be4b0c9d6adf71f76	58cfa83be4b0c9d6adf71f76	UNCID_2538528.b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2538528.b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00.sorted_genome_alignments	UNCID_2538528.b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00.sorted_genome_alignments.bam	23.1	1.96	0.18	58cfa83be4b0c9d6adf71f76	UNCID_2538528.b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-S2-AA1A-01A	31458638-E19C-43E5-AB13-9C64B3B3681D	Primary Tumor	Illumina HiSeq	40069B31-6E73-453D-8F72-E60291CAB7D5	Lung	68.0	A28CC4B4-4819-41EF-ADF7-34EE50E29BA6	B129C3F7-A2FF-40BA-91B0-A9C96F1E2B00	TCGA-S2-AA1A-01A-12R-A39D-07	HG19	TCGA-S2-AA1A	TCGA-LUAD		s10887	University of North Carolina	Albert Einstein Medical Center	United States	NO	T1b	N0	Lung Bronchioloalveolar Carcinoma Mucinous	Stage I	A39D-07	True
13722.58cfa831e4b0c9d6adf6c7f3	58cfa831e4b0c9d6adf6c7f3	TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted	TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted.bam	414.0	1.87	0.14	58cfa831e4b0c9d6adf6c7f3	TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-5577-01A	2DC154AA-C478-404B-A92E-86ABCC8DBDB7	Primary Tumor	Illumina HiSeq	e417c8be-9c96-4e81-a2c9-ac3f23791347	Stomach	53.0	93BBD9FD-2385-46C3-AF21-E46C72A8A75D	8FCA6D2A-04D8-4A60-AEA3-298853E74752	TCGA-D7-5577-01A-01D-1598-02	HG19_Broad_variant	TCGA-D7-5577	TCGA-STAD		s14908	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N3	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	1598-02	True
13767.58cfa839e4b0c9d6adf713ae	58cfa839e4b0c9d6adf713ae	UNCID_2308080.8d017f32-1008-4312-b94e-a98be428973f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2308080.8d017f32-1008-4312-b94e-a98be428973f.sorted_genome_alignments	UNCID_2308080.8d017f32-1008-4312-b94e-a98be428973f.sorted_genome_alignments.bam	53.95	1.88	0.18	58cfa839e4b0c9d6adf713ae	UNCID_2308080.8d017f32-1008-4312-b94e-a98be428973f.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-A7IH-01A	E4E0BC11-AD61-4419-857C-44FB5C7877A3	Primary Tumor	Illumina HiSeq	0D7F376D-6685-4136-A142-849D6961DCC2	Liver	58.0	40F9F3B1-545D-4743-912C-9C92AAC5F396	8D017F32-1008-4312-B94E-A98BE428973F	TCGA-CC-A7IH-01A-11R-A33J-07	HG19	TCGA-CC-A7IH	TCGA-LIHC		s16920	University of North Carolina	ILSbio	Vietnam	NO	T3	N0	Hepatocellular Carcinoma	Stage III	A33J-07	True
13722.58cfa82ee4b0c9d6adf6ac5e	58cfa82ee4b0c9d6adf6ac5e	G39019.TCGA-DA-A1I2-06A-21D-A19A-08.1.filtered.	WGS	G39019.TCGA-DA-A1I2-06A-21D-A19A-08.1	G39019.TCGA-DA-A1I2-06A-21D-A19A-08.1.bam	65.65		0.09	58cfa82ee4b0c9d6adf6ac5e	G39019.TCGA-DA-A1I2-06A-21D-A19A-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-DA-A1I2-06A	01AD975D-C2ED-4E4D-BD3B-C9512FC9073C	Metastatic	Illumina HiSeq	def664f3-25fc-4633-96bd-8ebf1a179021	Skin	45.0	1E373C9C-DDB0-4C77-87AF-468EE586F998	D432E99A-67FB-4609-B90F-99438EEE7CAE	TCGA-DA-A1I2-06A-21D-A19A-08	HG19_Broad_variant	TCGA-DA-A1I2	TCGA-SKCM		s7814	Broad Institute of MIT and Harvard	Yale	United States	NO	T4b	N2b		Stage III	A19A-08	True
13722.58cfa82ee4b0c9d6adf6aa40	58cfa82ee4b0c9d6adf6aa40	G26402.TCGA-06-2570-10A-01D-1495-08.1.filtered.	WGS	G26402.TCGA-06-2570-10A-01D-1495-08.1	G26402.TCGA-06-2570-10A-01D-1495-08.1.bam	120.0	1.9	0.05	58cfa82ee4b0c9d6adf6aa40	G26402.TCGA-06-2570-10A-01D-1495-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-2570-10A	B37D944C-C65C-46D6-BB8B-3EB37CB85B68	Blood Derived Normal	Illumina HiSeq	77f02364-41bf-40bd-b1db-7b5ee0760e38	Brain	21.0	E36E3BF5-C133-4297-ACCC-80C05C7F0AB3	ABEF86C9-DF6A-477E-99E9-B8D2AC0641D0	TCGA-06-2570-10A-01D-1495-08	HG19_Broad_variant	TCGA-06-2570	TCGA-GBM		s14265	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1495-08	False
13767.58cfa839e4b0c9d6adf710d1	58cfa839e4b0c9d6adf710d1	UNCID_2257236.d7632cab-ab0e-4a4c-a051-0bb8965918ff.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2257236.d7632cab-ab0e-4a4c-a051-0bb8965918ff.sorted_genome_alignments	UNCID_2257236.d7632cab-ab0e-4a4c-a051-0bb8965918ff.sorted_genome_alignments.bam	40.68	1.83	0.18	58cfa839e4b0c9d6adf710d1	UNCID_2257236.d7632cab-ab0e-4a4c-a051-0bb8965918ff.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-DM-A28A-01A	9B2C325C-1F03-43C7-AD5C-B49C6D205635	Primary Tumor	Illumina HiSeq	B2382BB5-A1BE-4F50-9257-FC6370DBD15B	Colorectal	78.0	5AB15B14-D6C2-4900-ADD7-24E3B8DF2680	D7632CAB-AB0E-4A4C-A051-0BB8965918FF	TCGA-DM-A28A-01A-21R-A32Y-07	HG19	TCGA-DM-A28A	TCGA-COAD	805.0	s13782	University of North Carolina	University of Michigan	Israel	NO	T3	N2	Colon Adenocarcinoma	Stage III	A32Y-07	True
13767.58cfa837e4b0c9d6adf702c0	58cfa837e4b0c9d6adf702c0	UNCID_1927246.a36865ec-a5fa-4277-a887-325373acadb1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1927246.a36865ec-a5fa-4277-a887-325373acadb1.sorted_genome_alignments	UNCID_1927246.a36865ec-a5fa-4277-a887-325373acadb1.sorted_genome_alignments.bam	16.74	1.8	0.16	58cfa837e4b0c9d6adf702c0	UNCID_1927246.a36865ec-a5fa-4277-a887-325373acadb1.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A43S-01A	77236911-D9E0-4B85-829A-A98F1E4B92D2	Primary Tumor	Illumina HiSeq	C002762C-27CB-421F-97E3-218901601EF2	Bladder	71.0	6EB06B71-55D3-4356-8198-BB2643C29E45	A36865EC-A5FA-4277-A887-325373ACADB1	TCGA-FD-A43S-01A-21R-A23W-07	HG19	TCGA-FD-A43S	TCGA-BLCA		s3346	University of North Carolina	BLN - University Of Chicago	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A23W-07	True
13767.58cfa83ce4b0c9d6adf72ffe	58cfa83ce4b0c9d6adf72ffe	_1_TCGA-HU-A4H2-01A-11R-A251-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-HU-A4H2-01A-11R-A251-31_rnaseq	_1_TCGA-HU-A4H2-01A-11R-A251-31_rnaseq.bam	73.53	1.81	0.16	58cfa83ce4b0c9d6adf72ffe	_1_TCGA-HU-A4H2-01A-11R-A251-31_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4H2-01A	7B594344-573D-46A0-B735-6727F6F15585	Primary Tumor	Illumina HiSeq	4A46244E-AC69-4C2D-B521-8BB0EC7D8B48	Stomach	58.0	79787A68-78E6-4FBE-9FA8-FFF839E9534D	C563F7E8-E92A-446A-ABDB-0AA680D50E8C	TCGA-HU-A4H2-01A-11R-A251-31	GRCh37-lite	TCGA-HU-A4H2	TCGA-STAD		s14874	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T3	N3b	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	A251-31	True
13722.58cfa832e4b0c9d6adf6cecb	58cfa832e4b0c9d6adf6cecb	TCGA-EM-A3O3-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EM-A3O3-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_6_rg.sorted	TCGA-EM-A3O3-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_6_rg.sorted.bam	74.0		0.15	58cfa832e4b0c9d6adf6cecb	TCGA-EM-A3O3-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_6_rg.sorted.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A3O3-10A	2A398AF1-AEA5-4AAE-AB00-A2DC152F965A	Blood Derived Normal	Illumina HiSeq	3a397284-a4e0-4b4d-bcfc-8a9df5e73588	Thyroid	83.0	0F899B5B-6290-4C1E-94F2-2C98F06011D1	C9FDBBBB-FC72-494D-98BC-CDB6D98F618A	TCGA-EM-A3O3-10A-01D-A221-26	HG19_Broad_variant	TCGA-EM-A3O3	TCGA-THCA		s11998	MD Anderson - Institute for Applied Cancer Science	University Health Network	Canada	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A221-26	True
13722.58cfa82de4b0c9d6adf6a596	58cfa82de4b0c9d6adf6a596	5f3d3040681cc587e66a46c6fe973f92.filtered.	WGS	5f3d3040681cc587e66a46c6fe973f92	5f3d3040681cc587e66a46c6fe973f92.bam	97.64	1.84	0.08	58cfa82de4b0c9d6adf6a596	5f3d3040681cc587e66a46c6fe973f92.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-DS-A0VL-01A	DFD30F94-19E3-4838-95DF-14A3763419AF	Primary Tumor	Illumina HiSeq	2c9bc14c-a6d3-4389-8360-024e9c04a5d4	Cervix	25.0	CDF4AB19-F243-4EFC-A5DC-8253CBE48845	E07991A4-0901-4ED1-8704-AA376565D862	TCGA-DS-A0VL-01A-21D-A200-09	GRCh37-lite	TCGA-DS-A0VL	TCGA-CESC		s1350	Washington University School of Medicine	Cedars Sinai	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma		A200-09	True
13722.58cfa831e4b0c9d6adf6c849	58cfa831e4b0c9d6adf6c849	TCGA-D7-6525-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_8_rg.sorted.filtered.	WGS	TCGA-D7-6525-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_8_rg.sorted	TCGA-D7-6525-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_8_rg.sorted.bam	270.0	1.9	0.16	58cfa831e4b0c9d6adf6c849	TCGA-D7-6525-10A-01D-1798_130214_SN1120_0237_BD1TGLACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6525-10A	82F9A197-040D-4C5E-89D9-D87A7AA0168D	Blood Derived Normal	Illumina HiSeq	f95ec729-b7a8-4b1f-9c2c-ef00b3a74a77	Stomach	58.0	A523DD59-E6A8-4E71-AF54-E8064F3CDE61	11034761-0AB1-435A-A8A9-1F362E312403	TCGA-D7-6525-10A-01D-1798-02	HG19_Broad_variant	TCGA-D7-6525	TCGA-STAD		s14558	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage III	1798-02	True
13767.58cfa82ee4b0c9d6adf6a9e8	58cfa82ee4b0c9d6adf6a9e8	G17663.TCGA-19-2619-01A-01R-1850-01.2.filtered.	RNA-Seq	G17663.TCGA-19-2619-01A-01R-1850-01.2	G17663.TCGA-19-2619-01A-01R-1850-01.2.bam	243.7	1.8	0.15	58cfa82ee4b0c9d6adf6a9e8	G17663.TCGA-19-2619-01A-01R-1850-01.2.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-2619-01A	F2DE4316-026C-4C2D-B091-47BC0EC8612A	Primary Tumor	Illumina HiSeq	505DB837-697E-4049-8505-486D0669CC66	Brain	55.0	BC1FA4FB-9B73-460F-9C4D-D1180C3ABBA8	ADAFA15C-5834-427E-BC93-24D3C4F775A9	TCGA-19-2619-01A-01R-1850-01	HG19_Broad_variant	TCGA-19-2619	TCGA-GBM		s14292	Broad Institute of MIT and Harvard	Case Western	None	NO			Untreated primary (de novo) GBM		1850-01	True
13767.58cfa839e4b0c9d6adf710d5	58cfa839e4b0c9d6adf710d5	UNCID_2250859.02c76d24-f1d2-4029-95b4-8be3bda8fdbe.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2250859.02c76d24-f1d2-4029-95b4-8be3bda8fdbe.sorted_genome_alignments	UNCID_2250859.02c76d24-f1d2-4029-95b4-8be3bda8fdbe.sorted_genome_alignments.bam	30.26	1.85	0.18	58cfa839e4b0c9d6adf710d5	UNCID_2250859.02c76d24-f1d2-4029-95b4-8be3bda8fdbe.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A5VV-06A	080BB1F8-F20C-4DAA-9DE3-B5782B69583C	Metastatic	Illumina HiSeq	EF4D112D-14D5-43E7-9497-3E820BC64DC2	Skin	74.0	A676470F-101D-4FB2-A9B3-382F88570E4A	02C76D24-F1D2-4029-95B4-8BE3BDA8FDBE	TCGA-EB-A5VV-06A-11R-A32P-07	HG19	TCGA-EB-A5VV	TCGA-SKCM		s8084	University of North Carolina	Asterand	Ukraine	NO	T3b	N1		Stage III	A32P-07	True
13767.58cfa835e4b0c9d6adf6ebfa	58cfa835e4b0c9d6adf6ebfa	UNCID_1285414.a9b12880-decd-416f-805b-f3484cd25e8a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1285414.a9b12880-decd-416f-805b-f3484cd25e8a.sorted_genome_alignments	UNCID_1285414.a9b12880-decd-416f-805b-f3484cd25e8a.sorted_genome_alignments.bam	35.74	1.84	0.16	58cfa835e4b0c9d6adf6ebfa	UNCID_1285414.a9b12880-decd-416f-805b-f3484cd25e8a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2GK-06A	F18CFE4A-FFFD-4E09-9EEF-343BA9FFD0D1	Metastatic	Illumina HiSeq	23323283-0E33-48A7-94C0-DDFA20631BBE	Skin	46.0	AB987A54-03BF-4AE8-A1C4-3FFF5C495A6A	A9B12880-DECD-416F-805B-F3484CD25E8A	TCGA-EE-A2GK-06A-11R-A18S-07	HG19	TCGA-EE-A2GK	TCGA-SKCM		s7920	University of North Carolina	University of Sydney	Australia	NO	T1	N0		Stage I	A18S-07	True
13722.58cfa830e4b0c9d6adf6c298	58cfa830e4b0c9d6adf6c298	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.bam	48.65	2.08	0.16	58cfa830e4b0c9d6adf6c298	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0GY-01A	7D9D3522-EC3B-4EFE-8C8E-C0E675276EF5	Primary Tumor	Illumina HiSeq	bcac7e1b-ddeb-43d6-ba44-db40336bf564	Breast	67.0	A7E71EAC-1768-4FC2-8EBA-1576D22E0F43	F5C72179-9BDA-4BC6-B006-93EB616804BC	TCGA-BH-A0GY-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0GY	TCGA-BRCA		s6771	Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A060-02	True
13767.58cfa838e4b0c9d6adf70a44	58cfa838e4b0c9d6adf70a44	UNCID_2075246.3d8fc38f-1005-47c9-adb7-62525f5ccfad.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2075246.3d8fc38f-1005-47c9-adb7-62525f5ccfad.sorted_genome_alignments	UNCID_2075246.3d8fc38f-1005-47c9-adb7-62525f5ccfad.sorted_genome_alignments.bam	26.28	1.86	0.17	58cfa838e4b0c9d6adf70a44	UNCID_2075246.3d8fc38f-1005-47c9-adb7-62525f5ccfad.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-A512-01A	BCB6447F-3E4C-44FE-AFC3-100D5DBE9BA2	Primary Tumor	Illumina HiSeq	C4FD709E-9467-415C-AB56-FED6405B195E	Lung	46.0	2C02E281-D84C-4D1B-A89C-C48439BECC39	3D8FC38F-1005-47C9-ADB7-62525F5CCFAD	TCGA-85-A512-01A-11R-A26W-07	HG19	TCGA-85-A512	TCGA-LUSC		s10341	University of North Carolina	Asterand	Russia	NO	T1b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A26W-07	True
13722.58cfa831e4b0c9d6adf6c949	58cfa831e4b0c9d6adf6c949	TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted	TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.bam	21.24	1.93	0.16	58cfa831e4b0c9d6adf6c949	TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13O-01A	77D5B246-33BA-4A96-9D73-06ACA797653E	Primary Tumor	Illumina HiSeq	ae4a78d9-4c9a-40f7-9612-17d11799ea67	Thyroid	56.0	457B11C0-3C36-4907-8C76-60E3861EBABB	EC713290-9998-489B-9D1E-CC9D33CF5428	TCGA-DJ-A13O-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13O	TCGA-THCA		s12241	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A10R-02	True
13767.58cfa834e4b0c9d6adf6e35c	58cfa834e4b0c9d6adf6e35c	UNCID_1187218.2738c180-bd2d-47af-9809-4ab4e313ce15.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1187218.2738c180-bd2d-47af-9809-4ab4e313ce15.sorted_genome_alignments	UNCID_1187218.2738c180-bd2d-47af-9809-4ab4e313ce15.sorted_genome_alignments.bam	98.8	1.8	0.14	58cfa834e4b0c9d6adf6e35c	UNCID_1187218.2738c180-bd2d-47af-9809-4ab4e313ce15.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-5591-11A	F1AE0181-74F8-47FD-83BE-83A7D01101CC	Solid Tissue Normal	Illumina HiSeq	2D84D591-2531-469E-9CD6-B1220A64FFCD	Kidney	56.0	89D874E8-C997-474F-9A0F-9B232582BD31	2738C180-BD2D-47AF-9809-4AB4E313CE15	TCGA-CW-5591-11A-01R-1541-07	HG19	TCGA-CW-5591	TCGA-KIRC		s9210	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1541-07	True
13767.58cfa834e4b0c9d6adf6e90e	58cfa834e4b0c9d6adf6e90e	UNCID_1235439.7aa49ecf-9e25-4166-9ed2-487c41f1066c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1235439.7aa49ecf-9e25-4166-9ed2-487c41f1066c.sorted_genome_alignments	UNCID_1235439.7aa49ecf-9e25-4166-9ed2-487c41f1066c.sorted_genome_alignments.bam	52.2	1.8	0.16	58cfa834e4b0c9d6adf6e90e	UNCID_1235439.7aa49ecf-9e25-4166-9ed2-487c41f1066c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6496-11A	CE2B7E17-424E-4954-8A68-19D7F98D2E7E	Solid Tissue Normal	Illumina HiSeq	09532D74-4180-4164-A6F2-0BA2626419D9	Prostate	61.0	AAC5503D-CF55-490D-A630-5FC255016058	7AA49ECF-9E25-4166-9ED2-487C41F1066C	TCGA-G9-6496-11A-01R-1789-07	HG19	TCGA-G9-6496	TCGA-PRAD		s3824	University of North Carolina	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		1789-07	True
13767.58cfa838e4b0c9d6adf70d1a	58cfa838e4b0c9d6adf70d1a	UNCID_2153634.f7e2e36f-3018-4570-9ed2-f256048a9427.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2153634.f7e2e36f-3018-4570-9ed2-f256048a9427.sorted_genome_alignments	UNCID_2153634.f7e2e36f-3018-4570-9ed2-f256048a9427.sorted_genome_alignments.bam	51.5	1.83	0.17	58cfa838e4b0c9d6adf70d1a	UNCID_2153634.f7e2e36f-3018-4570-9ed2-f256048a9427.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-LP-A4AX-01A	3223FEC6-1D35-419A-8EE9-7C5885B8BE1E	Primary Tumor	Illumina HiSeq	600FCB5C-0255-4A5D-84E3-E4FA2BC0D873	Cervix	45.0	067A2E35-52E4-42E2-9C22-DB555589C0CF	F7E2E36F-3018-4570-9ED2-F256048A9427	TCGA-LP-A4AX-01A-12R-A24H-07	HG19	TCGA-LP-A4AX	TCGA-CESC		s1578	University of North Carolina	ILSbio	Vietnam	NO	T1b1	N0	Cervical Squamous Cell Carcinoma		A24H-07	True
13722.58cfa830e4b0c9d6adf6bef6	58cfa830e4b0c9d6adf6bef6	TCGA-BJ-A28Z-10A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BJ-A28Z-10A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_4_rg.sorted	TCGA-BJ-A28Z-10A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_4_rg.sorted.bam	68.68	1.83	0.15	58cfa830e4b0c9d6adf6bef6	TCGA-BJ-A28Z-10A-01D-A16N_120718_SN590_0169_AC0WL7ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28Z-10A	6BA76174-620E-4851-857A-D0ADBFD6F3E6	Blood Derived Normal	Illumina HiSeq	55bc34ed-0652-4e21-bc91-8a8301ae8813	Thyroid	46.0	D186595F-2F60-4DA1-9E19-EF9866667CBC	525DE278-22C8-4601-A667-19DF54F0ADAD	TCGA-BJ-A28Z-10A-01D-A16N-02	HG19_Broad_variant	TCGA-BJ-A28Z	TCGA-THCA		s12103	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A16N-02	True
13767.58cfa834e4b0c9d6adf6e687	58cfa834e4b0c9d6adf6e687	UNCID_1209597.47039a8f-de54-4ff9-84e2-6c1cdcd97dc0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1209597.47039a8f-de54-4ff9-84e2-6c1cdcd97dc0.sorted_genome_alignments	UNCID_1209597.47039a8f-de54-4ff9-84e2-6c1cdcd97dc0.sorted_genome_alignments.bam	35.35	1.84	0.17	58cfa834e4b0c9d6adf6e687	UNCID_1209597.47039a8f-de54-4ff9-84e2-6c1cdcd97dc0.sorted_genome_alignments.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CP-01A	2F59F12D-CA0C-4AC6-9718-98A6D455AF46	Primary Tumor	Illumina HiSeq	AAD24755-049E-4F93-849F-A4AA9264E9C0	Thyroid	26.0	043765F1-FFBD-4AC9-B0AE-733C3643083D	47039A8F-DE54-4FF9-84E2-6C1CDCD97DC0	TCGA-EM-A2CP-01A-11R-A180-07	HG19	TCGA-EM-A2CP	TCGA-THCA		s12763	University of North Carolina	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A180-07	True
13767.58cfa837e4b0c9d6adf70014	58cfa837e4b0c9d6adf70014	UNCID_1817176.64613ae3-9307-49ef-bc90-47a2b08b3d90.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1817176.64613ae3-9307-49ef-bc90-47a2b08b3d90.sorted_genome_alignments	UNCID_1817176.64613ae3-9307-49ef-bc90-47a2b08b3d90.sorted_genome_alignments.bam	67.38	1.82	0.16	58cfa837e4b0c9d6adf70014	UNCID_1817176.64613ae3-9307-49ef-bc90-47a2b08b3d90.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A45J-01A	6B85D76D-6098-47EA-9823-586238526CF1	Primary Tumor	Illumina HiSeq	42993CD5-9764-4028-947C-915CC44DBCB9	Thyroid	39.0	E98DC4DC-30D3-4240-84CC-1118D60D161D	64613AE3-9307-49EF-BC90-47A2B08B3D90	TCGA-BJ-A45J-01A-11R-A23W-07	HG19	TCGA-BJ-A45J	TCGA-THCA		s12320	University of North Carolina	University of Pittsburgh	United States	NO	T1a	N1a	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage I	A23W-07	True
13722.58cfa831e4b0c9d6adf6c72a	58cfa831e4b0c9d6adf6c72a	TCGA-D1-A17R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D1-A17R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_2_rg.sorted	TCGA-D1-A17R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_2_rg.sorted.bam	27.3	1.96	0.17	58cfa831e4b0c9d6adf6c72a	TCGA-D1-A17R-10A-01D-A12F_120523_SN1222_0109_BD12MPACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17R-10A	73A0DD38-115D-48FB-B683-04AA5D612F2A	Blood Derived Normal	Illumina HiSeq	c8e63bfe-78b9-440d-bab8-d90db0329891	Uterus	58.0	3F4549BD-550F-4E11-B0F0-D08C43DB73D9	24FD6EF3-8975-4674-85CF-6593CBFA7129	TCGA-D1-A17R-10A-01D-A12F-02	HG19_Broad_variant	TCGA-D1-A17R	TCGA-UCEC	339.0	s4447	Harvard Medical School	Mayo Clinic	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13722.58cfa82fe4b0c9d6adf6b583	58cfa82fe4b0c9d6adf6b583	TCGA-29-1704-01B-01D-0926-12_Illumina.filtered.	WGS	TCGA-29-1704-01B-01D-0926-12_Illumina	TCGA-29-1704-01B-01D-0926-12_Illumina.bam	100.0	1.9	0.14	58cfa82fe4b0c9d6adf6b583	TCGA-29-1704-01B-01D-0926-12_Illumina.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1704-01B	8E7F1C74-7CB3-43C0-B07C-BF69B780053F	Primary Tumor	Illumina HiSeq	900a0414-df0c-4e17-8651-8c01bfce6964	Ovary	61.0	0B7F454A-33B0-4E5C-9E55-81D7B00D15F4	A73BA735-1C59-47FC-915B-D2603510DC73	TCGA-29-1704-01B-01D-0926-12	NCBI36_BCM_variant	TCGA-29-1704	TCGA-OV		s17389	Baylor College of Medicine	Duke	None	NO			Serous Cystadenocarcinoma		0926-12	True
13722.58cfa831e4b0c9d6adf6cbf4	58cfa831e4b0c9d6adf6cbf4	TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted	TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted.bam	344.3		0.16	58cfa831e4b0c9d6adf6cbf4	TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7782-01A	1426B4BF-F4A5-477C-BBBB-E0E656549764	Primary Tumor	Illumina HiSeq	f92312ba-ec6b-477e-a08c-12c8af6d1775	Prostate	71.0	951C894E-9354-45AD-834A-FFC04441A3A9	47FB5E53-DD88-4B25-B6EF-C1ABE55FD5BA	TCGA-EJ-7782-01A-11D-2111-02	HG19_Broad_variant	TCGA-EJ-7782	TCGA-PRAD		s3794	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		2111-02	True
13767.58cfa831e4b0c9d6adf6cd35	58cfa831e4b0c9d6adf6cd35	TCGA-F1-6874-01A-11R-1884-13_rnaseq.filtered.	RNA-Seq	TCGA-F1-6874-01A-11R-1884-13_rnaseq	TCGA-F1-6874-01A-11R-1884-13_rnaseq.bam	341.2	1.8	0.17	58cfa831e4b0c9d6adf6cd35	TCGA-F1-6874-01A-11R-1884-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-F1-6874-01A	106F3344-F699-4B2C-8F62-4AC6C948DDE4	Primary Tumor	Illumina HiSeq	9CD28F98-D327-40A5-B030-CE9D2CEC9DDD	Stomach	79.0	C28FEBB9-E845-462F-B6A0-CB565EE6A049	A5093DA8-06AA-4D19-83C4-A00449069859	TCGA-F1-6874-01A-11R-1884-13	GRCh37-lite	TCGA-F1-6874	TCGA-STAD		s15333	Canada's Michael Smith Genome Sciences Centre	UNC	United States	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1884-13	True
13722.58cfa832e4b0c9d6adf6cfc4	58cfa832e4b0c9d6adf6cfc4	TCGA-FU-A3TQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_2_rg.sorted.filtered.	WGS	TCGA-FU-A3TQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_2_rg.sorted	TCGA-FU-A3TQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_2_rg.sorted.bam	67.6		0.17	58cfa832e4b0c9d6adf6cfc4	TCGA-FU-A3TQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3TQ-10A	7218AA6F-3345-484F-A329-A3B6169A67C7	Blood Derived Normal	Illumina HiSeq	ea233e9d-f242-4136-9f61-e20710d8c141	Cervix	55.0	B76ED8FA-2F4E-489F-AAF7-A69CC535C888	D4E0FFAC-F931-49AE-B959-F40F5E92F290	TCGA-FU-A3TQ-10A-01D-A232-26	HG19_Broad_variant	TCGA-FU-A3TQ	TCGA-CESC		s1370	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N1	Cervical Squamous Cell Carcinoma		A232-26	True
13767.58cfa836e4b0c9d6adf6f5a6	58cfa836e4b0c9d6adf6f5a6	UNCID_1573378.8fabb97c-5921-4156-98c0-86bdd642c612.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1573378.8fabb97c-5921-4156-98c0-86bdd642c612.sorted_genome_alignments	UNCID_1573378.8fabb97c-5921-4156-98c0-86bdd642c612.sorted_genome_alignments.bam	17.2		0.14	58cfa836e4b0c9d6adf6f5a6	UNCID_1573378.8fabb97c-5921-4156-98c0-86bdd642c612.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-69-8254-01A	F0C94F68-BFD9-45CB-B4FD-8BB1AE4E9A2B	Primary Tumor	Illumina HiSeq	F6BAD4C4-12EE-42C4-B0A8-517E24DA06B4	Lung	85.0	96BDAFE1-B0FB-4126-9734-1374D615EF6D	8FABB97C-5921-4156-98C0-86BDD642C612	TCGA-69-8254-01A-11R-2287-07	HG19	TCGA-69-8254	TCGA-LUAD		s11065	University of North Carolina	Washington University - Cleveland Clinic	United States	NO	T2b		Lung Adenocarcinoma Mixed Subtype		2287-07	True
13722.58cfa82ee4b0c9d6adf6ada2	58cfa82ee4b0c9d6adf6ada2	G39020.TCGA-BR-8690-10A-01D-2394-08.4.filtered.	WGS	G39020.TCGA-BR-8690-10A-01D-2394-08.4	G39020.TCGA-BR-8690-10A-01D-2394-08.4.bam	420.0		0.05	58cfa82ee4b0c9d6adf6ada2	G39020.TCGA-BR-8690-10A-01D-2394-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8690-10A	337819D2-5281-4B41-9583-A476924BC837	Blood Derived Normal	Illumina HiSeq	faf51861-5df1-4d45-845e-598709a60996	Stomach	54.0	F29DE83F-FE29-4CD9-909D-61C66457348B	3E7926EB-67FF-43C6-A3BE-7A3CC78D03C2	TCGA-BR-8690-10A-01D-2394-08	HG19_Broad_variant	TCGA-BR-8690	TCGA-STAD		s14805	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2394-08	True
13767.58cfa834e4b0c9d6adf6e71c	58cfa834e4b0c9d6adf6e71c	UNCID_1211908.1b08c8c9-5739-409d-9cbc-3b06ad1f60e6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1211908.1b08c8c9-5739-409d-9cbc-3b06ad1f60e6.sorted_genome_alignments	UNCID_1211908.1b08c8c9-5739-409d-9cbc-3b06ad1f60e6.sorted_genome_alignments.bam	56.52	1.78	0.18	58cfa834e4b0c9d6adf6e71c	UNCID_1211908.1b08c8c9-5739-409d-9cbc-3b06ad1f60e6.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FT-A3EE-01A	CCE62116-3DCD-400D-ADA0-9839CA02466E	Primary Tumor	Illumina HiSeq	2E4A31C8-A399-4C60-82DB-2653B3A15C1B	Bladder	80.0	2356F78C-0653-468F-83DB-6CF6107BD259	1B08C8C9-5739-409D-9CBC-3B06AD1F60E6	TCGA-FT-A3EE-01A-11R-A206-07	HG19	TCGA-FT-A3EE	TCGA-BLCA	99.0	s2949	University of North Carolina	BLN - University of Miami	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A206-07	True
13767.58cfa835e4b0c9d6adf6ef0c	58cfa835e4b0c9d6adf6ef0c	UNCID_1469067.20CA7C4D-7EF0-4FC5-907B-A90FEC12A561.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1469067.20CA7C4D-7EF0-4FC5-907B-A90FEC12A561.sorted_genome_alignments	UNCID_1469067.20CA7C4D-7EF0-4FC5-907B-A90FEC12A561.sorted_genome_alignments.bam	67.92	1.83	0.17	58cfa835e4b0c9d6adf6ef0c	UNCID_1469067.20CA7C4D-7EF0-4FC5-907B-A90FEC12A561.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PK-01A	73041FCF-F3B6-4851-B34D-1D62A1FCF6FE	Primary Tumor	Illumina HiSeq	E7FD1094-999B-4BA7-8602-21E5579386D4	Bladder	80.0	F09E1EEB-BCD5-4DBA-92F0-7D4B34B81CE7	20CA7C4D-7EF0-4FC5-907B-A90FEC12A561	TCGA-BT-A3PK-01A-21R-A220-07	HG19	TCGA-BT-A3PK	TCGA-BLCA		s2964	University of North Carolina	University of Pittsburgh	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A220-07	True
13767.58cfa838e4b0c9d6adf70430	58cfa838e4b0c9d6adf70430	UNCID_1905302.80c995f9-48bf-49a7-82ac-27d646b93e81.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1905302.80c995f9-48bf-49a7-82ac-27d646b93e81.sorted_genome_alignments	UNCID_1905302.80c995f9-48bf-49a7-82ac-27d646b93e81.sorted_genome_alignments.bam	126.2		0.15	58cfa838e4b0c9d6adf70430	UNCID_1905302.80c995f9-48bf-49a7-82ac-27d646b93e81.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-8614-01A	A8DE1BEB-6296-44EB-BD63-C603F70FAAF3	Primary Tumor	Illumina HiSeq	33BC7A60-DC53-4871-9034-266124C96F10	Lung	76.0	556BB046-BD81-4366-A167-E86D991EE732	80C995F9-48BF-49A7-82AC-27D646B93E81	TCGA-55-8614-01A-11R-2403-07	HG19	TCGA-55-8614	TCGA-LUAD		s10872	University of North Carolina	International Genomics Consortium	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2403-07	True
13767.58cfa839e4b0c9d6adf711f0	58cfa839e4b0c9d6adf711f0	UNCID_2276497.c5284e5c-9566-4248-a168-362eb039ffe7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2276497.c5284e5c-9566-4248-a168-362eb039ffe7.sorted_genome_alignments	UNCID_2276497.c5284e5c-9566-4248-a168-362eb039ffe7.sorted_genome_alignments.bam	11.27	1.85	0.15	58cfa839e4b0c9d6adf711f0	UNCID_2276497.c5284e5c-9566-4248-a168-362eb039ffe7.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-P5-A72X-01A	2FB951F1-00A0-4CAF-AC93-096056E77B1F	Primary Tumor	Illumina HiSeq	BB39706F-F485-4120-932B-4EDD3550AB6C	Brain	21.0	61314349-61B0-4B96-9A08-10996B56802D	C5284E5C-9566-4248-A168-362EB039FFE7	TCGA-P5-A72X-01A-11R-A32Q-07	HG19	TCGA-P5-A72X	TCGA-LGG		s8462	University of North Carolina	Cureline	Russia	NO			Astrocytoma		A32Q-07	True
13722.58cfa82ee4b0c9d6adf6af38	58cfa82ee4b0c9d6adf6af38	G48125.TCGA-09-2050-10A-01D-A312-08.1.filtered.	WGS	G48125.TCGA-09-2050-10A-01D-A312-08.1	G48125.TCGA-09-2050-10A-01D-A312-08.1.bam	52.27	1.8	0.08	58cfa82ee4b0c9d6adf6af38	G48125.TCGA-09-2050-10A-01D-A312-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-2050-10A	3C037ACF-F453-4513-A6DD-129163DDDE2A	Blood Derived Normal	Illumina HiSeq	f1580a69-43db-42d6-a2d0-260c67584092	Ovary	65.0	A52263B0-156F-49D8-8BB9-7E07F2665E64	8EBCAFA8-59FE-4BBD-8D36-C7DC65C13376	TCGA-09-2050-10A-01D-A312-08	HG19_Broad_variant	TCGA-09-2050	TCGA-OV		s17483	Broad Institute of MIT and Harvard	UCSF	None	NO			Serous Cystadenocarcinoma		A312-08	True
13722.58cfa831e4b0c9d6adf6c629	58cfa831e4b0c9d6adf6c629	TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted	TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted.bam	54.0		0.16	58cfa831e4b0c9d6adf6c629	TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6219-10A	0CA3D25A-22E9-4E40-834B-65F402535005	Blood Derived Normal	Illumina HiSeq	24f2b999-b137-4cd9-8d46-948ef995485d	Head and Neck	50.0	A10F3B24-FF67-48FB-9EB3-AFB10B3D36FB	008B9151-B9C9-42D8-AC2A-E2F3C4A62ABC	TCGA-CQ-6219-10A-01D-1911-02	HG19_Broad_variant	TCGA-CQ-6219	TCGA-HNSC	479.0	s15770	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2a	Head and Neck Squamous Cell Carcinoma	Stage IV	1911-02	True
13767.58cfa838e4b0c9d6adf70aab	58cfa838e4b0c9d6adf70aab	UNCID_2087422.25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2087422.25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd.sorted_genome_alignments	UNCID_2087422.25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd.sorted_genome_alignments.bam	95.62	1.89	0.18	58cfa838e4b0c9d6adf70aab	UNCID_2087422.25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AJ-A5DW-01A	C0B684D1-B96C-4420-9285-172402B7B123	Primary Tumor	Illumina HiSeq	28391013-0557-4365-B64B-162D14C8A29D	Uterus	56.0	AE83512D-3739-4E4D-9F27-8B01E6400479	25B2C2D1-38B6-4FA7-AB1C-C2DE3B6FB2FD	TCGA-AJ-A5DW-01A-11R-A27V-07	HG19	TCGA-AJ-A5DW	TCGA-UCEC		s4528	University of North Carolina	International Genomics Conosrtium	United States	NO			Endometrioid endometrial adenocarcinoma		A27V-07	True
13767.58cfa831e4b0c9d6adf6c842	58cfa831e4b0c9d6adf6c842	TCGA-D7-6526-01A-11R-1802-13_rnaseq.filtered.	RNA-Seq	TCGA-D7-6526-01A-11R-1802-13_rnaseq	TCGA-D7-6526-01A-11R-1802-13_rnaseq.bam	351.2	1.8	0.15	58cfa831e4b0c9d6adf6c842	TCGA-D7-6526-01A-11R-1802-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6526-01A	A28E57E2-9071-4558-856A-162F7A837380	Primary Tumor	Illumina HiSeq	74D30ACB-9D0C-4DDB-B9AE-C7154C8428E9	Stomach	67.0	DDCEA84E-3135-445C-BA0D-62F686463797	6F613F7B-2636-4792-AF81-07439E22BB1A	TCGA-D7-6526-01A-11R-1802-13	GRCh37-lite	TCGA-D7-6526	TCGA-STAD		s14560	Canada's Michael Smith Genome Sciences Centre	Greater Poland Cancer Center	Poland	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	1802-13	True
13722.58cfa82fe4b0c9d6adf6b858	58cfa82fe4b0c9d6adf6b858	TCGA-29-1710-01A-02D-0926-12_Illumina.filtered.	WGS	TCGA-29-1710-01A-02D-0926-12_Illumina	TCGA-29-1710-01A-02D-0926-12_Illumina.bam	265.0	1.9	0.15	58cfa82fe4b0c9d6adf6b858	TCGA-29-1710-01A-02D-0926-12_Illumina.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1710-01A	4261267C-7042-4C6E-83ED-12FB401003FC	Primary Tumor	Illumina HiSeq	3d865220-b0b8-4ca4-b4a1-56e05dc83e6f	Ovary	54.0	61513DA0-4EB3-4CAE-BFFF-7B05F3362488	6BA4DE87-C332-42B8-AF95-EB14A4C7F229	TCGA-29-1710-01A-02D-0926-12	NCBI36_BCM_variant	TCGA-29-1710	TCGA-OV	951.0	s17882	Baylor College of Medicine	Duke	None	NO			Serous Cystadenocarcinoma		0926-12	True
13722.58cfa830e4b0c9d6adf6c10e	58cfa830e4b0c9d6adf6c10e	TCGA-BS-A0TI-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BS-A0TI-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_5_rg.sorted	TCGA-BS-A0TI-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_5_rg.sorted.bam	6.8	2.0	0.17	58cfa830e4b0c9d6adf6c10e	TCGA-BS-A0TI-10A-01D-A101_120409_SN1222_0095_AD0V1JACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TI-10A	DF857BC6-FD6A-4713-BEF9-6EE1301E5FB1	Blood Derived Normal	Illumina HiSeq	6c79babf-5d05-4b25-be49-7ca0b6cd759a	Uterus	64.0	F4052639-340A-488B-810A-8403FC796000	3CB294E3-4240-49DE-BA0E-8F802CF741CF	TCGA-BS-A0TI-10A-01D-A101-02	HG19_Broad_variant	TCGA-BS-A0TI	TCGA-UCEC		s4605	Harvard Medical School	University of Hawaii	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa834e4b0c9d6adf6e8ec	58cfa834e4b0c9d6adf6e8ec	UNCID_1237505.312ea080-3831-453d-aa8c-e466192c8309.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1237505.312ea080-3831-453d-aa8c-e466192c8309.sorted_genome_alignments	UNCID_1237505.312ea080-3831-453d-aa8c-e466192c8309.sorted_genome_alignments.bam	54.55	1.81	0.17	58cfa834e4b0c9d6adf6e8ec	UNCID_1237505.312ea080-3831-453d-aa8c-e466192c8309.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LA-01A	797A71EE-372D-41E5-AEEE-5AB3C4661110	Primary Tumor	Illumina HiSeq	7602F547-4A0A-423A-9C44-2E1CFC8C913D	Bladder	54.0	6ED52558-8039-4658-A245-78A29968CE2F	312EA080-3831-453D-AA8C-E466192C8309	TCGA-BT-A2LA-01A-11R-A18C-07	HG19	TCGA-BT-A2LA	TCGA-BLCA		s3152	University of North Carolina	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A18C-07	True
13722.58cfa831e4b0c9d6adf6ccd4	58cfa831e4b0c9d6adf6ccd4	TCGA-EJ-5511-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EJ-5511-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_8_rg.sorted	TCGA-EJ-5511-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_8_rg.sorted.bam	599.4	1.9	0.17	58cfa831e4b0c9d6adf6ccd4	TCGA-EJ-5511-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_8_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5511-10A	F8A42FEB-FBC9-4A13-BAD5-1DCEFCA2A9BF	Blood Derived Normal	Illumina HiSeq	22de66f2-6831-4ec8-8ee6-15de1605d466	Prostate	55.0	5D8C39A9-AC3C-46D2-97DE-DFC1F512EC40	FDDE3ED3-6525-4F34-B6E8-77A171410743	TCGA-EJ-5511-10A-01D-1573-02	HG19_Broad_variant	TCGA-EJ-5511	TCGA-PRAD		s3791	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1573-02	True
13767.58cfa834e4b0c9d6adf6e508	58cfa834e4b0c9d6adf6e508	UNCID_1201162.aed585d4-f5ff-4de3-a405-64c6c057d52e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1201162.aed585d4-f5ff-4de3-a405-64c6c057d52e.sorted_genome_alignments	UNCID_1201162.aed585d4-f5ff-4de3-a405-64c6c057d52e.sorted_genome_alignments.bam	120.0	1.8	0.14	58cfa834e4b0c9d6adf6e508	UNCID_1201162.aed585d4-f5ff-4de3-a405-64c6c057d52e.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4845-01A	CF77FE39-0B4A-4B38-B563-2A244B9FB5C0	Primary Tumor	Illumina HiSeq	B64E7F13-15CF-4D49-8E2D-FB53262BF09D	Kidney	70.0	EAB2C452-8263-4351-9150-7B51F84066C3	AED585D4-F5FF-4DE3-A405-64C6C057D52E	TCGA-B0-4845-01A-01R-1277-07	HG19	TCGA-B0-4845	TCGA-KIRC	1986.0	s9831	University of North Carolina	University of Pittsburgh	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1277-07	True
13722.58cfa831e4b0c9d6adf6c98b	58cfa831e4b0c9d6adf6c98b	TCGA-DJ-A1QL-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DJ-A1QL-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_3_rg.sorted	TCGA-DJ-A1QL-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_3_rg.sorted.bam	21.22	1.98	0.16	58cfa831e4b0c9d6adf6c98b	TCGA-DJ-A1QL-10A-01D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_3_rg.sorted.bam	Alive	MALE		NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QL-10A	E4B08E66-0772-4956-8670-E5C6553EECBE	Blood Derived Normal	Illumina HiSeq	72e4c07c-b432-4b1b-a6d3-b48c1c758af3	Thyroid	70.0	4A3FF681-4C8C-43DA-BFC7-9CF2598375B4	7160E4B1-ED02-4BB5-A8C9-6DE807D0B976	TCGA-DJ-A1QL-10A-01D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QL	TCGA-THCA		s12242	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14U-02	True
13722.58cfa83ce4b0c9d6adf73204	58cfa83ce4b0c9d6adf73204	e1a5abee600fb4b0041613970a420df5.filtered.	WGS	e1a5abee600fb4b0041613970a420df5	e1a5abee600fb4b0041613970a420df5.bam	15.35	1.9	0.07	58cfa83ce4b0c9d6adf73204	e1a5abee600fb4b0041613970a420df5.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GA-10A	71FED998-8FAC-4E6B-B38A-22C83E05E958	Blood Derived Normal	Illumina HiSeq	539ccf4d-b32a-4206-9646-db8e092ecd9b	Uterus	67.0	FAE7E73A-D9EF-4A6F-807E-A46A46C29179	E2C40A5B-5DE4-415C-87FF-8573B83E8AAC	TCGA-A5-A0GA-10A-01D-A066-09	GRCh37-lite	TCGA-A5-A0GA	TCGA-UCEC	543.0	s4764	Washington University School of Medicine	Cedars Sinai	None	NO			Endometrioid endometrial adenocarcinoma		A066-09	True
13722.58cfa831e4b0c9d6adf6cc13	58cfa831e4b0c9d6adf6cc13	TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted	TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted.bam	234.3	1.9	0.15	58cfa831e4b0c9d6adf6cc13	TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6402-01A	152F028E-EE29-40E0-8E75-5CAFFFACBD45	Primary Tumor	Illumina HiSeq	d556f16a-ad20-42eb-8e92-57114d46e174	Brain	52.0	0E594B0A-05E4-40C8-80BA-0D4BB08E437D	A60A9995-6A02-4035-9C3E-2FEE0E6E87C5	TCGA-DU-6402-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-6402	TCGA-LGG	214.0	s8563	Harvard Medical School	Henry Ford Hospital	United States	NO			Astrocytoma		1703-02	True
13767.58cfa83be4b0c9d6adf7265c	58cfa83be4b0c9d6adf7265c	UNCID_2633645.e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2633645.e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed.sorted_genome_alignments	UNCID_2633645.e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed.sorted_genome_alignments.bam	86.38	1.87	0.17	58cfa83be4b0c9d6adf7265c	UNCID_2633645.e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed.sorted_genome_alignments.bam	Dead	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-AACH-01A	219B067C-522F-4971-B0D0-86F9971D369D	Primary Tumor	Illumina HiSeq	6AB4C9EC-5195-46DF-BCD6-E73740AF5BA3	Liver	69.0	31DFD0A9-31C4-4665-ADAD-3CBE49C1C5EB	E23FF6AC-2FDF-4838-AAA3-27E012BBF6ED	TCGA-DD-AACH-01A-11R-A41C-07	HG19	TCGA-DD-AACH	TCGA-LIHC	195.0	s16953	University of North Carolina	Mayo Clinic - Rochester	Korea South	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A41C-07	True
13722.58cfa82fe4b0c9d6adf6b730	58cfa82fe4b0c9d6adf6b730	TCGA-44-3919-11A-01D-1103_110707_SN590_0095_BD0D4KABXX_s_6_rg.sorted.filtered.	WGS	TCGA-44-3919-11A-01D-1103_110707_SN590_0095_BD0D4KABXX_s_6_rg.sorted	TCGA-44-3919-11A-01D-1103_110707_SN590_0095_BD0D4KABXX_s_6_rg.sorted.bam	569.93	1.9	0.14	58cfa82fe4b0c9d6adf6b730	TCGA-44-3919-11A-01D-1103_110707_SN590_0095_BD0D4KABXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-3919-11A	66ED89F6-8BA2-49D0-AF0F-4B6EBF2381BF	Solid Tissue Normal	Illumina HiSeq	0b6ce057-abf2-4149-a103-a243ae3d9354	Lung	71.0	6C4744D1-7AAF-4A93-8C76-82B253C39EFC	7186DA3A-2D33-4087-9B1F-541223684945	TCGA-44-3919-11A-01D-1103-02	HG19_Broad_variant	TCGA-44-3919	TCGA-LUAD		s11547	Harvard Medical School	Christiana Healthcare	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1103-02	True
13722.58cfa83ce4b0c9d6adf72e98	58cfa83ce4b0c9d6adf72e98	c7785537c59d3349dd69e0f8e87266b7.filtered.	WGS	c7785537c59d3349dd69e0f8e87266b7	c7785537c59d3349dd69e0f8e87266b7.bam	27.86	1.93	0.08	58cfa83ce4b0c9d6adf72e98	c7785537c59d3349dd69e0f8e87266b7.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LL-01A	2A84997D-CCEE-4F46-BEA2-752534F26416	Primary Tumor	Illumina HiSeq	85360168-d41d-4201-8416-2cb4b45fca0f	Breast	73.0	E57574E4-7E01-4E61-BD29-EE4EC63DDDD6	47312F61-5EF4-4F25-9320-8FBB4758790E	TCGA-E2-A1LL-01A-11D-A142-09	GRCh37-lite	TCGA-E2-A1LL	TCGA-BRCA		s5780	Washington University School of Medicine	Roswell Park	United States	NO	T3	N2a	Infiltrating Ductal Carcinoma	Stage III	A142-09	False
13722.58cfa82ee4b0c9d6adf6af61	58cfa82ee4b0c9d6adf6af61	G47088.TCGA-98-8022-10A-01D-2244-08.2.filtered.	WGS	G47088.TCGA-98-8022-10A-01D-2244-08.2	G47088.TCGA-98-8022-10A-01D-2244-08.2.bam	195.33		0.05	58cfa82ee4b0c9d6adf6af61	G47088.TCGA-98-8022-10A-01D-2244-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-98-8022-10A	ADC853B1-B8BF-488C-A1E2-E95603459B55	Blood Derived Normal	Illumina HiSeq	8d0ddb26-6b8a-44ee-bfdf-88ffc74c969e	Lung	61.0	9008AD7B-1F1B-4E23-9B53-321D7EC63ED7	CB63D740-4040-4D71-81E9-1211736B0E5C	TCGA-98-8022-10A-01D-2244-08	HG19_Broad_variant	TCGA-98-8022	TCGA-LUSC		s10160	Broad Institute of MIT and Harvard	Washington University - Alabama	United States	NO	T1a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2244-08	False
13767.58cfa83ce4b0c9d6adf72b5e	58cfa83ce4b0c9d6adf72b5e	UNCID_359890.TCGA-BP-4332-01A-01R-1289-07.110503_UNC10-SN254_0214_AB0BCKABXX.3.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_359890.TCGA-BP-4332-01A-01R-1289-07.110503_UNC10-SN254_0214_AB0BCKABXX.3.trimmed.annotated.translated_to_genomic	UNCID_359890.TCGA-BP-4332-01A-01R-1289-07.110503_UNC10-SN254_0214_AB0BCKABXX.3.trimmed.annotated.translated_to_genomic.bam	23.3	1.8	0.13	58cfa83ce4b0c9d6adf72b5e	UNCID_359890.TCGA-BP-4332-01A-01R-1289-07.110503_UNC10-SN254_0214_AB0BCKABXX.3.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4332-01A	E9847C37-0D93-47BF-B669-C7F7A1ABFA88	Primary Tumor	Illumina HiSeq	E8A23932-3FD0-4E4A-89F5-2C5BBEFAA564	Kidney	36.0	247D2218-72F7-463B-8493-B2EA1A103370	9CB6DF63-9EB5-47EF-A56C-EA1EC9D25F31	TCGA-BP-4332-01A-01R-1289-07	HG19	TCGA-BP-4332	TCGA-KIRC		s9098	University of North Carolina	MSKCC	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1289-07	True
13722.58cfa830e4b0c9d6adf6bc2c	58cfa830e4b0c9d6adf6bc2c	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	78.64	1.86	0.08	58cfa830e4b0c9d6adf6bc2c	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J4-01A	A9B7D7FE-BE31-4F71-AFEE-C1BFDF511888	Primary Tumor	Illumina HiSeq	b518df9f-2eae-4c82-92e3-3eb196cdd3a5	Breast	41.0	CF11642A-EB96-4B37-B914-371C71F8E0CA	110B5F05-DED7-45EC-B0F6-A941C92D77DD	TCGA-AO-A0J4-01A-11D-A128-09	GRCh37-lite	TCGA-AO-A0J4	TCGA-BRCA		s5960	Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A128-09	True
13767.58cfa82fe4b0c9d6adf6b626	58cfa82fe4b0c9d6adf6b626	TCGA-2H-A9GO-01A-11R-A37I-31_rnaseq.filtered.	RNA-Seq	TCGA-2H-A9GO-01A-11R-A37I-31_rnaseq	TCGA-2H-A9GO-01A-11R-A37I-31_rnaseq.bam	79.22	2.02	0.18	58cfa82fe4b0c9d6adf6b626	TCGA-2H-A9GO-01A-11R-A37I-31_rnaseq.bam	Dead	MALE			Esophageal Carcinoma	Aligned reads	TCGA-2H-A9GO-01A	CA400EA1-3E4E-437E-A54C-446431B741DA	Primary Tumor	Illumina HiSeq	C4FB2BE6-4DC4-41EA-A386-79149A5F636B	Esophagus	58.0	6C07CBBB-43A3-479F-AB35-2372F0EE6302	B4AB4EDC-6163-4211-80C2-12D8BBBD8A2A	TCGA-2H-A9GO-01A-11R-A37I-31	GRCh37-lite	TCGA-2H-A9GO	TCGA-ESCA	494.0	s1617	Canada's Michael Smith Genome Sciences Centre	Erasmus MC	Netherlands	NO	T3	N1		Stage IV	A37I-31	True
13722.58cfa831e4b0c9d6adf6c80f	58cfa831e4b0c9d6adf6c80f	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.bam	62.7	2.0	0.16	58cfa831e4b0c9d6adf6c80f	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6938-01A	FF9DB03D-F81C-4079-8B05-F5A8C05B8CFE	Primary Tumor	Illumina HiSeq	a328ffc7-c5cd-4726-a75a-e625d33859a8	Head and Neck	87.0	9EB292E6-AE4D-4613-98EE-0197FD97B633	87E1BCCB-5B03-40AF-A262-0B2B5E6A08D2	TCGA-CV-6938-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6938	TCGA-HNSC	144.0	s16050	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II	1911-02	True
13722.58cfa832e4b0c9d6adf6d474	58cfa832e4b0c9d6adf6d474	TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted.filtered.	WGS	TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted	TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted.bam	32.62		0.17	58cfa832e4b0c9d6adf6d474	TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EI-01A	B533E555-90CF-4657-80C6-15B67DA8AD26	Primary Tumor	Illumina HiSeq	ffc1ec43-7da7-4a9b-ab87-1ad3a3ba5c42	Eye	78.0	0077CCB8-615D-4725-95E7-72708732E963	B0CCF5D2-B334-4B7C-858E-53005B6FD0D7	TCGA-V4-A9EI-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EI	TCGA-UVM	389.0	s203	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4c	N0		Stage III	A40D-26	True
13767.58cfa83be4b0c9d6adf7276a	58cfa83be4b0c9d6adf7276a	UNCID_2657340.a2dee72c-85ab-44fc-b37f-bb8c82ced8a2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2657340.a2dee72c-85ab-44fc-b37f-bb8c82ced8a2.sorted_genome_alignments	UNCID_2657340.a2dee72c-85ab-44fc-b37f-bb8c82ced8a2.sorted_genome_alignments.bam	66.72	1.87	0.17	58cfa83be4b0c9d6adf7276a	UNCID_2657340.a2dee72c-85ab-44fc-b37f-bb8c82ced8a2.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-WQ-AB4B-01A	D5471A2B-F14C-44DE-9142-5A5FB07B6FC2	Primary Tumor	Illumina HiSeq	B71094D1-BD29-4096-8A35-99654ED5ED96	Liver	62.0	0EE59A68-AE0F-4421-9805-D4C48C64B613	A2DEE72C-85AB-44FC-B37F-BB8C82CED8A2	TCGA-WQ-AB4B-01A-11R-A41C-07	HG19	TCGA-WQ-AB4B	TCGA-LIHC		s16963	University of North Carolina	University of Kansas	United States	NO	T2	NX	Hepatocellular Carcinoma	Stage II	A41C-07	True
13767.58cfa82ee4b0c9d6adf6a82e	58cfa82ee4b0c9d6adf6a82e	G17642.TCGA-41-2572-01A-01R-1850-01.2.filtered.	RNA-Seq	G17642.TCGA-41-2572-01A-01R-1850-01.2	G17642.TCGA-41-2572-01A-01R-1850-01.2.bam	28.7	1.9	0.17	58cfa82ee4b0c9d6adf6a82e	G17642.TCGA-41-2572-01A-01R-1850-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-41-2572-01A	1E80CCF6-EF81-4662-BF5E-392F092C1E67	Primary Tumor	Illumina HiSeq	E10F3F06-B885-46A4-AFF9-8F36D326BAC5	Brain	67.0	6DA1271F-AE25-4301-84BE-6468E9B494F9	F46E05F2-56B9-4A31-B0EC-882414A7AAF6	TCGA-41-2572-01A-01R-1850-01	HG19_Broad_variant	TCGA-41-2572	TCGA-GBM	406.0	s14215	Broad Institute of MIT and Harvard	Christiana Healthcare	None	NO			Untreated primary (de novo) GBM		1850-01	True
13767.58cfa832e4b0c9d6adf6d6b4	58cfa832e4b0c9d6adf6d6b4	UNCID_1034525.56a11c6f-f63f-46b3-84d3-c444dae76628.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1034525.56a11c6f-f63f-46b3-84d3-c444dae76628.sorted_genome_alignments	UNCID_1034525.56a11c6f-f63f-46b3-84d3-c444dae76628.sorted_genome_alignments.bam	10.89	1.79	0.15	58cfa832e4b0c9d6adf6d6b4	UNCID_1034525.56a11c6f-f63f-46b3-84d3-c444dae76628.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A2N7-11A	CBAB7A72-11F7-4DFE-80F8-1B1EF1CF0055	Solid Tissue Normal	Illumina HiSeq	3D61CA9C-460B-4077-9E07-83C2E6EBD22C	Thyroid	30.0	54F8CEF4-CCFD-4315-9B86-F98321BDE207	56A11C6F-F63F-46B3-84D3-C444DAE76628	TCGA-BJ-A2N7-11A-11R-A18C-07	HG19	TCGA-BJ-A2N7	TCGA-THCA		s12536	University of North Carolina	University of Pittsburgh	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A18C-07	True
13722.58cfa830e4b0c9d6adf6bed7	58cfa830e4b0c9d6adf6bed7	TCGA-B3-4104-11A-01D-1253-10_wgs_Illumina.filtered.	WGS	TCGA-B3-4104-11A-01D-1253-10_wgs_Illumina	TCGA-B3-4104-11A-01D-1253-10_wgs_Illumina.bam	422.94	1.9	0.16	58cfa830e4b0c9d6adf6bed7	TCGA-B3-4104-11A-01D-1253-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B3-4104-11A	E15A108E-0B32-426F-926A-3FB1AF0A82D3	Solid Tissue Normal	Illumina HiSeq	481f034b-553d-4240-b733-83c3d008050c	Kidney	75.0	88D9FC64-AA05-40DE-A445-2CA369A3743E	A540DA82-D1A3-485A-9137-B513E2D8A766	TCGA-B3-4104-11A-01D-1253-10	GRCh37-lite	TCGA-B3-4104	TCGA-KIRP		s11643	Baylor College of Medicine	Christiana Healthcare	None	NO	T2	NX	Kidney Papillary Renal Cell Carcinoma	Stage II	1253-10	False
13722.58cfa831e4b0c9d6adf6cb24	58cfa831e4b0c9d6adf6cb24	TCGA-ED-A4XI-10A-01D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-ED-A4XI-10A-01D-A25V-10_wgs_Illumina	TCGA-ED-A4XI-10A-01D-A25V-10_wgs_Illumina.bam	114.45		0.07	58cfa831e4b0c9d6adf6cb24	TCGA-ED-A4XI-10A-01D-A25V-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ED-A4XI-10A	C52ABAC9-07DA-4B3D-BF8A-2161CACF9682	Blood Derived Normal	Illumina HiSeq	ab48e1e5-a430-43b9-b55a-01fd7d27cfa7	Liver	58.0	03B9FCC8-4CF6-4A81-B1D7-382CB1570AB4	72F5179F-1C32-4E78-8F77-027A5400E7FD	TCGA-ED-A4XI-10A-01D-A25V-10	GRCh37-lite	TCGA-ED-A4XI	TCGA-LIHC		s16681	Baylor College of Medicine	Asterand	Vietnam	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A25V-10	True
13767.58cfa82fe4b0c9d6adf6b3b0	58cfa82fe4b0c9d6adf6b3b0	TCGA-24-1849-01A-01R-1567-13_rnaseq.filtered.	RNA-Seq	TCGA-24-1849-01A-01R-1567-13_rnaseq	TCGA-24-1849-01A-01R-1567-13_rnaseq.bam	262.0	1.9	0.16	58cfa82fe4b0c9d6adf6b3b0	TCGA-24-1849-01A-01R-1567-13_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1849-01A	94EFD4F9-69B0-4EFA-8A0C-61106E898FDD	Primary Tumor	Illumina HiSeq	DB65C20B-0E7F-40E3-9AB1-1739453321F3	Ovary	80.0	121DB3FB-CC6B-48BB-8BFE-A582075658FE	58F3764A-4651-4C26-A667-74AEF5C5679C	TCGA-24-1849-01A-01R-1567-13	NCBI36_BCCAGSC_variant	TCGA-24-1849	TCGA-OV		s17445	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1567-13	True
13722.58cfa82ee4b0c9d6adf6ae96	58cfa82ee4b0c9d6adf6ae96	G49538.TCGA-06-0152-02A-01D-2280-08.1.filtered.	WGS	G49538.TCGA-06-0152-02A-01D-2280-08.1	G49538.TCGA-06-0152-02A-01D-2280-08.1.bam	600.0	1.9	0.05	58cfa82ee4b0c9d6adf6ae96	G49538.TCGA-06-0152-02A-01D-2280-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0152-02A	F5BC5D97-E054-4E53-992D-71B896BD97D5	Recurrent Tumor	Illumina HiSeq	1d482a80-dbcc-48ae-8e59-ad77dc2d332c	Brain	68.0	1BF99D0E-EE8B-40A8-B279-DB2F06A9B188	841EB82B-347D-4D7F-805F-3F3701A2983D	TCGA-06-0152-02A-01D-2280-08	HG19_Broad_variant	TCGA-06-0152	TCGA-GBM	375.0	s13929	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		2280-08	False
13722.58cfa831e4b0c9d6adf6ca70	58cfa831e4b0c9d6adf6ca70	TCGA-DK-A1AB-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_4_rg.sorted.filtered.	WGS	TCGA-DK-A1AB-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_4_rg.sorted	TCGA-DK-A1AB-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_4_rg.sorted.bam	31.2	1.94	0.18	58cfa831e4b0c9d6adf6ca70	TCGA-DK-A1AB-10A-01D-A13U_121002_SN1222_0154_AC1A3DACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AB-10A	F027D254-EC01-4882-A8A7-964AE90B7D49	Blood Derived Normal	Illumina HiSeq	9eaeaeec-3d40-4c27-8e58-b9aa313a628f	Bladder	74.0	8A3DABE6-85A3-43E6-9223-654B16A7180B	DD644B8E-4BFF-4511-82CF-251EED30CD3E	TCGA-DK-A1AB-10A-01D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AB	TCGA-BLCA		s2705	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13U-02	True
13722.58cfa832e4b0c9d6adf6d25c	58cfa832e4b0c9d6adf6d25c	TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted.filtered.	WGS	TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted	TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted.bam	19.49		0.14	58cfa832e4b0c9d6adf6d25c	TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-JX-A3PZ-01A	3DF6ABE2-2123-4BFA-A4E4-88DF5F940C04	Primary Tumor	Illumina HiSeq	ecad03c2-29cd-48c4-8c37-7eade85970f7	Cervix	25.0	BD39C4C4-A4DD-4B2D-9F3C-608CA8708958	1B04D621-E036-4D1E-9D57-6CCCD0C020D8	TCGA-JX-A3PZ-01A-11D-A245-26	HG19_Broad_variant	TCGA-JX-A3PZ	TCGA-CESC	642.0	s1540	MD Anderson - Institute for Applied Cancer Science	Washington University	United States	NO	T1b	N0	Cervical Squamous Cell Carcinoma		A245-26	True
13767.58cfa83ae4b0c9d6adf715e5	58cfa83ae4b0c9d6adf715e5	UNCID_2377933.2ea07252-37a1-4c62-924c-6674242fe238.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2377933.2ea07252-37a1-4c62-924c-6674242fe238.sorted_genome_alignments	UNCID_2377933.2ea07252-37a1-4c62-924c-6674242fe238.sorted_genome_alignments.bam	30.38	1.78	0.16	58cfa83ae4b0c9d6adf715e5	UNCID_2377933.2ea07252-37a1-4c62-924c-6674242fe238.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-WB-A815-01A	7395B02F-C0DB-449D-A51A-64E80B619AD7	Primary Tumor	Illumina HiSeq	0576CA24-120B-465E-B06F-9F9F85F7C663	Nervous System	68.0	6F01B62E-B562-4FFE-BE11-BD6F178C99F9	2EA07252-37A1-4C62-924C-6674242FE238	TCGA-WB-A815-01A-11R-A35L-07	HG19	TCGA-WB-A815	TCGA-PCPG		s1046	University of North Carolina	Erasmus MC	France	NO					A35L-07	True
13767.58cfa839e4b0c9d6adf71548	58cfa839e4b0c9d6adf71548	UNCID_2362394.b524a0e1-2127-4848-9806-0c3454c56e22.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2362394.b524a0e1-2127-4848-9806-0c3454c56e22.sorted_genome_alignments	UNCID_2362394.b524a0e1-2127-4848-9806-0c3454c56e22.sorted_genome_alignments.bam	41.86	1.96	0.18	58cfa839e4b0c9d6adf71548	UNCID_2362394.b524a0e1-2127-4848-9806-0c3454c56e22.sorted_genome_alignments.bam	Alive	MALE			Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-SX-A7SL-01A	2E930925-9EAF-4469-9328-35241F60EDDD	Primary Tumor	Illumina HiSeq	BF07C90C-CBBA-4647-8A12-A24929A817D0	Kidney	74.0	66BB7BB3-6236-4D71-BFC9-CF38B2019CF1	B524A0E1-2127-4848-9806-0C3454C56E22	TCGA-SX-A7SL-01A-11R-A355-07	HG19	TCGA-SX-A7SL	TCGA-KIRP		s18153	University of North Carolina	Mayo Clinic Arizona	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A355-07	True
13722.58cfa82ee4b0c9d6adf6a85e	58cfa82ee4b0c9d6adf6a85e	G32528.TCGA-DJ-A2Q8-10A-01D-A18F-08.5.filtered.	WGS	G32528.TCGA-DJ-A2Q8-10A-01D-A18F-08.5	G32528.TCGA-DJ-A2Q8-10A-01D-A18F-08.5.bam	31.65		0.08	58cfa82ee4b0c9d6adf6a85e	G32528.TCGA-DJ-A2Q8-10A-01D-A18F-08.5.bam	Alive	FEMALE		NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q8-10A	F9CF605F-F287-4EBA-8E8F-8BA47E14ECC4	Blood Derived Normal	Illumina HiSeq	bfe70f21-633e-4c43-86c5-82c6414362a0	Thyroid	47.0	FDE5E0FB-6D0B-4CDC-858F-0FB96E5CD0E6	CF88AECB-DC11-4F6F-9072-BC153C7A62D9	TCGA-DJ-A2Q8-10A-01D-A18F-08	HG19_Broad_variant	TCGA-DJ-A2Q8	TCGA-THCA		s12726	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1a	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage I	A18F-08	False
13722.58cfa82ee4b0c9d6adf6ab9d	58cfa82ee4b0c9d6adf6ab9d	G37566.TCGA-EJ-5503-10A-01D-1577-08.2.filtered.	WGS	G37566.TCGA-EJ-5503-10A-01D-1577-08.2	G37566.TCGA-EJ-5503-10A-01D-1577-08.2.bam	248.4	1.9	0.05	58cfa82ee4b0c9d6adf6ab9d	G37566.TCGA-EJ-5503-10A-01D-1577-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5503-10A	AA252F78-EBF3-42F9-86AF-BB6E57345706	Blood Derived Normal	Illumina HiSeq	aa2d4c6b-fca5-4975-9fee-f2013c3563dc	Prostate	50.0	84460943-D44C-4B47-9BF1-DEB1C5B5E0BD	0799B439-9364-4606-A024-7F100A249F53	TCGA-EJ-5503-10A-01D-1577-08	HG19_Broad_variant	TCGA-EJ-5503	TCGA-PRAD		s3758	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1577-08	False
13722.58cfa830e4b0c9d6adf6c204	58cfa830e4b0c9d6adf6c204	TCGA-BG-A0M8-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BG-A0M8-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_6_rg.sorted	TCGA-BG-A0M8-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_6_rg.sorted.bam	11.34	2.0	0.14	58cfa830e4b0c9d6adf6c204	TCGA-BG-A0M8-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0M8-10A	E055DB71-F3DA-43D3-A9B2-2F65DFB23D3E	Blood Derived Normal	Illumina HiSeq	59c03a66-dea6-47f6-a91b-d3d200938b26	Uterus	50.0	575EA3DD-0638-4CFE-9FC6-80D1C566D266	4B474E3A-F2D2-40E5-956C-316AD96A9840	TCGA-BG-A0M8-10A-01D-A101-02	HG19_Broad_variant	TCGA-BG-A0M8	TCGA-UCEC		s4430	Harvard Medical School	University of Pittsburgh	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa834e4b0c9d6adf6e13e	58cfa834e4b0c9d6adf6e13e	UNCID_1166834.4a6f7935-86f8-4c08-9d0e-9fe77878f2ce.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1166834.4a6f7935-86f8-4c08-9d0e-9fe77878f2ce.sorted_genome_alignments	UNCID_1166834.4a6f7935-86f8-4c08-9d0e-9fe77878f2ce.sorted_genome_alignments.bam	46.82	1.87	0.16	58cfa834e4b0c9d6adf6e13e	UNCID_1166834.4a6f7935-86f8-4c08-9d0e-9fe77878f2ce.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1EY-01A	0741B5DB-4405-42BA-B63A-C6EE4F341480	Primary Tumor	Illumina HiSeq	3A6D0F39-B6FF-44BA-8E58-755D876333DB	Breast	79.0	14193A12-5601-4F0C-90AA-ECD24D6AC41B	4A6F7935-86F8-4C08-9D0E-9FE77878F2CE	TCGA-BH-A1EY-01A-11R-A13Q-07	HG19	TCGA-BH-A1EY	TCGA-BRCA	538.0	s6712	University of North Carolina	University of Pittsburgh	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A13Q-07	True
13767.58cfa83be4b0c9d6adf720fe	58cfa83be4b0c9d6adf720fe	UNCID_2559749.5eba7c31-9866-41d9-a9b3-d4b80ee7f631.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2559749.5eba7c31-9866-41d9-a9b3-d4b80ee7f631.sorted_genome_alignments	UNCID_2559749.5eba7c31-9866-41d9-a9b3-d4b80ee7f631.sorted_genome_alignments.bam	24.52	1.94	0.17	58cfa83be4b0c9d6adf720fe	UNCID_2559749.5eba7c31-9866-41d9-a9b3-d4b80ee7f631.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F3-01A	E21D8018-8FE9-4C92-8B36-28D7D3F7DF2B	Primary Tumor	Illumina HiSeq	81B4C131-4FF4-4360-A10D-EDCCC3C49A84	Eye	49.0	6805D6DB-775C-4817-9F1B-5BE44AE2DA45	5EBA7C31-9866-41D9-A9B3-D4B80EE7F631	TCGA-V4-A9F3-01A-11R-A405-07	HG19	TCGA-V4-A9F3	TCGA-UVM		s313	University of North Carolina	Institut Curie	France	NO	T4a	N0		Stage III	A405-07	True
13722.58cfa831e4b0c9d6adf6c712	58cfa831e4b0c9d6adf6c712	TCGA-CW-5585-11A-01D-2103-10_wgs_Illumina.filtered.	WGS	TCGA-CW-5585-11A-01D-2103-10_wgs_Illumina	TCGA-CW-5585-11A-01D-2103-10_wgs_Illumina.bam	39.4	1.9	0.14	58cfa831e4b0c9d6adf6c712	TCGA-CW-5585-11A-01D-2103-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-5585-11A	0487FC41-386C-4D76-9084-DAF959BF5E98	Solid Tissue Normal	Illumina HiSeq	a7895f58-d78c-4e4b-8499-be0b7238081e	Kidney	51.0	3EBDB6A2-509D-421B-A186-989ABA538664	ADE59498-FBB4-4680-8CCD-B8D739E5AB50	TCGA-CW-5585-11A-01D-2103-10	GRCh37-lite	TCGA-CW-5585	TCGA-KIRC		s9451	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	2103-10	False
13767.58cfa833e4b0c9d6adf6da89	58cfa833e4b0c9d6adf6da89	UNCID_1117001.ff7159e7-e9f2-4cc8-ab89-f4167d19672c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1117001.ff7159e7-e9f2-4cc8-ab89-f4167d19672c.sorted_genome_alignments	UNCID_1117001.ff7159e7-e9f2-4cc8-ab89-f4167d19672c.sorted_genome_alignments.bam	37.63	1.86	0.16	58cfa833e4b0c9d6adf6da89	UNCID_1117001.ff7159e7-e9f2-4cc8-ab89-f4167d19672c.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A1J9-01A	D5E9A403-88CE-40FC-BB85-80CF3F8FF6BC	Primary Tumor	Illumina HiSeq	2F609FED-7C0F-4FB6-BEE5-86B0759D720D	Breast	48.0	ED00A16B-6B8E-44E4-998A-AE4DCCA5A93C	FF7159E7-E9F2-4CC8-AB89-F4167D19672C	TCGA-D8-A1J9-01A-11R-A13Q-07	HG19	TCGA-D8-A1J9	TCGA-BRCA		s6295	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A13Q-07	True
13767.58cfa837e4b0c9d6adf70247	58cfa837e4b0c9d6adf70247	UNCID_1845444.7e6e755a-5503-4729-a3f4-249183687647.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1845444.7e6e755a-5503-4729-a3f4-249183687647.sorted_genome_alignments	UNCID_1845444.7e6e755a-5503-4729-a3f4-249183687647.sorted_genome_alignments.bam	71.11	1.97	0.18	58cfa837e4b0c9d6adf70247	UNCID_1845444.7e6e755a-5503-4729-a3f4-249183687647.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-EP-A26S-01A	B7D6621C-8BCE-4A01-8588-9D7761D9372B	Primary Tumor	Illumina HiSeq	5D9D6629-A5B2-4227-87D9-131240235E8B	Liver	70.0	A0B2FF38-E6BF-4F27-98AB-5CF924B0E236	7E6E755A-5503-4729-A3F4-249183687647	TCGA-EP-A26S-01A-11R-A16W-07	HG19	TCGA-EP-A26S	TCGA-LIHC		s16707	University of North Carolina	Christiana Healthcare	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A16W-07	True
13767.58cfa837e4b0c9d6adf702b0	58cfa837e4b0c9d6adf702b0	UNCID_1919666.1695c22b-f771-45da-8627-394516eb87de.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1919666.1695c22b-f771-45da-8627-394516eb87de.sorted_genome_alignments	UNCID_1919666.1695c22b-f771-45da-8627-394516eb87de.sorted_genome_alignments.bam	9.2		0.14	58cfa837e4b0c9d6adf702b0	UNCID_1919666.1695c22b-f771-45da-8627-394516eb87de.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-8288-01A	186CA7D6-8354-43A2-B8A5-9AC79627331F	Primary Tumor	Illumina HiSeq	3E223E04-C56D-4B8A-9FC7-0A9C7FE00B4F	Lung	70.0	134694A5-14A6-4016-9230-DECA5F6548B5	1695C22B-F771-45DA-8627-394516EB87DE	TCGA-85-8288-01A-11R-2296-07	HG19	TCGA-85-8288	TCGA-LUSC		s10457	University of North Carolina	Asterand	Russia	NO	T1b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	2296-07	True
13722.58cfa82fe4b0c9d6adf6ba1a	58cfa82fe4b0c9d6adf6ba1a	TCGA-A3-3370-11A-01D-2099-10_Illumina.filtered.	WGS	TCGA-A3-3370-11A-01D-2099-10_Illumina	TCGA-A3-3370-11A-01D-2099-10_Illumina.bam	110.0	1.9	0.16	58cfa82fe4b0c9d6adf6ba1a	TCGA-A3-3370-11A-01D-2099-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3370-11A	9F632FC3-2241-469A-A14A-CD537350155F	Solid Tissue Normal	Illumina HiSeq	20e9c9ab-d5ad-4cb7-aaaa-2d31e8ae5b47	Kidney	48.0	8C23898C-2B3E-4A33-A4C0-A81496645297	CA5FD3CB-D784-4B44-93A7-6704FB6103C6	TCGA-A3-3370-11A-01D-2099-10	GRCh37-lite	TCGA-A3-3370	TCGA-KIRC		s9300	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2099-10	False
13767.58cfa835e4b0c9d6adf6f176	58cfa835e4b0c9d6adf6f176	UNCID_1466857.a588764f-f972-4d3a-b8f8-d0209fc7d2a1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1466857.a588764f-f972-4d3a-b8f8-d0209fc7d2a1.sorted_genome_alignments	UNCID_1466857.a588764f-f972-4d3a-b8f8-d0209fc7d2a1.sorted_genome_alignments.bam	369.3	1.8	0.15	58cfa835e4b0c9d6adf6f176	UNCID_1466857.a588764f-f972-4d3a-b8f8-d0209fc7d2a1.sorted_genome_alignments.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4389-01A	A3DE401D-91FE-49A2-BB07-81C1A06506E6	Primary Tumor	Illumina HiSeq	8BFA7F34-E6A3-4481-80FC-C75E7C2394EC	Lung	70.0	ED61AC6A-F21F-4B88-928A-029340D4AEBD	A588764F-F972-4D3A-B8F8-D0209FC7D2A1	TCGA-05-4389-01A-01R-1206-07	HG19	TCGA-05-4389	TCGA-LUAD		s11292	University of North Carolina	Indivumed	Germany	NO	T1	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	1206-07	True
13767.58cfa833e4b0c9d6adf6dced	58cfa833e4b0c9d6adf6dced	UNCID_1090309.e6aecb65-29f2-48de-a8a0-55b25fbafef1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1090309.e6aecb65-29f2-48de-a8a0-55b25fbafef1.sorted_genome_alignments	UNCID_1090309.e6aecb65-29f2-48de-a8a0-55b25fbafef1.sorted_genome_alignments.bam	138.2	1.7	0.14	58cfa833e4b0c9d6adf6dced	UNCID_1090309.e6aecb65-29f2-48de-a8a0-55b25fbafef1.sorted_genome_alignments.bam	Dead	MALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-78-7156-01A	7B0622AB-63EA-483F-AE40-D3EA587BDBBA	Primary Tumor	Illumina HiSeq	D862B3D1-A55A-4E8A-B11C-704204397892	Lung	62.0	FAB452A2-A57A-4D63-80BC-2AD2B5A20F03	E6AECB65-29F2-48DE-A8A0-55B25FBAFEF1	TCGA-78-7156-01A-11R-2039-07	HG19	TCGA-78-7156	TCGA-LUAD	976.0	s10675	University of North Carolina	Prince Charles Hospital	Australia	NO	T4	N1	Lung Adenocarcinoma Mixed Subtype	Stage IV	2039-07	True
13767.58cfa838e4b0c9d6adf70912	58cfa838e4b0c9d6adf70912	UNCID_2043712.93bf6de4-c67e-4d0b-8fe6-2431a0e0d342.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2043712.93bf6de4-c67e-4d0b-8fe6-2431a0e0d342.sorted_genome_alignments	UNCID_2043712.93bf6de4-c67e-4d0b-8fe6-2431a0e0d342.sorted_genome_alignments.bam	48.4	1.81	0.17	58cfa838e4b0c9d6adf70912	UNCID_2043712.93bf6de4-c67e-4d0b-8fe6-2431a0e0d342.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A57G-01A	968BD652-786C-4DDB-A937-DC480CB821FC	Primary Tumor	Illumina HiSeq	871FF1EA-FFAC-4CA8-8DB4-B1AA6C1062EB	Cervix	49.0	F91EA887-55A6-47AC-8807-7CD4FB075E14	93BF6DE4-C67E-4D0B-8FE6-2431A0E0D342	TCGA-FU-A57G-01A-11R-A26T-07	HG19	TCGA-FU-A57G	TCGA-CESC		s1263	University of North Carolina	International Genomics Consortium	United States	NO	T1b2	N0	Endocervical Type of Adenocarcinoma		A26T-07	True
13767.58cfa834e4b0c9d6adf6e411	58cfa834e4b0c9d6adf6e411	UNCID_1188613.186a9b74-4d34-43d5-a0e9-e69958f39eba.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1188613.186a9b74-4d34-43d5-a0e9-e69958f39eba.sorted_genome_alignments	UNCID_1188613.186a9b74-4d34-43d5-a0e9-e69958f39eba.sorted_genome_alignments.bam	41.3	1.8	0.14	58cfa834e4b0c9d6adf6e411	UNCID_1188613.186a9b74-4d34-43d5-a0e9-e69958f39eba.sorted_genome_alignments.bam	Alive	MALE	ASIAN		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4998-01A	5C73B91A-2BEE-4388-854C-1C3A6AE732DB	Primary Tumor	Illumina HiSeq	2904622B-FF89-4BE5-AE63-01E0186DD2F1	Kidney	49.0	1E83AC72-12E9-4E44-A928-E9E8AA092EA7	186A9B74-4D34-43D5-A0E9-E69958F39EBA	TCGA-BP-4998-01A-01R-1334-07	HG19	TCGA-BP-4998	TCGA-KIRC		s9052	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13722.58cfa82ee4b0c9d6adf6a9aa	58cfa82ee4b0c9d6adf6a9aa	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.filtered.	WGS	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.bam	46.65		0.08	58cfa82ee4b0c9d6adf6a9aa	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3CX-01A	934A58AF-0FFC-487E-9E95-FA7643B7D5CB	Primary Tumor	Illumina HiSeq	7466949f-795d-4b2c-99e4-92d507c8772e	Thyroid	22.0	C65B5941-3E1D-41C6-9458-CDE70425E7C7	D0A33FD2-085C-488B-B843-2CA97C85A5CB	TCGA-EL-A3CX-01A-11D-A19J-08	HG19_Broad_variant	TCGA-EL-A3CX	TCGA-THCA		s12337	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19J-08	False
13767.58cfa838e4b0c9d6adf708b8	58cfa838e4b0c9d6adf708b8	UNCID_2043888.95086d05-3789-400a-b663-5d9d3a346325.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2043888.95086d05-3789-400a-b663-5d9d3a346325.sorted_genome_alignments	UNCID_2043888.95086d05-3789-400a-b663-5d9d3a346325.sorted_genome_alignments.bam	23.78	1.86	0.17	58cfa838e4b0c9d6adf708b8	UNCID_2043888.95086d05-3789-400a-b663-5d9d3a346325.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-HC-A631-01A	DB4793DC-CD45-4B81-93CE-8322031C2AA3	Primary Tumor	Illumina HiSeq	4E9A735F-798F-4156-AEF6-332E1D9BDF19	Prostate	67.0	66D9FEA0-D11C-4027-AEF4-06110BB27EED	95086D05-3789-400A-B663-5D9D3A346325	TCGA-HC-A631-01A-11R-A29R-07	HG19	TCGA-HC-A631	TCGA-PRAD		s3512	University of North Carolina	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		A29R-07	True
13722.58cfa82fe4b0c9d6adf6b86c	58cfa82fe4b0c9d6adf6b86c	TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted.filtered.	WGS	TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted	TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted.bam	77.93	2.03	0.16	58cfa82fe4b0c9d6adf6b86c	TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0VP-01A	2DB0FB62-64CE-457C-9E22-DD05EF59F684	Primary Tumor	Illumina HiSeq	26cc510d-e8a9-4782-9488-478373dbc1df	Uterus	74.0	F1FBE4AC-F3FD-4609-9A2B-507820ABE77E	E23FE404-0449-453D-971C-6E940B546119	TCGA-A5-A0VP-01A-21D-A101-02	HG19_Broad_variant	TCGA-A5-A0VP	TCGA-UCEC		s4992	Harvard Medical School	Cedars Sinai	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13722.58cfa82fe4b0c9d6adf6b8cc	58cfa82fe4b0c9d6adf6b8cc	TCGA-49-4501-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4501-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4501-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	199.2	1.9	0.16	58cfa82fe4b0c9d6adf6b8cc	TCGA-49-4501-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4501-11A	0780EB43-D5B5-4C3D-9825-BEACBA5CC723	Solid Tissue Normal	Illumina HiSeq	2e94d307-de8c-4849-a870-8731a029c297	Lung	67.0	21AC5886-832B-4352-95D2-0147F90423CC	CE4FA727-5E58-4C07-921C-2C3B9BC509DB	TCGA-49-4501-11A-01D-1203-02	GRCh37	TCGA-49-4501	TCGA-LUAD	1421.0	s10905	Harvard Medical School	Johns Hopkins	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1203-02	True
13722.58cfa82fe4b0c9d6adf6b81e	58cfa82fe4b0c9d6adf6b81e	TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted	TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted.bam	82.92	2.0	0.17	58cfa82fe4b0c9d6adf6b81e	TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GE-01A	A587E62E-430E-4F1B-82B7-6FBE856FDAF1	Primary Tumor	Illumina HiSeq	d3918efd-f063-4ea7-b839-9c0c143fd07c	Uterus	38.0	20C3F64D-ACF6-45B3-9ACE-2F93B3A951C8	3E23FB82-C875-460A-B19D-5EF9DCC58B9A	TCGA-A5-A0GE-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GE	TCGA-UCEC		s4995	Harvard Medical School	Cedars Sinai	None	NO			Endometrioid endometrial adenocarcinoma		A043-02	True
13767.58cfa83ce4b0c9d6adf72e48	58cfa83ce4b0c9d6adf72e48	_1_TCGA-HU-A4GU-01A-11R-A251-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-HU-A4GU-01A-11R-A251-31_rnaseq	_1_TCGA-HU-A4GU-01A-11R-A251-31_rnaseq.bam	81.43	1.78	0.16	58cfa83ce4b0c9d6adf72e48	_1_TCGA-HU-A4GU-01A-11R-A251-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4GU-01A	B93221BA-2076-4DD4-9931-179571B7E16C	Primary Tumor	Illumina HiSeq	81F358E6-6D65-4D0E-8D75-E41138A8696E	Stomach	73.0	1FF2C1AA-9F09-46C8-A0EC-E0F40F8680E0	ADC1B9AA-0166-4983-AB4E-FD4C8F097B76	TCGA-HU-A4GU-01A-11R-A251-31	GRCh37-lite	TCGA-HU-A4GU	TCGA-STAD		s15036	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T3	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage II	A251-31	True
13767.58cfa838e4b0c9d6adf70b84	58cfa838e4b0c9d6adf70b84	UNCID_2096552.a66ddf41-6af9-47c0-952b-688aac83c8c8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2096552.a66ddf41-6af9-47c0-952b-688aac83c8c8.sorted_genome_alignments	UNCID_2096552.a66ddf41-6af9-47c0-952b-688aac83c8c8.sorted_genome_alignments.bam	59.09	1.9	0.17	58cfa838e4b0c9d6adf70b84	UNCID_2096552.a66ddf41-6af9-47c0-952b-688aac83c8c8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A6B1-01A	0D2CD56C-09C6-467D-B3AA-1F7FE0CC60E1	Primary Tumor	Illumina HiSeq	449499FF-8F8C-4457-B843-99C4DFA80FA4	Bladder	67.0	7DA631CE-B5F9-480D-A420-EBBE76A0927C	A66DDF41-6AF9-47C0-952B-688AAC83C8C8	TCGA-DK-A6B1-01A-12R-A30C-07	HG19	TCGA-DK-A6B1	TCGA-BLCA		s3001	University of North Carolina	Memorial Sloan Kettering	United States	NO	T2a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A30C-07	True
13722.58cfa832e4b0c9d6adf6d11e	58cfa832e4b0c9d6adf6d11e	TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina	TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.bam	41.34		0.08	58cfa832e4b0c9d6adf6d11e	TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A4ZQ-01A	65E430E1-0C9A-4045-83A9-653B7CFF811D	Primary Tumor	Illumina HiSeq	34884ff9-c16b-4800-9b84-dd3ec001b261	Liver	52.0	56DAAD30-A336-4311-9FEB-26CF3E48C734	D02597F8-3AC7-4165-A65F-0E134E5D215B	TCGA-FV-A4ZQ-01A-11D-A25V-10	GRCh37-lite	TCGA-FV-A4ZQ	TCGA-LIHC		s16592	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A25V-10	True
13767.58cfa831e4b0c9d6adf6ca45	58cfa831e4b0c9d6adf6ca45	TCGA-D7-8576-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-D7-8576-01A-11R-2343-13_rnaseq	TCGA-D7-8576-01A-11R-2343-13_rnaseq.bam	281.7		0.13	58cfa831e4b0c9d6adf6ca45	TCGA-D7-8576-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-8576-01A	EC8268C7-943D-451A-9036-F0196078B6C5	Primary Tumor	Illumina HiSeq	DC3430F2-6090-4BC6-8EC0-21718B256EE1	Stomach	54.0	28BD43CF-A80C-495D-A4FF-E4F57B6D4970	A9A69F94-128A-453F-819E-20C6A7E43091	TCGA-D7-8576-01A-11R-2343-13	GRCh37-lite	TCGA-D7-8576	TCGA-STAD		s15134	Canada's Michael Smith Genome Sciences Centre	Greater Poland Cancer Center	Poland	NO	T3	N3a	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	2343-13	True
13722.58cfa832e4b0c9d6adf6d422	58cfa832e4b0c9d6adf6d422	TCGA-VD-AA8M-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_2_rg.sorted.filtered.	WGS	TCGA-VD-AA8M-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_2_rg.sorted	TCGA-VD-AA8M-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_2_rg.sorted.bam	9.04		0.15	58cfa832e4b0c9d6adf6d422	TCGA-VD-AA8M-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_2_rg.sorted.bam	Alive	MALE			Uveal Melanoma	Aligned reads	TCGA-VD-AA8M-10A	9DC5CC23-C903-4FE2-8354-64F8316FF0D4	Blood Derived Normal	Illumina HiSeq	351608b2-545c-499d-994e-ef14265e37e9	Eye	64.0	09175EE2-1543-4A0D-94CB-3FE6F48F74CF	4728EFB8-39E2-49C2-A060-66EDB562A396	TCGA-VD-AA8M-10A-01D-A40E-26	HG19_Broad_variant	TCGA-VD-AA8M	TCGA-UVM		s268	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T2a	N0		Stage II	A40E-26	True
13722.58cfa82de4b0c9d6adf6a74a	58cfa82de4b0c9d6adf6a74a	G13227.TCGA-43-3394-01A-01D-1553-08.1.filtered.	WGS	G13227.TCGA-43-3394-01A-01D-1553-08.1	G13227.TCGA-43-3394-01A-01D-1553-08.1.bam	532.37	1.9	0.05	58cfa82de4b0c9d6adf6a74a	G13227.TCGA-43-3394-01A-01D-1553-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-3394-01A	CE8612AB-3149-4A6A-B424-29C0C21C9B8B	Primary Tumor	Illumina HiSeq	bc49e74a-6128-4677-93fa-776314b3caef	Lung	52.0	D8F165AF-1DF5-4876-ABF8-7596E52A3BC3	EFE4D5DD-FFFB-41DF-AB86-BE06CC16646F	TCGA-43-3394-01A-01D-1553-08	HG19_Broad_variant	TCGA-43-3394	TCGA-LUSC		s10073	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1553-08	False
13767.58cfa839e4b0c9d6adf71394	58cfa839e4b0c9d6adf71394	UNCID_2333645.b44ca533-fb1e-4f34-b85c-a8b47f972332.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2333645.b44ca533-fb1e-4f34-b85c-a8b47f972332.sorted_genome_alignments	UNCID_2333645.b44ca533-fb1e-4f34-b85c-a8b47f972332.sorted_genome_alignments.bam	47.54	1.81	0.17	58cfa839e4b0c9d6adf71394	UNCID_2333645.b44ca533-fb1e-4f34-b85c-a8b47f972332.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Mesothelioma	Aligned reads	TCGA-SH-A7BH-01A	E611EE05-92C8-41D6-A052-18DD749F8779	Primary Tumor	Illumina HiSeq	7664115B-4A2E-4BAF-9DC6-2791E371A2D7	Mesothelium	65.0	D41D45FE-5FD6-4FF1-B7E6-1AED94CE3BDC	B44CA533-FB1E-4F34-B85C-A8B47F972332	TCGA-SH-A7BH-01A-11R-A34F-07	HG19	TCGA-SH-A7BH	TCGA-MESO	243.0	s383	University of North Carolina	Papworth Hospital	United Kingdom	NO	T3	N0		Stage III	A34F-07	True
13767.58cfa83be4b0c9d6adf72006	58cfa83be4b0c9d6adf72006	UNCID_2543734.012cd145-9f6c-4b79-b929-3f42f61e3dce.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2543734.012cd145-9f6c-4b79-b929-3f42f61e3dce.sorted_genome_alignments	UNCID_2543734.012cd145-9f6c-4b79-b929-3f42f61e3dce.sorted_genome_alignments.bam	74.81	1.94	0.18	58cfa83be4b0c9d6adf72006	UNCID_2543734.012cd145-9f6c-4b79-b929-3f42f61e3dce.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Cholangiocarcinoma	Aligned reads	TCGA-ZH-A8Y4-01A	95B69517-4971-450E-9ED0-43BC8B2C0534	Primary Tumor	Illumina HiSeq	E8690AA2-9CC9-4B57-92A4-3271E7E95B30	Bile Duct	58.0	69C14659-DA45-46A7-BD76-7625EC37B2CE	012CD145-9F6C-4B79-B929-3F42F61E3DCE	TCGA-ZH-A8Y4-01A-11R-A41I-07	HG19	TCGA-ZH-A8Y4	TCGA-CHOL	741.0	s30	University of North Carolina	University of North Carolina	United States	NO	T1	N0		Stage I	A41I-07	True
13767.58cfa838e4b0c9d6adf70b08	58cfa838e4b0c9d6adf70b08	UNCID_2144143.6991a561-ff49-4546-9bc7-74cca88916ae.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2144143.6991a561-ff49-4546-9bc7-74cca88916ae.sorted_genome_alignments	UNCID_2144143.6991a561-ff49-4546-9bc7-74cca88916ae.sorted_genome_alignments.bam	44.54	1.87	0.17	58cfa838e4b0c9d6adf70b08	UNCID_2144143.6991a561-ff49-4546-9bc7-74cca88916ae.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Adrenocortical Carcinoma	Aligned reads	TCGA-OR-A5KZ-01A	99F86B57-3894-45C5-BFBE-C757C69A3050	Primary Tumor	Illumina HiSeq	AB52CAB5-57EB-4801-92B0-DCFC65377B4B	Adrenal Gland	42.0	0C9C6928-BA38-49DA-A5CF-67DD8E038F60	6991A561-FF49-4546-9BC7-74CCA88916AE	TCGA-OR-A5KZ-01A-11R-A29S-07	HG19	TCGA-OR-A5KZ	TCGA-ACC	125.0	s144	University of North Carolina	University of Michigan	Germany	NO	T2	N0		Stage II	A29S-07	True
13767.58cfa836e4b0c9d6adf6fba1	58cfa836e4b0c9d6adf6fba1	UNCID_1662593.9ED1D311-747A-434E-9AB4-5DF6BC6B75DE.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1662593.9ED1D311-747A-434E-9AB4-5DF6BC6B75DE.sorted_genome_alignments	UNCID_1662593.9ED1D311-747A-434E-9AB4-5DF6BC6B75DE.sorted_genome_alignments.bam	56.77	1.85	0.17	58cfa836e4b0c9d6adf6fba1	UNCID_1662593.9ED1D311-747A-434E-9AB4-5DF6BC6B75DE.sorted_genome_alignments.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A3OA-01A	24CF6397-60EF-4635-81F0-78A67157AAC0	Primary Tumor	Illumina HiSeq	FF51856B-D2DD-4C13-B7F1-B9A6F7F30A84	Thyroid	55.0	8B048263-6C2F-4BF6-8F37-C69DA9F3839F	9ED1D311-747A-434E-9AB4-5DF6BC6B75DE	TCGA-EM-A3OA-01A-11R-A220-07	HG19	TCGA-EM-A3OA	TCGA-THCA		s12057	University of North Carolina	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A220-07	True
13767.58cfa834e4b0c9d6adf6e631	58cfa834e4b0c9d6adf6e631	UNCID_1191074.48997d33-baf4-499d-9931-fa552d7fc313.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1191074.48997d33-baf4-499d-9931-fa552d7fc313.sorted_genome_alignments	UNCID_1191074.48997d33-baf4-499d-9931-fa552d7fc313.sorted_genome_alignments.bam	144.8	1.7	0.15	58cfa834e4b0c9d6adf6e631	UNCID_1191074.48997d33-baf4-499d-9931-fa552d7fc313.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5701-01A	8F8A632D-7FBD-4C86-B909-AFB7EDB9AD28	Primary Tumor	Illumina HiSeq	FD295029-001B-48FD-BF21-CC300E50C998	Kidney	65.0	9DAB1969-D52D-4646-B2FC-465C12C48CE9	48997D33-BAF4-499D-9931-FA552D7FC313	TCGA-B0-5701-01A-11R-1541-07	HG19	TCGA-B0-5701	TCGA-KIRC		s9490	University of North Carolina	University of Pittsburgh	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1541-07	True
13767.58cfa835e4b0c9d6adf6ece0	58cfa835e4b0c9d6adf6ece0	UNCID_1346803.63fcdb32-0c58-4541-afbc-96b34020c5c8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1346803.63fcdb32-0c58-4541-afbc-96b34020c5c8.sorted_genome_alignments	UNCID_1346803.63fcdb32-0c58-4541-afbc-96b34020c5c8.sorted_genome_alignments.bam	37.1	1.83	0.17	58cfa835e4b0c9d6adf6ece0	UNCID_1346803.63fcdb32-0c58-4541-afbc-96b34020c5c8.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MI-01A	F1EBF96B-8DF9-4E59-ACEF-7AD433E40214	Primary Tumor	Illumina HiSeq	B218E3D6-1226-4C59-B21E-F90E98D59202	Bladder	62.0	A373568A-BBD3-4D67-92D6-96E8378065CF	63FCDB32-0C58-4541-AFBC-96B34020C5C8	TCGA-CF-A3MI-01A-11R-A20F-07	HG19	TCGA-CF-A3MI	TCGA-BLCA		s2764	University of North Carolina	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A20F-07	True
13722.58cfa82ee4b0c9d6adf6ae16	58cfa82ee4b0c9d6adf6ae16	G49837.TCGA-94-7943-01A-11D-A320-08.2.filtered.	WGS	G49837.TCGA-94-7943-01A-11D-A320-08.2	G49837.TCGA-94-7943-01A-11D-A320-08.2.bam	203.0		0.08	58cfa82ee4b0c9d6adf6ae16	G49837.TCGA-94-7943-01A-11D-A320-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-94-7943-01A	AECF85CC-058C-46F3-9CDC-3573AC3B8438	Primary Tumor	Illumina HiSeq	f0eef218-f0af-4e9d-8f67-cdfc840480bc	Lung	80.0	E447DA47-227D-4956-9F46-AD1F81B73EBA	7731EF7F-25BD-42F5-9A20-BE249306A711	TCGA-94-7943-01A-11D-A320-08	HG19_Broad_variant	TCGA-94-7943	TCGA-LUSC		s10509	Broad Institute of MIT and Harvard	Washington University - Emory	United States	NO	T1b	NX	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	A320-08	True
13767.58cfa836e4b0c9d6adf6f6d4	58cfa836e4b0c9d6adf6f6d4	UNCID_1573578.16ced370-3e97-40a5-9743-6bdd7bbc37d3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1573578.16ced370-3e97-40a5-9743-6bdd7bbc37d3.sorted_genome_alignments	UNCID_1573578.16ced370-3e97-40a5-9743-6bdd7bbc37d3.sorted_genome_alignments.bam	86.66	1.83	0.16	58cfa836e4b0c9d6adf6f6d4	UNCID_1573578.16ced370-3e97-40a5-9743-6bdd7bbc37d3.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-DS-A0VM-01A	ED6D989D-DA09-4818-8FED-F33D88B628AF	Primary Tumor	Illumina HiSeq	D3E48087-BC59-4864-92BB-10D7672D4E32	Cervix	51.0	52C90714-B4ED-42FA-8763-914140308FFA	16CED370-3E97-40A5-9743-6BDD7BBC37D3	TCGA-DS-A0VM-01A-11R-A10U-07	HG19	TCGA-DS-A0VM	TCGA-CESC		s1220	University of North Carolina	Cedars Sinai	United States	NO	T1b1	N1	Cervical Squamous Cell Carcinoma		A10U-07	True
13767.58cfa82ee4b0c9d6adf6a85c	58cfa82ee4b0c9d6adf6a85c	G17637.TCGA-06-5418-01A-01R-1849-01.2.filtered.	RNA-Seq	G17637.TCGA-06-5418-01A-01R-1849-01.2	G17637.TCGA-06-5418-01A-01R-1849-01.2.bam	171.2	1.8	0.14	58cfa82ee4b0c9d6adf6a85c	G17637.TCGA-06-5418-01A-01R-1849-01.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-5418-01A	51C3409D-5DF7-4720-83DB-0E6DE065F82C	Primary Tumor	Illumina HiSeq	6990F455-E99D-4CDA-BB4F-5E1109A8DD6B	Brain	75.0	54C53F07-1492-49B6-83C9-BD12C86F95A8	E48C8261-5E7B-4CBE-95ED-8A7D1C356D70	TCGA-06-5418-01A-01R-1849-01	HG19_Broad_variant	TCGA-06-5418	TCGA-GBM	83.0	s14051	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13722.58cfa831e4b0c9d6adf6cc9a	58cfa831e4b0c9d6adf6cc9a	TCGA-EE-A2MI-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EE-A2MI-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_8_rg.sorted	TCGA-EE-A2MI-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_8_rg.sorted.bam	26.57		0.15	58cfa831e4b0c9d6adf6cc9a	TCGA-EE-A2MI-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2MI-10A	C061AE6C-7A02-47C3-AECD-A56487C01603	Blood Derived Normal	Illumina HiSeq	270078f3-9359-471b-99e5-0c398664d8ef	Skin	43.0	A0DABFDB-1FCF-47E3-B822-7E4B54D9B38E	B1AE52DE-36C5-4F03-9302-B226F153B066	TCGA-EE-A2MI-10A-01D-A190-02	HG19_Broad_variant	TCGA-EE-A2MI	TCGA-SKCM	6225.0	s7345	Harvard Medical School	University of Sydney	Australia	NO	T4	N0		Stage II	A190-02	True
13722.58cfa830e4b0c9d6adf6c232	58cfa830e4b0c9d6adf6c232	TCGA-BA-5557-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BA-5557-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_7_rg.sorted	TCGA-BA-5557-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_7_rg.sorted.bam	209.4	1.9	0.15	58cfa830e4b0c9d6adf6c232	TCGA-BA-5557-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_7_rg.sorted.bam	Alive	FEMALE		HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5557-10A	7E0575CE-670B-4035-8A90-4D35279707B2	Blood Derived Normal	Illumina HiSeq	11ddaf7c-cee4-47b6-a167-60967da1bd66	Head and Neck	41.0	C56044D3-D6D5-41CD-B9A0-62EE45944B88	5F826C70-5AA0-40C4-8ACC-A7C17A74B457	TCGA-BA-5557-10A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5557	TCGA-HNSC		s15878	Harvard Medical School	UNC	None	NO	T1	N1	Head and Neck Squamous Cell Carcinoma	Stage III	1509-02	True
13767.58cfa835e4b0c9d6adf6ed82	58cfa835e4b0c9d6adf6ed82	UNCID_1369699.3e095f21-2bc5-4ee8-bf9f-0035164d2113.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1369699.3e095f21-2bc5-4ee8-bf9f-0035164d2113.sorted_genome_alignments	UNCID_1369699.3e095f21-2bc5-4ee8-bf9f-0035164d2113.sorted_genome_alignments.bam	19.8	1.7	0.15	58cfa835e4b0c9d6adf6ed82	UNCID_1369699.3e095f21-2bc5-4ee8-bf9f-0035164d2113.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6400-01A	178AB87C-0582-4B02-BF6B-3A4C59A5EE1B	Primary Tumor	Illumina HiSeq	DD9A8E2F-E65D-4EA4-85D4-AF4C8B15091D	Brain	66.0	3B4D0299-9B10-4105-871A-786E610657A2	3E095F21-2BC5-4EE8-BF9F-0035164D2113	TCGA-DU-6400-01A-12R-1708-07	HG19	TCGA-DU-6400	TCGA-LGG	37.0	s8156	University of North Carolina	Henry Ford Hospital	United States	NO			Oligodendroglioma		1708-07	True
13722.58cfa82ee4b0c9d6adf6aa4d	58cfa82ee4b0c9d6adf6aa4d	G26368.TCGA-19-2629-01A-01D-1495-08.1.filtered.	WGS	G26368.TCGA-19-2629-01A-01D-1495-08.1	G26368.TCGA-19-2629-01A-01D-1495-08.1.bam	169.1	1.9	0.05	58cfa82ee4b0c9d6adf6aa4d	G26368.TCGA-19-2629-01A-01D-1495-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-2629-01A	E17A6048-7A72-42C0-AD3F-97CBFF02BC9F	Primary Tumor	Illumina HiSeq	f54e5ef9-adae-4612-98af-8247a3499567	Brain	60.0	B89A4D5D-EE24-4052-B454-B67169328737	56FFAA35-814C-4C0B-B3C6-D4514D34FEC2	TCGA-19-2629-01A-01D-1495-08	HG19_Broad_variant	TCGA-19-2629	TCGA-GBM	737.0	s14367	Broad Institute of MIT and Harvard	Case Western	None	NO			Untreated primary (de novo) GBM		1495-08	False
13722.58cfa82ee4b0c9d6adf6a7ea	58cfa82ee4b0c9d6adf6a7ea	G23065.TCGA_BA_5153_01A_01D_2268_08.1.filtered.	WGS	G23065.TCGA_BA_5153_01A_01D_2268_08.1	G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam	422.7	1.9	0.15	58cfa82ee4b0c9d6adf6a7ea	G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5153-01A	B3631718-9E0A-454C-BEE1-8F36EBC509D8	Primary Tumor	Illumina HiSeq	29740348-2de4-44e6-bdb0-05a2fb2fd9eb	Head and Neck	51.0	2DC7070A-9C70-4BB1-9634-8C934BB9C8D1	24D2B176-B1AB-4789-B394-616B722E63DF	TCGA-BA-5153-01A-01D-2268-08	HG19_Broad_variant	TCGA-BA-5153	TCGA-HNSC	1762.0	s15484	Broad Institute of MIT and Harvard	UNC	None	NO	T2	NX	Head and Neck Squamous Cell Carcinoma		2268-08	True
13767.58cfa834e4b0c9d6adf6e840	58cfa834e4b0c9d6adf6e840	UNCID_1227128.b598c4fd-14e6-476e-852a-83d396ec2d0f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1227128.b598c4fd-14e6-476e-852a-83d396ec2d0f.sorted_genome_alignments	UNCID_1227128.b598c4fd-14e6-476e-852a-83d396ec2d0f.sorted_genome_alignments.bam	140.2	1.8	0.14	58cfa834e4b0c9d6adf6e840	UNCID_1227128.b598c4fd-14e6-476e-852a-83d396ec2d0f.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-BQ-7053-01A	6369A2B1-921B-4D35-A0C8-6EDAC508A702	Primary Tumor	Illumina HiSeq	DBAC97B8-4E8B-499A-9B9E-85929EFC7AE5	Kidney	57.0	DFC0F2AC-CEDB-40D9-AAA7-53FA7FE0AC8D	B598C4FD-14E6-476E-852A-83D396EC2D0F	TCGA-BQ-7053-01A-11R-1965-07	HG19	TCGA-BQ-7053	TCGA-KIRP		s11680	University of North Carolina	MSKCC	United States	NO	T3	NX	Kidney Papillary Renal Cell Carcinoma	Stage III	1965-07	True
13767.58cfa833e4b0c9d6adf6dde6	58cfa833e4b0c9d6adf6dde6	UNCID_1133340.8bb3543b-5c83-41c6-b81c-b20935c38d72.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1133340.8bb3543b-5c83-41c6-b81c-b20935c38d72.sorted_genome_alignments	UNCID_1133340.8bb3543b-5c83-41c6-b81c-b20935c38d72.sorted_genome_alignments.bam	33.6	1.82	0.16	58cfa833e4b0c9d6adf6dde6	UNCID_1133340.8bb3543b-5c83-41c6-b81c-b20935c38d72.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1B0-01A	996BD3F0-D767-4EFF-9C82-99FCB5A3006A	Primary Tumor	Illumina HiSeq	F7CC25F3-A65D-475C-B2E6-CFCEC55CA66F	Breast	50.0	06479CFC-C43C-43F5-9D2F-44B3ADC45D84	8BB3543B-5C83-41C6-B81C-B20935C38D72	TCGA-E2-A1B0-01A-11R-A12P-07	HG19	TCGA-E2-A1B0	TCGA-BRCA		s6161	University of North Carolina	Roswell Park	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage III	A12P-07	True
13722.58cfa830e4b0c9d6adf6bbf6	58cfa830e4b0c9d6adf6bbf6	TCGA-AA-A01C-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_6_rg.sorted.filtered.	WGS	TCGA-AA-A01C-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_6_rg.sorted	TCGA-AA-A01C-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_6_rg.sorted.bam	34.25	1.75	0.15	58cfa830e4b0c9d6adf6bbf6	TCGA-AA-A01C-10A-01D-A078_110329_SN208_0198_B702NLABXX_s_6_rg.sorted.bam	Alive	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01C-10A	80809D79-92E1-4D6C-BA2E-0A9589997792	Blood Derived Normal	Illumina HiSeq	5008c942-2f6d-42fb-bac0-f992c3f5f122	Colorectal	75.0	0D2F53A8-9261-4E57-A0CD-5CD5E6376743	8683DA63-3130-447E-89E9-3137D78E8475	TCGA-AA-A01C-10A-01D-A078-02	HG18_Broad_variant	TCGA-AA-A01C	TCGA-COAD		s13533	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Colon Adenocarcinoma	Stage III	A078-02	True
13722.58cfa82ee4b0c9d6adf6aea0	58cfa82ee4b0c9d6adf6aea0	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.filtered.	WGS	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.bam	37.07		0.08	58cfa82ee4b0c9d6adf6aea0	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A2QD-01A	B0CB6ED7-3D9F-4D5E-8DF5-EDCC921C43B4	Primary Tumor	Illumina HiSeq	102342da-d9ce-4eb4-8c20-dda6ce072830	Thyroid	61.0	08D3CB3B-9A80-4034-B06D-B37DD38C8B9B	E7335A24-E5FC-4558-9EBA-511C5A802320	TCGA-FY-A2QD-01A-11D-A19J-08	HG19_Broad_variant	TCGA-FY-A2QD	TCGA-THCA		s12226	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual		A19J-08	False
13767.58cfa83be4b0c9d6adf721b6	58cfa83be4b0c9d6adf721b6	UNCID_2599365.2a0ba833-5509-464d-98b1-a221101788f2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2599365.2a0ba833-5509-464d-98b1-a221101788f2.sorted_genome_alignments	UNCID_2599365.2a0ba833-5509-464d-98b1-a221101788f2.sorted_genome_alignments.bam	31.81	1.88	0.16	58cfa83be4b0c9d6adf721b6	UNCID_2599365.2a0ba833-5509-464d-98b1-a221101788f2.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thymoma	Aligned reads	TCGA-ZB-A96M-01A	3EAB80E6-21BC-45DD-A7B5-411A5DAD4E9A	Primary Tumor	Illumina HiSeq	98C666C5-E2DA-4FB7-A74E-BBE66AD98645	Thymus	56.0	091BDF91-19A5-44A0-A8A7-284144ECEADA	2A0BA833-5509-464D-98B1-A221101788F2	TCGA-ZB-A96M-01A-11R-A42S-07	HG19	TCGA-ZB-A96M	TCGA-THYM		s547	University of North Carolina	Thoraxklinik	Germany	NO					A42S-07	True
13767.58cfa830e4b0c9d6adf6bf12	58cfa830e4b0c9d6adf6bf12	TCGA-BR-4256-01A-01R-1131-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-4256-01A-01R-1131-13_rnaseq	TCGA-BR-4256-01A-01R-1131-13_rnaseq.bam	54.3	1.8	0.15	58cfa830e4b0c9d6adf6bf12	TCGA-BR-4256-01A-01R-1131-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4256-01A	7B0D69CA-13A6-46E0-839C-E433BBEDE3AD	Primary Tumor	Illumina HiSeq	A2B97561-64DD-4A53-BB00-5DE5327C4803	Stomach	80.0	61C7AAB0-51D9-4706-A37C-D5058007DAF1	408F2950-EA38-4DBD-A067-6598D401F091	TCGA-BR-4256-01A-01R-1131-13	GRCh37-lite	TCGA-BR-4256	TCGA-STAD		s14466	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	TX	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)		1131-13	True
13722.58cfa831e4b0c9d6adf6c867	58cfa831e4b0c9d6adf6c867	TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted	TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted.bam	876.0	1.9	0.14	58cfa831e4b0c9d6adf6c867	TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6827-10A	3C5BC678-41E9-46B3-9686-5CD95659AB71	Blood Derived Normal	Illumina HiSeq	aef80235-e93d-436c-8a32-888344249391	Head and Neck	55.0	2EF80E58-961D-45D6-AC3A-A520BE3728C9	E38F279E-881E-4A80-806E-50B316E0741D	TCGA-D6-6827-10A-01D-1911-02	HG19_Broad_variant	TCGA-D6-6827	TCGA-HNSC		s15653	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	1911-02	True
13767.58cfa834e4b0c9d6adf6e225	58cfa834e4b0c9d6adf6e225	UNCID_1168369.2b5a753c-2fb5-41e5-bf95-8c3e894f57b2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1168369.2b5a753c-2fb5-41e5-bf95-8c3e894f57b2.sorted_genome_alignments	UNCID_1168369.2b5a753c-2fb5-41e5-bf95-8c3e894f57b2.sorted_genome_alignments.bam	143.3	1.8	0.15	58cfa834e4b0c9d6adf6e225	UNCID_1168369.2b5a753c-2fb5-41e5-bf95-8c3e894f57b2.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-4858-01A	F06BDEA2-4528-4A14-9CEA-280AF6B4C702	Primary Tumor	Illumina HiSeq	7F739A4C-43CF-4275-867A-BF0202E40E42	Kidney	39.0	A335A2D4-7B58-4BAA-93E2-CFFDBBDBF09B	2B5A753C-2FB5-41E5-BF95-8C3E894F57B2	TCGA-CZ-4858-01A-01R-1305-07	HG19	TCGA-CZ-4858	TCGA-KIRC		s9753	University of North Carolina	Harvard	None	NO	T2	NX	Kidney Clear Cell Renal Carcinoma	Stage II	1305-07	True
13722.58cfa82de4b0c9d6adf6a4c4	58cfa82de4b0c9d6adf6a4c4	361e7a513afa7609e295faeb67b6c110.filtered.	WGS	361e7a513afa7609e295faeb67b6c110	361e7a513afa7609e295faeb67b6c110.bam	37.98	1.84	0.09	58cfa82de4b0c9d6adf6a4c4	361e7a513afa7609e295faeb67b6c110.bam	Dead	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1ML-10A	374F614A-BCD1-4283-AC6F-FC27DDC79987	Blood Derived Normal	Illumina HiSeq	89c8b231-ff58-48a3-9017-7ec06043377d	Cervix	49.0	49DCA437-04B4-4224-AD9E-C81ABFA2DF0E	EEC629E1-E1C3-4A64-9F06-08C0607F8B90	TCGA-C5-A1ML-10A-01D-A200-09	GRCh37-lite	TCGA-C5-A1ML	TCGA-CESC	636.0	s1349	Washington University School of Medicine	Medical College of Wisconsin	United States	NO			Cervical Squamous Cell Carcinoma		A200-09	True
13722.58cfa831e4b0c9d6adf6c854	58cfa831e4b0c9d6adf6c854	TCGA-D3-A2JD-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D3-A2JD-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_1_rg.sorted	TCGA-D3-A2JD-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_1_rg.sorted.bam	57.77		0.15	58cfa831e4b0c9d6adf6c854	TCGA-D3-A2JD-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A2JD-06A	A5F95C6C-E25A-4AD8-BD5D-FCFD8A31933C	Metastatic	Illumina HiSeq	65653c49-be73-44c2-b13c-3aa7f55d5748	Skin	58.0	5A484E4E-D555-4AC6-9269-6E36FCC955B9	512AF874-0BA3-4BD2-A1FE-361C73F3EADF	TCGA-D3-A2JD-06A-11D-A18Z-02	HG19_Broad_variant	TCGA-D3-A2JD	TCGA-SKCM	361.0	s7669	Harvard Medical School	MD Anderson	United States	NO	T4b	N1b		Stage III	A18Z-02	True
13767.58cfa837e4b0c9d6adf7032a	58cfa837e4b0c9d6adf7032a	UNCID_1874254.4bc6fee0-71a0-43c6-a700-e3dc86865d70.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1874254.4bc6fee0-71a0-43c6-a700-e3dc86865d70.sorted_genome_alignments	UNCID_1874254.4bc6fee0-71a0-43c6-a700-e3dc86865d70.sorted_genome_alignments.bam	160.2	1.7	0.15	58cfa837e4b0c9d6adf7032a	UNCID_1874254.4bc6fee0-71a0-43c6-a700-e3dc86865d70.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CA-6718-01A	DF5AB6CC-6F68-4B6B-95E2-954C6B57BA9C	Primary Tumor	Illumina HiSeq	C23BF491-9CF8-450A-99F6-71D1FB768900	Colorectal	46.0	F235AFBB-DC2A-41DD-B373-77C0AACEFB37	4BC6FEE0-71A0-43C6-A700-E3DC86865D70	TCGA-CA-6718-01A-11R-1839-07	HG19	TCGA-CA-6718	TCGA-COAD		s13770	University of North Carolina	ILSbio	Vietnam	NO	T3	N0	Colon Adenocarcinoma	Stage II	1839-07	True
13767.58cfa835e4b0c9d6adf6ed6c	58cfa835e4b0c9d6adf6ed6c	UNCID_1370929.f0b0d0c2-4b26-4cf9-b3c7-2f973f958729.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1370929.f0b0d0c2-4b26-4cf9-b3c7-2f973f958729.sorted_genome_alignments	UNCID_1370929.f0b0d0c2-4b26-4cf9-b3c7-2f973f958729.sorted_genome_alignments.bam	55.8	1.8	0.15	58cfa835e4b0c9d6adf6ed6c	UNCID_1370929.f0b0d0c2-4b26-4cf9-b3c7-2f973f958729.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5870-01A	EB42625E-FBBB-4BEE-BBE9-315B3CA2138A	Primary Tumor	Illumina HiSeq	82C333C3-9F32-43C4-B37A-D9A0785B811B	Brain	34.0	25E75875-4A84-4C29-9030-0E0922BD6567	F0B0D0C2-4B26-4CF9-B3C7-2F973F958729	TCGA-DU-5870-01A-11R-1708-07	HG19	TCGA-DU-5870	TCGA-LGG		s8161	University of North Carolina	Henry Ford Hospital	United States	NO			Oligodendroglioma		1708-07	True
13722.58cfa82ee4b0c9d6adf6acfa	58cfa82ee4b0c9d6adf6acfa	G49537.TCGA-EL-A3T9-11A-11D-A22D-08.2.filtered.	WGS	G49537.TCGA-EL-A3T9-11A-11D-A22D-08.2	G49537.TCGA-EL-A3T9-11A-11D-A22D-08.2.bam	26.78		0.07	58cfa82ee4b0c9d6adf6acfa	G49537.TCGA-EL-A3T9-11A-11D-A22D-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T9-11A	8A233B01-2959-467F-8950-02BE16309156	Solid Tissue Normal	Illumina HiSeq	5d9b0003-3982-421b-84bc-419bc0af4d04	Thyroid	69.0	B2B3F5B7-EBD3-48DB-8678-3E105653985F	60ECCA33-9F6A-4C77-A862-6F3D723029C9	TCGA-EL-A3T9-11A-11D-A22D-08	HG19_Broad_variant	TCGA-EL-A3T9	TCGA-THCA	174.0	s12346	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T4	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A22D-08	True
13767.58cfa838e4b0c9d6adf7043b	58cfa838e4b0c9d6adf7043b	UNCID_1920715.e58c5f71-33ca-4443-890e-49b85916f080.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1920715.e58c5f71-33ca-4443-890e-49b85916f080.sorted_genome_alignments	UNCID_1920715.e58c5f71-33ca-4443-890e-49b85916f080.sorted_genome_alignments.bam	84.2		0.14	58cfa838e4b0c9d6adf7043b	UNCID_1920715.e58c5f71-33ca-4443-890e-49b85916f080.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-8308-01A	399C936E-BA68-4040-98D4-917A87DAD603	Primary Tumor	Illumina HiSeq	15B1F483-E9F7-4634-A713-051825336D3D	Lung	79.0	57A554B7-E96B-440B-97FD-A452D06D3986	E58C5F71-33CA-4443-890E-49B85916F080	TCGA-56-8308-01A-11R-2296-07	HG19	TCGA-56-8308	TCGA-LUSC		s10322	University of North Carolina	International Genomics Consortium	United States	NO	T3	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	2296-07	True
13767.58cfa83be4b0c9d6adf723ec	58cfa83be4b0c9d6adf723ec	UNCID_2575941.aa64f00c-804a-4c4b-95fc-85ab0887cdf8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2575941.aa64f00c-804a-4c4b-95fc-85ab0887cdf8.sorted_genome_alignments	UNCID_2575941.aa64f00c-804a-4c4b-95fc-85ab0887cdf8.sorted_genome_alignments.bam	47.31	1.87	0.18	58cfa83be4b0c9d6adf723ec	UNCID_2575941.aa64f00c-804a-4c4b-95fc-85ab0887cdf8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-2G-AAFY-01A	1B1E7D1D-634F-4D39-BEA1-3C1D72BB2AF4	Primary Tumor	Illumina HiSeq	B8206563-E058-40F4-B331-F351BB0CB5C6	Testis	24.0	AB6BA5E6-85AB-4704-B142-497E906F802F	AA64F00C-804A-4C4B-95FC-85AB0887CDF8	TCGA-2G-AAFY-01A-11R-A430-07	HG19	TCGA-2G-AAFY	TCGA-TGCT		s615	University of North Carolina	Erasmus MC	Netherlands	NO	T2	N1		Stage II	A430-07	True
13767.58cfa82fe4b0c9d6adf6b592	58cfa82fe4b0c9d6adf6b592	TCGA-29-1701-01A-01R-1567-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-29-1701-01A-01R-1567-13_GRCh37-lite_rnaseq	TCGA-29-1701-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	276.0	1.8	0.16	58cfa82fe4b0c9d6adf6b592	TCGA-29-1701-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1701-01A	86B513BA-DF09-485D-92D4-FB9E888F7350	Primary Tumor	Illumina HiSeq	3078467A-D633-461C-91A7-9283EC48000B	Ovary	56.0	EAE870BE-BBC8-4FFE-BFFC-86D87414FF4B	E5E6F25B-D641-4598-8BB1-0850750EF048	TCGA-29-1701-01A-01R-1567-13	GRCh37-lite	TCGA-29-1701	TCGA-OV	515.0	s17386	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa83ce4b0c9d6adf72e2e	58cfa83ce4b0c9d6adf72e2e	_1_TCGA-BR-8590-01A-11R-2402-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-8590-01A-11R-2402-13_rnaseq	_1_TCGA-BR-8590-01A-11R-2402-13_rnaseq.bam	250.2		0.16	58cfa83ce4b0c9d6adf72e2e	_1_TCGA-BR-8590-01A-11R-2402-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8590-01A	D59824BD-816E-4FFC-8AAE-1C3EFF1F800E	Primary Tumor	Illumina HiSeq	AA0E361C-F996-47CF-9FE6-51EDC3B9242C	Stomach	62.0	A0C5A5F3-2ED1-496C-9CCE-45B7D6619960	697DEA65-C1E2-4B70-990D-B2A7717A5152	TCGA-BR-8590-01A-11R-2402-13	GRCh37-lite	TCGA-BR-8590	TCGA-STAD		s15359	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4b	N2	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2402-13	True
13722.58cfa831e4b0c9d6adf6ca2b	58cfa831e4b0c9d6adf6ca2b	TCGA-DD-A1E9-01A-21D-A152-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A1E9-01A-21D-A152-10_wgs_Illumina	TCGA-DD-A1E9-01A-21D-A152-10_wgs_Illumina.bam	41.55	2.03	0.08	58cfa831e4b0c9d6adf6ca2b	TCGA-DD-A1E9-01A-21D-A152-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1E9-01A	8153A862-0790-4A33-80DB-ED47FEDCD4EF	Primary Tumor	Illumina HiSeq	85774f15-e638-438b-8515-92f3e9a8fa8e	Liver	70.0	966C4541-84D4-4A4F-9BB9-209431B620C7	84A0BC36-9F29-4B23-AEE1-BF5FF71F697B	TCGA-DD-A1E9-01A-21D-A152-10	GRCh37-lite	TCGA-DD-A1E9	TCGA-LIHC	2759.0	s16978	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A152-10	True
13767.58cfa837e4b0c9d6adf702e6	58cfa837e4b0c9d6adf702e6	UNCID_1952833.f2b931d2-b2cf-44d7-a2b6-4f94b0395cbc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1952833.f2b931d2-b2cf-44d7-a2b6-4f94b0395cbc.sorted_genome_alignments	UNCID_1952833.f2b931d2-b2cf-44d7-a2b6-4f94b0395cbc.sorted_genome_alignments.bam	15.99	1.81	0.17	58cfa837e4b0c9d6adf702e6	UNCID_1952833.f2b931d2-b2cf-44d7-a2b6-4f94b0395cbc.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-HZ-A49I-01A	27286A38-1035-4A22-9EBC-874DF8C49026	Primary Tumor	Illumina HiSeq	93622D03-E8E5-488D-8D95-866BC28D1BA7	Pancreas	77.0	81F10E63-73E0-4C07-BE8B-B8C6D163B9AD	F2B931D2-B2CF-44D7-A2B6-4F94B0395CBC	TCGA-HZ-A49I-01A-12R-A26U-07	HG19	TCGA-HZ-A49I	TCGA-PAAD		s771	University of North Carolina	International Genomics Consortium	United States	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	A26U-07	True
13767.58cfa838e4b0c9d6adf70f4a	58cfa838e4b0c9d6adf70f4a	UNCID_2214906.8fadca85-e334-4277-9f5f-6f0de8f54cb5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2214906.8fadca85-e334-4277-9f5f-6f0de8f54cb5.sorted_genome_alignments	UNCID_2214906.8fadca85-e334-4277-9f5f-6f0de8f54cb5.sorted_genome_alignments.bam	49.42	0.85	0.15	58cfa838e4b0c9d6adf70f4a	UNCID_2214906.8fadca85-e334-4277-9f5f-6f0de8f54cb5.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A3BV-01A	C14A0460-30B0-453B-AB81-DA03AD4AD02E	Primary Tumor	Illumina HiSeq	AC31C8D9-4596-49C1-AD35-78D1F1EFCE5E	Thyroid	47.0	2E78D231-1272-432B-BA71-20930F970971	8FADCA85-E334-4277-9F5F-6F0DE8F54CB5	TCGA-ET-A3BV-01A-11R-A19O-07	HG19	TCGA-ET-A3BV	TCGA-THCA		s12334	University of North Carolina	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A19O-07	True
13767.58cfa82ee4b0c9d6adf6a9ce	58cfa82ee4b0c9d6adf6a9ce	G17813.TCGA-76-4927-01A-01R-1850-01.4.filtered.	RNA-Seq	G17813.TCGA-76-4927-01A-01R-1850-01.4	G17813.TCGA-76-4927-01A-01R-1850-01.4.bam	64.7	1.8	0.15	58cfa82ee4b0c9d6adf6a9ce	G17813.TCGA-76-4927-01A-01R-1850-01.4.bam	Dead	MALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-76-4927-01A	9D1D9AE5-4640-4060-A207-C9C5B0E905E1	Primary Tumor	Illumina HiSeq	F0E5861C-2740-4348-812C-BFDC84EA4208	Brain	58.0	D245834B-90B5-4A79-BE65-3B76AE526B27	777C1AD8-AE6D-4C17-AD59-8B26ADB67A1B	TCGA-76-4927-01A-01R-1850-01	HG19_Broad_variant	TCGA-76-4927	TCGA-GBM	535.0	s14337	Broad Institute of MIT and Harvard	Thomas Jefferson University	None	NO			Untreated primary (de novo) GBM		1850-01	True
13722.58cfa831e4b0c9d6adf6cb80	58cfa831e4b0c9d6adf6cb80	TCGA-EE-A2ME-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EE-A2ME-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_7_rg.sorted	TCGA-EE-A2ME-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_7_rg.sorted.bam	18.96		0.16	58cfa831e4b0c9d6adf6cb80	TCGA-EE-A2ME-10A-01D-A190_120724_SN1222_0139_BD13UNACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2ME-10A	D70E0D27-7F27-4807-A36E-9FB7B00F0A70	Blood Derived Normal	Illumina HiSeq	18ac5a1c-5e50-4962-ab78-94e561021d0c	Skin	51.0	C51882CD-DAC8-4FB1-973A-1287195E7CBF	F92F171E-3442-4EF7-B30A-B4A11C86AA47	TCGA-EE-A2ME-10A-01D-A190-02	HG19_Broad_variant	TCGA-EE-A2ME	TCGA-SKCM	3141.0	s8012	Harvard Medical School	University of Sydney	Australia	NO	T2	N0		Stage I	A190-02	True
13722.58cfa832e4b0c9d6adf6d26a	58cfa832e4b0c9d6adf6d26a	TCGA-KL-8326-11A-01D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8326-11A-01D-2310-10_wgs_Illumina	TCGA-KL-8326-11A-01D-2310-10_wgs_Illumina.bam	280.3		0.05	58cfa832e4b0c9d6adf6d26a	TCGA-KL-8326-11A-01D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8326-11A	03F3DD32-E1D1-485B-A968-3F55798F4D46	Solid Tissue Normal	Illumina HiSeq	4ad06c9b-8c29-4b0e-bc96-97e2322c580a	Kidney	69.0	7413DDDE-761F-43EB-82FE-EC2A63F963D0	5D6A5BA0-8213-4F89-85E0-021E4B4CC894	TCGA-KL-8326-11A-01D-2310-10	GRCh37-lite	TCGA-KL-8326	TCGA-KICH		s16422	Baylor College of Medicine	MSKCC	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2310-10	True
13722.58cfa830e4b0c9d6adf6ba72	58cfa830e4b0c9d6adf6ba72	TCGA-AA-3514-10A-01D-1953-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3514-10A-01D-1953-10_wgs_Illumina	TCGA-AA-3514-10A-01D-1953-10_wgs_Illumina.bam	20.0	1.9	0.14	58cfa830e4b0c9d6adf6ba72	TCGA-AA-3514-10A-01D-1953-10_wgs_Illumina.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-3514-10A	DDF69ED9-4C53-48B8-9F01-495BD60C3425	Blood Derived Normal	Illumina HiSeq	878b531a-852c-4466-8dcd-2f1ec7299ef6	Colorectal	81.0	8ED957C3-4D09-4D1C-AD6D-D7E7B7FCC517	49F65CE5-0AF1-43B9-A942-64607A230D7B	TCGA-AA-3514-10A-01D-1953-10	GRCh37-lite	TCGA-AA-3514	TCGA-COAD		s13664	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	1953-10	False
13767.58cfa83ae4b0c9d6adf71860	58cfa83ae4b0c9d6adf71860	UNCID_2345191.234d1db1-82a5-4b7d-b5f3-044a440b4233.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2345191.234d1db1-82a5-4b7d-b5f3-044a440b4233.sorted_genome_alignments	UNCID_2345191.234d1db1-82a5-4b7d-b5f3-044a440b4233.sorted_genome_alignments.bam	14.96	1.89	0.16	58cfa83ae4b0c9d6adf71860	UNCID_2345191.234d1db1-82a5-4b7d-b5f3-044a440b4233.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-A7YV-01A	23C335F6-5749-4443-8AE8-61CCCBB137CB	Primary Tumor	Illumina HiSeq	CED82CB9-F13A-4C4B-8776-F18CBC228992	Brain	26.0	37524C17-0862-4A76-81D7-DBDA878766FD	234D1DB1-82A5-4B7D-B5F3-044A440B4233	TCGA-E1-A7YV-01A-11R-A34R-07	HG19	TCGA-E1-A7YV	TCGA-LGG	987.0	s8497	University of North Carolina	Duke	United States	NO			Oligoastrocytoma		A34R-07	True
13767.58cfa83ce4b0c9d6adf72dff	58cfa83ce4b0c9d6adf72dff	_1_TCGA-BR-6453-11A-01R-1802-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-6453-11A-01R-1802-13_rnaseq	_1_TCGA-BR-6453-11A-01R-1802-13_rnaseq.bam	198.7	1.8	0.15	58cfa83ce4b0c9d6adf72dff	_1_TCGA-BR-6453-11A-01R-1802-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6453-11A	AE633E83-303F-4A90-AC3B-34458FD9BEEF	Solid Tissue Normal	Illumina HiSeq	14857B85-94AB-4868-B542-53DEDCAC4C88	Stomach	54.0	B6DFCC18-F388-4486-8D3D-611C5E15FB29	688CA868-1DE0-4E38-A1C2-C41112731C70	TCGA-BR-6453-11A-01R-1802-13	GRCh37-lite	TCGA-BR-6453	TCGA-STAD		s14508	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T2	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1802-13	True
13767.58cfa833e4b0c9d6adf6dadc	58cfa833e4b0c9d6adf6dadc	UNCID_1107951.6a4b7295-a738-4d4a-a264-72fba462e60c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1107951.6a4b7295-a738-4d4a-a264-72fba462e60c.sorted_genome_alignments	UNCID_1107951.6a4b7295-a738-4d4a-a264-72fba462e60c.sorted_genome_alignments.bam	83.2	1.8	0.15	58cfa833e4b0c9d6adf6dadc	UNCID_1107951.6a4b7295-a738-4d4a-a264-72fba462e60c.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6775-01A	3C4FF061-D214-4D1C-8D2E-3034F207C252	Primary Tumor	Illumina HiSeq	C4769EE9-0D0A-495B-A004-BD9BFF9941F3	Lung	72.0	7C606F64-69A1-465C-9F4E-2EB1EBEDA5D7	6A4B7295-A738-4D4A-A264-72FBA462E60C	TCGA-44-6775-01A-11R-1858-07	HG19	TCGA-44-6775	TCGA-LUAD		s10693	University of North Carolina	Christiana Healthcare	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1858-07	True
13722.58cfa831e4b0c9d6adf6cb0e	58cfa831e4b0c9d6adf6cb0e	TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted	TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted.bam	30.33		0.15	58cfa831e4b0c9d6adf6cb0e	TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3Y4-01A	3AC62513-B5F4-4063-AABD-DAD08A1F56FB	Primary Tumor	Illumina HiSeq	32cd0b72-100c-4e6c-81f1-6be30738cafb	Cervix	40.0	FF97C148-76BA-480E-9456-5DD7D7238373	A7529CB6-2386-410F-B09A-62E10BAFF8CB	TCGA-EA-A3Y4-01A-51D-A245-26	HG19_Broad_variant	TCGA-EA-A3Y4	TCGA-CESC		s1362	MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO	T1b	N0	Cervical Squamous Cell Carcinoma		A245-26	True
13722.58cfa831e4b0c9d6adf6ca43	58cfa831e4b0c9d6adf6ca43	TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted	TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.bam	77.76	1.96	0.18	58cfa831e4b0c9d6adf6ca43	TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.bam	Alive	MALE		NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QL-01A	E4B08E66-0772-4956-8670-E5C6553EECBE	Primary Tumor	Illumina HiSeq	115df95b-61fb-4fef-a23f-df0ade71c646	Thyroid	70.0	62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0	C5B8FBAE-98B5-437B-A8BD-D695C5E8CB4F	TCGA-DJ-A1QL-01A-11D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QL	TCGA-THCA		s12373	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14U-02	True
13767.58cfa83ce4b0c9d6adf72ba4	58cfa83ce4b0c9d6adf72ba4	UNCID_372521.48001fdd-8904-4ce7-a52c-519fdee5e246.110425_UNC14-SN744_0100_AB0281ABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_372521.48001fdd-8904-4ce7-a52c-519fdee5e246.110425_UNC14-SN744_0100_AB0281ABXX.5.trimmed.annotated.translated_to_genomic	UNCID_372521.48001fdd-8904-4ce7-a52c-519fdee5e246.110425_UNC14-SN744_0100_AB0281ABXX.5.trimmed.annotated.translated_to_genomic.bam	59.0	1.7	0.14	58cfa83ce4b0c9d6adf72ba4	UNCID_372521.48001fdd-8904-4ce7-a52c-519fdee5e246.110425_UNC14-SN744_0100_AB0281ABXX.5.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4163-01A	E7C159B7-E7C3-4482-8E80-72402DC3FDB4	Primary Tumor	Illumina HiSeq	8478FB80-7861-4D39-AF14-3B5079E07823	Kidney	60.0	E44DE28C-BCE0-471D-BD4C-BEA710F7C3CC	48001FDD-8904-4CE7-A52C-519FDEE5E246	TCGA-BP-4163-01A-02R-1325-07	HG19	TCGA-BP-4163	TCGA-KIRC		s9267	University of North Carolina	MSKCC	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1325-07	True
13722.58cfa831e4b0c9d6adf6c5a8	58cfa831e4b0c9d6adf6c5a8	TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted	TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted.bam	550.4	1.9	0.15	58cfa831e4b0c9d6adf6c5a8	TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4731-10A	50E25A4B-2EB2-4770-9A2D-8922A1E0AB56	Blood Derived Normal	Illumina HiSeq	bb50f6f4-9a32-49a6-a81f-dca3c16699cd	Head and Neck	63.0	C01EE9F4-05A4-438A-BA60-0F5A92864398	C54FB259-8BCF-495A-B96B-40266CAD460F	TCGA-CN-4731-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4731	TCGA-HNSC		s15756	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IV	1431-02	True
13722.58cfa831e4b0c9d6adf6c9ee	58cfa831e4b0c9d6adf6c9ee	TCGA-DD-A3A8-11A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A3A8-11A-11D-A22F-10_wgs_Illumina	TCGA-DD-A3A8-11A-11D-A22F-10_wgs_Illumina.bam	29.6		0.08	58cfa831e4b0c9d6adf6c9ee	TCGA-DD-A3A8-11A-11D-A22F-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A3A8-11A	69D6881B-9E9A-407B-8B02-BAD5FC2455BF	Solid Tissue Normal	Illumina HiSeq	45ebbc1e-08d7-483c-b473-676199924458	Liver	75.0	F070E7DB-1215-4864-9293-C778F161AE68	20E24E02-0CAA-4E55-812B-B081B3BB03D8	TCGA-DD-A3A8-11A-11D-A22F-10	GRCh37-lite	TCGA-DD-A3A8	TCGA-LIHC	11.0	s17058	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A22F-10	True
13767.58cfa834e4b0c9d6adf6ea3e	58cfa834e4b0c9d6adf6ea3e	UNCID_1269993.912e1936-9538-44c4-b2da-d553a06bb61f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1269993.912e1936-9538-44c4-b2da-d553a06bb61f.sorted_genome_alignments	UNCID_1269993.912e1936-9538-44c4-b2da-d553a06bb61f.sorted_genome_alignments.bam	36.3	1.8	0.15	58cfa834e4b0c9d6adf6ea3e	UNCID_1269993.912e1936-9538-44c4-b2da-d553a06bb61f.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3376-01A	46240F32-116B-470C-9846-3616A6DB4F2E	Primary Tumor	Illumina HiSeq	D3784AB7-EA3E-4981-9D9E-743F8A44FA65	Kidney	51.0	18C3A1DE-B145-437F-A4EE-16FC58F83A61	912E1936-9538-44C4-B2DA-D553A06BB61F	TCGA-A3-3376-01A-02R-1420-07	HG19	TCGA-A3-3376	TCGA-KIRC		s8917	University of North Carolina	International Genomics Consortium	United States	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1420-07	True
13767.58cfa833e4b0c9d6adf6df83	58cfa833e4b0c9d6adf6df83	UNCID_1155165.15acd388-f958-4f43-bc38-39bab4cb830e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1155165.15acd388-f958-4f43-bc38-39bab4cb830e.sorted_genome_alignments	UNCID_1155165.15acd388-f958-4f43-bc38-39bab4cb830e.sorted_genome_alignments.bam	46.93	1.81	0.14	58cfa833e4b0c9d6adf6df83	UNCID_1155165.15acd388-f958-4f43-bc38-39bab4cb830e.sorted_genome_alignments.bam	Alive	FEMALE			Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A07S-01A	A20FA2C4-A502-47E3-BFAA-2EC4CCE3A859	Primary Tumor	Illumina HiSeq	9C040309-BA3B-483B-8085-2A1F07661391	Breast	73.0	0126489D-C12A-4651-8700-D7090732D7AB	15ACD388-F958-4F43-BC38-39BAB4CB830E	TCGA-A8-A07S-01A-11R-A034-07	HG19	TCGA-A8-A07S	TCGA-BRCA		s6536	University of North Carolina	Indivumed	Germany	NO	T2	N0	Mixed Histology (please specify)	Stage II	A034-07	True
13767.58cfa83ce4b0c9d6adf72cea	58cfa83ce4b0c9d6adf72cea	UNCID_405094.95365098-d660-415e-843d-3726e8821022.110719_UNC11-SN627_0127_AB0AE0ABXX.3.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_405094.95365098-d660-415e-843d-3726e8821022.110719_UNC11-SN627_0127_AB0AE0ABXX.3.trimmed.annotated.translated_to_genomic	UNCID_405094.95365098-d660-415e-843d-3726e8821022.110719_UNC11-SN627_0127_AB0AE0ABXX.3.trimmed.annotated.translated_to_genomic.bam	0.0	1.8	0.14	58cfa83ce4b0c9d6adf72cea	UNCID_405094.95365098-d660-415e-843d-3726e8821022.110719_UNC11-SN627_0127_AB0AE0ABXX.3.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-4856-01A	FCECAFA8-8B8B-4AE6-81BC-73ACF05B211A	Primary Tumor	Illumina HiSeq	19293394-630C-409B-A49A-4834884B533F	Kidney	62.0	6F6C9F00-D6E5-452F-BA04-F77B146B780B	95365098-D660-415E-843D-3726E8821022	TCGA-CZ-4856-01A-02R-1426-07	HG19	TCGA-CZ-4856	TCGA-KIRC		s8977	University of North Carolina	Harvard	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1426-07	True
13767.58cfa83be4b0c9d6adf72472	58cfa83be4b0c9d6adf72472	UNCID_2563139.976c3fd8-2aec-4dc9-9343-cf0df50b60a3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2563139.976c3fd8-2aec-4dc9-9343-cf0df50b60a3.sorted_genome_alignments	UNCID_2563139.976c3fd8-2aec-4dc9-9343-cf0df50b60a3.sorted_genome_alignments.bam	20.04	1.9	0.17	58cfa83be4b0c9d6adf72472	UNCID_2563139.976c3fd8-2aec-4dc9-9343-cf0df50b60a3.sorted_genome_alignments.bam	Dead	MALE			Uveal Melanoma	Aligned reads	TCGA-VD-A8KF-01A	78039723-94A9-4903-8BB4-C00852E8E889	Primary Tumor	Illumina HiSeq	27E4DE85-7403-439A-AFE9-2451C8A6B167	Eye	68.0	B48C5179-16E6-47F1-87C7-EE8B71989BF9	976C3FD8-2AEC-4DC9-9343-CF0DF50B60A3	TCGA-VD-A8KF-01A-11R-A405-07	HG19	TCGA-VD-A8KF	TCGA-UVM	40.0	s335	University of North Carolina	University of Liverpool	United Kingdom	NO	T4b	NX		Stage III	A405-07	True
13722.58cfa82fe4b0c9d6adf6b522	58cfa82fe4b0c9d6adf6b522	TCGA-29-1704-02A-01D-0926-12_Illumina.filtered.	WGS	TCGA-29-1704-02A-01D-0926-12_Illumina	TCGA-29-1704-02A-01D-0926-12_Illumina.bam	100.0	1.9	0.14	58cfa82fe4b0c9d6adf6b522	TCGA-29-1704-02A-01D-0926-12_Illumina.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1704-02A	8E7F1C74-7CB3-43C0-B07C-BF69B780053F	Recurrent Tumor	Illumina HiSeq	5096c5f8-0949-4fba-b265-2bb2a87a9cea	Ovary	61.0	81E2FBF0-5809-4832-A6D5-75AEBA6F0D81	FFCF9262-42AB-4874-9874-D2AF7D33490B	TCGA-29-1704-02A-01D-0926-12	NCBI36_BCM_variant	TCGA-29-1704	TCGA-OV		s17345	Baylor College of Medicine	Duke	None	NO			Serous Cystadenocarcinoma		0926-12	True
13767.58cfa833e4b0c9d6adf6df70	58cfa833e4b0c9d6adf6df70	UNCID_1151023.f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1151023.f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0.sorted_genome_alignments	UNCID_1151023.f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0.sorted_genome_alignments.bam	9.36	1.78	0.13	58cfa833e4b0c9d6adf6df70	UNCID_1151023.f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0CT-01A	378778D2-B331-4867-A93B-C64028C8B4C7	Primary Tumor	Illumina HiSeq	1BAF5633-C931-431D-B967-B02CBDD053D5	Breast	71.0	3490858A-B2EF-4700-91EA-5E71C71CFF67	F33B0A48-706B-4FD8-B8B3-0A9F625BD0C0	TCGA-A2-A0CT-01A-31R-A056-07	HG19	TCGA-A2-A0CT	TCGA-BRCA		s5701	University of North Carolina	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A056-07	True
13722.58cfa831e4b0c9d6adf6c7ba	58cfa831e4b0c9d6adf6c7ba	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.bam	193.0	1.9	0.08	58cfa831e4b0c9d6adf6c7ba	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6011-01A	E7D49212-E9CB-4CD7-923A-BDFC82A4A150	Primary Tumor	Illumina HiSeq	33680362-5ef1-477f-9dbc-64dc2ed0d5a8	Head and Neck	57.0	AFBF3020-1715-4E74-8224-05E316796999	21205681-A0C7-48D0-81D4-0B7EF31158CF	TCGA-CN-6011-01A-11D-A32X-10	GRCh37-lite	TCGA-CN-6011	TCGA-HNSC		s15500	Baylor College of Medicine	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IV	A32X-10	True
13767.58cfa832e4b0c9d6adf6d763	58cfa832e4b0c9d6adf6d763	UNCID_1032122.13daa1a0-a236-474e-b621-eb131be34af1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1032122.13daa1a0-a236-474e-b621-eb131be34af1.sorted_genome_alignments	UNCID_1032122.13daa1a0-a236-474e-b621-eb131be34af1.sorted_genome_alignments.bam	230.7		0.15	58cfa832e4b0c9d6adf6d763	UNCID_1032122.13daa1a0-a236-474e-b621-eb131be34af1.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-7222-01A	3768CF73-E389-449A-BDE3-29EB20C9E249	Primary Tumor	Illumina HiSeq	AA93167A-49F9-4F08-9045-691A205060D8	Lung	60.0	F0F4AA30-1BEE-42A9-B109-75C60A42DA76	13DAA1A0-A236-474E-B621-EB131BE34AF1	TCGA-56-7222-01A-11R-2045-07	HG19	TCGA-56-7222	TCGA-LUSC		s10510	University of North Carolina	International Genomics Consortium	United States	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)		2045-07	True
13722.58cfa830e4b0c9d6adf6baaa	58cfa830e4b0c9d6adf6baaa	TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted.filtered.	WGS	TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted	TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted.bam	96.48	1.95	0.14	58cfa830e4b0c9d6adf6baaa	TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GD-01A	1486A031-B74D-4976-8B0B-4569E6978F49	Primary Tumor	Illumina HiSeq	98b5ea92-9e57-4d1f-937d-8bb0dd2a3cf2	Uterus	75.0	F449F50A-7664-4DDC-87AA-6A061EE7190C	069406A8-56D7-4E93-8570-7880A99D6C2D	TCGA-A5-A0GD-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GD	TCGA-UCEC		s4771	Harvard Medical School	Cedars Sinai	None	NO			Endometrioid endometrial adenocarcinoma		A043-02	True
13767.58cfa833e4b0c9d6adf6dba5	58cfa833e4b0c9d6adf6dba5	UNCID_1099441.c2711074-5019-4c8f-a5d7-7bf4654f5647.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1099441.c2711074-5019-4c8f-a5d7-7bf4654f5647.sorted_genome_alignments	UNCID_1099441.c2711074-5019-4c8f-a5d7-7bf4654f5647.sorted_genome_alignments.bam	51.2	1.8	0.14	58cfa833e4b0c9d6adf6dba5	UNCID_1099441.c2711074-5019-4c8f-a5d7-7bf4654f5647.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-55-6986-01A	028E99E9-5B9A-4954-BB6E-6D4709A3CEA8	Primary Tumor	Illumina HiSeq	E0CD71DD-EBD6-45DA-9837-183367788EC7	Lung	74.0	9622C370-68D0-48DA-A7E0-5EB4765B6F27	C2711074-5019-4C8F-A5D7-7BF4654F5647	TCGA-55-6986-01A-11R-1949-07	HG19	TCGA-55-6986	TCGA-LUAD		s10681	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage I	1949-07	True
13722.58cfa831e4b0c9d6adf6c524	58cfa831e4b0c9d6adf6c524	TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	471.0	1.9	0.14	58cfa831e4b0c9d6adf6c524	TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4744-01A	CC15469C-7BAD-4E86-9DA3-AE0C72E9D380	Primary Tumor	Illumina HiSeq	e1403b52-6792-4d08-acad-95659ceeca82	Colorectal	69.0	A545FB9A-C386-4A80-9A25-660DC4F62904	6D073A6F-FB7B-4ED2-BD24-5233E019D64A	TCGA-CM-4744-01A-01D-1405-02	HG18	TCGA-CM-4744	TCGA-COAD		s13689	Harvard Medical School	MSKCC	None	NO	T2	N0	Colon Adenocarcinoma	Stage I	1405-02	True
13767.58cfa82fe4b0c9d6adf6b73d	58cfa82fe4b0c9d6adf6b73d	TCGA-61-1728-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-61-1728-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-61-1728-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	396.0	1.8	0.15	58cfa82fe4b0c9d6adf6b73d	TCGA-61-1728-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-1728-01A	07FBDB3C-8337-4319-8255-F2363F8A031E	Primary Tumor	Illumina HiSeq	5A6C84D5-F82A-4896-8685-748930D66F51	Ovary	59.0	9C3D5CAF-78E2-4A1C-9E08-1CA5AA1C5625	BF909020-D6A1-49F1-8007-4192D39ABD04	TCGA-61-1728-01A-01R-1568-13	GRCh37-lite	TCGA-61-1728	TCGA-OV		s17321	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa835e4b0c9d6adf6ed97	58cfa835e4b0c9d6adf6ed97	UNCID_1367446.a5e6acbf-7027-4837-85d7-aacfe707900d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1367446.a5e6acbf-7027-4837-85d7-aacfe707900d.sorted_genome_alignments	UNCID_1367446.a5e6acbf-7027-4837-85d7-aacfe707900d.sorted_genome_alignments.bam	55.2		0.14	58cfa835e4b0c9d6adf6ed97	UNCID_1367446.a5e6acbf-7027-4837-85d7-aacfe707900d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-95-7948-01A	A52E99D6-A61A-439D-B0B1-CA7A0EABCB04	Primary Tumor	Illumina HiSeq	8C108E95-698C-4FC7-9648-3BAD21E76687	Lung	42.0	BF5D88DA-2302-4B32-BE0F-CC45638039C9	A5E6ACBF-7027-4837-85D7-AACFE707900D	TCGA-95-7948-01A-11R-2187-07	HG19	TCGA-95-7948	TCGA-LUAD		s10719	University of North Carolina	Washington University - Emory	United States	NO	T2a	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	2187-07	True
13767.58cfa833e4b0c9d6adf6d9ca	58cfa833e4b0c9d6adf6d9ca	UNCID_1085551.6b5daf02-c700-4c32-9770-2a6a903c9011.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1085551.6b5daf02-c700-4c32-9770-2a6a903c9011.sorted_genome_alignments	UNCID_1085551.6b5daf02-c700-4c32-9770-2a6a903c9011.sorted_genome_alignments.bam	112.8	1.8	0.15	58cfa833e4b0c9d6adf6d9ca	UNCID_1085551.6b5daf02-c700-4c32-9770-2a6a903c9011.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5691-11A	31A0DD95-8199-4D25-B40D-4B353644AF46	Solid Tissue Normal	Illumina HiSeq	180F6898-F0C8-4D64-BF51-4ADDD5AF0733	Kidney	66.0	18E2FEB8-5C4E-4DE9-8946-8872F1712182	6B5DAF02-C700-4C32-9770-2A6A903C9011	TCGA-B0-5691-11A-01R-1541-07	HG19	TCGA-B0-5691	TCGA-KIRC		s9744	University of North Carolina	University of Pittsburgh	None	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa83be4b0c9d6adf72587	58cfa83be4b0c9d6adf72587	UNCID_2658231.e0178b54-86f9-45e7-949d-2c4132ac9822.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2658231.e0178b54-86f9-45e7-949d-2c4132ac9822.sorted_genome_alignments	UNCID_2658231.e0178b54-86f9-45e7-949d-2c4132ac9822.sorted_genome_alignments.bam	63.29	1.87	0.18	58cfa83be4b0c9d6adf72587	UNCID_2658231.e0178b54-86f9-45e7-949d-2c4132ac9822.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-AADU-01A	CF358FB8-866C-4780-A550-D6C1C30B8C63	Primary Tumor	Illumina HiSeq	2BC4BE85-B517-4749-9EF3-EAC22C0CC7A1	Liver	60.0	8566DFB0-570B-4540-B4CD-EAEC48CC27FD	E0178B54-86F9-45E7-949D-2C4132AC9822	TCGA-DD-AADU-01A-11R-A41C-07	HG19	TCGA-DD-AADU	TCGA-LIHC		s17055	University of North Carolina	Mayo Clinic - Rochester	Korea South	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A41C-07	True
13722.58cfa832e4b0c9d6adf6cfde	58cfa832e4b0c9d6adf6cfde	TCGA-GV-A3JZ-10A-01D-A21C_120830_SN590_0178_AD143RACXX_s_8_rg.sorted.filtered.	WGS	TCGA-GV-A3JZ-10A-01D-A21C_120830_SN590_0178_AD143RACXX_s_8_rg.sorted	TCGA-GV-A3JZ-10A-01D-A21C_120830_SN590_0178_AD143RACXX_s_8_rg.sorted.bam	40.03		0.17	58cfa832e4b0c9d6adf6cfde	TCGA-GV-A3JZ-10A-01D-A21C_120830_SN590_0178_AD143RACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JZ-10A	9CC92795-7A24-4875-87F0-3EFCCBFCC970	Blood Derived Normal	Illumina HiSeq	4b54f30a-eae2-443c-8c0c-f198b72091d1	Bladder	55.0	06A54EE0-6B26-49FA-8C3D-38D97027C679	90FA8258-8CF7-4F2D-A075-17706DD69BA8	TCGA-GV-A3JZ-10A-01D-A21C-26	HG19_Broad_variant	TCGA-GV-A3JZ	TCGA-BLCA		s2739	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T4a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A21C-26	True
13767.58cfa83ae4b0c9d6adf71e80	58cfa83ae4b0c9d6adf71e80	UNCID_2536905.ac2b7bb6-0d88-49ab-8812-2cb71acec8bf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2536905.ac2b7bb6-0d88-49ab-8812-2cb71acec8bf.sorted_genome_alignments	UNCID_2536905.ac2b7bb6-0d88-49ab-8812-2cb71acec8bf.sorted_genome_alignments.bam	50.95	1.9	0.17	58cfa83ae4b0c9d6adf71e80	UNCID_2536905.ac2b7bb6-0d88-49ab-8812-2cb71acec8bf.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-3A-A9IJ-01A	5F468C25-73C3-49D5-BA12-50653DFE2C41	Primary Tumor	Illumina HiSeq	95F87D12-2362-4F05-87A7-4674D2D658D6	Pancreas	65.0	F80E9141-3634-49CD-8C85-610C7F644D83	AC2B7BB6-0D88-49AB-8812-2CB71ACEC8BF	TCGA-3A-A9IJ-01A-11R-A39D-07	HG19	TCGA-3A-A9IJ	TCGA-PAAD		s867	University of North Carolina	Moffitt Cancer Center	United States	NO	T2	N0	Pancreas-Adenocarcinoma-Other Subtype	Stage I	A39D-07	True
13767.58cfa83ae4b0c9d6adf71bac	58cfa83ae4b0c9d6adf71bac	UNCID_2481436.e1788048-2730-4c02-9745-00d1ce97f34b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2481436.e1788048-2730-4c02-9745-00d1ce97f34b.sorted_genome_alignments	UNCID_2481436.e1788048-2730-4c02-9745-00d1ce97f34b.sorted_genome_alignments.bam	35.77	1.9	0.17	58cfa83ae4b0c9d6adf71bac	UNCID_2481436.e1788048-2730-4c02-9745-00d1ce97f34b.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-UZ-A9PO-01A	43D92569-FE5D-4EEB-A9CC-F7CD26FB3284	Primary Tumor	Illumina HiSeq	1C2CB140-FED2-4786-9C20-9F2CC8EABEFF	Kidney	80.0	A31DDFEE-3A4E-4728-B84C-051058AC1A5E	E1788048-2730-4C02-9745-00D1CE97F34B	TCGA-UZ-A9PO-01A-11R-A38C-07	HG19	TCGA-UZ-A9PO	TCGA-KIRP		s11950	University of North Carolina	University of California San Francisco	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A38C-07	True
13767.58cfa838e4b0c9d6adf70426	58cfa838e4b0c9d6adf70426	UNCID_1956935.ccf08a46-d1e6-4f3d-a511-6a1560a8dc52.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1956935.ccf08a46-d1e6-4f3d-a511-6a1560a8dc52.sorted_genome_alignments	UNCID_1956935.ccf08a46-d1e6-4f3d-a511-6a1560a8dc52.sorted_genome_alignments.bam	52.3	1.86	0.18	58cfa838e4b0c9d6adf70426	UNCID_1956935.ccf08a46-d1e6-4f3d-a511-6a1560a8dc52.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-A4MX-01A	AD80A042-C4B4-445C-9678-1C2614422684	Primary Tumor	Illumina HiSeq	F709D928-A7BC-422E-8C9B-22C8070C20D5	Brain	47.0	C68078F1-31FA-4CAD-B7FF-851156833FE5	CCF08A46-D1E6-4F3D-A511-6A1560A8DC52	TCGA-FG-A4MX-01A-11R-A26U-07	HG19	TCGA-FG-A4MX	TCGA-LGG		s8218	University of North Carolina	Case Western	United States	NO			Astrocytoma		A26U-07	True
13767.58cfa838e4b0c9d6adf705a4	58cfa838e4b0c9d6adf705a4	UNCID_1971294.0770ad2b-1ae6-40bc-9b15-6b5509b8cd84.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1971294.0770ad2b-1ae6-40bc-9b15-6b5509b8cd84.sorted_genome_alignments	UNCID_1971294.0770ad2b-1ae6-40bc-9b15-6b5509b8cd84.sorted_genome_alignments.bam	29.02	1.85	0.18	58cfa838e4b0c9d6adf705a4	UNCID_1971294.0770ad2b-1ae6-40bc-9b15-6b5509b8cd84.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A51E-06A	963858B8-A8B6-498E-989A-271654713772	Metastatic	Illumina HiSeq	8A5957B2-9206-444D-9CFE-4640E1A99E50	Skin	39.0	7549D446-942E-4956-8F92-A263EF055668	0770AD2B-1AE6-40BC-9B15-6B5509B8CD84	TCGA-D3-A51E-06A-11R-A266-07	HG19	TCGA-D3-A51E	TCGA-SKCM		s7612	University of North Carolina	MD Anderson	United States	NO	T2	N0		Stage I	A266-07	True
13767.58cfa838e4b0c9d6adf70aac	58cfa838e4b0c9d6adf70aac	UNCID_2087990.41d56421-a998-43b9-b319-18535315c820.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2087990.41d56421-a998-43b9-b319-18535315c820.sorted_genome_alignments	UNCID_2087990.41d56421-a998-43b9-b319-18535315c820.sorted_genome_alignments.bam	35.54	1.87	0.18	58cfa838e4b0c9d6adf70aac	UNCID_2087990.41d56421-a998-43b9-b319-18535315c820.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-PD-A5DF-01A	1987B453-F97D-45C7-9C89-B9A33313D645	Primary Tumor	Illumina HiSeq	88317D90-153C-4B67-8A82-B71ED43D827E	Liver	58.0	0B88D087-50FB-4893-AE37-2FC5990A5B15	41D56421-A998-43B9-B319-18535315C820	TCGA-PD-A5DF-01A-11R-A27V-07	HG19	TCGA-PD-A5DF	TCGA-LIHC	639.0	s16810	University of North Carolina	Fox Chase	United States	NO	T4	N0	Hepatocellular Carcinoma	Stage III	A27V-07	True
13722.58cfa83ce4b0c9d6adf731e4	58cfa83ce4b0c9d6adf731e4	bd005f17f054b1b98796b9efd0bfb272.filtered.	WGS	bd005f17f054b1b98796b9efd0bfb272	bd005f17f054b1b98796b9efd0bfb272.bam	37.54	1.75	0.08	58cfa83ce4b0c9d6adf731e4	bd005f17f054b1b98796b9efd0bfb272.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A053-10A	AF37D8F0-FEA0-47F6-BE0A-2FB55A5DA5C4	Blood Derived Normal	Illumina HiSeq	8da3862a-d5b8-478c-b9c0-d34cb7ba05a3	Uterus	90.0	757841ED-29DF-4180-A650-76D65700680F	5ACE153C-C849-4FFC-88DF-E6F1D07C1539	TCGA-AP-A053-10A-01D-A013-09	GRCh37-lite	TCGA-AP-A053	TCGA-UCEC		s4968	Washington University School of Medicine	MSKCC	None	NO			Endometrioid endometrial adenocarcinoma		A013-09	True
13767.58cfa836e4b0c9d6adf6fbc8	58cfa836e4b0c9d6adf6fbc8	UNCID_1656297.37F1CC69-2CF8-46AE-A052-EA82ACAB9BEF.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1656297.37F1CC69-2CF8-46AE-A052-EA82ACAB9BEF.sorted_genome_alignments	UNCID_1656297.37F1CC69-2CF8-46AE-A052-EA82ACAB9BEF.sorted_genome_alignments.bam	61.3	1.8	0.17	58cfa836e4b0c9d6adf6fbc8	UNCID_1656297.37F1CC69-2CF8-46AE-A052-EA82ACAB9BEF.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A3VK-01A	94443DF0-7F16-4178-9E66-BEE82F6CA33A	Primary Tumor	Illumina HiSeq	F4357F5A-D791-43F4-B0D4-8053278EEAEE	Thyroid	63.0	F99E9FA1-2E21-4438-94DF-0D03CDEDD443	37F1CC69-2CF8-46AE-A052-EA82ACAB9BEF	TCGA-DJ-A3VK-01A-11R-A23N-07	HG19	TCGA-DJ-A3VK	TCGA-THCA		s12306	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A23N-07	True
13767.58cfa833e4b0c9d6adf6dd1c	58cfa833e4b0c9d6adf6dd1c	UNCID_1097747.33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1097747.33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da.sorted_genome_alignments	UNCID_1097747.33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da.sorted_genome_alignments.bam	193.8	1.8	0.14	58cfa833e4b0c9d6adf6dd1c	UNCID_1097747.33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da.sorted_genome_alignments.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-5429-01A	63BD2175-4B7C-44C9-AEF3-9EFC8F79837B	Primary Tumor	Illumina HiSeq	43C45EBB-C8E3-471A-8441-2487D8750758	Lung	60.0	FBC90B42-7D26-456B-A166-41993A1D3F0D	33F213FA-6FA4-48ED-BD7E-A63ED8C3A8DA	TCGA-05-5429-01A-01R-1628-07	HG19	TCGA-05-5429	TCGA-LUAD		s11368	University of North Carolina	Indivumed	Germany	NO	T3	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1628-07	True
13722.58cfa832e4b0c9d6adf6cf02	58cfa832e4b0c9d6adf6cf02	TCGA-FS-A1YY-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_6_rg.sorted.filtered.	WGS	TCGA-FS-A1YY-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_6_rg.sorted	TCGA-FS-A1YY-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_6_rg.sorted.bam	36.8		0.16	58cfa832e4b0c9d6adf6cf02	TCGA-FS-A1YY-10A-01D-A190_120718_SN1222_0127_BD147HACXX_s_6_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1YY-10A	C3A8881B-70F8-402C-AC75-1CC49FCA4E87	Blood Derived Normal	Illumina HiSeq	80ab908d-d526-4748-b549-a33d238a0ddd	Skin	55.0	33C8D0DE-B147-4027-A599-90ED0F46B095	64FBFA57-CFF3-4193-A826-415DE8F91396	TCGA-FS-A1YY-10A-01D-A190-02	HG19_Broad_variant	TCGA-FS-A1YY	TCGA-SKCM	6953.0	s7364	Harvard Medical School	Essen	Germany	NO	T3a	N0		Stage II	A190-02	True
13767.58cfa839e4b0c9d6adf71252	58cfa839e4b0c9d6adf71252	UNCID_2307190.f572c953-e1aa-4dd2-a8f8-e292ab7bd139.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2307190.f572c953-e1aa-4dd2-a8f8-e292ab7bd139.sorted_genome_alignments	UNCID_2307190.f572c953-e1aa-4dd2-a8f8-e292ab7bd139.sorted_genome_alignments.bam	62.82	2.14	0.16	58cfa839e4b0c9d6adf71252	UNCID_2307190.f572c953-e1aa-4dd2-a8f8-e292ab7bd139.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A6VW-01A	98E709E7-E195-4B37-9537-F6081AFFB609	Primary Tumor	Illumina HiSeq	5D4853FC-2AFE-4106-82ED-B2FEF777084D	Breast	48.0	4320C739-978F-4EBF-85C6-23D4735A38C1	F572C953-E1AA-4DD2-A8F8-E292AB7BD139	TCGA-A7-A6VW-01A-21R-A33J-07	HG19	TCGA-A7-A6VW	TCGA-BRCA		s6088	University of North Carolina	Christiana Healthcare	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A33J-07	True
13767.58cfa82fe4b0c9d6adf6b410	58cfa82fe4b0c9d6adf6b410	TCGA-24-1469-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-24-1469-01A-01R-1566-13_rnaseq	TCGA-24-1469-01A-01R-1566-13_rnaseq.bam	223.0	1.8	0.15	58cfa82fe4b0c9d6adf6b410	TCGA-24-1469-01A-01R-1566-13_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1469-01A	CD6E5D3D-1C86-40DD-9CB3-B2E2075DEC56	Primary Tumor	Illumina HiSeq	842DFF4A-6D44-4962-8DFF-60675200DE67	Ovary	71.0	389C632D-45CF-447E-9069-11B2FCB543F5	7B6FE6E3-145B-46E6-884E-FCEC23514674	TCGA-24-1469-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-24-1469	TCGA-OV		s17340	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa838e4b0c9d6adf70602	58cfa838e4b0c9d6adf70602	UNCID_1919840.e6889ad6-caa9-429f-9123-0ff0c7ae195a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1919840.e6889ad6-caa9-429f-9123-0ff0c7ae195a.sorted_genome_alignments	UNCID_1919840.e6889ad6-caa9-429f-9123-0ff0c7ae195a.sorted_genome_alignments.bam	204.2		0.16	58cfa838e4b0c9d6adf70602	UNCID_1919840.e6889ad6-caa9-429f-9123-0ff0c7ae195a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-8277-01A	8E6020A1-68DF-4D57-AD4E-33ACC0861FB3	Primary Tumor	Illumina HiSeq	06D1C68C-F642-4976-891D-465E3AB16B01	Lung	70.0	5600CB1A-D0F4-468E-B8D2-E431B77496BF	E6889AD6-CAA9-429F-9123-0FF0C7AE195A	TCGA-85-8277-01A-11R-2296-07	HG19	TCGA-85-8277	TCGA-LUSC		s10133	University of North Carolina	Asterand	Russia	NO	T3	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	2296-07	True
13767.58cfa838e4b0c9d6adf7042a	58cfa838e4b0c9d6adf7042a	UNCID_1949727.575b0136-4ffe-4ecc-8967-4e5af3c3c8ec.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1949727.575b0136-4ffe-4ecc-8967-4e5af3c3c8ec.sorted_genome_alignments	UNCID_1949727.575b0136-4ffe-4ecc-8967-4e5af3c3c8ec.sorted_genome_alignments.bam	10.44	1.78	0.17	58cfa838e4b0c9d6adf7042a	UNCID_1949727.575b0136-4ffe-4ecc-8967-4e5af3c3c8ec.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-DM-A280-01A	6775CE57-B4CF-425C-A898-061BB9A8A1A8	Primary Tumor	Illumina HiSeq	29085C3A-8201-4DDF-B009-88CB97673BF0	Colorectal	70.0	E0766706-BAF6-4009-833E-6C3B0B9543CE	575B0136-4FFE-4ECC-8967-4E5AF3C3C8EC	TCGA-DM-A280-01A-12R-A16W-07	HG19	TCGA-DM-A280	TCGA-COAD	236.0	s12961	University of North Carolina	University of Michigan	Israel	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage II	A16W-07	True
13722.58cfa82de4b0c9d6adf6a508	58cfa82de4b0c9d6adf6a508	3ff0f4f5e508ac0ae2c9b8406e4ff866.filtered.	WGS	3ff0f4f5e508ac0ae2c9b8406e4ff866	3ff0f4f5e508ac0ae2c9b8406e4ff866.bam	32.07	1.75	0.07	58cfa82de4b0c9d6adf6a508	3ff0f4f5e508ac0ae2c9b8406e4ff866.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A05A-10A	C350B53B-3C27-4B9E-8B57-D7B6A1205A1F	Blood Derived Normal	Illumina HiSeq	0cc0d677-617d-4b5d-aae8-f65ef03bee67	Uterus	81.0	723254A1-4F6F-4CD0-A39F-987A211D06CB	C3AF584A-7000-4B6C-BBE9-C27AC5787B0C	TCGA-AP-A05A-10A-01D-A013-09	GRCh37-lite	TCGA-AP-A05A	TCGA-UCEC		s4408	Washington University School of Medicine	MSKCC	None	NO			Serous endometrial adenocarcinoma		A013-09	True
13767.58cfa83ae4b0c9d6adf7179c	58cfa83ae4b0c9d6adf7179c	UNCID_2388836.3380e6d8-52a0-4b19-acb1-2fb686cbd5df.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2388836.3380e6d8-52a0-4b19-acb1-2fb686cbd5df.sorted_genome_alignments	UNCID_2388836.3380e6d8-52a0-4b19-acb1-2fb686cbd5df.sorted_genome_alignments.bam	23.06	1.83	0.17	58cfa83ae4b0c9d6adf7179c	UNCID_2388836.3380e6d8-52a0-4b19-acb1-2fb686cbd5df.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-DS-A7WH-01A	DADCF6D5-03EB-4090-BCC3-B9E9DC3C7E08	Primary Tumor	Illumina HiSeq	2861B6BB-46A2-4CA6-9829-C7B1CEDDF918	Cervix	34.0	B742714F-55C2-48B7-9D4B-667F82056F68	3380E6D8-52A0-4B19-ACB1-2FB686CBD5DF	TCGA-DS-A7WH-01A-22R-A352-07	HG19	TCGA-DS-A7WH	TCGA-CESC		s1453	University of North Carolina	Cedars Sinai	United States	NO	T1b1	N0	Mucinous Adenocarcinoma of Endocervical Type		A352-07	True
13722.58cfa832e4b0c9d6adf6d5f6	58cfa832e4b0c9d6adf6d5f6	TCGA-LN-A49V-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-LN-A49V-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_8_rg.sorted	TCGA-LN-A49V-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_8_rg.sorted.bam	40.05		0.17	58cfa832e4b0c9d6adf6d5f6	TCGA-LN-A49V-10A-01D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_8_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49V-10A	0AB29DE2-EB9E-4A25-99DE-5F543CFBDB53	Blood Derived Normal	Illumina HiSeq	693ea7aa-4e14-484b-87a9-564ba5815ad3	Esophagus	49.0	54100362-D87F-4360-B9C3-8042B2B670EB	94EC2C86-92CE-4560-94F0-E82AE31B9245	TCGA-LN-A49V-10A-01D-A248-26	HG19_Broad_variant	TCGA-LN-A49V	TCGA-ESCA		s1867	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0		Stage II	A248-26	True
13767.58cfa833e4b0c9d6adf6dfc5	58cfa833e4b0c9d6adf6dfc5	UNCID_1148319.f77e9ef0-0a62-426b-98d9-6813edeb63a5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1148319.f77e9ef0-0a62-426b-98d9-6813edeb63a5.sorted_genome_alignments	UNCID_1148319.f77e9ef0-0a62-426b-98d9-6813edeb63a5.sorted_genome_alignments.bam	80.33	1.64	0.14	58cfa833e4b0c9d6adf6dfc5	UNCID_1148319.f77e9ef0-0a62-426b-98d9-6813edeb63a5.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IJ-01A	2C86C3EA-D926-4D39-A5AE-39ECE4774287	Primary Tumor	Illumina HiSeq	776D5237-23A2-41B4-927D-90AC83AF069E	Breast	42.0	9EF8142A-8627-4DCF-8C87-15B1BC2BFEA2	F77E9EF0-0A62-426B-98D9-6813EDEB63A5	TCGA-B6-A0IJ-01A-11R-A034-07	HG19	TCGA-B6-A0IJ	TCGA-BRCA		s5873	University of North Carolina	Duke	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A034-07	True
13722.58cfa831e4b0c9d6adf6c375	58cfa831e4b0c9d6adf6c375	TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted	TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted.bam	281.2	1.9	0.14	58cfa831e4b0c9d6adf6c375	TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4477-01A	18D0AAE7-9694-4252-B8FE-16E62DADAB07	Primary Tumor	Illumina HiSeq	854ac518-e119-4ce6-97c4-b123e75a99ee	Stomach	58.0	6D7C7B4E-6913-487D-9DC3-DDA901434192	3AE56504-30EE-4C03-9F69-C5B415DE6738	TCGA-CG-4477-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4477	TCGA-STAD		s14907	Harvard Medical School	Indivumed	Germany	NO	T2a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1154-02	True
13722.58cfa82de4b0c9d6adf6a748	58cfa82de4b0c9d6adf6a748	G14850.TCGA-49-4486-11A-01D-1931-08.3.filtered.	WGS	G14850.TCGA-49-4486-11A-01D-1931-08.3	G14850.TCGA-49-4486-11A-01D-1931-08.3.bam	176.53	1.9	0.16	58cfa82de4b0c9d6adf6a748	G14850.TCGA-49-4486-11A-01D-1931-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4486-11A	61C655EC-52B5-453F-A6CC-B2ABA445B027	Solid Tissue Normal	Illumina HiSeq	83ce2c4a-f55f-47bf-af39-3fe89232672b	Lung	72.0	5AF4A67E-13EF-41DD-945C-18669C7D2701	3041C54D-431B-4CC6-8AB4-623673BC6CFD	TCGA-49-4486-11A-01D-1931-08	HG19_Broad_variant	TCGA-49-4486	TCGA-LUAD	2318.0	s11210	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1931-08	True
13767.58cfa839e4b0c9d6adf7111a	58cfa839e4b0c9d6adf7111a	UNCID_2254000.e77c56f5-7575-46f0-9751-723085dbd6fc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2254000.e77c56f5-7575-46f0-9751-723085dbd6fc.sorted_genome_alignments	UNCID_2254000.e77c56f5-7575-46f0-9751-723085dbd6fc.sorted_genome_alignments.bam	15.96	1.75	0.17	58cfa839e4b0c9d6adf7111a	UNCID_2254000.e77c56f5-7575-46f0-9751-723085dbd6fc.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LI-01A	75BC22D8-738D-45F8-B6C0-C664F5FEF47C	Primary Tumor	Illumina HiSeq	A5F6C74B-B5E2-4D53-BA7A-044747C547BB	Cervix	48.0	EBFA4682-49C9-4AC1-8147-E3860D852D28	E77C56F5-7575-46F0-9751-723085DBD6FC	TCGA-IR-A3LI-01A-11R-A32Y-07	HG19	TCGA-IR-A3LI	TCGA-CESC		s1585	University of North Carolina	Memorial Sloan Kettering	United States	NO	T2b	N1	Endocervical Type of Adenocarcinoma		A32Y-07	True
13767.58cfa833e4b0c9d6adf6da63	58cfa833e4b0c9d6adf6da63	UNCID_1072839.2d8e77a9-f69e-4c27-acaa-1ae73dbc5997.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1072839.2d8e77a9-f69e-4c27-acaa-1ae73dbc5997.sorted_genome_alignments	UNCID_1072839.2d8e77a9-f69e-4c27-acaa-1ae73dbc5997.sorted_genome_alignments.bam	267.8	1.8	0.14	58cfa833e4b0c9d6adf6da63	UNCID_1072839.2d8e77a9-f69e-4c27-acaa-1ae73dbc5997.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-5480-01A	396932AB-C4B3-4526-9201-9222F5F062A5	Primary Tumor	Illumina HiSeq	B89D0D94-EE06-4ABB-93B9-042758224B73	Lung	66.0	490B0C15-EC7E-44BA-8522-08B467C34876	2D8E77A9-F69E-4C27-ACAA-1AE73DBC5997	TCGA-22-5480-01A-01R-1635-07	HG19	TCGA-22-5480	TCGA-LUSC	2170.0	s10017	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T1b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1635-07	True
13767.58cfa834e4b0c9d6adf6e662	58cfa834e4b0c9d6adf6e662	UNCID_1188880.27fc767b-a79b-4d0a-9daa-869f1c05a928.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1188880.27fc767b-a79b-4d0a-9daa-869f1c05a928.sorted_genome_alignments	UNCID_1188880.27fc767b-a79b-4d0a-9daa-869f1c05a928.sorted_genome_alignments.bam	55.8	1.7	0.15	58cfa834e4b0c9d6adf6e662	UNCID_1188880.27fc767b-a79b-4d0a-9daa-869f1c05a928.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5679-01A	3FA6C93E-E7FE-402C-9526-C81411AA0920	Primary Tumor	Illumina HiSeq	81B6E910-CDFE-4358-BED5-F0C9A888F054	Kidney	73.0	17313700-6052-4901-8850-981FEAD99D6C	27FC767B-A79B-4D0A-9DAA-869F1C05A928	TCGA-CJ-5679-01A-11R-1541-07	HG19	TCGA-CJ-5679	TCGA-KIRC	679.0	s9489	University of North Carolina	MD Anderson Cancer Center	None	NO	T3b	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1541-07	True
13722.58cfa82de4b0c9d6adf6a49a	58cfa82de4b0c9d6adf6a49a	1d2f2091a246a644d3f997d0edfd860a.filtered.	WGS	1d2f2091a246a644d3f997d0edfd860a	1d2f2091a246a644d3f997d0edfd860a.bam	17.4	1.97	0.08	58cfa82de4b0c9d6adf6a49a	1d2f2091a246a644d3f997d0edfd860a.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0EY-01A	D67CD793-2931-429A-9084-2F3C4C8BE7AD	Primary Tumor	Illumina HiSeq	79cc669f-41ce-4384-ac00-fe94ad0c8cd5	Breast	62.0	2A3E4DBB-AAFF-4B14-BBED-F2D7CF0F8FA3	01658141-8398-4585-9F0F-8355DD9B0604	TCGA-A2-A0EY-01A-11D-A19H-09	GRCh37-lite	TCGA-A2-A0EY	TCGA-BRCA		s5947	Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A19H-09	True
13767.58cfa835e4b0c9d6adf6edac	58cfa835e4b0c9d6adf6edac	UNCID_1377923.c2972973-dec9-4723-8fc6-af9db22e1cde.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1377923.c2972973-dec9-4723-8fc6-af9db22e1cde.sorted_genome_alignments	UNCID_1377923.c2972973-dec9-4723-8fc6-af9db22e1cde.sorted_genome_alignments.bam	33.2		0.16	58cfa835e4b0c9d6adf6edac	UNCID_1377923.c2972973-dec9-4723-8fc6-af9db22e1cde.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-69-7978-01A	F462CFEF-F60A-4D3E-B92D-B8D8F50B6BB3	Primary Tumor	Illumina HiSeq	37343821-5F78-4492-9A42-2200B9ACEF65	Lung	59.0	EDBA8888-6D1B-43A7-988D-5DF420922C80	C2972973-DEC9-4723-8FC6-AF9DB22E1CDE	TCGA-69-7978-01A-11R-2187-07	HG19	TCGA-69-7978	TCGA-LUAD		s11395	University of North Carolina	Washington University - Cleveland Clinic	United States	NO	T2b	N1	Lung Adenocarcinoma Mixed Subtype	Stage II	2187-07	True
13767.58cfa836e4b0c9d6adf6f65c	58cfa836e4b0c9d6adf6f65c	UNCID_1573875.0C8A92AE-0B90-471A-9EF8-FA8E42F6204D.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1573875.0C8A92AE-0B90-471A-9EF8-FA8E42F6204D.sorted_genome_alignments	UNCID_1573875.0C8A92AE-0B90-471A-9EF8-FA8E42F6204D.sorted_genome_alignments.bam	15.46	1.77	0.16	58cfa836e4b0c9d6adf6f65c	UNCID_1573875.0C8A92AE-0B90-471A-9EF8-FA8E42F6204D.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A3WA-01A	59221E3A-2927-40BF-A38D-4A5843EA179B	Primary Tumor	Illumina HiSeq	2C205591-E08E-454B-893A-8AB28557735D	Thyroid	52.0	67A68931-520A-4D95-BD5E-99896AAA133B	0C8A92AE-0B90-471A-9EF8-FA8E42F6204D	TCGA-FY-A3WA-01A-11R-A22L-07	HG19	TCGA-FY-A3WA	TCGA-THCA		s12577	University of North Carolina	International Genomics Consortium	United States	NO	T1a	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A22L-07	True
13767.58cfa835e4b0c9d6adf6eae0	58cfa835e4b0c9d6adf6eae0	UNCID_1325265.731721fa-4ced-445d-855f-e4ded85f9726.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1325265.731721fa-4ced-445d-855f-e4ded85f9726.sorted_genome_alignments	UNCID_1325265.731721fa-4ced-445d-855f-e4ded85f9726.sorted_genome_alignments.bam	255.2		0.15	58cfa835e4b0c9d6adf6eae0	UNCID_1325265.731721fa-4ced-445d-855f-e4ded85f9726.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7784-01A	4BC71292-60BB-4B63-86C1-0FE021083804	Primary Tumor	Illumina HiSeq	AC2CA082-31A4-4BDA-83FD-F8BECB1D91F4	Prostate	63.0	0D3EC78C-3DA8-443F-BAA6-93CAED5B065C	731721FA-4CED-445D-855F-E4DED85F9726	TCGA-EJ-7784-01A-11R-2118-07	HG19	TCGA-EJ-7784	TCGA-PRAD		s4175	University of North Carolina	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13722.58cfa830e4b0c9d6adf6c2b2	58cfa830e4b0c9d6adf6c2b2	TCGA-CF-A1HR-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CF-A1HR-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_4_rg.sorted	TCGA-CF-A1HR-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_4_rg.sorted.bam	57.84	1.95	0.16	58cfa830e4b0c9d6adf6c2b2	TCGA-CF-A1HR-10A-01D-A13U_121011_SN590_0184_BC192GACXX_s_4_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A1HR-10A	39EA19E1-4959-4F1B-9934-54BDAF766842	Blood Derived Normal	Illumina HiSeq	8f5d258a-5720-4244-a4e2-2288d64a7ef9	Bladder	62.0	0AE65E89-1DB2-4E20-96D7-D337AACBB040	A854E387-FD99-4C95-9F75-0B359B1592FD	TCGA-CF-A1HR-10A-01D-A13U-02	HG19_Broad_variant	TCGA-CF-A1HR	TCGA-BLCA		s2701	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13U-02	True
13722.58cfa830e4b0c9d6adf6beb1	58cfa830e4b0c9d6adf6beb1	TCGA-AG-3890-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3890-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3890-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	8.59	1.9	0.17	58cfa830e4b0c9d6adf6beb1	TCGA-AG-3890-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3890-10A	E2D395F8-BF13-4FE4-8031-683B0EEDD875	Blood Derived Normal	Illumina HiSeq	4dc195af-fda9-4230-ab6a-998f1e36540b	Colorectal	62.0	C5DC7F19-74F0-4053-A405-42EF3E6049B4	B0DA3675-FA73-4BC9-9E24-63A31968FDCB	TCGA-AG-3890-10A-01D-1115-02	HG18	TCGA-AG-3890	TCGA-READ		s1971	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	1115-02	True
13767.58cfa83ce4b0c9d6adf72cfa	58cfa83ce4b0c9d6adf72cfa	UNCID_603093.920f6f9b-c7d2-4c60-b4e8-7cb74c0b26fb.111007_UNC9-SN296_0248_AD0CFWABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_603093.920f6f9b-c7d2-4c60-b4e8-7cb74c0b26fb.111007_UNC9-SN296_0248_AD0CFWABXX.8.trimmed.annotated.translated_to_genomic	UNCID_603093.920f6f9b-c7d2-4c60-b4e8-7cb74c0b26fb.111007_UNC9-SN296_0248_AD0CFWABXX.8.trimmed.annotated.translated_to_genomic.bam	29.8	1.7	0.16	58cfa83ce4b0c9d6adf72cfa	UNCID_603093.920f6f9b-c7d2-4c60-b4e8-7cb74c0b26fb.111007_UNC9-SN296_0248_AD0CFWABXX.8.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-DV-5575-01A	0FF579A1-E295-408D-B194-FEBBCA798E34	Primary Tumor	Illumina HiSeq	E57F4C29-5C84-4877-9A01-9EDB1E925E46	Kidney	52.0	602A2497-298C-4687-A843-0DB6FFDE7386	920F6F9B-C7D2-4C60-B4E8-7CB74C0B26FB	TCGA-DV-5575-01A-01R-1541-07	HG19	TCGA-DV-5575	TCGA-KIRC		s9149	University of North Carolina	NCI Urologic Oncology Branch	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa837e4b0c9d6adf6ffa8	58cfa837e4b0c9d6adf6ffa8	UNCID_1808443.3f4f3e8c-af8c-405e-8fd4-c971f394e35f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1808443.3f4f3e8c-af8c-405e-8fd4-c971f394e35f.sorted_genome_alignments	UNCID_1808443.3f4f3e8c-af8c-405e-8fd4-c971f394e35f.sorted_genome_alignments.bam	76.2		0.16	58cfa837e4b0c9d6adf6ffa8	UNCID_1808443.3f4f3e8c-af8c-405e-8fd4-c971f394e35f.sorted_genome_alignments.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-52-7811-01A	0F5CEBB3-A37B-471F-BBD3-B03CE171812A	Primary Tumor	Illumina HiSeq	2FA029BB-384E-4F73-908B-3BE4C7574EA4	Lung	67.0	4C0D91B4-0DB2-4834-AEA6-C8437FE5BA3D	3F4F3E8C-AF8C-405E-8FD4-C971F394E35F	TCGA-52-7811-01A-11R-2125-07	HG19	TCGA-52-7811	TCGA-LUSC	266.0	s10440	University of North Carolina	University of Miami	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2125-07	True
13767.58cfa836e4b0c9d6adf6f4e3	58cfa836e4b0c9d6adf6f4e3	UNCID_1573142.106facc9-9e09-46e7-84db-1d0a541be7b8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1573142.106facc9-9e09-46e7-84db-1d0a541be7b8.sorted_genome_alignments	UNCID_1573142.106facc9-9e09-46e7-84db-1d0a541be7b8.sorted_genome_alignments.bam	49.2		0.16	58cfa836e4b0c9d6adf6f4e3	UNCID_1573142.106facc9-9e09-46e7-84db-1d0a541be7b8.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-IB-7886-01A	F73DFD7F-E054-46FF-9485-E8D05AFE2DA6	Primary Tumor	Illumina HiSeq	06FD56E3-36C0-444C-850C-144CAF2BA7E4	Pancreas	80.0	1AC9E2AE-4A92-4A03-9B6A-4BA8CF314BC6	106FACC9-9E09-46E7-84DB-1D0A541BE7B8	TCGA-IB-7886-01A-11R-2156-07	HG19	TCGA-IB-7886	TCGA-PAAD	123.0	s737	University of North Carolina	Alberta Health Services	Canada	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	2156-07	True
13722.58cfa82de4b0c9d6adf6a646	58cfa82de4b0c9d6adf6a646	7cdc3dce590a37c14215501abc56072b.filtered.	WGS	7cdc3dce590a37c14215501abc56072b	7cdc3dce590a37c14215501abc56072b.bam	11.23		0.07	58cfa82de4b0c9d6adf6a646	7cdc3dce590a37c14215501abc56072b.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-HB-A5W3-10A	C5B0E6BE-48B5-40E5-9D90-F9112050AA88	Blood Derived Normal	Illumina HiSeq	f325a922-a166-48d2-b2bf-f33cd8576feb	Mesenchymal	58.0	EBD8957C-5F46-48F2-8A39-1D327C3B724F	546CFD48-E472-4186-A83A-09F5AEF53000	TCGA-HB-A5W3-10A-01D-A29N-09	GRCh37-lite	TCGA-HB-A5W3	TCGA-SARC	384.0	s2343	Washington University School of Medicine	University of North Carolina	United States	NO					A29N-09	False
13767.58cfa838e4b0c9d6adf70c5a	58cfa838e4b0c9d6adf70c5a	UNCID_2097138.dc1f01da-cff9-4b61-b743-0452e023e2a1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2097138.dc1f01da-cff9-4b61-b743-0452e023e2a1.sorted_genome_alignments	UNCID_2097138.dc1f01da-cff9-4b61-b743-0452e023e2a1.sorted_genome_alignments.bam	10.63	1.83	0.15	58cfa838e4b0c9d6adf70c5a	UNCID_2097138.dc1f01da-cff9-4b61-b743-0452e023e2a1.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-NJ-A4YF-01A	595FC3AD-F603-421B-B130-52F1F617050B	Primary Tumor	Illumina HiSeq	C021FA87-4377-46E3-BBA2-D420917A4D99	Lung	50.0	ECBAF334-D86B-4316-AE93-84FEFF5DA296	DC1F01DA-CFF9-4B61-B743-0452E023E2A1	TCGA-NJ-A4YF-01A-12R-A262-07	HG19	TCGA-NJ-A4YF	TCGA-LUAD		s11533	University of North Carolina	Washington University - Rush University	United States	NO	T1	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	A262-07	True
13767.58cfa83ae4b0c9d6adf71c26	58cfa83ae4b0c9d6adf71c26	UNCID_2487435.8a5081d6-358e-4e94-a794-5d9fcdf467fb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2487435.8a5081d6-358e-4e94-a794-5d9fcdf467fb.sorted_genome_alignments	UNCID_2487435.8a5081d6-358e-4e94-a794-5d9fcdf467fb.sorted_genome_alignments.bam	51.79	1.89	0.17	58cfa83ae4b0c9d6adf71c26	UNCID_2487435.8a5081d6-358e-4e94-a794-5d9fcdf467fb.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-2Y-A9HA-01A	A25A714E-C142-482B-91C8-4FEA763E0254	Primary Tumor	Illumina HiSeq	1EFC2CBC-AB28-4E09-8233-E36A54611D1D	Liver	70.0	40EC7948-F54B-4888-A0C2-DF47F32A85F4	8A5081D6-358E-4E94-A794-5D9FCDF467FB	TCGA-2Y-A9HA-01A-11R-A39D-07	HG19	TCGA-2Y-A9HA	TCGA-LIHC	36.0	s16935	University of North Carolina	Moffitt Cancer Center	United States	NO	T2	NX	Hepatocellular Carcinoma	Stage II	A39D-07	True
13722.58cfa82ee4b0c9d6adf6af3a	58cfa82ee4b0c9d6adf6af3a	G48125.TCGA-13-0912-01A-01D-A312-08.3.filtered.	WGS	G48125.TCGA-13-0912-01A-01D-A312-08.3	G48125.TCGA-13-0912-01A-01D-A312-08.3.bam	120.67	1.9	0.08	58cfa82ee4b0c9d6adf6af3a	G48125.TCGA-13-0912-01A-01D-A312-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0912-01A	58D34254-4F5B-40A4-9E9F-7160062FB2A4	Primary Tumor	Illumina HiSeq	5e598e0f-da1d-4e41-9a69-4ab15597c460	Ovary	58.0	BFC06061-2299-4785-9943-67F5EC9EBE3F	95FC38AC-2B36-4C46-ABBF-8D2D52FF9626	TCGA-13-0912-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-0912	TCGA-OV		s17801	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		A312-08	True
13767.58cfa83ae4b0c9d6adf71b3c	58cfa83ae4b0c9d6adf71b3c	UNCID_2442085.4593c891-d086-4f9d-b4b8-d7f1e389e51f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2442085.4593c891-d086-4f9d-b4b8-d7f1e389e51f.sorted_genome_alignments	UNCID_2442085.4593c891-d086-4f9d-b4b8-d7f1e389e51f.sorted_genome_alignments.bam	66.17	1.98	0.18	58cfa83ae4b0c9d6adf71b3c	UNCID_2442085.4593c891-d086-4f9d-b4b8-d7f1e389e51f.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-T7-A92I-01A	DF1E2E79-0126-4F3A-85E3-36F59BE04622	Primary Tumor	Illumina HiSeq	D2706AF3-6AB8-4997-8762-AE620C3B6D00	Kidney	47.0	8DEA410D-98AF-4AA0-A3C1-ECD853570265	4593C891-D086-4F9D-B4B8-D7F1E389E51F	TCGA-T7-A92I-01A-11R-A37O-07	HG19	TCGA-T7-A92I	TCGA-KIRC		s9665	University of North Carolina	Molecular Response	United States	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	A37O-07	True
13767.58cfa834e4b0c9d6adf6e5e0	58cfa834e4b0c9d6adf6e5e0	UNCID_1190350.c9fe1e72-5413-41c6-a387-569b7edc7c1a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1190350.c9fe1e72-5413-41c6-a387-569b7edc7c1a.sorted_genome_alignments	UNCID_1190350.c9fe1e72-5413-41c6-a387-569b7edc7c1a.sorted_genome_alignments.bam	64.8	1.8	0.16	58cfa834e4b0c9d6adf6e5e0	UNCID_1190350.c9fe1e72-5413-41c6-a387-569b7edc7c1a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-5587-11A	73FC6AE6-7C5E-44DE-A9A0-17292CBB01CC	Solid Tissue Normal	Illumina HiSeq	9CAC4331-5568-46A7-9694-66D69EFA1935	Kidney	62.0	E8ACD20A-3901-4FB7-A0CB-8C4AEF14D1C3	C9FE1E72-5413-41C6-A387-569B7EDC7C1A	TCGA-CW-5587-11A-01R-1541-07	HG19	TCGA-CW-5587	TCGA-KIRC		s9794	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1541-07	True
13767.58cfa82ee4b0c9d6adf6a87e	58cfa82ee4b0c9d6adf6a87e	G17219.TCGA-06-0158-01A-01R-1849-01.2.filtered.	RNA-Seq	G17219.TCGA-06-0158-01A-01R-1849-01.2	G17219.TCGA-06-0158-01A-01R-1849-01.2.bam	105.3	1.82	0.17	58cfa82ee4b0c9d6adf6a87e	G17219.TCGA-06-0158-01A-01R-1849-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0158-01A	BC316A17-9D73-4EF3-97E9-C4AC5516B75A	Primary Tumor	Illumina HiSeq	A133D2EF-446B-4EF1-ABCD-19AE07780CF1	Brain	73.0	7606E925-5BCA-45B3-B528-DAB338CC43DE	4DF60632-CB31-4C0F-8929-D18129668469	TCGA-06-0158-01A-01R-1849-01	HG19_Broad_variant	TCGA-06-0158	TCGA-GBM	329.0	s14253	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13767.58cfa82de4b0c9d6adf6a78a	58cfa82de4b0c9d6adf6a78a	G17189.TCGA-06-0132-01A-02R-1849-01.2.filtered.	RNA-Seq	G17189.TCGA-06-0132-01A-02R-1849-01.2	G17189.TCGA-06-0132-01A-02R-1849-01.2.bam	17.1	1.8	0.18	58cfa82de4b0c9d6adf6a78a	G17189.TCGA-06-0132-01A-02R-1849-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0132-01A	9AD6C241-CCC5-4532-A6AC-098271B13B5F	Primary Tumor	Illumina HiSeq	5198430D-1C86-49E3-9AF9-30F4C6894AEC	Brain	49.0	D495C228-2BEB-4813-ABD6-B5B089C01EBA	66F6DA01-B85B-4E29-8059-0BB6A32D709F	TCGA-06-0132-01A-02R-1849-01	HG19_Broad_variant	TCGA-06-0132	TCGA-GBM	771.0	s14285	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13767.58cfa835e4b0c9d6adf6ec58	58cfa835e4b0c9d6adf6ec58	UNCID_1311286.95cdfdf7-26d2-41b6-bac7-a6305a91ec3c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1311286.95cdfdf7-26d2-41b6-bac7-a6305a91ec3c.sorted_genome_alignments	UNCID_1311286.95cdfdf7-26d2-41b6-bac7-a6305a91ec3c.sorted_genome_alignments.bam	65.32	1.8	0.17	58cfa835e4b0c9d6adf6ec58	UNCID_1311286.95cdfdf7-26d2-41b6-bac7-a6305a91ec3c.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EI-01A	3ACF7438-FD65-442C-8A30-68B6714537F3	Primary Tumor	Illumina HiSeq	A8DC0DE1-45B4-48B5-BEB3-7FBDFB3005C5	Liver	46.0	65FB618A-9296-47AD-BBA9-A93FC3F88E68	95CDFDF7-26D2-41B6-BAC7-A6305A91EC3C	TCGA-DD-A1EI-01A-11R-A131-07	HG19	TCGA-DD-A1EI	TCGA-LIHC		s16606	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A131-07	True
13767.58cfa839e4b0c9d6adf71329	58cfa839e4b0c9d6adf71329	UNCID_2307189.692abecd-9c2a-48ec-8794-7e84a5317c46.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2307189.692abecd-9c2a-48ec-8794-7e84a5317c46.sorted_genome_alignments	UNCID_2307189.692abecd-9c2a-48ec-8794-7e84a5317c46.sorted_genome_alignments.bam	24.45	1.86	0.18	58cfa839e4b0c9d6adf71329	UNCID_2307189.692abecd-9c2a-48ec-8794-7e84a5317c46.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A6S9-01A	9676E46B-8F29-43CD-AB65-EB6A535CCED4	Primary Tumor	Illumina HiSeq	0188CE11-1553-4418-90B3-5BF6055C9D15	Breast	34.0	4DDA3F93-216C-41D5-B1C0-85EE571D7759	692ABECD-9C2A-48EC-8794-7E84A5317C46	TCGA-EW-A6S9-01A-22R-A33J-07	HG19	TCGA-EW-A6S9	TCGA-BRCA		s6241	University of North Carolina	University of Miami	United States	NO	T1c	N1	Infiltrating Ductal Carcinoma	Stage II	A33J-07	True
13767.58cfa833e4b0c9d6adf6dfdf	58cfa833e4b0c9d6adf6dfdf	UNCID_1146509.8bbaef6c-31c4-47a4-8e7b-7e6242d02666.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1146509.8bbaef6c-31c4-47a4-8e7b-7e6242d02666.sorted_genome_alignments	UNCID_1146509.8bbaef6c-31c4-47a4-8e7b-7e6242d02666.sorted_genome_alignments.bam	9.36	1.84	0.13	58cfa833e4b0c9d6adf6dfdf	UNCID_1146509.8bbaef6c-31c4-47a4-8e7b-7e6242d02666.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HX-01A	3B01D064-8C00-4972-9F07-407EAC8E7534	Primary Tumor	Illumina HiSeq	7B22FBAC-9E3C-4A59-898B-6D3224645B36	Breast	54.0	989C2DF5-5183-4DAA-A8DA-FC9AB18A437C	8BBAEF6C-31C4-47A4-8E7B-7E6242D02666	TCGA-BH-A0HX-01A-21R-A056-07	HG19	TCGA-BH-A0HX	TCGA-BRCA		s6933	University of North Carolina	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A056-07	True
13767.58cfa82fe4b0c9d6adf6b491	58cfa82fe4b0c9d6adf6b491	TCGA-24-2267-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-24-2267-01A-01R-1568-13_rnaseq	TCGA-24-2267-01A-01R-1568-13_rnaseq.bam	547.0	1.8	0.15	58cfa82fe4b0c9d6adf6b491	TCGA-24-2267-01A-01R-1568-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-2267-01A	99A61986-7B23-46B5-99A4-EFBA6BAD3766	Primary Tumor	Illumina HiSeq	7D6FC03C-5C1A-4BDB-A42F-93B806453B35	Ovary	58.0	00BE5EC1-3B0F-4B5A-B116-4EFCE25D2CC8	9EBB3535-6536-49FC-A88B-473235972378	TCGA-24-2267-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-24-2267	TCGA-OV	1446.0	s17249	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa830e4b0c9d6adf6c0c0	58cfa830e4b0c9d6adf6c0c0	TCGA-BR-8679-01A-11R-2402-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-8679-01A-11R-2402-13_rnaseq	TCGA-BR-8679-01A-11R-2402-13_rnaseq.bam	201.2		0.15	58cfa830e4b0c9d6adf6c0c0	TCGA-BR-8679-01A-11R-2402-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8679-01A	03E3082E-9F8B-4689-9013-0A9954146DFA	Primary Tumor	Illumina HiSeq	BD7B0078-A602-47DE-9DB6-B715BF38A4A1	Stomach	63.0	A9C9F13C-0A67-4403-9BBC-304EC7690929	C8C08DB4-752F-4B6E-9F17-247453977D42	TCGA-BR-8679-01A-11R-2402-13	GRCh37-lite	TCGA-BR-8679	TCGA-STAD		s15313	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T2	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	2402-13	True
13767.58cfa837e4b0c9d6adf6fd8a	58cfa837e4b0c9d6adf6fd8a	UNCID_1725661.59d21a33-8d29-4c23-95a8-7986d2a3db36.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1725661.59d21a33-8d29-4c23-95a8-7986d2a3db36.sorted_genome_alignments	UNCID_1725661.59d21a33-8d29-4c23-95a8-7986d2a3db36.sorted_genome_alignments.bam	61.75	1.86	0.17	58cfa837e4b0c9d6adf6fd8a	UNCID_1725661.59d21a33-8d29-4c23-95a8-7986d2a3db36.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RB-01A	F92A994D-B080-42C9-966F-34C1000865E3	Primary Tumor	Illumina HiSeq	FB2E371D-F682-481C-BC59-5672312955EB	Cervix	48.0	8254CF9E-5176-4649-B8F5-A6F61EAD3CD6	59D21A33-8D29-4C23-95A8-7986D2A3DB36	TCGA-EK-A2RB-01A-11R-A18M-07	HG19	TCGA-EK-A2RB	TCGA-CESC		s1426	University of North Carolina	Gynecologic Oncology Group	United States	NO			Cervical Squamous Cell Carcinoma		A18M-07	True
13767.58cfa838e4b0c9d6adf70788	58cfa838e4b0c9d6adf70788	UNCID_2028193.e873f2ee-21a1-48f9-a6d1-8062786148de.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2028193.e873f2ee-21a1-48f9-a6d1-8062786148de.sorted_genome_alignments	UNCID_2028193.e873f2ee-21a1-48f9-a6d1-8062786148de.sorted_genome_alignments.bam	25.44	1.83	0.17	58cfa838e4b0c9d6adf70788	UNCID_2028193.e873f2ee-21a1-48f9-a6d1-8062786148de.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-L3-A4E7-01A	D856855F-3069-4169-A192-9113D8542CFB	Primary Tumor	Illumina HiSeq	0BA8859B-F3D6-4D72-81DF-A5A8BD5A223F	Lung	71.0	843DC876-F4EF-4B7B-9A1E-C3AA9FD08BBF	E873F2EE-21A1-48F9-A6D1-8062786148DE	TCGA-L3-A4E7-01A-11R-A24Z-07	HG19	TCGA-L3-A4E7	TCGA-LUSC		s10232	University of North Carolina	Gundersen Lutheran Health System	United States	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	A24Z-07	True
13767.58cfa837e4b0c9d6adf702c6	58cfa837e4b0c9d6adf702c6	UNCID_1942896.db0d3ef1-a8d7-4a5e-863e-f9e2717dee54.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1942896.db0d3ef1-a8d7-4a5e-863e-f9e2717dee54.sorted_genome_alignments	UNCID_1942896.db0d3ef1-a8d7-4a5e-863e-f9e2717dee54.sorted_genome_alignments.bam	136.2		0.14	58cfa837e4b0c9d6adf702c6	UNCID_1942896.db0d3ef1-a8d7-4a5e-863e-f9e2717dee54.sorted_genome_alignments.bam	Alive	MALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-55-8302-01A	807CC7D2-6E3B-4F2D-9531-0DA994EEEADA	Primary Tumor	Illumina HiSeq	DCCDB57E-F6F3-4DA7-828E-8A780FC164DB	Lung	54.0	97DF724F-AFE1-4DB4-9563-853245093FBB	DB0D3EF1-A8D7-4A5E-863E-F9E2717DEE54	TCGA-55-8302-01A-11R-2326-07	HG19	TCGA-55-8302	TCGA-LUAD		s11188	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2326-07	True
13722.58cfa82ee4b0c9d6adf6ae71	58cfa82ee4b0c9d6adf6ae71	TCGA-05-4402-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-05-4402-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-05-4402-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	65.9	1.8	0.14	58cfa82ee4b0c9d6adf6ae71	TCGA-05-4402-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4402-10A	722D6818-F1CB-49F4-B68A-FD0A31304681	Blood Derived Normal	Illumina HiSeq	30d6ff50-187c-495a-8364-d0ae343f89c2	Lung	57.0	02C4F8D1-061F-4897-AF1F-755345D7D91B	A9423B91-152F-4BD3-97FC-8B715A63136A	TCGA-05-4402-10A-01D-1203-02	GRCh37	TCGA-05-4402	TCGA-LUAD	244.0	s10983	Harvard Medical School	Indivumed	Germany	NO	T2	NX	Lung Adenocarcinoma Mixed Subtype	Stage IV	1203-02	True
13767.58cfa837e4b0c9d6adf6ff00	58cfa837e4b0c9d6adf6ff00	UNCID_1781570.bd5b7c93-fabe-4bb8-a78f-981aeed75d79.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1781570.bd5b7c93-fabe-4bb8-a78f-981aeed75d79.sorted_genome_alignments	UNCID_1781570.bd5b7c93-fabe-4bb8-a78f-981aeed75d79.sorted_genome_alignments.bam	35.09	1.82	0.18	58cfa837e4b0c9d6adf6ff00	UNCID_1781570.bd5b7c93-fabe-4bb8-a78f-981aeed75d79.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3QK-01B	9EE8E704-C61D-413D-B69D-257EF829FDAE	Primary Tumor	Illumina HiSeq	A2993899-41D7-4700-9F7C-55830F40AB6D	Bladder	56.0	9BF2D470-CBC4-454A-95AB-3109F045684C	BD5B7C93-FABE-4BB8-A78F-981AEED75D79	TCGA-GV-A3QK-01B-11R-A23N-07	HG19	TCGA-GV-A3QK	TCGA-BLCA		s2982	University of North Carolina	BLN - Cleveland Clinic	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A23N-07	True
13767.58cfa82fe4b0c9d6adf6b390	58cfa82fe4b0c9d6adf6b390	TCGA-24-2035-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-2035-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-24-2035-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	92.0	1.8	0.14	58cfa82fe4b0c9d6adf6b390	TCGA-24-2035-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-2035-01A	062982F8-9F49-425A-99E9-008AF5ED9040	Primary Tumor	Illumina HiSeq	A0C12541-9C68-459D-B080-A6311C685549	Ovary	65.0	E4CCC95D-79CA-49E3-8CD0-C8452C5F9AA2	E78F43FF-0B31-4F9B-A9C1-02155EE3D8B0	TCGA-24-2035-01A-01R-1568-13	GRCh37-lite	TCGA-24-2035	TCGA-OV	857.0	s17248	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa839e4b0c9d6adf71274	58cfa839e4b0c9d6adf71274	UNCID_2281450.2532b16b-1217-43df-aa69-cdbb5f9c3778.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2281450.2532b16b-1217-43df-aa69-cdbb5f9c3778.sorted_genome_alignments	UNCID_2281450.2532b16b-1217-43df-aa69-cdbb5f9c3778.sorted_genome_alignments.bam	6.24	1.86	0.12	58cfa839e4b0c9d6adf71274	UNCID_2281450.2532b16b-1217-43df-aa69-cdbb5f9c3778.sorted_genome_alignments.bam					Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-FL-A1YT-11A	1E5053AE-9A78-41ED-81CD-1A43756FCA09	Solid Tissue Normal	Illumina HiSeq	C9AE58BB-B08D-4CEE-A2A2-ACF740053AAA	Uterus		B67349D0-BC63-43E0-9B52-13095E184B94	2532B16B-1217-43DF-AA69-CDBB5F9C3778	TCGA-FL-A1YT-11A-12R-A32Y-07	HG19	TCGA-FL-A1YT	TCGA-UCEC		s4537	University of North Carolina	University of Hawaii - Normal Study	United States	NO					A32Y-07	True
13722.58cfa82ee4b0c9d6adf6a9d5	58cfa82ee4b0c9d6adf6a9d5	G25788.TCGA-55-7281-01A-11D-2036-08.1.filtered.	WGS	G25788.TCGA-55-7281-01A-11D-2036-08.1	G25788.TCGA-55-7281-01A-11D-2036-08.1.bam	196.7		0.05	58cfa82ee4b0c9d6adf6a9d5	G25788.TCGA-55-7281-01A-11D-2036-08.1.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-55-7281-01A	659668E8-F0D9-4FF2-BBC8-9246F2EF49AB	Primary Tumor	Illumina HiSeq	19c6ac35-62fd-4db0-8641-22abc19d0b52	Lung	70.0	AFEC3B25-C3F7-4E48-8FB0-6FB4DD581081	D5443922-FEA5-4FF0-BD6E-8CE04E1951D8	TCGA-55-7281-01A-11D-2036-08	HG19_Broad_variant	TCGA-55-7281	TCGA-LUAD		s11213	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2036-08	True
13722.58cfa831e4b0c9d6adf6cc8a	58cfa831e4b0c9d6adf6cc8a	TCGA-EM-A3OA-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EM-A3OA-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_8_rg.sorted	TCGA-EM-A3OA-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_8_rg.sorted.bam	45.54		0.16	58cfa831e4b0c9d6adf6cc8a	TCGA-EM-A3OA-10A-01D-A221_120610_SN1120_0151_AC0WN0ACXX_s_8_rg.sorted.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A3OA-10A	24CF6397-60EF-4635-81F0-78A67157AAC0	Blood Derived Normal	Illumina HiSeq	3c187948-81e7-47b3-9daa-642120425827	Thyroid	55.0	CC8519D3-1D5A-4895-A850-E6C7662EDA6D	94813927-BC9D-4638-9424-BCB3053A87B8	TCGA-EM-A3OA-10A-01D-A221-26	HG19_Broad_variant	TCGA-EM-A3OA	TCGA-THCA		s12755	MD Anderson - Institute for Applied Cancer Science	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A221-26	True
13767.58cfa839e4b0c9d6adf713fa	58cfa839e4b0c9d6adf713fa	UNCID_2306102.fa74ebb2-007d-407a-ba07-12976b75056d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2306102.fa74ebb2-007d-407a-ba07-12976b75056d.sorted_genome_alignments	UNCID_2306102.fa74ebb2-007d-407a-ba07-12976b75056d.sorted_genome_alignments.bam	49.22	1.92	0.17	58cfa839e4b0c9d6adf713fa	UNCID_2306102.fa74ebb2-007d-407a-ba07-12976b75056d.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GU-A762-01A	6A1EEE8D-CF62-47E9-9322-C18633CB3EE9	Primary Tumor	Illumina HiSeq	80BD303D-1402-4F9D-8266-C89F617DFFF9	Bladder	87.0	E70BF0B1-0E0E-4484-93F2-E312AA575F98	FA74EBB2-007D-407A-BA07-12976B75056D	TCGA-GU-A762-01A-11R-A33J-07	HG19	TCGA-GU-A762	TCGA-BLCA		s2801	University of North Carolina	BLN - UT Southwestern Medical Center at Dallas	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A33J-07	True
13767.58cfa834e4b0c9d6adf6e282	58cfa834e4b0c9d6adf6e282	UNCID_1177328.3d7aafed-3205-47c6-9394-2a6a84d90a0a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1177328.3d7aafed-3205-47c6-9394-2a6a84d90a0a.sorted_genome_alignments	UNCID_1177328.3d7aafed-3205-47c6-9394-2a6a84d90a0a.sorted_genome_alignments.bam	3.8	1.8	0.14	58cfa834e4b0c9d6adf6e282	UNCID_1177328.3d7aafed-3205-47c6-9394-2a6a84d90a0a.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5712-11A	514AF471-31D2-43FA-88DC-8639A5E97181	Solid Tissue Normal	Illumina HiSeq	E59BA2E2-BDFF-4147-9A45-DBBEB3247636	Kidney	68.0	5E6B9787-9256-4C94-90C5-57FE8B3E3078	3D7AAFED-3205-47C6-9394-2A6A84D90A0A	TCGA-B0-5712-11A-01R-1672-07	HG19	TCGA-B0-5712	TCGA-KIRC		s9594	University of North Carolina	University of Pittsburgh	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1672-07	True
13767.58cfa836e4b0c9d6adf6fb2f	58cfa836e4b0c9d6adf6fb2f	UNCID_1660125.88E25F76-1B1F-4AFB-AB08-215D4F7F08B5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1660125.88E25F76-1B1F-4AFB-AB08-215D4F7F08B5.sorted_genome_alignments	UNCID_1660125.88E25F76-1B1F-4AFB-AB08-215D4F7F08B5.sorted_genome_alignments.bam	34.51	1.82	0.16	58cfa836e4b0c9d6adf6fb2f	UNCID_1660125.88E25F76-1B1F-4AFB-AB08-215D4F7F08B5.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13L-01A	C7A2F394-3E3F-4C90-9F1E-F2BE3E5B0D6B	Primary Tumor	Illumina HiSeq	211A79DC-8E94-4DD2-A75A-76809B811A39	Thyroid	85.0	AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8	88E25F76-1B1F-4AFB-AB08-215D4F7F08B5	TCGA-DJ-A13L-01A-11R-A220-07	HG19	TCGA-DJ-A13L	TCGA-THCA		s12701	University of North Carolina	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage I	A220-07	True
13767.58cfa837e4b0c9d6adf6fe2e	58cfa837e4b0c9d6adf6fe2e	UNCID_1729631.ab48f18b-485b-4258-9940-b8b536bd2d04.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1729631.ab48f18b-485b-4258-9940-b8b536bd2d04.sorted_genome_alignments	UNCID_1729631.ab48f18b-485b-4258-9940-b8b536bd2d04.sorted_genome_alignments.bam	140.2		0.15	58cfa837e4b0c9d6adf6fe2e	UNCID_1729631.ab48f18b-485b-4258-9940-b8b536bd2d04.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KL-8330-01A	0F3C4F8F-0766-46B0-81B4-18CA4F6EA20A	Primary Tumor	Illumina HiSeq	6E89CE42-0BE6-46BE-826B-62BBE9881D7F	Kidney	44.0	81431ED0-D762-4131-895B-852B2F78786D	AB48F18B-485B-4258-9940-B8B536BD2D04	TCGA-KL-8330-01A-11R-2315-07	HG19	TCGA-KL-8330	TCGA-KICH		s16470	University of North Carolina	MSKCC	United States	NO	T2b	N0	Kidney Chromophobe	Stage II	2315-07	True
13767.58cfa831e4b0c9d6adf6cdee	58cfa831e4b0c9d6adf6cdee	TCGA-FP-8099-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-FP-8099-01A-11R-2343-13_rnaseq	TCGA-FP-8099-01A-11R-2343-13_rnaseq.bam	183.2		0.15	58cfa831e4b0c9d6adf6cdee	TCGA-FP-8099-01A-11R-2343-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-FP-8099-01A	5956529E-F359-47C9-8222-0BD7F68C1E65	Primary Tumor	Illumina HiSeq	BA85422B-66A1-434D-A6E9-99B0BDD38981	Stomach	79.0	18C474CA-2389-4F75-A796-B0EFDAD03ADD	DC525737-BCD1-4360-9D81-6793C2EE6A4A	TCGA-FP-8099-01A-11R-2343-13	GRCh37-lite	TCGA-FP-8099	TCGA-STAD		s15335	Canada's Michael Smith Genome Sciences Centre	International Genomics Consortium	United States	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2343-13	True
13722.58cfa82de4b0c9d6adf6a4bc	58cfa82de4b0c9d6adf6a4bc	11061be66fae71c16788fd9fc1a73afb.filtered.	WGS	11061be66fae71c16788fd9fc1a73afb	11061be66fae71c16788fd9fc1a73afb.bam	22.65	1.95	0.08	58cfa82de4b0c9d6adf6a4bc	11061be66fae71c16788fd9fc1a73afb.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A1AY-10A	5FD9552A-C742-4388-940D-295D1107AE00	Blood Derived Normal	Illumina HiSeq	08e07f8e-1ab8-4039-a26d-4a7e1fcb9d98	Breast	65.0	1A474269-BC7C-4490-A7AE-30EA51124792	1C6D0926-E635-4F26-97A6-642C012E930D	TCGA-AR-A1AY-10A-01D-A12Q-09	GRCh37-lite	TCGA-AR-A1AY	TCGA-BRCA		s6453	Washington University School of Medicine	Mayo	None	NO	T1	N0	Infiltrating Ductal Carcinoma	Stage I	A12Q-09	False
13767.58cfa83be4b0c9d6adf727c6	58cfa83be4b0c9d6adf727c6	UNCID_337955.TCGA-BP-4167-01A-02R-1325-07.110418_UNC15-SN850_0062_AB07THABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_337955.TCGA-BP-4167-01A-02R-1325-07.110418_UNC15-SN850_0062_AB07THABXX.5.trimmed.annotated.translated_to_genomic	UNCID_337955.TCGA-BP-4167-01A-02R-1325-07.110418_UNC15-SN850_0062_AB07THABXX.5.trimmed.annotated.translated_to_genomic.bam	16.63	1.8	0.17	58cfa83be4b0c9d6adf727c6	UNCID_337955.TCGA-BP-4167-01A-02R-1325-07.110418_UNC15-SN850_0062_AB07THABXX.5.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4167-01A	E7BBC8A9-B63B-4967-812B-F9280A5E181E	Primary Tumor	Illumina HiSeq	50C645F1-4074-4D69-BBC0-DD304F461FFB	Kidney	59.0	9AAA185B-41A7-49FB-82F7-254854B8B775	B0D47E92-693D-41AF-8DF1-1C762AE35251	TCGA-BP-4167-01A-02R-1325-07	HG19	TCGA-BP-4167	TCGA-KIRC		s9961	University of North Carolina	MSKCC	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1325-07	True
13767.58cfa837e4b0c9d6adf70408	58cfa837e4b0c9d6adf70408	UNCID_1870473.8c338800-ae53-4bd8-a6c3-9dcdcd324db6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1870473.8c338800-ae53-4bd8-a6c3-9dcdcd324db6.sorted_genome_alignments	UNCID_1870473.8c338800-ae53-4bd8-a6c3-9dcdcd324db6.sorted_genome_alignments.bam	73.2	1.7	0.16	58cfa837e4b0c9d6adf70408	UNCID_1870473.8c338800-ae53-4bd8-a6c3-9dcdcd324db6.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-F5-6571-01A	85947797-54B8-44FB-910B-5CD689542994	Primary Tumor	Illumina HiSeq	AAF95794-7649-4BAD-823B-9C2DFEBF720F	Colorectal	62.0	949DA28B-F59C-4A7A-AEC1-A2581588121B	8C338800-AE53-4BD8-A6C3-9DCDCD324DB6	TCGA-F5-6571-01A-12R-1830-07	HG19	TCGA-F5-6571	TCGA-READ		s2059	University of North Carolina	Asterand	Russia	NO	T3	N0	Rectal Adenocarcinoma	Stage II	1830-07	True
13767.58cfa830e4b0c9d6adf6bfc2	58cfa830e4b0c9d6adf6bfc2	TCGA-BR-6457-01A-21R-1802-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-6457-01A-21R-1802-13_rnaseq	TCGA-BR-6457-01A-21R-1802-13_rnaseq.bam	50.2	1.8	0.16	58cfa830e4b0c9d6adf6bfc2	TCGA-BR-6457-01A-21R-1802-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6457-01A	05CE16D4-A999-491A-91AD-9449A57228FF	Primary Tumor	Illumina HiSeq	07B6042E-B179-4F2E-9A44-B1C1A9F6F37C	Stomach	69.0	BADB9AE0-9C44-41D4-848B-EE03B6FCA503	58C02EAF-0AA3-4487-921B-4CD12AC460F3	TCGA-BR-6457-01A-21R-1802-13	GRCh37-lite	TCGA-BR-6457	TCGA-STAD		s14612	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1802-13	True
13767.58cfa838e4b0c9d6adf70aa2	58cfa838e4b0c9d6adf70aa2	UNCID_2063309.4f8626b1-b8cd-41a2-b9b0-63847d2168be.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2063309.4f8626b1-b8cd-41a2-b9b0-63847d2168be.sorted_genome_alignments	UNCID_2063309.4f8626b1-b8cd-41a2-b9b0-63847d2168be.sorted_genome_alignments.bam	25.86	1.82	0.16	58cfa838e4b0c9d6adf70aa2	UNCID_2063309.4f8626b1-b8cd-41a2-b9b0-63847d2168be.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-98-A53I-01A	96533D5B-6E44-4D8F-8FD7-270DD4F0362E	Primary Tumor	Illumina HiSeq	6239F627-35C4-453C-8863-982770F08FE3	Lung	64.0	E350E922-0A73-4AFC-BC24-D40659468FE7	4F8626B1-B8CD-41A2-B9B0-63847D2168BE	TCGA-98-A53I-01A-31R-A262-07	HG19	TCGA-98-A53I	TCGA-LUSC		s10047	University of North Carolina	Washington University - Alabama	United States	NO	T2a	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A262-07	True
13722.58cfa830e4b0c9d6adf6c0fe	58cfa830e4b0c9d6adf6c0fe	TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted	TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted.bam	31.24	2.03	0.14	58cfa830e4b0c9d6adf6c0fe	TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted.bam	Alive	FEMALE			Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K4-01A	A8F38E37-978B-4435-B676-E8D4C34DA909	Primary Tumor	Illumina HiSeq	a95ec772-f010-453f-b4a3-20abf1f681e3	Uterus	51.0	A4AC1F6E-3411-47AE-9592-513B3D32223F	4612DB59-3A8E-4F32-968A-76BCE0D4F042	TCGA-B5-A0K4-01A-11D-A043-02	HG19_Broad_variant	TCGA-B5-A0K4	TCGA-UCEC		s5389	Harvard Medical School	Duke	United States	NO			Endometrioid endometrial adenocarcinoma		A043-02	True
13767.58cfa838e4b0c9d6adf70634	58cfa838e4b0c9d6adf70634	UNCID_1967570.f282d6e9-6a6a-4515-8efd-d5fff0367ee8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1967570.f282d6e9-6a6a-4515-8efd-d5fff0367ee8.sorted_genome_alignments	UNCID_1967570.f282d6e9-6a6a-4515-8efd-d5fff0367ee8.sorted_genome_alignments.bam	58.12	1.37	0.16	58cfa838e4b0c9d6adf70634	UNCID_1967570.f282d6e9-6a6a-4515-8efd-d5fff0367ee8.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AJ-A3BF-01A	40287CDC-19DD-4370-A6A0-F324960E1148	Primary Tumor	Illumina HiSeq	0885DF24-7A91-46B4-BA7A-56606AAAB411	Uterus	65.0	EF33DD67-2E71-4A81-91DC-F5E404FB25F7	F282D6E9-6A6A-4515-8EFD-D5FFF0367EE8	TCGA-AJ-A3BF-01A-11R-A213-07	HG19	TCGA-AJ-A3BF	TCGA-UCEC		s4872	University of North Carolina	International Genomics Conosrtium	United States	NO			Serous endometrial adenocarcinoma		A213-07	True
13767.58cfa83be4b0c9d6adf720c0	58cfa83be4b0c9d6adf720c0	UNCID_2567731.800c9072-512b-4067-8687-8bc4e9aa57fd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2567731.800c9072-512b-4067-8687-8bc4e9aa57fd.sorted_genome_alignments	UNCID_2567731.800c9072-512b-4067-8687-8bc4e9aa57fd.sorted_genome_alignments.bam	24.18	1.82	0.17	58cfa83be4b0c9d6adf720c0	UNCID_2567731.800c9072-512b-4067-8687-8bc4e9aa57fd.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-2G-AAH4-01A	D1E7A280-963A-48B0-B6FB-1ACF7C1A435E	Primary Tumor	Illumina HiSeq	0DE8BD76-471C-492A-9D62-B206E8CF2FCA	Testis	34.0	5650D127-61D4-46E8-9594-10109920FC11	800C9072-512B-4067-8687-8BC4E9AA57FD	TCGA-2G-AAH4-01A-12R-A430-07	HG19	TCGA-2G-AAH4	TCGA-TGCT		s584	University of North Carolina	Erasmus MC	Netherlands	NO	T1	NX		Stage II	A430-07	True
13722.58cfa832e4b0c9d6adf6d100	58cfa832e4b0c9d6adf6d100	TCGA-HE-A5NF-10A-01D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-HE-A5NF-10A-01D-A26P-10_wgs_Illumina	TCGA-HE-A5NF-10A-01D-A26P-10_wgs_Illumina.bam	57.0		0.08	58cfa832e4b0c9d6adf6d100	TCGA-HE-A5NF-10A-01D-A26P-10_wgs_Illumina.bam	Alive	MALE			Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-A5NF-10A	36B46540-472F-4A4D-A801-B8B6AE660DC9	Blood Derived Normal	Illumina HiSeq	15024aea-5d7e-4446-8e81-23aff148daf3	Kidney	58.0	82E8A2F8-D697-459B-8517-4E2642E459DC	FCFC53C2-52B3-44D1-AE32-76375E3A0836	TCGA-HE-A5NF-10A-01D-A26P-10	GRCh37-lite	TCGA-HE-A5NF	TCGA-KIRP		s11648	Baylor College of Medicine	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	True
13722.58cfa831e4b0c9d6adf6c79a	58cfa831e4b0c9d6adf6c79a	TCGA-CV-7255-01A-11D-2276-10_Illumina.filtered.	WGS	TCGA-CV-7255-01A-11D-2276-10_Illumina	TCGA-CV-7255-01A-11D-2276-10_Illumina.bam	143.73		0.05	58cfa831e4b0c9d6adf6c79a	TCGA-CV-7255-01A-11D-2276-10_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7255-01A	534F85F2-B9EB-45BE-87D5-C3DFFD13D541	Primary Tumor	Illumina HiSeq	7f307e2b-3164-4bb0-aa04-90c538b8bb46	Head and Neck	32.0	45A42060-1F1C-45FF-9717-9BE2F7FDF3F7	1AFF91A6-1B0F-4575-8F4B-4E064A50B886	TCGA-CV-7255-01A-11D-2276-10	GRCh37-lite	TCGA-CV-7255	TCGA-HNSC	64.0	s16051	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IV	2276-10	True
13722.58cfa82ee4b0c9d6adf6ab2a	58cfa82ee4b0c9d6adf6ab2a	G32558.TCGA-FS-A1ZD-06A-11D-A197-08.2.filtered.	WGS	G32558.TCGA-FS-A1ZD-06A-11D-A197-08.2	G32558.TCGA-FS-A1ZD-06A-11D-A197-08.2.bam	66.27		0.08	58cfa82ee4b0c9d6adf6ab2a	G32558.TCGA-FS-A1ZD-06A-11D-A197-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZD-06A	C2948FE9-5798-43BC-A743-511E94E417F8	Metastatic	Illumina HiSeq	3de1f925-49e8-4363-b1dd-cc78303f6594	Skin	63.0	3B63CB75-EC13-4CAB-B11D-EB6E7FAA8641	8EA666B7-2B6E-4DF8-9A9D-B8265B9749B4	TCGA-FS-A1ZD-06A-11D-A197-08	HG19_Broad_variant	TCGA-FS-A1ZD	TCGA-SKCM	1628.0	s7305	Broad Institute of MIT and Harvard	Essen	Germany	NO	T2b	N0		Stage II	A197-08	True
13767.58cfa838e4b0c9d6adf709d6	58cfa838e4b0c9d6adf709d6	UNCID_2084067.19377cf4-aafe-449a-b10b-f637b4eef29f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2084067.19377cf4-aafe-449a-b10b-f637b4eef29f.sorted_genome_alignments	UNCID_2084067.19377cf4-aafe-449a-b10b-f637b4eef29f.sorted_genome_alignments.bam	67.19	1.79	0.17	58cfa838e4b0c9d6adf709d6	UNCID_2084067.19377cf4-aafe-449a-b10b-f637b4eef29f.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-A3MC-01A	0277F393-3743-47D6-A96F-155BAEC9EB49	Primary Tumor	Illumina HiSeq	A578EF92-3473-4DCF-822E-96DB68E12E03	Liver	54.0	38E9689A-3698-45CD-A7A4-D2C4F0AF11C6	19377CF4-AAFE-449A-B10B-F637B4EEF29F	TCGA-CC-A3MC-01A-11R-A22L-07	HG19	TCGA-CC-A3MC	TCGA-LIHC		s16908	University of North Carolina	ILSbio	Vietnam	NO	T3	N0	Hepatocellular Carcinoma	Stage III	A22L-07	True
13767.58cfa838e4b0c9d6adf70a2c	58cfa838e4b0c9d6adf70a2c	UNCID_2054982.d231f3e4-48e2-4e94-a995-dcbfc9f0d471.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2054982.d231f3e4-48e2-4e94-a995-dcbfc9f0d471.sorted_genome_alignments	UNCID_2054982.d231f3e4-48e2-4e94-a995-dcbfc9f0d471.sorted_genome_alignments.bam	27.83	1.9	0.17	58cfa838e4b0c9d6adf70a2c	UNCID_2054982.d231f3e4-48e2-4e94-a995-dcbfc9f0d471.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-5963-02A	68F550CA-3A33-45E4-B1C9-14F99E543263	Recurrent Tumor	Illumina HiSeq	D0F3B99D-98DD-46E9-B080-4AEBE98FF629	Brain	23.0	F98732CA-5BE1-485E-808C-327E9055DBAC	D231F3E4-48E2-4E94-A995-DCBFC9F0D471	TCGA-FG-5963-02A-12R-A29R-07	HG19	TCGA-FG-5963	TCGA-LGG		s8665	University of North Carolina	Case Western	United States	NO			Astrocytoma		A29R-07	True
13767.58cfa833e4b0c9d6adf6dd22	58cfa833e4b0c9d6adf6dd22	UNCID_1118259.44d93b9f-95d6-4382-9590-f6e7bdda65c5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1118259.44d93b9f-95d6-4382-9590-f6e7bdda65c5.sorted_genome_alignments	UNCID_1118259.44d93b9f-95d6-4382-9590-f6e7bdda65c5.sorted_genome_alignments.bam	50.53	2.04	0.15	58cfa833e4b0c9d6adf6dd22	UNCID_1118259.44d93b9f-95d6-4382-9590-f6e7bdda65c5.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A1-A0SI-01A	16368C32-2118-4FCF-8693-6C89995E49D8	Primary Tumor	Illumina HiSeq	A422E407-02D6-4DEF-A69A-D640E81E95D1	Breast	52.0	C5181AE5-BD05-459F-920D-26BD31BD9088	44D93B9F-95D6-4382-9590-F6E7BDDA65C5	TCGA-A1-A0SI-01A-11R-A144-07	HG19	TCGA-A1-A0SI	TCGA-BRCA		s6923	University of North Carolina	UCSF	United States	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A144-07	True
13767.58cfa82fe4b0c9d6adf6b76d	58cfa82fe4b0c9d6adf6b76d	TCGA-29-1768-01A-01R-1567-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-29-1768-01A-01R-1567-13_GRCh37-lite_rnaseq	TCGA-29-1768-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	160.0	1.8	0.17	58cfa82fe4b0c9d6adf6b76d	TCGA-29-1768-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1768-01A	838693D5-1AE0-4D75-834B-E1B89B96B0ED	Primary Tumor	Illumina HiSeq	8416F4A2-A233-4B3B-8F94-9D8C9F16E2CE	Ovary	50.0	F21AC7CE-B8B2-4C44-BE65-4C4ABF8A86C4	D327786C-EB87-43B2-ABD1-7BB9446CF34F	TCGA-29-1768-01A-01R-1567-13	GRCh37-lite	TCGA-29-1768	TCGA-OV	952.0	s17455	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa83be4b0c9d6adf7238c	58cfa83be4b0c9d6adf7238c	UNCID_2598044.624f6894-46fe-408d-a119-973067034c28.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2598044.624f6894-46fe-408d-a119-973067034c28.sorted_genome_alignments	UNCID_2598044.624f6894-46fe-408d-a119-973067034c28.sorted_genome_alignments.bam	46.19	1.9	0.17	58cfa83be4b0c9d6adf7238c	UNCID_2598044.624f6894-46fe-408d-a119-973067034c28.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-VF-A8A9-01A	56CE11F3-4193-4314-9254-54BC514EFBAD	Primary Tumor	Illumina HiSeq	4B88660C-2274-4969-A05B-9181B6C79AA4	Testis	31.0	3A3252B2-096A-40BE-92DF-D24B0DD55BF1	624F6894-46FE-408D-A119-973067034C28	TCGA-VF-A8A9-01A-11R-A431-07	HG19	TCGA-VF-A8A9	TCGA-TGCT		s654	University of North Carolina	University of Pennsylvania	United States	NO	T1	N0		Stage I	A431-07	True
13722.58cfa82ee4b0c9d6adf6ad36	58cfa82ee4b0c9d6adf6ad36	G49837.TCGA-18-3415-11A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-18-3415-11A-01D-A320-08.2	G49837.TCGA-18-3415-11A-01D-A320-08.2.bam	45.94	1.9	0.08	58cfa82ee4b0c9d6adf6ad36	G49837.TCGA-18-3415-11A-01D-A320-08.2.bam	Alive	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-18-3415-11A	9A874B64-D0D6-416E-97BC-E9071ED0B16B	Solid Tissue Normal	Illumina HiSeq	d744b6bf-d7a7-45f4-bbf7-84b25f7b4a7a	Lung	77.0	92069F9F-20CA-4922-B802-2562448EBC65	97E65421-89B2-4BEA-A9B2-E6294B28EB3C	TCGA-18-3415-11A-01D-A320-08	HG19_Broad_variant	TCGA-18-3415	TCGA-LUSC		s9979	Broad Institute of MIT and Harvard	Princess Margaret Hospital (Canada)	Canada	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	A320-08	True
13722.58cfa82ee4b0c9d6adf6ac76	58cfa82ee4b0c9d6adf6ac76	G41960.TCGA-50-5932-01A-11D-1753-08.2.filtered.	WGS	G41960.TCGA-50-5932-01A-11D-1753-08.2	G41960.TCGA-50-5932-01A-11D-1753-08.2.bam	289.4	1.9	0.05	58cfa82ee4b0c9d6adf6ac76	G41960.TCGA-50-5932-01A-11D-1753-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5932-01A	EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465	Primary Tumor	Illumina HiSeq	3c2b6b67-de08-43ef-a735-28548120fa66	Lung	75.0	7ECB9621-7A1F-4876-9DFB-9B77CC4CB7B4	6726C157-F688-491D-8B56-35628645DF89	TCGA-50-5932-01A-11D-1753-08	HG19_Broad_variant	TCGA-50-5932	TCGA-LUAD	1235.0	s11324	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1753-08	True
13767.58cfa833e4b0c9d6adf6ddea	58cfa833e4b0c9d6adf6ddea	UNCID_1137825.754fd66b-f39a-4308-a57c-05de251f9014.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1137825.754fd66b-f39a-4308-a57c-05de251f9014.sorted_genome_alignments	UNCID_1137825.754fd66b-f39a-4308-a57c-05de251f9014.sorted_genome_alignments.bam	35.09	1.92	0.17	58cfa833e4b0c9d6adf6ddea	UNCID_1137825.754fd66b-f39a-4308-a57c-05de251f9014.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15S-01A	0F7AB21B-1FD0-45E0-9A47-17C4691EB84F	Primary Tumor	Illumina HiSeq	40290A6B-FC21-4613-9616-ED43D542A2A0	Breast	34.0	0AC12A02-8FE3-4C1B-A885-848AA924A339	754FD66B-F39A-4308-A57C-05DE251F9014	TCGA-E2-A15S-01A-11R-A115-07	HG19	TCGA-E2-A15S	TCGA-BRCA		s6513	University of North Carolina	Roswell Park	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A115-07	True
13722.58cfa82ee4b0c9d6adf6ac1e	58cfa82ee4b0c9d6adf6ac1e	G37566.TCGA-G9-7522-01A-11D-2260-08.1.filtered.	WGS	G37566.TCGA-G9-7522-01A-11D-2260-08.1	G37566.TCGA-G9-7522-01A-11D-2260-08.1.bam	146.7		0.05	58cfa82ee4b0c9d6adf6ac1e	G37566.TCGA-G9-7522-01A-11D-2260-08.1.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-G9-7522-01A	87959988-BB25-47EE-AFC1-9AF92592BBE7	Primary Tumor	Illumina HiSeq	07b2c012-7fce-49d8-a6b8-6d5eb4907508	Prostate	49.0	10BFE256-C4A2-4D88-B907-56F86EF63DE9	F54442D1-80FA-4678-AC94-C3AD03BC37FB	TCGA-G9-7522-01A-11D-2260-08	HG19_Broad_variant	TCGA-G9-7522	TCGA-PRAD		s3923	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		2260-08	False
13767.58cfa838e4b0c9d6adf70c56	58cfa838e4b0c9d6adf70c56	UNCID_2109840.eaf5ff83-0419-4f44-bec0-93f8517a56c9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2109840.eaf5ff83-0419-4f44-bec0-93f8517a56c9.sorted_genome_alignments	UNCID_2109840.eaf5ff83-0419-4f44-bec0-93f8517a56c9.sorted_genome_alignments.bam	14.64	1.88	0.16	58cfa838e4b0c9d6adf70c56	UNCID_2109840.eaf5ff83-0419-4f44-bec0-93f8517a56c9.sorted_genome_alignments.bam	Dead	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-MP-A4TJ-01A	8F52CCCD-5709-4753-9670-31A573EE27AB	Primary Tumor	Illumina HiSeq	3409659D-6772-4F14-8CBE-2960B7891820	Lung	62.0	2CF77E0E-8054-4EC4-97A6-247C7C881C6F	EAF5FF83-0419-4F44-BEC0-93F8517A56C9	TCGA-MP-A4TJ-01A-51R-A262-07	HG19	TCGA-MP-A4TJ	TCGA-LUAD	339.0	s10963	University of North Carolina	Washington University - Mayo Clinic	United States	NO	T1	N0	Lung Signet Ring Adenocarcinoma	Stage I	A262-07	True
13767.58cfa83ae4b0c9d6adf71cca	58cfa83ae4b0c9d6adf71cca	UNCID_2504190.23cfc123-e7e9-4e13-bbcf-4ec06d0bf378.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2504190.23cfc123-e7e9-4e13-bbcf-4ec06d0bf378.sorted_genome_alignments	UNCID_2504190.23cfc123-e7e9-4e13-bbcf-4ec06d0bf378.sorted_genome_alignments.bam	36.4	1.89	0.18	58cfa83ae4b0c9d6adf71cca	UNCID_2504190.23cfc123-e7e9-4e13-bbcf-4ec06d0bf378.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A76V-01A	812A2D18-C43B-4484-8A8D-234056A0E90B	Primary Tumor	Illumina HiSeq	49AE611A-3F69-49D4-8657-6DBDF1EA4466	Thyroid	54.0	567DB7D7-CBD2-4643-9644-9E2A38EDED7A	23CFC123-E7E9-4E13-BBCF-4EC06D0BF378	TCGA-FY-A76V-01A-11R-A39I-07	HG19	TCGA-FY-A76V	TCGA-THCA		s12612	University of North Carolina	International Genomics Consortium	United States	NO	T2	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A39I-07	True
13767.58cfa83be4b0c9d6adf72014	58cfa83be4b0c9d6adf72014	UNCID_2552652.99d6fe5c-a560-4df9-b85d-3d657d9be33e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2552652.99d6fe5c-a560-4df9-b85d-3d657d9be33e.sorted_genome_alignments	UNCID_2552652.99d6fe5c-a560-4df9-b85d-3d657d9be33e.sorted_genome_alignments.bam	60.54	1.89	0.17	58cfa83be4b0c9d6adf72014	UNCID_2552652.99d6fe5c-a560-4df9-b85d-3d657d9be33e.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Mesothelioma	Aligned reads	TCGA-TS-A7OU-01B	880BEFCF-2BB1-4D37-B65B-5F2970BFB18B	Primary Tumor	Illumina HiSeq	4F5F34FB-79B2-4356-ACF1-1E70DFA1BEEA	Mesothelium	56.0	949787A8-0BFA-45C8-8A43-BB8A9DAFC9F5	99D6FE5C-A560-4DF9-B85D-3D657D9BE33E	TCGA-TS-A7OU-01B-11R-A40A-07	HG19	TCGA-TS-A7OU	TCGA-MESO	1675.0	s406	University of North Carolina	University of Pennsylvania	United States	NO	T4	N0		Stage IV	A40A-07	True
13722.58cfa832e4b0c9d6adf6d1b2	58cfa832e4b0c9d6adf6d1b2	TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina.filtered.	WGS	TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina	TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina.bam	454.7		0.05	58cfa832e4b0c9d6adf6d1b2	TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FF-8041-01A	1F971AF1-6772-4FE6-8D35-BBE527A037FE	Primary Tumor	Illumina HiSeq	90920dc3-b0bd-48f3-a446-87f757968eab	Lymph Nodes	28.0	738A6FD7-D8E1-4FC3-9F73-AD6C9B67DA2A	FA676301-902F-473F-8313-5BFF34AE549A	TCGA-FF-8041-01A-11D-2210-10	GRCh37-lite	TCGA-FF-8041	TCGA-DLBC		s1109	Baylor College of Medicine	SingHealth	Singapore	NO			Primary mediastinal (thymic) DLBCL		2210-10	True
13722.58cfa831e4b0c9d6adf6c757	58cfa831e4b0c9d6adf6c757	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.bam	7.43		0.14	58cfa831e4b0c9d6adf6c757	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7183-01A	DE206681-3E27-4D4F-8669-AEFB12B5B1E3	Primary Tumor	Illumina HiSeq	f449ea84-f7cf-4a26-bc43-707ac56f0038	Head and Neck	53.0	0BFD11FD-B227-41EF-BD54-7BE877BCE5A2	C2030338-EFEF-48CD-B893-BBDB8D85456E	TCGA-CV-7183-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7183	TCGA-HNSC		s15652	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2317-26	True
13722.58cfa832e4b0c9d6adf6ce24	58cfa832e4b0c9d6adf6ce24	TCGA-FI-A2D0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-FI-A2D0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_4_rg.sorted	TCGA-FI-A2D0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_4_rg.sorted.bam	151.56		0.16	58cfa832e4b0c9d6adf6ce24	TCGA-FI-A2D0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-FI-A2D0-10A	1B35D083-F7C9-47D2-9A9E-718788F9E39A	Blood Derived Normal	Illumina HiSeq	452078a9-1e91-4915-9a31-397391041482	Uterus	55.0	96923E73-5E5F-4234-BF2E-E34EAE4C0AB5	FB0BFE72-D375-41D6-90F6-DF04FA514215	TCGA-FI-A2D0-10A-01D-A17E-02	HG19_Broad_variant	TCGA-FI-A2D0	TCGA-UCEC		s4806	Harvard Medical School	Washington University	United States	NO			Endometrioid endometrial adenocarcinoma		A17E-02	True
13722.58cfa831e4b0c9d6adf6c7f7	58cfa831e4b0c9d6adf6c7f7	TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted	TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted.bam	46.77	1.95	0.15	58cfa831e4b0c9d6adf6c7f7	TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17C-01A	6F4F0CDD-8387-45D0-A9E8-EFCE6260159D	Primary Tumor	Illumina HiSeq	554e5953-4680-4681-a963-fcc940b3f448	Uterus	78.0	2D5AC7FC-BED4-4C7F-927D-9B44846324C4	99444E9D-219B-4653-9410-B258D28DEEB7	TCGA-D1-A17C-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A17C	TCGA-UCEC		s4801	Harvard Medical School	Mayo Clinic	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13767.58cfa837e4b0c9d6adf70002	58cfa837e4b0c9d6adf70002	UNCID_1815783.34f062f8-e5c5-4bb3-9778-d2cf440a4178.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1815783.34f062f8-e5c5-4bb3-9778-d2cf440a4178.sorted_genome_alignments	UNCID_1815783.34f062f8-e5c5-4bb3-9778-d2cf440a4178.sorted_genome_alignments.bam	35.82	1.86	0.16	58cfa837e4b0c9d6adf70002	UNCID_1815783.34f062f8-e5c5-4bb3-9778-d2cf440a4178.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A2EA-01A	980D1C65-B675-4568-9CE8-C0278686AE8D	Primary Tumor	Illumina HiSeq	DF9E8A12-3FC1-4BA0-B997-5081355A7A49	Thyroid	52.0	DC79E975-13A4-4EBD-A5FE-F6EB20CAE943	34F062F8-E5C5-4BB3-9778-D2CF440A4178	TCGA-E8-A2EA-01A-11R-A180-07	HG19	TCGA-E8-A2EA	TCGA-THCA		s12831	University of North Carolina	Asterand	Russia	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A180-07	True
13767.58cfa832e4b0c9d6adf6d3d1	58cfa832e4b0c9d6adf6d3d1	TCGA-RD-A8N2-01A-12R-A36D-31_rnaseq.filtered.	RNA-Seq	TCGA-RD-A8N2-01A-12R-A36D-31_rnaseq	TCGA-RD-A8N2-01A-12R-A36D-31_rnaseq.bam	12.18	1.71	0.15	58cfa832e4b0c9d6adf6d3d1	TCGA-RD-A8N2-01A-12R-A36D-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-RD-A8N2-01A	158B6BD2-1E7D-4C7E-9D8A-42467342C9C2	Primary Tumor	Illumina HiSeq	AE2A717F-1D49-4B4A-83EE-9DAC7A3AAAF0	Stomach	59.0	411903D8-A00B-44E1-84BC-C04DED539730	C3E4CEA3-5DF9-43DA-83D2-BDD6831BA4B8	TCGA-RD-A8N2-01A-12R-A36D-31	GRCh37-lite	TCGA-RD-A8N2	TCGA-STAD		s15075	Canada's Michael Smith Genome Sciences Centre	Peter MacCallum Cancer Center	Australia	NO	T2	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage I	A36D-31	True
13722.58cfa82ee4b0c9d6adf6aff0	58cfa82ee4b0c9d6adf6aff0	TCGA-05-4434-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_1_rg.sorted.filtered.	WGS	TCGA-05-4434-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_1_rg.sorted	TCGA-05-4434-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_1_rg.sorted.bam	30.0	1.9	0.16	58cfa82ee4b0c9d6adf6aff0	TCGA-05-4434-10A-01D-1203_111013_SN208_0253_B00PJACXX_s_1_rg.sorted.bam	Dead	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4434-10A	D94FE32F-BEDD-4F4C-9FEB-FCB60D40F4BB	Blood Derived Normal	Illumina HiSeq	9a0b4c83-372f-4226-889a-a732c74385ac	Lung	67.0	FE65992A-E982-44B2-BD53-D714C17A5E4A	8B98B536-3F48-4FA0-8FDB-EC787499CBD5	TCGA-05-4434-10A-01D-1203-02	HG19_Broad_variant	TCGA-05-4434	TCGA-LUAD	457.0	s11224	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Lung Adenocarcinoma Mixed Subtype	Stage IV	1203-02	True
13767.58cfa838e4b0c9d6adf70fe8	58cfa838e4b0c9d6adf70fe8	UNCID_2088755.c7fdad9d-8804-403c-8171-c6fff106b33d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2088755.c7fdad9d-8804-403c-8171-c6fff106b33d.sorted_genome_alignments	UNCID_2088755.c7fdad9d-8804-403c-8171-c6fff106b33d.sorted_genome_alignments.bam	13.21	1.89	0.18	58cfa838e4b0c9d6adf70fe8	UNCID_2088755.c7fdad9d-8804-403c-8171-c6fff106b33d.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-90-A4ED-01A	75AB9203-30FA-4F1A-B8F2-AA61E02111F5	Primary Tumor	Illumina HiSeq	3A1FF842-DF35-467F-B923-73BEEC0E6135	Lung	69.0	B6B49045-D237-4956-B6D3-144C85BB7A9F	C7FDAD9D-8804-403C-8171-C6FFF106B33D	TCGA-90-A4ED-01A-31R-A24Z-07	HG19	TCGA-90-A4ED	TCGA-LUSC		s10476	University of North Carolina	ABS - IUPUI	United States	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	A24Z-07	True
13722.58cfa82fe4b0c9d6adf6b974	58cfa82fe4b0c9d6adf6b974	TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	570.96	1.9	0.14	58cfa82fe4b0c9d6adf6b974	TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-3675-01A	41658CF8-0DE1-4A97-BB60-0F0107C84E00	Primary Tumor	Illumina HiSeq	f57af06a-9d5a-4a69-888a-8d611982b88e	Colorectal	84.0	A4CE3727-4506-493B-95F4-2F11CEB09CEB	D611373E-EF0A-46E4-8D3E-0722F221E828	TCGA-AA-3675-01A-02D-1109-02	HG18	TCGA-AA-3675	TCGA-COAD		s13672	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1109-02	True
13767.58cfa83ae4b0c9d6adf71900	58cfa83ae4b0c9d6adf71900	UNCID_2366887.5b56898c-ea92-4ef1-a877-b68b0c40d1ba.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2366887.5b56898c-ea92-4ef1-a877-b68b0c40d1ba.sorted_genome_alignments	UNCID_2366887.5b56898c-ea92-4ef1-a877-b68b0c40d1ba.sorted_genome_alignments.bam	26.5	1.84	0.18	58cfa83ae4b0c9d6adf71900	UNCID_2366887.5b56898c-ea92-4ef1-a877-b68b0c40d1ba.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-RW-A68A-01A	FC0E7281-6E0E-4057-B064-7D8B3060D134	Primary Tumor	Illumina HiSeq	722D1AF3-04F5-4B5A-9E30-1D77403B9D7E	Nervous System	19.0	A42BF8A2-C4BD-4BF6-80D2-E60FB86BFF7A	5B56898C-EA92-4EF1-A877-B68B0C40D1BA	TCGA-RW-A68A-01A-11R-A35K-07	HG19	TCGA-RW-A68A	TCGA-PCPG		s989	University of North Carolina	Michigan University	United States	NO					A35K-07	True
13767.58cfa834e4b0c9d6adf6e419	58cfa834e4b0c9d6adf6e419	UNCID_1177277.d4a3d2d7-35c6-40b5-9e67-093f4f5834a4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1177277.d4a3d2d7-35c6-40b5-9e67-093f4f5834a4.sorted_genome_alignments	UNCID_1177277.d4a3d2d7-35c6-40b5-9e67-093f4f5834a4.sorted_genome_alignments.bam	14.22	1.91	0.16	58cfa834e4b0c9d6adf6e419	UNCID_1177277.d4a3d2d7-35c6-40b5-9e67-093f4f5834a4.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20W-11A	4DC5CFFE-ED8C-47AB-B5FC-F9615B5414F7	Solid Tissue Normal	Illumina HiSeq	329FA93A-C96C-4F77-B822-802AA4C768AC	Bladder	71.0	5FF660D2-10DE-4D72-BDE0-93840309B5E5	D4A3D2D7-35C6-40B5-9E67-093F4F5834A4	TCGA-BT-A20W-11A-11R-A14Y-07	HG19	TCGA-BT-A20W	TCGA-BLCA	254.0	s2748	University of North Carolina	University of Pittsburgh	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A14Y-07	True
13722.58cfa830e4b0c9d6adf6c20b	58cfa830e4b0c9d6adf6c20b	TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted	TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted.bam	747.33	1.9	0.16	58cfa830e4b0c9d6adf6c20b	TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4078-01A	C7353D6A-82A2-4A0D-8CD4-8C8957943EDB	Primary Tumor	Illumina HiSeq	aaa9123e-a827-4226-9b51-0b04709fadb2	Head and Neck	83.0	2027EDE3-13F5-40F6-BEF6-16704981D676	66A9CFF2-397E-415E-BF54-9A75CCC80BDE	TCGA-BA-4078-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4078	TCGA-HNSC	276.0	s15493	Harvard Medical School	UNC	None	NO			Head and Neck Squamous Cell Carcinoma		1431-02	True
13722.58cfa831e4b0c9d6adf6c436	58cfa831e4b0c9d6adf6c436	TCGA-CJ-4870-11A-01D-2098-10_wgs_Illumina.filtered.	WGS	TCGA-CJ-4870-11A-01D-2098-10_wgs_Illumina	TCGA-CJ-4870-11A-01D-2098-10_wgs_Illumina.bam	79.07	1.9	0.15	58cfa831e4b0c9d6adf6c436	TCGA-CJ-4870-11A-01D-2098-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4870-11A	78048432-2DE1-498C-9CF1-9C5BD43DAA39	Solid Tissue Normal	Illumina HiSeq	e9961b9b-48ad-43c1-9e27-a9438ed497f3	Kidney	58.0	14B6F5F6-87E6-4DA5-BBC9-13E97299EAB8	745368F9-27B8-4E11-ADA9-7DDF99ACD180	TCGA-CJ-4870-11A-01D-2098-10	GRCh37-lite	TCGA-CJ-4870	TCGA-KIRC		s9167	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	2098-10	True
13767.58cfa836e4b0c9d6adf6fa2b	58cfa836e4b0c9d6adf6fa2b	UNCID_1655253.6C9706BF-5C90-4436-A2D9-E8A6E08A2AFB.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1655253.6C9706BF-5C90-4436-A2D9-E8A6E08A2AFB.sorted_genome_alignments	UNCID_1655253.6C9706BF-5C90-4436-A2D9-E8A6E08A2AFB.sorted_genome_alignments.bam	10.22	1.8	0.17	58cfa836e4b0c9d6adf6fa2b	UNCID_1655253.6C9706BF-5C90-4436-A2D9-E8A6E08A2AFB.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A2MX-11C	59681E8F-CF57-47B4-82E1-6BE8EAD9583E	Solid Tissue Normal	Illumina HiSeq	E29BC987-7898-4A61-9F59-B78C737880E3	Thyroid	27.0	21627F0D-C6BD-436E-8129-DB340C15552A	6C9706BF-5C90-4436-A2D9-E8A6E08A2AFB	TCGA-ET-A2MX-11C-11R-A23N-07	HG19	TCGA-ET-A2MX	TCGA-THCA		s12583	University of North Carolina	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23N-07	True
13722.58cfa831e4b0c9d6adf6c942	58cfa831e4b0c9d6adf6c942	TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted	TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted.bam	8.43		0.16	58cfa831e4b0c9d6adf6c942	TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7247-10A	5E25AB76-A8AB-4779-AA03-8DE658F18DA1	Blood Derived Normal	Illumina HiSeq	eda6d221-38ba-4187-8a10-2c0217d09e31	Head and Neck	55.0	2E9CDAD5-53EC-4B5E-8A1E-4F8ABEE04149	16906F53-CCD9-4D19-8DBF-8DD6A59D392F	TCGA-CV-7247-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7247	TCGA-HNSC	577.0	s16049	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	2317-26	True
13767.58cfa833e4b0c9d6adf6da9f	58cfa833e4b0c9d6adf6da9f	UNCID_1116352.fce05b98-e717-4364-8c8d-c15759e1170a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1116352.fce05b98-e717-4364-8c8d-c15759e1170a.sorted_genome_alignments	UNCID_1116352.fce05b98-e717-4364-8c8d-c15759e1170a.sorted_genome_alignments.bam	133.3	1.8	0.14	58cfa833e4b0c9d6adf6da9f	UNCID_1116352.fce05b98-e717-4364-8c8d-c15759e1170a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4662-01A	294FF941-AEA1-4588-9A0E-E9F5393E2BB6	Primary Tumor	Illumina HiSeq	3FBB975A-0349-46FC-AA90-91152A1CF2CF	Lung	65.0	C7D727B6-47C6-4339-B9DD-5BAF41527BD4	FCE05B98-E717-4364-8C8D-C15759E1170A	TCGA-73-4662-01A-01R-1206-07	HG19	TCGA-73-4662	TCGA-LUAD		s11482	University of North Carolina	Roswell Park	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1206-07	True
13767.58cfa83ce4b0c9d6adf72e80	58cfa83ce4b0c9d6adf72e80	_1_TCGA-CD-8530-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-CD-8530-01A-11R-2343-13_rnaseq	_1_TCGA-CD-8530-01A-11R-2343-13_rnaseq.bam	104.2		0.16	58cfa83ce4b0c9d6adf72e80	_1_TCGA-CD-8530-01A-11R-2343-13_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-8530-01A	0A11E958-7EC0-493C-BD7A-EB17536FACD7	Primary Tumor	Illumina HiSeq	5B0543B9-6293-4653-B8C0-E9A7882BC5CE	Stomach	51.0	D0FF07BB-06A4-4FFC-9329-6AFAC91CC7A2	1154B879-DC40-4A89-BDE7-D5CD7B7B6C88	TCGA-CD-8530-01A-11R-2343-13	GRCh37-lite	TCGA-CD-8530	TCGA-STAD		s14729	Canada's Michael Smith Genome Sciences Centre	ILSbio	Vietnam	NO	T3	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage II	2343-13	True
13767.58cfa838e4b0c9d6adf70793	58cfa838e4b0c9d6adf70793	UNCID_1988130.3c1b6647-26bb-4110-aaea-f542024e8bf3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1988130.3c1b6647-26bb-4110-aaea-f542024e8bf3.sorted_genome_alignments	UNCID_1988130.3c1b6647-26bb-4110-aaea-f542024e8bf3.sorted_genome_alignments.bam	32.18	1.9	0.16	58cfa838e4b0c9d6adf70793	UNCID_1988130.3c1b6647-26bb-4110-aaea-f542024e8bf3.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AQ-A54O-01A	35CA5E2A-861A-4DD2-A4CE-D294CF080DA3	Primary Tumor	Illumina HiSeq	981C8927-FF2B-4707-96FD-0C7C82D57982	Breast	51.0	E7BB0755-D706-480D-989D-108B3E817973	3C1B6647-26BB-4110-AAEA-F542024E8BF3	TCGA-AQ-A54O-01A-11R-A266-07	HG19	TCGA-AQ-A54O	TCGA-BRCA		s5753	University of North Carolina		United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A266-07	True
13722.58cfa831e4b0c9d6adf6cd12	58cfa831e4b0c9d6adf6cd12	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.bam	30.78		0.17	58cfa831e4b0c9d6adf6cd12	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SJ-01A	6D8D8169-0C1A-4CDB-BE6F-9761C981A369	Primary Tumor	Illumina HiSeq	2635ae0a-878a-4237-ad5c-5f0092134ee3	Bladder	59.0	491A8898-7CC5-45D9-9502-FD24399C239D	E9F8EE08-E951-41A8-88AB-E7A98618EECC	TCGA-FD-A3SJ-01A-12D-A233-26	HG19_Broad_variant	TCGA-FD-A3SJ	TCGA-BLCA	739.0	s2909	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	True
13722.58cfa831e4b0c9d6adf6c7fb	58cfa831e4b0c9d6adf6c7fb	TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted	TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted.bam	423.4	1.9	0.15	58cfa831e4b0c9d6adf6c7fb	TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6526-01A	A28E57E2-9071-4558-856A-162F7A837380	Primary Tumor	Illumina HiSeq	0a9e4a52-46b9-4c50-9dd3-9418ed5569e2	Stomach	67.0	DDCEA84E-3135-445C-BA0D-62F686463797	737041EA-9798-4D2E-9C0B-371F533E058F	TCGA-D7-6526-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6526	TCGA-STAD		s15251	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	1798-02	True
13722.58cfa830e4b0c9d6adf6beea	58cfa830e4b0c9d6adf6beea	TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted	TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted.bam	106.84	1.77	0.15	58cfa830e4b0c9d6adf6beea	TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LL-01A	D17668C4-5D66-4E16-8B70-B54616581AAE	Primary Tumor	Illumina HiSeq	0ea2fbb0-cc11-44d9-9706-2523b9d268be	Uterus	56.0	488A7462-8348-422C-91D3-7D9F0C39D25E	0D29C555-7C7C-4BBB-A4C6-E554CC758CA7	TCGA-AP-A0LL-01A-12D-A101-02	HG19_Broad_variant	TCGA-AP-A0LL	TCGA-UCEC		s4595	Harvard Medical School	MSKCC	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa834e4b0c9d6adf6e928	58cfa834e4b0c9d6adf6e928	UNCID_1233771.bb36bff9-44fd-4f93-a82f-8c23658c335c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1233771.bb36bff9-44fd-4f93-a82f-8c23658c335c.sorted_genome_alignments	UNCID_1233771.bb36bff9-44fd-4f93-a82f-8c23658c335c.sorted_genome_alignments.bam	122.8	1.8	0.14	58cfa834e4b0c9d6adf6e928	UNCID_1233771.bb36bff9-44fd-4f93-a82f-8c23658c335c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5762-01A	D4FFAFDC-EE83-43DF-AA3B-7326503C6438	Primary Tumor	Illumina HiSeq	B66AA3D3-55FB-4CC4-B76A-B536AD26DF76	Prostate	60.0	6D1A2D44-72F3-4333-8506-E53CDC4E5185	BB36BFF9-44FD-4F93-A82F-8C23658C335C	TCGA-CH-5762-01A-11R-1580-07	HG19	TCGA-CH-5762	TCGA-PRAD		s4165	University of North Carolina	Indivumed	Germany	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		1580-07	True
13767.58cfa834e4b0c9d6adf6e421	58cfa834e4b0c9d6adf6e421	UNCID_1182944.43c53585-76cc-48a1-a9b1-fe0f96912ff1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1182944.43c53585-76cc-48a1-a9b1-fe0f96912ff1.sorted_genome_alignments	UNCID_1182944.43c53585-76cc-48a1-a9b1-fe0f96912ff1.sorted_genome_alignments.bam	101.8	1.7	0.15	58cfa834e4b0c9d6adf6e421	UNCID_1182944.43c53585-76cc-48a1-a9b1-fe0f96912ff1.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5399-01A	F6D3E963-5BFF-40F6-8430-1C6FB5EC6503	Primary Tumor	Illumina HiSeq	F985BED8-D348-48BA-8B18-C41A4E5FDB12	Kidney	46.0	A1DDDBED-C780-412A-B563-914F71E5C75D	43C53585-76CC-48A1-A9B1-FE0F96912FF1	TCGA-B0-5399-01A-01R-1503-07	HG19	TCGA-B0-5399	TCGA-KIRC		s8881	University of North Carolina	University of Pittsburgh	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1503-07	True
13722.58cfa832e4b0c9d6adf6d55c	58cfa832e4b0c9d6adf6d55c	TCGA-PD-A5DF-10A-01D-A27I-10_wgs_Illumina.filtered.	WGS	TCGA-PD-A5DF-10A-01D-A27I-10_wgs_Illumina	TCGA-PD-A5DF-10A-01D-A27I-10_wgs_Illumina.bam	39.46		0.08	58cfa832e4b0c9d6adf6d55c	TCGA-PD-A5DF-10A-01D-A27I-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-PD-A5DF-10A	1987B453-F97D-45C7-9C89-B9A33313D645	Blood Derived Normal	Illumina HiSeq	650467d1-b257-46dd-9990-25e96f3b2dd8	Liver	58.0	8938CC2A-D3FD-4253-9BDD-B672A42721E0	CE137C9C-43DF-49E8-82F8-3530D13EECFD	TCGA-PD-A5DF-10A-01D-A27I-10	GRCh37-lite	TCGA-PD-A5DF	TCGA-LIHC	639.0	s16791	Baylor College of Medicine	Fox Chase	United States	NO	T4	N0	Hepatocellular Carcinoma	Stage III	A27I-10	True
13767.58cfa832e4b0c9d6adf6d7b4	58cfa832e4b0c9d6adf6d7b4	UNCID_1067682.cd60c90b-bd9a-4494-ad73-993664b12f33.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1067682.cd60c90b-bd9a-4494-ad73-993664b12f33.sorted_genome_alignments	UNCID_1067682.cd60c90b-bd9a-4494-ad73-993664b12f33.sorted_genome_alignments.bam	213.3	1.8	0.15	58cfa832e4b0c9d6adf6d7b4	UNCID_1067682.cd60c90b-bd9a-4494-ad73-993664b12f33.sorted_genome_alignments.bam	Alive	MALE	WHITE		Lung Squamous Cell Carcinoma	Aligned reads	TCGA-39-5036-01A	3EBD3DCD-B4F1-449C-8B2F-86F90643676B	Primary Tumor	Illumina HiSeq	5E8C05F9-C5EE-4E40-B7AC-0423F39F8C7F	Lung	73.0	ED8042D0-27F6-44BD-8E86-A3A41AA6DC36	CD60C90B-BD9A-4494-AD73-993664B12F33	TCGA-39-5036-01A-01R-1443-07	HG19	TCGA-39-5036	TCGA-LUSC		s10290	University of North Carolina	MSKCC	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1443-07	True
13767.58cfa834e4b0c9d6adf6e16d	58cfa834e4b0c9d6adf6e16d	UNCID_1167104.c870e04b-c3b7-495c-8465-7ef2a00fadc7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1167104.c870e04b-c3b7-495c-8465-7ef2a00fadc7.sorted_genome_alignments	UNCID_1167104.c870e04b-c3b7-495c-8465-7ef2a00fadc7.sorted_genome_alignments.bam	18.65	1.88	0.17	58cfa834e4b0c9d6adf6e16d	UNCID_1167104.c870e04b-c3b7-495c-8465-7ef2a00fadc7.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1FN-01A	6DD0DD7B-62FF-4FD1-A99A-B265F1A91DCA	Primary Tumor	Illumina HiSeq	F8CCA706-8EE1-4772-A7B4-19A7B8EC0F64	Breast	34.0	AE08DBD6-548A-469C-BA12-B6A87515BCE7	C870E04B-C3B7-495C-8465-7EF2A00FADC7	TCGA-BH-A1FN-01A-11R-A13Q-07	HG19	TCGA-BH-A1FN	TCGA-BRCA	2192.0	s5719	University of North Carolina	University of Pittsburgh	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A13Q-07	True
13767.58cfa836e4b0c9d6adf6f622	58cfa836e4b0c9d6adf6f622	UNCID_1598539.9D3DFA06-4C69-49A8-93C2-EE54AAB7B2D8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1598539.9D3DFA06-4C69-49A8-93C2-EE54AAB7B2D8.sorted_genome_alignments	UNCID_1598539.9D3DFA06-4C69-49A8-93C2-EE54AAB7B2D8.sorted_genome_alignments.bam	22.84	1.84	0.16	58cfa836e4b0c9d6adf6f622	UNCID_1598539.9D3DFA06-4C69-49A8-93C2-EE54AAB7B2D8.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3TB-01A	A09D0BE0-FD41-4B30-B488-9A9F2ABEF8E7	Primary Tumor	Illumina HiSeq	A0177E89-DC61-42F7-B02A-9158655CE3A0	Thyroid	47.0	11671156-4BBF-4A3C-B074-7D6C27EE4FEE	9D3DFA06-4C69-49A8-93C2-EE54AAB7B2D8	TCGA-EL-A3TB-01A-11R-A22L-07	HG19	TCGA-EL-A3TB	TCGA-THCA		s12296	University of North Carolina	MD Anderson	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A22L-07	True
13767.58cfa832e4b0c9d6adf6d45e	58cfa832e4b0c9d6adf6d45e	TCGA-R6-A6L6-01B-11R-A336-31_rnaseq.filtered.	RNA-Seq	TCGA-R6-A6L6-01B-11R-A336-31_rnaseq	TCGA-R6-A6L6-01B-11R-A336-31_rnaseq.bam	21.18	2.04	0.18	58cfa832e4b0c9d6adf6d45e	TCGA-R6-A6L6-01B-11R-A336-31_rnaseq.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-R6-A6L6-01B	7E53564C-4132-40BD-A4D5-1D35473F224F	Primary Tumor	Illumina HiSeq	702C84A3-5C21-4747-8A72-96C96A6B231F	Esophagus	68.0	58AC6453-F187-4676-A8FE-054284F1A673	B72CECA3-60D5-4E2F-B5F4-A021EEF6D240	TCGA-R6-A6L6-01B-11R-A336-31	GRCh37-lite	TCGA-R6-A6L6	TCGA-ESCA	214.0	s1691	Canada's Michael Smith Genome Sciences Centre	MD Anderson Cancer Center	United States	NO					A336-31	True
13722.58cfa82ee4b0c9d6adf6aade	58cfa82ee4b0c9d6adf6aade	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.filtered.	WGS	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.bam	55.89		0.07	58cfa82ee4b0c9d6adf6aade	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PJ-01A	CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A	Primary Tumor	Illumina HiSeq	d7aa3a92-c61a-478e-af73-14d0204cba5d	Bladder	76.0	29D79B83-FA80-490E-A8A1-C51C9AD061FE	B73523D7-F5A5-4140-8537-4DF4D1ECF465	TCGA-BT-A3PJ-01A-21D-A21Z-08	HG19_Broad_variant	TCGA-BT-A3PJ	TCGA-BLCA		s3071	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A21Z-08	True
13767.58cfa83be4b0c9d6adf725f4	58cfa83be4b0c9d6adf725f4	UNCID_2635709.5f0f8fbb-4f3c-4786-9cb5-4faf8263a813.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2635709.5f0f8fbb-4f3c-4786-9cb5-4faf8263a813.sorted_genome_alignments	UNCID_2635709.5f0f8fbb-4f3c-4786-9cb5-4faf8263a813.sorted_genome_alignments.bam	16.96	1.82	0.18	58cfa83be4b0c9d6adf725f4	UNCID_2635709.5f0f8fbb-4f3c-4786-9cb5-4faf8263a813.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-FB-AAQ0-01A	81B6B844-D760-4146-9B01-1C4B2596EB77	Primary Tumor	Illumina HiSeq	A335986B-1224-4BD9-BE23-05A37EB5AF43	Pancreas	68.0	00585894-808A-4635-8A2E-94CD72599C1A	5F0F8FBB-4F3C-4786-9CB5-4FAF8263A813	TCGA-FB-AAQ0-01A-31R-A41B-07	HG19	TCGA-FB-AAQ0	TCGA-PAAD	473.0	s905	University of North Carolina	Asterand	United States	NO	T3	N0	Pancreas-Adenocarcinoma Ductal Type	Stage II	A41B-07	True
13722.58cfa82fe4b0c9d6adf6b5f0	58cfa82fe4b0c9d6adf6b5f0	TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted.filtered.	WGS	TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted	TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted.bam	168.4	2.0	0.15	58cfa82fe4b0c9d6adf6b5f0	TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5933-01A	7A0EA814-F0DE-4BC4-A81A-DAA000559369	Primary Tumor	Illumina HiSeq	ca97b42b-d723-4c0a-8f71-819eca1bb805	Lung	72.0	D2355F3A-E2CE-4791-B1FB-B570850681DF	1D83B47D-66A8-4AE9-81BB-BDC03FA64AC6	TCGA-50-5933-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5933	TCGA-LUAD	2393.0	s11009	Harvard Medical School	University of Pittsburgh	United States	NO	T4	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1751-02	True
13767.58cfa831e4b0c9d6adf6c4d8	58cfa831e4b0c9d6adf6c4d8	TCGA-CG-5730-11A-01R-1602-13_rnaseq.filtered.	RNA-Seq	TCGA-CG-5730-11A-01R-1602-13_rnaseq	TCGA-CG-5730-11A-01R-1602-13_rnaseq.bam	92.8	1.7	0.15	58cfa831e4b0c9d6adf6c4d8	TCGA-CG-5730-11A-01R-1602-13_rnaseq.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5730-11A	09587F1C-5C99-4102-BC49-84D50FA8D0CE	Solid Tissue Normal	Illumina HiSeq	BF075DB4-1756-4E16-82B6-B0F2895757B5	Stomach	80.0	16225D9E-2074-42AE-91E5-4D0352916465	84EA97AE-849C-44ED-B0DC-400F263D519D	TCGA-CG-5730-11A-01R-1602-13	GRCh37-lite	TCGA-CG-5730	TCGA-STAD		s14834	Canada's Michael Smith Genome Sciences Centre	Indivumed	Germany	NO	T2	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1602-13	True
13767.58cfa83be4b0c9d6adf72850	58cfa83be4b0c9d6adf72850	UNCID_355787.TCGA-CJ-4895-01A-01R-1305-07.110525_UNC14-SN744_0119_BC03HKABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_355787.TCGA-CJ-4895-01A-01R-1305-07.110525_UNC14-SN744_0119_BC03HKABXX.7.trimmed.annotated.translated_to_genomic	UNCID_355787.TCGA-CJ-4895-01A-01R-1305-07.110525_UNC14-SN744_0119_BC03HKABXX.7.trimmed.annotated.translated_to_genomic.bam	55.3	1.7	0.15	58cfa83be4b0c9d6adf72850	UNCID_355787.TCGA-CJ-4895-01A-01R-1305-07.110525_UNC14-SN744_0119_BC03HKABXX.7.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4895-01A	B7994839-77A5-4725-AA58-A9E8C79DBFC2	Primary Tumor	Illumina HiSeq	84D133DE-2F6D-472D-A132-4EA07A2D3459	Kidney	62.0	7F989EB7-0544-43E3-8E76-AC038DE76666	334C16F3-5A5F-41B9-8893-C86FCBAC028A	TCGA-CJ-4895-01A-01R-1305-07	HG19	TCGA-CJ-4895	TCGA-KIRC	1200.0	s8931	University of North Carolina	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1305-07	True
13767.58cfa833e4b0c9d6adf6df98	58cfa833e4b0c9d6adf6df98	UNCID_1155745.83fe3d7b-6905-49ea-bbc8-ea9c468004f6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1155745.83fe3d7b-6905-49ea-bbc8-ea9c468004f6.sorted_genome_alignments	UNCID_1155745.83fe3d7b-6905-49ea-bbc8-ea9c468004f6.sorted_genome_alignments.bam	27.34	1.9	0.16	58cfa833e4b0c9d6adf6df98	UNCID_1155745.83fe3d7b-6905-49ea-bbc8-ea9c468004f6.sorted_genome_alignments.bam	Alive	FEMALE			Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A0AB-01A	22EABA28-BE67-4730-9846-860BC1FCA29A	Primary Tumor	Illumina HiSeq	9B952D71-4287-46D7-97DB-06C7951FD8D0	Breast	54.0	860BAF5B-ABCF-4014-8B4B-D0A4B0D15C51	83FE3D7B-6905-49EA-BBC8-EA9C468004F6	TCGA-A8-A0AB-01A-11R-A034-07	HG19	TCGA-A8-A0AB	TCGA-BRCA		s6543	University of North Carolina	Indivumed	Germany	NO	T2	N0	Infiltrating Lobular Carcinoma	Stage II	A034-07	True
13767.58cfa83ae4b0c9d6adf7164b	58cfa83ae4b0c9d6adf7164b	UNCID_2400348.1d7d22de-0bfc-4357-8c5a-7289aa0d97b8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2400348.1d7d22de-0bfc-4357-8c5a-7289aa0d97b8.sorted_genome_alignments	UNCID_2400348.1d7d22de-0bfc-4357-8c5a-7289aa0d97b8.sorted_genome_alignments.bam	19.59	1.82	0.16	58cfa83ae4b0c9d6adf7164b	UNCID_2400348.1d7d22de-0bfc-4357-8c5a-7289aa0d97b8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-RY-A847-01A	FFF304A2-113F-499D-A88C-9D3660C348D9	Primary Tumor	Illumina HiSeq	7C8C32BD-6172-4DBE-9C84-B9CC4F6C05A7	Brain	45.0	BF8E8426-DC44-40B0-8459-AD1DBAF9BA5A	1D7D22DE-0BFC-4357-8C5A-7289AA0D97B8	TCGA-RY-A847-01A-11R-A36H-07	HG19	TCGA-RY-A847	TCGA-LGG		s8821	University of North Carolina	University of California San Francisco	United States	NO			Oligodendroglioma		A36H-07	True
13767.58cfa832e4b0c9d6adf6d790	58cfa832e4b0c9d6adf6d790	UNCID_1057381.ba725298-74f8-4ff3-a28b-1e4a92331f07.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1057381.ba725298-74f8-4ff3-a28b-1e4a92331f07.sorted_genome_alignments	UNCID_1057381.ba725298-74f8-4ff3-a28b-1e4a92331f07.sorted_genome_alignments.bam	122.2	1.7	0.15	58cfa832e4b0c9d6adf6d790	UNCID_1057381.ba725298-74f8-4ff3-a28b-1e4a92331f07.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-46-6025-01A	6020EC67-8F3B-409F-A0ED-2AF849B4D76F	Primary Tumor	Illumina HiSeq	68CEFB5F-08BE-4988-8266-3B4203535952	Lung	71.0	2896F7FB-D6CB-4DA3-AB40-52D1E739B8D9	BA725298-74F8-4FF3-A28B-1E4A92331F07	TCGA-46-6025-01A-11R-1820-07	HG19	TCGA-46-6025	TCGA-LUSC		s10514	University of North Carolina	St Joseph's Medical Center (MD)	United States	NO	T2b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	1820-07	True
13722.58cfa82ee4b0c9d6adf6a7e8	58cfa82ee4b0c9d6adf6a7e8	G25773.TCGA-75-5147-01A-01D-1625-08.2.filtered.	WGS	G25773.TCGA-75-5147-01A-01D-1625-08.2	G25773.TCGA-75-5147-01A-01D-1625-08.2.bam	817.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7e8	G25773.TCGA-75-5147-01A-01D-1625-08.2.bam	Alive	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-75-5147-01A	D2824E6D-3784-45C2-9B0F-52B17356B5DA	Primary Tumor	Illumina HiSeq	6ec725e2-6d00-4866-8473-fd1b02309066	Lung		F9F9C1DD-8462-4560-82B8-AEA4309854C9	52910A60-BB15-4BA5-9D09-50D8EE6A445B	TCGA-75-5147-01A-01D-1625-08	HG19_Broad_variant	TCGA-75-5147	TCGA-LUAD		s10974	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1625-08	False
13722.58cfa832e4b0c9d6adf6ce00	58cfa832e4b0c9d6adf6ce00	TCGA-G3-A25W-01A-11D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A25W-01A-11D-A16V-10_wgs_Illumina	TCGA-G3-A25W-01A-11D-A16V-10_wgs_Illumina.bam	16.34	1.85	0.09	58cfa832e4b0c9d6adf6ce00	TCGA-G3-A25W-01A-11D-A16V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A25W-01A	06AC44E9-1226-4202-828B-6F224766D7AC	Primary Tumor	Illumina HiSeq	8e1a9b98-38eb-4a80-8ceb-050f57ca4d78	Liver	79.0	859CDE68-B3BB-4867-BCED-C016BFAFFDE9	36E1D9CC-32EC-4A0A-8FB1-C46F058A6FB8	TCGA-G3-A25W-01A-11D-A16V-10	GRCh37-lite	TCGA-G3-A25W	TCGA-LIHC		s16788	Baylor College of Medicine	Alberta Health Services	Canada	NO	T3b	N0	Hepatocellular Carcinoma	Stage III	A16V-10	True
13767.58cfa833e4b0c9d6adf6d90f	58cfa833e4b0c9d6adf6d90f	UNCID_1077596.4ff760c4-074e-4876-b63f-71098942c780.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1077596.4ff760c4-074e-4876-b63f-71098942c780.sorted_genome_alignments	UNCID_1077596.4ff760c4-074e-4876-b63f-71098942c780.sorted_genome_alignments.bam	130.2		0.15	58cfa833e4b0c9d6adf6d90f	UNCID_1077596.4ff760c4-074e-4876-b63f-71098942c780.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-7910-01A	B2BC53D6-EF78-4AE9-A6B5-1C7CAD9A43EB	Primary Tumor	Illumina HiSeq	E47CA89E-4872-4C07-8F2C-DC8CBF89CE36	Lung	50.0	796A6E60-2289-48E0-8A50-DDFCE6EBF73B	4FF760C4-074E-4876-B63F-71098942C780	TCGA-55-7910-01A-11R-2170-07	HG19	TCGA-55-7910	TCGA-LUAD		s11134	University of North Carolina	International Genomics Consortium	United States	NO	T2b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	2170-07	True
13767.58cfa839e4b0c9d6adf71220	58cfa839e4b0c9d6adf71220	UNCID_2276474.4c7061f2-ff48-4079-97b6-7ae3c7c0f905.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2276474.4c7061f2-ff48-4079-97b6-7ae3c7c0f905.sorted_genome_alignments	UNCID_2276474.4c7061f2-ff48-4079-97b6-7ae3c7c0f905.sorted_genome_alignments.bam	15.14	1.94	0.16	58cfa839e4b0c9d6adf71220	UNCID_2276474.4c7061f2-ff48-4079-97b6-7ae3c7c0f905.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-A6S2-01A	BAADDD76-277F-4C90-9CC2-0FECE30C9735	Primary Tumor	Illumina HiSeq	07085C8F-2830-4A1C-B29A-F91B52C0CDF3	Brain	37.0	4E3F8A46-A57F-4780-BFE7-58557DF8E592	4C7061F2-FF48-4079-97B6-7AE3C7C0F905	TCGA-DU-A6S2-01A-21R-A32Q-07	HG19	TCGA-DU-A6S2	TCGA-LGG		s8457	University of North Carolina	Henry Ford Hospital	United States	NO			Oligodendroglioma		A32Q-07	True
13767.58cfa83be4b0c9d6adf72505	58cfa83be4b0c9d6adf72505	UNCID_2648447.7d481f46-fd01-47ce-b321-39240129af48.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2648447.7d481f46-fd01-47ce-b321-39240129af48.sorted_genome_alignments	UNCID_2648447.7d481f46-fd01-47ce-b321-39240129af48.sorted_genome_alignments.bam	64.69	1.86	0.17	58cfa83be4b0c9d6adf72505	UNCID_2648447.7d481f46-fd01-47ce-b321-39240129af48.sorted_genome_alignments.bam	Dead	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-VS-A9V1-01A	A6A07BC7-AB1B-429D-81ED-D7A890C88E51	Primary Tumor	Illumina HiSeq	E78AD7D0-82F4-4480-AF82-4B576D969EEC	Cervix	46.0	457C7D04-B8CA-4478-9A41-D086261150AA	7D481F46-FD01-47CE-B321-39240129AF48	TCGA-VS-A9V1-01A-11R-A42T-07	HG19	TCGA-VS-A9V1	TCGA-CESC	157.0	s1605	University of North Carolina	Barretos Cancer Hospital	Brazil	NO	T3b	NX	Mucinous Adenocarcinoma of Endocervical Type		A42T-07	True
13767.58cfa83be4b0c9d6adf72ab2	58cfa83be4b0c9d6adf72ab2	UNCID_359824.TCGA-BP-4341-01A-01R-1289-07.110511_UNC11-SN627_0085_BC01AFABXX.4.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_359824.TCGA-BP-4341-01A-01R-1289-07.110511_UNC11-SN627_0085_BC01AFABXX.4.trimmed.annotated.translated_to_genomic	UNCID_359824.TCGA-BP-4341-01A-01R-1289-07.110511_UNC11-SN627_0085_BC01AFABXX.4.trimmed.annotated.translated_to_genomic.bam	58.3	1.7	0.15	58cfa83be4b0c9d6adf72ab2	UNCID_359824.TCGA-BP-4341-01A-01R-1289-07.110511_UNC11-SN627_0085_BC01AFABXX.4.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4341-01A	8BE7D2E2-1504-49D0-BBDD-893D3D12E072	Primary Tumor	Illumina HiSeq	4C94C268-FCF6-4CC5-87EE-D7735EE11EAE	Kidney	67.0	B8502218-20E3-4317-A1A4-3DFD2659AFC0	1566EBF2-801E-42DA-A0D2-3FF69E1C7E4B	TCGA-BP-4341-01A-01R-1289-07	HG19	TCGA-BP-4341	TCGA-KIRC	1589.0	s9870	University of North Carolina	MSKCC	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1289-07	True
13767.58cfa835e4b0c9d6adf6ebc2	58cfa835e4b0c9d6adf6ebc2	UNCID_1328134.dcbfdc62-310c-48e0-bb03-f32a657b210a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1328134.dcbfdc62-310c-48e0-bb03-f32a657b210a.sorted_genome_alignments	UNCID_1328134.dcbfdc62-310c-48e0-bb03-f32a657b210a.sorted_genome_alignments.bam	74.7	1.81	0.15	58cfa835e4b0c9d6adf6ebc2	UNCID_1328134.dcbfdc62-310c-48e0-bb03-f32a657b210a.sorted_genome_alignments.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A3BX-01A	8A02F305-6FD8-4908-BC19-06BABF028B5B	Primary Tumor	Illumina HiSeq	A4B42AC7-28E3-4344-BEA6-1A29B9285041	Thyroid	24.0	7A756CE5-C46A-47E9-B18B-3B0FC471366C	DCBFDC62-310C-48E0-BB03-F32A657B210A	TCGA-ET-A3BX-01A-11R-A19O-07	HG19	TCGA-ET-A3BX	TCGA-THCA		s12667	University of North Carolina	Johns Hopkins	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19O-07	True
13767.58cfa82fe4b0c9d6adf6b42a	58cfa82fe4b0c9d6adf6b42a	TCGA-24-1552-01A-01R-1566-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-1552-01A-01R-1566-13_GRCh37-lite_rnaseq	TCGA-24-1552-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	824.7	1.8	0.14	58cfa82fe4b0c9d6adf6b42a	TCGA-24-1552-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1552-01A	62379BE5-13F0-474B-94D3-6F944EC4EE96	Primary Tumor	Illumina HiSeq	F8D23DEA-62B9-4A5C-B1FD-145A39D11509	Ovary	77.0	411B4C26-FCC4-438A-8731-D0CF5DD6C74F	990BCB1F-7269-4020-8EA5-8BA338B390B8	TCGA-24-1552-01A-01R-1566-13	GRCh37-lite	TCGA-24-1552	TCGA-OV	1259.0	s17938	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1566-13	True
13722.58cfa830e4b0c9d6adf6bdd8	58cfa830e4b0c9d6adf6bdd8	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	55.87	1.93	0.08	58cfa830e4b0c9d6adf6bdd8	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0E0-01A	20E8106B-1290-4735-ABE4-7621E08E3DC8	Primary Tumor	Illumina HiSeq	fc737335-21e7-4997-b267-04d3f91043f5	Breast	38.0	662CC11C-DA31-4E31-8E77-46011B38EA96	E8392F20-C9E3-4649-B64F-5B266C393A76	TCGA-BH-A0E0-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0E0	TCGA-BRCA		s5804	Washington University School of Medicine	University of Pittsburgh	None	NO	T3	N3a	Infiltrating Ductal Carcinoma	Stage III	A128-09	True
13767.58cfa837e4b0c9d6adf702ac	58cfa837e4b0c9d6adf702ac	UNCID_1920096.e57426eb-3223-41dc-b70e-ff7233e3403a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1920096.e57426eb-3223-41dc-b70e-ff7233e3403a.sorted_genome_alignments	UNCID_1920096.e57426eb-3223-41dc-b70e-ff7233e3403a.sorted_genome_alignments.bam	113.2		0.14	58cfa837e4b0c9d6adf702ac	UNCID_1920096.e57426eb-3223-41dc-b70e-ff7233e3403a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-8049-01A	F43B511B-93D1-4A6E-AB17-E84448A084B2	Primary Tumor	Illumina HiSeq	2CDFAA5E-D3DE-465E-BAEE-0D073E47FCAD	Lung	57.0	577DE230-8E3C-433B-B01E-0AB8AD21FCC5	E57426EB-3223-41DC-B70E-FF7233E3403A	TCGA-85-8049-01A-11R-2247-07	HG19	TCGA-85-8049	TCGA-LUSC		s10328	University of North Carolina	Asterand	Russia	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2247-07	True
13722.58cfa83ce4b0c9d6adf7313a	58cfa83ce4b0c9d6adf7313a	ff180684131876b77d5fa19e93aaeb1e.filtered.	WGS	ff180684131876b77d5fa19e93aaeb1e	ff180684131876b77d5fa19e93aaeb1e.bam	52.23		0.08	58cfa83ce4b0c9d6adf7313a	ff180684131876b77d5fa19e93aaeb1e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IW-A3M4-01A	0DA5EE6C-D012-4A57-9992-9D74937AAA5F	Primary Tumor	Illumina HiSeq	62a7d6f2-3b71-4449-83fe-da6beea65873	Mesenchymal	48.0	F854DB6B-57CB-4DA7-9252-B2ADE22C2675	6AA00162-6294-4CE7-B6B7-0C3452E24CD6	TCGA-IW-A3M4-01A-11D-A21Q-09	GRCh37-lite	TCGA-IW-A3M4	TCGA-SARC		s2673	Washington University School of Medicine	Cedars Sinai	United States	NO					A21Q-09	True
13767.58cfa837e4b0c9d6adf70094	58cfa837e4b0c9d6adf70094	UNCID_1815335.db75b249-f02e-47d8-ba4c-37a5ba7c4b33.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1815335.db75b249-f02e-47d8-ba4c-37a5ba7c4b33.sorted_genome_alignments	UNCID_1815335.db75b249-f02e-47d8-ba4c-37a5ba7c4b33.sorted_genome_alignments.bam	9.2		0.14	58cfa837e4b0c9d6adf70094	UNCID_1815335.db75b249-f02e-47d8-ba4c-37a5ba7c4b33.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-8558-01A	9B288F0E-5155-4736-BC22-E0E801D8B738	Primary Tumor	Illumina HiSeq	787619BF-CA14-401F-8591-216EC6DCB8A0	Brain	29.0	83F578EB-5A18-4062-85A2-6A36FE511FE1	DB75B249-F02E-47D8-BA4C-37A5BA7C4B33	TCGA-HT-8558-01A-21R-2404-07	HG19	TCGA-HT-8558	TCGA-LGG		s8429	University of North Carolina	Case Western - St Joes	United States	NO			Oligodendroglioma		2404-07	True
13722.58cfa82de4b0c9d6adf6a488	58cfa82de4b0c9d6adf6a488	13cf3705382d9fa3718c1f9ee909853b.filtered.	WGS	13cf3705382d9fa3718c1f9ee909853b	13cf3705382d9fa3718c1f9ee909853b.bam	32.16	2.06	0.08	58cfa82de4b0c9d6adf6a488	13cf3705382d9fa3718c1f9ee909853b.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E9-A1NH-11A	B2AAC45B-2073-4C7A-ADB9-769A4FDCC111	Solid Tissue Normal	Illumina HiSeq	9ec85678-e1a8-44bd-9676-72b0d1b991d7	Breast	71.0	A646C533-70B4-43B7-B1B1-0D26509A13CC	0EE95056-A7CC-415C-A487-3AD08604DFC0	TCGA-E9-A1NH-11A-33D-A14G-09	GRCh37-lite	TCGA-E9-A1NH	TCGA-BRCA		s6258	Washington University School of Medicine	Asterand	Russia	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A14G-09	False
13722.58cfa831e4b0c9d6adf6c708	58cfa831e4b0c9d6adf6c708	TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted	TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted.bam	8.8	2.09	0.14	58cfa831e4b0c9d6adf6c708	TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YN-11A	679A6869-2CE9-4472-8DB1-8869E2C1A440	Solid Tissue Normal	Illumina HiSeq	4f24b2d4-a63d-40e7-82c7-bc6e188fbb4a	Bladder	60.0	CAAC9355-9BAC-41D8-B7A7-8EEB775179FA	25F4133F-37D6-46DA-9405-03D506557044	TCGA-CU-A0YN-11A-11D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YN	TCGA-BLCA	393.0	s3277	Harvard Medical School	UNC	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A10R-02	True
13767.58cfa836e4b0c9d6adf6f3b6	58cfa836e4b0c9d6adf6f3b6	UNCID_1509346.8a63eeeb-2e0d-466f-a446-ac6649cba90c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1509346.8a63eeeb-2e0d-466f-a446-ac6649cba90c.sorted_genome_alignments	UNCID_1509346.8a63eeeb-2e0d-466f-a446-ac6649cba90c.sorted_genome_alignments.bam	31.2		0.14	58cfa836e4b0c9d6adf6f3b6	UNCID_1509346.8a63eeeb-2e0d-466f-a446-ac6649cba90c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7793-01A	DA07DA37-BDE6-480A-A302-98683AE3931A	Primary Tumor	Illumina HiSeq	9BE7B464-A960-4761-8082-3E3CB4B74C42	Prostate	49.0	11CE16B7-6CF6-416D-AC47-089C813CC34C	8A63EEEB-2E0D-466F-A446-AC6649CBA90C	TCGA-EJ-7793-01A-31R-2263-07	HG19	TCGA-EJ-7793	TCGA-PRAD		s3493	University of North Carolina	University of Pittsburgh	United States	NO	T2c		Prostate Adenocarcinoma Acinar Type		2263-07	True
13767.58cfa83be4b0c9d6adf72666	58cfa83be4b0c9d6adf72666	UNCID_2634859.2f48ea8f-6e03-4f00-acc5-e9bc491ad673.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2634859.2f48ea8f-6e03-4f00-acc5-e9bc491ad673.sorted_genome_alignments	UNCID_2634859.2f48ea8f-6e03-4f00-acc5-e9bc491ad673.sorted_genome_alignments.bam	59.76	1.91	0.18	58cfa83be4b0c9d6adf72666	UNCID_2634859.2f48ea8f-6e03-4f00-acc5-e9bc491ad673.sorted_genome_alignments.bam	Dead	FEMALE			Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-VS-A9UV-01A	C9E4BAC6-0CAC-4FCA-A548-527DEAC5B880	Primary Tumor	Illumina HiSeq	DCEDAB46-A5A5-4351-8919-71C75A24B569	Cervix	74.0	60817F05-7C77-4631-A77E-D7A018AA1A23	2F48EA8F-6E03-4F00-ACC5-E9BC491AD673	TCGA-VS-A9UV-01A-11R-A42T-07	HG19	TCGA-VS-A9UV	TCGA-CESC	104.0	s1484	University of North Carolina	Barretos Cancer Hospital	Brazil	NO	T4	NX	Cervical Squamous Cell Carcinoma		A42T-07	True
13767.58cfa83ce4b0c9d6adf72c9a	58cfa83ce4b0c9d6adf72c9a	UNCID_405063.5992e0cb-a453-473f-bb06-4641681099bd.110719_UNC11-SN627_0127_AB0AE0ABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_405063.5992e0cb-a453-473f-bb06-4641681099bd.110719_UNC11-SN627_0127_AB0AE0ABXX.5.trimmed.annotated.translated_to_genomic	UNCID_405063.5992e0cb-a453-473f-bb06-4641681099bd.110719_UNC11-SN627_0127_AB0AE0ABXX.5.trimmed.annotated.translated_to_genomic.bam	66.3	1.7	0.16	58cfa83ce4b0c9d6adf72c9a	UNCID_405063.5992e0cb-a453-473f-bb06-4641681099bd.110719_UNC11-SN627_0127_AB0AE0ABXX.5.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5178-01A	6E9E5E05-2BF8-4724-8E31-241F517289DE	Primary Tumor	Illumina HiSeq	7F16C232-B4C3-4DCB-A769-678149AD7346	Kidney	71.0	A3627887-D988-455C-B87F-A9D2BA8BB6A1	5992E0CB-A453-473F-BB06-4641681099BD	TCGA-BP-5178-01A-01R-1426-07	HG19	TCGA-BP-5178	TCGA-KIRC	1912.0	s8975	University of North Carolina	MSKCC	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1426-07	True
13722.58cfa82fe4b0c9d6adf6b940	58cfa82fe4b0c9d6adf6b940	TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	236.0	1.9	0.14	58cfa82fe4b0c9d6adf6b940	TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-3808-01A	4F9775F2-B663-4DAF-AA9E-50915CAE9407	Primary Tumor	Illumina HiSeq	58504a37-4eb0-44ec-bb5d-83e955521de2	Colorectal	73.0	037BA047-2228-43DE-8DF8-32920A689ECA	2B2625B5-FBDD-41C3-9BB3-71566C5FBBA4	TCGA-A6-3808-01A-01D-1167-02	HG18	TCGA-A6-3808	TCGA-COAD		s13173	Harvard Medical School	Christiana Healthcare	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1167-02	True
13722.58cfa832e4b0c9d6adf6d1a8	58cfa832e4b0c9d6adf6d1a8	TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted.filtered.	WGS	TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted	TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted.bam	62.7		0.17	58cfa832e4b0c9d6adf6d1a8	TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7472-01A	482D4078-7576-48CF-BF7C-29014935FD47	Primary Tumor	Illumina HiSeq	518f9b23-97da-447f-90e5-a03c5ae09642	Brain	38.0	F05081A2-2465-4EA4-9EC3-319810FE2D45	A68374D7-4782-4FF5-B921-35D45468A4D1	TCGA-HT-7472-01A-11D-2022-02	HG19_Broad_variant	TCGA-HT-7472	TCGA-LGG		s8574	Harvard Medical School	Case Western - St Joes	United States	NO			Oligodendroglioma		2022-02	True
13722.58cfa830e4b0c9d6adf6becb	58cfa830e4b0c9d6adf6becb	TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted.filtered.	WGS	TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted	TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted.bam	42.91	2.0	0.14	58cfa830e4b0c9d6adf6becb	TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JL-10A	D5D8E76E-2F2A-49BC-BA0A-D51283611B16	Blood Derived Normal	Illumina HiSeq	4db7f9bb-a3b8-4b87-b98c-8ba5be69963f	Breast	59.0	6F0C9CAE-2A0F-4512-9B36-E94917CF2561	5159552D-2BC4-4C78-A5FD-3B34084C6A4E	TCGA-AO-A0JL-10A-01D-A060-02	HG19_Broad_variant	TCGA-AO-A0JL	TCGA-BRCA		s6122	Harvard Medical School	MSKCC	None	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage III	A060-02	True
13767.58cfa838e4b0c9d6adf70b60	58cfa838e4b0c9d6adf70b60	UNCID_2121865.425af988-b4b8-4476-ba67-8fc7148f4452.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2121865.425af988-b4b8-4476-ba67-8fc7148f4452.sorted_genome_alignments	UNCID_2121865.425af988-b4b8-4476-ba67-8fc7148f4452.sorted_genome_alignments.bam	19.43	1.89	0.18	58cfa838e4b0c9d6adf70b60	UNCID_2121865.425af988-b4b8-4476-ba67-8fc7148f4452.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-33-A5GW-01A	8D32BEA5-51EF-4AB0-83AE-1DE31E7D4B43	Primary Tumor	Illumina HiSeq	A98539C2-C238-4304-8C59-68C31ACC94B5	Lung	67.0	AD27DC24-38A2-4851-8598-AE2BDEB4A9D3	425AF988-B4B8-4476-BA67-8FC7148F4452	TCGA-33-A5GW-01A-11R-A27Q-07	HG19	TCGA-33-A5GW	TCGA-LUSC		s10068	University of North Carolina	Johns Hopkins	United States	NO	T1a	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A27Q-07	True
13767.58cfa830e4b0c9d6adf6ba90	58cfa830e4b0c9d6adf6ba90	TCGA-61-1741-01A-02R-1567-13_rnaseq.filtered.	RNA-Seq	TCGA-61-1741-01A-02R-1567-13_rnaseq	TCGA-61-1741-01A-02R-1567-13_rnaseq.bam	274.0	1.8	0.14	58cfa830e4b0c9d6adf6ba90	TCGA-61-1741-01A-02R-1567-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-1741-01A	16CED1B8-64D5-4498-82DF-4D37BFE5B310	Primary Tumor	Illumina HiSeq	32B80AE5-617F-412E-AC61-BC54EC62A67F	Ovary	76.0	E5E22755-8759-4349-A6BA-87FFF441183C	92D5764E-C576-47CD-A6BD-68ED0365C213	TCGA-61-1741-01A-02R-1567-13	NCBI36_BCCAGSC_variant	TCGA-61-1741	TCGA-OV	1024.0	s17759	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa83be4b0c9d6adf7236f	58cfa83be4b0c9d6adf7236f	UNCID_2610720.86afec38-04ce-4ddd-966e-5e185715e993.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2610720.86afec38-04ce-4ddd-966e-5e185715e993.sorted_genome_alignments	UNCID_2610720.86afec38-04ce-4ddd-966e-5e185715e993.sorted_genome_alignments.bam	8.21	1.79	0.18	58cfa83be4b0c9d6adf7236f	UNCID_2610720.86afec38-04ce-4ddd-966e-5e185715e993.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-FB-AAQ3-01A	5965CD7B-F384-4473-826A-8381E362D10E	Primary Tumor	Illumina HiSeq	B8956869-10BA-44D4-9F29-E4C7A5F01003	Pancreas	65.0	1F877E0A-02E7-4B3F-88F0-221054D20B6C	86AFEC38-04CE-4DDD-966E-5E185715E993	TCGA-FB-AAQ3-01A-11R-A41B-07	HG19	TCGA-FB-AAQ3	TCGA-PAAD	31.0	s875	University of North Carolina	Asterand	United States	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	A41B-07	True
13767.58cfa83ae4b0c9d6adf71e40	58cfa83ae4b0c9d6adf71e40	UNCID_2504414.4cab604d-59f6-46d2-8c35-d3416977e313.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2504414.4cab604d-59f6-46d2-8c35-d3416977e313.sorted_genome_alignments	UNCID_2504414.4cab604d-59f6-46d2-8c35-d3416977e313.sorted_genome_alignments.bam	46.79	1.92	0.17	58cfa83ae4b0c9d6adf71e40	UNCID_2504414.4cab604d-59f6-46d2-8c35-d3416977e313.sorted_genome_alignments.bam	Alive	MALE	WHITE		Bladder Urothelial Carcinoma	Aligned reads	TCGA-4Z-AA7M-01A	1ECFDF16-F5E9-4A08-8834-37F4B474179D	Primary Tumor	Illumina HiSeq	E7A3044D-B012-49A5-B075-24A4AE6778C5	Bladder	65.0	837E7E71-56F8-4438-887C-406B5EEACC71	4CAB604D-59F6-46D2-8C35-D3416977E313	TCGA-4Z-AA7M-01A-11R-A39I-07	HG19	TCGA-4Z-AA7M	TCGA-BLCA		s3031	University of North Carolina	Barretos Cancer Hospital	Brazil	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A39I-07	True
13722.58cfa832e4b0c9d6adf6cf34	58cfa832e4b0c9d6adf6cf34	TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted	TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted.bam	313.4	1.8	0.13	58cfa832e4b0c9d6adf6cf34	TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6363-01A	B5B3871C-078C-46A7-AC50-EF916D4A6781	Primary Tumor	Illumina HiSeq	a64da28b-c092-4dfb-9503-06c15e566ac3	Prostate	64.0	65D588FF-58E3-4932-A7F4-25EF23C433D5	DBF42C34-D2E5-4136-83F5-093453913D5B	TCGA-G9-6363-01A-21D-1784-02	HG19_Broad_variant	TCGA-G9-6363	TCGA-PRAD		s3452	Harvard Medical School	Roswell Park	United States	NO	T4	N0	Prostate Adenocarcinoma Acinar Type		1784-02	True
13767.58cfa839e4b0c9d6adf71455	58cfa839e4b0c9d6adf71455	UNCID_2308350.c8fd7f63-e309-4a7e-876d-7ca2cf954abe.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2308350.c8fd7f63-e309-4a7e-876d-7ca2cf954abe.sorted_genome_alignments	UNCID_2308350.c8fd7f63-e309-4a7e-876d-7ca2cf954abe.sorted_genome_alignments.bam	65.88	1.9	0.17	58cfa839e4b0c9d6adf71455	UNCID_2308350.c8fd7f63-e309-4a7e-876d-7ca2cf954abe.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E7-A7DV-01A	3EFFD691-570C-478A-8903-3771A1B43F2E	Primary Tumor	Illumina HiSeq	49B07442-0198-4D5E-BE67-1A33CAECD0A5	Bladder	44.0	D8F4C926-CC18-4D72-9E3D-AE7F58D846CF	C8FD7F63-E309-4A7E-876D-7CA2CF954ABE	TCGA-E7-A7DV-01A-11R-A33J-07	HG19	TCGA-E7-A7DV	TCGA-BLCA		s3199	University of North Carolina	Asterand	Romania	NO	T4	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A33J-07	True
13767.58cfa839e4b0c9d6adf7123c	58cfa839e4b0c9d6adf7123c	UNCID_2308647.9070435a-8d76-4107-8d96-900db04b0d94.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2308647.9070435a-8d76-4107-8d96-900db04b0d94.sorted_genome_alignments	UNCID_2308647.9070435a-8d76-4107-8d96-900db04b0d94.sorted_genome_alignments.bam	9.18	1.8	0.16	58cfa839e4b0c9d6adf7123c	UNCID_2308647.9070435a-8d76-4107-8d96-900db04b0d94.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-S9-A6U9-01A	38ECA720-AD68-43A7-8A1C-F79F838D5D03	Primary Tumor	Illumina HiSeq	C839072B-96D2-474F-869D-F39C23D27D2D	Brain	36.0	C97E86CE-ABEC-4129-97C5-94DEE65E1311	9070435A-8D76-4107-8D96-900DB04B0D94	TCGA-S9-A6U9-01A-11R-A32Q-07	HG19	TCGA-S9-A6U9	TCGA-LGG		s8468	University of North Carolina	Dept of Neurosurgery at University of Heidelberg	Germany	NO			Astrocytoma		A32Q-07	True
13767.58cfa82ee4b0c9d6adf6b1c6	58cfa82ee4b0c9d6adf6b1c6	TCGA-09-1659-01B-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-09-1659-01B-01R-1564-13_rnaseq	TCGA-09-1659-01B-01R-1564-13_rnaseq.bam	269.0	1.8	0.16	58cfa82ee4b0c9d6adf6b1c6	TCGA-09-1659-01B-01R-1564-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-1659-01B	644A88A7-DC56-468A-AF5C-60278AAB7642	Primary Tumor	Illumina HiSeq	CF4B46F9-50C4-4867-9994-FF91ACFFCBDF	Ovary	51.0	01A6F7CD-10CC-4F33-AA75-B29ABD6C2EDB	32D5209E-2EF2-4EF0-B902-585542D7D16B	TCGA-09-1659-01B-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-09-1659	TCGA-OV	304.0	s17597	Canada's Michael Smith Genome Sciences Centre	UCSF	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa83be4b0c9d6adf72975	58cfa83be4b0c9d6adf72975	UNCID_358787.TCGA-CZ-4854-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_358787.TCGA-CZ-4854-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.5.trimmed.annotated.translated_to_genomic	UNCID_358787.TCGA-CZ-4854-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.5.trimmed.annotated.translated_to_genomic.bam	31.3	1.8	0.14	58cfa83be4b0c9d6adf72975	UNCID_358787.TCGA-CZ-4854-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.5.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-4854-01A	2EFCEFCA-5E52-4B3D-A48A-9E9C73CC0141	Primary Tumor	Illumina HiSeq	C86DE566-EC9C-4579-A5F2-E4873FDC0BC1	Kidney	68.0	B7F4ACB3-A84D-45C9-B3BC-E90200BCA754	B57FDEC6-F477-4366-A707-E519A3518790	TCGA-CZ-4854-01A-01R-1305-07	HG19	TCGA-CZ-4854	TCGA-KIRC	1404.0	s9255	University of North Carolina	Harvard	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1305-07	True
13722.58cfa831e4b0c9d6adf6cb66	58cfa831e4b0c9d6adf6cb66	TCGA-EE-A2GS-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EE-A2GS-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_6_rg.sorted	TCGA-EE-A2GS-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_6_rg.sorted.bam	19.44		0.15	58cfa831e4b0c9d6adf6cb66	TCGA-EE-A2GS-10A-01D-A190_120724_SN208_0418_BD13N7ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2GS-10A	880BB701-F1D3-4BF2-BFC8-143AD8D07B6A	Blood Derived Normal	Illumina HiSeq	49f9daa4-da67-4d32-9183-82c94e8344b4	Skin	28.0	DA45B6F7-4C97-4614-BE20-3BD10F785476	C21B6ECB-F70F-4E2E-964B-CBA7E8EBAEE9	TCGA-EE-A2GS-10A-01D-A190-02	HG19_Broad_variant	TCGA-EE-A2GS	TCGA-SKCM		s7350	Harvard Medical School	University of Sydney	Australia	NO	T2a	N0		Stage I	A190-02	True
13767.58cfa834e4b0c9d6adf6e398	58cfa834e4b0c9d6adf6e398	UNCID_1188795.fc338903-8318-40e4-8652-26b116ad394a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1188795.fc338903-8318-40e4-8652-26b116ad394a.sorted_genome_alignments	UNCID_1188795.fc338903-8318-40e4-8652-26b116ad394a.sorted_genome_alignments.bam	17.3	1.7	0.14	58cfa834e4b0c9d6adf6e398	UNCID_1188795.fc338903-8318-40e4-8652-26b116ad394a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4975-01A	D97AC1D1-FC06-4E9B-B3AD-415582FF66F1	Primary Tumor	Illumina HiSeq	3F9EF3D7-A2E7-4328-B637-9C1FD418E9E3	Kidney	40.0	3E998594-1665-43F7-9FEC-15C2C6226361	FC338903-8318-40E4-8652-26B116AD394A	TCGA-BP-4975-01A-01R-1334-07	HG19	TCGA-BP-4975	TCGA-KIRC		s8892	University of North Carolina	MSKCC	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13767.58cfa838e4b0c9d6adf706f6	58cfa838e4b0c9d6adf706f6	UNCID_1987133.112e7329-5135-4307-bda5-d041bc04f0ea.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1987133.112e7329-5135-4307-bda5-d041bc04f0ea.sorted_genome_alignments	UNCID_1987133.112e7329-5135-4307-bda5-d041bc04f0ea.sorted_genome_alignments.bam	29.53	1.8	0.18	58cfa838e4b0c9d6adf706f6	UNCID_1987133.112e7329-5135-4307-bda5-d041bc04f0ea.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-A46B-01A	1170F449-DFB5-417A-A89B-B2229A2785DB	Primary Tumor	Illumina HiSeq	D5724584-752B-44C4-9E5D-7E6891BB4969	Prostate	66.0	6F63E03B-4C63-4E29-BFD9-DD5095289F23	112E7329-5135-4307-BDA5-D041BC04F0EA	TCGA-EJ-A46B-01A-31R-A250-07	HG19	TCGA-EJ-A46B	TCGA-PRAD		s4045	University of North Carolina	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		A250-07	True
13767.58cfa839e4b0c9d6adf71050	58cfa839e4b0c9d6adf71050	UNCID_2234488.3648cb64-1da6-455b-8259-95574dde606f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2234488.3648cb64-1da6-455b-8259-95574dde606f.sorted_genome_alignments	UNCID_2234488.3648cb64-1da6-455b-8259-95574dde606f.sorted_genome_alignments.bam	19.34	1.85	0.15	58cfa839e4b0c9d6adf71050	UNCID_2234488.3648cb64-1da6-455b-8259-95574dde606f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-PZ-A5RE-01A	C26002E7-ABF1-42B9-BF36-0E97249D872F	Primary Tumor	Illumina HiSeq	5DAFF3A8-64A2-4A2A-9415-E6D999FB3CE5	Pancreas	44.0	BE7E2197-4C7C-4AB5-A003-940054104848	3648CB64-1DA6-455B-8259-95574DDE606F	TCGA-PZ-A5RE-01A-11R-A32O-07	HG19	TCGA-PZ-A5RE	TCGA-PAAD		s790	University of North Carolina		United States	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	A32O-07	True
13722.58cfa831e4b0c9d6adf6c6e6	58cfa831e4b0c9d6adf6c6e6	TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted	TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted.bam	850.4	1.9	0.15	58cfa831e4b0c9d6adf6c6e6	TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4734-10A	B80FDC9A-341D-4277-9664-8E8F770D9DDD	Blood Derived Normal	Illumina HiSeq	dc55020c-4480-41b1-ad6f-0295abea2b6c	Head and Neck	70.0	782C9013-4F6F-461B-AA33-5E60D38BFCCC	67C9A43F-0254-47C0-9AE7-B3328D75CBFA	TCGA-CN-4734-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4734	TCGA-HNSC		s16321	Harvard Medical School	University of Pittsburgh	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1431-02	True
13767.58cfa83be4b0c9d6adf7251c	58cfa83be4b0c9d6adf7251c	UNCID_2646725.fbca79e2-8904-4bdf-aede-b2049cb81302.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2646725.fbca79e2-8904-4bdf-aede-b2049cb81302.sorted_genome_alignments	UNCID_2646725.fbca79e2-8904-4bdf-aede-b2049cb81302.sorted_genome_alignments.bam	74.26	1.85	0.17	58cfa83be4b0c9d6adf7251c	UNCID_2646725.fbca79e2-8904-4bdf-aede-b2049cb81302.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-XF-AAML-01A	329D372C-C44E-4595-B8AC-474C5A1321A5	Primary Tumor	Illumina HiSeq	5B781CFA-DD7C-4AE9-8BE9-325E9C1B8CC9	Bladder	75.0	90F7397E-7264-4A41-B5F0-E9725A84DE3E	FBCA79E2-8904-4BDF-AEDE-B2049CB81302	TCGA-XF-AAML-01A-11R-A42T-07	HG19	TCGA-XF-AAML	TCGA-BLCA	232.0	s2839	University of North Carolina	University of Southern California	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A42T-07	True
13767.58cfa833e4b0c9d6adf6de72	58cfa833e4b0c9d6adf6de72	UNCID_1135428.091cb252-dd08-4e9c-939c-749f595713f6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1135428.091cb252-dd08-4e9c-939c-749f595713f6.sorted_genome_alignments	UNCID_1135428.091cb252-dd08-4e9c-939c-749f595713f6.sorted_genome_alignments.bam	44.85	1.76	0.16	58cfa833e4b0c9d6adf6de72	UNCID_1135428.091cb252-dd08-4e9c-939c-749f595713f6.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A1JJ-01A	F7AB565C-83B5-4988-B9BE-8A46F65DCA8C	Primary Tumor	Illumina HiSeq	3C5DB605-8194-4245-AF16-483404CDFA11	Breast	54.0	AE28FD1E-2445-47AD-8C01-1B47D6396694	091CB252-DD08-4E9C-939C-749F595713F6	TCGA-D8-A1JJ-01A-31R-A14M-07	HG19	TCGA-D8-A1JJ	TCGA-BRCA		s5674	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A14M-07	True
13767.58cfa838e4b0c9d6adf70c90	58cfa838e4b0c9d6adf70c90	UNCID_2147252.3b2af3d9-31f1-4075-8a42-2e4f371cd0a6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2147252.3b2af3d9-31f1-4075-8a42-2e4f371cd0a6.sorted_genome_alignments	UNCID_2147252.3b2af3d9-31f1-4075-8a42-2e4f371cd0a6.sorted_genome_alignments.bam	15.99	1.84	0.18	58cfa838e4b0c9d6adf70c90	UNCID_2147252.3b2af3d9-31f1-4075-8a42-2e4f371cd0a6.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D9-A6EA-06A	CFE787B3-8297-4318-987C-BFADD743D767	Metastatic	Illumina HiSeq	2DC9B5C4-A35D-4E66-A6D5-E5837838103C	Skin	70.0	BA2A173A-96F0-415A-AC8D-9AD6480317E8	3B2AF3D9-31F1-4075-8A42-2E4F371CD0A6	TCGA-D9-A6EA-06A-11R-A311-07	HG19	TCGA-D9-A6EA	TCGA-SKCM		s8082	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T4a	N3		Stage III	A311-07	True
13722.58cfa830e4b0c9d6adf6c136	58cfa830e4b0c9d6adf6c136	TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted	TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted.bam	125.71	2.0	0.17	58cfa830e4b0c9d6adf6c136	TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0UJ-01A	FF82548A-F1BB-4DAA-A8F7-B3831B5843AD	Primary Tumor	Illumina HiSeq	094adbd4-f2af-42bb-9509-0dcfa2c6672f	Uterus	68.0	2EA1339F-A5EB-4552-AC13-858FA70E606E	15FDA615-0A79-4211-B5DE-F61741E8937A	TCGA-BS-A0UJ-01A-12D-A101-02	HG19_Broad_variant	TCGA-BS-A0UJ	TCGA-UCEC		s5221	Harvard Medical School	University of Hawaii	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa835e4b0c9d6adf6ec40	58cfa835e4b0c9d6adf6ec40	UNCID_1322607.fa3d0703-ce5e-49a9-96a6-0777f8e81cd3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1322607.fa3d0703-ce5e-49a9-96a6-0777f8e81cd3.sorted_genome_alignments	UNCID_1322607.fa3d0703-ce5e-49a9-96a6-0777f8e81cd3.sorted_genome_alignments.bam	197.7		0.13	58cfa835e4b0c9d6adf6ec40	UNCID_1322607.fa3d0703-ce5e-49a9-96a6-0777f8e81cd3.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-86-8075-01A	8869000D-09D7-465A-AC32-54D1935C43E7	Primary Tumor	Illumina HiSeq	9B1401CC-6F87-4BDF-9036-7D0E0904492D	Lung	66.0	23157CE2-7257-4118-9A6E-4CDFBC6C4BF7	FA3D0703-CE5E-49A9-96A6-0777F8E81CD3	TCGA-86-8075-01A-11R-2241-07	HG19	TCGA-86-8075	TCGA-LUAD		s11288	University of North Carolina	Asterand	Russia	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2241-07	True
13767.58cfa830e4b0c9d6adf6c0e6	58cfa830e4b0c9d6adf6c0e6	TCGA-BR-8297-01A-12R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-8297-01A-12R-2343-13_rnaseq	TCGA-BR-8297-01A-12R-2343-13_rnaseq.bam	69.2		0.15	58cfa830e4b0c9d6adf6c0e6	TCGA-BR-8297-01A-12R-2343-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8297-01A	304AAB66-4A2A-4B9F-AF87-4A591D518CA1	Primary Tumor	Illumina HiSeq	589DBF9E-1509-464E-B3A0-778188A2F2ED	Stomach	58.0	3A4B1C75-5258-4770-8B86-786FC6603A38	848AF30E-B9FD-4601-B656-5EFE82E5B9B7	TCGA-BR-8297-01A-12R-2343-13	GRCh37-lite	TCGA-BR-8297	TCGA-STAD		s14475	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4b	N3a	Stomach  Adenocarcinoma  Diffuse Type	Stage III	2343-13	True
13767.58cfa83ce4b0c9d6adf72f51	58cfa83ce4b0c9d6adf72f51	_1_TCGA-BR-8371-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-8371-01A-11R-2343-13_rnaseq	_1_TCGA-BR-8371-01A-11R-2343-13_rnaseq.bam	9.5		0.14	58cfa83ce4b0c9d6adf72f51	_1_TCGA-BR-8371-01A-11R-2343-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8371-01A	4020B1B1-576D-4869-9FF5-552E3AFB3AB5	Primary Tumor	Illumina HiSeq	0AEF653D-DDFD-4F8A-A765-0DD0E1FD6F44	Stomach	62.0	5014A0D9-535D-45C0-AD9E-710FFF6BA527	D9BFE0DD-31C7-47CD-8A1E-1EB36F8003D3	TCGA-BR-8371-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8371	TCGA-STAD		s15432	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2343-13	True
13767.58cfa837e4b0c9d6adf6fea4	58cfa837e4b0c9d6adf6fea4	UNCID_1781178.e35d643d-003d-4eed-88ce-65b7d4ba5a92.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1781178.e35d643d-003d-4eed-88ce-65b7d4ba5a92.sorted_genome_alignments	UNCID_1781178.e35d643d-003d-4eed-88ce-65b7d4ba5a92.sorted_genome_alignments.bam	141.8	1.8	0.15	58cfa837e4b0c9d6adf6fea4	UNCID_1781178.e35d643d-003d-4eed-88ce-65b7d4ba5a92.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-G4-6311-01A	79D33C28-A7E2-4FCA-8BE1-A16FB6D68D49	Primary Tumor	Illumina HiSeq	5D6C9683-FBF2-458A-ACBB-FBCE9E80E3B4	Colorectal	80.0	BAAC9AEB-B124-47BC-A454-4026847EB3E3	E35D643D-003D-4EED-88CE-65B7D4BA5A92	TCGA-G4-6311-01A-11R-1723-07	HG19	TCGA-G4-6311	TCGA-COAD		s13731	University of North Carolina	Roswell Park	None	NO	T3	N1	Colon Adenocarcinoma	Stage III	1723-07	True
13767.58cfa836e4b0c9d6adf6f3fe	58cfa836e4b0c9d6adf6f3fe	UNCID_1509622.625da09e-ed21-4b10-95f2-c889171194d1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1509622.625da09e-ed21-4b10-95f2-c889171194d1.sorted_genome_alignments	UNCID_1509622.625da09e-ed21-4b10-95f2-c889171194d1.sorted_genome_alignments.bam	29.2	1.7	0.15	58cfa836e4b0c9d6adf6f3fe	UNCID_1509622.625da09e-ed21-4b10-95f2-c889171194d1.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-6689-01A	8D07B1E8-5D1D-4A43-B616-D29DD58CE5FE	Primary Tumor	Illumina HiSeq	CC4AAB0F-6E56-450F-ADA9-2079C41D5E2E	Brain	30.0	D81C3F19-BBCF-4071-8BA4-CB8C505307D7	625DA09E-ED21-4B10-95F2-C889171194D1	TCGA-FG-6689-01A-11R-1896-07	HG19	TCGA-FG-6689	TCGA-LGG		s8173	University of North Carolina	Case Western	United States	NO			Astrocytoma		1896-07	True
13722.58cfa831e4b0c9d6adf6cde6	58cfa831e4b0c9d6adf6cde6	TCGA-FS-A1YX-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FS-A1YX-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_1_rg.sorted	TCGA-FS-A1YX-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_1_rg.sorted.bam	36.84		0.16	58cfa831e4b0c9d6adf6cde6	TCGA-FS-A1YX-06A-11D-A18Y_120724_SN208_0417_AC117BACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1YX-06A	4537C0E1-B2BD-425F-A6F4-27F4733DC25A	Metastatic	Illumina HiSeq	6126185a-3723-4e2e-8299-9b572802970a	Skin	39.0	15D812E2-2BB0-47F0-80D2-5F72697BA71B	F487FF4F-86E2-4F0B-A166-39A39670A9F9	TCGA-FS-A1YX-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-FS-A1YX	TCGA-SKCM	1478.0	s7365	Harvard Medical School	Essen	Germany	NO	T2	N0		Stage I	A18Y-02	True
13722.58cfa832e4b0c9d6adf6d2ba	58cfa832e4b0c9d6adf6d2ba	TCGA-KL-8333-11A-01D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8333-11A-01D-2310-10_wgs_Illumina	TCGA-KL-8333-11A-01D-2310-10_wgs_Illumina.bam	115.3		0.05	58cfa832e4b0c9d6adf6d2ba	TCGA-KL-8333-11A-01D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8333-11A	02EC7A3A-2812-4A65-93CD-07BF655CC91B	Solid Tissue Normal	Illumina HiSeq	fb409ada-99b5-4fcd-84cb-ab8b46e02999	Kidney	69.0	DC041EC8-D19C-4066-AA97-719683AA5F83	422375BA-7C98-42A5-B8CC-F88084A938F6	TCGA-KL-8333-11A-01D-2310-10	GRCh37-lite	TCGA-KL-8333	TCGA-KICH		s16569	Baylor College of Medicine	MSKCC	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	True
13767.58cfa82fe4b0c9d6adf6b9b5	58cfa82fe4b0c9d6adf6b9b5	TCGA-59-2348-01A-01R-1569-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-59-2348-01A-01R-1569-13_GRCh37-lite_rnaseq	TCGA-59-2348-01A-01R-1569-13_GRCh37-lite_rnaseq.bam	658.0	1.8	0.14	58cfa82fe4b0c9d6adf6b9b5	TCGA-59-2348-01A-01R-1569-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-59-2348-01A	20CF00EA-D7DA-42BB-BCE7-F005F0B952EB	Primary Tumor	Illumina HiSeq	21B56485-EA74-423D-B613-898FF9656B21	Ovary	59.0	CBDAFA49-7DD7-4A42-B0A5-891AAD11A802	7162D809-FF1A-4346-BB00-C8086386EC46	TCGA-59-2348-01A-01R-1569-13	GRCh37-lite	TCGA-59-2348	TCGA-OV		s17642	Canada's Michael Smith Genome Sciences Centre	Roswell Park	None	NO			Serous Cystadenocarcinoma		1569-13	True
13767.58cfa839e4b0c9d6adf71226	58cfa839e4b0c9d6adf71226	UNCID_2283356.323b6c3b-a058-4bea-a4fa-38752f26ca6c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2283356.323b6c3b-a058-4bea-a4fa-38752f26ca6c.sorted_genome_alignments	UNCID_2283356.323b6c3b-a058-4bea-a4fa-38752f26ca6c.sorted_genome_alignments.bam	200.2		0.14	58cfa839e4b0c9d6adf71226	UNCID_2283356.323b6c3b-a058-4bea-a4fa-38752f26ca6c.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-A4-7734-01A	D8B73891-05E0-4AB5-AB2E-0ACF8D03595C	Primary Tumor	Illumina HiSeq	B149F10F-E105-4865-96AC-A0BF14B11778	Kidney	53.0	F1E7A305-C9D8-4391-A86A-0BBDB8864508	323B6C3B-A058-4BEA-A4FA-38752F26CA6C	TCGA-A4-7734-01A-11R-A32Z-07	HG19	TCGA-A4-7734	TCGA-KIRP		s11927	University of North Carolina	International Genomics Consortium	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A32Z-07	True
13722.58cfa82ee4b0c9d6adf6ae7b	58cfa82ee4b0c9d6adf6ae7b	G49537.TCGA-FE-A233-10A-01D-A14W-08.1.filtered.	WGS	G49537.TCGA-FE-A233-10A-01D-A14W-08.1	G49537.TCGA-FE-A233-10A-01D-A14W-08.1.bam	21.67	2.0	0.09	58cfa82ee4b0c9d6adf6ae7b	G49537.TCGA-FE-A233-10A-01D-A14W-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A233-10A	E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB	Blood Derived Normal	Illumina HiSeq	ebf0fa86-af7b-4163-8475-c1e634821353	Thyroid	18.0	B9FD4BE0-F412-494D-8837-BEB45B0A3B03	C978BBEE-66B4-4C0C-AA14-7667A1765DBB	TCGA-FE-A233-10A-01D-A14W-08	HG19_Broad_variant	TCGA-FE-A233	TCGA-THCA		s12222	Broad Institute of MIT and Harvard	Ohio State University	United States	NO	T2	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14W-08	True
13767.58cfa83ce4b0c9d6adf72e82	58cfa83ce4b0c9d6adf72e82	_1_TCGA-CD-8524-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-CD-8524-01A-11R-2343-13_rnaseq	_1_TCGA-CD-8524-01A-11R-2343-13_rnaseq.bam	130.2		0.15	58cfa83ce4b0c9d6adf72e82	_1_TCGA-CD-8524-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-8524-01A	315B8DE8-9842-4738-B23B-1D61722F9583	Primary Tumor	Illumina HiSeq	94074B9F-4EBF-4BD1-A234-6483CD38D8C9	Stomach	61.0	BF8DE758-5BBB-48BE-81AE-B310A10B71F6	F5CA8802-12EC-404D-ABCD-3CD49AD3601F	TCGA-CD-8524-01A-11R-2343-13	GRCh37-lite	TCGA-CD-8524	TCGA-STAD		s15020	Canada's Michael Smith Genome Sciences Centre	ILSbio	Vietnam	NO	T3	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2343-13	True
13767.58cfa82fe4b0c9d6adf6b356	58cfa82fe4b0c9d6adf6b356	TCGA-24-1923-01A-01R-1567-13_rnaseq.filtered.	RNA-Seq	TCGA-24-1923-01A-01R-1567-13_rnaseq	TCGA-24-1923-01A-01R-1567-13_rnaseq.bam	426.0	1.8	0.13	58cfa82fe4b0c9d6adf6b356	TCGA-24-1923-01A-01R-1567-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1923-01A	8449955F-42D9-46F6-919A-5CC5D59E6284	Primary Tumor	Illumina HiSeq	7023EE7F-F0BD-4B0A-907B-01DD48472562	Ovary	51.0	84D06F56-6611-4FA1-89FD-DF8780F7F446	D34AE25D-8073-4129-A1B8-3F43E19AF73B	TCGA-24-1923-01A-01R-1567-13	NCBI36_BCCAGSC_variant	TCGA-24-1923	TCGA-OV	690.0	s17245	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa830e4b0c9d6adf6c095	58cfa830e4b0c9d6adf6c095	TCGA-BR-8373-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-8373-01A-11R-2343-13_rnaseq	TCGA-BR-8373-01A-11R-2343-13_rnaseq.bam	117.5		0.15	58cfa830e4b0c9d6adf6c095	TCGA-BR-8373-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8373-01A	60879669-96C2-4710-82E0-0AE9D0E5B242	Primary Tumor	Illumina HiSeq	2F9DF6A9-D705-470E-B907-C01737325431	Stomach	65.0	4370B4F3-4FD7-4558-BF59-DAAE486BADC3	14FD82B2-A288-403B-8608-C1D99F602C6F	TCGA-BR-8373-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8373	TCGA-STAD		s15310	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T4a	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2343-13	True
13767.58cfa838e4b0c9d6adf70cd6	58cfa838e4b0c9d6adf70cd6	UNCID_2173211.43a88718-f528-4d0b-88e6-f2ade6854c53.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2173211.43a88718-f528-4d0b-88e6-f2ade6854c53.sorted_genome_alignments	UNCID_2173211.43a88718-f528-4d0b-88e6-f2ade6854c53.sorted_genome_alignments.bam	6.25	1.89	0.15	58cfa838e4b0c9d6adf70cd6	UNCID_2173211.43a88718-f528-4d0b-88e6-f2ade6854c53.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A572-01A	06EF6E83-5583-45B9-A0BD-EDEA68943083	Primary Tumor	Illumina HiSeq	65325ACE-9192-48BF-8AE1-6CDFE01C23E9	Breast	72.0	9DE14345-B948-4929-AAD7-8ABC4E2D35BA	43A88718-F528-4D0B-88E6-F2ADE6854C53	TCGA-E2-A572-01A-13R-A31O-07	HG19	TCGA-E2-A572	TCGA-BRCA		s5607	University of North Carolina	Roswell Park	United States	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage III	A31O-07	True
13767.58cfa83ce4b0c9d6adf72b4e	58cfa83ce4b0c9d6adf72b4e	UNCID_373081.TCGA-B8-4151-01A-01R-1188-07.110418_UNC15-SN850_0063_BB07MAABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_373081.TCGA-B8-4151-01A-01R-1188-07.110418_UNC15-SN850_0063_BB07MAABXX.8.trimmed.annotated.translated_to_genomic	UNCID_373081.TCGA-B8-4151-01A-01R-1188-07.110418_UNC15-SN850_0063_BB07MAABXX.8.trimmed.annotated.translated_to_genomic.bam	32.63	1.8	0.15	58cfa83ce4b0c9d6adf72b4e	UNCID_373081.TCGA-B8-4151-01A-01R-1188-07.110418_UNC15-SN850_0063_BB07MAABXX.8.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B8-4151-01A	B428463A-75D5-4663-A53B-EC2993795CC0	Primary Tumor	Illumina HiSeq	B8C58B1B-3DF0-4C0D-9DF2-E991169C75C1	Kidney	51.0	641BC815-243D-443A-9364-ABC84E3861E5	7EA95D05-854F-40B3-B308-A6DF97F5C805	TCGA-B8-4151-01A-01R-1188-07	HG19	TCGA-B8-4151	TCGA-KIRC		s9269	University of North Carolina	UNC	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1188-07	True
13767.58cfa833e4b0c9d6adf6df32	58cfa833e4b0c9d6adf6df32	UNCID_1156152.a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1156152.a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb.sorted_genome_alignments	UNCID_1156152.a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb.sorted_genome_alignments.bam	40.93	1.83	0.14	58cfa833e4b0c9d6adf6df32	UNCID_1156152.a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb.sorted_genome_alignments.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A03O-01A	1111FB30-46CE-4722-98DA-EC9BA2323D90	Primary Tumor	Illumina HiSeq	ECA0E3AB-D899-4B8C-B9AC-873996BDB1CC	Breast	69.0	A19FBCC1-A781-4496-97ED-487AA83AAE29	A1460E9A-C4AA-4E07-ABF4-FDB5F42F5EEB	TCGA-AO-A03O-01A-11R-A00Z-07	HG19	TCGA-AO-A03O	TCGA-BRCA	2483.0	s6375	University of North Carolina	MSKCC	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A00Z-07	True
13767.58cfa83be4b0c9d6adf724ff	58cfa83be4b0c9d6adf724ff	UNCID_2646747.e5241411-aec5-4822-8522-8e74c51a0d79.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2646747.e5241411-aec5-4822-8522-8e74c51a0d79.sorted_genome_alignments	UNCID_2646747.e5241411-aec5-4822-8522-8e74c51a0d79.sorted_genome_alignments.bam	56.56	1.85	0.16	58cfa83be4b0c9d6adf724ff	UNCID_2646747.e5241411-aec5-4822-8522-8e74c51a0d79.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-VS-A9U5-01A	939ABCA1-8BD0-4271-9A9B-666764EEB3B6	Primary Tumor	Illumina HiSeq	6B8AB7DC-88FA-40E6-AC2C-7BA8CD8EBB60	Cervix	57.0	CAB5DA46-F163-42EB-8BA8-43ED69E8E518	E5241411-AEC5-4822-8522-8E74C51A0D79	TCGA-VS-A9U5-01A-11R-A42T-07	HG19	TCGA-VS-A9U5	TCGA-CESC		s1327	University of North Carolina	Barretos Cancer Hospital	Brazil	NO	T2b	NX	Cervical Squamous Cell Carcinoma		A42T-07	True
13767.58cfa83ce4b0c9d6adf72b73	58cfa83ce4b0c9d6adf72b73	UNCID_373899.TCGA-A3-3319-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_373899.TCGA-A3-3319-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.7.trimmed.annotated.translated_to_genomic	UNCID_373899.TCGA-A3-3319-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.7.trimmed.annotated.translated_to_genomic.bam	53.33	1.8	0.14	58cfa83ce4b0c9d6adf72b73	UNCID_373899.TCGA-A3-3319-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.7.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3319-01A	22B6724C-A59F-4796-8166-992253E8CAF1	Primary Tumor	Illumina HiSeq	3CCF4361-36AA-47E8-B83A-F2A2BB9D0EB5	Kidney	70.0	0050544D-D812-4A18-8370-96D629B487AB	32B0CB14-AF29-4F2E-A1C9-3510C8A03C97	TCGA-A3-3319-01A-02R-1325-07	HG19	TCGA-A3-3319	TCGA-KIRC		s9109	University of North Carolina	International Genomics Consortium	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1325-07	True
13767.58cfa82fe4b0c9d6adf6b73b	58cfa82fe4b0c9d6adf6b73b	TCGA-61-2104-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-61-2104-01A-01R-1568-13_rnaseq	TCGA-61-2104-01A-01R-1568-13_rnaseq.bam	555.0	1.8	0.16	58cfa82fe4b0c9d6adf6b73b	TCGA-61-2104-01A-01R-1568-13_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2104-01A	05263959-C4F5-4540-B6D2-D8C8A128861F	Primary Tumor	Illumina HiSeq	7339C657-3A84-443C-962B-036B7E28FE8C	Ovary	53.0	87B7ED22-4FE1-4539-8C37-AB085E2CB9C1	721A8FC8-BB54-4EC3-A19C-340C35F05280	TCGA-61-2104-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-61-2104	TCGA-OV		s17649	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa82fe4b0c9d6adf6b7ae	58cfa82fe4b0c9d6adf6b7ae	TCGA-30-1892-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-30-1892-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-30-1892-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	188.0	1.8	0.15	58cfa82fe4b0c9d6adf6b7ae	TCGA-30-1892-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-30-1892-01A	A09F0626-002A-48FD-8B2D-C66B8285CF23	Primary Tumor	Illumina HiSeq	F9E93769-AE5B-4742-A291-41E6986C1EEA	Ovary	52.0	5B68E68C-3CBF-4506-AC94-4B23B3DABA70	BB8DC795-80FF-4B42-8CF8-9F9716C13967	TCGA-30-1892-01A-01R-1568-13	GRCh37-lite	TCGA-30-1892	TCGA-OV	1484.0	s17692	Canada's Michael Smith Genome Sciences Centre	Harvard	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa82fe4b0c9d6adf6b208	58cfa82fe4b0c9d6adf6b208	TCGA-23-1023-01A-02R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-23-1023-01A-02R-1564-13_GRCh37-lite_rnaseq	TCGA-23-1023-01A-02R-1564-13_GRCh37-lite_rnaseq.bam	50.7	1.8	0.16	58cfa82fe4b0c9d6adf6b208	TCGA-23-1023-01A-02R-1564-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1023-01A	9E18238F-AE85-4B75-AE87-D92DA9731A40	Primary Tumor	Illumina HiSeq	D588C018-0194-4724-98F9-0FCD260D5EF7	Ovary	65.0	A6FDFC35-A178-4D5A-8E07-346B55DD936D	69BEC2DB-02C3-46CA-B17B-60EAE9A1E0BF	TCGA-23-1023-01A-02R-1564-13	GRCh37-lite	TCGA-23-1023	TCGA-OV		s17668	Canada's Michael Smith Genome Sciences Centre	Cedars Sinai	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa834e4b0c9d6adf6e66c	58cfa834e4b0c9d6adf6e66c	UNCID_1188874.500ee741-b6df-437b-8852-c21371f0212f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1188874.500ee741-b6df-437b-8852-c21371f0212f.sorted_genome_alignments	UNCID_1188874.500ee741-b6df-437b-8852-c21371f0212f.sorted_genome_alignments.bam	14.8	1.7	0.14	58cfa834e4b0c9d6adf6e66c	UNCID_1188874.500ee741-b6df-437b-8852-c21371f0212f.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-DV-5565-01A	F6D28A1D-6691-4AC1-8AFB-AB0E7DCEF867	Primary Tumor	Illumina HiSeq	32501311-8FA0-44C3-8E6D-00FBF7FE4A7A	Kidney	59.0	39A226B0-3F39-4A2F-9E38-2AD77349A213	500EE741-B6DF-437B-8852-C21371F0212F	TCGA-DV-5565-01A-01R-1541-07	HG19	TCGA-DV-5565	TCGA-KIRC		s9488	University of North Carolina	NCI Urologic Oncology Branch	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa838e4b0c9d6adf70558	58cfa838e4b0c9d6adf70558	UNCID_1943204.42a4a133-ec9d-4f5a-8b95-be83cbddb148.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1943204.42a4a133-ec9d-4f5a-8b95-be83cbddb148.sorted_genome_alignments	UNCID_1943204.42a4a133-ec9d-4f5a-8b95-be83cbddb148.sorted_genome_alignments.bam	99.2		0.13	58cfa838e4b0c9d6adf70558	UNCID_1943204.42a4a133-ec9d-4f5a-8b95-be83cbddb148.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-8460-01A	497CC506-03FE-4FFA-860B-5A12ADB1BC7D	Primary Tumor	Illumina HiSeq	9A107790-CF55-40E8-8A41-1F407B7D7A43	Lung	74.0	40BFEEE7-9932-47D6-87A8-5FD7514C2917	42A4A133-EC9D-4F5A-8B95-BE83CBDDB148	TCGA-50-8460-01A-11R-2326-07	HG19	TCGA-50-8460	TCGA-LUAD		s11074	University of North Carolina	University of Pittsburgh	United States	NO	T1a	N0	Lung Papillary Adenocarcinoma	Stage I	2326-07	True
13722.58cfa831e4b0c9d6adf6cae6	58cfa831e4b0c9d6adf6cae6	TCGA-D9-A1JX-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D9-A1JX-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_5_rg.sorted	TCGA-D9-A1JX-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_5_rg.sorted.bam	50.25		0.14	58cfa831e4b0c9d6adf6cae6	TCGA-D9-A1JX-06A-11D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D9-A1JX-06A	F505058F-74F2-4476-887F-06590A605980	Metastatic	Illumina HiSeq	88b1dbb7-2897-4de5-a042-e5a7d53d6389	Skin	80.0	24A6A89E-4FA9-4245-BB7F-C28C9385AE0F	1A90853A-2BEE-415D-854B-456C8CDABC0C	TCGA-D9-A1JX-06A-11D-A18Z-02	HG19_Broad_variant	TCGA-D9-A1JX	TCGA-SKCM		s8002	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	TX	NX			A18Z-02	True
13722.58cfa830e4b0c9d6adf6bcaa	58cfa830e4b0c9d6adf6bcaa	TCGA-AG-3727-10A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3727-10A-01D-1989-10_wgs_Illumina	TCGA-AG-3727-10A-01D-1989-10_wgs_Illumina.bam	55.31	1.9	0.15	58cfa830e4b0c9d6adf6bcaa	TCGA-AG-3727-10A-01D-1989-10_wgs_Illumina.bam	Alive	FEMALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3727-10A	E6827400-0D95-46B0-8874-6CE9E9D5011B	Blood Derived Normal	Illumina HiSeq	07ae68ae-0178-476c-b9ec-f0d898ced469	Colorectal	78.0	A2FEF5A0-A5B1-4835-B92E-6F1E8C88C510	8AECF7AD-6962-433A-8D76-9A0DAF6C4FDE	TCGA-AG-3727-10A-01D-1989-10	GRCh37-lite	TCGA-AG-3727	TCGA-READ		s2307	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage III	1989-10	True
13767.58cfa835e4b0c9d6adf6ef54	58cfa835e4b0c9d6adf6ef54	UNCID_1464777.6cee6409-b66f-4081-ad97-e61adb5e1102.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1464777.6cee6409-b66f-4081-ad97-e61adb5e1102.sorted_genome_alignments	UNCID_1464777.6cee6409-b66f-4081-ad97-e61adb5e1102.sorted_genome_alignments.bam	34.8	1.7	0.14	58cfa835e4b0c9d6adf6ef54	UNCID_1464777.6cee6409-b66f-4081-ad97-e61adb5e1102.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-EU-5906-01A	68A1A23A-E762-440B-859E-2BEBB42D0D59	Primary Tumor	Illumina HiSeq	01CDB997-544F-4414-AC76-0A276D2A2B37	Kidney	55.0	A04C6BDB-0842-43D1-B88A-7DD75AC40486	6CEE6409-B66F-4081-AD97-E61ADB5E1102	TCGA-EU-5906-01A-11R-1672-07	HG19	TCGA-EU-5906	TCGA-KIRC		s9234	University of North Carolina	CHI-Penrose Colorado	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1672-07	True
13722.58cfa831e4b0c9d6adf6cc8b	58cfa831e4b0c9d6adf6cc8b	TCGA-ER-A19N-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_7_rg.sorted.filtered.	WGS	TCGA-ER-A19N-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_7_rg.sorted	TCGA-ER-A19N-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_7_rg.sorted.bam	45.46		0.16	58cfa831e4b0c9d6adf6cc8b	TCGA-ER-A19N-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A19N-10A	9EE83669-D7A4-476E-8857-304600B4917A	Blood Derived Normal	Illumina HiSeq	0b049bb6-7ac6-4ef2-b258-988bafaf88e0	Skin	47.0	7872967C-2ADD-4157-9CC0-FD87C2F32AEE	708F03DF-83EE-47F7-99F4-AD2E7E0DB63B	TCGA-ER-A19N-10A-01D-A190-02	HG19_Broad_variant	TCGA-ER-A19N	TCGA-SKCM		s7694	Harvard Medical School	University of Pittsburgh	United States	NO					A190-02	True
13767.58cfa833e4b0c9d6adf6d9ee	58cfa833e4b0c9d6adf6d9ee	UNCID_1078643.87ef65df-919a-4c65-87db-364380aec736.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1078643.87ef65df-919a-4c65-87db-364380aec736.sorted_genome_alignments	UNCID_1078643.87ef65df-919a-4c65-87db-364380aec736.sorted_genome_alignments.bam	286.0	1.8	0.15	58cfa833e4b0c9d6adf6d9ee	UNCID_1078643.87ef65df-919a-4c65-87db-364380aec736.sorted_genome_alignments.bam	Alive	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2781-01A	D49B0369-905C-4608-96A9-CC854980FC4C	Primary Tumor	Illumina HiSeq	2DF5A1DB-2623-4101-9DA7-CB8D3D563DB1	Lung	67.0	C7B943AB-3CA3-43D3-9BFC-4C6785964B28	87EF65DF-919A-4C65-87DB-364380AEC736	TCGA-66-2781-01A-01R-0851-07	HG19	TCGA-66-2781	TCGA-LUSC		s10300	University of North Carolina	Indivumed	Germany	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	0851-07	True
13722.58cfa82de4b0c9d6adf6a62e	58cfa82de4b0c9d6adf6a62e	5e5b36501f397d1baded6fb8e0d1272a.filtered.	WGS	5e5b36501f397d1baded6fb8e0d1272a	5e5b36501f397d1baded6fb8e0d1272a.bam	14.43	1.39	0.08	58cfa82de4b0c9d6adf6a62e	5e5b36501f397d1baded6fb8e0d1272a.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16G-10A	16E69011-C295-479F-B521-86E66FBA498D	Blood Derived Normal	Illumina HiSeq	da837283-ab60-47a3-bbd9-5a449b9e409e	Uterus	74.0	5F56BA05-2FAF-4052-B4C7-1F6E0C349C51	6D3D68E8-21D1-40AF-9B9F-933980A38801	TCGA-D1-A16G-10A-01D-A12J-09	GRCh37-lite	TCGA-D1-A16G	TCGA-UCEC	834.0	s4239	Washington University School of Medicine	Mayo Clinic	None	NO			Serous endometrial adenocarcinoma		A12J-09	False
13767.58cfa837e4b0c9d6adf70312	58cfa837e4b0c9d6adf70312	UNCID_1948345.0dc7cb6e-bb27-4da5-90ed-c062dc9fda0b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1948345.0dc7cb6e-bb27-4da5-90ed-c062dc9fda0b.sorted_genome_alignments	UNCID_1948345.0dc7cb6e-bb27-4da5-90ed-c062dc9fda0b.sorted_genome_alignments.bam	19.8	1.7	0.14	58cfa837e4b0c9d6adf70312	UNCID_1948345.0dc7cb6e-bb27-4da5-90ed-c062dc9fda0b.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-G4-6310-01A	14C13B05-ABFE-472E-83A9-B28F60E58AD8	Primary Tumor	Illumina HiSeq	CCC44CA2-2E42-4083-9252-597D398BE401	Colorectal	69.0	A0322F55-0853-4B63-9788-4E750557BB58	0DC7CB6E-BB27-4DA5-90ED-C062DC9FDA0B	TCGA-G4-6310-01A-11R-1723-07	HG19	TCGA-G4-6310	TCGA-COAD		s13857	University of North Carolina	Roswell Park	United States	NO	T3	N1	Colon Adenocarcinoma	Stage III	1723-07	True
13722.58cfa830e4b0c9d6adf6c263	58cfa830e4b0c9d6adf6c263	TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted	TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted.bam	7.54	2.03	0.13	58cfa830e4b0c9d6adf6c263	TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HX-10A	3B01D064-8C00-4972-9F07-407EAC8E7534	Blood Derived Normal	Illumina HiSeq	f43d0ad4-4ad4-4388-833e-94faf1db1598	Breast	54.0	B17B1EEF-04FD-4D51-B4AE-6E071AFBED16	39C48C76-B9AC-4485-A7C3-4729A56F830C	TCGA-BH-A0HX-10A-02D-A060-02	HG19_Broad_variant	TCGA-BH-A0HX	TCGA-BRCA		s6466	Harvard Medical School	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A060-02	True
13767.58cfa833e4b0c9d6adf6dc4f	58cfa833e4b0c9d6adf6dc4f	UNCID_1123719.fce0d59e-78a5-4d7b-8136-b8421f5116b0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1123719.fce0d59e-78a5-4d7b-8136-b8421f5116b0.sorted_genome_alignments	UNCID_1123719.fce0d59e-78a5-4d7b-8136-b8421f5116b0.sorted_genome_alignments.bam	10.87	1.82	0.15	58cfa833e4b0c9d6adf6dc4f	UNCID_1123719.fce0d59e-78a5-4d7b-8136-b8421f5116b0.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A2FB-01A	02BBB632-0F7F-439D-B8F0-C86A06237424	Primary Tumor	Illumina HiSeq	4781EEE7-46D5-48AB-914D-1B2253D7ED5D	Breast	65.0	7E2ED541-38EE-473F-AC5D-3CAE6F5D9A56	FCE0D59E-78A5-4D7B-8136-B8421F5116B0	TCGA-AC-A2FB-01A-11R-A17B-07	HG19	TCGA-AC-A2FB	TCGA-BRCA		s5996	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Infiltrating Lobular Carcinoma	Stage II	A17B-07	True
13767.58cfa837e4b0c9d6adf6fcdc	58cfa837e4b0c9d6adf6fcdc	UNCID_1674392.7509b7dc-18cc-4430-ad93-fa598fc97330.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1674392.7509b7dc-18cc-4430-ad93-fa598fc97330.sorted_genome_alignments	UNCID_1674392.7509b7dc-18cc-4430-ad93-fa598fc97330.sorted_genome_alignments.bam	63.76	1.71	0.16	58cfa837e4b0c9d6adf6fcdc	UNCID_1674392.7509b7dc-18cc-4430-ad93-fa598fc97330.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A03Y-01A	A991644B-3EE6-4CDA-ACF0-E37DE48A49FC	Primary Tumor	Illumina HiSeq	767A3B3B-4FF3-4D84-9CC4-3BF56C963EA0	Breast	66.0	95C533D3-798C-4ACA-8F38-DC4825F254B5	7509B7DC-18CC-4430-AD93-FA598FC97330	TCGA-AN-A03Y-01A-21R-A00Z-07	HG19	TCGA-AN-A03Y	TCGA-BRCA		s6068	University of North Carolina	Cureline	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A00Z-07	True
13767.58cfa837e4b0c9d6adf6ff42	58cfa837e4b0c9d6adf6ff42	UNCID_1797311.8c79f5ec-ce4f-4c86-8d1c-71495c276d74.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1797311.8c79f5ec-ce4f-4c86-8d1c-71495c276d74.sorted_genome_alignments	UNCID_1797311.8c79f5ec-ce4f-4c86-8d1c-71495c276d74.sorted_genome_alignments.bam	30.44	1.82	0.16	58cfa837e4b0c9d6adf6ff42	UNCID_1797311.8c79f5ec-ce4f-4c86-8d1c-71495c276d74.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FJ-A3Z7-01A	6B2D63F2-F390-4601-9640-F769F6E91BF4	Primary Tumor	Illumina HiSeq	96191F48-4530-45E8-939F-757917D53060	Bladder	76.0	59C94C10-41DC-4599-AA18-AE37F3715134	8C79F5EC-CE4F-4C86-8D1C-71495C276D74	TCGA-FJ-A3Z7-01A-12R-A23N-07	HG19	TCGA-FJ-A3Z7	TCGA-BLCA		s2777	University of North Carolina	BLN - Baylor	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A23N-07	True
13767.58cfa83ce4b0c9d6adf72cbc	58cfa83ce4b0c9d6adf72cbc	UNCID_609742.14861126-c113-48e2-af64-41d946dc09ec.111027_UNC11-SN627_0163_AC0537ABXX.2.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_609742.14861126-c113-48e2-af64-41d946dc09ec.111027_UNC11-SN627_0163_AC0537ABXX.2.trimmed.annotated.translated_to_genomic	UNCID_609742.14861126-c113-48e2-af64-41d946dc09ec.111027_UNC11-SN627_0163_AC0537ABXX.2.trimmed.annotated.translated_to_genomic.bam	81.8	1.7	0.15	58cfa83ce4b0c9d6adf72cbc	UNCID_609742.14861126-c113-48e2-af64-41d946dc09ec.111027_UNC11-SN627_0163_AC0537ABXX.2.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5686-01A	0631DC8C-5950-4419-ADF2-EC3B1E259FC8	Primary Tumor	Illumina HiSeq	133E7A60-BF4A-4E5F-9B1D-E174E9122FC3	Kidney	59.0	6FC94822-85D4-43FF-87DC-0775840A15B4	14861126-C113-48E2-AF64-41D946DC09EC	TCGA-CJ-5686-01A-11R-1672-07	HG19	TCGA-CJ-5686	TCGA-KIRC		s9933	University of North Carolina	MD Anderson Cancer Center	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1672-07	True
13767.58cfa834e4b0c9d6adf6e346	58cfa834e4b0c9d6adf6e346	UNCID_1187397.e1437c87-6524-47c2-b123-32699e5a7bb7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1187397.e1437c87-6524-47c2-b123-32699e5a7bb7.sorted_genome_alignments	UNCID_1187397.e1437c87-6524-47c2-b123-32699e5a7bb7.sorted_genome_alignments.bam	41.8	1.8	0.15	58cfa834e4b0c9d6adf6e346	UNCID_1187397.e1437c87-6524-47c2-b123-32699e5a7bb7.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5690-11A	794AEB92-205F-4C75-BB1A-0B2C6DB99FEA	Solid Tissue Normal	Illumina HiSeq	405BF0D9-D55A-4C95-BAED-C4943865FB98	Kidney	53.0	BB0BF831-BFD2-43F3-A39C-3ACE235AF98B	E1437C87-6524-47C2-B123-32699E5A7BB7	TCGA-B0-5690-11A-01R-1541-07	HG19	TCGA-B0-5690	TCGA-KIRC		s9623	University of North Carolina	University of Pittsburgh	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa834e4b0c9d6adf6e471	58cfa834e4b0c9d6adf6e471	UNCID_1199623.ad98ce63-0a5d-46cc-b1cc-ee2aebe8ae59.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1199623.ad98ce63-0a5d-46cc-b1cc-ee2aebe8ae59.sorted_genome_alignments	UNCID_1199623.ad98ce63-0a5d-46cc-b1cc-ee2aebe8ae59.sorted_genome_alignments.bam	33.3	1.8	0.17	58cfa834e4b0c9d6adf6e471	UNCID_1199623.ad98ce63-0a5d-46cc-b1cc-ee2aebe8ae59.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4345-01A	8958C2BF-B986-4C07-98D2-09DFE2375A14	Primary Tumor	Illumina HiSeq	2297C173-36C4-479D-90DF-B4FFC0AA2B3E	Kidney	62.0	8485819F-DB44-43B9-B330-1AA55F1B8FC7	AD98CE63-0A5D-46CC-B1CC-EE2AEBE8AE59	TCGA-BP-4345-01A-01R-1289-07	HG19	TCGA-BP-4345	TCGA-KIRC		s9819	University of North Carolina	MSKCC	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1289-07	True
13722.58cfa82ee4b0c9d6adf6acb0	58cfa82ee4b0c9d6adf6acb0	G48125.TCGA-13-0727-10B-01D-A312-08.2.filtered.	WGS	G48125.TCGA-13-0727-10B-01D-A312-08.2	G48125.TCGA-13-0727-10B-01D-A312-08.2.bam	43.3	1.9	0.09	58cfa82ee4b0c9d6adf6acb0	G48125.TCGA-13-0727-10B-01D-A312-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0727-10B	90F4B65C-CFD4-4066-A5B9-842885C172E2	Blood Derived Normal	Illumina HiSeq	53740d76-9b94-4e51-8980-c22f626c8d0e	Ovary	71.0	C34A0507-6FD2-4792-90ED-84DF9C699016	1B4A88E7-AB45-4584-8824-C008D74BFBF1	TCGA-13-0727-10B-01D-A312-08	HG19_Broad_variant	TCGA-13-0727	TCGA-OV	462.0	s17348	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		A312-08	True
13767.58cfa82fe4b0c9d6adf6b2a4	58cfa82fe4b0c9d6adf6b2a4	TCGA-13-0906-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0906-01A-01R-1564-13_rnaseq	TCGA-13-0906-01A-01R-1564-13_rnaseq.bam	166.0	1.8	0.15	58cfa82fe4b0c9d6adf6b2a4	TCGA-13-0906-01A-01R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0906-01A	E43D3769-E25F-4FB7-9080-EA26DEFAF094	Primary Tumor	Illumina HiSeq	A698B8D8-0B98-456C-99E6-16A64EDBEEA8	Ovary	50.0	A0C48680-3CAF-49BD-B495-C9FD3A9CBE76	7FA0EBA3-8A33-425D-A7FB-2FA169E5F8E6	TCGA-13-0906-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-13-0906	TCGA-OV		s17917	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa83be4b0c9d6adf72016	58cfa83be4b0c9d6adf72016	UNCID_2548332.5f6c1690-7f39-4fbb-bee2-266c6f6fc307.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2548332.5f6c1690-7f39-4fbb-bee2-266c6f6fc307.sorted_genome_alignments	UNCID_2548332.5f6c1690-7f39-4fbb-bee2-266c6f6fc307.sorted_genome_alignments.bam	53.05	1.83	0.17	58cfa83be4b0c9d6adf72016	UNCID_2548332.5f6c1690-7f39-4fbb-bee2-266c6f6fc307.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Mesothelioma	Aligned reads	TCGA-ZN-A9VO-01A	894B5569-4E33-4E8D-A70C-63DD4C74C3CF	Primary Tumor	Illumina HiSeq	6F5C407C-712A-4B72-89C8-96BD63CD9D76	Mesothelium	36.0	D39DA5A5-2C0D-40E1-B0BF-C9C75530A2C5	5F6C1690-7F39-4FBB-BEE2-266C6F6FC307	TCGA-ZN-A9VO-01A-11R-A40A-07	HG19	TCGA-ZN-A9VO	TCGA-MESO		s420	University of North Carolina	Brigham and Women's Hospital Division of Thoracic Surgery	United States	NO	T4	N2		Stage IV	A40A-07	True
13722.58cfa82ee4b0c9d6adf6ad33	58cfa82ee4b0c9d6adf6ad33	G49837.TCGA-66-2759-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-66-2759-01A-01D-A320-08.2	G49837.TCGA-66-2759-01A-01D-A320-08.2.bam	604.93	1.9	0.08	58cfa82ee4b0c9d6adf6ad33	G49837.TCGA-66-2759-01A-01D-A320-08.2.bam	Alive	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2759-01A	E6B72C24-1607-43B9-8B8A-7BF83EEA5895	Primary Tumor	Illumina HiSeq	38482025-33d2-4b12-a2f0-2654d26fe714	Lung	66.0	33918A59-C2B0-435E-BA63-8A39DA191712	7AC0B303-D685-4FA5-BFEC-34D2BA1DBC8E	TCGA-66-2759-01A-01D-A320-08	HG19_Broad_variant	TCGA-66-2759	TCGA-LUSC		s10165	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	A320-08	True
13767.58cfa838e4b0c9d6adf70bf1	58cfa838e4b0c9d6adf70bf1	UNCID_2146640.896ab3e0-3ea4-4459-b0bf-9ccd6b74578c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2146640.896ab3e0-3ea4-4459-b0bf-9ccd6b74578c.sorted_genome_alignments	UNCID_2146640.896ab3e0-3ea4-4459-b0bf-9ccd6b74578c.sorted_genome_alignments.bam	45.58	1.96	0.15	58cfa838e4b0c9d6adf70bf1	UNCID_2146640.896ab3e0-3ea4-4459-b0bf-9ccd6b74578c.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-GJ-A6C0-01A	1B326242-4BE6-4F05-B5FB-07ED76B49850	Primary Tumor	Illumina HiSeq	DD1A3173-1E0F-4BE8-BBAC-A9E57EC6C205	Liver	75.0	9D33DAB1-CE73-42C6-B504-42E127839882	896AB3E0-3EA4-4459-B0BF-9CCD6B74578C	TCGA-GJ-A6C0-01A-12R-A311-07	HG19	TCGA-GJ-A6C0	TCGA-LIHC	31.0	s16727	University of North Carolina	ABS - IUPUI	United States	NO	T2	NX	Hepatocellular Carcinoma	Stage II	A311-07	True
13767.58cfa839e4b0c9d6adf7109c	58cfa839e4b0c9d6adf7109c	UNCID_2248406.00624286-41dd-476f-a63b-d2a5f484bb45.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2248406.00624286-41dd-476f-a63b-d2a5f484bb45.sorted_genome_alignments	UNCID_2248406.00624286-41dd-476f-a63b-d2a5f484bb45.sorted_genome_alignments.bam	20.72	1.87	0.17	58cfa839e4b0c9d6adf7109c	UNCID_2248406.00624286-41dd-476f-a63b-d2a5f484bb45.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GN-A4U7-06A	088C296E-8E13-4DC8-8A99-B27F4B27F95E	Metastatic	Illumina HiSeq	1B09D039-7D08-475E-824F-3DCA2220D1A2	Skin	56.0	E2D4951F-8942-4A0D-B70D-050670D5E643	00624286-41DD-476F-A63B-D2A5F484BB45	TCGA-GN-A4U7-06A-21R-A32P-07	HG19	TCGA-GN-A4U7	TCGA-SKCM		s7775	University of North Carolina	Roswell	United States	NO	T2b	N3		Stage III	A32P-07	True
13767.58cfa833e4b0c9d6adf6df7a	58cfa833e4b0c9d6adf6df7a	UNCID_1151346.229ebbe9-4dc8-434f-998c-fc0660cd2b00.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1151346.229ebbe9-4dc8-434f-998c-fc0660cd2b00.sorted_genome_alignments	UNCID_1151346.229ebbe9-4dc8-434f-998c-fc0660cd2b00.sorted_genome_alignments.bam	27.44	1.75	0.16	58cfa833e4b0c9d6adf6df7a	UNCID_1151346.229ebbe9-4dc8-434f-998c-fc0660cd2b00.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0CZ-01A	9F93EA0A-1687-44E0-9E8A-EEB4097D471C	Primary Tumor	Illumina HiSeq	F9CD318F-291D-42E2-8517-3AFBF131B7E6	Breast	46.0	AA1E0129-D008-4648-8098-24F1981BC386	229EBBE9-4DC8-434F-998C-FC0660CD2B00	TCGA-A2-A0CZ-01A-11R-A034-07	HG19	TCGA-A2-A0CZ	TCGA-BRCA		s6697	University of North Carolina	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A034-07	True
13767.58cfa836e4b0c9d6adf6f87c	58cfa836e4b0c9d6adf6f87c	UNCID_1642800.c891ca94-dfb0-4932-95ea-b2f1858b43b8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1642800.c891ca94-dfb0-4932-95ea-b2f1858b43b8.sorted_genome_alignments	UNCID_1642800.c891ca94-dfb0-4932-95ea-b2f1858b43b8.sorted_genome_alignments.bam	55.2		0.17	58cfa836e4b0c9d6adf6f87c	UNCID_1642800.c891ca94-dfb0-4932-95ea-b2f1858b43b8.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-IB-7654-01A	65E5BF5F-F22A-4EC2-8839-AEDA37212B98	Primary Tumor	Illumina HiSeq	BBAE3B59-CAC9-4571-9A7F-0A2D8D3BA7B0	Pancreas	80.0	53C7C6F8-3D1C-43DB-B49F-C88ED37C741F	C891CA94-DFB0-4932-95EA-B2F1858B43B8	TCGA-IB-7654-01A-11R-2156-07	HG19	TCGA-IB-7654	TCGA-PAAD	476.0	s747	University of North Carolina	Alberta Health Services	Canada	NO	T2	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	2156-07	True
13767.58cfa83ce4b0c9d6adf72e4c	58cfa83ce4b0c9d6adf72e4c	_1_TCGA-HU-A4GX-01A-12R-A251-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-HU-A4GX-01A-12R-A251-31_rnaseq	_1_TCGA-HU-A4GX-01A-12R-A251-31_rnaseq.bam	56.66	1.78	0.15	58cfa83ce4b0c9d6adf72e4c	_1_TCGA-HU-A4GX-01A-12R-A251-31_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4GX-01A	75915370-0895-4933-8875-8A31C65C3D50	Primary Tumor	Illumina HiSeq	7BA64F13-1377-42CF-886A-D7558850F574	Stomach	70.0	33FA171E-C497-4C64-85CE-C2E3DFBF573B	9E1E0CCC-ABEB-4B49-88EB-1A5E6CB073A7	TCGA-HU-A4GX-01A-12R-A251-31	GRCh37-lite	TCGA-HU-A4GX	TCGA-STAD		s14801	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T4b	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage III	A251-31	True
13767.58cfa83ae4b0c9d6adf71d2d	58cfa83ae4b0c9d6adf71d2d	UNCID_2507342.9e1c37bb-1c94-4a98-8e44-e03953aa8ad9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2507342.9e1c37bb-1c94-4a98-8e44-e03953aa8ad9.sorted_genome_alignments	UNCID_2507342.9e1c37bb-1c94-4a98-8e44-e03953aa8ad9.sorted_genome_alignments.bam	39.86	1.88	0.16	58cfa83ae4b0c9d6adf71d2d	UNCID_2507342.9e1c37bb-1c94-4a98-8e44-e03953aa8ad9.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-ZF-A9R7-01A	CE4E4549-BEFC-447F-9B79-ED46E302E6D7	Primary Tumor	Illumina HiSeq	200C1BB8-E815-46AB-A43A-C085A513AD6B	Bladder	76.0	616B3B82-DF11-428B-8882-6B830125AE4B	9E1C37BB-1C94-4A98-8E44-E03953AA8AD9	TCGA-ZF-A9R7-01A-11R-A38B-07	HG19	TCGA-ZF-A9R7	TCGA-BLCA		s3038	University of North Carolina	University of Sheffield	United Kingdom	NO		NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A38B-07	True
13767.58cfa838e4b0c9d6adf70616	58cfa838e4b0c9d6adf70616	UNCID_1975882.6addf668-7b4d-4e3d-9086-b95818648be2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1975882.6addf668-7b4d-4e3d-9086-b95818648be2.sorted_genome_alignments	UNCID_1975882.6addf668-7b4d-4e3d-9086-b95818648be2.sorted_genome_alignments.bam	161.2		0.14	58cfa838e4b0c9d6adf70616	UNCID_1975882.6addf668-7b4d-4e3d-9086-b95818648be2.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-86-8358-01A	467D96D7-4A42-4116-8C32-0E4B34F96D8A	Primary Tumor	Illumina HiSeq	BEB8AB7B-DC9C-4B47-929C-A5731727D983	Lung	44.0	5942F197-2B77-4A7F-8BCA-763CC1902A0B	6ADDF668-7B4D-4E3D-9086-B95818648BE2	TCGA-86-8358-01A-11R-2326-07	HG19	TCGA-86-8358	TCGA-LUAD		s10739	University of North Carolina	Asterand	Russia	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2326-07	True
13767.58cfa83ce4b0c9d6adf73050	58cfa83ce4b0c9d6adf73050	_1_TCGA-D7-5577-01A-01R-1602-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-D7-5577-01A-01R-1602-13_rnaseq	_1_TCGA-D7-5577-01A-01R-1602-13_rnaseq.bam	318.8	1.8	0.13	58cfa83ce4b0c9d6adf73050	_1_TCGA-D7-5577-01A-01R-1602-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-5577-01A	2DC154AA-C478-404B-A92E-86ABCC8DBDB7	Primary Tumor	Illumina HiSeq	C95B0AA2-725C-427A-8CD3-534365B4E96C	Stomach	53.0	93BBD9FD-2385-46C3-AF21-E46C72A8A75D	3D71FCEA-73CE-4334-83B5-81CCCCCF45F7	TCGA-D7-5577-01A-01R-1602-13	GRCh37-lite	TCGA-D7-5577	TCGA-STAD		s15476	Canada's Michael Smith Genome Sciences Centre	Greater Poland Cancer Center	Poland	NO	T2	N3	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	1602-13	True
13767.58cfa836e4b0c9d6adf6fb17	58cfa836e4b0c9d6adf6fb17	UNCID_1649367.2D965E21-BFD1-4513-A87C-83F7E570D07F.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1649367.2D965E21-BFD1-4513-A87C-83F7E570D07F.sorted_genome_alignments	UNCID_1649367.2D965E21-BFD1-4513-A87C-83F7E570D07F.sorted_genome_alignments.bam	9.15	1.83	0.17	58cfa836e4b0c9d6adf6fb17	UNCID_1649367.2D965E21-BFD1-4513-A87C-83F7E570D07F.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A414-01A	23F47401-1BAB-4395-970F-4E388AAB2542	Primary Tumor	Illumina HiSeq	28EBAABD-CB52-4541-AD7D-D6358F4AF7B5	Thyroid	45.0	6BD8B6E3-7205-4507-8A32-703E3D127248	2D965E21-BFD1-4513-A87C-83F7E570D07F	TCGA-E8-A414-01A-11R-A23N-07	HG19	TCGA-E8-A414	TCGA-THCA		s12297	University of North Carolina	Asterand	Vietnam	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A23N-07	True
13767.58cfa832e4b0c9d6adf6d67e	58cfa832e4b0c9d6adf6d67e	TCGA-VQ-A927-01A-12R-A414-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-A927-01A-12R-A414-31_rnaseq	TCGA-VQ-A927-01A-12R-A414-31_rnaseq.bam	26.7	1.91	0.18	58cfa832e4b0c9d6adf6d67e	TCGA-VQ-A927-01A-12R-A414-31_rnaseq.bam	Dead	MALE	WHITE		Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-A927-01A	76A4E24E-E645-47C5-836A-6A029E97A4C8	Primary Tumor	Illumina HiSeq	B263B898-12DF-4E79-AE6D-D06BA05E61E6	Stomach	81.0	3D0945D3-DE0F-400D-A498-01DCAC2BC16B	1A5A3F15-4700-454B-813D-93D64E663636	TCGA-VQ-A927-01A-12R-A414-31	GRCh37-lite	TCGA-VQ-A927	TCGA-STAD	200.0	s15007	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T3	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage III	A414-31	True
13767.58cfa83ce4b0c9d6adf73006	58cfa83ce4b0c9d6adf73006	_1_TCGA-IN-8663-11A-01R-2402-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-IN-8663-11A-01R-2402-13_rnaseq	_1_TCGA-IN-8663-11A-01R-2402-13_rnaseq.bam	331.2		0.15	58cfa83ce4b0c9d6adf73006	_1_TCGA-IN-8663-11A-01R-2402-13_rnaseq.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-IN-8663-11A	D5550422-DC4B-4EBF-ACB5-AA5243FFF49F	Solid Tissue Normal	Illumina HiSeq	28AFFF8A-AF95-483D-9FE6-28B77820A167	Stomach	68.0	01B0DE1E-B577-4AF2-BB3C-5B785D3E8417	42C40205-06B0-4983-9CAE-127384A07267	TCGA-IN-8663-11A-01R-2402-13	GRCh37-lite	TCGA-IN-8663	TCGA-STAD	103.0	s15093	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	United States	NO	T2	N2	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2402-13	True
13767.58cfa82fe4b0c9d6adf6b5d8	58cfa82fe4b0c9d6adf6b5d8	TCGA-36-1575-01A-01R-1566-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-36-1575-01A-01R-1566-13_GRCh37-lite_rnaseq	TCGA-36-1575-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	348.0	1.8	0.14	58cfa82fe4b0c9d6adf6b5d8	TCGA-36-1575-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE			Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-36-1575-01A	6EA9877F-EB8D-4EE9-AF4C-32A78474D9A6	Primary Tumor	Illumina HiSeq	25BB39D0-7ED1-49DA-B3C3-A65B43E856C6	Ovary	83.0	E53C2985-F410-43F1-8FDE-7181112B9C14	A28EF775-C78B-416F-AFEB-89BA265440F0	TCGA-36-1575-01A-01R-1566-13	GRCh37-lite	TCGA-36-1575	TCGA-OV		s17465	Canada's Michael Smith Genome Sciences Centre	BC Cancer Agency	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa834e4b0c9d6adf6e4b6	58cfa834e4b0c9d6adf6e4b6	UNCID_1191368.43c73c50-4c72-4ab3-b2bd-793a512e5d0b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1191368.43c73c50-4c72-4ab3-b2bd-793a512e5d0b.sorted_genome_alignments	UNCID_1191368.43c73c50-4c72-4ab3-b2bd-793a512e5d0b.sorted_genome_alignments.bam	7.3	1.8	0.14	58cfa834e4b0c9d6adf6e4b6	UNCID_1191368.43c73c50-4c72-4ab3-b2bd-793a512e5d0b.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4964-01A	DB601D82-E2E7-469C-91DA-3DBFCB477326	Primary Tumor	Illumina HiSeq	16C725B7-719E-4486-A3F5-066B1E6A42A9	Kidney	54.0	154211F4-73D9-4F3D-9F52-D1A8FE3BC828	43C73C50-4C72-4AB3-B2BD-793A512E5D0B	TCGA-BP-4964-01A-01R-1334-07	HG19	TCGA-BP-4964	TCGA-KIRC		s9627	University of North Carolina	MSKCC	None	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13722.58cfa832e4b0c9d6adf6cffc	58cfa832e4b0c9d6adf6cffc	TCGA-G9-6329-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_2_rg.sorted.filtered.	WGS	TCGA-G9-6329-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_2_rg.sorted	TCGA-G9-6329-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_2_rg.sorted.bam	25.0	1.8	0.16	58cfa832e4b0c9d6adf6cffc	TCGA-G9-6329-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6329-10A	A08FD0A6-A89A-4ADB-B641-D4C1238ABB71	Blood Derived Normal	Illumina HiSeq	b3789c8a-7d5b-4bac-9ad7-4d8c002c629c	Prostate	67.0	07C6CFE4-E843-4E47-BB5F-AEC0EF337CEC	1EBB9324-2F1E-4AEA-9669-C29E1F251DF7	TCGA-G9-6329-10A-01D-1957-02	HG19_Broad_variant	TCGA-G9-6329	TCGA-PRAD		s3448	Harvard Medical School	Roswell Park	United States	NO	T2c		Prostate Adenocarcinoma Acinar Type		1957-02	True
13722.58cfa831e4b0c9d6adf6c3d2	58cfa831e4b0c9d6adf6c3d2	TCGA-CG-5721-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CG-5721-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_4_rg.sorted	TCGA-CG-5721-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_4_rg.sorted.bam	141.0	1.9	0.15	58cfa831e4b0c9d6adf6c3d2	TCGA-CG-5721-11A-01D-1598_121011_SN208_0434_AC18MYACXX_s_4_rg.sorted.bam	Alive	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5721-11A	588ABAEA-AB16-42F4-9457-5901EE791B5F	Solid Tissue Normal	Illumina HiSeq	259d4033-0c05-4f3b-ab2a-b0c7018bad33	Stomach	58.0	700FCA23-4807-4ED5-9745-87C6BCD51FBF	87FDC6BA-3120-4F7F-94FC-B5E0E6B5306C	TCGA-CG-5721-11A-01D-1598-02	HG19_Broad_variant	TCGA-CG-5721	TCGA-STAD		s14989	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1598-02	True
13767.58cfa838e4b0c9d6adf70a78	58cfa838e4b0c9d6adf70a78	UNCID_2075621.b9af6223-4001-41ad-adc1-be15c76d8150.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2075621.b9af6223-4001-41ad-adc1-be15c76d8150.sorted_genome_alignments	UNCID_2075621.b9af6223-4001-41ad-adc1-be15c76d8150.sorted_genome_alignments.bam	17.14	1.85	0.17	58cfa838e4b0c9d6adf70a78	UNCID_2075621.b9af6223-4001-41ad-adc1-be15c76d8150.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-A56U-01A	4D6B5B30-0DEA-4745-BC46-34EBD98F7418	Primary Tumor	Illumina HiSeq	1508BEEA-B17B-475B-B8EF-4AE1B4DC2B7A	Lung	76.0	7535D9D1-F49B-4579-AAE5-5E84B0279D73	B9AF6223-4001-41AD-ADC1-BE15C76D8150	TCGA-43-A56U-01A-11R-A26W-07	HG19	TCGA-43-A56U	TCGA-LUSC		s10051	University of North Carolina	Christiana Healthcare	United States	NO	T1b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	A26W-07	True
13767.58cfa82ee4b0c9d6adf6b138	58cfa82ee4b0c9d6adf6b138	TCGA-13-1485-01A-02R-1565-13_rnaseq.filtered.	RNA-Seq	TCGA-13-1485-01A-02R-1565-13_rnaseq	TCGA-13-1485-01A-02R-1565-13_rnaseq.bam	285.0	1.8	0.15	58cfa82ee4b0c9d6adf6b138	TCGA-13-1485-01A-02R-1565-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1485-01A	49BFD0FE-48CE-49DB-9F76-CE2310410950	Primary Tumor	Illumina HiSeq	ABE1E2BA-8002-43E4-8ECA-BD66716356A6	Ovary	48.0	558827DE-87A0-4041-89B2-FE439AC820A2	50F08F95-3C5A-4D6B-BACC-CCB4A3A720B8	TCGA-13-1485-01A-02R-1565-13	NCBI36_BCCAGSC_variant	TCGA-13-1485	TCGA-OV	629.0	s17128	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13722.58cfa82de4b0c9d6adf6a59d	58cfa82de4b0c9d6adf6a59d	6507fcb7033a99eba7d09d1768996237.filtered.	WGS	6507fcb7033a99eba7d09d1768996237	6507fcb7033a99eba7d09d1768996237.bam	128.45	2.03	0.08	58cfa82de4b0c9d6adf6a59d	6507fcb7033a99eba7d09d1768996237.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0L8-01A	9AA8C2B4-DB32-4899-BF0C-D578CB175E90	Primary Tumor	Illumina HiSeq	13a692ca-4d87-484b-aec0-1562b201470f	Uterus	70.0	D1A7A58F-7A35-4A94-A337-051AE56DED00	15D597DE-D26C-4CE1-B0CB-077E39B55F30	TCGA-AP-A0L8-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0L8	TCGA-UCEC	1484.0	s5378	Washington University School of Medicine	MSKCC	None	NO			Serous endometrial adenocarcinoma		A066-09	True
13767.58cfa837e4b0c9d6adf7037e	58cfa837e4b0c9d6adf7037e	UNCID_1900755.9bea59ee-e522-41c7-ba60-4cb0cb6b266a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1900755.9bea59ee-e522-41c7-ba60-4cb0cb6b266a.sorted_genome_alignments	UNCID_1900755.9bea59ee-e522-41c7-ba60-4cb0cb6b266a.sorted_genome_alignments.bam	58.62	1.78	0.16	58cfa837e4b0c9d6adf7037e	UNCID_1900755.9bea59ee-e522-41c7-ba60-4cb0cb6b266a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A4K7-01A	DC392A57-2028-4ECA-8BF3-760EC99703EE	Primary Tumor	Illumina HiSeq	E6AE462E-FE72-45A0-9BB5-A5B930D05481	Thyroid	74.0	27BC60C8-C2CB-4DDC-92F2-E5A437002B11	9BEA59EE-E522-41C7-BA60-4CB0CB6B266A	TCGA-EL-A4K7-01A-11R-A250-07	HG19	TCGA-EL-A4K7	TCGA-THCA		s12835	University of North Carolina	MD Anderson	United States	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A250-07	True
13767.58cfa833e4b0c9d6adf6db23	58cfa833e4b0c9d6adf6db23	UNCID_1101367.ed74a7e1-90de-4943-9ca2-e7f94a5540e4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1101367.ed74a7e1-90de-4943-9ca2-e7f94a5540e4.sorted_genome_alignments	UNCID_1101367.ed74a7e1-90de-4943-9ca2-e7f94a5540e4.sorted_genome_alignments.bam	22.32	1.71	0.18	58cfa833e4b0c9d6adf6db23	UNCID_1101367.ed74a7e1-90de-4943-9ca2-e7f94a5540e4.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A2B8-01A	6E126B73-D3E8-4641-A128-306F3B313E40	Primary Tumor	Illumina HiSeq	3C94E410-8B6D-43B5-9BA0-1C4F5A4DD95A	Breast	84.0	FABFEC99-220B-4A94-A8FE-01DFD71487F6	ED74A7E1-90DE-4943-9CA2-E7F94A5540E4	TCGA-AC-A2B8-01A-11R-A17B-07	HG19	TCGA-AC-A2B8	TCGA-BRCA		s5969	University of North Carolina	International Genomics Consortium	United States	NO	T3	N0 (i-)	Infiltrating Lobular Carcinoma	Stage II	A17B-07	True
13767.58cfa835e4b0c9d6adf6ee5c	58cfa835e4b0c9d6adf6ee5c	UNCID_1403136.ab2b78d1-773b-4935-b458-60befcf470af.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1403136.ab2b78d1-773b-4935-b458-60befcf470af.sorted_genome_alignments	UNCID_1403136.ab2b78d1-773b-4935-b458-60befcf470af.sorted_genome_alignments.bam	136.8	1.8	0.14	58cfa835e4b0c9d6adf6ee5c	UNCID_1403136.ab2b78d1-773b-4935-b458-60befcf470af.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6405-01A	9239A22E-80B1-49A2-B0D5-CBAB7E415254	Primary Tumor	Illumina HiSeq	629F586B-8109-4834-AA46-B69AA0C1E550	Brain	51.0	54BFF4F3-312D-4E1A-8327-F08F5A270EAC	AB2B78D1-773B-4935-B458-60BEFCF470AF	TCGA-DU-6405-01A-11R-1708-07	HG19	TCGA-DU-6405	TCGA-LGG	605.0	s8385	University of North Carolina	Henry Ford Hospital	United States	NO			Astrocytoma		1708-07	True
13767.58cfa831e4b0c9d6adf6c48c	58cfa831e4b0c9d6adf6c48c	TCGA-CD-8526-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-CD-8526-01A-11R-2343-13_rnaseq	TCGA-CD-8526-01A-11R-2343-13_rnaseq.bam	202.2		0.16	58cfa831e4b0c9d6adf6c48c	TCGA-CD-8526-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-8526-01A	6A9B3D65-AE15-4E3C-84ED-468E2196372B	Primary Tumor	Illumina HiSeq	96CD4395-D678-4809-AF74-FD042B3D19ED	Stomach	73.0	CBD8B935-7A19-45FB-B78B-6F586D253FE8	3EE4DAB2-2B48-4339-AE90-AAAFB547E789	TCGA-CD-8526-01A-11R-2343-13	GRCh37-lite	TCGA-CD-8526	TCGA-STAD		s15243	Canada's Michael Smith Genome Sciences Centre	ILSbio	Vietnam	NO	T3	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2343-13	True
13722.58cfa830e4b0c9d6adf6bb40	58cfa830e4b0c9d6adf6bb40	TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	146.73	1.77	0.15	58cfa830e4b0c9d6adf6bb40	TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02R-01A	764C97C9-01D3-45CB-86BD-F8A52B5468DA	Primary Tumor	Illumina HiSeq	5affe933-9b26-4971-81d9-e380618fbfa0	Colorectal	84.0	197245F6-A310-4AF4-9231-0AFEFC547ECD	A803F2CD-F90D-4E51-8D90-1E6AF6897413	TCGA-AA-A02R-01A-01D-A077-02	HG18	TCGA-AA-A02R	TCGA-COAD	670.0	s13204	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	A077-02	True
13767.58cfa833e4b0c9d6adf6da4a	58cfa833e4b0c9d6adf6da4a	UNCID_1075713.cdae461e-021e-4e59-ac04-d640d29d29dc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1075713.cdae461e-021e-4e59-ac04-d640d29d29dc.sorted_genome_alignments	UNCID_1075713.cdae461e-021e-4e59-ac04-d640d29d29dc.sorted_genome_alignments.bam	121.2	1.8	0.15	58cfa833e4b0c9d6adf6da4a	UNCID_1075713.cdae461e-021e-4e59-ac04-d640d29d29dc.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-5231-01A	F8733921-44BC-4C62-8B2D-33A9B82EF665	Primary Tumor	Illumina HiSeq	3B893C42-69EE-4B35-B377-754F03D258DD	Lung	72.0	A2A8125A-AADB-4E8F-9E80-841B65C647EE	CDAE461E-021E-4E59-AC04-D640D29D29DC	TCGA-34-5231-01A-21R-1820-07	HG19	TCGA-34-5231	TCGA-LUSC		s10203	University of North Carolina	University of Pittsburgh	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1820-07	True
13767.58cfa83ce4b0c9d6adf72bae	58cfa83ce4b0c9d6adf72bae	UNCID_399869.2d12d6c7-a3b8-4a0e-a501-a291f1e86eb9.110712_UNC12-SN629_0108_AC0402ABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_399869.2d12d6c7-a3b8-4a0e-a501-a291f1e86eb9.110712_UNC12-SN629_0108_AC0402ABXX.5.trimmed.annotated.translated_to_genomic	UNCID_399869.2d12d6c7-a3b8-4a0e-a501-a291f1e86eb9.110712_UNC12-SN629_0108_AC0402ABXX.5.trimmed.annotated.translated_to_genomic.bam	102.3	1.7	0.15	58cfa83ce4b0c9d6adf72bae	UNCID_399869.2d12d6c7-a3b8-4a0e-a501-a291f1e86eb9.110712_UNC12-SN629_0108_AC0402ABXX.5.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5183-01A	64AA0DD1-A80E-401E-96DF-60D121D2CBEC	Primary Tumor	Illumina HiSeq	83D5B1C4-601A-490A-ADB7-692E6AEAB578	Kidney	57.0	583F4290-C8CF-4D90-882D-25E459A12C26	2D12D6C7-A3B8-4A0E-A501-A291F1E86EB9	TCGA-BP-5183-01A-01R-1426-07	HG19	TCGA-BP-5183	TCGA-KIRC		s9421	University of North Carolina	MSKCC	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1426-07	True
13722.58cfa832e4b0c9d6adf6ce22	58cfa832e4b0c9d6adf6ce22	TCGA-EJ-5524-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EJ-5524-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_8_rg.sorted	TCGA-EJ-5524-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_8_rg.sorted.bam	437.4	1.9	0.15	58cfa832e4b0c9d6adf6ce22	TCGA-EJ-5524-10A-01D-1573_130218_SN208_0454_BD1TBTACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5524-10A	4048C139-1329-4E6A-8D2F-C0AA104A68EE	Blood Derived Normal	Illumina HiSeq	f7ef709a-7e6b-4b7e-9827-28d64d2cedb3	Prostate	57.0	330555E0-0B47-46B8-BDB6-125675717E3B	6D03C8FA-1441-410F-B980-CABF11F60930	TCGA-EJ-5524-10A-01D-1573-02	HG19_Broad_variant	TCGA-EJ-5524	TCGA-PRAD		s3945	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1573-02	True
13767.58cfa835e4b0c9d6adf6ec3c	58cfa835e4b0c9d6adf6ec3c	UNCID_1322422.c9cf5f5f-30de-4062-99c3-dcb9cfd55870.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1322422.c9cf5f5f-30de-4062-99c3-dcb9cfd55870.sorted_genome_alignments	UNCID_1322422.c9cf5f5f-30de-4062-99c3-dcb9cfd55870.sorted_genome_alignments.bam	53.7		0.13	58cfa835e4b0c9d6adf6ec3c	UNCID_1322422.c9cf5f5f-30de-4062-99c3-dcb9cfd55870.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-86-8076-01A	8609EDFC-119D-4D63-9188-C86AABD5CA52	Primary Tumor	Illumina HiSeq	D7AF5626-3410-491E-8017-5079DBE78495	Lung	42.0	A06A952F-AAEA-4471-8004-26108E382A9B	C9CF5F5F-30DE-4062-99C3-DCB9CFD55870	TCGA-86-8076-01A-31R-2241-07	HG19	TCGA-86-8076	TCGA-LUAD		s11052	University of North Carolina	Asterand	Russia	NO	T1	N0	Lung Papillary Adenocarcinoma	Stage I	2241-07	True
13767.58cfa837e4b0c9d6adf6fdb4	58cfa837e4b0c9d6adf6fdb4	UNCID_1727647.e8cc9981-3f57-49cc-9779-72d1c50bc59a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1727647.e8cc9981-3f57-49cc-9779-72d1c50bc59a.sorted_genome_alignments	UNCID_1727647.e8cc9981-3f57-49cc-9779-72d1c50bc59a.sorted_genome_alignments.bam	77.2		0.16	58cfa837e4b0c9d6adf6fdb4	UNCID_1727647.e8cc9981-3f57-49cc-9779-72d1c50bc59a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KN-8424-01A	8C9E1F60-1838-4AA4-A667-C1CEF7DDDBDF	Primary Tumor	Illumina HiSeq	B37CD465-2DBD-404F-9910-B13A6F1CBE89	Kidney	42.0	93B1AE00-43E1-466C-BBC1-8755CB1A1A0C	E8CC9981-3F57-49CC-9779-72D1C50BC59A	TCGA-KN-8424-01A-11R-2315-07	HG19	TCGA-KN-8424	TCGA-KICH		s16512	University of North Carolina	Harvard	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2315-07	True
13767.58cfa83ce4b0c9d6adf72e59	58cfa83ce4b0c9d6adf72e59	_1_TCGA-BR-7722-01A-31R-2203-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-7722-01A-31R-2203-13_rnaseq	_1_TCGA-BR-7722-01A-31R-2203-13_rnaseq.bam	262.2		0.15	58cfa83ce4b0c9d6adf72e59	_1_TCGA-BR-7722-01A-31R-2203-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7722-01A	8D3E3D09-BC61-4D5E-B8D6-5AEE6CB488AE	Primary Tumor	Illumina HiSeq	1C80CAE7-CCE8-4D4B-BD0C-13AF9AF14672	Stomach	62.0	58038C32-1359-49EB-AAFE-2F44EC697F52	B66F73E6-F4FA-404C-89F8-1958E753D40F	TCGA-BR-7722-01A-31R-2203-13	GRCh37-lite	TCGA-BR-7722	TCGA-STAD		s14664	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2203-13	True
13767.58cfa82ee4b0c9d6adf6b14c	58cfa82ee4b0c9d6adf6b14c	TCGA-13-0906-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-0906-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-13-0906-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	166.0	1.8	0.15	58cfa82ee4b0c9d6adf6b14c	TCGA-13-0906-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0906-01A	E43D3769-E25F-4FB7-9080-EA26DEFAF094	Primary Tumor	Illumina HiSeq	F55435BD-1736-42E9-98D7-8E33C5D9F25E	Ovary	50.0	A0C48680-3CAF-49BD-B495-C9FD3A9CBE76	7FA0EBA3-8A33-425D-A7FB-2FA169E5F8E6	TCGA-13-0906-01A-01R-1564-13	GRCh37-lite	TCGA-13-0906	TCGA-OV		s17773	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa832e4b0c9d6adf6d4b6	58cfa832e4b0c9d6adf6d4b6	TCGA-VG-A8LO-01A-11R-A406-31_rnaseq.filtered.	RNA-Seq	TCGA-VG-A8LO-01A-11R-A406-31_rnaseq	TCGA-VG-A8LO-01A-11R-A406-31_rnaseq.bam	75.8	1.84	0.18	58cfa832e4b0c9d6adf6d4b6	TCGA-VG-A8LO-01A-11R-A406-31_rnaseq.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-VG-A8LO-01A	8628F1B2-3763-4BA9-A375-083874BB18F2	Primary Tumor	Illumina HiSeq	A6B73846-727B-40BB-857A-CFB78F2D538C	Ovary	55.0	CCD3903E-EEE6-41F0-9A07-4351A00A7DC3	FBAD0BA1-131D-48AF-9957-E9CA56F54E84	TCGA-VG-A8LO-01A-11R-A406-31	GRCh37-lite	TCGA-VG-A8LO	TCGA-OV	24.0	s18146	Canada's Michael Smith Genome Sciences Centre	Institute of Human Virology Nigeria	Nigeria	NO			Serous Cystadenocarcinoma		A406-31	True
13722.58cfa830e4b0c9d6adf6bf14	58cfa830e4b0c9d6adf6bf14	TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted	TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted.bam	265.9	1.9	0.13	58cfa830e4b0c9d6adf6bf14	TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4267-01A	0D0F0200-25B8-483B-B04A-82A7833B4D30	Primary Tumor	Illumina HiSeq	cd48e485-3a3f-4eec-92e7-f1c52c0866f1	Stomach	51.0	32D28ED3-2E33-4D83-8DE6-82E156B33211	F0DB5AF5-091F-4CDC-9917-BEFD658BF454	TCGA-BR-4267-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4267	TCGA-STAD		s15044	Harvard Medical School	Asterand	None	NO	T2a	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1128-02	True
13722.58cfa832e4b0c9d6adf6d4d0	58cfa832e4b0c9d6adf6d4d0	TCGA-V4-A9F5-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-V4-A9F5-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_5_rg.sorted	TCGA-V4-A9F5-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_5_rg.sorted.bam	11.84		0.16	58cfa832e4b0c9d6adf6d4d0	TCGA-V4-A9F5-10A-01D-A40E_140716_SN208_0519_BC5946ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F5-10A	BBF07E1F-8C17-4C2E-89ED-38332D82E455	Blood Derived Normal	Illumina HiSeq	33f50b70-0a01-4be3-8b48-20c7ba37721e	Eye	85.0	01218558-DF35-423E-A4A5-9237F6B3BCCE	839EE0D1-59B0-4818-BEE2-43500FF6C271	TCGA-V4-A9F5-10A-01D-A40E-26	HG19_Broad_variant	TCGA-V4-A9F5	TCGA-UVM		s278	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4e	N0		Stage IV	A40E-26	True
13767.58cfa835e4b0c9d6adf6ed8a	58cfa835e4b0c9d6adf6ed8a	UNCID_1370598.314e8006-a060-4b71-a51e-ba450bbbb86c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1370598.314e8006-a060-4b71-a51e-ba450bbbb86c.sorted_genome_alignments	UNCID_1370598.314e8006-a060-4b71-a51e-ba450bbbb86c.sorted_genome_alignments.bam	226.8	1.8	0.17	58cfa835e4b0c9d6adf6ed8a	UNCID_1370598.314e8006-a060-4b71-a51e-ba450bbbb86c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5530-01A	E4A755E3-4938-4321-B5A9-27A445036791	Primary Tumor	Illumina HiSeq	016F3FC7-9C63-4436-AAB4-5690E5DF5C51	Prostate	61.0	27D61473-39D6-478A-A576-427D1AEDA01F	314E8006-A060-4B71-A51E-BA450BBBB86C	TCGA-EJ-5530-01A-01R-1580-07	HG19	TCGA-EJ-5530	TCGA-PRAD		s3667	University of North Carolina	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		1580-07	True
13722.58cfa831e4b0c9d6adf6c552	58cfa831e4b0c9d6adf6c552	TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted	TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted.bam	211.7	1.9	0.15	58cfa831e4b0c9d6adf6c552	TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5762-01A	D4FFAFDC-EE83-43DF-AA3B-7326503C6438	Primary Tumor	Illumina HiSeq	70b297c6-c1f6-4651-93c3-17888cf0b118	Prostate	60.0	6D1A2D44-72F3-4333-8506-E53CDC4E5185	25189A34-4C05-4D77-9A3B-212A475F66B1	TCGA-CH-5762-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5762	TCGA-PRAD		s3594	Harvard Medical School	Indivumed	Germany	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		1572-02	True
13767.58cfa83be4b0c9d6adf72a1f	58cfa83be4b0c9d6adf72a1f	UNCID_368906.TCGA-AK-3450-01A-02R-1277-07.110415_UNC9-SN296_0171_BB07RHABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_368906.TCGA-AK-3450-01A-02R-1277-07.110415_UNC9-SN296_0171_BB07RHABXX.8.trimmed.annotated.translated_to_genomic	UNCID_368906.TCGA-AK-3450-01A-02R-1277-07.110415_UNC9-SN296_0171_BB07RHABXX.8.trimmed.annotated.translated_to_genomic.bam	63.63	1.8	0.13	58cfa83be4b0c9d6adf72a1f	UNCID_368906.TCGA-AK-3450-01A-02R-1277-07.110415_UNC9-SN296_0171_BB07RHABXX.8.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-AK-3450-01A	0709749F-A30A-4FDD-A409-D12BE09A5899	Primary Tumor	Illumina HiSeq	98DD53A7-AE00-48F9-92D6-E40DD1E313D3	Kidney	85.0	EED7F3A0-32B9-4202-BFE8-F96A8DD92244	810CBF0C-2C8C-419A-9FA0-780552841AC2	TCGA-AK-3450-01A-02R-1277-07	HG19	TCGA-AK-3450	TCGA-KIRC		s9101	University of North Carolina	Fox Chase	United States	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1277-07	True
13767.58cfa82ee4b0c9d6adf6a86e	58cfa82ee4b0c9d6adf6a86e	G17662.TCGA-32-1970-01A-01R-1850-01.2.filtered.	RNA-Seq	G17662.TCGA-32-1970-01A-01R-1850-01.2	G17662.TCGA-32-1970-01A-01R-1850-01.2.bam	78.7	1.8	0.15	58cfa82ee4b0c9d6adf6a86e	G17662.TCGA-32-1970-01A-01R-1850-01.2.bam	Dead	MALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-32-1970-01A	6C5154D2-AF36-492F-B520-D925528824E4	Primary Tumor	Illumina HiSeq	7785B34D-BEA1-4E14-BB43-63F61FB87034	Brain	59.0	115D06A0-7FFB-4E2F-BC09-59EA55D12894	A344DE7B-5980-4612-9D58-1C8058A2BFD9	TCGA-32-1970-01A-01R-1850-01	HG19_Broad_variant	TCGA-32-1970	TCGA-GBM	468.0	s14214	Broad Institute of MIT and Harvard	St. Joseph's Hospital (AZ)	None	NO			Untreated primary (de novo) GBM		1850-01	True
13767.58cfa836e4b0c9d6adf6faa0	58cfa836e4b0c9d6adf6faa0	UNCID_1654729.29D6F5E8-46CB-4EFC-B230-F213F4B25A8C.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1654729.29D6F5E8-46CB-4EFC-B230-F213F4B25A8C.sorted_genome_alignments	UNCID_1654729.29D6F5E8-46CB-4EFC-B230-F213F4B25A8C.sorted_genome_alignments.bam	39.38	1.86	0.17	58cfa836e4b0c9d6adf6faa0	UNCID_1654729.29D6F5E8-46CB-4EFC-B230-F213F4B25A8C.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A3V8-01A	A3B49C90-FA9F-4189-A442-64EC1AD97A01	Primary Tumor	Illumina HiSeq	9668568D-1808-407C-9B38-9279CF28C375	Thyroid	28.0	152A2105-2B04-408F-AAAA-3F6EAF58F845	29D6F5E8-46CB-4EFC-B230-F213F4B25A8C	TCGA-DJ-A3V8-01A-11R-A23N-07	HG19	TCGA-DJ-A3V8	TCGA-THCA		s12181	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage I	A23N-07	True
13767.58cfa838e4b0c9d6adf70924	58cfa838e4b0c9d6adf70924	UNCID_2043662.c995e591-f2b7-4c3e-ae81-9e72b9548b57.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2043662.c995e591-f2b7-4c3e-ae81-9e72b9548b57.sorted_genome_alignments	UNCID_2043662.c995e591-f2b7-4c3e-ae81-9e72b9548b57.sorted_genome_alignments.bam	54.8		0.15	58cfa838e4b0c9d6adf70924	UNCID_2043662.c995e591-f2b7-4c3e-ae81-9e72b9548b57.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7817-01B	F3AA40B9-7B4D-465A-B7C9-591AEBDB56C2	Primary Tumor	Illumina HiSeq	D4472D71-4479-4CCE-A050-A7AF41F3C723	Prostate	52.0	BA22B09B-2328-4725-8810-2EE294B319C4	C995E591-F2B7-4C3E-AE81-9E72B9548B57	TCGA-HC-7817-01B-11R-A29R-07	HG19	TCGA-HC-7817	TCGA-PRAD		s4048	University of North Carolina	International Genomics Consortium	United States	NO	T3b		Prostate Adenocarcinoma Acinar Type		A29R-07	True
13767.58cfa836e4b0c9d6adf6fc6e	58cfa836e4b0c9d6adf6fc6e	UNCID_1665182.FEA9C2BF-A2B5-44FE-BCCC-20C99837CFAB.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1665182.FEA9C2BF-A2B5-44FE-BCCC-20C99837CFAB.sorted_genome_alignments	UNCID_1665182.FEA9C2BF-A2B5-44FE-BCCC-20C99837CFAB.sorted_genome_alignments.bam	55.75	1.83	0.18	58cfa836e4b0c9d6adf6fc6e	UNCID_1665182.FEA9C2BF-A2B5-44FE-BCCC-20C99837CFAB.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3ZP-01A	EA859A83-00C3-40B2-97C1-FB24AD027EA6	Primary Tumor	Illumina HiSeq	1A3C77C6-1180-4FDF-9687-DE66C6BA1BC9	Thyroid	19.0	6937BEB3-2941-40F5-82DF-F7EB8DBC10B8	FEA9C2BF-A2B5-44FE-BCCC-20C99837CFAB	TCGA-EL-A3ZP-01A-11R-A23N-07	HG19	TCGA-EL-A3ZP	TCGA-THCA		s12596	University of North Carolina	MD Anderson	United States	NO	T4	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23N-07	True
13722.58cfa82de4b0c9d6adf6a563	58cfa82de4b0c9d6adf6a563	00a016cbe7ea291456bdcbd03dc828b0.filtered.	WGS	00a016cbe7ea291456bdcbd03dc828b0	00a016cbe7ea291456bdcbd03dc828b0.bam	44.19		0.07	58cfa82de4b0c9d6adf6a563	00a016cbe7ea291456bdcbd03dc828b0.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-FX-A3RE-10A	7F9031DA-124A-4A38-83E6-878A50E58C24	Blood Derived Normal	Illumina HiSeq	c9ab74b3-9a97-414a-a208-65134953cbb7	Mesenchymal	65.0	5007F7B1-7911-4EB8-B679-B8E59025D36E	833EC0AA-F61E-49FC-ACF0-DDD1A0A1F5C4	TCGA-FX-A3RE-10A-01D-A22A-09	GRCh37-lite	TCGA-FX-A3RE	TCGA-SARC		s2329	Washington University School of Medicine	International Genomics Consortium	United States	NO					A22A-09	False
13767.58cfa835e4b0c9d6adf6eab4	58cfa835e4b0c9d6adf6eab4	UNCID_1286037.0872770d-ed18-47c4-8190-212b7250f7cf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1286037.0872770d-ed18-47c4-8190-212b7250f7cf.sorted_genome_alignments	UNCID_1286037.0872770d-ed18-47c4-8190-212b7250f7cf.sorted_genome_alignments.bam	28.08	1.63	0.18	58cfa835e4b0c9d6adf6eab4	UNCID_1286037.0872770d-ed18-47c4-8190-212b7250f7cf.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A2DN-01A	56BBD282-B88D-4730-9242-AB97D08DC83A	Primary Tumor	Illumina HiSeq	80B042A5-03E6-40D3-A86D-CB518E4ABA82	Breast	58.0	E46B29B9-C697-4739-B292-398674A5ADB9	0872770D-ED18-47C4-8190-212B7250F7CF	TCGA-GM-A2DN-01A-11R-A180-07	HG19	TCGA-GM-A2DN	TCGA-BRCA		s5731	University of North Carolina	MD Anderson	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A180-07	True
13722.58cfa831e4b0c9d6adf6c803	58cfa831e4b0c9d6adf6c803	TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted	TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted.bam	99.18	1.97	0.15	58cfa831e4b0c9d6adf6c803	TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16N-01A	DBBBDDAE-D711-40F5-BD10-863735885B1F	Primary Tumor	Illumina HiSeq	0cea9a43-7170-4273-879f-084cb6e14196	Uterus	51.0	6D916A47-DCFF-4C98-9E88-348AAA353F98	133CBA56-19C9-47AE-AB5E-37FF35A7E71E	TCGA-D1-A16N-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A16N	TCGA-UCEC		s4263	Harvard Medical School	Mayo Clinic	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13767.58cfa834e4b0c9d6adf6e4ce	58cfa834e4b0c9d6adf6e4ce	UNCID_1191330.a09990d3-3a16-4fad-b5d5-c45e9e4bc8b8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1191330.a09990d3-3a16-4fad-b5d5-c45e9e4bc8b8.sorted_genome_alignments	UNCID_1191330.a09990d3-3a16-4fad-b5d5-c45e9e4bc8b8.sorted_genome_alignments.bam	80.8	1.8	0.15	58cfa834e4b0c9d6adf6e4ce	UNCID_1191330.a09990d3-3a16-4fad-b5d5-c45e9e4bc8b8.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4700-11A	E33DFF22-5BF1-4DD8-BED7-063CB555677C	Solid Tissue Normal	Illumina HiSeq	74B1AF83-1AAD-49D0-A330-3176D1F03290	Kidney	60.0	455AC62D-7709-4390-B415-63ABB5E3A59B	A09990D3-3A16-4FAD-B5D5-C45E9E4BC8B8	TCGA-B0-4700-11A-01R-1541-07	HG19	TCGA-B0-4700	TCGA-KIRC	1980.0	s9951	University of North Carolina	University of Pittsburgh	None	NO	T4	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1541-07	True
13767.58cfa833e4b0c9d6adf6dd47	58cfa833e4b0c9d6adf6dd47	UNCID_1133094.71b58051-3bf8-4dfb-a431-c8aceab7c799.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1133094.71b58051-3bf8-4dfb-a431-c8aceab7c799.sorted_genome_alignments	UNCID_1133094.71b58051-3bf8-4dfb-a431-c8aceab7c799.sorted_genome_alignments.bam	35.68	2.04	0.16	58cfa833e4b0c9d6adf6dd47	UNCID_1133094.71b58051-3bf8-4dfb-a431-c8aceab7c799.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A12H-01A	B5B99291-507E-4B68-A039-9A0F571F55DF	Primary Tumor	Illumina HiSeq	3754EEE3-E9AC-4C45-9529-D6483AAE4295	Breast	69.0	D8AFCB32-81D0-43B3-AD5C-E8C735710624	71B58051-3BF8-4DFB-A431-C8ACEAB7C799	TCGA-AO-A12H-01A-11R-A115-07	HG19	TCGA-AO-A12H	TCGA-BRCA		s5843	University of North Carolina	MSKCC	None	NO	T2	N0 (i-)	Other  specify	Stage II	A115-07	True
13722.58cfa831e4b0c9d6adf6c61d	58cfa831e4b0c9d6adf6c61d	TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted	TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted.bam	38.4	1.9	0.13	58cfa831e4b0c9d6adf6c61d	TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE		Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4740-10A	E37C83DC-C2C4-4E5F-A57B-39FFCF9AA3CF	Blood Derived Normal	Illumina HiSeq	d36d8c79-6394-457e-a92f-c582f98097a0	Head and Neck	79.0	533B0EC7-41DD-405E-A6B5-6E82CB689CDE	A820807E-4D6F-4481-BD39-C29522B3C3FE	TCGA-CN-4740-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4740	TCGA-HNSC		s15886	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IV	1431-02	True
13767.58cfa838e4b0c9d6adf70cfa	58cfa838e4b0c9d6adf70cfa	UNCID_2173753.6f5b0c12-0853-49c8-8421-58faa14b3955.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2173753.6f5b0c12-0853-49c8-8421-58faa14b3955.sorted_genome_alignments	UNCID_2173753.6f5b0c12-0853-49c8-8421-58faa14b3955.sorted_genome_alignments.bam	80.5	1.83	0.17	58cfa838e4b0c9d6adf70cfa	UNCID_2173753.6f5b0c12-0853-49c8-8421-58faa14b3955.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-A65D-01A	8E1FF72B-F1DB-4BF9-A8D3-F422E25A65E1	Primary Tumor	Illumina HiSeq	D72E1F46-676D-47EE-A788-7F022C871BD7	Prostate	66.0	243DA837-F54B-449C-A7E7-5737935D53D6	6F5B0C12-0853-49C8-8421-58FAA14B3955	TCGA-EJ-A65D-01A-11R-A30B-07	HG19	TCGA-EJ-A65D	TCGA-PRAD		s3874	University of North Carolina	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma  Other Subtype		A30B-07	True
13767.58cfa838e4b0c9d6adf7070a	58cfa838e4b0c9d6adf7070a	UNCID_1984081.9aa74fcf-9845-4708-a09b-a17aa4b9e94a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1984081.9aa74fcf-9845-4708-a09b-a17aa4b9e94a.sorted_genome_alignments	UNCID_1984081.9aa74fcf-9845-4708-a09b-a17aa4b9e94a.sorted_genome_alignments.bam	18.38	1.98	0.18	58cfa838e4b0c9d6adf7070a	UNCID_1984081.9aa74fcf-9845-4708-a09b-a17aa4b9e94a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-58-A46L-01A	1BA4E70C-692C-487A-ABC5-36E5F0A03286	Primary Tumor	Illumina HiSeq	C6D1909A-1149-4781-8440-5E45F99A5028	Lung	73.0	BB9354B5-7D3D-4C82-8F9E-D634ED62943D	9AA74FCF-9845-4708-A09B-A17AA4B9E94A	TCGA-58-A46L-01A-11R-A24H-07	HG19	TCGA-58-A46L	TCGA-LUSC		s10335	University of North Carolina	Thoraxklinik at University Hospital Heidelberg	Germany	NO	T2	N2	Lung Basaloid Squamous Cell Carcinoma	Stage III	A24H-07	True
13722.58cfa830e4b0c9d6adf6bee2	58cfa830e4b0c9d6adf6bee2	TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted.filtered.	WGS	TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted	TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted.bam	90.97	2.13	0.17	58cfa830e4b0c9d6adf6bee2	TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LO-01A	A081DA6F-51F3-4555-A6B8-736F8C6CDA39	Primary Tumor	Illumina HiSeq	4726575a-1ad0-471a-8a8e-26eb668681f2	Uterus	45.0	9846D8F3-5B22-48E9-B972-A0FE9F509FB4	A91FCC79-7AE0-4BD1-BCAE-543E49E2D62E	TCGA-AP-A0LO-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0LO	TCGA-UCEC	1016.0	s4243	Harvard Medical School	MSKCC	None	NO			Endometrioid endometrial adenocarcinoma		A043-02	True
13722.58cfa82ee4b0c9d6adf6adac	58cfa82ee4b0c9d6adf6adac	G39020.TCGA-CD-8529-01A-11D-2340-08.2.filtered.	WGS	G39020.TCGA-CD-8529-01A-11D-2340-08.2	G39020.TCGA-CD-8529-01A-11D-2340-08.2.bam	200.7		0.05	58cfa82ee4b0c9d6adf6adac	G39020.TCGA-CD-8529-01A-11D-2340-08.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-8529-01A	5B7E557A-6AEE-4077-B3CD-C96179E643AE	Primary Tumor	Illumina HiSeq	65281f4c-9277-4d03-8566-75feb73c114d	Stomach	65.0	EB18C784-32F7-4570-A661-E4DF8F55378C	931B24DA-5D6D-4C2D-8DE9-EF32D6EB8565	TCGA-CD-8529-01A-11D-2340-08	HG19_Broad_variant	TCGA-CD-8529	TCGA-STAD		s14958	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T4	N0	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage IV	2340-08	False
13767.58cfa834e4b0c9d6adf6e3e7	58cfa834e4b0c9d6adf6e3e7	UNCID_1180064.bfe2a633-8c76-4b72-a807-fe986c35944f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1180064.bfe2a633-8c76-4b72-a807-fe986c35944f.sorted_genome_alignments	UNCID_1180064.bfe2a633-8c76-4b72-a807-fe986c35944f.sorted_genome_alignments.bam	44.0	1.8	0.16	58cfa834e4b0c9d6adf6e3e7	UNCID_1180064.bfe2a633-8c76-4b72-a807-fe986c35944f.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3382-01A	E1663694-17DD-4B01-B613-2516E022DFB7	Primary Tumor	Illumina HiSeq	04CF2A5C-6EA6-41E5-BD0C-9583BC802950	Kidney	69.0	3DE5B87E-B12F-446C-AA04-6C20370DE727	BFE2A633-8C76-4B72-A807-FE986C35944F	TCGA-A3-3382-01A-02R-1325-07	HG19	TCGA-A3-3382	TCGA-KIRC		s9770	University of North Carolina	International Genomics Consortium	United States	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1325-07	True
13722.58cfa82ee4b0c9d6adf6a93c	58cfa82ee4b0c9d6adf6a93c	G32454.TCGA-CF-A27C-10A-01D-A16O-08.4.filtered.	WGS	G32454.TCGA-CF-A27C-10A-01D-A16O-08.4	G32454.TCGA-CF-A27C-10A-01D-A16O-08.4.bam	178.36	1.89	0.09	58cfa82ee4b0c9d6adf6a93c	G32454.TCGA-CF-A27C-10A-01D-A16O-08.4.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A27C-10A	7FEE9D6F-C0EA-43C2-89C2-66D965A077A8	Blood Derived Normal	Illumina HiSeq	1c684efa-c878-42dc-893a-da27ef782036	Bladder	52.0	1C4C59DC-B0B3-48B0-9888-42891CF1E8F8	7C729B94-1488-4DEC-B534-5D73530E535C	TCGA-CF-A27C-10A-01D-A16O-08	HG19_Broad_variant	TCGA-CF-A27C	TCGA-BLCA		s2681	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A16O-08	False
13767.58cfa830e4b0c9d6adf6bfa1	58cfa830e4b0c9d6adf6bfa1	TCGA-BR-6453-11A-01R-1802-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-6453-11A-01R-1802-13_rnaseq	TCGA-BR-6453-11A-01R-1802-13_rnaseq.bam	198.7	1.8	0.15	58cfa830e4b0c9d6adf6bfa1	TCGA-BR-6453-11A-01R-1802-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6453-11A	AE633E83-303F-4A90-AC3B-34458FD9BEEF	Solid Tissue Normal	Illumina HiSeq	9EFEA7AC-9495-4DC5-878C-D8F9569B92A7	Stomach	54.0	B6DFCC18-F388-4486-8D3D-611C5E15FB29	688CA868-1DE0-4E38-A1C2-C41112731C70	TCGA-BR-6453-11A-01R-1802-13	GRCh37-lite	TCGA-BR-6453	TCGA-STAD		s14533	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T2	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1802-13	True
13767.58cfa839e4b0c9d6adf710a7	58cfa839e4b0c9d6adf710a7	UNCID_2247411.131525c8-7f24-48c3-bef9-cc9414e793b8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2247411.131525c8-7f24-48c3-bef9-cc9414e793b8.sorted_genome_alignments	UNCID_2247411.131525c8-7f24-48c3-bef9-cc9414e793b8.sorted_genome_alignments.bam	32.53	1.98	0.18	58cfa839e4b0c9d6adf710a7	UNCID_2247411.131525c8-7f24-48c3-bef9-cc9414e793b8.sorted_genome_alignments.bam	Dead	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A7CL-01A	BAE2AF5E-484A-44F7-AD6B-66137CDAE300	Primary Tumor	Illumina HiSeq	D6A61BCA-545A-4727-B423-8572B12E55DF	Cervix	48.0	695043A5-66DA-4B86-8540-6ACA605AEC86	131525C8-7F24-48C3-BEF9-CC9414E793B8	TCGA-C5-A7CL-01A-11R-A32P-07	HG19	TCGA-C5-A7CL	TCGA-CESC	471.0	s1581	University of North Carolina	Medical College of Wisconsin	United States	NO			Cervical Squamous Cell Carcinoma		A32P-07	True
13767.58cfa838e4b0c9d6adf70423	58cfa838e4b0c9d6adf70423	UNCID_1949206.322cb03d-69ba-4015-888f-330ced0b4600.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1949206.322cb03d-69ba-4015-888f-330ced0b4600.sorted_genome_alignments	UNCID_1949206.322cb03d-69ba-4015-888f-330ced0b4600.sorted_genome_alignments.bam	161.2	1.7	0.16	58cfa838e4b0c9d6adf70423	UNCID_1949206.322cb03d-69ba-4015-888f-330ced0b4600.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-G4-6294-01A	41F8C9FD-AE52-4458-886B-FAF37DE77DD0	Primary Tumor	Illumina HiSeq	D69D1A9C-1434-41EE-939C-19C605713A3E	Colorectal	75.0	4F4D9529-09E0-4A0D-8A9F-0060B643444D	322CB03D-69BA-4015-888F-330CED0B4600	TCGA-G4-6294-01A-11R-1774-07	HG19	TCGA-G4-6294	TCGA-COAD	858.0	s13286	University of North Carolina	Roswell Park	United States	NO	T3	N1	Colon Adenocarcinoma	Stage IV	1774-07	True
13767.58cfa83be4b0c9d6adf72a0d	58cfa83be4b0c9d6adf72a0d	UNCID_368274.TCGA-B0-4694-01A-01R-1277-07.110503_UNC15-SN850_0067_BB08W4ABXX.2.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_368274.TCGA-B0-4694-01A-01R-1277-07.110503_UNC15-SN850_0067_BB08W4ABXX.2.trimmed.annotated.translated_to_genomic	UNCID_368274.TCGA-B0-4694-01A-01R-1277-07.110503_UNC15-SN850_0067_BB08W4ABXX.2.trimmed.annotated.translated_to_genomic.bam	34.63	1.7	0.14	58cfa83be4b0c9d6adf72a0d	UNCID_368274.TCGA-B0-4694-01A-01R-1277-07.110503_UNC15-SN850_0067_BB08W4ABXX.2.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4694-01A	123B1A31-3635-4E90-B714-0C20DF64CF0D	Primary Tumor	Illumina HiSeq	7EDCEA18-CF0D-40B9-BC97-4D56C1361FD7	Kidney	72.0	C3DE6341-C2E6-4668-892B-4DD254E1C93A	53A10EC3-896E-4B22-A1C7-97EBF243C5B2	TCGA-B0-4694-01A-01R-1277-07	HG19	TCGA-B0-4694	TCGA-KIRC	106.0	s9100	University of North Carolina	University of Pittsburgh	None	NO	T3b	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1277-07	True
13767.58cfa83be4b0c9d6adf72a5a	58cfa83be4b0c9d6adf72a5a	UNCID_368859.TCGA-A3-3367-01A-02R-1420-07.110608_UNC13-SN749_0072_AC03JFABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_368859.TCGA-A3-3367-01A-02R-1420-07.110608_UNC13-SN749_0072_AC03JFABXX.8.trimmed.annotated.translated_to_genomic	UNCID_368859.TCGA-A3-3367-01A-02R-1420-07.110608_UNC13-SN749_0072_AC03JFABXX.8.trimmed.annotated.translated_to_genomic.bam	32.3	1.8	0.14	58cfa83be4b0c9d6adf72a5a	UNCID_368859.TCGA-A3-3367-01A-02R-1420-07.110608_UNC13-SN749_0072_AC03JFABXX.8.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3367-01A	69FB3EFF-A32C-48E1-AAB8-645EF31D163A	Primary Tumor	Illumina HiSeq	D0370D28-9159-4E25-9755-481535AFBF55	Kidney	72.0	E8C78F06-00DA-47E9-B134-741CE2583F5B	44F00CAC-2554-4B46-83A6-95FAC5691128	TCGA-A3-3367-01A-02R-1420-07	HG19	TCGA-A3-3367	TCGA-KIRC		s9412	University of North Carolina	International Genomics Consortium	United States	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1420-07	True
13767.58cfa834e4b0c9d6adf6e60c	58cfa834e4b0c9d6adf6e60c	UNCID_1191832.7694eaf3-732e-4b23-b8fe-ce713c1a4b18.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1191832.7694eaf3-732e-4b23-b8fe-ce713c1a4b18.sorted_genome_alignments	UNCID_1191832.7694eaf3-732e-4b23-b8fe-ce713c1a4b18.sorted_genome_alignments.bam	30.8	1.7	0.16	58cfa834e4b0c9d6adf6e60c	UNCID_1191832.7694eaf3-732e-4b23-b8fe-ce713c1a4b18.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-5585-01A	0487FC41-386C-4D76-9084-DAF959BF5E98	Primary Tumor	Illumina HiSeq	B03D3F70-393E-4E6B-94D0-149403267071	Kidney	51.0	B5040DA2-0D96-422A-9760-98A95C136FE8	7694EAF3-732E-4B23-B8FE-CE713C1A4B18	TCGA-CW-5585-01A-01R-1541-07	HG19	TCGA-CW-5585	TCGA-KIRC		s9215	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1541-07	True
13767.58cfa835e4b0c9d6adf6ec78	58cfa835e4b0c9d6adf6ec78	UNCID_1338734.772b8a77-bb90-40a8-ad48-f7a1fc1769de.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1338734.772b8a77-bb90-40a8-ad48-f7a1fc1769de.sorted_genome_alignments	UNCID_1338734.772b8a77-bb90-40a8-ad48-f7a1fc1769de.sorted_genome_alignments.bam	39.57	1.78	0.16	58cfa835e4b0c9d6adf6ec78	UNCID_1338734.772b8a77-bb90-40a8-ad48-f7a1fc1769de.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MG-01A	39EFA06A-FFE5-40B3-8F8A-A2D7071BC9E3	Primary Tumor	Illumina HiSeq	53CA3DC8-BEAF-4305-A03D-BBB665D11CB9	Bladder	48.0	1ACF91C8-4971-4893-AC27-64EA4A4C3023	772B8A77-BB90-40A8-AD48-F7A1FC1769DE	TCGA-CF-A3MG-01A-11R-A20F-07	HG19	TCGA-CF-A3MG	TCGA-BLCA		s3322	University of North Carolina	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A20F-07	True
13767.58cfa83be4b0c9d6adf71ede	58cfa83be4b0c9d6adf71ede	UNCID_2512135.169bde29-467d-44b1-9260-6dc8cfb1e207.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2512135.169bde29-467d-44b1-9260-6dc8cfb1e207.sorted_genome_alignments	UNCID_2512135.169bde29-467d-44b1-9260-6dc8cfb1e207.sorted_genome_alignments.bam	48.53	1.87	0.17	58cfa83be4b0c9d6adf71ede	UNCID_2512135.169bde29-467d-44b1-9260-6dc8cfb1e207.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ED-A97K-01A	8778DC9E-A7DB-4464-A8AF-11ADDB5E441A	Primary Tumor	Illumina HiSeq	4CD1927F-CD09-4FAF-80D5-1A6E4AABD7CE	Liver	54.0	6B015154-D6C7-4AA4-B631-45439CECFB97	169BDE29-467D-44B1-9260-6DC8CFB1E207	TCGA-ED-A97K-01A-21R-A38B-07	HG19	TCGA-ED-A97K	TCGA-LIHC		s17038	University of North Carolina	Asterand	Vietnam	NO	T3a	N0	Hepatocholangiocarcinoma (Mixed)	Stage III	A38B-07	True
13767.58cfa838e4b0c9d6adf70569	58cfa838e4b0c9d6adf70569	UNCID_1976184.74d7c232-3a85-4e1a-8f0e-0c33f4c63064.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1976184.74d7c232-3a85-4e1a-8f0e-0c33f4c63064.sorted_genome_alignments	UNCID_1976184.74d7c232-3a85-4e1a-8f0e-0c33f4c63064.sorted_genome_alignments.bam	166.2		0.15	58cfa838e4b0c9d6adf70569	UNCID_1976184.74d7c232-3a85-4e1a-8f0e-0c33f4c63064.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-IZ-8195-01A	A007B49B-297C-48C7-9F0A-12BDB470DF4B	Primary Tumor	Illumina HiSeq	56DA2B32-4C09-4DF1-A645-696E8E9BA86B	Kidney	82.0	3FF79014-B22B-4BD6-B2A9-669640696EFD	74D7C232-3A85-4E1A-8F0E-0C33F4C63064	TCGA-IZ-8195-01A-31R-2404-07	HG19	TCGA-IZ-8195	TCGA-KIRP		s11905	University of North Carolina	ABS - Lahey Clinic	United States	NO	T2a	NX	Kidney Papillary Renal Cell Carcinoma	Stage II	2404-07	True
13767.58cfa82fe4b0c9d6adf6b739	58cfa82fe4b0c9d6adf6b739	TCGA-61-2102-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-61-2102-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-61-2102-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	521.0	1.8	0.15	58cfa82fe4b0c9d6adf6b739	TCGA-61-2102-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2102-01A	7A08EFD0-F984-430E-A8EB-1881047214B6	Primary Tumor	Illumina HiSeq	21A5758B-3DA0-49DA-BCA8-07EAAB18F619	Ovary	74.0	D800778E-CC83-4447-9CFA-CA29ADEACB8F	7AC6AF79-C14A-4026-84AA-A288AFCB96DA	TCGA-61-2102-01A-01R-1568-13	GRCh37-lite	TCGA-61-2102	TCGA-OV	197.0	s17146	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa830e4b0c9d6adf6bcfc	58cfa830e4b0c9d6adf6bcfc	TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina.filtered.	WGS	TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina	TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina.bam	177.7		0.05	58cfa830e4b0c9d6adf6bcfc	TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AD-6964-01A	5E7074A6-5011-4DC5-950C-41365DBC6D09	Primary Tumor	Illumina HiSeq	67abf892-45e8-4468-a1fd-8446401b3f55	Colorectal	58.0	4D16E41A-B100-4080-A759-1F62E54C1C91	42D20028-0DDC-4DAC-9F05-D674F8915F21	TCGA-AD-6964-01A-11D-1924-10	GRCh37-lite	TCGA-AD-6964	TCGA-COAD		s13536	Baylor College of Medicine	International Genomics Consortium	United States	NO	T4a	N2b	Colon Adenocarcinoma		1924-10	False
13767.58cfa83ae4b0c9d6adf71df2	58cfa83ae4b0c9d6adf71df2	UNCID_2510042.563461ba-d9db-4b4a-8e43-ef420422f6f1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2510042.563461ba-d9db-4b4a-8e43-ef420422f6f1.sorted_genome_alignments	UNCID_2510042.563461ba-d9db-4b4a-8e43-ef420422f6f1.sorted_genome_alignments.bam	43.24	1.83	0.17	58cfa83ae4b0c9d6adf71df2	UNCID_2510042.563461ba-d9db-4b4a-8e43-ef420422f6f1.sorted_genome_alignments.bam	Dead	MALE	WHITE		Pancreatic Adenocarcinoma	Aligned reads	TCGA-2L-AAQA-01A	D8AA891C-8050-471E-AD3E-32B9C5E9DB03	Primary Tumor	Illumina HiSeq	4942BA22-4214-4B5D-A409-17A7F48984B3	Pancreas	76.0	D08F79B2-150A-44CF-9B8F-4B1DAD26300E	563461BA-D9DB-4B4A-8E43-EF420422F6F1	TCGA-2L-AAQA-01A-21R-A38C-07	HG19	TCGA-2L-AAQA	TCGA-PAAD	143.0	s865	University of North Carolina	Technical University of Munich	Germany	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	A38C-07	True
13767.58cfa83ae4b0c9d6adf71c92	58cfa83ae4b0c9d6adf71c92	UNCID_2474521.33b64021-96cf-4916-92db-948b9a767d1b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2474521.33b64021-96cf-4916-92db-948b9a767d1b.sorted_genome_alignments	UNCID_2474521.33b64021-96cf-4916-92db-948b9a767d1b.sorted_genome_alignments.bam	80.22	1.98	0.18	58cfa83ae4b0c9d6adf71c92	UNCID_2474521.33b64021-96cf-4916-92db-948b9a767d1b.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-A8HT-01A	95408571-9D4E-412B-8EE8-7992E0270B0F	Primary Tumor	Illumina HiSeq	22880DDD-E6A1-4747-A22E-6805C7ABB7CE	Liver	74.0	5F78BF91-E73D-4B78-9CD7-EC6502E764AA	33B64021-96CF-4916-92DB-948B9A767D1B	TCGA-CC-A8HT-01A-11R-A36F-07	HG19	TCGA-CC-A8HT	TCGA-LIHC		s16645	University of North Carolina	ILSbio	Vietnam	NO	T3	N0	Hepatocellular Carcinoma	Stage III	A36F-07	True
13767.58cfa834e4b0c9d6adf6e49b	58cfa834e4b0c9d6adf6e49b	UNCID_1193638.017b8d94-3c24-4bb0-9aff-f8bc623d2f4b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1193638.017b8d94-3c24-4bb0-9aff-f8bc623d2f4b.sorted_genome_alignments	UNCID_1193638.017b8d94-3c24-4bb0-9aff-f8bc623d2f4b.sorted_genome_alignments.bam	134.8	1.8	0.15	58cfa834e4b0c9d6adf6e49b	UNCID_1193638.017b8d94-3c24-4bb0-9aff-f8bc623d2f4b.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5681-01A	2939C03A-6F3F-4F7B-B246-34361BAADEB9	Primary Tumor	Illumina HiSeq	37BE4759-02DE-4AB6-A0DE-D0E793942CB1	Kidney	44.0	252836BE-AFF6-4967-8887-D93B178A4FF9	017B8D94-3C24-4BB0-9AFF-F8BC623D2F4B	TCGA-CJ-5681-01A-11R-1541-07	HG19	TCGA-CJ-5681	TCGA-KIRC	552.0	s9953	University of North Carolina	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1541-07	True
13767.58cfa839e4b0c9d6adf71154	58cfa839e4b0c9d6adf71154	UNCID_2281141.ca1b7ca7-5c8b-442d-ab3d-29bd16de1229.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2281141.ca1b7ca7-5c8b-442d-ab3d-29bd16de1229.sorted_genome_alignments	UNCID_2281141.ca1b7ca7-5c8b-442d-ab3d-29bd16de1229.sorted_genome_alignments.bam	115.75	1.79	0.17	58cfa839e4b0c9d6adf71154	UNCID_2281141.ca1b7ca7-5c8b-442d-ab3d-29bd16de1229.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A2G0-01A	6F661F0D-F08B-486E-8BD7-4306E1593EB9	Primary Tumor	Illumina HiSeq	88F551DB-6887-48BD-AC02-8ED51CE3E03F	Uterus	70.0	134CD317-CBEB-4633-B540-B639454615F7	CA1B7CA7-5C8B-442D-AB3D-29BD16DE1229	TCGA-D1-A2G0-01A-11R-A32Y-07	HG19	TCGA-D1-A2G0	TCGA-UCEC		s5128	University of North Carolina	Mayo Clinic	United States	NO			Mixed serous and endometrioid		A32Y-07	True
13767.58cfa834e4b0c9d6adf6e772	58cfa834e4b0c9d6adf6e772	UNCID_1215851.f2d8ec72-3f79-4cc4-9999-935bc74d7f72.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1215851.f2d8ec72-3f79-4cc4-9999-935bc74d7f72.sorted_genome_alignments	UNCID_1215851.f2d8ec72-3f79-4cc4-9999-935bc74d7f72.sorted_genome_alignments.bam	150.8	1.8	0.16	58cfa834e4b0c9d6adf6e772	UNCID_1215851.f2d8ec72-3f79-4cc4-9999-935bc74d7f72.sorted_genome_alignments.bam	Dead	MALE			Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-BQ-5882-01A	91A605B2-929A-44CE-8522-2FF793DDF82F	Primary Tumor	Illumina HiSeq	CEBCEED4-ED2A-4B65-A10F-3119EC7653D3	Kidney	54.0	5A9C4D75-5FA7-4806-8CC6-73717D1378F0	F2D8EC72-3F79-4CC4-9999-935BC74D7F72	TCGA-BQ-5882-01A-11R-1592-07	HG19	TCGA-BQ-5882	TCGA-KIRP	658.0	s11874	University of North Carolina	MSKCC	None	NO	T3b	N0	Kidney Papillary Renal Cell Carcinoma	Stage III	1592-07	True
13767.58cfa83be4b0c9d6adf72a17	58cfa83be4b0c9d6adf72a17	UNCID_368783.TCGA-BP-4345-01A-01R-1289-07.110429_SN851_0035_AB0AKJABXX.4.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_368783.TCGA-BP-4345-01A-01R-1289-07.110429_SN851_0035_AB0AKJABXX.4.trimmed.annotated.translated_to_genomic	UNCID_368783.TCGA-BP-4345-01A-01R-1289-07.110429_SN851_0035_AB0AKJABXX.4.trimmed.annotated.translated_to_genomic.bam	33.3	1.8	0.17	58cfa83be4b0c9d6adf72a17	UNCID_368783.TCGA-BP-4345-01A-01R-1289-07.110429_SN851_0035_AB0AKJABXX.4.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4345-01A	8958C2BF-B986-4C07-98D2-09DFE2375A14	Primary Tumor	Illumina HiSeq	E8A03663-38B1-4647-8876-AFFF602A969C	Kidney	62.0	8485819F-DB44-43B9-B330-1AA55F1B8FC7	AD98CE63-0A5D-46CC-B1CC-EE2AEBE8AE59	TCGA-BP-4345-01A-01R-1289-07	HG19	TCGA-BP-4345	TCGA-KIRC		s9692	University of North Carolina	MSKCC	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1289-07	True
13767.58cfa834e4b0c9d6adf6e66d	58cfa834e4b0c9d6adf6e66d	UNCID_1209266.102d50cb-a421-42d3-b417-be1e96a85ec8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1209266.102d50cb-a421-42d3-b417-be1e96a85ec8.sorted_genome_alignments	UNCID_1209266.102d50cb-a421-42d3-b417-be1e96a85ec8.sorted_genome_alignments.bam	30.58	1.87	0.16	58cfa834e4b0c9d6adf6e66d	UNCID_1209266.102d50cb-a421-42d3-b417-be1e96a85ec8.sorted_genome_alignments.bam	Alive	MALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CK-01A	7802140A-E518-4AE6-9BD1-C26D80B14AB1	Primary Tumor	Illumina HiSeq	E479B09B-6A95-492C-B1D2-834C5D06EB88	Thyroid	28.0	53B4B1BF-2C13-4530-8E58-9629B20C658E	102D50CB-A421-42D3-B417-BE1E96A85EC8	TCGA-EM-A2CK-01A-11R-A180-07	HG19	TCGA-EM-A2CK	TCGA-THCA		s12764	University of North Carolina	University Health Network	Canada	NO	T2	N1b	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A180-07	True
13767.58cfa837e4b0c9d6adf70046	58cfa837e4b0c9d6adf70046	UNCID_1885875.d620baa1-c329-46c6-a56a-dc08dfa23470.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1885875.d620baa1-c329-46c6-a56a-dc08dfa23470.sorted_genome_alignments	UNCID_1885875.d620baa1-c329-46c6-a56a-dc08dfa23470.sorted_genome_alignments.bam	14.95	1.92	0.17	58cfa837e4b0c9d6adf70046	UNCID_1885875.d620baa1-c329-46c6-a56a-dc08dfa23470.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A2QI-01A	C57835BE-77AB-4CF5-9B23-62C11A7B2EAF	Primary Tumor	Illumina HiSeq	5CDF27AB-2CD3-438E-886E-5AF3AE4345D3	Breast	76.0	08F10BB1-6DD4-4F36-86A3-1801F9762187	D620BAA1-C329-46C6-A56A-DC08DFA23470	TCGA-AC-A2QI-01A-12R-A19W-07	HG19	TCGA-AC-A2QI	TCGA-BRCA		s5922	University of North Carolina	International Genomics Consortium	United States	NO	T3	N1a	Infiltrating Lobular Carcinoma	Stage III	A19W-07	True
13767.58cfa82ee4b0c9d6adf6abee	58cfa82ee4b0c9d6adf6abee	G17210.TCGA-12-0616-01A-01R-1849-01.2.filtered.	RNA-Seq	G17210.TCGA-12-0616-01A-01R-1849-01.2	G17210.TCGA-12-0616-01A-01R-1849-01.2.bam	17.7	1.8	0.17	58cfa82ee4b0c9d6adf6abee	G17210.TCGA-12-0616-01A-01R-1849-01.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-12-0616-01A	EDCFAC32-ADB4-4FE7-86A0-309D3C6430E5	Primary Tumor	Illumina HiSeq	97B6BE07-1DA5-4F4E-901B-B4CF3EE8F175	Brain	36.0	DF94E750-C66A-45ED-AD6C-5D690A216575	23C2C2D5-D035-4875-A109-AA0A4C34C20E	TCGA-12-0616-01A-01R-1849-01	HG19_Broad_variant	TCGA-12-0616	TCGA-GBM	448.0	s13873	Broad Institute of MIT and Harvard	Duke	None	NO			Untreated primary (de novo) GBM		1849-01	True
13722.58cfa831e4b0c9d6adf6cdad	58cfa831e4b0c9d6adf6cdad	TCGA-FD-A3SQ-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_6_rg.sorted.filtered.	WGS	TCGA-FD-A3SQ-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_6_rg.sorted	TCGA-FD-A3SQ-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_6_rg.sorted.bam	54.42		0.15	58cfa831e4b0c9d6adf6cdad	TCGA-FD-A3SQ-10A-01D-A233_120830_SN208_0424_BD1DKLACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SQ-10A	3071CB51-DCF5-41F7-B047-AFC2DCBF0AAF	Blood Derived Normal	Illumina HiSeq	ccb5242d-6bc3-405b-829a-ed7ff3c509b0	Bladder	62.0	D6E68B46-7FB2-4AEE-8A99-EF0962049EC5	A98425A7-CDC8-4AEC-89BC-A615B125CAA0	TCGA-FD-A3SQ-10A-01D-A233-26	HG19_Broad_variant	TCGA-FD-A3SQ	TCGA-BLCA	1423.0	s2905	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	True
13767.58cfa83ce4b0c9d6adf7308e	58cfa83ce4b0c9d6adf7308e	_1_TCGA-BR-A4J6-01A-11R-A251-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-A4J6-01A-11R-A251-31_rnaseq	_1_TCGA-BR-A4J6-01A-11R-A251-31_rnaseq.bam	27.05	1.85	0.17	58cfa83ce4b0c9d6adf7308e	_1_TCGA-BR-A4J6-01A-11R-A251-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-A4J6-01A	0F344863-11CC-4FAE-8386-8247DFF59DE4	Primary Tumor	Illumina HiSeq	B4ABFF56-BA61-4E49-9ED4-A01C3E9CE06C	Stomach	69.0	FBE616B2-C372-4314-AE34-2CC71ADC6ADB	97E9C291-956E-4C1F-88DC-B20E9985FA28	TCGA-BR-A4J6-01A-11R-A251-31	GRCh37-lite	TCGA-BR-A4J6	TCGA-STAD		s14512	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	A251-31	True
13767.58cfa834e4b0c9d6adf6e81a	58cfa834e4b0c9d6adf6e81a	UNCID_1213348.b99e1ad8-15ec-4a57-bf8f-8aea5333975c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1213348.b99e1ad8-15ec-4a57-bf8f-8aea5333975c.sorted_genome_alignments	UNCID_1213348.b99e1ad8-15ec-4a57-bf8f-8aea5333975c.sorted_genome_alignments.bam	81.3	1.8	0.15	58cfa834e4b0c9d6adf6e81a	UNCID_1213348.b99e1ad8-15ec-4a57-bf8f-8aea5333975c.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4761-01A	270C9A0B-D71A-4D4E-8686-F183412159F2	Primary Tumor	Illumina HiSeq	0B7EDBA7-B0B1-4CBF-A9F3-7136286E57A7	Kidney	57.0	CB58CF8E-3D4C-4421-A3F0-F3C1540F12B2	B99E1AD8-15EC-4A57-BF8F-8AEA5333975C	TCGA-BP-4761-01A-01R-1289-07	HG19	TCGA-BP-4761	TCGA-KIRC		s9835	University of North Carolina	MSKCC	None	NO	T3a	N1	Kidney Clear Cell Renal Carcinoma	Stage III	1289-07	True
13767.58cfa82fe4b0c9d6adf6b638	58cfa82fe4b0c9d6adf6b638	TCGA-61-2008-01A-02R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-61-2008-01A-02R-1568-13_GRCh37-lite_rnaseq	TCGA-61-2008-01A-02R-1568-13_GRCh37-lite_rnaseq.bam	264.7	1.8	0.14	58cfa82fe4b0c9d6adf6b638	TCGA-61-2008-01A-02R-1568-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2008-01A	3AC45A71-C463-4F0F-B030-58C475A34418	Primary Tumor	Illumina HiSeq	86963BB0-3EF0-443F-9E40-1517664233B2	Ovary	40.0	69D76E7A-E0CB-4A8D-B6CD-67D8702D2AF9	10271F7F-CCE6-44FD-8754-7A4BEABFB394	TCGA-61-2008-01A-02R-1568-13	GRCh37-lite	TCGA-61-2008	TCGA-OV		s17797	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa831e4b0c9d6adf6c650	58cfa831e4b0c9d6adf6c650	TCGA-CG-4455-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_6_rg.sorted.filtered.	WGS	TCGA-CG-4455-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_6_rg.sorted	TCGA-CG-4455-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_6_rg.sorted.bam	67.9	1.9	0.16	58cfa831e4b0c9d6adf6c650	TCGA-CG-4455-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_6_rg.sorted.bam	Alive	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4455-10A	8A173D98-20A1-4C84-86C1-97818E1C665A	Blood Derived Normal	Illumina HiSeq	761098d4-2b01-462b-95d1-962819d14226	Stomach	72.0	DDD0129D-79B1-497A-BB38-60745BD9DEB4	7E88B22D-C19E-45C9-AD0C-4951B5A361A0	TCGA-CG-4455-10A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4455	TCGA-STAD		s14412	Harvard Medical School	Indivumed	Germany	NO	T2b	N1	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage II	1154-02	True
13722.58cfa830e4b0c9d6adf6bea9	58cfa830e4b0c9d6adf6bea9	TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	208.89	1.9	0.14	58cfa830e4b0c9d6adf6bea9	TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3909-01A	769880AE-34D9-405E-8EA7-33BA47CF2DD2	Primary Tumor	Illumina HiSeq	f11e5abe-82c7-4b53-bc65-7bde2dbc2bb1	Colorectal	69.0	12A43BEB-EDB6-4ABC-8322-CA8246D64B3F	F168205F-B2ED-4563-A211-DA59223830AB	TCGA-AG-3909-01A-01D-1115-02	HG18	TCGA-AG-3909	TCGA-READ		s1987	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage III	1115-02	True
13767.58cfa83be4b0c9d6adf72574	58cfa83be4b0c9d6adf72574	UNCID_2636627.751f3b6e-a9c0-4ad8-a8af-06b40d67159d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2636627.751f3b6e-a9c0-4ad8-a8af-06b40d67159d.sorted_genome_alignments	UNCID_2636627.751f3b6e-a9c0-4ad8-a8af-06b40d67159d.sorted_genome_alignments.bam	12.95	1.45	0.18	58cfa83be4b0c9d6adf72574	UNCID_2636627.751f3b6e-a9c0-4ad8-a8af-06b40d67159d.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-WS-AB45-01A	7F6898E2-A840-4AD1-80F7-783F8B766FCC	Primary Tumor	Illumina HiSeq	310C2876-344C-4D3F-88F2-88F7C8DF36E7	Colorectal	52.0	EB97D34E-7333-4E9D-B559-34DD6436C14C	751F3B6E-A9C0-4AD8-A8AF-06B40D67159D	TCGA-WS-AB45-01A-11R-A41B-07	HG19	TCGA-WS-AB45	TCGA-COAD		s12982	University of North Carolina	University of Kansas	United States	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage II	A41B-07	True
13767.58cfa835e4b0c9d6adf6f031	58cfa835e4b0c9d6adf6f031	UNCID_1505001.779acc52-4279-4249-b993-88ed032ccefa.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1505001.779acc52-4279-4249-b993-88ed032ccefa.sorted_genome_alignments	UNCID_1505001.779acc52-4279-4249-b993-88ed032ccefa.sorted_genome_alignments.bam	47.2	1.5	0.16	58cfa835e4b0c9d6adf6f031	UNCID_1505001.779acc52-4279-4249-b993-88ed032ccefa.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-6987-01A	2EFC156C-464A-4C2F-A854-39FEFE32081C	Primary Tumor	Illumina HiSeq	F104B90F-29D5-4646-8E86-9F72E7557717	Lung	77.0	D0BFB6CC-ABC4-4B09-B668-1003F3EED1A7	779ACC52-4279-4249-B993-88ED032CCEFA	TCGA-55-6987-01A-11R-1949-07	HG19	TCGA-55-6987	TCGA-LUAD		s11402	University of North Carolina	International Genomics Consortium	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1949-07	True
13767.58cfa839e4b0c9d6adf711a0	58cfa839e4b0c9d6adf711a0	UNCID_2234626.13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2234626.13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7.sorted_genome_alignments	UNCID_2234626.13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7.sorted_genome_alignments.bam	20.98	1.93	0.15	58cfa839e4b0c9d6adf711a0	UNCID_2234626.13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-KK-A7B0-01A	73D4E806-2C15-4C9E-A978-106FB9494E82	Primary Tumor	Illumina HiSeq	9CE3DFC3-9B62-4188-A084-3214792E3BFC	Prostate	67.0	E93CC6CC-CE3B-45EB-8928-D5B13D7194AF	13D2199F-D552-4EA3-9D7C-C2D1FB01D7A7	TCGA-KK-A7B0-01A-11R-A32O-07	HG19	TCGA-KK-A7B0	TCGA-PRAD		s4066	University of North Carolina	MD Anderson Cancer Center	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		A32O-07	True
13767.58cfa837e4b0c9d6adf6fe00	58cfa837e4b0c9d6adf6fe00	UNCID_1726764.a882f372-5345-4810-87d1-bf82a4be5aa3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1726764.a882f372-5345-4810-87d1-bf82a4be5aa3.sorted_genome_alignments	UNCID_1726764.a882f372-5345-4810-87d1-bf82a4be5aa3.sorted_genome_alignments.bam	174.2		0.15	58cfa837e4b0c9d6adf6fe00	UNCID_1726764.a882f372-5345-4810-87d1-bf82a4be5aa3.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8428-11A	455FD7D4-5FF4-423F-83CE-4630AEF89BB7	Solid Tissue Normal	Illumina HiSeq	18EE11C8-B359-4281-91AC-4D2E5FBD64DC	Kidney	71.0	63BEB494-E581-44E7-800B-5F0FC1EDD6AF	A882F372-5345-4810-87D1-BF82A4BE5AA3	TCGA-KN-8428-11A-01R-2315-07	HG19	TCGA-KN-8428	TCGA-KICH	1590.0	s16558	University of North Carolina	Harvard	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2315-07	True
13722.58cfa831e4b0c9d6adf6cd68	58cfa831e4b0c9d6adf6cd68	TCGA-FE-A232-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_8_rg.sorted.filtered.	WGS	TCGA-FE-A232-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_8_rg.sorted	TCGA-FE-A232-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_8_rg.sorted.bam	19.22	1.85	0.18	58cfa831e4b0c9d6adf6cd68	TCGA-FE-A232-10A-01D-A14U_120629_SN1222_0120_AC0WKWACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A232-10A	5EB0D577-223B-4409-89D1-5C5D196AFFC3	Blood Derived Normal	Illumina HiSeq	b0870db2-3e35-4d95-926d-744f50c9ad56	Thyroid	44.0	305278F6-641B-45C8-A758-5148346161C8	8DC86F0D-2853-49B9-89D3-046871A44F42	TCGA-FE-A232-10A-01D-A14U-02	HG19_Broad_variant	TCGA-FE-A232	TCGA-THCA		s12005	Harvard Medical School	Ohio State University	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	True
13767.58cfa834e4b0c9d6adf6e4dc	58cfa834e4b0c9d6adf6e4dc	UNCID_1178694.c4e5b7ad-4b5e-4e34-a6e8-b67d53b0f7f9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1178694.c4e5b7ad-4b5e-4e34-a6e8-b67d53b0f7f9.sorted_genome_alignments	UNCID_1178694.c4e5b7ad-4b5e-4e34-a6e8-b67d53b0f7f9.sorted_genome_alignments.bam	78.3	1.8	0.14	58cfa834e4b0c9d6adf6e4dc	UNCID_1178694.c4e5b7ad-4b5e-4e34-a6e8-b67d53b0f7f9.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4884-01A	4FD166D4-0B77-4815-AE6A-2165522F8251	Primary Tumor	Illumina HiSeq	EB6ED05A-42CE-4BBF-9512-F5B7E4537780	Kidney	72.0	9FD8F5F4-771F-44CF-A728-C9FE61F4022F	C4E5B7AD-4B5E-4E34-A6E8-B67D53B0F7F9	TCGA-CJ-4884-01A-01R-1305-07	HG19	TCGA-CJ-4884	TCGA-KIRC		s9030	University of North Carolina	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1305-07	True
13767.58cfa839e4b0c9d6adf712d0	58cfa839e4b0c9d6adf712d0	UNCID_2325070.063e82c8-a923-4ca5-94cb-9fce3cccd226.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2325070.063e82c8-a923-4ca5-94cb-9fce3cccd226.sorted_genome_alignments	UNCID_2325070.063e82c8-a923-4ca5-94cb-9fce3cccd226.sorted_genome_alignments.bam	30.9	2.02	0.17	58cfa839e4b0c9d6adf712d0	UNCID_2325070.063e82c8-a923-4ca5-94cb-9fce3cccd226.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-A7T6-01A	A0672F6F-6406-4D49-96D0-6AFD571BBD00	Primary Tumor	Illumina HiSeq	3EDD2847-FC9E-4498-A86B-ED4F95DDB9A7	Brain	73.0	542A367D-D5F2-4D93-B9E0-F7702372A36C	063E82C8-A923-4CA5-94CB-9FCE3CCCD226	TCGA-DU-A7T6-01A-11R-A33Z-07	HG19	TCGA-DU-A7T6	TCGA-LGG	547.0	s8476	University of North Carolina	Henry Ford Hospital	United States	NO			Oligodendroglioma		A33Z-07	True
13767.58cfa82fe4b0c9d6adf6b6eb	58cfa82fe4b0c9d6adf6b6eb	TCGA-57-1994-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-57-1994-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-57-1994-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	671.0	1.8	0.15	58cfa82fe4b0c9d6adf6b6eb	TCGA-57-1994-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-57-1994-01A	602E2934-223A-44DB-8C33-06EB05D72F94	Primary Tumor	Illumina HiSeq	C2D55F0F-5C41-4B5F-80A9-D8347DAB2C4E	Ovary	63.0	A2667408-6465-4258-9E68-F88EC3CD7B7D	2CF309EA-0C2E-4F28-A94B-342DC9A1AAE8	TCGA-57-1994-01A-01R-1568-13	GRCh37-lite	TCGA-57-1994	TCGA-OV		s18014	Canada's Michael Smith Genome Sciences Centre	International Genomics Consortium	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa831e4b0c9d6adf6c972	58cfa831e4b0c9d6adf6c972	TCGA-D7-6528-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-D7-6528-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_6_rg.sorted	TCGA-D7-6528-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_6_rg.sorted.bam	291.7	1.9	0.15	58cfa831e4b0c9d6adf6c972	TCGA-D7-6528-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6528-10A	35496E4E-598F-4FFC-B11E-8EDAEB676079	Blood Derived Normal	Illumina HiSeq	d4ea96e7-6bf3-4ac4-88ad-e0199ddef1b7	Stomach	70.0	45FE00A2-0D61-4861-8F22-B0D306458CE4	E9E37E3D-03CA-41A1-B725-2768EDFB3017	TCGA-D7-6528-10A-01D-1798-02	HG19_Broad_variant	TCGA-D7-6528	TCGA-STAD		s15407	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage I	1798-02	True
13767.58cfa83ce4b0c9d6adf72c74	58cfa83ce4b0c9d6adf72c74	UNCID_574220.5513eb8f-2d59-438b-a1b1-d2f758d2f7e0.110916_UNC16-SN851_0088_BB00T0ABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_574220.5513eb8f-2d59-438b-a1b1-d2f758d2f7e0.110916_UNC16-SN851_0088_BB00T0ABXX.8.trimmed.annotated.translated_to_genomic	UNCID_574220.5513eb8f-2d59-438b-a1b1-d2f758d2f7e0.110916_UNC16-SN851_0088_BB00T0ABXX.8.trimmed.annotated.translated_to_genomic.bam	58.8	1.7	0.15	58cfa83ce4b0c9d6adf72c74	UNCID_574220.5513eb8f-2d59-438b-a1b1-d2f758d2f7e0.110916_UNC16-SN851_0088_BB00T0ABXX.8.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5696-01A	1D176C53-6CBB-4A39-9A6F-669B4F1CB575	Primary Tumor	Illumina HiSeq	ABE9C885-D709-493F-B2A8-8D9B817EF10A	Kidney	69.0	7246D6B4-6A1E-4718-BE30-58176937894F	5513EB8F-2D59-438B-A1B1-D2F758D2F7E0	TCGA-B0-5696-01A-11R-1541-07	HG19	TCGA-B0-5696	TCGA-KIRC		s9555	University of North Carolina	University of Pittsburgh	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1541-07	True
13722.58cfa832e4b0c9d6adf6d304	58cfa832e4b0c9d6adf6d304	TCGA-KM-8443-10A-01D-2311-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8443-10A-01D-2311-10_wgs_Illumina	TCGA-KM-8443-10A-01D-2311-10_wgs_Illumina.bam	126.6		0.05	58cfa832e4b0c9d6adf6d304	TCGA-KM-8443-10A-01D-2311-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8443-10A	2F1C4DB6-88A7-4A5D-A5FE-94D85F569440	Blood Derived Normal	Illumina HiSeq	9d5dbe83-f6f5-453a-b475-b59155c2110b	Kidney	57.0	8B524689-0730-4061-BD05-9A497249EF81	982DBBF8-FDF8-4653-91ED-2E857E1A7708	TCGA-KM-8443-10A-01D-2311-10	GRCh37-lite	TCGA-KM-8443	TCGA-KICH		s16534	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2311-10	True
13767.58cfa83ce4b0c9d6adf72faa	58cfa83ce4b0c9d6adf72faa	_1_TCGA-CG-4441-01A-01R-1802-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-CG-4441-01A-01R-1802-13_rnaseq	_1_TCGA-CG-4441-01A-01R-1802-13_rnaseq.bam	212.7	1.8	0.15	58cfa83ce4b0c9d6adf72faa	_1_TCGA-CG-4441-01A-01R-1802-13_rnaseq.bam	Dead	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4441-01A	37E22429-EFD7-4D6A-B79A-9D8C7BE2170C	Primary Tumor	Illumina HiSeq	ADEF22E5-4C5D-4F82-B406-BF22855B8B0F	Stomach	83.0	60937697-57BA-4D03-9545-B0E321215448	484434A5-5522-43EC-A43D-46B426D89DC4	TCGA-CG-4441-01A-01R-1802-13	GRCh37-lite	TCGA-CG-4441	TCGA-STAD	426.0	s15360	Canada's Michael Smith Genome Sciences Centre	Indivumed	Germany	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1802-13	True
13722.58cfa830e4b0c9d6adf6bdc0	58cfa830e4b0c9d6adf6bdc0	TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted	TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted.bam	79.77	1.93	0.17	58cfa830e4b0c9d6adf6bdc0	TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A186-01A	FE4DB898-3A9F-4DFF-ADCB-7B8C30137350	Primary Tumor	Illumina HiSeq	f65268ef-b937-4d49-922e-a5e3ebc0eab8	Uterus	61.0	B1645A83-57B7-4357-B977-63A5B6AEE39E	ECF410AD-B160-4F00-A165-38529FAE974B	TCGA-BG-A186-01A-11D-A12F-02	HG19_Broad_variant	TCGA-BG-A186	TCGA-UCEC		s4792	Harvard Medical School	University of Pittsburgh	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13722.58cfa82ee4b0c9d6adf6afb2	58cfa82ee4b0c9d6adf6afb2	TCGA-05-4418-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-05-4418-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-05-4418-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	65.9	1.9	0.13	58cfa82ee4b0c9d6adf6afb2	TCGA-05-4418-10A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4418-10A	D2C1E896-6886-4122-BB48-5FBCD3F641F4	Blood Derived Normal	Illumina HiSeq	ba806a17-fb08-48cf-8ed8-069510bc4e50	Lung	69.0	5808A3F7-0876-4816-94D6-4DBE08257955	7D13B485-47B6-4326-BBA6-28C5E5014829	TCGA-05-4418-10A-01D-1203-02	GRCh37	TCGA-05-4418	TCGA-LUAD	274.0	s11330	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Lung Adenocarcinoma Mixed Subtype	Stage III	1203-02	True
13767.58cfa838e4b0c9d6adf70487	58cfa838e4b0c9d6adf70487	UNCID_1958178.9ee990f0-1982-4012-96d7-4495ab1f4e4b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1958178.9ee990f0-1982-4012-96d7-4495ab1f4e4b.sorted_genome_alignments	UNCID_1958178.9ee990f0-1982-4012-96d7-4495ab1f4e4b.sorted_genome_alignments.bam	103.7		0.16	58cfa838e4b0c9d6adf70487	UNCID_1958178.9ee990f0-1982-4012-96d7-4495ab1f4e4b.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-AL-7173-01A	A0F4EE95-B457-43CF-8B6C-0B6882DD99CE	Primary Tumor	Illumina HiSeq	C0F928C2-7ED9-4578-B10C-D1B1C09E90BF	Kidney	72.0	7DF2FAB4-3111-4A93-A6EA-C2B701B71438	9EE990F0-1982-4012-96D7-4495AB1F4E4B	TCGA-AL-7173-01A-11R-2139-07	HG19	TCGA-AL-7173	TCGA-KIRP		s11699	University of North Carolina	Fox Chase	United States	NO	T3	N2	Kidney Papillary Renal Cell Carcinoma	Stage IV	2139-07	True
13767.58cfa830e4b0c9d6adf6c2f9	58cfa830e4b0c9d6adf6c2f9	TCGA-BR-7723-01A-11R-2055-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-7723-01A-11R-2055-13_rnaseq	TCGA-BR-7723-01A-11R-2055-13_rnaseq.bam	218.2		0.16	58cfa830e4b0c9d6adf6c2f9	TCGA-BR-7723-01A-11R-2055-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7723-01A	BB3729FE-2FA2-47FC-AFDE-C14036CB84F5	Primary Tumor	Illumina HiSeq	4D933C79-EAC5-42EC-9EC3-64C5FFCE3242	Stomach	59.0	35FD9C18-60D0-4974-B96F-BD6B2B9A49C8	7D26F5C0-FA12-4972-A2E6-40A29B4AEE34	TCGA-BR-7723-01A-11R-2055-13	GRCh37-lite	TCGA-BR-7723	TCGA-STAD		s14536	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2055-13	True
13722.58cfa830e4b0c9d6adf6bb48	58cfa830e4b0c9d6adf6bb48	TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	84.8	1.91	0.16	58cfa830e4b0c9d6adf6bb48	TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02Y-01A	A435FDF4-A89A-499E-9006-CBB5693EAB26	Primary Tumor	Illumina HiSeq	faa460a7-9c39-4da6-93c1-22d5d99742f0	Colorectal	73.0	8537633B-6426-4B66-A2A3-FA942EEDF01B	CD188DB1-ED81-42A6-B550-07D4008143EE	TCGA-AA-A02Y-01A-43D-A079-02	HG18	TCGA-AA-A02Y	TCGA-COAD		s13195	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A079-02	True
13767.58cfa837e4b0c9d6adf6fdb2	58cfa837e4b0c9d6adf6fdb2	UNCID_1727448.42ac5002-fdad-426e-9037-e5cc99d093eb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1727448.42ac5002-fdad-426e-9037-e5cc99d093eb.sorted_genome_alignments	UNCID_1727448.42ac5002-fdad-426e-9037-e5cc99d093eb.sorted_genome_alignments.bam	67.5		0.14	58cfa837e4b0c9d6adf6fdb2	UNCID_1727448.42ac5002-fdad-426e-9037-e5cc99d093eb.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8414-01A	E562C60C-8E6E-481F-AD4F-28B067437ECE	Primary Tumor	Illumina HiSeq	D61E4359-6F84-48CB-9842-55295F8E1049	Kidney	50.0	2D47BE98-DDC5-4E67-B034-A71B3B7530F4	42AC5002-FDAD-426E-9037-E5CC99D093EB	TCGA-KO-8414-01A-11R-2315-07	HG19	TCGA-KO-8414	TCGA-KICH		s16561	University of North Carolina	MD Anderson Cancer Center	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2315-07	True
13767.58cfa839e4b0c9d6adf71058	58cfa839e4b0c9d6adf71058	UNCID_2223881.9e8f4ed7-78c0-436a-9333-5fb281fda266.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2223881.9e8f4ed7-78c0-436a-9333-5fb281fda266.sorted_genome_alignments	UNCID_2223881.9e8f4ed7-78c0-436a-9333-5fb281fda266.sorted_genome_alignments.bam	119.8	1.8	0.14	58cfa839e4b0c9d6adf71058	UNCID_2223881.9e8f4ed7-78c0-436a-9333-5fb281fda266.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-G4-6307-01A	568DBDA7-88B5-4330-881F-DC5D6C7CE4AE	Primary Tumor	Illumina HiSeq	4318F341-BAA2-4326-9F84-9CD973F1EAEF	Colorectal	37.0	801B8D05-2D29-4F8C-8D8D-634B2E21B867	9E8F4ED7-78C0-436A-9333-5FB281FDA266	TCGA-G4-6307-01A-11R-1723-07	HG19	TCGA-G4-6307	TCGA-COAD		s13471	University of North Carolina	Roswell Park	United States	NO	T3	N1	Colon Adenocarcinoma	Stage III	1723-07	True
13722.58cfa82de4b0c9d6adf6a740	58cfa82de4b0c9d6adf6a740	G14850.TCGA-49-4486-01A-01D-1931-08.3.filtered.	WGS	G14850.TCGA-49-4486-01A-01D-1931-08.3	G14850.TCGA-49-4486-01A-01D-1931-08.3.bam	142.53	1.9	0.14	58cfa82de4b0c9d6adf6a740	G14850.TCGA-49-4486-01A-01D-1931-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4486-01A	61C655EC-52B5-453F-A6CC-B2ABA445B027	Primary Tumor	Illumina HiSeq	53a1d9af-aa10-4382-bfad-f13af3c6cab9	Lung	72.0	5AE9B10F-347C-48C3-90CD-9290055CFE4B	23D86395-9E20-4CF9-BF7E-F76544A1F772	TCGA-49-4486-01A-01D-1931-08	HG19_Broad_variant	TCGA-49-4486	TCGA-LUAD	2318.0	s10628	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1931-08	True
13722.58cfa82fe4b0c9d6adf6b5dc	58cfa82fe4b0c9d6adf6b5dc	TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted	TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted.bam	111.7	1.9	0.15	58cfa82fe4b0c9d6adf6b5dc	TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5939-01A	12B79B4F-C28C-418E-A1E7-E622F33FDCC2	Primary Tumor	Illumina HiSeq	7a3d6187-a909-4946-83bf-0d6fc6a753ee	Lung	85.0	6A27F5F8-F4EE-45C7-B953-DDD7D0291DBB	08D803D0-A294-4F70-9560-563357172BBB	TCGA-50-5939-01A-11D-1623-02	HG19_Broad_variant	TCGA-50-5939	TCGA-LUAD	460.0	s11007	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	1623-02	True
13767.58cfa83ae4b0c9d6adf71d73	58cfa83ae4b0c9d6adf71d73	UNCID_2506941.a929b343-b542-46e9-9f3f-22eea752a980.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2506941.a929b343-b542-46e9-9f3f-22eea752a980.sorted_genome_alignments	UNCID_2506941.a929b343-b542-46e9-9f3f-22eea752a980.sorted_genome_alignments.bam	17.15	1.87	0.17	58cfa83ae4b0c9d6adf71d73	UNCID_2506941.a929b343-b542-46e9-9f3f-22eea752a980.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-IB-AAUV-01A	6983FC34-9577-45E1-B246-40E18FAB953F	Primary Tumor	Illumina HiSeq	6A62E9CD-FA6F-48DB-B2C6-742CF3A087D9	Pancreas	49.0	3DFDA380-23D2-42B5-BC4D-A76784F12B55	A929B343-B542-46E9-9F3F-22EEA752A980	TCGA-IB-AAUV-01A-11R-A38C-07	HG19	TCGA-IB-AAUV	TCGA-PAAD		s860	University of North Carolina	Alberta Health Services	Canada	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	A38C-07	True
13722.58cfa831e4b0c9d6adf6cb5e	58cfa831e4b0c9d6adf6cb5e	TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted	TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted.bam	193.7		0.15	58cfa831e4b0c9d6adf6cb5e	TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7018-01A	F18DAB99-26B0-4727-89A9-7F16BD382356	Primary Tumor	Illumina HiSeq	2736e751-ccc3-4721-b516-238f987ad26f	Brain	57.0	FE98F78B-2C80-4999-B430-E1D95A53F356	02FCFCBB-05D7-4671-BDDF-DED65316FCC6	TCGA-DU-7018-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7018	TCGA-LGG	933.0	s8567	Harvard Medical School	Henry Ford Hospital	United States	NO			Oligodendroglioma		2022-02	True
13722.58cfa831e4b0c9d6adf6c465	58cfa831e4b0c9d6adf6c465	TCGA-CG-5733-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CG-5733-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_3_rg.sorted	TCGA-CG-5733-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_3_rg.sorted.bam	332.0	1.9	0.15	58cfa831e4b0c9d6adf6c465	TCGA-CG-5733-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_3_rg.sorted.bam	Dead	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5733-01A	8A9AFA5E-63CE-41EB-AAFB-B0B03653DA5A	Primary Tumor	Illumina HiSeq	4b31f837-59fa-48a7-bfbc-475e1251bd07	Stomach	83.0	315E485B-3069-4ADC-8AB5-BEDCC0642930	73EA65AA-3677-425F-B084-1FC3BEBA2D03	TCGA-CG-5733-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5733	TCGA-STAD	641.0	s14492	Harvard Medical School	Indivumed	Germany	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1598-02	True
13767.58cfa837e4b0c9d6adf70202	58cfa837e4b0c9d6adf70202	UNCID_1874137.f53cf9e2-dcf1-4b70-b266-284dcf11f492.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1874137.f53cf9e2-dcf1-4b70-b266-284dcf11f492.sorted_genome_alignments	UNCID_1874137.f53cf9e2-dcf1-4b70-b266-284dcf11f492.sorted_genome_alignments.bam	79.2	1.7	0.15	58cfa837e4b0c9d6adf70202	UNCID_1874137.f53cf9e2-dcf1-4b70-b266-284dcf11f492.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CA-6717-01A	268C01B3-D2CE-44C0-A2FE-EA846A1253CC	Primary Tumor	Illumina HiSeq	FD787F3C-8048-47DF-9FC2-1F06F7143278	Colorectal	57.0	D412011F-061C-43D6-8FA7-F917DA658AFF	F53CF9E2-DCF1-4B70-B266-284DCF11F492	TCGA-CA-6717-01A-11R-1839-07	HG19	TCGA-CA-6717	TCGA-COAD		s12958	University of North Carolina	ILSbio	Vietnam	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage II	1839-07	True
13767.58cfa83ae4b0c9d6adf716c5	58cfa83ae4b0c9d6adf716c5	UNCID_2407796.bd46f867-070c-49a3-9180-8c78b72183a8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2407796.bd46f867-070c-49a3-9180-8c78b72183a8.sorted_genome_alignments	UNCID_2407796.bd46f867-070c-49a3-9180-8c78b72183a8.sorted_genome_alignments.bam	8.06	1.89	0.17	58cfa83ae4b0c9d6adf716c5	UNCID_2407796.bd46f867-070c-49a3-9180-8c78b72183a8.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Brain Lower Grade Glioma	Aligned reads	TCGA-VM-A8CH-01A	484DD45B-A16C-4650-BAC9-832FBE4D96EB	Primary Tumor	Illumina HiSeq	E044D113-3767-4FCC-8FE8-566E5CC14104	Brain	24.0	E56F0F34-9EE0-492C-9BBE-EBD31468D808	BD46F867-070C-49A3-9180-8C78B72183A8	TCGA-VM-A8CH-01A-12R-A36H-07	HG19	TCGA-VM-A8CH	TCGA-LGG		s8299	University of North Carolina	Huntsman Cancer Institute	United States	NO			Astrocytoma		A36H-07	True
13767.58cfa834e4b0c9d6adf6e2be	58cfa834e4b0c9d6adf6e2be	UNCID_1183340.cd609b10-8909-4f86-b95d-88005881bc0d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1183340.cd609b10-8909-4f86-b95d-88005881bc0d.sorted_genome_alignments	UNCID_1183340.cd609b10-8909-4f86-b95d-88005881bc0d.sorted_genome_alignments.bam	35.8	1.8	0.17	58cfa834e4b0c9d6adf6e2be	UNCID_1183340.cd609b10-8909-4f86-b95d-88005881bc0d.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4712-11A	3F72D63F-AD48-4500-BAF6-897B1D6DDA7D	Solid Tissue Normal	Illumina HiSeq	5820EACC-086A-46F6-89A7-A680B1A4969F	Kidney	76.0	AEA04397-89BC-4A73-AB41-34C0BA34FAF6	CD609B10-8909-4F86-B95D-88005881BC0D	TCGA-B0-4712-11A-02R-1503-07	HG19	TCGA-B0-4712	TCGA-KIRC	1337.0	s8873	University of North Carolina	University of Pittsburgh	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1503-07	True
13722.58cfa83ce4b0c9d6adf730e4	58cfa83ce4b0c9d6adf730e4	c1708e13b2a9faaf5f50fc2e1f491bca.filtered.	WGS	c1708e13b2a9faaf5f50fc2e1f491bca	c1708e13b2a9faaf5f50fc2e1f491bca.bam	14.09		0.09	58cfa83ce4b0c9d6adf730e4	c1708e13b2a9faaf5f50fc2e1f491bca.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RL-10A	61EB08D0-EA01-45E7-884B-AC3D6070172A	Blood Derived Normal	Illumina HiSeq	59e94488-d19c-44a4-9cb9-0a2d4d5836ab	Cervix	32.0	D4A4CABD-FA00-4DBF-A25B-B3635FC0AD9A	B64F18C1-731E-4988-A079-1306B8D9C14D	TCGA-EK-A2RL-10A-01D-A34H-09	GRCh37-lite	TCGA-EK-A2RL	TCGA-CESC		s1610	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	T1b1	N1	Endocervical Type of Adenocarcinoma		A34H-09	True
13767.58cfa82fe4b0c9d6adf6b512	58cfa82fe4b0c9d6adf6b512	TCGA-29-1690-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-29-1690-01A-01R-1566-13_rnaseq	TCGA-29-1690-01A-01R-1566-13_rnaseq.bam	184.0	1.8	0.15	58cfa82fe4b0c9d6adf6b512	TCGA-29-1690-01A-01R-1566-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1690-01A	6B06281B-D3A9-440E-A86C-EE7DB003352A	Primary Tumor	Illumina HiSeq	22EBFE4B-727B-41C0-9376-604C540A489C	Ovary	66.0	50633D92-0D7D-476E-8D4B-9A8DE94771A2	D78906D7-C8F2-4BF0-86CC-2B60B067AAA6	TCGA-29-1690-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-29-1690	TCGA-OV	1448.0	s18057	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa83ce4b0c9d6adf72dca	58cfa83ce4b0c9d6adf72dca	UNCID_612174.488893ff-fbb6-4ca6-a8b5-7d45635a0ccf.111025_UNC12-SN629_0164_BC04WGABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_612174.488893ff-fbb6-4ca6-a8b5-7d45635a0ccf.111025_UNC12-SN629_0164_BC04WGABXX.8.trimmed.annotated.translated_to_genomic	UNCID_612174.488893ff-fbb6-4ca6-a8b5-7d45635a0ccf.111025_UNC12-SN629_0164_BC04WGABXX.8.trimmed.annotated.translated_to_genomic.bam	5.8	1.7	0.14	58cfa83ce4b0c9d6adf72dca	UNCID_612174.488893ff-fbb6-4ca6-a8b5-7d45635a0ccf.111025_UNC12-SN629_0164_BC04WGABXX.8.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-6090-01A	4DD51EDF-05D1-445A-B43C-6FCE29EB21D4	Primary Tumor	Illumina HiSeq	AF896875-B3E9-43D6-A226-ECAD3380B6D5	Kidney	68.0	20A8B74C-0548-4816-B89B-107A5BB62D7D	488893FF-FBB6-4CA6-A8B5-7D45635A0CCF	TCGA-CW-6090-01A-11R-1672-07	HG19	TCGA-CW-6090	TCGA-KIRC		s9931	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1672-07	True
13767.58cfa834e4b0c9d6adf6e621	58cfa834e4b0c9d6adf6e621	UNCID_1199358.a5702ea5-2ed9-40c9-881e-f20dcdc904a1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1199358.a5702ea5-2ed9-40c9-881e-f20dcdc904a1.sorted_genome_alignments	UNCID_1199358.a5702ea5-2ed9-40c9-881e-f20dcdc904a1.sorted_genome_alignments.bam	56.3	1.8	0.15	58cfa834e4b0c9d6adf6e621	UNCID_1199358.a5702ea5-2ed9-40c9-881e-f20dcdc904a1.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4643-01A	F11F68AC-5AD2-416B-A0C2-697AC3E9718A	Primary Tumor	Illumina HiSeq	07494CFF-F279-4E6B-A717-C03AB7475808	Kidney	67.0	D2BAFF9A-220A-4F44-BBDB-A02CDFD908C9	A5702EA5-2ED9-40C9-881E-F20DCDC904A1	TCGA-CJ-4643-01A-02R-1325-07	HG19	TCGA-CJ-4643	TCGA-KIRC		s9510	University of North Carolina	MD Anderson Cancer Center	None	NO	T2b	N0	Kidney Clear Cell Renal Carcinoma	Stage II	1325-07	True
13767.58cfa837e4b0c9d6adf6fd58	58cfa837e4b0c9d6adf6fd58	UNCID_1676989.b740efb3-f63b-4c0c-b6cd-4c0ceb7b8100.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1676989.b740efb3-f63b-4c0c-b6cd-4c0ceb7b8100.sorted_genome_alignments	UNCID_1676989.b740efb3-f63b-4c0c-b6cd-4c0ceb7b8100.sorted_genome_alignments.bam	140.2		0.16	58cfa837e4b0c9d6adf6fd58	UNCID_1676989.b740efb3-f63b-4c0c-b6cd-4c0ceb7b8100.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-HZ-7918-01A	620E0648-EC20-4A12-A6CB-5546FE829C77	Primary Tumor	Illumina HiSeq	A6B36AED-259C-413D-A380-076F80678789	Pancreas	72.0	42AE9A70-EA04-4403-86CC-3DA6FD120CDE	B740EFB3-F63B-4C0C-B6CD-4C0CEB7B8100	TCGA-HZ-7918-01A-11R-2156-07	HG19	TCGA-HZ-7918	TCGA-PAAD		s755	University of North Carolina	International Genomics Consortium	United States	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	2156-07	True
13722.58cfa830e4b0c9d6adf6ba7a	58cfa830e4b0c9d6adf6ba7a	TCGA-AA-A02Y-10A-01D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A02Y-10A-01D-A079-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A02Y-10A-01D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	42.84	1.95	0.15	58cfa830e4b0c9d6adf6ba7a	TCGA-AA-A02Y-10A-01D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02Y-10A	A435FDF4-A89A-499E-9006-CBB5693EAB26	Blood Derived Normal	Illumina HiSeq	2769747d-4ce8-4519-b01e-2cb2d9afd496	Colorectal	73.0	DDA1BA9D-36A4-45EA-A100-8B9B8204A3EF	129EA15A-A5D4-4971-BDA2-22700248990B	TCGA-AA-A02Y-10A-01D-A079-02	HG18	TCGA-AA-A02Y	TCGA-COAD		s13535	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A079-02	True
13767.58cfa837e4b0c9d6adf6fe78	58cfa837e4b0c9d6adf6fe78	UNCID_1781098.7dab0105-975d-459f-97d3-f1462afddd4d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1781098.7dab0105-975d-459f-97d3-f1462afddd4d.sorted_genome_alignments	UNCID_1781098.7dab0105-975d-459f-97d3-f1462afddd4d.sorted_genome_alignments.bam	132.8	1.7	0.15	58cfa837e4b0c9d6adf6fe78	UNCID_1781098.7dab0105-975d-459f-97d3-f1462afddd4d.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-6168-01A	75C3004D-1EF4-49F9-86E0-1BB7B9553A3D	Primary Tumor	Illumina HiSeq	55F6A0BF-1007-473B-93B5-F34574A2C23D	Colorectal	84.0	FF1F5513-8463-4B1E-B254-72D9E0863D35	7DAB0105-975D-459F-97D3-F1462AFDDD4D	TCGA-CM-6168-01A-11R-1653-07	HG19	TCGA-CM-6168	TCGA-COAD		s12930	University of North Carolina	MSKCC	United States	NO	T3	N0	Colon Adenocarcinoma	Stage II	1653-07	True
13767.58cfa83ce4b0c9d6adf72b38	58cfa83ce4b0c9d6adf72b38	UNCID_372575.TCGA-BP-4970-01A-01R-1334-07.110620_UNC14-SN744_0132_AD0CP3ABXX.1.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_372575.TCGA-BP-4970-01A-01R-1334-07.110620_UNC14-SN744_0132_AD0CP3ABXX.1.trimmed.annotated.translated_to_genomic	UNCID_372575.TCGA-BP-4970-01A-01R-1334-07.110620_UNC14-SN744_0132_AD0CP3ABXX.1.trimmed.annotated.translated_to_genomic.bam	19.3	1.8	0.14	58cfa83ce4b0c9d6adf72b38	UNCID_372575.TCGA-BP-4970-01A-01R-1334-07.110620_UNC14-SN744_0132_AD0CP3ABXX.1.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	ASIAN		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4970-01A	C01AFA58-AF3F-40F1-B4FE-36909AE3871E	Primary Tumor	Illumina HiSeq	7071A909-9C2F-44F6-B5CB-401E9CA865DA	Kidney	44.0	0255EFBD-9E20-4B51-A18D-0814E138572D	5FD3A24B-6C3A-426C-A647-C2CB711A497B	TCGA-BP-4970-01A-01R-1334-07	HG19	TCGA-BP-4970	TCGA-KIRC		s9698	University of North Carolina	MSKCC	None	NO	T1a	N1	Kidney Clear Cell Renal Carcinoma	Stage III	1334-07	True
13767.58cfa82fe4b0c9d6adf6b65e	58cfa82fe4b0c9d6adf6b65e	TCGA-59-2355-01A-01R-1569-13_rnaseq.filtered.	RNA-Seq	TCGA-59-2355-01A-01R-1569-13_rnaseq	TCGA-59-2355-01A-01R-1569-13_rnaseq.bam	456.0	1.8	0.14	58cfa82fe4b0c9d6adf6b65e	TCGA-59-2355-01A-01R-1569-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-59-2355-01A	708EEC28-2348-4E15-B98C-8C6F9D057B1E	Primary Tumor	Illumina HiSeq	0465E3E7-1D8B-40C0-A0B2-F269985CCC3A	Ovary	58.0	FC1A6B07-E91E-47C5-BF00-80BE3C167605	866C7355-E2EC-4816-953F-7BF791033283	TCGA-59-2355-01A-01R-1569-13	NCBI36_BCCAGSC_variant	TCGA-59-2355	TCGA-OV	65.0	s17469	Canada's Michael Smith Genome Sciences Centre	Roswell Park	None	NO			Serous Cystadenocarcinoma		1569-13	True
13722.58cfa830e4b0c9d6adf6bcc6	58cfa830e4b0c9d6adf6bcc6	TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.filtered.	WGS	TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted	TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.bam	93.54	2.18	0.15	58cfa830e4b0c9d6adf6bcc6	TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0L9-01A	7B9947D5-E86B-4006-8890-EA5209584A88	Primary Tumor	Illumina HiSeq	df10c3ed-7978-4d58-b4f6-52a76db0994a	Uterus	71.0	53D0521F-10D6-4F70-9277-D99025A6B963	DAA573AF-564D-456D-8181-DF4C07B77672	TCGA-AP-A0L9-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0L9	TCGA-UCEC		s4423	Harvard Medical School	MSKCC	None	NO			Serous endometrial adenocarcinoma		A043-02	True
13722.58cfa832e4b0c9d6adf6d116	58cfa832e4b0c9d6adf6d116	TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted	TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted.bam	42.52		0.14	58cfa832e4b0c9d6adf6d116	TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-JX-A3Q0-01A	20280122-A66A-4C83-8F25-0B9D97558DC2	Primary Tumor	Illumina HiSeq	20d5be50-f8a2-406a-9415-bc65cdff0cad	Cervix	63.0	04FFDFC0-A73F-47AE-9014-73870B69AD91	A7EE4E31-77DF-470B-A748-87BB4DF76FD5	TCGA-JX-A3Q0-01A-11D-A245-26	HG19_Broad_variant	TCGA-JX-A3Q0	TCGA-CESC		s1218	MD Anderson - Institute for Applied Cancer Science	Washington University	United States	NO	T3	N0	Cervical Squamous Cell Carcinoma		A245-26	True
13767.58cfa838e4b0c9d6adf709c1	58cfa838e4b0c9d6adf709c1	UNCID_2086757.f31b5e70-af25-4f1a-b7e3-13f17998e7e2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2086757.f31b5e70-af25-4f1a-b7e3-13f17998e7e2.sorted_genome_alignments	UNCID_2086757.f31b5e70-af25-4f1a-b7e3-13f17998e7e2.sorted_genome_alignments.bam	97.34	1.85	0.16	58cfa838e4b0c9d6adf709c1	UNCID_2086757.f31b5e70-af25-4f1a-b7e3-13f17998e7e2.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A3G9-01A	F7527B5E-5330-49EA-82CE-F6F2CDCCBADC	Primary Tumor	Illumina HiSeq	0C300F49-4834-40EF-ACA5-A08114518A1E	Uterus	63.0	739CF2F3-E9EB-4F4A-8310-2D7413E323E4	F31B5E70-AF25-4F1A-B7E3-13F17998E7E2	TCGA-AX-A3G9-01A-11R-A22K-07	HG19	TCGA-AX-A3G9	TCGA-UCEC		s4334	University of North Carolina	Gynecologic Oncology Group	United States	NO			Endometrioid endometrial adenocarcinoma		A22K-07	True
13767.58cfa832e4b0c9d6adf6d7d2	58cfa832e4b0c9d6adf6d7d2	UNCID_1033144.7ea63ff9-467e-4645-bacb-d91fe95a8c62.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1033144.7ea63ff9-467e-4645-bacb-d91fe95a8c62.sorted_genome_alignments	UNCID_1033144.7ea63ff9-467e-4645-bacb-d91fe95a8c62.sorted_genome_alignments.bam	12.2		0.13	58cfa832e4b0c9d6adf6d7d2	UNCID_1033144.7ea63ff9-467e-4645-bacb-d91fe95a8c62.sorted_genome_alignments.bam	Dead	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-7138-01A	DEA2269F-7E15-4EA1-88A4-2314A819C731	Primary Tumor	Illumina HiSeq	7DB5346B-8E22-47D4-B83B-9CA3114ACA44	Lung	67.0	63DBCF72-C115-4367-8230-8188913ECADE	7EA63FF9-467E-4645-BACB-D91FE95A8C62	TCGA-77-7138-01A-41R-2045-07	HG19	TCGA-77-7138	TCGA-LUSC	340.0	s10171	University of North Carolina	Prince Charles Hospital	Australia	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2045-07	True
13767.58cfa835e4b0c9d6adf6f298	58cfa835e4b0c9d6adf6f298	UNCID_1508016.e1adae95-dfa9-4279-8fc1-2f899f432360.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1508016.e1adae95-dfa9-4279-8fc1-2f899f432360.sorted_genome_alignments	UNCID_1508016.e1adae95-dfa9-4279-8fc1-2f899f432360.sorted_genome_alignments.bam	34.2	1.7	0.17	58cfa835e4b0c9d6adf6f298	UNCID_1508016.e1adae95-dfa9-4279-8fc1-2f899f432360.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-55-6986-11A	028E99E9-5B9A-4954-BB6E-6D4709A3CEA8	Solid Tissue Normal	Illumina HiSeq	CDE33A5B-45D4-4EFD-9623-061EDA4D1CC3	Lung	74.0	E8E0E53A-4009-4141-BA6F-EED35FCAAD7B	E1ADAE95-DFA9-4279-8FC1-2F899F432360	TCGA-55-6986-11A-01R-1949-07	HG19	TCGA-55-6986	TCGA-LUAD		s11062	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage I	1949-07	True
13722.58cfa832e4b0c9d6adf6d262	58cfa832e4b0c9d6adf6d262	TCGA-JX-A3Q8-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_4_rg.sorted.filtered.	WGS	TCGA-JX-A3Q8-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_4_rg.sorted	TCGA-JX-A3Q8-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_4_rg.sorted.bam	73.18		0.14	58cfa832e4b0c9d6adf6d262	TCGA-JX-A3Q8-10A-01D-A245_140206_SN1222_0239_BC2RAKACXX_s_4_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-JX-A3Q8-10A	34629EB8-0C5E-4910-8E13-BF7D6A1E337F	Blood Derived Normal	Illumina HiSeq	638ee124-3225-4587-944a-aff7c7759987	Cervix	40.0	A5162279-45AE-4031-B119-71A8C934918F	DFEDE0BA-0E85-4D22-9A70-88E798CD267A	TCGA-JX-A3Q8-10A-01D-A245-26	HG19_Broad_variant	TCGA-JX-A3Q8	TCGA-CESC		s1219	MD Anderson - Institute for Applied Cancer Science	Washington University	United States	NO	T1b1	N0	Endocervical Type of Adenocarcinoma		A245-26	True
13767.58cfa832e4b0c9d6adf6d634	58cfa832e4b0c9d6adf6d634	TCGA-VQ-A92D-01A-11R-A414-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-A92D-01A-11R-A414-31_rnaseq	TCGA-VQ-A92D-01A-11R-A414-31_rnaseq.bam	64.37	1.83	0.15	58cfa832e4b0c9d6adf6d634	TCGA-VQ-A92D-01A-11R-A414-31_rnaseq.bam	Alive	MALE	WHITE		Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-A92D-01A	ABA9439A-EA8D-404F-9FAF-EB71A306684D	Primary Tumor	Illumina HiSeq	29EDE6E6-0FCC-4F80-BB75-9FDAD3022195	Stomach	67.0	0440AD49-C2D8-4565-8521-0C9B71523A01	B12FDA34-D4B1-473D-A4FF-875CC2208E04	TCGA-VQ-A92D-01A-11R-A414-31	GRCh37-lite	TCGA-VQ-A92D	TCGA-STAD		s15010	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T2b	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage I	A414-31	True
13767.58cfa837e4b0c9d6adf6ffaf	58cfa837e4b0c9d6adf6ffaf	UNCID_1812610.a323e90d-02b3-4f8f-8d70-f3ca2957e4d5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1812610.a323e90d-02b3-4f8f-8d70-f3ca2957e4d5.sorted_genome_alignments	UNCID_1812610.a323e90d-02b3-4f8f-8d70-f3ca2957e4d5.sorted_genome_alignments.bam	5.2	1.4	0.08	58cfa837e4b0c9d6adf6ffaf	UNCID_1812610.a323e90d-02b3-4f8f-8d70-f3ca2957e4d5.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-D5-6534-01A	D259EEB2-D15E-436D-9D37-2D0B7658BC91	Primary Tumor	Illumina HiSeq	58FE5B2B-FDA5-4425-8169-8C52EE225EFC	Colorectal	62.0	A73684E4-7CF1-4E9D-83B8-A6EBEBD51101	A323E90D-02B3-4F8F-8D70-F3CA2957E4D5	TCGA-D5-6534-01A-21R-1928-07	HG19	TCGA-D5-6534	TCGA-COAD		s13448	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage II	1928-07	True
13722.58cfa82ee4b0c9d6adf6abb0	58cfa82ee4b0c9d6adf6abb0	G26366.TCGA-06-0686-01A-01D-1492-08.2.filtered.	WGS	G26366.TCGA-06-0686-01A-01D-1492-08.2	G26366.TCGA-06-0686-01A-01D-1492-08.2.bam	420.57	1.91	0.05	58cfa82ee4b0c9d6adf6abb0	G26366.TCGA-06-0686-01A-01D-1492-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0686-01A	C931F3BD-74C5-4EBD-BC0F-C7C6BECD25AB	Primary Tumor	Illumina HiSeq	4d80b67a-08f2-45cf-84b2-9aabce938c2f	Brain	53.0	7AF6D7A5-B550-42D9-983A-241EC76FD7F4	2C71D542-1653-4D97-8752-F2FD05C7E75D	TCGA-06-0686-01A-01D-1492-08	HG19_Broad_variant	TCGA-06-0686	TCGA-GBM		s14344	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1492-08	False
13767.58cfa835e4b0c9d6adf6ef32	58cfa835e4b0c9d6adf6ef32	UNCID_1464744.d299b4ed-2ebf-4c53-9d3b-aa5f6eaae646.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1464744.d299b4ed-2ebf-4c53-9d3b-aa5f6eaae646.sorted_genome_alignments	UNCID_1464744.d299b4ed-2ebf-4c53-9d3b-aa5f6eaae646.sorted_genome_alignments.bam	189.2		0.15	58cfa835e4b0c9d6adf6ef32	UNCID_1464744.d299b4ed-2ebf-4c53-9d3b-aa5f6eaae646.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-A4-7997-01A	2797088E-F534-4C1E-ABF8-CC6F832CD911	Primary Tumor	Illumina HiSeq	417D0DC7-1136-4F20-BA82-F6F74C44FF68	Kidney	67.0	7177DBEF-522E-460C-BFA3-1095BE2F6B3F	D299B4ED-2EBF-4C53-9D3B-AA5F6EAAE646	TCGA-A4-7997-01A-11R-2204-07	HG19	TCGA-A4-7997	TCGA-KIRP		s11612	University of North Carolina	International Genomics Consortium	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	2204-07	True
13722.58cfa830e4b0c9d6adf6ba9e	58cfa830e4b0c9d6adf6ba9e	TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina	TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina.bam	71.0	1.92	0.07	58cfa830e4b0c9d6adf6ba9e	TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01X-01A	2E386E48-B99B-4806-A3E3-081D72A606E7	Primary Tumor	Illumina HiSeq	4b96a6ce-adbd-45b8-9c53-ea1850f0731c	Colorectal	80.0	0225A318-9BB2-4340-A34A-99FCBC563E0A	B7F2E85A-3C6A-48B7-8A4F-2DEC1D85359D	TCGA-AA-A01X-01A-21D-A17O-10	GRCh37-lite	TCGA-AA-A01X	TCGA-COAD		s12880	Baylor College of Medicine	Indivumed	Germany	NO	T2	N1	Colon Adenocarcinoma	Stage III	A17O-10	True
13722.58cfa832e4b0c9d6adf6d594	58cfa832e4b0c9d6adf6d594	TCGA-MH-A561-10A-01D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-MH-A561-10A-01D-A26P-10_wgs_Illumina	TCGA-MH-A561-10A-01D-A26P-10_wgs_Illumina.bam	15.21		0.08	58cfa832e4b0c9d6adf6d594	TCGA-MH-A561-10A-01D-A26P-10_wgs_Illumina.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-MH-A561-10A	E6E6A773-B155-45A9-989F-75C12CE1702A	Blood Derived Normal	Illumina HiSeq	31ebd3e6-0042-434d-b07e-bb3deec6e478	Kidney	66.0	3EAF17CF-C3FA-461E-A233-75E06FDCE379	EBF9EE83-790D-43A8-AE04-E32E2F61BFA6	TCGA-MH-A561-10A-01D-A26P-10	GRCh37-lite	TCGA-MH-A561	TCGA-KIRP		s11783	Baylor College of Medicine	BLN - Baylor	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	True
13767.58cfa834e4b0c9d6adf6e6f6	58cfa834e4b0c9d6adf6e6f6	UNCID_1170769.39fe5d50-f454-4f7b-b07b-1a59b5c828f9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1170769.39fe5d50-f454-4f7b-b07b-1a59b5c828f9.sorted_genome_alignments	UNCID_1170769.39fe5d50-f454-4f7b-b07b-1a59b5c828f9.sorted_genome_alignments.bam	16.63	1.78	0.17	58cfa834e4b0c9d6adf6e6f6	UNCID_1170769.39fe5d50-f454-4f7b-b07b-1a59b5c828f9.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1FG-01A	D4E7426C-9739-4585-9114-E564B13C7C02	Primary Tumor	Illumina HiSeq	C78228F3-8D76-4FA8-B00C-79E008D50C7E	Breast	88.0	33F49B4E-924E-4590-8AFA-E17403602137	39FE5D50-F454-4F7B-B07B-1A59B5C828F9	TCGA-BH-A1FG-01A-11R-A13Q-07	HG19	TCGA-BH-A1FG	TCGA-BRCA	3738.0	s5896	University of North Carolina	University of Pittsburgh	None	NO	T1c	NX	Infiltrating Ductal Carcinoma	Stage I	A13Q-07	True
13722.58cfa831e4b0c9d6adf6cc2f	58cfa831e4b0c9d6adf6cc2f	TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted	TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted.bam	111.0		0.15	58cfa831e4b0c9d6adf6cc2f	TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7008-01A	427C40F6-D1BD-49F2-B303-A975793B937E	Primary Tumor	Illumina HiSeq	3a51e8e7-621e-4d62-bb3d-cb6700af6a43	Brain	41.0	7A0C3571-4265-4D36-AFBC-FA234970F94B	7602BA72-B5E0-49C7-940A-6E9EFBDB5C58	TCGA-DU-7008-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7008	TCGA-LGG		s8566	Harvard Medical School	Henry Ford Hospital	United States	NO			Oligodendroglioma		2022-02	True
13767.58cfa838e4b0c9d6adf70d6c	58cfa838e4b0c9d6adf70d6c	UNCID_2115816.341d1383-93bd-42d7-80ad-5dba732c1925.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2115816.341d1383-93bd-42d7-80ad-5dba732c1925.sorted_genome_alignments	UNCID_2115816.341d1383-93bd-42d7-80ad-5dba732c1925.sorted_genome_alignments.bam	26.11	1.9	0.17	58cfa838e4b0c9d6adf70d6c	UNCID_2115816.341d1383-93bd-42d7-80ad-5dba732c1925.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A62S-01A	05A1402E-5A79-4D54-9430-065844ED1505	Primary Tumor	Illumina HiSeq	1FFAC053-8D28-4EE3-82A9-B1CDA9AC7029	Bladder	60.0	3D473ACB-5C41-4D9F-A4A9-41846F445B48	341D1383-93BD-42D7-80AD-5DBA732C1925	TCGA-FD-A62S-01A-11R-A30C-07	HG19	TCGA-FD-A62S	TCGA-BLCA		s3353	University of North Carolina	BLN - University Of Chicago	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A30C-07	True
13767.58cfa830e4b0c9d6adf6c0fc	58cfa830e4b0c9d6adf6c0fc	TCGA-BR-A4QL-01A-31R-A251-31_rnaseq.filtered.	RNA-Seq	TCGA-BR-A4QL-01A-31R-A251-31_rnaseq	TCGA-BR-A4QL-01A-31R-A251-31_rnaseq.bam	58.61	1.86	0.16	58cfa830e4b0c9d6adf6c0fc	TCGA-BR-A4QL-01A-31R-A251-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-A4QL-01A	AA2C5D29-2764-4804-9181-5870C0956904	Primary Tumor	Illumina HiSeq	BFA1B587-9618-4021-BDAF-8E3D7A694E2E	Stomach	75.0	E5E60060-A748-4864-BAB2-EC7343095BCA	B52A9EBF-2C18-41DA-9518-B874D0E4432C	TCGA-BR-A4QL-01A-31R-A251-31	GRCh37-lite	TCGA-BR-A4QL	TCGA-STAD		s14974	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	A251-31	True
13722.58cfa82fe4b0c9d6adf6b3c0	58cfa82fe4b0c9d6adf6b3c0	TCGA-24-1558-10A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-24-1558-10A-01D-A324-10_wgs_Illumina	TCGA-24-1558-10A-01D-A324-10_wgs_Illumina.bam	280.27	1.9	0.07	58cfa82fe4b0c9d6adf6b3c0	TCGA-24-1558-10A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1558-10A	BA68F2CF-9271-41FD-9655-1FAC7681F588	Blood Derived Normal	Illumina HiSeq	40db651c-2e1d-469d-8e29-a8f1ef202e04	Ovary	73.0	6CF18D9D-2A3B-4F22-89FD-801956564218	8A8BA44D-E172-4276-A10E-EFDCD7505F3D	TCGA-24-1558-10A-01D-A324-10	GRCh37-lite	TCGA-24-1558	TCGA-OV	594.0	s17783	Baylor College of Medicine	Washington University	None	NO			Serous Cystadenocarcinoma		A324-10	True
13767.58cfa837e4b0c9d6adf70078	58cfa837e4b0c9d6adf70078	UNCID_1805951.2a591fdd-c9e5-4c6e-90f8-8f993450a8d7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1805951.2a591fdd-c9e5-4c6e-90f8-8f993450a8d7.sorted_genome_alignments	UNCID_1805951.2a591fdd-c9e5-4c6e-90f8-8f993450a8d7.sorted_genome_alignments.bam	27.37	1.77	0.16	58cfa837e4b0c9d6adf70078	UNCID_1805951.2a591fdd-c9e5-4c6e-90f8-8f993450a8d7.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A401-01A	48FF0420-0F19-4E9D-A75D-6C54949A461A	Primary Tumor	Illumina HiSeq	25A60D7D-E31C-49A9-824F-ED6E867D8FB5	Breast	47.0	4C932085-E46B-4544-A32C-C38B2BAC837A	2A591FDD-C9E5-4C6E-90F8-8F993450A8D7	TCGA-B6-A401-01A-11R-A239-07	HG19	TCGA-B6-A401	TCGA-BRCA		s6727	University of North Carolina	Duke	United States	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage II	A239-07	True
13767.58cfa83be4b0c9d6adf71eb6	58cfa83be4b0c9d6adf71eb6	UNCID_2532147.b4468779-3068-40d2-809c-7b513d0a752f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2532147.b4468779-3068-40d2-809c-7b513d0a752f.sorted_genome_alignments	UNCID_2532147.b4468779-3068-40d2-809c-7b513d0a752f.sorted_genome_alignments.bam	76.06	1.87	0.17	58cfa83be4b0c9d6adf71eb6	UNCID_2532147.b4468779-3068-40d2-809c-7b513d0a752f.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Cholangiocarcinoma	Aligned reads	TCGA-W5-AA31-01A	2D6E20B2-82C7-4C12-92D0-93282B0A9031	Primary Tumor	Illumina HiSeq	A42AC201-3B3D-4362-B444-BB3BCE86ECA0	Bile Duct	71.0	A7919C8D-B6F4-4404-B7C0-9AE43DC73CE7	B4468779-3068-40D2-809C-7B513D0A752F	TCGA-W5-AA31-01A-11R-A41I-07	HG19	TCGA-W5-AA31	TCGA-CHOL		s33	University of North Carolina	Mayo Clinic Rochester	United States	NO	T1	N0		Stage I	A41I-07	True
13767.58cfa832e4b0c9d6adf6d5fd	58cfa832e4b0c9d6adf6d5fd	TCGA-L7-A56G-01A-21R-A260-31_rnaseq.filtered.	RNA-Seq	TCGA-L7-A56G-01A-21R-A260-31_rnaseq	TCGA-L7-A56G-01A-21R-A260-31_rnaseq.bam	29.81	1.9	0.17	58cfa832e4b0c9d6adf6d5fd	TCGA-L7-A56G-01A-21R-A260-31_rnaseq.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-L7-A56G-01A	70C5CE85-4022-46C0-8BD0-F5E9009DDF41	Primary Tumor	Illumina HiSeq	9620654F-A33C-4ACC-AAC3-3C3385CF0AF5	Esophagus	65.0	3DD6751A-6FA6-4365-8E5E-FCB3D17910F6	E3C5C0AF-ED9C-4E0C-9A55-DA118276B896	TCGA-L7-A56G-01A-21R-A260-31	GRCh37-lite	TCGA-L7-A56G	TCGA-ESCA		s1860	Canada's Michael Smith Genome Sciences Centre	Christiana Care	United States	NO					A260-31	True
13767.58cfa839e4b0c9d6adf7106c	58cfa839e4b0c9d6adf7106c	UNCID_2245708.3c6d1cda-258e-42f4-ad31-16069e437ac3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2245708.3c6d1cda-258e-42f4-ad31-16069e437ac3.sorted_genome_alignments	UNCID_2245708.3c6d1cda-258e-42f4-ad31-16069e437ac3.sorted_genome_alignments.bam	29.16	1.89	0.15	58cfa839e4b0c9d6adf7106c	UNCID_2245708.3c6d1cda-258e-42f4-ad31-16069e437ac3.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7325-01B	45A04209-8FAC-4181-BBA3-1437C8FD7F09	Primary Tumor	Illumina HiSeq	61AE4EF7-36F9-449A-A058-EA562965F8E3	Prostate	63.0	6C83B5FA-4647-4977-B0CF-8A33944B1BD5	3C6D1CDA-258E-42F4-AD31-16069E437AC3	TCGA-EJ-7325-01B-11R-A32O-07	HG19	TCGA-EJ-7325	TCGA-PRAD		s4202	University of North Carolina	University of Pittsburgh	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		A32O-07	True
13722.58cfa82de4b0c9d6adf6a6b4	58cfa82de4b0c9d6adf6a6b4	94b51555d1de0d10503b34342b586c3b.filtered.	WGS	94b51555d1de0d10503b34342b586c3b	94b51555d1de0d10503b34342b586c3b.bam	54.48	2.0	0.08	58cfa82de4b0c9d6adf6a6b4	94b51555d1de0d10503b34342b586c3b.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A130-10A	8CF54607-01CE-42B0-9BD9-8627EDD9F3B7	Blood Derived Normal	Illumina HiSeq	44978a5f-a9ce-40ac-8b2e-3ade35e32525	Breast	52.0	4D3B8AD8-94CE-49A7-A7AF-F56AC17891F6	D141E42E-AA3B-46ED-815F-3192B1959BF4	TCGA-C8-A130-10A-01D-A19H-09	GRCh37-lite	TCGA-C8-A130	TCGA-BRCA		s6628	Washington University School of Medicine	ILSbio	Vietnam	NO	T3	N2	Infiltrating Ductal Carcinoma	Stage III	A19H-09	True
13767.58cfa837e4b0c9d6adf6fd2a	58cfa837e4b0c9d6adf6fd2a	UNCID_1674395.fa1917b0-c3e1-412d-b063-e74b5cafb8dc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1674395.fa1917b0-c3e1-412d-b063-e74b5cafb8dc.sorted_genome_alignments	UNCID_1674395.fa1917b0-c3e1-412d-b063-e74b5cafb8dc.sorted_genome_alignments.bam	24.24	1.8	0.16	58cfa837e4b0c9d6adf6fd2a	UNCID_1674395.fa1917b0-c3e1-412d-b063-e74b5cafb8dc.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1BD-01A	0E1D0D46-7A7B-4538-95DD-B9FC20A15AEC	Primary Tumor	Illumina HiSeq	4E3FD27D-B2E5-4627-994E-9520D9557C93	Breast	53.0	1DDC4C86-029F-49B5-893C-A218240D3FA4	FA1917B0-C3E1-412D-B063-E74B5CAFB8DC	TCGA-E2-A1BD-01A-11R-A12P-07	HG19	TCGA-E2-A1BD	TCGA-BRCA		s6405	University of North Carolina	Roswell Park	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A12P-07	True
13722.58cfa82ee4b0c9d6adf6a94d	58cfa82ee4b0c9d6adf6a94d	G35154.TCGA-DU-5874-01A-11D-1705-08.2.filtered.	WGS	G35154.TCGA-DU-5874-01A-11D-1705-08.2	G35154.TCGA-DU-5874-01A-11D-1705-08.2.bam	301.3	1.9	0.05	58cfa82ee4b0c9d6adf6a94d	G35154.TCGA-DU-5874-01A-11D-1705-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5874-01A	1CC53ADE-73C0-492B-A7DC-328269FD0E66	Primary Tumor	Illumina HiSeq	b0268c63-93dc-4e0b-b29b-217fd6028c92	Brain	62.0	3C7CE3D5-F9E4-4FAE-B033-2058446ED7F3	85D915B8-0184-4EC7-93AD-E9FFA2F5743B	TCGA-DU-5874-01A-11D-1705-08	HG19_Broad_variant	TCGA-DU-5874	TCGA-LGG		s8546	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO			Oligodendroglioma		1705-08	False
13722.58cfa832e4b0c9d6adf6d0d5	58cfa832e4b0c9d6adf6d0d5	TCGA-FS-A1Z4-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-FS-A1Z4-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_6_rg.sorted	TCGA-FS-A1Z4-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_6_rg.sorted.bam	127.26		0.17	58cfa832e4b0c9d6adf6d0d5	TCGA-FS-A1Z4-10A-01D-A190_120711_SN208_0414_BD13L5ACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1Z4-10A	8465257B-7212-44A3-BD9F-1F7D017499AD	Blood Derived Normal	Illumina HiSeq	95ed4f71-803b-44ac-a13b-342354376a61	Skin	62.0	FC080989-3E83-45CE-A52E-52BD231F2B1A	FDA54930-6F29-4C59-AE0A-721F9BAADB89	TCGA-FS-A1Z4-10A-01D-A190-02	HG19_Broad_variant	TCGA-FS-A1Z4	TCGA-SKCM	854.0	s7367	Harvard Medical School	Essen	Germany	NO	T1	N0		Stage I	A190-02	True
13722.58cfa832e4b0c9d6adf6d5a2	58cfa832e4b0c9d6adf6d5a2	TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina	TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina.bam	8.04		0.07	58cfa832e4b0c9d6adf6d5a2	TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-MH-A560-01A	A40BEABE-496E-4324-A1D1-5A7D8B002AAB	Primary Tumor	Illumina HiSeq	b1efdb03-f6ae-443f-85cc-d545d7710c21	Kidney	62.0	2697D1DE-3D7E-4BD6-9EDE-7516BD10A701	CF5DEB22-F7EB-409D-A0E4-882716199C39	TCGA-MH-A560-01A-11D-A26P-10	GRCh37-lite	TCGA-MH-A560	TCGA-KIRP		s11594	Baylor College of Medicine	BLN - Baylor	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	True
13767.58cfa837e4b0c9d6adf6fda2	58cfa837e4b0c9d6adf6fda2	UNCID_1726949.5ee3613b-e8d8-44fb-a17b-1d5e59ed5fb8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1726949.5ee3613b-e8d8-44fb-a17b-1d5e59ed5fb8.sorted_genome_alignments	UNCID_1726949.5ee3613b-e8d8-44fb-a17b-1d5e59ed5fb8.sorted_genome_alignments.bam	54.2		0.16	58cfa837e4b0c9d6adf6fda2	UNCID_1726949.5ee3613b-e8d8-44fb-a17b-1d5e59ed5fb8.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8415-01A	FB322D32-D753-41CC-A21E-E47BF063D5BB	Primary Tumor	Illumina HiSeq	C5FD58EE-BF43-48F5-9328-932BEF289B88	Kidney	44.0	386C5601-F478-4D33-8909-789E2BFC4D0E	5EE3613B-E8D8-44FB-A17B-1D5E59ED5FB8	TCGA-KO-8415-01A-11R-2315-07	HG19	TCGA-KO-8415	TCGA-KICH		s16559	University of North Carolina	MD Anderson Cancer Center	United States	NO	T1	N0	Kidney Chromophobe	Stage I	2315-07	True
13722.58cfa831e4b0c9d6adf6c83b	58cfa831e4b0c9d6adf6c83b	TCGA-CV-7180-01A-11D-2266-10_Illumina.filtered.	WGS	TCGA-CV-7180-01A-11D-2266-10_Illumina	TCGA-CV-7180-01A-11D-2266-10_Illumina.bam	52.7		0.05	58cfa831e4b0c9d6adf6c83b	TCGA-CV-7180-01A-11D-2266-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7180-01A	D2CA9A4D-C14C-40C0-871C-88794A02E4AA	Primary Tumor	Illumina HiSeq	b66083b7-e0ae-4f6e-ab6a-76caf55a13bc	Head and Neck	34.0	551B5AC7-41E8-42BC-B64D-20E7E156DBBC	1727E88B-DF0A-4AF2-9191-8C6061D98AD0	TCGA-CV-7180-01A-11D-2266-10	GRCh37-lite	TCGA-CV-7180	TCGA-HNSC	327.0	s15648	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II	2266-10	True
13767.58cfa834e4b0c9d6adf6e348	58cfa834e4b0c9d6adf6e348	UNCID_1187073.d5261ff1-e2ae-4a72-83c7-df812cf9a947.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1187073.d5261ff1-e2ae-4a72-83c7-df812cf9a947.sorted_genome_alignments	UNCID_1187073.d5261ff1-e2ae-4a72-83c7-df812cf9a947.sorted_genome_alignments.bam	47.33	1.7	0.15	58cfa834e4b0c9d6adf6e348	UNCID_1187073.d5261ff1-e2ae-4a72-83c7-df812cf9a947.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3374-01A	0B970FEB-914F-4159-912F-6EFEC02B617F	Primary Tumor	Illumina HiSeq	74348354-77FA-4C16-99B4-66AF5C0F3E37	Kidney	51.0	60AD6615-67F1-426A-A74F-19DEDAED2A7E	D5261FF1-E2AE-4A72-83C7-DF812CF9A947	TCGA-A3-3374-01A-02R-1325-07	HG19	TCGA-A3-3374	TCGA-KIRC		s8889	University of North Carolina	International Genomics Consortium	United States	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1325-07	True
13722.58cfa830e4b0c9d6adf6bc5a	58cfa830e4b0c9d6adf6bc5a	TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted	TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.bam	94.43	2.0	0.16	58cfa830e4b0c9d6adf6bc5a	TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LH-01A	7DCE4215-01F6-43E9-9378-9E22C26C23A2	Primary Tumor	Illumina HiSeq	4334c333-7627-4949-90aa-55897232ec49	Uterus	60.0	4C657AD4-2C53-4EA9-82B5-52996E74E3FF	FCA1C7F5-E456-4574-9716-79770E6DAE8C	TCGA-AP-A0LH-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0LH	TCGA-UCEC	1106.0	s5203	Harvard Medical School	MSKCC	None	NO			Mixed serous and endometrioid		A043-02	True
13722.58cfa830e4b0c9d6adf6be13	58cfa830e4b0c9d6adf6be13	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.bam	55.92	1.91	0.16	58cfa830e4b0c9d6adf6be13	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0W5-01A	DA9C10EA-C13F-4D88-8B94-A0CBC106D036	Primary Tumor	Illumina HiSeq	eeccc516-2d3d-4f41-a324-c90f92a6f944	Breast	77.0	050E66BB-438A-49D5-A005-7967A006B3F0	6C8B3A70-CD58-4BFC-9418-54182588CFCB	TCGA-BH-A0W5-01A-11D-A106-02	HG19_Broad_variant	TCGA-BH-A0W5	TCGA-BRCA		s5803	Harvard Medical School	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage II	A106-02	False
13767.58cfa83be4b0c9d6adf71f43	58cfa83be4b0c9d6adf71f43	UNCID_2512657.1cbf20fc-9898-46da-98e4-1940201abee8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2512657.1cbf20fc-9898-46da-98e4-1940201abee8.sorted_genome_alignments	UNCID_2512657.1cbf20fc-9898-46da-98e4-1940201abee8.sorted_genome_alignments.bam	49.43	1.88	0.16	58cfa83be4b0c9d6adf71f43	UNCID_2512657.1cbf20fc-9898-46da-98e4-1940201abee8.sorted_genome_alignments.bam	Alive	MALE		HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-SX-A7SU-01A	3E5385F5-D4FF-4B96-8259-312602EC1196	Primary Tumor	Illumina HiSeq	E2B6DB4A-B9E9-4461-989E-4BC450FDE4C2	Kidney	47.0	7C87E6D8-7850-43DD-AB7C-46AAC1F77ECB	1CBF20FC-9898-46DA-98E4-1940201ABEE8	TCGA-SX-A7SU-01A-11R-A36F-07	HG19	TCGA-SX-A7SU	TCGA-KIRP		s11954	University of North Carolina	Mayo Clinic Arizona	United States	NO	T1	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A36F-07	True
13767.58cfa837e4b0c9d6adf6fef0	58cfa837e4b0c9d6adf6fef0	UNCID_1781503.e4a881ab-362f-4ddc-a80f-2d4eb2a96258.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1781503.e4a881ab-362f-4ddc-a80f-2d4eb2a96258.sorted_genome_alignments	UNCID_1781503.e4a881ab-362f-4ddc-a80f-2d4eb2a96258.sorted_genome_alignments.bam	112.8	1.8	0.14	58cfa837e4b0c9d6adf6fef0	UNCID_1781503.e4a881ab-362f-4ddc-a80f-2d4eb2a96258.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-G4-6320-01A	DA21E143-DBF6-4AC7-8872-F1D9AE39512D	Primary Tumor	Illumina HiSeq	35D502E8-EB02-4511-9ED7-AACA333EFEC4	Colorectal	73.0	40DD997D-CFDF-46F9-9C0A-F238B8D6F758	E4A881AB-362F-4DDC-A80F-2D4EB2A96258	TCGA-G4-6320-01A-11R-1723-07	HG19	TCGA-G4-6320	TCGA-COAD		s12929	University of North Carolina	Roswell Park	United States	NO	T3	N1	Colon Adenocarcinoma	Stage III	1723-07	True
13722.58cfa830e4b0c9d6adf6c2e2	58cfa830e4b0c9d6adf6c2e2	TCGA-AD-A5EK-10A-01D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-AD-A5EK-10A-01D-A28G-10_wgs_Illumina	TCGA-AD-A5EK-10A-01D-A28G-10_wgs_Illumina.bam	39.53		0.08	58cfa830e4b0c9d6adf6c2e2	TCGA-AD-A5EK-10A-01D-A28G-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AD-A5EK-10A	E8EC26BD-C88D-42B9-AC8A-AB121B8140F8	Blood Derived Normal	Illumina HiSeq	3f5d539e-383b-419e-8904-03f97fd7ffb0	Colorectal	51.0	114D22E0-DDE4-4AF3-8BBC-1A1BC6AF3A06	0BAAE245-5034-4A34-A076-E831DC38355E	TCGA-AD-A5EK-10A-01D-A28G-10	GRCh37-lite	TCGA-AD-A5EK	TCGA-COAD		s13209	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	N0	Colon Adenocarcinoma	Stage I	A28G-10	True
13767.58cfa83ae4b0c9d6adf71cde	58cfa83ae4b0c9d6adf71cde	UNCID_2434464.aa91c19b-008d-497a-8121-a06cf9dc7b29.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2434464.aa91c19b-008d-497a-8121-a06cf9dc7b29.sorted_genome_alignments	UNCID_2434464.aa91c19b-008d-497a-8121-a06cf9dc7b29.sorted_genome_alignments.bam	71.18	1.94	0.17	58cfa83ae4b0c9d6adf71cde	UNCID_2434464.aa91c19b-008d-497a-8121-a06cf9dc7b29.sorted_genome_alignments.bam	Alive	FEMALE			Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-VS-A8EG-01A	B0B293C1-BD7E-4BA8-9F44-47398488EF2C	Primary Tumor	Illumina HiSeq	14A804FF-7009-4072-8ACA-D679F5D19997	Cervix	36.0	2D433014-1B56-4790-8C83-6FFA37040D9C	AA91C19B-008D-497A-8121-A06CF9DC7B29	TCGA-VS-A8EG-01A-11R-A36F-07	HG19	TCGA-VS-A8EG	TCGA-CESC		s1305	University of North Carolina	Barretos Cancer Hospital	Brazil	NO	T1b1	NX	Cervical Squamous Cell Carcinoma		A36F-07	True
13767.58cfa83ce4b0c9d6adf72e8c	58cfa83ce4b0c9d6adf72e8c	_1_TCGA-BR-7717-01A-11R-2055-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-7717-01A-11R-2055-13_rnaseq	_1_TCGA-BR-7717-01A-11R-2055-13_rnaseq.bam	137.2		0.15	58cfa83ce4b0c9d6adf72e8c	_1_TCGA-BR-7717-01A-11R-2055-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7717-01A	93A337AE-2BD3-4464-B38F-93DFF92D3FDE	Primary Tumor	Illumina HiSeq	A8739FFF-79CC-425B-A663-896E287B5DFD	Stomach	63.0	0D12D2E2-385D-4712-AFC8-EC85B25E8AE5	0C3EB790-F5A4-4D39-982A-D5ED71CDD72F	TCGA-BR-7717-01A-11R-2055-13	GRCh37-lite	TCGA-BR-7717	TCGA-STAD		s15351	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	2055-13	True
13767.58cfa832e4b0c9d6adf6d340	58cfa832e4b0c9d6adf6d340	TCGA-L5-A43I-01A-11R-A24K-31_rnaseq.filtered.	RNA-Seq	TCGA-L5-A43I-01A-11R-A24K-31_rnaseq	TCGA-L5-A43I-01A-11R-A24K-31_rnaseq.bam	70.33	1.82	0.16	58cfa832e4b0c9d6adf6d340	TCGA-L5-A43I-01A-11R-A24K-31_rnaseq.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A43I-01A	22EE75E0-5D61-41F4-AACD-B4E09C70D2C3	Primary Tumor	Illumina HiSeq	40EAE462-3484-465B-BF3E-BEE01BC52B9B	Esophagus	77.0	210B53EB-2664-4E0E-A00B-A24838804726	5892256A-F428-46FE-AFF1-2215FD8090BE	TCGA-L5-A43I-01A-11R-A24K-31	GRCh37-lite	TCGA-L5-A43I	TCGA-ESCA	556.0	s1648	Canada's Michael Smith Genome Sciences Centre	University of Michigan	United States	NO	T3	N1		Stage III	A24K-31	True
13767.58cfa831e4b0c9d6adf6c4cc	58cfa831e4b0c9d6adf6c4cc	TCGA-CG-5726-01A-11R-1602-13_rnaseq.filtered.	RNA-Seq	TCGA-CG-5726-01A-11R-1602-13_rnaseq	TCGA-CG-5726-01A-11R-1602-13_rnaseq.bam	263.8	1.7	0.15	58cfa831e4b0c9d6adf6c4cc	TCGA-CG-5726-01A-11R-1602-13_rnaseq.bam	Dead	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5726-01A	863AD936-E2A0-471C-8D95-3A548BB94AFA	Primary Tumor	Illumina HiSeq	9D27C2C1-C7F9-40BE-9EBE-50872392EAC1	Stomach	73.0	C881739A-982C-436F-9BE2-4638DB792C53	10719477-DCB2-4783-A9FF-343998D4D7A6	TCGA-CG-5726-01A-11R-1602-13	GRCh37-lite	TCGA-CG-5726	TCGA-STAD	881.0	s15066	Canada's Michael Smith Genome Sciences Centre	Indivumed	Germany	NO	T1	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1602-13	True
13767.58cfa834e4b0c9d6adf6e252	58cfa834e4b0c9d6adf6e252	UNCID_1169412.8dd30d68-86d0-456f-814c-ae59a5c0a071.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1169412.8dd30d68-86d0-456f-814c-ae59a5c0a071.sorted_genome_alignments	UNCID_1169412.8dd30d68-86d0-456f-814c-ae59a5c0a071.sorted_genome_alignments.bam	26.34	1.75	0.16	58cfa834e4b0c9d6adf6e252	UNCID_1169412.8dd30d68-86d0-456f-814c-ae59a5c0a071.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A1Y0-01A	CED2C048-B047-43FF-B0E7-CD7AD480850C	Primary Tumor	Illumina HiSeq	F9663365-9A51-4594-BDDE-1E7EAC4E02D4	Breast	65.0	92F1452B-54AF-408F-98A8-CD76191F472B	8DD30D68-86D0-456F-814C-AE59A5C0A071	TCGA-D8-A1Y0-01A-11R-A14M-07	HG19	TCGA-D8-A1Y0	TCGA-BRCA		s6059	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T1c	N2a	Infiltrating Ductal Carcinoma	Stage III	A14M-07	True
13767.58cfa835e4b0c9d6adf6ed0c	58cfa835e4b0c9d6adf6ed0c	UNCID_1343202.e33ab42a-bfb3-4923-a305-a6babcee61f4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1343202.e33ab42a-bfb3-4923-a305-a6babcee61f4.sorted_genome_alignments	UNCID_1343202.e33ab42a-bfb3-4923-a305-a6babcee61f4.sorted_genome_alignments.bam	24.95	1.83	0.17	58cfa835e4b0c9d6adf6ed0c	UNCID_1343202.e33ab42a-bfb3-4923-a305-a6babcee61f4.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IT-01A	58520C66-7688-435A-B09F-653B18768C41	Primary Tumor	Illumina HiSeq	2A13274C-4E40-40EC-97F9-63F68F428F05	Bladder	62.0	6B48DAE5-B757-450A-8248-65C2434A7AFC	E33AB42A-BFB3-4923-A305-A6BABCEE61F4	TCGA-DK-A3IT-01A-31R-A20F-07	HG19	TCGA-DK-A3IT	TCGA-BLCA		s3323	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A20F-07	True
13722.58cfa831e4b0c9d6adf6c6f2	58cfa831e4b0c9d6adf6c6f2	TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted	TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted.bam	37.0	1.9	0.14	58cfa831e4b0c9d6adf6c6f2	TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5976-11A	23062172-7361-4E61-8EE6-B0A613D72A24	Solid Tissue Normal	Illumina HiSeq	f5c4e8eb-c5ca-4eb2-b92d-a5a054c4a0c6	Head and Neck	50.0	B721E292-1D8D-451C-BB08-77BC2A61A1B0	662DE6A8-5889-4EB1-86D6-7C5E4012F914	TCGA-CV-5976-11A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5976	TCGA-HNSC		s15642	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IV	1681-02	True
13722.58cfa830e4b0c9d6adf6c2d6	58cfa830e4b0c9d6adf6c2d6	TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted	TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted.bam	333.7	1.9	0.15	58cfa830e4b0c9d6adf6c2d6	TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6707-01A	DF3DF249-86C2-43D4-ABE1-796CD7DF653F	Primary Tumor	Illumina HiSeq	e2babdbd-1849-48ed-8726-1e3788be6064	Stomach	75.0	36F691AA-B737-4369-AD62-84F987F697A6	AA430360-2BE7-4C92-A10C-52588D8A6061	TCGA-BR-6707-01A-11D-1880-02	HG19_Broad_variant	TCGA-BR-6707	TCGA-STAD		s14890	Harvard Medical School	Asterand	Ukraine	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1880-02	True
13767.58cfa832e4b0c9d6adf6d82c	58cfa832e4b0c9d6adf6d82c	UNCID_1064336.7db69d77-75ce-4f75-9e95-7205c55e5e6d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1064336.7db69d77-75ce-4f75-9e95-7205c55e5e6d.sorted_genome_alignments	UNCID_1064336.7db69d77-75ce-4f75-9e95-7205c55e5e6d.sorted_genome_alignments.bam	65.2	1.7	0.15	58cfa832e4b0c9d6adf6d82c	UNCID_1064336.7db69d77-75ce-4f75-9e95-7205c55e5e6d.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-7107-01A	BEF26F5E-A17E-49B7-8EB4-2BC079983764	Primary Tumor	Illumina HiSeq	099A3D04-F6A5-41D6-89CB-63909430CA1C	Lung	70.0	36796228-18E1-4FB7-B1BB-E5ECB8661517	7DB69D77-75CE-4F75-9E95-7205C55E5E6D	TCGA-34-7107-01A-11R-1949-07	HG19	TCGA-34-7107	TCGA-LUSC	34.0	s10184	University of North Carolina	University of Pittsburgh	United States	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	1949-07	True
13767.58cfa831e4b0c9d6adf6c881	58cfa831e4b0c9d6adf6c881	TCGA-D7-6817-01A-11R-1884-13_rnaseq.filtered.	RNA-Seq	TCGA-D7-6817-01A-11R-1884-13_rnaseq	TCGA-D7-6817-01A-11R-1884-13_rnaseq.bam	614.2	1.8	0.15	58cfa831e4b0c9d6adf6c881	TCGA-D7-6817-01A-11R-1884-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6817-01A	6FFEFB3F-3919-4FEF-AB15-5D32D8F51D57	Primary Tumor	Illumina HiSeq	9273A6EE-CA75-4A56-8AA7-E7D14642AAC7	Stomach	63.0	9E01F1D4-7BA6-42B7-A43C-833195EF4B49	8728D914-26AA-4DD6-8780-9E8C7DB02115	TCGA-D7-6817-01A-11R-1884-13	GRCh37-lite	TCGA-D7-6817	TCGA-STAD		s14911	Canada's Michael Smith Genome Sciences Centre	Greater Poland Cancer Center	Poland	NO	T2b	N3	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	1884-13	True
13767.58cfa832e4b0c9d6adf6d390	58cfa832e4b0c9d6adf6d390	TCGA-L5-A4OO-01A-11R-A260-31_rnaseq.filtered.	RNA-Seq	TCGA-L5-A4OO-01A-11R-A260-31_rnaseq	TCGA-L5-A4OO-01A-11R-A260-31_rnaseq.bam	68.51	1.92	0.17	58cfa832e4b0c9d6adf6d390	TCGA-L5-A4OO-01A-11R-A260-31_rnaseq.bam	Alive	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OO-01A	53990B20-16BD-4792-A4CA-4FD411C841F4	Primary Tumor	Illumina HiSeq	1464C3F4-70DA-4993-B680-E32784DCCB86	Esophagus	75.0	BC5F0813-0C0B-4BB1-9659-AFFD6513A5BE	0C798AB9-D08B-4EAF-B53A-54C8B369C61E	TCGA-L5-A4OO-01A-11R-A260-31	GRCh37-lite	TCGA-L5-A4OO	TCGA-ESCA		s1921	Canada's Michael Smith Genome Sciences Centre	University of Michigan	United States	NO	T3	N3		Stage III	A260-31	True
13767.58cfa834e4b0c9d6adf6e152	58cfa834e4b0c9d6adf6e152	UNCID_1160657.7265c93b-7138-4bc8-bc9c-22ce1abf0ef2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1160657.7265c93b-7138-4bc8-bc9c-22ce1abf0ef2.sorted_genome_alignments	UNCID_1160657.7265c93b-7138-4bc8-bc9c-22ce1abf0ef2.sorted_genome_alignments.bam	58.24	1.86	0.17	58cfa834e4b0c9d6adf6e152	UNCID_1160657.7265c93b-7138-4bc8-bc9c-22ce1abf0ef2.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A25E-01A	BA89CB4F-CD63-47B1-9550-76FDAFF89F2E	Primary Tumor	Illumina HiSeq	018B2CD9-0A23-4791-A223-AD0DA426F73B	Breast	34.0	8DA9C00E-1EC3-4657-9511-A2A00B8961CB	7265C93B-7138-4BC8-BC9C-22CE1ABF0EF2	TCGA-A2-A25E-01A-11R-A169-07	HG19	TCGA-A2-A25E	TCGA-BRCA		s6707	University of North Carolina	Walter Reed	United States	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage III	A169-07	True
13767.58cfa839e4b0c9d6adf71253	58cfa839e4b0c9d6adf71253	UNCID_2281851.108c3fda-c681-4030-8a51-c21b0108b78e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2281851.108c3fda-c681-4030-8a51-c21b0108b78e.sorted_genome_alignments	UNCID_2281851.108c3fda-c681-4030-8a51-c21b0108b78e.sorted_genome_alignments.bam	209.2		0.15	58cfa839e4b0c9d6adf71253	UNCID_2281851.108c3fda-c681-4030-8a51-c21b0108b78e.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-A4-7583-01A	CFBEEFDC-667F-4DF0-967F-74B625F0D96A	Primary Tumor	Illumina HiSeq	CE1418C3-F336-4E92-BB73-2C028BAC89BA	Kidney	60.0	497ACA75-1EFB-40C2-81E8-0B51414FDE4A	108C3FDA-C681-4030-8A51-C21B0108B78E	TCGA-A4-7583-01A-11R-A32Z-07	HG19	TCGA-A4-7583	TCGA-KIRP		s11826	University of North Carolina	International Genomics Consortium	United States	NO	T1	N0	Kidney Papillary Renal Cell Carcinoma	Stage I	A32Z-07	True
13767.58cfa82ee4b0c9d6adf6a993	58cfa82ee4b0c9d6adf6a993	G17502.TCGA-14-0871-01A-01R-1849-01.2.filtered.	RNA-Seq	G17502.TCGA-14-0871-01A-01R-1849-01.2	G17502.TCGA-14-0871-01A-01R-1849-01.2.bam	270.7	1.8	0.14	58cfa82ee4b0c9d6adf6a993	G17502.TCGA-14-0871-01A-01R-1849-01.2.bam	Dead	FEMALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-14-0871-01A	72F88D18-03BE-4B51-9F4A-1151521B7292	Primary Tumor	Illumina HiSeq	E622A412-2D3F-42E1-A7F6-DD619AA118C4	Brain	74.0	FD202256-3168-4D4A-B3CC-1C667838C313	4BD8BBAE-7370-43C7-89CB-0FE0028553DD	TCGA-14-0871-01A-01R-1849-01	HG19_Broad_variant	TCGA-14-0871	TCGA-GBM	880.0	s14291	Broad Institute of MIT and Harvard	Emory University	None	NO			Untreated primary (de novo) GBM		1849-01	True
13767.58cfa834e4b0c9d6adf6e916	58cfa834e4b0c9d6adf6e916	UNCID_1239099.83e1f144-8970-4d50-961d-51493ba417f3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1239099.83e1f144-8970-4d50-961d-51493ba417f3.sorted_genome_alignments	UNCID_1239099.83e1f144-8970-4d50-961d-51493ba417f3.sorted_genome_alignments.bam	17.11	1.74	0.16	58cfa834e4b0c9d6adf6e916	UNCID_1239099.83e1f144-8970-4d50-961d-51493ba417f3.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A1Q9-06A	798074D3-0B84-4DD5-AA88-91FEDA9AC8C6	Metastatic	Illumina HiSeq	5B9D746A-F0D3-4634-BBA9-9BF431FA8201	Skin	72.0	F5AA07C1-3302-4B54-A791-007714139901	83E1F144-8970-4D50-961D-51493BA417F3	TCGA-D3-A1Q9-06A-11R-A18T-07	HG19	TCGA-D3-A1Q9	TCGA-SKCM	961.0	s7586	University of North Carolina	MD Anderson	United States	NO	T4b	N2a		Stage III	A18T-07	True
13722.58cfa82fe4b0c9d6adf6b920	58cfa82fe4b0c9d6adf6b920	TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina	TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina.bam	21.0		0.08	58cfa82fe4b0c9d6adf6b920	TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-A4-A48D-01A	925AE8FF-3200-4564-BE76-94DB0984B027	Primary Tumor	Illumina HiSeq	ca65f407-1de9-4171-8ae5-67e4d85f5beb	Kidney	84.0	4DDC37D4-35B8-4A5D-BBF1-6DBF0548852B	5ECC88F7-8391-4168-AF11-07A6BF9B3652	TCGA-A4-A48D-01A-11D-A25F-10	GRCh37-lite	TCGA-A4-A48D	TCGA-KIRP		s11850	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A25F-10	True
13767.58cfa83ae4b0c9d6adf7167b	58cfa83ae4b0c9d6adf7167b	UNCID_2408127.a57d41bc-71b6-4215-804a-d66071f60594.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2408127.a57d41bc-71b6-4215-804a-d66071f60594.sorted_genome_alignments	UNCID_2408127.a57d41bc-71b6-4215-804a-d66071f60594.sorted_genome_alignments.bam	11.29	1.91	0.15	58cfa83ae4b0c9d6adf7167b	UNCID_2408127.a57d41bc-71b6-4215-804a-d66071f60594.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-RY-A845-01A	36615695-921C-4C8A-93D6-6C788079BEAE	Primary Tumor	Illumina HiSeq	7577F22A-EB50-4D01-92CE-6792C8D58262	Brain	40.0	27B43551-4D86-4113-8FB0-3A20ABED5A1A	A57D41BC-71B6-4215-804A-D66071F60594	TCGA-RY-A845-01A-11R-A36H-07	HG19	TCGA-RY-A845	TCGA-LGG		s8312	University of North Carolina	University of California San Francisco	United States	NO			Oligoastrocytoma		A36H-07	True
13767.58cfa832e4b0c9d6adf6d46a	58cfa832e4b0c9d6adf6d46a	TCGA-VQ-A8P3-01A-11R-A36D-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-A8P3-01A-11R-A36D-31_rnaseq	TCGA-VQ-A8P3-01A-11R-A36D-31_rnaseq.bam	58.14	1.85	0.17	58cfa832e4b0c9d6adf6d46a	TCGA-VQ-A8P3-01A-11R-A36D-31_rnaseq.bam	Alive	MALE	WHITE		Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-A8P3-01A	5C68E3E4-58F7-4699-989D-80D2E4996794	Primary Tumor	Illumina HiSeq	ABECB8A8-E8B2-4D15-A4BF-47B898AEB81F	Stomach	72.0	4E9A78D5-C8DC-4C61-9812-6A213CA67430	C21B1977-9380-43E6-8A14-2B9830C46BEF	TCGA-VQ-A8P3-01A-11R-A36D-31	GRCh37-lite	TCGA-VQ-A8P3	TCGA-STAD		s14433	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T4	N1	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	A36D-31	True
13767.58cfa83be4b0c9d6adf72a30	58cfa83be4b0c9d6adf72a30	UNCID_369670.TCGA-BP-4337-01A-01R-1289-07.110429_SN851_0035_AB0AKJABXX.3.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_369670.TCGA-BP-4337-01A-01R-1289-07.110429_SN851_0035_AB0AKJABXX.3.trimmed.annotated.translated_to_genomic	UNCID_369670.TCGA-BP-4337-01A-01R-1289-07.110429_SN851_0035_AB0AKJABXX.3.trimmed.annotated.translated_to_genomic.bam	80.3	1.8	0.15	58cfa83be4b0c9d6adf72a30	UNCID_369670.TCGA-BP-4337-01A-01R-1289-07.110429_SN851_0035_AB0AKJABXX.3.trimmed.annotated.translated_to_genomic.bam	Dead	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4337-01A	2913FAF2-D722-4993-8E9A-3C4CC1F5D82B	Primary Tumor	Illumina HiSeq	30EC64B2-3B99-47A9-8B84-A58B3756B3B1	Kidney	76.0	C661AE6A-D44B-4BCF-A79A-E41CD3809E8B	17340B58-DD83-4A86-8A17-1BFD7DE839BF	TCGA-BP-4337-01A-01R-1289-07	HG19	TCGA-BP-4337	TCGA-KIRC	2.0	s9882	University of North Carolina	MSKCC	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1289-07	True
13767.58cfa83be4b0c9d6adf72374	58cfa83be4b0c9d6adf72374	UNCID_2579700.6575d941-3ebf-449e-a2d9-ed80cf8bbe85.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2579700.6575d941-3ebf-449e-a2d9-ed80cf8bbe85.sorted_genome_alignments	UNCID_2579700.6575d941-3ebf-449e-a2d9-ed80cf8bbe85.sorted_genome_alignments.bam	51.93	1.89	0.15	58cfa83be4b0c9d6adf72374	UNCID_2579700.6575d941-3ebf-449e-a2d9-ed80cf8bbe85.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thymoma	Aligned reads	TCGA-XU-AAXV-01A	80606B1C-E8C8-4C3D-8475-3D846A84CA98	Primary Tumor	Illumina HiSeq	5356BE6F-F400-4F37-94CB-2DAA76C0852C	Thymus	45.0	EE2525EE-68C8-4229-9438-AF3AB583FF33	6575D941-3EBF-449E-A2D9-ED80CF8BBE85	TCGA-XU-AAXV-01A-11R-A42C-07	HG19	TCGA-XU-AAXV	TCGA-THYM		s503	University of North Carolina	University Health Network	Canada	NO					A42C-07	True
13722.58cfa832e4b0c9d6adf6cf5b	58cfa832e4b0c9d6adf6cf5b	TCGA-GN-A265-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GN-A265-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_5_rg.sorted	TCGA-GN-A265-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_5_rg.sorted.bam	16.67		0.18	58cfa832e4b0c9d6adf6cf5b	TCGA-GN-A265-10A-01D-A190_120602_SN208_0304_BC0WTWACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GN-A265-10A	61B777F6-A59A-4500-AD33-107E2C9254C1	Blood Derived Normal	Illumina HiSeq	8ad44bb1-82fb-42de-8306-68b2e86c747f	Skin	53.0	5045BC39-C8BA-4AC5-A6F4-F175E41DB27C	7457238B-0093-49A0-8B19-F71894346253	TCGA-GN-A265-10A-01D-A190-02	HG19_Broad_variant	TCGA-GN-A265	TCGA-SKCM		s7541	Harvard Medical School	Roswell	United States	NO					A190-02	True
13722.58cfa83ce4b0c9d6adf7307f	58cfa83ce4b0c9d6adf7307f	b58386e952752d807a06a013a922b7ae.filtered.	WGS	b58386e952752d807a06a013a922b7ae	b58386e952752d807a06a013a922b7ae.bam	17.96	1.86	0.07	58cfa83ce4b0c9d6adf7307f	b58386e952752d807a06a013a922b7ae.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A13D-01A	8785012F-F73E-4D68-87CF-1D804AF32782	Primary Tumor	Illumina HiSeq	3c8a206a-59d4-412a-97c1-9dd31cb9b7c0	Breast	46.0	79FC9ED3-4E96-4C0E-869E-1756CBDABB39	418E916B-7A4E-4FAB-8616-15DCEC4D79F8	TCGA-A7-A13D-01A-13D-A12Q-09	GRCh37-lite	TCGA-A7-A13D	TCGA-BRCA		s6443	Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A12Q-09	False
13767.58cfa834e4b0c9d6adf6e750	58cfa834e4b0c9d6adf6e750	UNCID_1219913.6e4145d0-e417-4690-8956-c5d1c1194fe3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1219913.6e4145d0-e417-4690-8956-c5d1c1194fe3.sorted_genome_alignments	UNCID_1219913.6e4145d0-e417-4690-8956-c5d1c1194fe3.sorted_genome_alignments.bam	23.78	1.83	0.17	58cfa834e4b0c9d6adf6e750	UNCID_1219913.6e4145d0-e417-4690-8956-c5d1c1194fe3.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2MM-06A	C9DEA107-FC12-4559-AD27-2800AE6B42E4	Metastatic	Illumina HiSeq	6CA0DBF3-3AFC-4D96-9520-C429FDAF180B	Skin	63.0	1B5CC782-F8EB-4F06-9487-CB8496E462A0	6E4145D0-E417-4690-8956-C5D1C1194FE3	TCGA-EE-A2MM-06A-11R-A18S-07	HG19	TCGA-EE-A2MM	TCGA-SKCM	5107.0	s7717	University of North Carolina	University of Sydney	Australia	NO	T2	N0		Stage I	A18S-07	True
13767.58cfa83ce4b0c9d6adf7313c	58cfa83ce4b0c9d6adf7313c	_1_TCGA-CD-A4MG-01A-11R-A251-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-CD-A4MG-01A-11R-A251-31_rnaseq	_1_TCGA-CD-A4MG-01A-11R-A251-31_rnaseq.bam	56.18	1.9	0.16	58cfa83ce4b0c9d6adf7313c	_1_TCGA-CD-A4MG-01A-11R-A251-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-A4MG-01A	028632ED-D75A-49BB-B579-41962BA502FE	Primary Tumor	Illumina HiSeq	458F388B-AFDC-4C1C-A39C-84D7185CDB71	Stomach	76.0	E6851ECB-E630-43A3-87BA-AFA0FDDD0568	ADBB10E6-54D3-453E-97BA-8C80C815B04C	TCGA-CD-A4MG-01A-11R-A251-31	GRCh37-lite	TCGA-CD-A4MG	TCGA-STAD		s14730	Canada's Michael Smith Genome Sciences Centre	ILSbio	Vietnam	NO	T3	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage II	A251-31	True
13767.58cfa82ee4b0c9d6adf6b094	58cfa82ee4b0c9d6adf6b094	TCGA-13-0908-01B-01R-1565-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0908-01B-01R-1565-13_rnaseq	TCGA-13-0908-01B-01R-1565-13_rnaseq.bam	672.0	1.8	0.17	58cfa82ee4b0c9d6adf6b094	TCGA-13-0908-01B-01R-1565-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0908-01B	0BA7B6CC-E5F5-47D7-859A-24E31AA336AB	Primary Tumor	Illumina HiSeq	FC4C3D08-18D0-4472-8780-D08C5A76C912	Ovary	58.0	B2F596EA-10AD-4A17-AEA3-88756FB0B7F9	5324831D-94BE-40C6-BCB1-5B29BBBAAB1B	TCGA-13-0908-01B-01R-1565-13	NCBI36_BCCAGSC_variant	TCGA-13-0908	TCGA-OV		s17364	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa83be4b0c9d6adf7250b	58cfa83be4b0c9d6adf7250b	UNCID_2640696.cbc184c2-4bda-4a56-9b49-453f503e16ab.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2640696.cbc184c2-4bda-4a56-9b49-453f503e16ab.sorted_genome_alignments	UNCID_2640696.cbc184c2-4bda-4a56-9b49-453f503e16ab.sorted_genome_alignments.bam	97.04	1.86	0.17	58cfa83be4b0c9d6adf7250b	UNCID_2640696.cbc184c2-4bda-4a56-9b49-453f503e16ab.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-XF-A9T6-01A	6EE18B9A-3F45-491F-9535-502820CFCF46	Primary Tumor	Illumina HiSeq	1A98A229-1C65-4152-8D06-A2231F34860C	Bladder	88.0	3EF041C5-FFD2-497E-89B6-0E5C552D279C	CBC184C2-4BDA-4A56-9B49-453F503E16AB	TCGA-XF-A9T6-01A-11R-A42T-07	HG19	TCGA-XF-A9T6	TCGA-BLCA		s3235	University of North Carolina	University of Southern California	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A42T-07	True
13767.58cfa839e4b0c9d6adf71096	58cfa839e4b0c9d6adf71096	UNCID_2247551.7c73dae6-4478-4cbc-aee1-0b18e730f7a2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2247551.7c73dae6-4478-4cbc-aee1-0b18e730f7a2.sorted_genome_alignments	UNCID_2247551.7c73dae6-4478-4cbc-aee1-0b18e730f7a2.sorted_genome_alignments.bam	17.74	1.88	0.16	58cfa839e4b0c9d6adf71096	UNCID_2247551.7c73dae6-4478-4cbc-aee1-0b18e730f7a2.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A6R9-01A	43CC074D-B85A-4B0B-8FEB-833094FFC565	Primary Tumor	Illumina HiSeq	B904E35E-807A-4E49-9419-7B73C87BD6D6	Breast	61.0	65842833-68A7-4EFD-A781-19B5DC6BD257	7C73DAE6-4478-4CBC-AEE1-0B18E730F7A2	TCGA-BH-A6R9-01A-21R-A32P-07	HG19	TCGA-BH-A6R9	TCGA-BRCA		s5764	University of North Carolina	University of Pittsburgh	United States	NO	T2	N0	Metaplastic Carcinoma	Stage II	A32P-07	True
13722.58cfa82ee4b0c9d6adf6ad57	58cfa82ee4b0c9d6adf6ad57	G8893.TCGA-66-2766-01A-01D-1180-08.4.filtered.	WGS	G8893.TCGA-66-2766-01A-01D-1180-08.4	G8893.TCGA-66-2766-01A-01D-1180-08.4.bam	564.3	1.9	0.14	58cfa82ee4b0c9d6adf6ad57	G8893.TCGA-66-2766-01A-01D-1180-08.4.bam	Alive	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2766-01A	B913D254-8307-4B8A-8313-D978E32BB38F	Primary Tumor	Illumina HiSeq	cba17a86-671f-4744-a52b-a93f56b8ee16	Lung	54.0	09215E83-EDAC-472D-B849-9225C532358C	45E16B70-C3EC-493E-86D1-505FFDF5056C	TCGA-66-2766-01A-01D-1180-08	HG19_Broad_variant	TCGA-66-2766	TCGA-LUSC		s10262	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	1180-08	False
13722.58cfa831e4b0c9d6adf6cc70	58cfa831e4b0c9d6adf6cc70	TCGA-DU-7294-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_4_rg.sorted.filtered.	WGS	TCGA-DU-7294-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_4_rg.sorted	TCGA-DU-7294-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_4_rg.sorted.bam	41.0		0.15	58cfa831e4b0c9d6adf6cc70	TCGA-DU-7294-10A-01D-2022_130911_SN1222_0218_BC2A1NACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7294-10A	3F6FFB08-32A9-4555-BFD1-243B7F526105	Blood Derived Normal	Illumina HiSeq	fb816713-22f8-4650-a51e-d1dc31150849	Brain	53.0	8B4922DC-8990-4A9A-892F-CA57EBD6D987	E6951FEB-A4F1-42ED-BC55-E6BC8DFBC1AD	TCGA-DU-7294-10A-01D-2022-02	HG19_Broad_variant	TCGA-DU-7294	TCGA-LGG		s8568	Harvard Medical School	Henry Ford Hospital	United States	NO			Oligodendroglioma		2022-02	True
13767.58cfa83ce4b0c9d6adf72ffc	58cfa83ce4b0c9d6adf72ffc	_1_TCGA-HU-8602-01A-11R-2402-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-HU-8602-01A-11R-2402-13_rnaseq	_1_TCGA-HU-8602-01A-11R-2402-13_rnaseq.bam	168.2		0.15	58cfa83ce4b0c9d6adf72ffc	_1_TCGA-HU-8602-01A-11R-2402-13_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-8602-01A	EDCE7AAC-1D8B-41CB-88E2-F50B8EECA4D8	Primary Tumor	Illumina HiSeq	37686941-314D-40D2-B719-E580A89A5B58	Stomach	58.0	37FCEF05-07DD-4D0D-8380-02D6605C6DDC	75DD5750-C619-4593-AC46-E0AEC842D5A9	TCGA-HU-8602-01A-11R-2402-13	GRCh37-lite	TCGA-HU-8602	TCGA-STAD		s15227	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T4a	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage II	2402-13	True
13767.58cfa83be4b0c9d6adf71f4a	58cfa83be4b0c9d6adf71f4a	UNCID_2538263.c720ac3f-9cb8-4a5c-aa7a-0fb852e11360.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2538263.c720ac3f-9cb8-4a5c-aa7a-0fb852e11360.sorted_genome_alignments	UNCID_2538263.c720ac3f-9cb8-4a5c-aa7a-0fb852e11360.sorted_genome_alignments.bam	29.1	1.83	0.17	58cfa83be4b0c9d6adf71f4a	UNCID_2538263.c720ac3f-9cb8-4a5c-aa7a-0fb852e11360.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-ZF-A9R1-01A	F1BD8305-5C3F-4C82-9E68-BA9CF4ECDF7B	Primary Tumor	Illumina HiSeq	4F3E8E47-1ED8-4F18-BD85-EF50194B6E02	Bladder	81.0	58A00E33-ADBC-499F-BB0D-5C8463AE7A5D	C720AC3F-9CB8-4A5C-AA7A-0FB852E11360	TCGA-ZF-A9R1-01A-11R-A39I-07	HG19	TCGA-ZF-A9R1	TCGA-BLCA		s3387	University of North Carolina	University of Sheffield	United Kingdom	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A39I-07	True
13767.58cfa838e4b0c9d6adf70898	58cfa838e4b0c9d6adf70898	UNCID_2043790.41c1975d-219d-4131-a77e-e70224ed6c41.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2043790.41c1975d-219d-4131-a77e-e70224ed6c41.sorted_genome_alignments	UNCID_2043790.41c1975d-219d-4131-a77e-e70224ed6c41.sorted_genome_alignments.bam	58.82	1.81	0.18	58cfa838e4b0c9d6adf70898	UNCID_2043790.41c1975d-219d-4131-a77e-e70224ed6c41.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A44S-01A	CFB61FD8-0BCA-40B4-878C-CC914A289792	Primary Tumor	Illumina HiSeq	5EA4B9BC-9847-4F75-B68F-BA529E317612	Cervix	31.0	0D96E0B0-5ABD-4528-A733-354308E0CFEF	41C1975D-219D-4131-A77E-E70224ED6C41	TCGA-EA-A44S-01A-12R-A26T-07	HG19	TCGA-EA-A44S	TCGA-CESC		s1572	University of North Carolina	Asterand	Ukraine	NO	T2a2	N1	Cervical Squamous Cell Carcinoma		A26T-07	True
13767.58cfa834e4b0c9d6adf6e8de	58cfa834e4b0c9d6adf6e8de	UNCID_1229184.80ee8813-997d-48b9-9853-520080e22e05.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1229184.80ee8813-997d-48b9-9853-520080e22e05.sorted_genome_alignments	UNCID_1229184.80ee8813-997d-48b9-9853-520080e22e05.sorted_genome_alignments.bam	46.2	1.8	0.15	58cfa834e4b0c9d6adf6e8de	UNCID_1229184.80ee8813-997d-48b9-9853-520080e22e05.sorted_genome_alignments.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-51-4080-11A	8479EC58-F5E7-4D9D-A382-2688ED93CA8E	Solid Tissue Normal	Illumina HiSeq	F315225C-5695-495B-B08B-A84D9C09AA77	Lung	65.0	BE87DA43-09A8-4949-92CE-1C9FBF467E0D	80EE8813-997D-48B9-9853-520080E22E05	TCGA-51-4080-11A-01R-1758-07	HG19	TCGA-51-4080	TCGA-LUSC	12.0	s10027	University of North Carolina	UNC	United States	NO	T4	N1	Lung Basaloid Squamous Cell Carcinoma	Stage III	1758-07	True
13767.58cfa836e4b0c9d6adf6fc5a	58cfa836e4b0c9d6adf6fc5a	UNCID_1659271.67107614-9A9D-4D62-9C2E-3B8E242AC92D.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1659271.67107614-9A9D-4D62-9C2E-3B8E242AC92D.sorted_genome_alignments	UNCID_1659271.67107614-9A9D-4D62-9C2E-3B8E242AC92D.sorted_genome_alignments.bam	23.8	1.79	0.18	58cfa836e4b0c9d6adf6fc5a	UNCID_1659271.67107614-9A9D-4D62-9C2E-3B8E242AC92D.sorted_genome_alignments.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A3O7-01A	3A211D5A-085F-4902-86B6-50E4EB36B897	Primary Tumor	Illumina HiSeq	DD0706E9-0325-464F-9169-9E1BB867F29A	Thyroid	46.0	362F0CC2-B884-404B-8DF1-2BFC2A75E9C3	67107614-9A9D-4D62-9C2E-3B8E242AC92D	TCGA-EM-A3O7-01A-11R-A220-07	HG19	TCGA-EM-A3O7	TCGA-THCA		s12697	University of North Carolina	University Health Network	Canada	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A220-07	True
13722.58cfa830e4b0c9d6adf6bc9e	58cfa830e4b0c9d6adf6bc9e	TCGA-AZ-4315-10A-01D-1405_110225_SN177_0142_B81JPFABXX_s_4.rg.sorted.filtered.	WGS	TCGA-AZ-4315-10A-01D-1405_110225_SN177_0142_B81JPFABXX_s_4.rg.sorted	TCGA-AZ-4315-10A-01D-1405_110225_SN177_0142_B81JPFABXX_s_4.rg.sorted.bam	287.72	1.9	0.15	58cfa830e4b0c9d6adf6bc9e	TCGA-AZ-4315-10A-01D-1405_110225_SN177_0142_B81JPFABXX_s_4.rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4315-10A	DE287A25-981D-49F8-81AF-FE0300E4CD31	Blood Derived Normal	Illumina HiSeq	9a6322eb-3fac-4d37-bbec-89355ddc9dbb	Colorectal	61.0	8D10297B-DEF9-4F00-B231-B1448967FA7A	59F67AA1-B650-40DD-A6F8-D2BC53380B6C	TCGA-AZ-4315-10A-01D-1405-02	HG18_Broad_variant	TCGA-AZ-4315	TCGA-COAD		s13541	Harvard Medical School	University of Pittsburgh	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1405-02	True
13767.58cfa834e4b0c9d6adf6e8aa	58cfa834e4b0c9d6adf6e8aa	UNCID_1218532.2bad2998-4066-4796-8569-1de516cb0d36.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1218532.2bad2998-4066-4796-8569-1de516cb0d36.sorted_genome_alignments	UNCID_1218532.2bad2998-4066-4796-8569-1de516cb0d36.sorted_genome_alignments.bam	33.44	1.79	0.15	58cfa834e4b0c9d6adf6e8aa	UNCID_1218532.2bad2998-4066-4796-8569-1de516cb0d36.sorted_genome_alignments.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A1CS-01A	E92BDB0D-969A-4D98-ADA8-5DFEC68119B5	Primary Tumor	Illumina HiSeq	1B33D998-3AC3-4CBB-88E1-1B4E12434399	Thyroid	55.0	C1DAF740-06E2-4509-86BE-5BFCC52B508A	2BAD2998-4066-4796-8569-1DE516CB0D36	TCGA-EM-A1CS-01A-11R-A13Y-07	HG19	TCGA-EM-A1CS	TCGA-THCA		s12767	University of North Carolina	University Health Network	Canada	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13Y-07	True
13767.58cfa832e4b0c9d6adf6d6ca	58cfa832e4b0c9d6adf6d6ca	UNCID_1040601.0057e13d-5489-4c48-9772-9fd45db4d84f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1040601.0057e13d-5489-4c48-9772-9fd45db4d84f.sorted_genome_alignments	UNCID_1040601.0057e13d-5489-4c48-9772-9fd45db4d84f.sorted_genome_alignments.bam	181.2	1.8	0.16	58cfa832e4b0c9d6adf6d6ca	UNCID_1040601.0057e13d-5489-4c48-9772-9fd45db4d84f.sorted_genome_alignments.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN		Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-BQ-7045-01A	2D813726-B8A6-4719-9323-A7496547E156	Primary Tumor	Illumina HiSeq	1A6C883A-37EC-47B0-A17A-41B479D489D4	Kidney	78.0	A4FD4933-86ED-4875-9DDD-305B968B15CE	0057E13D-5489-4C48-9772-9FD45DB4D84F	TCGA-BQ-7045-01A-31R-1965-07	HG19	TCGA-BQ-7045	TCGA-KIRP	1468.0	s11867	University of North Carolina	MSKCC	United States	NO	T1b	N0	Kidney Papillary Renal Cell Carcinoma	Stage I	1965-07	True
13767.58cfa82fe4b0c9d6adf6ba28	58cfa82fe4b0c9d6adf6ba28	TCGA-61-2092-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-61-2092-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-61-2092-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	1109.0	1.8	0.15	58cfa82fe4b0c9d6adf6ba28	TCGA-61-2092-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2092-01A	C183D3FB-2EEE-44F8-890E-B9BF907141E6	Primary Tumor	Illumina HiSeq	BD2017E5-D739-4C57-A3E5-38F2477A6BF6	Ovary	57.0	962BB8FD-018E-49D0-B1DF-DC0192E1B2A6	0ED6E7A9-CDAA-48DC-962F-219F1EB39C1A	TCGA-61-2092-01A-01R-1568-13	GRCh37-lite	TCGA-61-2092	TCGA-OV		s17276	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa832e4b0c9d6adf6cfa6	58cfa832e4b0c9d6adf6cfa6	TCGA-FS-A1ZZ-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FS-A1ZZ-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_5_rg.sorted	TCGA-FS-A1ZZ-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_5_rg.sorted.bam	76.94		0.18	58cfa832e4b0c9d6adf6cfa6	TCGA-FS-A1ZZ-06A-11D-A18Y_120602_SN1120_0146_AC0WLVACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZZ-06A	F6FF5E77-60D8-4987-9A92-654FD4DB81F1	Metastatic	Illumina HiSeq	a063d15d-a203-4c9c-ba64-60b38c6876fa	Skin	54.0	6FCB5378-D9E3-460E-9409-4298EA610BB6	45F0846F-66B7-49B9-A950-CBCD1D5ABA94	TCGA-FS-A1ZZ-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-FS-A1ZZ	TCGA-SKCM	822.0	s7538	Harvard Medical School	Essen	Germany	NO	T3b	N0		Stage II	A18Y-02	True
13722.58cfa832e4b0c9d6adf6d042	58cfa832e4b0c9d6adf6d042	TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted	TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted.bam	43.71		0.16	58cfa832e4b0c9d6adf6d042	TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3EO-01A	B7F2958F-256E-4C30-9C61-11E76DDB36BA	Primary Tumor	Illumina HiSeq	31874bb0-fa47-43d4-8135-1be05e8163eb	Cervix	55.0	59F1684E-5631-4E1E-A1DC-91739F7C159C	50DBFC58-57DC-4878-8506-7B6B21899DF5	TCGA-FU-A3EO-01A-11D-A20X-26	HG19_Broad_variant	TCGA-FU-A3EO	TCGA-CESC		s1201	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N0	Endocervical Type of Adenocarcinoma		A20X-26	True
13722.58cfa830e4b0c9d6adf6c1fe	58cfa830e4b0c9d6adf6c1fe	TCGA-AF-2689-10A-01D-1167_101023_SN208_0167_B80L4DABXX_s_4_rg.sorted.filtered.	WGS	TCGA-AF-2689-10A-01D-1167_101023_SN208_0167_B80L4DABXX_s_4_rg.sorted	TCGA-AF-2689-10A-01D-1167_101023_SN208_0167_B80L4DABXX_s_4_rg.sorted.bam	3.21	1.9	0.14	58cfa830e4b0c9d6adf6c1fe	TCGA-AF-2689-10A-01D-1167_101023_SN208_0167_B80L4DABXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-AF-2689-10A	335D0351-3740-4847-9FF4-BE2F078C70F7	Blood Derived Normal	Illumina HiSeq	86649ab3-345e-430f-9b1e-e734f487554a	Colorectal	41.0	DC4852E8-3E77-4D45-8E7E-F9B6EFFF01E4	6EFA7CE1-E770-4DD6-9E61-E52E87134298	TCGA-AF-2689-10A-01D-1167-02	HG18_Broad_variant	TCGA-AF-2689	TCGA-READ		s1960	Harvard Medical School	Christiana Healthcare	None	NO	T3	N2	Rectal Adenocarcinoma	Stage IV	1167-02	True
13767.58cfa832e4b0c9d6adf6d7de	58cfa832e4b0c9d6adf6d7de	UNCID_1032619.31f009cc-8211-45db-b74b-416bab8c30df.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1032619.31f009cc-8211-45db-b74b-416bab8c30df.sorted_genome_alignments	UNCID_1032619.31f009cc-8211-45db-b74b-416bab8c30df.sorted_genome_alignments.bam	8.37	1.74	0.17	58cfa832e4b0c9d6adf6d7de	UNCID_1032619.31f009cc-8211-45db-b74b-416bab8c30df.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZT-06A	57882F61-4A32-49F1-AFD4-61C70B184D8B	Metastatic	Illumina HiSeq	06DF91F9-5B7D-4E51-9ABC-A3929FB46A13	Skin	55.0	2812580B-D88A-4141-BC61-92A08C292C5F	31F009CC-8211-45DB-B74B-416BAB8C30DF	TCGA-FS-A1ZT-06A-11R-A18U-07	HG19	TCGA-FS-A1ZT	TCGA-SKCM		s7876	University of North Carolina	Essen	Germany	NO	T2	N1b		Stage III	A18U-07	True
13722.58cfa831e4b0c9d6adf6ccb6	58cfa831e4b0c9d6adf6ccb6	TCGA-EE-A2ML-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EE-A2ML-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_3_rg.sorted	TCGA-EE-A2ML-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_3_rg.sorted.bam	60.49		0.15	58cfa831e4b0c9d6adf6ccb6	TCGA-EE-A2ML-06A-11D-A18Y_120724_SN1222_0138_AC1168ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2ML-06A	01CFBFAE-F344-439D-AEAB-A9E15D636325	Metastatic	Illumina HiSeq	2336ae9f-4b2d-45d1-853f-e0ed0b651e71	Skin	35.0	0CD2BB77-7E7F-4CA7-8E5F-87BC5B46C550	A77E44A0-C4ED-45C0-B21A-1B6DEE9B1EFB	TCGA-EE-A2ML-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-EE-A2ML	TCGA-SKCM		s7688	Harvard Medical School	University of Sydney	Australia	NO	T3a	N0		Stage II	A18Y-02	True
13722.58cfa830e4b0c9d6adf6c1ae	58cfa830e4b0c9d6adf6c1ae	TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina.filtered.	WGS	TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina	TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina.bam	45.94	1.9	0.15	58cfa830e4b0c9d6adf6c1ae	TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-4617-01A	A6E960AF-3CA5-42FB-B546-451C2583282D	Primary Tumor	Illumina HiSeq	dbbf365c-a7c9-4093-8ffb-acf0b6eabf20	Kidney	41.0	605B6DD3-552B-403C-98D9-C8B441B37A90	BEF23192-57CD-4301-B7A7-5E82CA62482D	TCGA-B9-4617-01A-01D-1253-10	GRCh37-lite	TCGA-B9-4617	TCGA-KIRP		s11586	Baylor College of Medicine	UNC	None	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma		1253-10	False
13767.58cfa83ce4b0c9d6adf73000	58cfa83ce4b0c9d6adf73000	_1_TCGA-HU-A4GC-11A-11R-A251-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-HU-A4GC-11A-11R-A251-31_rnaseq	_1_TCGA-HU-A4GC-11A-11R-A251-31_rnaseq.bam	8.69	1.77	0.16	58cfa83ce4b0c9d6adf73000	_1_TCGA-HU-A4GC-11A-11R-A251-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4GC-11A	13E5A0AD-6D0C-4FB4-BF62-325F5C8ED329	Solid Tissue Normal	Illumina HiSeq	9817F368-39FE-45A8-AB1E-47E30AE2EF36	Stomach	74.0	EB4F750C-18B5-425A-B871-733303241EC8	282D05C1-C029-4206-B765-994FA1C6825F	TCGA-HU-A4GC-11A-11R-A251-31	GRCh37-lite	TCGA-HU-A4GC	TCGA-STAD		s14675	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage III	A251-31	True
13767.58cfa838e4b0c9d6adf705aa	58cfa838e4b0c9d6adf705aa	UNCID_1905376.bdaceebb-1720-4ed0-b4e2-e3dec1d2335b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1905376.bdaceebb-1720-4ed0-b4e2-e3dec1d2335b.sorted_genome_alignments	UNCID_1905376.bdaceebb-1720-4ed0-b4e2-e3dec1d2335b.sorted_genome_alignments.bam	127.2		0.13	58cfa838e4b0c9d6adf705aa	UNCID_1905376.bdaceebb-1720-4ed0-b4e2-e3dec1d2335b.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-8514-01A	6845099A-B2C9-48D8-B856-9903D39BB92E	Primary Tumor	Illumina HiSeq	9102B462-ED8E-4A16-A3EA-BC8DEE2640AA	Lung	70.0	A236F15A-76CC-4A2D-9087-E824AD581453	BDACEEBB-1720-4ED0-B4E2-E3DEC1D2335B	TCGA-55-8514-01A-11R-2403-07	HG19	TCGA-55-8514	TCGA-LUAD		s11300	University of North Carolina	International Genomics Consortium	None	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2403-07	True
13722.58cfa830e4b0c9d6adf6c193	58cfa830e4b0c9d6adf6c193	TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted	TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted.bam	64.4	1.9	0.14	58cfa830e4b0c9d6adf6c193	TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5555-10A	8970F713-4A7A-4125-892C-6A34139371D8	Blood Derived Normal	Illumina HiSeq	cb082daa-fb68-4836-bd36-abeed40b581c	Head and Neck	54.0	99CA3C12-0D63-428F-8B1B-03E4A3E8E233	8837A50C-34E3-471D-89FE-D9444255804B	TCGA-BA-5555-10A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5555	TCGA-HNSC		s16317	Harvard Medical School	UNC	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IV	1509-02	True
13722.58cfa832e4b0c9d6adf6cf72	58cfa832e4b0c9d6adf6cf72	TCGA-G9-6370-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-G9-6370-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_6_rg.sorted	TCGA-G9-6370-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_6_rg.sorted.bam	43.7	1.8	0.15	58cfa832e4b0c9d6adf6cf72	TCGA-G9-6370-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6370-10A	F947B0BC-BDAC-44E8-B5B9-FFAE4147740A	Blood Derived Normal	Illumina HiSeq	843714e6-d7a1-47d1-b3e1-9bc71c2e21ca	Prostate	52.0	8FF4EEBE-420C-442E-A41D-4C1F050B0EED	1BFB79D5-D5EE-47A3-AD7D-07F41AD4BA47	TCGA-G9-6370-10A-01D-1784-02	HG19_Broad_variant	TCGA-G9-6370	TCGA-PRAD		s4148	Harvard Medical School	Roswell Park	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		1784-02	True
13767.58cfa835e4b0c9d6adf6f01e	58cfa835e4b0c9d6adf6f01e	UNCID_1474434.AD2EE4B7-EC51-4076-BC5B-6601B5ABEECB.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1474434.AD2EE4B7-EC51-4076-BC5B-6601B5ABEECB.sorted_genome_alignments	UNCID_1474434.AD2EE4B7-EC51-4076-BC5B-6601B5ABEECB.sorted_genome_alignments.bam	10.4	1.8	0.17	58cfa835e4b0c9d6adf6f01e	UNCID_1474434.AD2EE4B7-EC51-4076-BC5B-6601B5ABEECB.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3OO-01A	1FF60FD9-3CA3-43BE-92A8-8DBA2CD4D4DF	Primary Tumor	Illumina HiSeq	2857B181-CA18-411A-B3FA-FB7D9D5241DB	Bladder	79.0	91E7F41C-17B3-4724-96EF-D3C207B964E1	AD2EE4B7-EC51-4076-BC5B-6601B5ABEECB	TCGA-GC-A3OO-01A-11R-A22U-07	HG19	TCGA-GC-A3OO	TCGA-BLCA		s2974	University of North Carolina	International Genomics Consortium	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A22U-07	True
13767.58cfa833e4b0c9d6adf6db31	58cfa833e4b0c9d6adf6db31	UNCID_1098987.4cc61cbe-fa79-499b-9fd5-9b454030154c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1098987.4cc61cbe-fa79-499b-9fd5-9b454030154c.sorted_genome_alignments	UNCID_1098987.4cc61cbe-fa79-499b-9fd5-9b454030154c.sorted_genome_alignments.bam	1.2	1.7	0.14	58cfa833e4b0c9d6adf6db31	UNCID_1098987.4cc61cbe-fa79-499b-9fd5-9b454030154c.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5931-11A	12CCD581-A921-41BC-BCEE-4E9BE54532CC	Solid Tissue Normal	Illumina HiSeq	01414665-D574-4352-87B1-8BC1A7A318E7	Lung	75.0	0EBE60D2-3A5B-41A5-A3F2-8E50A72DC2D1	4CC61CBE-FA79-499B-9FD5-9B454030154C	TCGA-50-5931-11A-01R-1858-07	HG19	TCGA-50-5931	TCGA-LUAD	434.0	s11561	University of North Carolina	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1858-07	True
13767.58cfa83be4b0c9d6adf72408	58cfa83be4b0c9d6adf72408	UNCID_2614159.66dc8005-3575-4b72-8c02-4f920bdfd8e3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2614159.66dc8005-3575-4b72-8c02-4f920bdfd8e3.sorted_genome_alignments	UNCID_2614159.66dc8005-3575-4b72-8c02-4f920bdfd8e3.sorted_genome_alignments.bam	13.86	1.88	0.16	58cfa83be4b0c9d6adf72408	UNCID_2614159.66dc8005-3575-4b72-8c02-4f920bdfd8e3.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EK-01A	4464418C-EC35-4826-B3D5-152AC2A27A04	Primary Tumor	Illumina HiSeq	F2B8E026-1DF9-4F4D-AC47-3FCCFFEC4392	Eye	37.0	9F324851-EAAE-41B8-BB0E-5D5CEB9E5B23	66DC8005-3575-4B72-8C02-4F920BDFD8E3	TCGA-V4-A9EK-01A-11R-A405-07	HG19	TCGA-V4-A9EK	TCGA-UVM		s362	University of North Carolina	Institut Curie	France	NO	T3a	N0		Stage II	A405-07	True
13767.58cfa82fe4b0c9d6adf6b450	58cfa82fe4b0c9d6adf6b450	TCGA-24-2290-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-2290-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-24-2290-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	965.0	1.8	0.15	58cfa82fe4b0c9d6adf6b450	TCGA-24-2290-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-2290-01A	2B14123B-8FCD-402C-9399-4E7C47F20252	Primary Tumor	Illumina HiSeq	91616830-9B90-45BC-BFFC-3B59D4F60505	Ovary	56.0	BBFED693-79E1-4DC7-896E-15B98FC7DBAC	A3173B33-AA16-48A2-B733-0345AAD49755	TCGA-24-2290-01A-01R-1568-13	GRCh37-lite	TCGA-24-2290	TCGA-OV	1102.0	s18123	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa831e4b0c9d6adf6c993	58cfa831e4b0c9d6adf6c993	TCGA-D9-A1JW-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_6_rg.sorted.filtered.	WGS	TCGA-D9-A1JW-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_6_rg.sorted	TCGA-D9-A1JW-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_6_rg.sorted.bam	44.09		0.18	58cfa831e4b0c9d6adf6c993	TCGA-D9-A1JW-10A-01D-A18Z_120517_SN208_0300_BC0VYMACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D9-A1JW-10A	9A903FC2-57D7-4A02-94E7-9B9B7EE99276	Blood Derived Normal	Illumina HiSeq	81b083e1-deb3-4935-b274-bded2a4d47fb	Skin	82.0	7402F1FA-E9DF-45A3-9DD7-B5F82F427F52	790E7D9B-A1E6-40EF-B46D-22E35DAB4E5D	TCGA-D9-A1JW-10A-01D-A18Z-02	HG19_Broad_variant	TCGA-D9-A1JW	TCGA-SKCM		s7673	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T1a	N2a			A18Z-02	True
13722.58cfa82ee4b0c9d6adf6af92	58cfa82ee4b0c9d6adf6af92	TCGA-04-1367-10A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-04-1367-10A-01D-A324-10_wgs_Illumina	TCGA-04-1367-10A-01D-A324-10_wgs_Illumina.bam	673.97	1.9	0.07	58cfa82ee4b0c9d6adf6af92	TCGA-04-1367-10A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1367-10A	30B8F4CD-9245-4496-A8A8-C3E59093BC0A	Blood Derived Normal	Illumina HiSeq	f49ebc21-8fdb-4881-8c66-51e2acc29fe0	Ovary	50.0	3B27CAB3-81F8-4918-B472-57BD5EBD943D	4E1CCB7D-E262-4E93-B08B-8B84E98F8784	TCGA-04-1367-10A-01D-A324-10	GRCh37-lite	TCGA-04-1367	TCGA-OV		s17709	Baylor College of Medicine	Gynecologic Oncology Group	None	NO			Serous Cystadenocarcinoma		A324-10	True
13767.58cfa83be4b0c9d6adf721e8	58cfa83be4b0c9d6adf721e8	UNCID_2585843.032d7100-65e4-4d6b-9e51-ca7c2155e63c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2585843.032d7100-65e4-4d6b-9e51-ca7c2155e63c.sorted_genome_alignments	UNCID_2585843.032d7100-65e4-4d6b-9e51-ca7c2155e63c.sorted_genome_alignments.bam	34.35	1.82	0.16	58cfa83be4b0c9d6adf721e8	UNCID_2585843.032d7100-65e4-4d6b-9e51-ca7c2155e63c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-2G-AAKD-01A	9C947FBA-E570-4A4B-9D16-9496DAE1EE2E	Primary Tumor	Illumina HiSeq	0ADED485-2540-4360-9DC2-74B912CF865F	Testis	18.0	676918EE-96CF-42FB-B989-D899C315564E	032D7100-65E4-4D6B-9E51-CA7C2155E63C	TCGA-2G-AAKD-01A-31R-A430-07	HG19	TCGA-2G-AAKD	TCGA-TGCT		s616	University of North Carolina	Erasmus MC	Netherlands	NO	T2	NX		Stage III	A430-07	True
13767.58cfa838e4b0c9d6adf7063f	58cfa838e4b0c9d6adf7063f	UNCID_1972035.d8f9dd84-aa5a-4f16-af01-8f82699bcd66.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1972035.d8f9dd84-aa5a-4f16-af01-8f82699bcd66.sorted_genome_alignments	UNCID_1972035.d8f9dd84-aa5a-4f16-af01-8f82699bcd66.sorted_genome_alignments.bam	88.8	1.7	0.14	58cfa838e4b0c9d6adf7063f	UNCID_1972035.d8f9dd84-aa5a-4f16-af01-8f82699bcd66.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-DC-6155-01A	EB75CA70-E60F-453F-820C-485390ABAD88	Primary Tumor	Illumina HiSeq	282B7F37-CF2D-4DAE-9EA8-B657ED94D0F8	Colorectal	31.0	7ED983AB-5C6A-42B7-B08E-550702E32A5B	D8F9DD84-AA5A-4F16-AF01-8F82699BCD66	TCGA-DC-6155-01A-11R-1660-07	HG19	TCGA-DC-6155	TCGA-READ		s2258	University of North Carolina	MSKCC	United States	NO	T2	N1b	Rectal Adenocarcinoma	Stage III	1660-07	True
13722.58cfa82ee4b0c9d6adf6ac08	58cfa82ee4b0c9d6adf6ac08	G39019.TCGA-DA-A3F8-10A-01D-A20D-08.3.filtered.	WGS	G39019.TCGA-DA-A3F8-10A-01D-A20D-08.3	G39019.TCGA-DA-A3F8-10A-01D-A20D-08.3.bam	12.11		0.08	58cfa82ee4b0c9d6adf6ac08	G39019.TCGA-DA-A3F8-10A-01D-A20D-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-DA-A3F8-10A	B6691E3C-EE3F-49A2-8BD4-2086413E5D8D	Blood Derived Normal	Illumina HiSeq	d29917b4-2d02-4eaa-89e2-5ba8eb0f0297	Skin	39.0	AA130B28-0388-4CE1-A4E5-EE86BFC6300A	D7B2AEED-1A42-4335-A545-0D284FC5E463	TCGA-DA-A3F8-10A-01D-A20D-08	HG19_Broad_variant	TCGA-DA-A3F8	TCGA-SKCM		s7666	Broad Institute of MIT and Harvard	Yale	United States	NO	T2a	N2b		Stage III	A20D-08	True
13767.58cfa834e4b0c9d6adf6e5fa	58cfa834e4b0c9d6adf6e5fa	UNCID_1201223.d6cb14d4-1ee1-4d83-ad3f-efa19969c00f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1201223.d6cb14d4-1ee1-4d83-ad3f-efa19969c00f.sorted_genome_alignments	UNCID_1201223.d6cb14d4-1ee1-4d83-ad3f-efa19969c00f.sorted_genome_alignments.bam	85.09	1.78	0.15	58cfa834e4b0c9d6adf6e5fa	UNCID_1201223.d6cb14d4-1ee1-4d83-ad3f-efa19969c00f.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BC-A10R-01A	0BF5BBD4-D9E8-42A6-9AB5-F2C174DEC12C	Primary Tumor	Illumina HiSeq	73F69200-3B5D-4858-BA49-5E5AD6CD9CA5	Liver	66.0	995180F2-5AA7-47B9-BB3F-585F94B2457A	D6CB14D4-1EE1-4D83-AD3F-EFA19969C00F	TCGA-BC-A10R-01A-11R-A131-07	HG19	TCGA-BC-A10R	TCGA-LIHC	308.0	s16990	University of North Carolina	UNC	United States	NO	T3	NX	Hepatocellular Carcinoma		A131-07	True
13722.58cfa831e4b0c9d6adf6cb90	58cfa831e4b0c9d6adf6cb90	TCGA-EJ-5508-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EJ-5508-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_2_rg.sorted	TCGA-EJ-5508-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_2_rg.sorted.bam	1081.4	1.9	0.17	58cfa831e4b0c9d6adf6cb90	TCGA-EJ-5508-10A-01D-1573_130308_SN590_0219_BC1UVPACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5508-10A	BD18DD01-D894-4BDD-9CE2-E25705A52A57	Blood Derived Normal	Illumina HiSeq	0d2993b7-024f-4363-9ff1-9d3ce308eca0	Prostate	65.0	8E8F4F4E-5BE8-4372-8DC0-19B70A671E24	40F79B17-FF1D-4EF6-A784-2D6B3952C371	TCGA-EJ-5508-10A-01D-1573-02	HG19_Broad_variant	TCGA-EJ-5508	TCGA-PRAD		s3434	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1573-02	True
13722.58cfa830e4b0c9d6adf6bc7c	58cfa830e4b0c9d6adf6bc7c	TCGA-AP-A0LQ-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-AP-A0LQ-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_5_rg.sorted	TCGA-AP-A0LQ-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_5_rg.sorted.bam	63.33	2.03	0.16	58cfa830e4b0c9d6adf6bc7c	TCGA-AP-A0LQ-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LQ-01A	252500D2-86A3-4090-A57F-1E8C3D44C573	Primary Tumor	Illumina HiSeq	cf355e19-2857-4830-9be8-5053dc9c4d0a	Uterus	59.0	B75648DC-B25B-4EE6-850A-7D1F3A353E83	F8D9DE13-1935-483C-B2F4-B1CD8D61613F	TCGA-AP-A0LQ-01A-12D-A101-02	HG19_Broad_variant	TCGA-AP-A0LQ	TCGA-UCEC		s5000	Harvard Medical School	MSKCC	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa838e4b0c9d6adf709d0	58cfa838e4b0c9d6adf709d0	UNCID_2063285.2807ba60-128f-49fc-9e15-bb3678c12f56.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2063285.2807ba60-128f-49fc-9e15-bb3678c12f56.sorted_genome_alignments	UNCID_2063285.2807ba60-128f-49fc-9e15-bb3678c12f56.sorted_genome_alignments.bam	35.44	1.84	0.16	58cfa838e4b0c9d6adf709d0	UNCID_2063285.2807ba60-128f-49fc-9e15-bb3678c12f56.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-Q1-A5R3-01A	73AA428A-4288-45F8-8A53-CEC173DCC61F	Primary Tumor	Illumina HiSeq	75F74FA8-D8F4-4FBA-BF62-7E840CA8357F	Cervix	56.0	3671D7C8-AF2D-44A8-A3B1-DA74AD6CCDA2	2807BA60-128F-49FC-9E15-BB3678C12F56	TCGA-Q1-A5R3-01A-11R-A28H-07	HG19	TCGA-Q1-A5R3	TCGA-CESC		s1435	University of North Carolina	University of Oklahoma HSC	United States	NO	TX	NX	Cervical Squamous Cell Carcinoma		A28H-07	True
13767.58cfa831e4b0c9d6adf6ca6c	58cfa831e4b0c9d6adf6ca6c	TCGA-D7-A6EX-01A-11R-A31P-31_rnaseq.filtered.	RNA-Seq	TCGA-D7-A6EX-01A-11R-A31P-31_rnaseq	TCGA-D7-A6EX-01A-11R-A31P-31_rnaseq.bam	42.19	2.02	0.18	58cfa831e4b0c9d6adf6ca6c	TCGA-D7-A6EX-01A-11R-A31P-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-A6EX-01A	1B391187-1D9A-4428-BA9A-EF1800F17D3E	Primary Tumor	Illumina HiSeq	D1FF5DCC-0989-4E22-A93F-6197FCB7800A	Stomach	72.0	DC6728A7-2CFB-4A3C-A540-036DFEEF4AB8	CC0EB13B-11CD-4A8D-91D6-9ECE3271976E	TCGA-D7-A6EX-01A-11R-A31P-31	GRCh37-lite	TCGA-D7-A6EX	TCGA-STAD		s14771	Canada's Michael Smith Genome Sciences Centre	Greater Poland Cancer Center	Poland	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	A31P-31	True
13722.58cfa82fe4b0c9d6adf6b808	58cfa82fe4b0c9d6adf6b808	TCGA-44-5643-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_4_rg.sorted.filtered.	WGS	TCGA-44-5643-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_4_rg.sorted	TCGA-44-5643-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_4_rg.sorted.bam	105.7	1.9	0.14	58cfa82fe4b0c9d6adf6b808	TCGA-44-5643-11A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_4_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-5643-11A	27FCEEC1-3298-4CDD-A4E6-8F5CF34604F0	Solid Tissue Normal	Illumina HiSeq	7f469523-6155-4b35-86b7-4dd7791a1ea5	Lung	53.0	57F5E960-B2D3-41ED-A062-DC21ABA0E07B	320B802D-2F12-4C61-A021-E3B66486F1CE	TCGA-44-5643-11A-01D-1623-02	HG19_Broad_variant	TCGA-44-5643	TCGA-LUAD		s11230	Harvard Medical School	Christiana Healthcare	United States	NO	T2b	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1623-02	True
13722.58cfa82ee4b0c9d6adf6aaa8	58cfa82ee4b0c9d6adf6aaa8	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.filtered.	WGS	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.bam	59.04	1.91	0.08	58cfa82ee4b0c9d6adf6aaa8	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A5-01A	904A8757-E0C5-41EF-B583-C8F170CAAAC1	Primary Tumor	Illumina HiSeq	bc2dfa86-f2b0-4747-beb4-8940c4a6c000	Bladder	79.0	A9EF3EC5-B1C1-481F-89CF-1729FAB50173	448FE471-3F4E-4DC8-A4E0-6F147DC93ABE	TCGA-DK-A1A5-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A5	TCGA-BLCA	65.0	s3253	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A13W-08	True
13767.58cfa838e4b0c9d6adf70a3a	58cfa838e4b0c9d6adf70a3a	UNCID_2061330.9cf2d1c9-90c2-46a5-bdf2-ff27745b7808.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2061330.9cf2d1c9-90c2-46a5-bdf2-ff27745b7808.sorted_genome_alignments	UNCID_2061330.9cf2d1c9-90c2-46a5-bdf2-ff27745b7808.sorted_genome_alignments.bam	19.84	1.89	0.18	58cfa838e4b0c9d6adf70a3a	UNCID_2061330.9cf2d1c9-90c2-46a5-bdf2-ff27745b7808.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-A4ZK-01A	A77675BD-ED25-45F4-B418-CB8FC979C780	Primary Tumor	Illumina HiSeq	AF4078EF-C9A5-4C75-BFDF-0B72669D9880	Lung	76.0	439FB36E-6505-4FDC-9E00-05925D3BB2F6	9CF2D1C9-90C2-46A5-BDF2-FF27745B7808	TCGA-56-A4ZK-01A-11R-A262-07	HG19	TCGA-56-A4ZK	TCGA-LUSC		s10050	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	A262-07	True
13767.58cfa837e4b0c9d6adf703a8	58cfa837e4b0c9d6adf703a8	UNCID_1861499.8220b852-fe5f-4dcb-bd92-bfee5147cacf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1861499.8220b852-fe5f-4dcb-bd92-bfee5147cacf.sorted_genome_alignments	UNCID_1861499.8220b852-fe5f-4dcb-bd92-bfee5147cacf.sorted_genome_alignments.bam	82.2	1.8	0.15	58cfa837e4b0c9d6adf703a8	UNCID_1861499.8220b852-fe5f-4dcb-bd92-bfee5147cacf.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-F4-6807-01A	9382987C-B5B3-48FE-8194-4D83FE340CD0	Primary Tumor	Illumina HiSeq	9A8BC7DC-0B2E-4522-B6E2-CE68C79C7C33	Colorectal	51.0	0985B9CE-B40A-40E1-B965-C52D69BFE76B	8220B852-FE5F-4DCB-BD92-BFEE5147CACF	TCGA-F4-6807-01A-11R-1839-07	HG19	TCGA-F4-6807	TCGA-COAD		s13272	University of North Carolina	Asterand	Russia	NO	T3	N2b	Colon Adenocarcinoma	Stage III	1839-07	True
13767.58cfa833e4b0c9d6adf6db74	58cfa833e4b0c9d6adf6db74	UNCID_1098631.8ccc7a37-a9a4-4d77-9126-c8513c20bb29.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1098631.8ccc7a37-a9a4-4d77-9126-c8513c20bb29.sorted_genome_alignments	UNCID_1098631.8ccc7a37-a9a4-4d77-9126-c8513c20bb29.sorted_genome_alignments.bam	65.2	1.7	0.15	58cfa833e4b0c9d6adf6db74	UNCID_1098631.8ccc7a37-a9a4-4d77-9126-c8513c20bb29.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6836-01A	0B31DBDF-0623-48E4-A0EC-017650DCEDA7	Primary Tumor	Illumina HiSeq	19691BC9-B5A1-4234-92B7-020ACF06B71E	Lung	52.0	49A0AB8A-F379-4394-ACCF-0B4B08D2DCC6	8CCC7A37-A9A4-4D77-9126-C8513C20BB29	TCGA-91-6836-01A-21R-1858-07	HG19	TCGA-91-6836	TCGA-LUAD		s11026	University of North Carolina	ABS - IUPUI	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1858-07	True
13767.58cfa838e4b0c9d6adf70684	58cfa838e4b0c9d6adf70684	UNCID_1967385.887b3624-2609-4928-9b17-d6e82cc4baa5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1967385.887b3624-2609-4928-9b17-d6e82cc4baa5.sorted_genome_alignments	UNCID_1967385.887b3624-2609-4928-9b17-d6e82cc4baa5.sorted_genome_alignments.bam	41.0	1.79	0.18	58cfa838e4b0c9d6adf70684	UNCID_1967385.887b3624-2609-4928-9b17-d6e82cc4baa5.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-KC-A4BN-01A	5A468990-D76D-4C67-8437-62689B593AE2	Primary Tumor	Illumina HiSeq	7ED5BCA8-6938-4A31-A95C-BF264A3E596D	Prostate	55.0	D724F384-0640-4143-9CD0-9A387A257CEC	887B3624-2609-4928-9B17-D6E82CC4BAA5	TCGA-KC-A4BN-01A-61R-A250-07	HG19	TCGA-KC-A4BN	TCGA-PRAD		s3863	University of North Carolina	Cornell Medical College	United States	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type		A250-07	True
13767.58cfa838e4b0c9d6adf70a32	58cfa838e4b0c9d6adf70a32	UNCID_2055019.9ecc833d-b92d-474a-a981-d6e0c12292e0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2055019.9ecc833d-b92d-474a-a981-d6e0c12292e0.sorted_genome_alignments	UNCID_2055019.9ecc833d-b92d-474a-a981-d6e0c12292e0.sorted_genome_alignments.bam	66.74	1.79	0.15	58cfa838e4b0c9d6adf70a32	UNCID_2055019.9ecc833d-b92d-474a-a981-d6e0c12292e0.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A5O9-01A	1636242C-12DA-412E-A362-914A20ADD708	Primary Tumor	Illumina HiSeq	5632CE47-9B37-4A99-80FC-553A09BCDA13	Cervix	39.0	8E088A1E-D5DD-4B3C-A520-DD7FBC716D00	9ECC833D-B92D-474A-A981-D6E0C12292E0	TCGA-EA-A5O9-01A-11R-A28H-07	HG19	TCGA-EA-A5O9	TCGA-CESC		s1269	University of North Carolina	Asterand	Ukraine	NO	T1b2	N0	Cervical Squamous Cell Carcinoma		A28H-07	True
13722.58cfa82ee4b0c9d6adf6a8c5	58cfa82ee4b0c9d6adf6a8c5	G26391.TCGA-26-5135-10A-01D-1486-08.1.filtered.	WGS	G26391.TCGA-26-5135-10A-01D-1486-08.1	G26391.TCGA-26-5135-10A-01D-1486-08.1.bam	1134.03	1.9	0.05	58cfa82ee4b0c9d6adf6a8c5	G26391.TCGA-26-5135-10A-01D-1486-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-26-5135-10A	69D56F2D-6924-409B-9D1E-C8D69B400270	Blood Derived Normal	Illumina HiSeq	8e72e896-81dd-423e-9281-48ba03a34a81	Brain	72.0	CD1E6F91-F07B-4804-B8C9-A03DB048C1B1	8F36AD24-C425-4474-9D03-A5198E2E4901	TCGA-26-5135-10A-01D-1486-08	HG19_Broad_variant	TCGA-26-5135	TCGA-GBM	270.0	s13980	Broad Institute of MIT and Harvard	University of Florida	None	NO			Untreated primary (de novo) GBM		1486-08	False
13722.58cfa831e4b0c9d6adf6c50e	58cfa831e4b0c9d6adf6c50e	TCGA-CH-5771-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CH-5771-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_8_rg.sorted	TCGA-CH-5771-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_8_rg.sorted.bam	129.7	2.0	0.13	58cfa831e4b0c9d6adf6c50e	TCGA-CH-5771-11A-01D-1572_130104_SN208_0446_BD1KR5ACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5771-11A	3ACD8328-76F7-4F43-9660-394B95748C3D	Solid Tissue Normal	Illumina HiSeq	353ba45f-47db-42c5-bb67-3baf1e0a1733	Prostate	63.0	3BAC387D-1199-4842-863C-8BCC09EFBF3F	6C19FDB0-3E90-4740-8660-263965F296B2	TCGA-CH-5771-11A-01D-1572-02	HG19_Broad_variant	TCGA-CH-5771	TCGA-PRAD		s3773	Harvard Medical School	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		1572-02	True
13722.58cfa82fe4b0c9d6adf6b58d	58cfa82fe4b0c9d6adf6b58d	TCGA-29-1707-01A-01D-0926-12_Illumina.filtered.	WGS	TCGA-29-1707-01A-01D-0926-12_Illumina	TCGA-29-1707-01A-01D-0926-12_Illumina.bam	162.7	1.9	0.17	58cfa82fe4b0c9d6adf6b58d	TCGA-29-1707-01A-01D-0926-12_Illumina.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1707-01A	7FD6AB8A-201E-431D-A886-6AB553B6CA36	Primary Tumor	Illumina HiSeq	a4acbdd6-5aa4-4824-bc5b-55b505b69d8d	Ovary	41.0	64B5EB1A-1D6E-477E-A33B-C9A4546DAEF3	08CD6E0B-DB36-4479-883F-8E3337F7E3A2	TCGA-29-1707-01A-01D-0926-12	NCBI36_BCM_variant	TCGA-29-1707	TCGA-OV		s18004	Baylor College of Medicine	Duke	None	NO			Serous Cystadenocarcinoma		0926-12	True
13767.58cfa833e4b0c9d6adf6dc79	58cfa833e4b0c9d6adf6dc79	UNCID_1126242.e88bcf68-e904-4511-92f6-01cbd0da62de.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1126242.e88bcf68-e904-4511-92f6-01cbd0da62de.sorted_genome_alignments	UNCID_1126242.e88bcf68-e904-4511-92f6-01cbd0da62de.sorted_genome_alignments.bam	28.79	1.88	0.15	58cfa833e4b0c9d6adf6dc79	UNCID_1126242.e88bcf68-e904-4511-92f6-01cbd0da62de.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DT-01A	74F31744-0AED-4633-BEEC-4E203315F0B7	Primary Tumor	Illumina HiSeq	B81A0DF3-4D5E-4377-91C8-CCC0B96741A4	Breast	41.0	EB11D414-2F0E-44A1-843C-ECACC7212E91	E88BCF68-E904-4511-92F6-01CBD0DA62DE	TCGA-BH-A0DT-01A-21R-A12D-07	HG19	TCGA-BH-A0DT	TCGA-BRCA		s5836	University of North Carolina	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage II	A12D-07	True
13767.58cfa83ae4b0c9d6adf71cc0	58cfa83ae4b0c9d6adf71cc0	UNCID_2509845.bd7c10f2-12d7-4405-a3bc-0809237dcb85.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2509845.bd7c10f2-12d7-4405-a3bc-0809237dcb85.sorted_genome_alignments	UNCID_2509845.bd7c10f2-12d7-4405-a3bc-0809237dcb85.sorted_genome_alignments.bam	54.24	1.86	0.18	58cfa83ae4b0c9d6adf71cc0	UNCID_2509845.bd7c10f2-12d7-4405-a3bc-0809237dcb85.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-ZF-A9RM-01A	7D71945A-B81A-405C-BB17-CEC9B1D7592C	Primary Tumor	Illumina HiSeq	E5CA18B1-DC3F-4460-823B-7DD4344D8799	Bladder	70.0	6167B47F-C0ED-4AAF-AF10-271EEF31B663	BD7C10F2-12D7-4405-A3BC-0809237DCB85	TCGA-ZF-A9RM-01A-11R-A38B-07	HG19	TCGA-ZF-A9RM	TCGA-BLCA		s3383	University of North Carolina	University of Sheffield	United Kingdom	NO	T0	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A38B-07	True
13767.58cfa835e4b0c9d6adf6ee7c	58cfa835e4b0c9d6adf6ee7c	UNCID_1415794.d4cd474d-abe3-423c-9772-a8edce3bb8c7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1415794.d4cd474d-abe3-423c-9772-a8edce3bb8c7.sorted_genome_alignments	UNCID_1415794.d4cd474d-abe3-423c-9772-a8edce3bb8c7.sorted_genome_alignments.bam	62.8	1.8	0.15	58cfa835e4b0c9d6adf6ee7c	UNCID_1415794.d4cd474d-abe3-423c-9772-a8edce3bb8c7.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6403-01A	8DAA29C0-F652-4130-A004-5183BBE30C63	Primary Tumor	Illumina HiSeq	34E4DAD9-5C18-4F19-9A86-602EA71B5F42	Brain	60.0	664226B3-6C8B-4E0A-A75B-955D65E62DA9	D4CD474D-ABE3-423C-9772-A8EDCE3BB8C7	TCGA-DU-6403-01A-11R-1708-07	HG19	TCGA-DU-6403	TCGA-LGG	354.0	s8166	University of North Carolina	Henry Ford Hospital	United States	NO			Oligoastrocytoma		1708-07	True
13722.58cfa82fe4b0c9d6adf6b756	58cfa82fe4b0c9d6adf6b756	TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted.filtered.	WGS	TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted	TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted.bam	328.7	1.9	0.14	58cfa82fe4b0c9d6adf6b756	TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6835-01A	2F09479F-87FC-4C34-8E2C-333E970A3681	Primary Tumor	Illumina HiSeq	8c5e1a0f-e9a8-4ce4-b066-97b2040c5327	Lung	81.0	EFD3F14F-F785-4AEC-9EFD-6DD8E9C41EBA	A4DC40A6-EE0F-4637-937F-406F5FC8579F	TCGA-91-6835-01A-11D-1853-02	HG19_Broad_variant	TCGA-91-6835	TCGA-LUAD		s10913	Harvard Medical School	ABS - IUPUI	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1853-02	True
13767.58cfa83ce4b0c9d6adf72c8a	58cfa83ce4b0c9d6adf72c8a	UNCID_399985.d0100b1d-9fa8-46b6-94f0-af3f9e747972.110712_UNC12-SN629_0108_AC0402ABXX.2.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_399985.d0100b1d-9fa8-46b6-94f0-af3f9e747972.110712_UNC12-SN629_0108_AC0402ABXX.2.trimmed.annotated.translated_to_genomic	UNCID_399985.d0100b1d-9fa8-46b6-94f0-af3f9e747972.110712_UNC12-SN629_0108_AC0402ABXX.2.trimmed.annotated.translated_to_genomic.bam	63.63	1.6	0.15	58cfa83ce4b0c9d6adf72c8a	UNCID_399985.d0100b1d-9fa8-46b6-94f0-af3f9e747972.110712_UNC12-SN629_0108_AC0402ABXX.2.trimmed.annotated.translated_to_genomic.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4920-01A	73C712FE-54D6-4743-90BB-03313EB9FA77	Primary Tumor	Illumina HiSeq	7A9C81B1-91C0-4379-A0A1-2FAF690C9254	Kidney	64.0	DF548CB7-7766-47E9-AAFA-D8EC610AB3DB	D0100B1D-9FA8-46B6-94F0-AF3F9E747972	TCGA-CJ-4920-01A-01R-1426-07	HG19	TCGA-CJ-4920	TCGA-KIRC	139.0	s9545	University of North Carolina	MD Anderson Cancer Center	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1426-07	True
13767.58cfa838e4b0c9d6adf70ca2	58cfa838e4b0c9d6adf70ca2	UNCID_2166293.b660dd38-f986-4143-9445-b66cb60f42dd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2166293.b660dd38-f986-4143-9445-b66cb60f42dd.sorted_genome_alignments	UNCID_2166293.b660dd38-f986-4143-9445-b66cb60f42dd.sorted_genome_alignments.bam	62.63	1.92	0.17	58cfa838e4b0c9d6adf70ca2	UNCID_2166293.b660dd38-f986-4143-9445-b66cb60f42dd.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A6I3-01A	ACF6BDF3-6349-49DC-B99A-4EDA648EEAC5	Primary Tumor	Illumina HiSeq	B5D12313-3D6D-4091-8133-319A10145720	Bladder	90.0	E1A1B0FA-4CAE-4542-9DFB-0A7569BD60F3	B660DD38-F986-4143-9445-B66CB60F42DD	TCGA-GC-A6I3-01A-11R-A31N-07	HG19	TCGA-GC-A6I3	TCGA-BLCA		s2790	University of North Carolina	International Genomics Consortium	United States	NO	T3a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A31N-07	True
13767.58cfa838e4b0c9d6adf706bc	58cfa838e4b0c9d6adf706bc	UNCID_1980993.276b4801-2b93-4224-99a2-d3fb73fca361.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1980993.276b4801-2b93-4224-99a2-d3fb73fca361.sorted_genome_alignments	UNCID_1980993.276b4801-2b93-4224-99a2-d3fb73fca361.sorted_genome_alignments.bam	20.72	1.82	0.16	58cfa838e4b0c9d6adf706bc	UNCID_1980993.276b4801-2b93-4224-99a2-d3fb73fca361.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-A4XF-01A	40587B69-0F62-4A2A-88CB-1BD711377F19	Primary Tumor	Illumina HiSeq	C52339C9-A212-48D2-BD3F-D01633CBD728	Brain	41.0	F39A5F9D-0747-44AF-8575-D86361FC04BA	276B4801-2B93-4224-99A2-D3FB73FCA361	TCGA-DB-A4XF-01A-11R-A27Q-07	HG19	TCGA-DB-A4XF	TCGA-LGG		s8439	University of North Carolina	Mayo Clinic - Rochester	United States	NO			Astrocytoma		A27Q-07	True
13722.58cfa832e4b0c9d6adf6ce02	58cfa832e4b0c9d6adf6ce02	TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted	TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted.bam	248.7	1.9	0.14	58cfa832e4b0c9d6adf6ce02	TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5524-01A	4048C139-1329-4E6A-8D2F-C0AA104A68EE	Primary Tumor	Illumina HiSeq	bc7b862d-c88b-41f2-9061-6c4895d6b5be	Prostate	57.0	C197A81D-2AA5-4285-88E3-761798E2C190	4B173FC3-DBE0-47AA-8ACC-D36466B5522D	TCGA-EJ-5524-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5524	TCGA-PRAD		s3435	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1572-02	True
13767.58cfa838e4b0c9d6adf70f5a	58cfa838e4b0c9d6adf70f5a	UNCID_2193444.accfd874-53de-4771-91e0-55f09b02e597.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2193444.accfd874-53de-4771-91e0-55f09b02e597.sorted_genome_alignments	UNCID_2193444.accfd874-53de-4771-91e0-55f09b02e597.sorted_genome_alignments.bam	37.91	2.12	0.16	58cfa838e4b0c9d6adf70f5a	UNCID_2193444.accfd874-53de-4771-91e0-55f09b02e597.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B1-A657-01A	77657EB5-0C77-4F85-9A5E-9F7071D82155	Primary Tumor	Illumina HiSeq	63170E2A-0CC2-460A-84D9-2BA5F7FB3233	Kidney	54.0	2D5ECE93-2155-4CF0-996C-184E42FC4C0F	ACCFD874-53DE-4771-91E0-55F09B02E597	TCGA-B1-A657-01A-11R-A31O-07	HG19	TCGA-B1-A657	TCGA-KIRP		s11721	University of North Carolina	University of Pittsburgh	United States	NO	T1b	N0	Kidney Papillary Renal Cell Carcinoma	Stage I	A31O-07	True
13722.58cfa83ce4b0c9d6adf73074	58cfa83ce4b0c9d6adf73074	f69f0ef802b7feefa79f55fe3e188902.filtered.	WGS	f69f0ef802b7feefa79f55fe3e188902	f69f0ef802b7feefa79f55fe3e188902.bam	35.42	1.97	0.08	58cfa83ce4b0c9d6adf73074	f69f0ef802b7feefa79f55fe3e188902.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A12Q-01A	A824B3BD-34D5-4CC1-A92F-F9D6AC0F1814	Primary Tumor	Illumina HiSeq	bb80680a-245c-421b-a3ef-198dc78bad1e	Breast	78.0	8867F07E-0993-4C9A-96DF-18E24801BA80	D8C6D4B8-F279-4EDC-AAA3-A1CC266AEC4D	TCGA-C8-A12Q-01A-11D-A19H-09	GRCh37-lite	TCGA-C8-A12Q	TCGA-BRCA		s6108	Washington University School of Medicine	ILSbio	None	NO	T1	N2	Infiltrating Ductal Carcinoma	Stage III	A19H-09	True
13767.58cfa838e4b0c9d6adf70b18	58cfa838e4b0c9d6adf70b18	UNCID_2086813.9fc02f84-548e-42a4-8857-717cd8426575.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2086813.9fc02f84-548e-42a4-8857-717cd8426575.sorted_genome_alignments	UNCID_2086813.9fc02f84-548e-42a4-8857-717cd8426575.sorted_genome_alignments.bam	71.94	1.9	0.17	58cfa838e4b0c9d6adf70b18	UNCID_2086813.9fc02f84-548e-42a4-8857-717cd8426575.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A5SJ-01A	2C8A1E74-33DE-453F-8D1E-E226185E52FC	Primary Tumor	Illumina HiSeq	C333FC56-CEA3-4720-B073-736FA7C640EA	Liver	59.0	74A3B091-F6DE-49FE-BE1D-7E091348DA2C	9FC02F84-548E-42A4-8857-717CD8426575	TCGA-G3-A5SJ-01A-11R-A27V-07	HG19	TCGA-G3-A5SJ	TCGA-LIHC		s16911	University of North Carolina	Alberta Health Services	Canada	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A27V-07	True
13767.58cfa82fe4b0c9d6adf6b2b2	58cfa82fe4b0c9d6adf6b2b2	TCGA-23-1116-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-23-1116-01A-01R-1564-13_rnaseq	TCGA-23-1116-01A-01R-1564-13_rnaseq.bam	305.0	1.8	0.16	58cfa82fe4b0c9d6adf6b2b2	TCGA-23-1116-01A-01R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1116-01A	70FE08BD-A0B4-4A88-B82E-813B176F8E40	Primary Tumor	Illumina HiSeq	516647D1-C8AD-49FB-AFD8-4E5F117BFEA9	Ovary	83.0	91FBC26E-C049-49AF-8307-22C7980079DF	AB28A926-0266-4602-8E90-529934CF43AB	TCGA-23-1116-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-23-1116	TCGA-OV		s17823	Canada's Michael Smith Genome Sciences Centre	Cedars Sinai	None	NO			Serous Cystadenocarcinoma		1564-13	True
13722.58cfa830e4b0c9d6adf6bf6a	58cfa830e4b0c9d6adf6bf6a	TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted	TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted.bam	409.4	1.9	0.16	58cfa830e4b0c9d6adf6bf6a	TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6452-01A	27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9	Primary Tumor	Illumina HiSeq	cfd9aa7a-7f3d-4b70-9359-2c93f0238361	Stomach	78.0	76144F2F-2498-430D-B33C-F000394C427E	460DE564-5AAB-46B0-8174-36AF18D2DF4C	TCGA-BR-6452-01A-12D-1798-02	HG19_Broad_variant	TCGA-BR-6452	TCGA-STAD		s14744	Harvard Medical School	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1798-02	True
13767.58cfa834e4b0c9d6adf6ea1a	58cfa834e4b0c9d6adf6ea1a	UNCID_1269249.f2ad4c22-c476-44af-a8ca-dffcae313ae2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1269249.f2ad4c22-c476-44af-a8ca-dffcae313ae2.sorted_genome_alignments	UNCID_1269249.f2ad4c22-c476-44af-a8ca-dffcae313ae2.sorted_genome_alignments.bam	139.2	1.8	0.15	58cfa834e4b0c9d6adf6ea1a	UNCID_1269249.f2ad4c22-c476-44af-a8ca-dffcae313ae2.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6348-11A	8AD78C4F-C84C-4F9E-88C9-42A05EB65498	Solid Tissue Normal	Illumina HiSeq	71CE1638-2591-4E2D-8AEF-0999BE1D4DC6	Prostate	68.0	90811D39-D677-4955-8B62-ED36DFE86A5B	F2AD4C22-C476-44AF-A8CA-DFFCAE313AE2	TCGA-G9-6348-11A-01R-1789-07	HG19	TCGA-G9-6348	TCGA-PRAD		s4002	University of North Carolina	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		1789-07	True
13767.58cfa837e4b0c9d6adf7012c	58cfa837e4b0c9d6adf7012c	UNCID_1891750.07401514-29ef-43a8-8a7f-a4e147852470.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1891750.07401514-29ef-43a8-8a7f-a4e147852470.sorted_genome_alignments	UNCID_1891750.07401514-29ef-43a8-8a7f-a4e147852470.sorted_genome_alignments.bam	59.6	1.83	0.17	58cfa837e4b0c9d6adf7012c	UNCID_1891750.07401514-29ef-43a8-8a7f-a4e147852470.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A3I0-11A	A8C2AA08-9156-4845-AD77-5E060858C757	Solid Tissue Normal	Illumina HiSeq	FC0B09F0-153A-4D5D-B0E9-1FEED87F8EB5	Liver	76.0	52BCA35C-ECF3-4E3C-8E98-596622B4ADFD	07401514-29EF-43A8-8A7F-A4E147852470	TCGA-FV-A3I0-11A-11R-A22L-07	HG19	TCGA-FV-A3I0	TCGA-LIHC		s16615	University of North Carolina	International Genomics Consortium	United States	NO	T2	NX	Hepatocholangiocarcinoma (Mixed)	Stage II	A22L-07	True
13767.58cfa838e4b0c9d6adf706d0	58cfa838e4b0c9d6adf706d0	UNCID_1983001.f5b03cae-1e62-46aa-9c0b-a2fb62948aed.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1983001.f5b03cae-1e62-46aa-9c0b-a2fb62948aed.sorted_genome_alignments	UNCID_1983001.f5b03cae-1e62-46aa-9c0b-a2fb62948aed.sorted_genome_alignments.bam	24.79	1.83	0.17	58cfa838e4b0c9d6adf706d0	UNCID_1983001.f5b03cae-1e62-46aa-9c0b-a2fb62948aed.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-58-A46M-01A	F37F9827-9C3B-4AED-A2CB-5E905F1E2D2E	Primary Tumor	Illumina HiSeq	74DED989-9E3E-4F0E-AA59-BC9FE6A2CBA5	Lung	61.0	C5CF6CDE-0DB3-40D2-8AC4-2A13484B3442	F5B03CAE-1E62-46AA-9C0B-A2FB62948AED	TCGA-58-A46M-01A-11R-A24H-07	HG19	TCGA-58-A46M	TCGA-LUSC		s10137	University of North Carolina	Thoraxklinik at University Hospital Heidelberg	Germany	NO	T2b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A24H-07	True
13722.58cfa831e4b0c9d6adf6c75a	58cfa831e4b0c9d6adf6c75a	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.bam	127.7	1.9	0.15	58cfa831e4b0c9d6adf6c75a	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6515-01A	8E0E456E-85EE-4DE5-8F0B-72393D6ACDE0	Primary Tumor	Illumina HiSeq	5a79073a-b6a0-41df-b26b-247649784d4d	Head and Neck	82.0	4453D224-F846-4CEE-972F-8438C964913B	D6E287D9-D7C4-496C-829F-F7D7980D77A2	TCGA-D6-6515-01A-21D-1868-02	HG19_Broad_variant	TCGA-D6-6515	TCGA-HNSC	403.0	s15914	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1868-02	True
13767.58cfa838e4b0c9d6adf70c33	58cfa838e4b0c9d6adf70c33	UNCID_2137914.51ce9c93-c640-46fb-891d-b06a98d1f156.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2137914.51ce9c93-c640-46fb-891d-b06a98d1f156.sorted_genome_alignments	UNCID_2137914.51ce9c93-c640-46fb-891d-b06a98d1f156.sorted_genome_alignments.bam	24.68	1.87	0.15	58cfa838e4b0c9d6adf70c33	UNCID_2137914.51ce9c93-c640-46fb-891d-b06a98d1f156.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Carcinosarcoma	Aligned reads	TCGA-N6-A4VE-01A	4F0124A6-4A5B-4E42-B9FF-D7DE51D2148C	Primary Tumor	Illumina HiSeq	FE322461-96AA-4DA9-B14B-7229C3DCBED8	Uterus	84.0	174A5796-B44C-4C98-850E-FECDF2B06759	51CE9C93-C640-46FB-891D-B06A98D1F156	TCGA-N6-A4VE-01A-11R-A28V-07	HG19	TCGA-N6-A4VE	TCGA-UCS	291.0	s78	University of North Carolina	University of Pittsburgh	United States	NO					A28V-07	True
13767.58cfa838e4b0c9d6adf70479	58cfa838e4b0c9d6adf70479	UNCID_1912593.f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1912593.f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238.sorted_genome_alignments	UNCID_1912593.f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238.sorted_genome_alignments.bam	164.2		0.15	58cfa838e4b0c9d6adf70479	UNCID_1912593.f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-8626-01A	A4495428-39CC-49F6-BC41-1BECDD94113F	Primary Tumor	Illumina HiSeq	9D93AB92-2FCC-4B06-8044-D1DDB01DA6F7	Lung	59.0	BBF7C533-2058-4F01-BA33-35EFCEAC3F1C	F9CC97C0-AF9A-4D77-B68E-FCFE9CA9D238	TCGA-56-8626-01A-11R-2403-07	HG19	TCGA-56-8626	TCGA-LUSC		s10563	University of North Carolina	International Genomics Consortium	United States	NO	T1a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2403-07	True
13767.58cfa834e4b0c9d6adf6e8b0	58cfa834e4b0c9d6adf6e8b0	UNCID_1218467.175e3a6e-b748-4db8-982c-02abb8c23991.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1218467.175e3a6e-b748-4db8-982c-02abb8c23991.sorted_genome_alignments	UNCID_1218467.175e3a6e-b748-4db8-982c-02abb8c23991.sorted_genome_alignments.bam	46.25	1.8	0.16	58cfa834e4b0c9d6adf6e8b0	UNCID_1218467.175e3a6e-b748-4db8-982c-02abb8c23991.sorted_genome_alignments.bam	Alive	MALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A1CU-01A	4E80F403-0E10-4725-854D-F023C12EE1E2	Primary Tumor	Illumina HiSeq	3B6F9090-C81D-4BE3-B750-8C8E85E1DEDE	Thyroid	31.0	C285C3AC-26D7-4481-BAAF-769F49AED55A	175E3A6E-B748-4DB8-982C-02ABB8C23991	TCGA-EM-A1CU-01A-11R-A13Y-07	HG19	TCGA-EM-A1CU	TCGA-THCA		s12400	University of North Carolina	University Health Network	Canada	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13Y-07	True
13767.58cfa834e4b0c9d6adf6e0a2	58cfa834e4b0c9d6adf6e0a2	UNCID_1161138.6130b450-8b88-4a9a-b462-a34ec94183c9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1161138.6130b450-8b88-4a9a-b462-a34ec94183c9.sorted_genome_alignments	UNCID_1161138.6130b450-8b88-4a9a-b462-a34ec94183c9.sorted_genome_alignments.bam	16.3	2.27	0.16	58cfa834e4b0c9d6adf6e0a2	UNCID_1161138.6130b450-8b88-4a9a-b462-a34ec94183c9.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A26E-01A	011B9B2D-EBE5-42BF-9662-D922FACCC7A1	Primary Tumor	Illumina HiSeq	AADC9354-FE60-4575-822A-591C69E3DA88	Breast	71.0	D6023F30-0D07-4839-98D1-0B22B366CC51	6130B450-8B88-4A9A-B462-A34EC94183C9	TCGA-A7-A26E-01A-11R-A169-07	HG19	TCGA-A7-A26E	TCGA-BRCA		s6049	University of North Carolina	Christiana Healthcare	United States	NO	T3	N1a	Infiltrating Lobular Carcinoma	Stage III	A169-07	True
13722.58cfa82fe4b0c9d6adf6b842	58cfa82fe4b0c9d6adf6b842	TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	260.29	1.9	0.14	58cfa82fe4b0c9d6adf6b842	TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2674-01A	57CDAA1C-4E94-4A28-AB3B-300C0457555F	Primary Tumor	Illumina HiSeq	92b3a16b-1a9e-47a3-9146-1a297c51c5a3	Colorectal	71.0	8ACA008C-F55A-420A-82C7-ACD2CCA77D85	9FDFC199-B878-4049-994E-B5CA384678FB	TCGA-A6-2674-01A-02D-1167-02	HG18	TCGA-A6-2674	TCGA-COAD		s13013	Harvard Medical School	Christiana Healthcare	None	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage IV	1167-02	True
13722.58cfa830e4b0c9d6adf6c13e	58cfa830e4b0c9d6adf6c13e	TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina	TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina.bam	19.16		0.08	58cfa830e4b0c9d6adf6c13e	TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-A44B-01A	B809C2F2-185C-496A-A1D4-589294443A1D	Primary Tumor	Illumina HiSeq	148c4a68-bab6-4ff6-bcd7-fc69c33bea94	Kidney	70.0	07C08E8F-4DCA-42E4-9954-C62C32FED225	88E35D25-D98D-4576-8EBE-1CD74010ECD8	TCGA-B9-A44B-01A-11D-A25F-10	GRCh37-lite	TCGA-B9-A44B	TCGA-KIRP		s11860	Baylor College of Medicine	UNC	United States	NO	T3b	NX	Kidney Papillary Renal Cell Carcinoma	Stage III	A25F-10	True
13722.58cfa82fe4b0c9d6adf6b624	58cfa82fe4b0c9d6adf6b624	TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted.filtered.	WGS	TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted	TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted.bam	692.7	1.9	0.15	58cfa82fe4b0c9d6adf6b624	TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-75-5146-01A	1D276B62-5E64-48FB-B2CE-5192B511FE37	Primary Tumor	Illumina HiSeq	926ac8ca-ff8f-4822-bf62-819bf5525a5d	Lung		373C5231-B6AE-49DB-AC0D-D674A0C9C100	2578C781-0BDF-4CA2-A8FA-8B624489818B	TCGA-75-5146-01A-01D-1623-02	HG19_Broad_variant	TCGA-75-5146	TCGA-LUAD		s10668	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1623-02	True
13722.58cfa830e4b0c9d6adf6bdd0	58cfa830e4b0c9d6adf6bdd0	TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted	TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted.bam	8.18	2.06	0.13	58cfa830e4b0c9d6adf6bdd0	TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0GY-10A	7D9D3522-EC3B-4EFE-8C8E-C0E675276EF5	Blood Derived Normal	Illumina HiSeq	2e13622c-8cd4-44aa-a010-0de1e4dbcbee	Breast	67.0	CD531C9F-A0E9-498A-9032-42040EC975DE	A9C89A38-C132-4BA7-A2D4-26B3184AA047	TCGA-BH-A0GY-10A-01D-A060-02	HG19_Broad_variant	TCGA-BH-A0GY	TCGA-BRCA		s6918	Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A060-02	True
13767.58cfa838e4b0c9d6adf7076f	58cfa838e4b0c9d6adf7076f	UNCID_2009606.bbc5dea9-50e1-44b7-9d43-82896b9229b5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2009606.bbc5dea9-50e1-44b7-9d43-82896b9229b5.sorted_genome_alignments	UNCID_2009606.bbc5dea9-50e1-44b7-9d43-82896b9229b5.sorted_genome_alignments.bam	30.61	1.89	0.18	58cfa838e4b0c9d6adf7076f	UNCID_2009606.bbc5dea9-50e1-44b7-9d43-82896b9229b5.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-KK-A59Z-01A	DF7BBD9C-0B35-4855-ACDE-46F4956F4DF1	Primary Tumor	Illumina HiSeq	481409A3-9A3B-4B00-A693-47C45C0D582C	Prostate	66.0	CE99D7F7-F2BC-4246-8849-4752353475B3	BBC5DEA9-50E1-44B7-9D43-82896B9229B5	TCGA-KK-A59Z-01A-12R-A26U-07	HG19	TCGA-KK-A59Z	TCGA-PRAD		s3691	University of North Carolina	MD Anderson Cancer Center	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		A26U-07	True
13722.58cfa831e4b0c9d6adf6c79e	58cfa831e4b0c9d6adf6c79e	TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted	TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted.bam	473.7	1.9	0.17	58cfa831e4b0c9d6adf6c79e	TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6019-10A	EE3061EC-273C-4BEF-A325-35E9C469BF01	Blood Derived Normal	Illumina HiSeq	7b49ae2c-674f-4f8f-b99b-fd2884c78a1b	Head and Neck	61.0	71ABA174-1006-4B0E-96FA-EF1BF171314B	2138A253-33D1-4402-8F65-BBE6F609AB58	TCGA-CN-6019-10A-01D-1681-02	HG19_Broad_variant	TCGA-CN-6019	TCGA-HNSC		s15761	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IV	1681-02	True
13722.58cfa830e4b0c9d6adf6c02c	58cfa830e4b0c9d6adf6c02c	TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted	TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.bam	26.88	1.91	0.16	58cfa830e4b0c9d6adf6c02c	TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZC-01A	6675C581-297D-44CD-B80F-AE7E53D48228	Primary Tumor	Illumina HiSeq	a470b305-96a5-43a8-b1f4-db15c7b0b4d5	Thyroid	55.0	1F945AFF-7BC2-40F5-87DB-92313E541243	0E4A0528-883D-47A5-B399-57B1B15EC412	TCGA-BJ-A0ZC-01A-12D-A13U-02	HG19_Broad_variant	TCGA-BJ-A0ZC	TCGA-THCA		s12232	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13U-02	True
13722.58cfa830e4b0c9d6adf6bb8a	58cfa830e4b0c9d6adf6bb8a	TCGA-AA-A00R-10A-01D-A126-10_hg19_wgs_Illumina.filtered.	WGS	TCGA-AA-A00R-10A-01D-A126-10_hg19_wgs_Illumina	TCGA-AA-A00R-10A-01D-A126-10_hg19_wgs_Illumina.bam	44.4	1.73	0.08	58cfa830e4b0c9d6adf6bb8a	TCGA-AA-A00R-10A-01D-A126-10_hg19_wgs_Illumina.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00R-10A	CA22EDD4-EB7C-4677-84AA-6F0354459A19	Blood Derived Normal	Illumina HiSeq	42955a5e-a807-4ee3-82db-e48b37ae1db5	Colorectal	64.0	610F87EF-BAC9-4B0F-BE44-A61B3FBBCBEF	5E84FC1E-F5D1-4CFA-B23B-8E826F8A9EF5	TCGA-AA-A00R-10A-01D-A126-10	GRCh37-lite	TCGA-AA-A00R	TCGA-COAD		s12868	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A126-10	False
13722.58cfa82ee4b0c9d6adf6a988	58cfa82ee4b0c9d6adf6a988	G35154.TCGA-DU-6407-02A-12D-A36O-08.2.filtered.	WGS	G35154.TCGA-DU-6407-02A-12D-A36O-08.2	G35154.TCGA-DU-6407-02A-12D-A36O-08.2.bam	8.83		0.09	58cfa82ee4b0c9d6adf6a988	G35154.TCGA-DU-6407-02A-12D-A36O-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6407-02A	70939245-41E0-4845-A473-5FEF719B9828	Recurrent Tumor	Illumina HiSeq	5c3c83f3-c65b-4c23-99d4-64183122fe2c	Brain	35.0	C6DF9292-94A9-4804-B1D7-A471AFA1DADE	1C4E4BCA-3C01-4651-9F8B-509196553AEB	TCGA-DU-6407-02A-12D-A36O-08	HG19_Broad_variant	TCGA-DU-6407	TCGA-LGG	2875.0	s8540	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO			Oligodendroglioma		A36O-08	True
13767.58cfa833e4b0c9d6adf6e034	58cfa833e4b0c9d6adf6e034	UNCID_1142329.222c7e4d-f6ed-4db0-ba36-1670159cee1b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1142329.222c7e4d-f6ed-4db0-ba36-1670159cee1b.sorted_genome_alignments	UNCID_1142329.222c7e4d-f6ed-4db0-ba36-1670159cee1b.sorted_genome_alignments.bam	13.54	1.81	0.15	58cfa833e4b0c9d6adf6e034	UNCID_1142329.222c7e4d-f6ed-4db0-ba36-1670159cee1b.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A12E-01A	2CBEADFF-A8A3-4787-9D4E-F6B74C3AB5D9	Primary Tumor	Illumina HiSeq	FAC285B5-DE82-4D81-BBA5-6A03651DA34D	Breast	51.0	A869827A-F639-4CBF-8EFB-1A5F00ED2D0A	222C7E4D-F6ED-4DB0-BA36-1670159CEE1B	TCGA-AO-A12E-01A-11R-A10J-07	HG19	TCGA-AO-A12E	TCGA-BRCA		s6348	University of North Carolina	MSKCC	None	NO	T3	N0 (i+)	Infiltrating Lobular Carcinoma	Stage II	A10J-07	True
13767.58cfa837e4b0c9d6adf6fe10	58cfa837e4b0c9d6adf6fe10	UNCID_1729798.0fbc9c35-cfb7-40dc-8b00-8322eb00ffc9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1729798.0fbc9c35-cfb7-40dc-8b00-8322eb00ffc9.sorted_genome_alignments	UNCID_1729798.0fbc9c35-cfb7-40dc-8b00-8322eb00ffc9.sorted_genome_alignments.bam	22.64	1.87	0.15	58cfa837e4b0c9d6adf6fe10	UNCID_1729798.0fbc9c35-cfb7-40dc-8b00-8322eb00ffc9.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A45D-01A	E7CF1CCA-384E-4A00-BB30-BED154EC15C0	Primary Tumor	Illumina HiSeq	BAB63940-257D-4AF2-A6AD-2F63A84153AB	Thyroid	36.0	A8250761-DA38-4337-A276-056347C96ED2	0FBC9C35-CFB7-40DC-8B00-8322EB00FFC9	TCGA-BJ-A45D-01A-11R-A23W-07	HG19	TCGA-BJ-A45D	TCGA-THCA		s12317	University of North Carolina	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A23W-07	True
13767.58cfa83ce4b0c9d6adf73038	58cfa83ce4b0c9d6adf73038	_1_TCGA-BR-6707-01A-11R-1884-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-6707-01A-11R-1884-13_rnaseq	_1_TCGA-BR-6707-01A-11R-1884-13_rnaseq.bam	247.2	1.8	0.16	58cfa83ce4b0c9d6adf73038	_1_TCGA-BR-6707-01A-11R-1884-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6707-01A	DF3DF249-86C2-43D4-ABE1-796CD7DF653F	Primary Tumor	Illumina HiSeq	839CDFBE-7536-4B44-828D-1314269FCB73	Stomach	75.0	36F691AA-B737-4369-AD62-84F987F697A6	B456BB25-0C74-40CA-AB53-A0DAF5B7E9B0	TCGA-BR-6707-01A-11R-1884-13	GRCh37-lite	TCGA-BR-6707	TCGA-STAD		s15217	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1884-13	True
13722.58cfa832e4b0c9d6adf6d5fc	58cfa832e4b0c9d6adf6d5fc	TCGA-LN-A49N-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_8_rg.sorted.filtered.	WGS	TCGA-LN-A49N-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_8_rg.sorted	TCGA-LN-A49N-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_8_rg.sorted.bam	55.78		0.15	58cfa832e4b0c9d6adf6d5fc	TCGA-LN-A49N-10A-01D-A248_130101_SN590_0206_AC1H8RACXX_s_8_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49N-10A	AE404398-6544-4F3A-8830-44A4A227F8D5	Blood Derived Normal	Illumina HiSeq	aa86a081-bb87-417e-87f5-749a306c5c4e	Esophagus	50.0	DC16E711-F7E7-4E14-8514-A5C27E5A6301	91E04C4D-5947-4A49-A21D-56E02B9DE417	TCGA-LN-A49N-10A-01D-A248-26	HG19_Broad_variant	TCGA-LN-A49N	TCGA-ESCA		s1854	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N1		Stage II	A248-26	True
13767.58cfa82fe4b0c9d6adf6b4ec	58cfa82fe4b0c9d6adf6b4ec	TCGA-25-1318-01A-01R-1565-13_rnaseq.filtered.	RNA-Seq	TCGA-25-1318-01A-01R-1565-13_rnaseq	TCGA-25-1318-01A-01R-1565-13_rnaseq.bam	291.0	1.8	0.15	58cfa82fe4b0c9d6adf6b4ec	TCGA-25-1318-01A-01R-1565-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1318-01A	13319C20-02F6-4B5F-B24F-3D8F4084094C	Primary Tumor	Illumina HiSeq	A099F3A9-2496-41DE-BCDF-105F0D8824D1	Ovary	54.0	CED18B90-CBCC-4593-9EAF-2D91DAA9D756	4D3E0164-1346-4E8E-B478-29BD8B1F1CE5	TCGA-25-1318-01A-01R-1565-13	NCBI36_BCCAGSC_variant	TCGA-25-1318	TCGA-OV	1064.0	s17949	Canada's Michael Smith Genome Sciences Centre	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa834e4b0c9d6adf6e8e8	58cfa834e4b0c9d6adf6e8e8	UNCID_1221183.c063e297-0583-4b7c-b1b9-3aaaae108aa6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1221183.c063e297-0583-4b7c-b1b9-3aaaae108aa6.sorted_genome_alignments	UNCID_1221183.c063e297-0583-4b7c-b1b9-3aaaae108aa6.sorted_genome_alignments.bam	12.86	1.72	0.17	58cfa834e4b0c9d6adf6e8e8	UNCID_1221183.c063e297-0583-4b7c-b1b9-3aaaae108aa6.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A19F-06A	0BB8C284-412B-4BBC-A508-D0A21DB376CD	Metastatic	Illumina HiSeq	41C688B9-1F36-4C67-979D-0CD0A54EC2BE	Skin	82.0	1D1D5FDE-E8B1-4D04-93E0-534FDB964840	C063E297-0583-4B7C-B1B9-3AAAAE108AA6	TCGA-ER-A19F-06A-11R-A18S-07	HG19	TCGA-ER-A19F	TCGA-SKCM	802.0	s7558	University of North Carolina	University of Pittsburgh	United States	NO		N0			A18S-07	True
13767.58cfa834e4b0c9d6adf6e874	58cfa834e4b0c9d6adf6e874	UNCID_1226297.b74b611d-7090-4beb-ae34-13086884a7e3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1226297.b74b611d-7090-4beb-ae34-13086884a7e3.sorted_genome_alignments	UNCID_1226297.b74b611d-7090-4beb-ae34-13086884a7e3.sorted_genome_alignments.bam	138.2	1.7	0.16	58cfa834e4b0c9d6adf6e874	UNCID_1226297.b74b611d-7090-4beb-ae34-13086884a7e3.sorted_genome_alignments.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-75-6206-01A	C4C1469D-752F-42B6-8686-714AD4A8AC97	Primary Tumor	Illumina HiSeq	1659D2A1-3E57-4044-A770-28CF51338BD3	Lung		4AFC6152-819B-4E55-817D-DF8A42EB0D36	B74B611D-7090-4BEB-AE34-13086884A7E3	TCGA-75-6206-01A-11R-1755-07	HG19	TCGA-75-6206	TCGA-LUAD		s11503	University of North Carolina	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1755-07	True
13767.58cfa838e4b0c9d6adf706d2	58cfa838e4b0c9d6adf706d2	UNCID_1983613.7533fbaf-dbbd-4778-b213-741229a58f4c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1983613.7533fbaf-dbbd-4778-b213-741229a58f4c.sorted_genome_alignments	UNCID_1983613.7533fbaf-dbbd-4778-b213-741229a58f4c.sorted_genome_alignments.bam	23.02	1.44	0.16	58cfa838e4b0c9d6adf706d2	UNCID_1983613.7533fbaf-dbbd-4778-b213-741229a58f4c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-A474-01A	AE2C650C-600B-4C58-893B-7FD73D44AF47	Primary Tumor	Illumina HiSeq	B79A51E4-93CA-4026-826A-42D6D7640FFA	Lung	66.0	FF9EEA7A-7817-49BF-BE11-6EE744C1172A	7533FBAF-DBBD-4778-B213-741229A58F4C	TCGA-43-A474-01A-11R-A24H-07	HG19	TCGA-43-A474	TCGA-LUSC		s10574	University of North Carolina	Christiana Healthcare	United States	NO	T2b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A24H-07	True
13767.58cfa83be4b0c9d6adf72a45	58cfa83be4b0c9d6adf72a45	UNCID_368302.TCGA-A3-3378-01A-02R-1325-07.110427_UNC15-SN850_0065_BB09BPABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_368302.TCGA-A3-3378-01A-02R-1325-07.110427_UNC15-SN850_0065_BB09BPABXX.7.trimmed.annotated.translated_to_genomic	UNCID_368302.TCGA-A3-3378-01A-02R-1325-07.110427_UNC15-SN850_0065_BB09BPABXX.7.trimmed.annotated.translated_to_genomic.bam	146.0	1.7	0.15	58cfa83be4b0c9d6adf72a45	UNCID_368302.TCGA-A3-3378-01A-02R-1325-07.110427_UNC15-SN850_0065_BB09BPABXX.7.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3378-01A	798D51FF-182E-406C-8885-8A198D9959D1	Primary Tumor	Illumina HiSeq	2EF5E8C4-5808-4B18-B91C-CF8CD88400FF	Kidney	60.0	101490E4-190B-4F9B-87C7-F2F18D6E3580	E84A4171-7AFF-4496-8442-ABF9ED1AD229	TCGA-A3-3378-01A-02R-1325-07	HG19	TCGA-A3-3378	TCGA-KIRC		s9261	University of North Carolina	International Genomics Consortium	United States	NO	T1	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1325-07	True
13722.58cfa82ee4b0c9d6adf6aa74	58cfa82ee4b0c9d6adf6aa74	G32550.TCGA-EE-A3J5-06A-11D-A20D-08.2.filtered.	WGS	G32550.TCGA-EE-A3J5-06A-11D-A20D-08.2	G32550.TCGA-EE-A3J5-06A-11D-A20D-08.2.bam	42.57		0.08	58cfa82ee4b0c9d6adf6aa74	G32550.TCGA-EE-A3J5-06A-11D-A20D-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A3J5-06A	D6283AB0-9019-4AD2-93AA-2E6B39CD9641	Metastatic	Illumina HiSeq	5cbf3199-cbc6-4578-9d34-210fbc92a3f1	Skin	71.0	5F915D13-4C74-43A6-BCDD-D0B1596E817F	B07BAD52-D44C-4B27-900A-960985BFADEC	TCGA-EE-A3J5-06A-11D-A20D-08	HG19_Broad_variant	TCGA-EE-A3J5	TCGA-SKCM	1124.0	s7478	Broad Institute of MIT and Harvard	University of Sydney	Australia	NO	T4a	N1		Stage III	A20D-08	True
13767.58cfa83ae4b0c9d6adf716fb	58cfa83ae4b0c9d6adf716fb	UNCID_2401551.3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2401551.3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6.sorted_genome_alignments	UNCID_2401551.3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6.sorted_genome_alignments.bam	22.01	1.87	0.17	58cfa83ae4b0c9d6adf716fb	UNCID_2401551.3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-QH-A86X-01A	A96BCA45-ECC7-44F6-ACB6-48B0CEC3DE4D	Primary Tumor	Illumina HiSeq	3604D277-B9FA-4AF0-966A-271E5D6F7F29	Brain	33.0	66CAC82B-7066-4BF9-933D-C9FAAA7B5D50	3C8EBEB7-68EF-4D11-80B0-FC5560DD01D6	TCGA-QH-A86X-01A-11R-A36H-07	HG19	TCGA-QH-A86X	TCGA-LGG		s8507	University of North Carolina	Fondazione-Besta	Italy	NO			Oligodendroglioma		A36H-07	True
13767.58cfa835e4b0c9d6adf6ee3a	58cfa835e4b0c9d6adf6ee3a	UNCID_1381949.42db28fc-4d5f-4b0f-aa86-7d27197c7649.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1381949.42db28fc-4d5f-4b0f-aa86-7d27197c7649.sorted_genome_alignments	UNCID_1381949.42db28fc-4d5f-4b0f-aa86-7d27197c7649.sorted_genome_alignments.bam	32.43	1.83	0.17	58cfa835e4b0c9d6adf6ee3a	UNCID_1381949.42db28fc-4d5f-4b0f-aa86-7d27197c7649.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IK-01A	3F0A0748-9ACC-4D0B-BA18-7C08BD183F86	Primary Tumor	Illumina HiSeq	FF24BA18-F2FD-410C-9DC6-2020A0DE02CD	Bladder	87.0	4FF20C48-29EE-4101-B409-C4573E38CF92	42DB28FC-4D5F-4B0F-AA86-7D27197C7649	TCGA-DK-A3IK-01A-32R-A21D-07	HG19	TCGA-DK-A3IK	TCGA-BLCA		s2959	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A21D-07	True
13722.58cfa82fe4b0c9d6adf6b8fb	58cfa82fe4b0c9d6adf6b8fb	TCGA-AA-3518-01A-02D-1525-10_Illumina.filtered.	WGS	TCGA-AA-3518-01A-02D-1525-10_Illumina	TCGA-AA-3518-01A-02D-1525-10_Illumina.bam	3.86	1.9	0.05	58cfa82fe4b0c9d6adf6b8fb	TCGA-AA-3518-01A-02D-1525-10_Illumina.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-3518-01A	C5C4A0A5-900D-483D-9282-475654D63265	Primary Tumor	Illumina HiSeq	7d2638fc-9574-4f2a-baf2-495e6ba99e93	Colorectal	81.0	BC08B757-ED0A-44C0-88CD-85496BB72A75	F4B9D98F-7B76-4EAA-9595-10B0973D5FF7	TCGA-AA-3518-01A-02D-1525-10	NCBI36_BCM_variant	TCGA-AA-3518	TCGA-COAD		s13027	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1525-10	True
13767.58cfa833e4b0c9d6adf6d9c2	58cfa833e4b0c9d6adf6d9c2	UNCID_1086505.0d559ef8-c7f0-486a-bfa8-532fd38d993d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1086505.0d559ef8-c7f0-486a-bfa8-532fd38d993d.sorted_genome_alignments	UNCID_1086505.0d559ef8-c7f0-486a-bfa8-532fd38d993d.sorted_genome_alignments.bam	44.3	1.4	0.14	58cfa833e4b0c9d6adf6d9c2	UNCID_1086505.0d559ef8-c7f0-486a-bfa8-532fd38d993d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5177-01A	8F54D854-22EA-4BD0-8CB1-1AB708544095	Primary Tumor	Illumina HiSeq	0446FD85-A6D4-4539-B060-8894EAC57FA3	Kidney	46.0	1C7D1B8B-C755-4B3A-A1E9-F472AA71AE7D	0D559EF8-C7F0-486A-BFA8-532FD38D993D	TCGA-BP-5177-01A-01R-1426-07	HG19	TCGA-BP-5177	TCGA-KIRC		s9460	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1426-07	True
13722.58cfa832e4b0c9d6adf6d2e6	58cfa832e4b0c9d6adf6d2e6	TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina.bam	50.3		0.05	58cfa832e4b0c9d6adf6d2e6	TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8476-01A	4E4FAF51-2CBF-4910-A093-186660E4A19B	Primary Tumor	Illumina HiSeq	bcb52a60-30eb-4af3-8ec1-512d6157e6be	Kidney	47.0	450DFCB0-F059-4427-9A72-EA51DC48956E	5BEBC389-DE0D-45B8-9D2F-6476988C358A	TCGA-KM-8476-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8476	TCGA-KICH		s16391	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T1	NX	Kidney Chromophobe	Stage I	2310-10	True
13722.58cfa831e4b0c9d6adf6c7f8	58cfa831e4b0c9d6adf6c7f8	TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted	TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted.bam	955.03		0.14	58cfa831e4b0c9d6adf6c7f8	TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6998-10A	039788EC-1364-40C7-9E9D-13DC305674E9	Blood Derived Normal	Illumina HiSeq	3bcec620-bcec-4025-afe3-25731e0db2a4	Head and Neck	53.0	5938BBFB-E390-437D-BC1F-BFC0FD6A9497	81C32657-4CBF-41AA-BFD9-7F4D50D33275	TCGA-CN-6998-10A-01D-2317-26	HG19_Broad_variant	TCGA-CN-6998	TCGA-HNSC		s15508	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IV	2317-26	True
13722.58cfa830e4b0c9d6adf6bc3f	58cfa830e4b0c9d6adf6bc3f	TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	111.5	1.95	0.08	58cfa830e4b0c9d6adf6bc3f	TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J4-10A	A9B7D7FE-BE31-4F71-AFEE-C1BFDF511888	Blood Derived Normal	Illumina HiSeq	4d68d5de-7417-49a8-adf6-12b3ccc612c0	Breast	41.0	82BB4CE9-08E3-4EAE-83B6-268225097575	F146C30D-FCE0-49BC-B684-8AD9CCACA7CF	TCGA-AO-A0J4-10A-01D-A128-09	GRCh37-lite	TCGA-AO-A0J4	TCGA-BRCA		s5961	Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A128-09	True
13767.58cfa83be4b0c9d6adf72331	58cfa83be4b0c9d6adf72331	UNCID_2610756.0aad6d2a-1699-4403-8d45-f0b315ec89c7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2610756.0aad6d2a-1699-4403-8d45-f0b315ec89c7.sorted_genome_alignments	UNCID_2610756.0aad6d2a-1699-4403-8d45-f0b315ec89c7.sorted_genome_alignments.bam	31.42	1.84	0.16	58cfa83be4b0c9d6adf72331	UNCID_2610756.0aad6d2a-1699-4403-8d45-f0b315ec89c7.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-LL-A9Q3-01A	6AF6D256-A753-46D2-B611-E4094FF265AA	Primary Tumor	Illumina HiSeq	943277B7-67FF-4C6A-989C-1AB35B709BC9	Breast	69.0	1152AD19-6FB1-4DFE-AF73-B74323A47AC7	0AAD6D2A-1699-4403-8D45-F0B315EC89C7	TCGA-LL-A9Q3-01A-11R-A41B-07	HG19	TCGA-LL-A9Q3	TCGA-BRCA		s6096	University of North Carolina	Candler	United States	NO	T3	N3a	Infiltrating Lobular Carcinoma	Stage III	A41B-07	True
13722.58cfa832e4b0c9d6adf6d384	58cfa832e4b0c9d6adf6d384	TCGA-LN-A4A2-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_6_rg.sorted.filtered.	WGS	TCGA-LN-A4A2-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_6_rg.sorted	TCGA-LN-A4A2-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_6_rg.sorted.bam	55.13		0.16	58cfa832e4b0c9d6adf6d384	TCGA-LN-A4A2-10A-01D-A267_131001_SN1120_0279_AC2DKPACXX_s_6_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A4A2-10A	A91C3F09-5F48-4B54-B669-C768F9FE9682	Blood Derived Normal	Illumina HiSeq	851a5275-b983-4599-85c4-1977d891d109	Esophagus	57.0	837916DC-D5EA-4BA2-99DB-51B8939E11EA	FE78EF12-EB65-4ACC-B5B4-FFADD627B6A0	TCGA-LN-A4A2-10A-01D-A267-26	HG19_Broad_variant	TCGA-LN-A4A2	TCGA-ESCA		s1783	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0		Stage II	A267-26	True
13767.58cfa834e4b0c9d6adf6e172	58cfa834e4b0c9d6adf6e172	UNCID_1167012.874de789-c1c4-4fd3-b45c-e885f62aaeab.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1167012.874de789-c1c4-4fd3-b45c-e885f62aaeab.sorted_genome_alignments	UNCID_1167012.874de789-c1c4-4fd3-b45c-e885f62aaeab.sorted_genome_alignments.bam	29.03	1.61	0.15	58cfa834e4b0c9d6adf6e172	UNCID_1167012.874de789-c1c4-4fd3-b45c-e885f62aaeab.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A1JN-01A	28911B97-42BF-4189-9961-522FC0AEEBC6	Primary Tumor	Illumina HiSeq	81F028E0-DDFA-4344-9680-133C80FEF7DD	Breast	80.0	80265A56-75CA-479D-B92B-4FDAEB18ED17	874DE789-C1C4-4FD3-B45C-E885F62AAEAB	TCGA-D8-A1JN-01A-11R-A13Q-07	HG19	TCGA-D8-A1JN	TCGA-BRCA		s6946	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T3	N3a	Infiltrating Lobular Carcinoma	Stage III	A13Q-07	True
13722.58cfa830e4b0c9d6adf6bd86	58cfa830e4b0c9d6adf6bd86	TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted	TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted.bam	65.42	2.11	0.15	58cfa830e4b0c9d6adf6bd86	TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0LX-01A	AC1D3946-FE6C-4BD8-B02C-638799CB0F67	Primary Tumor	Illumina HiSeq	182220ca-d437-40a2-adeb-d4cb1ce2f284	Uterus	57.0	99CDF3A0-90DC-4992-B75A-11DD41928D43	B294F25A-93D9-49A6-8FD3-6D2B0BBEF27C	TCGA-BG-A0LX-01A-11D-A043-02	HG19_Broad_variant	TCGA-BG-A0LX	TCGA-UCEC		s5218	Harvard Medical School	University of Pittsburgh	None	NO			Endometrioid endometrial adenocarcinoma		A043-02	True
13722.58cfa82de4b0c9d6adf6a47a	58cfa82de4b0c9d6adf6a47a	36b47238be0497f388623d943762497c.filtered.	WGS	36b47238be0497f388623d943762497c	36b47238be0497f388623d943762497c.bam	64.57		0.08	58cfa82de4b0c9d6adf6a47a	36b47238be0497f388623d943762497c.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2R9-01A	00AD0FFE-2105-4829-A495-1C2ACEB5BB31	Primary Tumor	Illumina HiSeq	d25f9f12-7f03-4bbe-befe-f9250955975c	Cervix	58.0	7EFD873D-8165-40F8-A07D-69CFD68A491E	9FF21093-58D7-4B69-AADE-C242A383EA56	TCGA-EK-A2R9-01A-11D-A34H-09	GRCh37-lite	TCGA-EK-A2R9	TCGA-CESC		s1347	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma		A34H-09	True
13767.58cfa835e4b0c9d6adf6ebd8	58cfa835e4b0c9d6adf6ebd8	UNCID_1327159.e1b31092-1532-4072-9085-31625dce207a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1327159.e1b31092-1532-4072-9085-31625dce207a.sorted_genome_alignments	UNCID_1327159.e1b31092-1532-4072-9085-31625dce207a.sorted_genome_alignments.bam	69.33	1.8	0.15	58cfa835e4b0c9d6adf6ebd8	UNCID_1327159.e1b31092-1532-4072-9085-31625dce207a.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-AK-3426-01A	C5265CA6-2CB5-406D-A635-C4C783561107	Primary Tumor	Illumina HiSeq	CC08EEBB-7B13-4A7F-A1D3-43CFAD98BBBC	Kidney	37.0	325C9A60-DFE5-4FE4-BFD1-5393734F49FA	E1B31092-1532-4072-9085-31625DCE207A	TCGA-AK-3426-01A-02R-1325-07	HG19	TCGA-AK-3426	TCGA-KIRC	885.0	s9656	University of North Carolina	Fox Chase	None	NO	T3a	N1	Kidney Clear Cell Renal Carcinoma	Stage III	1325-07	True
13722.58cfa832e4b0c9d6adf6d27e	58cfa832e4b0c9d6adf6d27e	TCGA-IR-A3LA-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_6_rg.sorted.filtered.	WGS	TCGA-IR-A3LA-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_6_rg.sorted	TCGA-IR-A3LA-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_6_rg.sorted.bam	21.13		0.17	58cfa832e4b0c9d6adf6d27e	TCGA-IR-A3LA-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LA-10A	7B8C04D7-824D-493D-8F2C-9ED87A907192	Blood Derived Normal	Illumina HiSeq	5b0c885d-73d4-4af1-9c47-a5d59d6a0664	Cervix	60.0	D0EBB92C-01A5-4486-A39F-6C89187AC640	95138E7D-C1D7-410C-8A64-F28B128A4F24	TCGA-IR-A3LA-10A-01D-A232-26	HG19_Broad_variant	TCGA-IR-A3LA	TCGA-CESC		s1215	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T1b1	N0	Endometrioid Adenocarcinoma of Endocervix		A232-26	True
13767.58cfa837e4b0c9d6adf6ff04	58cfa837e4b0c9d6adf6ff04	UNCID_1783906.45ef09fb-4989-4774-812a-e33937b13621.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1783906.45ef09fb-4989-4774-812a-e33937b13621.sorted_genome_alignments	UNCID_1783906.45ef09fb-4989-4774-812a-e33937b13621.sorted_genome_alignments.bam	205.8	1.8	0.14	58cfa837e4b0c9d6adf6ff04	UNCID_1783906.45ef09fb-4989-4774-812a-e33937b13621.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CK-4952-01A	5342E2E8-1465-4F7B-9450-EF27280F80C7	Primary Tumor	Illumina HiSeq	F6FDEA9E-3F42-4966-A0AA-23166251073E	Colorectal	48.0	88B3045C-BB2E-4AD6-ADBB-B52FABB7B917	45EF09FB-4989-4774-812A-E33937B13621	TCGA-CK-4952-01A-01R-1723-07	HG19	TCGA-CK-4952	TCGA-COAD		s13747	University of North Carolina	Harvard	None	NO	T4	N2	Colon Mucinous Adenocarcinoma	Stage III	1723-07	True
13767.58cfa82ee4b0c9d6adf6a822	58cfa82ee4b0c9d6adf6a822	G17797.TCGA-28-5207-01A-01R-1850-01.4.filtered.	RNA-Seq	G17797.TCGA-28-5207-01A-01R-1850-01.4	G17797.TCGA-28-5207-01A-01R-1850-01.4.bam	93.7	1.8	0.13	58cfa82ee4b0c9d6adf6a822	G17797.TCGA-28-5207-01A-01R-1850-01.4.bam	Dead	MALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-28-5207-01A	D9FCF27F-48E3-43FD-A8CF-3DB246CF4221	Primary Tumor	Illumina HiSeq	90CC44C9-C757-477F-B4EB-9FB05C1ECC96	Brain	71.0	7CABD150-1C5F-47AB-9218-D77B672F5BF4	6251A0DF-D7FF-4A1B-9AA6-7D12EA04BD2C	TCGA-28-5207-01A-01R-1850-01	HG19_Broad_variant	TCGA-28-5207	TCGA-GBM	343.0	s14133	Broad Institute of MIT and Harvard	Cedars Sinai	None	NO			Untreated primary (de novo) GBM		1850-01	True
13722.58cfa82fe4b0c9d6adf6b6ae	58cfa82fe4b0c9d6adf6b6ae	TCGA-29-1705-02A-01D-0926-12_Illumina.filtered.	WGS	TCGA-29-1705-02A-01D-0926-12_Illumina	TCGA-29-1705-02A-01D-0926-12_Illumina.bam	20.0	1.9	0.14	58cfa82fe4b0c9d6adf6b6ae	TCGA-29-1705-02A-01D-0926-12_Illumina.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1705-02A	F9C835DB-2AB6-4BF5-826F-48723493C0EC	Recurrent Tumor	Illumina HiSeq	09c58620-3616-4c48-81b8-2e6fa34352f6	Ovary	47.0	B5163587-A94D-4674-9F11-76A5ADC9151D	49596020-9105-4488-B83C-C629CD1C3B83	TCGA-29-1705-02A-01D-0926-12	NCBI36_BCM_variant	TCGA-29-1705	TCGA-OV	555.0	s17883	Baylor College of Medicine	Duke	None	NO			Serous Cystadenocarcinoma		0926-12	True
13767.58cfa830e4b0c9d6adf6c2e8	58cfa830e4b0c9d6adf6c2e8	TCGA-BR-6705-01A-12R-1884-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-6705-01A-12R-1884-13_rnaseq	TCGA-BR-6705-01A-12R-1884-13_rnaseq.bam	37.2	1.8	0.15	58cfa830e4b0c9d6adf6c2e8	TCGA-BR-6705-01A-12R-1884-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6705-01A	B14F2FCB-E869-475E-BC7C-ADAF6E7E636F	Primary Tumor	Illumina HiSeq	68F93A09-4E1D-4185-AD4F-5CBACB35D623	Stomach	68.0	DB8D0AC1-23B7-49AB-8BB3-44782156F038	9BD078F0-600E-42D0-8D29-FAF44E7BCEEB	TCGA-BR-6705-01A-12R-1884-13	GRCh37-lite	TCGA-BR-6705	TCGA-STAD		s14473	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1884-13	True
13722.58cfa831e4b0c9d6adf6c71e	58cfa831e4b0c9d6adf6c71e	TCGA-D7-6518-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D7-6518-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_3_rg.sorted	TCGA-D7-6518-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_3_rg.sorted.bam	59.4	1.8	0.16	58cfa831e4b0c9d6adf6c71e	TCGA-D7-6518-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6518-01A	40E507FB-E285-424B-A98B-362E47A53E4A	Primary Tumor	Illumina HiSeq	d4c1a136-c2f2-4cac-9b15-79669253b6e8	Stomach	75.0	B6B986E2-6770-4C59-9D0F-AEA3F3BA26E9	2BAFD8B4-962F-411F-89C6-BB5C7E2A1E78	TCGA-D7-6518-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6518	TCGA-STAD		s14994	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage III	1798-02	True
13767.58cfa834e4b0c9d6adf6e0aa	58cfa834e4b0c9d6adf6e0aa	UNCID_1154796.6050d8b9-2d10-4a03-ae57-979cba25bb70.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1154796.6050d8b9-2d10-4a03-ae57-979cba25bb70.sorted_genome_alignments	UNCID_1154796.6050d8b9-2d10-4a03-ae57-979cba25bb70.sorted_genome_alignments.bam	77.38	1.81	0.14	58cfa834e4b0c9d6adf6e0aa	UNCID_1154796.6050d8b9-2d10-4a03-ae57-979cba25bb70.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0AM-01A	00A2D166-78C9-4687-A195-3D6315C27574	Primary Tumor	Illumina HiSeq	30031E51-98E9-4F84-9D97-7079AE50DA1D	Breast	56.0	2E4B5BA3-CCC8-40F6-80AC-EDAEA1685204	6050D8B9-2D10-4A03-AE57-979CBA25BB70	TCGA-AN-A0AM-01A-11R-A034-07	HG19	TCGA-AN-A0AM	TCGA-BRCA		s6034	University of North Carolina	Cureline	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A034-07	True
13767.58cfa83ce4b0c9d6adf73024	58cfa83ce4b0c9d6adf73024	_1_TCGA-FP-8209-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-FP-8209-01A-11R-2343-13_rnaseq	_1_TCGA-FP-8209-01A-11R-2343-13_rnaseq.bam	36.5		0.15	58cfa83ce4b0c9d6adf73024	_1_TCGA-FP-8209-01A-11R-2343-13_rnaseq.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-FP-8209-01A	233CB00F-B470-47FB-AD93-2A1597655ED6	Primary Tumor	Illumina HiSeq	CBA4600A-039F-4BA2-A4C9-D61B69427547	Stomach	49.0	2BB47B77-02FF-4661-A6DB-6BC4A408438C	AC704DF7-3391-49B0-89B3-4647A1B90A84	TCGA-FP-8209-01A-11R-2343-13	GRCh37-lite	TCGA-FP-8209	TCGA-STAD	1811.0	s15031	Canada's Michael Smith Genome Sciences Centre	International Genomics Consortium	United States	NO	T2a	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage I	2343-13	True
13767.58cfa837e4b0c9d6adf6ffcb	58cfa837e4b0c9d6adf6ffcb	UNCID_1802011.b4fe4472-ff04-497b-bd11-f9bab81b2062.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1802011.b4fe4472-ff04-497b-bd11-f9bab81b2062.sorted_genome_alignments	UNCID_1802011.b4fe4472-ff04-497b-bd11-f9bab81b2062.sorted_genome_alignments.bam	47.8	1.8	0.16	58cfa837e4b0c9d6adf6ffcb	UNCID_1802011.b4fe4472-ff04-497b-bd11-f9bab81b2062.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AD-5900-01A	0F008098-D8AA-46DC-8445-CCA59838C582	Primary Tumor	Illumina HiSeq	0D5B7A58-AF15-451E-B7B7-D061DCA742A7	Colorectal	67.0	8824FCD3-242A-47A9-933E-632D5531BD6C	B4FE4472-FF04-497B-BD11-F9BAB81B2062	TCGA-AD-5900-01A-11R-1653-07	HG19	TCGA-AD-5900	TCGA-COAD		s13596	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Colon Mucinous Adenocarcinoma	Stage I	1653-07	True
13767.58cfa838e4b0c9d6adf7069a	58cfa838e4b0c9d6adf7069a	UNCID_1967584.08a5e204-0002-4148-8b87-bbb9b490e825.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1967584.08a5e204-0002-4148-8b87-bbb9b490e825.sorted_genome_alignments	UNCID_1967584.08a5e204-0002-4148-8b87-bbb9b490e825.sorted_genome_alignments.bam	38.8	1.84	0.16	58cfa838e4b0c9d6adf7069a	UNCID_1967584.08a5e204-0002-4148-8b87-bbb9b490e825.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-KK-A59Y-01A	4C197D76-DAF6-474D-B561-DED42905F52A	Primary Tumor	Illumina HiSeq	C4BB08FF-1545-40D2-9BB2-E1020194AD60	Prostate	56.0	F1CA4735-9AA5-4598-8B8A-D2DF857273C8	08A5E204-0002-4148-8B87-BBB9B490E825	TCGA-KK-A59Y-01A-11R-A26U-07	HG19	TCGA-KK-A59Y	TCGA-PRAD		s3507	University of North Carolina	MD Anderson Cancer Center	United States	NO	T3a	N1	Prostate Adenocarcinoma Acinar Type		A26U-07	True
13722.58cfa82ee4b0c9d6adf6ae64	58cfa82ee4b0c9d6adf6ae64	TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted	TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.bam	301.7	1.9	0.16	58cfa82ee4b0c9d6adf6ae64	TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.bam	Dead	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4396-01A	9F81C602-8AFA-4588-B0B6-6E5A1A128D5A	Primary Tumor	Illumina HiSeq	61bb72a1-5c87-411d-af04-3e058c2beab2	Lung	76.0	4D85772B-287E-4790-B1E8-CD1C0E88AD48	1F0C98A3-3EED-45E0-BF81-78632C02D375	TCGA-05-4396-01A-21D-1853-02	HG19_Broad_variant	TCGA-05-4396	TCGA-LUAD	303.0	s10640	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Lung Adenocarcinoma Mixed Subtype	Stage III	1853-02	True
13722.58cfa831e4b0c9d6adf6cb58	58cfa831e4b0c9d6adf6cb58	TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted	TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted.bam	56.25		0.15	58cfa831e4b0c9d6adf6cb58	TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A299-01A	90402C32-9548-432E-85B8-A4F80E14401E	Primary Tumor	Illumina HiSeq	8780c547-110c-4e3a-88fa-1feeb9a57ad0	Skin	63.0	5678AE8F-382C-4167-839E-A160CE6710C7	C164DE0A-E762-48BE-B940-9E5EA31AD026	TCGA-EB-A299-01A-21D-A18Y-02	HG19_Broad_variant	TCGA-EB-A299	TCGA-SKCM		s7844	Harvard Medical School	Asterand	Russia	NO	T2b	N0		Stage II	A18Y-02	True
13767.58cfa82fe4b0c9d6adf6b79c	58cfa82fe4b0c9d6adf6b79c	TCGA-61-2012-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-61-2012-01A-01R-1568-13_rnaseq	TCGA-61-2012-01A-01R-1568-13_rnaseq.bam	487.0	1.8	0.13	58cfa82fe4b0c9d6adf6b79c	TCGA-61-2012-01A-01R-1568-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2012-01A	20C6BE4D-7BAF-4EA0-93E2-A5212F2E9B9C	Primary Tumor	Illumina HiSeq	D918CC6C-B397-48FF-8BDC-E71BDE0B11B2	Ovary	81.0	0BEFD656-457C-4FA2-81C0-6C5A56F70196	929C2BC4-4CEE-4F82-B336-918FE041A588	TCGA-61-2012-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-61-2012	TCGA-OV		s17731	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa838e4b0c9d6adf708bc	58cfa838e4b0c9d6adf708bc	UNCID_2045557.06e6ef85-0e04-4473-bbfb-2b277c36b54e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2045557.06e6ef85-0e04-4473-bbfb-2b277c36b54e.sorted_genome_alignments	UNCID_2045557.06e6ef85-0e04-4473-bbfb-2b277c36b54e.sorted_genome_alignments.bam	32.16	1.84	0.16	58cfa838e4b0c9d6adf708bc	UNCID_2045557.06e6ef85-0e04-4473-bbfb-2b277c36b54e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-IA-A40Y-01A	1DB41963-A520-47F0-828C-ED5C626507B1	Primary Tumor	Illumina HiSeq	C8EE0D04-6818-4F6D-AE76-2DF2A558D733	Kidney	60.0	05ACDAC8-480B-43B6-82F5-B0DDC4A1C36F	06E6EF85-0E04-4473-BBFB-2B277C36B54E	TCGA-IA-A40Y-01A-11R-A24Z-07	HG19	TCGA-IA-A40Y	TCGA-KIRP		s11912	University of North Carolina	Cleveland Clinic	United States	NO	T3a	N1	Kidney Papillary Renal Cell Carcinoma	Stage III	A24Z-07	True
13767.58cfa838e4b0c9d6adf709fe	58cfa838e4b0c9d6adf709fe	UNCID_2078068.60fc2e50-f36c-4074-879b-b5773d75a466.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2078068.60fc2e50-f36c-4074-879b-b5773d75a466.sorted_genome_alignments	UNCID_2078068.60fc2e50-f36c-4074-879b-b5773d75a466.sorted_genome_alignments.bam	104.41	1.76	0.17	58cfa838e4b0c9d6adf709fe	UNCID_2078068.60fc2e50-f36c-4074-879b-b5773d75a466.sorted_genome_alignments.bam	Dead	FEMALE			Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-DF-A2L0-01A	7ADAF608-19A5-4184-8B79-BBC6F9CF24AE	Primary Tumor	Illumina HiSeq	8015B7EB-984F-4D33-B11A-3387E9C07AC7	Uterus	60.0	E3F9C326-544D-46E2-A58E-FC95E5ECD702	60FC2E50-F36C-4074-879B-B5773D75A466	TCGA-DF-A2L0-01A-11R-A180-07	HG19	TCGA-DF-A2L0	TCGA-UCEC	788.0	s4901	University of North Carolina	Ontario Institute for Cancer Research	Canada	NO			Endometrioid endometrial adenocarcinoma		A180-07	True
13767.58cfa836e4b0c9d6adf6f8bc	58cfa836e4b0c9d6adf6f8bc	UNCID_1648499.654ea6d9-1a5b-442a-8627-5d6f4baa8460.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1648499.654ea6d9-1a5b-442a-8627-5d6f4baa8460.sorted_genome_alignments	UNCID_1648499.654ea6d9-1a5b-442a-8627-5d6f4baa8460.sorted_genome_alignments.bam	47.2		0.14	58cfa836e4b0c9d6adf6f8bc	UNCID_1648499.654ea6d9-1a5b-442a-8627-5d6f4baa8460.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-8163-01A	C81D4681-C02F-4B33-ABE0-B6AD7D61194D	Primary Tumor	Illumina HiSeq	E94DA28F-7409-4641-9558-BA3FE5486194	Brain	29.0	5911EDD4-CEF7-468B-9367-86DCD3E7AAC0	654EA6D9-1A5B-442A-8627-5D6F4BAA8460	TCGA-DU-8163-01A-11R-2256-07	HG19	TCGA-DU-8163	TCGA-LGG		s8617	University of North Carolina	Henry Ford Hospital	United States	NO			Oligoastrocytoma		2256-07	True
13722.58cfa831e4b0c9d6adf6ca54	58cfa831e4b0c9d6adf6ca54	TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted	TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted.bam	325.7	1.9	0.15	58cfa831e4b0c9d6adf6ca54	TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-5280-01A	4797C600-F024-42FE-B287-D919B24DCB79	Primary Tumor	Illumina HiSeq	47363648-94bb-4221-a905-4832396ef90e	Brain	43.0	D9B929FD-335C-46B1-B60D-B846C372AA6A	677B8F71-325E-49F9-B3D7-B6ADB6831ED5	TCGA-DB-5280-01A-01D-1465-02	HG19_Broad_variant	TCGA-DB-5280	TCGA-LGG		s8130	Harvard Medical School	Mayo Clinic - Rochester	United States	NO			Oligoastrocytoma		1465-02	True
13722.58cfa831e4b0c9d6adf6cc68	58cfa831e4b0c9d6adf6cc68	TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted.filtered.	WGS	TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted	TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted.bam	58.64		0.17	58cfa831e4b0c9d6adf6cc68	TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2R8-01A	D4510801-8CE4-4F10-8B31-25C0A39B5135	Primary Tumor	Illumina HiSeq	d050a7c3-8fe5-472e-bc71-4dff85991e92	Cervix	48.0	6B8E0AF3-1632-4FED-9A37-879EA013AE24	80B2C20E-8EFB-4105-8A96-A695FCFB73CB	TCGA-EK-A2R8-01A-21D-A18I-02	HG19_Broad_variant	TCGA-EK-A2R8	TCGA-CESC		s1190	Harvard Medical School	Gynecologic Oncology Group	United States	NO	T1b2	N1	Cervical Squamous Cell Carcinoma		A18I-02	True
13767.58cfa838e4b0c9d6adf7095b	58cfa838e4b0c9d6adf7095b	UNCID_2076407.10db67e9-5b8f-4bda-b26b-c63e70c3c95e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2076407.10db67e9-5b8f-4bda-b26b-c63e70c3c95e.sorted_genome_alignments	UNCID_2076407.10db67e9-5b8f-4bda-b26b-c63e70c3c95e.sorted_genome_alignments.bam	11.4	1.86	0.16	58cfa838e4b0c9d6adf7095b	UNCID_2076407.10db67e9-5b8f-4bda-b26b-c63e70c3c95e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Lung Squamous Cell Carcinoma	Aligned reads	TCGA-NC-A5HK-01A	87410C09-5B61-4F61-85A5-93C288AECA03	Primary Tumor	Illumina HiSeq	D2808342-73D7-4A74-9549-F25AEC4DD1C5	Lung	58.0	289898CD-6E42-43F4-B183-C21951E8A0E1	10DB67E9-5B8F-4BDA-B26B-C63E70C3C95E	TCGA-NC-A5HK-01A-11R-A26W-07	HG19	TCGA-NC-A5HK	TCGA-LUSC		s10619	University of North Carolina	Washington University - CHUV	Switzerland	NO	T3	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A26W-07	True
13767.58cfa83be4b0c9d6adf7264c	58cfa83be4b0c9d6adf7264c	UNCID_2633498.bdf870fd-2b18-4aac-aa9a-b01bd6bf9834.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2633498.bdf870fd-2b18-4aac-aa9a-b01bd6bf9834.sorted_genome_alignments	UNCID_2633498.bdf870fd-2b18-4aac-aa9a-b01bd6bf9834.sorted_genome_alignments.bam	50.75	1.89	0.18	58cfa83be4b0c9d6adf7264c	UNCID_2633498.bdf870fd-2b18-4aac-aa9a-b01bd6bf9834.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thymoma	Aligned reads	TCGA-5V-A9RR-01A	BFE41BA3-2BCF-4760-AE65-CD417E22393F	Primary Tumor	Illumina HiSeq	CC1FD03F-78A0-4C54-99DB-DD2052A75280	Thymus	67.0	52148A0E-A674-4E87-AB6B-83177B75CB2F	BDF870FD-2B18-4AAC-AA9A-B01BD6BF9834	TCGA-5V-A9RR-01A-11R-A42C-07	HG19	TCGA-5V-A9RR	TCGA-THYM		s564	University of North Carolina	Roswell Park	United States	NO					A42C-07	True
13722.58cfa832e4b0c9d6adf6cfaf	58cfa832e4b0c9d6adf6cfaf	TCGA-GC-A3BM-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_4_rg.sorted.filtered.	WGS	TCGA-GC-A3BM-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_4_rg.sorted	TCGA-GC-A3BM-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_4_rg.sorted.bam	29.57		0.16	58cfa832e4b0c9d6adf6cfaf	TCGA-GC-A3BM-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3BM-10A	7840AEA9-40C4-473E-BE33-8FA0B9F332C9	Blood Derived Normal	Illumina HiSeq	1701d500-8ca9-4b1b-87a0-fccb8808328e	Bladder	70.0	9090938A-4845-482F-8CD3-C74B9DEE11D1	6CF9CAE6-FB82-4A94-B37C-B03F213D509D	TCGA-GC-A3BM-10A-01D-A23Q-26	HG19_Broad_variant	TCGA-GC-A3BM	TCGA-BLCA		s3127	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A23Q-26	True
13767.58cfa832e4b0c9d6adf6d048	58cfa832e4b0c9d6adf6d048	TCGA-IG-A51D-01A-11R-A36D-31_rnaseq.filtered.	RNA-Seq	TCGA-IG-A51D-01A-11R-A36D-31_rnaseq	TCGA-IG-A51D-01A-11R-A36D-31_rnaseq.bam	71.59	1.92	0.18	58cfa832e4b0c9d6adf6d048	TCGA-IG-A51D-01A-11R-A36D-31_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A51D-01A	F8DBAB24-B9F4-4B8A-BFEA-57856CCF6364	Primary Tumor	Illumina HiSeq	AE354911-4806-477C-B47B-1228A2E5925C	Esophagus	63.0	3889C9FE-3777-4B3D-9CF1-12135D4D7F7D	2235D68C-75EA-47F2-A3C5-9E9CFF416D22	TCGA-IG-A51D-01A-11R-A36D-31	GRCh37-lite	TCGA-IG-A51D	TCGA-ESCA		s1631	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T1	N1		Stage II	A36D-31	True
13722.58cfa82de4b0c9d6adf6a50a	58cfa82de4b0c9d6adf6a50a	3ac5940e7260ebdac67fda67f843bb37.filtered.	WGS	3ac5940e7260ebdac67fda67f843bb37	3ac5940e7260ebdac67fda67f843bb37.bam	16.06		0.09	58cfa82de4b0c9d6adf6a50a	3ac5940e7260ebdac67fda67f843bb37.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A2J0-10A	2FF6AEDE-7BCD-440B-99AB-7A023FAF658E	Blood Derived Normal	Illumina HiSeq	112d3432-8361-4b26-a990-963dfe67246f	Mesenchymal	61.0	415CE513-C8A5-400D-AEBE-05B9D7D60EAE	EADFBA85-5283-41EA-A71A-DC89AC1BAB4C	TCGA-DX-A2J0-10A-01D-A21Q-09	GRCh37-lite	TCGA-DX-A2J0	TCGA-SARC	295.0	s2482	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO					A21Q-09	True
13767.58cfa835e4b0c9d6adf6ec50	58cfa835e4b0c9d6adf6ec50	UNCID_1324377.54e59fdb-a377-4f69-84aa-8aa21312d270.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1324377.54e59fdb-a377-4f69-84aa-8aa21312d270.sorted_genome_alignments	UNCID_1324377.54e59fdb-a377-4f69-84aa-8aa21312d270.sorted_genome_alignments.bam	34.2		0.15	58cfa835e4b0c9d6adf6ec50	UNCID_1324377.54e59fdb-a377-4f69-84aa-8aa21312d270.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-J2-8192-01A	369F14C4-2191-4962-A309-3E23DDC4E5FC	Primary Tumor	Illumina HiSeq	1A0A0A30-3BE8-46AD-8FEC-4ED618DE70CE	Lung	65.0	45021EBD-8E13-44C2-8203-AA9F72B50E6E	54E59FDB-A377-4F69-84AA-8AA21312D270	TCGA-J2-8192-01A-11R-2241-07	HG19	TCGA-J2-8192	TCGA-LUAD		s10949	University of North Carolina	ABS - Lahey Clinic	United States	NO	T2a	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	2241-07	True
13767.58cfa832e4b0c9d6adf6d050	58cfa832e4b0c9d6adf6d050	TCGA-IN-7806-01A-11R-2055-13_rnaseq.filtered.	RNA-Seq	TCGA-IN-7806-01A-11R-2055-13_rnaseq	TCGA-IN-7806-01A-11R-2055-13_rnaseq.bam	153.2		0.15	58cfa832e4b0c9d6adf6d050	TCGA-IN-7806-01A-11R-2055-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-IN-7806-01A	87C217D4-66F4-46CA-8244-7856CE658FD3	Primary Tumor	Illumina HiSeq	2439E9BD-BB45-4D42-A172-7FEF032E247D	Stomach	50.0	9B864C79-BF5C-4430-86E8-D8479ED90D25	6D98D09B-CDEC-4F71-AFB3-2C53BEE990C4	TCGA-IN-7806-01A-11R-2055-13	GRCh37-lite	TCGA-IN-7806	TCGA-STAD		s15342	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	United States	NO	T3	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage II	2055-13	True
13767.58cfa82ee4b0c9d6adf6b1a9	58cfa82ee4b0c9d6adf6b1a9	TCGA-13-1510-01A-02R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-1510-01A-02R-1565-13_GRCh37-lite_rnaseq	TCGA-13-1510-01A-02R-1565-13_GRCh37-lite_rnaseq.bam	403.0	1.8	0.17	58cfa82ee4b0c9d6adf6b1a9	TCGA-13-1510-01A-02R-1565-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1510-01A	DAC96910-0CB2-44EA-B108-2D6D51B07112	Primary Tumor	Illumina HiSeq	7A3673D2-C04B-459F-8D16-027E777E981F	Ovary	62.0	557F7CAB-8204-4295-831E-9A8CACF72231	B75DB551-4254-4736-A089-0A38890E7778	TCGA-13-1510-01A-02R-1565-13	GRCh37-lite	TCGA-13-1510	TCGA-OV		s17501	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa832e4b0c9d6adf6d092	58cfa832e4b0c9d6adf6d092	TCGA-IG-A3QL-01A-11R-A24K-31_rnaseq.filtered.	RNA-Seq	TCGA-IG-A3QL-01A-11R-A24K-31_rnaseq	TCGA-IG-A3QL-01A-11R-A24K-31_rnaseq.bam	35.09	2.02	0.17	58cfa832e4b0c9d6adf6d092	TCGA-IG-A3QL-01A-11R-A24K-31_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A3QL-01A	0AC08ECF-4D70-48A4-9DFD-F44032551CB9	Primary Tumor	Illumina HiSeq	03D6585A-DB23-40E7-B0C9-E36E03BF953C	Esophagus	54.0	D571A2B3-892B-46C4-883C-FDED4980492F	35DB6527-EC8A-4B0C-B296-81EE1340F3D4	TCGA-IG-A3QL-01A-11R-A24K-31	GRCh37-lite	TCGA-IG-A3QL	TCGA-ESCA		s1632	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T2	N0		Stage II	A24K-31	True
13767.58cfa834e4b0c9d6adf6e176	58cfa834e4b0c9d6adf6e176	UNCID_1167082.1b831e2d-c265-4eac-aee0-248493a14218.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1167082.1b831e2d-c265-4eac-aee0-248493a14218.sorted_genome_alignments	UNCID_1167082.1b831e2d-c265-4eac-aee0-248493a14218.sorted_genome_alignments.bam	11.25	1.83	0.15	58cfa834e4b0c9d6adf6e176	UNCID_1167082.1b831e2d-c265-4eac-aee0-248493a14218.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1FH-11B	1783CAC1-253A-40AF-A9AC-48DFB20E1AB8	Solid Tissue Normal	Illumina HiSeq	C4C633F4-2B6B-4AC5-83C8-5FADF50A91EA	Breast	47.0	C75BC2C7-CF1F-482C-B615-F60B56983124	1B831E2D-C265-4EAC-AEE0-248493A14218	TCGA-BH-A1FH-11B-42R-A13Q-07	HG19	TCGA-BH-A1FH	TCGA-BRCA	1123.0	s5891	University of North Carolina	University of Pittsburgh	None	NO	T2	N1b	Infiltrating Ductal Carcinoma	Stage IV	A13Q-07	True
13767.58cfa83be4b0c9d6adf721e5	58cfa83be4b0c9d6adf721e5	UNCID_2584704.806be13f-779c-4781-8c48-aba71f31d217.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2584704.806be13f-779c-4781-8c48-aba71f31d217.sorted_genome_alignments	UNCID_2584704.806be13f-779c-4781-8c48-aba71f31d217.sorted_genome_alignments.bam	66.19	1.83	0.17	58cfa83be4b0c9d6adf721e5	UNCID_2584704.806be13f-779c-4781-8c48-aba71f31d217.sorted_genome_alignments.bam	Alive	MALE	WHITE		Thymoma	Aligned reads	TCGA-YT-A95E-01A	D3189C8E-FFE0-41FF-9C7B-64DA4C83B991	Primary Tumor	Illumina HiSeq	424363F6-33A5-480B-B5F3-FA4087B3A40B	Thymus	52.0	74353A4C-7AFB-4C90-B00E-247BF2838E86	806BE13F-779C-4781-8C48-ABA71F31D217	TCGA-YT-A95E-01A-11R-A42C-07	HG19	TCGA-YT-A95E	TCGA-THYM		s516	University of North Carolina	Barretos Cancer Hospital	Brazil	NO					A42C-07	True
13767.58cfa82ee4b0c9d6adf6a9e2	58cfa82ee4b0c9d6adf6a9e2	G17232.TCGA-06-0210-02A-01R-2005-01.2.filtered.	RNA-Seq	G17232.TCGA-06-0210-02A-01R-2005-01.2	G17232.TCGA-06-0210-02A-01R-2005-01.2.bam	200.0	1.8	0.16	58cfa82ee4b0c9d6adf6a9e2	G17232.TCGA-06-0210-02A-01R-2005-01.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0210-02A	DE7B7CAC-F094-4D59-8651-E991E34EA093	Recurrent Tumor	Illumina HiSeq	49B2E2C7-C6E3-47D9-ACB7-E4B961EF7E5A	Brain	72.0	15E8851A-EA08-4CF5-84A3-86FD47B60258	26200B50-C40C-4E09-89C4-083B873BCF25	TCGA-06-0210-02A-01R-2005-01	HG19_Broad_variant	TCGA-06-0210	TCGA-GBM	225.0	s14206	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		2005-01	True
13722.58cfa832e4b0c9d6adf6ce76	58cfa832e4b0c9d6adf6ce76	TCGA-FV-A496-10A-01D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A496-10A-01D-A25V-10_wgs_Illumina	TCGA-FV-A496-10A-01D-A25V-10_wgs_Illumina.bam	104.34		0.07	58cfa832e4b0c9d6adf6ce76	TCGA-FV-A496-10A-01D-A25V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A496-10A	8AFA3140-DCBD-44C0-AB13-4ADA6A0444D4	Blood Derived Normal	Illumina HiSeq	36411133-c902-48e9-bad1-9a5c7f215769	Liver	84.0	F47202C2-A5BB-44E3-B209-24AAF42457BB	B736880F-AB1F-41FA-8776-38421620F821	TCGA-FV-A496-10A-01D-A25V-10	GRCh37-lite	TCGA-FV-A496	TCGA-LIHC		s16860	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A25V-10	True
13722.58cfa82fe4b0c9d6adf6b657	58cfa82fe4b0c9d6adf6b657	TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted	TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted.bam	702.7	1.9	0.15	58cfa82fe4b0c9d6adf6b657	TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-5778-01A	8FDBD88F-19AE-4AB8-BCD7-6BFA1BBDE742	Primary Tumor	Illumina HiSeq	bd5570f2-ed45-408a-a615-0a6808c31d84	Lung	60.0	92514FD2-A178-42E8-8929-0910558E7F87	BC8FFDB4-AB99-44B7-95B0-7BC2F8110B76	TCGA-64-5778-01A-01D-1623-02	HG19_Broad_variant	TCGA-64-5778	TCGA-LUAD		s10796	Harvard Medical School	Fox Chase	United States	NO	T2	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage I	1623-02	True
13722.58cfa832e4b0c9d6adf6d210	58cfa832e4b0c9d6adf6d210	TCGA-H2-A26U-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_6_rg.sorted.filtered.	WGS	TCGA-H2-A26U-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_6_rg.sorted	TCGA-H2-A26U-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_6_rg.sorted.bam	169.94	1.69	0.15	58cfa832e4b0c9d6adf6d210	TCGA-H2-A26U-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-H2-A26U-10A	E61FB24B-613A-4B6D-BB2B-00CCEDBD3DBC	Blood Derived Normal	Illumina HiSeq	861454f1-5ad7-4baf-b14f-04dac8c86852	Thyroid	54.0	272D97A5-448E-4382-AEB3-3CD13A8433B6	83710020-E939-4AB3-A482-D51DCC937377	TCGA-H2-A26U-10A-01D-A16N-02	HG19_Broad_variant	TCGA-H2-A26U	TCGA-THCA		s12533	Harvard Medical School	Christiana Healthcare	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A16N-02	True
13767.58cfa83ae4b0c9d6adf71d1e	58cfa83ae4b0c9d6adf71d1e	UNCID_2508740.530bf880-039e-490c-8a9d-a27bc9b3d918.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2508740.530bf880-039e-490c-8a9d-a27bc9b3d918.sorted_genome_alignments	UNCID_2508740.530bf880-039e-490c-8a9d-a27bc9b3d918.sorted_genome_alignments.bam	49.11	1.84	0.16	58cfa83ae4b0c9d6adf71d1e	UNCID_2508740.530bf880-039e-490c-8a9d-a27bc9b3d918.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-ZF-A9R4-01A	371B5D70-9797-4DAE-B523-247F5EAEB4AB	Primary Tumor	Illumina HiSeq	5E4EBBCD-43E1-4959-BF49-A26807100937	Bladder	83.0	733B0CA7-7350-459C-B7C6-9D3C7745417C	530BF880-039E-490C-8A9D-A27BC9B3D918	TCGA-ZF-A9R4-01A-11R-A38B-07	HG19	TCGA-ZF-A9R4	TCGA-BLCA		s3040	University of North Carolina	University of Sheffield	None	NO	T2	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A38B-07	True
13722.58cfa831e4b0c9d6adf6cafc	58cfa831e4b0c9d6adf6cafc	TCGA-EA-A3QE-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_4_rg.sorted.filtered.	WGS	TCGA-EA-A3QE-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_4_rg.sorted	TCGA-EA-A3QE-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_4_rg.sorted.bam	52.94		0.15	58cfa831e4b0c9d6adf6cafc	TCGA-EA-A3QE-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3QE-10A	A4E444B5-BBCA-4EF0-B92F-908D608CBB91	Blood Derived Normal	Illumina HiSeq	dfcbe88f-984f-4e3b-bbe6-02ac2ea58cf6	Cervix	45.0	1AB52CDC-8A5C-4F21-AEC9-F4BE1691C1CE	D6202D9F-5AFD-4AA6-A4AD-05D1D5EF4147	TCGA-EA-A3QE-10A-01D-A245-26	HG19_Broad_variant	TCGA-EA-A3QE	TCGA-CESC		s1363	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T1b	N0	Cervical Squamous Cell Carcinoma		A245-26	True
13722.58cfa83ce4b0c9d6adf72f12	58cfa83ce4b0c9d6adf72f12	c535b5e8e14454d2fb5975ead8bd9321.filtered.	WGS	c535b5e8e14454d2fb5975ead8bd9321	c535b5e8e14454d2fb5975ead8bd9321.bam	22.35	1.97	0.08	58cfa83ce4b0c9d6adf72f12	c535b5e8e14454d2fb5975ead8bd9321.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D4-10A	75113445-D2D6-44A0-866C-C9175E6D214B	Blood Derived Normal	Illumina HiSeq	231cf234-5a6f-486a-805f-8e2f12139cb6	Breast	37.0	138745F8-F15E-486B-A7DA-B835C1D7A67E	C462D06F-679D-451B-9BB9-0DA8E349A49B	TCGA-A2-A0D4-10A-01D-A314-09	GRCh37-lite	TCGA-A2-A0D4	TCGA-BRCA		s6104	Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A314-09	True
13767.58cfa832e4b0c9d6adf6d680	58cfa832e4b0c9d6adf6d680	TCGA-VQ-AA6I-01A-11R-A414-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-AA6I-01A-11R-A414-31_rnaseq	TCGA-VQ-AA6I-01A-11R-A414-31_rnaseq.bam	60.03	1.86	0.17	58cfa832e4b0c9d6adf6d680	TCGA-VQ-AA6I-01A-11R-A414-31_rnaseq.bam	Dead	MALE	WHITE		Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-AA6I-01A	3CCBE7C7-C779-4A98-B495-FF020D3E9E55	Primary Tumor	Illumina HiSeq	E4955B58-C646-401E-907C-52996C8A3584	Stomach	68.0	BE85EA17-F3C8-4DAD-9F8A-4627153C3112	88DB7CEA-8C74-445D-BBC9-F83A3D1C2136	TCGA-VQ-AA6I-01A-11R-A414-31	GRCh37-lite	TCGA-VQ-AA6I	TCGA-STAD	491.0	s15347	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T3	N3	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	A414-31	True
13722.58cfa82ee4b0c9d6adf6ae84	58cfa82ee4b0c9d6adf6ae84	G49537.TCGA-FE-A22Z-10A-01D-A35R-08.1.filtered.	WGS	G49537.TCGA-FE-A22Z-10A-01D-A35R-08.1	G49537.TCGA-FE-A22Z-10A-01D-A35R-08.1.bam	27.97	1.9	0.08	58cfa82ee4b0c9d6adf6ae84	G49537.TCGA-FE-A22Z-10A-01D-A35R-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A22Z-10A	78D14F86-896A-4F98-9274-B2E8E387ADD9	Blood Derived Normal	Illumina HiSeq	36b50f79-9237-4b80-ae5d-014b02df659a	Thyroid	61.0	7727F473-C83D-4CF2-B779-C4FDB6172AA7	E9058FDE-C9DF-49EC-94F3-B918A84C4C2E	TCGA-FE-A22Z-10A-01D-A35R-08	HG19_Broad_variant	TCGA-FE-A22Z	TCGA-THCA		s11978	Broad Institute of MIT and Harvard	Ohio State University	United States	NO	T4a	N1	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IV	A35R-08	False
13767.58cfa838e4b0c9d6adf70c72	58cfa838e4b0c9d6adf70c72	UNCID_2156986.f873fe6d-9733-48a9-b7e0-23dc50874fbc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2156986.f873fe6d-9733-48a9-b7e0-23dc50874fbc.sorted_genome_alignments	UNCID_2156986.f873fe6d-9733-48a9-b7e0-23dc50874fbc.sorted_genome_alignments.bam	56.35	1.89	0.18	58cfa838e4b0c9d6adf70c72	UNCID_2156986.f873fe6d-9733-48a9-b7e0-23dc50874fbc.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-K4-A6FZ-01A	610811D5-E45E-4A4F-BDC1-8D700EFD6E43	Primary Tumor	Illumina HiSeq	E5291EAA-7136-458E-8E4F-1AC7C4ADB2C2	Bladder	75.0	81DCB3AF-128A-4934-8781-CC60310B258F	F873FE6D-9733-48A9-B7E0-23DC50874FBC	TCGA-K4-A6FZ-01A-11R-A31N-07	HG19	TCGA-K4-A6FZ	TCGA-BLCA		s3188	University of North Carolina	ABS - Lahey Clinic	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A31N-07	True
13767.58cfa83be4b0c9d6adf725b8	58cfa83be4b0c9d6adf725b8	UNCID_2659059.ddadccf6-be6f-44d4-8ad0-9e6bb4582bc1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2659059.ddadccf6-be6f-44d4-8ad0-9e6bb4582bc1.sorted_genome_alignments	UNCID_2659059.ddadccf6-be6f-44d4-8ad0-9e6bb4582bc1.sorted_genome_alignments.bam	27.36	1.84	0.18	58cfa83be4b0c9d6adf725b8	UNCID_2659059.ddadccf6-be6f-44d4-8ad0-9e6bb4582bc1.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-MM-A563-01A	FE1F95A3-A6C2-4A39-8586-F8A70E975DD4	Primary Tumor	Illumina HiSeq	9A0D8831-D5D9-4817-9CCF-394E4A1BFE44	Kidney	41.0	9A7DC276-B019-4AD7-9923-71B365896092	DDADCCF6-BE6F-44D4-8AD0-9E6BB4582BC1	TCGA-MM-A563-01A-11R-A266-07	HG19	TCGA-MM-A563	TCGA-KIRC		s8925	University of North Carolina	BLN - Baylor	United States	NO	T3	NX	Kidney Clear Cell Renal Carcinoma	Stage I	A266-07	True
13767.58cfa82fe4b0c9d6adf6b338	58cfa82fe4b0c9d6adf6b338	TCGA-24-0982-01A-01R-1565-13_rnaseq.filtered.	RNA-Seq	TCGA-24-0982-01A-01R-1565-13_rnaseq	TCGA-24-0982-01A-01R-1565-13_rnaseq.bam	95.7	1.8	0.16	58cfa82fe4b0c9d6adf6b338	TCGA-24-0982-01A-01R-1565-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-0982-01A	206CE0ED-36A4-47AB-AC8E-F6FCA6AC5C18	Primary Tumor	Illumina HiSeq	9F102AE1-BA4F-4280-8290-7A435596F060	Ovary	77.0	7FEC33CD-6F46-44C7-8204-E0F42B543ABE	AE158B16-5D93-42D5-A793-3294629AF24D	TCGA-24-0982-01A-01R-1565-13	NCBI36_BCCAGSC_variant	TCGA-24-0982	TCGA-OV	679.0	s17669	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa82ee4b0c9d6adf6b025	58cfa82ee4b0c9d6adf6b025	TCGA-13-0720-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-0720-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-13-0720-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	260.0	1.8	0.16	58cfa82ee4b0c9d6adf6b025	TCGA-13-0720-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0720-01A	0D23FA5B-95F8-4626-A4D2-C72AD3CC553B	Primary Tumor	Illumina HiSeq	E43E9ED6-F830-41DA-B1CC-2E11EF0C5DCC	Ovary	48.0	5C315F82-D4AC-40FD-9CC2-C4BC61286F8E	1FE43034-DF2B-4BEF-BE77-07DBB68083A4	TCGA-13-0720-01A-01R-1564-13	GRCh37-lite	TCGA-13-0720	TCGA-OV	1355.0	s17421	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa835e4b0c9d6adf6ef0e	58cfa835e4b0c9d6adf6ef0e	UNCID_1407350.149fe971-260e-4cbf-a5aa-41eca339847a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1407350.149fe971-260e-4cbf-a5aa-41eca339847a.sorted_genome_alignments	UNCID_1407350.149fe971-260e-4cbf-a5aa-41eca339847a.sorted_genome_alignments.bam	12.3	1.8	0.16	58cfa835e4b0c9d6adf6ef0e	UNCID_1407350.149fe971-260e-4cbf-a5aa-41eca339847a.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-5318-01A	400B2FA3-BAF7-4BAA-99B4-88B9F25B5049	Primary Tumor	Illumina HiSeq	41614662-3DA5-4097-9964-8A10DAD570B8	Brain	42.0	EDC32A96-F912-4348-80D4-72D08129DB53	149FE971-260E-4CBF-A5AA-41ECA339847A	TCGA-E1-5318-01A-01R-1470-07	HG19	TCGA-E1-5318	TCGA-LGG	2379.0	s8584	University of North Carolina	Duke	United States	NO			Oligodendroglioma		1470-07	True
13767.58cfa834e4b0c9d6adf6e6c8	58cfa834e4b0c9d6adf6e6c8	UNCID_1171554.9797fc8a-18aa-4fc1-bd71-dd1b5fc39222.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1171554.9797fc8a-18aa-4fc1-bd71-dd1b5fc39222.sorted_genome_alignments	UNCID_1171554.9797fc8a-18aa-4fc1-bd71-dd1b5fc39222.sorted_genome_alignments.bam	75.3	1.7	0.15	58cfa834e4b0c9d6adf6e6c8	UNCID_1171554.9797fc8a-18aa-4fc1-bd71-dd1b5fc39222.sorted_genome_alignments.bam	Dead	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4787-01A	500636A5-D42B-469F-98E2-FDD4DDDC61A0	Primary Tumor	Illumina HiSeq	246BCAE4-9512-4D3D-AF46-7383E9194FA7	Kidney	59.0	3F52005C-4F85-4651-B027-C455BA143BCC	9797FC8A-18AA-4FC1-BD71-DD1B5FC39222	TCGA-BP-4787-01A-01R-1305-07	HG19	TCGA-BP-4787	TCGA-KIRC	480.0	s9323	University of North Carolina	MSKCC	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1305-07	True
13767.58cfa839e4b0c9d6adf71352	58cfa839e4b0c9d6adf71352	UNCID_2310444.0c18423b-7a7e-440d-96a7-ec3815aa411c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2310444.0c18423b-7a7e-440d-96a7-ec3815aa411c.sorted_genome_alignments	UNCID_2310444.0c18423b-7a7e-440d-96a7-ec3815aa411c.sorted_genome_alignments.bam	21.12	1.86	0.17	58cfa839e4b0c9d6adf71352	UNCID_2310444.0c18423b-7a7e-440d-96a7-ec3815aa411c.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-M7-A720-01A	444E78F7-1221-4882-ADE2-7E45D828EA2A	Primary Tumor	Illumina HiSeq	7A47D566-8779-4DC1-A971-39C6EB1A6129	Prostate	53.0	E325C4BE-1952-49C8-88F1-B53C8DFCFB8E	0C18423B-7A7E-440D-96A7-EC3815AA411C	TCGA-M7-A720-01A-12R-A32O-07	HG19	TCGA-M7-A720	TCGA-PRAD		s3882	University of North Carolina	University of North Carolina	United States	NO	T2c		Prostate Adenocarcinoma Acinar Type		A32O-07	True
13767.58cfa82fe4b0c9d6adf6b546	58cfa82fe4b0c9d6adf6b546	TCGA-29-1705-01A-01R-1567-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-29-1705-01A-01R-1567-13_GRCh37-lite_rnaseq	TCGA-29-1705-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	450.7	1.8	0.15	58cfa82fe4b0c9d6adf6b546	TCGA-29-1705-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1705-01A	F9C835DB-2AB6-4BF5-826F-48723493C0EC	Primary Tumor	Illumina HiSeq	742B6DE5-F883-44DC-8835-FF6E3AAA72AE	Ovary	47.0	FD3E7BA8-21A5-438B-82EE-482ED6905310	D1603029-2B45-4C5C-B313-8846D0EBDBDB	TCGA-29-1705-01A-01R-1567-13	GRCh37-lite	TCGA-29-1705	TCGA-OV	555.0	s17630	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa834e4b0c9d6adf6e0f2	58cfa834e4b0c9d6adf6e0f2	UNCID_1164976.2f315234-dee1-4f36-b7dc-72280c219a1c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1164976.2f315234-dee1-4f36-b7dc-72280c219a1c.sorted_genome_alignments	UNCID_1164976.2f315234-dee1-4f36-b7dc-72280c219a1c.sorted_genome_alignments.bam	27.22	1.88	0.17	58cfa834e4b0c9d6adf6e0f2	UNCID_1164976.2f315234-dee1-4f36-b7dc-72280c219a1c.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E9-A227-01A	89A8DA07-4487-47C6-8D3C-442A87E4F632	Primary Tumor	Illumina HiSeq	E33390E1-01EA-460B-87C3-ACED845BED7F	Breast	42.0	409B906A-5E2C-4CE6-BC85-20A59FA383F4	2F315234-DEE1-4F36-B7DC-72280C219A1C	TCGA-E9-A227-01A-11R-A157-07	HG19	TCGA-E9-A227	TCGA-BRCA		s5578	University of North Carolina	Asterand	United States	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A157-07	True
13767.58cfa834e4b0c9d6adf6e529	58cfa834e4b0c9d6adf6e529	UNCID_1197406.181ba652-f81f-4077-88d7-02a4a7fe2312.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1197406.181ba652-f81f-4077-88d7-02a4a7fe2312.sorted_genome_alignments	UNCID_1197406.181ba652-f81f-4077-88d7-02a4a7fe2312.sorted_genome_alignments.bam	98.3	1.8	0.16	58cfa834e4b0c9d6adf6e529	UNCID_1197406.181ba652-f81f-4077-88d7-02a4a7fe2312.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4811-01A	57578A0D-B719-46E7-83AB-872A4E984DBB	Primary Tumor	Illumina HiSeq	FFB2E00A-B97B-4135-9A69-138F1CCF4866	Kidney	48.0	F96C746B-DDC6-4901-9F32-72ED777C4CE7	181BA652-F81F-4077-88D7-02A4A7FE2312	TCGA-B0-4811-01A-01R-1503-07	HG19	TCGA-B0-4811	TCGA-KIRC	1417.0	s9505	University of North Carolina	University of Pittsburgh	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1503-07	True
13722.58cfa831e4b0c9d6adf6c9b0	58cfa831e4b0c9d6adf6c9b0	TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted	TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.bam	24.89	1.93	0.14	58cfa831e4b0c9d6adf6c9b0	TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13M-01A	BA9DEC81-FFC0-453A-9621-94BEBA45FAB1	Primary Tumor	Illumina HiSeq	6d7b5f3b-5fba-469e-a651-31a4569d7877	Thyroid	28.0	28913C64-8637-4537-AF8C-7315097A5AD1	8C708D3B-B312-4C27-898B-A0FE87110474	TCGA-DJ-A13M-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13M	TCGA-THCA		s12369	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10R-02	True
13722.58cfa82de4b0c9d6adf6a560	58cfa82de4b0c9d6adf6a560	0a1391284ac30b02d85a5885bca3ad6d.filtered.	WGS	0a1391284ac30b02d85a5885bca3ad6d	0a1391284ac30b02d85a5885bca3ad6d.bam	13.48		0.09	58cfa82de4b0c9d6adf6a560	0a1391284ac30b02d85a5885bca3ad6d.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RE-10A	9AA36AC2-8418-4109-A3C1-63CA8742BAAB	Blood Derived Normal	Illumina HiSeq	e89116c7-baf6-41ea-a3b7-90fbdd692255	Cervix	26.0	49B39F9A-A7BE-40D3-A3D7-3DF579DAFAAE	A756A6D1-19C0-4C17-A1DA-12A5A23718A0	TCGA-EK-A2RE-10A-01D-A34H-09	GRCh37-lite	TCGA-EK-A2RE	TCGA-CESC		s1345	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	T2a2	N0	Cervical Squamous Cell Carcinoma		A34H-09	True
13767.58cfa833e4b0c9d6adf6da8d	58cfa833e4b0c9d6adf6da8d	UNCID_1117368.7fdf1ebf-149a-43d5-bae7-6e01beb647dd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1117368.7fdf1ebf-149a-43d5-bae7-6e01beb647dd.sorted_genome_alignments	UNCID_1117368.7fdf1ebf-149a-43d5-bae7-6e01beb647dd.sorted_genome_alignments.bam	22.16	1.86	0.15	58cfa833e4b0c9d6adf6da8d	UNCID_1117368.7fdf1ebf-149a-43d5-bae7-6e01beb647dd.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A1-A0SN-01A	0DC337FA-DA8B-42C4-B9A7-FB76D81C161F	Primary Tumor	Illumina HiSeq	C59B08AE-976B-4FF5-B61B-2AC5AFBFFCC6	Breast	50.0	62D2A36E-FEB1-4084-8111-7EA38A4E3049	7FDF1EBF-149A-43D5-BAE7-6E01BEB647DD	TCGA-A1-A0SN-01A-11R-A144-07	HG19	TCGA-A1-A0SN	TCGA-BRCA		s5816	University of North Carolina	UCSF	United States	NO	T1c	N1	Infiltrating Ductal Carcinoma	Stage II	A144-07	True
13722.58cfa831e4b0c9d6adf6c4d6	58cfa831e4b0c9d6adf6c4d6	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.bam	55.07		0.16	58cfa831e4b0c9d6adf6c4d6	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MF-01A	1E308B12-0590-4DAE-94D0-A539FCF25DF7	Primary Tumor	Illumina HiSeq	57be2848-15e4-489c-b122-a660f03c68dd	Bladder	34.0	E9889071-4C6E-4761-9D65-06C6B5989FB7	6646401F-5235-4847-A4E6-006F98CAFE85	TCGA-CF-A3MF-01A-12D-A21C-26	HG19_Broad_variant	TCGA-CF-A3MF	TCGA-BLCA		s3092	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A21C-26	True
13767.58cfa837e4b0c9d6adf70259	58cfa837e4b0c9d6adf70259	UNCID_1896492.6b264e41-b852-4221-8e09-692a6a639ccf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1896492.6b264e41-b852-4221-8e09-692a6a639ccf.sorted_genome_alignments	UNCID_1896492.6b264e41-b852-4221-8e09-692a6a639ccf.sorted_genome_alignments.bam	85.2	1.8	0.14	58cfa837e4b0c9d6adf70259	UNCID_1896492.6b264e41-b852-4221-8e09-692a6a639ccf.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6351-11A	F59B9C65-46E8-4CC3-AA71-8844F6C2273C	Solid Tissue Normal	Illumina HiSeq	B78EE658-C989-45C0-9F75-A47623E45811	Prostate	51.0	C3834F6C-79EC-4A6D-AFA0-BD5D93B7A8F0	6B264E41-B852-4221-8E09-692A6A639CCF	TCGA-G9-6351-11A-01R-1965-07	HG19	TCGA-G9-6351	TCGA-PRAD		s3856	University of North Carolina	Roswell Park	United States	NO	T2c		Prostate Adenocarcinoma Acinar Type		1965-07	True
13722.58cfa831e4b0c9d6adf6cb14	58cfa831e4b0c9d6adf6cb14	TCGA-DU-6405-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DU-6405-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_5_rg.sorted	TCGA-DU-6405-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_5_rg.sorted.bam	22.0	2.6	0.15	58cfa831e4b0c9d6adf6cb14	TCGA-DU-6405-10A-01D-1703_130813_SN1440_0161_BC29ENACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6405-10A	9239A22E-80B1-49A2-B0D5-CBAB7E415254	Blood Derived Normal	Illumina HiSeq	107b4f56-260b-41d1-85fc-a6746e87ca0e	Brain	51.0	D2389FBB-2FCA-4A1B-8992-3DB9B9BF6FBB	D0282997-6C05-4DF5-B79B-48E0788F2332	TCGA-DU-6405-10A-01D-1703-02	HG19_Broad_variant	TCGA-DU-6405	TCGA-LGG	605.0	s8138	Harvard Medical School	Henry Ford Hospital	United States	NO			Astrocytoma		1703-02	True
13767.58cfa833e4b0c9d6adf6dc94	58cfa833e4b0c9d6adf6dc94	UNCID_1112765.519e1ea1-6658-4978-9f3d-313d7cc1e0c1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1112765.519e1ea1-6658-4978-9f3d-313d7cc1e0c1.sorted_genome_alignments	UNCID_1112765.519e1ea1-6658-4978-9f3d-313d7cc1e0c1.sorted_genome_alignments.bam	62.7	1.89	0.14	58cfa833e4b0c9d6adf6dc94	UNCID_1112765.519e1ea1-6658-4978-9f3d-313d7cc1e0c1.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0WA-01A	786E8DBE-442E-4551-87B3-B4C333B04DD4	Primary Tumor	Illumina HiSeq	4E4F0A2D-BAA5-4CA5-ABAC-0EC889FF662D	Breast	82.0	8EF7AD6F-A6E4-405C-B20E-D547985BD9D6	519E1EA1-6658-4978-9F3D-313D7CC1E0C1	TCGA-BH-A0WA-01A-11R-A109-07	HG19	TCGA-BH-A0WA	TCGA-BRCA		s5970	University of North Carolina	University of Pittsburgh	None	NO	T1c	N0 (i-)		Stage I	A109-07	True
13767.58cfa833e4b0c9d6adf6decc	58cfa833e4b0c9d6adf6decc	UNCID_1128890.7b234c36-729b-422d-8e2a-ebd42af74bce.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1128890.7b234c36-729b-422d-8e2a-ebd42af74bce.sorted_genome_alignments	UNCID_1128890.7b234c36-729b-422d-8e2a-ebd42af74bce.sorted_genome_alignments.bam	21.0	2.02	0.17	58cfa833e4b0c9d6adf6decc	UNCID_1128890.7b234c36-729b-422d-8e2a-ebd42af74bce.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1EV-11A	417DEA5F-F68E-4DAB-940E-43AE8C67E5E6	Solid Tissue Normal	Illumina HiSeq	1B4201FB-842E-492C-9D25-6952E5EADF63	Breast	45.0	1B3867A3-80DB-417D-8E5C-F6F602C14760	7B234C36-729B-422D-8E2A-EBD42AF74BCE	TCGA-BH-A1EV-11A-24R-A137-07	HG19	TCGA-BH-A1EV	TCGA-BRCA	365.0	s6505	University of North Carolina	University of Pittsburgh	None	NO	T3	N1b	Infiltrating Ductal Carcinoma	Stage III	A137-07	True
13722.58cfa830e4b0c9d6adf6bc0f	58cfa830e4b0c9d6adf6bc0f	TCGA-AG-A00Y-10A-01D-A078-02_110405_SN590_0074_AB04EUABXX_s_8.rg.sorted.filtered.	WGS	TCGA-AG-A00Y-10A-01D-A078-02_110405_SN590_0074_AB04EUABXX_s_8.rg.sorted	TCGA-AG-A00Y-10A-01D-A078-02_110405_SN590_0074_AB04EUABXX_s_8.rg.sorted.bam	21.77	1.74	0.15	58cfa830e4b0c9d6adf6bc0f	TCGA-AG-A00Y-10A-01D-A078-02_110405_SN590_0074_AB04EUABXX_s_8.rg.sorted.bam	Alive	MALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A00Y-10A	C7E09161-60D6-4DFF-A840-7CEC3BB7A30A	Blood Derived Normal	Illumina HiSeq	6f10226b-f6f1-4624-8526-bff208e827a0	Colorectal	68.0	B67C3548-2135-4E0B-8687-624F330FD0AA	49EBF21C-8481-4D18-BF18-81A24A168FCA	TCGA-AG-A00Y-10A-01D-A078-02	HG18_Broad_variant	TCGA-AG-A00Y	TCGA-READ		s1977	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage II	A078-02	True
13767.58cfa837e4b0c9d6adf6fcbc	58cfa837e4b0c9d6adf6fcbc	UNCID_1704013.13f286ad-31e3-4ac7-94d2-d6f6a6c12c0e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1704013.13f286ad-31e3-4ac7-94d2-d6f6a6c12c0e.sorted_genome_alignments	UNCID_1704013.13f286ad-31e3-4ac7-94d2-d6f6a6c12c0e.sorted_genome_alignments.bam	57.2		0.17	58cfa837e4b0c9d6adf6fcbc	UNCID_1704013.13f286ad-31e3-4ac7-94d2-d6f6a6c12c0e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8433-11A	E8C2A8C6-5C2B-460B-B536-60BC537E6BE3	Solid Tissue Normal	Illumina HiSeq	72B7BB4F-AD81-4877-9CB4-AC8656D7E059	Kidney	46.0	6FD430CE-AE28-40F8-AA65-540B179BF3F1	13F286AD-31E3-4AC7-94D2-D6F6A6C12C0E	TCGA-KN-8433-11A-01R-2315-07	HG19	TCGA-KN-8433	TCGA-KICH		s16498	University of North Carolina	Harvard	United States	NO	T3a	NX	Kidney Chromophobe	Stage III	2315-07	True
13722.58cfa832e4b0c9d6adf6ce83	58cfa832e4b0c9d6adf6ce83	TCGA-G2-A2EJ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_4_rg.sorted.filtered.	WGS	TCGA-G2-A2EJ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_4_rg.sorted	TCGA-G2-A2EJ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_4_rg.sorted.bam	9.62		0.16	58cfa832e4b0c9d6adf6ce83	TCGA-G2-A2EJ-10A-01D-A17R_120921_SN208_0430_AC18CWACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EJ-10A	C6227D39-D9E8-4E28-9E70-D7F720AB25E4	Blood Derived Normal	Illumina HiSeq	5ca74123-b721-4ec8-bade-785975c82891	Bladder	56.0	B695C910-8DA4-4F65-94E3-BB8463305582	39AE305E-B2CB-406E-B625-9DEDF1191A86	TCGA-G2-A2EJ-10A-01D-A17R-02	HG19_Broad_variant	TCGA-G2-A2EJ	TCGA-BLCA		s2918	Harvard Medical School	MD Anderson	United States	NO		N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A17R-02	True
13767.58cfa836e4b0c9d6adf6fb77	58cfa836e4b0c9d6adf6fb77	UNCID_1661271.C97AD389-99D9-4C27-B19E-CBF454C04E43.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1661271.C97AD389-99D9-4C27-B19E-CBF454C04E43.sorted_genome_alignments	UNCID_1661271.C97AD389-99D9-4C27-B19E-CBF454C04E43.sorted_genome_alignments.bam	51.41	1.88	0.17	58cfa836e4b0c9d6adf6fb77	UNCID_1661271.C97AD389-99D9-4C27-B19E-CBF454C04E43.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A3PU-01A	4CCCC34B-DAF6-41CA-9BF8-F1614525EAC9	Primary Tumor	Illumina HiSeq	059004A9-E9F7-4FAC-BC7C-C35D3527D090	Thyroid	52.0	0BE2571E-3572-4974-95CE-21B9972B24B2	C97AD389-99D9-4C27-B19E-CBF454C04E43	TCGA-BJ-A3PU-01A-11R-A220-07	HG19	TCGA-BJ-A3PU	TCGA-THCA		s12316	University of North Carolina	University of Pittsburgh	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A220-07	True
13722.58cfa82ee4b0c9d6adf6aa42	58cfa82ee4b0c9d6adf6aa42	G32450.TCGA-FD-A3N5-10A-01D-A21A-08.4.filtered.	WGS	G32450.TCGA-FD-A3N5-10A-01D-A21A-08.4	G32450.TCGA-FD-A3N5-10A-01D-A21A-08.4.bam	27.72		0.07	58cfa82ee4b0c9d6adf6aa42	G32450.TCGA-FD-A3N5-10A-01D-A21A-08.4.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N5-10A	A658BECF-3934-49F2-9E74-291DCA61D4BB	Blood Derived Normal	Illumina HiSeq	c85e79ff-7813-4679-9c88-de2565ff4afa	Bladder	69.0	E5E8BC12-FB3C-4404-AEE2-2B90A11384A0	8AEE029E-9DA1-4714-933A-7613313DD998	TCGA-FD-A3N5-10A-01D-A21A-08	HG19_Broad_variant	TCGA-FD-A3N5	TCGA-BLCA		s2845	Broad Institute of MIT and Harvard	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21A-08	True
13767.58cfa82fe4b0c9d6adf6b4ed	58cfa82fe4b0c9d6adf6b4ed	TCGA-25-1323-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-25-1323-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-25-1323-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	409.0	1.8	0.15	58cfa82fe4b0c9d6adf6b4ed	TCGA-25-1323-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1323-01A	2EE36D9D-128B-4761-AA1A-A637DA106F3D	Primary Tumor	Illumina HiSeq	0337210A-F483-470A-9018-3EFC1277BA0D	Ovary	72.0	B1D85C32-1698-44ED-A4E2-707611A3889C	CD401B89-AE05-4775-94B0-6800F88652B0	TCGA-25-1323-01A-01R-1565-13	GRCh37-lite	TCGA-25-1323	TCGA-OV	395.0	s17383	Canada's Michael Smith Genome Sciences Centre	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		1565-13	True
13722.58cfa82fe4b0c9d6adf6b646	58cfa82fe4b0c9d6adf6b646	TCGA-75-5126-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_6_rg.sorted.filtered.	WGS	TCGA-75-5126-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_6_rg.sorted	TCGA-75-5126-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_6_rg.sorted.bam	72.7	1.9	0.16	58cfa82fe4b0c9d6adf6b646	TCGA-75-5126-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_6_rg.sorted.bam	Alive	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-75-5126-10A	93766482-2F20-4C8F-BBD8-BDD203C37D5A	Blood Derived Normal	Illumina HiSeq	c15f5681-638a-4471-a349-56138d68fe62	Lung		9D7D2BB6-7463-4695-AD94-E70C4CE0BAA8	43ACFB6F-D582-4016-BD27-24FA2B22B6E7	TCGA-75-5126-10A-01D-1751-02	HG19_Broad_variant	TCGA-75-5126	TCGA-LUAD		s10801	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T3	N2	Lung Papillary Adenocarcinoma	Stage III	1751-02	True
13767.58cfa838e4b0c9d6adf70694	58cfa838e4b0c9d6adf70694	UNCID_1976132.7c895abd-3ee8-44ac-bc5d-894bf55a888a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1976132.7c895abd-3ee8-44ac-bc5d-894bf55a888a.sorted_genome_alignments	UNCID_1976132.7c895abd-3ee8-44ac-bc5d-894bf55a888a.sorted_genome_alignments.bam	252.7		0.15	58cfa838e4b0c9d6adf70694	UNCID_1976132.7c895abd-3ee8-44ac-bc5d-894bf55a888a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-A4-8518-01A	A8EC7A72-7E3A-41CC-9EB7-62E7A0642A20	Primary Tumor	Illumina HiSeq	CEA9309E-89C2-4C65-81AC-AF276FC52F71	Kidney	48.0	11AB651D-4D89-4881-BD70-6A47626BB168	7C895ABD-3EE8-44AC-BC5D-894BF55A888A	TCGA-A4-8518-01A-11R-2404-07	HG19	TCGA-A4-8518	TCGA-KIRP		s11907	University of North Carolina	International Genomics Consortium	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	2404-07	True
13767.58cfa83be4b0c9d6adf7232c	58cfa83be4b0c9d6adf7232c	UNCID_2577075.e9c11710-18d6-43e5-91c3-e278512c9f9d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2577075.e9c11710-18d6-43e5-91c3-e278512c9f9d.sorted_genome_alignments	UNCID_2577075.e9c11710-18d6-43e5-91c3-e278512c9f9d.sorted_genome_alignments.bam	31.11	1.83	0.17	58cfa83be4b0c9d6adf7232c	UNCID_2577075.e9c11710-18d6-43e5-91c3-e278512c9f9d.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-2G-AAG9-01A	39A18C44-1990-4F01-A126-A6EDA1D4AB1D	Primary Tumor	Illumina HiSeq	B27E31B1-341A-4955-8181-E6B421AA4921	Testis	25.0	00E7DED1-DC9E-4A9C-8C71-22A549AACA31	E9C11710-18D6-43E5-91C3-E278512C9F9D	TCGA-2G-AAG9-01A-11R-A430-07	HG19	TCGA-2G-AAG9	TCGA-TGCT		s610	University of North Carolina	Erasmus MC	Netherlands	NO	T2	N1		Stage III	A430-07	True
13722.58cfa82ee4b0c9d6adf6ab9c	58cfa82ee4b0c9d6adf6ab9c	G25777.TCGA-67-6215-01A-11D-1753-08.1.filtered.	WGS	G25777.TCGA-67-6215-01A-11D-1753-08.1	G25777.TCGA-67-6215-01A-11D-1753-08.1.bam	292.4	1.9	0.05	58cfa82ee4b0c9d6adf6ab9c	G25777.TCGA-67-6215-01A-11D-1753-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-67-6215-01A	DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2	Primary Tumor	Illumina HiSeq	70835707-2b01-4434-88b9-57b2c434b88e	Lung	52.0	3BA5F6B9-6458-44E2-A0AA-B5C7E5FCD632	68C2A355-862C-4657-B296-5776ED8447B0	TCGA-67-6215-01A-11D-1753-08	HG19_Broad_variant	TCGA-67-6215	TCGA-LUAD		s10633	Broad Institute of MIT and Harvard	St Joseph's Medical Center (MD)	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1753-08	True
13767.58cfa834e4b0c9d6adf6e35a	58cfa834e4b0c9d6adf6e35a	UNCID_1187542.241dddc6-7972-4f13-9fc4-b07389eb29ef.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1187542.241dddc6-7972-4f13-9fc4-b07389eb29ef.sorted_genome_alignments	UNCID_1187542.241dddc6-7972-4f13-9fc4-b07389eb29ef.sorted_genome_alignments.bam	37.8	1.8	0.17	58cfa834e4b0c9d6adf6e35a	UNCID_1187542.241dddc6-7972-4f13-9fc4-b07389eb29ef.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5705-11A	62CF9546-B932-4A5E-BC9B-4103506D296D	Solid Tissue Normal	Illumina HiSeq	1E309CE9-0666-4B26-BE6D-FD0702E2DE61	Kidney	65.0	E98B63C1-84B9-453C-B38E-B7E123E18B7E	241DDDC6-7972-4F13-9FC4-B07389EB29EF	TCGA-B0-5705-11A-01R-1541-07	HG19	TCGA-B0-5705	TCGA-KIRC		s8887	University of North Carolina	University of Pittsburgh	None	NO	T1	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa83ce4b0c9d6adf72d96	58cfa83ce4b0c9d6adf72d96	UNCID_634583.27fc767b-a79b-4d0a-9daa-869f1c05a928.110930_UNC12-SN629_0145_AD0E5GABXX.1.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_634583.27fc767b-a79b-4d0a-9daa-869f1c05a928.110930_UNC12-SN629_0145_AD0E5GABXX.1.trimmed.annotated.translated_to_genomic	UNCID_634583.27fc767b-a79b-4d0a-9daa-869f1c05a928.110930_UNC12-SN629_0145_AD0E5GABXX.1.trimmed.annotated.translated_to_genomic.bam	55.8	1.7	0.15	58cfa83ce4b0c9d6adf72d96	UNCID_634583.27fc767b-a79b-4d0a-9daa-869f1c05a928.110930_UNC12-SN629_0145_AD0E5GABXX.1.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5679-01A	3FA6C93E-E7FE-402C-9526-C81411AA0920	Primary Tumor	Illumina HiSeq	B88B0C47-B206-41C9-8AC1-D0995B83B0EB	Kidney	73.0	17313700-6052-4901-8850-981FEAD99D6C	27FC767B-A79B-4D0A-9DAA-869F1C05A928	TCGA-CJ-5679-01A-11R-1541-07	HG19	TCGA-CJ-5679	TCGA-KIRC	679.0	s9934	University of North Carolina	MD Anderson Cancer Center	None	NO	T3b	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1541-07	True
13722.58cfa82ee4b0c9d6adf6ad53	58cfa82ee4b0c9d6adf6ad53	G37566.TCGA-CH-5788-10A-01D-1576-08.4.filtered.	WGS	G37566.TCGA-CH-5788-10A-01D-1576-08.4	G37566.TCGA-CH-5788-10A-01D-1576-08.4.bam	101.4	1.9	0.05	58cfa82ee4b0c9d6adf6ad53	G37566.TCGA-CH-5788-10A-01D-1576-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5788-10A	C039014F-821C-43D6-9D3C-914F9C8D98FA	Blood Derived Normal	Illumina HiSeq	4087c08f-e268-43c8-939a-54a67cf78246	Prostate	69.0	7B15C08B-3DB1-4505-A8A7-21FF56A7DCA6	EBC70303-3561-4CF6-A274-8C83D1D5F9BD	TCGA-CH-5788-10A-01D-1576-08	HG19_Broad_variant	TCGA-CH-5788	TCGA-PRAD		s3404	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type		1576-08	True
13767.58cfa82fe4b0c9d6adf6b2aa	58cfa82fe4b0c9d6adf6b2aa	TCGA-13-0885-01A-02R-1569-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0885-01A-02R-1569-13_rnaseq	TCGA-13-0885-01A-02R-1569-13_rnaseq.bam	254.0	1.8	0.16	58cfa82fe4b0c9d6adf6b2aa	TCGA-13-0885-01A-02R-1569-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0885-01A	2A924999-1FBF-470A-97BD-FD2276A9A366	Primary Tumor	Illumina HiSeq	612A30E5-D436-454A-871A-171D7B2D4649	Ovary	70.0	8486F0D0-2BB2-41A0-8B21-308407CE4ABA	E0F48D4D-4C10-4B83-9A13-9427A08371D3	TCGA-13-0885-01A-02R-1569-13	NCBI36_BCCAGSC_variant	TCGA-13-0885	TCGA-OV		s17911	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1569-13	True
13767.58cfa834e4b0c9d6adf6e94e	58cfa834e4b0c9d6adf6e94e	UNCID_1221100.634e6e3a-bbfa-4be9-bcde-b8d0c53b22d9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1221100.634e6e3a-bbfa-4be9-bcde-b8d0c53b22d9.sorted_genome_alignments	UNCID_1221100.634e6e3a-bbfa-4be9-bcde-b8d0c53b22d9.sorted_genome_alignments.bam	24.62	1.8	0.17	58cfa834e4b0c9d6adf6e94e	UNCID_1221100.634e6e3a-bbfa-4be9-bcde-b8d0c53b22d9.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2MK-06A	47FFE5EF-7D1F-44EB-9307-104771B39381	Metastatic	Illumina HiSeq	4785919D-F179-4421-82E3-CE0FEA5654E1	Skin	18.0	BC2A30BA-E2C9-4658-ADDE-C03682E195BE	634E6E3A-BBFA-4BE9-BCDE-B8D0C53B22D9	TCGA-EE-A2MK-06A-11R-A18S-07	HG19	TCGA-EE-A2MK	TCGA-SKCM		s7389	University of North Carolina	University of Sydney	Australia	NO	T4a	N0		Stage III	A18S-07	True
13767.58cfa834e4b0c9d6adf6e2fe	58cfa834e4b0c9d6adf6e2fe	UNCID_1174936.ff2558cb-1184-42fa-9333-503390fd220e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1174936.ff2558cb-1184-42fa-9333-503390fd220e.sorted_genome_alignments	UNCID_1174936.ff2558cb-1184-42fa-9333-503390fd220e.sorted_genome_alignments.bam	37.63	1.8	0.14	58cfa834e4b0c9d6adf6e2fe	UNCID_1174936.ff2558cb-1184-42fa-9333-503390fd220e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5113-01A	439794A8-51BD-4C70-968C-34CF26B90148	Primary Tumor	Illumina HiSeq	891434F8-5C2D-4BD3-A746-7FB17822DBB6	Kidney	69.0	899991FD-C376-4A7A-83EF-879C143FB5CA	FF2558CB-1184-42FA-9333-503390FD220E	TCGA-B0-5113-01A-01R-1420-07	HG19	TCGA-B0-5113	TCGA-KIRC		s9762	University of North Carolina	University of Pittsburgh	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1420-07	True
13722.58cfa831e4b0c9d6adf6c3a2	58cfa831e4b0c9d6adf6c3a2	TCGA-BS-A0UV-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BS-A0UV-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_5_rg.sorted	TCGA-BS-A0UV-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_5_rg.sorted.bam	11.85	1.97	0.15	58cfa831e4b0c9d6adf6c3a2	TCGA-BS-A0UV-10A-01D-A101_120409_SN1222_0096_BD0VA2ACXX_s_5_rg.sorted.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0UV-10A	B19425AB-A82F-4C2A-BF58-D1BD30511D74	Blood Derived Normal	Illumina HiSeq	262ac8f5-08d6-47ea-9493-ded1af443ae2	Uterus	55.0	C1DB0188-CBB7-4202-B8CF-65D4DB60F512	B546C8AD-A075-4840-B01B-FE19371815D3	TCGA-BS-A0UV-10A-01D-A101-02	HG19_Broad_variant	TCGA-BS-A0UV	TCGA-UCEC		s4611	Harvard Medical School	University of Hawaii	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13722.58cfa831e4b0c9d6adf6ca7a	58cfa831e4b0c9d6adf6ca7a	TCGA-DK-A3IT-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DK-A3IT-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_6_rg.sorted	TCGA-DK-A3IT-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_6_rg.sorted.bam	22.32		0.15	58cfa831e4b0c9d6adf6ca7a	TCGA-DK-A3IT-10A-01D-A210_120911_SN1120_0189_BD1D04ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IT-10A	58520C66-7688-435A-B09F-653B18768C41	Blood Derived Normal	Illumina HiSeq	a0fae593-7715-4c62-865f-1a19df61e8c1	Bladder	62.0	6FEB6861-FDCD-48B4-8B5B-E5B977832E17	9707C724-039B-4347-AFA6-F6668BBEE70D	TCGA-DK-A3IT-10A-01D-A210-26	HG19_Broad_variant	TCGA-DK-A3IT	TCGA-BLCA		s2718	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A210-26	True
13722.58cfa83ce4b0c9d6adf730f3	58cfa83ce4b0c9d6adf730f3	bfb755eba2cb74f4b267ec11599be1e6.filtered.	WGS	bfb755eba2cb74f4b267ec11599be1e6	bfb755eba2cb74f4b267ec11599be1e6.bam	34.65	1.78	0.08	58cfa83ce4b0c9d6adf730f3	bfb755eba2cb74f4b267ec11599be1e6.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A05D-10A	F7E06A10-74CA-4F52-A944-B3F22C016998	Blood Derived Normal	Illumina HiSeq	e5f25684-823e-40cc-af50-3fe79d356351	Uterus	67.0	2010755C-C987-427A-B3F0-3DBD4BB1249F	2B203ABC-26AB-49C2-9D47-766366BE3992	TCGA-AP-A05D-10A-01D-A013-09	GRCh37-lite	TCGA-AP-A05D	TCGA-UCEC		s4398	Washington University School of Medicine	MSKCC	None	NO			Serous endometrial adenocarcinoma		A013-09	True
13767.58cfa82fe4b0c9d6adf6b2ac	58cfa82fe4b0c9d6adf6b2ac	TCGA-23-1110-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-23-1110-01A-01R-1564-13_rnaseq	TCGA-23-1110-01A-01R-1564-13_rnaseq.bam	261.0	1.8	0.16	58cfa82fe4b0c9d6adf6b2ac	TCGA-23-1110-01A-01R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1110-01A	9FB1BA57-2007-4477-B000-2D36F163EFD2	Primary Tumor	Illumina HiSeq	8163CAB2-49A0-4C46-A269-63BE2B73F5B8	Ovary	42.0	5ADCA90E-F8AE-4A74-9C7F-A2B64FDA2B31	D93E1F93-20D0-493F-8B54-939FA4BA64F9	TCGA-23-1110-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-23-1110	TCGA-OV		s17234	Canada's Michael Smith Genome Sciences Centre	Cedars Sinai	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa834e4b0c9d6adf6e20e	58cfa834e4b0c9d6adf6e20e	UNCID_1166809.4317b197-dc43-44f2-8854-557832570098.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1166809.4317b197-dc43-44f2-8854-557832570098.sorted_genome_alignments	UNCID_1166809.4317b197-dc43-44f2-8854-557832570098.sorted_genome_alignments.bam	18.59	1.85	0.15	58cfa834e4b0c9d6adf6e20e	UNCID_1166809.4317b197-dc43-44f2-8854-557832570098.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BJ-11A	D6F911B5-E895-43F8-8F86-0AC2F1BC6FAE	Solid Tissue Normal	Illumina HiSeq	D1C4ED7B-3748-4394-A211-925E1AA0FDDC	Breast	41.0	C585BD29-35D3-4B6E-8142-F16479F89AB9	4317B197-DC43-44F2-8854-557832570098	TCGA-BH-A0BJ-11A-23R-A089-07	HG19	TCGA-BH-A0BJ	TCGA-BRCA		s6052	University of North Carolina	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A089-07	True
13767.58cfa839e4b0c9d6adf71353	58cfa839e4b0c9d6adf71353	UNCID_2309058.0ba1f5ce-704d-4a40-854a-fcde2b4dee86.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2309058.0ba1f5ce-704d-4a40-854a-fcde2b4dee86.sorted_genome_alignments	UNCID_2309058.0ba1f5ce-704d-4a40-854a-fcde2b4dee86.sorted_genome_alignments.bam	15.11	1.83	0.18	58cfa839e4b0c9d6adf71353	UNCID_2309058.0ba1f5ce-704d-4a40-854a-fcde2b4dee86.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-QH-A6X4-01A	976D067B-9D7F-4920-A04D-E831EDC6C2C2	Primary Tumor	Illumina HiSeq	A20EDEDD-C6E0-4A16-8A74-895453A7B35D	Brain	47.0	4A31B528-DAA9-4793-B3E9-282A49245868	0BA1F5CE-704D-4A40-854A-FCDE2B4DEE86	TCGA-QH-A6X4-01A-51R-A32Q-07	HG19	TCGA-QH-A6X4	TCGA-LGG		s8265	University of North Carolina	Fondazione-Besta	Italy	NO			Oligoastrocytoma		A32Q-07	True
13722.58cfa832e4b0c9d6adf6cf77	58cfa832e4b0c9d6adf6cf77	TCGA-FV-A23B-11A-11D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A23B-11A-11D-A16V-10_wgs_Illumina	TCGA-FV-A23B-11A-11D-A16V-10_wgs_Illumina.bam	59.54	1.84	0.08	58cfa832e4b0c9d6adf6cf77	TCGA-FV-A23B-11A-11D-A16V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A23B-11A	C95ED407-BCC2-44AA-BC59-BF7549F2D665	Solid Tissue Normal	Illumina HiSeq	21726edb-b580-4d98-92c8-f4311975c3c8	Liver	70.0	CF3E04FE-9FC4-4293-A7C0-B46510F590E9	6C3072B0-3EB6-4A43-8A18-74E5A5869D4C	TCGA-FV-A23B-11A-11D-A16V-10	GRCh37-lite	TCGA-FV-A23B	TCGA-LIHC		s17062	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A16V-10	True
13722.58cfa82ee4b0c9d6adf6ab48	58cfa82ee4b0c9d6adf6ab48	G26360.TCGA-32-1970-10A-01D-1494-08.1.filtered.	WGS	G26360.TCGA-32-1970-10A-01D-1494-08.1	G26360.TCGA-32-1970-10A-01D-1494-08.1.bam	113.0	1.9	0.05	58cfa82ee4b0c9d6adf6ab48	G26360.TCGA-32-1970-10A-01D-1494-08.1.bam	Dead	MALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-32-1970-10A	6C5154D2-AF36-492F-B520-D925528824E4	Blood Derived Normal	Illumina HiSeq	f792ee4f-eb81-4856-97d1-10351392d58c	Brain	59.0	CF12C642-B9F8-4EF0-BD54-509536FE001D	5B9D2DB6-F2B7-47B8-8105-BA44FF3274B7	TCGA-32-1970-10A-01D-1494-08	HG19_Broad_variant	TCGA-32-1970	TCGA-GBM	468.0	s14302	Broad Institute of MIT and Harvard	St. Joseph's Hospital (AZ)	None	NO			Untreated primary (de novo) GBM		1494-08	True
13722.58cfa82ee4b0c9d6adf6adf9	58cfa82ee4b0c9d6adf6adf9	G49837.TCGA-77-7139-10A-01D-A320-08.3.filtered.	WGS	G49837.TCGA-77-7139-10A-01D-A320-08.3	G49837.TCGA-77-7139-10A-01D-A320-08.3.bam	88.3		0.08	58cfa82ee4b0c9d6adf6adf9	G49837.TCGA-77-7139-10A-01D-A320-08.3.bam	Alive	MALE	WHITE		Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-7139-10A	EE850103-6314-41A3-9734-8B520DE95B40	Blood Derived Normal	Illumina HiSeq	a87795cf-51a0-468f-bc46-142e6bf5d1c1	Lung	56.0	13CE75EA-0190-4FC3-8276-FB1DA412C1FA	C765A6F5-18F4-4D57-BAB3-719BBC3DA28A	TCGA-77-7139-10A-01D-A320-08	HG19_Broad_variant	TCGA-77-7139	TCGA-LUSC		s10507	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A320-08	True
13767.58cfa834e4b0c9d6adf6e20c	58cfa834e4b0c9d6adf6e20c	UNCID_1167087.27706c21-96cb-48e9-88ec-1c52769bfe45.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1167087.27706c21-96cb-48e9-88ec-1c52769bfe45.sorted_genome_alignments	UNCID_1167087.27706c21-96cb-48e9-88ec-1c52769bfe45.sorted_genome_alignments.bam	39.69	1.71	0.18	58cfa834e4b0c9d6adf6e20c	UNCID_1167087.27706c21-96cb-48e9-88ec-1c52769bfe45.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A1JI-01A	BAF2AFC8-F16C-488F-947C-EFC9083C6BEF	Primary Tumor	Illumina HiSeq	6650ABDF-F109-4AEF-BD09-456125FF1A1D	Breast	54.0	5A4C0145-86EB-40AE-9983-ADB13652A9A2	27706C21-96CB-48E9-88EC-1C52769BFE45	TCGA-D8-A1JI-01A-11R-A13Q-07	HG19	TCGA-D8-A1JI	TCGA-BRCA		s6054	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage II	A13Q-07	True
13767.58cfa837e4b0c9d6adf6fde7	58cfa837e4b0c9d6adf6fde7	UNCID_1728401.17f52efc-8576-41cc-9ae0-e76c860ea47c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1728401.17f52efc-8576-41cc-9ae0-e76c860ea47c.sorted_genome_alignments	UNCID_1728401.17f52efc-8576-41cc-9ae0-e76c860ea47c.sorted_genome_alignments.bam	36.75	1.8	0.18	58cfa837e4b0c9d6adf6fde7	UNCID_1728401.17f52efc-8576-41cc-9ae0-e76c860ea47c.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A438-01A	F12FA57B-3427-45FE-994B-602F498B68DA	Primary Tumor	Illumina HiSeq	CC6290BB-DE1E-4632-B95E-F4BF89F04BB4	Thyroid	23.0	18761057-8D3E-4494-BE02-A1C5D5650C00	17F52EFC-8576-41CC-9AE0-E76C860EA47C	TCGA-E8-A438-01A-11R-A23W-07	HG19	TCGA-E8-A438	TCGA-THCA		s12598	University of North Carolina	Asterand	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23W-07	True
13767.58cfa83be4b0c9d6adf720d8	58cfa83be4b0c9d6adf720d8	UNCID_2568455.2b0831e8-21b8-4e97-8ef0-268683adb76c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2568455.2b0831e8-21b8-4e97-8ef0-268683adb76c.sorted_genome_alignments	UNCID_2568455.2b0831e8-21b8-4e97-8ef0-268683adb76c.sorted_genome_alignments.bam	23.91	1.85	0.15	58cfa83be4b0c9d6adf720d8	UNCID_2568455.2b0831e8-21b8-4e97-8ef0-268683adb76c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-2G-AAGM-01A	BD42CF82-4281-41BF-93E5-8403F1A94905	Primary Tumor	Illumina HiSeq	05EE1E67-F467-4CD3-8E91-A044C7E57D55	Testis	51.0	62CA77D4-3A90-4501-8524-C6AF1399BD72	2B0831E8-21B8-4E97-8EF0-268683ADB76C	TCGA-2G-AAGM-01A-11R-A430-07	HG19	TCGA-2G-AAGM	TCGA-TGCT		s583	University of North Carolina	Erasmus MC	Netherlands	NO	T2	N0		Stage I	A430-07	True
13767.58cfa838e4b0c9d6adf70bc0	58cfa838e4b0c9d6adf70bc0	UNCID_2115650.c394bf58-ce01-4ad3-a0f7-f2c5a251356d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2115650.c394bf58-ce01-4ad3-a0f7-f2c5a251356d.sorted_genome_alignments	UNCID_2115650.c394bf58-ce01-4ad3-a0f7-f2c5a251356d.sorted_genome_alignments.bam	9.29	1.92	0.16	58cfa838e4b0c9d6adf70bc0	UNCID_2115650.c394bf58-ce01-4ad3-a0f7-f2c5a251356d.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-R3-A69X-01A	692A6CED-0246-4E5E-AD2F-20450073F335	Primary Tumor	Illumina HiSeq	079DB9B0-62D3-4807-8414-5CB746AC2AC8	Bladder	70.0	311CCB15-C5D3-4E70-850A-BDF75779238C	C394BF58-CE01-4AD3-A0F7-F2C5A251356D	TCGA-R3-A69X-01A-22R-A30C-07	HG19	TCGA-R3-A69X	TCGA-BLCA		s2787	University of North Carolina	CHI-Penrose Colorado	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A30C-07	True
13722.58cfa82fe4b0c9d6adf6b716	58cfa82fe4b0c9d6adf6b716	TCGA-73-4662-11A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_6_rg.sorted.filtered.	WGS	TCGA-73-4662-11A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_6_rg.sorted	TCGA-73-4662-11A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_6_rg.sorted.bam	648.3	1.9	0.15	58cfa82fe4b0c9d6adf6b716	TCGA-73-4662-11A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4662-11A	294FF941-AEA1-4588-9A0E-E9F5393E2BB6	Solid Tissue Normal	Illumina HiSeq	2018de7f-d9e8-4e7f-8459-9794814494b5	Lung	65.0	D4E6A949-F60C-4B76-8810-A778180F9139	998F30CD-957A-4E93-87A8-BED043774480	TCGA-73-4662-11A-01D-1203-02	HG19_Broad_variant	TCGA-73-4662	TCGA-LUAD		s11245	Harvard Medical School	Roswell Park	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1203-02	True
13767.58cfa834e4b0c9d6adf6e7ac	58cfa834e4b0c9d6adf6e7ac	UNCID_1224338.381f4721-580b-4b93-9988-862780e177bb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1224338.381f4721-580b-4b93-9988-862780e177bb.sorted_genome_alignments	UNCID_1224338.381f4721-580b-4b93-9988-862780e177bb.sorted_genome_alignments.bam	7.14	1.87	0.16	58cfa834e4b0c9d6adf6e7ac	UNCID_1224338.381f4721-580b-4b93-9988-862780e177bb.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A2C5-11A	5D54C742-5A8E-4C40-8D62-95E75E210AB8	Solid Tissue Normal	Illumina HiSeq	F15F3D47-9017-4A0B-B3D4-8BE237A09041	Bladder	53.0	892EB338-9C49-4378-A934-623F4EDACF7D	381F4721-580B-4B93-9988-862780E177BB	TCGA-GD-A2C5-11A-11R-A180-07	HG19	TCGA-GD-A2C5	TCGA-BLCA		s2950	University of North Carolina	ABS - IUPUI	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A180-07	True
13767.58cfa834e4b0c9d6adf6e120	58cfa834e4b0c9d6adf6e120	UNCID_1166114.8cc55a92-1d4d-4283-be67-ca67eed7e51b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1166114.8cc55a92-1d4d-4283-be67-ca67eed7e51b.sorted_genome_alignments	UNCID_1166114.8cc55a92-1d4d-4283-be67-ca67eed7e51b.sorted_genome_alignments.bam	41.8	1.8	0.14	58cfa834e4b0c9d6adf6e120	UNCID_1166114.8cc55a92-1d4d-4283-be67-ca67eed7e51b.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5987-11A	F5759059-C0E3-4F1A-AF96-5C7197D3C33C	Solid Tissue Normal	Illumina HiSeq	8AA3A7CF-D038-423F-A5A8-9F72FD46E55A	Kidney	60.0	145E54BA-08E3-4593-BC73-C19094EB8255	8CC55A92-1D4D-4283-BE67-CA67EED7E51B	TCGA-CZ-5987-11A-01R-1672-07	HG19	TCGA-CZ-5987	TCGA-KIRC	445.0	s9181	University of North Carolina	Harvard	None	NO	T3b	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1672-07	True
13767.58cfa833e4b0c9d6adf6da83	58cfa833e4b0c9d6adf6da83	TCGA-VQ-A924-01A-11R-A414-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-A924-01A-11R-A414-31_rnaseq	TCGA-VQ-A924-01A-11R-A414-31_rnaseq.bam	62.49	1.91	0.18	58cfa833e4b0c9d6adf6da83	TCGA-VQ-A924-01A-11R-A414-31_rnaseq.bam	Dead	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-A924-01A	C656375B-6B63-4728-A126-DBD746A1F437	Primary Tumor	Illumina HiSeq	EC47FC0E-34E1-4383-B50C-E0374D960DD3	Stomach	69.0	F93F944F-F817-4E06-AF7C-020A60B0435E	4459D3F0-8AD7-4049-B438-DEE31647A99E	TCGA-VQ-A924-01A-11R-A414-31	GRCh37-lite	TCGA-VQ-A924	TCGA-STAD	1686.0	s14927	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T3	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage II	A414-31	True
13722.58cfa831e4b0c9d6adf6ca97	58cfa831e4b0c9d6adf6ca97	TCGA-D1-A17K-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D1-A17K-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_5_rg.sorted	TCGA-D1-A17K-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_5_rg.sorted.bam	29.91	1.96	0.17	58cfa831e4b0c9d6adf6ca97	TCGA-D1-A17K-10A-01D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17K-10A	5C22C8D6-5805-455C-8E1C-E6B8006738E4	Blood Derived Normal	Illumina HiSeq	3aa41447-e70b-41dc-9ca0-cac568fa8e39	Uterus	74.0	72719D9E-F802-4E2B-8979-0A080EE83E09	BE759333-002C-4763-8F1A-4A1CF5EDC33B	TCGA-D1-A17K-10A-01D-A12F-02	HG19_Broad_variant	TCGA-D1-A17K	TCGA-UCEC		s4615	Harvard Medical School	Mayo Clinic	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13722.58cfa82de4b0c9d6adf6a4d4	58cfa82de4b0c9d6adf6a4d4	406aecbc23505359850e57fbf05d5b67.filtered.	WGS	406aecbc23505359850e57fbf05d5b67	406aecbc23505359850e57fbf05d5b67.bam	85.32	1.85	0.08	58cfa82de4b0c9d6adf6a4d4	406aecbc23505359850e57fbf05d5b67.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LI-01A	E1E8DC66-467C-48A5-BE56-3DB4F665B9F1	Primary Tumor	Illumina HiSeq	626ae092-ba0a-4c13-b860-b407436bc53b	Uterus	67.0	981D9E3B-63C5-41E9-827F-7F1D268D62F4	DEC775C5-7D9A-4DC5-B399-DC4B7BA49D73	TCGA-AP-A0LI-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0LI	TCGA-UCEC		s5189	Washington University School of Medicine	MSKCC	None	NO			Serous endometrial adenocarcinoma		A066-09	True
13767.58cfa83be4b0c9d6adf71f40	58cfa83be4b0c9d6adf71f40	UNCID_2512683.2a0132e7-bd21-4c84-affb-c6f87120383c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2512683.2a0132e7-bd21-4c84-affb-c6f87120383c.sorted_genome_alignments	UNCID_2512683.2a0132e7-bd21-4c84-affb-c6f87120383c.sorted_genome_alignments.bam	40.91	1.98	0.17	58cfa83be4b0c9d6adf71f40	UNCID_2512683.2a0132e7-bd21-4c84-affb-c6f87120383c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-SX-A7SR-01A	CD54AFF9-BEE4-41AA-B347-48F8684DCECE	Primary Tumor	Illumina HiSeq	EA692328-3D12-42B7-95DE-5D70CAD74E72	Kidney	66.0	AD476933-C528-42E4-A1EA-185AF5F9AA5F	2A0132E7-BD21-4C84-AFFB-C6F87120383C	TCGA-SX-A7SR-01A-12R-A36F-07	HG19	TCGA-SX-A7SR	TCGA-KIRP		s11840	University of North Carolina	Mayo Clinic Arizona	United States	NO	T2a	NX	Kidney Papillary Renal Cell Carcinoma	Stage II	A36F-07	True
13767.58cfa834e4b0c9d6adf6e6ac	58cfa834e4b0c9d6adf6e6ac	UNCID_1202585.0cfbefba-24ff-474b-8bfa-b44a1f71b48c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1202585.0cfbefba-24ff-474b-8bfa-b44a1f71b48c.sorted_genome_alignments	UNCID_1202585.0cfbefba-24ff-474b-8bfa-b44a1f71b48c.sorted_genome_alignments.bam	136.2	1.7	0.14	58cfa834e4b0c9d6adf6e6ac	UNCID_1202585.0cfbefba-24ff-474b-8bfa-b44a1f71b48c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6848-01A	0232D299-4CDF-4FD7-9A5E-8D13C208B40C	Primary Tumor	Illumina HiSeq	E73249F1-E61C-4BDB-90A6-CFBFA82ED00A	Lung	59.0	93B55CE3-3AB0-4BC1-B1A2-3F02B13DC7B0	0CFBEFBA-24FF-474B-8BFA-B44A1F71B48C	TCGA-91-6848-01A-11R-1949-07	HG19	TCGA-91-6848	TCGA-LUAD		s11278	University of North Carolina	ABS - IUPUI	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1949-07	True
13722.58cfa830e4b0c9d6adf6bf04	58cfa830e4b0c9d6adf6bf04	TCGA-BP-4807-11A-01D-2098-10_wgs_Illumina.filtered.	WGS	TCGA-BP-4807-11A-01D-2098-10_wgs_Illumina	TCGA-BP-4807-11A-01D-2098-10_wgs_Illumina.bam	198.7	1.9	0.15	58cfa830e4b0c9d6adf6bf04	TCGA-BP-4807-11A-01D-2098-10_wgs_Illumina.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4807-11A	33CF0893-0411-4758-AA90-602BFEDF0850	Solid Tissue Normal	Illumina HiSeq	b1310112-22ca-40b1-9754-d93cec283294	Kidney	42.0	6A8AD307-FADA-432D-A223-8D9780C4ECCC	EE755D38-9449-422A-9036-51EC0EAB50FB	TCGA-BP-4807-11A-01D-2098-10	GRCh37-lite	TCGA-BP-4807	TCGA-KIRC		s9161	Baylor College of Medicine	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2098-10	True
13767.58cfa837e4b0c9d6adf70302	58cfa837e4b0c9d6adf70302	UNCID_1954254.c2c0b6ee-f0d3-431c-8cc4-9eca5173df37.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1954254.c2c0b6ee-f0d3-431c-8cc4-9eca5173df37.sorted_genome_alignments	UNCID_1954254.c2c0b6ee-f0d3-431c-8cc4-9eca5173df37.sorted_genome_alignments.bam	25.64	1.88	0.17	58cfa837e4b0c9d6adf70302	UNCID_1954254.c2c0b6ee-f0d3-431c-8cc4-9eca5173df37.sorted_genome_alignments.bam	Alive	MALE			Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-A5NK-01A	F9306CB1-C4E4-42EB-8AA9-EE906C408E10	Primary Tumor	Illumina HiSeq	C659E725-8150-47BE-A9E9-843BB61E997C	Kidney	82.0	A3EDB023-35B4-4FB5-98A0-FF51C0348187	C2C0B6EE-F0D3-431C-8CC4-9ECA5173DF37	TCGA-HE-A5NK-01A-11R-A26U-07	HG19	TCGA-HE-A5NK	TCGA-KIRP		s11896	University of North Carolina	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma		A26U-07	True
13767.58cfa833e4b0c9d6adf6da15	58cfa833e4b0c9d6adf6da15	UNCID_1083503.8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1083503.8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc.sorted_genome_alignments	UNCID_1083503.8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc.sorted_genome_alignments.bam	142.2		0.15	58cfa833e4b0c9d6adf6da15	UNCID_1083503.8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-7725-01A	9FCDCCAE-676E-4071-93C3-23D2D3AB0C00	Primary Tumor	Illumina HiSeq	4A3EC7F0-73BF-488F-822B-AE02B6CCD2F1	Lung	68.0	F9455BBC-A475-476E-BD97-6137FB011E65	8B1695B3-8ABD-4BFC-98E4-7D0AD20A5ACC	TCGA-55-7725-01A-11R-2170-07	HG19	TCGA-55-7725	TCGA-LUAD		s11135	University of North Carolina	International Genomics Consortium	United States	NO	T1a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2170-07	True
13767.58cfa836e4b0c9d6adf6fa55	58cfa836e4b0c9d6adf6fa55	UNCID_1654613.A4153890-D27B-4F55-A5E5-5204B7F59392.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1654613.A4153890-D27B-4F55-A5E5-5204B7F59392.sorted_genome_alignments	UNCID_1654613.A4153890-D27B-4F55-A5E5-5204B7F59392.sorted_genome_alignments.bam	11.15	1.86	0.16	58cfa836e4b0c9d6adf6fa55	UNCID_1654613.A4153890-D27B-4F55-A5E5-5204B7F59392.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A416-01A	86B82345-6F4D-44FD-A9DB-6F107DE62F53	Primary Tumor	Illumina HiSeq	9CF8F1BC-4F75-44A0-8DAA-356348650D99	Thyroid	51.0	AF7B5868-2C11-4C74-8033-E914C987ECE6	A4153890-D27B-4F55-A5E5-5204B7F59392	TCGA-E8-A416-01A-11R-A23N-07	HG19	TCGA-E8-A416	TCGA-THCA		s12174	University of North Carolina	Asterand	Vietnam	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23N-07	True
13722.58cfa832e4b0c9d6adf6d139	58cfa832e4b0c9d6adf6d139	TCGA-FS-A1ZE-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FS-A1ZE-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_5_rg.sorted	TCGA-FS-A1ZE-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_5_rg.sorted.bam	51.96		0.16	58cfa832e4b0c9d6adf6d139	TCGA-FS-A1ZE-10A-01D-A190_120609_SN208_0343_BC0WVWACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZE-10A	2C79ADD1-8093-4E81-8F80-069AF7B7C2FA	Blood Derived Normal	Illumina HiSeq	c24d750d-c28d-461b-b1b0-31a50556c535	Skin	40.0	B3D6F0EE-2E71-4139-A421-044034679F48	D2393DD6-8CE3-42D4-BD36-27FEF8F4F170	TCGA-FS-A1ZE-10A-01D-A190-02	HG19_Broad_variant	TCGA-FS-A1ZE	TCGA-SKCM		s8030	Harvard Medical School	Essen	Germany	NO	T4b	N0		Stage II	A190-02	True
13767.58cfa836e4b0c9d6adf6f992	58cfa836e4b0c9d6adf6f992	UNCID_1654095.965FECE0-A9D5-4165-9904-82F46AB8DA01.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1654095.965FECE0-A9D5-4165-9904-82F46AB8DA01.sorted_genome_alignments	UNCID_1654095.965FECE0-A9D5-4165-9904-82F46AB8DA01.sorted_genome_alignments.bam	15.09	1.78	0.17	58cfa836e4b0c9d6adf6f992	UNCID_1654095.965FECE0-A9D5-4165-9904-82F46AB8DA01.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3ZR-11A	96B95A2C-FB4F-4CBA-89E7-A7F0E90DB146	Solid Tissue Normal	Illumina HiSeq	04ED8516-AAC0-45CE-B004-E97F41432044	Thyroid	46.0	22D5E7DE-D90C-47E0-BD25-BA214562117A	965FECE0-A9D5-4165-9904-82F46AB8DA01	TCGA-EL-A3ZR-11A-11R-A23N-07	HG19	TCGA-EL-A3ZR	TCGA-THCA		s12810	University of North Carolina	MD Anderson	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A23N-07	True
13722.58cfa832e4b0c9d6adf6d40c	58cfa832e4b0c9d6adf6d40c	TCGA-VD-AA8O-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_4_rg.sorted.filtered.	WGS	TCGA-VD-AA8O-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_4_rg.sorted	TCGA-VD-AA8O-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_4_rg.sorted.bam	9.27		0.15	58cfa832e4b0c9d6adf6d40c	TCGA-VD-AA8O-10A-01D-A40E_140807_SN1440_0194_AC5B5RACXX_s_4_rg.sorted.bam	Alive	MALE			Uveal Melanoma	Aligned reads	TCGA-VD-AA8O-10A	99D1BFCC-1989-4DD2-A5E9-78E08F6CE7CF	Blood Derived Normal	Illumina HiSeq	9b42d7d1-b15e-4989-b862-5312e7eadbcf	Eye	77.0	1C4D043F-1BE0-4C47-9D0D-F5C551CE15FB	BF083593-194A-4549-AFF8-7A5188EF4082	TCGA-VD-AA8O-10A-01D-A40E-26	HG19_Broad_variant	TCGA-VD-AA8O	TCGA-UVM		s250	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T3a	N0		Stage II	A40E-26	True
13767.58cfa833e4b0c9d6adf6e060	58cfa833e4b0c9d6adf6e060	UNCID_1147285.25068ef3-d87f-45e2-a15f-152b87e9dedb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1147285.25068ef3-d87f-45e2-a15f-152b87e9dedb.sorted_genome_alignments	UNCID_1147285.25068ef3-d87f-45e2-a15f-152b87e9dedb.sorted_genome_alignments.bam	15.05	1.96	0.15	58cfa833e4b0c9d6adf6e060	UNCID_1147285.25068ef3-d87f-45e2-a15f-152b87e9dedb.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RV-01A	CD3FAA15-743C-476F-AB0D-F205B14126B6	Primary Tumor	Illumina HiSeq	849ECE05-1776-4214-A776-4132267E4D71	Breast	42.0	8A0C0515-ABDD-4E78-9205-BD8F80F60397	25068EF3-D87F-45E2-A15F-152B87E9DEDB	TCGA-B6-A0RV-01A-11R-A084-07	HG19	TCGA-B6-A0RV	TCGA-BRCA		s6688	University of North Carolina	Duke	United States	NO	T3	N2	Mixed Histology (please specify)	Stage III	A084-07	True
13722.58cfa83ce4b0c9d6adf72fec	58cfa83ce4b0c9d6adf72fec	f45b766a6494688451a4e74a68b954b5.filtered.	WGS	f45b766a6494688451a4e74a68b954b5	f45b766a6494688451a4e74a68b954b5.bam	31.78		0.08	58cfa83ce4b0c9d6adf72fec	f45b766a6494688451a4e74a68b954b5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-HB-A43Z-01A	9C9B53E5-CDBE-4510-A839-4A3B5039681B	Primary Tumor	Illumina HiSeq	209a73b4-3820-4d16-9437-d67356ab9735	Mesenchymal	58.0	A6BBEE06-44BF-446A-8D21-550AA6E71960	16D33E09-2E21-4DA2-8E57-E78CE28C4408	TCGA-HB-A43Z-01A-11D-A24N-09	GRCh37-lite	TCGA-HB-A43Z	TCGA-SARC		s2637	Washington University School of Medicine	University of North Carolina	United States	NO					A24N-09	True
13722.58cfa832e4b0c9d6adf6d334	58cfa832e4b0c9d6adf6d334	TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina	TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.bam	157.0		0.05	58cfa832e4b0c9d6adf6d334	TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8639-01A	2EA84E23-6A0A-4C5D-9C70-D5355A85DF35	Primary Tumor	Illumina HiSeq	f1dafc21-d5b0-48e6-ab3e-2fffa2d599e4	Kidney	67.0	E1D3EE37-402B-4727-8E27-B797D42F46BA	0B811C6A-8F05-44BD-AC33-FB720D189E71	TCGA-KM-8639-01A-11D-2397-10	GRCh37-lite	TCGA-KM-8639	TCGA-KICH		s16572	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T1a	NX	Kidney Chromophobe	Stage I	2397-10	False
13767.58cfa838e4b0c9d6adf7058a	58cfa838e4b0c9d6adf7058a	UNCID_1926381.f68894de-6db1-472b-bbda-f1c6e60a818b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1926381.f68894de-6db1-472b-bbda-f1c6e60a818b.sorted_genome_alignments	UNCID_1926381.f68894de-6db1-472b-bbda-f1c6e60a818b.sorted_genome_alignments.bam	37.75	1.86	0.16	58cfa838e4b0c9d6adf7058a	UNCID_1926381.f68894de-6db1-472b-bbda-f1c6e60a818b.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A43X-01A	4FF4D9FE-EAB8-4AB3-9AE4-9F15B2581A8F	Primary Tumor	Illumina HiSeq	EAF892BE-FE0D-40AF-9818-D990D5D7825D	Bladder	84.0	88C99351-F64D-4310-BC80-44C4399DA91E	F68894DE-6DB1-472B-BBDA-F1C6E60A818B	TCGA-FD-A43X-01A-11R-A23W-07	HG19	TCGA-FD-A43X	TCGA-BLCA		s3344	University of North Carolina	BLN - University Of Chicago	United States	NO	T2a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A23W-07	True
13722.58cfa832e4b0c9d6adf6d2fa	58cfa832e4b0c9d6adf6d2fa	TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina.bam	71.3		0.05	58cfa832e4b0c9d6adf6d2fa	TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8443-01A	2F1C4DB6-88A7-4A5D-A5FE-94D85F569440	Primary Tumor	Illumina HiSeq	eecb2ae5-92c3-432e-be0c-d7463b8efbb1	Kidney	57.0	F606FE9C-7D9F-4615-AB16-0BB4C796ADEA	C00DE7A0-0B09-4E07-988C-EF2A7F8E932A	TCGA-KM-8443-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8443	TCGA-KICH		s16528	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	True
13767.58cfa833e4b0c9d6adf6e024	58cfa833e4b0c9d6adf6e024	UNCID_1131943.6a345a9e-8173-4c9e-972d-df0b154c97b0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1131943.6a345a9e-8173-4c9e-972d-df0b154c97b0.sorted_genome_alignments	UNCID_1131943.6a345a9e-8173-4c9e-972d-df0b154c97b0.sorted_genome_alignments.bam	34.8	1.67	0.16	58cfa833e4b0c9d6adf6e024	UNCID_1131943.6a345a9e-8173-4c9e-972d-df0b154c97b0.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A155-01A	01F50ABF-FC15-446E-9D07-EDEECC545A32	Primary Tumor	Illumina HiSeq	B155F100-847D-41F2-A1B9-BEE505B6849E	Breast	58.0	6AE685E1-CD02-4C07-839D-0F2507077955	6A345A9E-8173-4C9E-972D-DF0B154C97B0	TCGA-E2-A155-01A-11R-A12D-07	HG19	TCGA-E2-A155	TCGA-BRCA		s5666	University of North Carolina	Roswell Park	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A12D-07	True
13722.58cfa832e4b0c9d6adf6d2aa	58cfa832e4b0c9d6adf6d2aa	TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina.bam	71.3		0.05	58cfa832e4b0c9d6adf6d2aa	TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8326-01A	03F3DD32-E1D1-485B-A968-3F55798F4D46	Primary Tumor	Illumina HiSeq	b96eaa8e-2627-4ac2-a3fb-1140269babf6	Kidney	69.0	59703768-8BE1-47A7-8C7D-D794C0936019	4729FE4B-C1AC-489B-A67E-91E5C5E3FF8C	TCGA-KL-8326-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8326	TCGA-KICH		s16519	Baylor College of Medicine	MSKCC	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2310-10	True
13767.58cfa82ee4b0c9d6adf6b13c	58cfa82ee4b0c9d6adf6b13c	TCGA-09-1665-01B-01R-1566-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-09-1665-01B-01R-1566-13_GRCh37-lite_rnaseq	TCGA-09-1665-01B-01R-1566-13_GRCh37-lite_rnaseq.bam	55.0	1.8	0.16	58cfa82ee4b0c9d6adf6b13c	TCGA-09-1665-01B-01R-1566-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-1665-01B	9D25CD0E-0A3E-4EE0-B1A3-58FFAB348C9D	Primary Tumor	Illumina HiSeq	7EB8EA44-B8F0-494E-8546-B3838EADE436	Ovary	73.0	D66FB62F-8483-459C-999E-D5B64B835E11	C06F72E0-E59F-4CBB-8233-1EB6637EA23F	TCGA-09-1665-01B-01R-1566-13	GRCh37-lite	TCGA-09-1665	TCGA-OV	1266.0	s17118	Canada's Michael Smith Genome Sciences Centre	UCSF	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa839e4b0c9d6adf71055	58cfa839e4b0c9d6adf71055	UNCID_2224091.f11c2ee8-9bf1-4a41-b154-7fb31af15298.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2224091.f11c2ee8-9bf1-4a41-b154-7fb31af15298.sorted_genome_alignments	UNCID_2224091.f11c2ee8-9bf1-4a41-b154-7fb31af15298.sorted_genome_alignments.bam	52.05	1.86	0.17	58cfa839e4b0c9d6adf71055	UNCID_2224091.f11c2ee8-9bf1-4a41-b154-7fb31af15298.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E7-A519-01A	74216D58-9E34-4A2B-B4AF-886C4A3DC079	Primary Tumor	Illumina HiSeq	BBD38E02-582D-48D4-BD83-9156AD0FC89E	Bladder	72.0	A7760929-71CA-4792-9828-2FDDFF3FCA3C	F11C2EE8-9BF1-4A41-B154-7FB31AF15298	TCGA-E7-A519-01A-11R-A26T-07	HG19	TCGA-E7-A519	TCGA-BLCA		s2795	University of North Carolina	Asterand	Russia	NO	T2b	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A26T-07	True
13722.58cfa82fe4b0c9d6adf6b8e2	58cfa82fe4b0c9d6adf6b8e2	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.filtered.	WGS	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.bam	8.32		0.14	58cfa82fe4b0c9d6adf6b8e2	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A26F-01B	3B7B9C1E-A84C-47ED-983C-9E4B00CBF01A	Primary Tumor	Illumina HiSeq	4925c013-4605-47d0-9c97-2e8a69233aa4	Breast	55.0	29619D1E-E8B4-411E-BBBA-07F2CFB69E8A	A723DE1E-A9E0-487D-8D86-7AA4A062A1C2	TCGA-A7-A26F-01B-04D-A22S-26	HG19_Broad_variant	TCGA-A7-A26F	TCGA-BRCA		s6916	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	YES	T1	N0	Other  specify	Stage I	A22S-26	False
13767.58cfa83ae4b0c9d6adf71a4c	58cfa83ae4b0c9d6adf71a4c	UNCID_2455641.4866c074-094a-4432-8d23-825fd698eeda.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2455641.4866c074-094a-4432-8d23-825fd698eeda.sorted_genome_alignments	UNCID_2455641.4866c074-094a-4432-8d23-825fd698eeda.sorted_genome_alignments.bam	13.1	1.93	0.15	58cfa83ae4b0c9d6adf71a4c	UNCID_2455641.4866c074-094a-4432-8d23-825fd698eeda.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-V1-A8ML-01A	69174712-AF41-422D-952A-D8D0D16D7182	Primary Tumor	Illumina HiSeq	3164977A-DB78-4B68-A751-583EB9D2BE31	Prostate	63.0	7E64E9CD-64A6-4AD0-B851-CEA249D4A27A	4866C074-094A-4432-8D23-825FD698EEDA	TCGA-V1-A8ML-01A-11R-A37L-07	HG19	TCGA-V1-A8ML	TCGA-PRAD		s3729	University of North Carolina	University of California San Francisco	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		A37L-07	True
13767.58cfa834e4b0c9d6adf6e08e	58cfa834e4b0c9d6adf6e08e	UNCID_1161887.2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1161887.2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b.sorted_genome_alignments	UNCID_1161887.2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b.sorted_genome_alignments.bam	65.73	2.08	0.16	58cfa834e4b0c9d6adf6e08e	UNCID_1161887.2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A26F-01A	3B7B9C1E-A84C-47ED-983C-9E4B00CBF01A	Primary Tumor	Illumina HiSeq	5A42ACF1-120A-4EC2-8BAC-1BFD3C10E75F	Breast	55.0	0EDCCD9B-72E9-4C69-899E-4BBA4DBACB40	2A4747B5-1EEB-45B1-9E92-0E0E3D7A9C1B	TCGA-A7-A26F-01A-21R-A169-07	HG19	TCGA-A7-A26F	TCGA-BRCA		s6047	University of North Carolina	Christiana Healthcare	United States	NO	T1	N0	Other  specify	Stage I	A169-07	True
13767.58cfa832e4b0c9d6adf6d13c	58cfa832e4b0c9d6adf6d13c	TCGA-HU-A4GH-01A-11R-A24K-31_rnaseq.filtered.	RNA-Seq	TCGA-HU-A4GH-01A-11R-A24K-31_rnaseq	TCGA-HU-A4GH-01A-11R-A24K-31_rnaseq.bam	72.72	1.76	0.17	58cfa832e4b0c9d6adf6d13c	TCGA-HU-A4GH-01A-11R-A24K-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4GH-01A	D9424178-9CB4-4BFB-9814-BA1AFE7AD954	Primary Tumor	Illumina HiSeq	C19AAFDD-AAC0-4FC5-AC29-D1238A8AF58D	Stomach	75.0	24FFB7B6-04C9-4B35-98D6-2F59DB9204F1	20354D6E-80F0-4478-8591-B0E64EC44515	TCGA-HU-A4GH-01A-11R-A24K-31	GRCh37-lite	TCGA-HU-A4GH	TCGA-STAD		s15258	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T1b	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage I	A24K-31	True
13767.58cfa82ee4b0c9d6adf6b02a	58cfa82ee4b0c9d6adf6b02a	TCGA-13-0714-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-0714-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-13-0714-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	29.0	1.8	0.19	58cfa82ee4b0c9d6adf6b02a	TCGA-13-0714-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0714-01A	1E14F098-17B2-4F54-8E4F-E38088008DF7	Primary Tumor	Illumina HiSeq	4463DB72-38C3-4BA7-9629-E970D55B0760	Ovary	55.0	7CB799D4-B69F-4CAC-B975-1DF91396250A	DA337502-6FEF-45B6-8770-B2F0889CD802	TCGA-13-0714-01A-01R-1564-13	GRCh37-lite	TCGA-13-0714	TCGA-OV	189.0	s17598	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa839e4b0c9d6adf71397	58cfa839e4b0c9d6adf71397	UNCID_2315903.535ab8cf-47a9-4541-b3ef-223bba76a13e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2315903.535ab8cf-47a9-4541-b3ef-223bba76a13e.sorted_genome_alignments	UNCID_2315903.535ab8cf-47a9-4541-b3ef-223bba76a13e.sorted_genome_alignments.bam	34.83	1.92	0.18	58cfa839e4b0c9d6adf71397	UNCID_2315903.535ab8cf-47a9-4541-b3ef-223bba76a13e.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-LL-A73Y-01A	EA645243-DF49-4466-A255-9F3D4321E357	Primary Tumor	Illumina HiSeq	ABCC187F-7C02-43D8-9525-0C6EE0D0206F	Breast	67.0	4D088B92-CCB7-44FE-A582-F1D9034CD643	535AB8CF-47A9-4541-B3EF-223BBA76A13E	TCGA-LL-A73Y-01A-11R-A33J-07	HG19	TCGA-LL-A73Y	TCGA-BRCA		s5769	University of North Carolina	Candler	United States	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A33J-07	True
13767.58cfa834e4b0c9d6adf6e832	58cfa834e4b0c9d6adf6e832	UNCID_1233995.6a2c4d22-f7b6-4e0a-bd71-a669786da5b1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1233995.6a2c4d22-f7b6-4e0a-bd71-a669786da5b1.sorted_genome_alignments	UNCID_1233995.6a2c4d22-f7b6-4e0a-bd71-a669786da5b1.sorted_genome_alignments.bam	301.2	1.8	0.14	58cfa834e4b0c9d6adf6e832	UNCID_1233995.6a2c4d22-f7b6-4e0a-bd71-a669786da5b1.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6496-01A	CE2B7E17-424E-4954-8A68-19D7F98D2E7E	Primary Tumor	Illumina HiSeq	CBF2F09F-AEB8-493F-B3D4-87656E1FB418	Prostate	61.0	ECE85143-957D-4AD1-BFCC-B71307EFB911	6A2C4D22-F7B6-4E0A-BD71-A669786DA5B1	TCGA-G9-6496-01A-11R-1789-07	HG19	TCGA-G9-6496	TCGA-PRAD		s3470	University of North Carolina	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		1789-07	True
13722.58cfa830e4b0c9d6adf6bbb8	58cfa830e4b0c9d6adf6bbb8	TCGA-AA-A01T-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_6.rg.sorted.filtered.	WGS	TCGA-AA-A01T-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_6.rg.sorted	TCGA-AA-A01T-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_6.rg.sorted.bam	40.17	1.97	0.14	58cfa830e4b0c9d6adf6bbb8	TCGA-AA-A01T-11A-11D-A079-02_110409_SN590_0077_BB04EHABXX_s_6.rg.sorted.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01T-11A	F87C6DCC-1A9E-4DF5-962C-1F946E2611F8	Solid Tissue Normal	Illumina HiSeq	bb48e041-be2a-4f2c-83ff-39500c7790bb	Colorectal	63.0	4B1CA823-0752-4F67-AD05-70BDBCDC73B6	C5BE2240-6C97-4875-A26F-79B7F17D067F	TCGA-AA-A01T-11A-11D-A079-02	HG18_Broad_variant	TCGA-AA-A01T	TCGA-COAD		s13031	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	A079-02	True
13722.58cfa831e4b0c9d6adf6c62c	58cfa831e4b0c9d6adf6c62c	TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted	TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted.bam	84.9	1.9	0.15	58cfa831e4b0c9d6adf6c62c	TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4301-01A	7E13FE2A-3D6E-487F-900D-F5891D986AA2	Primary Tumor	Illumina HiSeq	7d1cd13f-5ac5-457f-8e7b-89cabb2463c6	Stomach	75.0	F8CCC777-65A2-41FA-95AC-AB33C3E9AD9A	55F814EC-D386-4277-8CF1-245313CF373D	TCGA-CG-4301-01A-01D-A326-26	HG19_Broad_variant	TCGA-CG-4301	TCGA-STAD		s15456	MD Anderson - Institute for Applied Cancer Science	Indivumed	Germany	NO	T4	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	A326-26	True
13767.58cfa833e4b0c9d6adf6da62	58cfa833e4b0c9d6adf6da62	UNCID_1089948.07a4d275-d7bb-4aee-ae7e-b056a8785643.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1089948.07a4d275-d7bb-4aee-ae7e-b056a8785643.sorted_genome_alignments	UNCID_1089948.07a4d275-d7bb-4aee-ae7e-b056a8785643.sorted_genome_alignments.bam	45.3	1.8	0.14	58cfa833e4b0c9d6adf6da62	UNCID_1089948.07a4d275-d7bb-4aee-ae7e-b056a8785643.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4918-01A	267FF78B-BCEB-466E-8582-C560FE227FF0	Primary Tumor	Illumina HiSeq	6BFD6EE4-3CCD-4AE6-895D-9C9969A0133E	Kidney	64.0	8262BF2A-F944-4101-8E43-51658B580747	07A4D275-D7BB-4AEE-AE7E-B056A8785643	TCGA-CJ-4918-01A-01R-1426-07	HG19	TCGA-CJ-4918	TCGA-KIRC	93.0	s9012	University of North Carolina	MD Anderson Cancer Center	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1426-07	True
13767.58cfa837e4b0c9d6adf70279	58cfa837e4b0c9d6adf70279	UNCID_1886222.24f42719-6ad5-48fb-b27d-5812c3447b46.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1886222.24f42719-6ad5-48fb-b27d-5812c3447b46.sorted_genome_alignments	UNCID_1886222.24f42719-6ad5-48fb-b27d-5812c3447b46.sorted_genome_alignments.bam	66.18	1.86	0.18	58cfa837e4b0c9d6adf70279	UNCID_1886222.24f42719-6ad5-48fb-b27d-5812c3447b46.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1ED-01A	0FF6364A-E6F4-47CA-A7E7-14705BF0A8DF	Primary Tumor	Illumina HiSeq	1407DFDB-F00D-42A0-B729-6C9D890956E5	Liver	68.0	1CF84C3E-E7E2-43A6-B9AF-E0042312F02F	24F42719-6AD5-48FB-B27D-5812C3447B46	TCGA-DD-A1ED-01A-11R-A155-07	HG19	TCGA-DD-A1ED	TCGA-LIHC		s16887	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A155-07	True
13767.58cfa838e4b0c9d6adf7075c	58cfa838e4b0c9d6adf7075c	UNCID_2010585.6d6ae00d-66bd-4a2b-9715-9b7347d1035e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2010585.6d6ae00d-66bd-4a2b-9715-9b7347d1035e.sorted_genome_alignments	UNCID_2010585.6d6ae00d-66bd-4a2b-9715-9b7347d1035e.sorted_genome_alignments.bam	52.6	1.89	0.18	58cfa838e4b0c9d6adf7075c	UNCID_2010585.6d6ae00d-66bd-4a2b-9715-9b7347d1035e.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A44R-06A	5C091729-7B87-4046-BFA4-41C26C32837A	Metastatic	Illumina HiSeq	D8429100-CA9F-4B56-9F02-563A885683F7	Skin	52.0	3C0F0902-6FC1-45FE-B651-CA6A3C05DFF7	6D6AE00D-66BD-4A2B-9715-9B7347D1035E	TCGA-EB-A44R-06A-41R-A266-07	HG19	TCGA-EB-A44R	TCGA-SKCM		s7615	University of North Carolina	Asterand	Vietnam	NO	TX	N2b		Stage III	A266-07	True
13722.58cfa82ee4b0c9d6adf6ace6	58cfa82ee4b0c9d6adf6ace6	G39020.TCGA-CD-5802-01A-11D-1600-08.1.filtered.	WGS	G39020.TCGA-CD-5802-01A-11D-1600-08.1	G39020.TCGA-CD-5802-01A-11D-1600-08.1.bam	199.0	2.0	0.05	58cfa82ee4b0c9d6adf6ace6	G39020.TCGA-CD-5802-01A-11D-1600-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5802-01A	0AECAC64-5982-4D76-8F31-958F6A00951D	Primary Tumor	Illumina HiSeq	314d6a95-e101-4389-b923-7b28a44e27c9	Stomach	58.0	93C38FFB-27AC-4C91-939D-7102EE72F404	C1B44966-0F72-4C4F-8783-AB3FFE7F17B2	TCGA-CD-5802-01A-11D-1600-08	HG19_Broad_variant	TCGA-CD-5802	TCGA-STAD		s15171	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1600-08	True
13767.58cfa838e4b0c9d6adf70940	58cfa838e4b0c9d6adf70940	UNCID_2088735.2b4e9c4e-0f22-4251-947f-0e23a1fbbe62.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2088735.2b4e9c4e-0f22-4251-947f-0e23a1fbbe62.sorted_genome_alignments	UNCID_2088735.2b4e9c4e-0f22-4251-947f-0e23a1fbbe62.sorted_genome_alignments.bam	51.02	1.94	0.18	58cfa838e4b0c9d6adf70940	UNCID_2088735.2b4e9c4e-0f22-4251-947f-0e23a1fbbe62.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-A5RA-01A	5A2D3BFA-4BDD-417D-9796-E3699760114C	Primary Tumor	Illumina HiSeq	FD635492-6EAF-45D3-A901-610D6D3DC006	Brain	65.0	CD11E820-890F-42D2-81D8-CC7508725782	2B4E9C4E-0F22-4251-947F-0E23A1FBBE62	TCGA-HT-A5RA-01A-11R-A28M-07	HG19	TCGA-HT-A5RA	TCGA-LGG		s8447	University of North Carolina	Case Western - St Joes	United States	NO			Astrocytoma		A28M-07	True
13767.58cfa838e4b0c9d6adf7065e	58cfa838e4b0c9d6adf7065e	UNCID_1976436.b7e0eaf4-ff94-413e-8c1c-6b95c9167eb1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1976436.b7e0eaf4-ff94-413e-8c1c-6b95c9167eb1.sorted_genome_alignments	UNCID_1976436.b7e0eaf4-ff94-413e-8c1c-6b95c9167eb1.sorted_genome_alignments.bam	347.2		0.15	58cfa838e4b0c9d6adf7065e	UNCID_1976436.b7e0eaf4-ff94-413e-8c1c-6b95c9167eb1.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-J7-8537-01A	847865CA-9CF4-414B-BF59-A55965F37EC6	Primary Tumor	Illumina HiSeq	72B2E070-A397-4503-8E5B-D4C1838492F4	Kidney	37.0	D9EA2C79-08A4-4AB2-89FD-F3A875CAD6B2	B7E0EAF4-FF94-413E-8C1C-6B95C9167EB1	TCGA-J7-8537-01A-11R-2404-07	HG19	TCGA-J7-8537	TCGA-KIRP		s11812	University of North Carolina	ILSbio	Vietnam	NO	T3	N1	Kidney Papillary Renal Cell Carcinoma	Stage III	2404-07	True
13767.58cfa835e4b0c9d6adf6ea61	58cfa835e4b0c9d6adf6ea61	UNCID_1269657.f913d61f-70f0-4dd3-a9f9-384133734d43.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1269657.f913d61f-70f0-4dd3-a9f9-384133734d43.sorted_genome_alignments	UNCID_1269657.f913d61f-70f0-4dd3-a9f9-384133734d43.sorted_genome_alignments.bam	274.2	1.8	0.15	58cfa835e4b0c9d6adf6ea61	UNCID_1269657.f913d61f-70f0-4dd3-a9f9-384133734d43.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-G7-6795-01A	11D7CF4D-4AD2-4CE7-A1AC-3B729A8D566E	Primary Tumor	Illumina HiSeq	ADB3FFD2-1DE2-45D5-B918-DD74385329E6	Kidney	56.0	474C3B6C-5E0F-4DCC-9C61-70D449420CDB	F913D61F-70F0-4DD3-A9F9-384133734D43	TCGA-G7-6795-01A-11R-1965-07	HG19	TCGA-G7-6795	TCGA-KIRP		s11886	University of North Carolina	Roswell Park	United States	NO	T1a	N0	Kidney Papillary Renal Cell Carcinoma	Stage I	1965-07	True
13767.58cfa831e4b0c9d6adf6c4b9	58cfa831e4b0c9d6adf6c4b9	TCGA-BR-8284-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-8284-01A-11R-2343-13_rnaseq	TCGA-BR-8284-01A-11R-2343-13_rnaseq.bam	178.2		0.14	58cfa831e4b0c9d6adf6c4b9	TCGA-BR-8284-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8284-01A	A89E46F4-4808-41E5-A047-ACEBF8744EB7	Primary Tumor	Illumina HiSeq	05FDDAD9-9694-4C30-86F1-3363916039A8	Stomach	72.0	2012FAA6-F33B-4BFE-800D-FEE233F742A5	C0BC08C4-A9ED-4B0E-A830-F777581ECED7	TCGA-BR-8284-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8284	TCGA-STAD		s15388	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4a	N3a	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2343-13	True
13767.58cfa834e4b0c9d6adf6e4b2	58cfa834e4b0c9d6adf6e4b2	UNCID_1193744.b7896fd3-9fc0-47cc-aecf-c1ab6d7ded37.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1193744.b7896fd3-9fc0-47cc-aecf-c1ab6d7ded37.sorted_genome_alignments	UNCID_1193744.b7896fd3-9fc0-47cc-aecf-c1ab6d7ded37.sorted_genome_alignments.bam	100.3	1.8	0.14	58cfa834e4b0c9d6adf6e4b2	UNCID_1193744.b7896fd3-9fc0-47cc-aecf-c1ab6d7ded37.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-4866-01A	291F45AB-1B77-456A-9783-06106FBE3053	Primary Tumor	Illumina HiSeq	3C92F742-8D0D-4CF7-9063-07157F3F81AF	Kidney	79.0	2E66D442-786A-484E-8050-C9B9198FE9DC	B7896FD3-9FC0-47CC-AECF-C1AB6D7DED37	TCGA-CZ-4866-01A-01R-1503-07	HG19	TCGA-CZ-4866	TCGA-KIRC		s9216	University of North Carolina	Harvard	None	NO	T1	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1503-07	True
13767.58cfa835e4b0c9d6adf6eaea	58cfa835e4b0c9d6adf6eaea	UNCID_1325220.776e6a2e-e939-4c92-b8dc-000c91bf5f64.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1325220.776e6a2e-e939-4c92-b8dc-000c91bf5f64.sorted_genome_alignments	UNCID_1325220.776e6a2e-e939-4c92-b8dc-000c91bf5f64.sorted_genome_alignments.bam	20.2		0.14	58cfa835e4b0c9d6adf6eaea	UNCID_1325220.776e6a2e-e939-4c92-b8dc-000c91bf5f64.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7818-01A	EBE711E4-45AF-4082-BDF6-B0F7AC899B3E	Primary Tumor	Illumina HiSeq	52F286A7-AF08-43D5-A455-26CCED6A9A93	Prostate	66.0	152BC45F-6D11-48C3-AB68-2119E4534D64	776E6A2E-E939-4C92-B8DC-000C91BF5F64	TCGA-HC-7818-01A-11R-2118-07	HG19	TCGA-HC-7818	TCGA-PRAD		s3650	University of North Carolina	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13767.58cfa833e4b0c9d6adf6d975	58cfa833e4b0c9d6adf6d975	UNCID_1087021.0bfc47d8-bd48-49e9-8d37-6a418d049aef.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1087021.0bfc47d8-bd48-49e9-8d37-6a418d049aef.sorted_genome_alignments	UNCID_1087021.0bfc47d8-bd48-49e9-8d37-6a418d049aef.sorted_genome_alignments.bam	129.2		0.14	58cfa833e4b0c9d6adf6d975	UNCID_1087021.0bfc47d8-bd48-49e9-8d37-6a418d049aef.sorted_genome_alignments.bam	Alive	MALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-50-5946-02A	C95957A7-1A1A-4C8D-BB61-7C99B500F224	Recurrent Tumor	Illumina HiSeq	DD58248C-5BDB-4E94-A428-E0F3D7AF7C4D	Lung	62.0	1233CC10-AE87-42D7-B2D3-A9F6D761D0D8	0BFC47D8-BD48-49E9-8D37-6A418D049AEF	TCGA-50-5946-02A-11R-2090-07	HG19	TCGA-50-5946	TCGA-LUAD		s10916	University of North Carolina	University of Pittsburgh	United States	NO	T1	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	2090-07	True
13767.58cfa83be4b0c9d6adf726f4	58cfa83be4b0c9d6adf726f4	UNCID_2624242.98498920-e1fe-447a-929f-ff975eef9c32.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2624242.98498920-e1fe-447a-929f-ff975eef9c32.sorted_genome_alignments	UNCID_2624242.98498920-e1fe-447a-929f-ff975eef9c32.sorted_genome_alignments.bam	11.66	1.85	0.17	58cfa83be4b0c9d6adf726f4	UNCID_2624242.98498920-e1fe-447a-929f-ff975eef9c32.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-XD-AAUG-01A	F89D429F-4747-468B-B894-89583BD8AB02	Primary Tumor	Illumina HiSeq	138F1B25-6884-4944-8F67-7B4D2433291A	Pancreas	66.0	744575CB-A16A-4F4C-AB75-B67085A5E56A	98498920-E1FE-447A-929F-FF975EEF9C32	TCGA-XD-AAUG-01A-61R-A41B-07	HG19	TCGA-XD-AAUG	TCGA-PAAD		s890	University of North Carolina	Providence Portland Medical Center	United States	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage IV	A41B-07	True
13767.58cfa839e4b0c9d6adf7122a	58cfa839e4b0c9d6adf7122a	UNCID_2277042.e60804b1-edc8-40e6-b9a1-9a02682f30d6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2277042.e60804b1-edc8-40e6-b9a1-9a02682f30d6.sorted_genome_alignments	UNCID_2277042.e60804b1-edc8-40e6-b9a1-9a02682f30d6.sorted_genome_alignments.bam	19.82	1.85	0.17	58cfa839e4b0c9d6adf7122a	UNCID_2277042.e60804b1-edc8-40e6-b9a1-9a02682f30d6.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-P5-A72W-01A	59012B43-AB0B-42C3-AED3-94E224A3DFA7	Primary Tumor	Illumina HiSeq	249A7886-B7A9-4365-85D9-90DEDB65DC3E	Brain	35.0	09090B7E-88E1-4B32-ACAF-107805EBF457	E60804B1-EDC8-40E6-B9A1-9A02682F30D6	TCGA-P5-A72W-01A-11R-A32Q-07	HG19	TCGA-P5-A72W	TCGA-LGG		s8690	University of North Carolina	Cureline	Russia	NO			Astrocytoma		A32Q-07	True
13767.58cfa83ae4b0c9d6adf71dd5	58cfa83ae4b0c9d6adf71dd5	UNCID_2509435.4eb34863-1da8-4d8e-a1db-431d2e0de388.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2509435.4eb34863-1da8-4d8e-a1db-431d2e0de388.sorted_genome_alignments	UNCID_2509435.4eb34863-1da8-4d8e-a1db-431d2e0de388.sorted_genome_alignments.bam	20.39	1.75	0.16	58cfa83ae4b0c9d6adf71dd5	UNCID_2509435.4eb34863-1da8-4d8e-a1db-431d2e0de388.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-3A-A9I5-01A	9924E309-5C47-42FE-B937-547F2B3D6842	Primary Tumor	Illumina HiSeq	531838FE-EA8D-44F0-B45A-86789693814C	Pancreas	57.0	D005DA54-BDFC-433D-A661-B71B6C19B91C	4EB34863-1DA8-4D8E-A1DB-431D2E0DE388	TCGA-3A-A9I5-01A-11R-A38C-07	HG19	TCGA-3A-A9I5	TCGA-PAAD		s856	University of North Carolina	Moffitt Cancer Center	United States	NO		N0	Pancreas-Adenocarcinoma Ductal Type		A38C-07	True
13767.58cfa83ae4b0c9d6adf71a34	58cfa83ae4b0c9d6adf71a34	UNCID_2439790.c8a18d2b-fc77-44e6-8f1f-1064cb5a91a2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2439790.c8a18d2b-fc77-44e6-8f1f-1064cb5a91a2.sorted_genome_alignments	UNCID_2439790.c8a18d2b-fc77-44e6-8f1f-1064cb5a91a2.sorted_genome_alignments.bam	44.99	1.94	0.18	58cfa83ae4b0c9d6adf71a34	UNCID_2439790.c8a18d2b-fc77-44e6-8f1f-1064cb5a91a2.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A8GD-06A	74DC56E9-0076-458B-A12C-D50D7F057C47	Metastatic	Illumina HiSeq	B3C45E03-8F87-4503-B09A-FD4706392148	Skin	63.0	CA696371-CFC9-4524-9E1D-39E2B9901602	C8A18D2B-FC77-44E6-8F1F-1064CB5A91A2	TCGA-D3-A8GD-06A-11R-A37K-07	HG19	TCGA-D3-A8GD	TCGA-SKCM		s8088	University of North Carolina	MD Anderson	United States	NO	T4b	N3		Stage III	A37K-07	True
13722.58cfa832e4b0c9d6adf6cf07	58cfa832e4b0c9d6adf6cf07	TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted.filtered.	WGS	TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted	TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted.bam	133.0		0.15	58cfa832e4b0c9d6adf6cf07	TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7079-01A	10FBE481-F111-4F88-AE45-4D67CB265567	Primary Tumor	Illumina HiSeq	5debd428-e42f-459c-8945-f3e0a3053b9e	Prostate	51.0	190EF71A-5B5D-4009-B707-68F10147CB65	3935531A-0F99-4617-A5B6-6774E74CEE5E	TCGA-HC-7079-01A-11D-1957-02	HG19_Broad_variant	TCGA-HC-7079	TCGA-PRAD		s3624	Harvard Medical School	International Genomics Consortium	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1957-02	True
13767.58cfa839e4b0c9d6adf71596	58cfa839e4b0c9d6adf71596	UNCID_2408158.2111b1a5-6018-4647-83dc-96a70dac667b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2408158.2111b1a5-6018-4647-83dc-96a70dac667b.sorted_genome_alignments	UNCID_2408158.2111b1a5-6018-4647-83dc-96a70dac667b.sorted_genome_alignments.bam	23.37	1.87	0.15	58cfa839e4b0c9d6adf71596	UNCID_2408158.2111b1a5-6018-4647-83dc-96a70dac667b.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TM-A84C-01A	8643437F-CD1B-47C8-86BD-87B6C2F80747	Primary Tumor	Illumina HiSeq	5E823B91-E4A4-43A7-B2D0-62E74594F8ED	Brain	32.0	8B558AF1-2B40-4FCB-9C65-C91A897AFC85	2111B1A5-6018-4647-83DC-96A70DAC667B	TCGA-TM-A84C-01A-11R-A36H-07	HG19	TCGA-TM-A84C	TCGA-LGG		s8825	University of North Carolina	The University of New South Wales	Australia	NO			Astrocytoma		A36H-07	True
13722.58cfa83ce4b0c9d6adf72f7b	58cfa83ce4b0c9d6adf72f7b	ea3e2e897deb676e1aa5ff1ce3ef39eb.filtered.	WGS	ea3e2e897deb676e1aa5ff1ce3ef39eb	ea3e2e897deb676e1aa5ff1ce3ef39eb.bam	18.52		0.08	58cfa83ce4b0c9d6adf72f7b	ea3e2e897deb676e1aa5ff1ce3ef39eb.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IF-A4AJ-01A	4E8C570C-3CBE-4878-8B2C-B966868DD60D	Primary Tumor	Illumina HiSeq	5773814e-9b28-40f3-9285-0eed8b3ba493	Mesenchymal	80.0	86AE3E79-5C03-480F-8A5A-35BAC00CB89D	D53C2680-89AC-4F87-A7BA-F4C669546B76	TCGA-IF-A4AJ-01A-11D-A24N-09	GRCh37-lite	TCGA-IF-A4AJ	TCGA-SARC	767.0	s2634	Washington University School of Medicine	University of Texas MD Anderson Cancer Center	United States	NO					A24N-09	True
13767.58cfa833e4b0c9d6adf6df44	58cfa833e4b0c9d6adf6df44	UNCID_1151896.01370d42-f75c-4532-9b9c-24ff7302b033.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1151896.01370d42-f75c-4532-9b9c-24ff7302b033.sorted_genome_alignments	UNCID_1151896.01370d42-f75c-4532-9b9c-24ff7302b033.sorted_genome_alignments.bam	45.32	1.8	0.14	58cfa833e4b0c9d6adf6df44	UNCID_1151896.01370d42-f75c-4532-9b9c-24ff7302b033.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D1-01A	084C6AEC-94F7-4090-8F3F-59FA9E89721A	Primary Tumor	Illumina HiSeq	3252D852-5CF6-44A8-A8B0-330750292317	Breast	76.0	12ECE355-F1D0-446C-84E9-0AED3E6D29F8	01370D42-F75C-4532-9B9C-24FF7302B033	TCGA-A2-A0D1-01A-11R-A034-07	HG19	TCGA-A2-A0D1	TCGA-BRCA		s6035	University of North Carolina	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A034-07	True
13767.58cfa839e4b0c9d6adf712a2	58cfa839e4b0c9d6adf712a2	UNCID_2330037.386214f6-caab-4e0f-b3ed-e6103110c3bb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2330037.386214f6-caab-4e0f-b3ed-e6103110c3bb.sorted_genome_alignments	UNCID_2330037.386214f6-caab-4e0f-b3ed-e6103110c3bb.sorted_genome_alignments.bam	20.83	1.91	0.18	58cfa839e4b0c9d6adf712a2	UNCID_2330037.386214f6-caab-4e0f-b3ed-e6103110c3bb.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-HM-A6W2-06A	929505F7-0270-475E-A9D6-00BF38DC78BA	Metastatic	Illumina HiSeq	1018122C-491C-4D32-8E8F-F964873298EA	Cervix	34.0	CB0CE562-7679-4843-9B4A-FB245280A45B	386214F6-CAAB-4E0F-B3ED-E6103110C3BB	TCGA-HM-A6W2-06A-22R-A33Z-07	HG19	TCGA-HM-A6W2	TCGA-CESC		s1288	University of North Carolina	Christiana Healthcare	United States	NO	T2a	N0	Adenosquamous		A33Z-07	True
13767.58cfa83ce4b0c9d6adf72bd4	58cfa83ce4b0c9d6adf72bd4	UNCID_407359.bd434e6d-97f9-4264-952f-91b910b6249c.110707_UNC11-SN627_0117_BC03YCABXX.2.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_407359.bd434e6d-97f9-4264-952f-91b910b6249c.110707_UNC11-SN627_0117_BC03YCABXX.2.trimmed.annotated.translated_to_genomic	UNCID_407359.bd434e6d-97f9-4264-952f-91b910b6249c.110707_UNC11-SN627_0117_BC03YCABXX.2.trimmed.annotated.translated_to_genomic.bam	174.3	1.8	0.14	58cfa83ce4b0c9d6adf72bd4	UNCID_407359.bd434e6d-97f9-4264-952f-91b910b6249c.110707_UNC11-SN627_0117_BC03YCABXX.2.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5169-01A	2D7E2AE4-09BA-40AF-82CE-66AC7DBD4831	Primary Tumor	Illumina HiSeq	E5F22E6E-D212-408B-AAAB-3C74862F4CD2	Kidney	70.0	9D3ACF1C-7DD9-4D5B-8FAE-5E66B76315AC	BD434E6D-97F9-4264-952F-91B910B6249C	TCGA-BP-5169-01A-01R-1426-07	HG19	TCGA-BP-5169	TCGA-KIRC		s9281	University of North Carolina	MSKCC	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1426-07	True
13767.58cfa835e4b0c9d6adf6eb74	58cfa835e4b0c9d6adf6eb74	UNCID_1262804.8a91ad45-592a-4539-90ed-2dddf33b10a4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1262804.8a91ad45-592a-4539-90ed-2dddf33b10a4.sorted_genome_alignments	UNCID_1262804.8a91ad45-592a-4539-90ed-2dddf33b10a4.sorted_genome_alignments.bam	29.95	1.87	0.16	58cfa835e4b0c9d6adf6eb74	UNCID_1262804.8a91ad45-592a-4539-90ed-2dddf33b10a4.sorted_genome_alignments.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A1YA-01A	567E4D90-5C5A-44F0-A462-90C831F3C096	Primary Tumor	Illumina HiSeq	7783E632-0024-4718-9E77-6B84F2FBB88D	Thyroid	74.0	D0880877-36CF-4DED-87B2-898C3446F90D	8A91AD45-592A-4539-90ED-2DDDF33B10A4	TCGA-EM-A1YA-01A-11R-A14Y-07	HG19	TCGA-EM-A1YA	TCGA-THCA		s12662	University of North Carolina	University Health Network	Canada	NO	T2	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14Y-07	True
13767.58cfa82fe4b0c9d6adf6b5be	58cfa82fe4b0c9d6adf6b5be	TCGA-29-1762-01A-01R-1567-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-29-1762-01A-01R-1567-13_GRCh37-lite_rnaseq	TCGA-29-1762-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	500.0	1.8	0.14	58cfa82fe4b0c9d6adf6b5be	TCGA-29-1762-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1762-01A	5495B18A-10EC-427B-83B8-03EF4B587B13	Primary Tumor	Illumina HiSeq	4E94F24C-F816-438A-8E1C-BAA3507DE97E	Ovary	59.0	5DF514E7-6E12-474A-92F2-067898B351AC	C3559AE3-3355-4F38-9C07-E557E435FCBD	TCGA-29-1762-01A-01R-1567-13	GRCh37-lite	TCGA-29-1762	TCGA-OV	2634.0	s17791	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1567-13	True
13722.58cfa832e4b0c9d6adf6d258	58cfa832e4b0c9d6adf6d258	TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted.filtered.	WGS	TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted	TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted.bam	14.71		0.15	58cfa832e4b0c9d6adf6d258	TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-K4-A3WV-11A	D53EADE8-A845-4252-AECE-92F3573486A7	Solid Tissue Normal	Illumina HiSeq	3dc4b7a1-75cf-4f52-b921-7d6dcb7d1046	Bladder	77.0	C8B4ED6D-69C0-4052-BEC2-9FE6A3CFC481	30325C24-68C0-40DD-987B-DF84C4B5FBEA	TCGA-K4-A3WV-11A-21D-A23Q-26	HG19_Broad_variant	TCGA-K4-A3WV	TCGA-BLCA		s2938	MD Anderson - Institute for Applied Cancer Science	ABS - Lahey Clinic	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A23Q-26	True
13767.58cfa837e4b0c9d6adf701ac	58cfa837e4b0c9d6adf701ac	UNCID_1879077.3e775d6c-3845-49a7-80e0-82c5c68a473c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1879077.3e775d6c-3845-49a7-80e0-82c5c68a473c.sorted_genome_alignments	UNCID_1879077.3e775d6c-3845-49a7-80e0-82c5c68a473c.sorted_genome_alignments.bam	24.71	1.89	0.16	58cfa837e4b0c9d6adf701ac	UNCID_1879077.3e775d6c-3845-49a7-80e0-82c5c68a473c.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A3W5-01A	4C313E5B-4DC3-408E-8E92-22427F74743E	Primary Tumor	Illumina HiSeq	D592B7C1-A7E3-426F-BA66-0215380E1ED8	Breast	65.0	083F4985-57C0-4931-BA8A-00F565430DA9	3E775D6C-3845-49A7-80E0-82C5C68A473C	TCGA-AC-A3W5-01A-11R-A22K-07	HG19	TCGA-AC-A3W5	TCGA-BRCA		s6731	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Infiltrating Lobular Carcinoma	Stage II	A22K-07	True
13767.58cfa83be4b0c9d6adf72a78	58cfa83be4b0c9d6adf72a78	UNCID_359370.TCGA-CJ-4888-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.4.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_359370.TCGA-CJ-4888-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.4.trimmed.annotated.translated_to_genomic	UNCID_359370.TCGA-CJ-4888-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.4.trimmed.annotated.translated_to_genomic.bam	41.3	1.8	0.17	58cfa83be4b0c9d6adf72a78	UNCID_359370.TCGA-CJ-4888-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.4.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4888-01A	F2FCA062-CA87-4089-916D-49B9FF146797	Primary Tumor	Illumina HiSeq	663DCBFB-829F-4E4A-8A47-C853CDD44FF0	Kidney	59.0	E803E3FE-27FA-4AF5-A81E-5B61F85DECAC	83454A4F-B4AB-479E-90D7-252985CCA3BC	TCGA-CJ-4888-01A-01R-1305-07	HG19	TCGA-CJ-4888	TCGA-KIRC	1567.0	s9683	University of North Carolina	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1305-07	True
13722.58cfa830e4b0c9d6adf6bdf1	58cfa830e4b0c9d6adf6bdf1	TCGA-AK-3428-01A-02D-2096-10_Illumina.filtered.	WGS	TCGA-AK-3428-01A-02D-2096-10_Illumina	TCGA-AK-3428-01A-02D-2096-10_Illumina.bam	23.4	1.9	0.14	58cfa830e4b0c9d6adf6bdf1	TCGA-AK-3428-01A-02D-2096-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-AK-3428-01A	9DA334ED-314C-4445-BA29-FFD9BB42403C	Primary Tumor	Illumina HiSeq	46d21c8f-8493-4886-82f4-91fd488b4364	Kidney	62.0	0B96A41E-6A0C-4FC6-8F21-8E5F992CE5D1	D01710F9-EFC8-4B5F-9E53-300B30F9219F	TCGA-AK-3428-01A-02D-2096-10	GRCh37-lite	TCGA-AK-3428	TCGA-KIRC		s9303	Baylor College of Medicine	Fox Chase	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	2096-10	False
13767.58cfa836e4b0c9d6adf6f9da	58cfa836e4b0c9d6adf6f9da	UNCID_1648550.550b677c-c33a-499c-95dc-68250384b6a8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1648550.550b677c-c33a-499c-95dc-68250384b6a8.sorted_genome_alignments	UNCID_1648550.550b677c-c33a-499c-95dc-68250384b6a8.sorted_genome_alignments.bam	46.27	1.82	0.16	58cfa836e4b0c9d6adf6f9da	UNCID_1648550.550b677c-c33a-499c-95dc-68250384b6a8.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2PL-01A	45CADCF3-EA98-4063-9255-5C18D6A5CBAB	Primary Tumor	Illumina HiSeq	60507474-1B3A-459C-BBB9-0C2CE43F2280	Cervix	36.0	6EE33187-69A7-4328-9521-173CFCDE7A1B	550B677C-C33A-499C-95DC-68250384B6A8	TCGA-EK-A2PL-01A-11R-A18M-07	HG19	TCGA-EK-A2PL	TCGA-CESC		s1387	University of North Carolina	Gynecologic Oncology Group	United States	NO			Cervical Squamous Cell Carcinoma		A18M-07	True
13767.58cfa839e4b0c9d6adf710ae	58cfa839e4b0c9d6adf710ae	UNCID_2248983.0697ab9a-88cc-4428-b02a-7666f0a772fa.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2248983.0697ab9a-88cc-4428-b02a-7666f0a772fa.sorted_genome_alignments	UNCID_2248983.0697ab9a-88cc-4428-b02a-7666f0a772fa.sorted_genome_alignments.bam	40.07	2.16	0.17	58cfa839e4b0c9d6adf710ae	UNCID_2248983.0697ab9a-88cc-4428-b02a-7666f0a772fa.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-JW-A69B-01A	FB4AF6B2-4BED-4DBE-9309-29F59ED30FB2	Primary Tumor	Illumina HiSeq	86724626-609B-4609-82E7-9F7BA6CFE42F	Cervix	44.0	BDCFFDB1-2753-4211-ADC2-57A0CB363CA3	0697AB9A-88CC-4428-B02A-7666F0A772FA	TCGA-JW-A69B-01A-11R-A32P-07	HG19	TCGA-JW-A69B	TCGA-CESC		s1283	University of North Carolina	BLN - Baylor	United States	NO	T1b2	NX	Endocervical Type of Adenocarcinoma		A32P-07	True
13767.58cfa83be4b0c9d6adf72884	58cfa83be4b0c9d6adf72884	UNCID_343048.8da87146-a8a4-4b2a-b25d-43cd0ac9d6e4.110706_UNC15-SN850_0092_AB0BJEABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_343048.8da87146-a8a4-4b2a-b25d-43cd0ac9d6e4.110706_UNC15-SN850_0092_AB0BJEABXX.7.trimmed.annotated.translated_to_genomic	UNCID_343048.8da87146-a8a4-4b2a-b25d-43cd0ac9d6e4.110706_UNC15-SN850_0092_AB0BJEABXX.7.trimmed.annotated.translated_to_genomic.bam	36.3	1.8	0.13	58cfa83be4b0c9d6adf72884	UNCID_343048.8da87146-a8a4-4b2a-b25d-43cd0ac9d6e4.110706_UNC15-SN850_0092_AB0BJEABXX.7.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4899-01A	900B5F21-E8FB-4A3F-B8E3-EF098716E508	Primary Tumor	Illumina HiSeq	2B937520-14C8-46BE-895B-7551CFB206B1	Kidney	42.0	E2D40747-F751-4CCB-A45C-A60B06046DB1	8DA87146-A8A4-4B2A-B25D-43CD0AC9D6E4	TCGA-CJ-4899-01A-01R-1334-07	HG19	TCGA-CJ-4899	TCGA-KIRC		s9530	University of North Carolina	MD Anderson Cancer Center	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13722.58cfa82ee4b0c9d6adf6a894	58cfa82ee4b0c9d6adf6a894	G26383.TCGA-02-2485-01A-01D-1494-08.1.filtered.	WGS	G26383.TCGA-02-2485-01A-01D-1494-08.1	G26383.TCGA-02-2485-01A-01D-1494-08.1.bam	521.7	1.9	0.05	58cfa82ee4b0c9d6adf6a894	G26383.TCGA-02-2485-01A-01D-1494-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-02-2485-01A	521EA765-1BD1-423D-A75D-091243DF37A9	Primary Tumor	Illumina HiSeq	fd79ff6d-c0aa-4d12-8e39-1e3f1aab26a2	Brain	53.0	5B5F7C1D-8F3D-4F35-8295-58BC3EEFEAB0	0332B017-17D5-4083-8FC4-9D6F8FDBBBDE	TCGA-02-2485-01A-01D-1494-08	HG19_Broad_variant	TCGA-02-2485	TCGA-GBM		s14220	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO			Untreated primary (de novo) GBM		1494-08	True
13767.58cfa82fe4b0c9d6adf6b271	58cfa82fe4b0c9d6adf6b271	TCGA-20-1682-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-20-1682-01A-01R-1564-13_rnaseq	TCGA-20-1682-01A-01R-1564-13_rnaseq.bam	179.0	1.8	0.15	58cfa82fe4b0c9d6adf6b271	TCGA-20-1682-01A-01R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-20-1682-01A	94BD4C68-4BFC-4DB3-9365-97C867747133	Primary Tumor	Illumina HiSeq	3388AF23-9054-44CE-BFC9-ABAB7A161D41	Ovary	56.0	3C3DA068-A62F-43C9-91C7-41EAD1CA7F75	F03D023B-CBA8-413D-A88D-0378EE7B7748	TCGA-20-1682-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-20-1682	TCGA-OV		s17181	Canada's Michael Smith Genome Sciences Centre	Fox Chase Cancer Center	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa82fe4b0c9d6adf6ba30	58cfa82fe4b0c9d6adf6ba30	TCGA-61-2009-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-61-2009-01A-01R-1568-13_rnaseq	TCGA-61-2009-01A-01R-1568-13_rnaseq.bam	437.0	1.8	0.14	58cfa82fe4b0c9d6adf6ba30	TCGA-61-2009-01A-01R-1568-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2009-01A	AE914F23-87B9-4169-A7F7-A3483078C902	Primary Tumor	Illumina HiSeq	684CCB21-A5B5-4EFC-B537-C8B558C5DA8A	Ovary	65.0	8832FA0D-1BD8-42A9-B002-1A02500D48EB	B6ED2184-0885-49BA-8B00-A3E57E4E5500	TCGA-61-2009-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-61-2009	TCGA-OV		s17278	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa82fe4b0c9d6adf6b3a2	58cfa82fe4b0c9d6adf6b3a2	TCGA-24-1419-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-24-1419-01A-01D-A324-10_wgs_Illumina	TCGA-24-1419-01A-01D-A324-10_wgs_Illumina.bam	589.97	1.9	0.09	58cfa82fe4b0c9d6adf6b3a2	TCGA-24-1419-01A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1419-01A	5E18B17D-4626-4B6D-8AC6-E560CEE0376C	Primary Tumor	Illumina HiSeq	915b863a-f427-4e28-8809-4e9f244f9f4d	Ovary	62.0	92D562DF-4A58-43DA-8811-843D3D3C9438	2F2EAECC-6509-423F-B63A-8C3BEA1BA4A4	TCGA-24-1419-01A-01D-A324-10	GRCh37-lite	TCGA-24-1419	TCGA-OV		s17620	Baylor College of Medicine	Washington University	None	NO			Serous Cystadenocarcinoma		A324-10	True
13722.58cfa831e4b0c9d6adf6c332	58cfa831e4b0c9d6adf6c332	TCGA-CG-4472-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4472-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_1_rg.sorted	TCGA-CG-4472-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_1_rg.sorted.bam	157.9	1.9	0.14	58cfa831e4b0c9d6adf6c332	TCGA-CG-4472-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_1_rg.sorted.bam	Alive	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4472-01A	306F0222-8734-44CA-9A31-86E4E62B0A1B	Primary Tumor	Illumina HiSeq	74cc19cf-8ff9-4786-87d9-936dcbb9196e	Stomach	49.0	A474CFDD-0822-42E8-A478-C0895A409CCD	8363DF43-B859-4A78-8CDE-3E06C6230EB2	TCGA-CG-4472-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4472	TCGA-STAD		s14640	Harvard Medical School	Indivumed	Germany	NO	T4	N1		Stage IV	1154-02	True
13767.58cfa836e4b0c9d6adf6fc34	58cfa836e4b0c9d6adf6fc34	UNCID_1659549.9100EDAC-3939-4318-993E-276E0F6CE00D.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1659549.9100EDAC-3939-4318-993E-276E0F6CE00D.sorted_genome_alignments	UNCID_1659549.9100EDAC-3939-4318-993E-276E0F6CE00D.sorted_genome_alignments.bam	8.53	2.04	0.16	58cfa836e4b0c9d6adf6fc34	UNCID_1659549.9100EDAC-3939-4318-993E-276E0F6CE00D.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T2-11A	8A476795-0E05-4DA6-BBE1-FF7304DA1B39	Solid Tissue Normal	Illumina HiSeq	FC852B73-85A4-464C-8DFD-3F5AC40128B0	Thyroid	55.0	E62C667D-E457-477E-89BD-E94BF1555CDA	9100EDAC-3939-4318-993E-276E0F6CE00D	TCGA-EL-A3T2-11A-11R-A22L-07	HG19	TCGA-EL-A3T2	TCGA-THCA		s12311	University of North Carolina	MD Anderson	United States	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A22L-07	True
13767.58cfa82fe4b0c9d6adf6b335	58cfa82fe4b0c9d6adf6b335	TCGA-24-1924-01A-01R-1567-13_rnaseq.filtered.	RNA-Seq	TCGA-24-1924-01A-01R-1567-13_rnaseq	TCGA-24-1924-01A-01R-1567-13_rnaseq.bam	481.0	1.8	0.13	58cfa82fe4b0c9d6adf6b335	TCGA-24-1924-01A-01R-1567-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1924-01A	26558703-A659-43F2-86CB-0695989BC14E	Primary Tumor	Illumina HiSeq	3F8DF0C0-FA6E-4895-AE5A-2F5E80EA76FE	Ovary	65.0	525471C8-0249-45ED-A443-DB52CA6C04D9	2592F314-CC0A-4D00-BDCF-6376AFD32BB7	TCGA-24-1924-01A-01R-1567-13	NCBI36_BCCAGSC_variant	TCGA-24-1924	TCGA-OV	919.0	s17941	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa834e4b0c9d6adf6e8ee	58cfa834e4b0c9d6adf6e8ee	UNCID_1223856.7c23f39f-6b3f-41d8-bb17-c35788b2b060.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1223856.7c23f39f-6b3f-41d8-bb17-c35788b2b060.sorted_genome_alignments	UNCID_1223856.7c23f39f-6b3f-41d8-bb17-c35788b2b060.sorted_genome_alignments.bam	12.02	1.84	0.18	58cfa834e4b0c9d6adf6e8ee	UNCID_1223856.7c23f39f-6b3f-41d8-bb17-c35788b2b060.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A19E-06A	3FEA3F02-2DB3-44E0-984E-C61130D92C9B	Metastatic	Illumina HiSeq	5DA789EA-6FAC-43D3-ACCC-BB01A0939282	Skin	36.0	96BB672C-48FB-4AAE-9FA5-7CEAF98E5348	7C23F39F-6B3F-41D8-BB17-C35788B2B060	TCGA-ER-A19E-06A-11R-A18S-07	HG19	TCGA-ER-A19E	TCGA-SKCM	396.0	s8042	University of North Carolina	University of Pittsburgh	United States	NO	T2a	N0		Stage I	A18S-07	True
13767.58cfa833e4b0c9d6adf6d8bc	58cfa833e4b0c9d6adf6d8bc	UNCID_1110153.42b99ee7-a1ae-4383-b343-adf468cb8b51.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1110153.42b99ee7-a1ae-4383-b343-adf468cb8b51.sorted_genome_alignments	UNCID_1110153.42b99ee7-a1ae-4383-b343-adf468cb8b51.sorted_genome_alignments.bam	51.19	1.84	0.16	58cfa833e4b0c9d6adf6d8bc	UNCID_1110153.42b99ee7-a1ae-4383-b343-adf468cb8b51.sorted_genome_alignments.bam	Alive	FEMALE			Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A06Z-01A	2399CAEB-EAD2-4003-AF38-809DB4AC2E2B	Primary Tumor	Illumina HiSeq	CA31245A-82F9-421C-9A76-879B7196FFB9	Breast	84.0	993D2CBA-B4F8-4A46-994B-B97BB9F10D34	42B99EE7-A1AE-4383-B343-ADF468CB8B51	TCGA-A8-A06Z-01A-11R-A00Z-07	HG19	TCGA-A8-A06Z	TCGA-BRCA		s6780	University of North Carolina	Indivumed	Germany	NO	T3	N0	Infiltrating Ductal Carcinoma	Stage II	A00Z-07	True
13767.58cfa833e4b0c9d6adf6d8ca	58cfa833e4b0c9d6adf6d8ca	UNCID_1110404.7b9dc578-8869-4322-a705-bfb9942d9b65.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1110404.7b9dc578-8869-4322-a705-bfb9942d9b65.sorted_genome_alignments	UNCID_1110404.7b9dc578-8869-4322-a705-bfb9942d9b65.sorted_genome_alignments.bam	161.3	1.8	0.13	58cfa833e4b0c9d6adf6d8ca	UNCID_1110404.7b9dc578-8869-4322-a705-bfb9942d9b65.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-2656-01A	42CA54FC-C1AE-41CD-BCA1-7FE9810DB460	Primary Tumor	Illumina HiSeq	39C3E7E3-3C7A-4D1B-A755-157EEC616CF9	Lung	59.0	5593F581-3D45-4A4A-A525-BFAE1F4753A0	7B9DC578-8869-4322-A705-BFB9942D9B65	TCGA-44-2656-01A-02R-0946-07	HG19	TCGA-44-2656	TCGA-LUAD		s11374	University of North Carolina	Christiana Healthcare	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	0946-07	True
13767.58cfa833e4b0c9d6adf6da80	58cfa833e4b0c9d6adf6da80	UNCID_1117955.e9d4f9c8-7355-44c4-9b18-923db7bae832.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1117955.e9d4f9c8-7355-44c4-9b18-923db7bae832.sorted_genome_alignments	UNCID_1117955.e9d4f9c8-7355-44c4-9b18-923db7bae832.sorted_genome_alignments.bam	62.54	1.63	0.16	58cfa833e4b0c9d6adf6da80	UNCID_1117955.e9d4f9c8-7355-44c4-9b18-923db7bae832.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1P5-01A	53D0AF48-D7EA-42C9-8695-C614B89B415B	Primary Tumor	Illumina HiSeq	982229A4-2C3F-420D-BD3E-E42E410C2887	Breast	77.0	C5EB7BF2-FC4A-497E-ACE9-C715FEA47E5B	E9D4F9C8-7355-44C4-9B18-923DB7BAE832	TCGA-EW-A1P5-01A-11R-A144-07	HG19	TCGA-EW-A1P5	TCGA-BRCA		s5651	University of North Carolina	University of Miami	United States	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A144-07	True
13767.58cfa838e4b0c9d6adf708c4	58cfa838e4b0c9d6adf708c4	UNCID_1990828.b31f6ff5-bd06-43d7-966e-426b787222e8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1990828.b31f6ff5-bd06-43d7-966e-426b787222e8.sorted_genome_alignments	UNCID_1990828.b31f6ff5-bd06-43d7-966e-426b787222e8.sorted_genome_alignments.bam	9.28	1.89	0.18	58cfa838e4b0c9d6adf708c4	UNCID_1990828.b31f6ff5-bd06-43d7-966e-426b787222e8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-93-A4JN-01A	9DDA72EC-1698-44E2-B35C-11E9A2704380	Primary Tumor	Illumina HiSeq	2CD35523-9018-4C96-9FF4-A5FDD3280FBA	Lung	71.0	1E39A044-EED2-4C19-9CC7-4C80D21087AB	B31F6FF5-BD06-43D7-966E-426B787222E8	TCGA-93-A4JN-01A-11R-A24X-07	HG19	TCGA-93-A4JN	TCGA-LUAD		s10742	University of North Carolina	Washington University - St. Louis	United States	NO	T2a	N0	Lung Acinar Adenocarcinoma	Stage IV	A24X-07	True
13767.58cfa832e4b0c9d6adf6d05c	58cfa832e4b0c9d6adf6d05c	TCGA-IN-7808-01A-11R-2203-13_rnaseq.filtered.	RNA-Seq	TCGA-IN-7808-01A-11R-2203-13_rnaseq	TCGA-IN-7808-01A-11R-2203-13_rnaseq.bam	212.2		0.15	58cfa832e4b0c9d6adf6d05c	TCGA-IN-7808-01A-11R-2203-13_rnaseq.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-IN-7808-01A	8F9BE4E3-A1E5-4FA3-8D31-A53DE781ED97	Primary Tumor	Illumina HiSeq	FEFD8A39-F1A6-4634-A8F5-B0C9A101C7E7	Stomach	59.0	95E36503-33A7-4CD4-9290-F8EF97B8ABBB	9AACDA24-BF9F-48E7-BE07-EC43190C0581	TCGA-IN-7808-01A-11R-2203-13	GRCh37-lite	TCGA-IN-7808	TCGA-STAD	105.0	s15207	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	United States	NO	T3	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage III	2203-13	True
13767.58cfa83ae4b0c9d6adf71b65	58cfa83ae4b0c9d6adf71b65	UNCID_2431547.88441fa0-588f-4829-a353-a6b845c90333.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2431547.88441fa0-588f-4829-a353-a6b845c90333.sorted_genome_alignments	UNCID_2431547.88441fa0-588f-4829-a353-a6b845c90333.sorted_genome_alignments.bam	28.39	1.9	0.17	58cfa83ae4b0c9d6adf71b65	UNCID_2431547.88441fa0-588f-4829-a353-a6b845c90333.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-DA-A95X-06A	D241A660-1C84-44FA-A6B3-EC9284333BD2	Metastatic	Illumina HiSeq	43F4417F-C799-4109-8BC0-464BACE5D111	Skin	62.0	0C1BF90E-8D7E-40DC-8FD9-703B28E6BC9D	88441FA0-588F-4829-A353-A6B845C90333	TCGA-DA-A95X-06A-11R-A37K-07	HG19	TCGA-DA-A95X	TCGA-SKCM		s7633	University of North Carolina	Yale	United States	NO	T2a	N0		Stage I	A37K-07	True
13767.58cfa82ee4b0c9d6adf6b0ae	58cfa82ee4b0c9d6adf6b0ae	TCGA-13-0923-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-0923-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-13-0923-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	391.0	1.7	0.15	58cfa82ee4b0c9d6adf6b0ae	TCGA-13-0923-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0923-01A	378F7EA2-86B4-4072-80B8-E12D67193106	Primary Tumor	Illumina HiSeq	3B9940CF-AB4B-428C-AE4E-B93BBEEE89EE	Ovary	74.0	38E5FC32-615E-435D-AE6E-B79701ABA593	B75DE387-11AE-4D46-81A1-54D15ECAE42A	TCGA-13-0923-01A-01R-1564-13	GRCh37-lite	TCGA-13-0923	TCGA-OV		s17151	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13722.58cfa831e4b0c9d6adf6ca05	58cfa831e4b0c9d6adf6ca05	TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted	TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.bam	60.48	2.03	0.14	58cfa831e4b0c9d6adf6ca05	TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A0Y3-01B	C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7	Primary Tumor	Illumina HiSeq	e17f6c8d-d069-4561-8371-8138731e3dd2	Thyroid	60.0	3AE03B86-1473-409C-8118-A91A73A36F60	F3099D9B-DBBE-46CB-BA22-DAD7F9428C4F	TCGA-DE-A0Y3-01B-11D-A10R-02	HG19_Broad_variant	TCGA-DE-A0Y3	TCGA-THCA		s12848	Harvard Medical School	University of North Carolina	United States	NO	T4a	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A10R-02	True
13722.58cfa832e4b0c9d6adf6d5e3	58cfa832e4b0c9d6adf6d5e3	TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted	TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted.bam	24.19		0.15	58cfa832e4b0c9d6adf6d5e3	TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49U-01A	931A50FF-3149-4C4A-9456-45ED3A9DD457	Primary Tumor	Illumina HiSeq	c075129e-527d-4603-9336-8b26a5ce10d2	Esophagus	62.0	9B3E9E79-52EB-40F7-87EC-E1CB360004E6	FF6F10D6-874C-4281-AB3B-79FF2440A901	TCGA-LN-A49U-01A-31D-A267-26	HG19_Broad_variant	TCGA-LN-A49U	TCGA-ESCA		s1777	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0		Stage II	A267-26	True
13722.58cfa832e4b0c9d6adf6d18a	58cfa832e4b0c9d6adf6d18a	TCGA-HC-7079-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_1_rg.sorted.filtered.	WGS	TCGA-HC-7079-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_1_rg.sorted	TCGA-HC-7079-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_1_rg.sorted.bam	183.3		0.15	58cfa832e4b0c9d6adf6d18a	TCGA-HC-7079-10A-01D-1957_130422_SN590_0225_BD23TLACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7079-10A	10FBE481-F111-4F88-AE45-4D67CB265567	Blood Derived Normal	Illumina HiSeq	105059d4-8eb5-4f7a-a63f-838e9c234d43	Prostate	51.0	53CD52BA-57F8-4924-9143-9CE98DDB607E	C5549F0E-C3F4-450A-A8DE-4D3AD0155C85	TCGA-HC-7079-10A-01D-1957-02	HG19_Broad_variant	TCGA-HC-7079	TCGA-PRAD		s3460	Harvard Medical School	International Genomics Consortium	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1957-02	True
13722.58cfa82de4b0c9d6adf6a46d	58cfa82de4b0c9d6adf6a46d	0434f7930c67bd9c412cb31f2ada0466.filtered.	WGS	0434f7930c67bd9c412cb31f2ada0466	0434f7930c67bd9c412cb31f2ada0466.bam	27.89	1.93	0.08	58cfa82de4b0c9d6adf6a46d	0434f7930c67bd9c412cb31f2ada0466.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18R-01A	F6E1EC78-5AD9-4879-9B7E-262D17B166AD	Primary Tumor	Illumina HiSeq	14062e7f-b11d-44a9-ae98-3383c517bf91	Breast	50.0	518BE2C7-FBA5-47B1-8C8B-FEF812FA74A4	9C70688D-6E43-4520-9262-EAAE4E4D597D	TCGA-BH-A18R-01A-11D-A19H-09	GRCh37-lite	TCGA-BH-A18R	TCGA-BRCA	1142.0	s6259	Washington University School of Medicine	University of Pittsburgh	None	NO	T2b	N1	Infiltrating Ductal Carcinoma	Stage II	A19H-09	True
13722.58cfa82fe4b0c9d6adf6b67d	58cfa82fe4b0c9d6adf6b67d	TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	142.53	1.9	0.14	58cfa82fe4b0c9d6adf6b67d	TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4486-01A	61C655EC-52B5-453F-A6CC-B2ABA445B027	Primary Tumor	Illumina HiSeq	cb4d8cf1-9903-481c-8ba1-df0586b69916	Lung	72.0	5AE9B10F-347C-48C3-90CD-9290055CFE4B	EC0EE49C-D1D4-490D-BA82-CFAE6D451B8D	TCGA-49-4486-01A-01D-1203-02	GRCh37	TCGA-49-4486	TCGA-LUAD	2318.0	s10907	Harvard Medical School	Johns Hopkins	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1203-02	True
13767.58cfa83be4b0c9d6adf723fa	58cfa83be4b0c9d6adf723fa	UNCID_2613092.61271279-c2a0-476d-8dea-263d9b8ca4da.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2613092.61271279-c2a0-476d-8dea-263d9b8ca4da.sorted_genome_alignments	UNCID_2613092.61271279-c2a0-476d-8dea-263d9b8ca4da.sorted_genome_alignments.bam	38.93	1.92	0.17	58cfa83be4b0c9d6adf723fa	UNCID_2613092.61271279-c2a0-476d-8dea-263d9b8ca4da.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-VF-A8AB-01A	D5A27462-BC30-4F5F-9572-7BEA0844CE38	Primary Tumor	Illumina HiSeq	03B4B252-5FFC-4EE5-9D47-9BCE258D19DA	Testis	31.0	88124259-ED17-410C-BA27-A2FC32954F73	61271279-C2A0-476D-8DEA-263D9B8CA4DA	TCGA-VF-A8AB-01A-31R-A431-07	HG19	TCGA-VF-A8AB	TCGA-TGCT		s717	University of North Carolina	University of Pennsylvania	United States	NO	T1	N0		Stage I	A431-07	True
13722.58cfa82ee4b0c9d6adf6a999	58cfa82ee4b0c9d6adf6a999	G32459.TCGA-BL-A13J-10A-01D-A10S-08.3.filtered.	WGS	G32459.TCGA-BL-A13J-10A-01D-A10S-08.3	G32459.TCGA-BL-A13J-10A-01D-A10S-08.3.bam	16.09	2.03	0.07	58cfa82ee4b0c9d6adf6a999	G32459.TCGA-BL-A13J-10A-01D-A10S-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13J-10A	556FCBC8-172A-4AF1-8822-AE036E8D68E8	Blood Derived Normal	Illumina HiSeq	6e36a1bf-75a4-43f2-b7dc-0d143c21b150	Bladder	65.0	C7348A4B-9360-4249-B1E2-CFD8647D3633	E34479B8-834F-4747-984B-E77272F1379D	TCGA-BL-A13J-10A-01D-A10S-08	HG19_Broad_variant	TCGA-BL-A13J	TCGA-BLCA	81.0	s3077	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T4	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A10S-08	True
13722.58cfa82de4b0c9d6adf6a638	58cfa82de4b0c9d6adf6a638	4f775502d475a2bb06ef956ee457c09b.filtered.	WGS	4f775502d475a2bb06ef956ee457c09b	4f775502d475a2bb06ef956ee457c09b.bam	66.75	1.91	0.08	58cfa82de4b0c9d6adf6a638	4f775502d475a2bb06ef956ee457c09b.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PH-10A	4DA999A0-EF41-4A0B-B1D1-446B39CC855A	Blood Derived Normal	Illumina HiSeq	9bb03dd1-4a31-4ff3-930f-2ccf230339ae	Breast	52.0	2EDC0D6D-F928-45EC-AC6B-2CEE7B111A87	8F191915-D076-4C9E-95C7-1DE76EA96CC0	TCGA-EW-A1PH-10A-01D-A17G-09	GRCh37-lite	TCGA-EW-A1PH	TCGA-BRCA		s6456	Washington University School of Medicine	University of Miami	United States	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage II	A17G-09	False
13767.58cfa837e4b0c9d6adf6ff60	58cfa837e4b0c9d6adf6ff60	UNCID_1806228.f6cbfa5a-7d10-4efb-ae74-195e1a1e9774.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1806228.f6cbfa5a-7d10-4efb-ae74-195e1a1e9774.sorted_genome_alignments	UNCID_1806228.f6cbfa5a-7d10-4efb-ae74-195e1a1e9774.sorted_genome_alignments.bam	8.66	1.77	0.16	58cfa837e4b0c9d6adf6ff60	UNCID_1806228.f6cbfa5a-7d10-4efb-ae74-195e1a1e9774.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3XW-01A	C02699B5-580A-4D55-971E-F4692B2CCE57	Primary Tumor	Illumina HiSeq	46C992E5-03F3-44D9-B3F2-B5CD675DA03D	Breast	42.0	9D306F32-10BF-4EF7-AC97-91DC07D8EB4A	F6CBFA5A-7D10-4EFB-AE74-195E1A1E9774	TCGA-A2-A3XW-01A-11R-A239-07	HG19	TCGA-A2-A3XW	TCGA-BRCA		s6725	University of North Carolina	Walter Reed	United States	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A239-07	True
13767.58cfa83ae4b0c9d6adf71dea	58cfa83ae4b0c9d6adf71dea	UNCID_2500167.ebf67004-06d9-4466-824a-ffb03aa26316.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2500167.ebf67004-06d9-4466-824a-ffb03aa26316.sorted_genome_alignments	UNCID_2500167.ebf67004-06d9-4466-824a-ffb03aa26316.sorted_genome_alignments.bam	26.58	1.92	0.17	58cfa83ae4b0c9d6adf71dea	UNCID_2500167.ebf67004-06d9-4466-824a-ffb03aa26316.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-3A-A9IS-01A	CF825B86-7EC2-4E90-BCCE-3B5637B90B70	Primary Tumor	Illumina HiSeq	C0E272BB-AB27-410B-AB90-2B552F3A595A	Pancreas	67.0	405B467E-41D2-4AF1-8544-7B74D36DEEBD	EBF67004-06D9-4466-824A-FFB03AA26316	TCGA-3A-A9IS-01A-21R-A39D-07	HG19	TCGA-3A-A9IS	TCGA-PAAD		s849	University of North Carolina	Moffitt Cancer Center	United States	NO	T2	N0	Pancreas-Adenocarcinoma-Other Subtype	Stage I	A39D-07	True
13767.58cfa838e4b0c9d6adf70ac0	58cfa838e4b0c9d6adf70ac0	UNCID_2144186.e85fc5ec-7838-46c3-8767-a69f765b066d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2144186.e85fc5ec-7838-46c3-8767-a69f765b066d.sorted_genome_alignments	UNCID_2144186.e85fc5ec-7838-46c3-8767-a69f765b066d.sorted_genome_alignments.bam	64.14	1.8	0.18	58cfa838e4b0c9d6adf70ac0	UNCID_2144186.e85fc5ec-7838-46c3-8767-a69f765b066d.sorted_genome_alignments.bam	Dead	FEMALE	WHITE		Adrenocortical Carcinoma	Aligned reads	TCGA-OR-A5K2-01A	6D980941-219E-40A0-9B41-E84C3FB0BD1A	Primary Tumor	Illumina HiSeq	04146A0F-1ECA-488E-96C8-E018690DC524	Adrenal Gland	32.0	9DDAA508-3D15-4751-AB0F-69E4D8218FB3	E85FC5EC-7838-46C3-8767-A69F765B066D	TCGA-OR-A5K2-01A-11R-A29S-07	HG19	TCGA-OR-A5K2	TCGA-ACC	994.0	s147	University of North Carolina	University of Michigan	United States	NO	T4	N0		Stage III	A29S-07	True
13767.58cfa83ae4b0c9d6adf71ce2	58cfa83ae4b0c9d6adf71ce2	UNCID_2507123.1a65f0c1-c6e4-470b-8be1-1744332a1470.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2507123.1a65f0c1-c6e4-470b-8be1-1744332a1470.sorted_genome_alignments	UNCID_2507123.1a65f0c1-c6e4-470b-8be1-1744332a1470.sorted_genome_alignments.bam	37.75	1.9	0.17	58cfa83ae4b0c9d6adf71ce2	UNCID_2507123.1a65f0c1-c6e4-470b-8be1-1744332a1470.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A9FF-01A	736E8CDF-E2D7-4141-86A9-45C34178A1C8	Primary Tumor	Illumina HiSeq	17FBBE2F-4D7E-4814-8DEC-C12570C204C0	Bladder	52.0	286D1A8D-F384-4A49-A612-8511C5E9A8AF	1A65F0C1-C6E4-470B-8BE1-1744332A1470	TCGA-CF-A9FF-01A-11R-A38B-07	HG19	TCGA-CF-A9FF	TCGA-BLCA		s3224	University of North Carolina	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A38B-07	True
13722.58cfa830e4b0c9d6adf6bc54	58cfa830e4b0c9d6adf6bc54	TCGA-AG-3582-10A-01D-1167_101105_SN208_0168_A80A3BABXX_s_2_rg.sorted.filtered.	WGS	TCGA-AG-3582-10A-01D-1167_101105_SN208_0168_A80A3BABXX_s_2_rg.sorted	TCGA-AG-3582-10A-01D-1167_101105_SN208_0168_A80A3BABXX_s_2_rg.sorted.bam	20.0	1.9	0.17	58cfa830e4b0c9d6adf6bc54	TCGA-AG-3582-10A-01D-1167_101105_SN208_0168_A80A3BABXX_s_2_rg.sorted.bam	Alive	MALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3582-10A	DB1E3104-8BFD-4353-854A-C478BA1F7D07	Blood Derived Normal	Illumina HiSeq	f5b3fbbc-73ee-4343-9f0d-d1ed07587650	Colorectal	75.0	E948F2D0-E1BF-46FA-A0E0-A733036D3DA3	1D663F25-1724-47FF-9D68-6842EF17F51A	TCGA-AG-3582-10A-01D-1167-02	HG18_Broad_variant	TCGA-AG-3582	TCGA-READ		s1961	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IV	1167-02	True
13722.58cfa83ce4b0c9d6adf72ed8	58cfa83ce4b0c9d6adf72ed8	e56f2db4726f327debd64334f96bcd04.filtered.	WGS	e56f2db4726f327debd64334f96bcd04	e56f2db4726f327debd64334f96bcd04.bam	45.06		0.08	58cfa83ce4b0c9d6adf72ed8	e56f2db4726f327debd64334f96bcd04.bam	Dead	FEMALE	WHITE		Sarcoma	Aligned reads	TCGA-IW-A3M5-01A	C20682A1-F340-430D-99F9-077FE093ED19	Primary Tumor	Illumina HiSeq	83802f59-1279-444a-b96b-4bbdf0aa3baa	Mesenchymal	76.0	34B60937-76B3-401C-A8DD-3F78E2B20A38	03CED0CE-186A-4349-8D98-572C2BC90382	TCGA-IW-A3M5-01A-22D-A21Q-09	GRCh37-lite	TCGA-IW-A3M5	TCGA-SARC	180.0	s2671	Washington University School of Medicine	Cedars Sinai	United States	NO					A21Q-09	True
13722.58cfa830e4b0c9d6adf6c308	58cfa830e4b0c9d6adf6c308	TCGA-BR-6458-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BR-6458-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_6_rg.sorted	TCGA-BR-6458-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_6_rg.sorted.bam	250.7	1.9	0.16	58cfa830e4b0c9d6adf6c308	TCGA-BR-6458-10A-01D-1798_130116_SN208_0448_AC1J58ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6458-10A	E516880B-C4E5-43CD-A358-BE0DB88564D7	Blood Derived Normal	Illumina HiSeq	0fb3d589-66c9-49b8-9263-a04b09abcdd4	Stomach	57.0	ECBEC910-E4E1-4899-9547-0F649528E162	B787599F-7B73-4249-A813-19B87FFA98A2	TCGA-BR-6458-10A-01D-1798-02	HG19_Broad_variant	TCGA-BR-6458	TCGA-STAD		s15380	Harvard Medical School	Asterand	Ukraine	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1798-02	True
13722.58cfa832e4b0c9d6adf6d3b6	58cfa832e4b0c9d6adf6d3b6	TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted.filtered.	WGS	TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted	TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted.bam	47.01		0.17	58cfa832e4b0c9d6adf6d3b6	TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A4ON-01A	CABA34F2-3877-48CA-9FBC-665C3960F574	Primary Tumor	Illumina HiSeq	9bb22695-702d-410d-98a3-d4adcf022a94	Esophagus	65.0	B801A0D7-09E8-48D8-9C8E-C6D52767F7C1	469616E0-7C5B-491E-8D25-E71CCDB27D18	TCGA-L5-A4ON-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4ON	TCGA-ESCA	558.0	s1843	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N1		Stage II	A267-26	True
13767.58cfa83be4b0c9d6adf72504	58cfa83be4b0c9d6adf72504	UNCID_2640797.d3011182-eb79-48a8-8698-f9cf8f091924.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2640797.d3011182-eb79-48a8-8698-f9cf8f091924.sorted_genome_alignments	UNCID_2640797.d3011182-eb79-48a8-8698-f9cf8f091924.sorted_genome_alignments.bam	31.56	1.92	0.17	58cfa83be4b0c9d6adf72504	UNCID_2640797.d3011182-eb79-48a8-8698-f9cf8f091924.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-5N-A9KM-01A	9743E684-25DD-4DD9-9B84-6AE9518D1818	Primary Tumor	Illumina HiSeq	7F5E5AF7-E24C-4DBB-B1E3-CB0A5C7497D2	Bladder	73.0	4EF0D483-B954-47DD-AB58-EB0F4DB31B1D	D3011182-EB79-48A8-8698-F9CF8F091924	TCGA-5N-A9KM-01A-11R-A42T-07	HG19	TCGA-5N-A9KM	TCGA-BLCA	530.0	s3236	University of North Carolina	University Hospital Erlangen	Germany	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A42T-07	True
13767.58cfa835e4b0c9d6adf6ebc7	58cfa835e4b0c9d6adf6ebc7	UNCID_1321830.3e2b99bc-6a05-4de8-b135-923d443cd4fa.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1321830.3e2b99bc-6a05-4de8-b135-923d443cd4fa.sorted_genome_alignments	UNCID_1321830.3e2b99bc-6a05-4de8-b135-923d443cd4fa.sorted_genome_alignments.bam	15.2		0.15	58cfa835e4b0c9d6adf6ebc7	UNCID_1321830.3e2b99bc-6a05-4de8-b135-923d443cd4fa.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7745-11A	6641A298-1DBD-445D-A4AB-95CEB98E1427	Solid Tissue Normal	Illumina HiSeq	8B3E0610-EF6E-4E35-9845-B8A99874AB61	Prostate	65.0	69B0052E-39BB-4DAB-99A6-523CCE8B4C5E	3E2B99BC-6A05-4DE8-B135-923D443CD4FA	TCGA-HC-7745-11A-01R-2118-07	HG19	TCGA-HC-7745	TCGA-PRAD		s4171	University of North Carolina	International Genomics Consortium	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13722.58cfa831e4b0c9d6adf6c98e	58cfa831e4b0c9d6adf6c98e	TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted.filtered.	WGS	TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted	TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted.bam	94.4	1.9	0.14	58cfa831e4b0c9d6adf6c98e	TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6520-01A	3C573AF6-6298-49DE-8DE0-6A7F9CE9B000	Primary Tumor	Illumina HiSeq	46b79d94-56c0-4b23-955d-2395a50ecaf9	Stomach	53.0	7C162352-903E-4723-AF91-6FDD8E8EAD3B	F1CB7996-BD0E-4123-84E9-D359E5DB7700	TCGA-D7-6520-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6520	TCGA-STAD		s14494	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2b	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	1798-02	True
13767.58cfa82ee4b0c9d6adf6b1d8	58cfa82ee4b0c9d6adf6b1d8	TCGA-13-0804-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-0804-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-13-0804-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	366.0	1.8	0.17	58cfa82ee4b0c9d6adf6b1d8	TCGA-13-0804-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0804-01A	7E34D3C1-1FAB-4326-9A69-4260D2BAC558	Primary Tumor	Illumina HiSeq	505DBC4B-BF5E-4F5D-99A6-58CD19924166	Ovary	73.0	7432F954-A16F-4053-BEDD-AA776F939F71	220B144C-9F9C-459A-B332-5D6E5DEDB686	TCGA-13-0804-01A-01R-1564-13	GRCh37-lite	TCGA-13-0804	TCGA-OV	1073.0	s17557	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa83be4b0c9d6adf727fc	58cfa83be4b0c9d6adf727fc	UNCID_2657639.b05b2c69-27f3-46db-891a-9d2f8b0d8b97.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2657639.b05b2c69-27f3-46db-891a-9d2f8b0d8b97.sorted_genome_alignments	UNCID_2657639.b05b2c69-27f3-46db-891a-9d2f8b0d8b97.sorted_genome_alignments.bam	69.84	1.84	0.18	58cfa83be4b0c9d6adf727fc	UNCID_2657639.b05b2c69-27f3-46db-891a-9d2f8b0d8b97.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-AADS-01A	460A3CBD-C63C-4E6F-B670-2619687AC5A0	Primary Tumor	Illumina HiSeq	BA7FB93A-0ED1-4054-B11E-EB2FE9EC2397	Liver	63.0	31A1ACBE-DF1C-42B1-817A-DA0E805C7FB3	B05B2C69-27F3-46DB-891A-9D2F8B0D8B97	TCGA-DD-AADS-01A-11R-A41C-07	HG19	TCGA-DD-AADS	TCGA-LIHC		s16968	University of North Carolina	Mayo Clinic - Rochester	Korea South	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A41C-07	True
13767.58cfa834e4b0c9d6adf6e768	58cfa834e4b0c9d6adf6e768	UNCID_1212300.7e9d858a-10ed-4a90-b7da-b13958393555.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1212300.7e9d858a-10ed-4a90-b7da-b13958393555.sorted_genome_alignments	UNCID_1212300.7e9d858a-10ed-4a90-b7da-b13958393555.sorted_genome_alignments.bam	7.44	1.82	0.17	58cfa834e4b0c9d6adf6e768	UNCID_1212300.7e9d858a-10ed-4a90-b7da-b13958393555.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2QA-01A	B07435D4-1341-4B41-9B11-D13A4F1CA0AD	Primary Tumor	Illumina HiSeq	AA4B7F0F-1962-4764-A940-C9464DAC0721	Thyroid	56.0	2277F3F2-411E-47AB-A2B9-F80FD33540A1	7E9D858A-10ED-4A90-B7DA-B13958393555	TCGA-DJ-A2QA-01A-11R-A18C-07	HG19	TCGA-DJ-A2QA	TCGA-THCA		s12130	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A18C-07	True
13767.58cfa837e4b0c9d6adf6fe8c	58cfa837e4b0c9d6adf6fe8c	UNCID_1772261.6c392517-fe3d-4d86-8397-c08734fe20cc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1772261.6c392517-fe3d-4d86-8397-c08734fe20cc.sorted_genome_alignments	UNCID_1772261.6c392517-fe3d-4d86-8397-c08734fe20cc.sorted_genome_alignments.bam	27.81	1.8	0.18	58cfa837e4b0c9d6adf6fe8c	UNCID_1772261.6c392517-fe3d-4d86-8397-c08734fe20cc.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-K4-A3WU-01B	9AA6522A-120A-4691-993E-3F8534F644B5	Primary Tumor	Illumina HiSeq	2BC66125-029F-4506-83EC-BB2549166459	Bladder	87.0	F91A5F96-CD62-4BDB-B4AA-15C24BEE80DE	6C392517-FE3D-4D86-8397-C08734FE20CC	TCGA-K4-A3WU-01B-11R-A23N-07	HG19	TCGA-K4-A3WU	TCGA-BLCA		s2980	University of North Carolina	ABS - Lahey Clinic	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A23N-07	True
13722.58cfa830e4b0c9d6adf6bb9e	58cfa830e4b0c9d6adf6bb9e	TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	24.55	1.83	0.07	58cfa830e4b0c9d6adf6bb9e	TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN		Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04P-10A	CCD4A24B-D8CC-4686-9DEE-C98B0C5A8D21	Blood Derived Normal	Illumina HiSeq	38b3f71f-fbf5-46cd-91b9-a6233ac79a89	Breast	36.0	C8A2B99E-2188-43E4-A7CB-3DD57D4E7662	07F6C203-D1CF-4C40-B181-B717D327DADE	TCGA-A2-A04P-10A-01D-A128-09	GRCh37-lite	TCGA-A2-A04P	TCGA-BRCA	548.0	s5957	Washington University School of Medicine	Walter Reed	None	NO	T2	N3c	Infiltrating Ductal Carcinoma	Stage III	A128-09	True
13767.58cfa834e4b0c9d6adf6e8ac	58cfa834e4b0c9d6adf6e8ac	UNCID_1216113.2170c29a-1256-45eb-b08e-e1192dad3560.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1216113.2170c29a-1256-45eb-b08e-e1192dad3560.sorted_genome_alignments	UNCID_1216113.2170c29a-1256-45eb-b08e-e1192dad3560.sorted_genome_alignments.bam	47.2	1.8	0.16	58cfa834e4b0c9d6adf6e8ac	UNCID_1216113.2170c29a-1256-45eb-b08e-e1192dad3560.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-2668-11A	BAB43415-D413-40BE-A4C0-2C40A52AFE6A	Solid Tissue Normal	Illumina HiSeq	F4BB7795-C16C-47F6-99EA-8B0BF145273C	Lung	51.0	275B1D31-BC89-4E56-9861-626AFB8BBCC0	2170C29A-1256-45EB-B08E-E1192DAD3560	TCGA-44-2668-11A-01R-1758-07	HG19	TCGA-44-2668	TCGA-LUAD		s11385	University of North Carolina	Christiana Healthcare	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1758-07	True
13767.58cfa82fe4b0c9d6adf6ba2a	58cfa82fe4b0c9d6adf6ba2a	TCGA-61-1911-01A-01R-1567-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-61-1911-01A-01R-1567-13_GRCh37-lite_rnaseq	TCGA-61-1911-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	552.0	1.8	0.14	58cfa82fe4b0c9d6adf6ba2a	TCGA-61-1911-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-1911-01A	93095C36-2263-438F-A619-A4A4D6AE13C7	Primary Tumor	Illumina HiSeq	40BE9753-46EA-4604-9777-F8CBD3144FB2	Ovary	55.0	7F7B442A-3985-4F4A-98B1-DA82670C957C	1EC9CBC3-FD76-4D44-BE24-8FF296D3C4C9	TCGA-61-1911-01A-01R-1567-13	GRCh37-lite	TCGA-61-1911	TCGA-OV		s17643	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa833e4b0c9d6adf6de2b	58cfa833e4b0c9d6adf6de2b	UNCID_1122003.b1c4af00-f395-47ac-93c7-b32a293ca060.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1122003.b1c4af00-f395-47ac-93c7-b32a293ca060.sorted_genome_alignments	UNCID_1122003.b1c4af00-f395-47ac-93c7-b32a293ca060.sorted_genome_alignments.bam	31.12	1.82	0.16	58cfa833e4b0c9d6adf6de2b	UNCID_1122003.b1c4af00-f395-47ac-93c7-b32a293ca060.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1J5-01A	5D8ED961-A012-4B6B-BFFB-9468D3953646	Primary Tumor	Illumina HiSeq	CAC9ECC0-1A0E-48E3-8DF6-6EF35A154EF8	Breast	59.0	BF42E8CE-CD3E-46C8-92F9-EA5CDA443A6F	B1C4AF00-F395-47AC-93C7-B32A293CA060	TCGA-EW-A1J5-01A-11R-A13Q-07	HG19	TCGA-EW-A1J5	TCGA-BRCA		s6793	University of North Carolina	University of Miami	United States	NO	T3	N0 (i-)	Infiltrating Lobular Carcinoma	Stage II	A13Q-07	True
13767.58cfa83ce4b0c9d6adf72c13	58cfa83ce4b0c9d6adf72c13	UNCID_502987.328f67c7-f88e-4364-8ea7-ca5d95ff30e6.110829_UNC9-SN296_0235_BC040DABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_502987.328f67c7-f88e-4364-8ea7-ca5d95ff30e6.110829_UNC9-SN296_0235_BC040DABXX.8.trimmed.annotated.translated_to_genomic	UNCID_502987.328f67c7-f88e-4364-8ea7-ca5d95ff30e6.110829_UNC9-SN296_0235_BC040DABXX.8.trimmed.annotated.translated_to_genomic.bam	137.3	1.8	0.14	58cfa83ce4b0c9d6adf72c13	UNCID_502987.328f67c7-f88e-4364-8ea7-ca5d95ff30e6.110829_UNC9-SN296_0235_BC040DABXX.8.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3329-01A	21EEA125-1298-42D3-A50C-57D596E0420D	Primary Tumor	Illumina HiSeq	210487E3-63CA-4831-914D-82ADC32A67A7	Kidney	75.0	1AA8FF4C-CF2A-45B2-A74E-A07CC83FF634	328F67C7-F88E-4364-8EA7-CA5D95FF30E6	TCGA-A3-3329-01A-01R-0864-07	HG19	TCGA-A3-3329	TCGA-KIRC		s9433	University of North Carolina	International Genomics Consortium	United States	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	0864-07	True
13722.58cfa832e4b0c9d6adf6d1fa	58cfa832e4b0c9d6adf6d1fa	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.bam	45.77		0.15	58cfa832e4b0c9d6adf6d1fa	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JW-01A	3D644EAF-82FC-4BC7-93B7-3E600E8C6511	Primary Tumor	Illumina HiSeq	586abfdd-f50a-4834-8143-3bda5638ea60	Bladder	74.0	B02C03B6-24AA-42D3-9310-741DE1EF0D30	D7EFF32B-E9EB-4891-93D7-4C3D10BE21EA	TCGA-GV-A3JW-01A-11D-A210-26	HG19_Broad_variant	TCGA-GV-A3JW	TCGA-BLCA		s2737	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T2	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	True
13767.58cfa82fe4b0c9d6adf6b854	58cfa82fe4b0c9d6adf6b854	TCGA-29-1776-01A-01R-1567-13_rnaseq.filtered.	RNA-Seq	TCGA-29-1776-01A-01R-1567-13_rnaseq	TCGA-29-1776-01A-01R-1567-13_rnaseq.bam	161.0	1.8	0.15	58cfa82fe4b0c9d6adf6b854	TCGA-29-1776-01A-01R-1567-13_rnaseq.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1776-01A	7472B3BA-9B15-4D97-8708-A2DD82CA0F45	Primary Tumor	Illumina HiSeq	C5EBEA4C-2777-48B9-85A4-9EABC60E5193	Ovary	63.0	5B6791A5-2FEC-41C8-87FB-9D83A3BED4BC	50867FED-2FDA-4C45-AA08-042087E7DAA9	TCGA-29-1776-01A-01R-1567-13	NCBI36_BCCAGSC_variant	TCGA-29-1776	TCGA-OV		s18135	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa82ee4b0c9d6adf6b118	58cfa82ee4b0c9d6adf6b118	TCGA-13-0899-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0899-01A-01R-1564-13_rnaseq	TCGA-13-0899-01A-01R-1564-13_rnaseq.bam	256.0	1.8	0.14	58cfa82ee4b0c9d6adf6b118	TCGA-13-0899-01A-01R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0899-01A	5C6F3CD4-19C5-418D-B1BE-D3FBF63E99DB	Primary Tumor	Illumina HiSeq	1F45689D-5A91-4471-9A66-90AA28BBB2F1	Ovary	60.0	D14005F6-55DF-422B-A152-3C313B8DF92F	605D0AED-4637-4A09-82DD-EEDD1AA76CA0	TCGA-13-0899-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-13-0899	TCGA-OV		s17220	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa83be4b0c9d6adf72294	58cfa83be4b0c9d6adf72294	UNCID_2567665.bb493954-d408-485e-857e-58b8c927d843.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2567665.bb493954-d408-485e-857e-58b8c927d843.sorted_genome_alignments	UNCID_2567665.bb493954-d408-485e-857e-58b8c927d843.sorted_genome_alignments.bam	19.12	1.76	0.17	58cfa83be4b0c9d6adf72294	UNCID_2567665.bb493954-d408-485e-857e-58b8c927d843.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-2G-AAGX-01A	9ED4368B-AC80-419E-B6AD-1C70D56EF4E7	Primary Tumor	Illumina HiSeq	C27AED47-FB38-4720-B9C8-579F0865B099	Testis	22.0	67D84A68-F5E8-4D4B-B8EA-ABD3EDDE74DB	BB493954-D408-485E-857E-58B8C927D843	TCGA-2G-AAGX-01A-11R-A430-07	HG19	TCGA-2G-AAGX	TCGA-TGCT		s590	University of North Carolina	Erasmus MC	Netherlands	NO	T1	N0		Stage I	A430-07	True
13767.58cfa838e4b0c9d6adf7097e	58cfa838e4b0c9d6adf7097e	UNCID_2088143.12be39a5-bbae-439a-84a9-28b790e89aa9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2088143.12be39a5-bbae-439a-84a9-28b790e89aa9.sorted_genome_alignments	UNCID_2088143.12be39a5-bbae-439a-84a9-28b790e89aa9.sorted_genome_alignments.bam	41.95	1.88	0.16	58cfa838e4b0c9d6adf7097e	UNCID_2088143.12be39a5-bbae-439a-84a9-28b790e89aa9.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A5OC-01A	AE8A4958-5407-4C01-93C3-8090862533AE	Primary Tumor	Illumina HiSeq	BE3D7F0A-2508-43FB-9786-A1B9EEA47104	Uterus	71.0	69AC12C0-A986-44AC-8687-134CCB12AC21	12BE39A5-BBAE-439A-84A9-28B790E89AA9	TCGA-B5-A5OC-01A-21R-A27V-07	HG19	TCGA-B5-A5OC	TCGA-UCEC		s4529	University of North Carolina	Duke	United States	NO			Endometrioid endometrial adenocarcinoma		A27V-07	True
13767.58cfa835e4b0c9d6adf6ec6d	58cfa835e4b0c9d6adf6ec6d	UNCID_1338259.42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1338259.42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3.sorted_genome_alignments	UNCID_1338259.42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3.sorted_genome_alignments.bam	27.38	2.06	0.16	58cfa835e4b0c9d6adf6ec6d	UNCID_1338259.42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15E-01A	0A2A3529-F645-4967-9A58-89EE20B8BB62	Primary Tumor	Illumina HiSeq	9E35DA63-E786-44D2-81AF-18A4D2739243	Breast	40.0	9992EEB9-901B-4A32-BADC-E9BE7C9BA4BA	42BA8E87-8D37-4CBD-82F0-BCA0CBE5DCD3	TCGA-E2-A15E-01A-11R-A12D-07	HG19	TCGA-E2-A15E	TCGA-BRCA		s6568	University of North Carolina	Roswell Park	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage II	A12D-07	True
13767.58cfa83ae4b0c9d6adf71b86	58cfa83ae4b0c9d6adf71b86	UNCID_2469183.8a5804cb-d45f-4a6c-b7a0-af505b4b4237.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2469183.8a5804cb-d45f-4a6c-b7a0-af505b4b4237.sorted_genome_alignments	UNCID_2469183.8a5804cb-d45f-4a6c-b7a0-af505b4b4237.sorted_genome_alignments.bam	47.95	1.85	0.18	58cfa83ae4b0c9d6adf71b86	UNCID_2469183.8a5804cb-d45f-4a6c-b7a0-af505b4b4237.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ZP-A9D1-01A	447AC9E3-0533-461A-BC92-906A7B2180C3	Primary Tumor	Illumina HiSeq	82F93CE9-B54D-4A5D-ACA9-22D50FB54FE2	Liver	56.0	D64641FE-43F3-4251-8332-72C6AF236178	8A5804CB-D45F-4A6C-B7A0-AF505B4B4237	TCGA-ZP-A9D1-01A-11R-A38B-07	HG19	TCGA-ZP-A9D1	TCGA-LIHC		s17095	University of North Carolina	Medical College of Wisconsin	United States	NO	T1	NX	Hepatocellular Carcinoma		A38B-07	True
13722.58cfa82ee4b0c9d6adf6b140	58cfa82ee4b0c9d6adf6b140	G49538.TCGA-06-0190-10B-01D-A32W-08.1.filtered.	WGS	G49538.TCGA-06-0190-10B-01D-A32W-08.1	G49538.TCGA-06-0190-10B-01D-A32W-08.1.bam	128.7	1.91	0.09	58cfa82ee4b0c9d6adf6b140	G49538.TCGA-06-0190-10B-01D-A32W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0190-10B	74139255-A635-4C87-814D-3DD04ED630A8	Blood Derived Normal	Illumina HiSeq	f04aa2a8-0893-4143-9c55-621b2bcc01d5	Brain	62.0	5E4F6C38-9B1F-4406-8BF3-8B3FA6D3399F	EF89DA1C-E378-418D-B3E8-E15D3BBB309E	TCGA-06-0190-10B-01D-A32W-08	HG19_Broad_variant	TCGA-06-0190	TCGA-GBM	317.0	s14266	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		A32W-08	False
13767.58cfa837e4b0c9d6adf6fe26	58cfa837e4b0c9d6adf6fe26	UNCID_1729730.828c21a3-2e9b-4c2e-b2b5-47ec3ad7c548.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1729730.828c21a3-2e9b-4c2e-b2b5-47ec3ad7c548.sorted_genome_alignments	UNCID_1729730.828c21a3-2e9b-4c2e-b2b5-47ec3ad7c548.sorted_genome_alignments.bam	28.2	1.9	0.16	58cfa837e4b0c9d6adf6fe26	UNCID_1729730.828c21a3-2e9b-4c2e-b2b5-47ec3ad7c548.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A45C-01A	A1196D5F-8C7D-4D9D-9E46-C5C22A9C2FEF	Primary Tumor	Illumina HiSeq	BC4B50F1-997C-4983-A5EE-961A1930D384	Thyroid	78.0	62DB8FDB-DCD5-4582-A214-0A9B67F32EAF	828C21A3-2E9B-4C2E-B2B5-47EC3AD7C548	TCGA-BJ-A45C-01A-11R-A23W-07	HG19	TCGA-BJ-A45C	TCGA-THCA		s12194	University of North Carolina	University of Pittsburgh	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A23W-07	True
13767.58cfa834e4b0c9d6adf6e372	58cfa834e4b0c9d6adf6e372	UNCID_1186395.5d41239a-7e24-4d75-b4e7-21eb4a48dc4d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1186395.5d41239a-7e24-4d75-b4e7-21eb4a48dc4d.sorted_genome_alignments	UNCID_1186395.5d41239a-7e24-4d75-b4e7-21eb4a48dc4d.sorted_genome_alignments.bam	117.3	1.7	0.14	58cfa834e4b0c9d6adf6e372	UNCID_1186395.5d41239a-7e24-4d75-b4e7-21eb4a48dc4d.sorted_genome_alignments.bam	Dead	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4981-01A	CE0AB696-4E50-4B05-A7E5-5191C257BFBE	Primary Tumor	Illumina HiSeq	100B7927-BF62-45B1-9F1A-A64EB69B9C0D	Kidney	75.0	4A3C1455-336E-44DA-B780-E3A168824276	5D41239A-7E24-4D75-B4E7-21EB4A48DC4D	TCGA-BP-4981-01A-01R-1334-07	HG19	TCGA-BP-4981	TCGA-KIRC	1097.0	s9790	University of North Carolina	MSKCC	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1334-07	True
13767.58cfa832e4b0c9d6adf6d428	58cfa832e4b0c9d6adf6d428	TCGA-R6-A6XQ-01B-11R-A336-31_rnaseq.filtered.	RNA-Seq	TCGA-R6-A6XQ-01B-11R-A336-31_rnaseq	TCGA-R6-A6XQ-01B-11R-A336-31_rnaseq.bam	7.56	1.89	0.15	58cfa832e4b0c9d6adf6d428	TCGA-R6-A6XQ-01B-11R-A336-31_rnaseq.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-R6-A6XQ-01B	8373BC4A-490D-4050-BBB1-48B6472EBA34	Primary Tumor	Illumina HiSeq	0344A050-0882-4BD6-90A3-A7C24B577622	Esophagus	58.0	610D9004-DB0B-4C8E-9C1D-7EEBFAE5B570	501C9CF2-FF7F-4F35-BACE-52CC4392237D	TCGA-R6-A6XQ-01B-11R-A336-31	GRCh37-lite	TCGA-R6-A6XQ	TCGA-ESCA	193.0	s1944	Canada's Michael Smith Genome Sciences Centre	MD Anderson Cancer Center	United States	NO					A336-31	True
13767.58cfa836e4b0c9d6adf6f5aa	58cfa836e4b0c9d6adf6f5aa	UNCID_1567182.61e0c561-bf01-400c-843a-7c63e5a74b9f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1567182.61e0c561-bf01-400c-843a-7c63e5a74b9f.sorted_genome_alignments	UNCID_1567182.61e0c561-bf01-400c-843a-7c63e5a74b9f.sorted_genome_alignments.bam	9.2		0.15	58cfa836e4b0c9d6adf6f5aa	UNCID_1567182.61e0c561-bf01-400c-843a-7c63e5a74b9f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-97-8177-01A	09078761-1C14-4D01-8E15-535C19A9B0F9	Primary Tumor	Illumina HiSeq	DE68D048-BA45-4068-ADA7-752B665A0F4A	Lung	59.0	5711CE53-0BAC-4A5D-B7BA-4E1BC0C56924	61E0C561-BF01-400C-843A-7C63E5A74B9F	TCGA-97-8177-01A-11R-2287-07	HG19	TCGA-97-8177	TCGA-LUAD		s11063	University of North Carolina	Washington University - NYU	United States	NO	T2a	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	2287-07	True
13722.58cfa830e4b0c9d6adf6bded	58cfa830e4b0c9d6adf6bded	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.bam	43.73	2.05	0.16	58cfa830e4b0c9d6adf6bded	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DK-01A	F2BBFA9D-9A9D-4F46-9FDE-378E4C44E2AD	Primary Tumor	Illumina HiSeq	71acb20b-f186-44d4-a92e-a2751f845fe3	Breast	49.0	1ACAE6E0-3100-4DE8-A436-E15CDBE1322B	92245807-8B1B-4E96-8567-6CFE5E70ADE4	TCGA-BH-A0DK-01A-21D-A060-02	HG19_Broad_variant	TCGA-BH-A0DK	TCGA-BRCA		s5493	Harvard Medical School	University of Pittsburgh	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A060-02	True
13767.58cfa83ae4b0c9d6adf71e78	58cfa83ae4b0c9d6adf71e78	UNCID_2536846.fb71ca5f-3349-488f-95e9-772028da98c1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2536846.fb71ca5f-3349-488f-95e9-772028da98c1.sorted_genome_alignments	UNCID_2536846.fb71ca5f-3349-488f-95e9-772028da98c1.sorted_genome_alignments.bam	18.28	1.92	0.16	58cfa83ae4b0c9d6adf71e78	UNCID_2536846.fb71ca5f-3349-488f-95e9-772028da98c1.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-YD-A9TA-06A	CEB45393-54EE-4801-8C6F-C0AA66E37E60	Metastatic	Illumina HiSeq	9EC60A0D-3E48-4E4A-A980-3887A522711C	Skin	75.0	027065BF-61AD-47E1-A0AC-73DB6E62C647	FB71CA5F-3349-488F-95E9-772028DA98C1	TCGA-YD-A9TA-06A-11R-A39D-07	HG19	TCGA-YD-A9TA	TCGA-SKCM		s7800	University of North Carolina	Spectrum Health	United States	NO					A39D-07	True
13767.58cfa838e4b0c9d6adf70a22	58cfa838e4b0c9d6adf70a22	UNCID_2077604.24ee58d3-60c9-4808-b35a-2767594b83f8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2077604.24ee58d3-60c9-4808-b35a-2767594b83f8.sorted_genome_alignments	UNCID_2077604.24ee58d3-60c9-4808-b35a-2767594b83f8.sorted_genome_alignments.bam	75.92	1.82	0.16	58cfa838e4b0c9d6adf70a22	UNCID_2077604.24ee58d3-60c9-4808-b35a-2767594b83f8.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EO-A22Y-01A	E6183A43-24B9-4FE1-95C3-4CFF67E6C1ED	Primary Tumor	Illumina HiSeq	3155886C-04C3-499E-8B7F-24C808129DF5	Uterus	68.0	1FCDC9C7-5448-4A87-9AD5-CFB60837C296	24EE58D3-60C9-4808-B35A-2767594B83F8	TCGA-EO-A22Y-01A-11R-A180-07	HG19	TCGA-EO-A22Y	TCGA-UCEC		s5316	University of North Carolina	University Health Network	Canada	NO			Endometrioid endometrial adenocarcinoma		A180-07	True
13722.58cfa82ee4b0c9d6adf6aefb	58cfa82ee4b0c9d6adf6aefb	TCGA-05-4415-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_6_rg.sorted.filtered.	WGS	TCGA-05-4415-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_6_rg.sorted	TCGA-05-4415-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_6_rg.sorted.bam	48.0	1.8	0.14	58cfa82ee4b0c9d6adf6aefb	TCGA-05-4415-10A-01D-1853_120228_SN1120_0116_AD0KRVACXX_s_6_rg.sorted.bam	Dead	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4415-10A	D15B7B29-C5C5-41D8-B83B-7CC12FE92820	Blood Derived Normal	Illumina HiSeq	57cfe098-8cf8-4aab-ba84-1d57f4617af9	Lung	57.0	DD13F373-F9B3-4263-8E0C-C925B2AE5FD1	6D2948A0-4BB5-4959-971B-B98B8944FB0A	TCGA-05-4415-10A-01D-1853-02	HG19_Broad_variant	TCGA-05-4415	TCGA-LUAD	91.0	s10771	Harvard Medical School	Indivumed	Germany	NO	T4	N2	Lung Adenocarcinoma Mixed Subtype	Stage III	1853-02	True
13767.58cfa838e4b0c9d6adf707bc	58cfa838e4b0c9d6adf707bc	UNCID_1990572.038898c8-e2f3-4bd9-9b8e-da45b86ea2ea.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1990572.038898c8-e2f3-4bd9-9b8e-da45b86ea2ea.sorted_genome_alignments	UNCID_1990572.038898c8-e2f3-4bd9-9b8e-da45b86ea2ea.sorted_genome_alignments.bam	18.54	1.94	0.17	58cfa838e4b0c9d6adf707bc	UNCID_1990572.038898c8-e2f3-4bd9-9b8e-da45b86ea2ea.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-97-A4M7-01A	C6B680E3-D96E-4FC7-8053-77454B7A14FA	Primary Tumor	Illumina HiSeq	20271715-E5A2-4757-9983-0B7E58FC0BA2	Lung	74.0	3D39D81B-C341-426C-B979-560C429B3AF2	038898C8-E2F3-4BD9-9B8E-DA45B86EA2EA	TCGA-97-A4M7-01A-11R-A24X-07	HG19	TCGA-97-A4M7	TCGA-LUAD		s11410	University of North Carolina	Washington University - NYU	United States	NO	T1b	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	A24X-07	True
13767.58cfa834e4b0c9d6adf6e57a	58cfa834e4b0c9d6adf6e57a	UNCID_1195876.8d7fdc1d-55f9-435b-8ecb-5dd94b484580.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1195876.8d7fdc1d-55f9-435b-8ecb-5dd94b484580.sorted_genome_alignments	UNCID_1195876.8d7fdc1d-55f9-435b-8ecb-5dd94b484580.sorted_genome_alignments.bam	46.33	1.8	0.14	58cfa834e4b0c9d6adf6e57a	UNCID_1195876.8d7fdc1d-55f9-435b-8ecb-5dd94b484580.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3362-01A	C7E9BA09-0826-466C-8555-6595DE31ED31	Primary Tumor	Illumina HiSeq	3E88182F-9FB2-4469-A309-A1E539C4A953	Kidney	60.0	1CAFC728-E080-47B7-95E8-EB5194C8FCB9	8D7FDC1D-55F9-435B-8ECB-5DD94B484580	TCGA-A3-3362-01A-02R-1325-07	HG19	TCGA-A3-3362	TCGA-KIRC		s9508	University of North Carolina	International Genomics Consortium	None	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1325-07	True
13767.58cfa836e4b0c9d6adf6fbf8	58cfa836e4b0c9d6adf6fbf8	UNCID_1665449.26616de7-08df-4359-9c00-c649409b1480.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1665449.26616de7-08df-4359-9c00-c649409b1480.sorted_genome_alignments	UNCID_1665449.26616de7-08df-4359-9c00-c649409b1480.sorted_genome_alignments.bam	60.77	1.83	0.17	58cfa836e4b0c9d6adf6fbf8	UNCID_1665449.26616de7-08df-4359-9c00-c649409b1480.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LT-01A	FB66B7F5-22CA-4D4D-97C2-30E6EDFFF781	Primary Tumor	Illumina HiSeq	BC5664DB-3E36-4734-93CB-1A87DA449A0F	Cervix	38.0	EEDE6958-96A5-433D-8823-503B58559ED4	26616DE7-08DF-4359-9C00-C649409B1480	TCGA-C5-A2LT-01A-11R-A18M-07	HG19	TCGA-C5-A2LT	TCGA-CESC		s1239	University of North Carolina	Medical College of Wisconsin	United States	NO	T1b	N0	Cervical Squamous Cell Carcinoma		A18M-07	True
13767.58cfa83ae4b0c9d6adf71cc8	58cfa83ae4b0c9d6adf71cc8	UNCID_2439430.01d666b4-9605-422a-bfba-231b0d6ef20f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2439430.01d666b4-9605-422a-bfba-231b0d6ef20f.sorted_genome_alignments	UNCID_2439430.01d666b4-9605-422a-bfba-231b0d6ef20f.sorted_genome_alignments.bam	57.56	1.83	0.17	58cfa83ae4b0c9d6adf71cc8	UNCID_2439430.01d666b4-9605-422a-bfba-231b0d6ef20f.sorted_genome_alignments.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A7UI-01A	CE5765FB-5221-4CBF-AA76-BB863803DF57	Primary Tumor	Illumina HiSeq	525C46AB-0463-4860-AC3E-1EC6E81E8D2A	Cervix	42.0	24EA2D5E-66D2-479B-8BE6-AE59336876DF	01D666B4-9605-422A-BFBA-231B0D6EF20F	TCGA-C5-A7UI-01A-11R-A36F-07	HG19	TCGA-C5-A7UI	TCGA-CESC	2888.0	s1307	University of North Carolina	Medical College of Wisconsin	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma		A36F-07	True
13767.58cfa82fe4b0c9d6adf6b538	58cfa82fe4b0c9d6adf6b538	TCGA-25-1628-01A-01R-1566-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-25-1628-01A-01R-1566-13_GRCh37-lite_rnaseq	TCGA-25-1628-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	224.0	1.8	0.15	58cfa82fe4b0c9d6adf6b538	TCGA-25-1628-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1628-01A	3F917550-89A6-404B-94DF-938C99121411	Primary Tumor	Illumina HiSeq	4ECCF21C-D3D9-4A5F-8CCD-3193C7ECE981	Ovary	67.0	EFE5AE48-C145-4B24-A1DF-BA485D355DFA	A3083FD8-F5D0-486B-BF3D-31AE094B1CBF	TCGA-25-1628-01A-01R-1566-13	GRCh37-lite	TCGA-25-1628	TCGA-OV	627.0	s18129	Canada's Michael Smith Genome Sciences Centre	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa830e4b0c9d6adf6c082	58cfa830e4b0c9d6adf6c082	TCGA-BR-8289-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-8289-01A-11R-2343-13_rnaseq	TCGA-BR-8289-01A-11R-2343-13_rnaseq.bam	170.2		0.14	58cfa830e4b0c9d6adf6c082	TCGA-BR-8289-01A-11R-2343-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8289-01A	889CB779-36A5-4AC6-B2CF-EA7BE0CC387D	Primary Tumor	Illumina HiSeq	DC5578CB-E1F9-418D-B102-F75F94693709	Stomach	57.0	92ABC4EF-88AC-4D4E-BF85-4A7AB9A1960B	78F7F4E5-2E95-4E84-9A0E-E4D7D3BA3102	TCGA-BR-8289-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8289	TCGA-STAD		s14541	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4	N3a	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	2343-13	True
13722.58cfa82ee4b0c9d6adf6a9ee	58cfa82ee4b0c9d6adf6a9ee	G26398.TCGA-06-5411-01A-01D-1696-08.2.filtered.	WGS	G26398.TCGA-06-5411-01A-01D-1696-08.2	G26398.TCGA-06-5411-01A-01D-1696-08.2.bam	407.03	1.9	0.05	58cfa82ee4b0c9d6adf6a9ee	G26398.TCGA-06-5411-01A-01D-1696-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-5411-01A	3F960D3B-A58C-43D0-A8A4-F3555B399C9D	Primary Tumor	Illumina HiSeq	a5235cf1-9584-4e39-be51-b383765f3fec	Brain	51.0	7790FA3D-C06F-4C74-B180-CA6D4F53DC7D	2FDAB641-D73B-4F9A-AA4C-C1944F131A69	TCGA-06-5411-01A-01D-1696-08	HG19_Broad_variant	TCGA-06-5411	TCGA-GBM	254.0	s14170	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1696-08	False
13767.58cfa837e4b0c9d6adf70044	58cfa837e4b0c9d6adf70044	UNCID_1898866.09940f4e-69df-4ada-96ab-a6749b70e4b8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1898866.09940f4e-69df-4ada-96ab-a6749b70e4b8.sorted_genome_alignments	UNCID_1898866.09940f4e-69df-4ada-96ab-a6749b70e4b8.sorted_genome_alignments.bam	129.9	1.7	0.16	58cfa837e4b0c9d6adf70044	UNCID_1898866.09940f4e-69df-4ada-96ab-a6749b70e4b8.sorted_genome_alignments.bam	Alive	MALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3731-01A	72756208-A5ED-47D2-8C4C-19A8D39F7B9D	Primary Tumor	Illumina HiSeq	C56898FA-2E3E-4C39-9A3B-9097D24FE23F	Colorectal	65.0	2B007105-28B0-4B4A-9F0C-C77EF40492E6	09940F4E-69DF-4ADA-96AB-A6749B70E4B8	TCGA-AG-3731-01A-11R-1736-07	HG19	TCGA-AG-3731	TCGA-READ		s2079	University of North Carolina	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IV	1736-07	True
13767.58cfa834e4b0c9d6adf6e76a	58cfa834e4b0c9d6adf6e76a	UNCID_1211902.3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1211902.3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90.sorted_genome_alignments	UNCID_1211902.3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90.sorted_genome_alignments.bam	146.2	1.8	0.15	58cfa834e4b0c9d6adf6e76a	UNCID_1211902.3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-78-7161-01A	86FAF16C-56FD-4B7B-A6B2-B4C83BEC93E1	Primary Tumor	Illumina HiSeq	3E45D31D-C775-47FC-8BE0-714A1E7824A9	Lung	69.0	08ACBA8A-143F-43E6-9562-E41DCACBA681	3BC1FE5D-5EFF-46F2-ADF6-E6BC8B7E8F90	TCGA-78-7161-01A-11R-2039-07	HG19	TCGA-78-7161	TCGA-LUAD		s11281	University of North Carolina	Prince Charles Hospital	Australia	NO	T3	N0	Lung Adenocarcinoma Mixed Subtype	Stage II	2039-07	True
13767.58cfa834e4b0c9d6adf6e5a1	58cfa834e4b0c9d6adf6e5a1	UNCID_1207290.013f7a4f-eec9-4ba8-8473-6515cdc9be68.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1207290.013f7a4f-eec9-4ba8-8473-6515cdc9be68.sorted_genome_alignments	UNCID_1207290.013f7a4f-eec9-4ba8-8473-6515cdc9be68.sorted_genome_alignments.bam	64.2	1.8	0.15	58cfa834e4b0c9d6adf6e5a1	UNCID_1207290.013f7a4f-eec9-4ba8-8473-6515cdc9be68.sorted_genome_alignments.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4433-01A	AEA68827-DC0F-484D-A00D-06DEEAA4B3CE	Primary Tumor	Illumina HiSeq	13888D90-F0CB-407C-BD54-3D72E6F0299E	Lung	82.0	1E9DAC94-1A10-47D0-AE92-81D38A264376	013F7A4F-EEC9-4BA8-8473-6515CDC9BE68	TCGA-05-4433-01A-22R-1858-07	HG19	TCGA-05-4433	TCGA-LUAD		s11380	University of North Carolina	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	1858-07	True
13767.58cfa838e4b0c9d6adf70433	58cfa838e4b0c9d6adf70433	UNCID_1905515.78dd0304-d459-4d26-b0ba-39a8078c59d0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1905515.78dd0304-d459-4d26-b0ba-39a8078c59d0.sorted_genome_alignments	UNCID_1905515.78dd0304-d459-4d26-b0ba-39a8078c59d0.sorted_genome_alignments.bam	109.2		0.14	58cfa838e4b0c9d6adf70433	UNCID_1905515.78dd0304-d459-4d26-b0ba-39a8078c59d0.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-8616-01A	FE714AC0-F874-426A-924B-A2980232B5F7	Primary Tumor	Illumina HiSeq	B21C13B9-1365-42AE-A605-8F7100363355	Lung	58.0	2F073FFA-787E-4657-B1CD-D2DB4865C809	78DD0304-D459-4D26-B0BA-39A8078C59D0	TCGA-55-8616-01A-11R-2403-07	HG19	TCGA-55-8616	TCGA-LUAD		s10732	University of North Carolina	International Genomics Consortium	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2403-07	True
13722.58cfa831e4b0c9d6adf6cbee	58cfa831e4b0c9d6adf6cbee	TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted	TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted.bam	43.27		0.16	58cfa831e4b0c9d6adf6cbee	TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2PM-01A	085FB6D8-6265-484E-9307-8292386714B7	Primary Tumor	Illumina HiSeq	332b29bf-f948-4e2c-bf51-f768f819e9e9	Cervix	81.0	2E7F29FB-97DE-4EE0-BCA7-6A51C4C3E5CF	C32BE42D-CF78-4F46-B461-748796CEDA4A	TCGA-EK-A2PM-01A-11D-A18I-02	HG19_Broad_variant	TCGA-EK-A2PM	TCGA-CESC		s1195	Harvard Medical School	Gynecologic Oncology Group	United States	NO			Cervical Squamous Cell Carcinoma		A18I-02	True
13722.58cfa831e4b0c9d6adf6c48e	58cfa831e4b0c9d6adf6c48e	TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted	TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted.bam	74.36	1.93	0.16	58cfa831e4b0c9d6adf6c48e	TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted.bam	Alive	FEMALE			Bladder Urothelial Carcinoma	Aligned reads	TCGA-C4-A0F6-01A	4FF9B4F2-6D04-4FED-8796-155902A8BF28	Primary Tumor	Illumina HiSeq	2332be3a-c2a5-446a-ae60-b8f873fe1866	Bladder	82.0	905D2BF1-08CB-4260-8188-00B60D881CF2	1765E178-12BD-4682-AB4A-368C4DCB5AEE	TCGA-C4-A0F6-01A-11D-A10R-02	HG19_Broad_variant	TCGA-C4-A0F6	TCGA-BLCA		s3084	Harvard Medical School	Indivumed	Germany	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A10R-02	True
13767.58cfa837e4b0c9d6adf6fe14	58cfa837e4b0c9d6adf6fe14	UNCID_1728491.cac2a45e-6d54-4e63-a921-3b4183b8677a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1728491.cac2a45e-6d54-4e63-a921-3b4183b8677a.sorted_genome_alignments	UNCID_1728491.cac2a45e-6d54-4e63-a921-3b4183b8677a.sorted_genome_alignments.bam	78.2		0.13	58cfa837e4b0c9d6adf6fe14	UNCID_1728491.cac2a45e-6d54-4e63-a921-3b4183b8677a.sorted_genome_alignments.bam	Dead	FEMALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8336-01A	63643BA6-BED9-4C36-91DD-A18105FADC06	Primary Tumor	Illumina HiSeq	6BE19928-58C6-494B-97C0-109956F46223	Kidney	51.0	6C61ACB9-F159-4C51-9141-4E148AC7B9B8	CAC2A45E-6D54-4E63-A921-3B4183B8677A	TCGA-KL-8336-01A-11R-2315-07	HG19	TCGA-KL-8336	TCGA-KICH	920.0	s16514	University of North Carolina	MSKCC	United States	NO	T3b	N2	Kidney Chromophobe	Stage IV	2315-07	True
13767.58cfa835e4b0c9d6adf6eaa6	58cfa835e4b0c9d6adf6eaa6	UNCID_1286408.25672b5b-2ac2-41dc-9aa0-a9968d05430d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1286408.25672b5b-2ac2-41dc-9aa0-a9968d05430d.sorted_genome_alignments	UNCID_1286408.25672b5b-2ac2-41dc-9aa0-a9968d05430d.sorted_genome_alignments.bam	28.7	1.8	0.17	58cfa835e4b0c9d6adf6eaa6	UNCID_1286408.25672b5b-2ac2-41dc-9aa0-a9968d05430d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-DA-A1IB-06A	8FC9CC74-F388-49F0-B957-DEBB62638634	Metastatic	Illumina HiSeq	DC2028AA-5637-4A0A-8FA5-61591AA888D2	Skin	69.0	E6019993-7537-4368-A2A2-60458EB94AE7	25672B5B-2AC2-41DC-9AA0-A9968D05430D	TCGA-DA-A1IB-06A-11R-A18S-07	HG19	TCGA-DA-A1IB	TCGA-SKCM		s7916	University of North Carolina	Yale	United States	NO	T2b	N2b		Stage III	A18S-07	True
13767.58cfa838e4b0c9d6adf705fe	58cfa838e4b0c9d6adf705fe	UNCID_1912168.d34945c6-2882-4e48-ada0-2f61d9f7a4e5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1912168.d34945c6-2882-4e48-ada0-2f61d9f7a4e5.sorted_genome_alignments	UNCID_1912168.d34945c6-2882-4e48-ada0-2f61d9f7a4e5.sorted_genome_alignments.bam	173.2		0.16	58cfa838e4b0c9d6adf705fe	UNCID_1912168.d34945c6-2882-4e48-ada0-2f61d9f7a4e5.sorted_genome_alignments.bam	Alive	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-8139-01A	1FDBEB6A-8C73-46DB-9D21-C56A834064F6	Primary Tumor	Illumina HiSeq	C4F89C96-EAEA-49C2-877B-31D357AD180A	Lung	72.0	E040D9C5-8E56-4A95-A88C-65037FA0F386	D34945C6-2882-4E48-ADA0-2F61D9F7A4E5	TCGA-77-8139-01A-11R-2247-07	HG19	TCGA-77-8139	TCGA-LUSC		s10449	University of North Carolina	Prince Charles Hospital	Australia	NO	T3	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	2247-07	True
13722.58cfa832e4b0c9d6adf6d618	58cfa832e4b0c9d6adf6d618	TCGA-LN-A4MR-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_8_rg.sorted.filtered.	WGS	TCGA-LN-A4MR-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_8_rg.sorted	TCGA-LN-A4MR-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_8_rg.sorted.bam	38.53		0.17	58cfa832e4b0c9d6adf6d618	TCGA-LN-A4MR-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_8_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A4MR-01A	CC14603B-E32C-43F3-8218-B6ED7EE2EC18	Primary Tumor	Illumina HiSeq	6c329173-3100-4df0-ad53-2f0bdffd2143	Esophagus	57.0	CB5E48F2-2803-4F25-9D6C-4A812722E900	65B1AB3A-A807-44D1-A734-DE9A6821151C	TCGA-LN-A4MR-01A-11D-A28P-26	HG19_Broad_variant	TCGA-LN-A4MR	TCGA-ESCA		s1774	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0		Stage II	A28P-26	True
13722.58cfa830e4b0c9d6adf6bba0	58cfa830e4b0c9d6adf6bba0	TCGA-AA-A01V-11A-11D-A079_110409_SN590_0077_BB04EHABXX_s_7_rg.sorted.filtered.	WGS	TCGA-AA-A01V-11A-11D-A079_110409_SN590_0077_BB04EHABXX_s_7_rg.sorted	TCGA-AA-A01V-11A-11D-A079_110409_SN590_0077_BB04EHABXX_s_7_rg.sorted.bam	40.0	1.86	0.13	58cfa830e4b0c9d6adf6bba0	TCGA-AA-A01V-11A-11D-A079_110409_SN590_0077_BB04EHABXX_s_7_rg.sorted.bam	Alive	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01V-11A	0CB0DAC8-4CE2-444A-B1AE-1550E065B4D9	Solid Tissue Normal	Illumina HiSeq	a0120ca6-fc3e-4ff4-b926-6c38e3180674	Colorectal	59.0	398A605C-0A45-4757-BC28-996816990576	725B35D1-7AAA-4471-9539-6CC0EA98A6DE	TCGA-AA-A01V-11A-11D-A079-02	HG18_Broad_variant	TCGA-AA-A01V	TCGA-COAD		s13528	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A079-02	True
13767.58cfa834e4b0c9d6adf6e543	58cfa834e4b0c9d6adf6e543	UNCID_1192537.0f380c26-38fb-41ff-880f-2490b4259695.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1192537.0f380c26-38fb-41ff-880f-2490b4259695.sorted_genome_alignments	UNCID_1192537.0f380c26-38fb-41ff-880f-2490b4259695.sorted_genome_alignments.bam	80.8	1.7	0.15	58cfa834e4b0c9d6adf6e543	UNCID_1192537.0f380c26-38fb-41ff-880f-2490b4259695.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5692-01A	9C377F9B-79DD-4412-80AC-CEA9A3529888	Primary Tumor	Illumina HiSeq	5B22C648-63E6-4C05-A3A8-F63CE479D892	Kidney	66.0	18223FC1-A5A8-4007-9696-728F8C302A23	0F380C26-38FB-41FF-880F-2490B4259695	TCGA-B0-5692-01A-11R-1541-07	HG19	TCGA-B0-5692	TCGA-KIRC		s9062	University of North Carolina	University of Pittsburgh	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1541-07	True
13722.58cfa82fe4b0c9d6adf6b724	58cfa82fe4b0c9d6adf6b724	TCGA-71-6725-10A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-71-6725-10A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_1_rg.sorted	TCGA-71-6725-10A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_1_rg.sorted.bam	166.0	1.9	0.15	58cfa82fe4b0c9d6adf6b724	TCGA-71-6725-10A-01D-1853_120305_SN1120_0119_BD0REAACXX_s_1_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-71-6725-10A	4B7CD595-E7F9-45A8-B736-A8C7C42D9539	Blood Derived Normal	Illumina HiSeq	6ab86bce-d92f-4638-a2d7-4761bcc675d7	Lung	48.0	9BE42F9A-4AC0-427F-A1BA-45FB541174B7	62E9B0D2-3A69-47EA-BE27-551213D303CC	TCGA-71-6725-10A-01D-1853-02	HG19_Broad_variant	TCGA-71-6725	TCGA-LUAD		s10665	Harvard Medical School	ILSbio	Vietnam	NO	T2	N0	Lung Papillary Adenocarcinoma	Stage I	1853-02	True
13767.58cfa82ee4b0c9d6adf6ab3d	58cfa82ee4b0c9d6adf6ab3d	G17479.TCGA-14-1034-02B-01R-2005-01.2.filtered.	RNA-Seq	G17479.TCGA-14-1034-02B-01R-2005-01.2	G17479.TCGA-14-1034-02B-01R-2005-01.2.bam	500.0	1.8	0.15	58cfa82ee4b0c9d6adf6ab3d	G17479.TCGA-14-1034-02B-01R-2005-01.2.bam	Dead	FEMALE			Glioblastoma Multiforme	Aligned reads	TCGA-14-1034-02B	0078B0C4-68A9-483B-9AAB-61156D263213	Recurrent Tumor	Illumina HiSeq	5EB0426B-0998-488C-A66A-9ABF207CA0A6	Brain	60.0	AFD6ABEE-DD83-4B1A-B66F-8FD50190287B	EE783DA8-98C4-4107-8E9B-AF8580AC2F24	TCGA-14-1034-02B-01R-2005-01	HG19_Broad_variant	TCGA-14-1034	TCGA-GBM	485.0	s14047	Broad Institute of MIT and Harvard	Emory University	None	NO			Untreated primary (de novo) GBM		2005-01	True
13767.58cfa83ce4b0c9d6adf72ecf	58cfa83ce4b0c9d6adf72ecf	_1_TCGA-BR-A453-01A-11R-A24K-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-A453-01A-11R-A24K-31_rnaseq	_1_TCGA-BR-A453-01A-11R-A24K-31_rnaseq.bam	6.54	1.98	0.16	58cfa83ce4b0c9d6adf72ecf	_1_TCGA-BR-A453-01A-11R-A24K-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-A453-01A	1A1D4702-254B-4FFF-9609-182442EDB83E	Primary Tumor	Illumina HiSeq	6ABFDAD2-5AF3-4BDE-B236-04C108B3FE55	Stomach	51.0	24A91ADB-F3E1-4CA2-8501-82A4DBFD57E7	BA142DD8-933E-42B4-903A-22B2BA38DDF9	TCGA-BR-A453-01A-11R-A24K-31	GRCh37-lite	TCGA-BR-A453	TCGA-STAD		s15087	Canada's Michael Smith Genome Sciences Centre	Asterand	Vietnam	NO	T4a	N3a	Stomach Adenocarcinoma  Signet Ring Type	Stage IV	A24K-31	True
13722.58cfa831e4b0c9d6adf6c667	58cfa831e4b0c9d6adf6c667	TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted	TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted.bam	143.3	1.9	0.14	58cfa831e4b0c9d6adf6c667	TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4466-01A	2F1B96B2-7031-4F7D-9490-14728D320F3E	Primary Tumor	Illumina HiSeq	cea9fe91-10d4-464c-80a6-24b7ed98ba9c	Stomach	81.0	0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9	623D5E6A-A5D3-4580-BEF7-04673D42A1D0	TCGA-CG-4466-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4466	TCGA-STAD		s14757	Harvard Medical School	Indivumed	Germany	NO	T2a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1154-02	True
13767.58cfa834e4b0c9d6adf6e09a	58cfa834e4b0c9d6adf6e09a	UNCID_1156484.354adce5-6ca4-4d6d-a519-4eabc01c6b36.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1156484.354adce5-6ca4-4d6d-a519-4eabc01c6b36.sorted_genome_alignments	UNCID_1156484.354adce5-6ca4-4d6d-a519-4eabc01c6b36.sorted_genome_alignments.bam	51.81	1.76	0.14	58cfa834e4b0c9d6adf6e09a	UNCID_1156484.354adce5-6ca4-4d6d-a519-4eabc01c6b36.sorted_genome_alignments.bam	Alive	FEMALE			Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A08X-01A	F5539207-6534-4EDC-A5A5-7666B5D16BA4	Primary Tumor	Illumina HiSeq	0138B810-201A-416C-AC5A-26145EDD7DD5	Breast	43.0	32B46B33-43D1-4663-BEBD-F31673F18A16	354ADCE5-6CA4-4D6D-A519-4EABC01C6B36	TCGA-A8-A08X-01A-21R-A00Z-07	HG19	TCGA-A8-A08X	TCGA-BRCA		s5574	University of North Carolina	Indivumed	Germany	NO	T4d	N3a	Infiltrating Ductal Carcinoma	Stage III	A00Z-07	True
13767.58cfa836e4b0c9d6adf6f4f4	58cfa836e4b0c9d6adf6f4f4	UNCID_1572446.772f9a82-9a03-4bf0-b7ce-877b15e3d017.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1572446.772f9a82-9a03-4bf0-b7ce-877b15e3d017.sorted_genome_alignments	UNCID_1572446.772f9a82-9a03-4bf0-b7ce-877b15e3d017.sorted_genome_alignments.bam	99.2		0.15	58cfa836e4b0c9d6adf6f4f4	UNCID_1572446.772f9a82-9a03-4bf0-b7ce-877b15e3d017.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-83-5908-01A	25D4EA9E-F773-4F11-BAC9-64EFDAD73211	Primary Tumor	Illumina HiSeq	A036D5EE-8DBA-4A04-92F6-E178A877D0EA	Lung	59.0	D2B8A9F4-7D70-43A0-B5F6-5B7365A03944	772F9A82-9A03-4BF0-B7CE-877B15E3D017	TCGA-83-5908-01A-21R-2287-07	HG19	TCGA-83-5908	TCGA-LUAD		s10865	University of North Carolina	CHI-Penrose Colorado	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2287-07	True
13767.58cfa83ae4b0c9d6adf71c78	58cfa83ae4b0c9d6adf71c78	UNCID_2486878.c2a4a9ce-9d07-4964-b1ee-744967ba0e2d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2486878.c2a4a9ce-9d07-4964-b1ee-744967ba0e2d.sorted_genome_alignments	UNCID_2486878.c2a4a9ce-9d07-4964-b1ee-744967ba0e2d.sorted_genome_alignments.bam	36.06	1.89	0.18	58cfa83ae4b0c9d6adf71c78	UNCID_2486878.c2a4a9ce-9d07-4964-b1ee-744967ba0e2d.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-AF-A56N-01A	811F3FEB-A5A9-48B1-ACDA-FBB23FCBCF16	Primary Tumor	Illumina HiSeq	B1D0A492-8225-4BAF-8FEC-69E3B4B2253E	Colorectal	47.0	1BC6365D-F855-4F72-AC54-D343212A2014	C2A4A9CE-9D07-4964-B1EE-744967BA0E2D	TCGA-AF-A56N-01A-12R-A39D-07	HG19	TCGA-AF-A56N	TCGA-READ		s2091	University of North Carolina	Christiana Healthcare	United States	NO	T3	N0	Rectal Adenocarcinoma	Stage II	A39D-07	True
13722.58cfa830e4b0c9d6adf6bb3e	58cfa830e4b0c9d6adf6bb3e	TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted.filtered.	WGS	TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted	TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted.bam	89.57	1.8	0.13	58cfa830e4b0c9d6adf6bb3e	TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01S-01A	84E34CF2-B3BB-4A1A-8FB7-6C2C604C4008	Primary Tumor	Illumina HiSeq	fe7c227a-1329-4956-b9bf-08bbb6fe161d	Colorectal	47.0	5743700C-CBD3-4F87-8109-6349A96EB605	DC9E606A-12D6-4AA6-9780-1D999EB72C5A	TCGA-AA-A01S-01A-21D-A079-02	HG18_Broad_variant	TCGA-AA-A01S	TCGA-COAD		s13206	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	A079-02	True
13767.58cfa838e4b0c9d6adf707ce	58cfa838e4b0c9d6adf707ce	UNCID_2031262.fc8c0c74-cd1b-4bc7-ab1d-568d302c5719.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2031262.fc8c0c74-cd1b-4bc7-ab1d-568d302c5719.sorted_genome_alignments	UNCID_2031262.fc8c0c74-cd1b-4bc7-ab1d-568d302c5719.sorted_genome_alignments.bam	41.9	1.86	0.16	58cfa838e4b0c9d6adf707ce	UNCID_2031262.fc8c0c74-cd1b-4bc7-ab1d-568d302c5719.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Breast Invasive Carcinoma	Aligned reads	TCGA-OL-A5RZ-01A	7E8713BD-0B17-4F09-9696-BC29707D862B	Primary Tumor	Illumina HiSeq	6E0DD470-CA21-48BB-9659-22966262C278	Breast	57.0	99095138-B471-48D0-AED9-DD8AFC8DED68	FC8C0C74-CD1B-4BC7-AB1D-568D302C5719	TCGA-OL-A5RZ-01A-11R-A28M-07	HG19	TCGA-OL-A5RZ	TCGA-BRCA		s5928	University of North Carolina	University of Chicago	United States	NO	T1b	N0	Infiltrating Ductal Carcinoma	Stage I	A28M-07	True
13767.58cfa835e4b0c9d6adf6ee12	58cfa835e4b0c9d6adf6ee12	UNCID_1379858.f3872d71-1889-4756-bdb4-d5ae383758a8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1379858.f3872d71-1889-4756-bdb4-d5ae383758a8.sorted_genome_alignments	UNCID_1379858.f3872d71-1889-4756-bdb4-d5ae383758a8.sorted_genome_alignments.bam	69.97	1.75	0.17	58cfa835e4b0c9d6adf6ee12	UNCID_1379858.f3872d71-1889-4756-bdb4-d5ae383758a8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JZ-01A	9CC92795-7A24-4875-87F0-3EFCCBFCC970	Primary Tumor	Illumina HiSeq	A988F75D-8C55-4331-B7E3-FD375A9E135C	Bladder	55.0	449E18FB-CBC0-4365-AEEC-EDC6A6B276BD	F3872D71-1889-4756-BDB4-D5AE383758A8	TCGA-GV-A3JZ-01A-11R-A21D-07	HG19	TCGA-GV-A3JZ	TCGA-BLCA		s3328	University of North Carolina	BLN - Cleveland Clinic	United States	NO	T4a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A21D-07	True
13767.58cfa834e4b0c9d6adf6e7f6	58cfa834e4b0c9d6adf6e7f6	UNCID_1224854.d17f1df8-d3de-4a01-930c-a066942e9fe4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1224854.d17f1df8-d3de-4a01-930c-a066942e9fe4.sorted_genome_alignments	UNCID_1224854.d17f1df8-d3de-4a01-930c-a066942e9fe4.sorted_genome_alignments.bam	28.73	1.85	0.17	58cfa834e4b0c9d6adf6e7f6	UNCID_1224854.d17f1df8-d3de-4a01-930c-a066942e9fe4.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZK-06A	1404791B-86BF-4DFD-85B4-C8FF356F109C	Metastatic	Illumina HiSeq	75CAE83E-D1CC-4941-8194-D173FB1218D5	Skin	68.0	07E2FEA3-4BA5-49B3-AE9B-61FF8492026C	D17F1DF8-D3DE-4A01-930C-A066942E9FE4	TCGA-FS-A1ZK-06A-11R-A18T-07	HG19	TCGA-FS-A1ZK	TCGA-SKCM	728.0	s8044	University of North Carolina	Essen	Germany	NO	T4	N0		Stage II	A18T-07	True
13722.58cfa831e4b0c9d6adf6ccbc	58cfa831e4b0c9d6adf6ccbc	TCGA-EJ-7328-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EJ-7328-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_3_rg.sorted	TCGA-EJ-7328-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_3_rg.sorted.bam	211.6		0.15	58cfa831e4b0c9d6adf6ccbc	TCGA-EJ-7328-10A-01D-2111_130502_SN590_0228_AD24A9ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7328-10A	42B7D14F-09E5-4D91-BB98-5FE35907A6A9	Blood Derived Normal	Illumina HiSeq	ad1bcbc2-4111-46be-aa25-6f8222612d52	Prostate	70.0	562FB2D5-34A4-4AB3-A7C2-7FF5EDCAB189	C8679C7C-C1C9-4A07-A82B-AF7F768223E6	TCGA-EJ-7328-10A-01D-2111-02	HG19_Broad_variant	TCGA-EJ-7328	TCGA-PRAD		s3444	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		2111-02	True
13767.58cfa835e4b0c9d6adf6ebe4	58cfa835e4b0c9d6adf6ebe4	UNCID_1321475.752db3dc-92ba-4a16-a8d0-41ce260cef62.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1321475.752db3dc-92ba-4a16-a8d0-41ce260cef62.sorted_genome_alignments	UNCID_1321475.752db3dc-92ba-4a16-a8d0-41ce260cef62.sorted_genome_alignments.bam	32.07	1.79	0.16	58cfa835e4b0c9d6adf6ebe4	UNCID_1321475.752db3dc-92ba-4a16-a8d0-41ce260cef62.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3GO-01A	AA528913-CBBC-4E1D-B6D0-87F6A46BCBC9	Primary Tumor	Illumina HiSeq	7DF11EA2-D5DA-40F4-B02E-7A57D800D0A3	Thyroid	31.0	74CD44B7-728E-4951-A7C7-67A82BC0F887	752DB3DC-92BA-4A16-A8D0-41CE260CEF62	TCGA-EL-A3GO-01A-11R-A206-07	HG19	TCGA-EL-A3GO	TCGA-THCA		s12023	University of North Carolina	MD Anderson	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A206-07	True
13767.58cfa834e4b0c9d6adf6e280	58cfa834e4b0c9d6adf6e280	UNCID_1182063.932f313c-d695-4061-9abb-b1402aed8030.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1182063.932f313c-d695-4061-9abb-b1402aed8030.sorted_genome_alignments	UNCID_1182063.932f313c-d695-4061-9abb-b1402aed8030.sorted_genome_alignments.bam	48.8	1.8	0.15	58cfa834e4b0c9d6adf6e280	UNCID_1182063.932f313c-d695-4061-9abb-b1402aed8030.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5402-11A	D7AB7EC0-3DE7-4FFD-A5AC-F75579355B2A	Solid Tissue Normal	Illumina HiSeq	5EA4F8C4-2FD2-46B9-A8C8-76484CA7EF7E	Kidney	64.0	D27E0760-5CE6-4659-ADF4-E61967341288	932F313C-D695-4061-9ABB-B1402AED8030	TCGA-B0-5402-11A-01R-1503-07	HG19	TCGA-B0-5402	TCGA-KIRC		s9336	University of North Carolina	University of Pittsburgh	None	NO	T4	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1503-07	True
13767.58cfa83ce4b0c9d6adf72ece	58cfa83ce4b0c9d6adf72ece	_1_TCGA-BR-A4CR-01A-11R-A24K-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-A4CR-01A-11R-A24K-31_rnaseq	_1_TCGA-BR-A4CR-01A-11R-A24K-31_rnaseq.bam	64.87	1.87	0.15	58cfa83ce4b0c9d6adf72ece	_1_TCGA-BR-A4CR-01A-11R-A24K-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-A4CR-01A	794FBAD5-93CE-4F9A-AEE4-37A89A6719EC	Primary Tumor	Illumina HiSeq	C2E69CF8-DA21-4E9C-912D-5B4FAD0FFB21	Stomach	70.0	76165733-85CA-47D0-A82A-F64FA9B1B834	F266E336-6171-4FE6-AA4C-2EDD872478F7	TCGA-BR-A4CR-01A-11R-A24K-31	GRCh37-lite	TCGA-BR-A4CR	TCGA-STAD		s15430	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4b	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	A24K-31	True
13767.58cfa838e4b0c9d6adf70846	58cfa838e4b0c9d6adf70846	UNCID_2035144.b4a85000-c0fd-4287-83f2-fc0757fe4a60.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2035144.b4a85000-c0fd-4287-83f2-fc0757fe4a60.sorted_genome_alignments	UNCID_2035144.b4a85000-c0fd-4287-83f2-fc0757fe4a60.sorted_genome_alignments.bam	11.97	1.86	0.17	58cfa838e4b0c9d6adf70846	UNCID_2035144.b4a85000-c0fd-4287-83f2-fc0757fe4a60.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AJ-A3NE-11A	1DCF33E9-4C9B-4B2B-914E-15E6BE5DCD07	Solid Tissue Normal	Illumina HiSeq	1976D103-D397-44EF-924D-A17ACFD7F284	Uterus	46.0	6436BE59-08E6-4DB6-9D8D-FBECFBC00B7C	B4A85000-C0FD-4287-83F2-FC0757FE4A60	TCGA-AJ-A3NE-11A-11R-A22K-07	HG19	TCGA-AJ-A3NE	TCGA-UCEC		s4895	University of North Carolina	International Genomics Conosrtium	United States	NO			Endometrioid endometrial adenocarcinoma		A22K-07	True
13767.58cfa832e4b0c9d6adf6d0c6	58cfa832e4b0c9d6adf6d0c6	TCGA-HU-A4GN-11A-12R-A251-31_rnaseq.filtered.	RNA-Seq	TCGA-HU-A4GN-11A-12R-A251-31_rnaseq	TCGA-HU-A4GN-11A-12R-A251-31_rnaseq.bam	7.35	1.75	0.18	58cfa832e4b0c9d6adf6d0c6	TCGA-HU-A4GN-11A-12R-A251-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4GN-11A	F8A32CB0-8C3D-4BC2-8E53-561B89000BE7	Solid Tissue Normal	Illumina HiSeq	48F18F53-B295-4738-8ED8-617923D7C081	Stomach	61.0	9776B300-217E-4C5A-B9A5-74BF57D36E59	1CBBED6A-6117-48FF-94B1-C9018C5AAA67	TCGA-HU-A4GN-11A-12R-A251-31	GRCh37-lite	TCGA-HU-A4GN	TCGA-STAD		s15139	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T2	N1	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage II	A251-31	True
13767.58cfa837e4b0c9d6adf701ec	58cfa837e4b0c9d6adf701ec	UNCID_1861728.c6652862-6909-4778-8b3b-9db4cee801b6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1861728.c6652862-6909-4778-8b3b-9db4cee801b6.sorted_genome_alignments	UNCID_1861728.c6652862-6909-4778-8b3b-9db4cee801b6.sorted_genome_alignments.bam	73.2	1.8	0.14	58cfa837e4b0c9d6adf701ec	UNCID_1861728.c6652862-6909-4778-8b3b-9db4cee801b6.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-F4-6703-01A	0C53B010-4243-4DA3-A059-7F54C9A850EC	Primary Tumor	Illumina HiSeq	58AE146F-0223-417F-BBA5-F09D5D4D5ABE	Colorectal	64.0	04DD54D3-E4D1-4C72-860B-20E971609A5A	C6652862-6909-4778-8B3B-9DB4CEE801B6	TCGA-F4-6703-01A-11R-1839-07	HG19	TCGA-F4-6703	TCGA-COAD		s13106	University of North Carolina	Asterand	Ukraine	NO	T3	N0	Colon Adenocarcinoma	Stage II	1839-07	True
13767.58cfa833e4b0c9d6adf6dbde	58cfa833e4b0c9d6adf6dbde	UNCID_1114594.25be50e7-7705-492d-a44a-0e40180d10c8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1114594.25be50e7-7705-492d-a44a-0e40180d10c8.sorted_genome_alignments	UNCID_1114594.25be50e7-7705-492d-a44a-0e40180d10c8.sorted_genome_alignments.bam	18.48	1.86	0.18	58cfa833e4b0c9d6adf6dbde	UNCID_1114594.25be50e7-7705-492d-a44a-0e40180d10c8.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A23E-01A	E7BAE6E7-F779-449D-92B9-66996041E00D	Primary Tumor	Illumina HiSeq	D7C3908D-E9F4-4532-9424-69C92E6D5E27	Breast	50.0	D490330A-DE38-478F-9504-A69260AB3967	25BE50E7-7705-492D-A44A-0E40180D10C8	TCGA-AC-A23E-01A-11R-A157-07	HG19	TCGA-AC-A23E	TCGA-BRCA		s6287	University of North Carolina	International Genomics Consortium	United States	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A157-07	True
13767.58cfa837e4b0c9d6adf70264	58cfa837e4b0c9d6adf70264	UNCID_1896466.5330437a-0b3d-4249-9c70-a5f967f989de.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1896466.5330437a-0b3d-4249-9c70-a5f967f989de.sorted_genome_alignments	UNCID_1896466.5330437a-0b3d-4249-9c70-a5f967f989de.sorted_genome_alignments.bam	178.2	1.8	0.16	58cfa837e4b0c9d6adf70264	UNCID_1896466.5330437a-0b3d-4249-9c70-a5f967f989de.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7077-01A	92252560-5984-41F6-A4B5-A3AA8654C0C8	Primary Tumor	Illumina HiSeq	503A7AFE-5EFF-43A1-AA21-4A6B7DE0896A	Prostate	64.0	F3E4CC00-D6FE-4291-BB07-8E501E772CE1	5330437A-0B3D-4249-9C70-A5F967F989DE	TCGA-HC-7077-01A-11R-1965-07	HG19	TCGA-HC-7077	TCGA-PRAD		s3859	University of North Carolina	International Genomics Consortium	United States	NO	T3a		Prostate Adenocarcinoma Acinar Type		1965-07	True
13722.58cfa831e4b0c9d6adf6c741	58cfa831e4b0c9d6adf6c741	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.bam	52.73		0.13	58cfa831e4b0c9d6adf6c741	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7247-01A	5E25AB76-A8AB-4779-AA03-8DE658F18DA1	Primary Tumor	Illumina HiSeq	0b4ae8f3-7acd-4d37-a39f-cb4fc2b537b4	Head and Neck	55.0	F84AE44B-4BB7-4841-AEE0-139CD79B9680	A5BA905A-C959-4118-B1C9-F6466CB5541A	TCGA-CV-7247-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7247	TCGA-HNSC	577.0	s15904	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	2317-26	True
13767.58cfa838e4b0c9d6adf70b1a	58cfa838e4b0c9d6adf70b1a	UNCID_2083369.ef9e7c11-fee1-41ef-98e0-cfc3ba97e403.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2083369.ef9e7c11-fee1-41ef-98e0-cfc3ba97e403.sorted_genome_alignments	UNCID_2083369.ef9e7c11-fee1-41ef-98e0-cfc3ba97e403.sorted_genome_alignments.bam	40.73	1.88	0.16	58cfa838e4b0c9d6adf70b1a	UNCID_2083369.ef9e7c11-fee1-41ef-98e0-cfc3ba97e403.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A4MA-01A	89C72F0E-E724-4826-BB9C-D7524D1B1258	Primary Tumor	Illumina HiSeq	D4B9D46F-6B02-4E30-B954-0CFF62FEB315	Thyroid	52.0	2B19C88D-9BC3-4C86-AAEB-77F523F7FE50	EF9E7C11-FEE1-41EF-98E0-CFC3BA97E403	TCGA-DE-A4MA-01A-11R-A250-07	HG19	TCGA-DE-A4MA	TCGA-THCA		s12610	University of North Carolina	University of North Carolina	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A250-07	True
13767.58cfa833e4b0c9d6adf6d89a	58cfa833e4b0c9d6adf6d89a	UNCID_1094834.0f61b005-3643-4a6b-a075-bffb7320a2f3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1094834.0f61b005-3643-4a6b-a075-bffb7320a2f3.sorted_genome_alignments	UNCID_1094834.0f61b005-3643-4a6b-a075-bffb7320a2f3.sorted_genome_alignments.bam	269.8	1.8	0.15	58cfa833e4b0c9d6adf6d89a	UNCID_1094834.0f61b005-3643-4a6b-a075-bffb7320a2f3.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-5779-01A	1C58D9B8-17A2-4FC6-9898-FE6F47BD2C2A	Primary Tumor	Illumina HiSeq	D57A46FC-97EB-4816-A993-AA3C34F7593F	Lung	61.0	4131DA8F-3C6C-43E1-A7EB-81CB8988F524	0F61B005-3643-4A6B-A075-BFFB7320A2F3	TCGA-64-5779-01A-01R-1628-07	HG19	TCGA-64-5779	TCGA-LUAD		s11258	University of North Carolina	Fox Chase	United States	NO	T2	N2	Lung Acinar Adenocarcinoma	Stage III	1628-07	True
13722.58cfa82ee4b0c9d6adf6ada0	58cfa82ee4b0c9d6adf6ada0	G39020.TCGA-CD-5799-01A-11D-1600-08.1.filtered.	WGS	G39020.TCGA-CD-5799-01A-11D-1600-08.1	G39020.TCGA-CD-5799-01A-11D-1600-08.1.bam	177.7	2.0	0.05	58cfa82ee4b0c9d6adf6ada0	G39020.TCGA-CD-5799-01A-11D-1600-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5799-01A	C991697F-77F9-412A-9BD1-0E47F7387CB2	Primary Tumor	Illumina HiSeq	4086df7e-765b-48a9-bece-369629691ae0	Stomach	45.0	A3180E0E-EB99-49DD-8252-5FEA05A9885F	EB59B79F-BD36-4BF4-83E3-2AF73BD1D30A	TCGA-CD-5799-01A-11D-1600-08	HG19_Broad_variant	TCGA-CD-5799	TCGA-STAD		s14602	Broad Institute of MIT and Harvard	ILSBIO	Vietnam	NO	T2	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1600-08	True
13767.58cfa83be4b0c9d6adf724a8	58cfa83be4b0c9d6adf724a8	UNCID_2603620.97841894-fe38-4512-b5f5-b5526ec17836.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2603620.97841894-fe38-4512-b5f5-b5526ec17836.sorted_genome_alignments	UNCID_2603620.97841894-fe38-4512-b5f5-b5526ec17836.sorted_genome_alignments.bam	31.36	1.78	0.15	58cfa83be4b0c9d6adf724a8	UNCID_2603620.97841894-fe38-4512-b5f5-b5526ec17836.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-2G-AAKH-01A	C50D0EF9-1CC7-4BAD-B1DE-AA866276B977	Primary Tumor	Illumina HiSeq	DCA6087F-C9A3-454A-BAAC-B22FEF7C6598	Testis	19.0	00B9379A-616D-4E80-8F00-02FA9B91D620	97841894-FE38-4512-B5F5-B5526EC17836	TCGA-2G-AAKH-01A-11R-A430-07	HG19	TCGA-2G-AAKH	TCGA-TGCT		s691	University of North Carolina	Erasmus MC	Netherlands	NO	T1	NX		Stage II	A430-07	True
13767.58cfa838e4b0c9d6adf70b65	58cfa838e4b0c9d6adf70b65	UNCID_2063776.2ea1224b-66aa-48a4-a605-4d1262e84303.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2063776.2ea1224b-66aa-48a4-a605-4d1262e84303.sorted_genome_alignments	UNCID_2063776.2ea1224b-66aa-48a4-a605-4d1262e84303.sorted_genome_alignments.bam	13.83	1.89	0.18	58cfa838e4b0c9d6adf70b65	UNCID_2063776.2ea1224b-66aa-48a4-a605-4d1262e84303.sorted_genome_alignments.bam	Dead	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-MP-A4T8-01A	7C4ED533-EE66-48BE-A84B-FF8607742818	Primary Tumor	Illumina HiSeq	C83DCBF0-1805-4B2B-8001-746B3BEF2182	Lung	68.0	07B7F665-383C-4CF0-A677-52BCE36A674C	2EA1224B-66AA-48A4-A605-4D1262E84303	TCGA-MP-A4T8-01A-11R-A24X-07	HG19	TCGA-MP-A4T8	TCGA-LUAD	161.0	s11413	University of North Carolina	Washington University - Mayo Clinic	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	A24X-07	True
13767.58cfa83ae4b0c9d6adf715d4	58cfa83ae4b0c9d6adf715d4	UNCID_2369752.79ad5242-1b2c-4838-b5b6-93fd88ed98d8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2369752.79ad5242-1b2c-4838-b5b6-93fd88ed98d8.sorted_genome_alignments	UNCID_2369752.79ad5242-1b2c-4838-b5b6-93fd88ed98d8.sorted_genome_alignments.bam	23.95	1.83	0.17	58cfa83ae4b0c9d6adf715d4	UNCID_2369752.79ad5242-1b2c-4838-b5b6-93fd88ed98d8.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-SR-A6MT-01A	BCC5DD5C-B979-4B45-AAE5-B2C9871766E6	Primary Tumor	Illumina HiSeq	5A54CF03-B29A-496C-B848-F4A7B59EA36F	Nervous System	57.0	CCD876E3-C9AD-418D-A05B-4D6EF77D3D1A	79AD5242-1B2C-4838-B5B6-93FD88ED98D8	TCGA-SR-A6MT-01A-11R-A35L-07	HG19	TCGA-SR-A6MT	TCGA-PCPG		s990	University of North Carolina	Tufts Medical Center	United States	NO					A35L-07	True
13767.58cfa839e4b0c9d6adf7151c	58cfa839e4b0c9d6adf7151c	UNCID_2333930.44347235-2162-41f1-892e-1cf85f157ece.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2333930.44347235-2162-41f1-892e-1cf85f157ece.sorted_genome_alignments	UNCID_2333930.44347235-2162-41f1-892e-1cf85f157ece.sorted_genome_alignments.bam	7.42	1.91	0.18	58cfa839e4b0c9d6adf7151c	UNCID_2333930.44347235-2162-41f1-892e-1cf85f157ece.sorted_genome_alignments.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TQ-A7RV-01A	5A3EDEB6-133E-4116-9F80-2485BD70754D	Primary Tumor	Illumina HiSeq	CB6B6250-3E59-45CC-8C16-2791FB32AFC9	Brain	27.0	06D89076-34D4-496D-A412-F8C3B46A3A4B	44347235-2162-41F1-892E-1CF85F157ECE	TCGA-TQ-A7RV-01A-21R-A34F-07	HG19	TCGA-TQ-A7RV	TCGA-LGG		s8283	University of North Carolina	University of Sao Paulo	Brazil	NO			Astrocytoma		A34F-07	True
13767.58cfa83be4b0c9d6adf72a9f	58cfa83be4b0c9d6adf72a9f	UNCID_359422.TCGA-B8-5162-01A-01R-1420-07.110517_UNC14-SN744_0116_AD0C6JABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_359422.TCGA-B8-5162-01A-01R-1420-07.110517_UNC14-SN744_0116_AD0C6JABXX.8.trimmed.annotated.translated_to_genomic	UNCID_359422.TCGA-B8-5162-01A-01R-1420-07.110517_UNC14-SN744_0116_AD0C6JABXX.8.trimmed.annotated.translated_to_genomic.bam	8.3	1.8	0.14	58cfa83be4b0c9d6adf72a9f	UNCID_359422.TCGA-B8-5162-01A-01R-1420-07.110517_UNC14-SN744_0116_AD0C6JABXX.8.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B8-5162-01A	D62D39F9-C896-4758-A785-E236F0154F14	Primary Tumor	Illumina HiSeq	4FE92502-129B-463C-A40E-CC4843A34484	Kidney	62.0	EA4852E3-F4E8-4069-9DA0-BA2277767CEC	65334E64-43D0-4024-86AF-72B68EF869A7	TCGA-B8-5162-01A-01R-1420-07	HG19	TCGA-B8-5162	TCGA-KIRC		s9685	University of North Carolina	UNC	None	NO	T2a	NX	Kidney Clear Cell Renal Carcinoma	Stage II	1420-07	True
13722.58cfa832e4b0c9d6adf6d12c	58cfa832e4b0c9d6adf6d12c	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.bam	16.85		0.18	58cfa832e4b0c9d6adf6d12c	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EK-01A	5DA1CB68-C438-4DDC-999F-90AED0C4BD7A	Primary Tumor	Illumina HiSeq	f98c8702-90e5-4e7a-ad12-d11a9af57bf5	Bladder	57.0	FF1691F2-DF11-4068-8D8D-A778F384EC60	8A75CF19-7645-489D-AAEC-5D9AD293C4B1	TCGA-G2-A2EK-01A-22D-A18D-02	HG19_Broad_variant	TCGA-G2-A2EK	TCGA-BLCA		s2725	Harvard Medical School	MD Anderson	United States	NO		N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A18D-02	True
13722.58cfa832e4b0c9d6adf6cfb9	58cfa832e4b0c9d6adf6cfb9	TCGA-G9-6365-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-G9-6365-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_2_rg.sorted	TCGA-G9-6365-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_2_rg.sorted.bam	27.7	1.8	0.14	58cfa832e4b0c9d6adf6cfb9	TCGA-G9-6365-10A-01D-1784_130215_SN590_0212_BC1NP2ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6365-10A	6845076E-E940-4437-8618-81DB4A447544	Blood Derived Normal	Illumina HiSeq	cc8dcea7-b44b-4a7d-a9ef-f98a23c37e9a	Prostate	71.0	1668E387-F9EB-4301-9E72-9FDBDC521D45	CE08011F-F42E-46C6-8565-B825EB960B1D	TCGA-G9-6365-10A-01D-1784-02	HG19_Broad_variant	TCGA-G9-6365	TCGA-PRAD		s3614	Harvard Medical School	Roswell Park	United States	NO	T4	N0	Prostate Adenocarcinoma Acinar Type		1784-02	True
13767.58cfa832e4b0c9d6adf6d6ac	58cfa832e4b0c9d6adf6d6ac	UNCID_1067155.e778c0a5-1f5b-4e94-9779-2f7386586ff1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1067155.e778c0a5-1f5b-4e94-9779-2f7386586ff1.sorted_genome_alignments	UNCID_1067155.e778c0a5-1f5b-4e94-9779-2f7386586ff1.sorted_genome_alignments.bam	197.3	1.8	0.15	58cfa832e4b0c9d6adf6d6ac	UNCID_1067155.e778c0a5-1f5b-4e94-9779-2f7386586ff1.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-5241-01A	6013A4FD-89CF-48A7-A465-C7B644AFB4A5	Primary Tumor	Illumina HiSeq	93C54852-9F56-4195-BEC3-53C9455FE6A5	Lung	79.0	F9BDA334-2BD7-49E8-B054-858CC335F3C5	E778C0A5-1F5B-4E94-9779-2F7386586FF1	TCGA-34-5241-01A-01R-1443-07	HG19	TCGA-34-5241	TCGA-LUSC		s10602	University of North Carolina	University of Pittsburgh	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1443-07	True
13722.58cfa831e4b0c9d6adf6c931	58cfa831e4b0c9d6adf6c931	TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted	TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted.bam	33.0	1.9	0.15	58cfa831e4b0c9d6adf6c931	TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5624-10A	B4A41682-4ACA-4F1D-BACD-66F5E6EC7466	Blood Derived Normal	Illumina HiSeq	72bf54c2-0056-4578-8448-34fb30ed8b3a	Head and Neck	43.0	A782129D-F444-45AB-AFEC-0F45B369B258	55E14906-C54C-495E-B360-0384B230200D	TCGA-DQ-5624-10A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5624	TCGA-HNSC		s15786	Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma		1868-02	True
13767.58cfa83ce4b0c9d6adf73148	58cfa83ce4b0c9d6adf73148	_1_TCGA-D7-8579-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-D7-8579-01A-11R-2343-13_rnaseq	_1_TCGA-D7-8579-01A-11R-2343-13_rnaseq.bam	49.2		0.17	58cfa83ce4b0c9d6adf73148	_1_TCGA-D7-8579-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-8579-01A	81A7F6A2-E44C-43D6-B687-01158EAF44EE	Primary Tumor	Illumina HiSeq	C79EB787-91F1-4C2F-9137-F6B4F4290FA7	Stomach	66.0	6ACDFABC-7B32-471F-9D46-C8812BEA519F	E5706D2B-C271-479C-ACB0-54614C9F7C8E	TCGA-D7-8579-01A-11R-2343-13	GRCh37-lite	TCGA-D7-8579	TCGA-STAD		s14452	Canada's Michael Smith Genome Sciences Centre	Greater Poland Cancer Center	Poland	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2343-13	True
13767.58cfa838e4b0c9d6adf70720	58cfa838e4b0c9d6adf70720	UNCID_1988047.06d4cd28-11fb-4f25-8ae0-3fa8e3f3e325.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1988047.06d4cd28-11fb-4f25-8ae0-3fa8e3f3e325.sorted_genome_alignments	UNCID_1988047.06d4cd28-11fb-4f25-8ae0-3fa8e3f3e325.sorted_genome_alignments.bam	32.92	1.87	0.17	58cfa838e4b0c9d6adf70720	UNCID_1988047.06d4cd28-11fb-4f25-8ae0-3fa8e3f3e325.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A5BU-01A	980C7214-F708-4499-818D-F3DE87DC6DE7	Primary Tumor	Illumina HiSeq	485E2471-1824-42F0-A105-1E031DFC1F21	Bladder	76.0	5F0353BD-0F8B-44D5-8E0F-7F99C6B9E4BA	06D4CD28-11FB-4F25-8AE0-3FA8E3F3E325	TCGA-FD-A5BU-01A-31R-A26T-07	HG19	TCGA-FD-A5BU	TCGA-BLCA		s2994	University of North Carolina	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A26T-07	True
13722.58cfa831e4b0c9d6adf6cb42	58cfa831e4b0c9d6adf6cb42	TCGA-EE-A29B-06A-11D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EE-A29B-06A-11D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_1_rg.sorted	TCGA-EE-A29B-06A-11D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_1_rg.sorted.bam	66.45		0.17	58cfa831e4b0c9d6adf6cb42	TCGA-EE-A29B-06A-11D-A18Y_120807_SN590_0173_AC0VN5ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A29B-06A	905EA29F-588A-497B-9F06-2EEF3BDC9442	Metastatic	Illumina HiSeq	0d511b2e-752b-43a4-b27f-81a205cac15e	Skin	67.0	73ED3AA7-1AAD-42B6-AC8A-1CA284A75A48	4A8251BE-6505-4681-AB78-55086FC7D877	TCGA-EE-A29B-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-EE-A29B	TCGA-SKCM		s7677	Harvard Medical School	University of Sydney	Australia	NO	T3b	N0		Stage II	A18Y-02	True
13767.58cfa834e4b0c9d6adf6e786	58cfa834e4b0c9d6adf6e786	UNCID_1215636.8d250084-d374-4ec4-994b-6c5f9c0f1a14.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1215636.8d250084-d374-4ec4-994b-6c5f9c0f1a14.sorted_genome_alignments	UNCID_1215636.8d250084-d374-4ec4-994b-6c5f9c0f1a14.sorted_genome_alignments.bam	317.2	1.8	0.16	58cfa834e4b0c9d6adf6e786	UNCID_1215636.8d250084-d374-4ec4-994b-6c5f9c0f1a14.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7080-01A	FD50FF41-EC9D-4DB1-A673-36BA0CA1EAC8	Primary Tumor	Illumina HiSeq	FEBF39B6-CABC-4159-AA7C-C333224FCD30	Prostate	66.0	E30730B8-81F1-49A8-8446-547B5C3CC730	8D250084-D374-4EC4-994B-6C5F9C0F1A14	TCGA-HC-7080-01A-11R-1965-07	HG19	TCGA-HC-7080	TCGA-PRAD		s3466	University of North Carolina	International Genomics Consortium	United States	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type		1965-07	True
13767.58cfa83ce4b0c9d6adf72f9f	58cfa83ce4b0c9d6adf72f9f	_1_TCGA-BR-8588-01A-11R-2402-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-8588-01A-11R-2402-13_rnaseq	_1_TCGA-BR-8588-01A-11R-2402-13_rnaseq.bam	171.2		0.14	58cfa83ce4b0c9d6adf72f9f	_1_TCGA-BR-8588-01A-11R-2402-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8588-01A	AD73529B-92D7-412F-B001-920A61CEC313	Primary Tumor	Illumina HiSeq	ED639447-EDDE-4C9F-84A6-CC512E8F8321	Stomach	55.0	059DB5A3-4CD9-4C4F-8D59-B898BD9AD997	5669DE89-3CA4-4FFB-99CB-5E5CEB7B1273	TCGA-BR-8588-01A-11R-2402-13	GRCh37-lite	TCGA-BR-8588	TCGA-STAD		s14862	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4a	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2402-13	True
13767.58cfa838e4b0c9d6adf70723	58cfa838e4b0c9d6adf70723	UNCID_1988109.e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1988109.e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72.sorted_genome_alignments	UNCID_1988109.e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72.sorted_genome_alignments.bam	6.62	1.87	0.15	58cfa838e4b0c9d6adf70723	UNCID_1988109.e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A4Z1-01A	80419545-4E5D-4BAF-8948-F84589B5EF3E	Primary Tumor	Illumina HiSeq	2B1B195B-6506-4296-89EB-23C3F4CE3243	Breast	68.0	D36BAC7B-872B-44A8-8C7F-8CB850B49603	E6DBAF07-3551-4C73-A2F2-F1BEA4FA8E72	TCGA-D8-A4Z1-01A-21R-A266-07	HG19	TCGA-D8-A4Z1	TCGA-BRCA		s5926	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T1c	N0	Infiltrating Lobular Carcinoma	Stage I	A266-07	True
13767.58cfa836e4b0c9d6adf6f554	58cfa836e4b0c9d6adf6f554	UNCID_1578324.90E7F816-EAD8-413D-A5C4-3BB5B3C48461.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1578324.90E7F816-EAD8-413D-A5C4-3BB5B3C48461.sorted_genome_alignments	UNCID_1578324.90E7F816-EAD8-413D-A5C4-3BB5B3C48461.sorted_genome_alignments.bam	29.4	1.82	0.18	58cfa836e4b0c9d6adf6f554	UNCID_1578324.90E7F816-EAD8-413D-A5C4-3BB5B3C48461.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FK-A3SD-01A	63B01B43-A68A-4046-89B0-736BA4D08504	Primary Tumor	Illumina HiSeq	AA898AD8-26A3-4D49-AE16-D38B1795F5E9	Thyroid	61.0	B48D226E-610A-40DC-B62A-6DB863A7366C	90E7F816-EAD8-413D-A5C4-3BB5B3C48461	TCGA-FK-A3SD-01A-11R-A22L-07	HG19	TCGA-FK-A3SD	TCGA-THCA		s12168	University of North Carolina	Johns Hopkins	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22L-07	True
13767.58cfa83ae4b0c9d6adf715f3	58cfa83ae4b0c9d6adf715f3	UNCID_2396528.9c9b4aa6-08b2-43f3-b68b-995df66c0494.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2396528.9c9b4aa6-08b2-43f3-b68b-995df66c0494.sorted_genome_alignments	UNCID_2396528.9c9b4aa6-08b2-43f3-b68b-995df66c0494.sorted_genome_alignments.bam	36.07	1.8	0.15	58cfa83ae4b0c9d6adf715f3	UNCID_2396528.9c9b4aa6-08b2-43f3-b68b-995df66c0494.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-KQ-A41R-01A	E492D5A9-7EC5-454B-AE89-077C90F67489	Primary Tumor	Illumina HiSeq	1544E4C1-543C-4634-9601-8EA8DA2E01EC	Bladder	80.0	D25C4CBA-553C-459A-9249-433726B84C3A	9C9B4AA6-08B2-43F3-B68B-995DF66C0494	TCGA-KQ-A41R-01A-21R-A352-07	HG19	TCGA-KQ-A41R	TCGA-BLCA		s3364	University of North Carolina	Cornell Medical College	United States	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A352-07	True
13767.58cfa834e4b0c9d6adf6e248	58cfa834e4b0c9d6adf6e248	UNCID_1169660.d71e12c1-d92c-4cb6-8244-d100b2ef1c43.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1169660.d71e12c1-d92c-4cb6-8244-d100b2ef1c43.sorted_genome_alignments	UNCID_1169660.d71e12c1-d92c-4cb6-8244-d100b2ef1c43.sorted_genome_alignments.bam	43.04	1.81	0.15	58cfa834e4b0c9d6adf6e248	UNCID_1169660.d71e12c1-d92c-4cb6-8244-d100b2ef1c43.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04Q-01A	B5FBA77B-1F50-4E71-95B2-566AFBA4BDD7	Primary Tumor	Illumina HiSeq	7B2384F7-BEAE-4BE0-AB4D-5F2A58154940	Breast	48.0	E17E273D-6F53-4419-9F0C-1E4E667C5257	D71E12C1-D92C-4CB6-8244-D100B2EF1C43	TCGA-A2-A04Q-01A-21R-A034-07	HG19	TCGA-A2-A04Q	TCGA-BRCA		s5894	University of North Carolina	Walter Reed	None	NO	T1	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A034-07	True
13767.58cfa837e4b0c9d6adf701ae	58cfa837e4b0c9d6adf701ae	UNCID_1857007.a550da17-2d06-49ac-96dc-a2204298ddfb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1857007.a550da17-2d06-49ac-96dc-a2204298ddfb.sorted_genome_alignments	UNCID_1857007.a550da17-2d06-49ac-96dc-a2204298ddfb.sorted_genome_alignments.bam	36.36	1.85	0.17	58cfa837e4b0c9d6adf701ae	UNCID_1857007.a550da17-2d06-49ac-96dc-a2204298ddfb.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-JL-A3YW-01A	A2434F47-2168-47D0-9BBB-981071597843	Primary Tumor	Illumina HiSeq	10665CC0-A7C8-4FF5-82A9-87E14F21ECE6	Breast	49.0	CDE5B270-BEC9-40D4-9C59-29F93EF08293	A550DA17-2D06-49AC-96DC-A2204298DDFB	TCGA-JL-A3YW-01A-12R-A239-07	HG19	TCGA-JL-A3YW	TCGA-BRCA		s5748	University of North Carolina	ABS - Research Metrics Pakistan	Pakistan	NO	T2	N1	Infiltrating Lobular Carcinoma	Stage II	A239-07	True
13767.58cfa835e4b0c9d6adf6edbe	58cfa835e4b0c9d6adf6edbe	UNCID_1376497.0fc04e69-e44f-4789-86ea-75399f9c9f87.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1376497.0fc04e69-e44f-4789-86ea-75399f9c9f87.sorted_genome_alignments	UNCID_1376497.0fc04e69-e44f-4789-86ea-75399f9c9f87.sorted_genome_alignments.bam	84.2		0.15	58cfa835e4b0c9d6adf6edbe	UNCID_1376497.0fc04e69-e44f-4789-86ea-75399f9c9f87.sorted_genome_alignments.bam	Dead	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-8007-11A	C7B23A5A-C49A-4426-BD4E-B191F4227AC6	Solid Tissue Normal	Illumina HiSeq	EAF2B8C2-3982-488A-A842-B45E6B82557C	Lung	68.0	0145082F-DE51-4A4F-B353-E10F067CA40B	0FC04E69-E44F-4789-86EA-75399F9C9F87	TCGA-77-8007-11A-01R-2187-07	HG19	TCGA-77-8007	TCGA-LUSC	198.0	s10030	University of North Carolina	Prince Charles Hospital	Australia	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	2187-07	True
13722.58cfa831e4b0c9d6adf6cbfe	58cfa831e4b0c9d6adf6cbfe	TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted	TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted.bam	241.3	1.9	0.14	58cfa831e4b0c9d6adf6cbfe	TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6405-01A	9239A22E-80B1-49A2-B0D5-CBAB7E415254	Primary Tumor	Illumina HiSeq	2d1d4000-347f-44e4-8ff3-b61fea3daeb3	Brain	51.0	54BFF4F3-312D-4E1A-8327-F08F5A270EAC	9593D4DE-0DAB-4D1E-B86C-AF91CAC938E6	TCGA-DU-6405-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-6405	TCGA-LGG	605.0	s8359	Harvard Medical School	Henry Ford Hospital	United States	NO			Astrocytoma		1703-02	True
13767.58cfa83be4b0c9d6adf723d2	58cfa83be4b0c9d6adf723d2	UNCID_2614418.35900b9c-bc5c-49cc-acb4-410305e8ab64.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2614418.35900b9c-bc5c-49cc-acb4-410305e8ab64.sorted_genome_alignments	UNCID_2614418.35900b9c-bc5c-49cc-acb4-410305e8ab64.sorted_genome_alignments.bam	40.22	1.81	0.16	58cfa83be4b0c9d6adf723d2	UNCID_2614418.35900b9c-bc5c-49cc-acb4-410305e8ab64.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-V1-A9OY-01A	69FC0351-6496-46B5-BE22-25B80C1DC4CC	Primary Tumor	Illumina HiSeq	774DF78A-0249-45F1-881D-2E4654D49DE6	Prostate	57.0	001824EB-43F0-42EF-B18C-61BEF23235F7	35900B9C-BC5C-49CC-ACB4-410305E8AB64	TCGA-V1-A9OY-01A-11R-A41O-07	HG19	TCGA-V1-A9OY	TCGA-PRAD		s3752	University of North Carolina	University of California San Francisco	United States	NO	T3a	N1	Prostate Adenocarcinoma Acinar Type		A41O-07	True
13767.58cfa834e4b0c9d6adf6e67c	58cfa834e4b0c9d6adf6e67c	UNCID_1192914.c60635ad-1fc5-4262-b549-1e60e3df1f63.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1192914.c60635ad-1fc5-4262-b549-1e60e3df1f63.sorted_genome_alignments	UNCID_1192914.c60635ad-1fc5-4262-b549-1e60e3df1f63.sorted_genome_alignments.bam	50.8	1.7	0.15	58cfa834e4b0c9d6adf6e67c	UNCID_1192914.c60635ad-1fc5-4262-b549-1e60e3df1f63.sorted_genome_alignments.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5689-11A	E865D40A-9989-436C-8426-88CC84C863E8	Solid Tissue Normal	Illumina HiSeq	61D95ADB-19FC-497C-BB86-3786F05FF098	Kidney	90.0	F1421153-1786-4460-B84E-8DDB7C5DF064	C60635AD-1FC5-4262-B549-1E60E3DF1F63	TCGA-CJ-5689-11A-01R-1541-07	HG19	TCGA-CJ-5689	TCGA-KIRC	1620.0	s9636	University of North Carolina	MD Anderson Cancer Center	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa82fe4b0c9d6adf6b934	58cfa82fe4b0c9d6adf6b934	TCGA-61-1919-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-61-1919-01A-01R-1568-13_rnaseq	TCGA-61-1919-01A-01R-1568-13_rnaseq.bam	380.0	1.8	0.14	58cfa82fe4b0c9d6adf6b934	TCGA-61-1919-01A-01R-1568-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-1919-01A	CE871097-A6E9-4139-897E-642EE24EE123	Primary Tumor	Illumina HiSeq	59D77B52-A09C-4A77-933E-A494EFAF4583	Ovary	58.0	207BE628-FFC8-4EB6-88B3-1705A3EE2AB5	056CCA38-92DF-42FF-B064-B0C243F8A82F	TCGA-61-1919-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-61-1919	TCGA-OV	1161.0	s17733	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa82ee4b0c9d6adf6ad66	58cfa82ee4b0c9d6adf6ad66	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.filtered.	WGS	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.bam	17.75		0.08	58cfa82ee4b0c9d6adf6ad66	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-A5R7-01A	7E41BABA-7EF6-4030-B595-D95CD96336B5	Primary Tumor	Illumina HiSeq	c239bee2-d22d-4390-be44-ed4be0395f57	Brain	33.0	7BA53D9A-FE20-487A-B4BB-84451E207755	C71F8C39-653F-42F2-AD3E-439CF86A0738	TCGA-HT-A5R7-01A-11D-A461-08	HG19_Broad_variant	TCGA-HT-A5R7	TCGA-LGG		s8119	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO			Astrocytoma		A461-08	True
13767.58cfa837e4b0c9d6adf7007e	58cfa837e4b0c9d6adf7007e	UNCID_1804865.5693546f-76cc-460e-ae90-01d44f010cda.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1804865.5693546f-76cc-460e-ae90-01d44f010cda.sorted_genome_alignments	UNCID_1804865.5693546f-76cc-460e-ae90-01d44f010cda.sorted_genome_alignments.bam	30.3	1.8	0.17	58cfa837e4b0c9d6adf7007e	UNCID_1804865.5693546f-76cc-460e-ae90-01d44f010cda.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CK-4951-01A	2DB3C23D-C591-4EA0-B0A8-ED9C4343C80E	Primary Tumor	Illumina HiSeq	297E7FB7-87F0-4F2D-A70D-816C63F97A89	Colorectal	79.0	EA9E7E8C-4151-4CFC-8631-5880C6F1A21F	5693546F-76CC-460E-AE90-01D44F010CDA	TCGA-CK-4951-01A-01R-1410-07	HG19	TCGA-CK-4951	TCGA-COAD		s13089	University of North Carolina	Harvard	None	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage II	1410-07	True
13767.58cfa838e4b0c9d6adf70a02	58cfa838e4b0c9d6adf70a02	UNCID_2035514.4383201e-ca97-4192-8e89-c63b10caaa0c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2035514.4383201e-ca97-4192-8e89-c63b10caaa0c.sorted_genome_alignments	UNCID_2035514.4383201e-ca97-4192-8e89-c63b10caaa0c.sorted_genome_alignments.bam	59.58	1.86	0.16	58cfa838e4b0c9d6adf70a02	UNCID_2035514.4383201e-ca97-4192-8e89-c63b10caaa0c.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EO-A3L0-01A	423DA953-30AA-4F7E-96B5-1F6FD24F8874	Primary Tumor	Illumina HiSeq	55522900-A0C6-4D61-922D-DFA8F2B41961	Uterus	76.0	73D4918C-8BAB-4753-9D47-355B51DBBBFA	4383201E-CA97-4192-8E89-C63B10CAAA0C	TCGA-EO-A3L0-01A-11R-A22K-07	HG19	TCGA-EO-A3L0	TCGA-UCEC		s4707	University of North Carolina	University Health Network	Canada	NO			Endometrioid endometrial adenocarcinoma		A22K-07	True
13722.58cfa830e4b0c9d6adf6c22c	58cfa830e4b0c9d6adf6c22c	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.bam	12.85	1.87	0.15	58cfa830e4b0c9d6adf6c22c	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A0S7-01A	68BC786E-07C7-4964-BC88-5E2A8633626A	Primary Tumor	Illumina HiSeq	55a63ec5-a803-44ee-905f-c7bfff9162d6	Bladder	75.0	A9B73851-4609-4DF7-8EB8-45A56F4B2DD6	F415813D-F975-492B-9E4E-55CE47C967B9	TCGA-BT-A0S7-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BT-A0S7	TCGA-BLCA	200.0	s3269	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A10R-02	True
13722.58cfa831e4b0c9d6adf6c84c	58cfa831e4b0c9d6adf6c84c	TCGA-D7-6527-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D7-6527-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_4_rg.sorted	TCGA-D7-6527-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_4_rg.sorted.bam	227.7	1.9	0.15	58cfa831e4b0c9d6adf6c84c	TCGA-D7-6527-10A-01D-1798_130218_SN208_0453_AC1T26ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6527-10A	CB622CD6-776D-4681-8A67-4ADDD61C66B8	Blood Derived Normal	Illumina HiSeq	7fda4d3c-8153-4107-b896-7b7967fdf926	Stomach	62.0	1C932E82-DF6F-4CE3-B691-46C0D5E9F893	DBB176B8-D56A-4B76-B4D0-B0763370AEE3	TCGA-D7-6527-10A-01D-1798-02	HG19_Broad_variant	TCGA-D7-6527	TCGA-STAD		s15332	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N1	Stomach Intestinal Adenocarcinoma Papillary Type	Stage II	1798-02	True
13767.58cfa838e4b0c9d6adf70762	58cfa838e4b0c9d6adf70762	UNCID_2028202.a5f14d53-fe35-494e-b6b1-bc5c8484e4a9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2028202.a5f14d53-fe35-494e-b6b1-bc5c8484e4a9.sorted_genome_alignments	UNCID_2028202.a5f14d53-fe35-494e-b6b1-bc5c8484e4a9.sorted_genome_alignments.bam	11.24	1.83	0.15	58cfa838e4b0c9d6adf70762	UNCID_2028202.a5f14d53-fe35-494e-b6b1-bc5c8484e4a9.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A5J0-01A	DB55D9D9-DD56-4CA9-B1F1-0D929697B280	Primary Tumor	Illumina HiSeq	65662FB8-3B25-4EE5-AC85-04094DE72FAF	Breast	63.0	2969174B-856A-4BA1-97C3-9038891CF24F	A5F14D53-FE35-494E-B6B1-BC5C8484E4A9	TCGA-BH-A5J0-01A-11R-A27Q-07	HG19	TCGA-BH-A5J0	TCGA-BRCA		s6590	University of North Carolina	University of Pittsburgh	United States	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A27Q-07	True
13767.58cfa82ee4b0c9d6adf6b15a	58cfa82ee4b0c9d6adf6b15a	TCGA-13-0919-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-0919-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-13-0919-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	274.0	1.8	0.15	58cfa82ee4b0c9d6adf6b15a	TCGA-13-0919-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0919-01A	45957BE6-E4DF-4245-ACF8-39DFC118EE19	Primary Tumor	Illumina HiSeq	FF0682EC-7EFA-41F1-B4E0-A20B3347A8B4	Ovary	52.0	7BE971A8-031F-4DC0-A883-E1976F74EB21	36E20DFD-0D88-47BD-BF1F-164E069019D1	TCGA-13-0919-01A-01R-1564-13	GRCh37-lite	TCGA-13-0919	TCGA-OV		s18097	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa82fe4b0c9d6adf6b998	58cfa82fe4b0c9d6adf6b998	TCGA-57-1583-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-57-1583-01A-01R-1566-13_rnaseq	TCGA-57-1583-01A-01R-1566-13_rnaseq.bam	527.0	1.8	0.15	58cfa82fe4b0c9d6adf6b998	TCGA-57-1583-01A-01R-1566-13_rnaseq.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-57-1583-01A	76CC2D21-EEBC-4F09-9BC7-DBF7AF0AAFA8	Primary Tumor	Illumina HiSeq	78DC4B6F-152B-4C84-AE41-7B7EF2C3D359	Ovary	57.0	04B379AC-220B-4582-84C8-BE370D5AD619	3A37E320-0301-4F2B-BF09-F102C12502B1	TCGA-57-1583-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-57-1583	TCGA-OV	346.0	s18075	Canada's Michael Smith Genome Sciences Centre	International Genomics Consortium	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa83ae4b0c9d6adf71741	58cfa83ae4b0c9d6adf71741	UNCID_2374260.0d31feba-eda3-482c-bcbf-28f28b6cd9b2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2374260.0d31feba-eda3-482c-bcbf-28f28b6cd9b2.sorted_genome_alignments	UNCID_2374260.0d31feba-eda3-482c-bcbf-28f28b6cd9b2.sorted_genome_alignments.bam	42.88	1.92	0.18	58cfa83ae4b0c9d6adf71741	UNCID_2374260.0d31feba-eda3-482c-bcbf-28f28b6cd9b2.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-SP-A6QG-01A	6F8DF65F-326E-441E-91AC-61E5B32AC16F	Primary Tumor	Illumina HiSeq	C73BE2F0-BB0A-4EE7-B045-CB57B66D4299	Nervous System	35.0	51457EE0-2E47-4C26-A905-5CF996130F65	0D31FEBA-EDA3-482C-BCBF-28F28B6CD9B2	TCGA-SP-A6QG-01A-12R-A35L-07	HG19	TCGA-SP-A6QG	TCGA-PCPG		s1063	University of North Carolina	University Health Network	Canada	NO					A35L-07	True
13767.58cfa83be4b0c9d6adf7291f	58cfa83be4b0c9d6adf7291f	UNCID_2648316.e1adc304-07de-493e-a800-50fc1ab65b30.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2648316.e1adc304-07de-493e-a800-50fc1ab65b30.sorted_genome_alignments	UNCID_2648316.e1adc304-07de-493e-a800-50fc1ab65b30.sorted_genome_alignments.bam	49.82	1.79	0.16	58cfa83be4b0c9d6adf7291f	UNCID_2648316.e1adc304-07de-493e-a800-50fc1ab65b30.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-XF-AAN5-01A	C1591625-E794-4155-8AE4-B74D6264659F	Primary Tumor	Illumina HiSeq	CB360611-3E26-4519-8B4D-40F506E01BE7	Bladder	61.0	120124C2-DA96-44BC-869E-07C3489B4D39	E1ADC304-07DE-493E-A800-50FC1AB65B30	TCGA-XF-AAN5-01A-11R-A42T-07	HG19	TCGA-XF-AAN5	TCGA-BLCA		s3059	University of North Carolina	University of Southern California	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A42T-07	True
13767.58cfa835e4b0c9d6adf6ee72	58cfa835e4b0c9d6adf6ee72	UNCID_1407284.0edca07e-a874-4cfc-ae79-1080fee6a5f7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1407284.0edca07e-a874-4cfc-ae79-1080fee6a5f7.sorted_genome_alignments	UNCID_1407284.0edca07e-a874-4cfc-ae79-1080fee6a5f7.sorted_genome_alignments.bam	12.8	1.7	0.15	58cfa835e4b0c9d6adf6ee72	UNCID_1407284.0edca07e-a874-4cfc-ae79-1080fee6a5f7.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-5303-01A	44A5C3B4-62A7-407B-B492-7069E1A43A26	Primary Tumor	Illumina HiSeq	45A3DBCE-B4E0-40FC-B09E-70B74D7702D4	Brain	38.0	150856F7-77DA-4AA5-A28B-310A505AEA24	0EDCA07E-A874-4CFC-AE79-1080FEE6A5F7	TCGA-E1-5303-01A-01R-1470-07	HG19	TCGA-E1-5303	TCGA-LGG	2052.0	s8381	University of North Carolina	Duke	United States	NO			Astrocytoma		1470-07	True
13767.58cfa83ae4b0c9d6adf7172b	58cfa83ae4b0c9d6adf7172b	UNCID_2357916.a6976ea0-4858-4432-85f2-33a18784b499.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2357916.a6976ea0-4858-4432-85f2-33a18784b499.sorted_genome_alignments	UNCID_2357916.a6976ea0-4858-4432-85f2-33a18784b499.sorted_genome_alignments.bam	29.39	1.81	0.15	58cfa83ae4b0c9d6adf7172b	UNCID_2357916.a6976ea0-4858-4432-85f2-33a18784b499.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-IA-A83T-01A	DC39DF39-9945-4CB6-A852-D3B42177AC80	Primary Tumor	Illumina HiSeq	AE803467-4184-44C0-952E-8081E0711D6D	Kidney	80.0	5CC35795-FC4F-4CE6-B0F5-05F3C3D172E8	A6976EA0-4858-4432-85F2-33A18784B499	TCGA-IA-A83T-01A-11R-A355-07	HG19	TCGA-IA-A83T	TCGA-KIRP	2684.0	s11729	University of North Carolina	Cleveland Clinic	United States	NO	TX	NX	Kidney Papillary Renal Cell Carcinoma	Stage II	A355-07	True
13767.58cfa838e4b0c9d6adf7070c	58cfa838e4b0c9d6adf7070c	UNCID_1981041.035590dc-c5f6-461e-9160-b4e2b6faea29.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1981041.035590dc-c5f6-461e-9160-b4e2b6faea29.sorted_genome_alignments	UNCID_1981041.035590dc-c5f6-461e-9160-b4e2b6faea29.sorted_genome_alignments.bam	45.63	1.96	0.18	58cfa838e4b0c9d6adf7070c	UNCID_1981041.035590dc-c5f6-461e-9160-b4e2b6faea29.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A51B-01A	554270FB-1FB3-4AEB-81A1-F78C30B143B4	Primary Tumor	Illumina HiSeq	59844E18-DAEF-4F72-86BA-ABEBF3C77964	Skin	53.0	EE90A4FC-C88F-438B-969A-328EA7F23580	035590DC-C5F6-461E-9160-B4E2B6FAEA29	TCGA-EB-A51B-01A-11R-A27Q-07	HG19	TCGA-EB-A51B	TCGA-SKCM		s7435	University of North Carolina	Asterand	Ukraine	NO	T4b	NX		Stage II	A27Q-07	True
13767.58cfa83be4b0c9d6adf723a7	58cfa83be4b0c9d6adf723a7	UNCID_2580626.e9c0bbcb-376f-4ae3-a172-7cfce9feb4e3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2580626.e9c0bbcb-376f-4ae3-a172-7cfce9feb4e3.sorted_genome_alignments	UNCID_2580626.e9c0bbcb-376f-4ae3-a172-7cfce9feb4e3.sorted_genome_alignments.bam	43.31	1.89	0.18	58cfa83be4b0c9d6adf723a7	UNCID_2580626.e9c0bbcb-376f-4ae3-a172-7cfce9feb4e3.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-UZ-A9Q0-01A	32BBF3D8-FD0E-45E2-B2A8-80192E86A13C	Primary Tumor	Illumina HiSeq	FD0CD77D-626E-45DD-81C7-47D654D37329	Kidney	60.0	632CE271-729D-4CE5-8A11-9C935FEE5666	E9C0BBCB-376F-4AE3-A172-7CFCE9FEB4E3	TCGA-UZ-A9Q0-01A-12R-A42S-07	HG19	TCGA-UZ-A9Q0	TCGA-KIRP		s11750	University of North Carolina	University of California San Francisco	United States	NO	T1	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A42S-07	True
13722.58cfa82de4b0c9d6adf6a610	58cfa82de4b0c9d6adf6a610	6e5cc39dc99c646350c2188f42625edd.filtered.	WGS	6e5cc39dc99c646350c2188f42625edd	6e5cc39dc99c646350c2188f42625edd.bam	59.06	1.95	0.08	58cfa82de4b0c9d6adf6a610	6e5cc39dc99c646350c2188f42625edd.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A0TN-01A	14C65927-B9DD-4EF6-9917-DB7BC431FF2F	Primary Tumor	Illumina HiSeq	f860da6f-1cec-4913-aa35-b32670a1734f	Cervix	21.0	59B0B757-7D08-4B3E-9974-FD02747D3665	945E6808-2887-4F32-AC32-8F9E00353BF6	TCGA-C5-A0TN-01A-21D-A200-09	GRCh37-lite	TCGA-C5-A0TN	TCGA-CESC	348.0	s1165	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b	N1	Cervical Squamous Cell Carcinoma		A200-09	True
13767.58cfa836e4b0c9d6adf6fa76	58cfa836e4b0c9d6adf6fa76	UNCID_1648604.8d64e025-7822-4888-bd98-dd39ab8c73f1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1648604.8d64e025-7822-4888-bd98-dd39ab8c73f1.sorted_genome_alignments	UNCID_1648604.8d64e025-7822-4888-bd98-dd39ab8c73f1.sorted_genome_alignments.bam	126.2		0.15	58cfa836e4b0c9d6adf6fa76	UNCID_1648604.8d64e025-7822-4888-bd98-dd39ab8c73f1.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-8181-01A	1159C88C-39D0-4C03-9C66-36AF5340A67A	Primary Tumor	Illumina HiSeq	FDBB789C-F397-44A6-9269-7B7C278BD7DB	Brain	23.0	881C4A1D-CA81-4727-ADA0-BCFA7720AE3A	8D64E025-7822-4888-BD98-DD39AB8C73F1	TCGA-FG-8181-01A-11R-2256-07	HG19	TCGA-FG-8181	TCGA-LGG		s8781	University of North Carolina	Case Western	United States	NO			Oligoastrocytoma		2256-07	True
13767.58cfa833e4b0c9d6adf6dcc8	58cfa833e4b0c9d6adf6dcc8	UNCID_1128643.fb03a31f-6611-4343-816d-37a332147eac.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1128643.fb03a31f-6611-4343-816d-37a332147eac.sorted_genome_alignments	UNCID_1128643.fb03a31f-6611-4343-816d-37a332147eac.sorted_genome_alignments.bam	120.39	1.79	0.17	58cfa833e4b0c9d6adf6dcc8	UNCID_1128643.fb03a31f-6611-4343-816d-37a332147eac.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A27B-01A	F0D8A1FE-E313-44F1-99CC-B965CBEEFF0E	Primary Tumor	Illumina HiSeq	DDAA8BA3-F052-47B8-8584-9056E5769908	Breast	48.0	67D804D7-B6A5-4A70-92CD-F93195D928A4	FB03A31F-6611-4343-816D-37A332147EAC	TCGA-C8-A27B-01A-11R-A169-07	HG19	TCGA-C8-A27B	TCGA-BRCA		s5840	University of North Carolina	ILSbio	Vietnam	NO	T3	N0	Infiltrating Ductal Carcinoma	Stage II	A169-07	True
13722.58cfa82fe4b0c9d6adf6b720	58cfa82fe4b0c9d6adf6b720	TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted.filtered.	WGS	TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted	TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted.bam	282.4	1.9	0.13	58cfa82fe4b0c9d6adf6b720	TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-67-6217-01A	108A71CF-B9DB-47CD-AA74-C03EC989B41B	Primary Tumor	Illumina HiSeq	cb2962fe-7f6e-4a68-871a-11d696bb5279	Lung	73.0	BC0FE45C-3249-46D7-8991-C6888F0B9579	565E717D-310B-4FB1-B79A-5F40FF12BBB8	TCGA-67-6217-01A-11D-1751-02	HG19_Broad_variant	TCGA-67-6217	TCGA-LUAD		s11244	Harvard Medical School	St Joseph's Medical Center (MD)	United States	NO	T2a	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1751-02	True
13767.58cfa82fe4b0c9d6adf6ba2c	58cfa82fe4b0c9d6adf6ba2c	TCGA-61-2101-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-61-2101-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-61-2101-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	378.0	1.8	0.15	58cfa82fe4b0c9d6adf6ba2c	TCGA-61-2101-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2101-01A	5D1A54FE-E0DF-4C17-B623-B649A136DC82	Primary Tumor	Illumina HiSeq	A5A38B79-004D-49DE-860D-9425560503BB	Ovary	55.0	46D32513-DC68-4261-8E1B-26D407B6546A	95970BDB-E1F2-49DC-903B-C30088CEF71D	TCGA-61-2101-01A-01R-1568-13	GRCh37-lite	TCGA-61-2101	TCGA-OV	1688.0	s17860	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa83be4b0c9d6adf72484	58cfa83be4b0c9d6adf72484	UNCID_2600410.b3effe15-e80e-4e10-92e9-d0def1e53aaf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2600410.b3effe15-e80e-4e10-92e9-d0def1e53aaf.sorted_genome_alignments	UNCID_2600410.b3effe15-e80e-4e10-92e9-d0def1e53aaf.sorted_genome_alignments.bam	37.68	1.9	0.18	58cfa83be4b0c9d6adf72484	UNCID_2600410.b3effe15-e80e-4e10-92e9-d0def1e53aaf.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-5P-A9KC-01A	3BD50BD2-C291-4362-9663-7B783A84EC43	Primary Tumor	Illumina HiSeq	CDCE1EA5-DD23-49D7-A94B-71A943DEC52F	Kidney	51.0	9384A6B1-67E9-46F7-B4D9-442377E5163C	B3EFFE15-E80E-4E10-92E9-D0DEF1E53AAF	TCGA-5P-A9KC-01A-11R-A42S-07	HG19	TCGA-5P-A9KC	TCGA-KIRP		s11847	University of North Carolina	University Hospital Erlangen	Germany	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma		A42S-07	True
13767.58cfa83ae4b0c9d6adf71756	58cfa83ae4b0c9d6adf71756	UNCID_2388919.adb4622b-d3a2-414a-83a9-57ac28c52a7f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2388919.adb4622b-d3a2-414a-83a9-57ac28c52a7f.sorted_genome_alignments	UNCID_2388919.adb4622b-d3a2-414a-83a9-57ac28c52a7f.sorted_genome_alignments.bam	19.63	1.87	0.18	58cfa83ae4b0c9d6adf71756	UNCID_2388919.adb4622b-d3a2-414a-83a9-57ac28c52a7f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FR-A7UA-06A	E3905D75-9D0A-4981-AB42-83CE2C20C4EA	Metastatic	Illumina HiSeq	E3D68F12-2E70-4FC6-AAA0-4498B332D79D	Skin	65.0	F7D8C582-E85C-4CAA-9BEA-F8DBF7D28006	ADB4622B-D3A2-414A-83A9-57AC28C52A7F	TCGA-FR-A7UA-06A-32R-A352-07	HG19	TCGA-FR-A7UA	TCGA-SKCM		s7458	University of North Carolina	University of North Carolina	United States	NO	T2a	N0		Stage I	A352-07	True
13767.58cfa83be4b0c9d6adf726a4	58cfa83be4b0c9d6adf726a4	UNCID_2623367.c119a170-e1ba-4965-a9c6-5c0b41ceefba.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2623367.c119a170-e1ba-4965-a9c6-5c0b41ceefba.sorted_genome_alignments	UNCID_2623367.c119a170-e1ba-4965-a9c6-5c0b41ceefba.sorted_genome_alignments.bam	13.21	1.85	0.17	58cfa83be4b0c9d6adf726a4	UNCID_2623367.c119a170-e1ba-4965-a9c6-5c0b41ceefba.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A8OS-01A	D5E655FE-3FBC-47B0-BA23-1D1DD01D591C	Primary Tumor	Illumina HiSeq	72ADDED9-5B95-4282-81AD-E1A6C94C832F	Breast	71.0	B13AB974-E4A4-4926-BD17-17A1E9CA7CE6	C119A170-E1BA-4965-A9C6-5C0B41CEEFBA	TCGA-AC-A8OS-01A-12R-A41B-07	HG19	TCGA-AC-A8OS	TCGA-BRCA		s6902	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0 (i-)	Infiltrating Lobular Carcinoma	Stage II	A41B-07	True
13767.58cfa82fe4b0c9d6adf6b50e	58cfa82fe4b0c9d6adf6b50e	TCGA-29-1688-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-29-1688-01A-01R-1566-13_rnaseq	TCGA-29-1688-01A-01R-1566-13_rnaseq.bam	485.0	1.8	0.15	58cfa82fe4b0c9d6adf6b50e	TCGA-29-1688-01A-01R-1566-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1688-01A	05019013-7EA5-4905-AC79-901146BA2EE2	Primary Tumor	Illumina HiSeq	7DF08972-99C8-4B35-8621-547A3D39CDE1	Ovary	39.0	3385E66C-5764-4260-929F-B653A23C7AFB	5BE6BDBD-61ED-4CEB-BAD5-9559CBE5BEBF	TCGA-29-1688-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-29-1688	TCGA-OV	2400.0	s17688	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1566-13	True
13722.58cfa831e4b0c9d6adf6c8a8	58cfa831e4b0c9d6adf6c8a8	TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina.filtered.	WGS	TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina	TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina.bam	156.4	1.9	0.15	58cfa831e4b0c9d6adf6c8a8	TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5453-01A	577847B9-F9B6-4954-868F-3D5AB2B4F694	Primary Tumor	Illumina HiSeq	28e40615-1ae0-420f-b7c0-ca99eaa91361	Kidney	67.0	5C1B955D-9D60-4975-A1E6-C4D531E79190	64446AEC-C125-4C81-B9CC-62482CB1AAED	TCGA-CZ-5453-01A-01D-2102-10	GRCh37-lite	TCGA-CZ-5453	TCGA-KIRC		s9307	Baylor College of Medicine	Harvard	None	NO	T2	NX	Kidney Clear Cell Renal Carcinoma	Stage II	2102-10	False
13722.58cfa82ee4b0c9d6adf6ab40	58cfa82ee4b0c9d6adf6ab40	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.filtered.	WGS	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.bam	52.36		0.08	58cfa82ee4b0c9d6adf6ab40	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A2NF-01A	D32A4219-4CCA-470F-B6B3-11447D9F5E0B	Primary Tumor	Illumina HiSeq	a17559f3-505c-4dc1-855c-178b1740e1ac	Skin	53.0	52EDD1DB-F1C3-4B87-B959-B5B095E52463	0884FDF3-7A20-43BC-BF57-E71F36E11AB9	TCGA-ER-A2NF-01A-11D-A19A-08	HG19_Broad_variant	TCGA-ER-A2NF	TCGA-SKCM		s7989	Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T4b	N3		Stage III	A19A-08	True
13767.58cfa83be4b0c9d6adf72501	58cfa83be4b0c9d6adf72501	UNCID_2641047.878b8551-fb42-48bc-9403-178c568372cd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2641047.878b8551-fb42-48bc-9403-178c568372cd.sorted_genome_alignments	UNCID_2641047.878b8551-fb42-48bc-9403-178c568372cd.sorted_genome_alignments.bam	37.28	1.86	0.16	58cfa83be4b0c9d6adf72501	UNCID_2641047.878b8551-fb42-48bc-9403-178c568372cd.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-ZJ-AAXN-01A	5F22E050-C172-4F2D-A1F9-6CB749B6EF98	Primary Tumor	Illumina HiSeq	A6B70C6E-1A42-4516-8892-44DA4B063128	Cervix	34.0	019E7AEE-73C9-4330-B4D0-493A97D654B0	878B8551-FB42-48BC-9403-178C568372CD	TCGA-ZJ-AAXN-01A-11R-A42T-07	HG19	TCGA-ZJ-AAXN	TCGA-CESC		s1606	University of North Carolina	NCI HRE Branch	United States	NO	T1b2	N1	Cervical Squamous Cell Carcinoma		A42T-07	True
13767.58cfa838e4b0c9d6adf704ff	58cfa838e4b0c9d6adf704ff	UNCID_1906503.090c18f2-3ca7-4e56-ac8c-0ac3f93d4e31.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1906503.090c18f2-3ca7-4e56-ac8c-0ac3f93d4e31.sorted_genome_alignments	UNCID_1906503.090c18f2-3ca7-4e56-ac8c-0ac3f93d4e31.sorted_genome_alignments.bam	36.08	1.9	0.18	58cfa838e4b0c9d6adf704ff	UNCID_1906503.090c18f2-3ca7-4e56-ac8c-0ac3f93d4e31.sorted_genome_alignments.bam	Alive	MALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A22Q-01A	8492820D-B619-4A74-95D3-EB574067F3F3	Primary Tumor	Illumina HiSeq	01812BB1-AAC6-4549-8266-7CA31AE2BED2	Thyroid	36.0	ADC0DACA-205B-4A88-9C4F-2D191C762989	090C18F2-3CA7-4E56-AC8C-0AC3F93D4E31	TCGA-EM-A22Q-01A-11R-A180-07	HG19	TCGA-EM-A22Q	TCGA-THCA		s12486	University of North Carolina	University Health Network	Canada	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A180-07	True
13767.58cfa83be4b0c9d6adf729cc	58cfa83be4b0c9d6adf729cc	UNCID_355793.TCGA-CJ-4873-01A-01R-1305-07.110607_UNC11-SN627_0100_AD0CT7ABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_355793.TCGA-CJ-4873-01A-01R-1305-07.110607_UNC11-SN627_0100_AD0CT7ABXX.5.trimmed.annotated.translated_to_genomic	UNCID_355793.TCGA-CJ-4873-01A-01R-1305-07.110607_UNC11-SN627_0100_AD0CT7ABXX.5.trimmed.annotated.translated_to_genomic.bam	79.3	1.8	0.15	58cfa83be4b0c9d6adf729cc	UNCID_355793.TCGA-CJ-4873-01A-01R-1305-07.110607_UNC11-SN627_0100_AD0CT7ABXX.5.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4873-01A	53DEDE5A-4423-4DA5-BC1E-E5E98B011E36	Primary Tumor	Illumina HiSeq	2595170E-4AAD-4952-BDB3-A6A79D6300EE	Kidney	85.0	9433D0EC-47C9-48DF-B7D0-1F57ACB09C38	A72C1D4E-1BE3-4A21-B2CF-D7B5F8E78DF1	TCGA-CJ-4873-01A-01R-1305-07	HG19	TCGA-CJ-4873	TCGA-KIRC		s9962	University of North Carolina	MD Anderson Cancer Center	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1305-07	True
13767.58cfa838e4b0c9d6adf70b44	58cfa838e4b0c9d6adf70b44	UNCID_2089755.9c949f30-455e-48a6-ae31-73f26c609ffd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2089755.9c949f30-455e-48a6-ae31-73f26c609ffd.sorted_genome_alignments	UNCID_2089755.9c949f30-455e-48a6-ae31-73f26c609ffd.sorted_genome_alignments.bam	61.15	1.82	0.16	58cfa838e4b0c9d6adf70b44	UNCID_2089755.9c949f30-455e-48a6-ae31-73f26c609ffd.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A3G8-01A	6D3FDB58-FDC0-4937-AD38-3A455225EA51	Primary Tumor	Illumina HiSeq	6004275B-4FBC-4368-8AAD-D48167C61035	Uterus	76.0	DFE35835-D03E-4CE3-A76A-FDB15E601257	9C949F30-455E-48A6-AE31-73F26C609FFD	TCGA-AX-A3G8-01A-11R-A22K-07	HG19	TCGA-AX-A3G8	TCGA-UCEC		s4530	University of North Carolina	Gynecologic Oncology Group	United States	NO			Endometrioid endometrial adenocarcinoma		A22K-07	True
13767.58cfa832e4b0c9d6adf6d36e	58cfa832e4b0c9d6adf6d36e	TCGA-L5-A8NH-01A-11R-A37I-31_rnaseq.filtered.	RNA-Seq	TCGA-L5-A8NH-01A-11R-A37I-31_rnaseq	TCGA-L5-A8NH-01A-11R-A37I-31_rnaseq.bam	64.79	1.96	0.18	58cfa832e4b0c9d6adf6d36e	TCGA-L5-A8NH-01A-11R-A37I-31_rnaseq.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A8NH-01A	5AF0E222-3DC8-400B-BA61-2225921F2FD3	Primary Tumor	Illumina HiSeq	BBDE30B3-55D3-4762-83F5-AE00DD381DA5	Esophagus	54.0	7D82D2B8-85E1-4959-B440-D4C4CF2FBBB4	F43178E9-176F-4C0B-B31E-44A6F485E02E	TCGA-L5-A8NH-01A-11R-A37I-31	GRCh37-lite	TCGA-L5-A8NH	TCGA-ESCA	393.0	s1933	Canada's Michael Smith Genome Sciences Centre	University of Michigan	United States	NO	T1	N0		Stage IV	A37I-31	True
13767.58cfa838e4b0c9d6adf706ae	58cfa838e4b0c9d6adf706ae	UNCID_1980834.d1bbd8aa-a941-4640-ac65-0d8335f8f998.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1980834.d1bbd8aa-a941-4640-ac65-0d8335f8f998.sorted_genome_alignments	UNCID_1980834.d1bbd8aa-a941-4640-ac65-0d8335f8f998.sorted_genome_alignments.bam	19.96	1.84	0.16	58cfa838e4b0c9d6adf706ae	UNCID_1980834.d1bbd8aa-a941-4640-ac65-0d8335f8f998.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A550-01A	C757C326-6803-4451-A2D3-4368812855A7	Primary Tumor	Illumina HiSeq	29E166D9-190B-412E-99DD-4BCDC59D475C	Skin	75.0	976FA900-4709-4BED-9F20-2BD95C57A806	D1BBD8AA-A941-4640-AC65-0D8335F8F998	TCGA-EB-A550-01A-61R-A27Q-07	HG19	TCGA-EB-A550	TCGA-SKCM		s7946	University of North Carolina	Asterand	Ukraine	NO	T4b	NX		Stage II	A27Q-07	True
13767.58cfa83ce4b0c9d6adf72f4e	58cfa83ce4b0c9d6adf72f4e	_1_TCGA-BR-8081-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-8081-01A-11R-2343-13_rnaseq	_1_TCGA-BR-8081-01A-11R-2343-13_rnaseq.bam	433.7		0.14	58cfa83ce4b0c9d6adf72f4e	_1_TCGA-BR-8081-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8081-01A	1D3A03A5-B757-4617-B65A-50F429A0E026	Primary Tumor	Illumina HiSeq	2A736473-03A2-49E0-BBC4-70564BB02ACF	Stomach	71.0	A95FE711-1F13-4DE5-B300-2E4A8F3BE1FB	E85A1005-B2EA-4361-A5BE-A8220092AEC3	TCGA-BR-8081-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8081	TCGA-STAD		s14858	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4a	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2343-13	True
13722.58cfa830e4b0c9d6adf6bb7c	58cfa830e4b0c9d6adf6bb7c	TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina	TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina.bam	75.21	1.8	0.07	58cfa830e4b0c9d6adf6bb7c	TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina.bam	Alive	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01R-01A	97F6C8D3-09A0-4128-8F10-41E736648A5F	Primary Tumor	Illumina HiSeq	5b6c9797-7cfe-4bd0-a656-74dd069d72d9	Colorectal	47.0	73EE34E8-422D-4AB1-B0F0-DA8A5A2DD9AB	303ABBE5-4155-4A0D-BC3B-F8995261CA52	TCGA-AA-A01R-01A-21D-A17O-10	GRCh37-lite	TCGA-AA-A01R	TCGA-COAD		s13194	Baylor College of Medicine	Indivumed	Germany	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage III	A17O-10	True
13767.58cfa83ae4b0c9d6adf7186e	58cfa83ae4b0c9d6adf7186e	UNCID_2350321.4c09b51b-d52a-49f2-b5df-5fc38193bd3c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2350321.4c09b51b-d52a-49f2-b5df-5fc38193bd3c.sorted_genome_alignments	UNCID_2350321.4c09b51b-d52a-49f2-b5df-5fc38193bd3c.sorted_genome_alignments.bam	9.56	1.95	0.15	58cfa83ae4b0c9d6adf7186e	UNCID_2350321.4c09b51b-d52a-49f2-b5df-5fc38193bd3c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DH-A7UT-01A	B2B57E93-2722-4546-9A0B-20155B86EDEF	Primary Tumor	Illumina HiSeq	A3488557-845B-4F7D-9C54-FA1176B15262	Brain	30.0	8EE5EF13-CEFB-4882-AD66-B5EE9A7C5ACD	4C09B51B-D52A-49F2-B5DF-5FC38193BD3C	TCGA-DH-A7UT-01A-12R-A34F-07	HG19	TCGA-DH-A7UT	TCGA-LGG		s8494	University of North Carolina	University of Florida	United States	NO			Astrocytoma		A34F-07	True
13767.58cfa838e4b0c9d6adf7047f	58cfa838e4b0c9d6adf7047f	UNCID_1943218.24531d9f-822b-4eb8-add6-79fa27816a4b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1943218.24531d9f-822b-4eb8-add6-79fa27816a4b.sorted_genome_alignments	UNCID_1943218.24531d9f-822b-4eb8-add6-79fa27816a4b.sorted_genome_alignments.bam	135.2		0.14	58cfa838e4b0c9d6adf7047f	UNCID_1943218.24531d9f-822b-4eb8-add6-79fa27816a4b.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-8455-01A	02BA8600-9D3D-489D-9F0B-F1C59085ECD6	Primary Tumor	Illumina HiSeq	8C969303-5059-4A78-9D72-61765B177371	Lung	67.0	3CA60C35-4946-421D-B81F-9E49CBC243DE	24531D9F-822B-4EB8-ADD6-79FA27816A4B	TCGA-34-8455-01A-11R-2326-07	HG19	TCGA-34-8455	TCGA-LUSC	123.0	s10459	University of North Carolina	University of Pittsburgh	United States	NO	T4	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IV	2326-07	True
13722.58cfa82fe4b0c9d6adf6b9fc	58cfa82fe4b0c9d6adf6b9fc	TCGA-AA-3555-10A-01D-0959-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3555-10A-01D-0959-10_wgs_Illumina	TCGA-AA-3555-10A-01D-0959-10_wgs_Illumina.bam	0.0	1.9	0.14	58cfa82fe4b0c9d6adf6b9fc	TCGA-AA-3555-10A-01D-0959-10_wgs_Illumina.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-3555-10A	36EAF209-C332-4321-B6AA-51A3368ECD79	Blood Derived Normal	Illumina HiSeq	e46a72b9-a8a8-41dd-af2d-3dadc0faf711	Colorectal	81.0	A08213B9-B852-4C99-9469-8C9DF8A34AD0	A7CA59D7-DF34-4180-9192-754F38596C34	TCGA-AA-3555-10A-01D-0959-10	GRCh37-lite	TCGA-AA-3555	TCGA-COAD		s13359	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage II	0959-10	False
13722.58cfa82de4b0c9d6adf6a461	58cfa82de4b0c9d6adf6a461	077f179af5b7fe13cbfcc88a10123c85.filtered.	WGS	077f179af5b7fe13cbfcc88a10123c85	077f179af5b7fe13cbfcc88a10123c85.bam	83.7	1.97	0.08	58cfa82de4b0c9d6adf6a461	077f179af5b7fe13cbfcc88a10123c85.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1MI-01A	941F75A1-FEA4-4539-BA69-60BB11608F6D	Primary Tumor	Illumina HiSeq	e32cf6ef-190c-4456-b8a7-b40b9c9c8036	Cervix	50.0	A753BCF7-82D6-4FB1-AF0D-641898BBFF9C	14B8BBF2-310B-459B-B52D-A7EF510CE1CF	TCGA-C5-A1MI-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1MI	TCGA-CESC	1083.0	s1508	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b1	N1	Cervical Squamous Cell Carcinoma		A200-09	True
13722.58cfa82fe4b0c9d6adf6b704	58cfa82fe4b0c9d6adf6b704	TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	665.52	1.9	0.15	58cfa82fe4b0c9d6adf6b704	TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4659-01A	CD0DC947-B708-464E-BEB7-954C9D4583E7	Primary Tumor	Illumina HiSeq	37276b21-3a00-4b58-b1df-cc2199584cb0	Lung	66.0	C35A5ED1-1821-4077-BA1E-B972DFA3233B	277D2F7F-1A7F-4D39-BD15-0334CC02840E	TCGA-73-4659-01A-01D-1203-02	GRCh37	TCGA-73-4659	TCGA-LUAD	711.0	s11246	Harvard Medical School	Roswell Park	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1203-02	True
13767.58cfa838e4b0c9d6adf7044d	58cfa838e4b0c9d6adf7044d	UNCID_1891530.4cda696b-42da-43fd-9f6f-95dfc748a0ca.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1891530.4cda696b-42da-43fd-9f6f-95dfc748a0ca.sorted_genome_alignments	UNCID_1891530.4cda696b-42da-43fd-9f6f-95dfc748a0ca.sorted_genome_alignments.bam	22.23	1.82	0.18	58cfa838e4b0c9d6adf7044d	UNCID_1891530.4cda696b-42da-43fd-9f6f-95dfc748a0ca.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A3R2-01A	17833039-0D7E-47F0-90E6-8CABAE94C124	Primary Tumor	Illumina HiSeq	AB932A57-17B0-4F1A-9E65-B0A30F7B16B7	Liver	75.0	04BECA9F-830C-4CA8-A947-1BF2D7DF1B26	4CDA696B-42DA-43FD-9F6F-95DFC748A0CA	TCGA-FV-A3R2-01A-11R-A22L-07	HG19	TCGA-FV-A3R2	TCGA-LIHC	194.0	s16888	University of North Carolina	International Genomics Consortium	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A22L-07	True
13767.58cfa838e4b0c9d6adf70830	58cfa838e4b0c9d6adf70830	UNCID_2033884.88802e34-7269-4b5e-b552-a969281ab241.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2033884.88802e34-7269-4b5e-b552-a969281ab241.sorted_genome_alignments	UNCID_2033884.88802e34-7269-4b5e-b552-a969281ab241.sorted_genome_alignments.bam	14.1	1.87	0.16	58cfa838e4b0c9d6adf70830	UNCID_2033884.88802e34-7269-4b5e-b552-a969281ab241.sorted_genome_alignments.bam					Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-FL-A1YG-11A	7D8E6965-51EA-4864-968E-5CECFB7DA48A	Solid Tissue Normal	Illumina HiSeq	BC5224AA-8168-4F6F-BD5A-7ACB82B9231B	Uterus		7CE9C6EA-2D0B-448E-9D5F-3AB19714D979	88802E34-7269-4B5E-B552-A969281AB241	TCGA-FL-A1YG-11A-12R-A16F-07	HG19	TCGA-FL-A1YG	TCGA-UCEC		s5107	University of North Carolina	University of Hawaii - Normal Study	United States	NO					A16F-07	True
13722.58cfa832e4b0c9d6adf6cf52	58cfa832e4b0c9d6adf6cf52	TCGA-FS-A1ZC-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FS-A1ZC-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_3_rg.sorted	TCGA-FS-A1ZC-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_3_rg.sorted.bam	65.24		0.17	58cfa832e4b0c9d6adf6cf52	TCGA-FS-A1ZC-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZC-06A	B1739CB5-09BC-414A-8F05-C66D2CB9868D	Metastatic	Illumina HiSeq	446e73e5-004b-4ac5-9413-27d76ce8fad0	Skin	51.0	1C388CA4-2E3E-429D-844E-52D6DF03F240	30CED7B6-9CD7-4F9B-96CC-3264EF036734	TCGA-FS-A1ZC-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-FS-A1ZC	TCGA-SKCM	10870.0	s7366	Harvard Medical School	Essen	Germany	NO	TX	N0		Stage I	A18Y-02	True
13767.58cfa833e4b0c9d6adf6d997	58cfa833e4b0c9d6adf6d997	TCGA-VQ-A91S-01A-11R-A414-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-A91S-01A-11R-A414-31_rnaseq	TCGA-VQ-A91S-01A-11R-A414-31_rnaseq.bam	79.69	1.94	0.18	58cfa833e4b0c9d6adf6d997	TCGA-VQ-A91S-01A-11R-A414-31_rnaseq.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN		Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-A91S-01A	D22DE643-5F93-42D0-9199-1F55405241D6	Primary Tumor	Illumina HiSeq	375A2520-E978-4771-ABF4-D952F8A146BB	Stomach	63.0	6C166803-0AC8-4D62-BA53-3EAB2F7DBCD1	44AE10EA-7B07-4046-8CA0-5CD5AF40E960	TCGA-VQ-A91S-01A-11R-A414-31	GRCh37-lite	TCGA-VQ-A91S	TCGA-STAD		s14929	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T4b	N1	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage III	A414-31	True
13722.58cfa832e4b0c9d6adf6cefa	58cfa832e4b0c9d6adf6cefa	TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina	TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina.bam	20.02		0.08	58cfa832e4b0c9d6adf6cefa	TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE			Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-A5NH-01A	98A639C2-D615-4DC1-98F0-298752B69B09	Primary Tumor	Illumina HiSeq	7d7c81dd-4888-4bac-a7d7-0859f946423b	Kidney	62.0	E8CD0D5D-2AF6-444F-B8B9-05B1874EDAE2	33B7E799-AD10-498F-9948-8CE433311539	TCGA-HE-A5NH-01A-11D-A26P-10	GRCh37-lite	TCGA-HE-A5NH	TCGA-KIRP		s11591	Baylor College of Medicine	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	True
13722.58cfa830e4b0c9d6adf6c1f8	58cfa830e4b0c9d6adf6c1f8	TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted	TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted.bam	10.21	1.76	0.18	58cfa830e4b0c9d6adf6c1f8	TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20T-11A	096B4F32-10C1-4737-A0DD-CAE04C54EE33	Solid Tissue Normal	Illumina HiSeq	7205e655-2448-4a14-8a14-2a8a6a97c6ee	Bladder	63.0	27461A27-26EB-4C2C-9C54-E16FBD32C615	FF148CF3-AFB7-42F1-A137-AD7D6CB889C1	TCGA-BT-A20T-11A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20T	TCGA-BLCA	453.0	s2870	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A14U-02	True
13767.58cfa83be4b0c9d6adf720e0	58cfa83be4b0c9d6adf720e0	UNCID_2567706.8d939ab5-8119-44da-b595-5c5a154031c2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2567706.8d939ab5-8119-44da-b595-5c5a154031c2.sorted_genome_alignments	UNCID_2567706.8d939ab5-8119-44da-b595-5c5a154031c2.sorted_genome_alignments.bam	35.78	1.86	0.16	58cfa83be4b0c9d6adf720e0	UNCID_2567706.8d939ab5-8119-44da-b595-5c5a154031c2.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-4K-AA1H-01A	2A85E0E7-7829-4637-B2C9-3BEB3AEB571E	Primary Tumor	Illumina HiSeq	B2BF8F0F-B563-4E37-B672-9D17DE676FEC	Testis	26.0	BBE687E4-1580-4D25-9612-A4E6628F195E	8D939AB5-8119-44DA-B595-5C5A154031C2	TCGA-4K-AA1H-01A-11R-A430-07	HG19	TCGA-4K-AA1H	TCGA-TGCT		s586	University of North Carolina	Proteogenex, Inc	Russia	NO	T2	N0		Stage I	A430-07	True
13767.58cfa838e4b0c9d6adf70aa8	58cfa838e4b0c9d6adf70aa8	UNCID_2087981.47e8bbd2-fd10-4dc8-882e-cb88ca27338d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2087981.47e8bbd2-fd10-4dc8-882e-cb88ca27338d.sorted_genome_alignments	UNCID_2087981.47e8bbd2-fd10-4dc8-882e-cb88ca27338d.sorted_genome_alignments.bam	38.17	1.79	0.18	58cfa838e4b0c9d6adf70aa8	UNCID_2087981.47e8bbd2-fd10-4dc8-882e-cb88ca27338d.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-PG-A5BC-01A	22669A01-21D3-404C-AC19-CF0A6C03BB1D	Primary Tumor	Illumina HiSeq	FD0F3CD3-51FC-4631-8A69-4B695414D76A	Uterus	72.0	0A63BF84-A720-4B8B-8312-4EC59D14982E	47E8BBD2-FD10-4DC8-882E-CB88CA27338D	TCGA-PG-A5BC-01A-12R-A27V-07	HG19	TCGA-PG-A5BC	TCGA-UCEC		s5115	University of North Carolina	Montefiore Medical Center	United States	NO			Serous endometrial adenocarcinoma		A27V-07	True
13722.58cfa831e4b0c9d6adf6c32f	58cfa831e4b0c9d6adf6c32f	TCGA-CG-4474-01A-02D-1154_130815_VM001_0006_VMR0006CXX_s_3_rg.sorted.filtered.	WGS	TCGA-CG-4474-01A-02D-1154_130815_VM001_0006_VMR0006CXX_s_3_rg.sorted	TCGA-CG-4474-01A-02D-1154_130815_VM001_0006_VMR0006CXX_s_3_rg.sorted.bam	112.2	1.9	0.14	58cfa831e4b0c9d6adf6c32f	TCGA-CG-4474-01A-02D-1154_130815_VM001_0006_VMR0006CXX_s_3_rg.sorted.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4474-01A	39DD61A8-CD17-4DF3-AE17-61E239EB00BD	Primary Tumor	Illumina HiSeq	2b986f51-b858-4e25-a6f7-cbc49e180234	Stomach	67.0	68D21E75-16AC-48D0-B7CA-ABFDE13DED29	A3D7BAF1-387C-4094-957E-24BD2A78ED8D	TCGA-CG-4474-01A-02D-1154-02	HG19_Broad_variant	TCGA-CG-4474	TCGA-STAD		s15399	Harvard Medical School	Indivumed	Germany	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	1154-02	True
13767.58cfa838e4b0c9d6adf70ac4	58cfa838e4b0c9d6adf70ac4	UNCID_2145969.37e88158-0743-45b8-87cf-1d7fe878527f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2145969.37e88158-0743-45b8-87cf-1d7fe878527f.sorted_genome_alignments	UNCID_2145969.37e88158-0743-45b8-87cf-1d7fe878527f.sorted_genome_alignments.bam	48.64	1.87	0.18	58cfa838e4b0c9d6adf70ac4	UNCID_2145969.37e88158-0743-45b8-87cf-1d7fe878527f.sorted_genome_alignments.bam	Dead	MALE	WHITE		Adrenocortical Carcinoma	Aligned reads	TCGA-OR-A5J1-01A	B3164F7B-C826-4E08-9EE6-8FF96D29B913	Primary Tumor	Illumina HiSeq	DFB30C2D-0FD7-4EDF-B8C1-9BBBEEFCE7E2	Adrenal Gland	58.0	E4038EBB-6E6D-44B1-84AD-E35AAFCA7B70	37E88158-0743-45B8-87CF-1D7FE878527F	TCGA-OR-A5J1-01A-11R-A29S-07	HG19	TCGA-OR-A5J1	TCGA-ACC	1355.0	s134	University of North Carolina	University of Michigan	Australia	NO	T2	N0		Stage II	A29S-07	True
13767.58cfa83ce4b0c9d6adf72d48	58cfa83ce4b0c9d6adf72d48	UNCID_612329.bf2b423a-5128-4b75-b3a7-2b7b9337c519.111021_UNC13-SN749_0128_BD0ENWABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_612329.bf2b423a-5128-4b75-b3a7-2b7b9337c519.111021_UNC13-SN749_0128_BD0ENWABXX.5.trimmed.annotated.translated_to_genomic	UNCID_612329.bf2b423a-5128-4b75-b3a7-2b7b9337c519.111021_UNC13-SN749_0128_BD0ENWABXX.5.trimmed.annotated.translated_to_genomic.bam	88.8	1.8	0.15	58cfa83ce4b0c9d6adf72d48	UNCID_612329.bf2b423a-5128-4b75-b3a7-2b7b9337c519.111021_UNC13-SN749_0128_BD0ENWABXX.5.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5713-01A	C91A4CC3-AAA9-4BC9-B157-E46551D334C8	Primary Tumor	Illumina HiSeq	6C588796-15DD-4EBF-B5CA-F8A33CD84657	Kidney	75.0	A27DD46B-A5C5-493C-8254-567919D60FAF	BF2B423A-5128-4B75-B3A7-2B7B9337C519	TCGA-B0-5713-01A-11R-1672-07	HG19	TCGA-B0-5713	TCGA-KIRC		s9558	University of North Carolina	University of Pittsburgh	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1672-07	True
13722.58cfa830e4b0c9d6adf6bdea	58cfa830e4b0c9d6adf6bdea	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	73.41	1.97	0.07	58cfa830e4b0c9d6adf6bdea	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B9-01A	5A57DC25-D252-4B22-B192-4DE630D7002F	Primary Tumor	Illumina HiSeq	1a49cb56-547c-4a77-84e6-116bc406ba19	Breast	44.0	8137FFEE-BB4F-4E5F-B831-ACFC9C5585A8	CF599959-6AAF-48EA-8A15-8EF09163BAD7	TCGA-BH-A0B9-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0B9	TCGA-BRCA		s6770	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A128-09	True
13767.58cfa838e4b0c9d6adf70da4	58cfa838e4b0c9d6adf70da4	UNCID_2097312.38b432b3-c4db-43ba-91c5-d68343f9ec03.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2097312.38b432b3-c4db-43ba-91c5-d68343f9ec03.sorted_genome_alignments	UNCID_2097312.38b432b3-c4db-43ba-91c5-d68343f9ec03.sorted_genome_alignments.bam	16.67	1.82	0.16	58cfa838e4b0c9d6adf70da4	UNCID_2097312.38b432b3-c4db-43ba-91c5-d68343f9ec03.sorted_genome_alignments.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-P4-A5ED-11A	104604C8-2CB5-4538-B964-DBFF3B6BC19F	Solid Tissue Normal	Illumina HiSeq	522E0D88-0597-40C0-AC7F-6E64104ECD9B	Kidney	51.0	67860B89-D15D-40D2-98A9-E34F4B9B8F51	38B432B3-C4DB-43BA-91C5-D68343F9EC03	TCGA-P4-A5ED-11A-11R-A28H-07	HG19	TCGA-P4-A5ED	TCGA-KIRP		s11820	University of North Carolina		United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A28H-07	True
13722.58cfa82fe4b0c9d6adf6b907	58cfa82fe4b0c9d6adf6b907	TCGA-A6-A565-10A-01D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-A6-A565-10A-01D-A28G-10_wgs_Illumina	TCGA-A6-A565-10A-01D-A28G-10_wgs_Illumina.bam	50.98		0.08	58cfa82fe4b0c9d6adf6b907	TCGA-A6-A565-10A-01D-A28G-10_wgs_Illumina.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN		Colon Adenocarcinoma	Aligned reads	TCGA-A6-A565-10A	DD7A53EE-CB08-40C4-9935-51D1CA17E9E8	Blood Derived Normal	Illumina HiSeq	1a964232-376f-4359-a91e-ba7dd9d9c03a	Colorectal	34.0	33B05D64-7194-4A95-839A-99B33640242D	D2AC0FE8-17D5-4032-BE6D-543CCA1F7D5A	TCGA-A6-A565-10A-01D-A28G-10	GRCh37-lite	TCGA-A6-A565	TCGA-COAD	494.0	s13018	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage III	A28G-10	True
13722.58cfa831e4b0c9d6adf6c40a	58cfa831e4b0c9d6adf6c40a	TCGA-CH-5772-11A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CH-5772-11A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_2_rg.sorted	TCGA-CH-5772-11A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_2_rg.sorted.bam	52.7	2.0	0.15	58cfa831e4b0c9d6adf6c40a	TCGA-CH-5772-11A-01D-1572_130125_SN208_0450_AC1K3NACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5772-11A	ECF9F8BE-7830-4626-8617-694C68EF4074	Solid Tissue Normal	Illumina HiSeq	4101a708-70fa-42dd-8aae-c5e3d3b12dd5	Prostate	63.0	222A8CFC-3D32-48C2-BAAB-EBF25D7C8156	26283C5E-0BA5-4B9E-8771-401E1A31A437	TCGA-CH-5772-11A-01D-1572-02	HG19_Broad_variant	TCGA-CH-5772	TCGA-PRAD		s3776	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1572-02	True
13767.58cfa832e4b0c9d6adf6d1aa	58cfa832e4b0c9d6adf6d1aa	TCGA-IN-AB1X-11A-21R-A39E-31_rnaseq.filtered.	RNA-Seq	TCGA-IN-AB1X-11A-21R-A39E-31_rnaseq	TCGA-IN-AB1X-11A-21R-A39E-31_rnaseq.bam	21.12	1.83	0.17	58cfa832e4b0c9d6adf6d1aa	TCGA-IN-AB1X-11A-21R-A39E-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-IN-AB1X-11A	1E5A3796-6249-4A91-9FC8-0C273E337F29	Solid Tissue Normal	Illumina HiSeq	FFD4961D-284E-48C6-BE98-AFCE6E0BDA82	Stomach	78.0	8C9C8830-20C4-4020-8750-28F70148E686	529DEF1E-3DCA-496C-8576-B1B1EBF0FEDC	TCGA-IN-AB1X-11A-21R-A39E-31	GRCh37-lite	TCGA-IN-AB1X	TCGA-STAD		s15263	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	United States	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	A39E-31	True
13767.58cfa83be4b0c9d6adf724e0	58cfa83be4b0c9d6adf724e0	UNCID_2605099.30ed88e3-55ce-45de-bcec-b6ed37297cc5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2605099.30ed88e3-55ce-45de-bcec-b6ed37297cc5.sorted_genome_alignments	UNCID_2605099.30ed88e3-55ce-45de-bcec-b6ed37297cc5.sorted_genome_alignments.bam	53.77	1.84	0.18	58cfa83be4b0c9d6adf724e0	UNCID_2605099.30ed88e3-55ce-45de-bcec-b6ed37297cc5.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-5P-A9JY-01A	45DA55A6-AA58-49AF-9A28-95B8CA2D4614	Primary Tumor	Illumina HiSeq	848FBD31-5E70-4F3D-B338-2F93439BCF26	Kidney	79.0	C3E266D0-9908-4ED1-8C93-CAAD6293BD49	30ED88E3-55CE-45DE-BCEC-B6ED37297CC5	TCGA-5P-A9JY-01A-11R-A42S-07	HG19	TCGA-5P-A9JY	TCGA-KIRP	1508.0	s11965	University of North Carolina	University Hospital Erlangen	Germany	NO	T2	NX	Kidney Papillary Renal Cell Carcinoma		A42S-07	True
13767.58cfa837e4b0c9d6adf703b4	58cfa837e4b0c9d6adf703b4	UNCID_1910977.4e77399b-349d-47c9-b058-f1f1fc118a34.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1910977.4e77399b-349d-47c9-b058-f1f1fc118a34.sorted_genome_alignments	UNCID_1910977.4e77399b-349d-47c9-b058-f1f1fc118a34.sorted_genome_alignments.bam	32.26	1.8	0.17	58cfa837e4b0c9d6adf703b4	UNCID_1910977.4e77399b-349d-47c9-b058-f1f1fc118a34.sorted_genome_alignments.bam	Alive	MALE	ASIAN		Thyroid Carcinoma	Aligned reads	TCGA-KS-A4I3-01A	F9DB9757-04D8-40BD-A58D-605F4255B0E6	Primary Tumor	Illumina HiSeq	0FA0F18D-9410-4702-B143-3CA56C440A31	Thyroid	41.0	336FDE82-0AC7-4953-99EA-7FB078EC264E	4E77399B-349D-47C9-B058-F1F1FC118A34	TCGA-KS-A4I3-01A-11R-A250-07	HG19	TCGA-KS-A4I3	TCGA-THCA		s12080	University of North Carolina	University of Michigan	United States	NO	T3	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A250-07	True
13767.58cfa82ee4b0c9d6adf6a7f8	58cfa82ee4b0c9d6adf6a7f8	G17221.TCGA-06-0152-02A-01R-2005-01.2.filtered.	RNA-Seq	G17221.TCGA-06-0152-02A-01R-2005-01.2	G17221.TCGA-06-0152-02A-01R-2005-01.2.bam	350.0	1.8	0.16	58cfa82ee4b0c9d6adf6a7f8	G17221.TCGA-06-0152-02A-01R-2005-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0152-02A	F5BC5D97-E054-4E53-992D-71B896BD97D5	Recurrent Tumor	Illumina HiSeq	7FC0399E-DB8A-4A7A-A9EF-4996B3B8EA43	Brain	68.0	1BF99D0E-EE8B-40A8-B279-DB2F06A9B188	75ED138D-252F-4179-B93F-4AE8EB2524EE	TCGA-06-0152-02A-01R-2005-01	HG19_Broad_variant	TCGA-06-0152	TCGA-GBM	375.0	s13968	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		2005-01	True
13722.58cfa831e4b0c9d6adf6cb9c	58cfa831e4b0c9d6adf6cb9c	TCGA-EE-A29H-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EE-A29H-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_8_rg.sorted	TCGA-EE-A29H-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_8_rg.sorted.bam	28.94		0.15	58cfa831e4b0c9d6adf6cb9c	TCGA-EE-A29H-10A-01D-A190_120729_SN1120_0180_BC1176ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A29H-10A	C8BA1856-D055-4DC6-A184-72763C76AAE4	Blood Derived Normal	Illumina HiSeq	66ec2170-64e3-497d-aa60-e0f40b3875a6	Skin	59.0	D9FB008D-2BD2-4F50-99D3-C4E0863A5AE0	63B79CED-2594-4C16-9788-95BBF1F99D37	TCGA-EE-A29H-10A-01D-A190-02	HG19_Broad_variant	TCGA-EE-A29H	TCGA-SKCM		s7849	Harvard Medical School	University of Sydney	Australia	NO	T1a	N0		Stage I	A190-02	True
13767.58cfa837e4b0c9d6adf6fd5c	58cfa837e4b0c9d6adf6fd5c	UNCID_1673386.17d328ce-367a-47c4-8f70-7f4644b37506.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1673386.17d328ce-367a-47c4-8f70-7f4644b37506.sorted_genome_alignments	UNCID_1673386.17d328ce-367a-47c4-8f70-7f4644b37506.sorted_genome_alignments.bam	36.2		0.15	58cfa837e4b0c9d6adf6fd5c	UNCID_1673386.17d328ce-367a-47c4-8f70-7f4644b37506.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7694-01A	49A87025-D0A4-44B3-B6AD-563BF9651093	Primary Tumor	Illumina HiSeq	E9F91E38-7E8D-4C48-9C84-B00BD894A771	Brain	60.0	242CF713-1C1B-4A2F-8E8E-253FB50CFD7F	17D328CE-367A-47C4-8F70-7F4644B37506	TCGA-HT-7694-01A-11R-2256-07	HG19	TCGA-HT-7694	TCGA-LGG		s8637	University of North Carolina	Case Western - St Joes	United States	NO			Oligodendroglioma		2256-07	True
13722.58cfa830e4b0c9d6adf6bbf0	58cfa830e4b0c9d6adf6bbf0	TCGA-A6-3807-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-3807-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-3807-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	203.86	1.9	0.16	58cfa830e4b0c9d6adf6bbf0	TCGA-A6-3807-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-3807-11A	5116E3B4-2BAC-40F5-8046-B9C1783FAAA5	Solid Tissue Normal	Illumina HiSeq	e14fd460-b6c8-44b8-81ad-b9ce224af5cb	Colorectal	53.0	6CC29D0A-19C3-4C7F-AD8D-BF10E1392E09	BADA9982-36A5-48B3-BE62-DFD0D8AC7FC8	TCGA-A6-3807-11A-01D-1167-02	HG18	TCGA-A6-3807	TCGA-COAD		s13352	Harvard Medical School	Christiana Healthcare	None	NO	T3	N2	Colon Adenocarcinoma	Stage III	1167-02	True
13767.58cfa838e4b0c9d6adf708e8	58cfa838e4b0c9d6adf708e8	UNCID_2054817.80241bee-c4e9-4ce7-a920-022f8b00e21d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2054817.80241bee-c4e9-4ce7-a920-022f8b00e21d.sorted_genome_alignments	UNCID_2054817.80241bee-c4e9-4ce7-a920-022f8b00e21d.sorted_genome_alignments.bam	48.65	1.89	0.18	58cfa838e4b0c9d6adf708e8	UNCID_2054817.80241bee-c4e9-4ce7-a920-022f8b00e21d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-DS-A5RQ-01A	B16469AF-A721-43E9-A4D7-C39B94D1139F	Primary Tumor	Illumina HiSeq	07A7C8BA-234F-476A-BA4E-7AB078BB1DD0	Cervix	80.0	1C93033C-AA43-4F75-B299-7C5DAAFD226F	80241BEE-C4E9-4CE7-A920-022F8B00E21D	TCGA-DS-A5RQ-01A-11R-A28H-07	HG19	TCGA-DS-A5RQ	TCGA-CESC		s1268	University of North Carolina	Cedars Sinai	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma		A28H-07	True
13767.58cfa838e4b0c9d6adf706d6	58cfa838e4b0c9d6adf706d6	UNCID_1967660.4c8aa0aa-c1ae-4aff-96f2-4636bb1d5c47.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1967660.4c8aa0aa-c1ae-4aff-96f2-4636bb1d5c47.sorted_genome_alignments	UNCID_1967660.4c8aa0aa-c1ae-4aff-96f2-4636bb1d5c47.sorted_genome_alignments.bam	50.23	1.89	0.18	58cfa838e4b0c9d6adf706d6	UNCID_1967660.4c8aa0aa-c1ae-4aff-96f2-4636bb1d5c47.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-MV-A51V-01A	D2F329B3-5B44-414B-BCCD-7B2D1345D21E	Primary Tumor	Illumina HiSeq	D2149DB9-D72E-48B6-B9DE-5EA0C5D360BA	Bladder	75.0	C0DA46CF-81EB-4F1F-8F95-07BCCEE9F7DE	4C8AA0AA-C1AE-4AFF-96F2-4636BB1D5C47	TCGA-MV-A51V-01A-11R-A26T-07	HG19	TCGA-MV-A51V	TCGA-BLCA		s3177	University of North Carolina	University of Minnesota	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A26T-07	True
13722.58cfa830e4b0c9d6adf6bf6c	58cfa830e4b0c9d6adf6bf6c	TCGA-BR-6452-10A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-6452-10A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_3_rg.sorted	TCGA-BR-6452-10A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_3_rg.sorted.bam	34.7	1.9	0.15	58cfa830e4b0c9d6adf6bf6c	TCGA-BR-6452-10A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6452-10A	27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9	Blood Derived Normal	Illumina HiSeq	b5d222fd-498a-40a1-880d-322d0a7a1323	Stomach	78.0	14F163DB-E740-48B9-8126-AC2A5A691288	617B4921-0897-4062-A233-BDA2F15A1E47	TCGA-BR-6452-10A-01D-1798-02	HG19_Broad_variant	TCGA-BR-6452	TCGA-STAD		s14400	Harvard Medical School	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1798-02	True
13767.58cfa832e4b0c9d6adf6d806	58cfa832e4b0c9d6adf6d806	UNCID_1033008.49fb1ab4-cd04-4985-99ee-2ddef8685cdc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1033008.49fb1ab4-cd04-4985-99ee-2ddef8685cdc.sorted_genome_alignments	UNCID_1033008.49fb1ab4-cd04-4985-99ee-2ddef8685cdc.sorted_genome_alignments.bam	54.27	1.86	0.16	58cfa832e4b0c9d6adf6d806	UNCID_1033008.49fb1ab4-cd04-4985-99ee-2ddef8685cdc.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q5-01A	13C97CFB-EEA2-4AE8-9209-C967D9642CEF	Primary Tumor	Illumina HiSeq	C20908B8-930A-415B-BB8F-118FC740A63D	Thyroid	51.0	56FA075B-09E2-4DB9-A997-0B7EB2198B6C	49FB1AB4-CD04-4985-99EE-2DDEF8685CDC	TCGA-DJ-A2Q5-01A-11R-A18C-07	HG19	TCGA-DJ-A2Q5	TCGA-THCA		s12537	University of North Carolina	Memorial Sloan Kettering	United States	NO	T2	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A18C-07	True
13767.58cfa832e4b0c9d6adf6d08a	58cfa832e4b0c9d6adf6d08a	TCGA-HU-A4GP-01A-11R-A251-31_rnaseq.filtered.	RNA-Seq	TCGA-HU-A4GP-01A-11R-A251-31_rnaseq	TCGA-HU-A4GP-01A-11R-A251-31_rnaseq.bam	92.54	1.83	0.17	58cfa832e4b0c9d6adf6d08a	TCGA-HU-A4GP-01A-11R-A251-31_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4GP-01A	C46FF2BB-BDD0-48CD-B2AE-7EF421B4B91A	Primary Tumor	Illumina HiSeq	058A5F50-2578-462D-8613-D8DA50CE3FF7	Stomach	62.0	4C0EFD43-956F-499F-B0EA-2C3FA96F63F3	AFC9919B-8382-45BF-AEF1-D031F8278591	TCGA-HU-A4GP-01A-11R-A251-31	GRCh37-lite	TCGA-HU-A4GP	TCGA-STAD		s14566	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T2	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage II	A251-31	True
13767.58cfa834e4b0c9d6adf6e634	58cfa834e4b0c9d6adf6e634	UNCID_1191570.a917a34c-dc6a-410a-8063-fed4a94dfbff.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1191570.a917a34c-dc6a-410a-8063-fed4a94dfbff.sorted_genome_alignments	UNCID_1191570.a917a34c-dc6a-410a-8063-fed4a94dfbff.sorted_genome_alignments.bam	35.8	1.7	0.13	58cfa834e4b0c9d6adf6e634	UNCID_1191570.a917a34c-dc6a-410a-8063-fed4a94dfbff.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-DV-5567-01A	ABA26E6B-F11C-4AE6-A0D6-85BDD2060E8F	Primary Tumor	Illumina HiSeq	B798310B-DBD9-4E2D-8F3B-60684EEA6D92	Kidney	40.0	9597F316-8084-47E2-A60F-CFF2471FD619	A917A34C-DC6A-410A-8063-FED4A94DFBFF	TCGA-DV-5567-01A-01R-1541-07	HG19	TCGA-DV-5567	TCGA-KIRC		s9352	University of North Carolina	NCI Urologic Oncology Branch	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13722.58cfa830e4b0c9d6adf6bcac	58cfa830e4b0c9d6adf6bcac	TCGA-AG-3894-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3894-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3894-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	7.59	1.9	0.16	58cfa830e4b0c9d6adf6bcac	TCGA-AG-3894-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3894-10A	065B26FC-6827-44D5-83D8-1100C63FCDA6	Blood Derived Normal	Illumina HiSeq	6a9c36f1-b845-4ba6-abf3-648188c51636	Colorectal	65.0	5D172F3A-8B5B-4CEB-A5C7-314571E3EB30	6B64DF2F-F727-46E7-BD39-518D8D68F796	TCGA-AG-3894-10A-01D-1115-02	HG18	TCGA-AG-3894	TCGA-READ		s2165	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage II	1115-02	True
13767.58cfa839e4b0c9d6adf714ae	58cfa839e4b0c9d6adf714ae	UNCID_2334025.d3473471-b625-4f56-8300-590324d48002.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2334025.d3473471-b625-4f56-8300-590324d48002.sorted_genome_alignments	UNCID_2334025.d3473471-b625-4f56-8300-590324d48002.sorted_genome_alignments.bam	62.18	1.84	0.16	58cfa839e4b0c9d6adf714ae	UNCID_2334025.d3473471-b625-4f56-8300-590324d48002.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-SJ-A6ZJ-01A	FBFED398-2A44-44A9-83CF-657C29CB7D28	Primary Tumor	Illumina HiSeq	2A575105-4E8D-418B-AC90-5AA30450C370	Uterus	61.0	C3064816-C2C1-4AF0-8F0E-89D900E47D20	D3473471-B625-4F56-8300-590324D48002	TCGA-SJ-A6ZJ-01A-12R-A34R-07	HG19	TCGA-SJ-A6ZJ	TCGA-UCEC		s4918	University of North Carolina	Albert Einstein Medical Center	United States	NO			Endometrioid endometrial adenocarcinoma		A34R-07	True
13767.58cfa82ee4b0c9d6adf6a9d2	58cfa82ee4b0c9d6adf6a9d2	G17806.TCGA-19-4065-01A-01R-2005-01.4.filtered.	RNA-Seq	G17806.TCGA-19-4065-01A-01R-2005-01.4	G17806.TCGA-19-4065-01A-01R-2005-01.4.bam	218.0	1.9	0.16	58cfa82ee4b0c9d6adf6a9d2	G17806.TCGA-19-4065-01A-01R-2005-01.4.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-4065-01A	A262928C-E20A-4C02-8114-1227E05C43E1	Primary Tumor	Illumina HiSeq	EF74F307-04EA-4515-B0A3-46388FD0BE52	Brain	36.0	3C83DED3-3515-4071-8788-6E8BF2C2A173	3053A2C5-4426-4D56-85B0-50567F1E81C9	TCGA-19-4065-01A-01R-2005-01	HG19_Broad_variant	TCGA-19-4065	TCGA-GBM		s13945	Broad Institute of MIT and Harvard	Case Western	None	NO			Untreated primary (de novo) GBM		2005-01	True
13767.58cfa837e4b0c9d6adf70266	58cfa837e4b0c9d6adf70266	UNCID_1896978.0cb961d7-87be-40c2-b703-3e424b8c8e78.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1896978.0cb961d7-87be-40c2-b703-3e424b8c8e78.sorted_genome_alignments	UNCID_1896978.0cb961d7-87be-40c2-b703-3e424b8c8e78.sorted_genome_alignments.bam	47.2	1.8	0.15	58cfa837e4b0c9d6adf70266	UNCID_1896978.0cb961d7-87be-40c2-b703-3e424b8c8e78.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6499-11A	ACD5CEEF-C5CF-4E95-9394-C50FDBC70C8D	Solid Tissue Normal	Illumina HiSeq	A597BB55-24F8-44FA-AA56-1776175B1F36	Prostate	66.0	8C0D4ED2-F07E-4249-9294-85222D5F0936	0CB961D7-87BE-40C2-B703-3E424B8C8E78	TCGA-G9-6499-11A-02R-1965-07	HG19	TCGA-G9-6499	TCGA-PRAD		s3860	University of North Carolina	Roswell Park	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1965-07	True
13722.58cfa831e4b0c9d6adf6c550	58cfa831e4b0c9d6adf6c550	TCGA-CH-5754-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CH-5754-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_6_rg.sorted	TCGA-CH-5754-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_6_rg.sorted.bam	104.4	1.9	0.14	58cfa831e4b0c9d6adf6c550	TCGA-CH-5754-10A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5754-10A	0AAD0ABD-750A-400D-A34F-491DA996D46C	Blood Derived Normal	Illumina HiSeq	eff5ccea-5f74-449e-a9e6-4eb5a83e71c7	Prostate	65.0	C424E5E9-8E39-4C4B-A02D-37B6E7F11E38	76512EE5-8E1C-4A61-A662-AD9FF0DA8746	TCGA-CH-5754-10A-01D-1572-02	HG19_Broad_variant	TCGA-CH-5754	TCGA-PRAD		s3940	Harvard Medical School	Indivumed	Germany	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type		1572-02	True
13722.58cfa830e4b0c9d6adf6c1aa	58cfa830e4b0c9d6adf6c1aa	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.bam	213.7	1.9	0.16	58cfa830e4b0c9d6adf6c1aa	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5555-01A	8970F713-4A7A-4125-892C-6A34139371D8	Primary Tumor	Illumina HiSeq	cd7725ec-bc8e-4c93-aba5-19dbdeb78b0d	Head and Neck	54.0	2920CA1C-6035-4350-ADA4-C60D485DBFFF	4AB42DF9-A215-4965-A125-CC0C4122FF06	TCGA-BA-5555-01A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5555	TCGA-HNSC		s15609	Harvard Medical School	UNC	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IV	1509-02	True
13767.58cfa837e4b0c9d6adf6ff24	58cfa837e4b0c9d6adf6ff24	UNCID_1793110.7ac6df66-aaf9-4347-8a32-a23147f58acf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1793110.7ac6df66-aaf9-4347-8a32-a23147f58acf.sorted_genome_alignments	UNCID_1793110.7ac6df66-aaf9-4347-8a32-a23147f58acf.sorted_genome_alignments.bam	73.8	1.8	0.14	58cfa837e4b0c9d6adf6ff24	UNCID_1793110.7ac6df66-aaf9-4347-8a32-a23147f58acf.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CK-5915-01A	C658F35D-CEEB-4189-8E3D-03E3B9706667	Primary Tumor	Illumina HiSeq	E73066AB-0B6F-4A42-B542-5CC14467328E	Colorectal	63.0	076808F3-1A00-4C82-BFA3-91A325F1E73C	7AC6DF66-AAF9-4347-8A32-A23147F58ACF	TCGA-CK-5915-01A-11R-1653-07	HG19	TCGA-CK-5915	TCGA-COAD		s13258	University of North Carolina	Harvard	United States	NO	T2	N0	Colon Adenocarcinoma	Stage I	1653-07	True
13767.58cfa832e4b0c9d6adf6d3df	58cfa832e4b0c9d6adf6d3df	TCGA-L5-A43H-01A-11R-A24K-31_rnaseq.filtered.	RNA-Seq	TCGA-L5-A43H-01A-11R-A24K-31_rnaseq	TCGA-L5-A43H-01A-11R-A24K-31_rnaseq.bam	36.75	1.82	0.18	58cfa832e4b0c9d6adf6d3df	TCGA-L5-A43H-01A-11R-A24K-31_rnaseq.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A43H-01A	06CA7FC4-4AE0-47D5-9E83-F92BA42A957B	Primary Tumor	Illumina HiSeq	57737D74-2CBF-4C2D-8C2F-48824447B329	Esophagus	75.0	C144B311-B50C-4CB1-89B3-0B056871F54B	BA0C377F-8D53-4C55-9CE7-D92A53B70DA0	TCGA-L5-A43H-01A-11R-A24K-31	GRCh37-lite	TCGA-L5-A43H	TCGA-ESCA	9.0	s1834	Canada's Michael Smith Genome Sciences Centre	University of Michigan	United States	NO	T3	N1		Stage III	A24K-31	True
13767.58cfa83ce4b0c9d6adf72d6a	58cfa83ce4b0c9d6adf72d6a	UNCID_611888.e4f89d3b-82e2-4269-a70a-7224a9601c18.111025_UNC13-SN749_0130_AD0EYTABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_611888.e4f89d3b-82e2-4269-a70a-7224a9601c18.111025_UNC13-SN749_0130_AD0EYTABXX.5.trimmed.annotated.translated_to_genomic	UNCID_611888.e4f89d3b-82e2-4269-a70a-7224a9601c18.111025_UNC13-SN749_0130_AD0EYTABXX.5.trimmed.annotated.translated_to_genomic.bam	18.8	1.8	0.14	58cfa83ce4b0c9d6adf72d6a	UNCID_611888.e4f89d3b-82e2-4269-a70a-7224a9601c18.111025_UNC13-SN749_0130_AD0EYTABXX.5.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B8-4146-01B	CBA5705A-80DD-4496-9283-C5D3A92C7DBA	Primary Tumor	Illumina HiSeq	BB47161D-D233-4E7B-A33E-056E5B1EB410	Kidney	41.0	2C98B857-5550-4B7C-AD77-2C17348A2D85	E4F89D3B-82E2-4269-A70A-7224A9601C18	TCGA-B8-4146-01B-11R-1672-07	HG19	TCGA-B8-4146	TCGA-KIRC		s9928	University of North Carolina	UNC	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1672-07	True
13767.58cfa835e4b0c9d6adf6ee74	58cfa835e4b0c9d6adf6ee74	UNCID_1434445.f3196cf4-2cda-4377-9089-e29434cbd4d4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1434445.f3196cf4-2cda-4377-9089-e29434cbd4d4.sorted_genome_alignments	UNCID_1434445.f3196cf4-2cda-4377-9089-e29434cbd4d4.sorted_genome_alignments.bam	35.2		0.16	58cfa835e4b0c9d6adf6ee74	UNCID_1434445.f3196cf4-2cda-4377-9089-e29434cbd4d4.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-53-7626-01A	D3FF328C-2488-47BD-8663-366B6812C7B5	Primary Tumor	Illumina HiSeq	F5B30483-AC6B-4199-A820-3ED602ADBCD1	Lung	76.0	7D0017C2-DB42-4758-8DC4-0250EC5FD83C	F3196CF4-2CDA-4377-9089-E29434CBD4D4	TCGA-53-7626-01A-12R-2066-07	HG19	TCGA-53-7626	TCGA-LUAD	929.0	s10859	University of North Carolina	University of Miami	United States	NO	T1	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	2066-07	True
13722.58cfa830e4b0c9d6adf6bcc4	58cfa830e4b0c9d6adf6bcc4	TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	397.02	1.9	0.15	58cfa830e4b0c9d6adf6bcc4	TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4313-01A	1FD75C4D-E74C-410C-A150-814722C6C1CC	Primary Tumor	Illumina HiSeq	b8e9093c-1570-45c6-8278-f686c276ee91	Colorectal	51.0	475F161C-2F7F-43A2-B187-DE6038752F39	F64D4985-D460-435C-8EC0-477D313A895A	TCGA-AZ-4313-01A-01D-1405-02	HG18	TCGA-AZ-4313	TCGA-COAD		s13212	Harvard Medical School	University of Pittsburgh	None	NO	T1	N0	Colon Adenocarcinoma	Stage I	1405-02	True
13722.58cfa82ee4b0c9d6adf6aea8	58cfa82ee4b0c9d6adf6aea8	G39020.TCGA-BR-8373-01A-11D-2340-08.3.filtered.	WGS	G39020.TCGA-BR-8373-01A-11D-2340-08.3	G39020.TCGA-BR-8373-01A-11D-2340-08.3.bam	188.7		0.05	58cfa82ee4b0c9d6adf6aea8	G39020.TCGA-BR-8373-01A-11D-2340-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8373-01A	60879669-96C2-4710-82E0-0AE9D0E5B242	Primary Tumor	Illumina HiSeq	cbbdb4e0-d400-45ef-bb4f-790b2cc9cb87	Stomach	65.0	4370B4F3-4FD7-4558-BF59-DAAE486BADC3	1F2A8889-4374-4037-BB56-0F20733380E3	TCGA-BR-8373-01A-11D-2340-08	HG19_Broad_variant	TCGA-BR-8373	TCGA-STAD		s15094	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T4a	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2340-08	False
13722.58cfa830e4b0c9d6adf6bd8f	58cfa830e4b0c9d6adf6bd8f	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.bam	11.7	2.0	0.14	58cfa830e4b0c9d6adf6bd8f	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4223-01A	05F01280-BF77-4682-A7A8-20DD0EAC77BD	Primary Tumor	Illumina HiSeq	e8bc6546-004a-4702-9289-b5c90582298e	Head and Neck	48.0	82DB742D-885D-4788-B509-474715AE183B	007F0F41-C370-45F9-8053-2C774ADDED49	TCGA-BB-4223-01A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4223	TCGA-HNSC		s15490	Harvard Medical School	Johns Hopkins	United States	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IV	1431-02	True
13767.58cfa832e4b0c9d6adf6d80f	58cfa832e4b0c9d6adf6d80f	TCGA-VQ-A94O-01A-11R-A414-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-A94O-01A-11R-A414-31_rnaseq	TCGA-VQ-A94O-01A-11R-A414-31_rnaseq.bam	63.51	1.83	0.15	58cfa832e4b0c9d6adf6d80f	TCGA-VQ-A94O-01A-11R-A414-31_rnaseq.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN		Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-A94O-01A	E12D142E-7339-48FC-B17A-9E311B65327F	Primary Tumor	Illumina HiSeq	63C8C2AA-B585-47F3-89C9-0D0A7EFEF883	Stomach	74.0	318C7E4B-196F-4CC5-8503-8D111F1713E0	1E5DC398-27B8-44F9-8E61-5A752D3712DE	TCGA-VQ-A94O-01A-11R-A414-31	GRCh37-lite	TCGA-VQ-A94O	TCGA-STAD	640.0	s14505	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T4a	N3	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	A414-31	True
13767.58cfa834e4b0c9d6adf6e94c	58cfa834e4b0c9d6adf6e94c	UNCID_1234702.c07b7746-e340-4679-99bb-531c2d93b4e5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1234702.c07b7746-e340-4679-99bb-531c2d93b4e5.sorted_genome_alignments	UNCID_1234702.c07b7746-e340-4679-99bb-531c2d93b4e5.sorted_genome_alignments.bam	85.8	1.8	0.15	58cfa834e4b0c9d6adf6e94c	UNCID_1234702.c07b7746-e340-4679-99bb-531c2d93b4e5.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5495-01A	962DD3D5-8501-4658-8CB9-2424B476124C	Primary Tumor	Illumina HiSeq	609A141F-329E-4DBC-A5B1-0E78F48F16E4	Prostate	68.0	8E53414F-455E-4665-AE0E-9E7405262A96	C07B7746-E340-4679-99BB-531C2D93B4E5	TCGA-EJ-5495-01A-01R-1580-07	HG19	TCGA-EJ-5495	TCGA-PRAD		s3642	University of North Carolina	University of Pittsburgh	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type		1580-07	True
13722.58cfa831e4b0c9d6adf6c908	58cfa831e4b0c9d6adf6c908	TCGA-DK-A1AA-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_4_rg.sorted.filtered.	WGS	TCGA-DK-A1AA-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_4_rg.sorted	TCGA-DK-A1AA-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_4_rg.sorted.bam	46.88	1.88	0.15	58cfa831e4b0c9d6adf6c908	TCGA-DK-A1AA-10A-01D-A13U_121025_SN590_0188_AC190CACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AA-10A	56D8A1B8-1268-4362-A7F1-77B76FBF1B59	Blood Derived Normal	Illumina HiSeq	c6b09f3f-3fe9-4d73-a1d9-c6ce0084ac1e	Bladder	57.0	C976B658-9A59-4205-93FF-E1AAD1995C49	EB9F2A7C-67B3-4B46-9196-6596C8C5832B	TCGA-DK-A1AA-10A-01D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AA	TCGA-BLCA		s3283	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13U-02	True
13767.58cfa837e4b0c9d6adf6fdee	58cfa837e4b0c9d6adf6fdee	UNCID_1727937.d42c9589-3960-4964-be28-83d275bdc672.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1727937.d42c9589-3960-4964-be28-83d275bdc672.sorted_genome_alignments	UNCID_1727937.d42c9589-3960-4964-be28-83d275bdc672.sorted_genome_alignments.bam	119.2		0.15	58cfa837e4b0c9d6adf6fdee	UNCID_1727937.d42c9589-3960-4964-be28-83d275bdc672.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KN-8425-01A	CC316FAF-DCB1-4DEA-B8B0-A17D000FF40F	Primary Tumor	Illumina HiSeq	9E844F1E-7E08-4387-A41F-9E6F1813D345	Kidney	53.0	84ED1792-CEC8-4F98-9988-74B3F5F6F516	D42C9589-3960-4964-BE28-83D275BDC672	TCGA-KN-8425-01A-11R-2315-07	HG19	TCGA-KN-8425	TCGA-KICH		s16567	University of North Carolina	Harvard	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2315-07	True
13767.58cfa838e4b0c9d6adf7057d	58cfa838e4b0c9d6adf7057d	UNCID_1970928.fa279a9c-78d8-4727-a559-b7eca7a119b8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1970928.fa279a9c-78d8-4727-a559-b7eca7a119b8.sorted_genome_alignments	UNCID_1970928.fa279a9c-78d8-4727-a559-b7eca7a119b8.sorted_genome_alignments.bam	117.8	1.8	0.14	58cfa838e4b0c9d6adf7057d	UNCID_1970928.fa279a9c-78d8-4727-a559-b7eca7a119b8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-D5-6532-01A	AC13D568-F79E-4BA7-B7BF-18E4354E0920	Primary Tumor	Illumina HiSeq	51CA9951-94E0-42B7-B4A3-D905B716478F	Colorectal	61.0	5191B678-F7E1-42F4-A995-AA6ABE5FD976	FA279A9C-78D8-4727-A559-B7ECA7A119B8	TCGA-D5-6532-01A-11R-1723-07	HG19	TCGA-D5-6532	TCGA-COAD		s13287	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T3	N0	Colon Adenocarcinoma	Stage II	1723-07	True
13767.58cfa834e4b0c9d6adf6e1c0	58cfa834e4b0c9d6adf6e1c0	UNCID_1154431.bf23a402-18ab-47b7-8bca-a9b01eeaf605.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1154431.bf23a402-18ab-47b7-8bca-a9b01eeaf605.sorted_genome_alignments	UNCID_1154431.bf23a402-18ab-47b7-8bca-a9b01eeaf605.sorted_genome_alignments.bam	15.68	1.96	0.16	58cfa834e4b0c9d6adf6e1c0	UNCID_1154431.bf23a402-18ab-47b7-8bca-a9b01eeaf605.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BD-01A	B379BFB8-284E-4300-8325-85CFD6809CB8	Primary Tumor	Illumina HiSeq	5281CB3E-79DE-424A-88AA-944F3D076E66	Breast	47.0	832B8766-0E59-4AD4-B4C9-1E39B2CE4FB1	BF23A402-18AB-47B7-8BCA-A9B01EEAF605	TCGA-BH-A0BD-01A-11R-A034-07	HG19	TCGA-BH-A0BD	TCGA-BRCA		s6033	University of North Carolina	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage II	A034-07	True
13767.58cfa837e4b0c9d6adf6ffc4	58cfa837e4b0c9d6adf6ffc4	UNCID_1796006.0d76a939-8917-41f8-b61f-d87b0a4fa568.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1796006.0d76a939-8917-41f8-b61f-d87b0a4fa568.sorted_genome_alignments	UNCID_1796006.0d76a939-8917-41f8-b61f-d87b0a4fa568.sorted_genome_alignments.bam	73.8	1.8	0.15	58cfa837e4b0c9d6adf6ffc4	UNCID_1796006.0d76a939-8917-41f8-b61f-d87b0a4fa568.sorted_genome_alignments.bam	Alive	FEMALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3742-11A	FBCD7E69-533F-4B6C-9868-162139135B58	Solid Tissue Normal	Illumina HiSeq	A6969ECC-5425-4C8E-82ED-CAC51BA746B2	Colorectal	85.0	83C430D6-3F3F-49DB-BA30-98EE696744C1	0D76A939-8917-41F8-B61F-D87B0A4FA568	TCGA-AG-3742-11A-01R-1660-07	HG19	TCGA-AG-3742	TCGA-READ		s2228	University of North Carolina	Indivumed	Germany	NO	T1	N0	Rectal Adenocarcinoma	Stage I	1660-07	True
13767.58cfa839e4b0c9d6adf71070	58cfa839e4b0c9d6adf71070	UNCID_2247103.723cafa2-ce72-4c19-954b-9be09a1b08e9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2247103.723cafa2-ce72-4c19-954b-9be09a1b08e9.sorted_genome_alignments	UNCID_2247103.723cafa2-ce72-4c19-954b-9be09a1b08e9.sorted_genome_alignments.bam	44.98	2.08	0.18	58cfa839e4b0c9d6adf71070	UNCID_2247103.723cafa2-ce72-4c19-954b-9be09a1b08e9.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A7CJ-01A	F8F470D2-924F-41DD-92C5-516B0BF68E44	Primary Tumor	Illumina HiSeq	D01AD9BE-568C-454A-93E9-900A096D8AB0	Cervix	42.0	7E1EEA3A-3CED-45DC-86E7-43867738BF49	723CAFA2-CE72-4C19-954B-9BE09A1B08E9	TCGA-C5-A7CJ-01A-11R-A32P-07	HG19	TCGA-C5-A7CJ	TCGA-CESC	3097.0	s1444	University of North Carolina	Medical College of Wisconsin	United States	NO	T2a	N1	Cervical Squamous Cell Carcinoma		A32P-07	True
13767.58cfa831e4b0c9d6adf6c58c	58cfa831e4b0c9d6adf6c58c	TCGA-BR-4257-01A-01R-1131-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-4257-01A-01R-1131-13_rnaseq	TCGA-BR-4257-01A-01R-1131-13_rnaseq.bam	95.3	1.8	0.15	58cfa831e4b0c9d6adf6c58c	TCGA-BR-4257-01A-01R-1131-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4257-01A	DA112431-5579-4FD1-A230-9144B359B0E9	Primary Tumor	Illumina HiSeq	3AC2A7F3-D683-4E77-A3A4-AC9D8CFEE1EF	Stomach	79.0	97B44B05-97EB-486C-94DB-42838831DE0B	674E13FE-305F-44CD-9CF0-FD2B01EFFB4F	TCGA-BR-4257-01A-01R-1131-13	GRCh37-lite	TCGA-BR-4257	TCGA-STAD		s15378	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	TX	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)		1131-13	True
13767.58cfa838e4b0c9d6adf70f05	58cfa838e4b0c9d6adf70f05	UNCID_2135992.d268f4e1-937a-40a8-b058-a87949bedd8b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2135992.d268f4e1-937a-40a8-b058-a87949bedd8b.sorted_genome_alignments	UNCID_2135992.d268f4e1-937a-40a8-b058-a87949bedd8b.sorted_genome_alignments.bam	26.52	1.91	0.18	58cfa838e4b0c9d6adf70f05	UNCID_2135992.d268f4e1-937a-40a8-b058-a87949bedd8b.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-J4-A67T-01A	432F15BA-7401-4827-83A5-3EAAFAAA4BEA	Primary Tumor	Illumina HiSeq	67E97F60-457C-44F6-9150-D4469F88F9E2	Prostate	63.0	FC2033B2-79B6-4FEB-9084-07082EA73B8B	D268F4E1-937A-40A8-B058-A87949BEDD8B	TCGA-J4-A67T-01A-11R-A311-07	HG19	TCGA-J4-A67T	TCGA-PRAD		s3866	University of North Carolina	ABS - Lahey Clinic	United States	NO	T2c		Prostate Adenocarcinoma Acinar Type		A311-07	True
13722.58cfa831e4b0c9d6adf6cd46	58cfa831e4b0c9d6adf6cd46	TCGA-EP-A3RK-10A-01D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-EP-A3RK-10A-01D-A22F-10_wgs_Illumina	TCGA-EP-A3RK-10A-01D-A22F-10_wgs_Illumina.bam	79.75		0.08	58cfa831e4b0c9d6adf6cd46	TCGA-EP-A3RK-10A-01D-A22F-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-EP-A3RK-10A	F15279DD-5D12-460B-9BD1-B4F95681CA65	Blood Derived Normal	Illumina HiSeq	8d2f2b76-0b7a-4963-8bc2-dd72bed43ab9	Liver	73.0	A6FFC817-F4BE-49C1-AA99-3546778CB91F	F4EBCDB4-5FCB-4FBC-BB8C-D961EF98312B	TCGA-EP-A3RK-10A-01D-A22F-10	GRCh37-lite	TCGA-EP-A3RK	TCGA-LIHC		s16858	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3a	NX	Hepatocellular Carcinoma	Stage III	A22F-10	True
13767.58cfa831e4b0c9d6adf6cdde	58cfa831e4b0c9d6adf6cdde	TCGA-FP-A4BE-01A-12R-A24K-31_rnaseq.filtered.	RNA-Seq	TCGA-FP-A4BE-01A-12R-A24K-31_rnaseq	TCGA-FP-A4BE-01A-12R-A24K-31_rnaseq.bam	95.82	1.81	0.17	58cfa831e4b0c9d6adf6cdde	TCGA-FP-A4BE-01A-12R-A24K-31_rnaseq.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-FP-A4BE-01A	48ABE0EF-DFD5-4E36-A319-C4EC3165CBA1	Primary Tumor	Illumina HiSeq	5BAC4A96-70CD-493C-8443-B5C3DB6CBE4E	Stomach	55.0	E43BB2C6-F44E-4EBF-9378-1F8949F83AE7	D264F2FA-DC68-497E-861D-E20357E43E10	TCGA-FP-A4BE-01A-12R-A24K-31	GRCh37-lite	TCGA-FP-A4BE	TCGA-STAD		s14427	Canada's Michael Smith Genome Sciences Centre	International Genomics Consortium	United States	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	A24K-31	True
13722.58cfa82ee4b0c9d6adf6ab6c	58cfa82ee4b0c9d6adf6ab6c	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.filtered.	WGS	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.bam	35.04	2.0	0.07	58cfa82ee4b0c9d6adf6ab6c	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A7-01A	3ED614E7-F356-4D87-985B-D3BBBAE3BB40	Primary Tumor	Illumina HiSeq	4eade8e4-0984-473e-99f5-523fdc631190	Bladder	67.0	D68D16F7-6117-4D3D-8347-CF5CD3F23AE4	91F458E6-64B7-454D-A542-B0AA23638FD8	TCGA-DK-A1A7-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A7	TCGA-BLCA		s3074	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13W-08	True
13767.58cfa836e4b0c9d6adf6f4c6	58cfa836e4b0c9d6adf6f4c6	UNCID_1559814.5AA236CE-9A58-4439-81FA-0F882548407D.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1559814.5AA236CE-9A58-4439-81FA-0F882548407D.sorted_genome_alignments	UNCID_1559814.5AA236CE-9A58-4439-81FA-0F882548407D.sorted_genome_alignments.bam	8.76	1.78	0.16	58cfa836e4b0c9d6adf6f4c6	UNCID_1559814.5AA236CE-9A58-4439-81FA-0F882548407D.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3MY-11A	7746BE87-7AD0-48A7-84FB-08A81B220BDB	Solid Tissue Normal	Illumina HiSeq	8617CA21-50B9-46AC-8787-0340A5C05F59	Thyroid	81.0	B9413CBC-F373-4424-B112-E5AF63F4B070	5AA236CE-9A58-4439-81FA-0F882548407D	TCGA-EL-A3MY-11A-12R-A21D-07	HG19	TCGA-EL-A3MY	TCGA-THCA	533.0	s12440	University of North Carolina	MD Anderson	United States	NO	T4	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A21D-07	True
13722.58cfa82ee4b0c9d6adf6ac10	58cfa82ee4b0c9d6adf6ac10	G39019.TCGA-D3-A3MO-10A-01D-A21A-08.2.filtered.	WGS	G39019.TCGA-D3-A3MO-10A-01D-A21A-08.2	G39019.TCGA-D3-A3MO-10A-01D-A21A-08.2.bam	17.01		0.08	58cfa82ee4b0c9d6adf6ac10	G39019.TCGA-D3-A3MO-10A-01D-A21A-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A3MO-10A	85400BF1-23E0-4E0F-8DF7-F0D108641AEE	Blood Derived Normal	Illumina HiSeq	d0823cd7-aa05-4821-b9f7-753bb1af905c	Skin	47.0	9466E1F0-4649-4CE0-9C1C-2B665ADE3888	46EE8BA7-EF58-4B4C-913C-9507E7A9D7E2	TCGA-D3-A3MO-10A-01D-A21A-08	HG19_Broad_variant	TCGA-D3-A3MO	TCGA-SKCM	284.0	s7816	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	TX	N2c		Stage III	A21A-08	True
13767.58cfa83ae4b0c9d6adf71a2a	58cfa83ae4b0c9d6adf71a2a	UNCID_2439914.e1131850-061c-4831-aa0e-dc3e9d9ba043.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2439914.e1131850-061c-4831-aa0e-dc3e9d9ba043.sorted_genome_alignments	UNCID_2439914.e1131850-061c-4831-aa0e-dc3e9d9ba043.sorted_genome_alignments.bam	18.32	1.9	0.16	58cfa83ae4b0c9d6adf71a2a	UNCID_2439914.e1131850-061c-4831-aa0e-dc3e9d9ba043.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-Y8-A8RY-11A	A5B3DE4C-F3FA-414C-B809-59C3C1438AA7	Solid Tissue Normal	Illumina HiSeq	7CB01D31-D6BB-4920-BADA-F4DBA3CCE2D5	Kidney	63.0	4D8A7347-B897-459B-9DCC-1D18FE1BDD4D	E1131850-061C-4831-AA0E-DC3E9D9BA043	TCGA-Y8-A8RY-11A-11R-A37K-07	HG19	TCGA-Y8-A8RY	TCGA-KIRP		s11945	University of North Carolina	Spectrum Health	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A37K-07	True
13767.58cfa838e4b0c9d6adf7070e	58cfa838e4b0c9d6adf7070e	UNCID_1983401.c9eb7517-0b47-407c-abaa-abae989044fd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1983401.c9eb7517-0b47-407c-abaa-abae989044fd.sorted_genome_alignments	UNCID_1983401.c9eb7517-0b47-407c-abaa-abae989044fd.sorted_genome_alignments.bam	27.83	1.82	0.18	58cfa838e4b0c9d6adf7070e	UNCID_1983401.c9eb7517-0b47-407c-abaa-abae989044fd.sorted_genome_alignments.bam	Alive	MALE	WHITE		Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-A49D-01A	1AEABF26-AC51-4173-AB8B-5D439CECA9F4	Primary Tumor	Illumina HiSeq	C99A0C54-36DC-480A-B90C-87C98EF6CCA6	Lung	67.0	2036987B-F6FC-476E-A026-E288359AAD1B	C9EB7517-0B47-407C-ABAA-ABAE989044FD	TCGA-56-A49D-01A-11R-A24H-07	HG19	TCGA-56-A49D	TCGA-LUSC		s10462	University of North Carolina	International Genomics Consortium	United States	NO	T2a	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	A24H-07	True
13767.58cfa835e4b0c9d6adf6ebb4	58cfa835e4b0c9d6adf6ebb4	UNCID_1235112.b6a8b608-8bf6-4d57-a720-bd4aaced4591.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1235112.b6a8b608-8bf6-4d57-a720-bd4aaced4591.sorted_genome_alignments	UNCID_1235112.b6a8b608-8bf6-4d57-a720-bd4aaced4591.sorted_genome_alignments.bam	42.41	1.88	0.16	58cfa835e4b0c9d6adf6ebb4	UNCID_1235112.b6a8b608-8bf6-4d57-a720-bd4aaced4591.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LB-01A	D17A5AB1-3789-4652-AFF5-D8F4F2291F9C	Primary Tumor	Illumina HiSeq	004EE5F2-7D21-4828-B244-7E1F6820AC47	Bladder	73.0	7C6178A6-6D4C-4DEF-B4AC-A064AB4A6C8A	B6A8B608-8BF6-4D57-A720-BD4AACED4591	TCGA-BT-A2LB-01A-11R-A18C-07	HG19	TCGA-BT-A2LB	TCGA-BLCA		s2953	University of North Carolina	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A18C-07	True
13722.58cfa82fe4b0c9d6adf6b62c	58cfa82fe4b0c9d6adf6b62c	TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted.filtered.	WGS	TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted	TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted.bam	237.4	1.9	0.16	58cfa82fe4b0c9d6adf6b62c	TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-50-5941-01A	F3F024C2-52F1-400E-946C-398F5B72E6DC	Primary Tumor	Illumina HiSeq	f7c353bf-7be8-42d0-88d0-e89032718c2f	Lung	55.0	91719392-76CE-479F-BA05-E43BF0201CC4	666720AF-64D9-4A63-BE57-2B8E49E79413	TCGA-50-5941-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5941	TCGA-LUAD		s11128	Harvard Medical School	University of Pittsburgh	United States	NO	T2a	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1751-02	True
13722.58cfa831e4b0c9d6adf6cafa	58cfa831e4b0c9d6adf6cafa	TCGA-EA-A3HS-10B-01D-A20X_140106_SN590_0243_AC371BACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EA-A3HS-10B-01D-A20X_140106_SN590_0243_AC371BACXX_s_7_rg.sorted	TCGA-EA-A3HS-10B-01D-A20X_140106_SN590_0243_AC371BACXX_s_7_rg.sorted.bam	13.46		0.17	58cfa831e4b0c9d6adf6cafa	TCGA-EA-A3HS-10B-01D-A20X_140106_SN590_0243_AC371BACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3HS-10B	753EE373-FBCF-4349-B9B2-5A41936E27E9	Blood Derived Normal	Illumina HiSeq	66d157df-3130-4d6f-b945-b2b660c92060	Cervix	35.0	241D9F57-D791-41B8-8450-62543149792B	B53FE367-BD69-4183-BDC7-DF720E7858D2	TCGA-EA-A3HS-10B-01D-A20X-26	HG19_Broad_variant	TCGA-EA-A3HS	TCGA-CESC		s1519	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T1b	N0	Cervical Squamous Cell Carcinoma		A20X-26	True
13722.58cfa832e4b0c9d6adf6d388	58cfa832e4b0c9d6adf6d388	TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted	TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted.bam	41.04		0.17	58cfa832e4b0c9d6adf6d388	TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OP-01A	97031483-1185-41D6-9722-0A03B63CAA19	Primary Tumor	Illumina HiSeq	940f64ee-414a-4190-9fc9-c697ad112dfe	Esophagus	67.0	BA02D5B4-9CA9-4455-81D4-E5F2C8C0DF74	5D8E8DA5-04FF-4548-96EC-AE1E80C57CD1	TCGA-L5-A4OP-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OP	TCGA-ESCA		s1923	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N0		Stage I	A267-26	True
13767.58cfa82ee4b0c9d6adf6a9c6	58cfa82ee4b0c9d6adf6a9c6	G17807.TCGA-28-5209-01A-01R-1850-01.4.filtered.	RNA-Seq	G17807.TCGA-28-5209-01A-01R-1850-01.4	G17807.TCGA-28-5209-01A-01R-1850-01.4.bam	40.7	1.8	0.15	58cfa82ee4b0c9d6adf6a9c6	G17807.TCGA-28-5209-01A-01R-1850-01.4.bam	Alive	FEMALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-28-5209-01A	153C2442-EA61-4B5E-8C5C-C71D287C6055	Primary Tumor	Illumina HiSeq	EEE6AAC5-C92C-4B02-9F5D-66D153058A4F	Brain	66.0	77B63255-12FB-45E3-BD0B-C4836FCFC569	7A904020-5345-4D1F-8493-8DD07D45FAA3	TCGA-28-5209-01A-01R-1850-01	HG19_Broad_variant	TCGA-28-5209	TCGA-GBM		s13925	Broad Institute of MIT and Harvard	Cedars Sinai	None	NO			Untreated primary (de novo) GBM		1850-01	True
13767.58cfa834e4b0c9d6adf6e138	58cfa834e4b0c9d6adf6e138	UNCID_1156987.9560e482-cb14-4456-b9a6-d2ac12f96a4f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1156987.9560e482-cb14-4456-b9a6-d2ac12f96a4f.sorted_genome_alignments	UNCID_1156987.9560e482-cb14-4456-b9a6-d2ac12f96a4f.sorted_genome_alignments.bam	57.0	1.84	0.15	58cfa834e4b0c9d6adf6e138	UNCID_1156987.9560e482-cb14-4456-b9a6-d2ac12f96a4f.sorted_genome_alignments.bam	Alive	FEMALE			Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A09Q-01A	09C2BC35-C21F-4AA4-AC30-0D8DB02AD811	Primary Tumor	Illumina HiSeq	9BF6EE00-E24F-4035-83CF-089824250946	Breast	83.0	6F8B48BA-EF24-4D33-A0C3-BC900A6C8CD2	9560E482-CB14-4456-B9A6-D2AC12F96A4F	TCGA-A8-A09Q-01A-11R-A00Z-07	HG19	TCGA-A8-A09Q	TCGA-BRCA		s6040	University of North Carolina	Indivumed	Germany	NO	T4b	N2a	Infiltrating Ductal Carcinoma	Stage III	A00Z-07	True
13767.58cfa833e4b0c9d6adf6e012	58cfa833e4b0c9d6adf6e012	UNCID_1143727.d9f827bb-2498-49b0-aa85-71cb554eb926.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1143727.d9f827bb-2498-49b0-aa85-71cb554eb926.sorted_genome_alignments	UNCID_1143727.d9f827bb-2498-49b0-aa85-71cb554eb926.sorted_genome_alignments.bam	31.62	1.84	0.17	58cfa833e4b0c9d6adf6e012	UNCID_1143727.d9f827bb-2498-49b0-aa85-71cb554eb926.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A14X-01A	60DF7543-6DA5-4C75-943B-5800C1E08234	Primary Tumor	Illumina HiSeq	396BB054-1917-4202-B7A1-E4C210A0A95A	Breast	55.0	A7CC9298-D6F1-48EF-A93A-9C75FC0CB800	D9F827BB-2498-49B0-AA85-71CB554EB926	TCGA-E2-A14X-01A-11R-A115-07	HG19	TCGA-E2-A14X	TCGA-BRCA		s6177	University of North Carolina	Roswell Park	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage III	A115-07	True
13722.58cfa82fe4b0c9d6adf6b82d	58cfa82fe4b0c9d6adf6b82d	TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted.filtered.	WGS	TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted	TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted.bam	62.7	1.9	0.15	58cfa82fe4b0c9d6adf6b82d	TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-44-6779-01A	CBBEA9F1-396A-4BF3-B67C-2CAC3394DCEB	Primary Tumor	Illumina HiSeq	ab458a7b-afac-4c72-8db7-45994af6ceb8	Lung	50.0	5E04D394-7A40-4E89-BA20-892774DCB469	DB5F07FE-8DC0-4259-A6B1-E75B6F1188C5	TCGA-44-6779-01A-11D-1853-02	HG19_Broad_variant	TCGA-44-6779	TCGA-LUAD	500.0	s11344	Harvard Medical School	Christiana Healthcare	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1853-02	True
13767.58cfa83ae4b0c9d6adf718a0	58cfa83ae4b0c9d6adf718a0	UNCID_2396626.1f891baf-2b98-4c2f-8f5f-799018220513.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2396626.1f891baf-2b98-4c2f-8f5f-799018220513.sorted_genome_alignments	UNCID_2396626.1f891baf-2b98-4c2f-8f5f-799018220513.sorted_genome_alignments.bam	26.0	1.77	0.17	58cfa83ae4b0c9d6adf718a0	UNCID_2396626.1f891baf-2b98-4c2f-8f5f-799018220513.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-A7NJ-01A	F6743FF8-542E-4FDE-8FF2-4878FCABFFDA	Primary Tumor	Illumina HiSeq	30B718C6-CAEB-4B74-BA78-1D0B0C48175D	Prostate	59.0	B13D4E3D-898E-4339-A506-110B8E803B6E	1F891BAF-2B98-4C2F-8F5F-799018220513	TCGA-EJ-A7NJ-01A-22R-A352-07	HG19	TCGA-EJ-A7NJ	TCGA-PRAD		s4215	University of North Carolina	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		A352-07	True
13767.58cfa83be4b0c9d6adf723b1	58cfa83be4b0c9d6adf723b1	UNCID_2581165.97eb631e-69ef-451a-9aa6-d573c34c4f9b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2581165.97eb631e-69ef-451a-9aa6-d573c34c4f9b.sorted_genome_alignments	UNCID_2581165.97eb631e-69ef-451a-9aa6-d573c34c4f9b.sorted_genome_alignments.bam	43.52	1.87	0.17	58cfa83be4b0c9d6adf723b1	UNCID_2581165.97eb631e-69ef-451a-9aa6-d573c34c4f9b.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-UZ-A9PQ-01A	E3D519CF-7727-4AE1-92D1-156F5ADD1701	Primary Tumor	Illumina HiSeq	5008061E-5722-4D58-A0AA-40CBDB75FD61	Kidney	59.0	45C1E4F9-160E-4BB9-9B04-C8FBBA3B1934	97EB631E-69EF-451A-9AA6-D573C34C4F9B	TCGA-UZ-A9PQ-01A-11R-A42S-07	HG19	TCGA-UZ-A9PQ	TCGA-KIRP		s11748	University of North Carolina	University of California San Francisco	United States	NO	T2	N1	Kidney Papillary Renal Cell Carcinoma	Stage III	A42S-07	True
13722.58cfa830e4b0c9d6adf6be7e	58cfa830e4b0c9d6adf6be7e	TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted	TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.bam	32.81	2.02	0.17	58cfa830e4b0c9d6adf6be7e	TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE		Thyroid Carcinoma	Aligned reads	TCGA-BJ-A192-01A	B55375C3-9EF2-4D2F-9C29-224E746931C4	Primary Tumor	Illumina HiSeq	9218178e-761c-40ac-b3ca-044bf37f8686	Thyroid	54.0	582C3030-1F23-4535-9C8B-6B594E656AF4	6D770754-E14D-4E47-AE33-BE0FC9B40CE9	TCGA-BJ-A192-01A-31D-A13U-02	HG19_Broad_variant	TCGA-BJ-A192	TCGA-THCA		s12235	Harvard Medical School	University of Pittsburgh	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A13U-02	True
13722.58cfa82ee4b0c9d6adf6ac6e	58cfa82ee4b0c9d6adf6ac6e	G39019.TCGA-GN-A26A-10A-01D-A19A-08.3.filtered.	WGS	G39019.TCGA-GN-A26A-10A-01D-A19A-08.3	G39019.TCGA-GN-A26A-10A-01D-A19A-08.3.bam	9.89		0.08	58cfa82ee4b0c9d6adf6ac6e	G39019.TCGA-GN-A26A-10A-01D-A19A-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GN-A26A-10A	5BC515C8-7727-4D69-98E9-31BBCB748550	Blood Derived Normal	Illumina HiSeq	d853ff81-e3fc-4daa-87d0-8ef8835d6ff5	Skin	63.0	42A0B5DE-0878-404A-A809-6CB11E810186	268A11D4-51A7-491C-9060-7DC559DCDB9E	TCGA-GN-A26A-10A-01D-A19A-08	HG19_Broad_variant	TCGA-GN-A26A	TCGA-SKCM	988.0	s7489	Broad Institute of MIT and Harvard	Roswell	United States	NO	T3a	N1a		Stage III	A19A-08	True
13767.58cfa82fe4b0c9d6adf6b78a	58cfa82fe4b0c9d6adf6b78a	TCGA-61-2092-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-61-2092-01A-01R-1568-13_rnaseq	TCGA-61-2092-01A-01R-1568-13_rnaseq.bam	1109.0	1.8	0.15	58cfa82fe4b0c9d6adf6b78a	TCGA-61-2092-01A-01R-1568-13_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2092-01A	C183D3FB-2EEE-44F8-890E-B9BF907141E6	Primary Tumor	Illumina HiSeq	3AA21B3A-49C6-43C0-BE84-828EA0004F97	Ovary	57.0	962BB8FD-018E-49D0-B1DF-DC0192E1B2A6	0ED6E7A9-CDAA-48DC-962F-219F1EB39C1A	TCGA-61-2092-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-61-2092	TCGA-OV		s17142	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa839e4b0c9d6adf71558	58cfa839e4b0c9d6adf71558	UNCID_2362051.6d835ad5-66b9-46d1-b1dc-eb830b8912e4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2362051.6d835ad5-66b9-46d1-b1dc-eb830b8912e4.sorted_genome_alignments	UNCID_2362051.6d835ad5-66b9-46d1-b1dc-eb830b8912e4.sorted_genome_alignments.bam	36.76	1.96	0.18	58cfa839e4b0c9d6adf71558	UNCID_2362051.6d835ad5-66b9-46d1-b1dc-eb830b8912e4.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-Y8-A898-01A	048EBEA2-47EF-4359-9213-A1B7E4FDECF0	Primary Tumor	Illumina HiSeq	810F695E-72D1-436E-B4D9-8756F75B2365	Kidney	69.0	08771D29-1B8C-4B0E-8B84-A08664872E62	6D835AD5-66B9-46D1-B1DC-EB830B8912E4	TCGA-Y8-A898-01A-11R-A355-07	HG19	TCGA-Y8-A898	TCGA-KIRP		s11622	University of North Carolina	Spectrum Health	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A355-07	True
13767.58cfa837e4b0c9d6adf70042	58cfa837e4b0c9d6adf70042	UNCID_1897708.cf19f287-ebc8-4be0-a619-cb26e7d5a671.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1897708.cf19f287-ebc8-4be0-a619-cb26e7d5a671.sorted_genome_alignments	UNCID_1897708.cf19f287-ebc8-4be0-a619-cb26e7d5a671.sorted_genome_alignments.bam	47.39	1.76	0.18	58cfa837e4b0c9d6adf70042	UNCID_1897708.cf19f287-ebc8-4be0-a619-cb26e7d5a671.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A39K-01A	6E1C9AC8-EEAD-4DB9-8F30-EF3591DAF78B	Primary Tumor	Illumina HiSeq	A885505D-E609-4653-9B5C-C045C5A8E3EE	Thyroid	48.0	2669313A-0641-42E4-B284-964E426B9C9D	CF19F287-EBC8-4BE0-A619-CB26E7D5A671	TCGA-ET-A39K-01A-11R-A19O-07	HG19	TCGA-ET-A39K	TCGA-THCA		s12834	University of North Carolina	Johns Hopkins	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A19O-07	True
13722.58cfa831e4b0c9d6adf6c6de	58cfa831e4b0c9d6adf6c6de	TCGA-CG-4443-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_4_rg.sorted.filtered.	WGS	TCGA-CG-4443-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_4_rg.sorted	TCGA-CG-4443-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_4_rg.sorted.bam	80.9	1.9	0.16	58cfa831e4b0c9d6adf6c6de	TCGA-CG-4443-10A-01D-1154_130815_VM001_0004_VMR0004CXX_s_4_rg.sorted.bam	Alive	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4443-10A	8CB0144B-BE6B-40A1-86A2-708F96D9B615	Blood Derived Normal	Illumina HiSeq	d8d4539e-9091-4761-ba28-e83c2f89a9f3	Stomach	68.0	5F5EB83F-C6C8-409B-A8CE-89AF811FE35E	C3189796-A375-481F-9F34-1013B41FD585	TCGA-CG-4443-10A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4443	TCGA-STAD		s15191	Harvard Medical School	Indivumed	Germany	NO	T1	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1154-02	True
13767.58cfa839e4b0c9d6adf71006	58cfa839e4b0c9d6adf71006	UNCID_2234600.2faac3f0-67e2-433a-ad56-c43e794c7fee.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2234600.2faac3f0-67e2-433a-ad56-c43e794c7fee.sorted_genome_alignments	UNCID_2234600.2faac3f0-67e2-433a-ad56-c43e794c7fee.sorted_genome_alignments.bam	29.47	1.82	0.16	58cfa839e4b0c9d6adf71006	UNCID_2234600.2faac3f0-67e2-433a-ad56-c43e794c7fee.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-M7-A725-01A	FCA0331B-8096-40E8-B292-D438370C37C9	Primary Tumor	Illumina HiSeq	C980C228-0A0B-4613-BB5F-FC1D1481927E	Prostate	56.0	4C99BBF0-3C72-4704-BE63-560E6A697B41	2FAAC3F0-67E2-433A-AD56-C43E794C7FEE	TCGA-M7-A725-01A-12R-A32O-07	HG19	TCGA-M7-A725	TCGA-PRAD		s3876	University of North Carolina	University of North Carolina	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		A32O-07	True
13722.58cfa830e4b0c9d6adf6c2af	58cfa830e4b0c9d6adf6c2af	TCGA-AX-A0J1-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_5_rg.sorted.filtered.	WGS	TCGA-AX-A0J1-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_5_rg.sorted	TCGA-AX-A0J1-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_5_rg.sorted.bam	7.14	1.93	0.17	58cfa830e4b0c9d6adf6c2af	TCGA-AX-A0J1-10A-01D-A043_120403_SN1222_0094_BD0UKBACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A0J1-10A	EC7A9D74-8B3F-4747-8926-1739A016AB2B	Blood Derived Normal	Illumina HiSeq	a63b4482-6fb6-4554-a81b-a77003d1b12f	Uterus	80.0	7249199D-6E4A-4A4A-9F4C-996E9B7E2D20	89FA0B56-B5CD-49DA-8408-8A5ACA30813C	TCGA-AX-A0J1-10A-01D-A043-02	HG19_Broad_variant	TCGA-AX-A0J1	TCGA-UCEC		s4592	Harvard Medical School	Gynecologic Oncology Group	None	NO			Endometrioid endometrial adenocarcinoma		A043-02	True
13767.58cfa83ae4b0c9d6adf71a21	58cfa83ae4b0c9d6adf71a21	UNCID_2439887.7bee34e3-b559-48e9-bbc3-2d162b8f128a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2439887.7bee34e3-b559-48e9-bbc3-2d162b8f128a.sorted_genome_alignments	UNCID_2439887.7bee34e3-b559-48e9-bbc3-2d162b8f128a.sorted_genome_alignments.bam	53.46	1.88	0.16	58cfa83ae4b0c9d6adf71a21	UNCID_2439887.7bee34e3-b559-48e9-bbc3-2d162b8f128a.sorted_genome_alignments.bam	Alive	FEMALE		HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-XF-A8HB-01A	90BF49B7-6710-4665-82DF-30ECC22C59A3	Primary Tumor	Illumina HiSeq	66182922-443F-44E4-AF14-D81DA04478F5	Bladder	50.0	23790892-A2B5-4E06-AF1D-248E0F0DEF4F	7BEE34E3-B559-48E9-BBC3-2D162B8F128A	TCGA-XF-A8HB-01A-11R-A36F-07	HG19	TCGA-XF-A8HB	TCGA-BLCA		s3021	University of North Carolina	University of Southern California	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A36F-07	True
13722.58cfa82ee4b0c9d6adf6acf3	58cfa82ee4b0c9d6adf6acf3	G49537.TCGA-DJ-A2Q1-10A-01D-A19M-08.1.filtered.	WGS	G49537.TCGA-DJ-A2Q1-10A-01D-A19M-08.1	G49537.TCGA-DJ-A2Q1-10A-01D-A19M-08.1.bam	28.34		0.08	58cfa82ee4b0c9d6adf6acf3	G49537.TCGA-DJ-A2Q1-10A-01D-A19M-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q1-10A	E35B2928-8784-45D0-A71A-A2DF161542FA	Blood Derived Normal	Illumina HiSeq	da7c4856-942e-4ca5-a3f6-30e1d7351c4b	Thyroid	44.0	3D2DE63E-6D83-4F34-97EF-4D85FE55590E	AE3BDD94-C5B3-4D12-9B54-00AD13BDD3A2	TCGA-DJ-A2Q1-10A-01D-A19M-08	HG19_Broad_variant	TCGA-DJ-A2Q1	TCGA-THCA		s12738	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19M-08	False
13767.58cfa838e4b0c9d6adf70c2d	58cfa838e4b0c9d6adf70c2d	UNCID_2115513.4a0b6e3c-a167-4ca6-876b-6fb82fa8fdb6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2115513.4a0b6e3c-a167-4ca6-876b-6fb82fa8fdb6.sorted_genome_alignments	UNCID_2115513.4a0b6e3c-a167-4ca6-876b-6fb82fa8fdb6.sorted_genome_alignments.bam	27.05	1.87	0.15	58cfa838e4b0c9d6adf70c2d	UNCID_2115513.4a0b6e3c-a167-4ca6-876b-6fb82fa8fdb6.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A62P-01A	741311B6-CB15-498F-932D-CA282E1DB10D	Primary Tumor	Illumina HiSeq	07297DD0-A86F-4CEF-928C-BE560273AD44	Bladder	76.0	670F42FC-C213-4BA5-BDE8-3855C4868168	4A0B6E3C-A167-4CA6-876B-6FB82FA8FDB6	TCGA-FD-A62P-01A-32R-A30C-07	HG19	TCGA-FD-A62P	TCGA-BLCA	191.0	s3004	University of North Carolina	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A30C-07	True
13767.58cfa83ce4b0c9d6adf72c70	58cfa83ce4b0c9d6adf72c70	UNCID_430586.d6751801-aadf-461d-9cdd-2dd810ca951f.110816_UNC9-SN296_0228_AB09YVABXX.1.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_430586.d6751801-aadf-461d-9cdd-2dd810ca951f.110816_UNC9-SN296_0228_AB09YVABXX.1.trimmed.annotated.translated_to_genomic	UNCID_430586.d6751801-aadf-461d-9cdd-2dd810ca951f.110816_UNC9-SN296_0228_AB09YVABXX.1.trimmed.annotated.translated_to_genomic.bam	70.8	1.6	0.15	58cfa83ce4b0c9d6adf72c70	UNCID_430586.d6751801-aadf-461d-9cdd-2dd810ca951f.110816_UNC9-SN296_0228_AB09YVABXX.1.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5462-01A	E0127E51-43BA-4536-BC9D-004591F9C627	Primary Tumor	Illumina HiSeq	EFF753CB-E5B1-4DCB-A56E-CBD33A4C450A	Kidney	83.0	30365E6A-0968-4687-B1E1-0AEA8159E8A5	D6751801-AADF-461D-9CDD-2DD810CA951F	TCGA-CZ-5462-01A-01R-1503-07	HG19	TCGA-CZ-5462	TCGA-KIRC	311.0	s9136	University of North Carolina	Harvard	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1503-07	True
13767.58cfa834e4b0c9d6adf6e9d8	58cfa834e4b0c9d6adf6e9d8	UNCID_1249639.50c829d7-c1cb-46dc-a17d-f2cdcfa8e8a6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1249639.50c829d7-c1cb-46dc-a17d-f2cdcfa8e8a6.sorted_genome_alignments	UNCID_1249639.50c829d7-c1cb-46dc-a17d-f2cdcfa8e8a6.sorted_genome_alignments.bam	15.13	1.94	0.17	58cfa834e4b0c9d6adf6e9d8	UNCID_1249639.50c829d7-c1cb-46dc-a17d-f2cdcfa8e8a6.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A29Q-06A	6A1818F9-9303-41B0-B3B7-07FAF5055C86	Metastatic	Illumina HiSeq	D3EEEA59-D783-4842-974C-E55A48172403	Skin	70.0	9B9F0B93-CF1E-4052-8938-2C56AD8A2FD2	50C829D7-C1CB-46DC-A17D-F2CDCFA8E8A6	TCGA-EE-A29Q-06A-11R-A18T-07	HG19	TCGA-EE-A29Q	TCGA-SKCM		s7914	University of North Carolina	University of Sydney	Australia	NO	T3b	N0		Stage II	A18T-07	True
13767.58cfa83ce4b0c9d6adf72e0c	58cfa83ce4b0c9d6adf72e0c	_1_TCGA-BR-4280-01A-01R-1131-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-4280-01A-01R-1131-13_rnaseq	_1_TCGA-BR-4280-01A-01R-1131-13_rnaseq.bam	621.3	1.8	0.15	58cfa83ce4b0c9d6adf72e0c	_1_TCGA-BR-4280-01A-01R-1131-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4280-01A	E0916597-E489-45EF-A8F7-653A3C6591EF	Primary Tumor	Illumina HiSeq	F41703DA-48CC-4A88-970A-89B86ECEE654	Stomach	78.0	797D2D3A-F01C-4985-B27C-4E4C2838D34D	1B245B59-EE33-45D3-B36B-976D4069C8E7	TCGA-BR-4280-01A-01R-1131-13	GRCh37-lite	TCGA-BR-4280	TCGA-STAD		s14856	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T2b	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1131-13	True
13767.58cfa83ae4b0c9d6adf71ac4	58cfa83ae4b0c9d6adf71ac4	UNCID_2440963.f73824ee-cfc9-47fe-bae2-7a2de48c51bc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2440963.f73824ee-cfc9-47fe-bae2-7a2de48c51bc.sorted_genome_alignments	UNCID_2440963.f73824ee-cfc9-47fe-bae2-7a2de48c51bc.sorted_genome_alignments.bam	38.0	1.81	0.16	58cfa83ae4b0c9d6adf71ac4	UNCID_2440963.f73824ee-cfc9-47fe-bae2-7a2de48c51bc.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A2JE-06A	2EC330F8-96E4-4270-AADC-563BB72F4B2C	Metastatic	Illumina HiSeq	B72864EE-3DBC-4921-B15E-2B8845C061B7	Skin	75.0	A54BE799-201B-43F4-8B03-98C400B027DB	F73824EE-CFC9-47FE-BAE2-7A2DE48C51BC	TCGA-D3-A2JE-06A-11R-A37K-07	HG19	TCGA-D3-A2JE	TCGA-SKCM	841.0	s7635	University of North Carolina	MD Anderson	United States	NO	TX	N3		Stage III	A37K-07	True
13767.58cfa836e4b0c9d6adf6f9c6	58cfa836e4b0c9d6adf6f9c6	UNCID_1648603.7f5d8015-9a38-4d1c-b63d-2d5a0b882259.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1648603.7f5d8015-9a38-4d1c-b63d-2d5a0b882259.sorted_genome_alignments	UNCID_1648603.7f5d8015-9a38-4d1c-b63d-2d5a0b882259.sorted_genome_alignments.bam	104.2		0.16	58cfa836e4b0c9d6adf6f9c6	UNCID_1648603.7f5d8015-9a38-4d1c-b63d-2d5a0b882259.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-8186-01A	DCD45077-F068-490B-BDCC-4D4A62285116	Primary Tumor	Illumina HiSeq	1AD82D02-B063-4982-A8F6-AB354980A72A	Brain	42.0	B5E4E398-8344-4D8A-A2D9-3E2996C22FD9	7F5D8015-9A38-4D1C-B63D-2D5A0B882259	TCGA-FG-8186-01A-11R-2256-07	HG19	TCGA-FG-8186	TCGA-LGG		s8622	University of North Carolina	Case Western	United States	NO			Oligoastrocytoma		2256-07	True
13722.58cfa830e4b0c9d6adf6c222	58cfa830e4b0c9d6adf6c222	TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted	TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted.bam	63.03	1.9	0.14	58cfa830e4b0c9d6adf6c222	TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4078-10A	C7353D6A-82A2-4A0D-8CD4-8C8957943EDB	Blood Derived Normal	Illumina HiSeq	9f383e84-52bd-4beb-b916-e1c652c45e27	Head and Neck	83.0	25B0AE1D-2ADD-49B9-A5AE-99702A5C48F4	FA6F21FF-7667-491C-9A99-31B473C9D683	TCGA-BA-4078-10A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4078	TCGA-HNSC	276.0	s15618	Harvard Medical School	UNC	None	NO			Head and Neck Squamous Cell Carcinoma		1431-02	True
13722.58cfa83ce4b0c9d6adf72fd0	58cfa83ce4b0c9d6adf72fd0	b2efe67d968c5b6634b971bdef73c05a.filtered.	WGS	b2efe67d968c5b6634b971bdef73c05a	b2efe67d968c5b6634b971bdef73c05a.bam	60.09	1.81	0.07	58cfa83ce4b0c9d6adf72fd0	b2efe67d968c5b6634b971bdef73c05a.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A11H-01A	DEE43082-4AA7-4650-981C-A779E9FE7B55	Primary Tumor	Illumina HiSeq	f7538b9e-e9b1-41fd-b09d-9ef50a3553d5	Uterus	67.0	D78D2F6B-3EB3-4082-A7EA-F7B6202CDC58	ACCFC45B-EAE0-4991-A488-E217CDB46655	TCGA-B5-A11H-01A-11D-A122-09	GRCh37-lite	TCGA-B5-A11H	TCGA-UCEC		s4571	Washington University School of Medicine	Duke	United States	NO			Endometrioid endometrial adenocarcinoma		A122-09	True
13767.58cfa834e4b0c9d6adf6e7fa	58cfa834e4b0c9d6adf6e7fa	UNCID_1229575.ee665717-a903-44bc-8eaa-afb46bd4edf0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1229575.ee665717-a903-44bc-8eaa-afb46bd4edf0.sorted_genome_alignments	UNCID_1229575.ee665717-a903-44bc-8eaa-afb46bd4edf0.sorted_genome_alignments.bam	35.72	1.86	0.15	58cfa834e4b0c9d6adf6e7fa	UNCID_1229575.ee665717-a903-44bc-8eaa-afb46bd4edf0.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13W-01A	3B48CC5E-3396-4DD5-893D-54B75B98B016	Primary Tumor	Illumina HiSeq	9135EC22-D77B-4D69-A81D-787163EA1D59	Thyroid	45.0	4DCA97A5-B0E5-4383-8CC5-B6FF07741647	EE665717-A903-44BC-8EAA-AFB46BD4EDF0	TCGA-DJ-A13W-01A-11R-A10U-07	HG19	TCGA-DJ-A13W	TCGA-THCA		s12545	University of North Carolina	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10U-07	True
13722.58cfa832e4b0c9d6adf6cea0	58cfa832e4b0c9d6adf6cea0	TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted.filtered.	WGS	TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted	TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted.bam	52.36		0.16	58cfa832e4b0c9d6adf6cea0	TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A2NF-01A	D32A4219-4CCA-470F-B6B3-11447D9F5E0B	Primary Tumor	Illumina HiSeq	cf624be8-7ec3-4fce-9ab0-1d9ac2fb1edb	Skin	53.0	52EDD1DB-F1C3-4B87-B959-B5B095E52463	DB2D94A9-5B22-4163-AE7A-1DA11F7037A6	TCGA-ER-A2NF-01A-11D-A18Z-02	HG19_Broad_variant	TCGA-ER-A2NF	TCGA-SKCM		s7861	Harvard Medical School	University of Pittsburgh	None	NO	T4b	N3		Stage III	A18Z-02	True
13767.58cfa83ae4b0c9d6adf71e36	58cfa83ae4b0c9d6adf71e36	UNCID_2434277.39d645d6-f7ca-4a01-a3b0-5ae3754c8a68.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2434277.39d645d6-f7ca-4a01-a3b0-5ae3754c8a68.sorted_genome_alignments	UNCID_2434277.39d645d6-f7ca-4a01-a3b0-5ae3754c8a68.sorted_genome_alignments.bam	89.11	1.84	0.18	58cfa83ae4b0c9d6adf71e36	UNCID_2434277.39d645d6-f7ca-4a01-a3b0-5ae3754c8a68.sorted_genome_alignments.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A7X5-01A	AED93A3A-7DCB-4BA9-84C0-BC735CBD545F	Primary Tumor	Illumina HiSeq	1AB104D0-8547-477B-AB3F-D2D2E57AEB39	Cervix	72.0	39B3DD96-515B-42B1-AC56-66602E0CF8FE	39D645D6-F7CA-4A01-A3B0-5AE3754C8A68	TCGA-C5-A7X5-01A-11R-A36F-07	HG19	TCGA-C5-A7X5	TCGA-CESC	414.0	s1304	University of North Carolina	Medical College of Wisconsin	United States	NO			Cervical Squamous Cell Carcinoma		A36F-07	True
13722.58cfa830e4b0c9d6adf6bc14	58cfa830e4b0c9d6adf6bc14	TCGA-AG-A014-10A-01D-A078_110504_SN590_0081_BB0BM5ABXX_s_7_rg.sorted.filtered.	WGS	TCGA-AG-A014-10A-01D-A078_110504_SN590_0081_BB0BM5ABXX_s_7_rg.sorted	TCGA-AG-A014-10A-01D-A078_110504_SN590_0081_BB0BM5ABXX_s_7_rg.sorted.bam	27.2	1.76	0.15	58cfa830e4b0c9d6adf6bc14	TCGA-AG-A014-10A-01D-A078_110504_SN590_0081_BB0BM5ABXX_s_7_rg.sorted.bam	Alive	MALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A014-10A	51C37449-6A2E-4C3D-A7CC-06F901E1224F	Blood Derived Normal	Illumina HiSeq	a425b9fe-c528-4966-aee2-96c0be7b7839	Colorectal	86.0	0FA514AA-C0EB-4177-BA65-1B8616232054	36D22107-9741-44B7-9673-D26682C4280A	TCGA-AG-A014-10A-01D-A078-02	HG18_Broad_variant	TCGA-AG-A014	TCGA-READ		s2174	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	A078-02	True
13767.58cfa830e4b0c9d6adf6be11	58cfa830e4b0c9d6adf6be11	TCGA-B7-A5TJ-01A-11R-A31P-31_rnaseq.filtered.	RNA-Seq	TCGA-B7-A5TJ-01A-11R-A31P-31_rnaseq	TCGA-B7-A5TJ-01A-11R-A31P-31_rnaseq.bam	36.76	1.84	0.18	58cfa830e4b0c9d6adf6be11	TCGA-B7-A5TJ-01A-11R-A31P-31_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-B7-A5TJ-01A	5624BEAB-545A-4A5B-960E-C33429572272	Primary Tumor	Illumina HiSeq	DEE902AA-018E-418D-9BA3-B2D31FE05153	Stomach	74.0	FC264B14-C3CE-4A94-B9E5-205ABEEC9CAB	DA63F765-F4E4-41F4-9732-6A1E9804AFCC	TCGA-B7-A5TJ-01A-11R-A31P-31	GRCh37-lite	TCGA-B7-A5TJ	TCGA-STAD		s15299	Canada's Michael Smith Genome Sciences Centre	Cureline	Russia	NO	T4a	NX	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	A31P-31	True
13722.58cfa830e4b0c9d6adf6c072	58cfa830e4b0c9d6adf6c072	TCGA-B5-A0K7-10A-02D-A101_120406_SN208_0282_BC0L15ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-B5-A0K7-10A-02D-A101_120406_SN208_0282_BC0L15ACXX_s_7_rg.sorted	TCGA-B5-A0K7-10A-02D-A101_120406_SN208_0282_BC0L15ACXX_s_7_rg.sorted.bam	10.79	1.95	0.13	58cfa830e4b0c9d6adf6c072	TCGA-B5-A0K7-10A-02D-A101_120406_SN208_0282_BC0L15ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K7-10A	2F0640BC-598C-4714-9E9B-7E0F2CA4567F	Blood Derived Normal	Illumina HiSeq	75f5b2c3-8f25-414e-ba05-28be0f8f09af	Uterus	64.0	7CC26CBE-ED1E-4AB4-A83A-C776DFCB4FFD	93CE4D46-6D02-4B2D-8D50-E9B82A41E0F6	TCGA-B5-A0K7-10A-02D-A101-02	HG19_Broad_variant	TCGA-B5-A0K7	TCGA-UCEC		s4787	Harvard Medical School	Duke	United States	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa833e4b0c9d6adf6dd32	58cfa833e4b0c9d6adf6dd32	UNCID_1107082.037904cf-92c3-443c-8800-0156db1e3a89.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1107082.037904cf-92c3-443c-8800-0156db1e3a89.sorted_genome_alignments	UNCID_1107082.037904cf-92c3-443c-8800-0156db1e3a89.sorted_genome_alignments.bam	122.76	1.83	0.16	58cfa833e4b0c9d6adf6dd32	UNCID_1107082.037904cf-92c3-443c-8800-0156db1e3a89.sorted_genome_alignments.bam	Alive	MALE	WHITE		Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AC-01A	36C14E9D-1863-4C55-BBBB-F8C9DD418932	Primary Tumor	Illumina HiSeq	1B119832-4714-49B4-8C89-12981A8FAD1C	Bladder	72.0	CD2FB6B8-5DB9-42B4-A407-A5B6F7B8665F	037904CF-92C3-443C-8800-0156DB1E3A89	TCGA-DK-A1AC-01A-11R-A13Y-07	HG19	TCGA-DK-A1AC	TCGA-BLCA		s2741	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13Y-07	True
13767.58cfa836e4b0c9d6adf6fb11	58cfa836e4b0c9d6adf6fb11	UNCID_1665087.6366C684-E20D-4E51-916B-9CA2FBBBA85F.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1665087.6366C684-E20D-4E51-916B-9CA2FBBBA85F.sorted_genome_alignments	UNCID_1665087.6366C684-E20D-4E51-916B-9CA2FBBBA85F.sorted_genome_alignments.bam	30.24	1.88	0.17	58cfa836e4b0c9d6adf6fb11	UNCID_1665087.6366C684-E20D-4E51-916B-9CA2FBBBA85F.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A3PA-01A	10BDAFBB-831D-48B5-B9A3-AD374FC50235	Primary Tumor	Illumina HiSeq	3B5F1450-EDBB-42BE-9020-597CF0540855	Thyroid	16.0	D37BED2A-BF63-43E0-91D0-6C95E4CA2D45	6366C684-E20D-4E51-916B-9CA2FBBBA85F	TCGA-FE-A3PA-01A-12R-A220-07	HG19	TCGA-FE-A3PA	TCGA-THCA		s12823	University of North Carolina	Ohio State University	United States	NO	T4	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A220-07	True
13722.58cfa830e4b0c9d6adf6c2ca	58cfa830e4b0c9d6adf6c2ca	TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted	TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted.bam	73.32	1.95	0.16	58cfa830e4b0c9d6adf6c2ca	TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0RY-01A	F299AD43-BB16-46CE-9617-48CC6C6F29E7	Primary Tumor	Illumina HiSeq	5464e1b6-9efc-49a0-bd5b-4fcd152a7718	Uterus	68.0	260692E1-9B2C-4F8B-952D-1B95C042E659	8DB9ED84-C708-4075-B93D-CC58E84E6D99	TCGA-BG-A0RY-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0RY	TCGA-UCEC		s4258	Harvard Medical School	University of Pittsburgh	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa82fe4b0c9d6adf6b2c0	58cfa82fe4b0c9d6adf6b2c0	TCGA-23-1116-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-23-1116-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-23-1116-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	305.0	1.8	0.16	58cfa82fe4b0c9d6adf6b2c0	TCGA-23-1116-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1116-01A	70FE08BD-A0B4-4A88-B82E-813B176F8E40	Primary Tumor	Illumina HiSeq	A9040847-F14B-4205-A3FA-5D483DEC1CEA	Ovary	83.0	91FBC26E-C049-49AF-8307-22C7980079DF	AB28A926-0266-4602-8E90-529934CF43AB	TCGA-23-1116-01A-01R-1564-13	GRCh37-lite	TCGA-23-1116	TCGA-OV		s18106	Canada's Michael Smith Genome Sciences Centre	Cedars Sinai	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa837e4b0c9d6adf70008	58cfa837e4b0c9d6adf70008	UNCID_1815603.5fb19476-c09c-450c-af54-8573971769b1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1815603.5fb19476-c09c-450c-af54-8573971769b1.sorted_genome_alignments	UNCID_1815603.5fb19476-c09c-450c-af54-8573971769b1.sorted_genome_alignments.bam	25.46	1.83	0.17	58cfa837e4b0c9d6adf70008	UNCID_1815603.5fb19476-c09c-450c-af54-8573971769b1.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2PT-01A	39E68907-3FFB-4CA1-A955-DB5FA2F0DEB1	Primary Tumor	Illumina HiSeq	EA0F6C38-0683-4A32-B9C5-E6BF12E65F97	Thyroid	70.0	F905970F-9D60-44D9-AC7B-A23B6EF81548	5FB19476-C09C-450C-AF54-8573971769B1	TCGA-DJ-A2PT-01A-11R-A18C-07	HG19	TCGA-DJ-A2PT	TCGA-THCA		s12600	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage III	A18C-07	True
13722.58cfa832e4b0c9d6adf6d4c4	58cfa832e4b0c9d6adf6d4c4	TCGA-VD-A8KN-10B-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-VD-A8KN-10B-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_8_rg.sorted	TCGA-VD-A8KN-10B-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_8_rg.sorted.bam	7.78		0.14	58cfa832e4b0c9d6adf6d4c4	TCGA-VD-A8KN-10B-01D-A40E_140729_SN208_0521_BC5AF6ACXX_s_8_rg.sorted.bam	Alive	FEMALE			Uveal Melanoma	Aligned reads	TCGA-VD-A8KN-10B	B26CB5F2-4FF0-4476-8D02-7256ACE7D8A3	Blood Derived Normal	Illumina HiSeq	910bc203-3c1f-423f-b9c4-7a89912ed3bc	Eye	60.0	5F481155-99E3-4986-B9CC-D66B0BAD4509	81027108-022C-40BD-AFEB-0F072AAD1B08	TCGA-VD-A8KN-10B-01D-A40E-26	HG19_Broad_variant	TCGA-VD-A8KN	TCGA-UVM		s248	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T2a	NX		Stage II	A40E-26	True
13767.58cfa834e4b0c9d6adf6e7b0	58cfa834e4b0c9d6adf6e7b0	UNCID_1224107.1898ace6-5eda-42da-a355-5e55203d7e13.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1224107.1898ace6-5eda-42da-a355-5e55203d7e13.sorted_genome_alignments	UNCID_1224107.1898ace6-5eda-42da-a355-5e55203d7e13.sorted_genome_alignments.bam	18.34	1.76	0.17	58cfa834e4b0c9d6adf6e7b0	UNCID_1224107.1898ace6-5eda-42da-a355-5e55203d7e13.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GN-A268-06A	C6BE76D4-A1BA-4DD6-84BF-3B30CABE144E	Metastatic	Illumina HiSeq	B9EE72A8-CD04-4DCC-9414-09E7E8D185A8	Skin	83.0	336C47D6-1616-4E6A-ACA2-464223CA76B1	1898ACE6-5EDA-42DA-A355-5E55203D7E13	TCGA-GN-A268-06A-11R-A18T-07	HG19	TCGA-GN-A268	TCGA-SKCM	1910.0	s7396	University of North Carolina	Roswell	United States	NO	T4a	N0		Stage II	A18T-07	True
13722.58cfa830e4b0c9d6adf6be6a	58cfa830e4b0c9d6adf6be6a	TCGA-BL-A0C8-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BL-A0C8-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_2_rg.sorted	TCGA-BL-A0C8-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_2_rg.sorted.bam	19.58	1.95	0.14	58cfa830e4b0c9d6adf6be6a	TCGA-BL-A0C8-10A-01D-A10R_120926_SN590_0181_AC19HCACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A0C8-10A	A6003B1C-56A9-430A-A5E2-B70AF3F81BDB	Blood Derived Normal	Illumina HiSeq	ccc5396b-d9e0-4f96-85ec-4a894585996f	Bladder	73.0	4BD51539-3638-4721-B7CA-C9AFC50611B7	61A64D7A-438E-47DE-9521-B5FD28DFBA20	TCGA-BL-A0C8-10A-01D-A10R-02	HG19_Broad_variant	TCGA-BL-A0C8	TCGA-BLCA		s2856	Harvard Medical School	Christiana Healthcare	United States	NO	T1	NX		Stage I	A10R-02	True
13767.58cfa837e4b0c9d6adf7004c	58cfa837e4b0c9d6adf7004c	UNCID_1859588.5343646d-bb46-4acc-9361-7432813a886f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1859588.5343646d-bb46-4acc-9361-7432813a886f.sorted_genome_alignments	UNCID_1859588.5343646d-bb46-4acc-9361-7432813a886f.sorted_genome_alignments.bam	54.13	1.89	0.17	58cfa837e4b0c9d6adf7004c	UNCID_1859588.5343646d-bb46-4acc-9361-7432813a886f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A23B-01A	C95ED407-BCC2-44AA-BC59-BF7549F2D665	Primary Tumor	Illumina HiSeq	15A5CCD8-0F77-411E-8CA0-0289C85DF369	Liver	70.0	D056433D-C3E2-467A-8151-DDF2A6D8683A	5343646D-BB46-4ACC-9361-7432813A886F	TCGA-FV-A23B-01A-11R-A16W-07	HG19	TCGA-FV-A23B	TCGA-LIHC		s16884	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A16W-07	True
13767.58cfa833e4b0c9d6adf6dc20	58cfa833e4b0c9d6adf6dc20	UNCID_1098439.a4c1e9e8-a335-47b0-afc6-c2b490da4e58.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1098439.a4c1e9e8-a335-47b0-afc6-c2b490da4e58.sorted_genome_alignments	UNCID_1098439.a4c1e9e8-a335-47b0-afc6-c2b490da4e58.sorted_genome_alignments.bam	53.2	1.8	0.15	58cfa833e4b0c9d6adf6dc20	UNCID_1098439.a4c1e9e8-a335-47b0-afc6-c2b490da4e58.sorted_genome_alignments.bam	Alive	MALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-55-6969-01A	D6E274A0-6425-437B-BC07-1225BE7808D5	Primary Tumor	Illumina HiSeq	C2B90234-4AE7-42A7-B315-138FAFE0376B	Lung	52.0	64A45521-0494-45F6-B605-198E5C2C56BA	A4C1E9E8-A335-47B0-AFC6-C2B490DA4E58	TCGA-55-6969-01A-11R-1949-07	HG19	TCGA-55-6969	TCGA-LUAD		s11146	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1949-07	True
13722.58cfa82de4b0c9d6adf6a74c	58cfa82de4b0c9d6adf6a74c	G14084.TCGA-22-1016-01A-01D-1521-08.3.filtered.	WGS	G14084.TCGA-22-1016-01A-01D-1521-08.3	G14084.TCGA-22-1016-01A-01D-1521-08.3.bam	313.0	1.9	0.05	58cfa82de4b0c9d6adf6a74c	G14084.TCGA-22-1016-01A-01D-1521-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-1016-01A	037C57D1-B4A5-45DC-BDA4-0550461D321B	Primary Tumor	Illumina HiSeq	ec4da199-1467-4435-944a-7558f9ffd8ea	Lung	65.0	DDB395E5-4B12-4610-9755-01E444B35C2E	935B113E-F5ED-4A07-8E1D-1603DABA7F40	TCGA-22-1016-01A-01D-1521-08	HG19_Broad_variant	TCGA-22-1016	TCGA-LUSC	822.0	s9974	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1521-08	True
13767.58cfa837e4b0c9d6adf6fca8	58cfa837e4b0c9d6adf6fca8	UNCID_1670742.f4a540b2-5ad6-442b-b454-cdb23a4cbacc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1670742.f4a540b2-5ad6-442b-b454-cdb23a4cbacc.sorted_genome_alignments	UNCID_1670742.f4a540b2-5ad6-442b-b454-cdb23a4cbacc.sorted_genome_alignments.bam	51.2		0.14	58cfa837e4b0c9d6adf6fca8	UNCID_1670742.f4a540b2-5ad6-442b-b454-cdb23a4cbacc.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-8010-01A	114902C7-77B2-42CA-926B-6895E6DB5E36	Primary Tumor	Illumina HiSeq	540BDD65-2F12-4A7F-BCD8-FE400951FF84	Brain	64.0	AA7309EF-9CA0-4E40-927E-506EAEFA4558	F4A540B2-5AD6-442B-B454-CDB23A4CBACC	TCGA-HT-8010-01A-11R-2403-07	HG19	TCGA-HT-8010	TCGA-LGG		s8633	University of North Carolina	Case Western - St Joes	United States	NO			Oligodendroglioma		2403-07	True
13767.58cfa838e4b0c9d6adf70af4	58cfa838e4b0c9d6adf70af4	UNCID_2146897.1a52c8ac-cabd-4623-98d8-93ee225ab57a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2146897.1a52c8ac-cabd-4623-98d8-93ee225ab57a.sorted_genome_alignments	UNCID_2146897.1a52c8ac-cabd-4623-98d8-93ee225ab57a.sorted_genome_alignments.bam	20.03	1.83	0.17	58cfa838e4b0c9d6adf70af4	UNCID_2146897.1a52c8ac-cabd-4623-98d8-93ee225ab57a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A5SG-06A	44EB0DAA-A3ED-4AB5-A3E8-91911BAB0DEA	Metastatic	Illumina HiSeq	F2EE9875-368B-45B2-AB39-B8CBA3135AAB	Skin	57.0	A10AE34C-28DF-47B9-88CC-39574106FC5E	1A52C8AC-CABD-4623-98D8-93EE225AB57A	TCGA-EB-A5SG-06A-11R-A311-07	HG19	TCGA-EB-A5SG	TCGA-SKCM		s7449	University of North Carolina	Asterand	Russia	NO					A311-07	True
13722.58cfa831e4b0c9d6adf6c648	58cfa831e4b0c9d6adf6c648	TCGA-CG-4466-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CG-4466-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_6_rg.sorted	TCGA-CG-4466-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_6_rg.sorted.bam	67.9	1.9	0.15	58cfa831e4b0c9d6adf6c648	TCGA-CG-4466-10A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_6_rg.sorted.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4466-10A	2F1B96B2-7031-4F7D-9490-14728D320F3E	Blood Derived Normal	Illumina HiSeq	af58bea8-9aeb-47c8-946e-6b197b06ea79	Stomach	81.0	2775F741-265C-4B56-9D75-AF665CCBFC8A	45323803-2E2E-4A6F-B8C7-1D74C29E9C84	TCGA-CG-4466-10A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4466	TCGA-STAD		s14761	Harvard Medical School	Indivumed	Germany	NO	T2a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1154-02	True
13767.58cfa834e4b0c9d6adf6e330	58cfa834e4b0c9d6adf6e330	UNCID_1185722.1676db36-01d5-4338-aabe-5e92f4fca1c8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1185722.1676db36-01d5-4338-aabe-5e92f4fca1c8.sorted_genome_alignments	UNCID_1185722.1676db36-01d5-4338-aabe-5e92f4fca1c8.sorted_genome_alignments.bam	6.3	1.8	0.14	58cfa834e4b0c9d6adf6e330	UNCID_1185722.1676db36-01d5-4338-aabe-5e92f4fca1c8.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5008-01A	B472C982-F024-4E09-8326-071EE35EA55C	Primary Tumor	Illumina HiSeq	E678F030-88F7-4117-9F31-5EC5B08813DA	Kidney	46.0	41C094E9-6C23-4993-8D90-338B66EFEFC1	1676DB36-01D5-4338-AABE-5E92F4FCA1C8	TCGA-BP-5008-01A-01R-1334-07	HG19	TCGA-BP-5008	TCGA-KIRC		s9340	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13767.58cfa838e4b0c9d6adf70e24	58cfa838e4b0c9d6adf70e24	UNCID_2193774.cc1a8983-a6b3-41b9-8f03-94e15bee65dd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2193774.cc1a8983-a6b3-41b9-8f03-94e15bee65dd.sorted_genome_alignments	UNCID_2193774.cc1a8983-a6b3-41b9-8f03-94e15bee65dd.sorted_genome_alignments.bam	52.3	1.5	0.16	58cfa838e4b0c9d6adf70e24	UNCID_2193774.cc1a8983-a6b3-41b9-8f03-94e15bee65dd.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4822-01A	A46F36C3-E886-4EFE-945A-0CB2E5B765EF	Primary Tumor	Illumina HiSeq	AA206018-7A30-4F82-B9AA-0FFA8B801CAF	Kidney	78.0	9AF3DB94-6079-427E-B334-E0772386E65E	CC1A8983-A6B3-41B9-8F03-94E15BEE65DD	TCGA-B0-4822-01A-01R-1277-07	HG19	TCGA-B0-4822	TCGA-KIRC	1111.0	s8924	University of North Carolina	University of Pittsburgh	None	NO	T2	NX	Kidney Clear Cell Renal Carcinoma	Stage II	1277-07	True
13767.58cfa836e4b0c9d6adf6fbd0	58cfa836e4b0c9d6adf6fbd0	UNCID_1656577.BB5BE7FF-D74C-41F6-B3C7-9F79F494C024.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1656577.BB5BE7FF-D74C-41F6-B3C7-9F79F494C024.sorted_genome_alignments	UNCID_1656577.BB5BE7FF-D74C-41F6-B3C7-9F79F494C024.sorted_genome_alignments.bam	35.6	1.8	0.16	58cfa836e4b0c9d6adf6fbd0	UNCID_1656577.BB5BE7FF-D74C-41F6-B3C7-9F79F494C024.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3ZO-01A	3BFA52AF-CB40-45D8-9BDC-591985AAE7FB	Primary Tumor	Illumina HiSeq	017A6246-DB7E-46E5-9836-259A40174579	Thyroid	79.0	0C13351C-EA7C-44B1-A9EE-ED7E383B7924	BB5BE7FF-D74C-41F6-B3C7-9F79F494C024	TCGA-EL-A3ZO-01A-11R-A23N-07	HG19	TCGA-EL-A3ZO	TCGA-THCA		s12809	University of North Carolina	MD Anderson	United States	NO	T3	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A23N-07	True
13767.58cfa837e4b0c9d6adf702ea	58cfa837e4b0c9d6adf702ea	UNCID_1950584.d534dba4-b034-4451-9886-d66cdb7c7ef7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1950584.d534dba4-b034-4451-9886-d66cdb7c7ef7.sorted_genome_alignments	UNCID_1950584.d534dba4-b034-4451-9886-d66cdb7c7ef7.sorted_genome_alignments.bam	20.19	1.94	0.16	58cfa837e4b0c9d6adf702ea	UNCID_1950584.d534dba4-b034-4451-9886-d66cdb7c7ef7.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-MH-A560-01A	A40BEABE-496E-4324-A1D1-5A7D8B002AAB	Primary Tumor	Illumina HiSeq	6D768B4A-C2EF-498A-A370-71A7865AC601	Kidney	62.0	2697D1DE-3D7E-4BD6-9EDE-7516BD10A701	D534DBA4-B034-4451-9886-D66CDB7C7EF7	TCGA-MH-A560-01A-11R-A26U-07	HG19	TCGA-MH-A560	TCGA-KIRP		s11697	University of North Carolina	BLN - Baylor	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26U-07	True
13767.58cfa834e4b0c9d6adf6e38a	58cfa834e4b0c9d6adf6e38a	UNCID_1188620.7265ce4f-d385-4478-97cd-4fdafafed3cd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1188620.7265ce4f-d385-4478-97cd-4fdafafed3cd.sorted_genome_alignments	UNCID_1188620.7265ce4f-d385-4478-97cd-4fdafafed3cd.sorted_genome_alignments.bam	67.8	1.8	0.15	58cfa834e4b0c9d6adf6e38a	UNCID_1188620.7265ce4f-d385-4478-97cd-4fdafafed3cd.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5672-01A	EEE108D6-BB11-4369-B776-0F524AFEF6F3	Primary Tumor	Illumina HiSeq	C79CD72E-7A41-483F-9843-14321B926A88	Kidney	84.0	77B75B10-3D22-42E6-A058-CA617CAF1CE5	7265CE4F-D385-4478-97CD-4FDAFAFED3CD	TCGA-CJ-5672-01A-11R-1541-07	HG19	TCGA-CJ-5672	TCGA-KIRC	2190.0	s9485	University of North Carolina	MD Anderson Cancer Center	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa83be4b0c9d6adf72527	58cfa83be4b0c9d6adf72527	UNCID_2623112.653f5c38-8795-4ed9-8c4a-aaf5597eee8c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2623112.653f5c38-8795-4ed9-8c4a-aaf5597eee8c.sorted_genome_alignments	UNCID_2623112.653f5c38-8795-4ed9-8c4a-aaf5597eee8c.sorted_genome_alignments.bam	18.03	1.87	0.18	58cfa83be4b0c9d6adf72527	UNCID_2623112.653f5c38-8795-4ed9-8c4a-aaf5597eee8c.sorted_genome_alignments.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-AAR4-01A	765AD5A5-134B-4680-A6D4-1DD113DC47CC	Primary Tumor	Illumina HiSeq	50BA96AA-DDE9-40DA-AB9D-892D23C75FC7	Lung	51.0	3BCE57D8-32D5-4F56-B0A4-544C3FEE778F	653F5C38-8795-4ED9-8C4A-AAF5597EEE8C	TCGA-49-AAR4-01A-12R-A41B-07	HG19	TCGA-49-AAR4	TCGA-LUAD	879.0	s11539	University of North Carolina	Johns Hopkins	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	A41B-07	True
13767.58cfa839e4b0c9d6adf7129a	58cfa839e4b0c9d6adf7129a	UNCID_2281755.2d5bb19c-0df7-499a-891d-f67e6b202820.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2281755.2d5bb19c-0df7-499a-891d-f67e6b202820.sorted_genome_alignments	UNCID_2281755.2d5bb19c-0df7-499a-891d-f67e6b202820.sorted_genome_alignments.bam	150.2		0.16	58cfa839e4b0c9d6adf7129a	UNCID_2281755.2d5bb19c-0df7-499a-891d-f67e6b202820.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-7268-01A	BEAC52B4-AB6B-4F20-AEFF-8C15990AA710	Primary Tumor	Illumina HiSeq	737F45A6-C81D-4CC1-BE77-1AC0BC9D101A	Kidney	59.0	5858C402-3749-4CA7-954E-9B9BCCE64BFC	2D5BB19C-0DF7-499A-891D-F67E6B202820	TCGA-B9-7268-01A-11R-A32Z-07	HG19	TCGA-B9-7268	TCGA-KIRP		s11827	University of North Carolina	UNC	United States	NO	T2	N0	Kidney Papillary Renal Cell Carcinoma	Stage II	A32Z-07	True
13722.58cfa832e4b0c9d6adf6cf35	58cfa832e4b0c9d6adf6cf35	TCGA-G9-6356-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_2_rg.sorted.filtered.	WGS	TCGA-G9-6356-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_2_rg.sorted	TCGA-G9-6356-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_2_rg.sorted.bam	39.7	1.8	0.14	58cfa832e4b0c9d6adf6cf35	TCGA-G9-6356-10A-01D-1784_130215_SN590_0211_AC1UJWACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6356-10A	1D7FFBE7-6139-412B-8739-8082A63A2B33	Blood Derived Normal	Illumina HiSeq	c966ad1f-2ded-40de-950e-0b9ee42a5923	Prostate	60.0	6E069287-0274-4F2E-A996-0C27F81C9329	FA765A2B-44EA-4964-8135-3648FE153E05	TCGA-G9-6356-10A-01D-1784-02	HG19_Broad_variant	TCGA-G9-6356	TCGA-PRAD		s3971	Harvard Medical School	Roswell Park	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		1784-02	True
13767.58cfa835e4b0c9d6adf6ed6e	58cfa835e4b0c9d6adf6ed6e	UNCID_1371310.937a163b-b469-46a0-87b8-6d7c7e6105d7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1371310.937a163b-b469-46a0-87b8-6d7c7e6105d7.sorted_genome_alignments	UNCID_1371310.937a163b-b469-46a0-87b8-6d7c7e6105d7.sorted_genome_alignments.bam	168.2		0.14	58cfa835e4b0c9d6adf6ed6e	UNCID_1371310.937a163b-b469-46a0-87b8-6d7c7e6105d7.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-86-7955-01A	0D0D83D9-D558-4D38-977B-6F1B2471BEDA	Primary Tumor	Illumina HiSeq	82EF62DD-6444-46B2-837E-CD1D93EC7FA5	Lung	62.0	85E8A3BF-0536-4556-A40F-8A523C04B337	937A163B-B469-46A0-87B8-6D7C7E6105D7	TCGA-86-7955-01A-11R-2187-07	HG19	TCGA-86-7955	TCGA-LUAD		s11179	University of North Carolina	Asterand	Russia	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	2187-07	True
13767.58cfa838e4b0c9d6adf704ed	58cfa838e4b0c9d6adf704ed	UNCID_1864784.13397543-2451-40c1-a9ca-3cf2e6578a79.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1864784.13397543-2451-40c1-a9ca-3cf2e6578a79.sorted_genome_alignments	UNCID_1864784.13397543-2451-40c1-a9ca-3cf2e6578a79.sorted_genome_alignments.bam	158.2	1.7	0.15	58cfa838e4b0c9d6adf704ed	UNCID_1864784.13397543-2451-40c1-a9ca-3cf2e6578a79.sorted_genome_alignments.bam	Alive	MALE	WHITE		Colon Adenocarcinoma	Aligned reads	TCGA-AD-6899-01A	EA923671-3903-4A79-830D-E7E4B1EABAB0	Primary Tumor	Illumina HiSeq	84803720-0E56-49F2-AAE7-871E8359B4C7	Colorectal	84.0	73F2FC25-C775-4567-8CA1-5732AA0DD156	13397543-2451-40C1-A9CA-3CF2E6578A79	TCGA-AD-6899-01A-11R-1928-07	HG19	TCGA-AD-6899	TCGA-COAD		s12952	University of North Carolina	International Genomics Consortium	United States	NO	T4a	N2b	Colon Mucinous Adenocarcinoma	Stage III	1928-07	True
13722.58cfa82ee4b0c9d6adf6aa51	58cfa82ee4b0c9d6adf6aa51	G35155.TCGA-CR-5243-01A-01D-1512-08.2.filtered.	WGS	G35155.TCGA-CR-5243-01A-01D-1512-08.2	G35155.TCGA-CR-5243-01A-01D-1512-08.2.bam	348.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa51	G35155.TCGA-CR-5243-01A-01D-1512-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-5243-01A	E37F479F-CA05-45E4-AC6D-A974BED6E7F8	Primary Tumor	Illumina HiSeq	9b40a7ed-a315-4294-ade6-8b2194292f0b	Head and Neck	51.0	D89D46EA-9A7A-4FD8-B11E-9C9CA4780119	297E8B35-5B8B-4D5B-B812-86165F949A20	TCGA-CR-5243-01A-01D-1512-08	HG19_Broad_variant	TCGA-CR-5243	TCGA-HNSC		s15873	Broad Institute of MIT and Harvard	Vanderbilt University	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma		1512-08	False
13767.58cfa82ee4b0c9d6adf6ab76	58cfa82ee4b0c9d6adf6ab76	G17511.TCGA-06-2565-01A-01R-1849-01.2.filtered.	RNA-Seq	G17511.TCGA-06-2565-01A-01R-1849-01.2	G17511.TCGA-06-2565-01A-01R-1849-01.2.bam	330.4	1.8	0.16	58cfa82ee4b0c9d6adf6ab76	G17511.TCGA-06-2565-01A-01R-1849-01.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-2565-01A	C7B4FD72-B45D-4524-8424-983120ABFEC0	Primary Tumor	Illumina HiSeq	DEBDB819-4888-48C7-A65A-FAC873B539CF	Brain	59.0	20342F47-D86B-468F-9450-A0FEF449E21E	2EE686C6-DA57-4371-90A9-DB02AB6CB278	TCGA-06-2565-01A-01R-1849-01	HG19_Broad_variant	TCGA-06-2565	TCGA-GBM		s14087	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13767.58cfa838e4b0c9d6adf70970	58cfa838e4b0c9d6adf70970	UNCID_2039248.04e39981-d4c9-413e-8625-bd7aebf53876.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2039248.04e39981-d4c9-413e-8625-bd7aebf53876.sorted_genome_alignments	UNCID_2039248.04e39981-d4c9-413e-8625-bd7aebf53876.sorted_genome_alignments.bam	22.51	1.85	0.17	58cfa838e4b0c9d6adf70970	UNCID_2039248.04e39981-d4c9-413e-8625-bd7aebf53876.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A4M8-01A	A4A217C1-66E8-4CC5-805A-1172CE5DA721	Primary Tumor	Illumina HiSeq	5697BD91-CB08-4E5D-B8DC-95F23D953E1F	Thyroid	61.0	D3C59D4C-E370-45EC-800B-E6AAA05D2BDF	04E39981-D4C9-413E-8625-BD7AEBF53876	TCGA-DE-A4M8-01A-21R-A250-07	HG19	TCGA-DE-A4M8	TCGA-THCA		s12609	University of North Carolina	University of North Carolina	United States	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A250-07	True
13767.58cfa83ce4b0c9d6adf72bc2	58cfa83ce4b0c9d6adf72bc2	UNCID_373422.TCGA-CJ-4643-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.1.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_373422.TCGA-CJ-4643-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.1.trimmed.annotated.translated_to_genomic	UNCID_373422.TCGA-CJ-4643-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.1.trimmed.annotated.translated_to_genomic.bam	56.3	1.8	0.15	58cfa83ce4b0c9d6adf72bc2	UNCID_373422.TCGA-CJ-4643-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.1.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4643-01A	F11F68AC-5AD2-416B-A0C2-697AC3E9718A	Primary Tumor	Illumina HiSeq	D316A843-EEE8-4B25-B1BF-BC73A422E30C	Kidney	67.0	D2BAFF9A-220A-4F44-BBDB-A02CDFD908C9	A5702EA5-2ED9-40C9-881E-F20DCDC904A1	TCGA-CJ-4643-01A-02R-1325-07	HG19	TCGA-CJ-4643	TCGA-KIRC		s8957	University of North Carolina	MD Anderson Cancer Center	None	NO	T2b	N0	Kidney Clear Cell Renal Carcinoma	Stage II	1325-07	True
13767.58cfa832e4b0c9d6adf6d536	58cfa832e4b0c9d6adf6d536	TCGA-L5-A88S-01A-11R-A36D-31_rnaseq.filtered.	RNA-Seq	TCGA-L5-A88S-01A-11R-A36D-31_rnaseq	TCGA-L5-A88S-01A-11R-A36D-31_rnaseq.bam	28.46	1.87	0.18	58cfa832e4b0c9d6adf6d536	TCGA-L5-A88S-01A-11R-A36D-31_rnaseq.bam	Alive	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A88S-01A	25EB6A8A-5BD9-480D-BAAB-6113E1B3BE51	Primary Tumor	Illumina HiSeq	0D152AA0-A363-446C-BE08-24AB93AACD5D	Esophagus	84.0	0ECC7F6E-65A4-42E0-9BB0-D787BEECD88D	D9AEBA99-9F40-43F7-9F05-69A16C41D044	TCGA-L5-A88S-01A-11R-A36D-31	GRCh37-lite	TCGA-L5-A88S	TCGA-ESCA		s1673	Canada's Michael Smith Genome Sciences Centre	University of Michigan	United States	NO	T3	N0		Stage I	A36D-31	True
13767.58cfa82fe4b0c9d6adf6b418	58cfa82fe4b0c9d6adf6b418	TCGA-24-1435-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-24-1435-01A-01R-1566-13_rnaseq	TCGA-24-1435-01A-01R-1566-13_rnaseq.bam	358.0	1.8	0.14	58cfa82fe4b0c9d6adf6b418	TCGA-24-1435-01A-01R-1566-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1435-01A	49D2C0CF-A3F3-4519-A755-0A5F769DF2EA	Primary Tumor	Illumina HiSeq	F901BCF6-97DD-45B7-A5F1-98F55F68A18F	Ovary	57.0	A36AB3E1-B5FB-4557-AF54-88D4ADA2AAAF	C20BA763-E310-448A-9C85-0B4F680E6196	TCGA-24-1435-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-24-1435	TCGA-OV	1324.0	s17992	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1566-13	True
13722.58cfa82de4b0c9d6adf6a500	58cfa82de4b0c9d6adf6a500	1a412b398e31a45c322e65711a35d52f.filtered.	WGS	1a412b398e31a45c322e65711a35d52f	1a412b398e31a45c322e65711a35d52f.bam	27.3	2.03	0.08	58cfa82de4b0c9d6adf6a500	1a412b398e31a45c322e65711a35d52f.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0V8-10A	2B76CC9C-C379-43E4-9C3F-56197A3353BE	Blood Derived Normal	Illumina HiSeq	fa9ff5b6-2ff3-4c3b-bb39-b3df34a375d2	Uterus	68.0	6E63CD30-AE3C-4B5A-8001-26C93F903A10	332A9DF3-3816-4BA2-9C2A-732E0895294E	TCGA-BS-A0V8-10A-01D-A122-09	GRCh37-lite	TCGA-BS-A0V8	TCGA-UCEC		s4406	Washington University School of Medicine	University of Hawaii	None	NO			Endometrioid endometrial adenocarcinoma		A122-09	True
13767.58cfa835e4b0c9d6adf6ec74	58cfa835e4b0c9d6adf6ec74	UNCID_1329608.38dba480-1670-4534-8bf1-b6f58cd1dfec.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1329608.38dba480-1670-4534-8bf1-b6f58cd1dfec.sorted_genome_alignments	UNCID_1329608.38dba480-1670-4534-8bf1-b6f58cd1dfec.sorted_genome_alignments.bam	83.2	1.7	0.15	58cfa835e4b0c9d6adf6ec74	UNCID_1329608.38dba480-1670-4534-8bf1-b6f58cd1dfec.sorted_genome_alignments.bam	Alive	MALE			Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-7129-01A	04552448-4629-45C3-B2AB-0C1DEC9C36CD	Primary Tumor	Illumina HiSeq	233E5D05-EBA2-4897-8C4F-5CFC08DB31A1	Kidney		2D0A17BE-C8FF-4768-8E47-84D166BB7244	38DBA480-1670-4534-8BF1-B6F58CD1DFEC	TCGA-HE-7129-01A-11R-1965-07	HG19	TCGA-HE-7129	TCGA-KIRP		s11691	University of North Carolina	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	1965-07	True
13767.58cfa839e4b0c9d6adf71114	58cfa839e4b0c9d6adf71114	UNCID_2268944.6369f5c8-dbd0-4c80-a621-5c3310ebad45.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2268944.6369f5c8-dbd0-4c80-a621-5c3310ebad45.sorted_genome_alignments	UNCID_2268944.6369f5c8-dbd0-4c80-a621-5c3310ebad45.sorted_genome_alignments.bam	16.54	1.88	0.18	58cfa839e4b0c9d6adf71114	UNCID_2268944.6369f5c8-dbd0-4c80-a621-5c3310ebad45.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-QH-A6CY-01A	E1758D75-B2A0-4386-BD72-6B2421D4DA6B	Primary Tumor	Illumina HiSeq	FFB94C03-5C72-4759-8EDD-BEECE8FD3E32	Brain	38.0	E93B5E03-E2D0-4C86-8B3B-D3811D0F70B5	6369F5C8-DBD0-4C80-A621-5C3310EBAD45	TCGA-QH-A6CY-01A-11R-A32Q-07	HG19	TCGA-QH-A6CY	TCGA-LGG		s8254	University of North Carolina	Fondazione-Besta	Italy	NO			Oligoastrocytoma		A32Q-07	True
13767.58cfa82fe4b0c9d6adf6b751	58cfa82fe4b0c9d6adf6b751	TCGA-61-1740-01A-01R-1567-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-61-1740-01A-01R-1567-13_GRCh37-lite_rnaseq	TCGA-61-1740-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	381.0	1.8	0.15	58cfa82fe4b0c9d6adf6b751	TCGA-61-1740-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-1740-01A	005A6517-2E5A-4EA3-AB36-531522723607	Primary Tumor	Illumina HiSeq	A9F5F4CB-EEC1-4E62-BE13-0F7729DB71B3	Ovary	71.0	AC9C5B5E-8E14-4A76-A68D-78A8349C40F7	E7825482-380D-4323-A4FB-D11B365C7073	TCGA-61-1740-01A-01R-1567-13	GRCh37-lite	TCGA-61-1740	TCGA-OV	74.0	s17197	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa835e4b0c9d6adf6f274	58cfa835e4b0c9d6adf6f274	UNCID_1456115.a5e6c3d1-f729-4393-864b-f153863aec46.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1456115.a5e6c3d1-f729-4393-864b-f153863aec46.sorted_genome_alignments	UNCID_1456115.a5e6c3d1-f729-4393-864b-f153863aec46.sorted_genome_alignments.bam	55.45	1.88	0.15	58cfa835e4b0c9d6adf6f274	UNCID_1456115.a5e6c3d1-f729-4393-864b-f153863aec46.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13R-01A	3E787A0E-B5D2-401E-B1E5-077376090B3A	Primary Tumor	Illumina HiSeq	00E29B4B-795C-4A39-9B63-D7194B21B69B	Thyroid	50.0	27B0FF79-4213-4B57-B6E0-A393B8983D20	A5E6C3D1-F729-4393-864B-F153863AEC46	TCGA-DJ-A13R-01A-11R-A10U-07	HG19	TCGA-DJ-A13R	TCGA-THCA		s12673	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A10U-07	True
13767.58cfa82ee4b0c9d6adf6b0cf	58cfa82ee4b0c9d6adf6b0cf	TCGA-13-1411-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-1411-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-13-1411-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	325.0	1.8	0.15	58cfa82ee4b0c9d6adf6b0cf	TCGA-13-1411-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1411-01A	A9D3A7B0-FAF8-4E56-8600-D9E6882A4F23	Primary Tumor	Illumina HiSeq	E36BE6B0-51F6-44E7-90FB-9201E81FDA7F	Ovary	81.0	157062B7-9451-4A83-9047-294497DF3B28	0069C63D-F699-41D4-9798-9A109D1C09DF	TCGA-13-1411-01A-01R-1565-13	GRCh37-lite	TCGA-13-1411	TCGA-OV		s17816	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa82fe4b0c9d6adf6b464	58cfa82fe4b0c9d6adf6b464	TCGA-25-1317-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-25-1317-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-25-1317-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	457.0	1.8	0.15	58cfa82fe4b0c9d6adf6b464	TCGA-25-1317-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1317-01A	78777A80-CC6C-46C9-A14A-837AC7943719	Primary Tumor	Illumina HiSeq	527FD4A2-9162-49F4-B05D-A40C6C542196	Ovary	66.0	12BE4FE0-391E-4BDD-9AF9-33FA7A135975	423F3C95-8BF5-4C2C-8B7A-343D9AF1D0BF	TCGA-25-1317-01A-01R-1565-13	GRCh37-lite	TCGA-25-1317	TCGA-OV	61.0	s17722	Canada's Michael Smith Genome Sciences Centre	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa837e4b0c9d6adf6fcda	58cfa837e4b0c9d6adf6fcda	UNCID_1676654.02486980-EB4F-4930-BA27-356E346929B6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1676654.02486980-EB4F-4930-BA27-356E346929B6.sorted_genome_alignments	UNCID_1676654.02486980-EB4F-4930-BA27-356E346929B6.sorted_genome_alignments.bam	19.69	1.9	0.16	58cfa837e4b0c9d6adf6fcda	UNCID_1676654.02486980-EB4F-4930-BA27-356E346929B6.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D9-A3Z1-06A	4F7E7A0E-4AA2-4B6A-936F-6429C7D6A2A7	Metastatic	Illumina HiSeq	BFAF0160-334D-411C-B1BD-D829665399DD	Skin	66.0	37FDD3A3-9035-404D-971D-F4E326E10AD2	02486980-EB4F-4930-BA27-356E346929B6	TCGA-D9-A3Z1-06A-11R-A239-07	HG19	TCGA-D9-A3Z1	TCGA-SKCM		s7604	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T2a	N3		Stage III	A239-07	True
13767.58cfa839e4b0c9d6adf7135d	58cfa839e4b0c9d6adf7135d	UNCID_2318974.8a430d45-6511-4900-954e-fd01106d0f22.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2318974.8a430d45-6511-4900-954e-fd01106d0f22.sorted_genome_alignments	UNCID_2318974.8a430d45-6511-4900-954e-fd01106d0f22.sorted_genome_alignments.bam	7.95	1.98	0.15	58cfa839e4b0c9d6adf7135d	UNCID_2318974.8a430d45-6511-4900-954e-fd01106d0f22.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1P1-01A	F2E28AF9-C40E-41C4-9E82-205CCA38F26A	Primary Tumor	Illumina HiSeq	A5FCACBD-3054-44AC-B766-460570DA592A	Breast	68.0	652C3B39-D1CB-42E8-98E1-2ACB0011BD50	8A430D45-6511-4900-954E-FD01106D0F22	TCGA-EW-A1P1-01A-31R-A14D-07	HG19	TCGA-EW-A1P1	TCGA-BRCA		s6433	University of North Carolina	University of Miami	United States	NO	T2	N3b	Infiltrating Ductal Carcinoma	Stage III	A14D-07	True
13722.58cfa830e4b0c9d6adf6bf19	58cfa830e4b0c9d6adf6bf19	TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina	TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina.bam	62.42		0.07	58cfa830e4b0c9d6adf6bf19	TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Colon Adenocarcinoma	Aligned reads	TCGA-AY-A54L-01A	D8E9EA52-FF28-4626-BAA3-71350FD53DDF	Primary Tumor	Illumina HiSeq	709d8bea-f505-4558-b12a-7bd4322e75ea	Colorectal	74.0	52EFBEB4-7B23-4C49-92F9-931A3EB99055	080ECC31-756A-4A1B-A51E-D632AC8219F7	TCGA-AY-A54L-01A-11D-A28G-10	GRCh37-lite	TCGA-AY-A54L	TCGA-COAD		s13542	Baylor College of Medicine	UNC	United States	NO	T2	N0	Colon Adenocarcinoma	Stage I	A28G-10	True
13722.58cfa832e4b0c9d6adf6d1c5	58cfa832e4b0c9d6adf6d1c5	TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted	TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.bam	127.3		0.14	58cfa832e4b0c9d6adf6d1c5	TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HI-7171-01A	931FEB14-3F69-41C1-8435-5FD4FB775BDF	Primary Tumor	Illumina HiSeq	0dc8ef7a-58a8-4b25-ad57-4c31592151e2	Prostate	56.0	B9D6C505-4D71-4189-925F-36914241B831	5A0710CB-B515-48F7-94B1-5DCD72B30F3F	TCGA-HI-7171-01A-12D-2111-02	HG19_Broad_variant	TCGA-HI-7171	TCGA-PRAD	1329.0	s3814	Harvard Medical School	Fox Chase	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		2111-02	True
13767.58cfa838e4b0c9d6adf7049d	58cfa838e4b0c9d6adf7049d	UNCID_1957265.ae83a679-8155-4f3a-9c9b-a3b73c8cd332.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1957265.ae83a679-8155-4f3a-9c9b-a3b73c8cd332.sorted_genome_alignments	UNCID_1957265.ae83a679-8155-4f3a-9c9b-a3b73c8cd332.sorted_genome_alignments.bam	10.78	1.87	0.15	58cfa838e4b0c9d6adf7049d	UNCID_1957265.ae83a679-8155-4f3a-9c9b-a3b73c8cd332.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-A4XC-01A	33615113-791B-4286-A23A-AD3D1F8D4B09	Primary Tumor	Illumina HiSeq	95B65C98-15E6-43E7-9161-8CBE066DD131	Brain	26.0	3169A2CE-1431-4512-BE11-34D9038F748A	AE83A679-8155-4F3A-9C9B-A3B73C8CD332	TCGA-DB-A4XC-01A-11R-A26U-07	HG19	TCGA-DB-A4XC	TCGA-LGG		s8219	University of North Carolina	Mayo Clinic - Rochester	United States	NO			Oligoastrocytoma		A26U-07	True
13767.58cfa82ee4b0c9d6adf6ab4c	58cfa82ee4b0c9d6adf6ab4c	G17500.TCGA-27-1831-01A-01R-1850-01.2.filtered.	RNA-Seq	G17500.TCGA-27-1831-01A-01R-1850-01.2	G17500.TCGA-27-1831-01A-01R-1850-01.2.bam	99.4	1.9	0.16	58cfa82ee4b0c9d6adf6ab4c	G17500.TCGA-27-1831-01A-01R-1850-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-27-1831-01A	F45F4A30-6B4C-4F15-9140-959D6A25A45F	Primary Tumor	Illumina HiSeq	BA91CE19-EFE3-4AE3-9DAD-B79EFF3A9D4C	Brain	66.0	9BB49615-6F5E-471C-B68B-866E6199CEB7	D577AF6D-D9F1-435D-8429-73B5C5962238	TCGA-27-1831-01A-01R-1850-01	HG19_Broad_variant	TCGA-27-1831	TCGA-GBM	505.0	s13880	Broad Institute of MIT and Harvard	Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta	None	NO			Untreated primary (de novo) GBM		1850-01	True
13722.58cfa82fe4b0c9d6adf6ba35	58cfa82fe4b0c9d6adf6ba35	TCGA-A6-3810-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-3810-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-3810-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	469.86	1.9	0.15	58cfa82fe4b0c9d6adf6ba35	TCGA-A6-3810-11A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-3810-11A	B728E6E8-A0E4-496B-904C-6F07C12E901F	Solid Tissue Normal	Illumina HiSeq	f725df5d-8fb1-4c7b-b4c6-828a349265d2	Colorectal	62.0	A692CCDA-F941-46A5-9AC4-28E300686929	F933A74E-5E70-45F7-95A1-CFC3039EE936	TCGA-A6-3810-11A-01D-1167-02	HG18	TCGA-A6-3810	TCGA-COAD		s13653	Harvard Medical School	Christiana Healthcare	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1167-02	True
13767.58cfa838e4b0c9d6adf7052b	58cfa838e4b0c9d6adf7052b	UNCID_1905331.777c61bc-aa43-4661-a1d3-7a2f07dc055a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1905331.777c61bc-aa43-4661-a1d3-7a2f07dc055a.sorted_genome_alignments	UNCID_1905331.777c61bc-aa43-4661-a1d3-7a2f07dc055a.sorted_genome_alignments.bam	116.2		0.16	58cfa838e4b0c9d6adf7052b	UNCID_1905331.777c61bc-aa43-4661-a1d3-7a2f07dc055a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-8620-01A	5510AD32-62FD-4ADC-964A-AE4E997C2F4B	Primary Tumor	Illumina HiSeq	7BB4BB08-DE48-4FB3-94DD-91CF46AD8204	Lung	60.0	EE8A12E2-8827-4ABE-AF6F-AA39995F6B99	777C61BC-AA43-4661-A1D3-7A2F07DC055A	TCGA-55-8620-01A-11R-2403-07	HG19	TCGA-55-8620	TCGA-LUAD		s11071	University of North Carolina	International Genomics Consortium	United States	NO	T1a	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	2403-07	True
13722.58cfa82fe4b0c9d6adf6b631	58cfa82fe4b0c9d6adf6b631	TCGA-44-6148-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_8_rg.sorted.filtered.	WGS	TCGA-44-6148-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_8_rg.sorted	TCGA-44-6148-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_8_rg.sorted.bam	27.4	1.9	0.15	58cfa82fe4b0c9d6adf6b631	TCGA-44-6148-11A-01D-1751_110927_SN208_0243_BC00TKACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6148-11A	8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA	Solid Tissue Normal	Illumina HiSeq	453af1ae-a7ef-4716-8eff-3295325729cd	Lung	60.0	ACE83CB7-28BC-44BA-A600-8A6155E08A42	967F0F6A-855F-4544-BD9B-E49909EB6ACB	TCGA-44-6148-11A-01D-1751-02	HG19_Broad_variant	TCGA-44-6148	TCGA-LUAD		s10904	Harvard Medical School	Christiana Healthcare	United States	NO	T1b	N0	Lung Mucinous Adenocarcinoma	Stage I	1751-02	True
13767.58cfa832e4b0c9d6adf6d39c	58cfa832e4b0c9d6adf6d39c	TCGA-R5-A7O7-01A-11R-A33Y-31_rnaseq.filtered.	RNA-Seq	TCGA-R5-A7O7-01A-11R-A33Y-31_rnaseq	TCGA-R5-A7O7-01A-11R-A33Y-31_rnaseq.bam	8.43	1.96	0.15	58cfa832e4b0c9d6adf6d39c	TCGA-R5-A7O7-01A-11R-A33Y-31_rnaseq.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-R5-A7O7-01A	3BFA8069-6CA3-4405-9E32-11AA16B010AC	Primary Tumor	Illumina HiSeq	DC35136A-C6A8-4024-B32C-5B4916CFC983	Stomach	51.0	7B5B06DD-E720-4738-BD33-1B87FBBD3CD7	61261306-46BC-4731-A6FF-74C251C0CFE9	TCGA-R5-A7O7-01A-11R-A33Y-31	GRCh37-lite	TCGA-R5-A7O7	TCGA-STAD		s15414	Canada's Michael Smith Genome Sciences Centre	MD Anderson Cancer Center	United States	NO	T3	N1	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IV	A33Y-31	False
13722.58cfa830e4b0c9d6adf6bbea	58cfa830e4b0c9d6adf6bbea	TCGA-AG-A008-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_8.rg.sorted.filtered.	WGS	TCGA-AG-A008-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_8.rg.sorted	TCGA-AG-A008-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_8.rg.sorted.bam	47.46	1.73	0.15	58cfa830e4b0c9d6adf6bbea	TCGA-AG-A008-10A-01D-A078-02_110217_SN208_0190_B81CLKABXX_s_8.rg.sorted.bam	Alive	FEMALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A008-10A	E7503A51-6647-4CC2-80DD-645D0DF4DB43	Blood Derived Normal	Illumina HiSeq	6a8b3387-94d5-401f-ba50-c00e0b2d1c7f	Colorectal	50.0	5CD9C79F-D0C1-48B0-85AA-5270C0E866B5	2CEB5DAF-1FA5-4163-82EF-8304514D8D9A	TCGA-AG-A008-10A-01D-A078-02	HG18_Broad_variant	TCGA-AG-A008	TCGA-READ		s2311	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Mucinous Adenocarcinoma	Stage I	A078-02	True
13767.58cfa837e4b0c9d6adf7001c	58cfa837e4b0c9d6adf7001c	UNCID_1867605.d63bef42-b815-4987-a0de-a729a75d108d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1867605.d63bef42-b815-4987-a0de-a729a75d108d.sorted_genome_alignments	UNCID_1867605.d63bef42-b815-4987-a0de-a729a75d108d.sorted_genome_alignments.bam	22.2	1.7	0.15	58cfa837e4b0c9d6adf7001c	UNCID_1867605.d63bef42-b815-4987-a0de-a729a75d108d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-DC-6154-01A	33E91116-8844-4861-843D-784C70B4A6FC	Primary Tumor	Illumina HiSeq	378B8CFC-4AC0-4707-B1EE-D546C7DA1306	Colorectal	57.0	AB5D238F-901A-4C59-81A1-A3B8DCCCDBA2	D63BEF42-B815-4987-A0DE-A729A75D108D	TCGA-DC-6154-01A-31R-1928-07	HG19	TCGA-DC-6154	TCGA-READ		s2058	University of North Carolina	MSKCC	United States	NO	T4a	N2b	Rectal Adenocarcinoma	Stage IV	1928-07	True
13767.58cfa82fe4b0c9d6adf6b59e	58cfa82fe4b0c9d6adf6b59e	TCGA-29-1697-01A-01R-1567-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-29-1697-01A-01R-1567-13_GRCh37-lite_rnaseq	TCGA-29-1697-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	655.0	1.8	0.15	58cfa82fe4b0c9d6adf6b59e	TCGA-29-1697-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1697-01A	42EBD30B-175E-4ECE-A806-E55CB7E40E96	Primary Tumor	Illumina HiSeq	66E93571-B5AA-4DCB-831D-4F440722581B	Ovary	62.0	3669F3BD-DFFE-4737-BF81-07F38DECEB2E	75435634-4311-49D8-8E42-AE1069C1E2EF	TCGA-29-1697-01A-01R-1567-13	GRCh37-lite	TCGA-29-1697	TCGA-OV	949.0	s17845	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa82fe4b0c9d6adf6b23f	58cfa82fe4b0c9d6adf6b23f	TCGA-09-2056-01B-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-09-2056-01B-01R-1568-13_rnaseq	TCGA-09-2056-01B-01R-1568-13_rnaseq.bam	280.0	1.8	0.15	58cfa82fe4b0c9d6adf6b23f	TCGA-09-2056-01B-01R-1568-13_rnaseq.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-2056-01B	EA6405C4-0FE4-4F37-BEF2-275072F91E39	Primary Tumor	Illumina HiSeq	9150BE13-FD5F-4B0A-9C3A-F499080A200A	Ovary	62.0	C6045243-4072-4342-8FB1-F2BBEA55FE7B	67670628-AD07-41EF-8977-890080616900	TCGA-09-2056-01B-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-09-2056	TCGA-OV		s17171	Canada's Michael Smith Genome Sciences Centre	UCSF	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa839e4b0c9d6adf7104b	58cfa839e4b0c9d6adf7104b	UNCID_2232079.088b27e8-38f6-41ff-a861-d371415fd7f0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2232079.088b27e8-38f6-41ff-a861-d371415fd7f0.sorted_genome_alignments	UNCID_2232079.088b27e8-38f6-41ff-a861-d371415fd7f0.sorted_genome_alignments.bam	23.43	2.06	0.17	58cfa839e4b0c9d6adf7104b	UNCID_2232079.088b27e8-38f6-41ff-a861-d371415fd7f0.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A6TG-01A	0C890030-9BDB-4247-A3D5-A004F992F99C	Primary Tumor	Illumina HiSeq	CA8E8D52-B868-4D06-81A8-1D9404BF4CEA	Bladder	73.0	FA9F9744-0123-4D33-BE9A-000E8A24BD22	088B27E8-38F6-41FF-A861-D371415FD7F0	TCGA-FD-A6TG-01A-11R-A32O-07	HG19	TCGA-FD-A6TG	TCGA-BLCA		s2792	University of North Carolina	BLN - University Of Chicago	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A32O-07	True
13767.58cfa837e4b0c9d6adf70234	58cfa837e4b0c9d6adf70234	UNCID_1840927.9383278e-22a7-4ea3-8700-988b1c9d8fd9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1840927.9383278e-22a7-4ea3-8700-988b1c9d8fd9.sorted_genome_alignments	UNCID_1840927.9383278e-22a7-4ea3-8700-988b1c9d8fd9.sorted_genome_alignments.bam	157.2		0.15	58cfa837e4b0c9d6adf70234	UNCID_1840927.9383278e-22a7-4ea3-8700-988b1c9d8fd9.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-52-7809-01A	72C49014-F949-4D02-AE71-26A243E0B102	Primary Tumor	Illumina HiSeq	B08EF1DE-3928-4BEF-8522-81C0EFC97624	Lung	74.0	DE730557-B83A-4B0A-8570-B196C1BE4090	9383278E-22A7-4EA3-8700-988B1C9D8FD9	TCGA-52-7809-01A-21R-2125-07	HG19	TCGA-52-7809	TCGA-LUSC	166.0	s10558	University of North Carolina	University of Miami	United States	NO	T2	N0	Lung Basaloid Squamous Cell Carcinoma	Stage I	2125-07	True
13722.58cfa832e4b0c9d6adf6d2ca	58cfa832e4b0c9d6adf6d2ca	TCGA-KL-8332-11A-01D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8332-11A-01D-2310-10_wgs_Illumina	TCGA-KL-8332-11A-01D-2310-10_wgs_Illumina.bam	220.3		0.05	58cfa832e4b0c9d6adf6d2ca	TCGA-KL-8332-11A-01D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8332-11A	3EC3BCB3-492C-4942-BE02-76A67F57E38F	Solid Tissue Normal	Illumina HiSeq	b9597b47-d425-461c-8123-ce46cef3fe8d	Kidney	55.0	60BBC00F-DF46-4DDF-9D01-4F66F5B2B26A	1F3AF48C-BA6B-4DB5-BA11-75B7F50FAE1E	TCGA-KL-8332-11A-01D-2310-10	GRCh37-lite	TCGA-KL-8332	TCGA-KICH		s16433	Baylor College of Medicine	MSKCC	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2310-10	True
13722.58cfa831e4b0c9d6adf6c8b3	58cfa831e4b0c9d6adf6c8b3	TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted	TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted.bam	10.03		0.14	58cfa831e4b0c9d6adf6c8b3	TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7411-10A	600FC87B-A177-4BF9-9084-457F7E7E102C	Blood Derived Normal	Illumina HiSeq	9ad035d2-035c-4447-a744-24409cfeb23e	Head and Neck	64.0	3F69EF25-0751-46B5-934D-9501DA864535	2A1972F4-F2EE-40C5-BF2F-22F4C26237D7	TCGA-CV-7411-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7411	TCGA-HNSC	2717.0	s16207	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IV	2317-26	True
13767.58cfa836e4b0c9d6adf6fc26	58cfa836e4b0c9d6adf6fc26	UNCID_1664776.ab31f363-93f1-4ef9-a47a-731657fdf534.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1664776.ab31f363-93f1-4ef9-a47a-731657fdf534.sorted_genome_alignments	UNCID_1664776.ab31f363-93f1-4ef9-a47a-731657fdf534.sorted_genome_alignments.bam	29.95	1.8	0.16	58cfa836e4b0c9d6adf6fc26	UNCID_1664776.ab31f363-93f1-4ef9-a47a-731657fdf534.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1BQ-01C	E77C3F70-08D1-40D3-B038-F09A519423CC	Primary Tumor	Illumina HiSeq	DFA35857-6D25-4B5C-BE8D-9810BF20CF4A	Cervix	65.0	6EF38E19-07AC-4032-8FB4-59129A126D3F	AB31F363-93F1-4EF9-A47A-731657FDF534	TCGA-C5-A1BQ-01C-11R-A213-07	HG19	TCGA-C5-A1BQ	TCGA-CESC	604.0	s1552	University of North Carolina	Medical College of Wisconsin	United States	NO			Cervical Squamous Cell Carcinoma		A213-07	True
13767.58cfa839e4b0c9d6adf7156e	58cfa839e4b0c9d6adf7156e	UNCID_2367156.8f143ea3-314d-4d89-ad70-6209ff9852d4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2367156.8f143ea3-314d-4d89-ad70-6209ff9852d4.sorted_genome_alignments	UNCID_2367156.8f143ea3-314d-4d89-ad70-6209ff9852d4.sorted_genome_alignments.bam	40.01	1.92	0.16	58cfa839e4b0c9d6adf7156e	UNCID_2367156.8f143ea3-314d-4d89-ad70-6209ff9852d4.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-QT-A5XJ-01A	59F305D2-DCA8-4EC7-8708-27B4B105FC72	Primary Tumor	Illumina HiSeq	34854213-CC4F-4786-AE2D-9485F84A2A55	Nervous System	42.0	7E8299EE-2FE1-49D5-B2C4-5F0F2F79272F	8F143EA3-314D-4D89-AD70-6209FF9852D4	TCGA-QT-A5XJ-01A-11R-A35K-07	HG19	TCGA-QT-A5XJ	TCGA-PCPG		s981	University of North Carolina	University of North Carolina	United States	NO					A35K-07	True
13722.58cfa831e4b0c9d6adf6c850	58cfa831e4b0c9d6adf6c850	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.bam	263.7	1.9	0.15	58cfa831e4b0c9d6adf6c850	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6948-01A	FCF0DC48-B889-4593-A15B-AA715AAE7BF5	Primary Tumor	Illumina HiSeq	87c6cf32-e113-471b-86b3-cca360f47616	Head and Neck	79.0	21844F33-DD12-4940-B42D-2F9FABB2F7BA	8FEEA708-D971-4FD0-8542-1E31A9DFF8EA	TCGA-CV-6948-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6948	TCGA-HNSC	1289.0	s15650	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N3	Head and Neck Squamous Cell Carcinoma	Stage IV	1911-02	True
13722.58cfa832e4b0c9d6adf6d300	58cfa832e4b0c9d6adf6d300	TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina.bam	38.6		0.05	58cfa832e4b0c9d6adf6d300	TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8440-01A	872092B3-D31E-44D7-BD03-E29F52F8AB5A	Primary Tumor	Illumina HiSeq	e0e06c60-542a-4e20-928f-7fed440fcd2a	Kidney	37.0	614E4163-7DA8-4F77-A58D-405B004BE3E0	CDF313C8-59F9-41C6-9BD2-F47CB4287DA5	TCGA-KM-8440-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8440	TCGA-KICH		s16478	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T3a	NX	Kidney Chromophobe	Stage III	2310-10	True
13767.58cfa837e4b0c9d6adf700f2	58cfa837e4b0c9d6adf700f2	UNCID_1845300.0b233eab-4541-4b62-b9ae-baebf672403e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1845300.0b233eab-4541-4b62-b9ae-baebf672403e.sorted_genome_alignments	UNCID_1845300.0b233eab-4541-4b62-b9ae-baebf672403e.sorted_genome_alignments.bam	55.32	1.85	0.16	58cfa837e4b0c9d6adf700f2	UNCID_1845300.0b233eab-4541-4b62-b9ae-baebf672403e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-EP-A2KB-01A	18C08546-BED3-4ED9-B223-479AFE633C8E	Primary Tumor	Illumina HiSeq	004D036D-F6F1-4FA0-B0C4-6302292F395B	Liver	46.0	E2895132-DA4F-4DB5-B417-510E99FCE776	0B233EAB-4541-4B62-B9AE-BAEBF672403E	TCGA-EP-A2KB-01A-11R-A180-07	HG19	TCGA-EP-A2KB	TCGA-LIHC		s17074	University of North Carolina	Christiana Healthcare	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A180-07	True
13767.58cfa833e4b0c9d6adf6dd1a	58cfa833e4b0c9d6adf6dd1a	UNCID_1104093.b5036d12-d9cc-46a4-b60a-49740310380c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1104093.b5036d12-d9cc-46a4-b60a-49740310380c.sorted_genome_alignments	UNCID_1104093.b5036d12-d9cc-46a4-b60a-49740310380c.sorted_genome_alignments.bam	67.2	1.83	0.16	58cfa833e4b0c9d6adf6dd1a	UNCID_1104093.b5036d12-d9cc-46a4-b60a-49740310380c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AG-01A	F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5	Primary Tumor	Illumina HiSeq	01BAFD5A-7931-4346-940C-0E22F8E1BB65	Bladder	65.0	64668AA0-DDE5-4534-8CD0-378881E4A4E4	B5036D12-D9CC-46A4-B60A-49740310380C	TCGA-DK-A1AG-01A-11R-A13Y-07	HG19	TCGA-DK-A1AG	TCGA-BLCA		s2743	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13Y-07	True
13767.58cfa834e4b0c9d6adf6e53d	58cfa834e4b0c9d6adf6e53d	UNCID_1179386.7550fb8b-c3d1-47e2-b491-98878101919a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1179386.7550fb8b-c3d1-47e2-b491-98878101919a.sorted_genome_alignments	UNCID_1179386.7550fb8b-c3d1-47e2-b491-98878101919a.sorted_genome_alignments.bam	55.33	1.8	0.16	58cfa834e4b0c9d6adf6e53d	UNCID_1179386.7550fb8b-c3d1-47e2-b491-98878101919a.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3322-01A	36ED3269-0A57-4C50-BBFA-CFD2A7B56D4F	Primary Tumor	Illumina HiSeq	B2E7C342-7130-4784-BB82-DE938419FDAB	Kidney	51.0	6F329D07-3308-4C84-9113-2BF000E9BE3B	7550FB8B-C3D1-47E2-B491-98878101919A	TCGA-A3-3322-01A-02R-1325-07	HG19	TCGA-A3-3322	TCGA-KIRC		s9595	University of North Carolina	International Genomics Consortium	United States	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1325-07	True
13722.58cfa82ee4b0c9d6adf6ae46	58cfa82ee4b0c9d6adf6ae46	G49837.TCGA-33-4586-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-33-4586-01A-01D-A320-08.2	G49837.TCGA-33-4586-01A-01D-A320-08.2.bam	362.0	1.9	0.07	58cfa82ee4b0c9d6adf6ae46	G49837.TCGA-33-4586-01A-01D-A320-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-33-4586-01A	376DFD27-68E8-4A1A-9C4F-5064279B2A9E	Primary Tumor	Illumina HiSeq	e894d311-bbc3-468a-bed1-2c6328ae7bda	Lung	57.0	A41992A4-D0F9-4D5B-8D05-0E3025D9C8FF	B88F014E-BC0F-4775-8228-39E0B471C3B0	TCGA-33-4586-01A-01D-A320-08	HG19_Broad_variant	TCGA-33-4586	TCGA-LUSC	428.0	s10162	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	A320-08	True
13722.58cfa82de4b0c9d6adf6a53c	58cfa82de4b0c9d6adf6a53c	450a0ae734ab89c01b82ea2af8dacc92.filtered.	WGS	450a0ae734ab89c01b82ea2af8dacc92	450a0ae734ab89c01b82ea2af8dacc92.bam	75.68	1.83	0.09	58cfa82de4b0c9d6adf6a53c	450a0ae734ab89c01b82ea2af8dacc92.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A25B-01A	EADF8482-E60E-4307-ADB7-D5C3B9FA6CAE	Primary Tumor	Illumina HiSeq	372d2951-a381-41f0-88d7-72cc9da6b6db	Breast	39.0	2C619641-7849-4837-AB92-0DA80342B3E9	6E839EAF-1DBB-43F5-8846-C980E05540C7	TCGA-A2-A25B-01A-11D-A167-09	GRCh37-lite	TCGA-A2-A25B	TCGA-BRCA		s6761	Washington University School of Medicine	Walter Reed	United States	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A167-09	False
13767.58cfa839e4b0c9d6adf712ee	58cfa839e4b0c9d6adf712ee	UNCID_2281484.9cfe7287-c1aa-4fc0-8d4f-dc72655b2810.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2281484.9cfe7287-c1aa-4fc0-8d4f-dc72655b2810.sorted_genome_alignments	UNCID_2281484.9cfe7287-c1aa-4fc0-8d4f-dc72655b2810.sorted_genome_alignments.bam	62.02	1.75	0.15	58cfa839e4b0c9d6adf712ee	UNCID_2281484.9cfe7287-c1aa-4fc0-8d4f-dc72655b2810.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A2HH-01A	52FEF8A9-6860-48BD-B992-A56CCAD1243C	Primary Tumor	Illumina HiSeq	167054F1-A4CC-4B87-BCD2-3876DEE3ED15	Uterus	60.0	0E73EEAC-251A-43FA-9141-636262EE3129	9CFE7287-C1AA-4FC0-8D4F-DC72655B2810	TCGA-AX-A2HH-01A-11R-A32Y-07	HG19	TCGA-AX-A2HH	TCGA-UCEC		s4724	University of North Carolina	Gynecologic Oncology Group	United States	NO			Endometrioid endometrial adenocarcinoma		A32Y-07	True
13767.58cfa836e4b0c9d6adf6f4f2	58cfa836e4b0c9d6adf6f4f2	UNCID_1567041.2c56dc64-28cf-4b56-ac9d-1d7b906fd56d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1567041.2c56dc64-28cf-4b56-ac9d-1d7b906fd56d.sorted_genome_alignments	UNCID_1567041.2c56dc64-28cf-4b56-ac9d-1d7b906fd56d.sorted_genome_alignments.bam	0.2		0.16	58cfa836e4b0c9d6adf6f4f2	UNCID_1567041.2c56dc64-28cf-4b56-ac9d-1d7b906fd56d.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HW-7486-01A	55A67639-ED05-4143-AF96-A377BC5489EE	Primary Tumor	Illumina HiSeq	A5DA0B19-AE9A-493E-8EB5-E5EBA38770F2	Brain	37.0	F0C5DF7C-53AA-4D90-8189-44A2BB55A696	2C56DC64-28CF-4B56-AC9D-1D7B906FD56D	TCGA-HW-7486-01A-11R-2027-07	HG19	TCGA-HW-7486	TCGA-LGG		s8601	University of North Carolina	MSKCC	United States	NO			Oligodendroglioma		2027-07	True
13767.58cfa83be4b0c9d6adf7252a	58cfa83be4b0c9d6adf7252a	UNCID_2637038.fca16598-c7bf-46e5-a3d5-c30e0fd8866a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2637038.fca16598-c7bf-46e5-a3d5-c30e0fd8866a.sorted_genome_alignments	UNCID_2637038.fca16598-c7bf-46e5-a3d5-c30e0fd8866a.sorted_genome_alignments.bam	31.37	1.71	0.15	58cfa83be4b0c9d6adf7252a	UNCID_2637038.fca16598-c7bf-46e5-a3d5-c30e0fd8866a.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-FB-AAQ2-01A	F5558DC7-5BEF-426F-A6BF-B704FD5DBDA0	Primary Tumor	Illumina HiSeq	FED147E2-AB1F-4A1B-8705-8F876769CBAD	Pancreas	81.0	A180AB4A-9754-4E89-A00B-E0A0243D85B8	FCA16598-C7BF-46E5-A3D5-C30E0FD8866A	TCGA-FB-AAQ2-01A-31R-A41B-07	HG19	TCGA-FB-AAQ2	TCGA-PAAD	153.0	s911	University of North Carolina	Asterand	United States	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	A41B-07	True
13767.58cfa839e4b0c9d6adf71439	58cfa839e4b0c9d6adf71439	UNCID_2308451.efada68b-1ccd-4268-a636-0a4af550e15c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2308451.efada68b-1ccd-4268-a636-0a4af550e15c.sorted_genome_alignments	UNCID_2308451.efada68b-1ccd-4268-a636-0a4af550e15c.sorted_genome_alignments.bam	20.03	1.91	0.18	58cfa839e4b0c9d6adf71439	UNCID_2308451.efada68b-1ccd-4268-a636-0a4af550e15c.sorted_genome_alignments.bam					Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-A6NI-01A	2953131E-9C34-4FA2-8AF4-2C8D66EA2821	Primary Tumor	Illumina HiSeq	6FEA6B63-DEA9-40E8-9961-837DA15D0A75	Kidney		755C3447-77CE-40D7-BDB7-15CD08547ACE	EFADA68B-1CCD-4268-A636-0A4AF550E15C	TCGA-A3-A6NI-01A-11R-A33J-07	HG19	TCGA-A3-A6NI	TCGA-KIRC		s9849	University of North Carolina	International Genomics Consortium	United States	NO					A33J-07	True
13767.58cfa83be4b0c9d6adf72351	58cfa83be4b0c9d6adf72351	UNCID_2613068.4caa2b59-1435-4e64-9cf5-1658b3e9c147.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2613068.4caa2b59-1435-4e64-9cf5-1658b3e9c147.sorted_genome_alignments	UNCID_2613068.4caa2b59-1435-4e64-9cf5-1658b3e9c147.sorted_genome_alignments.bam	10.58	1.85	0.17	58cfa83be4b0c9d6adf72351	UNCID_2613068.4caa2b59-1435-4e64-9cf5-1658b3e9c147.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-XK-AAJT-01A	5D66AC77-1543-488B-A68F-665811BEC67A	Primary Tumor	Illumina HiSeq	4BCE0FB6-979A-43E4-82BD-83854709A7F3	Prostate	75.0	4791634B-BCD4-4FDA-ABDB-DEC79BA05086	4CAA2B59-1435-4E64-9CF5-1658B3E9C147	TCGA-XK-AAJT-01A-11R-A41O-07	HG19	TCGA-XK-AAJT	TCGA-PRAD		s3567	University of North Carolina	Mayo Clinic Arizona	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		A41O-07	True
13722.58cfa82ee4b0c9d6adf6a7f0	58cfa82ee4b0c9d6adf6a7f0	G32548.TCGA-EE-A2M5-10A-01D-A199-08.1.filtered.	WGS	G32548.TCGA-EE-A2M5-10A-01D-A199-08.1	G32548.TCGA-EE-A2M5-10A-01D-A199-08.1.bam	52.28		0.09	58cfa82ee4b0c9d6adf6a7f0	G32548.TCGA-EE-A2M5-10A-01D-A199-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2M5-10A	B5E37B9B-6264-4CC8-9B44-1D8AC0692D6C	Blood Derived Normal	Illumina HiSeq	48f84ddd-5849-4a0a-9f65-2f22c76c3943	Skin	49.0	0F5E478D-C3FA-44B6-8A17-BA0991516D60	3BF67116-BE87-4C02-B931-352EBB7F3B48	TCGA-EE-A2M5-10A-01D-A199-08	HG19_Broad_variant	TCGA-EE-A2M5	TCGA-SKCM	659.0	s7650	Broad Institute of MIT and Harvard	University of Sydney	Australia	NO	T2	N0		Stage I	A199-08	True
13767.58cfa834e4b0c9d6adf6e841	58cfa834e4b0c9d6adf6e841	UNCID_1233754.1059fbc0-46bf-4135-99d0-080ec225391b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1233754.1059fbc0-46bf-4135-99d0-080ec225391b.sorted_genome_alignments	UNCID_1233754.1059fbc0-46bf-4135-99d0-080ec225391b.sorted_genome_alignments.bam	111.8	1.8	0.15	58cfa834e4b0c9d6adf6e841	UNCID_1233754.1059fbc0-46bf-4135-99d0-080ec225391b.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5496-01A	6755C231-355F-4CC3-85F1-6306C7F5D44B	Primary Tumor	Illumina HiSeq	CAC9570E-E72C-4A75-BE16-7BC7A56BE7FD	Prostate	59.0	D0873929-EAC8-42E2-AF6F-DF3CB9CE698C	1059FBC0-46BF-4135-99D0-080EC225391B	TCGA-EJ-5496-01A-01R-1580-07	HG19	TCGA-EJ-5496	TCGA-PRAD		s3993	University of North Carolina	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		1580-07	True
13767.58cfa83ce4b0c9d6adf72c44	58cfa83ce4b0c9d6adf72c44	UNCID_404322.66c87341-61f8-4160-9078-e8e0603d7bf8.110707_UNC11-SN627_0117_BC03YCABXX.1.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_404322.66c87341-61f8-4160-9078-e8e0603d7bf8.110707_UNC11-SN627_0117_BC03YCABXX.1.trimmed.annotated.translated_to_genomic	UNCID_404322.66c87341-61f8-4160-9078-e8e0603d7bf8.110707_UNC11-SN627_0117_BC03YCABXX.1.trimmed.annotated.translated_to_genomic.bam	27.3	1.6	0.14	58cfa83ce4b0c9d6adf72c44	UNCID_404322.66c87341-61f8-4160-9078-e8e0603d7bf8.110707_UNC11-SN627_0117_BC03YCABXX.1.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5170-01A	30208A4C-ECB0-4B3C-A349-87E1C1F43E85	Primary Tumor	Illumina HiSeq	C4BE7299-209D-4A1F-A3D3-1081C8E37473	Kidney	55.0	1BCFFFD8-46B1-4D13-8188-0A9F8FDB2251	66C87341-61F8-4160-9078-E8E0603D7BF8	TCGA-BP-5170-01A-01R-1426-07	HG19	TCGA-BP-5170	TCGA-KIRC		s9901	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1426-07	True
13767.58cfa839e4b0c9d6adf711e8	58cfa839e4b0c9d6adf711e8	UNCID_2276586.6563f101-9cbe-4126-a5dd-fa33c694c257.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2276586.6563f101-9cbe-4126-a5dd-fa33c694c257.sorted_genome_alignments	UNCID_2276586.6563f101-9cbe-4126-a5dd-fa33c694c257.sorted_genome_alignments.bam	18.1	1.88	0.16	58cfa839e4b0c9d6adf711e8	UNCID_2276586.6563f101-9cbe-4126-a5dd-fa33c694c257.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-A74O-01A	723CAD09-AA2D-4492-B19D-661B310E1C58	Primary Tumor	Illumina HiSeq	909C6E70-AAA6-4426-8634-D86035D032B7	Brain	34.0	6B92979A-1629-4649-A631-9B1AE7FDC1F6	6563F101-9CBE-4126-A5DD-FA33C694C257	TCGA-HT-A74O-01A-11R-A32Q-07	HG19	TCGA-HT-A74O	TCGA-LGG		s8260	University of North Carolina	Case Western - St Joes	United States	NO			Astrocytoma		A32Q-07	True
13722.58cfa82fe4b0c9d6adf6b8fa	58cfa82fe4b0c9d6adf6b8fa	TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina.filtered.	WGS	TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina	TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina.bam	3.86	1.9	0.05	58cfa82fe4b0c9d6adf6b8fa	TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-3518-01A	C5C4A0A5-900D-483D-9282-475654D63265	Primary Tumor	Illumina HiSeq	e3929c47-b19b-4c57-9990-6448eb979647	Colorectal	81.0	BC08B757-ED0A-44C0-88CD-85496BB72A75	F4B9D98F-7B76-4EAA-9595-10B0973D5FF7	TCGA-AA-3518-01A-02D-1525-10	GRCh37-lite	TCGA-AA-3518	TCGA-COAD		s13663	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1525-10	True
13767.58cfa832e4b0c9d6adf6d76f	58cfa832e4b0c9d6adf6d76f	UNCID_1054324.a82887c2-9f01-41c0-8c74-2063aaf97261.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1054324.a82887c2-9f01-41c0-8c74-2063aaf97261.sorted_genome_alignments	UNCID_1054324.a82887c2-9f01-41c0-8c74-2063aaf97261.sorted_genome_alignments.bam	60.2	1.7	0.16	58cfa832e4b0c9d6adf6d76f	UNCID_1054324.a82887c2-9f01-41c0-8c74-2063aaf97261.sorted_genome_alignments.bam	Alive	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-63-6202-01A	E171B02C-DA2F-4452-A100-9ED989E73276	Primary Tumor	Illumina HiSeq	E50788C2-18A3-44E7-B176-A57B2A6C8A0F	Lung		C3A51666-BB41-4D90-8CBB-DD2F13E5C8F5	A82887C2-9F01-41C0-8C74-2063AAF97261	TCGA-63-6202-01A-11R-1820-07	HG19	TCGA-63-6202	TCGA-LUSC		s9996	University of North Carolina	Ontario Institute for Cancer Research	Canada	NO	T2b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	1820-07	True
13722.58cfa82fe4b0c9d6adf6b61e	58cfa82fe4b0c9d6adf6b61e	TCGA-75-5146-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-75-5146-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_5_rg.sorted	TCGA-75-5146-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_5_rg.sorted.bam	300.4	1.9	0.16	58cfa82fe4b0c9d6adf6b61e	TCGA-75-5146-10A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_5_rg.sorted.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-75-5146-10A	1D276B62-5E64-48FB-B2CE-5192B511FE37	Blood Derived Normal	Illumina HiSeq	22cccb1d-1901-4369-8c11-24895005a4df	Lung		5F68BDF1-1348-483B-8595-A8DB4044BF1F	0FB64824-EACC-4E60-B834-21E990B18FC5	TCGA-75-5146-10A-01D-1623-02	HG19_Broad_variant	TCGA-75-5146	TCGA-LUAD		s10798	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1623-02	True
13767.58cfa82fe4b0c9d6adf6b2f1	58cfa82fe4b0c9d6adf6b2f1	TCGA-24-1416-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-1416-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-24-1416-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	443.0	1.8	0.16	58cfa82fe4b0c9d6adf6b2f1	TCGA-24-1416-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1416-01A	F9793A4B-C0E7-4475-BF80-69543B7EE2F6	Primary Tumor	Illumina HiSeq	71C6FA8F-3F5F-4660-8E44-BFB02ACBDF5B	Ovary	34.0	7404E874-190E-4353-8755-1D9BE35EEDB7	67FCEA16-D5BC-4EDD-B66D-BFC5D56D976D	TCGA-24-1416-01A-01R-1565-13	GRCh37-lite	TCGA-24-1416	TCGA-OV		s17825	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa835e4b0c9d6adf6eddf	58cfa835e4b0c9d6adf6eddf	UNCID_1362867.eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1362867.eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b.sorted_genome_alignments	UNCID_1362867.eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b.sorted_genome_alignments.bam	115.2		0.16	58cfa835e4b0c9d6adf6eddf	UNCID_1362867.eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7748-01A	F6040682-4999-4D71-ABC2-354B473C6980	Primary Tumor	Illumina HiSeq	C8C6F93E-22A3-4303-A243-0E76525BACB8	Prostate	60.0	8C97A468-F8AF-4A81-912F-AC153AA98A08	EB9C4BC2-F85E-4EC1-BD7F-BA2EFF32FF1B	TCGA-HC-7748-01A-11R-2118-07	HG19	TCGA-HC-7748	TCGA-PRAD		s3666	University of North Carolina	International Genomics Consortium	United States	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13722.58cfa82ee4b0c9d6adf6aa3e	58cfa82ee4b0c9d6adf6aa3e	G26383.TCGA-02-2485-10A-01D-1494-08.1.filtered.	WGS	G26383.TCGA-02-2485-10A-01D-1494-08.1	G26383.TCGA-02-2485-10A-01D-1494-08.1.bam	83.0	1.9	0.05	58cfa82ee4b0c9d6adf6aa3e	G26383.TCGA-02-2485-10A-01D-1494-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-02-2485-10A	521EA765-1BD1-423D-A75D-091243DF37A9	Blood Derived Normal	Illumina HiSeq	47eadee3-8b51-492f-bbd2-2ae4e75e124c	Brain	53.0	1CC3998F-318A-4C25-8CCD-A720059FAFAD	8FAA4B6D-6C64-4C03-BB3D-E2D33DB491B0	TCGA-02-2485-10A-01D-1494-08	HG19_Broad_variant	TCGA-02-2485	TCGA-GBM		s14303	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO			Untreated primary (de novo) GBM		1494-08	True
13767.58cfa832e4b0c9d6adf6d73e	58cfa832e4b0c9d6adf6d73e	UNCID_1067477.f31fd0a1-b600-42bc-a6fa-689c05a581ce.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1067477.f31fd0a1-b600-42bc-a6fa-689c05a581ce.sorted_genome_alignments	UNCID_1067477.f31fd0a1-b600-42bc-a6fa-689c05a581ce.sorted_genome_alignments.bam	343.0	1.8	0.14	58cfa832e4b0c9d6adf6d73e	UNCID_1067477.f31fd0a1-b600-42bc-a6fa-689c05a581ce.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-33-4547-01A	44B1D457-3A50-404E-B54C-CA619262BC2F	Primary Tumor	Illumina HiSeq	8A3CFE07-1EF9-46CF-B9AA-A6733E711E34	Lung	68.0	0D7C693E-B6F6-4EE0-8F13-D1CE1033BFAE	F31FD0A1-B600-42BC-A6FA-689C05A581CE	TCGA-33-4547-01A-01R-1201-07	HG19	TCGA-33-4547	TCGA-LUSC		s10009	University of North Carolina	Johns Hopkins	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1201-07	True
13767.58cfa82ee4b0c9d6adf6ab5c	58cfa82ee4b0c9d6adf6ab5c	G17674.TCGA-12-1597-01B-01R-1849-01.2.filtered.	RNA-Seq	G17674.TCGA-12-1597-01B-01R-1849-01.2	G17674.TCGA-12-1597-01B-01R-1849-01.2.bam	21.7	1.8	0.13	58cfa82ee4b0c9d6adf6ab5c	G17674.TCGA-12-1597-01B-01R-1849-01.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-12-1597-01B	2B82E941-1B16-444E-AF41-24DBC0A7E8B5	Primary Tumor	Illumina HiSeq	055E3C6B-E021-49F1-ABC0-F4C6CB454117	Brain	62.0	496B5FDA-B5BF-4997-9569-33FD6AE0E78C	6F54BCD2-99E9-4F9B-A9B8-6963B922F783	TCGA-12-1597-01B-01R-1849-01	HG19_Broad_variant	TCGA-12-1597	TCGA-GBM	675.0	s14296	Broad Institute of MIT and Harvard	Duke	None	NO			Untreated primary (de novo) GBM		1849-01	True
13767.58cfa837e4b0c9d6adf7033a	58cfa837e4b0c9d6adf7033a	UNCID_1821752.902592e6-c7c5-46b8-b70b-5520df79a8a3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1821752.902592e6-c7c5-46b8-b70b-5520df79a8a3.sorted_genome_alignments	UNCID_1821752.902592e6-c7c5-46b8-b70b-5520df79a8a3.sorted_genome_alignments.bam	23.93	1.86	0.16	58cfa837e4b0c9d6adf7033a	UNCID_1821752.902592e6-c7c5-46b8-b70b-5520df79a8a3.sorted_genome_alignments.bam					Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A3TM-01A	67C73260-A242-4BBA-87C5-D2302556DFF7	Primary Tumor	Illumina HiSeq	08EC52D0-24D5-48AA-9CEE-2C6953D56B5A	Breast		4EE0389F-33EC-4A69-BC02-1C458D812CB2	902592E6-C7C5-46B8-B70B-5520DF79A8A3	TCGA-AC-A3TM-01A-11R-A22K-07	HG19	TCGA-AC-A3TM	TCGA-BRCA		s5919	University of North Carolina	International Genomics Consortium	United States	NO					A22K-07	True
13767.58cfa836e4b0c9d6adf6f4f6	58cfa836e4b0c9d6adf6f4f6	UNCID_1569618.8204b99d-4224-4bb9-b297-413956b203ee.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1569618.8204b99d-4224-4bb9-b297-413956b203ee.sorted_genome_alignments	UNCID_1569618.8204b99d-4224-4bb9-b297-413956b203ee.sorted_genome_alignments.bam	33.2		0.14	58cfa836e4b0c9d6adf6f4f6	UNCID_1569618.8204b99d-4224-4bb9-b297-413956b203ee.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-7637-01A	C40AB957-FE46-43B1-992D-B4E2040A3F57	Primary Tumor	Illumina HiSeq	A8AF88DD-C7EC-4157-857E-5D4DD0259EFD	Brain	49.0	B8E91848-0443-4333-AA38-B8551EB5C5F0	8204B99D-4224-4BB9-B297-413956B203EE	TCGA-FG-7637-01A-11R-2090-07	HG19	TCGA-FG-7637	TCGA-LGG		s8611	University of North Carolina	Case Western	United States	NO			Oligoastrocytoma		2090-07	True
13767.58cfa82ee4b0c9d6adf6aa10	58cfa82ee4b0c9d6adf6aa10	G17785.TCGA-06-5413-01A-01R-1849-01.4.filtered.	RNA-Seq	G17785.TCGA-06-5413-01A-01R-1849-01.4	G17785.TCGA-06-5413-01A-01R-1849-01.4.bam	211.2	1.8	0.16	58cfa82ee4b0c9d6adf6aa10	G17785.TCGA-06-5413-01A-01R-1849-01.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-5413-01A	8D2E88D9-D8D0-4C42-8AA2-205A788DEA58	Primary Tumor	Illumina HiSeq	4CF1E838-A8B3-46E0-BF70-2362E2DC2ECD	Brain	67.0	7CFDDAE2-AA56-485B-9DD7-B3B235ABAE2C	48F886D5-BB04-4FD1-809C-4B85730C4208	TCGA-06-5413-01A-01R-1849-01	HG19_Broad_variant	TCGA-06-5413	TCGA-GBM		s13887	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13767.58cfa82fe4b0c9d6adf6b586	58cfa82fe4b0c9d6adf6b586	TCGA-30-1714-01A-02R-1567-13_rnaseq.filtered.	RNA-Seq	TCGA-30-1714-01A-02R-1567-13_rnaseq	TCGA-30-1714-01A-02R-1567-13_rnaseq.bam	178.0	1.8	0.15	58cfa82fe4b0c9d6adf6b586	TCGA-30-1714-01A-02R-1567-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-30-1714-01A	09820A33-80B1-42D0-8366-A0DDAF94B122	Primary Tumor	Illumina HiSeq	9783876F-85D6-48E4-8FB9-F0F8EF90A8BF	Ovary	68.0	44B8B591-5DD6-4B93-BD8F-D1C3284AF41F	C990F93E-C4E1-4192-B948-31A5BDA0FF72	TCGA-30-1714-01A-02R-1567-13	NCBI36_BCCAGSC_variant	TCGA-30-1714	TCGA-OV	1158.0	s17633	Canada's Michael Smith Genome Sciences Centre	Harvard	None	NO			Serous Cystadenocarcinoma		1567-13	True
13767.58cfa834e4b0c9d6adf6e954	58cfa834e4b0c9d6adf6e954	UNCID_1229477.20c29e50-f961-465c-aa22-12e9ab187e71.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1229477.20c29e50-f961-465c-aa22-12e9ab187e71.sorted_genome_alignments	UNCID_1229477.20c29e50-f961-465c-aa22-12e9ab187e71.sorted_genome_alignments.bam	31.3	1.8	0.14	58cfa834e4b0c9d6adf6e954	UNCID_1229477.20c29e50-f961-465c-aa22-12e9ab187e71.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4628-01A	CC4BD56A-25C5-4C48-B583-AC3AEB778CA6	Primary Tumor	Illumina HiSeq	045ACB69-6E73-4E69-9023-2422F9633CFD	Lung	65.0	A74F6423-B5D3-4AE2-B61F-3EE04B1073BF	20C29E50-F961-465C-AA22-12E9AB187E71	TCGA-38-4628-01A-01R-1206-07	HG19	TCGA-38-4628	TCGA-LUAD	1492.0	s10847	University of North Carolina	UNC	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1206-07	True
13722.58cfa82de4b0c9d6adf6a6ec	58cfa82de4b0c9d6adf6a6ec	9730009cb05430035cc9988462351cef.filtered.	WGS	9730009cb05430035cc9988462351cef	9730009cb05430035cc9988462351cef.bam	38.58	2.02	0.08	58cfa82de4b0c9d6adf6a6ec	9730009cb05430035cc9988462351cef.bam	Alive	FEMALE			Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A0TX-01A	C364E81C-EB1E-4870-AB37-9C661F5F2E3D	Primary Tumor	Illumina HiSeq	e9fddd42-1948-4df8-ac61-4db49de8123f	Breast	64.0	D5ADAF35-04B1-4198-B308-F4720B3D6417	DDC7377D-82C3-480A-BE3C-3D1DA52C77D4	TCGA-AR-A0TX-01A-11D-A19H-09	GRCh37-lite	TCGA-AR-A0TX	TCGA-BRCA		s5632	Washington University School of Medicine	Mayo	None	NO	T1	N1	Infiltrating Ductal Carcinoma	Stage II	A19H-09	True
13767.58cfa833e4b0c9d6adf6dc06	58cfa833e4b0c9d6adf6dc06	UNCID_1106541.6491f391-9704-4249-bc81-d712e755ec74.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1106541.6491f391-9704-4249-bc81-d712e755ec74.sorted_genome_alignments	UNCID_1106541.6491f391-9704-4249-bc81-d712e755ec74.sorted_genome_alignments.bam	44.99	1.86	0.15	58cfa833e4b0c9d6adf6dc06	UNCID_1106541.6491f391-9704-4249-bc81-d712e755ec74.sorted_genome_alignments.bam	Alive	MALE	WHITE		Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AD-01A	88A521CE-A5E9-4C6F-83D4-EC36A62FEDB6	Primary Tumor	Illumina HiSeq	384E33E5-B8E4-4523-9367-17F776AADCBB	Bladder	69.0	C79F4327-675D-4651-994D-E683096DF9C3	6491F391-9704-4249-BC81-D712E755EC74	TCGA-DK-A1AD-01A-11R-A13Y-07	HG19	TCGA-DK-A1AD	TCGA-BLCA		s3132	University of North Carolina	Memorial Sloan Kettering	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13Y-07	True
13722.58cfa832e4b0c9d6adf6ceb4	58cfa832e4b0c9d6adf6ceb4	TCGA-EX-A3L1-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EX-A3L1-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_5_rg.sorted	TCGA-EX-A3L1-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_5_rg.sorted.bam	11.52		0.15	58cfa832e4b0c9d6adf6ceb4	TCGA-EX-A3L1-10A-01D-A245_140124_SN1440_0179_BD2DRDACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EX-A3L1-10A	F5D90810-8C4B-4CED-9360-383E42CB54B3	Blood Derived Normal	Illumina HiSeq	bfcd19d2-9301-411b-856a-ee0acb688dff	Cervix	32.0	92F592AF-39F4-4772-83BA-83D303BD1D60	2536ACAB-8A96-4ACC-ABE2-30701C9E79D9	TCGA-EX-A3L1-10A-01D-A245-26	HG19_Broad_variant	TCGA-EX-A3L1	TCGA-CESC		s1529	MD Anderson - Institute for Applied Cancer Science	University of North Carolina	United States	NO	T2a1	N0	Cervical Squamous Cell Carcinoma		A245-26	True
13767.58cfa837e4b0c9d6adf6fe34	58cfa837e4b0c9d6adf6fe34	UNCID_1726923.a6adbcc1-dc20-4d7f-8397-d699a64287e0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1726923.a6adbcc1-dc20-4d7f-8397-d699a64287e0.sorted_genome_alignments	UNCID_1726923.a6adbcc1-dc20-4d7f-8397-d699a64287e0.sorted_genome_alignments.bam	127.2		0.15	58cfa837e4b0c9d6adf6fe34	UNCID_1726923.a6adbcc1-dc20-4d7f-8397-d699a64287e0.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KN-8429-11A	366219B9-FDE3-4D2D-82D3-15FE6245AA98	Solid Tissue Normal	Illumina HiSeq	1D57ACDA-7CE2-466F-B0BF-E176811051F8	Kidney	38.0	F69DE2AF-C874-4667-B028-D1ED4FF5A11B	A6ADBCC1-DC20-4D7F-8397-D699A64287E0	TCGA-KN-8429-11A-01R-2315-07	HG19	TCGA-KN-8429	TCGA-KICH		s16510	University of North Carolina	Harvard	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2315-07	True
13722.58cfa831e4b0c9d6adf6cbb8	58cfa831e4b0c9d6adf6cbb8	TCGA-EK-A2PM-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EK-A2PM-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_6_rg.sorted	TCGA-EK-A2PM-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_6_rg.sorted.bam	122.14		0.17	58cfa831e4b0c9d6adf6cbb8	TCGA-EK-A2PM-10A-01D-A18I_140204_SN208_0508_BC2R1UACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2PM-10A	085FB6D8-6265-484E-9307-8292386714B7	Blood Derived Normal	Illumina HiSeq	c41a041f-a7af-40aa-b516-42ca0cca7082	Cervix	81.0	B62127DC-8526-4099-AFC3-BE2E295C7DEE	7A8CDBE5-834A-49F0-88D7-20F0D0E7127F	TCGA-EK-A2PM-10A-01D-A18I-02	HG19_Broad_variant	TCGA-EK-A2PM	TCGA-CESC		s1189	Harvard Medical School	Gynecologic Oncology Group	United States	NO			Cervical Squamous Cell Carcinoma		A18I-02	True
13722.58cfa83ce4b0c9d6adf72f85	58cfa83ce4b0c9d6adf72f85	aa376a5704c441fe39ce1a21a53e5eaa.filtered.	WGS	aa376a5704c441fe39ce1a21a53e5eaa	aa376a5704c441fe39ce1a21a53e5eaa.bam	29.16	1.98	0.08	58cfa83ce4b0c9d6adf72f85	aa376a5704c441fe39ce1a21a53e5eaa.bam	Alive	FEMALE		HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JM-10A	44BEC761-B603-49C0-8634-F6BFE0319BB1	Blood Derived Normal	Illumina HiSeq	ef8744a1-5a99-4907-a1ad-fd44bb54635d	Breast	40.0	0D7F390B-70D7-42EE-879C-B399A3D84A6A	440CC94E-413D-464C-9160-91D4B0F81D18	TCGA-AO-A0JM-10A-01D-A19H-09	GRCh37-lite	TCGA-AO-A0JM	TCGA-BRCA		s5777	Washington University School of Medicine	MSKCC	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A19H-09	True
13767.58cfa82fe4b0c9d6adf6b3b6	58cfa82fe4b0c9d6adf6b3b6	TCGA-24-1419-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-1419-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-24-1419-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	432.0	1.8	0.15	58cfa82fe4b0c9d6adf6b3b6	TCGA-24-1419-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1419-01A	5E18B17D-4626-4B6D-8AC6-E560CEE0376C	Primary Tumor	Illumina HiSeq	135CC427-4FD8-448F-807D-AAC770AF5ADB	Ovary	62.0	92D562DF-4A58-43DA-8811-843D3D3C9438	7BF43D51-2714-419E-A52F-863CA54C90E5	TCGA-24-1419-01A-01R-1565-13	GRCh37-lite	TCGA-24-1419	TCGA-OV		s17935	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1565-13	True
13722.58cfa82de4b0c9d6adf6a512	58cfa82de4b0c9d6adf6a512	3272b46f2b0b4ced2d306818a7890234.filtered.	WGS	3272b46f2b0b4ced2d306818a7890234	3272b46f2b0b4ced2d306818a7890234.bam	14.97		0.08	58cfa82de4b0c9d6adf6a512	3272b46f2b0b4ced2d306818a7890234.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LS-10A	39F68467-3D37-4B19-AA43-ED7B120C619D	Blood Derived Normal	Illumina HiSeq	e0e17855-f2c6-4b51-a6e0-09f313c6f967	Mesenchymal	78.0	1896CA69-CC92-479E-855F-A47EE30A1C62	DC2E1F2D-585D-4DAB-9BB2-AEE31EE5B436	TCGA-DX-A3LS-10A-01D-A21Q-09	GRCh37-lite	TCGA-DX-A3LS	TCGA-SARC	275.0	s2639	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO					A21Q-09	True
13767.58cfa833e4b0c9d6adf6def0	58cfa833e4b0c9d6adf6def0	UNCID_1140446.7aa46530-2311-41ed-a452-9ca06f38c0c1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1140446.7aa46530-2311-41ed-a452-9ca06f38c0c1.sorted_genome_alignments	UNCID_1140446.7aa46530-2311-41ed-a452-9ca06f38c0c1.sorted_genome_alignments.bam	15.53	1.86	0.15	58cfa833e4b0c9d6adf6def0	UNCID_1140446.7aa46530-2311-41ed-a452-9ca06f38c0c1.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A14T-01A	E0929C47-CFF3-4518-A188-8764AF01073A	Primary Tumor	Illumina HiSeq	D6DF6862-FB3A-44D9-9E98-C7C01AD6A6CA	Breast	52.0	AEEA59AD-9570-41C9-9244-348E1C8350FD	7AA46530-2311-41ED-A452-9CA06F38C0C1	TCGA-E2-A14T-01A-11R-A115-07	HG19	TCGA-E2-A14T	TCGA-BRCA		s6167	University of North Carolina	Roswell Park	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A115-07	True
13767.58cfa838e4b0c9d6adf70b98	58cfa838e4b0c9d6adf70b98	UNCID_2146723.1b2499f7-bb3e-472a-8216-68b2e137357c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2146723.1b2499f7-bb3e-472a-8216-68b2e137357c.sorted_genome_alignments	UNCID_2146723.1b2499f7-bb3e-472a-8216-68b2e137357c.sorted_genome_alignments.bam	20.62	1.84	0.16	58cfa838e4b0c9d6adf70b98	UNCID_2146723.1b2499f7-bb3e-472a-8216-68b2e137357c.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A5SH-06A	AA597E8B-7813-4837-B778-4DAFE3B091BB	Metastatic	Illumina HiSeq	E929CBD0-E5FA-44C8-85B0-F5CAD10C66B5	Skin	60.0	CB24E9F9-CBFE-4CEB-92FC-98724E21266C	1B2499F7-BB3E-472A-8216-68B2E137357C	TCGA-EB-A5SH-06A-11R-A311-07	HG19	TCGA-EB-A5SH	TCGA-SKCM		s8083	University of North Carolina	Asterand	Russia	NO	T4	N0		Stage III	A311-07	True
13767.58cfa838e4b0c9d6adf7054f	58cfa838e4b0c9d6adf7054f	UNCID_1913826.f3c5b879-2ca4-4d16-972b-6ed8f82b97a1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1913826.f3c5b879-2ca4-4d16-972b-6ed8f82b97a1.sorted_genome_alignments	UNCID_1913826.f3c5b879-2ca4-4d16-972b-6ed8f82b97a1.sorted_genome_alignments.bam	116.2		0.13	58cfa838e4b0c9d6adf7054f	UNCID_1913826.f3c5b879-2ca4-4d16-972b-6ed8f82b97a1.sorted_genome_alignments.bam					Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-7823-01B	7B236171-2E7A-4018-B297-560EA8279EC0	Primary Tumor	Illumina HiSeq	DB3C838A-9667-4697-AD77-DD76AB86D73C	Lung		0B8CC0DC-76AE-4F0F-AEBB-FF6813602E33	F3C5B879-2CA4-4D16-972B-6ED8F82B97A1	TCGA-56-7823-01B-11R-2247-07	HG19	TCGA-56-7823	TCGA-LUSC		s10317	University of North Carolina	International Genomics Consortium	United States	NO					2247-07	True
13722.58cfa831e4b0c9d6adf6c5e4	58cfa831e4b0c9d6adf6c5e4	TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted	TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted.bam	215.4	1.9	0.14	58cfa831e4b0c9d6adf6c5e4	TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted.bam	Alive	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4437-01A	6244E506-D163-4D34-8FEC-6158191679CB	Primary Tumor	Illumina HiSeq	ff02c427-3a7b-4e29-9ddc-0b8034807ad6	Stomach	83.0	A882F6C0-D12D-4D49-9A2A-3850EA736C37	B6D1C576-6AB8-4759-B1B0-6E18DC162962	TCGA-CG-4437-01A-01D-1798-02	HG19_Broad_variant	TCGA-CG-4437	TCGA-STAD		s14553	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1798-02	True
13767.58cfa834e4b0c9d6adf6e5fd	58cfa834e4b0c9d6adf6e5fd	UNCID_1195597.bcab2c32-2220-4d3f-920f-81af3a7df7eb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1195597.bcab2c32-2220-4d3f-920f-81af3a7df7eb.sorted_genome_alignments	UNCID_1195597.bcab2c32-2220-4d3f-920f-81af3a7df7eb.sorted_genome_alignments.bam	0.0	1.8	0.13	58cfa834e4b0c9d6adf6e5fd	UNCID_1195597.bcab2c32-2220-4d3f-920f-81af3a7df7eb.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5455-11A	74749FE8-F5D0-4D0D-8C7A-E56EBA6503B3	Solid Tissue Normal	Illumina HiSeq	99D30414-CBEA-4F34-BE1B-8D6A56042E02	Kidney	63.0	4206B385-00CC-4540-9BB0-92CE8E1B7201	BCAB2C32-2220-4D3F-920F-81AF3A7DF7EB	TCGA-CZ-5455-11A-01R-1503-07	HG19	TCGA-CZ-5455	TCGA-KIRC	561.0	s9218	University of North Carolina	Harvard	None	NO	T3b	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1503-07	True
13767.58cfa834e4b0c9d6adf6e462	58cfa834e4b0c9d6adf6e462	UNCID_1191207.627e1c9b-194b-4bd8-aa60-57400a2682a6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1191207.627e1c9b-194b-4bd8-aa60-57400a2682a6.sorted_genome_alignments	UNCID_1191207.627e1c9b-194b-4bd8-aa60-57400a2682a6.sorted_genome_alignments.bam	38.3	1.8	0.16	58cfa834e4b0c9d6adf6e462	UNCID_1191207.627e1c9b-194b-4bd8-aa60-57400a2682a6.sorted_genome_alignments.bam	Dead	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4974-01A	D6625C4D-CD1C-4C62-8100-E8B2A49CE3AD	Primary Tumor	Illumina HiSeq	A18E8598-CE5A-4FFA-A15D-686999D095BF	Kidney	58.0	A75C92B2-C67B-42B5-A8C2-7EEA1B567ED0	627E1C9B-194B-4BD8-AA60-57400A2682A6	TCGA-BP-4974-01A-01R-1334-07	HG19	TCGA-BP-4974	TCGA-KIRC	220.0	s9952	University of North Carolina	MSKCC	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1334-07	True
13767.58cfa838e4b0c9d6adf70435	58cfa838e4b0c9d6adf70435	UNCID_1965938.c8762ae1-49de-496d-a00f-4cde20bbd3af.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1965938.c8762ae1-49de-496d-a00f-4cde20bbd3af.sorted_genome_alignments	UNCID_1965938.c8762ae1-49de-496d-a00f-4cde20bbd3af.sorted_genome_alignments.bam	8.13	1.87	0.15	58cfa838e4b0c9d6adf70435	UNCID_1965938.c8762ae1-49de-496d-a00f-4cde20bbd3af.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-A44F-01A	258A3A41-211B-4C66-BD3B-EF03014A6967	Primary Tumor	Illumina HiSeq	BF00EC89-AAB6-4125-97C3-5AAACA43F6A7	Lung	80.0	45C17476-0525-46D2-8448-48D4DE6713F1	C8762AE1-49DE-496D-A00F-4CDE20BBD3AF	TCGA-38-A44F-01A-11R-A24H-07	HG19	TCGA-38-A44F	TCGA-LUAD		s11407	University of North Carolina	UNC	United States	NO	T2a	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	A24H-07	True
13767.58cfa83be4b0c9d6adf728d2	58cfa83be4b0c9d6adf728d2	UNCID_355767.TCGA-B0-5095-01A-01R-1420-07.110525_UNC14-SN744_0118_AD0D60ABXX.1.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_355767.TCGA-B0-5095-01A-01R-1420-07.110525_UNC14-SN744_0118_AD0D60ABXX.1.trimmed.annotated.translated_to_genomic	UNCID_355767.TCGA-B0-5095-01A-01R-1420-07.110525_UNC14-SN744_0118_AD0D60ABXX.1.trimmed.annotated.translated_to_genomic.bam	114.63	1.8	0.14	58cfa83be4b0c9d6adf728d2	UNCID_355767.TCGA-B0-5095-01A-01R-1420-07.110525_UNC14-SN744_0118_AD0D60ABXX.1.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5095-01A	616BC43C-34B9-48E8-8219-4EF4D052F91B	Primary Tumor	Illumina HiSeq	17AB5DC9-5CAD-4346-B782-24915A9A1BA2	Kidney	81.0	48A1A40D-462F-47E2-81AD-ED3C80F04552	C4F3E6E5-6B8B-4ECD-9FD7-99797D9A100B	TCGA-B0-5095-01A-01R-1420-07	HG19	TCGA-B0-5095	TCGA-KIRC	245.0	s9862	University of North Carolina	University of Pittsburgh	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1420-07	True
13767.58cfa830e4b0c9d6adf6c114	58cfa830e4b0c9d6adf6c114	TCGA-BR-A4J8-01A-11R-A251-31_rnaseq.filtered.	RNA-Seq	TCGA-BR-A4J8-01A-11R-A251-31_rnaseq	TCGA-BR-A4J8-01A-11R-A251-31_rnaseq.bam	21.45	1.9	0.17	58cfa830e4b0c9d6adf6c114	TCGA-BR-A4J8-01A-11R-A251-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-A4J8-01A	1EB2038D-3B4F-4DA2-964B-E629EA068215	Primary Tumor	Illumina HiSeq	6C52E193-ED56-482A-AF6E-47BA1C705FD8	Stomach	71.0	A0B8DF23-4EF7-4008-9576-B2F57F1EE8E2	38A69C3C-5B72-4CDE-B686-37AD6BB979B3	TCGA-BR-A4J8-01A-11R-A251-31	GRCh37-lite	TCGA-BR-A4J8	TCGA-STAD		s14407	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	A251-31	True
13767.58cfa839e4b0c9d6adf71072	58cfa839e4b0c9d6adf71072	UNCID_2245712.a378a703-e62d-4860-aec0-caa90f5af30f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2245712.a378a703-e62d-4860-aec0-caa90f5af30f.sorted_genome_alignments	UNCID_2245712.a378a703-e62d-4860-aec0-caa90f5af30f.sorted_genome_alignments.bam	23.24	1.9	0.18	58cfa839e4b0c9d6adf71072	UNCID_2245712.a378a703-e62d-4860-aec0-caa90f5af30f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28W-11A	A6D37F61-BECA-46EA-A59A-62257475AC77	Solid Tissue Normal	Illumina HiSeq	F814E0E1-EF3C-4F52-8A39-50BA3C8CC664	Thyroid	32.0	1A0C8FE8-A0F6-4266-80AF-79539C538FED	A378A703-E62D-4860-AEC0-CAA90F5AF30F	TCGA-BJ-A28W-11A-11R-A32Y-07	HG19	TCGA-BJ-A28W	TCGA-THCA		s12211	University of North Carolina	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A32Y-07	True
13767.58cfa838e4b0c9d6adf709c6	58cfa838e4b0c9d6adf709c6	UNCID_2075159.34b3ffb2-9fd1-4521-856a-f465f537804b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2075159.34b3ffb2-9fd1-4521-856a-f465f537804b.sorted_genome_alignments	UNCID_2075159.34b3ffb2-9fd1-4521-856a-f465f537804b.sorted_genome_alignments.bam	9.45	1.92	0.18	58cfa838e4b0c9d6adf709c6	UNCID_2075159.34b3ffb2-9fd1-4521-856a-f465f537804b.sorted_genome_alignments.bam	Alive	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-63-A5MV-01A	8D18E026-668B-4513-9C68-9E03B18592E3	Primary Tumor	Illumina HiSeq	EC4FFF69-940F-40A3-8C9C-3137AEDD3511	Lung	69.0	7CAC4663-B026-4CEE-84A4-866EE8E1447C	34B3FFB2-9FD1-4521-856A-F465F537804B	TCGA-63-A5MV-01A-21R-A26W-07	HG19	TCGA-63-A5MV	TCGA-LUSC		s10470	University of North Carolina	Ontario Institute for Cancer Research	Canada	NO	T2b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A26W-07	True
13722.58cfa82ee4b0c9d6adf6ad50	58cfa82ee4b0c9d6adf6ad50	G39020.TCGA-BR-8486-10A-01D-2394-08.2.filtered.	WGS	G39020.TCGA-BR-8486-10A-01D-2394-08.2	G39020.TCGA-BR-8486-10A-01D-2394-08.2.bam	225.0		0.05	58cfa82ee4b0c9d6adf6ad50	G39020.TCGA-BR-8486-10A-01D-2394-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8486-10A	B8A1C8C7-3945-4D84-8F58-3A1A1EB10730	Blood Derived Normal	Illumina HiSeq	4a10b9ff-71a3-46a4-8cca-d0b4f7dfec66	Stomach	90.0	AFED9302-CE38-41B4-BF0F-BC583BB6F473	0FA8CEE4-2D26-4CAF-9DA2-96047854F29F	TCGA-BR-8486-10A-01D-2394-08	HG19_Broad_variant	TCGA-BR-8486	TCGA-STAD		s14804	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T1b	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	2394-08	True
13722.58cfa831e4b0c9d6adf6ca92	58cfa831e4b0c9d6adf6ca92	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.bam	98.7	1.9	0.15	58cfa831e4b0c9d6adf6ca92	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5624-01A	B4A41682-4ACA-4F1D-BACD-66F5E6EC7466	Primary Tumor	Illumina HiSeq	72ea153a-e312-4f8e-8fa6-bd705df2b106	Head and Neck	43.0	39A74037-6C20-4713-A6AA-E972218EFF90	45F819EB-F6B5-4B82-9E47-060B2E111851	TCGA-DQ-5624-01A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5624	TCGA-HNSC		s15532	Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma		1868-02	True
13722.58cfa831e4b0c9d6adf6c6fe	58cfa831e4b0c9d6adf6c6fe	TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted	TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted.bam	37.0	1.9	0.13	58cfa831e4b0c9d6adf6c6fe	TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5970-11A	1F6167D9-C99D-4873-8D6E-E62A1C964135	Solid Tissue Normal	Illumina HiSeq	004bd2ad-a03c-45c2-9e51-6051014fe91b	Head and Neck	59.0	EF1AEFD1-1B8F-4840-9037-282DE48ED7F7	B31C32DB-0966-4A8A-AD18-0F5EDAFBBCCB	TCGA-CV-5970-11A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5970	TCGA-HNSC	406.0	s16337	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IV	1681-02	True
13767.58cfa837e4b0c9d6adf6fcfa	58cfa837e4b0c9d6adf6fcfa	UNCID_1722396.811B2337-58EC-416A-9C72-7E89A05459CE.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1722396.811B2337-58EC-416A-9C72-7E89A05459CE.sorted_genome_alignments	UNCID_1722396.811B2337-58EC-416A-9C72-7E89A05459CE.sorted_genome_alignments.bam	38.88	1.86	0.16	58cfa837e4b0c9d6adf6fcfa	UNCID_1722396.811B2337-58EC-416A-9C72-7E89A05459CE.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A40T-01A	2CAE34A6-73A0-4A67-8DCC-051468C41389	Primary Tumor	Illumina HiSeq	6604B5E8-9E0E-4514-A7B9-3B83B3CD78A7	Thyroid	26.0	2D7FF8FF-DE00-4C54-8096-46A2DC0729E4	811B2337-58EC-416A-9C72-7E89A05459CE	TCGA-ET-A40T-01A-11R-A23N-07	HG19	TCGA-ET-A40T	TCGA-THCA		s12068	University of North Carolina	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23N-07	True
13722.58cfa82ee4b0c9d6adf6aed4	58cfa82ee4b0c9d6adf6aed4	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.filtered.	WGS	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.bam	53.65		0.07	58cfa82ee4b0c9d6adf6aed4	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CP-01A	2F59F12D-CA0C-4AC6-9718-98A6D455AF46	Primary Tumor	Illumina HiSeq	3bca46e2-dbce-4b1c-8aec-37cc8615d471	Thyroid	26.0	043765F1-FFBD-4AC9-B0AE-733C3643083D	B8CD6882-BE27-4742-BC63-3227D31BF704	TCGA-EM-A2CP-01A-11D-A17V-08	HG19_Broad_variant	TCGA-EM-A2CP	TCGA-THCA		s12095	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A17V-08	True
13722.58cfa830e4b0c9d6adf6bf2e	58cfa830e4b0c9d6adf6bf2e	TCGA-BR-4255-01A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-4255-01A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_7_rg.sorted	TCGA-BR-4255-01A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_7_rg.sorted.bam	0.0	1.9	0.13	58cfa830e4b0c9d6adf6bf2e	TCGA-BR-4255-01A-01D-1128_120816_SN590_0176_BD13T7ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4255-01A	956017BA-5E4B-42C7-B93D-42316874BA93	Primary Tumor	Illumina HiSeq	17f1cd5b-fb98-46b4-bfb0-906c39341a06	Stomach	76.0	A64A7CB8-BA30-45A3-B1DC-2A62D6B1919F	11EA17E5-60EF-4695-866B-B328A51D15A9	TCGA-BR-4255-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4255	TCGA-STAD		s14741	Harvard Medical School	Asterand	Russia	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1128-02	True
13767.58cfa835e4b0c9d6adf6f11e	58cfa835e4b0c9d6adf6f11e	UNCID_1457485.0bf79d69-9960-4881-a7a7-2eabe048f81f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1457485.0bf79d69-9960-4881-a7a7-2eabe048f81f.sorted_genome_alignments	UNCID_1457485.0bf79d69-9960-4881-a7a7-2eabe048f81f.sorted_genome_alignments.bam	54.05	1.86	0.16	58cfa835e4b0c9d6adf6f11e	UNCID_1457485.0bf79d69-9960-4881-a7a7-2eabe048f81f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3N3-01A	00A02E62-E1AB-467A-91B3-5F526DD2251A	Primary Tumor	Illumina HiSeq	2FE4801C-ACA7-4FE0-B841-AAB0249EAC6C	Thyroid	53.0	CB3E83EF-1C8E-4F7D-8A92-B355DEF240CC	0BF79D69-9960-4881-A7A7-2EABE048F81F	TCGA-EL-A3N3-01A-11R-A20F-07	HG19	TCGA-EL-A3N3	TCGA-THCA		s12791	University of North Carolina	MD Anderson	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A20F-07	True
13722.58cfa831e4b0c9d6adf6c485	58cfa831e4b0c9d6adf6c485	TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	846.02	1.9	0.15	58cfa831e4b0c9d6adf6c485	TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4752-01A	7EA546CE-F48A-4D9C-96B4-A0124C692870	Primary Tumor	Illumina HiSeq	ad469933-d84b-4305-85e2-a7d919298b71	Colorectal	58.0	5703F0D8-DB96-40CE-8009-51D2EC188ABF	43756C1F-6ED2-468B-B0AD-D44A447C7709	TCGA-CM-4752-01A-01D-1405-02	HG18	TCGA-CM-4752	TCGA-COAD		s13219	Harvard Medical School	MSKCC	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1405-02	True
13722.58cfa832e4b0c9d6adf6cef7	58cfa832e4b0c9d6adf6cef7	TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted	TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted.bam	23.16		0.14	58cfa832e4b0c9d6adf6cef7	TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A5B8-01A	A4D36E09-5D8E-4006-855C-E466682B6813	Primary Tumor	Illumina HiSeq	948983f4-15f3-4b59-983e-18a248b1f4d9	Esophagus	72.0	C7E7425E-1F33-42B3-A2A2-ADDAAE6365E9	09D7FAFF-2E10-4C45-BB7E-E58B50911EFE	TCGA-IG-A5B8-01A-11D-A28P-26	HG19_Broad_variant	TCGA-IG-A5B8	TCGA-ESCA	24.0	s1817	MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO	T3	N0		Stage I	A28P-26	True
13767.58cfa834e4b0c9d6adf6e405	58cfa834e4b0c9d6adf6e405	UNCID_1178693.9195fcf1-8cba-4e90-9f20-c4a6897b8985.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1178693.9195fcf1-8cba-4e90-9f20-c4a6897b8985.sorted_genome_alignments	UNCID_1178693.9195fcf1-8cba-4e90-9f20-c4a6897b8985.sorted_genome_alignments.bam	50.0	1.7	0.15	58cfa834e4b0c9d6adf6e405	UNCID_1178693.9195fcf1-8cba-4e90-9f20-c4a6897b8985.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4846-01A	D99F31F7-2B3B-47E8-BD26-8D37DA22ACA0	Primary Tumor	Illumina HiSeq	DF84275E-5D80-41D0-8701-F759E6BE0059	Kidney	52.0	F9EA91AD-1D88-4F7E-AF93-619F9CC77D35	9195FCF1-8CBA-4E90-9F20-C4A6897B8985	TCGA-B0-4846-01A-01R-1277-07	HG19	TCGA-B0-4846	TCGA-KIRC	1200.0	s8871	University of North Carolina	University of Pittsburgh	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1277-07	True
13722.58cfa832e4b0c9d6adf6d3d0	58cfa832e4b0c9d6adf6d3d0	TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted	TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted.bam	17.75		0.17	58cfa832e4b0c9d6adf6d3d0	TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A43J-01A	209E2E16-CB88-4A8F-9CDB-10E152CAA26C	Primary Tumor	Illumina HiSeq	ed639604-bac1-4406-ad55-5a821261a54a	Esophagus	90.0	EEA7BE16-BAF9-4101-A712-CFAF5349476E	9BDD056B-DEC2-4856-9093-94FD133CF06B	TCGA-L5-A43J-01A-12D-A248-26	HG19_Broad_variant	TCGA-L5-A43J	TCGA-ESCA	131.0	s1739	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T3	N0		Stage II	A248-26	True
13767.58cfa834e4b0c9d6adf6e0ca	58cfa834e4b0c9d6adf6e0ca	UNCID_1164877.86373f83-264a-4875-8672-749ea434422f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1164877.86373f83-264a-4875-8672-749ea434422f.sorted_genome_alignments	UNCID_1164877.86373f83-264a-4875-8672-749ea434422f.sorted_genome_alignments.bam	37.28	1.79	0.16	58cfa834e4b0c9d6adf6e0ca	UNCID_1164877.86373f83-264a-4875-8672-749ea434422f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A250-01A	A0963E93-B63E-4DE2-86C1-81302E271D3E	Primary Tumor	Illumina HiSeq	F3BF36CB-7EEA-40B4-9A49-2F7FF37C013F	Breast	58.0	0D5C5F1C-D20E-480C-A89B-8FEBA01CAF96	86373F83-264A-4875-8672-749EA434422F	TCGA-AR-A250-01A-31R-A169-07	HG19	TCGA-AR-A250	TCGA-BRCA		s5884	University of North Carolina	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A169-07	True
13722.58cfa831e4b0c9d6adf6c9d4	58cfa831e4b0c9d6adf6c9d4	TCGA-DB-5276-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DB-5276-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_5_rg.sorted	TCGA-DB-5276-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_5_rg.sorted.bam	52.7	1.9	0.15	58cfa831e4b0c9d6adf6c9d4	TCGA-DB-5276-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-5276-01A	9D0C1552-00A7-4F0A-A04A-A82E721EE4E3	Primary Tumor	Illumina HiSeq	02206442-a052-4c44-a4b8-1467493df2eb	Brain	32.0	11CB167F-CD54-409F-BFEA-511E620C96FC	5396382E-9FBC-43DA-9C88-DF17FFDA1E2B	TCGA-DB-5276-01A-01D-1465-02	HG19_Broad_variant	TCGA-DB-5276	TCGA-LGG		s8131	Harvard Medical School	Mayo Clinic - Rochester	United States	NO			Oligoastrocytoma		1465-02	True
13767.58cfa83ae4b0c9d6adf7171e	58cfa83ae4b0c9d6adf7171e	UNCID_2375254.b2dc2165-2964-4aaf-84ab-fa8c56b94ac1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2375254.b2dc2165-2964-4aaf-84ab-fa8c56b94ac1.sorted_genome_alignments	UNCID_2375254.b2dc2165-2964-4aaf-84ab-fa8c56b94ac1.sorted_genome_alignments.bam	31.85	1.93	0.18	58cfa83ae4b0c9d6adf7171e	UNCID_2375254.b2dc2165-2964-4aaf-84ab-fa8c56b94ac1.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-SR-A6MQ-01A	CB96FD6F-322E-4BB1-9D20-AAE21D124308	Primary Tumor	Illumina HiSeq	BB175A01-D464-4669-B804-51C15A1022FE	Nervous System	61.0	A9EC3070-1EAB-4503-A406-A51FE3EB10FD	B2DC2165-2964-4AAF-84AB-FA8C56B94AC1	TCGA-SR-A6MQ-01A-11R-A35L-07	HG19	TCGA-SR-A6MQ	TCGA-PCPG		s1060	University of North Carolina	Tufts Medical Center	United States	NO					A35L-07	True
13767.58cfa83ae4b0c9d6adf71d39	58cfa83ae4b0c9d6adf71d39	UNCID_2501531.73e05f0f-01df-484e-94f5-b0586480f000.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2501531.73e05f0f-01df-484e-94f5-b0586480f000.sorted_genome_alignments	UNCID_2501531.73e05f0f-01df-484e-94f5-b0586480f000.sorted_genome_alignments.bam	35.72	1.86	0.16	58cfa83ae4b0c9d6adf71d39	UNCID_2501531.73e05f0f-01df-484e-94f5-b0586480f000.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-ZF-A9RC-01A	4ED34DB5-DDB5-4EFD-A49B-84BF26789AEE	Primary Tumor	Illumina HiSeq	BC387A4A-E077-4EF6-ADA9-B05A4B6FC537	Bladder	77.0	D9C9D1C0-9E14-4FDC-9463-FA8B223FA441	73E05F0F-01DF-484E-94F5-B0586480F000	TCGA-ZF-A9RC-01A-11R-A38B-07	HG19	TCGA-ZF-A9RC	TCGA-BLCA		s3027	University of North Carolina	University of Sheffield	United Kingdom	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A38B-07	True
13722.58cfa82ee4b0c9d6adf6b014	58cfa82ee4b0c9d6adf6b014	TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted.filtered.	WGS	TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted	TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted.bam	199.7	1.9	0.16	58cfa82ee4b0c9d6adf6b014	TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4433-01A	AEA68827-DC0F-484D-A00D-06DEEAA4B3CE	Primary Tumor	Illumina HiSeq	d1b6064d-6736-4aad-8ad3-70ab64c92e3d	Lung	82.0	1E9DAC94-1A10-47D0-AE92-81D38A264376	61B1812A-9455-437F-ACF7-D1AC3FA9F215	TCGA-05-4433-01A-22D-1853-02	HG19_Broad_variant	TCGA-05-4433	TCGA-LUAD		s10986	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	1853-02	True
13767.58cfa837e4b0c9d6adf6fcca	58cfa837e4b0c9d6adf6fcca	UNCID_1708383.bc33e129-174b-4193-b65a-844e06984a81.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1708383.bc33e129-174b-4193-b65a-844e06984a81.sorted_genome_alignments	UNCID_1708383.bc33e129-174b-4193-b65a-844e06984a81.sorted_genome_alignments.bam	53.2		0.14	58cfa837e4b0c9d6adf6fcca	UNCID_1708383.bc33e129-174b-4193-b65a-844e06984a81.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8324-01A	0697436F-E487-45DB-B0BC-AD9246F70196	Primary Tumor	Illumina HiSeq	E72DC398-70D2-4D99-8065-47155553638A	Kidney	67.0	16C2976B-C2C5-40F0-8D7D-8ECFB4A15317	BC33E129-174B-4193-B65A-844E06984A81	TCGA-KL-8324-01A-11R-2315-07	HG19	TCGA-KL-8324	TCGA-KICH		s16456	University of North Carolina	MSKCC	United States	NO	T2	NX	Kidney Chromophobe	Stage II	2315-07	True
13722.58cfa82fe4b0c9d6adf6b7ac	58cfa82fe4b0c9d6adf6b7ac	TCGA-35-4123-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_4_rg.sorted.filtered.	WGS	TCGA-35-4123-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_4_rg.sorted	TCGA-35-4123-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_4_rg.sorted.bam	256.63	1.9	0.16	58cfa82fe4b0c9d6adf6b7ac	TCGA-35-4123-10A-01D-1103_110804_SN208_0217_BC03EKABXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-35-4123-10A	6CF49CF0-DE4C-4C90-8358-EAE19C6206B0	Blood Derived Normal	Illumina HiSeq	49076069-b689-4bbd-984c-7718df09a20e	Lung	38.0	1BBB46B1-7CEA-49F8-AAA9-C7E7994BB9F3	0F2760D3-4015-4E5E-AFD8-0325AE5A7D9A	TCGA-35-4123-10A-01D-1103-02	HG19_Broad_variant	TCGA-35-4123	TCGA-LUAD		s10648	Harvard Medical School	Cureline	Russia	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1103-02	True
13767.58cfa83ce4b0c9d6adf72b60	58cfa83ce4b0c9d6adf72b60	UNCID_399292.4eb2db4b-f8de-435b-bb72-fde7780fb18a.110712_UNC12-SN629_0109_BC02BLABXX.2.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_399292.4eb2db4b-f8de-435b-bb72-fde7780fb18a.110712_UNC12-SN629_0109_BC02BLABXX.2.trimmed.annotated.translated_to_genomic	UNCID_399292.4eb2db4b-f8de-435b-bb72-fde7780fb18a.110712_UNC12-SN629_0109_BC02BLABXX.2.trimmed.annotated.translated_to_genomic.bam	42.3	1.8	0.14	58cfa83ce4b0c9d6adf72b60	UNCID_399292.4eb2db4b-f8de-435b-bb72-fde7780fb18a.110712_UNC12-SN629_0109_BC02BLABXX.2.trimmed.annotated.translated_to_genomic.bam	Dead	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5176-01A	9490CD1E-BE30-45D3-B1EA-42C157D5F49D	Primary Tumor	Illumina HiSeq	18F8F6B8-22BD-4ABC-916E-123A7D2FB593	Kidney	78.0	6A6DFBD9-937B-4939-B604-427BCA03BBCD	4EB2DB4B-F8DE-435B-BB72-FDE7780FB18A	TCGA-BP-5176-01A-01R-1426-07	HG19	TCGA-BP-5176	TCGA-KIRC	1590.0	s8961	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1426-07	True
13767.58cfa83be4b0c9d6adf71f30	58cfa83be4b0c9d6adf71f30	UNCID_2512579.001773a6-9cf3-48a1-8ea1-1f0da4991bc5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2512579.001773a6-9cf3-48a1-8ea1-1f0da4991bc5.sorted_genome_alignments	UNCID_2512579.001773a6-9cf3-48a1-8ea1-1f0da4991bc5.sorted_genome_alignments.bam	19.54	1.87	0.17	58cfa83be4b0c9d6adf71f30	UNCID_2512579.001773a6-9cf3-48a1-8ea1-1f0da4991bc5.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A8OP-01A	B9C6C069-2A2B-4CC7-A398-DC45C132D979	Primary Tumor	Illumina HiSeq	20725D82-9A5C-4811-AB26-A369457326C9	Breast	72.0	C32E8A89-BC6B-4E8A-8719-4509412B5729	001773A6-9CF3-48A1-8EA1-1F0DA4991BC5	TCGA-AC-A8OP-01A-11R-A36F-07	HG19	TCGA-AC-A8OP	TCGA-BRCA		s5937	University of North Carolina	International Genomics Consortium	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A36F-07	True
13767.58cfa835e4b0c9d6adf6ecd2	58cfa835e4b0c9d6adf6ecd2	UNCID_1349920.C4149CF6-980F-4DA1-B749-C24AAE86F351.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1349920.C4149CF6-980F-4DA1-B749-C24AAE86F351.sorted_genome_alignments	UNCID_1349920.C4149CF6-980F-4DA1-B749-C24AAE86F351.sorted_genome_alignments.bam	6.84	1.78	0.18	58cfa835e4b0c9d6adf6ecd2	UNCID_1349920.C4149CF6-980F-4DA1-B749-C24AAE86F351.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A3IY-01A	6B4E0262-F589-4532-B578-9F2D76C19D90	Primary Tumor	Illumina HiSeq	A22A63C6-28C9-41F1-AAA8-C1FA40D38EBF	Breast	71.0	FC56BE13-C3DD-4DD9-8C34-DC6C7F9D1E16	C4149CF6-980F-4DA1-B749-C24AAE86F351	TCGA-A7-A3IY-01A-21R-A21T-07	HG19	TCGA-A7-A3IY	TCGA-BRCA		s5586	University of North Carolina	Christiana Healthcare	United States	NO	T1c	N0	Mucinous Carcinoma	Stage I	A21T-07	True
13767.58cfa83ce4b0c9d6adf72f32	58cfa83ce4b0c9d6adf72f32	_1_TCGA-BR-8380-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-8380-01A-11R-2343-13_rnaseq	_1_TCGA-BR-8380-01A-11R-2343-13_rnaseq.bam	54.2		0.14	58cfa83ce4b0c9d6adf72f32	_1_TCGA-BR-8380-01A-11R-2343-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8380-01A	9EBC8B58-363B-4638-8365-CFBDE31A71AE	Primary Tumor	Illumina HiSeq	953707E9-9036-4CE1-B70A-76D8239CB2D9	Stomach	55.0	77E1DED5-6AAF-4321-946F-7E9173274D0A	E864806C-C8AB-432C-A7AC-09B45723F97F	TCGA-BR-8380-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8380	TCGA-STAD		s14666	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T4a	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2343-13	True
13767.58cfa835e4b0c9d6adf6ee9a	58cfa835e4b0c9d6adf6ee9a	UNCID_1435073.0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1435073.0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf.sorted_genome_alignments	UNCID_1435073.0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf.sorted_genome_alignments.bam	56.2		0.14	58cfa835e4b0c9d6adf6ee9a	UNCID_1435073.0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-7670-01A	9B38EDED-3F46-4AAA-9991-68008D97BDBE	Primary Tumor	Illumina HiSeq	ABA00169-7EEF-49CD-B228-EB3E07CBFB56	Lung	47.0	7F56DF3F-B649-43D1-AB46-AD460233E46B	0B8EF0BE-C6FB-4CA9-9DA0-F97DD22767BF	TCGA-44-7670-01A-11R-2066-07	HG19	TCGA-44-7670	TCGA-LUAD		s10723	University of North Carolina	Christiana Healthcare	United States	NO	T1b	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	2066-07	True
13767.58cfa837e4b0c9d6adf7007c	58cfa837e4b0c9d6adf7007c	UNCID_1804970.2ff064bb-9e08-497e-a83a-7360cf80f62d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1804970.2ff064bb-9e08-497e-a83a-7360cf80f62d.sorted_genome_alignments	UNCID_1804970.2ff064bb-9e08-497e-a83a-7360cf80f62d.sorted_genome_alignments.bam	38.59	1.83	0.17	58cfa837e4b0c9d6adf7007c	UNCID_1804970.2ff064bb-9e08-497e-a83a-7360cf80f62d.sorted_genome_alignments.bam	Alive	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01Z-01A	C9E829D9-CD08-41A9-A5A4-34F2D7D619C7	Primary Tumor	Illumina HiSeq	E1613B4E-455C-4FE3-A480-5E0E22398625	Colorectal	68.0	9CA7E5DF-F832-435F-842E-4BE86C01A554	2FF064BB-9E08-497E-A83A-7360CF80F62D	TCGA-AA-A01Z-01A-11R-A083-07	HG19	TCGA-AA-A01Z	TCGA-COAD		s13756	University of North Carolina	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	A083-07	False
13722.58cfa82ee4b0c9d6adf6a8e4	58cfa82ee4b0c9d6adf6a8e4	G35154.TCGA-DH-A669-02A-11D-A31L-08.3.filtered.	WGS	G35154.TCGA-DH-A669-02A-11D-A31L-08.3	G35154.TCGA-DH-A669-02A-11D-A31L-08.3.bam	35.84		0.08	58cfa82ee4b0c9d6adf6a8e4	G35154.TCGA-DH-A669-02A-11D-A31L-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DH-A669-02A	76E54EF6-1799-4FD9-BEC3-0EA960E8461E	Recurrent Tumor	Illumina HiSeq	bc4e3b89-3a13-471f-8769-7d711cfbad8e	Brain	70.0	DFC7F355-5480-4F67-A6B5-1F2945D15A36	B020B62A-8ACF-40D2-97AB-AA870AC61E96	TCGA-DH-A669-02A-11D-A31L-08	HG19_Broad_variant	TCGA-DH-A669	TCGA-LGG	919.0	s8527	Broad Institute of MIT and Harvard	University of Florida	United States	NO			Oligodendroglioma		A31L-08	False
13722.58cfa831e4b0c9d6adf6c9a3	58cfa831e4b0c9d6adf6c9a3	TCGA-DD-A1EI-11A-11D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A1EI-11A-11D-A12Z-10_wgs_Illumina	TCGA-DD-A1EI-11A-11D-A12Z-10_wgs_Illumina.bam	31.11	1.93	0.08	58cfa831e4b0c9d6adf6c9a3	TCGA-DD-A1EI-11A-11D-A12Z-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EI-11A	3ACF7438-FD65-442C-8A30-68B6714537F3	Solid Tissue Normal	Illumina HiSeq	7fc26219-b7be-4009-9daa-f8dc2c2883bc	Liver	46.0	48F02D39-0821-4A45-87A1-11349283E105	F48E484A-7373-4FFB-BBD7-41C3D2F91D5F	TCGA-DD-A1EI-11A-11D-A12Z-10	GRCh37-lite	TCGA-DD-A1EI	TCGA-LIHC		s16774	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A12Z-10	True
13722.58cfa83ce4b0c9d6adf730c7	58cfa83ce4b0c9d6adf730c7	fa6bec3d86dc832a801cad28a615155f.filtered.	WGS	fa6bec3d86dc832a801cad28a615155f	fa6bec3d86dc832a801cad28a615155f.bam	17.94	2.0	0.08	58cfa83ce4b0c9d6adf730c7	fa6bec3d86dc832a801cad28a615155f.bam	Alive	FEMALE			Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A08S-10A	2779FA01-AC93-4E80-A997-3385F72172C3	Blood Derived Normal	Illumina HiSeq	88281394-1a54-4fd8-8b8c-7c6fd3134331	Breast	71.0	793BE994-DEDD-4A82-A409-89E0832ABF23	A2C71708-A460-4CEE-AF93-D070BE1E6D2C	TCGA-A8-A08S-10A-01D-A19H-09	GRCh37-lite	TCGA-A8-A08S	TCGA-BRCA		s6752	Washington University School of Medicine	Indivumed	Germany	NO	T1c	N1	Infiltrating Ductal Carcinoma	Stage II	A19H-09	True
13722.58cfa832e4b0c9d6adf6cdfc	58cfa832e4b0c9d6adf6cdfc	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.bam	33.16		0.15	58cfa832e4b0c9d6adf6cdfc	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SN-01A	0FB043D3-D86B-4CD8-8C01-9E2B3E965BB0	Primary Tumor	Illumina HiSeq	2281a267-dad6-42d6-9df2-8d37a696c507	Bladder	79.0	127892ED-8A7A-41CB-8ABE-353E09E6D327	B0AD1373-0C51-41A3-9F8B-BDE28C67CFB8	TCGA-FD-A3SN-01A-12D-A233-26	HG19_Broad_variant	TCGA-FD-A3SN	TCGA-BLCA		s2719	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	True
13767.58cfa83be4b0c9d6adf72026	58cfa83be4b0c9d6adf72026	UNCID_2552646.ddfdcd45-0d1c-4efd-89a4-2fe6bc789bfe.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2552646.ddfdcd45-0d1c-4efd-89a4-2fe6bc789bfe.sorted_genome_alignments	UNCID_2552646.ddfdcd45-0d1c-4efd-89a4-2fe6bc789bfe.sorted_genome_alignments.bam	71.89	1.84	0.16	58cfa83be4b0c9d6adf72026	UNCID_2552646.ddfdcd45-0d1c-4efd-89a4-2fe6bc789bfe.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Mesothelioma	Aligned reads	TCGA-3U-A98E-01A	E0DF1FEF-C650-4088-A974-26F712ED4F64	Primary Tumor	Illumina HiSeq	9E891573-5AEE-4BC5-8258-CA23AFC8FF57	Mesothelium	71.0	432C1FA8-A151-4EA2-82E5-25958B7B1E20	DDFDCD45-0D1C-4EFD-89A4-2FE6BC789BFE	TCGA-3U-A98E-01A-11R-A40A-07	HG19	TCGA-3U-A98E	TCGA-MESO		s403	University of North Carolina	University of Chicago	United States	NO	T4	N2		Stage IV	A40A-07	True
13722.58cfa830e4b0c9d6adf6bf50	58cfa830e4b0c9d6adf6bf50	TCGA-BR-4279-11A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BR-4279-11A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_2_rg.sorted	TCGA-BR-4279-11A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_2_rg.sorted.bam	7.9	1.9	0.16	58cfa830e4b0c9d6adf6bf50	TCGA-BR-4279-11A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4279-11A	117EB38B-0C62-4336-A866-FA5BD013256A	Solid Tissue Normal	Illumina HiSeq	1fc5b32a-8266-4f98-8444-a219ed9631a2	Stomach	43.0	B87F1A8B-9A6A-44AE-BB89-686186F2FD2D	BB0A8962-7A53-4786-B7E5-ADE753A3D009	TCGA-BR-4279-11A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4279	TCGA-STAD		s15101	Harvard Medical School	Asterand	Russia	NO	T2a	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1128-02	True
13722.58cfa830e4b0c9d6adf6c30e	58cfa830e4b0c9d6adf6c30e	TCGA-BR-6801-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BR-6801-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_6_rg.sorted	TCGA-BR-6801-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_6_rg.sorted.bam	187.0	1.9	0.15	58cfa830e4b0c9d6adf6c30e	TCGA-BR-6801-10A-01D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6801-10A	24FED326-BDCF-4C20-A06E-7C1C3D6C9CC5	Blood Derived Normal	Illumina HiSeq	ad1f6971-d904-467d-a98d-2bc17299540c	Stomach	70.0	CC6EAF22-F6AB-413B-9495-BE715DA438E2	BC80C770-044A-41A1-8D11-171F99950B4C	TCGA-BR-6801-10A-01D-1880-02	HG19_Broad_variant	TCGA-BR-6801	TCGA-STAD		s15449	Harvard Medical School	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1880-02	True
13722.58cfa830e4b0c9d6adf6be60	58cfa830e4b0c9d6adf6be60	TCGA-AP-A0L9-10A-01D-A043_120318_SN590_0147_BD0U3RACXX_s_4_rg.sorted.filtered.	WGS	TCGA-AP-A0L9-10A-01D-A043_120318_SN590_0147_BD0U3RACXX_s_4_rg.sorted	TCGA-AP-A0L9-10A-01D-A043_120318_SN590_0147_BD0U3RACXX_s_4_rg.sorted.bam	35.11	1.93	0.15	58cfa830e4b0c9d6adf6be60	TCGA-AP-A0L9-10A-01D-A043_120318_SN590_0147_BD0U3RACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0L9-10A	7B9947D5-E86B-4006-8890-EA5209584A88	Blood Derived Normal	Illumina HiSeq	da796750-9751-47a4-a977-f1ef14fbfbe5	Uterus	71.0	60EAC6D9-6404-4C11-A30C-3986D1CACAF2	9BEEC8F7-2E37-425F-8FE7-8E205CABF969	TCGA-AP-A0L9-10A-01D-A043-02	HG19_Broad_variant	TCGA-AP-A0L9	TCGA-UCEC		s4424	Harvard Medical School	MSKCC	None	NO			Serous endometrial adenocarcinoma		A043-02	True
13767.58cfa838e4b0c9d6adf70e02	58cfa838e4b0c9d6adf70e02	UNCID_2105349.ca467949-9170-4c3f-8e67-5b7762d31d4a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2105349.ca467949-9170-4c3f-8e67-5b7762d31d4a.sorted_genome_alignments	UNCID_2105349.ca467949-9170-4c3f-8e67-5b7762d31d4a.sorted_genome_alignments.bam	8.05	1.89	0.18	58cfa838e4b0c9d6adf70e02	UNCID_2105349.ca467949-9170-4c3f-8e67-5b7762d31d4a.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-O1-A52J-01A	42432463-8E92-4F25-B72A-F03953527AA5	Primary Tumor	Illumina HiSeq	B575631B-6A58-4BA5-B82B-38AB6575A2EE	Lung	74.0	CF14428A-1964-4F11-AA9A-D60C6631C2C6	CA467949-9170-4C3F-8E67-5B7762D31D4A	TCGA-O1-A52J-01A-11R-A262-07	HG19	TCGA-O1-A52J	TCGA-LUAD	1798.0	s11417	University of North Carolina	Washington University - CALGB	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	A262-07	True
13722.58cfa831e4b0c9d6adf6cad4	58cfa831e4b0c9d6adf6cad4	TCGA-DA-A1I2-06A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DA-A1I2-06A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_1_rg.sorted	TCGA-DA-A1I2-06A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_1_rg.sorted.bam	65.65		0.18	58cfa831e4b0c9d6adf6cad4	TCGA-DA-A1I2-06A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-DA-A1I2-06A	01AD975D-C2ED-4E4D-BD3B-C9512FC9073C	Metastatic	Illumina HiSeq	01864b7d-181e-4599-9dd4-31fca5173ddd	Skin	45.0	1E373C9C-DDB0-4C77-87AF-468EE586F998	FFBDE34F-A8F9-458A-9022-EC29D8EC6277	TCGA-DA-A1I2-06A-21D-A18Z-02	HG19_Broad_variant	TCGA-DA-A1I2	TCGA-SKCM		s7328	Harvard Medical School	Yale	United States	NO	T4b	N2b		Stage III	A18Z-02	True
13767.58cfa82fe4b0c9d6adf6b206	58cfa82fe4b0c9d6adf6b206	TCGA-13-0920-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0920-01A-01R-1564-13_rnaseq	TCGA-13-0920-01A-01R-1564-13_rnaseq.bam	200.0	1.8	0.14	58cfa82fe4b0c9d6adf6b206	TCGA-13-0920-01A-01R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0920-01A	85A85A11-7200-4E96-97AF-6BA26D680D59	Primary Tumor	Illumina HiSeq	A72DC6DC-7423-42BE-83A3-55AF76CF7A58	Ovary	65.0	A2530FAC-9D42-4FBE-881B-E9BAD5A2D793	2D8E1B4D-85D0-4BFD-99F7-59559DABE978	TCGA-13-0920-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-13-0920	TCGA-OV		s17293	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa835e4b0c9d6adf6eb7e	58cfa835e4b0c9d6adf6eb7e	UNCID_1245724.7ef09c3e-1bd5-48c9-81ae-6da842739027.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1245724.7ef09c3e-1bd5-48c9-81ae-6da842739027.sorted_genome_alignments	UNCID_1245724.7ef09c3e-1bd5-48c9-81ae-6da842739027.sorted_genome_alignments.bam	63.54	1.67	0.15	58cfa835e4b0c9d6adf6eb7e	UNCID_1245724.7ef09c3e-1bd5-48c9-81ae-6da842739027.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A25P-01A	12ECC0E5-8CB8-406E-AC9F-4F8C22B64FC1	Primary Tumor	Illumina HiSeq	F66209CE-58B2-4763-AFDA-480DE8790DC4	Thyroid	24.0	C7146F26-5C75-4A56-A94B-C8A03C15A6F1	7EF09C3E-1BD5-48C9-81AE-6DA842739027	TCGA-ET-A25P-01A-11R-A16R-07	HG19	TCGA-ET-A25P	TCGA-THCA		s12020	University of North Carolina	Johns Hopkins	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16R-07	True
13767.58cfa83be4b0c9d6adf7216c	58cfa83be4b0c9d6adf7216c	UNCID_2586116.7e444b45-94bb-4c2e-b82f-df98997fac53.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2586116.7e444b45-94bb-4c2e-b82f-df98997fac53.sorted_genome_alignments	UNCID_2586116.7e444b45-94bb-4c2e-b82f-df98997fac53.sorted_genome_alignments.bam	8.14	1.9	0.16	58cfa83be4b0c9d6adf7216c	UNCID_2586116.7e444b45-94bb-4c2e-b82f-df98997fac53.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-2G-AAG6-01A	43E0141D-9BEA-4B26-86E0-88A11175053A	Primary Tumor	Illumina HiSeq	AE2DCD0E-F07A-499A-B1A5-4082449D61E0	Testis	24.0	E7CFD220-7A4B-4E6C-B95E-4A754D92C173	7E444B45-94BB-4C2E-B82F-DF98997FAC53	TCGA-2G-AAG6-01A-11R-A430-07	HG19	TCGA-2G-AAG6	TCGA-TGCT		s634	University of North Carolina	Erasmus MC	Netherlands	NO	T1	N0		Stage I	A430-07	True
13767.58cfa83be4b0c9d6adf72038	58cfa83be4b0c9d6adf72038	UNCID_2544268.d3b1d5c8-a823-4630-a160-599bc0d5fb9a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2544268.d3b1d5c8-a823-4630-a160-599bc0d5fb9a.sorted_genome_alignments	UNCID_2544268.d3b1d5c8-a823-4630-a160-599bc0d5fb9a.sorted_genome_alignments.bam	20.53	1.86	0.16	58cfa83be4b0c9d6adf72038	UNCID_2544268.d3b1d5c8-a823-4630-a160-599bc0d5fb9a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cholangiocarcinoma	Aligned reads	TCGA-W5-AA2R-01A	20BF79AF-3B0F-477D-B619-5597D42F5D5E	Primary Tumor	Illumina HiSeq	A3736439-1A9A-46EE-A681-8C680951570F	Bile Duct	77.0	7A195A13-D4BB-417F-AE78-30CBD8039AAC	D3B1D5C8-A823-4630-A160-599BC0D5FB9A	TCGA-W5-AA2R-01A-11R-A41I-07	HG19	TCGA-W5-AA2R	TCGA-CHOL		s43	University of North Carolina	Mayo Clinic Rochester	United States	NO	T1	N0		Stage I	A41I-07	True
13767.58cfa838e4b0c9d6adf7048d	58cfa838e4b0c9d6adf7048d	UNCID_1821451.fe5e8cb8-45e2-4321-ad32-a776f79bfcac.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1821451.fe5e8cb8-45e2-4321-ad32-a776f79bfcac.sorted_genome_alignments	UNCID_1821451.fe5e8cb8-45e2-4321-ad32-a776f79bfcac.sorted_genome_alignments.bam	5.14	1.82	0.16	58cfa838e4b0c9d6adf7048d	UNCID_1821451.fe5e8cb8-45e2-4321-ad32-a776f79bfcac.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0CK-01A	5ACA16CA-4516-4E27-8249-6914029A7EBF	Primary Tumor	Illumina HiSeq	1D6A27CB-5911-4C70-A2D6-14FC5F641580	Breast	60.0	D22E0F16-8D28-467D-AB10-2DD72F7EAB42	FE5E8CB8-45E2-4321-AD32-A776F79BFCAC	TCGA-A2-A0CK-01A-11R-A22K-07	HG19	TCGA-A2-A0CK	TCGA-BRCA		s6574	University of North Carolina	Walter Reed	United States	NO	T3	N2a	Infiltrating Lobular Carcinoma	Stage III	A22K-07	True
13767.58cfa837e4b0c9d6adf70296	58cfa837e4b0c9d6adf70296	UNCID_1856814.0931e34f-0ec0-41a7-bd0c-e1c4824c92ad.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1856814.0931e34f-0ec0-41a7-bd0c-e1c4824c92ad.sorted_genome_alignments	UNCID_1856814.0931e34f-0ec0-41a7-bd0c-e1c4824c92ad.sorted_genome_alignments.bam	24.15	1.75	0.16	58cfa837e4b0c9d6adf70296	UNCID_1856814.0931e34f-0ec0-41a7-bd0c-e1c4824c92ad.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A4O9-01A	CC84500C-0196-450D-87A1-CA394CC227B5	Primary Tumor	Illumina HiSeq	1AF20675-8BEB-4165-89E4-31622FED516A	Thyroid	51.0	72A05186-7575-4D52-A81A-5B036A71611D	0931E34F-0EC0-41A7-BD0C-E1C4824C92AD	TCGA-BJ-A4O9-01A-11R-A250-07	HG19	TCGA-BJ-A4O9	TCGA-THCA		s12832	University of North Carolina	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A250-07	True
13767.58cfa833e4b0c9d6adf6d89c	58cfa833e4b0c9d6adf6d89c	TCGA-WR-A838-01A-12R-A406-31_rnaseq.filtered.	RNA-Seq	TCGA-WR-A838-01A-12R-A406-31_rnaseq	TCGA-WR-A838-01A-12R-A406-31_rnaseq.bam	92.58	1.75	0.18	58cfa833e4b0c9d6adf6d89c	TCGA-WR-A838-01A-12R-A406-31_rnaseq.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-WR-A838-01A	B8023162-5E82-40E6-AD8C-8ACF81821F01	Primary Tumor	Illumina HiSeq	9BB58B1F-F622-4A17-BD9F-600320C45471	Ovary	72.0	828B6893-62CD-4248-A31B-7DA875D657F1	010E9BF0-B7A0-4C68-B028-90299840FBAF	TCGA-WR-A838-01A-12R-A406-31	GRCh37-lite	TCGA-WR-A838	TCGA-OV		s17650	Canada's Michael Smith Genome Sciences Centre	University of Kansas	United States	NO			Serous Cystadenocarcinoma		A406-31	True
13767.58cfa82ee4b0c9d6adf6afc6	58cfa82ee4b0c9d6adf6afc6	TCGA-09-0364-01A-02R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-09-0364-01A-02R-1564-13_rnaseq	TCGA-09-0364-01A-02R-1564-13_rnaseq.bam	350.0	1.8	0.16	58cfa82ee4b0c9d6adf6afc6	TCGA-09-0364-01A-02R-1564-13_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-0364-01A	6746533A-8D0B-4EBC-87EC-49C8738121A8	Primary Tumor	Illumina HiSeq	E988F49C-8234-4685-9B35-036179189B57	Ovary	80.0	469795C3-7CFA-4B95-9B0F-3FC7A3336F22	2D0702A8-BF85-458E-879C-EBC03A2AA3D1	TCGA-09-0364-01A-02R-1564-13	NCBI36_BCCAGSC_variant	TCGA-09-0364	TCGA-OV	887.0	s17805	Canada's Michael Smith Genome Sciences Centre	UCSF	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa837e4b0c9d6adf6fe7a	58cfa837e4b0c9d6adf6fe7a	UNCID_1777776.10e3d6b9-8f72-4902-94ca-f89811b98e35.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1777776.10e3d6b9-8f72-4902-94ca-f89811b98e35.sorted_genome_alignments	UNCID_1777776.10e3d6b9-8f72-4902-94ca-f89811b98e35.sorted_genome_alignments.bam	48.96	1.81	0.15	58cfa837e4b0c9d6adf6fe7a	UNCID_1777776.10e3d6b9-8f72-4902-94ca-f89811b98e35.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3YS-01A	4D323B18-CE5A-4516-862D-7ED1FDF1F008	Primary Tumor	Illumina HiSeq	A9F244AB-A93C-417B-903D-7ED827571166	Bladder	61.0	9606581B-1E91-4A91-865D-878B08631782	10E3D6B9-8F72-4902-94CA-F89811B98E35	TCGA-GC-A3YS-01A-11R-A23N-07	HG19	TCGA-GC-A3YS	TCGA-BLCA		s2776	University of North Carolina	International Genomics Consortium	United States	NO	T3a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A23N-07	True
13767.58cfa835e4b0c9d6adf6ef49	58cfa835e4b0c9d6adf6ef49	UNCID_1464835.cb6abcbc-4b97-4754-99ed-c55bc211ef68.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1464835.cb6abcbc-4b97-4754-99ed-c55bc211ef68.sorted_genome_alignments	UNCID_1464835.cb6abcbc-4b97-4754-99ed-c55bc211ef68.sorted_genome_alignments.bam	226.2		0.15	58cfa835e4b0c9d6adf6ef49	UNCID_1464835.cb6abcbc-4b97-4754-99ed-c55bc211ef68.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-G7-7502-01A	D2748E35-4719-43C1-A533-B6B0CD9688C3	Primary Tumor	Illumina HiSeq	6801E477-0B39-4335-B4CC-071FFA371239	Kidney	83.0	4192D07E-79A0-40DA-B067-C0559D6A35CB	CB6ABCBC-4B97-4754-99ED-C55BC211EF68	TCGA-G7-7502-01A-11R-2204-07	HG19	TCGA-G7-7502	TCGA-KIRP		s11893	University of North Carolina	Roswell Park	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	2204-07	True
13722.58cfa831e4b0c9d6adf6cb5c	58cfa831e4b0c9d6adf6cb5c	TCGA-EE-A2MD-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_4_rg.sorted.filtered.	WGS	TCGA-EE-A2MD-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_4_rg.sorted	TCGA-EE-A2MD-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_4_rg.sorted.bam	46.36		0.16	58cfa831e4b0c9d6adf6cb5c	TCGA-EE-A2MD-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2MD-06A	D28B2D64-2399-4CE1-9C9A-7538DABAB862	Metastatic	Illumina HiSeq	d129b319-ccf2-4715-9abd-3890ff13945f	Skin	52.0	FE5CCE9F-6DBD-4532-8926-BBF6BD850E71	5A62986F-DA0F-41F6-A848-4AD44A3E7885	TCGA-EE-A2MD-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-EE-A2MD	TCGA-SKCM	1438.0	s7517	Harvard Medical School	University of Sydney	Australia	NO	T3a	N0		Stage II	A18Y-02	True
13767.58cfa832e4b0c9d6adf6d34e	58cfa832e4b0c9d6adf6d34e	TCGA-L5-A4OR-11A-11R-A260-31_rnaseq.filtered.	RNA-Seq	TCGA-L5-A4OR-11A-11R-A260-31_rnaseq	TCGA-L5-A4OR-11A-11R-A260-31_rnaseq.bam	65.77	1.9	0.17	58cfa832e4b0c9d6adf6d34e	TCGA-L5-A4OR-11A-11R-A260-31_rnaseq.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OR-11A	09EACBFD-3F4A-4D2B-B7A7-C021535E2981	Solid Tissue Normal	Illumina HiSeq	891EE7CD-7158-43CE-B777-3CB9332003B5	Esophagus	83.0	29773D2B-78DD-4BB2-B44B-A02653783773	27645D9B-50EE-429F-8CD1-D6BA02DAE646	TCGA-L5-A4OR-11A-11R-A260-31	GRCh37-lite	TCGA-L5-A4OR	TCGA-ESCA	96.0	s1846	Canada's Michael Smith Genome Sciences Centre	University of Michigan	United States	NO	T1	N0		Stage I	A260-31	True
13767.58cfa834e4b0c9d6adf6e68c	58cfa834e4b0c9d6adf6e68c	UNCID_1189484.1cf6a04b-d795-4528-9a6d-fdf52c9a4a95.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1189484.1cf6a04b-d795-4528-9a6d-fdf52c9a4a95.sorted_genome_alignments	UNCID_1189484.1cf6a04b-d795-4528-9a6d-fdf52c9a4a95.sorted_genome_alignments.bam	116.3	1.8	0.15	58cfa834e4b0c9d6adf6e68c	UNCID_1189484.1cf6a04b-d795-4528-9a6d-fdf52c9a4a95.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4973-01A	CDD8EB5C-BDA8-4961-9DB4-72E0C4907E95	Primary Tumor	Illumina HiSeq	B48A0424-D604-40FD-8B71-9430F4493722	Kidney	47.0	2689F0BA-CCE5-45FB-8DB5-9832E88663F3	1CF6A04B-D795-4528-9A6D-FDF52C9A4A95	TCGA-BP-4973-01A-01R-1334-07	HG19	TCGA-BP-4973	TCGA-KIRC		s9795	University of North Carolina	MSKCC	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1334-07	True
13722.58cfa831e4b0c9d6adf6c76c	58cfa831e4b0c9d6adf6c76c	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.bam	199.73		0.16	58cfa831e4b0c9d6adf6c76c	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7178-01A	8F044599-3FBE-4B69-B67D-49AEE9168545	Primary Tumor	Illumina HiSeq	f76f830b-a361-4cf5-a60f-69d4d574723f	Head and Neck	64.0	CAAB8E84-3225-4543-949E-7B7EB11244A2	A139820A-0B76-4A95-A3EE-DDDDF514A9C3	TCGA-CV-7178-01A-21D-2317-26	HG19_Broad_variant	TCGA-CV-7178	TCGA-HNSC	2166.0	s15900	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2	Head and Neck Squamous Cell Carcinoma	Stage IV	2317-26	True
13767.58cfa837e4b0c9d6adf70010	58cfa837e4b0c9d6adf70010	UNCID_1864718.3b6806b3-f244-4d8f-882c-e675bfd95fd1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1864718.3b6806b3-f244-4d8f-882c-e675bfd95fd1.sorted_genome_alignments	UNCID_1864718.3b6806b3-f244-4d8f-882c-e675bfd95fd1.sorted_genome_alignments.bam	62.2	1.8	0.14	58cfa837e4b0c9d6adf70010	UNCID_1864718.3b6806b3-f244-4d8f-882c-e675bfd95fd1.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AD-6888-01A	13EFF2E5-E33A-485F-9BA4-8A7CCB3C7528	Primary Tumor	Illumina HiSeq	1EFED8AA-FB79-4033-818E-8626C3924EF4	Colorectal	73.0	ECF0F65B-BF3C-4D0E-899A-F209247CBE97	3B6806B3-F244-4D8F-882C-E675BFD95FD1	TCGA-AD-6888-01A-11R-1928-07	HG19	TCGA-AD-6888	TCGA-COAD		s12951	University of North Carolina	International Genomics Consortium	United States	NO	T3	N1b	Colon Adenocarcinoma	Stage III	1928-07	True
13767.58cfa832e4b0c9d6adf6d516	58cfa832e4b0c9d6adf6d516	TCGA-L5-A4ON-01A-11R-A260-31_rnaseq.filtered.	RNA-Seq	TCGA-L5-A4ON-01A-11R-A260-31_rnaseq	TCGA-L5-A4ON-01A-11R-A260-31_rnaseq.bam	46.22	1.81	0.16	58cfa832e4b0c9d6adf6d516	TCGA-L5-A4ON-01A-11R-A260-31_rnaseq.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A4ON-01A	CABA34F2-3877-48CA-9FBC-665C3960F574	Primary Tumor	Illumina HiSeq	AC2AA3B8-DC38-4A5C-9A31-C9297E644AC1	Esophagus	65.0	B801A0D7-09E8-48D8-9C8E-C6D52767F7C1	3B510F65-5290-4E7F-8067-A9F20C045308	TCGA-L5-A4ON-01A-11R-A260-31	GRCh37-lite	TCGA-L5-A4ON	TCGA-ESCA	558.0	s1837	Canada's Michael Smith Genome Sciences Centre	University of Michigan	United States	NO	T1	N1		Stage II	A260-31	True
13722.58cfa831e4b0c9d6adf6cc72	58cfa831e4b0c9d6adf6cc72	TCGA-ER-A199-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-ER-A199-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_5_rg.sorted	TCGA-ER-A199-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_5_rg.sorted.bam	39.1		0.16	58cfa831e4b0c9d6adf6cc72	TCGA-ER-A199-10A-01D-A190_120723_SN1120_0178_BD1887ACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A199-10A	E218FC54-1139-4944-82E2-742839E5553A	Blood Derived Normal	Illumina HiSeq	5f956b1c-bc43-469e-8611-72b020b8830c	Skin	86.0	1BDFB4EA-F6E1-4C77-9FC6-421C246E4A9A	9EC20523-003B-4DE2-B573-82355C08EFEB	TCGA-ER-A199-10A-01D-A190-02	HG19_Broad_variant	TCGA-ER-A199	TCGA-SKCM	279.0	s7519	Harvard Medical School	University of Pittsburgh	United States	NO	T4b	N3		Stage III	A190-02	True
13722.58cfa82ee4b0c9d6adf6adc1	58cfa82ee4b0c9d6adf6adc1	G39020.TCGA-CD-5802-10A-01D-1600-08.1.filtered.	WGS	G39020.TCGA-CD-5802-10A-01D-1600-08.1	G39020.TCGA-CD-5802-10A-01D-1600-08.1.bam	617.7	1.9	0.05	58cfa82ee4b0c9d6adf6adc1	G39020.TCGA-CD-5802-10A-01D-1600-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5802-10A	0AECAC64-5982-4D76-8F31-958F6A00951D	Blood Derived Normal	Illumina HiSeq	c1da67a6-2bf9-4bdf-9e88-6f4c4634df79	Stomach	58.0	602943B6-8FFC-4667-BE39-2E6A9FB3661A	AF722E36-4912-45C4-B431-A2CEFF596BAC	TCGA-CD-5802-10A-01D-1600-08	HG19_Broad_variant	TCGA-CD-5802	TCGA-STAD		s15368	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1600-08	True
13722.58cfa832e4b0c9d6adf6d4fe	58cfa832e4b0c9d6adf6d4fe	TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted.filtered.	WGS	TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted	TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted.bam	40.59		0.16	58cfa832e4b0c9d6adf6d4fe	TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OG-01A	EB4AD376-4CC1-4D2C-9B93-AD2B082C77C4	Primary Tumor	Illumina HiSeq	cef87877-7e34-43b9-9599-f98660d7b833	Esophagus	79.0	E8E44C65-B4E4-4688-A217-206905E68A7F	04C91C91-E55A-4075-B08A-F80568BB4A7B	TCGA-L5-A4OG-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OG	TCGA-ESCA		s1926	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N0		Stage I	A267-26	True
13767.58cfa82ee4b0c9d6adf6ab68	58cfa82ee4b0c9d6adf6ab68	G17217.TCGA-06-0749-01A-01R-1849-01.2.filtered.	RNA-Seq	G17217.TCGA-06-0749-01A-01R-1849-01.2	G17217.TCGA-06-0749-01A-01R-1849-01.2.bam	45.6	1.8	0.17	58cfa82ee4b0c9d6adf6ab68	G17217.TCGA-06-0749-01A-01R-1849-01.2.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0749-01A	E921772F-F81A-49BC-B35E-3354C94447C0	Primary Tumor	Illumina HiSeq	27F2642B-0B89-4976-B062-DB441D0B483F	Brain	50.0	1A3BAE5A-677D-4763-B019-BA26E0134929	EB455C55-74AC-4303-B149-475FFE21E3C6	TCGA-06-0749-01A-01R-1849-01	HG19_Broad_variant	TCGA-06-0749	TCGA-GBM	82.0	s13919	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13722.58cfa831e4b0c9d6adf6c665	58cfa831e4b0c9d6adf6c665	TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted	TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted.bam	38.0		0.14	58cfa831e4b0c9d6adf6c665	TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6225-10A	90F44998-3C05-44B2-9501-BBD0F43C5147	Blood Derived Normal	Illumina HiSeq	82431af8-972a-4db7-b424-bac44c375bc2	Head and Neck	65.0	D30CD5CB-D0DE-446A-8A57-4F8B69AB25FE	7F65174A-1AB8-492D-91B6-0C39F14243AF	TCGA-CQ-6225-10A-01D-1911-02	HG19_Broad_variant	TCGA-CQ-6225	TCGA-HNSC	403.0	s16326	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1911-02	True
13767.58cfa837e4b0c9d6adf700e6	58cfa837e4b0c9d6adf700e6	UNCID_1873939.5fd05a9a-f767-443e-b91c-4b0d7eb81740.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1873939.5fd05a9a-f767-443e-b91c-4b0d7eb81740.sorted_genome_alignments	UNCID_1873939.5fd05a9a-f767-443e-b91c-4b0d7eb81740.sorted_genome_alignments.bam	33.2	1.7	0.17	58cfa837e4b0c9d6adf700e6	UNCID_1873939.5fd05a9a-f767-443e-b91c-4b0d7eb81740.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-6674-01A	55697871-B9AA-4ACD-8DBE-DCD5391DB8F0	Primary Tumor	Illumina HiSeq	D2A4BA0E-C5D7-4064-8D54-398743462211	Colorectal	39.0	18C55689-4C2E-4592-867A-D7E0BA752ED7	5FD05A9A-F767-443E-B91C-4B0D7EB81740	TCGA-CM-6674-01A-11R-1839-07	HG19	TCGA-CM-6674	TCGA-COAD		s13456	University of North Carolina	MSKCC	United States	NO	T3	N0	Colon Adenocarcinoma	Stage II	1839-07	True
13722.58cfa83ce4b0c9d6adf731da	58cfa83ce4b0c9d6adf731da	bfa1e20d9b7b963ef3b548bde1c4cf00.filtered.	WGS	bfa1e20d9b7b963ef3b548bde1c4cf00	bfa1e20d9b7b963ef3b548bde1c4cf00.bam	46.34	1.95	0.08	58cfa83ce4b0c9d6adf731da	bfa1e20d9b7b963ef3b548bde1c4cf00.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A13D-10A	8785012F-F73E-4D68-87CF-1D804AF32782	Blood Derived Normal	Illumina HiSeq	b80530e4-9ddc-40fa-a763-ea5010e21813	Breast	46.0	82C28BC5-DB37-4400-9A77-9D65F5071CE5	DBC462F5-F723-4CF7-A48D-84001D2D51E9	TCGA-A7-A13D-10A-02D-A12Q-09	GRCh37-lite	TCGA-A7-A13D	TCGA-BRCA		s6445	Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A12Q-09	False
13767.58cfa833e4b0c9d6adf6db3e	58cfa833e4b0c9d6adf6db3e	UNCID_1106167.6abcb12e-73c2-491e-b9f3-4f61f8a4e854.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1106167.6abcb12e-73c2-491e-b9f3-4f61f8a4e854.sorted_genome_alignments	UNCID_1106167.6abcb12e-73c2-491e-b9f3-4f61f8a4e854.sorted_genome_alignments.bam	38.2	1.5	0.15	58cfa833e4b0c9d6adf6db3e	UNCID_1106167.6abcb12e-73c2-491e-b9f3-4f61f8a4e854.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-49-6744-11A	15340DD3-84AE-49FB-989A-EB212F3E73DA	Solid Tissue Normal	Illumina HiSeq	A38BA385-6848-4CC4-94AD-3F1FBF2CE9C8	Lung	64.0	E3962E0E-EAFA-4016-8FA4-1C4BA0D2A9AD	6ABCB12E-73C2-491E-B9F3-4F61F8A4E854	TCGA-49-6744-11A-01R-1858-07	HG19	TCGA-49-6744	TCGA-LUAD		s10930	University of North Carolina	Johns Hopkins	United States	NO	T2a	N1	Lung Adenocarcinoma Mixed Subtype	Stage II	1858-07	True
13722.58cfa82ee4b0c9d6adf6ae58	58cfa82ee4b0c9d6adf6ae58	TCGA-05-4398-10A-01D-1203_120322_SN208_0278_BD0RB0ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-05-4398-10A-01D-1203_120322_SN208_0278_BD0RB0ACXX_s_4_rg.sorted	TCGA-05-4398-10A-01D-1203_120322_SN208_0278_BD0RB0ACXX_s_4_rg.sorted.bam	168.23	1.9	0.14	58cfa82ee4b0c9d6adf6ae58	TCGA-05-4398-10A-01D-1203_120322_SN208_0278_BD0RB0ACXX_s_4_rg.sorted.bam	Alive	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4398-10A	31C96E35-5E2F-429C-B12A-7BC5A497A300	Blood Derived Normal	Illumina HiSeq	c5182685-5c5b-42dc-9a85-4c0076ee389a	Lung	47.0	A65C5573-B230-4CA0-8BE3-8BCCE6BE385E	900A4C89-CD98-4F90-AA26-CCC7B285A8CC	TCGA-05-4398-10A-01D-1203-02	HG19_Broad_variant	TCGA-05-4398	TCGA-LUAD		s10770	Harvard Medical School	Indivumed	Germany	NO	T4	N3	Lung Adenocarcinoma Mixed Subtype	Stage III	1203-02	True
13767.58cfa833e4b0c9d6adf6dd0c	58cfa833e4b0c9d6adf6dd0c	UNCID_1123916.c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1123916.c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa.sorted_genome_alignments	UNCID_1123916.c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa.sorted_genome_alignments.bam	34.69	2.02	0.16	58cfa833e4b0c9d6adf6dd0c	UNCID_1123916.c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A273-01A	5A5F0F48-2B13-4E78-B130-901B85D9A7F3	Primary Tumor	Illumina HiSeq	2B41D89A-E527-412C-A39F-6047169C20C3	Breast	29.0	4BDB6C69-67B3-406B-9AC6-9CCA2C15F52F	C2E4EB91-BC79-4C8A-BEEF-4C5ABC61D2FA	TCGA-C8-A273-01A-11R-A16F-07	HG19	TCGA-C8-A273	TCGA-BRCA		s6653	University of North Carolina	ILSbio	Vietnam	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A16F-07	True
13767.58cfa83be4b0c9d6adf72185	58cfa83be4b0c9d6adf72185	UNCID_2598225.91caa672-b054-4afc-b78e-19673410a900.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2598225.91caa672-b054-4afc-b78e-19673410a900.sorted_genome_alignments	UNCID_2598225.91caa672-b054-4afc-b78e-19673410a900.sorted_genome_alignments.bam	49.63	1.88	0.18	58cfa83be4b0c9d6adf72185	UNCID_2598225.91caa672-b054-4afc-b78e-19673410a900.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-VF-A8A8-01A	074C58A6-7304-4F34-BABC-C537DA15D971	Primary Tumor	Illumina HiSeq	BA1633CB-FF6D-42C4-8779-5EE39F345A0F	Testis	18.0	949EB54C-7D5D-4976-8EED-5B3165AFB206	91CAA672-B054-4AFC-B78E-19673410A900	TCGA-VF-A8A8-01A-11R-A431-07	HG19	TCGA-VF-A8A8	TCGA-TGCT		s656	University of North Carolina	University of Pennsylvania	United States	NO	T1	N0		Stage I	A431-07	True
13722.58cfa82ee4b0c9d6adf6a9de	58cfa82ee4b0c9d6adf6a9de	G25782.TCGA-55-6982-01A-11D-1945-08.2.filtered.	WGS	G25782.TCGA-55-6982-01A-11D-1945-08.2	G25782.TCGA-55-6982-01A-11D-1945-08.2.bam	86.7		0.05	58cfa82ee4b0c9d6adf6a9de	G25782.TCGA-55-6982-01A-11D-1945-08.2.bam	Dead	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-55-6982-01A	35CB7841-9B09-465A-90C5-E3B8A9FAAD49	Primary Tumor	Illumina HiSeq	c6027d22-f05d-42e4-a467-de21b4606751	Lung	79.0	3B284FC6-7DC4-46C2-8EC9-1121EF0B4308	B7F11036-7AC4-41BC-A9A4-64162725FDFC	TCGA-55-6982-01A-11D-1945-08	HG19_Broad_variant	TCGA-55-6982	TCGA-LUAD	995.0	s11109	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1945-08	True
13767.58cfa833e4b0c9d6adf6d921	58cfa833e4b0c9d6adf6d921	UNCID_1072427.523d5f7e-4980-4f87-be5d-3a81bb6f8314.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1072427.523d5f7e-4980-4f87-be5d-3a81bb6f8314.sorted_genome_alignments	UNCID_1072427.523d5f7e-4980-4f87-be5d-3a81bb6f8314.sorted_genome_alignments.bam	74.8	1.8	0.15	58cfa833e4b0c9d6adf6d921	UNCID_1072427.523d5f7e-4980-4f87-be5d-3a81bb6f8314.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-5234-01A	349E01B0-0C88-4321-839E-0A84EDF11A73	Primary Tumor	Illumina HiSeq	AEE62390-3629-41C8-B460-8AD5A6FF6878	Lung	71.0	8620B5A0-E9ED-427B-9675-EE8EE798686E	523D5F7E-4980-4F87-BE5D-3A81BB6F8314	TCGA-34-5234-01A-01R-1635-07	HG19	TCGA-34-5234	TCGA-LUSC		s10606	University of North Carolina	University of Pittsburgh	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1635-07	True
13767.58cfa83be4b0c9d6adf723fe	58cfa83be4b0c9d6adf723fe	UNCID_2614600.4c0ca123-3b83-4a25-aa0f-fe1a593ea969.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2614600.4c0ca123-3b83-4a25-aa0f-fe1a593ea969.sorted_genome_alignments	UNCID_2614600.4c0ca123-3b83-4a25-aa0f-fe1a593ea969.sorted_genome_alignments.bam	28.19	1.83	0.17	58cfa83be4b0c9d6adf723fe	UNCID_2614600.4c0ca123-3b83-4a25-aa0f-fe1a593ea969.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-V1-A9ZK-01A	7DC62C0F-B82D-417F-89A7-4CB984A9D304	Primary Tumor	Illumina HiSeq	5AA1D352-B838-4FA6-A4EA-3EAFA616D9EC	Prostate	68.0	B860310F-6079-4C82-809E-44624E936F5F	4C0CA123-3B83-4A25-AA0F-FE1A593EA969	TCGA-V1-A9ZK-01A-11R-A41O-07	HG19	TCGA-V1-A9ZK	TCGA-PRAD		s4113	University of North Carolina	University of California San Francisco	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		A41O-07	True
13767.58cfa834e4b0c9d6adf6e3d5	58cfa834e4b0c9d6adf6e3d5	UNCID_1180904.e7421840-5e51-4bb8-aefe-2843171b5bd0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1180904.e7421840-5e51-4bb8-aefe-2843171b5bd0.sorted_genome_alignments	UNCID_1180904.e7421840-5e51-4bb8-aefe-2843171b5bd0.sorted_genome_alignments.bam	69.3	1.8	0.14	58cfa834e4b0c9d6adf6e3d5	UNCID_1180904.e7421840-5e51-4bb8-aefe-2843171b5bd0.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4758-01A	44143697-C4B3-4051-9594-D53131C05889	Primary Tumor	Illumina HiSeq	EC35457C-86A3-4584-954E-5EE23D3221E2	Kidney	40.0	C2145112-A7AC-45C3-A50D-7A644D44C00F	E7421840-5E51-4BB8-AEFE-2843171B5BD0	TCGA-BP-4758-01A-01R-1289-07	HG19	TCGA-BP-4758	TCGA-KIRC		s9601	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1289-07	True
13767.58cfa834e4b0c9d6adf6e992	58cfa834e4b0c9d6adf6e992	UNCID_1236923.5c8adf9a-05bc-4690-a057-4638de231d93.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1236923.5c8adf9a-05bc-4690-a057-4638de231d93.sorted_genome_alignments	UNCID_1236923.5c8adf9a-05bc-4690-a057-4638de231d93.sorted_genome_alignments.bam	10.02	1.95	0.15	58cfa834e4b0c9d6adf6e992	UNCID_1236923.5c8adf9a-05bc-4690-a057-4638de231d93.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A29D-06A	EF608754-3F87-458E-9BCF-4434C54C8C9E	Metastatic	Illumina HiSeq	6396BBE0-D303-4344-931C-320C2D38F842	Skin	87.0	C129BD85-B320-4B3C-9316-CE00F58BA3D0	5C8ADF9A-05BC-4690-A057-4638DE231D93	TCGA-EE-A29D-06A-11R-A18T-07	HG19	TCGA-EE-A29D	TCGA-SKCM	425.0	s7573	University of North Carolina	University of Sydney	Australia	NO	T3b	N1b		Stage III	A18T-07	True
13722.58cfa831e4b0c9d6adf6c904	58cfa831e4b0c9d6adf6c904	TCGA-DD-A4NA-11A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A4NA-11A-11D-A25V-10_wgs_Illumina	TCGA-DD-A4NA-11A-11D-A25V-10_wgs_Illumina.bam	23.9		0.08	58cfa831e4b0c9d6adf6c904	TCGA-DD-A4NA-11A-11D-A25V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A4NA-11A	BEE9D6C8-948F-4B76-97CA-B985064249EF	Solid Tissue Normal	Illumina HiSeq	1d28c87c-de75-4b26-9f67-14d1cf638d90	Liver	67.0	58D8F5F1-4AA7-412C-83FC-744183FE5421	85FA6EFB-2977-466F-B260-4E95585F2E37	TCGA-DD-A4NA-11A-11D-A25V-10	GRCh37-lite	TCGA-DD-A4NA	TCGA-LIHC		s16680	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T2	N1	Hepatocellular Carcinoma	Stage III	A25V-10	True
13722.58cfa830e4b0c9d6adf6c102	58cfa830e4b0c9d6adf6c102	TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted	TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted.bam	97.15	2.16	0.13	58cfa830e4b0c9d6adf6c102	TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K9-01A	4485CC98-5D58-4EB4-8325-7D1A617B6461	Primary Tumor	Illumina HiSeq	71c016d1-ab89-4d8f-acb9-92767959d603	Uterus	88.0	52A96216-708F-43F2-A923-130A1C35922D	30D94271-91F3-4CF5-83C0-4708662115D0	TCGA-B5-A0K9-01A-21D-A101-02	HG19_Broad_variant	TCGA-B5-A0K9	TCGA-UCEC		s5210	Harvard Medical School	Duke	United States	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa83ce4b0c9d6adf72cc8	58cfa83ce4b0c9d6adf72cc8	UNCID_416905.809b49c6-f80b-471e-aa68-918f5c2f6f21.110608_UNC13-SN749_0072_AC03JFABXX.3.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_416905.809b49c6-f80b-471e-aa68-918f5c2f6f21.110608_UNC13-SN749_0072_AC03JFABXX.3.trimmed.annotated.translated_to_genomic	UNCID_416905.809b49c6-f80b-471e-aa68-918f5c2f6f21.110608_UNC13-SN749_0072_AC03JFABXX.3.trimmed.annotated.translated_to_genomic.bam	74.3	1.6	0.14	58cfa83ce4b0c9d6adf72cc8	UNCID_416905.809b49c6-f80b-471e-aa68-918f5c2f6f21.110608_UNC13-SN749_0072_AC03JFABXX.3.trimmed.annotated.translated_to_genomic.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4842-01A	1B0AD45E-B917-4E91-83C4-E5386CDF0EEE	Primary Tumor	Illumina HiSeq	A0DE2D99-1145-4F2F-AFBB-B466779B17CE	Kidney	73.0	50F4BC66-E2AF-478D-9253-8370AB937D88	809B49C6-F80B-471E-AA68-918F5C2F6F21	TCGA-B0-4842-01A-02R-1420-07	HG19	TCGA-B0-4842	TCGA-KIRC	1724.0	s9547	University of North Carolina	University of Pittsburgh	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1420-07	True
13767.58cfa838e4b0c9d6adf70e61	58cfa838e4b0c9d6adf70e61	UNCID_2193173.0e814275-e5f4-4071-a65f-58eac29774ee.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2193173.0e814275-e5f4-4071-a65f-58eac29774ee.sorted_genome_alignments	UNCID_2193173.0e814275-e5f4-4071-a65f-58eac29774ee.sorted_genome_alignments.bam	34.81	1.87	0.17	58cfa838e4b0c9d6adf70e61	UNCID_2193173.0e814275-e5f4-4071-a65f-58eac29774ee.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-GR-A4D5-01A	F855DAD1-6FFC-493E-BA6C-970874BC9210	Primary Tumor	Illumina HiSeq	52F97806-7D89-4CF1-821C-331D4589EC25	Lymph Nodes	46.0	64DB2111-1C24-4325-BB2F-0EDC77315C4A	0E814275-E5F4-4071-A65F-58EAC29774EE	TCGA-GR-A4D5-01A-11R-A31O-07	HG19	TCGA-GR-A4D5	TCGA-DLBC		s1127	University of North Carolina	University of Nebraska Medical Center (UNMC)	United States	NO			Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)		A31O-07	True
13722.58cfa830e4b0c9d6adf6c073	58cfa830e4b0c9d6adf6c073	TCGA-BJ-A0ZE-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZE-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_7_rg.sorted	TCGA-BJ-A0ZE-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_7_rg.sorted.bam	15.88	1.98	0.16	58cfa830e4b0c9d6adf6c073	TCGA-BJ-A0ZE-10A-01D-A10R_120617_SN1222_0117_BD1414ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZE-10A	AB8C9101-ADEB-4C43-A8BB-B089EBD711F6	Blood Derived Normal	Illumina HiSeq	4568433f-6965-4efc-8d70-3369d6a70e72	Thyroid	63.0	ABE80C37-F3CB-4A56-9C18-9080057AA81D	9A3C6D5A-4AD4-40BC-A4B0-69544AA5A5D0	TCGA-BJ-A0ZE-10A-01D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZE	TCGA-THCA		s12229	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A10R-02	True
13767.58cfa832e4b0c9d6adf6d742	58cfa832e4b0c9d6adf6d742	UNCID_1068002.d998fb64-f09e-462e-b7c4-d2e63e56a553.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1068002.d998fb64-f09e-462e-b7c4-d2e63e56a553.sorted_genome_alignments	UNCID_1068002.d998fb64-f09e-462e-b7c4-d2e63e56a553.sorted_genome_alignments.bam	323.3	1.8	0.15	58cfa832e4b0c9d6adf6d742	UNCID_1068002.d998fb64-f09e-462e-b7c4-d2e63e56a553.sorted_genome_alignments.bam	Dead	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-63-5131-01A	68107725-A883-4B33-A366-D9B4ADB18028	Primary Tumor	Illumina HiSeq	A8E4A941-4A43-4682-A57F-C24FE200DA24	Lung		B37CF4C9-E67C-4653-AF68-C4B4C57C8412	D998FB64-F09E-462E-B7C4-D2E63E56A553	TCGA-63-5131-01A-01R-1443-07	HG19	TCGA-63-5131	TCGA-LUSC		s10407	University of North Carolina	Ontario Institute for Cancer Research	Canada	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	1443-07	True
13767.58cfa832e4b0c9d6adf6d04a	58cfa832e4b0c9d6adf6d04a	TCGA-IG-A6QS-01A-12R-A336-31_rnaseq.filtered.	RNA-Seq	TCGA-IG-A6QS-01A-12R-A336-31_rnaseq	TCGA-IG-A6QS-01A-12R-A336-31_rnaseq.bam	60.45	1.91	0.18	58cfa832e4b0c9d6adf6d04a	TCGA-IG-A6QS-01A-12R-A336-31_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A6QS-01A	41B6C417-1EC1-4DB9-91A8-11AA4DBAD05D	Primary Tumor	Illumina HiSeq	B219C50D-67E9-438D-BCC6-A440EDFA9AF2	Esophagus	54.0	9030501E-46C9-411E-9859-FF3FC6254DF7	D4DC886F-538B-436C-9C8A-3C2728E9EF3F	TCGA-IG-A6QS-01A-12R-A336-31	GRCh37-lite	TCGA-IG-A6QS	TCGA-ESCA		s1914	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T2	N1		Stage II	A336-31	True
13722.58cfa831e4b0c9d6adf6c3ac	58cfa831e4b0c9d6adf6c3ac	TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted	TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted.bam	195.0	1.9	0.15	58cfa831e4b0c9d6adf6c3ac	TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5722-01A	F35E8FEF-F61D-4614-B73F-F7E1D0F21F52	Primary Tumor	Illumina HiSeq	05762233-5294-478d-b462-14b931579f63	Stomach	67.0	30D63C9D-E36A-4654-86B5-5D7A622089C2	F262DDED-846F-4DEB-8FC3-EF0DF814ECA4	TCGA-CG-5722-01A-21D-1598-02	HG19_Broad_variant	TCGA-CG-5722	TCGA-STAD		s14642	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1598-02	True
13722.58cfa82de4b0c9d6adf6a471	58cfa82de4b0c9d6adf6a471	1076369c844452a633e3edce84850064.filtered.	WGS	1076369c844452a633e3edce84850064	1076369c844452a633e3edce84850064.bam	59.16	1.89	0.09	58cfa82de4b0c9d6adf6a471	1076369c844452a633e3edce84850064.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A1C8-01A	BAD34C92-1E64-4187-A0B4-061105FD13BA	Primary Tumor	Illumina HiSeq	37d56097-9e5d-4008-bbc9-5bd69910436b	Uterus	77.0	83E4DFB0-F240-476B-BC25-F9F52C960AF5	00DB4DC2-3EC7-4FF9-9233-D69C8C8A607F	TCGA-AX-A1C8-01A-11D-A135-09	GRCh37-lite	TCGA-AX-A1C8	TCGA-UCEC		s4403	Washington University School of Medicine	Gynecologic Oncology Group	None	NO			Serous endometrial adenocarcinoma		A135-09	False
13767.58cfa83be4b0c9d6adf72460	58cfa83be4b0c9d6adf72460	UNCID_2619499.0e370e53-c3cc-4191-a6f5-68c932ee7641.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2619499.0e370e53-c3cc-4191-a6f5-68c932ee7641.sorted_genome_alignments	UNCID_2619499.0e370e53-c3cc-4191-a6f5-68c932ee7641.sorted_genome_alignments.bam	84.17	1.88	0.17	58cfa83be4b0c9d6adf72460	UNCID_2619499.0e370e53-c3cc-4191-a6f5-68c932ee7641.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-AACT-01A	3EA084C5-3783-4FDE-B341-5914D2EDB977	Primary Tumor	Illumina HiSeq	AAC4D0A6-0920-42D9-9B15-22B671D4D83B	Liver	69.0	D1CDC76A-E306-44A0-B509-8DDEF84DDFDF	0E370E53-C3CC-4191-A6F5-68C932EE7641	TCGA-DD-AACT-01A-11R-A41C-07	HG19	TCGA-DD-AACT	TCGA-LIHC		s16838	University of North Carolina	Mayo Clinic - Rochester	Korea South	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A41C-07	True
13767.58cfa838e4b0c9d6adf70f6e	58cfa838e4b0c9d6adf70f6e	UNCID_2221567.43d6f3d2-2bd6-41e1-9d85-735f5f60e25a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2221567.43d6f3d2-2bd6-41e1-9d85-735f5f60e25a.sorted_genome_alignments	UNCID_2221567.43d6f3d2-2bd6-41e1-9d85-735f5f60e25a.sorted_genome_alignments.bam	10.26	1.76	0.16	58cfa838e4b0c9d6adf70f6e	UNCID_2221567.43d6f3d2-2bd6-41e1-9d85-735f5f60e25a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-QH-A6CU-01A	76CB16F9-37BE-450E-B60A-5F0D0F1EC2BC	Primary Tumor	Illumina HiSeq	BFD186F5-D4D6-49BC-8F52-392B6D55A4BC	Brain	52.0	842DF84D-DA05-4AA5-91A4-C6893ECA2082	43D6F3D2-2BD6-41E1-9D85-735F5F60E25A	TCGA-QH-A6CU-01A-11R-A31N-07	HG19	TCGA-QH-A6CU	TCGA-LGG		s8249	University of North Carolina	Fondazione-Besta	Italy	NO			Oligodendroglioma		A31N-07	True
13767.58cfa83be4b0c9d6adf72177	58cfa83be4b0c9d6adf72177	UNCID_2597757.81674433-89de-4024-aadc-fd8fede17699.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2597757.81674433-89de-4024-aadc-fd8fede17699.sorted_genome_alignments	UNCID_2597757.81674433-89de-4024-aadc-fd8fede17699.sorted_genome_alignments.bam	30.5	1.89	0.15	58cfa83be4b0c9d6adf72177	UNCID_2597757.81674433-89de-4024-aadc-fd8fede17699.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-XK-AAJ3-01A	06C9EB11-6018-4015-9FBE-B46886B2C3E0	Primary Tumor	Illumina HiSeq	31041EB9-D220-4606-8167-59B82BF84E6B	Prostate	56.0	8B21DF1C-2190-4E34-B01F-E9D2E78B8A80	81674433-89DE-4024-AADC-FD8FEDE17699	TCGA-XK-AAJ3-01A-11R-A41O-07	HG19	TCGA-XK-AAJ3	TCGA-PRAD		s3739	University of North Carolina	Mayo Clinic Arizona	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		A41O-07	True
13767.58cfa82fe4b0c9d6adf6b224	58cfa82fe4b0c9d6adf6b224	TCGA-13-0924-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0924-01A-01R-1564-13_rnaseq	TCGA-13-0924-01A-01R-1564-13_rnaseq.bam	380.0	1.7	0.14	58cfa82fe4b0c9d6adf6b224	TCGA-13-0924-01A-01R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0924-01A	FBB45305-DE8D-4BAF-8BD0-047B29C2E9D9	Primary Tumor	Illumina HiSeq	9D161DC6-5F9E-41D1-B676-FF180CC47EBB	Ovary	45.0	5BE2767C-8F8E-4B30-A3FA-BFBCCE461C5C	85A4C41B-9829-48F8-9C7A-A9DE870332B6	TCGA-13-0924-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-13-0924	TCGA-OV		s17919	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa834e4b0c9d6adf6e756	58cfa834e4b0c9d6adf6e756	UNCID_1219870.78eb93c7-0300-4f16-ab32-7489715e3353.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1219870.78eb93c7-0300-4f16-ab32-7489715e3353.sorted_genome_alignments	UNCID_1219870.78eb93c7-0300-4f16-ab32-7489715e3353.sorted_genome_alignments.bam	80.15	1.87	0.16	58cfa834e4b0c9d6adf6e756	UNCID_1219870.78eb93c7-0300-4f16-ab32-7489715e3353.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EE-11A	654AF137-70D9-4EE4-9F69-793E352D30F8	Solid Tissue Normal	Illumina HiSeq	33AEB959-7423-4332-996C-480B4AAD5286	Liver	73.0	D9FD7E08-27AA-4081-96FE-86B7EC06D3DF	78EB93C7-0300-4F16-AB32-7489715E3353	TCGA-DD-A1EE-11A-11R-A131-07	HG19	TCGA-DD-A1EE	TCGA-LIHC		s16796	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T3	N0	Hepatocellular Carcinoma	Stage III	A131-07	True
13767.58cfa839e4b0c9d6adf7106e	58cfa839e4b0c9d6adf7106e	UNCID_2245713.48ad4bbc-d720-43da-98a8-e002c69ff5aa.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2245713.48ad4bbc-d720-43da-98a8-e002c69ff5aa.sorted_genome_alignments	UNCID_2245713.48ad4bbc-d720-43da-98a8-e002c69ff5aa.sorted_genome_alignments.bam	60.11	1.94	0.18	58cfa839e4b0c9d6adf7106e	UNCID_2245713.48ad4bbc-d720-43da-98a8-e002c69ff5aa.sorted_genome_alignments.bam	Alive	FEMALE		HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-Q1-A73O-01A	D0CBE668-5C95-4261-A1E8-CEF55093A0F7	Primary Tumor	Illumina HiSeq	4364548C-A981-4D71-9A45-406B1FDDB502	Cervix	37.0	BC95EA67-748A-4826-9112-8EC1EA2167CF	48AD4BBC-D720-43DA-98A8-E002C69FF5AA	TCGA-Q1-A73O-01A-11R-A32P-07	HG19	TCGA-Q1-A73O	TCGA-CESC		s1443	University of North Carolina	University of Oklahoma HSC	United States	NO	TX	NX	Cervical Squamous Cell Carcinoma		A32P-07	True
13767.58cfa834e4b0c9d6adf6e292	58cfa834e4b0c9d6adf6e292	UNCID_1177278.a2c80f8e-f08d-4574-90a0-f0651c0a9b1b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1177278.a2c80f8e-f08d-4574-90a0-f0651c0a9b1b.sorted_genome_alignments	UNCID_1177278.a2c80f8e-f08d-4574-90a0-f0651c0a9b1b.sorted_genome_alignments.bam	10.66	1.86	0.15	58cfa834e4b0c9d6adf6e292	UNCID_1177278.a2c80f8e-f08d-4574-90a0-f0651c0a9b1b.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1B5-01A	7241B3D4-31EE-4FD2-A4A5-35A9D5F37D6A	Primary Tumor	Illumina HiSeq	6656170E-86B0-47A3-88A9-762424E8AB78	Breast	46.0	5B01ED81-2119-4797-9BE9-67BC21ABC7D9	A2C80F8E-F08D-4574-90A0-F0651C0A9B1B	TCGA-E2-A1B5-01A-21R-A12P-07	HG19	TCGA-E2-A1B5	TCGA-BRCA		s6715	University of North Carolina	Roswell Park	None	NO	T2	N0	Infiltrating Lobular Carcinoma	Stage II	A12P-07	True
13767.58cfa839e4b0c9d6adf71449	58cfa839e4b0c9d6adf71449	UNCID_2309119.500000a8-420b-43e1-9ed1-e0d66fe2aece.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2309119.500000a8-420b-43e1-9ed1-e0d66fe2aece.sorted_genome_alignments	UNCID_2309119.500000a8-420b-43e1-9ed1-e0d66fe2aece.sorted_genome_alignments.bam	10.3	1.74	0.16	58cfa839e4b0c9d6adf71449	UNCID_2309119.500000a8-420b-43e1-9ed1-e0d66fe2aece.sorted_genome_alignments.bam					Brain Lower Grade Glioma	Aligned reads	TCGA-R8-A6YH-01A	BC66F21C-7AE6-4312-B6C1-EA3E19F90485	Primary Tumor	Illumina HiSeq	52B47751-2C36-467B-83DB-1B98E1442DAA	Brain		EF20B0BE-2CD0-4193-B564-5C3F0BFBF0C9	500000A8-420B-43E1-9ED1-E0D66FE2AECE	TCGA-R8-A6YH-01A-21R-A32Q-07	HG19	TCGA-R8-A6YH	TCGA-LGG		s8693	University of North Carolina	MD Anderson	United States	NO					A32Q-07	True
13767.58cfa838e4b0c9d6adf70678	58cfa838e4b0c9d6adf70678	UNCID_1959221.fa5377b9-8285-4101-8378-2dbe0820eaa2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1959221.fa5377b9-8285-4101-8378-2dbe0820eaa2.sorted_genome_alignments	UNCID_1959221.fa5377b9-8285-4101-8378-2dbe0820eaa2.sorted_genome_alignments.bam	19.2		0.15	58cfa838e4b0c9d6adf70678	UNCID_1959221.fa5377b9-8285-4101-8378-2dbe0820eaa2.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-DW-7834-01A	B11234B9-93D5-46DF-BB67-110D6ED3E664	Primary Tumor	Illumina HiSeq	B8CCA4D2-7891-4B4B-9C30-D23850DBD848	Kidney	53.0	77454149-8F6B-4CC7-9FB2-BE0FAD840D8F	FA5377B9-8285-4101-8378-2DBE0820EAA2	TCGA-DW-7834-01A-11R-2139-07	HG19	TCGA-DW-7834	TCGA-KIRP		s11810	University of North Carolina	NCI Urologic Oncology Branch	United States	NO	T1	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	2139-07	True
13722.58cfa82ee4b0c9d6adf6a7f2	58cfa82ee4b0c9d6adf6a7f2	G25776.TCGA-75-6203-10A-01D-1753-08.1.filtered.	WGS	G25776.TCGA-75-6203-10A-01D-1753-08.1	G25776.TCGA-75-6203-10A-01D-1753-08.1.bam	28.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7f2	G25776.TCGA-75-6203-10A-01D-1753-08.1.bam	Alive	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-75-6203-10A	A8D6694C-A213-4544-AC0B-63BCE16D8F4E	Blood Derived Normal	Illumina HiSeq	279e57e9-744f-4530-a856-cf989245b8ef	Lung		C9C3BFFA-9F10-4681-BDBD-FDACCBA1031C	FDF9B270-14FF-4961-978E-5DFF14D77FEB	TCGA-75-6203-10A-01D-1753-08	HG19_Broad_variant	TCGA-75-6203	TCGA-LUAD		s11317	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1753-08	True
13767.58cfa834e4b0c9d6adf6e112	58cfa834e4b0c9d6adf6e112	UNCID_1144962.7455cc98-aceb-4adc-932b-4fddd979c522.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1144962.7455cc98-aceb-4adc-932b-4fddd979c522.sorted_genome_alignments	UNCID_1144962.7455cc98-aceb-4adc-932b-4fddd979c522.sorted_genome_alignments.bam	57.0	1.76	0.15	58cfa834e4b0c9d6adf6e112	UNCID_1144962.7455cc98-aceb-4adc-932b-4fddd979c522.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J3-01A	39CDE586-DF95-435F-B9A6-73B0C0EE5E92	Primary Tumor	Illumina HiSeq	835E8CD5-309B-441D-A660-DD1903942951	Breast	67.0	F93C9B46-B07E-4A5F-9B3E-D7CEBE34EBED	7455CC98-ACEB-4ADC-932B-4FDDD979C522	TCGA-AO-A0J3-01A-11R-A034-07	HG19	TCGA-AO-A0J3	TCGA-BRCA		s6519	University of North Carolina	MSKCC	None	NO	T2	N1b	Other  specify	Stage II	A034-07	True
13767.58cfa833e4b0c9d6adf6dd09	58cfa833e4b0c9d6adf6dd09	UNCID_1126595.c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1126595.c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5.sorted_genome_alignments	UNCID_1126595.c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5.sorted_genome_alignments.bam	11.8	1.83	0.16	58cfa833e4b0c9d6adf6dd09	UNCID_1126595.c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5.sorted_genome_alignments.bam	Alive	MALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DD-11A	DBA9BEEC-5E51-48C0-9229-0EE286A02A1A	Solid Tissue Normal	Illumina HiSeq	66508629-A789-4158-8170-70BFC04A6FFC	Breast	58.0	BD6038FF-9634-45D5-80D8-97A3F1EA2D04	C38C7C6D-7C7C-45EA-9FAE-A889E6CE0DF5	TCGA-BH-A0DD-11A-23R-A12P-07	HG19	TCGA-BH-A0DD	TCGA-BRCA		s5837	University of North Carolina	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A12P-07	True
13767.58cfa837e4b0c9d6adf700b3	58cfa837e4b0c9d6adf700b3	UNCID_1857540.740c53d0-b037-4475-82b3-044b2f879aac.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1857540.740c53d0-b037-4475-82b3-044b2f879aac.sorted_genome_alignments	UNCID_1857540.740c53d0-b037-4475-82b3-044b2f879aac.sorted_genome_alignments.bam	8.4	1.78	0.17	58cfa837e4b0c9d6adf700b3	UNCID_1857540.740c53d0-b037-4475-82b3-044b2f879aac.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A3XN-01A	0930E97A-72EA-4BD5-B2F0-50C76AF695F3	Primary Tumor	Illumina HiSeq	6249DA0A-9A96-4832-823B-EBC49A708BDC	Breast	44.0	281F2BE7-7FB2-46F2-9A4A-033DB48329A1	740C53D0-B037-4475-82B3-044B2F879AAC	TCGA-GM-A3XN-01A-12R-A22U-07	HG19	TCGA-GM-A3XN	TCGA-BRCA		s6228	University of North Carolina	MD Anderson	United States	NO	T1c	N2a	Infiltrating Lobular Carcinoma	Stage III	A22U-07	True
13722.58cfa830e4b0c9d6adf6bfec	58cfa830e4b0c9d6adf6bfec	TCGA-AG-3885-10A-01D-0967-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3885-10A-01D-0967-10_wgs_Illumina	TCGA-AG-3885-10A-01D-0967-10_wgs_Illumina.bam	19.31	1.8	0.15	58cfa830e4b0c9d6adf6bfec	TCGA-AG-3885-10A-01D-0967-10_wgs_Illumina.bam	Alive	FEMALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3885-10A	E5E4AA9F-6015-4D62-A088-69920D7F2500	Blood Derived Normal	Illumina HiSeq	74661b7f-2008-4350-8dac-1a414f9e4b35	Colorectal	71.0	D7D09FF1-A9F4-4E5B-B1C1-854DF4A856C9	D7F5C210-C7B5-4BD6-9F42-7999FC4A2287	TCGA-AG-3885-10A-01D-0967-10	GRCh37-lite	TCGA-AG-3885	TCGA-READ		s1969	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage III	0967-10	False
13767.58cfa835e4b0c9d6adf6f0dc	58cfa835e4b0c9d6adf6f0dc	UNCID_1468539.C40FF5CD-BFFA-40C4-A192-9830B0DA3DAA.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1468539.C40FF5CD-BFFA-40C4-A192-9830B0DA3DAA.sorted_genome_alignments	UNCID_1468539.C40FF5CD-BFFA-40C4-A192-9830B0DA3DAA.sorted_genome_alignments.bam	19.7	1.83	0.17	58cfa835e4b0c9d6adf6f0dc	UNCID_1468539.C40FF5CD-BFFA-40C4-A192-9830B0DA3DAA.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A3QU-01A	AE6D853B-A7F0-4465-B7BF-5A45006AB3B3	Primary Tumor	Illumina HiSeq	9F77B280-1AD2-44B3-808F-C97745B60553	Bladder	58.0	75448068-DED8-42F0-BB99-6D1C4B3FFA4E	C40FF5CD-BFFA-40C4-A192-9830B0DA3DAA	TCGA-CU-A3QU-01A-11R-A22U-07	HG19	TCGA-CU-A3QU	TCGA-BLCA		s2769	University of North Carolina	UNC	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A22U-07	True
13767.58cfa835e4b0c9d6adf6ee3c	58cfa835e4b0c9d6adf6ee3c	UNCID_1374067.5c6bca7d-7dcc-4908-add3-c56606b313a7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1374067.5c6bca7d-7dcc-4908-add3-c56606b313a7.sorted_genome_alignments	UNCID_1374067.5c6bca7d-7dcc-4908-add3-c56606b313a7.sorted_genome_alignments.bam	77.8	1.8	0.15	58cfa835e4b0c9d6adf6ee3c	UNCID_1374067.5c6bca7d-7dcc-4908-add3-c56606b313a7.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5794-01A	A80D3EE7-60DD-49BB-B049-9335AFC035F5	Primary Tumor	Illumina HiSeq	3126239D-75AA-46C1-B458-3A5031FF7FD9	Prostate	65.0	D1A1CCFE-1215-4B34-94A9-C9765264F617	5C6BCA7D-7DCC-4908-ADD3-C56606B313A7	TCGA-CH-5794-01A-11R-1580-07	HG19	TCGA-CH-5794	TCGA-PRAD		s4183	University of North Carolina	Indivumed	Germany	NO	T2b	N0	Prostate Adenocarcinoma Acinar Type		1580-07	True
13722.58cfa831e4b0c9d6adf6cd08	58cfa831e4b0c9d6adf6cd08	TCGA-EJ-5495-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EJ-5495-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_2_rg.sorted	TCGA-EJ-5495-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_2_rg.sorted.bam	1161.4	1.9	0.16	58cfa831e4b0c9d6adf6cd08	TCGA-EJ-5495-10A-01D-1573_130125_SN1120_0233_AD1K3HACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5495-10A	962DD3D5-8501-4658-8CB9-2424B476124C	Blood Derived Normal	Illumina HiSeq	c1976dc5-9458-46ad-a1a5-1db90aa4eb04	Prostate	68.0	36329281-238C-492A-B442-70182FFCB017	642519A5-9911-4355-A257-97288162AC53	TCGA-EJ-5495-10A-01D-1573-02	HG19_Broad_variant	TCGA-EJ-5495	TCGA-PRAD		s3941	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type		1573-02	True
13767.58cfa834e4b0c9d6adf6e23a	58cfa834e4b0c9d6adf6e23a	UNCID_1169223.06a52d13-3cb4-4d5f-94ef-55d980562486.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1169223.06a52d13-3cb4-4d5f-94ef-55d980562486.sorted_genome_alignments	UNCID_1169223.06a52d13-3cb4-4d5f-94ef-55d980562486.sorted_genome_alignments.bam	86.24	1.92	0.16	58cfa834e4b0c9d6adf6e23a	UNCID_1169223.06a52d13-3cb4-4d5f-94ef-55d980562486.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-5264-01A	61902CB6-B041-48AC-AACC-483A28949865	Primary Tumor	Illumina HiSeq	E3808004-EC06-4EBD-831B-2552C1D7482B	Liver	71.0	EC67465B-DC08-4E09-8AF2-3B489BD15393	06A52D13-3CB4-4D5F-94EF-55D980562486	TCGA-CC-5264-01A-01R-A131-07	HG19	TCGA-CC-5264	TCGA-LIHC		s16601	University of North Carolina	ILSbio	None	NO	T3	N0	Hepatocellular Carcinoma	Stage III	A131-07	True
13767.58cfa834e4b0c9d6adf6e792	58cfa834e4b0c9d6adf6e792	UNCID_1225170.3458d1fe-d159-4522-a627-70c5cc180daa.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1225170.3458d1fe-d159-4522-a627-70c5cc180daa.sorted_genome_alignments	UNCID_1225170.3458d1fe-d159-4522-a627-70c5cc180daa.sorted_genome_alignments.bam	18.03	1.79	0.16	58cfa834e4b0c9d6adf6e792	UNCID_1225170.3458d1fe-d159-4522-a627-70c5cc180daa.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EL-01A	30C7445E-D0C4-4A0F-96A4-27E4259EE10B	Primary Tumor	Illumina HiSeq	31C6691C-9D0D-4C02-9F79-60CBB54D32B7	Bladder	77.0	90F1D206-3E97-4C88-922C-FE4773C37CAA	3458D1FE-D159-4522-A627-70C5CC180DAA	TCGA-G2-A2EL-01A-12R-A18C-07	HG19	TCGA-G2-A2EL	TCGA-BLCA	819.0	s3150	University of North Carolina	MD Anderson	United States	NO		N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A18C-07	True
13722.58cfa82ee4b0c9d6adf6ae54	58cfa82ee4b0c9d6adf6ae54	TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted.filtered.	WGS	TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted	TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted.bam	282.93	1.9	0.15	58cfa82ee4b0c9d6adf6ae54	TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted.bam	Dead	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4250-01A	F98ECD8A-B878-4F53-B911-20CD8E17281C	Primary Tumor	Illumina HiSeq	b7bbb240-9e61-41e0-a669-1744d0bda12b	Lung	79.0	8F274178-7A8E-46B6-8D2C-900338BBB946	A444B1E8-9FE9-492B-A361-93CAAB3681BC	TCGA-05-4250-01A-01D-1103-02	HG19_Broad_variant	TCGA-05-4250	TCGA-LUAD	121.0	s11441	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1103-02	True
13722.58cfa832e4b0c9d6adf6d418	58cfa832e4b0c9d6adf6d418	TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted	TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted.bam	38.01		0.16	58cfa832e4b0c9d6adf6d418	TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F2-01A	411DDF79-FE92-44AD-8D10-EEB703F11BE7	Primary Tumor	Illumina HiSeq	c4fcd1a4-5246-4a6b-b5b0-45b8b838edf2	Eye	78.0	2F2FF6C7-9568-47E4-AB09-6050F84BBF5C	87781EA6-C3E9-476A-B5D2-E58FC557FC7A	TCGA-V4-A9F2-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F2	TCGA-UVM		s207	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3b	N0		Stage III	A40D-26	True
13767.58cfa82ee4b0c9d6adf6a7b0	58cfa82ee4b0c9d6adf6a7b0	G17802.TCGA-28-5208-01A-01R-1850-01.4.filtered.	RNA-Seq	G17802.TCGA-28-5208-01A-01R-1850-01.4	G17802.TCGA-28-5208-01A-01R-1850-01.4.bam	222.7	1.8	0.14	58cfa82ee4b0c9d6adf6a7b0	G17802.TCGA-28-5208-01A-01R-1850-01.4.bam	Alive	MALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-28-5208-01A	46BFEBF4-0EF6-4348-81DC-D7D3CB52C08F	Primary Tumor	Illumina HiSeq	FDA06941-FB79-4D2A-9510-5667BF75CEE7	Brain	52.0	C286FAA9-5EA2-487D-8D17-651BE5988C04	63F989FF-890B-4DB8-973F-AB675912635F	TCGA-28-5208-01A-01R-1850-01	HG19_Broad_variant	TCGA-28-5208	TCGA-GBM		s14295	Broad Institute of MIT and Harvard	Cedars Sinai	None	NO			Untreated primary (de novo) GBM		1850-01	True
13767.58cfa834e4b0c9d6adf6e164	58cfa834e4b0c9d6adf6e164	UNCID_1167228.8801f107-f5d5-4ad5-877d-a5acb12596b3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1167228.8801f107-f5d5-4ad5-877d-a5acb12596b3.sorted_genome_alignments	UNCID_1167228.8801f107-f5d5-4ad5-877d-a5acb12596b3.sorted_genome_alignments.bam	26.36	1.73	0.14	58cfa834e4b0c9d6adf6e164	UNCID_1167228.8801f107-f5d5-4ad5-877d-a5acb12596b3.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04R-01A	F3A058B9-FB7F-4098-8F0E-83C2ACFA1ED5	Primary Tumor	Illumina HiSeq	9C8E6416-DEFA-439D-B567-48B47355A1FD	Breast	36.0	E29FC4E1-4C82-46D7-997C-BE59470C7751	8801F107-F5D5-4AD5-877D-A5ACB12596B3	TCGA-A2-A04R-01A-41R-A109-07	HG19	TCGA-A2-A04R	TCGA-BRCA		s5579	University of North Carolina	Walter Reed	None	NO	T1	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A109-07	True
13722.58cfa832e4b0c9d6adf6d0e0	58cfa832e4b0c9d6adf6d0e0	TCGA-FS-A1ZD-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_2_rg.sorted.filtered.	WGS	TCGA-FS-A1ZD-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_2_rg.sorted	TCGA-FS-A1ZD-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_2_rg.sorted.bam	66.27		0.17	58cfa832e4b0c9d6adf6d0e0	TCGA-FS-A1ZD-06A-11D-A18Y_120609_SN208_0343_BC0WVWACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZD-06A	C2948FE9-5798-43BC-A743-511E94E417F8	Metastatic	Illumina HiSeq	50f957e6-39df-4b6e-bd03-6b3ba6622543	Skin	63.0	3B63CB75-EC13-4CAB-B11D-EB6E7FAA8641	F550E879-225E-46BD-9A2C-8AD3ED801DF4	TCGA-FS-A1ZD-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-FS-A1ZD	TCGA-SKCM	1628.0	s7530	Harvard Medical School	Essen	Germany	NO	T2b	N0		Stage II	A18Y-02	True
13722.58cfa831e4b0c9d6adf6c37a	58cfa831e4b0c9d6adf6c37a	TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted	TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted.bam	46.0	1.9	0.17	58cfa831e4b0c9d6adf6c37a	TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5813-01A	152B9D8A-19FD-4665-B9E4-4FEDFB1608CD	Primary Tumor	Illumina HiSeq	ccc0d204-3529-43aa-b108-62d12f6465bd	Stomach	60.0	09E42E33-D2EC-406C-9A42-36D9D2EBD6C6	2118F0C5-3178-40EA-850D-C3F6F8752DD9	TCGA-CD-5813-01A-11D-1598-02	HG19_Broad_variant	TCGA-CD-5813	TCGA-STAD		s14408	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage II	1598-02	True
13767.58cfa838e4b0c9d6adf7085c	58cfa838e4b0c9d6adf7085c	UNCID_2035670.8b8048b4-fe60-45f4-97c5-662c45169334.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2035670.8b8048b4-fe60-45f4-97c5-662c45169334.sorted_genome_alignments	UNCID_2035670.8b8048b4-fe60-45f4-97c5-662c45169334.sorted_genome_alignments.bam	61.52	1.82	0.16	58cfa838e4b0c9d6adf7085c	UNCID_2035670.8b8048b4-fe60-45f4-97c5-662c45169334.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A3EW-01A	A31554AF-D77A-4862-8AED-4581FB2BD877	Primary Tumor	Illumina HiSeq	940A1E62-BB09-4473-8304-4F4CD71345E0	Uterus	62.0	BE387236-F691-4303-AA47-BE1D67CBDD5E	8B8048B4-FE60-45F4-97C5-662C45169334	TCGA-BG-A3EW-01A-11R-A22K-07	HG19	TCGA-BG-A3EW	TCGA-UCEC		s4710	University of North Carolina	University of Pittsburgh	United States	NO			Endometrioid endometrial adenocarcinoma		A22K-07	True
13722.58cfa831e4b0c9d6adf6c75b	58cfa831e4b0c9d6adf6c75b	TCGA-D1-A16D-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D1-A16D-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_4_rg.sorted	TCGA-D1-A16D-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_4_rg.sorted.bam	7.4	1.95	0.15	58cfa831e4b0c9d6adf6c75b	TCGA-D1-A16D-10A-01D-A12F_120511_SN208_0299_BD12J9ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16D-10A	5693302A-4548-4C0B-8725-0CB7C67BC4F8	Blood Derived Normal	Illumina HiSeq	1632a50b-463d-4306-a663-2af6737ce5c8	Uterus	49.0	9341A9C7-C7D3-4695-A721-2EE86F5F188D	FD5F8332-92E6-4A62-95A5-2A377BFAD623	TCGA-D1-A16D-10A-01D-A12F-02	HG19_Broad_variant	TCGA-D1-A16D	TCGA-UCEC		s5019	Harvard Medical School	Mayo Clinic	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13767.58cfa835e4b0c9d6adf6ed32	58cfa835e4b0c9d6adf6ed32	UNCID_1346379.df755d45-141e-40d1-96c8-6bfe29c17edc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1346379.df755d45-141e-40d1-96c8-6bfe29c17edc.sorted_genome_alignments	UNCID_1346379.df755d45-141e-40d1-96c8-6bfe29c17edc.sorted_genome_alignments.bam	46.37	1.85	0.17	58cfa835e4b0c9d6adf6ed32	UNCID_1346379.df755d45-141e-40d1-96c8-6bfe29c17edc.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A3IB-01A	AF53D51E-0B5C-437F-A1C0-EC5F55C49364	Primary Tumor	Illumina HiSeq	A95D1D0C-51F8-4585-8A50-B96CFE06C004	Bladder	66.0	791E4058-E872-4AF8-A431-F5782811F02A	DF755D45-141E-40D1-96C8-6BFE29C17EDC	TCGA-G2-A3IB-01A-11R-A20F-07	HG19	TCGA-G2-A3IB	TCGA-BLCA		s3153	University of North Carolina	MD Anderson	United States	NO		NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A20F-07	True
13767.58cfa835e4b0c9d6adf6ee00	58cfa835e4b0c9d6adf6ee00	UNCID_1363715.6551bbb1-297f-41db-969b-17bb3c432426.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1363715.6551bbb1-297f-41db-969b-17bb3c432426.sorted_genome_alignments	UNCID_1363715.6551bbb1-297f-41db-969b-17bb3c432426.sorted_genome_alignments.bam	93.2		0.16	58cfa835e4b0c9d6adf6ee00	UNCID_1363715.6551bbb1-297f-41db-969b-17bb3c432426.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7749-01A	13A63FD0-6C8C-4707-9135-8052F454D1AC	Primary Tumor	Illumina HiSeq	55A652E0-652D-487F-B066-F26B2867C876	Prostate	70.0	E7914D79-48AD-4EA1-8A8F-735183C16C56	6551BBB1-297F-41DB-969B-17BB3C432426	TCGA-HC-7749-01A-11R-2118-07	HG19	TCGA-HC-7749	TCGA-PRAD		s4024	University of North Carolina	International Genomics Consortium	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13722.58cfa830e4b0c9d6adf6bcb7	58cfa830e4b0c9d6adf6bcb7	TCGA-B0-5695-11A-01D-2103-10_wgs_Illumina.filtered.	WGS	TCGA-B0-5695-11A-01D-2103-10_wgs_Illumina	TCGA-B0-5695-11A-01D-2103-10_wgs_Illumina.bam	217.39	1.9	0.14	58cfa830e4b0c9d6adf6bcb7	TCGA-B0-5695-11A-01D-2103-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5695-11A	FB9BAFA5-7133-4955-8156-4EB6763DC8E1	Solid Tissue Normal	Illumina HiSeq	ea381ad1-7777-4408-9233-b13d6862e07e	Kidney	61.0	1CC1276D-0275-4B9A-8723-695CADE1B8E7	142F5162-1481-4C43-8CE4-52528EEDC283	TCGA-B0-5695-11A-01D-2103-10	GRCh37-lite	TCGA-B0-5695	TCGA-KIRC		s9446	Baylor College of Medicine	University of Pittsburgh	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2103-10	False
13767.58cfa833e4b0c9d6adf6df9c	58cfa833e4b0c9d6adf6df9c	UNCID_1156477.6330ab59-db9d-4b22-a96b-1024c9b4908d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1156477.6330ab59-db9d-4b22-a96b-1024c9b4908d.sorted_genome_alignments	UNCID_1156477.6330ab59-db9d-4b22-a96b-1024c9b4908d.sorted_genome_alignments.bam	38.42	1.78	0.14	58cfa833e4b0c9d6adf6df9c	UNCID_1156477.6330ab59-db9d-4b22-a96b-1024c9b4908d.sorted_genome_alignments.bam	Alive	FEMALE			Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A0A2-01A	34D5A193-85E5-4399-8A9B-E92858EAFDFE	Primary Tumor	Illumina HiSeq	EAD7D97A-3371-4C5F-9B29-9D113693CB06	Breast	66.0	9AE522C2-0FBF-493C-B3C7-A6CCD685C787	6330AB59-DB9D-4B22-A96B-1024C9B4908D	TCGA-A8-A0A2-01A-11R-A034-07	HG19	TCGA-A8-A0A2	TCGA-BRCA		s6849	University of North Carolina	Indivumed	Germany	NO	T2	N0	Infiltrating Lobular Carcinoma	Stage II	A034-07	True
13767.58cfa838e4b0c9d6adf709f8	58cfa838e4b0c9d6adf709f8	UNCID_2086731.2db9f19e-4614-44f9-a9f5-7541d6a20369.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2086731.2db9f19e-4614-44f9-a9f5-7541d6a20369.sorted_genome_alignments	UNCID_2086731.2db9f19e-4614-44f9-a9f5-7541d6a20369.sorted_genome_alignments.bam	33.88	1.8	0.16	58cfa838e4b0c9d6adf709f8	UNCID_2086731.2db9f19e-4614-44f9-a9f5-7541d6a20369.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A3FS-01A	8C6B9B54-58EB-4D5F-B8A9-8007163DB457	Primary Tumor	Illumina HiSeq	E70B4F6D-C9FE-4505-9051-C2B5A4E304F8	Uterus	82.0	272D64F9-0B4B-4136-ADFF-66C5401FC1D2	2DB9F19E-4614-44F9-A9F5-7541D6A20369	TCGA-AX-A3FS-01A-11R-A22K-07	HG19	TCGA-AX-A3FS	TCGA-UCEC		s5319	University of North Carolina	Gynecologic Oncology Group	United States	NO			Endometrioid endometrial adenocarcinoma		A22K-07	True
13767.58cfa833e4b0c9d6adf6ddb0	58cfa833e4b0c9d6adf6ddb0	UNCID_1131629.624ac458-8ff1-441c-a8c5-aaf4a08a4b84.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1131629.624ac458-8ff1-441c-a8c5-aaf4a08a4b84.sorted_genome_alignments	UNCID_1131629.624ac458-8ff1-441c-a8c5-aaf4a08a4b84.sorted_genome_alignments.bam	31.32	2.0	0.15	58cfa833e4b0c9d6adf6ddb0	UNCID_1131629.624ac458-8ff1-441c-a8c5-aaf4a08a4b84.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A13Z-01A	5A17DCD9-5CED-4A69-8069-23C7FD0649D1	Primary Tumor	Illumina HiSeq	9D6F8882-E7AF-4B47-A751-F4BB3E2E542C	Breast	51.0	8CAEC376-1F90-4802-947F-B893C370F219	624AC458-8FF1-441C-A8C5-AAF4A08A4B84	TCGA-D8-A13Z-01A-11R-A115-07	HG19	TCGA-D8-A13Z	TCGA-BRCA		s5847	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T2	N2a	Infiltrating Ductal Carcinoma		A115-07	True
13722.58cfa831e4b0c9d6adf6c4e4	58cfa831e4b0c9d6adf6c4e4	TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted.filtered.	WGS	TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted	TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted.bam	58.89		0.17	58cfa831e4b0c9d6adf6c4e4	TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LZ-01A	BE8FA67D-C2D3-4FFF-82FE-A46BA1FA8DF0	Primary Tumor	Illumina HiSeq	19f84215-7f5d-4cf8-a6f5-e135327ccd50	Cervix	65.0	6B9F4254-DBD3-4D82-BAE8-D43A4915A7CD	837B293C-0843-4002-A8AB-3A945E040C75	TCGA-C5-A2LZ-01A-11D-A20X-26	HG19_Broad_variant	TCGA-C5-A2LZ	TCGA-CESC	3046.0	s1173	MD Anderson - Institute for Applied Cancer Science	Medical College of Wisconsin	United States	NO			Cervical Squamous Cell Carcinoma		A20X-26	True
13722.58cfa82fe4b0c9d6adf6b7b0	58cfa82fe4b0c9d6adf6b7b0	TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	245.2	1.9	0.16	58cfa82fe4b0c9d6adf6b7b0	TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4494-01A	C6D78E27-E510-4F57-ABAE-19EFA6105A8D	Primary Tumor	Illumina HiSeq	3cb48d09-95ac-452f-9c92-19d7f966aec0	Lung	77.0	7CA68089-C61F-4D31-8CC8-FB11AE70910A	8DF0AEB4-1455-4760-A230-54FE1551D08C	TCGA-49-4494-01A-01D-1203-02	GRCh37	TCGA-49-4494	TCGA-LUAD	1081.0	s10783	Harvard Medical School	Johns Hopkins	United States	NO	T3	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1203-02	True
13767.58cfa83ce4b0c9d6adf72b22	58cfa83ce4b0c9d6adf72b22	UNCID_373302.TCGA-A3-3308-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.3.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_373302.TCGA-A3-3308-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.3.trimmed.annotated.translated_to_genomic	UNCID_373302.TCGA-A3-3308-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.3.trimmed.annotated.translated_to_genomic.bam	55.3	1.8	0.15	58cfa83ce4b0c9d6adf72b22	UNCID_373302.TCGA-A3-3308-01A-02R-1325-07.110421_UNC9-SN296_0172_AC0152ABXX.3.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3308-01A	3CBCA837-F5A7-4A87-8F02-C59EAC232D5A	Primary Tumor	Illumina HiSeq	F28445B8-F892-4E54-B772-5B286AB39CB8	Kidney	77.0	0B935ADB-0E19-4FCC-9BB0-B9D95872BCEF	F66AD0C1-2663-4F0D-80B0-FBDB6A94E607	TCGA-A3-3308-01A-02R-1325-07	HG19	TCGA-A3-3308	TCGA-KIRC		s9885	University of North Carolina	International Genomics Consortium	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1325-07	True
13767.58cfa83ce4b0c9d6adf72c88	58cfa83ce4b0c9d6adf72c88	UNCID_408500.12a59c4a-fb09-4063-9bb5-6161b10240e0.110503_UNC10-SN254_0215_BBOB7MABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_408500.12a59c4a-fb09-4063-9bb5-6161b10240e0.110503_UNC10-SN254_0215_BBOB7MABXX.7.trimmed.annotated.translated_to_genomic	UNCID_408500.12a59c4a-fb09-4063-9bb5-6161b10240e0.110503_UNC10-SN254_0215_BBOB7MABXX.7.trimmed.annotated.translated_to_genomic.bam	12.3	1.8	0.17	58cfa83ce4b0c9d6adf72c88	UNCID_408500.12a59c4a-fb09-4063-9bb5-6161b10240e0.110503_UNC10-SN254_0215_BBOB7MABXX.7.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4765-01A	6DC3788E-570F-4F39-9951-DCC7AD51E1F2	Primary Tumor	Illumina HiSeq	EF6EA409-DF98-44BD-B008-25239C4D7414	Kidney	43.0	17DE2D1B-B5F5-4BF2-BB65-EE05D110A88C	12A59C4A-FB09-4063-9BB5-6161B10240E0	TCGA-BP-4765-01A-01R-1289-07	HG19	TCGA-BP-4765	TCGA-KIRC		s9548	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1289-07	True
13767.58cfa835e4b0c9d6adf6ecca	58cfa835e4b0c9d6adf6ecca	UNCID_1341447.3e8b3913-495f-488c-872c-9ab46b85c301.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1341447.3e8b3913-495f-488c-872c-9ab46b85c301.sorted_genome_alignments	UNCID_1341447.3e8b3913-495f-488c-872c-9ab46b85c301.sorted_genome_alignments.bam	29.2		0.14	58cfa835e4b0c9d6adf6ecca	UNCID_1341447.3e8b3913-495f-488c-872c-9ab46b85c301.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-33-4587-11A	46CC3A2B-91C9-4A74-8989-992585634B87	Solid Tissue Normal	Illumina HiSeq	CB2DB2B9-0D9D-46B9-823F-31353865F73A	Lung	63.0	A4047782-532B-4F1A-BCDC-6A140CFA0F7F	3E8B3913-495F-488C-872C-9AB46B85C301	TCGA-33-4587-11A-01R-2125-07	HG19	TCGA-33-4587	TCGA-LUSC	1656.0	s10307	University of North Carolina	Johns Hopkins	United States	NO	T2	N0	Lung Small Cell Squamous Cell Carcinoma	Stage I	2125-07	True
13767.58cfa838e4b0c9d6adf708af	58cfa838e4b0c9d6adf708af	UNCID_2045692.4eabf441-dfaa-4c36-a0a4-8897d4008f3f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2045692.4eabf441-dfaa-4c36-a0a4-8897d4008f3f.sorted_genome_alignments	UNCID_2045692.4eabf441-dfaa-4c36-a0a4-8897d4008f3f.sorted_genome_alignments.bam	40.82	1.86	0.15	58cfa838e4b0c9d6adf708af	UNCID_2045692.4eabf441-dfaa-4c36-a0a4-8897d4008f3f.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B1-A47N-01A	F1EC5A7B-0973-4C38-9908-862196DF9541	Primary Tumor	Illumina HiSeq	BCB741E5-0F34-4601-BE2F-20F7C2EFCFAE	Kidney	62.0	C5EDE5F5-35D2-4059-9F0C-6736ABC6F899	4EABF441-DFAA-4C36-A0A4-8897D4008F3F	TCGA-B1-A47N-01A-11R-A24Z-07	HG19	TCGA-B1-A47N	TCGA-KIRP		s11913	University of North Carolina	University of Pittsburgh	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A24Z-07	True
13767.58cfa838e4b0c9d6adf706b2	58cfa838e4b0c9d6adf706b2	UNCID_1981680.83b592f7-21ce-4e32-aaf4-3f9402f48284.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1981680.83b592f7-21ce-4e32-aaf4-3f9402f48284.sorted_genome_alignments	UNCID_1981680.83b592f7-21ce-4e32-aaf4-3f9402f48284.sorted_genome_alignments.bam	12.63	1.87	0.15	58cfa838e4b0c9d6adf706b2	UNCID_1981680.83b592f7-21ce-4e32-aaf4-3f9402f48284.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A5FP-01A	2E6F9985-6D13-4B08-8A40-5EA44E9553F0	Primary Tumor	Illumina HiSeq	D8853DA8-48C1-4169-BF5E-BF620837DBA4	Skin	65.0	6A9B002F-81D5-46D9-B0F3-825FC527F92F	83B592F7-21CE-4E32-AAF4-3F9402F48284	TCGA-EB-A5FP-01A-11R-A27Q-07	HG19	TCGA-EB-A5FP	TCGA-SKCM		s8076	University of North Carolina	Asterand	Ukraine	NO	T4b	NX		Stage IV	A27Q-07	True
13722.58cfa83ce4b0c9d6adf72f72	58cfa83ce4b0c9d6adf72f72	ea57989a2a3017624491e77218b0f326.filtered.	WGS	ea57989a2a3017624491e77218b0f326	ea57989a2a3017624491e77218b0f326.bam	44.27	1.98	0.08	58cfa83ce4b0c9d6adf72f72	ea57989a2a3017624491e77218b0f326.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15E-01A	0A2A3529-F645-4967-9A58-89EE20B8BB62	Primary Tumor	Illumina HiSeq	3b80e735-e034-4867-be5e-52500f523ab5	Breast	40.0	9992EEB9-901B-4A32-BADC-E9BE7C9BA4BA	92B515EB-4036-4DAD-9CCA-DFB59C2EF26E	TCGA-E2-A15E-01A-11D-A19H-09	GRCh37-lite	TCGA-E2-A15E	TCGA-BRCA		s6753	Washington University School of Medicine	Roswell Park	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage II	A19H-09	True
13767.58cfa838e4b0c9d6adf70cbc	58cfa838e4b0c9d6adf70cbc	UNCID_2162393.0c8724f7-8a7e-4fc3-8100-b06b22d36a67.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2162393.0c8724f7-8a7e-4fc3-8100-b06b22d36a67.sorted_genome_alignments	UNCID_2162393.0c8724f7-8a7e-4fc3-8100-b06b22d36a67.sorted_genome_alignments.bam	16.84	1.88	0.16	58cfa838e4b0c9d6adf70cbc	UNCID_2162393.0c8724f7-8a7e-4fc3-8100-b06b22d36a67.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A6I3-11A	ACF6BDF3-6349-49DC-B99A-4EDA648EEAC5	Solid Tissue Normal	Illumina HiSeq	07ED39EC-5304-4031-96E5-70E12DA2B37C	Bladder	90.0	A6BD07C0-2568-42A3-8433-5F2EBFEC34B2	0C8724F7-8A7E-4FC3-8100-B06B22D36A67	TCGA-GC-A6I3-11A-11R-A31N-07	HG19	TCGA-GC-A6I3	TCGA-BLCA		s3008	University of North Carolina	International Genomics Consortium	United States	NO	T3a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A31N-07	True
13722.58cfa832e4b0c9d6adf6ced4	58cfa832e4b0c9d6adf6ced4	TCGA-FV-A495-10A-01D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A495-10A-01D-A25V-10_wgs_Illumina	TCGA-FV-A495-10A-01D-A25V-10_wgs_Illumina.bam	69.44		0.08	58cfa832e4b0c9d6adf6ced4	TCGA-FV-A495-10A-01D-A25V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A495-10A	BD48FA5E-0152-46F0-A4FA-8CF723FF2DCD	Blood Derived Normal	Illumina HiSeq	5fcb27fa-0faa-4474-9df8-33b05001f145	Liver	51.0	A6F9CD7E-5906-47C7-A344-7CCD199F28C9	88A0F90D-E075-45DA-B4BF-8DFC9FD6B6A8	TCGA-FV-A495-10A-01D-A25V-10	GRCh37-lite	TCGA-FV-A495	TCGA-LIHC		s16987	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	NX	Hepatocellular Carcinoma	Stage II	A25V-10	True
13767.58cfa834e4b0c9d6adf6e18a	58cfa834e4b0c9d6adf6e18a	UNCID_1167546.c2db17b1-c288-4f73-8e22-22929d846678.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1167546.c2db17b1-c288-4f73-8e22-22929d846678.sorted_genome_alignments	UNCID_1167546.c2db17b1-c288-4f73-8e22-22929d846678.sorted_genome_alignments.bam	42.27	1.96	0.16	58cfa834e4b0c9d6adf6e18a	UNCID_1167546.c2db17b1-c288-4f73-8e22-22929d846678.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1FR-11B	BF3B1481-AE31-4406-B084-B6CC1D7163E3	Solid Tissue Normal	Illumina HiSeq	767CE66C-282B-4789-96F0-F0870FA483DA	Breast	73.0	0729326E-9B85-44F5-8134-28CB10805BF4	C2DB17B1-C288-4F73-8E22-22929D846678	TCGA-BH-A1FR-11B-42R-A13Q-07	HG19	TCGA-BH-A1FR	TCGA-BRCA	4398.0	s6713	University of North Carolina	University of Pittsburgh	None	NO	T4b	N1a	Other  specify	Stage III	A13Q-07	True
13767.58cfa83ae4b0c9d6adf71d78	58cfa83ae4b0c9d6adf71d78	UNCID_2503099.6f3b244b-47b9-4af4-85c5-0051f6688aa8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2503099.6f3b244b-47b9-4af4-85c5-0051f6688aa8.sorted_genome_alignments	UNCID_2503099.6f3b244b-47b9-4af4-85c5-0051f6688aa8.sorted_genome_alignments.bam	76.58	1.87	0.17	58cfa83ae4b0c9d6adf71d78	UNCID_2503099.6f3b244b-47b9-4af4-85c5-0051f6688aa8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GU-AATP-01A	3B16881A-88C2-4048-B78F-E3E183503F70	Primary Tumor	Illumina HiSeq	28AD8E6C-7FEE-4C8B-B8EC-076A7628B004	Bladder	74.0	C9320B64-3928-4A33-A20D-C491A9FB8872	6F3B244B-47B9-4AF4-85C5-0051F6688AA8	TCGA-GU-AATP-01A-11R-A39I-07	HG19	TCGA-GU-AATP	TCGA-BLCA		s2817	University of North Carolina	BLN - UT Southwestern Medical Center at Dallas	United States	NO	T2	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A39I-07	True
13767.58cfa837e4b0c9d6adf70022	58cfa837e4b0c9d6adf70022	UNCID_1821206.20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1821206.20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26.sorted_genome_alignments	UNCID_1821206.20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26.sorted_genome_alignments.bam	10.89	1.79	0.18	58cfa837e4b0c9d6adf70022	UNCID_1821206.20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A3YI-01A	A45D296E-EFC0-479E-B2F6-BAD834668CDF	Primary Tumor	Illumina HiSeq	CB6418F1-6CA4-4D41-B273-31E5625E473E	Breast	74.0	EA7490BF-06AC-43E0-BB61-A2756D027836	20E8A6EB-4785-42F2-BB0C-BBDF5BEB6C26	TCGA-AC-A3YI-01A-21R-A239-07	HG19	TCGA-AC-A3YI	TCGA-BRCA		s5740	University of North Carolina	International Genomics Consortium	United States	NO	T1c	N3a	Infiltrating Lobular Carcinoma	Stage III	A239-07	True
13767.58cfa838e4b0c9d6adf70455	58cfa838e4b0c9d6adf70455	UNCID_1911128.13380c2f-2f59-40ac-ae0c-9f3dab833e39.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1911128.13380c2f-2f59-40ac-ae0c-9f3dab833e39.sorted_genome_alignments	UNCID_1911128.13380c2f-2f59-40ac-ae0c-9f3dab833e39.sorted_genome_alignments.bam	259.2		0.14	58cfa838e4b0c9d6adf70455	UNCID_1911128.13380c2f-2f59-40ac-ae0c-9f3dab833e39.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-8070-01A	67F40B3A-882C-4AC9-9038-0E7B10A5CCDC	Primary Tumor	Illumina HiSeq	061CEF9B-B70F-4733-BB70-2035050E9411	Lung	71.0	4B700F22-F0D2-49F9-B5C7-B15FDBD6B1F6	13380C2F-2F59-40AC-AE0C-9F3DAB833E39	TCGA-85-8070-01A-11R-2247-07	HG19	TCGA-85-8070	TCGA-LUSC		s10127	University of North Carolina	Asterand	Russia	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2247-07	True
13767.58cfa82fe4b0c9d6adf6b548	58cfa82fe4b0c9d6adf6b548	TCGA-25-2399-01A-01R-1569-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-25-2399-01A-01R-1569-13_GRCh37-lite_rnaseq	TCGA-25-2399-01A-01R-1569-13_GRCh37-lite_rnaseq.bam	763.0	1.8	0.15	58cfa82fe4b0c9d6adf6b548	TCGA-25-2399-01A-01R-1569-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-2399-01A	AD2B1A0A-153F-483D-B228-5763EBA3F6CC	Primary Tumor	Illumina HiSeq	91A2FE67-C96E-4124-B9DA-0734E1C18C95	Ovary	80.0	C9AA6CF0-F536-4640-8290-3E745AE2A36B	28A681DC-3E0F-4A9C-AD0C-F2BB10AAB0E1	TCGA-25-2399-01A-01R-1569-13	GRCh37-lite	TCGA-25-2399	TCGA-OV	608.0	s17312	Canada's Michael Smith Genome Sciences Centre	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		1569-13	True
13722.58cfa830e4b0c9d6adf6bddc	58cfa830e4b0c9d6adf6bddc	TCGA-BG-A0MU-10A-02D-A101_120406_SN1120_0131_BD0UK4ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BG-A0MU-10A-02D-A101_120406_SN1120_0131_BD0UK4ACXX_s_1_rg.sorted	TCGA-BG-A0MU-10A-02D-A101_120406_SN1120_0131_BD0UK4ACXX_s_1_rg.sorted.bam	10.2	2.0	0.17	58cfa830e4b0c9d6adf6bddc	TCGA-BG-A0MU-10A-02D-A101_120406_SN1120_0131_BD0UK4ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0MU-10A	A7329910-B1C7-4A18-B28E-8FAD79121339	Blood Derived Normal	Illumina HiSeq	56dc6ee6-2816-48fc-b41d-acea5bdb9330	Uterus	78.0	AE04F86F-3927-4E5E-BC46-997CD6BED18A	37E6CE2A-F097-4D62-B8BE-2C790F76774F	TCGA-BG-A0MU-10A-02D-A101-02	HG19_Broad_variant	TCGA-BG-A0MU	TCGA-UCEC		s4790	Harvard Medical School	University of Pittsburgh	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa83ae4b0c9d6adf71cd0	58cfa83ae4b0c9d6adf71cd0	UNCID_2503778.f2a5dbac-1f1f-48c0-8cb7-2b5df939c7c7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2503778.f2a5dbac-1f1f-48c0-8cb7-2b5df939c7c7.sorted_genome_alignments	UNCID_2503778.f2a5dbac-1f1f-48c0-8cb7-2b5df939c7c7.sorted_genome_alignments.bam	21.0	2.23	0.17	58cfa83ae4b0c9d6adf71cd0	UNCID_2503778.f2a5dbac-1f1f-48c0-8cb7-2b5df939c7c7.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A7U5-01A	2378935D-AEBD-4F6F-B31B-53BC6BD59BF9	Primary Tumor	Illumina HiSeq	AA076AF8-35DD-4225-A4C4-D49C84323B5E	Thyroid	36.0	8D3F3BF4-89C6-4036-BB36-89BC9EBCEB7E	F2A5DBAC-1F1F-48C0-8CB7-2B5DF939C7C7	TCGA-DE-A7U5-01A-11R-A39I-07	HG19	TCGA-DE-A7U5	TCGA-THCA		s12081	University of North Carolina	University of North Carolina	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A39I-07	True
13767.58cfa83be4b0c9d6adf72a4a	58cfa83be4b0c9d6adf72a4a	UNCID_368577.TCGA-BP-4760-01A-02R-1420-07.110608_UNC13-SN749_0072_AC03JFABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_368577.TCGA-BP-4760-01A-02R-1420-07.110608_UNC13-SN749_0072_AC03JFABXX.7.trimmed.annotated.translated_to_genomic	UNCID_368577.TCGA-BP-4760-01A-02R-1420-07.110608_UNC13-SN749_0072_AC03JFABXX.7.trimmed.annotated.translated_to_genomic.bam	35.3	1.7	0.13	58cfa83be4b0c9d6adf72a4a	UNCID_368577.TCGA-BP-4760-01A-02R-1420-07.110608_UNC13-SN749_0072_AC03JFABXX.7.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4760-01A	4CFE4F31-F62C-423A-8B9F-17F455B15313	Primary Tumor	Illumina HiSeq	46F124D0-4399-433D-806F-7D75326A893C	Kidney	69.0	0D8690FD-FDC0-4A88-B59E-E7C407966D94	3FEEABA3-8D99-45D2-B6CA-39FD130F74F3	TCGA-BP-4760-01A-02R-1420-07	HG19	TCGA-BP-4760	TCGA-KIRC		s9688	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1420-07	True
13767.58cfa830e4b0c9d6adf6c08a	58cfa830e4b0c9d6adf6c08a	TCGA-BR-7851-11A-01R-2203-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-7851-11A-01R-2203-13_rnaseq	TCGA-BR-7851-11A-01R-2203-13_rnaseq.bam	376.2		0.13	58cfa830e4b0c9d6adf6c08a	TCGA-BR-7851-11A-01R-2203-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7851-11A	08C73B36-EDE5-4136-B73B-0E964D432F89	Solid Tissue Normal	Illumina HiSeq	DE99F2DE-26F9-40B3-8D47-27EAE7FFA0E3	Stomach	74.0	2B208588-9566-4D5E-826A-7D4E45ADB83B	D4A1ABFF-50A8-483E-A91A-CF56F869C8E3	TCGA-BR-7851-11A-01R-2203-13	GRCh37-lite	TCGA-BR-7851	TCGA-STAD		s14968	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2203-13	True
13722.58cfa82fe4b0c9d6adf6b541	58cfa82fe4b0c9d6adf6b541	TCGA-25-2391-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-25-2391-01A-01D-A324-10_wgs_Illumina	TCGA-25-2391-01A-01D-A324-10_wgs_Illumina.bam	896.97	1.9	0.07	58cfa82fe4b0c9d6adf6b541	TCGA-25-2391-01A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-2391-01A	F5033D52-EC36-4E67-88D8-B6D898B81B2F	Primary Tumor	Illumina HiSeq	4c0ed657-169e-4ee1-b8b9-4544a43ed2ee	Ovary	57.0	2179798C-4FD4-4434-B1D5-1453F6054FA2	58FAF969-BF37-4180-8807-2F44F2CC8EDA	TCGA-25-2391-01A-01D-A324-10	GRCh37-lite	TCGA-25-2391	TCGA-OV	1492.0	s17137	Baylor College of Medicine	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		A324-10	True
13767.58cfa834e4b0c9d6adf6e649	58cfa834e4b0c9d6adf6e649	UNCID_1191176.52d8cab6-af14-4311-af92-9b02eff8f665.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1191176.52d8cab6-af14-4311-af92-9b02eff8f665.sorted_genome_alignments	UNCID_1191176.52d8cab6-af14-4311-af92-9b02eff8f665.sorted_genome_alignments.bam	173.8	1.8	0.15	58cfa834e4b0c9d6adf6e649	UNCID_1191176.52d8cab6-af14-4311-af92-9b02eff8f665.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3387-11A	9DC7812B-C7A2-4DE4-BF6D-4C7261384A62	Solid Tissue Normal	Illumina HiSeq	874C130E-96FF-4DFA-B934-6EDCAA26C6C7	Kidney	49.0	F2B36CA3-8D5D-453D-B445-82FAA22A8A35	52D8CAB6-AF14-4311-AF92-9B02EFF8F665	TCGA-A3-3387-11A-01R-1541-07	HG19	TCGA-A3-3387	TCGA-KIRC		s9801	University of North Carolina	International Genomics Consortium	United States	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa82ee4b0c9d6adf6b136	58cfa82ee4b0c9d6adf6b136	TCGA-04-1519-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-04-1519-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-04-1519-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	381.0	1.8	0.16	58cfa82ee4b0c9d6adf6b136	TCGA-04-1519-01A-01R-1565-13_GRCh37-lite_rnaseq.bam		FEMALE			Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1519-01A	E9B5336E-D724-4E7D-8C81-1147ABD0A80D	Primary Tumor	Illumina HiSeq	9F2829E8-DC7F-4A2B-8309-A7C092E42BB0	Ovary	48.0	EF8A2E99-C991-4D51-81BA-34F9A57949B8	193D3E7F-EC7F-453A-9C2A-77B240C4BA19	TCGA-04-1519-01A-01R-1565-13	GRCh37-lite	TCGA-04-1519	TCGA-OV		s18084	Canada's Michael Smith Genome Sciences Centre	Gynecologic Oncology Group	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa835e4b0c9d6adf6edea	58cfa835e4b0c9d6adf6edea	UNCID_1378157.4db58676-4bfe-46de-9db9-8270d67b49fe.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1378157.4db58676-4bfe-46de-9db9-8270d67b49fe.sorted_genome_alignments	UNCID_1378157.4db58676-4bfe-46de-9db9-8270d67b49fe.sorted_genome_alignments.bam	61.8	1.8	0.15	58cfa835e4b0c9d6adf6edea	UNCID_1378157.4db58676-4bfe-46de-9db9-8270d67b49fe.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5792-01A	8A5F2D7F-835C-4726-B238-F82D6A7F25BD	Primary Tumor	Illumina HiSeq	AF258A8B-F58D-46DA-9F47-07FA0FECF65C	Prostate	57.0	DA5F8107-7B69-45B5-8BEB-21D17B066CB4	4DB58676-4BFE-46DE-9DB9-8270D67B49FE	TCGA-CH-5792-01A-11R-1580-07	HG19	TCGA-CH-5792	TCGA-PRAD		s4027	University of North Carolina	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		1580-07	True
13767.58cfa82ee4b0c9d6adf6b08c	58cfa82ee4b0c9d6adf6b08c	TCGA-13-0893-01B-01R-1565-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0893-01B-01R-1565-13_rnaseq	TCGA-13-0893-01B-01R-1565-13_rnaseq.bam	482.0	1.8	0.14	58cfa82ee4b0c9d6adf6b08c	TCGA-13-0893-01B-01R-1565-13_rnaseq.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0893-01B	15170C7F-5880-4FB6-82CE-68D3DF0DFB68	Primary Tumor	Illumina HiSeq	C7E14E38-5E0A-4902-8821-04CC0239A015	Ovary	48.0	8F4F9492-0D28-4747-B4BB-25DDC99E4327	2B2D5FC7-B109-4D11-A632-DB8016268840	TCGA-13-0893-01B-01R-1565-13	NCBI36_BCCAGSC_variant	TCGA-13-0893	TCGA-OV	1319.0	s17126	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa82fe4b0c9d6adf6b5b6	58cfa82fe4b0c9d6adf6b5b6	TCGA-29-1695-01A-01R-1567-13_rnaseq.filtered.	RNA-Seq	TCGA-29-1695-01A-01R-1567-13_rnaseq	TCGA-29-1695-01A-01R-1567-13_rnaseq.bam	282.0	1.8	0.15	58cfa82fe4b0c9d6adf6b5b6	TCGA-29-1695-01A-01R-1567-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1695-01A	33D36B64-4688-40A7-9A4F-7CD3D4CC683D	Primary Tumor	Illumina HiSeq	F55C4E33-1A37-4093-BD77-BBCBB054960F	Ovary	62.0	7A1DB005-662A-4DF4-886A-EC3319BDE99A	33F1DDA6-7601-48C6-B46D-F0BA759E4048	TCGA-29-1695-01A-01R-1567-13	NCBI36_BCCAGSC_variant	TCGA-29-1695	TCGA-OV	1229.0	s17343	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1567-13	True
13722.58cfa830e4b0c9d6adf6c2a3	58cfa830e4b0c9d6adf6c2a3	TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina	TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina.bam	32.02		0.08	58cfa830e4b0c9d6adf6c2a3	TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B1-A47N-01A	F1EC5A7B-0973-4C38-9908-862196DF9541	Primary Tumor	Illumina HiSeq	57987e56-d118-4f55-98c4-340866fcf3e8	Kidney	62.0	C5EDE5F5-35D2-4059-9F0C-6736ABC6F899	BD2CC59D-F5CE-46ED-BEB0-4C80B24CBE71	TCGA-B1-A47N-01A-11D-A25F-10	GRCh37-lite	TCGA-B1-A47N	TCGA-KIRP		s11855	Baylor College of Medicine	University of Pittsburgh	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A25F-10	True
13722.58cfa831e4b0c9d6adf6c778	58cfa831e4b0c9d6adf6c778	TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted	TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted.bam	99.41	2.0	0.15	58cfa831e4b0c9d6adf6c778	TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17D-01A	7DDEDDD1-B2AD-425F-94A2-9C476B959F2A	Primary Tumor	Illumina HiSeq	9d6f1593-568e-447d-b4f7-10048102ce8f	Uterus	58.0	9EC5A25B-9CE1-4FDE-9341-13DA39BC74B0	0F6ECDCA-5659-426A-8DAC-3211183597BD	TCGA-D1-A17D-01A-12D-A12F-02	HG19_Broad_variant	TCGA-D1-A17D	TCGA-UCEC		s4443	Harvard Medical School	Mayo Clinic	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13767.58cfa834e4b0c9d6adf6e9c8	58cfa834e4b0c9d6adf6e9c8	UNCID_1240470.2fb46da1-3190-4ab7-a6e2-67f7ac1466dd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1240470.2fb46da1-3190-4ab7-a6e2-67f7ac1466dd.sorted_genome_alignments	UNCID_1240470.2fb46da1-3190-4ab7-a6e2-67f7ac1466dd.sorted_genome_alignments.bam	16.62	1.87	0.16	58cfa834e4b0c9d6adf6e9c8	UNCID_1240470.2fb46da1-3190-4ab7-a6e2-67f7ac1466dd.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A2JQ-11A	F69FF5FB-7E0B-4B16-9FC9-498379B11562	Solid Tissue Normal	Illumina HiSeq	CEFFEAC6-4FD6-4E82-B96D-E5374D8B9EA2	Thyroid	18.0	6A1E65A4-8BBE-4645-B2C9-0950B0ACABF9	2FB46DA1-3190-4AB7-A6E2-67F7AC1466DD	TCGA-E8-A2JQ-11A-11R-A180-07	HG19	TCGA-E8-A2JQ	TCGA-THCA		s12265	University of North Carolina	Asterand	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A180-07	True
13767.58cfa83be4b0c9d6adf723ca	58cfa83be4b0c9d6adf723ca	UNCID_2614548.e6f9cecd-b130-441d-9073-cf1df303e2ab.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2614548.e6f9cecd-b130-441d-9073-cf1df303e2ab.sorted_genome_alignments	UNCID_2614548.e6f9cecd-b130-441d-9073-cf1df303e2ab.sorted_genome_alignments.bam	10.95	1.84	0.16	58cfa83be4b0c9d6adf723ca	UNCID_2614548.e6f9cecd-b130-441d-9073-cf1df303e2ab.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-V1-A9OF-01A	D4DC7C5C-45B3-4741-B0C1-FEE477DA2EF4	Primary Tumor	Illumina HiSeq	D7DB61BD-A2EE-4692-AAB9-AB26C946C1DE	Prostate	49.0	2C17D9BE-A1E8-4C37-879C-C8BAB565B3FB	E6F9CECD-B130-441D-9073-CF1DF303E2AB	TCGA-V1-A9OF-01A-11R-A41O-07	HG19	TCGA-V1-A9OF	TCGA-PRAD		s3918	University of North Carolina	University of California San Francisco	United States	NO	T2c		Prostate Adenocarcinoma Acinar Type		A41O-07	True
13767.58cfa83be4b0c9d6adf721c0	58cfa83be4b0c9d6adf721c0	UNCID_2597625.2b98be20-55a0-43c8-b227-2dacda63c77d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2597625.2b98be20-55a0-43c8-b227-2dacda63c77d.sorted_genome_alignments	UNCID_2597625.2b98be20-55a0-43c8-b227-2dacda63c77d.sorted_genome_alignments.bam	85.15	1.83	0.17	58cfa83be4b0c9d6adf721c0	UNCID_2597625.2b98be20-55a0-43c8-b227-2dacda63c77d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thymoma	Aligned reads	TCGA-ZC-AAAF-01A	CD458290-F27B-479C-9B78-0AF23E7F63D9	Primary Tumor	Illumina HiSeq	DA4D1749-0555-4189-9C48-D3715411970F	Thymus	74.0	9FF2131A-4FDF-40BE-8B2C-D33F9A6BAAD3	2B98BE20-55A0-43C8-B227-2DACDA63C77D	TCGA-ZC-AAAF-01A-11R-A42S-07	HG19	TCGA-ZC-AAAF	TCGA-THYM		s551	University of North Carolina		Germany	NO					A42S-07	True
13767.58cfa838e4b0c9d6adf7080c	58cfa838e4b0c9d6adf7080c	UNCID_2034391.fbbc0349-e189-4f35-8c96-15c57b53f602.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2034391.fbbc0349-e189-4f35-8c96-15c57b53f602.sorted_genome_alignments	UNCID_2034391.fbbc0349-e189-4f35-8c96-15c57b53f602.sorted_genome_alignments.bam	21.61	1.85	0.17	58cfa838e4b0c9d6adf7080c	UNCID_2034391.fbbc0349-e189-4f35-8c96-15c57b53f602.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A4OZ-01A	236EF9CA-9362-44F3-A36B-2A19509BAB9D	Primary Tumor	Illumina HiSeq	515CB4C9-44DC-4B4F-A33E-06314677DCA6	Skin	41.0	70A845E0-AC4C-4F34-8384-87F990021CF5	FBBC0349-E189-4F35-8C96-15C57B53F602	TCGA-EB-A4OZ-01A-12R-A266-07	HG19	TCGA-EB-A4OZ	TCGA-SKCM		s7618	University of North Carolina	Asterand	Ukraine	NO	T4a	N3		Stage III	A266-07	True
13722.58cfa831e4b0c9d6adf6c75e	58cfa831e4b0c9d6adf6c75e	TCGA-D1-A1O0-10A-01D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D1-A1O0-10A-01D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_4_rg.sorted	TCGA-D1-A1O0-10A-01D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_4_rg.sorted.bam	19.49	1.98	0.17	58cfa831e4b0c9d6adf6c75e	TCGA-D1-A1O0-10A-01D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A1O0-10A	A98BBE29-8817-4380-A738-3C1BF9F8E0CC	Blood Derived Normal	Illumina HiSeq	28a1d78c-cec8-4067-8f4b-201ef9b7fe9d	Uterus	77.0	24C73392-0F24-418E-B89F-1C3D4613DDF3	BC47D6F0-E345-43D0-950B-89D6BFC019AE	TCGA-D1-A1O0-10A-01D-A17E-02	HG19_Broad_variant	TCGA-D1-A1O0	TCGA-UCEC		s5025	Harvard Medical School	Mayo Clinic	United States	NO			Endometrioid endometrial adenocarcinoma		A17E-02	True
13767.58cfa837e4b0c9d6adf700e2	58cfa837e4b0c9d6adf700e2	UNCID_1867703.e63057bc-ca98-4d72-8097-1c1fb2d19882.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1867703.e63057bc-ca98-4d72-8097-1c1fb2d19882.sorted_genome_alignments	UNCID_1867703.e63057bc-ca98-4d72-8097-1c1fb2d19882.sorted_genome_alignments.bam	142.2	1.8	0.14	58cfa837e4b0c9d6adf700e2	UNCID_1867703.e63057bc-ca98-4d72-8097-1c1fb2d19882.sorted_genome_alignments.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-3496-01A	639E1050-088A-48FE-A0EF-4A01A3468CAC	Primary Tumor	Illumina HiSeq	FCA50EFC-B8DE-4E07-AFC6-354FBD50BD24	Colorectal	83.0	288C3D74-C236-4985-A01C-E39CCCA065DA	E63057BC-CA98-4D72-8097-1C1FB2D19882	TCGA-AA-3496-01A-21R-1839-07	HG19	TCGA-AA-3496	TCGA-COAD		s13605	University of North Carolina	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1839-07	True
13722.58cfa832e4b0c9d6adf6cf94	58cfa832e4b0c9d6adf6cf94	TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted	TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.bam	36.82		0.16	58cfa832e4b0c9d6adf6cf94	TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3NI-01A	DAC27C24-CDBF-4527-9214-178FDE3D098A	Primary Tumor	Illumina HiSeq	e3d152ec-0ab5-4fb6-b2ca-ecdb79e43095	Cervix	45.0	C75C6FD3-79EF-48B8-B3BD-D097EF2A73AD	90DC57B8-74B7-4FB0-9EE7-52A4264D395F	TCGA-FU-A3NI-01A-11D-A245-26	HG19_Broad_variant	TCGA-FU-A3NI	TCGA-CESC		s1204	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T1b1	N1	Cervical Squamous Cell Carcinoma		A245-26	True
13767.58cfa82ee4b0c9d6adf6b1ec	58cfa82ee4b0c9d6adf6b1ec	TCGA-13-0724-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0724-01A-01R-1564-13_rnaseq	TCGA-13-0724-01A-01R-1564-13_rnaseq.bam	294.0	1.8	0.19	58cfa82ee4b0c9d6adf6b1ec	TCGA-13-0724-01A-01R-1564-13_rnaseq.bam	Dead	FEMALE	WHITE	HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0724-01A	A9ABE7A7-4126-414B-87D2-A6D25ABCF1FA	Primary Tumor	Illumina HiSeq	A054F2F2-48F7-4B46-9105-99B5945A0C89	Ovary	72.0	30ABE357-43D0-434C-99D1-AFFE0FD047D8	FC6DF206-8C77-486C-BC38-06B6CF20139D	TCGA-13-0724-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-13-0724	TCGA-OV	83.0	s17360	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13722.58cfa830e4b0c9d6adf6bdd2	58cfa830e4b0c9d6adf6bdd2	TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	12.94	2.03	0.08	58cfa830e4b0c9d6adf6bdd2	TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0E0-10A	20E8106B-1290-4735-ABE4-7621E08E3DC8	Blood Derived Normal	Illumina HiSeq	48d26da8-f7ee-4828-890b-be10385c1187	Breast	38.0	FE4E376B-7C87-4ED1-8994-7C8A8DAF402B	3448B251-9EE2-413B-8A08-F0160CEDEBA0	TCGA-BH-A0E0-10A-01D-A128-09	GRCh37-lite	TCGA-BH-A0E0	TCGA-BRCA		s6774	Washington University School of Medicine	University of Pittsburgh	None	NO	T3	N3a	Infiltrating Ductal Carcinoma	Stage III	A128-09	True
13767.58cfa833e4b0c9d6adf6e010	58cfa833e4b0c9d6adf6e010	UNCID_1146444.9384eb09-5787-49e8-b07e-bd9f71997771.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1146444.9384eb09-5787-49e8-b07e-bd9f71997771.sorted_genome_alignments	UNCID_1146444.9384eb09-5787-49e8-b07e-bd9f71997771.sorted_genome_alignments.bam	17.13	1.02	0.15	58cfa833e4b0c9d6adf6e010	UNCID_1146444.9384eb09-5787-49e8-b07e-bd9f71997771.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IP-01A	1402082D-25C9-4148-8A1E-F58450B706BB	Primary Tumor	Illumina HiSeq	B4F4FDE0-BD19-459C-AF85-165BDC3CEE47	Breast	74.0	6B1C8010-D4FE-40E7-8E09-7A7DBDDE6616	9384EB09-5787-49E8-B07E-BD9F71997771	TCGA-B6-A0IP-01A-11R-A034-07	HG19	TCGA-B6-A0IP	TCGA-BRCA		s6833	University of North Carolina	Duke	United States	NO	T1c	N0 (i-)	Infiltrating Lobular Carcinoma	Stage I	A034-07	True
13767.58cfa837e4b0c9d6adf6fcf1	58cfa837e4b0c9d6adf6fcf1	UNCID_1673586.049ee2d6-c67a-42e2-a39d-2eb15650ca63.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1673586.049ee2d6-c67a-42e2-a39d-2eb15650ca63.sorted_genome_alignments	UNCID_1673586.049ee2d6-c67a-42e2-a39d-2eb15650ca63.sorted_genome_alignments.bam	35.2		0.14	58cfa837e4b0c9d6adf6fcf1	UNCID_1673586.049ee2d6-c67a-42e2-a39d-2eb15650ca63.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7688-01A	7740824E-905F-47A0-B235-54561EF58BA3	Primary Tumor	Illumina HiSeq	D1B72AA6-E83E-4331-AD49-AE1345DD5039	Brain	59.0	E14F678B-FED4-4963-99B7-F42964D9D2EB	049EE2D6-C67A-42E2-A39D-2EB15650CA63	TCGA-HT-7688-01A-11R-2256-07	HG19	TCGA-HT-7688	TCGA-LGG		s8428	University of North Carolina	Case Western - St Joes	United States	NO			Oligodendroglioma		2256-07	True
13722.58cfa831e4b0c9d6adf6c7d0	58cfa831e4b0c9d6adf6c7d0	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.bam	155.7	1.9	0.14	58cfa831e4b0c9d6adf6c7d0	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6945-01A	15714E69-E075-4688-8F51-C7102FE4CA07	Primary Tumor	Illumina HiSeq	50a2b9f7-d572-47c4-bf4b-3d6255512094	Head and Neck	41.0	55849997-67DE-4FC6-B7BF-9D02D15920C9	FC2ACD2E-751C-4252-85A1-6C5A8E980964	TCGA-CV-6945-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6945	TCGA-HNSC	366.0	s15775	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2	Head and Neck Squamous Cell Carcinoma	Stage IV	1911-02	True
13767.58cfa836e4b0c9d6adf6f5a0	58cfa836e4b0c9d6adf6f5a0	UNCID_1572443.87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1572443.87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6.sorted_genome_alignments	UNCID_1572443.87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6.sorted_genome_alignments.bam	198.2		0.13	58cfa836e4b0c9d6adf6f5a0	UNCID_1572443.87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-86-8279-01A	2923E404-38F2-437A-B57E-23401FBE0273	Primary Tumor	Illumina HiSeq	D00617DC-4E89-41AE-AF58-E4D917B0A1CF	Lung	46.0	37901D81-DC2A-4F55-B6C5-F117274D50B8	87E51CCB-9DED-43C6-BB1A-A8A85D2D9FA6	TCGA-86-8279-01A-11R-2287-07	HG19	TCGA-86-8279	TCGA-LUAD		s11297	University of North Carolina	Asterand	Russia	NO	T2a	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	2287-07	True
13767.58cfa836e4b0c9d6adf6fbc4	58cfa836e4b0c9d6adf6fbc4	UNCID_1666085.3F6778E5-26ED-41BB-AC86-4AAAC7AB07A6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1666085.3F6778E5-26ED-41BB-AC86-4AAAC7AB07A6.sorted_genome_alignments	UNCID_1666085.3F6778E5-26ED-41BB-AC86-4AAAC7AB07A6.sorted_genome_alignments.bam	21.5	1.83	0.17	58cfa836e4b0c9d6adf6fbc4	UNCID_1666085.3F6778E5-26ED-41BB-AC86-4AAAC7AB07A6.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-H2-A422-01A	8ED1B900-A8A8-4164-B96B-F060F15D7075	Primary Tumor	Illumina HiSeq	A04C4BCD-5CA3-4CB6-B578-A7E788246C1D	Thyroid	40.0	0AD53C03-4BED-411D-BFAB-A17B82FB71BD	3F6778E5-26ED-41BB-AC86-4AAAC7AB07A6	TCGA-H2-A422-01A-11R-A23N-07	HG19	TCGA-H2-A422	TCGA-THCA		s12061	University of North Carolina	Christiana Healthcare	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23N-07	True
13767.58cfa834e4b0c9d6adf6e477	58cfa834e4b0c9d6adf6e477	UNCID_1199794.961472b2-ef4f-43c9-9027-06cd2d39610c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1199794.961472b2-ef4f-43c9-9027-06cd2d39610c.sorted_genome_alignments	UNCID_1199794.961472b2-ef4f-43c9-9027-06cd2d39610c.sorted_genome_alignments.bam	12.3	1.8	0.14	58cfa834e4b0c9d6adf6e477	UNCID_1199794.961472b2-ef4f-43c9-9027-06cd2d39610c.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-AK-3436-01A	B2FECA3F-8602-4A30-92BF-958AB2A2BD5D	Primary Tumor	Illumina HiSeq	E17EDCBA-36DD-4CF3-B6BC-F477453A2BB6	Kidney	40.0	83842F6E-5DF5-4172-9E58-99F00E74CBBE	961472B2-EF4F-43C9-9027-06CD2D39610C	TCGA-AK-3436-01A-02R-1325-07	HG19	TCGA-AK-3436	TCGA-KIRC		s8915	University of North Carolina	Fox Chase	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1325-07	True
13767.58cfa83ce4b0c9d6adf72e12	58cfa83ce4b0c9d6adf72e12	_1_TCGA-BR-7703-01A-11R-2055-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-7703-01A-11R-2055-13_rnaseq	_1_TCGA-BR-7703-01A-11R-2055-13_rnaseq.bam	240.2		0.17	58cfa83ce4b0c9d6adf72e12	_1_TCGA-BR-7703-01A-11R-2055-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7703-01A	2943375E-3DE8-4D42-959A-62F4192067AE	Primary Tumor	Illumina HiSeq	2FECDC34-5C9F-4DBA-A7A6-7C977283714A	Stomach	81.0	1084DBB1-AA80-419F-B661-581776609076	B27A2FAA-B3FB-485F-BEA5-14852F206D63	TCGA-BR-7703-01A-11R-2055-13	GRCh37-lite	TCGA-BR-7703	TCGA-STAD		s15152	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T1b	N0	Stomach Intestinal Adenocarcinoma Papillary Type	Stage I	2055-13	True
13767.58cfa832e4b0c9d6adf6d094	58cfa832e4b0c9d6adf6d094	TCGA-IG-A3I8-01A-11R-A24K-31_rnaseq.filtered.	RNA-Seq	TCGA-IG-A3I8-01A-11R-A24K-31_rnaseq	TCGA-IG-A3I8-01A-11R-A24K-31_rnaseq.bam	30.49	1.76	0.15	58cfa832e4b0c9d6adf6d094	TCGA-IG-A3I8-01A-11R-A24K-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A3I8-01A	7BF3F18B-A013-48D2-A743-26A57FDBE4C4	Primary Tumor	Illumina HiSeq	2B19A687-2375-42F3-964B-50EA96C0F58B	Esophagus	51.0	944A68B7-51D4-4831-88D4-D647BE17BC13	FD4FF8B7-2B34-4947-80BC-3E5FECCF30B3	TCGA-IG-A3I8-01A-11R-A24K-31	GRCh37-lite	TCGA-IG-A3I8	TCGA-ESCA		s1628	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T3	N0		Stage II	A24K-31	True
13767.58cfa837e4b0c9d6adf6fd46	58cfa837e4b0c9d6adf6fd46	UNCID_1708388.ba365c68-a51f-4802-98b4-7fbf7e35bafc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1708388.ba365c68-a51f-4802-98b4-7fbf7e35bafc.sorted_genome_alignments	UNCID_1708388.ba365c68-a51f-4802-98b4-7fbf7e35bafc.sorted_genome_alignments.bam	97.2		0.15	58cfa837e4b0c9d6adf6fd46	UNCID_1708388.ba365c68-a51f-4802-98b4-7fbf7e35bafc.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KN-8425-11A	CC316FAF-DCB1-4DEA-B8B0-A17D000FF40F	Solid Tissue Normal	Illumina HiSeq	CED0467B-7E8E-40CC-9EED-E0523B9A5774	Kidney	53.0	FFC74D53-1FBA-4387-A313-834174B6095F	BA365C68-A51F-4802-98B4-7FBF7E35BAFC	TCGA-KN-8425-11A-01R-2315-07	HG19	TCGA-KN-8425	TCGA-KICH		s16416	University of North Carolina	Harvard	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2315-07	True
13767.58cfa839e4b0c9d6adf71410	58cfa839e4b0c9d6adf71410	UNCID_2303561.fceb1551-4b16-45de-8ba0-7906aa3fe841.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2303561.fceb1551-4b16-45de-8ba0-7906aa3fe841.sorted_genome_alignments	UNCID_2303561.fceb1551-4b16-45de-8ba0-7906aa3fe841.sorted_genome_alignments.bam	52.74	1.88	0.17	58cfa839e4b0c9d6adf71410	UNCID_2303561.fceb1551-4b16-45de-8ba0-7906aa3fe841.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A6IW-01A	8183F0FB-2303-4D7B-BCCD-55E5031FC7DF	Primary Tumor	Illumina HiSeq	0F3FF16D-9E09-43F4-8418-69D06F13FBD0	Breast	73.0	D763EDF9-B6F2-4814-B263-180ACED12DA2	FCEB1551-4B16-45DE-8BA0-7906AA3FE841	TCGA-AC-A6IW-01A-12R-A33J-07	HG19	TCGA-AC-A6IW	TCGA-BRCA		s5766	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A33J-07	True
13767.58cfa839e4b0c9d6adf71102	58cfa839e4b0c9d6adf71102	UNCID_2266653.777d3cf0-1f4a-42e9-b88c-cdf2d783b24d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2266653.777d3cf0-1f4a-42e9-b88c-cdf2d783b24d.sorted_genome_alignments	UNCID_2266653.777d3cf0-1f4a-42e9-b88c-cdf2d783b24d.sorted_genome_alignments.bam	45.89	1.87	0.15	58cfa839e4b0c9d6adf71102	UNCID_2266653.777d3cf0-1f4a-42e9-b88c-cdf2d783b24d.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-LP-A4AV-01A	F241D6B1-2C32-4478-8F8D-8C746464F7D1	Primary Tumor	Illumina HiSeq	2D3EC78B-013F-4C55-B304-33498736CFE7	Cervix	63.0	522E7C48-5F2C-4FC3-9F3E-23A4347EC4B9	777D3CF0-1F4A-42E9-B88C-CDF2D783B24D	TCGA-LP-A4AV-01A-11R-A32Y-07	HG19	TCGA-LP-A4AV	TCGA-CESC		s1447	University of North Carolina	ILSbio	Vietnam	NO	T1b	N0	Cervical Squamous Cell Carcinoma		A32Y-07	True
13767.58cfa83ae4b0c9d6adf71a55	58cfa83ae4b0c9d6adf71a55	UNCID_2469365.e9f1e235-52ff-45fd-84ad-52135124cec9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2469365.e9f1e235-52ff-45fd-84ad-52135124cec9.sorted_genome_alignments	UNCID_2469365.e9f1e235-52ff-45fd-84ad-52135124cec9.sorted_genome_alignments.bam	39.45	1.89	0.17	58cfa83ae4b0c9d6adf71a55	UNCID_2469365.e9f1e235-52ff-45fd-84ad-52135124cec9.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-K7-AAU7-01A	1EACFCC0-1D05-4441-B3D8-B0790E1C40F1	Primary Tumor	Illumina HiSeq	F62B2BA7-7ECA-4E58-99A3-50A39BB50316	Liver	61.0	6E0902DD-F307-4354-9F61-47A9D97FA77F	E9F1E235-52FF-45FD-84AD-52135124CEC9	TCGA-K7-AAU7-01A-11R-A38B-07	HG19	TCGA-K7-AAU7	TCGA-LIHC		s16749	University of North Carolina	ABS - Lahey Clinic	United States	NO	T2a	NX	Hepatocholangiocarcinoma (Mixed)	Stage II	A38B-07	True
13722.58cfa831e4b0c9d6adf6c56f	58cfa831e4b0c9d6adf6c56f	TCGA-CJ-6033-11A-01D-2104-10_Illumina.filtered.	WGS	TCGA-CJ-6033-11A-01D-2104-10_Illumina	TCGA-CJ-6033-11A-01D-2104-10_Illumina.bam	13.66	1.9	0.13	58cfa831e4b0c9d6adf6c56f	TCGA-CJ-6033-11A-01D-2104-10_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-6033-11A	4EDFF57F-4B0E-4770-BEAC-590DA7D7232C	Solid Tissue Normal	Illumina HiSeq	7ceeb54a-f1a7-4e5d-9225-cc54c8337e53	Kidney	54.0	D8A6C759-7AA9-4002-ABD8-17C5E6CDB074	AA436363-9D2A-42F4-87C2-55E5DFA9F8D1	TCGA-CJ-6033-11A-01D-2104-10	GRCh37-lite	TCGA-CJ-6033	TCGA-KIRC	224.0	s8839	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	2104-10	False
13722.58cfa831e4b0c9d6adf6ca52	58cfa831e4b0c9d6adf6ca52	TCGA-DK-A3IM-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DK-A3IM-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_5_rg.sorted	TCGA-DK-A3IM-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_5_rg.sorted.bam	44.11		0.15	58cfa831e4b0c9d6adf6ca52	TCGA-DK-A3IM-10A-01D-A210_120913_SN208_0428_BC188KACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IM-10A	41B59716-116F-4942-8B63-409870A87E26	Blood Derived Normal	Illumina HiSeq	1f1106b7-eff0-48a4-828a-0a42816b6736	Bladder	76.0	1C583727-98EE-45B2-A73E-CD2F543EB5C8	C816A9A5-C7B7-455A-A8C1-07E6012B4984	TCGA-DK-A3IM-10A-01D-A210-26	HG19_Broad_variant	TCGA-DK-A3IM	TCGA-BLCA		s3103	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A210-26	True
13722.58cfa831e4b0c9d6adf6cd52	58cfa831e4b0c9d6adf6cd52	TCGA-ER-A19O-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_6_rg.sorted.filtered.	WGS	TCGA-ER-A19O-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_6_rg.sorted	TCGA-ER-A19O-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_6_rg.sorted.bam	45.99		0.17	58cfa831e4b0c9d6adf6cd52	TCGA-ER-A19O-10A-01D-A190_120718_SN208_0416_BD140PACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A19O-10A	69C0EF46-3117-46F3-B36E-581EB03EB829	Blood Derived Normal	Illumina HiSeq	e63520a0-e72d-453b-ac6c-6a1a491fac19	Skin	56.0	AD02F0ED-FBB4-49AE-9315-7D42D2C5F628	8AC49AAE-2C7C-4426-9FAA-B4652A8D51A8	TCGA-ER-A19O-10A-01D-A190-02	HG19_Broad_variant	TCGA-ER-A19O	TCGA-SKCM		s7695	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1b		Stage III	A190-02	True
13767.58cfa839e4b0c9d6adf71512	58cfa839e4b0c9d6adf71512	UNCID_2349384.7b1862eb-f21c-4ef4-93c5-e81e353bf5a2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2349384.7b1862eb-f21c-4ef4-93c5-e81e353bf5a2.sorted_genome_alignments	UNCID_2349384.7b1862eb-f21c-4ef4-93c5-e81e353bf5a2.sorted_genome_alignments.bam	13.41	1.8	0.17	58cfa839e4b0c9d6adf71512	UNCID_2349384.7b1862eb-f21c-4ef4-93c5-e81e353bf5a2.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Mesothelioma	Aligned reads	TCGA-LK-A4O6-01A	D940E476-FB0A-4CC3-8AB5-691156E7C09B	Primary Tumor	Illumina HiSeq	E591A660-276C-4646-B6C0-F7C5426F67C5	Mesothelium	66.0	8CBD9D11-24D4-46A4-A1DE-FD0ACA2B3DCF	7B1862EB-F21C-4EF4-93C5-E81E353BF5A2	TCGA-LK-A4O6-01A-11R-A34F-07	HG19	TCGA-LK-A4O6	TCGA-MESO		s393	University of North Carolina	University of Pittsburgh	United States	NO	T3	N1		Stage III	A34F-07	True
13767.58cfa837e4b0c9d6adf6fd52	58cfa837e4b0c9d6adf6fd52	UNCID_1722828.58d4d6ea-cb30-47f9-87ff-d2dec6e3385e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1722828.58d4d6ea-cb30-47f9-87ff-d2dec6e3385e.sorted_genome_alignments	UNCID_1722828.58d4d6ea-cb30-47f9-87ff-d2dec6e3385e.sorted_genome_alignments.bam	84.2		0.15	58cfa837e4b0c9d6adf6fd52	UNCID_1722828.58d4d6ea-cb30-47f9-87ff-d2dec6e3385e.sorted_genome_alignments.bam	Alive	FEMALE			Kidney Chromophobe	Aligned reads	TCGA-KN-8431-01A	04E9A63A-D742-488C-8564-BF9D79AA2091	Primary Tumor	Illumina HiSeq	1A3B8680-BAFC-4556-9B0D-20E9A8E62300	Kidney	35.0	2BBA3FAA-8D55-4AEC-863D-AAE1CEA6FEAB	58D4D6EA-CB30-47F9-87FF-D2DEC6E3385E	TCGA-KN-8431-01A-11R-2315-07	HG19	TCGA-KN-8431	TCGA-KICH		s16505	University of North Carolina	Harvard	United States	NO	T2	NX	Kidney Chromophobe	Stage II	2315-07	True
13767.58cfa82fe4b0c9d6adf6b28c	58cfa82fe4b0c9d6adf6b28c	TCGA-20-1684-01A-01R-1566-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-20-1684-01A-01R-1566-13_GRCh37-lite_rnaseq	TCGA-20-1684-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	455.0	1.8	0.15	58cfa82fe4b0c9d6adf6b28c	TCGA-20-1684-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-20-1684-01A	94030805-8BEB-441A-AF73-11A80768EDB5	Primary Tumor	Illumina HiSeq	AE52543D-25CA-4E44-BF25-B9AC3D820145	Ovary	51.0	D8ECB5E2-5AF0-4A84-8B51-22C395850721	91B2872A-73BC-4F52-A8F6-96CE81CBEF8A	TCGA-20-1684-01A-01R-1566-13	GRCh37-lite	TCGA-20-1684	TCGA-OV		s17503	Canada's Michael Smith Genome Sciences Centre	Fox Chase Cancer Center	None	NO			Serous Cystadenocarcinoma		1566-13	True
13722.58cfa82ee4b0c9d6adf6acb2	58cfa82ee4b0c9d6adf6acb2	G37566.TCGA-HC-7737-11A-02D-2114-08.3.filtered.	WGS	G37566.TCGA-HC-7737-11A-02D-2114-08.3	G37566.TCGA-HC-7737-11A-02D-2114-08.3.bam	113.3		0.05	58cfa82ee4b0c9d6adf6acb2	G37566.TCGA-HC-7737-11A-02D-2114-08.3.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN		Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7737-11A	73F875CB-BCFC-43BA-AB97-4E94CAF836D4	Solid Tissue Normal	Illumina HiSeq	0f09b06b-7747-47b8-be3c-4e592ca62c5d	Prostate	55.0	AA87EF38-E22C-436A-9F2D-CBD291063148	4ADEFA84-9FFB-4EFE-9A7F-BF1E307F6932	TCGA-HC-7737-11A-02D-2114-08	HG19_Broad_variant	TCGA-HC-7737	TCGA-PRAD		s3408	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2c	N1	Prostate Adenocarcinoma Acinar Type		2114-08	False
13767.58cfa835e4b0c9d6adf6ed52	58cfa835e4b0c9d6adf6ed52	UNCID_1359866.2d8faa2d-336f-46e9-992d-4a5a5dbc4ece.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1359866.2d8faa2d-336f-46e9-992d-4a5a5dbc4ece.sorted_genome_alignments	UNCID_1359866.2d8faa2d-336f-46e9-992d-4a5a5dbc4ece.sorted_genome_alignments.bam	8.2		0.13	58cfa835e4b0c9d6adf6ed52	UNCID_1359866.2d8faa2d-336f-46e9-992d-4a5a5dbc4ece.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7785-11A	2DEF2A53-D2E8-46F0-8B07-F32DBF1833A4	Solid Tissue Normal	Illumina HiSeq	19C3B0DB-5D7B-4D21-89C5-2A23EE1B6541	Prostate	54.0	86A6A5E0-FFD7-489E-BFD7-0A862164D1D3	2D8FAA2D-336F-46E9-992D-4A5A5DBC4ECE	TCGA-EJ-7785-11A-01R-2118-07	HG19	TCGA-EJ-7785	TCGA-PRAD		s4016	University of North Carolina	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13722.58cfa830e4b0c9d6adf6c1a4	58cfa830e4b0c9d6adf6c1a4	TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted	TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted.bam	94.4	1.9	0.15	58cfa830e4b0c9d6adf6c1a4	TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5559-10A	17B17D91-C3DF-4B89-9C10-4DB069AFF656	Blood Derived Normal	Illumina HiSeq	e4331399-eb06-4ee0-a375-64ffa929d8e7	Head and Neck	71.0	43FBB037-8BA4-4BA3-8458-71A027EDA822	673B6C98-3F56-42D2-BFF8-2E68992864F4	TCGA-BA-5559-10A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5559	TCGA-HNSC		s15491	Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma		1509-02	True
13722.58cfa832e4b0c9d6adf6ce73	58cfa832e4b0c9d6adf6ce73	TCGA-FV-A3I0-11A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A3I0-11A-11D-A22F-10_wgs_Illumina	TCGA-FV-A3I0-11A-11D-A22F-10_wgs_Illumina.bam	23.52		0.08	58cfa832e4b0c9d6adf6ce73	TCGA-FV-A3I0-11A-11D-A22F-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A3I0-11A	A8C2AA08-9156-4845-AD77-5E060858C757	Solid Tissue Normal	Illumina HiSeq	ab740f6f-aa21-4323-b5ef-e49cd057c11d	Liver	76.0	52BCA35C-ECF3-4E3C-8E98-596622B4ADFD	741183D6-2363-4CBF-B5F9-4548E1CAB32B	TCGA-FV-A3I0-11A-11D-A22F-10	GRCh37-lite	TCGA-FV-A3I0	TCGA-LIHC		s16785	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	NX	Hepatocholangiocarcinoma (Mixed)	Stage II	A22F-10	True
13767.58cfa83be4b0c9d6adf724d4	58cfa83be4b0c9d6adf724d4	UNCID_2605151.d9904f57-fde7-48bc-8c96-484d51017ff0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2605151.d9904f57-fde7-48bc-8c96-484d51017ff0.sorted_genome_alignments	UNCID_2605151.d9904f57-fde7-48bc-8c96-484d51017ff0.sorted_genome_alignments.bam	71.23	1.88	0.16	58cfa83be4b0c9d6adf724d4	UNCID_2605151.d9904f57-fde7-48bc-8c96-484d51017ff0.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-5P-A9K4-01A	CA245EB0-C60E-4A94-AFD8-CCF15C1008DF	Primary Tumor	Illumina HiSeq	5BA13058-34DA-420A-A7E6-5FB7BFAE63B7	Kidney	54.0	76A7A00A-B2A0-4297-B2F7-C147E3285BD5	D9904F57-FDE7-48BC-8C96-484D51017FF0	TCGA-5P-A9K4-01A-11R-A42S-07	HG19	TCGA-5P-A9K4	TCGA-KIRP		s11966	University of North Carolina	University Hospital Erlangen	Germany	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma		A42S-07	True
13767.58cfa837e4b0c9d6adf6fdd6	58cfa837e4b0c9d6adf6fdd6	UNCID_1677449.9715811a-fe94-4991-b850-5d50793de443.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1677449.9715811a-fe94-4991-b850-5d50793de443.sorted_genome_alignments	UNCID_1677449.9715811a-fe94-4991-b850-5d50793de443.sorted_genome_alignments.bam	116.2		0.15	58cfa837e4b0c9d6adf6fdd6	UNCID_1677449.9715811a-fe94-4991-b850-5d50793de443.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-IB-7885-01A	77E49007-3E44-4157-BEAE-8F7E94234C78	Primary Tumor	Illumina HiSeq	BAD48F42-7E01-45C7-ABFB-F7558BE9182F	Pancreas	78.0	5EFE29B7-FE78-480A-A2B7-DBB605482E83	9715811A-FE94-4991-B850-5D50793DE443	TCGA-IB-7885-01A-11R-2156-07	HG19	TCGA-IB-7885	TCGA-PAAD		s753	University of North Carolina	Alberta Health Services	Canada	NO	T3	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	2156-07	True
13767.58cfa83be4b0c9d6adf7261b	58cfa83be4b0c9d6adf7261b	UNCID_2634919.3e6d35a3-3a10-4629-a316-8df8cc951678.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2634919.3e6d35a3-3a10-4629-a316-8df8cc951678.sorted_genome_alignments	UNCID_2634919.3e6d35a3-3a10-4629-a316-8df8cc951678.sorted_genome_alignments.bam	97.13	1.89	0.18	58cfa83be4b0c9d6adf7261b	UNCID_2634919.3e6d35a3-3a10-4629-a316-8df8cc951678.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-AACQ-01A	0F34D654-8984-4B8B-B345-67066D611513	Primary Tumor	Illumina HiSeq	A84334C9-126F-48BA-9D76-E23F8F376DBE	Liver	50.0	9F0FA2F5-A595-4BA1-A42F-E2079C71C750	3E6D35A3-3A10-4629-A316-8DF8CC951678	TCGA-DD-AACQ-01A-11R-A41C-07	HG19	TCGA-DD-AACQ	TCGA-LIHC		s16659	University of North Carolina	Mayo Clinic - Rochester	Korea South	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A41C-07	True
13767.58cfa838e4b0c9d6adf704b5	58cfa838e4b0c9d6adf704b5	UNCID_1940989.82de5dc9-2d34-4395-ae7c-430b5632ed24.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1940989.82de5dc9-2d34-4395-ae7c-430b5632ed24.sorted_genome_alignments	UNCID_1940989.82de5dc9-2d34-4395-ae7c-430b5632ed24.sorted_genome_alignments.bam	77.2		0.15	58cfa838e4b0c9d6adf704b5	UNCID_1940989.82de5dc9-2d34-4395-ae7c-430b5632ed24.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-62-8398-01A	2FABEB98-05E3-4F55-97F5-FBC675E25A3D	Primary Tumor	Illumina HiSeq	C0A87F54-5BF4-4293-9D91-FE3035686C1A	Lung	55.0	EC51C45A-D518-4333-BD7E-3AE606B40D01	82DE5DC9-2D34-4395-AE7C-430B5632ED24	TCGA-62-8398-01A-11R-2326-07	HG19	TCGA-62-8398	TCGA-LUAD	444.0	s11189	University of North Carolina	Thoraxklinik at University Hospital Heidelberg	Germany	NO	T2	N2	Lung Adenocarcinoma Mixed Subtype	Stage III	2326-07	True
13767.58cfa831e4b0c9d6adf6c578	58cfa831e4b0c9d6adf6c578	TCGA-BR-8077-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-8077-01A-11R-2343-13_rnaseq	TCGA-BR-8077-01A-11R-2343-13_rnaseq.bam	169.2		0.14	58cfa831e4b0c9d6adf6c578	TCGA-BR-8077-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8077-01A	FAED873E-A019-49C0-95A9-E9880FC23093	Primary Tumor	Illumina HiSeq	A0F882FE-0024-4D12-8E54-C32EBA65507D	Stomach	58.0	7C205FC6-F200-42D1-83EC-66E05D8407AB	95A287CA-0F91-4D9F-838A-3E2AE35CE5FA	TCGA-BR-8077-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8077	TCGA-STAD		s14692	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4b	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2343-13	True
13767.58cfa839e4b0c9d6adf710aa	58cfa839e4b0c9d6adf710aa	UNCID_2248621.ff7431a9-243a-4651-80bb-096379925bbe.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2248621.ff7431a9-243a-4651-80bb-096379925bbe.sorted_genome_alignments	UNCID_2248621.ff7431a9-243a-4651-80bb-096379925bbe.sorted_genome_alignments.bam	9.91	1.85	0.17	58cfa839e4b0c9d6adf710aa	UNCID_2248621.ff7431a9-243a-4651-80bb-096379925bbe.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GN-A4U8-11A	D3B77DA8-BE1D-4955-B1C7-55B7769785E8	Solid Tissue Normal	Illumina HiSeq	5FAB794A-065F-4B3C-BD09-9A4A81E49DDF	Skin	51.0	725693B0-5239-4ED5-9CC1-DF220A86939D	FF7431A9-243A-4651-80BB-096379925BBE	TCGA-GN-A4U8-11A-11R-A32P-07	HG19	TCGA-GN-A4U8	TCGA-SKCM		s7455	University of North Carolina	Roswell	United States	NO					A32P-07	True
13722.58cfa831e4b0c9d6adf6cab0	58cfa831e4b0c9d6adf6cab0	TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted	TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.bam	76.6	1.95	0.16	58cfa831e4b0c9d6adf6cab0	TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13U-01A	8C5AEF43-341E-4A37-84EB-FD730EB957C7	Primary Tumor	Illumina HiSeq	c717fac6-b3b3-4335-8ee8-5862d742ea16	Thyroid	60.0	CD19D6BB-21A4-409A-A7BA-A4521A03ABD3	B80A7146-1AB2-49BD-A3B2-7F6650840195	TCGA-DJ-A13U-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13U	TCGA-THCA		s12104	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A10R-02	True
13722.58cfa82de4b0c9d6adf6a755	58cfa82de4b0c9d6adf6a755	G14082.TCGA-21-1076-11A-01D-1521-08.2.filtered.	WGS	G14082.TCGA-21-1076-11A-01D-1521-08.2	G14082.TCGA-21-1076-11A-01D-1521-08.2.bam	7.0	1.8	0.05	58cfa82de4b0c9d6adf6a755	G14082.TCGA-21-1076-11A-01D-1521-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-1076-11A	220BE009-8F1E-4A77-AB04-3220B5F87EA6	Solid Tissue Normal	Illumina HiSeq	a5561a9b-57ef-42b7-b1e7-6f208060564c	Lung	54.0	706EA9BD-2216-444B-8173-3A3E022B622B	578A4A76-B3A4-4C8E-9E54-B7AE27AC482F	TCGA-21-1076-11A-01D-1521-08	HG19_Broad_variant	TCGA-21-1076	TCGA-LUSC		s9975	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1521-08	True
13767.58cfa83ae4b0c9d6adf71cda	58cfa83ae4b0c9d6adf71cda	UNCID_2502401.9bd649f6-9b08-4d26-87b9-a6901a00f2ba.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2502401.9bd649f6-9b08-4d26-87b9-a6901a00f2ba.sorted_genome_alignments	UNCID_2502401.9bd649f6-9b08-4d26-87b9-a6901a00f2ba.sorted_genome_alignments.bam	53.91	1.85	0.15	58cfa83ae4b0c9d6adf71cda	UNCID_2502401.9bd649f6-9b08-4d26-87b9-a6901a00f2ba.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-XF-A8HI-01A	EED3908F-F1BD-4254-BCA8-BC1A7427E95C	Primary Tumor	Illumina HiSeq	7B43860B-0953-4CFE-9C18-0D2A3747FF8B	Bladder	57.0	227A8E56-3E04-4244-96EE-F9D2DA882079	9BD649F6-9B08-4D26-87B9-A6901A00F2BA	TCGA-XF-A8HI-01A-11R-A38B-07	HG19	TCGA-XF-A8HI	TCGA-BLCA	544.0	s3036	University of North Carolina	University of Southern California	United States	NO	T2b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A38B-07	True
13722.58cfa831e4b0c9d6adf6c822	58cfa831e4b0c9d6adf6c822	TCGA-D1-A2G0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-D1-A2G0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_6_rg.sorted	TCGA-D1-A2G0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_6_rg.sorted.bam	11.63		0.15	58cfa831e4b0c9d6adf6c822	TCGA-D1-A2G0-10A-01D-A17E_120511_SN1120_0140_AD12J0ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A2G0-10A	6F661F0D-F08B-486E-8BD7-4306E1593EB9	Blood Derived Normal	Illumina HiSeq	e49e2287-a4cb-4280-ad97-698435bac987	Uterus	70.0	87CB512B-1C17-4C8C-93DB-7B7E62880924	330535EC-19A5-4FB7-821E-58A8AD25060B	TCGA-D1-A2G0-10A-01D-A17E-02	HG19_Broad_variant	TCGA-D1-A2G0	TCGA-UCEC		s5228	Harvard Medical School	Mayo Clinic	United States	NO			Mixed serous and endometrioid		A17E-02	True
13722.58cfa82fe4b0c9d6adf6b7a8	58cfa82fe4b0c9d6adf6b7a8	TCGA-61-2000-11A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-61-2000-11A-01D-A324-10_wgs_Illumina	TCGA-61-2000-11A-01D-A324-10_wgs_Illumina.bam	246.27	2.0	0.08	58cfa82fe4b0c9d6adf6b7a8	TCGA-61-2000-11A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2000-11A	29949B65-2913-4C86-BBD7-B85C5DF6F15E	Solid Tissue Normal	Illumina HiSeq	5a752b74-9068-4290-96f5-28cef6542078	Ovary	67.0	433DD0C4-E3A8-4175-8CD9-A57D221AAB46	501C785E-AA57-44D4-A38E-187BE13546D7	TCGA-61-2000-11A-01D-A324-10	GRCh37-lite	TCGA-61-2000	TCGA-OV		s17143	Baylor College of Medicine	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		A324-10	True
13767.58cfa837e4b0c9d6adf6ff3c	58cfa837e4b0c9d6adf6ff3c	UNCID_1795902.fbf67b9e-05a7-4280-a7b8-13363f1bd1c4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1795902.fbf67b9e-05a7-4280-a7b8-13363f1bd1c4.sorted_genome_alignments	UNCID_1795902.fbf67b9e-05a7-4280-a7b8-13363f1bd1c4.sorted_genome_alignments.bam	59.8	1.8	0.15	58cfa837e4b0c9d6adf6ff3c	UNCID_1795902.fbf67b9e-05a7-4280-a7b8-13363f1bd1c4.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-DC-6158-01A	0011A67B-1BA9-4A32-A6B8-7850759A38CF	Primary Tumor	Illumina HiSeq	4FF0BE51-9586-452E-BF0C-F9561D32A53E	Colorectal	70.0	03877FE0-B0D6-4800-BE46-B45C70350E48	FBF67B9E-05A7-4280-A7B8-13363F1BD1C4	TCGA-DC-6158-01A-11R-1660-07	HG19	TCGA-DC-6158	TCGA-READ		s2227	University of North Carolina	MSKCC	United States	NO	T2	N0	Rectal Adenocarcinoma	Stage I	1660-07	True
13722.58cfa832e4b0c9d6adf6d55a	58cfa832e4b0c9d6adf6d55a	TCGA-L5-A4OF-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_7_rg.sorted.filtered.	WGS	TCGA-L5-A4OF-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_7_rg.sorted	TCGA-L5-A4OF-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_7_rg.sorted.bam	26.16		0.16	58cfa832e4b0c9d6adf6d55a	TCGA-L5-A4OF-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OF-01A	0C78B1B5-F480-45AD-A253-19297BC886B4	Primary Tumor	Illumina HiSeq	0b3ce949-4295-46f8-8809-392587ea21dc	Esophagus	63.0	B11F1BF7-3546-4F3C-872F-A4A910D910E7	921BE625-9769-4D00-B2FC-ACAE3ADFCAE7	TCGA-L5-A4OF-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OF	TCGA-ESCA		s1741	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N1		Stage II	A267-26	True
13767.58cfa82fe4b0c9d6adf6b27a	58cfa82fe4b0c9d6adf6b27a	TCGA-13-1498-01A-01R-1565-13_rnaseq.filtered.	RNA-Seq	TCGA-13-1498-01A-01R-1565-13_rnaseq	TCGA-13-1498-01A-01R-1565-13_rnaseq.bam	392.0	1.8	0.16	58cfa82fe4b0c9d6adf6b27a	TCGA-13-1498-01A-01R-1565-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1498-01A	56A30462-2819-4C18-95BE-8E73880A4921	Primary Tumor	Illumina HiSeq	53B17871-CE7E-4BD1-B4B5-A7D4D2003416	Ovary	73.0	B38F209A-000B-4CBF-A4BD-0BC6F027FCE3	176D1CA2-EB1D-4F49-9B10-C129C822FA5A	TCGA-13-1498-01A-01R-1565-13	NCBI36_BCCAGSC_variant	TCGA-13-1498	TCGA-OV		s17498	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13722.58cfa830e4b0c9d6adf6c2c4	58cfa830e4b0c9d6adf6c2c4	TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina	TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina.bam	58.87		0.08	58cfa830e4b0c9d6adf6c2c4	TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AD-A5EK-01A	E8EC26BD-C88D-42B9-AC8A-AB121B8140F8	Primary Tumor	Illumina HiSeq	e84aec8b-4304-43e0-96c7-d605fc64dd11	Colorectal	51.0	C48314EE-C778-4B82-8E5A-4923DF4C8413	D0A0D845-32E2-4590-B909-29BD27B92900	TCGA-AD-A5EK-01A-11D-A28G-10	GRCh37-lite	TCGA-AD-A5EK	TCGA-COAD		s13537	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	N0	Colon Adenocarcinoma	Stage I	A28G-10	True
13767.58cfa835e4b0c9d6adf6eae1	58cfa835e4b0c9d6adf6eae1	UNCID_1325496.13b585a4-2072-49c1-87fa-ad55d5447b6e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1325496.13b585a4-2072-49c1-87fa-ad55d5447b6e.sorted_genome_alignments	UNCID_1325496.13b585a4-2072-49c1-87fa-ad55d5447b6e.sorted_genome_alignments.bam	10.66	1.75	0.15	58cfa835e4b0c9d6adf6eae1	UNCID_1325496.13b585a4-2072-49c1-87fa-ad55d5447b6e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A39S-01A	DFE086E6-71A5-4131-9602-F20977BF7454	Primary Tumor	Illumina HiSeq	6CD0874B-55FB-4259-93DA-88F016DDE257	Thyroid	27.0	902ADB27-13EF-4C87-845C-9A79944A1644	13B585A4-2072-49C1-87FA-AD55D5447B6E	TCGA-ET-A39S-01A-11R-A19O-07	HG19	TCGA-ET-A39S	TCGA-THCA		s12779	University of North Carolina	Johns Hopkins	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19O-07	True
13722.58cfa830e4b0c9d6adf6c1b0	58cfa830e4b0c9d6adf6c1b0	TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina	TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina.bam	385.4	1.9	0.08	58cfa830e4b0c9d6adf6c1b0	TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5556-10A	70741B73-9683-42BD-87FC-6A021A70103B	Blood Derived Normal	Illumina HiSeq	a2799f35-a768-4cac-a6e3-80c77052b7f9	Head and Neck	58.0	F57EB501-88BB-446B-9F7E-85FCCD0A828F	31220135-1318-4D47-8D69-49CABF4D087F	TCGA-BA-5556-10A-01D-A32X-10	GRCh37-lite	TCGA-BA-5556	TCGA-HNSC		s15492	Baylor College of Medicine	UNC	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	A32X-10	True
13767.58cfa836e4b0c9d6adf6fbcc	58cfa836e4b0c9d6adf6fbcc	UNCID_1657359.51C0F97A-C059-4688-8E48-7B9975CD4B17.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1657359.51C0F97A-C059-4688-8E48-7B9975CD4B17.sorted_genome_alignments	UNCID_1657359.51C0F97A-C059-4688-8E48-7B9975CD4B17.sorted_genome_alignments.bam	28.49	2.11	0.16	58cfa836e4b0c9d6adf6fbcc	UNCID_1657359.51C0F97A-C059-4688-8E48-7B9975CD4B17.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3TA-01A	D4355111-3ABB-40F0-BDB7-B9EAA39DC771	Primary Tumor	Illumina HiSeq	5922C019-E83F-4744-B4AE-04CC50DC4679	Thyroid	42.0	8424B1F6-C75E-4403-B2BF-C670B9E935C9	51C0F97A-C059-4688-8E48-7B9975CD4B17	TCGA-EL-A3TA-01A-12R-A22L-07	HG19	TCGA-EL-A3TA	TCGA-THCA		s12186	University of North Carolina	MD Anderson	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22L-07	True
13767.58cfa832e4b0c9d6adf6d678	58cfa832e4b0c9d6adf6d678	TCGA-VR-AA7D-01A-11R-A406-31_rnaseq.filtered.	RNA-Seq	TCGA-VR-AA7D-01A-11R-A406-31_rnaseq	TCGA-VR-AA7D-01A-11R-A406-31_rnaseq.bam	88.89	1.84	0.18	58cfa832e4b0c9d6adf6d678	TCGA-VR-AA7D-01A-11R-A406-31_rnaseq.bam	Dead	MALE			Esophageal Carcinoma	Aligned reads	TCGA-VR-AA7D-01A	484B7B36-15DC-43A9-801D-580216A8CFCB	Primary Tumor	Illumina HiSeq	57F5B6B1-3D08-4129-B8DC-AEF24D3B2AE4	Esophagus	58.0	1AB4ED3B-16E3-4882-A64A-187DB8B06559	396AF380-AEE4-4C94-AB0D-9E3DA649C449	TCGA-VR-AA7D-01A-11R-A406-31	GRCh37-lite	TCGA-VR-AA7D	TCGA-ESCA	279.0	s1701	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T3	N3		Stage III	A406-31	True
13767.58cfa83ce4b0c9d6adf72adb	58cfa83ce4b0c9d6adf72adb	UNCID_389946.85344fe3-0087-4c61-b02b-96a311fa8034.110705_UNC10-SN254_0240_AD0DKKABXX.6.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_389946.85344fe3-0087-4c61-b02b-96a311fa8034.110705_UNC10-SN254_0240_AD0DKKABXX.6.trimmed.annotated.translated_to_genomic	UNCID_389946.85344fe3-0087-4c61-b02b-96a311fa8034.110705_UNC10-SN254_0240_AD0DKKABXX.6.trimmed.annotated.translated_to_genomic.bam	104.3	1.8	0.14	58cfa83ce4b0c9d6adf72adb	UNCID_389946.85344fe3-0087-4c61-b02b-96a311fa8034.110705_UNC10-SN254_0240_AD0DKKABXX.6.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4986-01A	CCD44D97-F0D5-47CD-9C12-AF458C750D23	Primary Tumor	Illumina HiSeq	711A0069-1327-439F-A305-6EB8E28D2A85	Kidney	75.0	1AA58F3B-788E-4224-8887-4AF8EB05F4D4	85344FE3-0087-4C61-B02B-96A311FA8034	TCGA-BP-4986-01A-01R-1334-07	HG19	TCGA-BP-4986	TCGA-KIRC		s9280	University of North Carolina	MSKCC	None	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13767.58cfa833e4b0c9d6adf6dc9a	58cfa833e4b0c9d6adf6dc9a	UNCID_1127198.141e15ac-1537-4182-9db5-ba2115cd93d6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1127198.141e15ac-1537-4182-9db5-ba2115cd93d6.sorted_genome_alignments	UNCID_1127198.141e15ac-1537-4182-9db5-ba2115cd93d6.sorted_genome_alignments.bam	36.64	2.04	0.15	58cfa833e4b0c9d6adf6dc9a	UNCID_1127198.141e15ac-1537-4182-9db5-ba2115cd93d6.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15K-01A	17C1D42C-CB84-4655-A4CD-B54BAE17ECAF	Primary Tumor	Illumina HiSeq	85F90113-13C5-4826-91FC-F7C589D9166E	Breast	58.0	3A36B403-EA38-49F9-9C28-710C5D141164	141E15AC-1537-4182-9DB5-BA2115CD93D6	TCGA-E2-A15K-01A-11R-A12P-07	HG19	TCGA-E2-A15K	TCGA-BRCA		s6662	University of North Carolina	Roswell Park	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage II	A12P-07	True
13767.58cfa83ce4b0c9d6adf73078	58cfa83ce4b0c9d6adf73078	_1_TCGA-BR-8060-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-8060-01A-11R-2343-13_rnaseq	_1_TCGA-BR-8060-01A-11R-2343-13_rnaseq.bam	250.2		0.16	58cfa83ce4b0c9d6adf73078	_1_TCGA-BR-8060-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8060-01A	23EF21A0-3695-4CA2-99E2-274805F11892	Primary Tumor	Illumina HiSeq	8BF810BB-8F76-43F4-B444-1B59AA7BC495	Stomach	75.0	15BE8683-19E2-42A1-8A78-78CE5F278E12	AC2E80E9-B11B-4C63-9404-580BAF900F90	TCGA-BR-8060-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8060	TCGA-STAD		s14584	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T2	N2	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2343-13	True
13722.58cfa831e4b0c9d6adf6cdca	58cfa831e4b0c9d6adf6cdca	TCGA-FG-6692-10A-01D-1891_130923_SN1222_0220_BC2DUUACXX_s_2_rg.sorted.filtered.	WGS	TCGA-FG-6692-10A-01D-1891_130923_SN1222_0220_BC2DUUACXX_s_2_rg.sorted	TCGA-FG-6692-10A-01D-1891_130923_SN1222_0220_BC2DUUACXX_s_2_rg.sorted.bam	278.3	1.9	0.14	58cfa831e4b0c9d6adf6cdca	TCGA-FG-6692-10A-01D-1891_130923_SN1222_0220_BC2DUUACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-6692-10A	5F10CD91-1E03-4016-B35A-8629A1A8FCC9	Blood Derived Normal	Illumina HiSeq	08012a5a-0f7a-4f6e-92cf-b1878218e33c	Brain	63.0	D7EA0C8C-8642-4491-982E-6FC30D6D9237	C8066486-BC5A-4D91-B766-437C0A491304	TCGA-FG-6692-10A-01D-1891-02	HG19_Broad_variant	TCGA-FG-6692	TCGA-LGG		s8369	Harvard Medical School	Case Western	United States	NO			Oligodendroglioma		1891-02	True
13767.58cfa837e4b0c9d6adf7028c	58cfa837e4b0c9d6adf7028c	UNCID_1810549.62f93124-31ae-499b-b550-4f24be28024e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1810549.62f93124-31ae-499b-b550-4f24be28024e.sorted_genome_alignments	UNCID_1810549.62f93124-31ae-499b-b550-4f24be28024e.sorted_genome_alignments.bam	55.2		0.14	58cfa837e4b0c9d6adf7028c	UNCID_1810549.62f93124-31ae-499b-b550-4f24be28024e.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-90-7767-11A	9DFF11CD-0784-4A60-9C77-43F8957D3DFA	Solid Tissue Normal	Illumina HiSeq	FDD74D3F-A265-4093-BEBB-7638B2618164	Lung	56.0	19C3BDDE-E891-4545-8F2D-9CB94641371F	62F93124-31AE-499B-B550-4F24BE28024E	TCGA-90-7767-11A-01R-2125-07	HG19	TCGA-90-7767	TCGA-LUSC		s10439	University of North Carolina	ABS - IUPUI	United States	NO	T2b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	2125-07	True
13767.58cfa834e4b0c9d6adf6e8fa	58cfa834e4b0c9d6adf6e8fa	UNCID_1234096.75838292-c5fe-45f1-8fa5-94403cfc3bdf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1234096.75838292-c5fe-45f1-8fa5-94403cfc3bdf.sorted_genome_alignments	UNCID_1234096.75838292-c5fe-45f1-8fa5-94403cfc3bdf.sorted_genome_alignments.bam	5.9	1.88	0.15	58cfa834e4b0c9d6adf6e8fa	UNCID_1234096.75838292-c5fe-45f1-8fa5-94403cfc3bdf.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A3C7-06A	3B62E38C-D473-4329-86AB-5D4977F92B09	Metastatic	Illumina HiSeq	AD758DE4-5E7F-45A3-AD2E-2A5B30276AA0	Skin	57.0	E66EF510-C44F-420B-906D-E8DCD29518DA	75838292-C5FE-45F1-8FA5-94403CFC3BDF	TCGA-D3-A3C7-06A-11R-A18U-07	HG19	TCGA-D3-A3C7	TCGA-SKCM		s7901	University of North Carolina	MD Anderson	United States	NO	T0	N1b		Stage III	A18U-07	True
13722.58cfa82fe4b0c9d6adf6b942	58cfa82fe4b0c9d6adf6b942	TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted	TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.bam	65.96	1.81	0.16	58cfa82fe4b0c9d6adf6b942	TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GN-01A	A2A2DBDA-D10C-49C4-86A8-61BAF6160CDA	Primary Tumor	Illumina HiSeq	7270b44f-635f-48bf-b3c4-8042b4557613	Uterus	65.0	F6F9C40B-1E58-47A3-B518-9694FB5FF2CF	41896FDE-677E-419C-B8B9-0171D6669A4A	TCGA-A5-A0GN-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GN	TCGA-UCEC		s4589	Harvard Medical School	Cedars Sinai	None	NO			Endometrioid endometrial adenocarcinoma		A043-02	True
13722.58cfa82fe4b0c9d6adf6b948	58cfa82fe4b0c9d6adf6b948	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	91.2	1.92	0.08	58cfa82fe4b0c9d6adf6b948	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04T-01A	B58AD350-5140-4FA8-BC2C-24BCA8395F3A	Primary Tumor	Illumina HiSeq	6dd42df3-896f-418a-9f13-468ac66d69bc	Breast	62.0	6DD4870F-1EC2-484B-8703-6397D8E67DAA	B752B444-F033-4BE4-9D24-E5E80B4181AF	TCGA-A2-A04T-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A04T	TCGA-BRCA		s5637	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage II	A128-09	True
13767.58cfa83be4b0c9d6adf72706	58cfa83be4b0c9d6adf72706	UNCID_2651377.b4df19ac-b93c-4de6-b0f6-823bca30b1d7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2651377.b4df19ac-b93c-4de6-b0f6-823bca30b1d7.sorted_genome_alignments	UNCID_2651377.b4df19ac-b93c-4de6-b0f6-823bca30b1d7.sorted_genome_alignments.bam	66.58	1.89	0.18	58cfa83be4b0c9d6adf72706	UNCID_2651377.b4df19ac-b93c-4de6-b0f6-823bca30b1d7.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-VS-A9UO-01A	4DA121DA-9193-4AC5-8206-03CB1F7C2C14	Primary Tumor	Illumina HiSeq	E7FCB47E-A7DD-4117-9957-6CC6FAE3E246	Cervix	43.0	729B1D94-980F-4C94-A154-64283241FFF5	B4DF19AC-B93C-4DE6-B0F6-823BCA30B1D7	TCGA-VS-A9UO-01A-11R-A42T-07	HG19	TCGA-VS-A9UO	TCGA-CESC		s1498	University of North Carolina	Barretos Cancer Hospital	Brazil	NO	T2b	N0	Mucinous Adenocarcinoma of Endocervical Type		A42T-07	True
13722.58cfa830e4b0c9d6adf6bb0c	58cfa830e4b0c9d6adf6bb0c	TCGA-AA-A00N-10A-01D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A00N-10A-01D-A17O-10_wgs_Illumina	TCGA-AA-A00N-10A-01D-A17O-10_wgs_Illumina.bam	26.63	1.73	0.08	58cfa830e4b0c9d6adf6bb0c	TCGA-AA-A00N-10A-01D-A17O-10_wgs_Illumina.bam	Dead	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00N-10A	E457344D-76FB-46BF-B362-61A6E811D131	Blood Derived Normal	Illumina HiSeq	524f4dbd-9c3a-4d0b-bbbd-02132d93caa1	Colorectal	75.0	CE518719-0573-4214-9F1E-4387673A57D8	F4561A74-4A93-459A-B865-8D385F36E0FD	TCGA-AA-A00N-10A-01D-A17O-10	GRCh37-lite	TCGA-AA-A00N	TCGA-COAD	122.0	s13373	Baylor College of Medicine	Indivumed	Germany	NO	T4	N0	Colon Mucinous Adenocarcinoma	Stage II	A17O-10	True
13767.58cfa836e4b0c9d6adf6fa8a	58cfa836e4b0c9d6adf6fa8a	UNCID_1648526.80dac2db-4e32-4854-ba10-2d9aa059bf45.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1648526.80dac2db-4e32-4854-ba10-2d9aa059bf45.sorted_genome_alignments	UNCID_1648526.80dac2db-4e32-4854-ba10-2d9aa059bf45.sorted_genome_alignments.bam	45.2		0.16	58cfa836e4b0c9d6adf6fa8a	UNCID_1648526.80dac2db-4e32-4854-ba10-2d9aa059bf45.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7471-01A	48314732-5D1C-43E6-9878-5B58DFAEB06A	Primary Tumor	Illumina HiSeq	F87B5C04-3815-4EF0-B147-7DD243BC3E74	Brain	37.0	4A579925-CCA7-4212-9299-843BB6EB0EB7	80DAC2DB-4E32-4854-BA10-2D9AA059BF45	TCGA-HT-7471-01A-11R-2256-07	HG19	TCGA-HT-7471	TCGA-LGG		s8780	University of North Carolina	Case Western - St Joes	United States	NO			Oligodendroglioma		2256-07	True
13767.58cfa82fe4b0c9d6adf6b3b2	58cfa82fe4b0c9d6adf6b3b2	TCGA-24-2261-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-24-2261-01A-01R-1568-13_rnaseq	TCGA-24-2261-01A-01R-1568-13_rnaseq.bam	648.0	1.8	0.15	58cfa82fe4b0c9d6adf6b3b2	TCGA-24-2261-01A-01R-1568-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-2261-01A	EEC69EA9-CEB8-456A-AFF4-41FB8A261E36	Primary Tumor	Illumina HiSeq	7E556BEA-7165-4E83-80ED-813652A0F3B0	Ovary	76.0	7BCD356D-7031-44B1-B1D7-8D8F60F0CAFF	75E9506A-D007-4FB2-8BDD-7E7780653A63	TCGA-24-2261-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-24-2261	TCGA-OV	24.0	s17948	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa831e4b0c9d6adf6cbaf	58cfa831e4b0c9d6adf6cbaf	TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted	TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted.bam	50.85		0.14	58cfa831e4b0c9d6adf6cbaf	TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A3GN-01A	F727FCB9-E457-4643-9468-F739133B7E9C	Primary Tumor	Illumina HiSeq	b9e845ee-3e61-4ccf-b14e-f8a6b8481bd3	Cervix	47.0	EB5034E2-D4A7-48E0-9524-31DDD63C9D94	49F2E671-D283-4B5C-B8A3-490C0A383FC1	TCGA-EK-A3GN-01A-11D-A20X-26	HG19_Broad_variant	TCGA-EK-A3GN	TCGA-CESC		s1364	MD Anderson - Institute for Applied Cancer Science	Gynecologic Oncology Group	United States	NO	TX	NX	Cervical Squamous Cell Carcinoma		A20X-26	True
13722.58cfa831e4b0c9d6adf6cba0	58cfa831e4b0c9d6adf6cba0	TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted	TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted.bam	233.7	1.9	0.15	58cfa831e4b0c9d6adf6cba0	TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5519-01A	5313A055-C2D7-4CBD-A8C1-57AC85912D89	Primary Tumor	Illumina HiSeq	75f448c7-b10b-4c15-ae49-4eb217c65391	Prostate	64.0	EEE1828E-D25F-462B-9735-89CA2ECCC7E1	4C2E88A3-B668-40A8-B625-B6D7A48DEAF5	TCGA-EJ-5519-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5519	TCGA-PRAD		s3949	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type		1572-02	True
13767.58cfa835e4b0c9d6adf6ed01	58cfa835e4b0c9d6adf6ed01	UNCID_1340930.df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1340930.df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7.sorted_genome_alignments	UNCID_1340930.df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7.sorted_genome_alignments.bam	75.2		0.14	58cfa835e4b0c9d6adf6ed01	UNCID_1340930.df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7821-01A	929837F9-297A-47C0-AC9A-A142EEF620D3	Primary Tumor	Illumina HiSeq	6D7C459E-2E3A-4055-9F17-60190B4BD570	Prostate	54.0	BDF77BE2-F833-45F2-BD32-DBF53EB11EB4	DF9EE925-86BC-4CCC-B308-0C7D6D1D4FD7	TCGA-HC-7821-01A-12R-2118-07	HG19	TCGA-HC-7821	TCGA-PRAD		s3832	University of North Carolina	International Genomics Consortium	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type		2118-07	True
13722.58cfa830e4b0c9d6adf6be96	58cfa830e4b0c9d6adf6be96	TCGA-AZ-4681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	495.02	1.9	0.14	58cfa830e4b0c9d6adf6be96	TCGA-AZ-4681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4681-01A	6FBC2B46-6762-4778-AA7E-782162C5397C	Primary Tumor	Illumina HiSeq	6ba6ed18-e876-4135-beef-7355f9bafa79	Colorectal	79.0	6171DB74-FE5A-4495-8B6A-724BE0CBA79E	37179766-A54A-4FA0-9E6E-5A33ABF3AC45	TCGA-AZ-4681-01A-01D-1405-02	HG18	TCGA-AZ-4681	TCGA-COAD		s13543	Harvard Medical School	University of Pittsburgh	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1405-02	True
13767.58cfa833e4b0c9d6adf6dba9	58cfa833e4b0c9d6adf6dba9	UNCID_1107568.fd4a3155-ca05-464c-b8d9-816103de489d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1107568.fd4a3155-ca05-464c-b8d9-816103de489d.sorted_genome_alignments	UNCID_1107568.fd4a3155-ca05-464c-b8d9-816103de489d.sorted_genome_alignments.bam	64.2	1.8	0.15	58cfa833e4b0c9d6adf6dba9	UNCID_1107568.fd4a3155-ca05-464c-b8d9-816103de489d.sorted_genome_alignments.bam	Alive	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4427-01A	78A24C56-576C-4245-BB42-6603B3D19897	Primary Tumor	Illumina HiSeq	E0BBF139-2563-4013-BDC2-59AF985885D7	Lung	65.0	785B0C56-BED5-4D19-B7B3-D1A0CEB5D648	FD4A3155-CA05-464C-B8D9-816103DE489D	TCGA-05-4427-01A-21R-1858-07	HG19	TCGA-05-4427	TCGA-LUAD		s11032	University of North Carolina	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage II	1858-07	True
13767.58cfa833e4b0c9d6adf6d876	58cfa833e4b0c9d6adf6d876	UNCID_1074673.31137a90-0e02-4c48-80c1-14c882eff26f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1074673.31137a90-0e02-4c48-80c1-14c882eff26f.sorted_genome_alignments	UNCID_1074673.31137a90-0e02-4c48-80c1-14c882eff26f.sorted_genome_alignments.bam	67.8	1.8	0.15	58cfa833e4b0c9d6adf6d876	UNCID_1074673.31137a90-0e02-4c48-80c1-14c882eff26f.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-5897-01A	B3A6EDCD-6592-44FB-9EC1-037138BFBDAF	Primary Tumor	Illumina HiSeq	4FF31D21-BBBC-468A-99A7-0888A267873D	Lung	74.0	D2AAF939-ECDE-499C-B301-134D1A9DCC5A	31137A90-0E02-4C48-80C1-14C882EFF26F	TCGA-56-5897-01A-11R-1635-07	HG19	TCGA-56-5897	TCGA-LUSC		s10415	University of North Carolina	International Genomics Consortium	United States	NO	T1b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1635-07	True
13767.58cfa832e4b0c9d6adf6d694	58cfa832e4b0c9d6adf6d694	TCGA-VR-A8EZ-01A-11R-A36D-31_rnaseq.filtered.	RNA-Seq	TCGA-VR-A8EZ-01A-11R-A36D-31_rnaseq	TCGA-VR-A8EZ-01A-11R-A36D-31_rnaseq.bam	47.83	1.9	0.17	58cfa832e4b0c9d6adf6d694	TCGA-VR-A8EZ-01A-11R-A36D-31_rnaseq.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-VR-A8EZ-01A	FD62F7B4-A2DA-4ACD-8A85-8FA8F91521CB	Primary Tumor	Illumina HiSeq	10C025D7-4CAA-4ACC-B36E-70DFF7FC66E2	Esophagus	47.0	38CEB260-B714-4340-88F0-F6B21DBBAE11	72C0CAA7-6424-44A6-87F3-8DBD9000ED85	TCGA-VR-A8EZ-01A-11R-A36D-31	GRCh37-lite	TCGA-VR-A8EZ	TCGA-ESCA	553.0	s1890	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T3	N3		Stage III	A36D-31	True
13767.58cfa837e4b0c9d6adf70141	58cfa837e4b0c9d6adf70141	UNCID_1840978.66811a13-8463-429b-87ae-298455ee961a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1840978.66811a13-8463-429b-87ae-298455ee961a.sorted_genome_alignments	UNCID_1840978.66811a13-8463-429b-87ae-298455ee961a.sorted_genome_alignments.bam	37.19	1.34	0.17	58cfa837e4b0c9d6adf70141	UNCID_1840978.66811a13-8463-429b-87ae-298455ee961a.sorted_genome_alignments.bam	Alive	MALE	WHITE		Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BD-A2L6-11A	13A97CEE-76B0-46A1-B728-D87B2248311E	Solid Tissue Normal	Illumina HiSeq	E23C5BF2-D35A-4285-A6D5-CE2EA5F70CEB	Liver	69.0	6049CD94-D7BF-4D5E-8F78-6AAB65C58FA4	66811A13-8463-429B-87AE-298455EE961A	TCGA-BD-A2L6-11A-21R-A213-07	HG19	TCGA-BD-A2L6	TCGA-LIHC		s16704	University of North Carolina	University of Pittsburgh	United States	NO	T2	NX	Hepatocellular Carcinoma		A213-07	True
13767.58cfa835e4b0c9d6adf6eb80	58cfa835e4b0c9d6adf6eb80	UNCID_1265174.8854ee68-24a7-4ff1-b411-50e9141404d9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1265174.8854ee68-24a7-4ff1-b411-50e9141404d9.sorted_genome_alignments	UNCID_1265174.8854ee68-24a7-4ff1-b411-50e9141404d9.sorted_genome_alignments.bam	62.51	1.92	0.16	58cfa835e4b0c9d6adf6eb80	UNCID_1265174.8854ee68-24a7-4ff1-b411-50e9141404d9.sorted_genome_alignments.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A22K-01A	DE9315B3-B3DF-45F0-ADC2-69AA6B8FF717	Primary Tumor	Illumina HiSeq	47080508-C392-489D-B86A-3ED872976104	Thyroid	46.0	8494EA4B-C009-4318-BFF6-FBE9449F64BA	8854EE68-24A7-4FF1-B411-50E9141404D9	TCGA-EM-A22K-01A-11R-A180-07	HG19	TCGA-EM-A22K	TCGA-THCA		s12775	University of North Carolina	University Health Network	Canada	NO	T1b	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A180-07	True
13767.58cfa838e4b0c9d6adf70570	58cfa838e4b0c9d6adf70570	UNCID_1971224.a1dbd4f4-b4a6-454c-b68d-06297e48323e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1971224.a1dbd4f4-b4a6-454c-b68d-06297e48323e.sorted_genome_alignments	UNCID_1971224.a1dbd4f4-b4a6-454c-b68d-06297e48323e.sorted_genome_alignments.bam	26.29	1.94	0.18	58cfa838e4b0c9d6adf70570	UNCID_1971224.a1dbd4f4-b4a6-454c-b68d-06297e48323e.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A51R-06A	1F66A0E1-640A-4CAA-85F1-61C6DE475CF1	Metastatic	Illumina HiSeq	E3EC05B6-D351-4A56-A885-B9741B24EC92	Skin	60.0	BAE063AB-25C3-44F9-8EC3-E726DE4F9616	A1DBD4F4-B4A6-454C-B68D-06297E48323E	TCGA-D3-A51R-06A-11R-A266-07	HG19	TCGA-D3-A51R	TCGA-SKCM		s7943	University of North Carolina	MD Anderson	United States	NO	T3a	N0		Stage II	A266-07	True
13722.58cfa831e4b0c9d6adf6c45f	58cfa831e4b0c9d6adf6c45f	TCGA-CG-5728-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CG-5728-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_8_rg.sorted	TCGA-CG-5728-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_8_rg.sorted.bam	309.0	1.9	0.15	58cfa831e4b0c9d6adf6c45f	TCGA-CG-5728-11A-01D-1598_121011_SN208_0435_BD1E43ACXX_s_8_rg.sorted.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5728-11A	1286AC33-A466-4F58-900E-F6B13FE9C25A	Solid Tissue Normal	Illumina HiSeq	db35e103-ab69-44f7-b5c2-913ab5032554	Stomach	88.0	AE411D6A-4E7B-4B8D-B41C-5153FB5D4D25	F3D1F1F3-EECE-45D5-96AC-16FF3D85F025	TCGA-CG-5728-11A-01D-1598-02	HG19_Broad_variant	TCGA-CG-5728	TCGA-STAD		s15461	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1598-02	True
13722.58cfa82ee4b0c9d6adf6ac27	58cfa82ee4b0c9d6adf6ac27	G37566.TCGA-HC-7737-01A-11D-2114-08.3.filtered.	WGS	G37566.TCGA-HC-7737-01A-11D-2114-08.3	G37566.TCGA-HC-7737-01A-11D-2114-08.3.bam	205.3		0.05	58cfa82ee4b0c9d6adf6ac27	G37566.TCGA-HC-7737-01A-11D-2114-08.3.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN		Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7737-01A	73F875CB-BCFC-43BA-AB97-4E94CAF836D4	Primary Tumor	Illumina HiSeq	855b7ac8-18b6-4ec4-9471-8d12a802bf46	Prostate	55.0	47B6E89A-EA86-475A-9F1D-02001069C895	DCF98ACC-736B-4AF6-BDCA-A320A413165A	TCGA-HC-7737-01A-11D-2114-08	HG19_Broad_variant	TCGA-HC-7737	TCGA-PRAD		s3407	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2c	N1	Prostate Adenocarcinoma Acinar Type		2114-08	False
13767.58cfa83ce4b0c9d6adf731ee	58cfa83ce4b0c9d6adf731ee	_1_TCGA-CG-5725-01A-11R-1602-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-CG-5725-01A-11R-1602-13_rnaseq	_1_TCGA-CG-5725-01A-11R-1602-13_rnaseq.bam	335.8	1.8	0.14	58cfa83ce4b0c9d6adf731ee	_1_TCGA-CG-5725-01A-11R-1602-13_rnaseq.bam	Dead	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5725-01A	129D95CA-71EF-44AA-A93D-F87803C37C9A	Primary Tumor	Illumina HiSeq	1A8E29AC-099F-43B9-91A5-9DDF9E5C08D1	Stomach	72.0	E1DED05A-1BC0-42A7-A560-DD67EB804EB4	6354EE93-B5E9-4475-8B34-6E946C222C61	TCGA-CG-5725-01A-11R-1602-13	GRCh37-lite	TCGA-CG-5725	TCGA-STAD	457.0	s15028	Canada's Michael Smith Genome Sciences Centre	Indivumed	Germany	NO	T2	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1602-13	True
13722.58cfa82de4b0c9d6adf6a656	58cfa82de4b0c9d6adf6a656	801434f25120f36fe582c7906500e08e.filtered.	WGS	801434f25120f36fe582c7906500e08e	801434f25120f36fe582c7906500e08e.bam	21.21		0.08	58cfa82de4b0c9d6adf6a656	801434f25120f36fe582c7906500e08e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3KC-01A	2D29A4AC-98E7-4663-9DD6-5681BC32AC2E	Primary Tumor	Illumina HiSeq	449d2c68-674e-4e86-89ff-574170845aa1	Breast	55.0	8318A9A4-E78E-4DB8-97C7-2CC733D0C512	F9F04E42-63A2-4EE1-ADE4-9E5BB5C20CDD	TCGA-A2-A3KC-01A-11D-A20S-09	GRCh37-lite	TCGA-A2-A3KC	TCGA-BRCA		s5952	Washington University School of Medicine	Walter Reed	United States	NO	T2	N1a	Infiltrating Lobular Carcinoma	Stage II	A20S-09	False
13767.58cfa836e4b0c9d6adf6fb46	58cfa836e4b0c9d6adf6fb46	UNCID_1656238.AC6623D5-A616-4AE9-87B9-3F3A5C00ABDF.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1656238.AC6623D5-A616-4AE9-87B9-3F3A5C00ABDF.sorted_genome_alignments	UNCID_1656238.AC6623D5-A616-4AE9-87B9-3F3A5C00ABDF.sorted_genome_alignments.bam	55.62	1.82	0.16	58cfa836e4b0c9d6adf6fb46	UNCID_1656238.AC6623D5-A616-4AE9-87B9-3F3A5C00ABDF.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A419-01A	A2E2FAC3-CCA5-4E33-AA6C-1D9D3AC3AEEC	Primary Tumor	Illumina HiSeq	163F9F1A-9A4A-422C-AC7A-5F2286EEC451	Thyroid	30.0	C7B4058E-21B2-4E6B-8FFF-E1981583B9CE	AC6623D5-A616-4AE9-87B9-3F3A5C00ABDF	TCGA-E8-A419-01A-11R-A23N-07	HG19	TCGA-E8-A419	TCGA-THCA		s12180	University of North Carolina	Asterand	Russia	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23N-07	True
13722.58cfa831e4b0c9d6adf6cd7c	58cfa831e4b0c9d6adf6cd7c	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.bam	42.39		0.15	58cfa831e4b0c9d6adf6cd7c	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B3-01A	4B5D873B-BFDA-482E-92A0-BF84C0F9032A	Primary Tumor	Illumina HiSeq	6b702a7f-ff83-4ff2-96a8-9da2f015ebcc	Bladder	74.0	769EE027-5ED7-4EC2-86B5-FE40F9D6FB5A	57731F40-BBEF-4C7B-BFDC-CE75DA6EB1EB	TCGA-FD-A3B3-01A-12D-A204-02	HG19_Broad_variant	TCGA-FD-A3B3	TCGA-BLCA		s2903	Harvard Medical School	BLN - University Of Chicago	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A204-02	True
13767.58cfa832e4b0c9d6adf6d110	58cfa832e4b0c9d6adf6d110	TCGA-HU-A4GT-01A-21R-A251-31_rnaseq.filtered.	RNA-Seq	TCGA-HU-A4GT-01A-21R-A251-31_rnaseq	TCGA-HU-A4GT-01A-21R-A251-31_rnaseq.bam	82.18	1.8	0.16	58cfa832e4b0c9d6adf6d110	TCGA-HU-A4GT-01A-21R-A251-31_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4GT-01A	7997F3D8-BFF6-4808-8DF0-D88D344D7C9E	Primary Tumor	Illumina HiSeq	7928E7B9-9D01-49B1-9C6A-917D805B9010	Stomach	71.0	3BD4F1D2-887C-43EB-BA6B-C41C7ABEC5A5	EFFBF8ED-F852-4A0A-BD94-D04047925F3A	TCGA-HU-A4GT-01A-21R-A251-31	GRCh37-lite	TCGA-HU-A4GT	TCGA-STAD		s14776	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T3	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage II	A251-31	True
13767.58cfa82ee4b0c9d6adf6a832	58cfa82ee4b0c9d6adf6a832	G17199.TCGA-06-0744-01A-01R-1849-01.2.filtered.	RNA-Seq	G17199.TCGA-06-0744-01A-01R-1849-01.2	G17199.TCGA-06-0744-01A-01R-1849-01.2.bam	11.6	1.95	0.18	58cfa82ee4b0c9d6adf6a832	G17199.TCGA-06-0744-01A-01R-1849-01.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0744-01A	5613F5F6-086D-470B-8F77-6DCB7F8625B7	Primary Tumor	Illumina HiSeq	85E09820-FABB-4773-8764-AAFD570A4781	Brain	66.0	C01952D4-AE81-48E2-8818-0E438E66B516	D29E5A15-6AD2-41F9-B4E8-5C4B0F3FDA9E	TCGA-06-0744-01A-01R-1849-01	HG19_Broad_variant	TCGA-06-0744	TCGA-GBM		s14327	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13767.58cfa833e4b0c9d6adf6dae4	58cfa833e4b0c9d6adf6dae4	UNCID_1115675.dbba4276-4b85-4309-8f98-951313c3a3dc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1115675.dbba4276-4b85-4309-8f98-951313c3a3dc.sorted_genome_alignments	UNCID_1115675.dbba4276-4b85-4309-8f98-951313c3a3dc.sorted_genome_alignments.bam	14.12	1.76	0.16	58cfa833e4b0c9d6adf6dae4	UNCID_1115675.dbba4276-4b85-4309-8f98-951313c3a3dc.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1F2-01A	6A2972E3-CCA9-47E5-AAC0-B770F2399EEB	Primary Tumor	Illumina HiSeq	30A03B54-4DB3-46F4-95A1-7E2657F38130	Breast	53.0	E5C171AC-F700-439C-9E44-6CFED2C9CEA7	DBBA4276-4B85-4309-8F98-951313C3A3DC	TCGA-BH-A1F2-01A-31R-A13Q-07	HG19	TCGA-BH-A1F2	TCGA-BRCA	959.0	s5979	University of North Carolina	University of Pittsburgh	None	NO	T4b	N1b	Infiltrating Ductal Carcinoma	Stage III	A13Q-07	True
13767.58cfa834e4b0c9d6adf6e467	58cfa834e4b0c9d6adf6e467	UNCID_1193279.48c6075a-684e-4229-9c89-d96f5cd56465.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1193279.48c6075a-684e-4229-9c89-d96f5cd56465.sorted_genome_alignments	UNCID_1193279.48c6075a-684e-4229-9c89-d96f5cd56465.sorted_genome_alignments.bam	49.8	1.6	0.16	58cfa834e4b0c9d6adf6e467	UNCID_1193279.48c6075a-684e-4229-9c89-d96f5cd56465.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5461-01A	393ABCF7-1155-4B32-85CA-CD44D259E4B4	Primary Tumor	Illumina HiSeq	51F68721-8B40-47A0-987B-58EAA91E6D1C	Kidney	52.0	27CF4AB8-B5B6-4AD3-8F60-088EF153C271	48C6075A-684E-4229-9C89-D96F5CD56465	TCGA-CZ-5461-01A-01R-1503-07	HG19	TCGA-CZ-5461	TCGA-KIRC	330.0	s9634	University of North Carolina	Harvard	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1503-07	True
13767.58cfa833e4b0c9d6adf6df72	58cfa833e4b0c9d6adf6df72	UNCID_1156459.7c8b9d9a-653a-4dc7-8c53-b196fbd0482a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1156459.7c8b9d9a-653a-4dc7-8c53-b196fbd0482a.sorted_genome_alignments	UNCID_1156459.7c8b9d9a-653a-4dc7-8c53-b196fbd0482a.sorted_genome_alignments.bam	65.19	1.82	0.15	58cfa833e4b0c9d6adf6df72	UNCID_1156459.7c8b9d9a-653a-4dc7-8c53-b196fbd0482a.sorted_genome_alignments.bam	Alive	FEMALE			Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A08C-01A	78E1DA41-127C-4E9C-AAAA-77A0D94C31D0	Primary Tumor	Illumina HiSeq	158C8010-AAE0-4203-8F38-11D001B3A34C	Breast	65.0	B1DE1587-FEBD-4E50-99AC-EB3DCB23033A	7C8B9D9A-653A-4DC7-8C53-B196FBD0482A	TCGA-A8-A08C-01A-11R-A00Z-07	HG19	TCGA-A8-A08C	TCGA-BRCA		s5880	University of North Carolina	Indivumed	Germany	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A00Z-07	True
13767.58cfa835e4b0c9d6adf6edf0	58cfa835e4b0c9d6adf6edf0	UNCID_1363245.23e9edc6-a5ab-4dca-9243-a40e69d65615.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1363245.23e9edc6-a5ab-4dca-9243-a40e69d65615.sorted_genome_alignments	UNCID_1363245.23e9edc6-a5ab-4dca-9243-a40e69d65615.sorted_genome_alignments.bam	190.2		0.15	58cfa835e4b0c9d6adf6edf0	UNCID_1363245.23e9edc6-a5ab-4dca-9243-a40e69d65615.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7212-01A	907B64D6-A26A-4092-A247-AC9AF444D1C7	Primary Tumor	Illumina HiSeq	0C27215D-A7DF-4FF8-95DD-A41F13F78E49	Prostate	56.0	92888479-B534-432D-8F70-CAE857E0074B	23E9EDC6-A5AB-4DCA-9243-A40E69D65615	TCGA-HC-7212-01A-11R-2118-07	HG19	TCGA-HC-7212	TCGA-PRAD		s3840	University of North Carolina	International Genomics Consortium	United States	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13722.58cfa830e4b0c9d6adf6be84	58cfa830e4b0c9d6adf6be84	TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted	TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.bam	110.16	1.93	0.17	58cfa830e4b0c9d6adf6be84	TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A191-01A	2501EE46-8D38-448B-8765-E9C9706CBBE8	Primary Tumor	Illumina HiSeq	fb73296b-b8ef-4ff9-a954-fab7d29ab101	Thyroid	49.0	C92FC4E3-7A96-4000-A969-AA894CA58A33	B3EDF2BC-5E8F-435A-ADA1-F292722EDD9C	TCGA-BJ-A191-01A-11D-A13U-02	HG19_Broad_variant	TCGA-BJ-A191	TCGA-THCA		s12237	Harvard Medical School	University of Pittsburgh	United States	NO	T1b	N0	Other  specify	Stage I	A13U-02	True
13767.58cfa834e4b0c9d6adf6e6fe	58cfa834e4b0c9d6adf6e6fe	UNCID_1211980.619741f2-4f5e-41ab-9033-bfc0dd525750.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1211980.619741f2-4f5e-41ab-9033-bfc0dd525750.sorted_genome_alignments	UNCID_1211980.619741f2-4f5e-41ab-9033-bfc0dd525750.sorted_genome_alignments.bam	39.92	1.79	0.18	58cfa834e4b0c9d6adf6e6fe	UNCID_1211980.619741f2-4f5e-41ab-9033-bfc0dd525750.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2PQ-01A	EDB90376-0EF9-47DD-BE6F-A6E8A0380A9C	Primary Tumor	Illumina HiSeq	80CE3B59-9211-4B42-8D22-6A04F4A590BC	Thyroid	26.0	2EB05E94-554E-402F-B319-1BE9DE36C66E	619741F2-4F5E-41AB-9033-BFC0DD525750	TCGA-DJ-A2PQ-01A-11R-A18C-07	HG19	TCGA-DJ-A2PQ	TCGA-THCA		s12657	University of North Carolina	Memorial Sloan Kettering	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A18C-07	True
13767.58cfa839e4b0c9d6adf71412	58cfa839e4b0c9d6adf71412	UNCID_2232296.ea34e227-a427-42a6-9f42-80069e972764.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2232296.ea34e227-a427-42a6-9f42-80069e972764.sorted_genome_alignments	UNCID_2232296.ea34e227-a427-42a6-9f42-80069e972764.sorted_genome_alignments.bam	17.23	1.88	0.16	58cfa839e4b0c9d6adf71412	UNCID_2232296.ea34e227-a427-42a6-9f42-80069e972764.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-A6RC-01A	AAE0FCA8-99E9-4FDE-A2E9-B0EA500737F8	Primary Tumor	Illumina HiSeq	159E9E4B-E8A1-40E5-B506-8551A3D2DE95	Prostate	64.0	B79ED761-77EF-4ABB-9C52-344ECA9BC08E	EA34E227-A427-42A6-9F42-80069E972764	TCGA-EJ-A6RC-01A-11R-A32O-07	HG19	TCGA-EJ-A6RC	TCGA-PRAD		s3527	University of North Carolina	University of Pittsburgh	United States	NO		N0	Prostate Adenocarcinoma Acinar Type		A32O-07	True
13722.58cfa832e4b0c9d6adf6cfcc	58cfa832e4b0c9d6adf6cfcc	TCGA-G9-6343-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_1_rg.sorted.filtered.	WGS	TCGA-G9-6343-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_1_rg.sorted	TCGA-G9-6343-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_1_rg.sorted.bam	38.0	1.8	0.15	58cfa832e4b0c9d6adf6cfcc	TCGA-G9-6343-10A-01D-1957_130405_SN590_0222_BD21LGACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6343-10A	36B87D12-9F96-460F-A3B5-A4C08CBF5B07	Blood Derived Normal	Illumina HiSeq	f331491f-dba0-4053-b733-d52da4ca549c	Prostate	62.0	E1A1845B-E19F-4AB0-A286-3175BE9F50D9	06C3E81B-4F68-4FA4-A2F0-B4ED6E7A87FB	TCGA-G9-6343-10A-01D-1957-02	HG19_Broad_variant	TCGA-G9-6343	TCGA-PRAD		s3975	Harvard Medical School	Roswell Park	United States	NO	T2c		Prostate Adenocarcinoma Acinar Type		1957-02	True
13767.58cfa83be4b0c9d6adf71f73	58cfa83be4b0c9d6adf71f73	UNCID_2539665.07f7b453-5716-466f-affd-74a24c4d5c53.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2539665.07f7b453-5716-466f-affd-74a24c4d5c53.sorted_genome_alignments	UNCID_2539665.07f7b453-5716-466f-affd-74a24c4d5c53.sorted_genome_alignments.bam	10.29	1.78	0.17	58cfa83be4b0c9d6adf71f73	UNCID_2539665.07f7b453-5716-466f-affd-74a24c4d5c53.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-99-AA5R-01A	D3E23815-7F9D-48AA-9AEF-3A1DD9D464D7	Primary Tumor	Illumina HiSeq	84C6E9CD-C153-4AA7-A79B-012E9B3B99CF	Lung	70.0	DDBE2867-B02A-45D6-8514-921EAF6074EA	07F7B453-5716-466F-AFFD-74A24C4D5C53	TCGA-99-AA5R-01A-11R-A39D-07	HG19	TCGA-99-AA5R	TCGA-LUAD		s11421	University of North Carolina	Washington University - Alabama	United States	NO	T1a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	A39D-07	True
13767.58cfa836e4b0c9d6adf6fc2b	58cfa836e4b0c9d6adf6fc2b	UNCID_1662635.B40B5BB9-ABC4-452B-9859-88873097739A.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1662635.B40B5BB9-ABC4-452B-9859-88873097739A.sorted_genome_alignments	UNCID_1662635.B40B5BB9-ABC4-452B-9859-88873097739A.sorted_genome_alignments.bam	7.17	1.85	0.16	58cfa836e4b0c9d6adf6fc2b	UNCID_1662635.B40B5BB9-ABC4-452B-9859-88873097739A.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A3PR-11A	FD036EC5-3FFB-40B1-8002-943BE0E2532E	Solid Tissue Normal	Illumina HiSeq	E0C32ECC-64C6-4F01-9815-75B204DF7A4C	Thyroid	69.0	3C13C880-E3E3-4C49-B486-C4388F8C33F3	B40B5BB9-ABC4-452B-9859-88873097739A	TCGA-BJ-A3PR-11A-11R-A220-07	HG19	TCGA-BJ-A3PR	TCGA-THCA		s12821	University of North Carolina	University of Pittsburgh	United States	NO	T1a	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A220-07	True
13767.58cfa83ce4b0c9d6adf72de8	58cfa83ce4b0c9d6adf72de8	_1_TCGA-BR-4257-01A-01R-1131-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-4257-01A-01R-1131-13_rnaseq	_1_TCGA-BR-4257-01A-01R-1131-13_rnaseq.bam	95.3	1.8	0.15	58cfa83ce4b0c9d6adf72de8	_1_TCGA-BR-4257-01A-01R-1131-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4257-01A	DA112431-5579-4FD1-A230-9144B359B0E9	Primary Tumor	Illumina HiSeq	8B636049-5F5C-4E4E-A9CC-69F95953E2B7	Stomach	79.0	97B44B05-97EB-486C-94DB-42838831DE0B	674E13FE-305F-44CD-9CF0-FD2B01EFFB4F	TCGA-BR-4257-01A-01R-1131-13	GRCh37-lite	TCGA-BR-4257	TCGA-STAD		s14786	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	TX	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)		1131-13	True
13767.58cfa834e4b0c9d6adf6e6f9	58cfa834e4b0c9d6adf6e6f9	UNCID_1210808.c32574a0-5f85-4053-bb98-8472b496975e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1210808.c32574a0-5f85-4053-bb98-8472b496975e.sorted_genome_alignments	UNCID_1210808.c32574a0-5f85-4053-bb98-8472b496975e.sorted_genome_alignments.bam	83.96	1.79	0.17	58cfa834e4b0c9d6adf6e6f9	UNCID_1210808.c32574a0-5f85-4053-bb98-8472b496975e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E5-A2PC-01A	4107AE6F-502C-4BDC-BF14-E4B3711CBA38	Primary Tumor	Illumina HiSeq	DC3B22A5-39EF-4AED-8A1E-070C58BD8543	Bladder	61.0	2195B75E-157F-4547-9705-1E7E75666CA8	C32574A0-5F85-4053-BB98-8472B496975E	TCGA-E5-A2PC-01A-11R-A206-07	HG19	TCGA-E5-A2PC	TCGA-BLCA		s3147	University of North Carolina	Roswell Park	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A206-07	True
13722.58cfa830e4b0c9d6adf6c010	58cfa830e4b0c9d6adf6c010	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted.filtered.	WGS	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted.bam	106.93	1.95	0.16	58cfa830e4b0c9d6adf6c010	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K0-01A	29C8F468-5AC1-4D6C-8376-E36E6D246926	Primary Tumor	Illumina HiSeq	e5550bf6-3edf-480e-9dc5-6d590e837e5e	Uterus	48.0	11C43948-E7C9-4436-A654-82FA8033B625	3296C785-7C20-487D-BAEC-C66022E77E53	TCGA-B5-A0K0-01A-11D-A043-02	HG19_Broad_variant	TCGA-B5-A0K0	TCGA-UCEC		s4598	Harvard Medical School	Duke	United States	NO			Endometrioid endometrial adenocarcinoma		A043-02	True
13767.58cfa83ce4b0c9d6adf72e35	58cfa83ce4b0c9d6adf72e35	_1_TCGA-D7-6525-01A-11R-1802-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-D7-6525-01A-11R-1802-13_rnaseq	_1_TCGA-D7-6525-01A-11R-1802-13_rnaseq.bam	166.2	1.8	0.14	58cfa83ce4b0c9d6adf72e35	_1_TCGA-D7-6525-01A-11R-1802-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6525-01A	82F9A197-040D-4C5E-89D9-D87A7AA0168D	Primary Tumor	Illumina HiSeq	F2114EC9-8B6D-4430-9FE4-1D7096CFF9D1	Stomach	58.0	C1AC6717-828B-4289-9755-7C56A6FC1392	A012DD75-F1B5-4DCE-B3D9-068039C9AF31	TCGA-D7-6525-01A-11R-1802-13	GRCh37-lite	TCGA-D7-6525	TCGA-STAD		s15166	Canada's Michael Smith Genome Sciences Centre	Greater Poland Cancer Center	Poland	NO	T2	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage III	1802-13	True
13767.58cfa832e4b0c9d6adf6d0b8	58cfa832e4b0c9d6adf6d0b8	TCGA-HU-A4GH-11A-11R-A36D-31_rnaseq.filtered.	RNA-Seq	TCGA-HU-A4GH-11A-11R-A36D-31_rnaseq	TCGA-HU-A4GH-11A-11R-A36D-31_rnaseq.bam	8.98	1.73	0.17	58cfa832e4b0c9d6adf6d0b8	TCGA-HU-A4GH-11A-11R-A36D-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4GH-11A	D9424178-9CB4-4BFB-9814-BA1AFE7AD954	Solid Tissue Normal	Illumina HiSeq	5182A7B3-94C3-4F1C-9F15-F71F5FCC3E57	Stomach	75.0	03B88C6B-984C-439A-9980-F9D8D05FF54D	D26DCB61-DD83-487D-B67F-665EC2631F18	TCGA-HU-A4GH-11A-11R-A36D-31	GRCh37-lite	TCGA-HU-A4GH	TCGA-STAD		s14429	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T1b	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage I	A36D-31	True
13767.58cfa83be4b0c9d6adf729c8	58cfa83be4b0c9d6adf729c8	UNCID_351549.TCGA-B0-5100-01A-01R-1420-07.110512_UNC9-SN296_0181_BD0C6RABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_351549.TCGA-B0-5100-01A-01R-1420-07.110512_UNC9-SN296_0181_BD0C6RABXX.8.trimmed.annotated.translated_to_genomic	UNCID_351549.TCGA-B0-5100-01A-01R-1420-07.110512_UNC9-SN296_0181_BD0C6RABXX.8.trimmed.annotated.translated_to_genomic.bam	28.63	1.8	0.14	58cfa83be4b0c9d6adf729c8	UNCID_351549.TCGA-B0-5100-01A-01R-1420-07.110512_UNC9-SN296_0181_BD0C6RABXX.8.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5100-01A	9CEEFC7E-FBA9-47EB-A0CA-2BC1FCCB5490	Primary Tumor	Illumina HiSeq	29595C9B-5E22-42E3-9E76-624890AE107C	Kidney	72.0	451A08A8-11FB-40CD-9759-61D36AF70A57	EBEF2E65-AAA0-4F86-ADA2-9BF6815DABA9	TCGA-B0-5100-01A-01R-1420-07	HG19	TCGA-B0-5100	TCGA-KIRC	1913.0	s9858	University of North Carolina	University of Pittsburgh	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1420-07	True
13767.58cfa83ce4b0c9d6adf72cce	58cfa83ce4b0c9d6adf72cce	UNCID_408416.f9b475ac-3fe7-40ac-be42-3d1d2572137d.110503_UNC10-SN254_0215_BBOB7MABXX.3.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_408416.f9b475ac-3fe7-40ac-be42-3d1d2572137d.110503_UNC10-SN254_0215_BBOB7MABXX.3.trimmed.annotated.translated_to_genomic	UNCID_408416.f9b475ac-3fe7-40ac-be42-3d1d2572137d.110503_UNC10-SN254_0215_BBOB7MABXX.3.trimmed.annotated.translated_to_genomic.bam	84.3	1.7	0.14	58cfa83ce4b0c9d6adf72cce	UNCID_408416.f9b475ac-3fe7-40ac-be42-3d1d2572137d.110503_UNC10-SN254_0215_BBOB7MABXX.3.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4325-01A	B81243B3-5130-4268-9883-07E547B8D728	Primary Tumor	Illumina HiSeq	C1D23189-AF68-472B-BC36-39F3CEE9AAF2	Kidney	64.0	7FECE61F-CE10-4AD3-9DCF-62AE73C7E71D	F9B475AC-3FE7-40AC-BE42-3D1D2572137D	TCGA-BP-4325-01A-02R-1289-07	HG19	TCGA-BP-4325	TCGA-KIRC		s8979	University of North Carolina	MSKCC	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1289-07	True
13767.58cfa82ee4b0c9d6adf6b1d2	58cfa82ee4b0c9d6adf6b1d2	TCGA-13-0766-01A-02R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0766-01A-02R-1564-13_rnaseq	TCGA-13-0766-01A-02R-1564-13_rnaseq.bam	223.0	1.8	0.18	58cfa82ee4b0c9d6adf6b1d2	TCGA-13-0766-01A-02R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0766-01A	8FE44099-B313-4BFD-A94A-27E72F2A818C	Primary Tumor	Illumina HiSeq	6B066DD3-E7F8-45AA-8024-A31A7C0D36EF	Ovary	42.0	03E8C3F2-99B6-40DA-862A-E8263475C434	30BE1179-7922-4AF7-B234-270FD88A2965	TCGA-13-0766-01A-02R-1564-13	NCBI36_BCCAGSC_variant	TCGA-13-0766	TCGA-OV		s17737	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa834e4b0c9d6adf6e671	58cfa834e4b0c9d6adf6e671	UNCID_1178736.337214b1-e061-4789-a364-e894a74c4a6e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1178736.337214b1-e061-4789-a364-e894a74c4a6e.sorted_genome_alignments	UNCID_1178736.337214b1-e061-4789-a364-e894a74c4a6e.sorted_genome_alignments.bam	403.3	1.8	0.15	58cfa834e4b0c9d6adf6e671	UNCID_1178736.337214b1-e061-4789-a364-e894a74c4a6e.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B3-4103-01A	1A726069-0B44-42AD-9A20-0EE90B31796B	Primary Tumor	Illumina HiSeq	25D0FCAD-25B3-4906-81FC-AE3E846D6318	Kidney	56.0	3829FA12-FDD5-4829-8F00-BDFBB057F23E	337214B1-E061-4789-A364-E894A74C4A6E	TCGA-B3-4103-01A-02R-1351-07	HG19	TCGA-B3-4103	TCGA-KIRP		s11595	University of North Carolina	Christiana Healthcare	None	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	1351-07	True
13767.58cfa837e4b0c9d6adf6ffaa	58cfa837e4b0c9d6adf6ffaa	UNCID_1808411.0ab02d97-2058-47bc-bc0d-3ec662c0b2d6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1808411.0ab02d97-2058-47bc-bc0d-3ec662c0b2d6.sorted_genome_alignments	UNCID_1808411.0ab02d97-2058-47bc-bc0d-3ec662c0b2d6.sorted_genome_alignments.bam	96.2		0.15	58cfa837e4b0c9d6adf6ffaa	UNCID_1808411.0ab02d97-2058-47bc-bc0d-3ec662c0b2d6.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-7698-01A	9A13A742-FF9A-4432-A7CE-7FCBB753BE01	Primary Tumor	Illumina HiSeq	189599F4-9711-45C8-8700-B56B64CDB577	Lung	48.0	541AE34D-A747-4DD1-820D-5D1E407BCEFE	0AB02D97-2058-47BC-BC0D-3EC662C0B2D6	TCGA-85-7698-01A-11R-2125-07	HG19	TCGA-85-7698	TCGA-LUSC		s10611	University of North Carolina	Asterand	Russia	NO	T1b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2125-07	True
13722.58cfa82ee4b0c9d6adf6af6c	58cfa82ee4b0c9d6adf6af6c	G48125.TCGA-13-0906-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-13-0906-01A-01D-A312-08.2	G48125.TCGA-13-0906-01A-01D-A312-08.2.bam	35.67	1.9	0.08	58cfa82ee4b0c9d6adf6af6c	G48125.TCGA-13-0906-01A-01D-A312-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0906-01A	E43D3769-E25F-4FB7-9080-EA26DEFAF094	Primary Tumor	Illumina HiSeq	aee22c2b-6ab3-4982-b343-b10b89c4b98b	Ovary	50.0	A0C48680-3CAF-49BD-B495-C9FD3A9CBE76	42AF8F74-FD4B-486D-BC11-DB53CC471D62	TCGA-13-0906-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-0906	TCGA-OV		s17760	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		A312-08	True
13767.58cfa835e4b0c9d6adf6f001	58cfa835e4b0c9d6adf6f001	UNCID_1457687.c8c2f184-1d51-4364-99f5-5d78cb89ecf3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1457687.c8c2f184-1d51-4364-99f5-5d78cb89ecf3.sorted_genome_alignments	UNCID_1457687.c8c2f184-1d51-4364-99f5-5d78cb89ecf3.sorted_genome_alignments.bam	13.77	1.72	0.15	58cfa835e4b0c9d6adf6f001	UNCID_1457687.c8c2f184-1d51-4364-99f5-5d78cb89ecf3.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E3-A3DZ-01A	59E47734-96DE-4328-ACA7-E9423DDA9C52	Primary Tumor	Illumina HiSeq	AEF6EA52-23A8-4711-8C74-C43B60671D9C	Thyroid	55.0	CC1213A0-BC99-4505-9B20-42FEA416F6AB	C8C2F184-1D51-4364-99F5-5D78CB89ECF3	TCGA-E3-A3DZ-01A-11R-A20F-07	HG19	TCGA-E3-A3DZ	TCGA-THCA		s12682	University of North Carolina	Roswell Park	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A20F-07	True
13767.58cfa83be4b0c9d6adf7247e	58cfa83be4b0c9d6adf7247e	UNCID_2583863.5f66ae56-8f05-412a-8c47-0e7012849f64.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2583863.5f66ae56-8f05-412a-8c47-0e7012849f64.sorted_genome_alignments	UNCID_2583863.5f66ae56-8f05-412a-8c47-0e7012849f64.sorted_genome_alignments.bam	71.34	1.92	0.17	58cfa83be4b0c9d6adf7247e	UNCID_2583863.5f66ae56-8f05-412a-8c47-0e7012849f64.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-5P-A9K3-01A	4BEC3959-D59D-4E80-855C-F044A5780780	Primary Tumor	Illumina HiSeq	195905D9-725C-40B1-A1FE-46EBB3A5018A	Kidney	59.0	27EDD073-2142-4D91-8D71-EE9425DD62EB	5F66AE56-8F05-412A-8C47-0E7012849F64	TCGA-5P-A9K3-01A-11R-A42S-07	HG19	TCGA-5P-A9K3	TCGA-KIRP	471.0	s11956	University of North Carolina	University Hospital Erlangen	Germany	NO	T2	NX	Kidney Papillary Renal Cell Carcinoma		A42S-07	True
13767.58cfa83be4b0c9d6adf7263e	58cfa83be4b0c9d6adf7263e	UNCID_2659101.89ad7202-565f-4459-a1ca-946dd27d07b7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2659101.89ad7202-565f-4459-a1ca-946dd27d07b7.sorted_genome_alignments	UNCID_2659101.89ad7202-565f-4459-a1ca-946dd27d07b7.sorted_genome_alignments.bam	28.82	1.82	0.16	58cfa83be4b0c9d6adf7263e	UNCID_2659101.89ad7202-565f-4459-a1ca-946dd27d07b7.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-AADB-01A	5EAAF7AE-36AF-4FB4-8940-E0861983CEB0	Primary Tumor	Illumina HiSeq	2770301D-1AAD-4532-AFC3-845135FE5CB0	Liver	51.0	D7116164-D537-4B2D-B699-EC091C094363	89AD7202-565F-4459-A1CA-946DD27D07B7	TCGA-DD-AADB-01A-11R-A41C-07	HG19	TCGA-DD-AADB	TCGA-LIHC		s16967	University of North Carolina	Mayo Clinic - Rochester	Korea South	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A41C-07	True
13722.58cfa831e4b0c9d6adf6cc38	58cfa831e4b0c9d6adf6cc38	TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina	TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina.bam	64.0		0.07	58cfa831e4b0c9d6adf6cc38	TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-EP-A26S-01A	B7D6621C-8BCE-4A01-8588-9D7761D9372B	Primary Tumor	Illumina HiSeq	e3122147-a994-4b8f-aa05-ddb36413802a	Liver	70.0	A0B2FF38-E6BF-4F27-98AB-5CF924B0E236	463BF060-8BA6-4A73-8173-172025F7B527	TCGA-EP-A26S-01A-11D-A16V-10	GRCh37-lite	TCGA-EP-A26S	TCGA-LIHC		s16982	Baylor College of Medicine	Christiana Healthcare	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A16V-10	True
13722.58cfa82ee4b0c9d6adf6acc5	58cfa82ee4b0c9d6adf6acc5	G47088.TCGA-68-8250-10A-01D-2293-08.1.filtered.	WGS	G47088.TCGA-68-8250-10A-01D-2293-08.1	G47088.TCGA-68-8250-10A-01D-2293-08.1.bam	129.6		0.05	58cfa82ee4b0c9d6adf6acc5	G47088.TCGA-68-8250-10A-01D-2293-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-68-8250-10A	7B982D5E-3A7D-40AC-BD25-6044C62879B6	Blood Derived Normal	Illumina HiSeq	aa4394b9-7fe0-4938-872a-fb718479a1af	Lung	66.0	69891F97-F793-439B-8805-6274650A6E66	F267353C-6734-4D87-9A84-264D54FC9BDA	TCGA-68-8250-10A-01D-2293-08	HG19_Broad_variant	TCGA-68-8250	TCGA-LUSC		s10255	Broad Institute of MIT and Harvard	Washington University - Cleveland Clinic	United States	NO	T1a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2293-08	False
13767.58cfa832e4b0c9d6adf6d273	58cfa832e4b0c9d6adf6d273	TCGA-HU-8238-11A-01R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-HU-8238-11A-01R-2343-13_rnaseq	TCGA-HU-8238-11A-01R-2343-13_rnaseq.bam	291.2		0.15	58cfa832e4b0c9d6adf6d273	TCGA-HU-8238-11A-01R-2343-13_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-8238-11A	AC77E22D-42C0-4E06-B904-0DD5B31EB0D8	Solid Tissue Normal	Illumina HiSeq	6B91900A-3696-43C0-99BE-7F740D8DD0D7	Stomach	56.0	108F1056-6373-4B49-A46C-D176E08B1EC2	9D79F806-1B24-4886-B73E-568EA5E41105	TCGA-HU-8238-11A-01R-2343-13	GRCh37-lite	TCGA-HU-8238	TCGA-STAD		s15004	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type		2343-13	True
13767.58cfa838e4b0c9d6adf70473	58cfa838e4b0c9d6adf70473	UNCID_1957860.1d43f7a5-43ac-4861-b4a7-7bfce13ac2c5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1957860.1d43f7a5-43ac-4861-b4a7-7bfce13ac2c5.sorted_genome_alignments	UNCID_1957860.1d43f7a5-43ac-4861-b4a7-7bfce13ac2c5.sorted_genome_alignments.bam	57.8	1.82	0.17	58cfa838e4b0c9d6adf70473	UNCID_1957860.1d43f7a5-43ac-4861-b4a7-7bfce13ac2c5.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-AL-A5DJ-01A	B06CDF61-61C9-4035-A55D-1EF21DC21069	Primary Tumor	Illumina HiSeq	242CFCFA-9E84-4996-82A2-1DA1B5A3D7E0	Kidney	54.0	BD6B7CBE-57B6-45B9-96F6-4D39B8303407	1D43F7A5-43AC-4861-B4A7-7BFCE13AC2C5	TCGA-AL-A5DJ-01A-11R-A26U-07	HG19	TCGA-AL-A5DJ	TCGA-KIRP		s11808	University of North Carolina	Fox Chase	United States	NO	T3a	NX	Kidney Papillary Renal Cell Carcinoma	Stage III	A26U-07	True
13722.58cfa82ee4b0c9d6adf6abde	58cfa82ee4b0c9d6adf6abde	G37566.TCGA-G9-6336-10A-01D-1786-08.1.filtered.	WGS	G37566.TCGA-G9-6336-10A-01D-1786-08.1	G37566.TCGA-G9-6336-10A-01D-1786-08.1.bam	16.7	1.9	0.05	58cfa82ee4b0c9d6adf6abde	G37566.TCGA-G9-6336-10A-01D-1786-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6336-10A	59207BCD-F127-481F-B576-8716DA7D7D97	Blood Derived Normal	Illumina HiSeq	35212dfd-bbf0-44ba-a0c5-8c4e26f5ca99	Prostate	57.0	71864139-EC05-4BB1-9DF7-27954283261E	AEFE7099-96E0-481C-BBFE-1566024DF395	TCGA-G9-6336-10A-01D-1786-08	HG19_Broad_variant	TCGA-G9-6336	TCGA-PRAD		s3585	Broad Institute of MIT and Harvard	Roswell Park	United States	NO		N0	Prostate Adenocarcinoma Acinar Type		1786-08	False
13767.58cfa83be4b0c9d6adf7212a	58cfa83be4b0c9d6adf7212a	UNCID_2563256.19aa7fd7-e119-41a5-a6d4-ea36f9f1aaab.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2563256.19aa7fd7-e119-41a5-a6d4-ea36f9f1aaab.sorted_genome_alignments	UNCID_2563256.19aa7fd7-e119-41a5-a6d4-ea36f9f1aaab.sorted_genome_alignments.bam	62.49	1.83	0.17	58cfa83be4b0c9d6adf7212a	UNCID_2563256.19aa7fd7-e119-41a5-a6d4-ea36f9f1aaab.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Mesothelioma	Aligned reads	TCGA-UD-AAC7-01A	0AC27BC8-346E-4006-A701-D9676FB91CB7	Primary Tumor	Illumina HiSeq	43558D93-CC99-47B5-A473-AEB6B6597BC8	Mesothelium	47.0	092AFC9D-A76A-4513-921E-4745ED1123E6	19AA7FD7-E119-41A5-A6D4-EA36F9F1AAAB	TCGA-UD-AAC7-01A-11R-A40A-07	HG19	TCGA-UD-AAC7	TCGA-MESO	406.0	s440	University of North Carolina		Australia	NO	T2	N0		Stage II	A40A-07	True
13722.58cfa831e4b0c9d6adf6cb59	58cfa831e4b0c9d6adf6cb59	TCGA-EE-A2MG-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EE-A2MG-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_2_rg.sorted	TCGA-EE-A2MG-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_2_rg.sorted.bam	51.09		0.15	58cfa831e4b0c9d6adf6cb59	TCGA-EE-A2MG-06A-11D-A18Y_120724_SN1222_0139_BD13UNACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2MG-06A	E653F888-37CF-41D5-A1CF-45397C90B31D	Metastatic	Illumina HiSeq	e2184793-28bf-4bf1-b685-2958c8c0b8a3	Skin	23.0	F68D55B0-001D-460D-9EB8-81B2AA26A909	8EAACD8C-A326-45BF-97C3-E1F300E1A1AA	TCGA-EE-A2MG-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-EE-A2MG	TCGA-SKCM	3139.0	s7348	Harvard Medical School	University of Sydney	Australia	NO	T2	N0		Stage I	A18Y-02	True
13767.58cfa82fe4b0c9d6adf6b802	58cfa82fe4b0c9d6adf6b802	TCGA-36-1578-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-36-1578-01A-01R-1566-13_rnaseq	TCGA-36-1578-01A-01R-1566-13_rnaseq.bam	1011.0	1.8	0.14	58cfa82fe4b0c9d6adf6b802	TCGA-36-1578-01A-01R-1566-13_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-36-1578-01A	F65F2E78-C001-4EF3-AE88-3E4F83C7ACEB	Primary Tumor	Illumina HiSeq	F618402F-9FE8-4F1C-B100-2E299B68C2BB	Ovary	63.0	25D8F564-9BA7-4336-9B92-038FC26DCBD1	7ECB58FE-E2FE-4DC8-996B-2B959DA43566	TCGA-36-1578-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-36-1578	TCGA-OV		s18074	Canada's Michael Smith Genome Sciences Centre	BC Cancer Agency	None	NO			Serous Cystadenocarcinoma		1566-13	True
13722.58cfa82ee4b0c9d6adf6aefa	58cfa82ee4b0c9d6adf6aefa	G49537.TCGA-DJ-A13R-10A-01D-A10S-08.1.filtered.	WGS	G49537.TCGA-DJ-A13R-10A-01D-A10S-08.1	G49537.TCGA-DJ-A13R-10A-01D-A10S-08.1.bam	60.3	1.88	0.08	58cfa82ee4b0c9d6adf6aefa	G49537.TCGA-DJ-A13R-10A-01D-A10S-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13R-10A	3E787A0E-B5D2-401E-B1E5-077376090B3A	Blood Derived Normal	Illumina HiSeq	b4d95ae2-708c-48db-80c9-15abba0835c3	Thyroid	50.0	4CD78789-F3CE-423A-A09E-0514C295A475	97808F8D-720C-41C2-BA0D-59922E48A182	TCGA-DJ-A13R-10A-01D-A10S-08	HG19_Broad_variant	TCGA-DJ-A13R	TCGA-THCA		s12227	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A10S-08	True
13767.58cfa83be4b0c9d6adf7210a	58cfa83be4b0c9d6adf7210a	UNCID_2559826.0ea136b8-d90d-4614-b77b-301e77f84598.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2559826.0ea136b8-d90d-4614-b77b-301e77f84598.sorted_genome_alignments	UNCID_2559826.0ea136b8-d90d-4614-b77b-301e77f84598.sorted_genome_alignments.bam	49.97	1.87	0.17	58cfa83be4b0c9d6adf7210a	UNCID_2559826.0ea136b8-d90d-4614-b77b-301e77f84598.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Mesothelioma	Aligned reads	TCGA-3U-A98J-01A	A61EA4C7-2506-4D56-AEB5-EDF83199D421	Primary Tumor	Illumina HiSeq	E0ED141E-6712-4A11-A1B3-07E7342220F9	Mesothelium	55.0	6078710B-E9D6-4C33-8DAC-94B4AFD86086	0EA136B8-D90D-4614-B77B-301E77F84598	TCGA-3U-A98J-01A-11R-A40A-07	HG19	TCGA-3U-A98J	TCGA-MESO		s412	University of North Carolina	University of Chicago	United States	NO	T3	N2		Stage III	A40A-07	True
13767.58cfa836e4b0c9d6adf6fb9c	58cfa836e4b0c9d6adf6fb9c	UNCID_1664310.3349e197-7ef8-4cfd-b365-1dbf5c7db58d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1664310.3349e197-7ef8-4cfd-b365-1dbf5c7db58d.sorted_genome_alignments	UNCID_1664310.3349e197-7ef8-4cfd-b365-1dbf5c7db58d.sorted_genome_alignments.bam	6.8	1.48	0.18	58cfa836e4b0c9d6adf6fb9c	UNCID_1664310.3349e197-7ef8-4cfd-b365-1dbf5c7db58d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3EO-11A	B7F2958F-256E-4C30-9C61-11E76DDB36BA	Solid Tissue Normal	Illumina HiSeq	162A3A89-9E63-42A0-8B59-E532C698650E	Cervix	55.0	B4C02B0C-1ABE-4C3F-BE7C-5DE397EFAC95	3349E197-7EF8-4CFD-B365-1DBF5C7DB58D	TCGA-FU-A3EO-11A-13R-A213-07	HG19	TCGA-FU-A3EO	TCGA-CESC		s1412	University of North Carolina	International Genomics Consortium	United States	NO	T2b	N0	Endocervical Type of Adenocarcinoma		A213-07	True
13722.58cfa832e4b0c9d6adf6d32c	58cfa832e4b0c9d6adf6d32c	TCGA-KN-8429-11A-01D-2311-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8429-11A-01D-2311-10_wgs_Illumina	TCGA-KN-8429-11A-01D-2311-10_wgs_Illumina.bam	298.3		0.05	58cfa832e4b0c9d6adf6d32c	TCGA-KN-8429-11A-01D-2311-10_wgs_Illumina.bam	Alive	FEMALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KN-8429-11A	366219B9-FDE3-4D2D-82D3-15FE6245AA98	Solid Tissue Normal	Illumina HiSeq	8009019c-2ba8-483b-9a77-38c124a731d5	Kidney	38.0	F69DE2AF-C874-4667-B028-D1ED4FF5A11B	8A9AADE0-01C0-49A8-9A47-1498341EDFF7	TCGA-KN-8429-11A-01D-2311-10	GRCh37-lite	TCGA-KN-8429	TCGA-KICH		s16443	Baylor College of Medicine	Harvard	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2311-10	True
13767.58cfa837e4b0c9d6adf6ffc8	58cfa837e4b0c9d6adf6ffc8	UNCID_1805627.5d5982c0-530f-4b2b-b1fb-d70c8168c793.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1805627.5d5982c0-530f-4b2b-b1fb-d70c8168c793.sorted_genome_alignments	UNCID_1805627.5d5982c0-530f-4b2b-b1fb-d70c8168c793.sorted_genome_alignments.bam	58.41	1.84	0.16	58cfa837e4b0c9d6adf6ffc8	UNCID_1805627.5d5982c0-530f-4b2b-b1fb-d70c8168c793.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A3YJ-01A	86CF879E-3B40-44DD-AAA7-6F49F54A15D9	Primary Tumor	Illumina HiSeq	CB9C5588-0F21-4609-B22B-B4B02BD89555	Breast	66.0	3447BDBF-5177-451E-BB93-736153EA76A9	5D5982C0-530F-4B2B-B1FB-D70C8168C793	TCGA-AC-A3YJ-01A-11R-A22U-07	HG19	TCGA-AC-A3YJ	TCGA-BRCA		s6413	University of North Carolina	International Genomics Consortium	United States	NO	T2	N0 (i-)	Other  specify	Stage II	A22U-07	True
13722.58cfa832e4b0c9d6adf6d4a6	58cfa832e4b0c9d6adf6d4a6	TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted.filtered.	WGS	TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted	TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted.bam	43.67		0.16	58cfa832e4b0c9d6adf6d4a6	TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EW-01A	6BE5176C-4980-4663-ADFF-D04F05737DA0	Primary Tumor	Illumina HiSeq	3dd4d560-67ce-426b-9eeb-63fec58eaf05	Eye	44.0	685D5387-B35F-40EE-8F14-491CE212F0DE	6B52C651-649F-41C5-B0DD-197F77F2AA10	TCGA-V4-A9EW-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EW	TCGA-UVM		s216	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0		Stage III	A40D-26	True
13767.58cfa834e4b0c9d6adf6e493	58cfa834e4b0c9d6adf6e493	UNCID_1204998.cdc81d17-1d85-42e5-a3ec-f458e6ab83f6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1204998.cdc81d17-1d85-42e5-a3ec-f458e6ab83f6.sorted_genome_alignments	UNCID_1204998.cdc81d17-1d85-42e5-a3ec-f458e6ab83f6.sorted_genome_alignments.bam	58.2	1.7	0.15	58cfa834e4b0c9d6adf6e493	UNCID_1204998.cdc81d17-1d85-42e5-a3ec-f458e6ab83f6.sorted_genome_alignments.bam	Alive	MALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-55-6980-11A	2F0710F4-827B-45B2-9B7E-C27385B481A7	Solid Tissue Normal	Illumina HiSeq	430CE1DF-9BA8-4672-A2C0-7140600B7C2F	Lung	56.0	2315F189-CCE1-4EE2-8943-9BBA2099A391	CDC81D17-1D85-42E5-A3EC-F458E6AB83F6	TCGA-55-6980-11A-01R-1949-07	HG19	TCGA-55-6980	TCGA-LUAD		s11279	University of North Carolina	International Genomics Consortium	United States	NO	T1	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage I	1949-07	True
13767.58cfa83be4b0c9d6adf71f6b	58cfa83be4b0c9d6adf71f6b	UNCID_2543772.cf410999-4cac-4f7b-9062-bfd807c50355.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2543772.cf410999-4cac-4f7b-9062-bfd807c50355.sorted_genome_alignments	UNCID_2543772.cf410999-4cac-4f7b-9062-bfd807c50355.sorted_genome_alignments.bam	76.39	1.77	0.16	58cfa83be4b0c9d6adf71f6b	UNCID_2543772.cf410999-4cac-4f7b-9062-bfd807c50355.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cholangiocarcinoma	Aligned reads	TCGA-W5-AA38-01A	48D17B17-348C-405A-AE92-F190372A3AAC	Primary Tumor	Illumina HiSeq	B1CEAEB0-83A7-4675-A42E-DE51A601B3AA	Bile Duct	55.0	3142E952-B78A-4E63-8537-DE8771D78006	CF410999-4CAC-4F7B-9062-BFD807C50355	TCGA-W5-AA38-01A-11R-A41I-07	HG19	TCGA-W5-AA38	TCGA-CHOL		s16	University of North Carolina	Mayo Clinic Rochester	United States	NO	T1	N0		Stage I	A41I-07	True
13767.58cfa83be4b0c9d6adf71f98	58cfa83be4b0c9d6adf71f98	UNCID_2539573.6a611e83-7aae-4d07-9a09-dbb1b3e2aadf.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2539573.6a611e83-7aae-4d07-9a09-dbb1b3e2aadf.sorted_genome_alignments	UNCID_2539573.6a611e83-7aae-4d07-9a09-dbb1b3e2aadf.sorted_genome_alignments.bam	23.78	1.83	0.15	58cfa83be4b0c9d6adf71f98	UNCID_2539573.6a611e83-7aae-4d07-9a09-dbb1b3e2aadf.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-AF-A56K-01A	BD818AE4-B31A-4616-9303-B8AEE56A848F	Primary Tumor	Illumina HiSeq	70610920-A14C-4DAE-B243-C6D59BD935C9	Colorectal	56.0	BD1B094F-A681-42DE-8A95-63F7E41B087F	6A611E83-7AAE-4D07-9A09-DBB1B3E2AADF	TCGA-AF-A56K-01A-32R-A39D-07	HG19	TCGA-AF-A56K	TCGA-READ		s2269	University of North Carolina	Christiana Healthcare	United States	NO	T3	N0	Rectal Adenocarcinoma	Stage II	A39D-07	True
13767.58cfa837e4b0c9d6adf703e8	58cfa837e4b0c9d6adf703e8	UNCID_1905906.e55a12d6-3ec4-4346-8849-cf7525fff740.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1905906.e55a12d6-3ec4-4346-8849-cf7525fff740.sorted_genome_alignments	UNCID_1905906.e55a12d6-3ec4-4346-8849-cf7525fff740.sorted_genome_alignments.bam	53.92	1.79	0.16	58cfa837e4b0c9d6adf703e8	UNCID_1905906.e55a12d6-3ec4-4346-8849-cf7525fff740.sorted_genome_alignments.bam	Alive	FEMALE			Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EB-11A	68015CC7-D3A1-4C90-B8FB-5D14143D9960	Solid Tissue Normal	Illumina HiSeq	3D372C76-CD71-4E34-8DC7-16DF6705F13C	Liver	72.0	759A494F-C699-4DD6-9553-45265C667DAE	E55A12D6-3EC4-4346-8849-CF7525FFF740	TCGA-DD-A1EB-11A-11R-A131-07	HG19	TCGA-DD-A1EB	TCGA-LIHC		s16619	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A131-07	True
13722.58cfa83ce4b0c9d6adf72eaf	58cfa83ce4b0c9d6adf72eaf	d546c291eab34ae1238698a788e2005c.filtered.	WGS	d546c291eab34ae1238698a788e2005c	d546c291eab34ae1238698a788e2005c.bam	17.4	2.0	0.07	58cfa83ce4b0c9d6adf72eaf	d546c291eab34ae1238698a788e2005c.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BK-A139-10A	8D9E4917-334B-4C76-AEE1-1E22BE772DB0	Blood Derived Normal	Illumina HiSeq	cca964ae-aded-4085-a219-920becf9df6c	Uterus	74.0	DC183CCA-CF96-4DF3-87DB-BFCFF58DC273	2AE69CBA-BE7F-46C3-B610-E27A48DAEF9D	TCGA-BK-A139-10A-01D-A122-09	GRCh37-lite	TCGA-BK-A139	TCGA-UCEC		s4973	Washington University School of Medicine	Christiana Healthcare	None	NO			Endometrioid endometrial adenocarcinoma		A122-09	True
13767.58cfa82fe4b0c9d6adf6b65a	58cfa82fe4b0c9d6adf6b65a	TCGA-61-2109-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-61-2109-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-61-2109-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	853.0	1.8	0.15	58cfa82fe4b0c9d6adf6b65a	TCGA-61-2109-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2109-01A	DC5A6CE7-01E5-408D-812E-E3E0DDC1CDE5	Primary Tumor	Illumina HiSeq	E9A1F1A1-3367-4068-82BD-7108320C0A38	Ovary	40.0	98198891-A060-4107-B56D-61F19AC5FAB5	C87DDFC3-D7A4-4704-B3CC-A19EDFB63452	TCGA-61-2109-01A-01R-1568-13	GRCh37-lite	TCGA-61-2109	TCGA-OV	629.0	s17705	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa83be4b0c9d6adf72379	58cfa83be4b0c9d6adf72379	UNCID_2574213.78874a6d-d476-488d-bdd4-3569276b243a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2574213.78874a6d-d476-488d-bdd4-3569276b243a.sorted_genome_alignments	UNCID_2574213.78874a6d-d476-488d-bdd4-3569276b243a.sorted_genome_alignments.bam	44.44	1.86	0.17	58cfa83be4b0c9d6adf72379	UNCID_2574213.78874a6d-d476-488d-bdd4-3569276b243a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thymoma	Aligned reads	TCGA-4V-A9QJ-01A	50612721-2E12-4DC3-8E1E-87624CF9333B	Primary Tumor	Illumina HiSeq	06256D21-DE63-44F1-BB36-A8C545C64027	Thymus	64.0	CA4818AB-7870-4D53-B7D3-C62293D1D765	78874A6D-D476-488D-BDD4-3569276B243A	TCGA-4V-A9QJ-01A-11R-A42C-07	HG19	TCGA-4V-A9QJ	TCGA-THYM		s478	University of North Carolina	Hospital Louis Pradel	France	NO					A42C-07	True
13767.58cfa83ae4b0c9d6adf71958	58cfa83ae4b0c9d6adf71958	UNCID_2414933.94f22e5d-e471-4add-9291-27bc5c96a519.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2414933.94f22e5d-e471-4add-9291-27bc5c96a519.sorted_genome_alignments	UNCID_2414933.94f22e5d-e471-4add-9291-27bc5c96a519.sorted_genome_alignments.bam	71.87	1.84	0.18	58cfa83ae4b0c9d6adf71958	UNCID_2414933.94f22e5d-e471-4add-9291-27bc5c96a519.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A8XK-01A	8AC819B3-4227-4EAE-BE03-8760B197DF9A	Primary Tumor	Illumina HiSeq	68B5C00B-77B3-42DD-8470-D237CB82EA42	Cervix	30.0	EDBCF0C7-E8C8-40E9-8170-BF91DE078F5F	94F22E5D-E471-4ADD-9291-27BC5C96A519	TCGA-C5-A8XK-01A-11R-A37O-07	HG19	TCGA-C5-A8XK	TCGA-CESC		s1467	University of North Carolina	Medical College of Wisconsin	United States	NO			Cervical Squamous Cell Carcinoma		A37O-07	True
13722.58cfa831e4b0c9d6adf6c686	58cfa831e4b0c9d6adf6c686	TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted	TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted.bam	702.7	1.9	0.16	58cfa831e4b0c9d6adf6c686	TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4737-10A	1F744ADA-6DE1-446D-B62C-76A7FC8B40AF	Blood Derived Normal	Illumina HiSeq	fdf0a7f2-3007-49fa-b8f8-88f75e9f9396	Head and Neck	19.0	E0D710B0-E301-4441-BF1C-44AE39CB3239	76742CF6-8394-4B19-A4A8-59C305F21DC4	TCGA-CN-4737-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4737	TCGA-HNSC		s16031	Harvard Medical School	University of Pittsburgh	None	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IV	1431-02	True
13767.58cfa83ce4b0c9d6adf730dc	58cfa83ce4b0c9d6adf730dc	_1_TCGA-BR-6705-01A-12R-1884-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-6705-01A-12R-1884-13_rnaseq	_1_TCGA-BR-6705-01A-12R-1884-13_rnaseq.bam	37.2	1.8	0.15	58cfa83ce4b0c9d6adf730dc	_1_TCGA-BR-6705-01A-12R-1884-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6705-01A	B14F2FCB-E869-475E-BC7C-ADAF6E7E636F	Primary Tumor	Illumina HiSeq	70A42578-6BAE-446D-AB1C-69AEA9FBB88A	Stomach	68.0	DB8D0AC1-23B7-49AB-8BB3-44782156F038	9BD078F0-600E-42D0-8D29-FAF44E7BCEEB	TCGA-BR-6705-01A-12R-1884-13	GRCh37-lite	TCGA-BR-6705	TCGA-STAD		s15469	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1884-13	True
13767.58cfa835e4b0c9d6adf6ed42	58cfa835e4b0c9d6adf6ed42	UNCID_1343316.56b4ee76-fe71-41fd-bb02-01cb4fcf5e38.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1343316.56b4ee76-fe71-41fd-bb02-01cb4fcf5e38.sorted_genome_alignments	UNCID_1343316.56b4ee76-fe71-41fd-bb02-01cb4fcf5e38.sorted_genome_alignments.bam	48.2		0.14	58cfa835e4b0c9d6adf6ed42	UNCID_1343316.56b4ee76-fe71-41fd-bb02-01cb4fcf5e38.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-7657-01A	DBECE124-C042-4ADC-8136-90E7940EE6AD	Primary Tumor	Illumina HiSeq	4DE2C74A-0C5F-4A6A-9C67-337617341F4E	Lung	68.0	F714CD57-39E0-46BF-A35A-988C574F75A1	56B4EE76-FE71-41FD-BB02-01CB4FCF5E38	TCGA-43-7657-01A-31R-2125-07	HG19	TCGA-43-7657	TCGA-LUSC		s10028	University of North Carolina	Christiana Healthcare	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	2125-07	True
13767.58cfa83ae4b0c9d6adf71785	58cfa83ae4b0c9d6adf71785	UNCID_2414607.971dec7f-6cb5-4575-85f7-be59097ae606.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2414607.971dec7f-6cb5-4575-85f7-be59097ae606.sorted_genome_alignments	UNCID_2414607.971dec7f-6cb5-4575-85f7-be59097ae606.sorted_genome_alignments.bam	49.43	1.8	0.16	58cfa83ae4b0c9d6adf71785	UNCID_2414607.971dec7f-6cb5-4575-85f7-be59097ae606.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A8XJ-01A	E89D0CB1-6EC2-43EE-A6D9-B922B680AF34	Primary Tumor	Illumina HiSeq	73DF7196-AB41-454D-AEC8-94A3A8D50702	Cervix	74.0	17E11D4A-17C9-4F67-B1C6-BB715BD79859	971DEC7F-6CB5-4575-85F7-BE59097AE606	TCGA-C5-A8XJ-01A-11R-A37O-07	HG19	TCGA-C5-A8XJ	TCGA-CESC		s1461	University of North Carolina	Medical College of Wisconsin	United States	NO			Cervical Squamous Cell Carcinoma		A37O-07	True
13722.58cfa830e4b0c9d6adf6c29c	58cfa830e4b0c9d6adf6c29c	TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted	TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.bam	66.31	1.98	0.16	58cfa830e4b0c9d6adf6c29c	TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.bam	Dead	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0T9-01A	4EB95566-0E73-4260-853E-F7DF650667A0	Primary Tumor	Illumina HiSeq	2c61f255-688e-4a53-83fd-bea3b66d5a15	Uterus	39.0	3C9FF865-013F-427A-8D4D-C8E60EA346A1	CB5B905D-7287-41B3-9B49-B2F7FF7D2173	TCGA-BS-A0T9-01A-11D-A12F-02	HG19_Broad_variant	TCGA-BS-A0T9	TCGA-UCEC	1428.0	s4260	Harvard Medical School	University of Hawaii	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13767.58cfa838e4b0c9d6adf706f0	58cfa838e4b0c9d6adf706f0	UNCID_1982626.12751dec-ada5-46b2-a86e-090c82a830cb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1982626.12751dec-ada5-46b2-a86e-090c82a830cb.sorted_genome_alignments	UNCID_1982626.12751dec-ada5-46b2-a86e-090c82a830cb.sorted_genome_alignments.bam	6.69	1.86	0.16	58cfa838e4b0c9d6adf706f0	UNCID_1982626.12751dec-ada5-46b2-a86e-090c82a830cb.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A5GL-06A	9E5B6BEE-0E10-4559-8D0E-2DC9677CC90C	Metastatic	Illumina HiSeq	430F6B39-760F-4080-8645-62E308014B15	Skin	74.0	5B5DE7E3-FE5C-4E59-A501-90E7B989F312	12751DEC-ADA5-46B2-A86E-090C82A830CB	TCGA-D3-A5GL-06A-11R-A27Q-07	HG19	TCGA-D3-A5GL	TCGA-SKCM		s8075	University of North Carolina	MD Anderson	United States	NO	T2a	N0		Stage I	A27Q-07	True
13767.58cfa832e4b0c9d6adf6d0eb	58cfa832e4b0c9d6adf6d0eb	TCGA-HU-A4GC-11A-11R-A251-31_rnaseq.filtered.	RNA-Seq	TCGA-HU-A4GC-11A-11R-A251-31_rnaseq	TCGA-HU-A4GC-11A-11R-A251-31_rnaseq.bam	8.69	1.77	0.16	58cfa832e4b0c9d6adf6d0eb	TCGA-HU-A4GC-11A-11R-A251-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4GC-11A	13E5A0AD-6D0C-4FB4-BF62-325F5C8ED329	Solid Tissue Normal	Illumina HiSeq	36658CD8-9BFB-4470-A914-629DC4ACAA9A	Stomach	74.0	EB4F750C-18B5-425A-B871-733303241EC8	282D05C1-C029-4206-B765-994FA1C6825F	TCGA-HU-A4GC-11A-11R-A251-31	GRCh37-lite	TCGA-HU-A4GC	TCGA-STAD		s14846	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage III	A251-31	True
13767.58cfa834e4b0c9d6adf6e78a	58cfa834e4b0c9d6adf6e78a	UNCID_1215850.90a1abbc-6287-48f9-a669-10033380c9db.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1215850.90a1abbc-6287-48f9-a669-10033380c9db.sorted_genome_alignments	UNCID_1215850.90a1abbc-6287-48f9-a669-10033380c9db.sorted_genome_alignments.bam	24.7	1.8	0.14	58cfa834e4b0c9d6adf6e78a	UNCID_1215850.90a1abbc-6287-48f9-a669-10033380c9db.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4627-11A	D717FA33-3C91-4CED-89C6-79FF5542F04C	Solid Tissue Normal	Illumina HiSeq	523D85C3-CE4A-42F0-A199-FD09A034EF27	Lung	64.0	43C2448E-0F93-4437-85CB-5F61397B0F4C	90A1ABBC-6287-48F9-A669-10033380C9DB	TCGA-38-4627-11A-01R-1758-07	HG19	TCGA-38-4627	TCGA-LUAD	1147.0	s11384	University of North Carolina	UNC	United States	NO	T1b	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1758-07	True
13767.58cfa833e4b0c9d6adf6d919	58cfa833e4b0c9d6adf6d919	UNCID_1095078.bf920e10-514e-4623-b92e-c83a3e32485f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1095078.bf920e10-514e-4623-b92e-c83a3e32485f.sorted_genome_alignments	UNCID_1095078.bf920e10-514e-4623-b92e-c83a3e32485f.sorted_genome_alignments.bam	60.2	1.7	0.16	58cfa833e4b0c9d6adf6d919	UNCID_1095078.bf920e10-514e-4623-b92e-c83a3e32485f.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-6984-01A	F063DDBB-1668-40DF-9EC2-B0A23CA2C389	Primary Tumor	Illumina HiSeq	D09869A7-3E5E-45E4-9EEB-0DFC8CD33CC2	Lung	71.0	76C0ADAE-EEF5-459E-A4C9-397D94EBFDCC	BF920E10-514E-4623-B92E-C83A3E32485F	TCGA-55-6984-01A-11R-1949-07	HG19	TCGA-55-6984	TCGA-LUAD	760.0	s10808	University of North Carolina	International Genomics Consortium	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1949-07	True
13767.58cfa837e4b0c9d6adf702e2	58cfa837e4b0c9d6adf702e2	UNCID_1949998.682139cf-a3bd-4caf-bddc-5b1f3250f8f0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1949998.682139cf-a3bd-4caf-bddc-5b1f3250f8f0.sorted_genome_alignments	UNCID_1949998.682139cf-a3bd-4caf-bddc-5b1f3250f8f0.sorted_genome_alignments.bam	32.09	1.88	0.17	58cfa837e4b0c9d6adf702e2	UNCID_1949998.682139cf-a3bd-4caf-bddc-5b1f3250f8f0.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-DM-A1HB-01A	8C0894FB-5E78-40AE-BE0B-329CA30F758A	Primary Tumor	Illumina HiSeq	629CBF97-0BE6-43C9-AA6D-AC8B1606268F	Colorectal	75.0	40B2B04E-371D-42EF-905E-5B9006384A65	682139CF-A3BD-4CAF-BDDC-5B1F3250F8F0	TCGA-DM-A1HB-01A-21R-A180-07	HG19	TCGA-DM-A1HB	TCGA-COAD		s13116	University of North Carolina	University of Michigan	None	NO	T3	N1		Stage III	A180-07	True
13767.58cfa832e4b0c9d6adf6d740	58cfa832e4b0c9d6adf6d740	UNCID_1068022.017e0cba-13b0-457a-80bb-8d6090506cc9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1068022.017e0cba-13b0-457a-80bb-8d6090506cc9.sorted_genome_alignments	UNCID_1068022.017e0cba-13b0-457a-80bb-8d6090506cc9.sorted_genome_alignments.bam	221.0	1.8	0.15	58cfa832e4b0c9d6adf6d740	UNCID_1068022.017e0cba-13b0-457a-80bb-8d6090506cc9.sorted_genome_alignments.bam	Dead	MALE	WHITE		Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-4604-01A	0C80AB20-7E33-4F1D-B136-07782B68E98B	Primary Tumor	Illumina HiSeq	C04D1659-FD69-40E3-9966-CA28CD6A440A	Lung	73.0	CEB7629B-71AE-458A-B6A2-5E34CAFCC41A	017E0CBA-13B0-457A-80BB-8D6090506CC9	TCGA-22-4604-01A-01R-1201-07	HG19	TCGA-22-4604	TCGA-LUSC	399.0	s10402	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T2a	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	1201-07	True
13767.58cfa83ae4b0c9d6adf71a1c	58cfa83ae4b0c9d6adf71a1c	UNCID_2439788.f99240d0-32ea-438a-b350-862202b18a30.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2439788.f99240d0-32ea-438a-b350-862202b18a30.sorted_genome_alignments	UNCID_2439788.f99240d0-32ea-438a-b350-862202b18a30.sorted_genome_alignments.bam	52.47	1.9	0.17	58cfa83ae4b0c9d6adf71a1c	UNCID_2439788.f99240d0-32ea-438a-b350-862202b18a30.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-VS-A94W-01A	2F6A0E87-1E6C-41F3-93E0-3E505FA654B0	Primary Tumor	Illumina HiSeq	79FDFA1E-8AA2-4507-9D55-DEB531DEEDF3	Cervix	39.0	2FBFB3CC-7CD7-41CE-81F4-4A4645840629	F99240D0-32EA-438A-B350-862202B18A30	TCGA-VS-A94W-01A-12R-A37O-07	HG19	TCGA-VS-A94W	TCGA-CESC		s1473	University of North Carolina	Barretos Cancer Hospital	Brazil	NO	T2b	N1	Cervical Squamous Cell Carcinoma		A37O-07	True
13767.58cfa83ae4b0c9d6adf71815	58cfa83ae4b0c9d6adf71815	UNCID_2400738.c44e9cfc-d595-4098-b55b-8275d7284f05.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2400738.c44e9cfc-d595-4098-b55b-8275d7284f05.sorted_genome_alignments	UNCID_2400738.c44e9cfc-d595-4098-b55b-8275d7284f05.sorted_genome_alignments.bam	15.12	1.88	0.17	58cfa83ae4b0c9d6adf71815	UNCID_2400738.c44e9cfc-d595-4098-b55b-8275d7284f05.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-RY-A83X-01A	739CC9F1-71BE-4F81-A5D1-EDA673903E45	Primary Tumor	Illumina HiSeq	14E33E97-C34E-49A8-B83D-7BBCF83A999F	Brain	46.0	5C88E117-AC37-49A9-A3D9-A1059B6A3671	C44E9CFC-D595-4098-B55B-8275D7284F05	TCGA-RY-A83X-01A-11R-A36H-07	HG19	TCGA-RY-A83X	TCGA-LGG		s8728	University of North Carolina	University of California San Francisco	United States	NO			Oligodendroglioma		A36H-07	True
13767.58cfa838e4b0c9d6adf70ce6	58cfa838e4b0c9d6adf70ce6	UNCID_2173441.74108a37-6306-4389-93c2-b2d306ad6709.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2173441.74108a37-6306-4389-93c2-b2d306ad6709.sorted_genome_alignments	UNCID_2173441.74108a37-6306-4389-93c2-b2d306ad6709.sorted_genome_alignments.bam	383.7		0.13	58cfa838e4b0c9d6adf70ce6	UNCID_2173441.74108a37-6306-4389-93c2-b2d306ad6709.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FA-8693-01A	A43E5F0E-A21F-48D8-97E0-084D413680B7	Primary Tumor	Illumina HiSeq	2E302729-E60D-47A2-B590-163ADFDCFB98	Lymph Nodes	75.0	08124449-BFBD-4C9B-9F44-6169F79F9D7D	74108A37-6306-4389-93C2-B2D306AD6709	TCGA-FA-8693-01A-11R-2404-07	HG19	TCGA-FA-8693	TCGA-DLBC		s1120	University of North Carolina	Asterand	Ukraine	NO			Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)		2404-07	True
13767.58cfa837e4b0c9d6adf702d0	58cfa837e4b0c9d6adf702d0	UNCID_1942664.9bb5155e-25b8-41b7-a424-8aeb81853366.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1942664.9bb5155e-25b8-41b7-a424-8aeb81853366.sorted_genome_alignments	UNCID_1942664.9bb5155e-25b8-41b7-a424-8aeb81853366.sorted_genome_alignments.bam	164.2		0.16	58cfa837e4b0c9d6adf702d0	UNCID_1942664.9bb5155e-25b8-41b7-a424-8aeb81853366.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-58-8391-01A	9ED5C6FE-24D2-4EE6-88BA-7319C9CFA05E	Primary Tumor	Illumina HiSeq	AF2B8B84-B54C-4938-B0DA-3C648CA97348	Lung	57.0	32A90A21-F9E2-4BCA-B540-E4F517E26AC3	9BB5155E-25B8-41B7-A424-8AEB81853366	TCGA-58-8391-01A-11R-2326-07	HG19	TCGA-58-8391	TCGA-LUSC		s10330	University of North Carolina	Thoraxklinik at University Hospital Heidelberg	Germany	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	2326-07	True
13722.58cfa832e4b0c9d6adf6d598	58cfa832e4b0c9d6adf6d598	TCGA-V3-A9ZY-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_3_rg.sorted.filtered.	WGS	TCGA-V3-A9ZY-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_3_rg.sorted	TCGA-V3-A9ZY-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_3_rg.sorted.bam	20.32		0.14	58cfa832e4b0c9d6adf6d598	TCGA-V3-A9ZY-10A-01D-A40E_140715_SN590_0250_BC3M6CACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V3-A9ZY-10A	2112A42A-9B85-475A-A31B-4CE7751CDEB9	Blood Derived Normal	Illumina HiSeq	655ee601-e167-428b-aff1-3d283d935e6f	Eye	54.0	85AB834C-34B5-4777-8EA7-6819A13B40BC	8416FCBC-F166-42C4-A25A-DEA20F77E6E7	TCGA-V3-A9ZY-10A-01D-A40E-26	HG19_Broad_variant	TCGA-V3-A9ZY	TCGA-UVM		s186	MD Anderson - Institute for Applied Cancer Science	Cleveland Clinic Foundation	United States	NO	T3a	NX		Stage II	A40E-26	True
13767.58cfa83ce4b0c9d6adf72ca8	58cfa83ce4b0c9d6adf72ca8	UNCID_547970.9deea671-7443-45bd-a45f-97fde279c948.110926_UNC10-SN254_0279_AD0E60ABXX.1.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_547970.9deea671-7443-45bd-a45f-97fde279c948.110926_UNC10-SN254_0279_AD0E60ABXX.1.trimmed.annotated.translated_to_genomic	UNCID_547970.9deea671-7443-45bd-a45f-97fde279c948.110926_UNC10-SN254_0279_AD0E60ABXX.1.trimmed.annotated.translated_to_genomic.bam	93.8	1.6	0.14	58cfa83ce4b0c9d6adf72ca8	UNCID_547970.9deea671-7443-45bd-a45f-97fde279c948.110926_UNC10-SN254_0279_AD0E60ABXX.1.trimmed.annotated.translated_to_genomic.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5693-01A	DB058EB4-9C5E-4226-92D1-DE24AEA83630	Primary Tumor	Illumina HiSeq	247619C6-96D4-477E-BF62-F49A358AA202	Kidney	47.0	20A21A6F-F615-47F7-9935-B330B116D51B	9DEEA671-7443-45BD-A45F-97FDE279C948	TCGA-B0-5693-01A-11R-1541-07	HG19	TCGA-B0-5693	TCGA-KIRC		s8987	University of North Carolina	University of Pittsburgh	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13722.58cfa830e4b0c9d6adf6bee0	58cfa830e4b0c9d6adf6bee0	TCGA-BP-4326-11A-01D-2097-10_wgs_Illumina.filtered.	WGS	TCGA-BP-4326-11A-01D-2097-10_wgs_Illumina	TCGA-BP-4326-11A-01D-2097-10_wgs_Illumina.bam	102.0	1.9	0.15	58cfa830e4b0c9d6adf6bee0	TCGA-BP-4326-11A-01D-2097-10_wgs_Illumina.bam	Alive	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4326-11A	7664C241-B369-4D76-9CD1-7F2BDC1D267F	Solid Tissue Normal	Illumina HiSeq	09e413fb-1e33-4076-9f66-ebc969fcc6a2	Kidney	53.0	B2DEA58E-527E-46E2-BA14-3070115C9A28	1AD7677C-68E0-490E-B1F9-B061155807EA	TCGA-BP-4326-11A-01D-2097-10	GRCh37-lite	TCGA-BP-4326	TCGA-KIRC		s9449	Baylor College of Medicine	MSKCC	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2097-10	False
13767.58cfa83ae4b0c9d6adf716f6	58cfa83ae4b0c9d6adf716f6	UNCID_2381167.1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2381167.1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca.sorted_genome_alignments	UNCID_2381167.1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca.sorted_genome_alignments.bam	28.02	1.93	0.15	58cfa83ae4b0c9d6adf716f6	UNCID_2381167.1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-VP-A87K-01A	24D7D4D8-F5C1-4D71-80E0-72A429FC9DBD	Primary Tumor	Illumina HiSeq	2645A695-8449-451F-9255-84BF7C74BCE1	Prostate	63.0	0D98F39E-CF75-4D68-8B25-1DF098BD4930	1A9B6614-F2FD-4A0F-9586-A8B7D339C7CA	TCGA-VP-A87K-01A-11R-A352-07	HG19	TCGA-VP-A87K	TCGA-PRAD		s4080	University of North Carolina	Washington University	United States	NO	T3b	N0	Prostate Adenocarcinoma  Other Subtype		A352-07	True
13722.58cfa82ee4b0c9d6adf6af42	58cfa82ee4b0c9d6adf6af42	G41960.TCGA-75-7030-10A-01D-1946-08.2.filtered.	WGS	G41960.TCGA-75-7030-10A-01D-1946-08.2	G41960.TCGA-75-7030-10A-01D-1946-08.2.bam	187.0		0.05	58cfa82ee4b0c9d6adf6af42	G41960.TCGA-75-7030-10A-01D-1946-08.2.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-75-7030-10A	DF576520-A6B6-4C9B-8D06-3F59CC5342FD	Blood Derived Normal	Illumina HiSeq	d5a3ce22-1fc8-401a-ac7b-fa7bc6fad8f7	Lung		09990635-9BE0-4DA6-BFE3-17D393AE8B96	9659D703-504E-4B47-A4F4-B376DBBBFBAC	TCGA-75-7030-10A-01D-1946-08	HG19_Broad_variant	TCGA-75-7030	TCGA-LUAD		s10764	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T3	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1946-08	False
13767.58cfa833e4b0c9d6adf6ddb9	58cfa833e4b0c9d6adf6ddb9	UNCID_1133483.1013446f-5beb-485d-809a-efe81a2138dd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1133483.1013446f-5beb-485d-809a-efe81a2138dd.sorted_genome_alignments	UNCID_1133483.1013446f-5beb-485d-809a-efe81a2138dd.sorted_genome_alignments.bam	82.71	1.81	0.15	58cfa833e4b0c9d6adf6ddb9	UNCID_1133483.1013446f-5beb-485d-809a-efe81a2138dd.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DL-01A	BA39BFBC-5CAC-4F6C-B55C-4EEE3466EE93	Primary Tumor	Illumina HiSeq	B28E9FB3-8865-46BB-AFD3-770BC057A83D	Breast	64.0	20308C88-18F2-4373-9E93-1F1D589D97E2	1013446F-5BEB-485D-809A-EFE81A2138DD	TCGA-BH-A0DL-01A-11R-A115-07	HG19	TCGA-BH-A0DL	TCGA-BRCA		s5669	University of North Carolina	University of Pittsburgh	None	NO	T2	N0	Other  specify	Stage II	A115-07	True
13722.58cfa831e4b0c9d6adf6c9c6	58cfa831e4b0c9d6adf6c9c6	TCGA-DA-A1I7-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DA-A1I7-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_7_rg.sorted	TCGA-DA-A1I7-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_7_rg.sorted.bam	24.4		0.15	58cfa831e4b0c9d6adf6c9c6	TCGA-DA-A1I7-10A-01D-A190_120730_SN208_0419_AC13W9ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-DA-A1I7-10A	DFE8BAA8-1C2C-4C36-92C9-61548CEBEC19	Blood Derived Normal	Illumina HiSeq	46644fd2-8d67-4fe0-bd0b-2a2d74d08596	Skin	62.0	3BB3E8C1-DF0C-4635-BF1B-7FFD3E58384C	9DB43937-2095-4F40-86BF-C86840D44150	TCGA-DA-A1I7-10A-01D-A190-02	HG19_Broad_variant	TCGA-DA-A1I7	TCGA-SKCM		s7327	Harvard Medical School	Yale	United States	NO	T0	N2b		Stage III	A190-02	True
13722.58cfa83ce4b0c9d6adf72ef4	58cfa83ce4b0c9d6adf72ef4	adc8fcb8e8a780076e27704767013d83.filtered.	WGS	adc8fcb8e8a780076e27704767013d83	adc8fcb8e8a780076e27704767013d83.bam	15.93		0.08	58cfa83ce4b0c9d6adf72ef4	adc8fcb8e8a780076e27704767013d83.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A240-01A	3608BFBB-2A92-4EC2-A330-BF4790A8B65C	Primary Tumor	Illumina HiSeq	d31b896e-0c05-4b82-9143-a039f927b80f	Mesenchymal	51.0	8ACAF190-5A0D-440C-9C9A-B9EABDF661BE	3DB6E6CC-1A06-49B9-834E-B6611CDE4C4B	TCGA-DX-A240-01A-32D-A27P-09	GRCh37-lite	TCGA-DX-A240	TCGA-SARC		s2670	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO					A27P-09	False
13767.58cfa830e4b0c9d6adf6c2ef	58cfa830e4b0c9d6adf6c2ef	TCGA-BR-7717-01A-11R-2055-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-7717-01A-11R-2055-13_rnaseq	TCGA-BR-7717-01A-11R-2055-13_rnaseq.bam	137.2		0.15	58cfa830e4b0c9d6adf6c2ef	TCGA-BR-7717-01A-11R-2055-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7717-01A	93A337AE-2BD3-4464-B38F-93DFF92D3FDE	Primary Tumor	Illumina HiSeq	4D192F63-80BC-4072-98F2-E47688260680	Stomach	63.0	0D12D2E2-385D-4712-AFC8-EC85B25E8AE5	0C3EB790-F5A4-4D39-982A-D5ED71CDD72F	TCGA-BR-7717-01A-11R-2055-13	GRCh37-lite	TCGA-BR-7717	TCGA-STAD		s15110	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	2055-13	True
13767.58cfa835e4b0c9d6adf6ec26	58cfa835e4b0c9d6adf6ec26	UNCID_1307556.a3568fd6-4b6d-4507-9c59-1788834d3a75.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1307556.a3568fd6-4b6d-4507-9c59-1788834d3a75.sorted_genome_alignments	UNCID_1307556.a3568fd6-4b6d-4507-9c59-1788834d3a75.sorted_genome_alignments.bam	17.33	1.83	0.15	58cfa835e4b0c9d6adf6ec26	UNCID_1307556.a3568fd6-4b6d-4507-9c59-1788834d3a75.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A1AK-01A	94B03E1D-50EC-4680-BFFD-7086D1536FF2	Primary Tumor	Illumina HiSeq	B8AA93A1-9019-4BE2-BAA2-088E441F7380	Breast	70.0	FE0DDCFC-F6E9-460D-B8E6-5187FFE8EB4F	A3568FD6-4B6D-4507-9C59-1788834D3A75	TCGA-AR-A1AK-01A-21R-A12P-07	HG19	TCGA-AR-A1AK	TCGA-BRCA		s6718	University of North Carolina	Mayo	None	NO	T1	N0	Infiltrating Lobular Carcinoma	Stage I	A12P-07	True
13767.58cfa838e4b0c9d6adf70ad8	58cfa838e4b0c9d6adf70ad8	UNCID_2144863.49e3ffbc-f75f-4f3d-99de-12c29ef69154.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2144863.49e3ffbc-f75f-4f3d-99de-12c29ef69154.sorted_genome_alignments	UNCID_2144863.49e3ffbc-f75f-4f3d-99de-12c29ef69154.sorted_genome_alignments.bam	54.6	1.8	0.18	58cfa838e4b0c9d6adf70ad8	UNCID_2144863.49e3ffbc-f75f-4f3d-99de-12c29ef69154.sorted_genome_alignments.bam	Alive	MALE	WHITE		Adrenocortical Carcinoma	Aligned reads	TCGA-OR-A5JP-01A	0B73CBBA-5520-4610-B649-912D76114033	Primary Tumor	Illumina HiSeq	EBB833C6-D9D7-4410-8EA6-94D37EF1B3EF	Adrenal Gland	40.0	1A580A44-6D1A-4DF5-8DF5-F6BB0B328E68	49E3FFBC-F75F-4F3D-99DE-12C29EF69154	TCGA-OR-A5JP-01A-11R-A29S-07	HG19	TCGA-OR-A5JP	TCGA-ACC		s160	University of North Carolina	University of Michigan	Australia	NO	T2	N0		Stage II	A29S-07	True
13767.58cfa831e4b0c9d6adf6c37c	58cfa831e4b0c9d6adf6c37c	TCGA-CD-A4MG-01A-11R-A251-31_rnaseq.filtered.	RNA-Seq	TCGA-CD-A4MG-01A-11R-A251-31_rnaseq	TCGA-CD-A4MG-01A-11R-A251-31_rnaseq.bam	56.18	1.9	0.16	58cfa831e4b0c9d6adf6c37c	TCGA-CD-A4MG-01A-11R-A251-31_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-A4MG-01A	028632ED-D75A-49BB-B579-41962BA502FE	Primary Tumor	Illumina HiSeq	F5C5A8D7-60D3-4238-A848-DF8EE0CEB3A9	Stomach	76.0	E6851ECB-E630-43A3-87BA-AFA0FDDD0568	ADBB10E6-54D3-453E-97BA-8C80C815B04C	TCGA-CD-A4MG-01A-11R-A251-31	GRCh37-lite	TCGA-CD-A4MG	TCGA-STAD		s15060	Canada's Michael Smith Genome Sciences Centre	ILSbio	Vietnam	NO	T3	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage II	A251-31	True
13767.58cfa835e4b0c9d6adf6ed18	58cfa835e4b0c9d6adf6ed18	UNCID_1343169.c08293b3-507d-4c7c-8b14-9a328e1d15fe.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1343169.c08293b3-507d-4c7c-8b14-9a328e1d15fe.sorted_genome_alignments	UNCID_1343169.c08293b3-507d-4c7c-8b14-9a328e1d15fe.sorted_genome_alignments.bam	112.2		0.15	58cfa835e4b0c9d6adf6ed18	UNCID_1343169.c08293b3-507d-4c7c-8b14-9a328e1d15fe.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7752-11A	9B84601B-EE05-4C15-AFE3-7BFA7CA5FFAC	Solid Tissue Normal	Illumina HiSeq	95EA4457-F6E2-42F1-ADFD-2E69EAF893C5	Prostate	61.0	AC6E4536-7D86-4EBF-A2D4-0558EDF513C2	C08293B3-507D-4C7C-8B14-9A328E1D15FE	TCGA-HC-7752-11A-01R-2118-07	HG19	TCGA-HC-7752	TCGA-PRAD		s4179	University of North Carolina	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13767.58cfa839e4b0c9d6adf715d0	58cfa839e4b0c9d6adf715d0	UNCID_2367166.355fc3cd-c43b-41cd-b608-3e88100693fd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2367166.355fc3cd-c43b-41cd-b608-3e88100693fd.sorted_genome_alignments	UNCID_2367166.355fc3cd-c43b-41cd-b608-3e88100693fd.sorted_genome_alignments.bam	34.4	1.93	0.18	58cfa839e4b0c9d6adf715d0	UNCID_2367166.355fc3cd-c43b-41cd-b608-3e88100693fd.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-RW-A7CZ-01A	D1EEA093-F349-435F-B8D4-1B40B35503D7	Primary Tumor	Illumina HiSeq	C21BABF6-347A-43E9-A930-E559CCF6435F	Nervous System	72.0	1D79930A-E91C-4BA8-B63D-D478077D76C5	355FC3CD-C43B-41CD-B608-3E88100693FD	TCGA-RW-A7CZ-01A-11R-A35K-07	HG19	TCGA-RW-A7CZ	TCGA-PCPG		s1017	University of North Carolina	Michigan University	United States	NO					A35K-07	True
13767.58cfa837e4b0c9d6adf6fdba	58cfa837e4b0c9d6adf6fdba	UNCID_1726775.a6a4630e-3d28-4a38-8c9f-29fc0c7b380a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1726775.a6a4630e-3d28-4a38-8c9f-29fc0c7b380a.sorted_genome_alignments	UNCID_1726775.a6a4630e-3d28-4a38-8c9f-29fc0c7b380a.sorted_genome_alignments.bam	15.84	1.84	0.18	58cfa837e4b0c9d6adf6fdba	UNCID_1726775.a6a4630e-3d28-4a38-8c9f-29fc0c7b380a.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LV-01A	00BCA18C-B3D4-45A3-8F19-034CC40449A4	Primary Tumor	Illumina HiSeq	D0715EC0-1CAA-4A0E-B164-E55819022233	Cervix	36.0	CBAD0C55-915A-4F65-B040-57111EAD3BDE	A6A4630E-3D28-4A38-8C9F-29FC0C7B380A	TCGA-C5-A2LV-01A-11R-A18M-07	HG19	TCGA-C5-A2LV	TCGA-CESC		s1425	University of North Carolina	Medical College of Wisconsin	United States	NO	T1b	N1	Cervical Squamous Cell Carcinoma		A18M-07	True
13767.58cfa82fe4b0c9d6adf6b52a	58cfa82fe4b0c9d6adf6b52a	TCGA-25-2400-01A-01R-1569-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-25-2400-01A-01R-1569-13_GRCh37-lite_rnaseq	TCGA-25-2400-01A-01R-1569-13_GRCh37-lite_rnaseq.bam	373.0	1.8	0.15	58cfa82fe4b0c9d6adf6b52a	TCGA-25-2400-01A-01R-1569-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-2400-01A	5C127332-5CA0-45F1-A5AC-4876AD94E491	Primary Tumor	Illumina HiSeq	29C0E2CF-AFB2-4E82-B667-0C9F5F48434B	Ovary	76.0	B5E8849B-9002-4B65-A2EA-6A46C04ABA4A	5C98C2C5-806F-4562-AD57-E152EA8388AB	TCGA-25-2400-01A-01R-1569-13	GRCh37-lite	TCGA-25-2400	TCGA-OV	1278.0	s17953	Canada's Michael Smith Genome Sciences Centre	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		1569-13	True
13767.58cfa838e4b0c9d6adf7049b	58cfa838e4b0c9d6adf7049b	UNCID_1952657.5a57d856-a9a7-4fb5-a55b-dbcc8c5f702b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1952657.5a57d856-a9a7-4fb5-a55b-dbcc8c5f702b.sorted_genome_alignments	UNCID_1952657.5a57d856-a9a7-4fb5-a55b-dbcc8c5f702b.sorted_genome_alignments.bam	14.96	2.02	0.16	58cfa838e4b0c9d6adf7049b	UNCID_1952657.5a57d856-a9a7-4fb5-a55b-dbcc8c5f702b.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-HZ-A49G-01A	47CB93BC-8F6B-4B2A-804C-BB4FC78DF9E1	Primary Tumor	Illumina HiSeq	BB346BC2-65DC-4AF9-96C1-F69A79FEA088	Pancreas	58.0	2B44F6C8-EC16-46B7-A810-622CB0DEC3C5	5A57D856-A9A7-4FB5-A55B-DBCC8C5F702B	TCGA-HZ-A49G-01A-11R-A26U-07	HG19	TCGA-HZ-A49G	TCGA-PAAD		s775	University of North Carolina	International Genomics Consortium	United States	NO	T2	N1	Pancreas-Adenocarcinoma Ductal Type	Stage II	A26U-07	True
13767.58cfa837e4b0c9d6adf6feba	58cfa837e4b0c9d6adf6feba	UNCID_1783519.8f8b493a-366c-4961-9586-bbc80878d91b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1783519.8f8b493a-366c-4961-9586-bbc80878d91b.sorted_genome_alignments	UNCID_1783519.8f8b493a-366c-4961-9586-bbc80878d91b.sorted_genome_alignments.bam	402.8	1.8	0.15	58cfa837e4b0c9d6adf6feba	UNCID_1783519.8f8b493a-366c-4961-9586-bbc80878d91b.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4743-01A	C8D7EB0F-2502-4277-A8EF-435B08F3C863	Primary Tumor	Illumina HiSeq	4C53BB87-9E00-42D2-9290-0BF91F2B6D54	Colorectal	69.0	14EB006D-42B2-4765-9DC2-B96F9AA03C10	8F8B493A-366C-4961-9586-BBC80878D91B	TCGA-CM-4743-01A-01R-1723-07	HG19	TCGA-CM-4743	TCGA-COAD		s13592	University of North Carolina	MSKCC	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1723-07	True
13767.58cfa82fe4b0c9d6adf6b552	58cfa82fe4b0c9d6adf6b552	TCGA-25-2391-01A-01R-1569-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-25-2391-01A-01R-1569-13_GRCh37-lite_rnaseq	TCGA-25-2391-01A-01R-1569-13_GRCh37-lite_rnaseq.bam	296.0	1.7	0.15	58cfa82fe4b0c9d6adf6b552	TCGA-25-2391-01A-01R-1569-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-2391-01A	F5033D52-EC36-4E67-88D8-B6D898B81B2F	Primary Tumor	Illumina HiSeq	4BE66960-A87C-4C5A-BFD3-9203BD4B5D6E	Ovary	57.0	2179798C-4FD4-4434-B1D5-1453F6054FA2	0EE0C708-77C4-4AC3-BE13-0D08E6444003	TCGA-25-2391-01A-01R-1569-13	GRCh37-lite	TCGA-25-2391	TCGA-OV	1492.0	s17522	Canada's Michael Smith Genome Sciences Centre	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		1569-13	True
13767.58cfa838e4b0c9d6adf70cdc	58cfa838e4b0c9d6adf70cdc	UNCID_2173071.14b3c94a-781d-4df9-9ee6-a3236d099dc6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2173071.14b3c94a-781d-4df9-9ee6-a3236d099dc6.sorted_genome_alignments	UNCID_2173071.14b3c94a-781d-4df9-9ee6-a3236d099dc6.sorted_genome_alignments.bam	28.13	1.94	0.18	58cfa838e4b0c9d6adf70cdc	UNCID_2173071.14b3c94a-781d-4df9-9ee6-a3236d099dc6.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-HC-A6AP-01A	EAD15A1B-726A-46AA-9005-A22F4B89D011	Primary Tumor	Illumina HiSeq	74349BBF-FD0E-446A-AAEE-375ED1EBC87D	Prostate	61.0	19E1137B-FBBB-4BBD-B5B3-A6892D91BF4E	14B3C94A-781D-4DF9-9EE6-A3236D099DC6	TCGA-HC-A6AP-01A-11R-A30B-07	HG19	TCGA-HC-A6AP	TCGA-PRAD		s4061	University of North Carolina	International Genomics Consortium	United States	NO	T2c		Prostate Adenocarcinoma Acinar Type		A30B-07	True
13767.58cfa83ae4b0c9d6adf71ca4	58cfa83ae4b0c9d6adf71ca4	UNCID_2495402.f18b7d09-aace-4a7e-839a-6f6eeb189f63.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2495402.f18b7d09-aace-4a7e-839a-6f6eeb189f63.sorted_genome_alignments	UNCID_2495402.f18b7d09-aace-4a7e-839a-6f6eeb189f63.sorted_genome_alignments.bam	37.12	1.86	0.16	58cfa83ae4b0c9d6adf71ca4	UNCID_2495402.f18b7d09-aace-4a7e-839a-6f6eeb189f63.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-ZF-AA52-01A	6C5F09F0-2019-4440-8554-E8912BCE5E98	Primary Tumor	Illumina HiSeq	9A041EB5-DF2D-469F-ACCA-A4C672144D2C	Bladder	70.0	1B16D49D-4DB7-472C-86BE-4BE3A1C68624	F18B7D09-AACE-4A7E-839A-6F6EEB189F63	TCGA-ZF-AA52-01A-12R-A39I-07	HG19	TCGA-ZF-AA52	TCGA-BLCA	1077.0	s2814	University of North Carolina	University of Sheffield	United Kingdom	NO	T3a	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A39I-07	True
13722.58cfa82ee4b0c9d6adf6a976	58cfa82ee4b0c9d6adf6a976	G32554.TCGA-FS-A1ZK-10A-01D-A199-08.1.filtered.	WGS	G32554.TCGA-FS-A1ZK-10A-01D-A199-08.1	G32554.TCGA-FS-A1ZK-10A-01D-A199-08.1.bam	50.13		0.08	58cfa82ee4b0c9d6adf6a976	G32554.TCGA-FS-A1ZK-10A-01D-A199-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZK-10A	1404791B-86BF-4DFD-85B4-C8FF356F109C	Blood Derived Normal	Illumina HiSeq	99af9f9f-fd5f-41ce-8394-6d9210c013a8	Skin	68.0	9F006B7F-4BE8-423E-86C6-36EF71215C9F	8BB3517F-9E54-4272-A6C2-A7B8E8CC567D	TCGA-FS-A1ZK-10A-01D-A199-08	HG19_Broad_variant	TCGA-FS-A1ZK	TCGA-SKCM	728.0	s7986	Broad Institute of MIT and Harvard	Essen	Germany	NO	T4	N0		Stage II	A199-08	True
13767.58cfa838e4b0c9d6adf70d55	58cfa838e4b0c9d6adf70d55	UNCID_2166732.16b68870-facd-4071-ba84-b30b2c60bc81.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2166732.16b68870-facd-4071-ba84-b30b2c60bc81.sorted_genome_alignments	UNCID_2166732.16b68870-facd-4071-ba84-b30b2c60bc81.sorted_genome_alignments.bam	11.81	1.9	0.17	58cfa838e4b0c9d6adf70d55	UNCID_2166732.16b68870-facd-4071-ba84-b30b2c60bc81.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-A6J1-01A	EA31C705-4CF8-48F5-8D13-E43563213C91	Primary Tumor	Illumina HiSeq	A3DACCC6-2E5D-4EE2-9C98-D2FE1C2BC247	Brain	44.0	3086D02F-F5EA-4B0C-A7E8-A6D90B7FCFC4	16B68870-FACD-4071-BA84-B30B2C60BC81	TCGA-FG-A6J1-01A-11R-A31N-07	HG19	TCGA-FG-A6J1	TCGA-LGG		s8672	University of North Carolina	Case Western	United States	NO			Oligodendroglioma		A31N-07	True
13767.58cfa834e4b0c9d6adf6e364	58cfa834e4b0c9d6adf6e364	UNCID_1186829.0a0a4e25-c733-4882-acc1-a617a052853a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1186829.0a0a4e25-c733-4882-acc1-a617a052853a.sorted_genome_alignments	UNCID_1186829.0a0a4e25-c733-4882-acc1-a617a052853a.sorted_genome_alignments.bam	103.8	1.8	0.16	58cfa834e4b0c9d6adf6e364	UNCID_1186829.0a0a4e25-c733-4882-acc1-a617a052853a.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5677-11A	D2664FDE-CE3B-45E6-9A23-4A07980F7BAC	Solid Tissue Normal	Illumina HiSeq	22EC374C-7B2B-4D3A-96D9-A472FE74E89B	Kidney	54.0	0A3FFD01-FA5C-4372-93AB-C38F8B1CE096	0A0A4E25-C733-4882-ACC1-A617A052853A	TCGA-CJ-5677-11A-01R-1541-07	HG19	TCGA-CJ-5677	TCGA-KIRC	782.0	s9039	University of North Carolina	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1541-07	True
13722.58cfa82fe4b0c9d6adf6ba3b	58cfa82fe4b0c9d6adf6ba3b	TCGA-A6-3807-10A-01D-1459-10_wgs_Illumina.filtered.	WGS	TCGA-A6-3807-10A-01D-1459-10_wgs_Illumina	TCGA-A6-3807-10A-01D-1459-10_wgs_Illumina.bam	1.2	1.9	0.05	58cfa82fe4b0c9d6adf6ba3b	TCGA-A6-3807-10A-01D-1459-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-3807-10A	5116E3B4-2BAC-40F5-8046-B9C1783FAAA5	Blood Derived Normal	Illumina HiSeq	1555806c-03b9-4392-b3ab-82a34f015b0d	Colorectal	53.0	F7D79CFA-E8AB-4023-85A3-34C12CA78C7B	C07AB48C-B3ED-405C-9813-5E2B69ABF492	TCGA-A6-3807-10A-01D-1459-10	GRCh37-lite	TCGA-A6-3807	TCGA-COAD		s13170	Baylor College of Medicine	Christiana Healthcare	None	NO	T3	N2	Colon Adenocarcinoma	Stage III	1459-10	False
13722.58cfa830e4b0c9d6adf6c1ba	58cfa830e4b0c9d6adf6c1ba	TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted	TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted.bam	65.26	1.97	0.13	58cfa830e4b0c9d6adf6c1ba	TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0UT-01A	E2B1D0DE-5221-44A1-8FAD-9708A3CADA14	Primary Tumor	Illumina HiSeq	ca5a88b7-6801-435a-aeef-b9ca9d963c17	Uterus	62.0	824D0DBC-293F-4893-A68C-24DEDD437EA5	12674687-D555-40DB-ACC9-7638F85D0661	TCGA-BS-A0UT-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0UT	TCGA-UCEC		s4608	Harvard Medical School	University of Hawaii	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13722.58cfa82ee4b0c9d6adf6adaa	58cfa82ee4b0c9d6adf6adaa	G25784.TCGA-91-6840-10A-01D-1946-08.3.filtered.	WGS	G25784.TCGA-91-6840-10A-01D-1946-08.3	G25784.TCGA-91-6840-10A-01D-1946-08.3.bam	277.0		0.05	58cfa82ee4b0c9d6adf6adaa	G25784.TCGA-91-6840-10A-01D-1946-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6840-10A	D5326429-9805-47F9-97B0-FBDA658E3F01	Blood Derived Normal	Illumina HiSeq	ecb2ce47-ebd7-406d-9b76-31a08bc2531c	Lung	59.0	939E41BA-B671-4B7A-8B40-8EC680F5327C	087D5121-0E86-4BE5-9E53-11EFD5184752	TCGA-91-6840-10A-01D-1946-08	HG19_Broad_variant	TCGA-91-6840	TCGA-LUAD		s10760	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T1b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1946-08	False
13767.58cfa83ae4b0c9d6adf71671	58cfa83ae4b0c9d6adf71671	UNCID_2367168.d2589a77-5a81-4e9b-8ca8-5adebb259b54.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2367168.d2589a77-5a81-4e9b-8ca8-5adebb259b54.sorted_genome_alignments	UNCID_2367168.d2589a77-5a81-4e9b-8ca8-5adebb259b54.sorted_genome_alignments.bam	28.76	2.26	0.18	58cfa83ae4b0c9d6adf71671	UNCID_2367168.d2589a77-5a81-4e9b-8ca8-5adebb259b54.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-QT-A7U0-01A	764FE189-5B13-4C2A-A1EC-587D462052C6	Primary Tumor	Illumina HiSeq	20ACF5F1-59BC-4B37-ADAF-076AE122C8FE	Nervous System	56.0	ABA9CD29-03DB-4F00-8AED-90480D332D97	D2589A77-5A81-4E9B-8CA8-5ADEBB259B54	TCGA-QT-A7U0-01A-11R-A35K-07	HG19	TCGA-QT-A7U0	TCGA-PCPG		s995	University of North Carolina	University of North Carolina	United States	NO					A35K-07	True
13767.58cfa832e4b0c9d6adf6d4b2	58cfa832e4b0c9d6adf6d4b2	TCGA-VQ-A8E0-01A-11R-A414-31_rnaseq.filtered.	RNA-Seq	TCGA-VQ-A8E0-01A-11R-A414-31_rnaseq	TCGA-VQ-A8E0-01A-11R-A414-31_rnaseq.bam	40.91	1.86	0.17	58cfa832e4b0c9d6adf6d4b2	TCGA-VQ-A8E0-01A-11R-A414-31_rnaseq.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN		Stomach Adenocarcinoma	Aligned reads	TCGA-VQ-A8E0-01A	EB9A558C-39EF-42C0-8DFC-64D01B729426	Primary Tumor	Illumina HiSeq	65BBFF36-9AC8-4772-9FA2-9E0403C03C46	Stomach	68.0	B6698067-C628-4AF6-AF33-097B633C1C97	D94E1449-4ED7-4B08-8F32-F6F7571FE76E	TCGA-VQ-A8E0-01A-11R-A414-31	GRCh37-lite	TCGA-VQ-A8E0	TCGA-STAD	562.0	s14782	Canada's Michael Smith Genome Sciences Centre	Barretos Cancer Hospital	Brazil	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	A414-31	True
13722.58cfa832e4b0c9d6adf6cf30	58cfa832e4b0c9d6adf6cf30	TCGA-HC-7075-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_5_rg.sorted.filtered.	WGS	TCGA-HC-7075-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_5_rg.sorted	TCGA-HC-7075-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_5_rg.sorted.bam	310.0		0.16	58cfa832e4b0c9d6adf6cf30	TCGA-HC-7075-10A-01D-1957_130412_SN590_0224_BC1YMJACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7075-10A	5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA	Blood Derived Normal	Illumina HiSeq	a027a038-5142-4ed8-a1ab-1ae31a4dc271	Prostate	63.0	3EC216B1-4260-45E7-BF41-3F13676F3222	FF9017A8-BB23-47A4-A137-833BD5E6F753	TCGA-HC-7075-10A-01D-1957-02	HG19_Broad_variant	TCGA-HC-7075	TCGA-PRAD		s3623	Harvard Medical School	International Genomics Consortium	United States	NO	T2a		Prostate Adenocarcinoma Acinar Type		1957-02	True
13767.58cfa837e4b0c9d6adf7021c	58cfa837e4b0c9d6adf7021c	UNCID_1859774.d5e3a3be-c4d9-41de-a39c-ae7aad3f3826.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1859774.d5e3a3be-c4d9-41de-a39c-ae7aad3f3826.sorted_genome_alignments	UNCID_1859774.d5e3a3be-c4d9-41de-a39c-ae7aad3f3826.sorted_genome_alignments.bam	35.46	1.88	0.15	58cfa837e4b0c9d6adf7021c	UNCID_1859774.d5e3a3be-c4d9-41de-a39c-ae7aad3f3826.sorted_genome_alignments.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ES-A2HT-11A	7DD3BDA9-3A0A-46FA-B052-A6D24B847804	Solid Tissue Normal	Illumina HiSeq	36677D18-1E0F-4558-9222-8B914060A802	Liver	54.0	723A470F-6855-409A-AAD4-D6B933313239	D5E3A3BE-C4D9-41DE-A39C-AE7AAD3F3826	TCGA-ES-A2HT-11A-11R-A180-07	HG19	TCGA-ES-A2HT	TCGA-LIHC	438.0	s17002	University of North Carolina	University of Florida	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A180-07	True
13722.58cfa82ee4b0c9d6adf6a9a0	58cfa82ee4b0c9d6adf6a9a0	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.filtered.	WGS	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.bam	11.46		0.08	58cfa82ee4b0c9d6adf6a9a0	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TM-A7CF-01A	033C1F48-9225-4159-B23B-7042272877DA	Primary Tumor	Illumina HiSeq	41c3ad23-569a-452e-8577-85a783c2a020	Brain	41.0	ABE68BC0-FE69-409E-851E-3CCF10C8AC94	979F7FD8-AB07-40A0-869A-D08FB8E598FF	TCGA-TM-A7CF-01A-11D-A32B-08	HG19_Broad_variant	TCGA-TM-A7CF	TCGA-LGG		s8116	Broad Institute of MIT and Harvard	The University of New South Wales	Australia	NO			Astrocytoma		A32B-08	False
13722.58cfa83ce4b0c9d6adf72f9e	58cfa83ce4b0c9d6adf72f9e	a10df74fe68e2f8902de76b1691f26cd.filtered.	WGS	a10df74fe68e2f8902de76b1691f26cd	a10df74fe68e2f8902de76b1691f26cd.bam	69.7	2.0	0.07	58cfa83ce4b0c9d6adf72f9e	a10df74fe68e2f8902de76b1691f26cd.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BK-A0CC-01A	2B865F8C-539F-4CB2-8F08-41709E9511E5	Primary Tumor	Illumina HiSeq	83ddf098-024c-49f8-80ef-b79b0b8182d5	Uterus	69.0	ED22CB10-EBDE-4019-9B6D-E19AB573CA94	E7D74D34-3255-4C20-90FD-B105E6E229C8	TCGA-BK-A0CC-01A-21D-A013-09	GRCh37-lite	TCGA-BK-A0CC	TCGA-UCEC		s5180	Washington University School of Medicine	Christiana Healthcare	None	NO			Serous endometrial adenocarcinoma		A013-09	True
13722.58cfa832e4b0c9d6adf6d4a2	58cfa832e4b0c9d6adf6d4a2	TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted	TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted.bam	54.24		0.17	58cfa832e4b0c9d6adf6d4a2	TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F8-01A	64BD88BD-1D5A-4569-9F46-F668D448C336	Primary Tumor	Illumina HiSeq	05bff1f2-adb9-4252-892d-c86207753ca1	Eye	68.0	6B903079-A499-4AE3-B399-59276DCB9C70	5FABEAFA-9ADE-43AA-B4EB-979826FAE9BF	TCGA-V4-A9F8-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F8	TCGA-UVM		s252	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0		Stage III	A40D-26	True
13767.58cfa835e4b0c9d6adf6f030	58cfa835e4b0c9d6adf6f030	UNCID_1505119.f66bb574-487a-426d-9b17-799718300e1e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1505119.f66bb574-487a-426d-9b17-799718300e1e.sorted_genome_alignments	UNCID_1505119.f66bb574-487a-426d-9b17-799718300e1e.sorted_genome_alignments.bam	448.3	1.8	0.15	58cfa835e4b0c9d6adf6f030	UNCID_1505119.f66bb574-487a-426d-9b17-799718300e1e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4666-01A	4C31127E-D095-4978-9DAC-35153C27F6ED	Primary Tumor	Illumina HiSeq	35B8E489-BE83-4B60-BCAC-6DBF23B7E3C7	Lung	52.0	5BAE2E45-6DBC-458C-A66F-702EB1AF7357	F66BB574-487A-426D-9B17-799718300E1E	TCGA-73-4666-01A-01R-1206-07	HG19	TCGA-73-4666	TCGA-LUAD		s11061	University of North Carolina	Roswell Park	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	1206-07	True
13722.58cfa831e4b0c9d6adf6ca3c	58cfa831e4b0c9d6adf6ca3c	TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted	TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted.bam	48.0	1.9	0.16	58cfa831e4b0c9d6adf6ca3c	TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DH-5143-01A	DCD0856D-423A-40D7-8070-4C0988D61416	Primary Tumor	Illumina HiSeq	9e2bca97-d504-4863-b306-8f559a2cc8a1	Brain	30.0	570101B6-3670-4D1A-A94D-0DDC8DF42061	55952783-8C2C-4528-A544-B4C962AB634A	TCGA-DH-5143-01A-01D-1465-02	HG19_Broad_variant	TCGA-DH-5143	TCGA-LGG		s8753	Harvard Medical School	University of Florida	United States	NO			Oligoastrocytoma		1465-02	True
13722.58cfa832e4b0c9d6adf6d1ce	58cfa832e4b0c9d6adf6d1ce	TCGA-HT-7473-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_7_rg.sorted.filtered.	WGS	TCGA-HT-7473-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_7_rg.sorted	TCGA-HT-7473-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_7_rg.sorted.bam	246.0		0.16	58cfa832e4b0c9d6adf6d1ce	TCGA-HT-7473-10A-01D-2022_130913_SN1440_0167_AC2A6PACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7473-10A	DBFACCB0-E8C0-48E8-9AEF-570267574822	Blood Derived Normal	Illumina HiSeq	2b1e29cb-e83c-4e25-a643-1ded3bbcccb6	Brain	28.0	996FE719-74D2-433B-9E73-76ED2775DDE9	8CDB3395-5562-4FAE-89AF-2980F5F9B09B	TCGA-HT-7473-10A-01D-2022-02	HG19_Broad_variant	TCGA-HT-7473	TCGA-LGG		s8152	Harvard Medical School	Case Western - St Joes	United States	NO			Oligoastrocytoma		2022-02	True
13722.58cfa82fe4b0c9d6adf6b97e	58cfa82fe4b0c9d6adf6b97e	TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam	353.96	1.9	0.15	58cfa82fe4b0c9d6adf6b97e	TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-3681-01A	ABB0D53F-F74E-45DC-8FBB-40863016F3C6	Primary Tumor	Illumina HiSeq	4a7f8872-1280-4a05-8448-a62ee6de1108	Colorectal	77.0	190FECAB-1EF1-43FA-87A2-104014EB2CE2	85305E56-627C-4471-BD16-6818AD3751C2	TCGA-AA-3681-01A-01D-1637-02	HG18	TCGA-AA-3681	TCGA-COAD		s13029	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	1637-02	False
13767.58cfa83ce4b0c9d6adf73194	58cfa83ce4b0c9d6adf73194	_1_TCGA-BR-8589-01A-11R-2402-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-8589-01A-11R-2402-13_rnaseq	_1_TCGA-BR-8589-01A-11R-2402-13_rnaseq.bam	391.2		0.16	58cfa83ce4b0c9d6adf73194	_1_TCGA-BR-8589-01A-11R-2402-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8589-01A	A1867D3E-A006-4E04-8118-478792BDCA4B	Primary Tumor	Illumina HiSeq	26EB83E3-572A-45A9-A5C5-DA369FF79873	Stomach	56.0	56E9B06F-8E06-48A7-B940-10FB9BC36310	AE9FC866-EC94-4D8F-9A47-94C8071EF46F	TCGA-BR-8589-01A-11R-2402-13	GRCh37-lite	TCGA-BR-8589	TCGA-STAD		s15017	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4b	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2402-13	True
13767.58cfa838e4b0c9d6adf70a88	58cfa838e4b0c9d6adf70a88	UNCID_2045700.c5a7673a-c45e-4789-a2c8-32889f39c102.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2045700.c5a7673a-c45e-4789-a2c8-32889f39c102.sorted_genome_alignments	UNCID_2045700.c5a7673a-c45e-4789-a2c8-32889f39c102.sorted_genome_alignments.bam	46.5	1.87	0.17	58cfa838e4b0c9d6adf70a88	UNCID_2045700.c5a7673a-c45e-4789-a2c8-32889f39c102.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Breast Invasive Carcinoma	Aligned reads	TCGA-OL-A5RW-01A	A82D0A57-4383-473D-B334-D13B278404B1	Primary Tumor	Illumina HiSeq	00AF6ABD-EF6B-4C43-A39B-AE0D33F35BC7	Breast	40.0	B280103F-8732-4EE4-9E61-357A9CB3A0A9	C5A7673A-C45E-4789-A2C8-32889F39C102	TCGA-OL-A5RW-01A-11R-A28M-07	HG19	TCGA-OL-A5RW	TCGA-BRCA		s6889	University of North Carolina	University of Chicago	United States	NO	T1c	N1	Infiltrating Ductal Carcinoma	Stage II	A28M-07	True
13767.58cfa838e4b0c9d6adf70cea	58cfa838e4b0c9d6adf70cea	UNCID_2173970.0595a9e2-f382-4f97-8d0e-69af86b9fb78.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2173970.0595a9e2-f382-4f97-8d0e-69af86b9fb78.sorted_genome_alignments	UNCID_2173970.0595a9e2-f382-4f97-8d0e-69af86b9fb78.sorted_genome_alignments.bam	64.79	1.9	0.16	58cfa838e4b0c9d6adf70cea	UNCID_2173970.0595a9e2-f382-4f97-8d0e-69af86b9fb78.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A5OE-01A	D5EE39E8-A1D2-4244-9C38-07D7C5C1BABA	Primary Tumor	Illumina HiSeq	395BC27B-17AB-486C-9D44-4C5331C63F91	Uterus	68.0	DF9184EC-0A56-4227-A0F7-CE92E5E6203E	0595A9E2-F382-4F97-8D0E-69AF86B9FB78	TCGA-B5-A5OE-01A-11R-A31O-07	HG19	TCGA-B5-A5OE	TCGA-UCEC		s5120	University of North Carolina	Duke	United States	NO			Serous endometrial adenocarcinoma		A31O-07	True
13767.58cfa836e4b0c9d6adf6f9c1	58cfa836e4b0c9d6adf6f9c1	UNCID_1652865.905404ec-68c8-45d8-a9ad-ec08cbe207f4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1652865.905404ec-68c8-45d8-a9ad-ec08cbe207f4.sorted_genome_alignments	UNCID_1652865.905404ec-68c8-45d8-a9ad-ec08cbe207f4.sorted_genome_alignments.bam	145.2		0.16	58cfa836e4b0c9d6adf6f9c1	UNCID_1652865.905404ec-68c8-45d8-a9ad-ec08cbe207f4.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7469-01A	B9E2F4D1-866C-4C62-A9C8-8DE7EB364A6E	Primary Tumor	Illumina HiSeq	D28D7C29-28F5-4D3D-A48F-2E7E59958217	Brain	30.0	3B977870-9E58-4F81-845C-347724171109	905404EC-68C8-45D8-A9AD-EC08CBE207F4	TCGA-HT-7469-01A-11R-2256-07	HG19	TCGA-HT-7469	TCGA-LGG		s8620	University of North Carolina	Case Western - St Joes	United States	NO			Oligodendroglioma		2256-07	True
13767.58cfa834e4b0c9d6adf6e48f	58cfa834e4b0c9d6adf6e48f	UNCID_1207082.5e45c9ab-f5fe-497b-b919-72b0d8dec83d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1207082.5e45c9ab-f5fe-497b-b919-72b0d8dec83d.sorted_genome_alignments	UNCID_1207082.5e45c9ab-f5fe-497b-b919-72b0d8dec83d.sorted_genome_alignments.bam	49.2	1.8	0.13	58cfa834e4b0c9d6adf6e48f	UNCID_1207082.5e45c9ab-f5fe-497b-b919-72b0d8dec83d.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4490-01A	6C3655CA-8AE7-4AD7-B3E4-0C3EC293FBA7	Primary Tumor	Illumina HiSeq	CE96C587-B06A-4314-8F86-61806C20D4D7	Lung	45.0	185BC9BD-1E20-467C-9C06-908C8AA27E7D	5E45C9AB-F5FE-497B-B919-72B0D8DEC83D	TCGA-49-4490-01A-21R-1858-07	HG19	TCGA-49-4490	TCGA-LUAD	385.0	s10831	University of North Carolina	Johns Hopkins	United States	NO	T3	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1858-07	True
13722.58cfa82de4b0c9d6adf6a73c	58cfa82de4b0c9d6adf6a73c	G13228.TCGA-43-3920-01A-01D-1553-08.4.filtered.	WGS	G13228.TCGA-43-3920-01A-01D-1553-08.4	G13228.TCGA-43-3920-01A-01D-1553-08.4.bam	835.37	1.9	0.05	58cfa82de4b0c9d6adf6a73c	G13228.TCGA-43-3920-01A-01D-1553-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-3920-01A	9293E197-E38A-4E19-A7D0-1B45D1AD48BD	Primary Tumor	Illumina HiSeq	3281e662-29ac-4441-86e2-07a71d47196c	Lung	71.0	BBC07C89-5540-4217-AA56-3608539983C2	A762DD44-A8AC-4269-8163-BBF6D0F8D4B3	TCGA-43-3920-01A-01D-1553-08	HG19_Broad_variant	TCGA-43-3920	TCGA-LUSC		s10157	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1553-08	False
13767.58cfa834e4b0c9d6adf6e6e6	58cfa834e4b0c9d6adf6e6e6	UNCID_1210812.b3797921-4b9a-43c4-8904-6fb80fc80c08.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1210812.b3797921-4b9a-43c4-8904-6fb80fc80c08.sorted_genome_alignments	UNCID_1210812.b3797921-4b9a-43c4-8904-6fb80fc80c08.sorted_genome_alignments.bam	45.16	1.82	0.16	58cfa834e4b0c9d6adf6e6e6	UNCID_1210812.b3797921-4b9a-43c4-8904-6fb80fc80c08.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20X-01A	BE8B3F36-AAA1-4302-B28E-DE1996FACEAF	Primary Tumor	Illumina HiSeq	4463AC89-A63F-471F-BA6D-3362D0D4ED17	Bladder	56.0	4D7D3354-6588-4E02-9354-AB5044BA1AB3	B3797921-4B9A-43C4-8904-6FB80FC80C08	TCGA-BT-A20X-01A-11R-A16R-07	HG19	TCGA-BT-A20X	TCGA-BLCA	251.0	s3146	University of North Carolina	University of Pittsburgh	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A16R-07	True
13767.58cfa833e4b0c9d6adf6dd80	58cfa833e4b0c9d6adf6dd80	UNCID_1108346.c1859475-12fd-47f6-887d-136d334399cd.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1108346.c1859475-12fd-47f6-887d-136d334399cd.sorted_genome_alignments	UNCID_1108346.c1859475-12fd-47f6-887d-136d334399cd.sorted_genome_alignments.bam	38.2	1.6	0.16	58cfa833e4b0c9d6adf6dd80	UNCID_1108346.c1859475-12fd-47f6-887d-136d334399cd.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-50-5944-01A	1C339545-C08A-4A77-B8E9-A7E49E53853F	Primary Tumor	Illumina HiSeq	6F81175B-BC3F-4513-90B8-3FACC2B9378F	Lung	69.0	BF8FDF82-62B4-4B5D-93E7-CE153576FE49	C1859475-12FD-47F6-887D-136D334399CD	TCGA-50-5944-01A-11R-1755-07	HG19	TCGA-50-5944	TCGA-LUAD		s10698	University of North Carolina	University of Pittsburgh	United States	NO	T1	N0	Lung Acinar Adenocarcinoma	Stage I	1755-07	True
13722.58cfa83ce4b0c9d6adf72f9a	58cfa83ce4b0c9d6adf72f9a	a246b48a0a312eda5cafb748151a117b.filtered.	WGS	a246b48a0a312eda5cafb748151a117b	a246b48a0a312eda5cafb748151a117b.bam	74.65	1.93	0.09	58cfa83ce4b0c9d6adf72f9a	a246b48a0a312eda5cafb748151a117b.bam	Alive	FEMALE	WHITE		Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A24Z-01A	9FEFBE7C-F66A-4940-843E-285CB7B392C1	Primary Tumor	Illumina HiSeq	1251c29c-8d85-4187-80dd-c459542e3080	Breast	57.0	5CDD3886-898B-4861-A748-D4164CE14A07	6C65CB6D-8C50-4C7C-BC84-EEEBE09FBE01	TCGA-AR-A24Z-01A-11D-A314-09	GRCh37-lite	TCGA-AR-A24Z	TCGA-BRCA		s5942	Washington University School of Medicine	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A314-09	True
13722.58cfa832e4b0c9d6adf6d082	58cfa832e4b0c9d6adf6d082	TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted	TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted.bam	131.3		0.15	58cfa832e4b0c9d6adf6d082	TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7210-01A	6A5AF80E-07AD-4CD3-AAAB-5DB1090835D9	Primary Tumor	Illumina HiSeq	e6934494-d8e1-44c6-a343-30a6aa2e6cbc	Prostate	74.0	9069FC65-9BAE-49F3-9329-B78C8CC6CF1E	D414D851-0AF6-4C8F-8E40-CCA9FDF79488	TCGA-HC-7210-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7210	TCGA-PRAD		s3983	Harvard Medical School	International Genomics Consortium	United States	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type		2111-02	True
13767.58cfa834e4b0c9d6adf6e539	58cfa834e4b0c9d6adf6e539	UNCID_1210217.3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1210217.3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f.sorted_genome_alignments	UNCID_1210217.3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f.sorted_genome_alignments.bam	207.8	1.8	0.15	58cfa834e4b0c9d6adf6e539	UNCID_1210217.3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5750-01A	DC40CF49-B208-4F59-B5F0-CFBDD02970B2	Primary Tumor	Illumina HiSeq	6961CF27-4D20-4C4F-94AB-703543CD70D0	Prostate	72.0	0386D0E9-7BD8-467F-BA97-A379C1D67A83	3D9BA7BD-FF22-44CF-AE6A-7588F5AA857F	TCGA-CH-5750-01A-11R-1580-07	HG19	TCGA-CH-5750	TCGA-PRAD		s3635	University of North Carolina	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		1580-07	True
13722.58cfa830e4b0c9d6adf6bd8e	58cfa830e4b0c9d6adf6bd8e	TCGA-BG-A0M3-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BG-A0M3-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_3_rg.sorted	TCGA-BG-A0M3-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_3_rg.sorted.bam	19.16	1.97	0.13	58cfa830e4b0c9d6adf6bd8e	TCGA-BG-A0M3-10A-01D-A101_120406_SN1120_0130_AD0UKGACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0M3-10A	8BDD4E0E-5BEC-43F2-B9FA-D6E94A72FE05	Blood Derived Normal	Illumina HiSeq	20d6cb0d-6d0f-4683-8837-180c95258795	Uterus	74.0	0EB45A88-73EA-4282-B0E1-2E2EA1E2D8F1	6A871B0F-421A-47E1-9B5D-150E4C3E0B99	TCGA-BG-A0M3-10A-01D-A101-02	HG19_Broad_variant	TCGA-BG-A0M3	TCGA-UCEC		s4255	Harvard Medical School	University of Pittsburgh	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13722.58cfa830e4b0c9d6adf6be64	58cfa830e4b0c9d6adf6be64	TCGA-BJ-A3PR-11A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BJ-A3PR-11A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_7_rg.sorted	TCGA-BJ-A3PR-11A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_7_rg.sorted.bam	32.54		0.15	58cfa830e4b0c9d6adf6be64	TCGA-BJ-A3PR-11A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A3PR-11A	FD036EC5-3FFB-40B1-8002-943BE0E2532E	Solid Tissue Normal	Illumina HiSeq	4e71bc35-c98b-4880-9538-13d5c74139d2	Thyroid	69.0	3C13C880-E3E3-4C49-B486-C4388F8C33F3	8EE14781-7682-49F7-BD24-B11B095F2BC3	TCGA-BJ-A3PR-11A-11D-A221-26	HG19_Broad_variant	TCGA-BJ-A3PR	TCGA-THCA		s12847	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T1a	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A221-26	True
13767.58cfa832e4b0c9d6adf6d818	58cfa832e4b0c9d6adf6d818	UNCID_1034446.c67a7631-4bbf-4bee-9743-0e470d0bdf86.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1034446.c67a7631-4bbf-4bee-9743-0e470d0bdf86.sorted_genome_alignments	UNCID_1034446.c67a7631-4bbf-4bee-9743-0e470d0bdf86.sorted_genome_alignments.bam	8.78	1.82	0.15	58cfa832e4b0c9d6adf6d818	UNCID_1034446.c67a7631-4bbf-4bee-9743-0e470d0bdf86.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZR-06A	9F4DDE50-FA0C-43BF-8D5D-70B76CC35793	Metastatic	Illumina HiSeq	A863D7A8-A03C-446E-8441-8D069A79E858	Skin	36.0	4EEC8951-5B1B-4881-BBC9-2B4C2C4FCD16	C67A7631-4BBF-4BEE-9743-0E470D0BDF86	TCGA-FS-A1ZR-06A-21R-A18U-07	HG19	TCGA-FS-A1ZR	TCGA-SKCM	347.0	s7708	University of North Carolina	Essen	Germany	NO	T2	N0		Stage II	A18U-07	True
13722.58cfa82fe4b0c9d6adf6b8d4	58cfa82fe4b0c9d6adf6b8d4	TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted.filtered.	WGS	TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted	TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted.bam	743.7	1.9	0.16	58cfa82fe4b0c9d6adf6b8d4	TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5049-01A	9944F46F-9FA8-4E2C-A806-776BEC7F8803	Primary Tumor	Illumina HiSeq	16ea05eb-f830-4b36-83bb-989c8de99568	Lung	70.0	21B2F32E-CCEA-4B20-86D3-6647E99825CF	26ED24EC-1AD1-492D-B2CB-46314B47919E	TCGA-50-5049-01A-01D-1623-02	HG19_Broad_variant	TCGA-50-5049	TCGA-LUAD		s11457	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1623-02	True
13767.58cfa82fe4b0c9d6adf6b1fc	58cfa82fe4b0c9d6adf6b1fc	TCGA-20-0991-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-20-0991-01A-01R-1564-13_rnaseq	TCGA-20-0991-01A-01R-1564-13_rnaseq.bam	212.0	1.8	0.15	58cfa82fe4b0c9d6adf6b1fc	TCGA-20-0991-01A-01R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-20-0991-01A	36595B52-2B5F-4E87-80EB-37C29109E92A	Primary Tumor	Illumina HiSeq	F788EF06-84C2-478A-B5F6-7EECDAD83D13	Ovary	78.0	62AF5B99-DB7F-4C92-97F1-92E825C15729	70004D87-7C1B-40E6-B246-04BB349DCA6C	TCGA-20-0991-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-20-0991	TCGA-OV		s17230	Canada's Michael Smith Genome Sciences Centre	Fox Chase Cancer Center	None	NO			Serous Cystadenocarcinoma		1564-13	True
13722.58cfa82de4b0c9d6adf6a4dc	58cfa82de4b0c9d6adf6a4dc	3a01287b5f545395a05cd849b38ca6c4.filtered.	WGS	3a01287b5f545395a05cd849b38ca6c4	3a01287b5f545395a05cd849b38ca6c4.bam	26.78		0.08	58cfa82de4b0c9d6adf6a4dc	3a01287b5f545395a05cd849b38ca6c4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3U5-10A	8F3F6F7C-4B50-467E-A6E8-D836735913F6	Blood Derived Normal	Illumina HiSeq	3d868952-9921-4c5f-888f-e248c302900e	Mesenchymal	52.0	BEE94F53-C054-4CFF-926B-1BF1B749D7CD	D88D98C1-20D6-4351-A37B-39915181BA3F	TCGA-DX-A3U5-10A-01D-A22A-09	GRCh37-lite	TCGA-DX-A3U5	TCGA-SARC		s2484	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO					A22A-09	False
13767.58cfa832e4b0c9d6adf6d46e	58cfa832e4b0c9d6adf6d46e	TCGA-R6-A6XG-01B-11R-A336-31_rnaseq.filtered.	RNA-Seq	TCGA-R6-A6XG-01B-11R-A336-31_rnaseq	TCGA-R6-A6XG-01B-11R-A336-31_rnaseq.bam	17.68	1.78	0.18	58cfa832e4b0c9d6adf6d46e	TCGA-R6-A6XG-01B-11R-A336-31_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-R6-A6XG-01B	3DF30783-C93D-4204-9703-C24C2349BA15	Primary Tumor	Illumina HiSeq	0B215708-E7D5-4921-B596-FABD984F5DAB	Esophagus	64.0	733F1FEF-C0C6-48EE-9624-1FCDC682D79E	16014DC9-B654-4670-8FBD-9D0DBB6D66D5	TCGA-R6-A6XG-01B-11R-A336-31	GRCh37-lite	TCGA-R6-A6XG	TCGA-ESCA		s1693	Canada's Michael Smith Genome Sciences Centre	MD Anderson Cancer Center	United States	NO					A336-31	True
13767.58cfa82fe4b0c9d6adf6b2d8	58cfa82fe4b0c9d6adf6b2d8	TCGA-24-0968-01A-01R-1569-13_rnaseq.filtered.	RNA-Seq	TCGA-24-0968-01A-01R-1569-13_rnaseq	TCGA-24-0968-01A-01R-1569-13_rnaseq.bam	176.0	1.8	0.14	58cfa82fe4b0c9d6adf6b2d8	TCGA-24-0968-01A-01R-1569-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-0968-01A	619B14F3-B8CC-4C0A-8304-6719853D592A	Primary Tumor	Illumina HiSeq	7A973523-7DCE-4D66-8633-F8F0D809B718	Ovary	59.0	BD548E12-22A8-471F-B13F-FD7EA5E4E406	B2F7C706-EC61-45D4-9394-44921DC99F8C	TCGA-24-0968-01A-01R-1569-13	NCBI36_BCCAGSC_variant	TCGA-24-0968	TCGA-OV		s17824	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1569-13	True
13767.58cfa839e4b0c9d6adf7107a	58cfa839e4b0c9d6adf7107a	UNCID_2245784.4cb51871-a26f-467e-8742-bb7c09b26ed2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2245784.4cb51871-a26f-467e-8742-bb7c09b26ed2.sorted_genome_alignments	UNCID_2245784.4cb51871-a26f-467e-8742-bb7c09b26ed2.sorted_genome_alignments.bam	39.09	1.93	0.18	58cfa839e4b0c9d6adf7107a	UNCID_2245784.4cb51871-a26f-467e-8742-bb7c09b26ed2.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-S3-A6ZH-01A	EC461EAF-F5CB-4225-A9A0-59D8E6C17EA6	Primary Tumor	Illumina HiSeq	A4F8168A-711F-4836-BD55-917B40E00324	Breast	29.0	62246534-B42C-4D81-B09E-792E55E3CB9A	4CB51871-A26F-467E-8742-BB7C09B26ED2	TCGA-S3-A6ZH-01A-22R-A32P-07	HG19	TCGA-S3-A6ZH	TCGA-BRCA		s6892	University of North Carolina	Albert Einstein Medical Center	United States	NO	T3	N3a	Infiltrating Ductal Carcinoma	Stage III	A32P-07	True
13767.58cfa838e4b0c9d6adf708f7	58cfa838e4b0c9d6adf708f7	UNCID_2055240.6589bdbc-b3a3-4949-8a08-3fd17952bf24.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2055240.6589bdbc-b3a3-4949-8a08-3fd17952bf24.sorted_genome_alignments	UNCID_2055240.6589bdbc-b3a3-4949-8a08-3fd17952bf24.sorted_genome_alignments.bam	18.99	1.89	0.18	58cfa838e4b0c9d6adf708f7	UNCID_2055240.6589bdbc-b3a3-4949-8a08-3fd17952bf24.sorted_genome_alignments.bam	Alive	FEMALE		HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-A64R-01A	67E9B426-72EB-4475-9689-EB75B22C4FD5	Primary Tumor	Illumina HiSeq	ABADEC92-8CFF-49AE-85B3-BE37BADD2832	Brain	24.0	F9DFB8E6-F3D1-4D30-A23C-A738BCEFBF16	6589BDBC-B3A3-4949-8A08-3FD17952BF24	TCGA-DB-A64R-01A-11R-A29R-07	HG19	TCGA-DB-A64R	TCGA-LGG		s8662	University of North Carolina	Mayo Clinic - Rochester	United States	NO			Oligodendroglioma		A29R-07	True
13722.58cfa831e4b0c9d6adf6c41e	58cfa831e4b0c9d6adf6c41e	TCGA-BT-A2LD-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A2LD-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_6_rg.sorted	TCGA-BT-A2LD-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_6_rg.sorted.bam	27.33		0.16	58cfa831e4b0c9d6adf6c41e	TCGA-BT-A2LD-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LD-10A	9DD97821-7AFD-4982-8B1D-F14F845B79F7	Blood Derived Normal	Illumina HiSeq	81838e98-98aa-4bf3-94e0-1819bd2a4c6b	Bladder	78.0	A06B15AF-EAC8-482A-90E2-8BD8E6154AD0	AF8D98C7-B75F-4115-8CF2-2B569B1AF6A8	TCGA-BT-A2LD-10A-01D-A210-26	HG19_Broad_variant	TCGA-BT-A2LD	TCGA-BLCA		s2861	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A210-26	True
13722.58cfa82fe4b0c9d6adf6b66d	58cfa82fe4b0c9d6adf6b66d	TCGA-50-6597-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_4_rg.sorted.filtered.	WGS	TCGA-50-6597-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_4_rg.sorted	TCGA-50-6597-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_4_rg.sorted.bam	14.0	1.8	0.14	58cfa82fe4b0c9d6adf6b66d	TCGA-50-6597-10A-01D-1853_120312_SN1120_0121_BD0RHPACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6597-10A	0D66BF6C-EED0-4726-BD5B-3BF6D610B4E0	Blood Derived Normal	Illumina HiSeq	cf5182e3-08aa-45af-8c6f-2d6afdf01d08	Lung	79.0	254F2707-C4FB-41DA-BFC0-2190EB9368D5	6E660AAE-3656-424B-966A-DEC114CCCBCE	TCGA-50-6597-10A-01D-1853-02	HG19_Broad_variant	TCGA-50-6597	TCGA-LUAD		s11129	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1853-02	True
13722.58cfa82ee4b0c9d6adf6aa4a	58cfa82ee4b0c9d6adf6aa4a	G35154.TCGA-HT-A61B-01A-11D-A461-08.2.filtered.	WGS	G35154.TCGA-HT-A61B-01A-11D-A461-08.2	G35154.TCGA-HT-A61B-01A-11D-A461-08.2.bam	20.91		0.08	58cfa82ee4b0c9d6adf6aa4a	G35154.TCGA-HT-A61B-01A-11D-A461-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-A61B-01A	CF2A1B98-5693-4C04-9167-F85E69A88A4A	Primary Tumor	Illumina HiSeq	95493209-d334-4fbe-aeef-683bf27cdf09	Brain	22.0	32C901F6-B277-4870-B3F4-7A7CE53F124E	46C0DD13-2F72-4396-9F7A-07ACB44D1D57	TCGA-HT-A61B-01A-11D-A461-08	HG19_Broad_variant	TCGA-HT-A61B	TCGA-LGG		s8747	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO			Astrocytoma		A461-08	True
13767.58cfa82ee4b0c9d6adf6af80	58cfa82ee4b0c9d6adf6af80	TCGA-04-1332-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-04-1332-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-04-1332-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	36.0	1.8	0.16	58cfa82ee4b0c9d6adf6af80	TCGA-04-1332-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1332-01A	B46263AB-C3CA-4FDA-A895-74C7E6E6FE22	Primary Tumor	Illumina HiSeq	ECE438AA-9812-4E1A-B491-673505C5B692	Ovary	70.0	B8243412-B7B4-4A7B-B823-4B33488FF429	08E7C700-7038-40B5-BEC0-2DD402E1A225	TCGA-04-1332-01A-01R-1564-13	GRCh37-lite	TCGA-04-1332	TCGA-OV	1247.0	s17764	Canada's Michael Smith Genome Sciences Centre	Gynecologic Oncology Group	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa82fe4b0c9d6adf6b49a	58cfa82fe4b0c9d6adf6b49a	TCGA-24-1565-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-24-1565-01A-01R-1566-13_rnaseq	TCGA-24-1565-01A-01R-1566-13_rnaseq.bam	272.0	1.8	0.15	58cfa82fe4b0c9d6adf6b49a	TCGA-24-1565-01A-01R-1566-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1565-01A	CF1E86EC-4BCB-403C-831B-D67BDDEF14EB	Primary Tumor	Illumina HiSeq	FA369439-1D9E-4710-9E98-3ED79E3EA918	Ovary	74.0	6FEB1257-DA6F-4A70-BBD1-F3AA843EF72A	0D80226B-8C70-44AB-A6D9-F054D89330F3	TCGA-24-1565-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-24-1565	TCGA-OV	312.0	s17378	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1566-13	True
13722.58cfa831e4b0c9d6adf6ccdc	58cfa831e4b0c9d6adf6ccdc	TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted	TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.bam	43.33	1.93	0.17	58cfa831e4b0c9d6adf6ccdc	TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A1YC-01A	0AD2A2B3-C1BB-4597-B28E-A6385F93D09C	Primary Tumor	Illumina HiSeq	256cee86-6dd3-4d12-bb0b-e3ab680044aa	Thyroid	71.0	17610B7B-F2EC-4B55-808C-1C2219A0D1BA	3D02FB7F-EB7D-49F9-BD40-20E9BDA1FBAB	TCGA-EM-A1YC-01A-11D-A14U-02	HG19_Broad_variant	TCGA-EM-A1YC	TCGA-THCA		s12752	Harvard Medical School	University Health Network	Canada	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A14U-02	True
13722.58cfa82de4b0c9d6adf6a72a	58cfa82de4b0c9d6adf6a72a	G14581.TCGA-64-1680-10A-01D-1040-01.2.filtered.	WGS	G14581.TCGA-64-1680-10A-01D-1040-01.2	G14581.TCGA-64-1680-10A-01D-1040-01.2.bam	43.93	2.0	0.15	58cfa82de4b0c9d6adf6a72a	G14581.TCGA-64-1680-10A-01D-1040-01.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-1680-10A	1AB7AD70-0F80-41D8-8EFA-3BAEBC8223CC	Blood Derived Normal	Illumina HiSeq	0e182f6d-70c5-46a2-a737-29990f3c472f	Lung	63.0	B98E2DDC-D065-4E90-B240-A0B37793245F	F4B8B2D5-ACC7-4FD6-B852-C80FD79BE99E	TCGA-64-1680-10A-01D-1040-01	HG19_Broad_variant	TCGA-64-1680	TCGA-LUAD		s10890	Broad Institute of MIT and Harvard	Fox Chase	None	NO	T2a	N2	Lung Adenocarcinoma Mixed Subtype	Stage IV	1040-01	False
13767.58cfa835e4b0c9d6adf6ea6e	58cfa835e4b0c9d6adf6ea6e	UNCID_1277782.047160f7-3727-4915-b02d-61557350d88b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1277782.047160f7-3727-4915-b02d-61557350d88b.sorted_genome_alignments	UNCID_1277782.047160f7-3727-4915-b02d-61557350d88b.sorted_genome_alignments.bam	34.9	1.83	0.17	58cfa835e4b0c9d6adf6ea6e	UNCID_1277782.047160f7-3727-4915-b02d-61557350d88b.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A2LK-01A	1B703058-E596-45BC-80FE-8B98D545C2E2	Primary Tumor	Illumina HiSeq	AD159F02-229E-406B-8168-1C785D4453BF	Breast	62.0	D6F5C34A-0F5C-4AED-977A-74A1E5D50915	047160F7-3727-4915-B02D-61557350D88B	TCGA-AR-A2LK-01A-11R-A180-07	HG19	TCGA-AR-A2LK	TCGA-BRCA		s6207	University of North Carolina	Mayo	United States	NO	T3	N2	Infiltrating Lobular Carcinoma	Stage III	A180-07	True
13767.58cfa838e4b0c9d6adf70997	58cfa838e4b0c9d6adf70997	UNCID_2081797.dff668bd-b423-4ab8-961c-93c0bc093763.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2081797.dff668bd-b423-4ab8-961c-93c0bc093763.sorted_genome_alignments	UNCID_2081797.dff668bd-b423-4ab8-961c-93c0bc093763.sorted_genome_alignments.bam	59.51	1.89	0.17	58cfa838e4b0c9d6adf70997	UNCID_2081797.dff668bd-b423-4ab8-961c-93c0bc093763.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-A5UE-01A	23D8E6A0-FA79-4323-A0A6-2DEA2A319667	Primary Tumor	Illumina HiSeq	A2E81869-9580-464C-BA80-C0C4F78458FA	Liver	48.0	E8A5EC1D-B962-4B48-8EAE-D49BD6291B6B	DFF668BD-B423-4AB8-961C-93C0BC093763	TCGA-CC-A5UE-01A-11R-A28V-07	HG19	TCGA-CC-A5UE	TCGA-LIHC		s16719	University of North Carolina	ILSbio	Vietnam	NO	T4	N0	Hepatocellular Carcinoma	Stage III	A28V-07	True
13722.58cfa832e4b0c9d6adf6cff4	58cfa832e4b0c9d6adf6cff4	TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted.filtered.	WGS	TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted	TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted.bam	8.9		0.16	58cfa832e4b0c9d6adf6cff4	TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2ES-11A	72D8EAE8-9EFB-45B2-ACBD-82C6B5732E38	Solid Tissue Normal	Illumina HiSeq	f8583339-ea56-43ba-af11-e7b5945ecfb4	Bladder	85.0	F7D5544F-E86D-410F-995C-86A717742036	F310E6C4-B237-4EA0-A8A1-679B5B49C50D	TCGA-G2-A2ES-11A-31D-A17R-02	HG19_Broad_variant	TCGA-G2-A2ES	TCGA-BLCA		s3119	Harvard Medical School	MD Anderson	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A17R-02	True
13767.58cfa837e4b0c9d6adf7004e	58cfa837e4b0c9d6adf7004e	UNCID_1857299.994c8287-b6e2-4743-80bb-fe8d0076ae44.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1857299.994c8287-b6e2-4743-80bb-fe8d0076ae44.sorted_genome_alignments	UNCID_1857299.994c8287-b6e2-4743-80bb-fe8d0076ae44.sorted_genome_alignments.bam	9.1	1.79	0.18	58cfa837e4b0c9d6adf7004e	UNCID_1857299.994c8287-b6e2-4743-80bb-fe8d0076ae44.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A423-01A	BDD08EC8-8892-4273-8F21-6FDE0F23C52D	Primary Tumor	Illumina HiSeq	4BA2719F-894B-4E47-A33F-56FEF9D89836	Breast	75.0	4B4DDC10-5B37-42D2-BBF8-B0CAC95AE1B3	994C8287-B6E2-4743-80BB-FE8D0076AE44	TCGA-EW-A423-01A-11R-A24H-07	HG19	TCGA-EW-A423	TCGA-BRCA		s6730	University of North Carolina	University of Miami	United States	NO	T2	N0	Infiltrating Lobular Carcinoma	Stage II	A24H-07	True
13767.58cfa838e4b0c9d6adf70b86	58cfa838e4b0c9d6adf70b86	UNCID_2134710.48dd74fe-11ff-4514-87b3-1569e9606c73.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2134710.48dd74fe-11ff-4514-87b3-1569e9606c73.sorted_genome_alignments	UNCID_2134710.48dd74fe-11ff-4514-87b3-1569e9606c73.sorted_genome_alignments.bam	60.88	1.82	0.17	58cfa838e4b0c9d6adf70b86	UNCID_2134710.48dd74fe-11ff-4514-87b3-1569e9606c73.sorted_genome_alignments.bam	Dead	FEMALE	WHITE		Adrenocortical Carcinoma	Aligned reads	TCGA-OR-A5K9-01A	D890CBF7-41D8-4992-99C2-24C60C77B156	Primary Tumor	Illumina HiSeq	5C7841D0-A133-46D7-A90B-F6522E612F79	Adrenal Gland	61.0	E78F3AC4-0E3A-4DF8-873A-B7AB384CAF62	48DD74FE-11FF-4514-87B3-1569E9606C73	TCGA-OR-A5K9-01A-11R-A29S-07	HG19	TCGA-OR-A5K9	TCGA-ACC	344.0	s104	University of North Carolina	University of Michigan	United States	NO	T2	N0		Stage II	A29S-07	True
13722.58cfa82ee4b0c9d6adf6adfc	58cfa82ee4b0c9d6adf6adfc	G49538.TCGA-06-0211-01A-01D-1491-08.1.filtered.	WGS	G49538.TCGA-06-0211-01A-01D-1491-08.1	G49538.TCGA-06-0211-01A-01D-1491-08.1.bam	0.0	1.88	0.05	58cfa82ee4b0c9d6adf6adfc	G49538.TCGA-06-0211-01A-01D-1491-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0211-01A	5C984433-33CF-42FC-B3BA-511EFCDCAB19	Primary Tumor	Illumina HiSeq	c68adb10-306f-4541-92b1-c6b5baa25d00	Brain	47.0	83177103-6AE2-444E-8AE7-E1BF76B1351D	CAEF21A2-190E-456D-95C9-3927A0B250AC	TCGA-06-0211-01A-01D-1491-08	HG19_Broad_variant	TCGA-06-0211	TCGA-GBM	360.0	s13948	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1491-08	False
13767.58cfa838e4b0c9d6adf70c7e	58cfa838e4b0c9d6adf70c7e	UNCID_2137969.7c34cec8-0cc8-409d-9a3d-30ef4b63583d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2137969.7c34cec8-0cc8-409d-9a3d-30ef4b63583d.sorted_genome_alignments	UNCID_2137969.7c34cec8-0cc8-409d-9a3d-30ef4b63583d.sorted_genome_alignments.bam	36.34	1.87	0.15	58cfa838e4b0c9d6adf70c7e	UNCID_2137969.7c34cec8-0cc8-409d-9a3d-30ef4b63583d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Carcinosarcoma	Aligned reads	TCGA-N8-A4PN-01A	8B7C42CD-FC2A-4023-843E-A411821F94FF	Primary Tumor	Illumina HiSeq	0B692990-F3AB-45D1-BB53-694F655EB0E5	Uterus	68.0	FB57DF69-928B-43EE-9CEB-B76386ABC8C0	7C34CEC8-0CC8-409D-9A3D-30EF4B63583D	TCGA-N8-A4PN-01A-11R-A28V-07	HG19	TCGA-N8-A4PN	TCGA-UCS		s90	University of North Carolina	University of North Carolina	United States	NO					A28V-07	True
13767.58cfa837e4b0c9d6adf6fd48	58cfa837e4b0c9d6adf6fd48	UNCID_1711502.981a7d0e-ca01-476d-bd58-a46b8d8595cc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1711502.981a7d0e-ca01-476d-bd58-a46b8d8595cc.sorted_genome_alignments	UNCID_1711502.981a7d0e-ca01-476d-bd58-a46b8d8595cc.sorted_genome_alignments.bam	129.2		0.15	58cfa837e4b0c9d6adf6fd48	UNCID_1711502.981a7d0e-ca01-476d-bd58-a46b8d8595cc.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KN-8422-11A	4A88BC85-4C6E-4FAC-8DBB-D3FC5F36B35E	Solid Tissue Normal	Illumina HiSeq	275022E0-71FA-4A06-9E36-8271867FAD46	Kidney	28.0	BBE0EF99-A144-4EA4-9A06-5C58326B1F62	981A7D0E-CA01-476D-BD58-A46B8D8595CC	TCGA-KN-8422-11A-01R-2315-07	HG19	TCGA-KN-8422	TCGA-KICH		s16556	University of North Carolina	Harvard	United States	NO	T1a	N0	Kidney Chromophobe	Stage I	2315-07	True
13722.58cfa831e4b0c9d6adf6c862	58cfa831e4b0c9d6adf6c862	TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina.filtered.	WGS	TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina	TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina.bam	112.4	1.9	0.05	58cfa831e4b0c9d6adf6c862	TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-6093-01A	3F93D1CF-A307-4E29-9E6F-239E9FFAA179	Primary Tumor	Illumina HiSeq	1e7df335-e096-49e1-8490-8be7151ec2db	Kidney	73.0	13BA18EB-C94B-4F6C-AB50-2A98A8044CED	51206157-94CC-4702-8247-C98283B487AA	TCGA-CW-6093-01A-11D-2279-10	GRCh37-lite	TCGA-CW-6093	TCGA-KIRC		s9571	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2279-10	False
13767.58cfa833e4b0c9d6adf6dfe8	58cfa833e4b0c9d6adf6dfe8	UNCID_1148929.d73174ef-182c-48b9-af79-dfb457d5b7be.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1148929.d73174ef-182c-48b9-af79-dfb457d5b7be.sorted_genome_alignments	UNCID_1148929.d73174ef-182c-48b9-af79-dfb457d5b7be.sorted_genome_alignments.bam	47.98	1.76	0.13	58cfa833e4b0c9d6adf6dfe8	UNCID_1148929.d73174ef-182c-48b9-af79-dfb457d5b7be.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JE-01A	36FE6152-F61E-4948-9CCC-23AC01A9D77D	Primary Tumor	Illumina HiSeq	6CB3EA86-745B-45D7-BCA2-E9C8CC785563	Breast	53.0	0A43AD98-2671-4701-9E5D-35AD63E8AD50	D73174EF-182C-48B9-AF79-DFB457D5B7BE	TCGA-AO-A0JE-01A-11R-A056-07	HG19	TCGA-AO-A0JE	TCGA-BRCA		s6690	University of North Carolina	MSKCC	None	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage III	A056-07	True
13767.58cfa835e4b0c9d6adf6eb68	58cfa835e4b0c9d6adf6eb68	UNCID_1323150.c0639498-dcbb-432b-816a-1aa025c5ad60.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1323150.c0639498-dcbb-432b-816a-1aa025c5ad60.sorted_genome_alignments	UNCID_1323150.c0639498-dcbb-432b-816a-1aa025c5ad60.sorted_genome_alignments.bam	145.2		0.14	58cfa835e4b0c9d6adf6eb68	UNCID_1323150.c0639498-dcbb-432b-816a-1aa025c5ad60.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-J2-8194-01A	2B68B51F-BD4C-4BBB-B4E6-2EEAD53DA2A4	Primary Tumor	Illumina HiSeq	0DA8656E-DB79-49AE-B358-BA13C805CD36	Lung	69.0	0D1AFF40-772D-436F-9802-971880A2058B	C0639498-DCBB-432B-816A-1AA025C5AD60	TCGA-J2-8194-01A-11R-2241-07	HG19	TCGA-J2-8194	TCGA-LUAD		s11566	University of North Carolina	ABS - Lahey Clinic	United States	NO	T3	N0	Lung Adenocarcinoma Mixed Subtype	Stage II	2241-07	True
13767.58cfa834e4b0c9d6adf6e635	58cfa834e4b0c9d6adf6e635	UNCID_1190912.8236c198-1836-47e3-8766-ad19de805fd6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1190912.8236c198-1836-47e3-8766-ad19de805fd6.sorted_genome_alignments	UNCID_1190912.8236c198-1836-47e3-8766-ad19de805fd6.sorted_genome_alignments.bam	39.8	1.8	0.16	58cfa834e4b0c9d6adf6e635	UNCID_1190912.8236c198-1836-47e3-8766-ad19de805fd6.sorted_genome_alignments.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5678-11A	822CF6C1-DD65-4814-94B1-0C335208AD9B	Solid Tissue Normal	Illumina HiSeq	3CCE7EE9-61E2-48D6-8C9A-2D2725B4955E	Kidney	62.0	E2A8A613-FA46-4458-8956-6A992099E93A	8236C198-1836-47E3-8766-AD19DE805FD6	TCGA-CJ-5678-11A-01R-1541-07	HG19	TCGA-CJ-5678	TCGA-KIRC	574.0	s9796	University of North Carolina	MD Anderson Cancer Center	None	NO	T2b	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1541-07	True
13767.58cfa831e4b0c9d6adf6c374	58cfa831e4b0c9d6adf6c374	TCGA-CD-8525-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	TCGA-CD-8525-01A-11R-2343-13_rnaseq	TCGA-CD-8525-01A-11R-2343-13_rnaseq.bam	330.2		0.15	58cfa831e4b0c9d6adf6c374	TCGA-CD-8525-01A-11R-2343-13_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-8525-01A	39ACB803-F282-422E-AC56-A3A50693D203	Primary Tumor	Illumina HiSeq	44D41211-9D71-401A-8206-D0D4EE23613B	Stomach	82.0	31B67C28-869B-44AC-90FE-9F0FFFA22DF1	21DB6663-DEF9-49C6-9184-4479AAD5D6F1	TCGA-CD-8525-01A-11R-2343-13	GRCh37-lite	TCGA-CD-8525	TCGA-STAD		s14634	Canada's Michael Smith Genome Sciences Centre	ILSbio	Vietnam	NO	T3	N1	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage III	2343-13	True
13722.58cfa831e4b0c9d6adf6cb20	58cfa831e4b0c9d6adf6cb20	TCGA-E7-A3Y1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_8_rg.sorted.filtered.	WGS	TCGA-E7-A3Y1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_8_rg.sorted	TCGA-E7-A3Y1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_8_rg.sorted.bam	30.66		0.15	58cfa831e4b0c9d6adf6cb20	TCGA-E7-A3Y1-10A-01D-A233_120829_SN1120_0184_BD1DRAACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E7-A3Y1-10A	F7C891EB-3B09-4E01-BB8A-53D570518CBE	Blood Derived Normal	Illumina HiSeq	57523af1-f9b2-4f88-abec-4cf325040361	Bladder	57.0	C731473C-DAFC-4F28-9683-7FCF109D79D8	42EB6C1F-26F0-4D41-9184-8614DD9EE356	TCGA-E7-A3Y1-10A-01D-A233-26	HG19_Broad_variant	TCGA-E7-A3Y1	TCGA-BLCA		s3396	MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO		N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A233-26	True
13767.58cfa838e4b0c9d6adf70d26	58cfa838e4b0c9d6adf70d26	UNCID_2154677.e3bf3a11-d3e5-4596-82ca-64833bd3f841.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2154677.e3bf3a11-d3e5-4596-82ca-64833bd3f841.sorted_genome_alignments	UNCID_2154677.e3bf3a11-d3e5-4596-82ca-64833bd3f841.sorted_genome_alignments.bam	19.87	1.87	0.15	58cfa838e4b0c9d6adf70d26	UNCID_2154677.e3bf3a11-d3e5-4596-82ca-64833bd3f841.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-MM-A564-01A	620BAEFA-DB8F-4AF9-9101-4B9B252FA73E	Primary Tumor	Illumina HiSeq	F6C24095-BBB4-4024-963E-5D6779DDAD66	Kidney	68.0	AD7FF747-BC4D-45A7-B389-D3D4705F48BE	E3BF3A11-D3E5-4596-82CA-64833BD3F841	TCGA-MM-A564-01A-11R-A266-07	HG19	TCGA-MM-A564	TCGA-KIRC		s9237	University of North Carolina	BLN - Baylor	United States	NO	T2a	NX	Kidney Clear Cell Renal Carcinoma	Stage II	A266-07	True
13767.58cfa833e4b0c9d6adf6dbd2	58cfa833e4b0c9d6adf6dbd2	UNCID_1123971.0a69935d-9552-4792-9b2e-1a630114691e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1123971.0a69935d-9552-4792-9b2e-1a630114691e.sorted_genome_alignments	UNCID_1123971.0a69935d-9552-4792-9b2e-1a630114691e.sorted_genome_alignments.bam	47.98	1.96	0.15	58cfa833e4b0c9d6adf6dbd2	UNCID_1123971.0a69935d-9552-4792-9b2e-1a630114691e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A27F-01A	1549DC64-3DAB-43FC-96E9-B07D520957E1	Primary Tumor	Illumina HiSeq	79705664-9101-460D-B5C1-BD3E54A4D524	Breast	40.0	7E9145F7-CCFF-4132-B2B7-9B992EEBEBF4	0A69935D-9552-4792-9B2E-1A630114691E	TCGA-D8-A27F-01A-11R-A16F-07	HG19	TCGA-D8-A27F	TCGA-BRCA		s6802	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A16F-07	True
13722.58cfa82fe4b0c9d6adf6b8f8	58cfa82fe4b0c9d6adf6b8f8	TCGA-A6-2683-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2683-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2683-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	790.56	1.9	0.16	58cfa82fe4b0c9d6adf6b8f8	TCGA-A6-2683-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2683-10A	FAFD4576-0709-49E1-926F-AD1EE09907EC	Blood Derived Normal	Illumina HiSeq	98608f88-13ef-4b96-91d0-d6f053a8a8a3	Colorectal	57.0	D62CA19B-102E-4018-A957-ACFB23055369	98056E22-3F16-4920-94E1-39E334B37D18	TCGA-A6-2683-10A-01D-1167-02	HG18	TCGA-A6-2683	TCGA-COAD		s13504	Harvard Medical School	Christiana Healthcare	None	NO	T4	N0	Colon Adenocarcinoma	Stage IV	1167-02	True
13767.58cfa839e4b0c9d6adf710ca	58cfa839e4b0c9d6adf710ca	UNCID_2250749.10f253bd-1cdd-4515-a7fa-b9ed6e1a1790.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2250749.10f253bd-1cdd-4515-a7fa-b9ed6e1a1790.sorted_genome_alignments	UNCID_2250749.10f253bd-1cdd-4515-a7fa-b9ed6e1a1790.sorted_genome_alignments.bam	38.72	1.91	0.18	58cfa839e4b0c9d6adf710ca	UNCID_2250749.10f253bd-1cdd-4515-a7fa-b9ed6e1a1790.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A6R0-01A	5BF40B29-D722-430A-91BC-CAD941EE3694	Primary Tumor	Illumina HiSeq	68E573D6-E633-4306-B460-A92DCFF7E953	Skin	58.0	2E8B6ECC-8921-4EB9-B5C3-3E1EBF77FB2F	10F253BD-1CDD-4515-A7FA-B9ED6E1A1790	TCGA-EB-A6R0-01A-12R-A32P-07	HG19	TCGA-EB-A6R0	TCGA-SKCM		s7454	University of North Carolina	Asterand	Ukraine	NO	T4b	N0		Stage II	A32P-07	True
13767.58cfa835e4b0c9d6adf6f254	58cfa835e4b0c9d6adf6f254	UNCID_1455462.889cd706-f713-482b-9c49-fe531d5dd4e1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1455462.889cd706-f713-482b-9c49-fe531d5dd4e1.sorted_genome_alignments	UNCID_1455462.889cd706-f713-482b-9c49-fe531d5dd4e1.sorted_genome_alignments.bam	26.68	1.8	0.18	58cfa835e4b0c9d6adf6f254	UNCID_1455462.889cd706-f713-482b-9c49-fe531d5dd4e1.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3GR-01A	B107B012-335A-4282-A7AA-273B740831F1	Primary Tumor	Illumina HiSeq	807F9C1E-6B14-427C-970F-7A9CF4108BEA	Thyroid	31.0	12693F53-FA09-494C-82EB-BF735EA84E98	889CD706-F713-482B-9C49-FE531D5DD4E1	TCGA-EL-A3GR-01A-21R-A206-07	HG19	TCGA-EL-A3GR	TCGA-THCA		s12292	University of North Carolina	MD Anderson	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A206-07	True
13767.58cfa837e4b0c9d6adf70175	58cfa837e4b0c9d6adf70175	UNCID_1856328.e6ea1a59-d3b3-44ef-9f81-ea80b7e60a0d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1856328.e6ea1a59-d3b3-44ef-9f81-ea80b7e60a0d.sorted_genome_alignments	UNCID_1856328.e6ea1a59-d3b3-44ef-9f81-ea80b7e60a0d.sorted_genome_alignments.bam	22.4	1.89	0.18	58cfa837e4b0c9d6adf70175	UNCID_1856328.e6ea1a59-d3b3-44ef-9f81-ea80b7e60a0d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GF-A4EO-06A	EC4CC744-04DF-4BA9-9159-E4940C702281	Metastatic	Illumina HiSeq	76CEE79B-2256-4F1D-B5BA-1FAC19F6414B	Skin	74.0	133CE2A1-53F0-45EE-A5A9-42C1F69D5452	E6EA1A59-D3B3-44EF-9F81-EA80B7E60A0D	TCGA-GF-A4EO-06A-12R-A24X-07	HG19	TCGA-GF-A4EO	TCGA-SKCM		s7760	University of North Carolina	ABS - IUPUI	United States	NO	T0	N3		Stage III	A24X-07	True
13722.58cfa831e4b0c9d6adf6c360	58cfa831e4b0c9d6adf6c360	TCGA-CG-5719-10A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CG-5719-10A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_3_rg.sorted	TCGA-CG-5719-10A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_3_rg.sorted.bam	94.7	1.8	0.15	58cfa831e4b0c9d6adf6c360	TCGA-CG-5719-10A-01D-1598_121029_SN208_0439_BD1KHKACXX_s_3_rg.sorted.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5719-10A	263F67E0-0A28-42E6-B3F3-1DDD0D397220	Blood Derived Normal	Illumina HiSeq	74d5e460-86bd-441b-9409-00b8f0248eb9	Stomach	54.0	6CF9DAA3-1ED5-45C2-9A6F-3340D256C9D7	B0A51CDD-A3AC-4497-B9CB-3B766E4A549F	TCGA-CG-5719-10A-01D-1598-02	HG19_Broad_variant	TCGA-CG-5719	TCGA-STAD		s14902	Harvard Medical School	Indivumed	Germany	NO	T4	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1598-02	True
13722.58cfa82ee4b0c9d6adf6ac16	58cfa82ee4b0c9d6adf6ac16	G39019.TCGA-GN-A264-06A-11D-A196-08.1.filtered.	WGS	G39019.TCGA-GN-A264-06A-11D-A196-08.1	G39019.TCGA-GN-A264-06A-11D-A196-08.1.bam	47.7		0.09	58cfa82ee4b0c9d6adf6ac16	G39019.TCGA-GN-A264-06A-11D-A196-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GN-A264-06A	76CC1D42-ACEC-46B3-9663-5E4DE2550353	Metastatic	Illumina HiSeq	c2a3d9c8-b29b-4246-be90-70b59cdcc922	Skin	60.0	E6B93BA0-FC9C-40C0-B82F-F7E71319EE0A	450E8EBA-A3A9-4DCB-B423-E33DFCD5C34E	TCGA-GN-A264-06A-11D-A196-08	HG19_Broad_variant	TCGA-GN-A264	TCGA-SKCM	3587.0	s7663	Broad Institute of MIT and Harvard	Roswell	United States	NO					A196-08	True
13767.58cfa837e4b0c9d6adf700d2	58cfa837e4b0c9d6adf700d2	UNCID_1805739.b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1805739.b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9.sorted_genome_alignments	UNCID_1805739.b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9.sorted_genome_alignments.bam	11.38	1.83	0.17	58cfa837e4b0c9d6adf700d2	UNCID_1805739.b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E9-A3X8-01A	95873E61-AFDB-496C-9F77-3F9BEB008CDA	Primary Tumor	Illumina HiSeq	C22D1F11-72C2-41EE-BB9C-CE19CB1B0695	Breast	48.0	C9E12D18-6092-499F-92AE-6FD6B16F2ACD	B2D76401-5EAE-4AA9-9C5C-3D6AD41F50D9	TCGA-E9-A3X8-01A-31R-A22U-07	HG19	TCGA-E9-A3X8	TCGA-BRCA		s6071	University of North Carolina	Asterand	Russia	NO	T2	N1	Infiltrating Lobular Carcinoma	Stage II	A22U-07	True
13767.58cfa838e4b0c9d6adf7059c	58cfa838e4b0c9d6adf7059c	UNCID_1966453.99471b35-21e6-44cb-863e-d60521a71b31.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1966453.99471b35-21e6-44cb-863e-d60521a71b31.sorted_genome_alignments	UNCID_1966453.99471b35-21e6-44cb-863e-d60521a71b31.sorted_genome_alignments.bam	57.99	1.8	0.15	58cfa838e4b0c9d6adf7059c	UNCID_1966453.99471b35-21e6-44cb-863e-d60521a71b31.sorted_genome_alignments.bam	Alive	FEMALE			Bladder Urothelial Carcinoma	Aligned reads	TCGA-HQ-A2OF-01A	691ADAA9-196A-4B62-9437-640C4AE6E2B2	Primary Tumor	Illumina HiSeq	CEAB5BF4-BB71-4BD9-BDE2-76B86C21138E	Bladder	52.0	6A971539-F1C4-4404-B825-6B50BDBD9B11	99471B35-21E6-44CB-863E-D60521A71B31	TCGA-HQ-A2OF-01A-11R-A26T-07	HG19	TCGA-HQ-A2OF	TCGA-BLCA		s3347	University of North Carolina	Ontario Institute for Cancer Research (OICR)	Canada	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A26T-07	True
13722.58cfa82ee4b0c9d6adf6ab6a	58cfa82ee4b0c9d6adf6ab6a	G32459.TCGA-BL-A13J-10A-01D-A10S-08.2.filtered.	WGS	G32459.TCGA-BL-A13J-10A-01D-A10S-08.2	G32459.TCGA-BL-A13J-10A-01D-A10S-08.2.bam	16.09	2.03	0.07	58cfa82ee4b0c9d6adf6ab6a	G32459.TCGA-BL-A13J-10A-01D-A10S-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13J-10A	556FCBC8-172A-4AF1-8822-AE036E8D68E8	Blood Derived Normal	Illumina HiSeq	05303fca-70be-4464-8117-63e19ea2b177	Bladder	65.0	C7348A4B-9360-4249-B1E2-CFD8647D3633	E34479B8-834F-4747-984B-E77272F1379D	TCGA-BL-A13J-10A-01D-A10S-08	HG19_Broad_variant	TCGA-BL-A13J	TCGA-BLCA	81.0	s3078	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T4	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A10S-08	True
13722.58cfa83ce4b0c9d6adf730ed	58cfa83ce4b0c9d6adf730ed	b2e10818826b4072c8f92e5b678b4332.filtered.	WGS	b2e10818826b4072c8f92e5b678b4332	b2e10818826b4072c8f92e5b678b4332.bam	76.73	1.92	0.08	58cfa83ce4b0c9d6adf730ed	b2e10818826b4072c8f92e5b678b4332.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IQ-01A	01EEF340-598C-4205-A990-CEC190AC2CA5	Primary Tumor	Illumina HiSeq	7f45dc68-74e8-4953-8221-00c2ba51dee4	Breast	40.0	183A47B2-1B00-4A72-ADEB-F35B55692EE1	8956D73D-7E36-4129-8A3E-D4F3B43BAF0B	TCGA-B6-A0IQ-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0IQ	TCGA-BRCA		s6102	Washington University School of Medicine	Duke	United States	NO	T3	N1b	Infiltrating Ductal Carcinoma	Stage III	A128-09	True
13767.58cfa83be4b0c9d6adf729b2	58cfa83be4b0c9d6adf729b2	UNCID_359227.TCGA-BP-4334-01A-01R-1289-07.110503_UNC10-SN254_0214_AB0BCKABXX.4.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_359227.TCGA-BP-4334-01A-01R-1289-07.110503_UNC10-SN254_0214_AB0BCKABXX.4.trimmed.annotated.translated_to_genomic	UNCID_359227.TCGA-BP-4334-01A-01R-1289-07.110503_UNC10-SN254_0214_AB0BCKABXX.4.trimmed.annotated.translated_to_genomic.bam	76.3	1.8	0.15	58cfa83be4b0c9d6adf729b2	UNCID_359227.TCGA-BP-4334-01A-01R-1289-07.110503_UNC10-SN254_0214_AB0BCKABXX.4.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4334-01A	E5ECA191-F585-490D-81E3-9CCED1047093	Primary Tumor	Illumina HiSeq	8949DDFC-A529-4A86-89BB-ECB54EC92321	Kidney	56.0	171B0609-F2AC-4B04-AEAF-27EC060D698E	AE10B2D3-93C1-44ED-866F-456BC56BDBDE	TCGA-BP-4334-01A-01R-1289-07	HG19	TCGA-BP-4334	TCGA-KIRC		s9873	University of North Carolina	MSKCC	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1289-07	True
13767.58cfa833e4b0c9d6adf6dc40	58cfa833e4b0c9d6adf6dc40	UNCID_1122956.c0f29396-d239-4f0d-a95a-0838770eb24a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1122956.c0f29396-d239-4f0d-a95a-0838770eb24a.sorted_genome_alignments	UNCID_1122956.c0f29396-d239-4f0d-a95a-0838770eb24a.sorted_genome_alignments.bam	29.23	1.87	0.18	58cfa833e4b0c9d6adf6dc40	UNCID_1122956.c0f29396-d239-4f0d-a95a-0838770eb24a.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A2FS-01A	D34471A1-B367-4F8A-B35A-C5901C4F5503	Primary Tumor	Illumina HiSeq	E0A3D913-D6A2-486A-9B1C-EA5E989A224B	Breast	41.0	D92B4202-25D2-40B1-A704-C6BCA0EB5BC3	C0F29396-D239-4F0D-A95A-0838770EB24A	TCGA-EW-A2FS-01A-11R-A17B-07	HG19	TCGA-EW-A2FS	TCGA-BRCA		s6493	University of North Carolina	University of Miami	United States	NO	T2	N1mi	Infiltrating Ductal Carcinoma	Stage II	A17B-07	True
13767.58cfa834e4b0c9d6adf6e301	58cfa834e4b0c9d6adf6e301	UNCID_1185109.8da87146-a8a4-4b2a-b25d-43cd0ac9d6e4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1185109.8da87146-a8a4-4b2a-b25d-43cd0ac9d6e4.sorted_genome_alignments	UNCID_1185109.8da87146-a8a4-4b2a-b25d-43cd0ac9d6e4.sorted_genome_alignments.bam	36.3	1.8	0.13	58cfa834e4b0c9d6adf6e301	UNCID_1185109.8da87146-a8a4-4b2a-b25d-43cd0ac9d6e4.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4899-01A	900B5F21-E8FB-4A3F-B8E3-EF098716E508	Primary Tumor	Illumina HiSeq	5895DAE3-F087-4FDD-ADA3-25AC5EF403E2	Kidney	42.0	E2D40747-F751-4CCB-A45C-A60B06046DB1	8DA87146-A8A4-4B2A-B25D-43CD0AC9D6E4	TCGA-CJ-4899-01A-01R-1334-07	HG19	TCGA-CJ-4899	TCGA-KIRC		s9605	University of North Carolina	MD Anderson Cancer Center	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13722.58cfa831e4b0c9d6adf6c68a	58cfa831e4b0c9d6adf6c68a	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.bam	36.74	1.82	0.16	58cfa831e4b0c9d6adf6c68a	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YR-01A	811B3950-36E7-485F-BC48-ACA1EEE2DDEF	Primary Tumor	Illumina HiSeq	197d19a7-07c1-4cd3-b41d-a8233c9d8a42	Bladder	83.0	B362FCFA-4E31-4321-9E17-11A8BAE839C3	0CB51232-CFEA-4F4F-A26A-173B1094A64B	TCGA-CU-A0YR-01A-12D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YR	TCGA-BLCA		s3096	Harvard Medical School	UNC	United States	NO	T2	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A10R-02	True
13767.58cfa833e4b0c9d6adf6dc64	58cfa833e4b0c9d6adf6dc64	UNCID_1119383.d0705a73-e6d0-4282-82b1-76d44bda242f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1119383.d0705a73-e6d0-4282-82b1-76d44bda242f.sorted_genome_alignments	UNCID_1119383.d0705a73-e6d0-4282-82b1-76d44bda242f.sorted_genome_alignments.bam	48.84	1.81	0.16	58cfa833e4b0c9d6adf6dc64	UNCID_1119383.d0705a73-e6d0-4282-82b1-76d44bda242f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1IG-01A	BC0BC70F-C6CF-4DBC-9DC3-8B7BC5F381A4	Primary Tumor	Illumina HiSeq	DD3971F6-BE26-420A-B568-6496D2BF6D79	Breast	45.0	5E429DD7-787C-4E7D-B672-B000B7B57929	D0705A73-E6D0-4282-82B1-76D44BDA242F	TCGA-E2-A1IG-01A-11R-A144-07	HG19	TCGA-E2-A1IG	TCGA-BRCA		s5988	University of North Carolina	Roswell Park	None	NO	T2	N1mi	Infiltrating Ductal Carcinoma	Stage II	A144-07	True
13722.58cfa831e4b0c9d6adf6c632	58cfa831e4b0c9d6adf6c632	TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted	TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted.bam	250.0	1.9	0.15	58cfa831e4b0c9d6adf6c632	TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted.bam	Dead	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4441-01A	37E22429-EFD7-4D6A-B79A-9D8C7BE2170C	Primary Tumor	Illumina HiSeq	d3542e45-2b25-406d-976d-5d4c63e4839e	Stomach	83.0	60937697-57BA-4D03-9545-B0E321215448	DE856FF9-FEF4-4AA8-9418-F29EB79932B0	TCGA-CG-4441-01A-01D-1798-02	HG19_Broad_variant	TCGA-CG-4441	TCGA-STAD	426.0	s14699	Harvard Medical School	Indivumed	Germany	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1798-02	True
13767.58cfa83be4b0c9d6adf720b4	58cfa83be4b0c9d6adf720b4	UNCID_2579481.c82f8da8-cc5f-4395-bb39-a3db75a8a247.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2579481.c82f8da8-cc5f-4395-bb39-a3db75a8a247.sorted_genome_alignments	UNCID_2579481.c82f8da8-cc5f-4395-bb39-a3db75a8a247.sorted_genome_alignments.bam	83.56	1.88	0.16	58cfa83be4b0c9d6adf720b4	UNCID_2579481.c82f8da8-cc5f-4395-bb39-a3db75a8a247.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thymoma	Aligned reads	TCGA-XM-AAZ1-01A	9084A558-11EA-448C-9F9D-0F90A94A29AF	Primary Tumor	Illumina HiSeq	004CB7A8-F41F-4955-8C70-B4682F2E8797	Thymus	42.0	2D6612AE-A9A2-4FF0-8EF2-23DF0EB155C3	C82F8DA8-CC5F-4395-BB39-A3DB75A8A247	TCGA-XM-AAZ1-01A-11R-A42C-07	HG19	TCGA-XM-AAZ1	TCGA-THYM		s511	University of North Carolina	MSKCC	United States	NO					A42C-07	True
13767.58cfa836e4b0c9d6adf6f582	58cfa836e4b0c9d6adf6f582	UNCID_1567656.11b3ce08-d237-4e4e-8656-a235d3964f8f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1567656.11b3ce08-d237-4e4e-8656-a235d3964f8f.sorted_genome_alignments	UNCID_1567656.11b3ce08-d237-4e4e-8656-a235d3964f8f.sorted_genome_alignments.bam	96.2		0.15	58cfa836e4b0c9d6adf6f582	UNCID_1567656.11b3ce08-d237-4e4e-8656-a235d3964f8f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-7638-01B	1F54D21E-752F-496D-8453-4B9B8738CBCE	Primary Tumor	Illumina HiSeq	A4B95C08-5197-48E5-834D-19821061B699	Brain	31.0	2362A118-C13A-4E4B-8158-8889BE60A6C3	11B3CE08-D237-4E4E-8656-A235D3964F8F	TCGA-FG-7638-01B-12R-2090-07	HG19	TCGA-FG-7638	TCGA-LGG		s8406	University of North Carolina	Case Western	United States	NO			Oligodendroglioma		2090-07	True
13767.58cfa838e4b0c9d6adf70abe	58cfa838e4b0c9d6adf70abe	UNCID_2144996.2928fe95-b646-44a3-808a-36f0751c887b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2144996.2928fe95-b646-44a3-808a-36f0751c887b.sorted_genome_alignments	UNCID_2144996.2928fe95-b646-44a3-808a-36f0751c887b.sorted_genome_alignments.bam	40.41	1.86	0.17	58cfa838e4b0c9d6adf70abe	UNCID_2144996.2928fe95-b646-44a3-808a-36f0751c887b.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Adrenocortical Carcinoma	Aligned reads	TCGA-OR-A5L5-01A	2F04E760-8A64-49F2-A1D6-3D390604745C	Primary Tumor	Illumina HiSeq	2303688B-5CE1-4578-B5A8-99CB87E312CE	Adrenal Gland	77.0	321A91CE-7CC6-49E0-9E50-130DB43DB7F5	2928FE95-B646-44A3-808A-36F0751C887B	TCGA-OR-A5L5-01A-11R-A29S-07	HG19	TCGA-OR-A5L5	TCGA-ACC		s161	University of North Carolina	University of Michigan	Germany	NO	T1	N0		Stage I	A29S-07	True
13722.58cfa831e4b0c9d6adf6c504	58cfa831e4b0c9d6adf6c504	TCGA-CF-A3MG-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CF-A3MG-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_8_rg.sorted	TCGA-CF-A3MG-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_8_rg.sorted.bam	60.19		0.16	58cfa831e4b0c9d6adf6c504	TCGA-CF-A3MG-10A-01D-A210_120914_SN590_0180_BC19KDACXX_s_8_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MG-10A	39EFA06A-FFE5-40B3-8F8A-A2D7071BC9E3	Blood Derived Normal	Illumina HiSeq	1385e047-6123-41fc-bd33-96122ff0e918	Bladder	48.0	97AAAEE6-F7F3-451C-8149-B4A7B783A4FC	640F6D03-1C1B-4B7F-8055-44E1F08FC852	TCGA-CF-A3MG-10A-01D-A210-26	HG19_Broad_variant	TCGA-CF-A3MG	TCGA-BLCA		s3093	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	True
13767.58cfa82ee4b0c9d6adf6ab0c	58cfa82ee4b0c9d6adf6ab0c	G17229.TCGA-15-0742-01A-01R-1850-01.2.filtered.	RNA-Seq	G17229.TCGA-15-0742-01A-01R-1850-01.2	G17229.TCGA-15-0742-01A-01R-1850-01.2.bam	94.93	1.81	0.18	58cfa82ee4b0c9d6adf6ab0c	G17229.TCGA-15-0742-01A-01R-1850-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-15-0742-01A	F19850CB-50C4-4F3A-BA80-B1464958FFA8	Primary Tumor	Illumina HiSeq	745E2994-A3FA-44B8-AE8A-9CD96833704E	Brain	65.0	FD8A47FE-13C9-4DBB-BD15-F37F59C05333	3721666C-F46F-4B43-9F5D-B3CF85AF176C	TCGA-15-0742-01A-01R-1850-01	HG19_Broad_variant	TCGA-15-0742	TCGA-GBM	419.0	s14015	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO			Untreated primary (de novo) GBM		1850-01	True
13722.58cfa831e4b0c9d6adf6cb44	58cfa831e4b0c9d6adf6cb44	TCGA-EE-A17X-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EE-A17X-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_7_rg.sorted	TCGA-EE-A17X-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_7_rg.sorted.bam	33.23		0.17	58cfa831e4b0c9d6adf6cb44	TCGA-EE-A17X-10A-01D-A190_120730_SN1222_0141_BC115GACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE		Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A17X-10A	5F8CC8D6-8A1C-41D0-BAD6-FEDD2948F40A	Blood Derived Normal	Illumina HiSeq	f56ec114-dd45-40eb-aeb3-d10b94e3af35	Skin	54.0	4E9EF0D5-E5B0-4C8A-9C13-C8D088F205D6	3578D9CB-AB85-4041-9777-8A4C3EA3BDEE	TCGA-EE-A17X-10A-01D-A190-02	HG19_Broad_variant	TCGA-EE-A17X	TCGA-SKCM	907.0	s7682	Harvard Medical School	University of Sydney	Australia	NO	T1a	N0		Stage I	A190-02	True
13767.58cfa83be4b0c9d6adf721b4	58cfa83be4b0c9d6adf721b4	UNCID_2598204.4d53a5bc-a63c-44fa-a950-d51c5bd1320e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2598204.4d53a5bc-a63c-44fa-a950-d51c5bd1320e.sorted_genome_alignments	UNCID_2598204.4d53a5bc-a63c-44fa-a950-d51c5bd1320e.sorted_genome_alignments.bam	98.7	2.0	0.16	58cfa83be4b0c9d6adf721b4	UNCID_2598204.4d53a5bc-a63c-44fa-a950-d51c5bd1320e.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Testicular Germ Cell Tumors	Aligned reads	TCGA-W4-A7U4-01A	BE3B6F94-9468-4164-9D96-ABC205F53E92	Primary Tumor	Illumina HiSeq	54D863DA-B74F-4CEF-B177-5A0146A68808	Testis	23.0	F577F827-1292-4507-B9EC-09ABC5EA69C2	4D53A5BC-A63C-44FA-A950-D51C5BD1320E	TCGA-W4-A7U4-01A-12R-A431-07	HG19	TCGA-W4-A7U4	TCGA-TGCT		s668	University of North Carolina	University of North Carolina	United States	NO	T2	NX			A431-07	True
13767.58cfa830e4b0c9d6adf6c0dc	58cfa830e4b0c9d6adf6c0dc	TCGA-BR-A4IZ-01A-32R-A251-31_rnaseq.filtered.	RNA-Seq	TCGA-BR-A4IZ-01A-32R-A251-31_rnaseq	TCGA-BR-A4IZ-01A-32R-A251-31_rnaseq.bam	18.96	1.83	0.17	58cfa830e4b0c9d6adf6c0dc	TCGA-BR-A4IZ-01A-32R-A251-31_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-A4IZ-01A	CADC555E-E350-40CF-8674-3536942F3E02	Primary Tumor	Illumina HiSeq	48AE6ECE-BE54-45AF-9A47-DC1C2B0CB7FC	Stomach	45.0	F767B6BF-3407-47C3-9F2D-9D8D301AA173	A28B68CF-FB20-46DD-BF2D-475754036485	TCGA-BR-A4IZ-01A-32R-A251-31	GRCh37-lite	TCGA-BR-A4IZ	TCGA-STAD		s14544	Canada's Michael Smith Genome Sciences Centre	Asterand	Vietnam	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage III	A251-31	True
13722.58cfa832e4b0c9d6adf6d124	58cfa832e4b0c9d6adf6d124	TCGA-GV-A3QH-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_6_rg.sorted.filtered.	WGS	TCGA-GV-A3QH-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_6_rg.sorted	TCGA-GV-A3QH-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_6_rg.sorted.bam	49.77		0.16	58cfa832e4b0c9d6adf6d124	TCGA-GV-A3QH-10A-01D-A221_120830_SN590_0178_AD143RACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3QH-10A	33BC6A7C-9844-41E3-96B3-1E34BB3FEDD5	Blood Derived Normal	Illumina HiSeq	f84af011-24a9-4fbb-b801-5d6062f0b896	Bladder	67.0	A5354509-A8C7-4AF4-B545-B1024B6553C1	E9F742A2-417D-4C42-A7D8-7CD91B81EA1B	TCGA-GV-A3QH-10A-01D-A221-26	HG19_Broad_variant	TCGA-GV-A3QH	TCGA-BLCA		s2933	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO		NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A221-26	True
13767.58cfa833e4b0c9d6adf6da08	58cfa833e4b0c9d6adf6da08	UNCID_1099026.ed630d55-aca9-4b8e-9128-f89177733bd5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1099026.ed630d55-aca9-4b8e-9128-f89177733bd5.sorted_genome_alignments	UNCID_1099026.ed630d55-aca9-4b8e-9128-f89177733bd5.sorted_genome_alignments.bam	40.2	1.7	0.14	58cfa833e4b0c9d6adf6da08	UNCID_1099026.ed630d55-aca9-4b8e-9128-f89177733bd5.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-6761-01A	4CD3D483-2283-4C6A-A57A-444216119D34	Primary Tumor	Illumina HiSeq	68E98403-2D56-451D-81B9-D3A9A16B17E7	Lung	68.0	B675E2FA-E96B-48A1-AFF0-7D311C053D5A	ED630D55-ACA9-4B8E-9128-F89177733BD5	TCGA-49-6761-01A-31R-1949-07	HG19	TCGA-49-6761	TCGA-LUAD		s10815	University of North Carolina	Johns Hopkins	United States	NO	T1	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1949-07	True
13767.58cfa838e4b0c9d6adf70bd3	58cfa838e4b0c9d6adf70bd3	UNCID_2114123.fc25de3e-e364-4e5b-aa61-a06353bba212.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2114123.fc25de3e-e364-4e5b-aa61-a06353bba212.sorted_genome_alignments	UNCID_2114123.fc25de3e-e364-4e5b-aa61-a06353bba212.sorted_genome_alignments.bam	73.2	1.84	0.16	58cfa838e4b0c9d6adf70bd3	UNCID_2114123.fc25de3e-e364-4e5b-aa61-a06353bba212.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN		Uterine Carcinosarcoma	Aligned reads	TCGA-N9-A4Q7-01A	9F15BF13-11D2-400F-B6F9-C8BE0A57C763	Primary Tumor	Illumina HiSeq	9DFBD99B-4549-4AF3-ACDA-5D0F7E653851	Uterus	69.0	5CCFD055-EC96-4976-916D-A4D2BECB8F6F	FC25DE3E-E364-4E5B-AA61-A06353BBA212	TCGA-N9-A4Q7-01A-11R-A28V-07	HG19	TCGA-N9-A4Q7	TCGA-UCS		s57	University of North Carolina	MD Anderson	United States	NO					A28V-07	True
13767.58cfa837e4b0c9d6adf6fdcc	58cfa837e4b0c9d6adf6fdcc	UNCID_1703627.e887731b-227e-458c-9a91-375ff7a91de1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1703627.e887731b-227e-458c-9a91-375ff7a91de1.sorted_genome_alignments	UNCID_1703627.e887731b-227e-458c-9a91-375ff7a91de1.sorted_genome_alignments.bam	150.2		0.15	58cfa837e4b0c9d6adf6fdcc	UNCID_1703627.e887731b-227e-458c-9a91-375ff7a91de1.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8415-11A	FB322D32-D753-41CC-A21E-E47BF063D5BB	Solid Tissue Normal	Illumina HiSeq	C3D5722F-AF25-46BA-B8D5-0084F7C30953	Kidney	44.0	38639DE4-4CEE-4528-8579-5A3874D872AD	E887731B-227E-458C-9A91-375FF7A91DE1	TCGA-KO-8415-11A-01R-2315-07	HG19	TCGA-KO-8415	TCGA-KICH		s16412	University of North Carolina	MD Anderson Cancer Center	United States	NO	T1	N0	Kidney Chromophobe	Stage I	2315-07	True
13767.58cfa834e4b0c9d6adf6e3a2	58cfa834e4b0c9d6adf6e3a2	UNCID_1186595.5dfb0514-3f93-446c-80be-1c964744dbb8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1186595.5dfb0514-3f93-446c-80be-1c964744dbb8.sorted_genome_alignments	UNCID_1186595.5dfb0514-3f93-446c-80be-1c964744dbb8.sorted_genome_alignments.bam	47.8	1.4	0.15	58cfa834e4b0c9d6adf6e3a2	UNCID_1186595.5dfb0514-3f93-446c-80be-1c964744dbb8.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5695-01A	FB9BAFA5-7133-4955-8156-4EB6763DC8E1	Primary Tumor	Illumina HiSeq	B7E205AD-B10E-4B62-A932-C89F256EA083	Kidney	61.0	86E4862C-7405-40B5-B73F-BE0C6C52EA6D	5DFB0514-3F93-446C-80BE-1C964744DBB8	TCGA-B0-5695-01A-11R-1541-07	HG19	TCGA-B0-5695	TCGA-KIRC		s9611	University of North Carolina	University of Pittsburgh	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1541-07	True
13767.58cfa83be4b0c9d6adf722dd	58cfa83be4b0c9d6adf722dd	UNCID_2583874.cd1688d0-04df-4275-a406-b6240d3a05b8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2583874.cd1688d0-04df-4275-a406-b6240d3a05b8.sorted_genome_alignments	UNCID_2583874.cd1688d0-04df-4275-a406-b6240d3a05b8.sorted_genome_alignments.bam	78.49	1.87	0.17	58cfa83be4b0c9d6adf722dd	UNCID_2583874.cd1688d0-04df-4275-a406-b6240d3a05b8.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-UZ-A9PR-01A	1F298BCC-C8D0-43BD-8CA6-5C160922B607	Primary Tumor	Illumina HiSeq	72E9FA80-D1D7-4256-B6F4-DCB9669DB492	Kidney	84.0	4D1BCB21-2064-48DE-9AED-D59FC2B83E3B	CD1688D0-04DF-4275-A406-B6240D3A05B8	TCGA-UZ-A9PR-01A-11R-A42S-07	HG19	TCGA-UZ-A9PR	TCGA-KIRP		s11630	University of North Carolina	University of California San Francisco	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A42S-07	True
13722.58cfa832e4b0c9d6adf6d17a	58cfa832e4b0c9d6adf6d17a	TCGA-K4-A3WV-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_7_rg.sorted.filtered.	WGS	TCGA-K4-A3WV-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_7_rg.sorted	TCGA-K4-A3WV-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_7_rg.sorted.bam	24.03		0.17	58cfa832e4b0c9d6adf6d17a	TCGA-K4-A3WV-10A-01D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-K4-A3WV-10A	D53EADE8-A845-4252-AECE-92F3573486A7	Blood Derived Normal	Illumina HiSeq	015c156d-7402-4fca-8adb-dbd88fbd9136	Bladder	77.0	BB5CD3CB-6946-4178-A1BB-2CD75E5F61BD	019DB289-ECE0-4A5C-8BA9-65BE2BB7635F	TCGA-K4-A3WV-10A-01D-A23Q-26	HG19_Broad_variant	TCGA-K4-A3WV	TCGA-BLCA		s2936	MD Anderson - Institute for Applied Cancer Science	ABS - Lahey Clinic	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A23Q-26	True
13722.58cfa831e4b0c9d6adf6c4e9	58cfa831e4b0c9d6adf6c4e9	TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	752.02	1.9	0.15	58cfa831e4b0c9d6adf6c4e9	TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4682-01B	E588714A-7753-4C3C-ABB6-EAF1AAB53AB3	Primary Tumor	Illumina HiSeq	fb93cdea-2ff1-454c-9fac-523a4bb11d62	Colorectal	61.0	A2412F6F-324E-4EF2-BD46-0D33596A033B	2007180A-F4AC-4300-A560-903ACEAC4F71	TCGA-AZ-4682-01B-01D-1405-02	HG18	TCGA-AZ-4682	TCGA-COAD	680.0	s13390	Harvard Medical School	University of Pittsburgh	None	NO	T3	N0	Colon Adenocarcinoma	Stage IV	1405-02	True
13767.58cfa837e4b0c9d6adf6fd4c	58cfa837e4b0c9d6adf6fd4c	UNCID_1725508.7e7e0d0f-aa97-4c0d-bffc-7d8977288836.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1725508.7e7e0d0f-aa97-4c0d-bffc-7d8977288836.sorted_genome_alignments	UNCID_1725508.7e7e0d0f-aa97-4c0d-bffc-7d8977288836.sorted_genome_alignments.bam	65.77	1.84	0.16	58cfa837e4b0c9d6adf6fd4c	UNCID_1725508.7e7e0d0f-aa97-4c0d-bffc-7d8977288836.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A2QG-01A	D5D8A818-D689-4C6F-96B0-13F2CB10C3CA	Primary Tumor	Illumina HiSeq	626D0917-F9DA-47F7-9CB0-B79B44F7BDA6	Cervix	29.0	81AE8E2D-E42E-4249-8490-2F36610351CB	7E7E0D0F-AA97-4C0D-BFFC-7D8977288836	TCGA-FU-A2QG-01A-11R-A18M-07	HG19	TCGA-FU-A2QG	TCGA-CESC		s1254	University of North Carolina	International Genomics Consortium	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma		A18M-07	True
13722.58cfa830e4b0c9d6adf6c0ba	58cfa830e4b0c9d6adf6c0ba	TCGA-BJ-A0ZF-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZF-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_3_rg.sorted	TCGA-BJ-A0ZF-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_3_rg.sorted.bam	11.62	1.93	0.17	58cfa830e4b0c9d6adf6c0ba	TCGA-BJ-A0ZF-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZF-10A	8BEEE000-ECAB-4A49-9C9D-BB8E677AE199	Blood Derived Normal	Illumina HiSeq	16e9c9be-3729-4e42-a182-b0de1f8a25be	Thyroid	54.0	2A0FC5CD-C936-44E4-852A-8C2797CB8729	E43257E9-B1AC-4DB6-8446-6661D5795ACE	TCGA-BJ-A0ZF-10A-01D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZF	TCGA-THCA		s12745	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Other  specify	Stage II	A10R-02	True
13767.58cfa834e4b0c9d6adf6e936	58cfa834e4b0c9d6adf6e936	UNCID_1233759.bbcc0f70-85ae-409a-a108-1cabc60d2532.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1233759.bbcc0f70-85ae-409a-a108-1cabc60d2532.sorted_genome_alignments	UNCID_1233759.bbcc0f70-85ae-409a-a108-1cabc60d2532.sorted_genome_alignments.bam	7.74	1.81	0.18	58cfa834e4b0c9d6adf6e936	UNCID_1233759.bbcc0f70-85ae-409a-a108-1cabc60d2532.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A20B-06A	F632EFFD-BE12-41AB-8E4F-2A5F38AF8BAE	Metastatic	Illumina HiSeq	DAB347B7-E25D-41A4-84C8-21898250146E	Skin	66.0	63F852C9-F529-45F9-96A6-303A10FD283D	BBCC0F70-85AE-409A-A108-1CABC60D2532	TCGA-EE-A20B-06A-11R-A18U-07	HG19	TCGA-EE-A20B	TCGA-SKCM		s7727	University of North Carolina	University of Sydney	Australia	NO	T3	N0		Stage II	A18U-07	True
13767.58cfa837e4b0c9d6adf703bd	58cfa837e4b0c9d6adf703bd	UNCID_1861014.5ad175e7-8649-4ccc-91a1-b10dc8cfa642.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1861014.5ad175e7-8649-4ccc-91a1-b10dc8cfa642.sorted_genome_alignments	UNCID_1861014.5ad175e7-8649-4ccc-91a1-b10dc8cfa642.sorted_genome_alignments.bam	286.2	1.7	0.15	58cfa837e4b0c9d6adf703bd	UNCID_1861014.5ad175e7-8649-4ccc-91a1-b10dc8cfa642.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-G4-6309-01A	E4BE17C8-0855-432C-BB80-28BB24B62F32	Primary Tumor	Illumina HiSeq	FE469A10-FD42-4864-9D0E-F462942BAB79	Colorectal	40.0	019736E0-3672-4AA7-A00D-891BDD1F7F5C	5AD175E7-8649-4CCC-91A1-B10DC8CFA642	TCGA-G4-6309-01A-21R-1839-07	HG19	TCGA-G4-6309	TCGA-COAD		s13766	University of North Carolina	Roswell Park	United States	NO	T3	N1	Colon Adenocarcinoma	Stage III	1839-07	True
13767.58cfa833e4b0c9d6adf6dce4	58cfa833e4b0c9d6adf6dce4	UNCID_1127694.733890d7-6557-454e-8697-fe9c619874e3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1127694.733890d7-6557-454e-8697-fe9c619874e3.sorted_genome_alignments	UNCID_1127694.733890d7-6557-454e-8697-fe9c619874e3.sorted_genome_alignments.bam	57.14	1.81	0.15	58cfa833e4b0c9d6adf6dce4	UNCID_1127694.733890d7-6557-454e-8697-fe9c619874e3.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18T-01A	30EC8B1F-28C4-4F46-8A1B-A8D51E558C7D	Primary Tumor	Illumina HiSeq	6036D46C-52F6-4B67-9E8D-B7A4D2B8EF6F	Breast	70.0	50233285-5AEF-412A-A225-3ED14EAA69D8	733890D7-6557-454E-8697-FE9C619874E3	TCGA-BH-A18T-01A-11R-A12D-07	HG19	TCGA-BH-A18T	TCGA-BRCA	224.0	s6156	University of North Carolina	University of Pittsburgh	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A12D-07	True
13722.58cfa830e4b0c9d6adf6bca2	58cfa830e4b0c9d6adf6bca2	TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina.filtered.	WGS	TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina	TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina.bam	171.0		0.5	58cfa830e4b0c9d6adf6bca2	TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4315-01A	DE287A25-981D-49F8-81AF-FE0300E4CD31	Primary Tumor	Illumina HiSeq	707a2d43-0ea1-4012-8f29-4202690c6608	Colorectal	61.0	BA9E5603-BB1D-4AA8-93E4-40043164F143	A9D1B074-7F36-4A04-B270-A2061249FF20	TCGA-AZ-4315-01A-01W-1461-10	GRCh37-lite	TCGA-AZ-4315	TCGA-COAD		s13211	Baylor College of Medicine	University of Pittsburgh	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1461-10	False
13767.58cfa834e4b0c9d6adf6e32b	58cfa834e4b0c9d6adf6e32b	UNCID_1185305.0f8f1a3b-f7ed-4dc2-afc2-2a96e25172de.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1185305.0f8f1a3b-f7ed-4dc2-afc2-2a96e25172de.sorted_genome_alignments	UNCID_1185305.0f8f1a3b-f7ed-4dc2-afc2-2a96e25172de.sorted_genome_alignments.bam	35.3	1.7	0.13	58cfa834e4b0c9d6adf6e32b	UNCID_1185305.0f8f1a3b-f7ed-4dc2-afc2-2a96e25172de.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4987-01A	AEBE37C4-5B37-41F3-ADE3-46E41BAD8EAB	Primary Tumor	Illumina HiSeq	07AA4A4E-9ED7-49D3-A435-7F18F227045A	Kidney	41.0	175E2961-9C4C-4F62-AE06-9FC562FC2952	0F8F1A3B-F7ED-4DC2-AFC2-2A96E25172DE	TCGA-BP-4987-01A-01R-1334-07	HG19	TCGA-BP-4987	TCGA-KIRC		s9787	University of North Carolina	MSKCC	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13767.58cfa832e4b0c9d6adf6d2bc	58cfa832e4b0c9d6adf6d2bc	TCGA-HU-8608-01A-11R-2402-13_rnaseq.filtered.	RNA-Seq	TCGA-HU-8608-01A-11R-2402-13_rnaseq	TCGA-HU-8608-01A-11R-2402-13_rnaseq.bam	181.2		0.16	58cfa832e4b0c9d6adf6d2bc	TCGA-HU-8608-01A-11R-2402-13_rnaseq.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-8608-01A	C6316FB5-99A7-4ADF-832F-DCE44DDCD3AA	Primary Tumor	Illumina HiSeq	DD18BA66-C8D0-4BE5-9F63-9236B1B341AE	Stomach	70.0	E70FE3AD-F9FA-4097-B472-86606C241D26	52739598-8083-45B3-B89E-4D841CB15D7A	TCGA-HU-8608-01A-11R-2402-13	GRCh37-lite	TCGA-HU-8608	TCGA-STAD		s15467	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage III	2402-13	True
13767.58cfa83ce4b0c9d6adf72b44	58cfa83ce4b0c9d6adf72b44	UNCID_372565.TCGA-B2-3923-01A-02R-1325-07.110425_UNC14-SN744_0100_AB0281ABXX.3.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_372565.TCGA-B2-3923-01A-02R-1325-07.110425_UNC14-SN744_0100_AB0281ABXX.3.trimmed.annotated.translated_to_genomic	UNCID_372565.TCGA-B2-3923-01A-02R-1325-07.110425_UNC14-SN744_0100_AB0281ABXX.3.trimmed.annotated.translated_to_genomic.bam	187.3	1.8	0.15	58cfa83ce4b0c9d6adf72b44	UNCID_372565.TCGA-B2-3923-01A-02R-1325-07.110425_UNC14-SN744_0100_AB0281ABXX.3.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B2-3923-01A	08A8EEC3-C97A-4493-A7DE-B2A686B4DF67	Primary Tumor	Illumina HiSeq	5979ED74-98FE-42CD-AAE1-AF98EEA15338	Kidney	59.0	5E3B35C6-0AB5-4E1B-BC38-38760287AC72	628F0D31-99D8-4519-859A-84AE5DD327A7	TCGA-B2-3923-01A-02R-1325-07	HG19	TCGA-B2-3923	TCGA-KIRC		s9416	University of North Carolina	Christiana Healthcare	None	NO	T2	NX	Kidney Clear Cell Renal Carcinoma	Stage II	1325-07	True
13722.58cfa831e4b0c9d6adf6cb4b	58cfa831e4b0c9d6adf6cb4b	TCGA-EE-A2A6-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EE-A2A6-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_1_rg.sorted	TCGA-EE-A2A6-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_1_rg.sorted.bam	65.73		0.16	58cfa831e4b0c9d6adf6cb4b	TCGA-EE-A2A6-06A-11D-A18Y_120726_SN590_0172_BC0WN3ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2A6-06A	CDCF4D91-98A1-4A65-98DD-C6FC80805A0C	Metastatic	Illumina HiSeq	6d7d5e8e-5581-42f1-9c7f-72f105da496d	Skin	43.0	5BB8D694-E4C5-4B02-91D6-B152DCDBA345	3C47A989-E13A-436B-8F57-783B8628D6C9	TCGA-EE-A2A6-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-EE-A2A6	TCGA-SKCM		s7680	Harvard Medical School	University of Sydney	Australia	NO	T1a	N0		Stage I	A18Y-02	True
13767.58cfa838e4b0c9d6adf70cb5	58cfa838e4b0c9d6adf70cb5	UNCID_2145109.60c8c1da-fea6-41f7-ba5b-33afba1ef301.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2145109.60c8c1da-fea6-41f7-ba5b-33afba1ef301.sorted_genome_alignments	UNCID_2145109.60c8c1da-fea6-41f7-ba5b-33afba1ef301.sorted_genome_alignments.bam	49.02	1.96	0.16	58cfa838e4b0c9d6adf70cb5	UNCID_2145109.60c8c1da-fea6-41f7-ba5b-33afba1ef301.sorted_genome_alignments.bam	Dead	MALE	WHITE		Adrenocortical Carcinoma	Aligned reads	TCGA-OR-A5JG-01A	71892706-F8B6-44E6-8DE4-6CBB43F612E0	Primary Tumor	Illumina HiSeq	214A2AFF-C868-40E2-B578-4910A7809EEA	Adrenal Gland	61.0	6D3146BA-8068-4DA5-BAAF-33C6946F138F	60C8C1DA-FEA6-41F7-BA5B-33AFBA1EF301	TCGA-OR-A5JG-01A-11R-A29S-07	HG19	TCGA-OR-A5JG	TCGA-ACC	541.0	s143	University of North Carolina	University of Michigan	Australia	NO	T4	N1		Stage IV	A29S-07	True
13722.58cfa831e4b0c9d6adf6cd72	58cfa831e4b0c9d6adf6cd72	TCGA-ET-A25M-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_8_rg.sorted.filtered.	WGS	TCGA-ET-A25M-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_8_rg.sorted	TCGA-ET-A25M-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_8_rg.sorted.bam	26.1	1.88	0.18	58cfa831e4b0c9d6adf6cd72	TCGA-ET-A25M-10A-01D-A16N_120718_SN590_0170_BD141RACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A25M-10A	8023D4C9-B56D-417A-9A52-D45B59C756ED	Blood Derived Normal	Illumina HiSeq	7f27862b-c742-46ca-b311-8c6eb5df24f3	Thyroid	33.0	5972C59C-3CD2-41D9-AE04-42DEC3ECC565	0B4371FA-86D7-4C34-8E65-3D53CE130BE2	TCGA-ET-A25M-10A-01D-A16N-02	HG19_Broad_variant	TCGA-ET-A25M	TCGA-THCA		s12385	Harvard Medical School	Johns Hopkins	United States	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	True
13767.58cfa82fe4b0c9d6adf6b7dc	58cfa82fe4b0c9d6adf6b7dc	TCGA-29-2425-01A-01R-1569-13_rnaseq.filtered.	RNA-Seq	TCGA-29-2425-01A-01R-1569-13_rnaseq	TCGA-29-2425-01A-01R-1569-13_rnaseq.bam	871.0	1.8	0.15	58cfa82fe4b0c9d6adf6b7dc	TCGA-29-2425-01A-01R-1569-13_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-2425-01A	40635BF3-D8BA-4833-B623-547E55E5D07E	Primary Tumor	Illumina HiSeq	D0C104DD-906B-4D68-89F0-7DC6B42E0780	Ovary	60.0	0A6D3BB3-512A-47BC-9B84-B6FA017DA9C3	3CE6B8C4-7020-447A-8EB8-5370EEF05344	TCGA-29-2425-01A-01R-1569-13	NCBI36_BCCAGSC_variant	TCGA-29-2425	TCGA-OV		s17850	Canada's Michael Smith Genome Sciences Centre	Duke	None	NO			Serous Cystadenocarcinoma		1569-13	True
13767.58cfa833e4b0c9d6adf6ddba	58cfa833e4b0c9d6adf6ddba	UNCID_1124419.8213eb8c-db23-4f92-b3d3-07b45eeec76a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1124419.8213eb8c-db23-4f92-b3d3-07b45eeec76a.sorted_genome_alignments	UNCID_1124419.8213eb8c-db23-4f92-b3d3-07b45eeec76a.sorted_genome_alignments.bam	35.39	1.9	0.16	58cfa833e4b0c9d6adf6ddba	UNCID_1124419.8213eb8c-db23-4f92-b3d3-07b45eeec76a.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A26Z-01A	DC11B1C7-1F00-4813-B4B5-ECF776B2EB37	Primary Tumor	Illumina HiSeq	B6E796B6-0739-416F-B04C-6511B4D5FBB9	Breast	59.0	5DA663CD-E223-41EC-8B2F-796C141EC677	8213EB8C-DB23-4F92-B3D3-07B45EEEC76A	TCGA-C8-A26Z-01A-11R-A16F-07	HG19	TCGA-C8-A26Z	TCGA-BRCA		s5990	University of North Carolina	ILSbio	Vietnam	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage II	A16F-07	True
13767.58cfa83be4b0c9d6adf72894	58cfa83be4b0c9d6adf72894	UNCID_339483.TCGA-B0-4691-01A-01R-1277-07.110324_UNC9-SN296_0160_AB038BABXX.5.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_339483.TCGA-B0-4691-01A-01R-1277-07.110324_UNC9-SN296_0160_AB038BABXX.5.trimmed.annotated.translated_to_genomic	UNCID_339483.TCGA-B0-4691-01A-01R-1277-07.110324_UNC9-SN296_0160_AB038BABXX.5.trimmed.annotated.translated_to_genomic.bam	187.3	1.7	0.15	58cfa83be4b0c9d6adf72894	UNCID_339483.TCGA-B0-4691-01A-01R-1277-07.110324_UNC9-SN296_0160_AB038BABXX.5.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4691-01A	949736AA-62D3-46E0-8507-ED2A84BE0073	Primary Tumor	Illumina HiSeq	F80BE113-9C7C-434E-9643-B19B2B178D69	Kidney	55.0	974C6544-6BDE-4699-A4CB-90316B582E1E	3A34F9F9-8071-46CF-A193-267FB8223CC9	TCGA-B0-4691-01A-01R-1277-07	HG19	TCGA-B0-4691	TCGA-KIRC	139.0	s9250	University of North Carolina	University of Pittsburgh	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1277-07	True
13767.58cfa838e4b0c9d6adf70dd6	58cfa838e4b0c9d6adf70dd6	UNCID_2106978.628fb2b6-09b2-4460-8815-fda9b89ac0c2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2106978.628fb2b6-09b2-4460-8815-fda9b89ac0c2.sorted_genome_alignments	UNCID_2106978.628fb2b6-09b2-4460-8815-fda9b89ac0c2.sorted_genome_alignments.bam	20.14	1.94	0.18	58cfa838e4b0c9d6adf70dd6	UNCID_2106978.628fb2b6-09b2-4460-8815-fda9b89ac0c2.sorted_genome_alignments.bam	Dead	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-NJ-A4YI-01A	2C03141E-A0BD-4E8D-91E4-9744D139CCCE	Primary Tumor	Illumina HiSeq	098DEF67-1250-4806-BEC4-C4F40F358385	Lung	87.0	E7ED1627-7EC0-48F5-983D-09B1241C28EC	628FB2B6-09B2-4460-8815-FDA9B89AC0C2	TCGA-NJ-A4YI-01A-11R-A262-07	HG19	TCGA-NJ-A4YI	TCGA-LUAD	4.0	s11416	University of North Carolina	Washington University - Rush University	United States	NO	T2	N2	Lung Papillary Adenocarcinoma	Stage III	A262-07	True
13722.58cfa82de4b0c9d6adf6a50e	58cfa82de4b0c9d6adf6a50e	29084d88d2f33ba899ea13cb6d938384.filtered.	WGS	29084d88d2f33ba899ea13cb6d938384	29084d88d2f33ba899ea13cb6d938384.bam	41.07	1.97	0.07	58cfa82de4b0c9d6adf6a50e	29084d88d2f33ba899ea13cb6d938384.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0XR-01A	F51AF6DB-2655-47FB-9FFC-83A503A728EA	Primary Tumor	Illumina HiSeq	19e1e7d4-80dd-4107-98b2-6796fe22947f	Breast	55.0	6EDCDB8A-80E8-42A8-86FF-3950C1F3CB89	E7DC7492-3A84-49C7-8DEA-8F508B53DC40	TCGA-AN-A0XR-01A-11D-A10G-09	GRCh37-lite	TCGA-AN-A0XR	TCGA-BRCA		s5477	Washington University School of Medicine	Cureline	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage III	A10G-09	False
13722.58cfa831e4b0c9d6adf6c6d8	58cfa831e4b0c9d6adf6c6d8	TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted	TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted.bam	183.9	1.9	0.15	58cfa831e4b0c9d6adf6c6d8	TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted.bam	Dead	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4460-01A	3C3D4EF0-019A-423E-89B2-4AC5A7B567AB	Primary Tumor	Illumina HiSeq	1d341d0a-b2f5-4f35-b60d-7c87f2a7dc78	Stomach	66.0	14FE3057-C82E-4D66-9798-BCD042CF64D6	1AE6944B-600D-40A8-ADD3-16F99982CDFE	TCGA-CG-4460-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4460	TCGA-STAD	669.0	s15396	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1154-02	True
13767.58cfa839e4b0c9d6adf71160	58cfa839e4b0c9d6adf71160	UNCID_2277885.fec08c47-a556-4bef-a20f-b3985d30a500.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2277885.fec08c47-a556-4bef-a20f-b3985d30a500.sorted_genome_alignments	UNCID_2277885.fec08c47-a556-4bef-a20f-b3985d30a500.sorted_genome_alignments.bam	6.74	1.84	0.16	58cfa839e4b0c9d6adf71160	UNCID_2277885.fec08c47-a556-4bef-a20f-b3985d30a500.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-A74J-01A	1A20F675-D9BB-48B0-A49F-D52270BD8973	Primary Tumor	Illumina HiSeq	4EAA47DF-BC51-4A5B-9A34-9EABA2F468C3	Brain	33.0	A29FBD4E-42F2-446A-9B78-CA084422DC91	FEC08C47-A556-4BEF-A20F-B3985D30A500	TCGA-HT-A74J-01A-12R-A32Q-07	HG19	TCGA-HT-A74J	TCGA-LGG		s8459	University of North Carolina	Case Western - St Joes	United States	NO			Oligoastrocytoma		A32Q-07	True
13722.58cfa82ee4b0c9d6adf6adb8	58cfa82ee4b0c9d6adf6adb8	G39020.TCGA-CG-4442-10A-01D-A290-08.2.filtered.	WGS	G39020.TCGA-CG-4442-10A-01D-A290-08.2	G39020.TCGA-CG-4442-10A-01D-A290-08.2.bam	57.9	1.9	0.08	58cfa82ee4b0c9d6adf6adb8	G39020.TCGA-CG-4442-10A-01D-A290-08.2.bam	Alive	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4442-10A	8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8	Blood Derived Normal	Illumina HiSeq	f593a6cb-9401-41cb-8797-9afa48927312	Stomach	85.0	85F0304A-7ED7-4715-B1B3-655DF4C87FBF	369C44C6-1EFA-44EF-BAF5-E769073C6A87	TCGA-CG-4442-10A-01D-A290-08	HG19_Broad_variant	TCGA-CG-4442	TCGA-STAD		s15296	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	A290-08	True
13767.58cfa834e4b0c9d6adf6e70e	58cfa834e4b0c9d6adf6e70e	UNCID_1189477.f47c8d1e-0cc6-4686-8913-80b6f0372293.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1189477.f47c8d1e-0cc6-4686-8913-80b6f0372293.sorted_genome_alignments	UNCID_1189477.f47c8d1e-0cc6-4686-8913-80b6f0372293.sorted_genome_alignments.bam	2.8	1.7	0.15	58cfa834e4b0c9d6adf6e70e	UNCID_1189477.f47c8d1e-0cc6-4686-8913-80b6f0372293.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5467-01A	B602A73B-809C-44C6-A787-D496705E7AE8	Primary Tumor	Illumina HiSeq	69D8488A-3520-47C9-84E0-97EBA744C35B	Kidney	86.0	0B6DFB9C-90A6-4F46-A44B-28B889AEC62A	F47C8D1E-0CC6-4686-8913-80B6F0372293	TCGA-CZ-5467-01A-01R-1503-07	HG19	TCGA-CZ-5467	TCGA-KIRC	73.0	s9624	University of North Carolina	Harvard	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	1503-07	True
13767.58cfa838e4b0c9d6adf70a4b	58cfa838e4b0c9d6adf70a4b	UNCID_2083531.5bd6ca42-16ca-484f-877f-cda4fb3f93a8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2083531.5bd6ca42-16ca-484f-877f-cda4fb3f93a8.sorted_genome_alignments	UNCID_2083531.5bd6ca42-16ca-484f-877f-cda4fb3f93a8.sorted_genome_alignments.bam	64.42	1.84	0.16	58cfa838e4b0c9d6adf70a4b	UNCID_2083531.5bd6ca42-16ca-484f-877f-cda4fb3f93a8.sorted_genome_alignments.bam	Dead	MALE			Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A3A7-01A	614C0ECF-6A84-4C86-8706-79BE5BB00991	Primary Tumor	Illumina HiSeq	3FFF4FA1-7002-4BA2-8CC6-9928DDC104FC	Liver	67.0	1EF290A3-D054-4E3A-9683-8F99A2010E3E	5BD6CA42-16CA-484F-877F-CDA4FB3F93A8	TCGA-DD-A3A7-01A-11R-A22L-07	HG19	TCGA-DD-A3A7	TCGA-LIHC	419.0	s16721	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T3b	N0	Hepatocellular Carcinoma	Stage III	A22L-07	True
13722.58cfa831e4b0c9d6adf6c82b	58cfa831e4b0c9d6adf6c82b	TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted	TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted.bam	77.69	1.86	0.16	58cfa831e4b0c9d6adf6c82b	TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17Q-01A	CA8DBBFD-8928-4E25-94C6-B875DE631BBD	Primary Tumor	Illumina HiSeq	77e56615-42dd-4c50-a518-cc93c3b80107	Uterus	54.0	B6ABEB01-B6EA-4AB4-AA00-AE16CFC88B7C	59FB249D-4C77-40B1-A557-98281869AC91	TCGA-D1-A17Q-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A17Q	TCGA-UCEC		s4442	Harvard Medical School	Mayo Clinic	None	NO			Endometrioid endometrial adenocarcinoma		A12F-02	True
13767.58cfa83ce4b0c9d6adf73130	58cfa83ce4b0c9d6adf73130	_1_TCGA-CG-5722-11A-02R-1602-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-CG-5722-11A-02R-1602-13_rnaseq	_1_TCGA-CG-5722-11A-02R-1602-13_rnaseq.bam	43.8	1.8	0.16	58cfa83ce4b0c9d6adf73130	_1_TCGA-CG-5722-11A-02R-1602-13_rnaseq.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5722-11A	F35E8FEF-F61D-4614-B73F-F7E1D0F21F52	Solid Tissue Normal	Illumina HiSeq	286BF77F-F83F-4963-A7AD-F06F2FDFA4E9	Stomach	67.0	756AEB10-195E-409D-A8AC-8B3A048FC51A	F0FCD1D0-9B3C-4351-AD61-E2C9E644AAC9	TCGA-CG-5722-11A-02R-1602-13	GRCh37-lite	TCGA-CG-5722	TCGA-STAD		s15290	Canada's Michael Smith Genome Sciences Centre	Indivumed	Germany	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1602-13	True
13722.58cfa82ee4b0c9d6adf6aa01	58cfa82ee4b0c9d6adf6aa01	G23078.TCGA_CR_6487_01A_11D_2268_08.2.filtered.	WGS	G23078.TCGA_CR_6487_01A_11D_2268_08.2	G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam	287.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa01	G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6487-01A	9AE5101B-6031-4AB1-BFCA-198C41AF3184	Primary Tumor	Illumina HiSeq	5efcbe11-0d48-4b66-abce-d78199fe8fd8	Head and Neck	50.0	027DEDD3-BD53-420E-B7F2-EB5B8C26BCDC	1DB83E80-BDF7-4D8D-8008-BD8406D641FC	TCGA-CR-6487-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6487	TCGA-HNSC		s15606	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	2268-08	True
13722.58cfa82de4b0c9d6adf6a640	58cfa82de4b0c9d6adf6a640	7a02be700709d5daf6393100f819a952.filtered.	WGS	7a02be700709d5daf6393100f819a952	7a02be700709d5daf6393100f819a952.bam	51.59		0.08	58cfa82de4b0c9d6adf6a640	7a02be700709d5daf6393100f819a952.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A2J0-01A	2FF6AEDE-7BCD-440B-99AB-7A023FAF658E	Primary Tumor	Illumina HiSeq	99a5bf7b-7b43-4753-ac23-1a777776a1dc	Mesenchymal	61.0	A8673BA9-EF34-42CA-A73E-1EFB4F186E88	CB783F8B-D092-4104-B809-3F90B19DF7DF	TCGA-DX-A2J0-01A-11D-A21Q-09	GRCh37-lite	TCGA-DX-A2J0	TCGA-SARC	295.0	s2346	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO					A21Q-09	True
13767.58cfa83ce4b0c9d6adf72e5b	58cfa83ce4b0c9d6adf72e5b	_1_TCGA-CG-5719-01A-11R-1602-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-CG-5719-01A-11R-1602-13_rnaseq	_1_TCGA-CG-5719-01A-11R-1602-13_rnaseq.bam	37.8	1.7	0.16	58cfa83ce4b0c9d6adf72e5b	_1_TCGA-CG-5719-01A-11R-1602-13_rnaseq.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5719-01A	263F67E0-0A28-42E6-B3F3-1DDD0D397220	Primary Tumor	Illumina HiSeq	8A326982-0E0B-4E6A-8143-D88F76689E12	Stomach	54.0	606573EE-ED11-4DB5-ABAF-E842EC575EEE	08B05889-938F-47B3-A81E-E3192482C878	TCGA-CG-5719-01A-11R-1602-13	GRCh37-lite	TCGA-CG-5719	TCGA-STAD		s15089	Canada's Michael Smith Genome Sciences Centre	Indivumed	Germany	NO	T4	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1602-13	True
13722.58cfa82fe4b0c9d6adf6b7c6	58cfa82fe4b0c9d6adf6b7c6	TCGA-49-4507-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4507-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4507-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	258.2	1.9	0.16	58cfa82fe4b0c9d6adf6b7c6	TCGA-49-4507-11A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4507-11A	50B2C647-AECD-4C81-AF22-0D8116593552	Solid Tissue Normal	Illumina HiSeq	85ba42cf-c97b-4bd6-910f-d3e06fb69a79	Lung	73.0	8A603532-91DB-487A-A4E2-A8C1F848FA19	6C9A73D4-8E10-4957-9739-603EAF942BBD	TCGA-49-4507-11A-01D-1203-02	GRCh37	TCGA-49-4507	TCGA-LUAD	268.0	s10781	Harvard Medical School	Johns Hopkins	United States	NO	T3	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage III	1203-02	True
13722.58cfa82ee4b0c9d6adf6aaec	58cfa82ee4b0c9d6adf6aaec	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.filtered.	WGS	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.bam	25.01		0.08	58cfa82ee4b0c9d6adf6aaec	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T0-01A	861F94CE-45FF-4588-ADDB-E1EA48878C2E	Primary Tumor	Illumina HiSeq	5c6477ae-68e1-4407-8f81-53f64006df76	Thyroid	45.0	913D384C-657A-4AE0-9E8E-E9BDB77D140E	54426B1A-E0D3-4D8E-9E81-2D8E6B153B22	TCGA-EL-A3T0-01A-22D-A22D-08	HG19_Broad_variant	TCGA-EL-A3T0	TCGA-THCA		s11975	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T3	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A22D-08	True
13722.58cfa82ee4b0c9d6adf6aa4c	58cfa82ee4b0c9d6adf6aa4c	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.filtered.	WGS	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.bam	12.75		0.07	58cfa82ee4b0c9d6adf6aa4c	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.bam	Dead	FEMALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TQ-A8XE-01A	135A149A-D153-465E-AA58-06D47BB18E00	Primary Tumor	Illumina HiSeq	3bc46ccf-d9f8-41bd-a003-42e547c7d758	Brain	42.0	7C60D0DE-B913-4454-BF9F-C554810911B5	4AAEBADF-13D2-4865-8AB5-CC989D80A261	TCGA-TQ-A8XE-01A-11D-A36O-08	HG19_Broad_variant	TCGA-TQ-A8XE	TCGA-LGG	954.0	s8339	Broad Institute of MIT and Harvard	University of Sao Paulo	Brazil	NO			Oligodendroglioma		A36O-08	True
13767.58cfa83ae4b0c9d6adf71b38	58cfa83ae4b0c9d6adf71b38	UNCID_2472087.4c243ea9-dfe1-42f0-a887-3c901fb38542.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2472087.4c243ea9-dfe1-42f0-a887-3c901fb38542.sorted_genome_alignments	UNCID_2472087.4c243ea9-dfe1-42f0-a887-3c901fb38542.sorted_genome_alignments.bam	15.35	1.86	0.18	58cfa83ae4b0c9d6adf71b38	UNCID_2472087.4c243ea9-dfe1-42f0-a887-3c901fb38542.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-3N-A9WB-06A	5564E6A7-2195-4B0D-994E-B0617B58E889	Metastatic	Illumina HiSeq	B1EF3D18-9C57-43C9-A00C-C21949964872	Skin	71.0	5B0C4070-1E90-4562-85E3-96DD34444E29	4C243EA9-DFE1-42F0-A887-3C901FB38542	TCGA-3N-A9WB-06A-11R-A38C-07	HG19	TCGA-3N-A9WB	TCGA-SKCM	518.0	s7972	University of North Carolina	Greenville Health System	United States	NO	T1a	NX		Stage I	A38C-07	True
13767.58cfa83ce4b0c9d6adf72ce6	58cfa83ce4b0c9d6adf72ce6	UNCID_462169.5a4ad263-7126-42f8-a2b2-f534dfaf50f9.110823_UNC10-SN254_0269_AC019UABXX.2.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_462169.5a4ad263-7126-42f8-a2b2-f534dfaf50f9.110823_UNC10-SN254_0269_AC019UABXX.2.trimmed.annotated.translated_to_genomic	UNCID_462169.5a4ad263-7126-42f8-a2b2-f534dfaf50f9.110823_UNC10-SN254_0269_AC019UABXX.2.trimmed.annotated.translated_to_genomic.bam	141.8	1.8	0.15	58cfa83ce4b0c9d6adf72ce6	UNCID_462169.5a4ad263-7126-42f8-a2b2-f534dfaf50f9.110823_UNC10-SN254_0269_AC019UABXX.2.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-AK-3458-01A	D7CF4FC0-6357-4973-AF4C-B456F430478A	Primary Tumor	Illumina HiSeq	9DDA1DFD-BF72-4AE0-945F-41742601A820	Kidney	48.0	7DADF224-ECEC-424E-A851-C5DEEEAEE6FF	5A4AD263-7126-42F8-A2B2-F534DFAF50F9	TCGA-AK-3458-01A-01R-1503-07	HG19	TCGA-AK-3458	TCGA-KIRC		s9549	University of North Carolina	Fox Chase	United States	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1503-07	True
13767.58cfa83ae4b0c9d6adf716ae	58cfa83ae4b0c9d6adf716ae	UNCID_2363867.3838e293-3045-4310-bea8-c94db4a79c3e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2363867.3838e293-3045-4310-bea8-c94db4a79c3e.sorted_genome_alignments	UNCID_2363867.3838e293-3045-4310-bea8-c94db4a79c3e.sorted_genome_alignments.bam	21.82	1.82	0.16	58cfa83ae4b0c9d6adf716ae	UNCID_2363867.3838e293-3045-4310-bea8-c94db4a79c3e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-RW-A67W-01A	297E13C1-8C36-4729-BAC9-142FA718DD04	Primary Tumor	Illumina HiSeq	F8CFFDFB-4FB7-4AC6-BC3B-E6486EC19D2F	Nervous System	46.0	5D2A0ADF-A855-460E-9A9B-BF0924C6F2B8	3838E293-3045-4310-BEA8-C94DB4A79C3E	TCGA-RW-A67W-01A-11R-A35K-07	HG19	TCGA-RW-A67W	TCGA-PCPG		s936	University of North Carolina	Michigan University	United States	NO					A35K-07	True
13767.58cfa82ee4b0c9d6adf6b1f6	58cfa82ee4b0c9d6adf6b1f6	TCGA-09-1667-01C-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-09-1667-01C-01R-1566-13_rnaseq	TCGA-09-1667-01C-01R-1566-13_rnaseq.bam	282.0	1.8	0.16	58cfa82ee4b0c9d6adf6b1f6	TCGA-09-1667-01C-01R-1566-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-1667-01C	32D4D200-1FDF-44ED-B81F-1954A9C93926	Primary Tumor	Illumina HiSeq	E9D0D62A-CD91-410C-8A5C-883444EB4359	Ovary	61.0	111F607F-5B87-4595-9AA7-DF9381717BEE	9B7A1EB0-014F-4CD6-BDE8-FD96131FAC3E	TCGA-09-1667-01C-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-09-1667	TCGA-OV		s17810	Canada's Michael Smith Genome Sciences Centre	UCSF	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa82ee4b0c9d6adf6a9c2	58cfa82ee4b0c9d6adf6a9c2	G17675.TCGA-19-2624-01A-01R-1850-01.2.filtered.	RNA-Seq	G17675.TCGA-19-2624-01A-01R-1850-01.2	G17675.TCGA-19-2624-01A-01R-1850-01.2.bam	291.7	1.9	0.13	58cfa82ee4b0c9d6adf6a9c2	G17675.TCGA-19-2624-01A-01R-1850-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-2624-01A	2F4A127F-101A-4192-B3E8-F9BE2C8648BC	Primary Tumor	Illumina HiSeq	448C4629-D39E-44A8-94E7-AA13D17D2421	Brain	51.0	C9E1BE85-0699-48B4-8977-0DB46AF4EC94	D5A281FD-C004-477F-AF62-C55FE20F1DEE	TCGA-19-2624-01A-01R-1850-01	HG19_Broad_variant	TCGA-19-2624	TCGA-GBM	5.0	s14055	Broad Institute of MIT and Harvard	Case Western	None	NO			Untreated primary (de novo) GBM		1850-01	True
13767.58cfa832e4b0c9d6adf6d24c	58cfa832e4b0c9d6adf6d24c	TCGA-IN-A7NT-01A-21R-A354-31_rnaseq.filtered.	RNA-Seq	TCGA-IN-A7NT-01A-21R-A354-31_rnaseq	TCGA-IN-A7NT-01A-21R-A354-31_rnaseq.bam	61.36	1.83	0.17	58cfa832e4b0c9d6adf6d24c	TCGA-IN-A7NT-01A-21R-A354-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-IN-A7NT-01A	53108D62-6B7C-429F-9FEC-474781174968	Primary Tumor	Illumina HiSeq	5D1265AE-46E2-459D-B9B0-F6E748FF7BBE	Stomach	73.0	3097A891-3611-4ACE-B2CF-4B6B18DF6385	48105F07-87E2-4D36-9F1E-9905D041D1BE	TCGA-IN-A7NT-01A-21R-A354-31	GRCh37-lite	TCGA-IN-A7NT	TCGA-STAD		s14568	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	United States	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	A354-31	True
13767.58cfa834e4b0c9d6adf6e8c2	58cfa834e4b0c9d6adf6e8c2	UNCID_1234535.e1be8377-176c-4f4c-b3aa-86bbb6cd0f3a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1234535.e1be8377-176c-4f4c-b3aa-86bbb6cd0f3a.sorted_genome_alignments	UNCID_1234535.e1be8377-176c-4f4c-b3aa-86bbb6cd0f3a.sorted_genome_alignments.bam	8.1	1.74	0.18	58cfa834e4b0c9d6adf6e8c2	UNCID_1234535.e1be8377-176c-4f4c-b3aa-86bbb6cd0f3a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A299-01A	90402C32-9548-432E-85B8-A4F80E14401E	Primary Tumor	Illumina HiSeq	553221F8-66C2-4137-8EE4-2BF7D104B28E	Skin	63.0	5678AE8F-382C-4167-839E-A160CE6710C7	E1BE8377-176C-4F4C-B3AA-86BBB6CD0F3A	TCGA-EB-A299-01A-21R-A18U-07	HG19	TCGA-EB-A299	TCGA-SKCM		s7581	University of North Carolina	Asterand	Russia	NO	T2b	N0		Stage II	A18U-07	True
13722.58cfa831e4b0c9d6adf6ccda	58cfa831e4b0c9d6adf6ccda	TCGA-EJ-5504-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EJ-5504-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_2_rg.sorted	TCGA-EJ-5504-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_2_rg.sorted.bam	178.4	1.9	0.15	58cfa831e4b0c9d6adf6ccda	TCGA-EJ-5504-10A-01D-1573_130315_SN590_0220_BD1WFMACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5504-10A	E1C3D1BD-CF8F-4FA4-AC8E-BF9E54F7AAD4	Blood Derived Normal	Illumina HiSeq	fdf14dea-7dab-403e-9c85-8b16dcf88d2c	Prostate	65.0	EFA8FC5E-04B7-47D0-8861-A36B500E0764	7EE9D6AF-14EE-4475-9D16-DD8252FE8410	TCGA-EJ-5504-10A-01D-1573-02	HG19_Broad_variant	TCGA-EJ-5504	TCGA-PRAD		s4135	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N1	Prostate Adenocarcinoma Acinar Type		1573-02	True
13767.58cfa83ce4b0c9d6adf731a4	58cfa83ce4b0c9d6adf731a4	_1_TCGA-CG-5717-01A-11R-1602-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-CG-5717-01A-11R-1602-13_rnaseq	_1_TCGA-CG-5717-01A-11R-1602-13_rnaseq.bam	158.3	1.7	0.14	58cfa83ce4b0c9d6adf731a4	_1_TCGA-CG-5717-01A-11R-1602-13_rnaseq.bam	Dead	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5717-01A	BDC3899E-15AE-421F-829B-0E07FBD27C60	Primary Tumor	Illumina HiSeq	473BB359-82B9-40B5-BB93-A212B39D888E	Stomach	58.0	CEA37BBD-1BCC-4205-BE3D-DAFAC2E30256	841F8235-7654-4879-B3B4-CFEDCB16CA5C	TCGA-CG-5717-01A-11R-1602-13	GRCh37-lite	TCGA-CG-5717	TCGA-STAD	212.0	s14795	Canada's Michael Smith Genome Sciences Centre	Indivumed	Germany	NO	T2b	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1602-13	True
13722.58cfa82de4b0c9d6adf6a683	58cfa82de4b0c9d6adf6a683	692c3778a86ca9872957c9a79f3cb1f1.filtered.	WGS	692c3778a86ca9872957c9a79f3cb1f1	692c3778a86ca9872957c9a79f3cb1f1.bam	54.86	1.92	0.09	58cfa82de4b0c9d6adf6a683	692c3778a86ca9872957c9a79f3cb1f1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A04D-10A	49717F75-0F2D-4E1C-9A12-F1CD7877B80A	Blood Derived Normal	Illumina HiSeq	4a1b29e7-a50b-4f6a-a8a5-0e1727c4647e	Breast	58.0	D3AACCDA-91D8-42D4-A1E6-1720F92214EC	03FE1DF5-EC6A-40E7-B609-A749B1AAFAD9	TCGA-AN-A04D-10A-01D-A314-09	GRCh37-lite	TCGA-AN-A04D	TCGA-BRCA		s5482	Washington University School of Medicine	Cureline	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A314-09	True
13722.58cfa831e4b0c9d6adf6cc28	58cfa831e4b0c9d6adf6cc28	TCGA-EE-A29R-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EE-A29R-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_6_rg.sorted	TCGA-EE-A29R-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_6_rg.sorted.bam	45.53		0.17	58cfa831e4b0c9d6adf6cc28	TCGA-EE-A29R-06A-11D-A18Y_120729_SN1120_0179_AC11G3ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A29R-06A	D73D1B38-9AB4-409E-A360-E93F8C54715C	Metastatic	Illumina HiSeq	39cebd09-df59-45a2-bd13-b75055a7a352	Skin	48.0	9C98FCC2-FD1F-4F19-A550-B0FF0B78CF89	86C0AB31-7A14-40E7-AEA8-2CAD1F90CB27	TCGA-EE-A29R-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-EE-A29R	TCGA-SKCM		s7679	Harvard Medical School	University of Sydney	Australia	NO	T3b	N1b		Stage III	A18Y-02	True
13767.58cfa837e4b0c9d6adf7003c	58cfa837e4b0c9d6adf7003c	UNCID_1859824.e642839c-9891-4ff0-93c4-556d81572af9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1859824.e642839c-9891-4ff0-93c4-556d81572af9.sorted_genome_alignments	UNCID_1859824.e642839c-9891-4ff0-93c4-556d81572af9.sorted_genome_alignments.bam	67.07	1.84	0.16	58cfa837e4b0c9d6adf7003c	UNCID_1859824.e642839c-9891-4ff0-93c4-556d81572af9.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ES-A2HS-01A	728AEDB3-551A-4C16-9BE3-7733A9539E9E	Primary Tumor	Illumina HiSeq	CDDA4E3D-0AF7-4A79-A6C5-40F268E34E5E	Liver	80.0	A06FE860-8D5F-4ED0-B7FC-72F74567FB7E	E642839C-9891-4FF0-93C4-556D81572AF9	TCGA-ES-A2HS-01A-11R-A180-07	HG19	TCGA-ES-A2HS	TCGA-LIHC	695.0	s16882	University of North Carolina	University of Florida	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A180-07	True
13722.58cfa82fe4b0c9d6adf6b96c	58cfa82fe4b0c9d6adf6b96c	TCGA-AA-3675-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3675-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3675-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	56.66	1.9	0.15	58cfa82fe4b0c9d6adf6b96c	TCGA-AA-3675-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-3675-10A	41658CF8-0DE1-4A97-BB60-0F0107C84E00	Blood Derived Normal	Illumina HiSeq	b96e4a5b-ccba-4670-96a2-87b4bde329ea	Colorectal	84.0	9C0C79F7-1500-452C-904C-35CC9D3C4634	07C43104-A2D5-4F74-B22F-166D8364562E	TCGA-AA-3675-10A-01D-1167-02	HG18	TCGA-AA-3675	TCGA-COAD		s12869	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1167-02	True
13722.58cfa82ee4b0c9d6adf6ace2	58cfa82ee4b0c9d6adf6ace2	G39020.TCGA-CG-4474-10A-01D-A290-08.1.filtered.	WGS	G39020.TCGA-CG-4474-10A-01D-A290-08.1	G39020.TCGA-CG-4474-10A-01D-A290-08.1.bam	15.9	1.8	0.08	58cfa82ee4b0c9d6adf6ace2	G39020.TCGA-CG-4474-10A-01D-A290-08.1.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4474-10A	39DD61A8-CD17-4DF3-AE17-61E239EB00BD	Blood Derived Normal	Illumina HiSeq	af9433c7-f0e8-4b30-ba69-0ffec543d03a	Stomach	67.0	A546EC24-E8CE-4B04-B25F-A230A5EA1067	7D3B75DB-B73D-4AD9-AAA9-3075CA5F025A	TCGA-CG-4474-10A-01D-A290-08	HG19_Broad_variant	TCGA-CG-4474	TCGA-STAD		s14460	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	A290-08	True
13767.58cfa83be4b0c9d6adf7209a	58cfa83be4b0c9d6adf7209a	UNCID_2583786.32d7a0c1-8c8f-4039-95ca-446d826b9f16.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2583786.32d7a0c1-8c8f-4039-95ca-446d826b9f16.sorted_genome_alignments	UNCID_2583786.32d7a0c1-8c8f-4039-95ca-446d826b9f16.sorted_genome_alignments.bam	65.71	1.86	0.18	58cfa83be4b0c9d6adf7209a	UNCID_2583786.32d7a0c1-8c8f-4039-95ca-446d826b9f16.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-UZ-A9PV-01A	5503F854-8EEA-49B7-A196-BDC6C3C5815B	Primary Tumor	Illumina HiSeq	8D0B32D2-9D05-488E-A176-0EC2B1232C83	Kidney	64.0	6BE35B9D-C799-41F6-B151-0F8BB4D77A97	32D7A0C1-8C8F-4039-95CA-446D826B9F16	TCGA-UZ-A9PV-01A-11R-A42S-07	HG19	TCGA-UZ-A9PV	TCGA-KIRP		s11845	University of North Carolina	University of California San Francisco	United States	NO	T1	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A42S-07	True
13722.58cfa82ee4b0c9d6adf6acdb	58cfa82ee4b0c9d6adf6acdb	G39020.TCGA-D7-6519-01A-11D-1800-08.2.filtered.	WGS	G39020.TCGA-D7-6519-01A-11D-1800-08.2	G39020.TCGA-D7-6519-01A-11D-1800-08.2.bam	266.4	1.9	0.05	58cfa82ee4b0c9d6adf6acdb	G39020.TCGA-D7-6519-01A-11D-1800-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6519-01A	E37CAE9E-0656-4B89-B326-739A5CC859E0	Primary Tumor	Illumina HiSeq	8f8b5fc2-7fb8-4a30-968b-375bf038514e	Stomach	64.0	FA7426E1-FCFB-4B08-AD50-1D9E903A81FB	A2E67393-50D7-4BCC-9BBD-C695086A936A	TCGA-D7-6519-01A-11D-1800-08	HG19_Broad_variant	TCGA-D7-6519	TCGA-STAD		s14683	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage III	1800-08	True
13722.58cfa830e4b0c9d6adf6bbca	58cfa830e4b0c9d6adf6bbca	TCGA-AG-4007-10A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-4007-10A-01D-1989-10_wgs_Illumina	TCGA-AG-4007-10A-01D-1989-10_wgs_Illumina.bam	3.59	1.9	0.16	58cfa830e4b0c9d6adf6bbca	TCGA-AG-4007-10A-01D-1989-10_wgs_Illumina.bam	Alive	MALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-4007-10A	8E00E7E7-FFAF-44F0-91A7-172671F18E08	Blood Derived Normal	Illumina HiSeq	bf5bf305-cd19-4e22-8e98-6671a1196153	Colorectal	87.0	EB3A1A59-B2C5-4436-A971-FCFE5C643820	3003C9F9-5637-4BD3-9377-1EB25C1D9AA5	TCGA-AG-4007-10A-01D-1989-10	GRCh37-lite	TCGA-AG-4007	TCGA-READ		s2154	Baylor College of Medicine	Indivumed	Germany	NO	T4	N2	Rectal Adenocarcinoma	Stage IV	1989-10	True
13722.58cfa831e4b0c9d6adf6c945	58cfa831e4b0c9d6adf6c945	TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted	TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted.bam	113.7	1.9	0.14	58cfa831e4b0c9d6adf6c945	TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6818-01A	AA2934F9-8783-428E-88A6-1D04B93FA1FD	Primary Tumor	Illumina HiSeq	5a217dfc-ada8-4dec-8f7c-06be0123b9ef	Stomach	53.0	953E155F-D9E1-41C8-BA12-351A38195D22	21E75BA4-E4C1-4D8A-BFA2-E4698B4FB46B	TCGA-D7-6818-01A-11D-1880-02	HG19_Broad_variant	TCGA-D7-6818	TCGA-STAD		s15464	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage III	1880-02	True
13767.58cfa838e4b0c9d6adf7074b	58cfa838e4b0c9d6adf7074b	UNCID_2010059.704d2001-9501-4426-b751-af5fc74a6378.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2010059.704d2001-9501-4426-b751-af5fc74a6378.sorted_genome_alignments	UNCID_2010059.704d2001-9501-4426-b751-af5fc74a6378.sorted_genome_alignments.bam	18.48	1.88	0.17	58cfa838e4b0c9d6adf7074b	UNCID_2010059.704d2001-9501-4426-b751-af5fc74a6378.sorted_genome_alignments.bam	Dead	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-MP-A4TK-01A	F7F9F522-DE88-4F9C-8BA4-7BE3726FAAF8	Primary Tumor	Illumina HiSeq	003249B3-DF71-4329-943C-6FA30D83CC14	Lung	56.0	E71A1971-E1C7-4CD9-AE0A-9458A053042D	704D2001-9501-4426-B751-AF5FC74A6378	TCGA-MP-A4TK-01A-11R-A24X-07	HG19	TCGA-MP-A4TK	TCGA-LUAD	582.0	s10961	University of North Carolina	Washington University - Mayo Clinic	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	A24X-07	True
13767.58cfa83ce4b0c9d6adf72b66	58cfa83ce4b0c9d6adf72b66	UNCID_359957.TCGA-BP-4761-01A-01R-1289-07.110511_UNC11-SN627_0085_BC01AFABXX.8.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_359957.TCGA-BP-4761-01A-01R-1289-07.110511_UNC11-SN627_0085_BC01AFABXX.8.trimmed.annotated.translated_to_genomic	UNCID_359957.TCGA-BP-4761-01A-01R-1289-07.110511_UNC11-SN627_0085_BC01AFABXX.8.trimmed.annotated.translated_to_genomic.bam	81.3	1.8	0.15	58cfa83ce4b0c9d6adf72b66	UNCID_359957.TCGA-BP-4761-01A-01R-1289-07.110511_UNC11-SN627_0085_BC01AFABXX.8.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4761-01A	270C9A0B-D71A-4D4E-8686-F183412159F2	Primary Tumor	Illumina HiSeq	AFDC41FD-618E-4F2B-9685-530280FE6E47	Kidney	57.0	CB58CF8E-3D4C-4421-A3F0-F3C1540F12B2	B99E1AD8-15EC-4A57-BF8F-8AEA5333975C	TCGA-BP-4761-01A-01R-1289-07	HG19	TCGA-BP-4761	TCGA-KIRC		s9963	University of North Carolina	MSKCC	None	NO	T3a	N1	Kidney Clear Cell Renal Carcinoma	Stage III	1289-07	True
13767.58cfa82fe4b0c9d6adf6b63f	58cfa82fe4b0c9d6adf6b63f	TCGA-61-2111-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-61-2111-01A-01R-1568-13_rnaseq	TCGA-61-2111-01A-01R-1568-13_rnaseq.bam	715.0	1.8	0.15	58cfa82fe4b0c9d6adf6b63f	TCGA-61-2111-01A-01R-1568-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2111-01A	91A17D40-C8CB-4CCE-B306-966382A8FE4A	Primary Tumor	Illumina HiSeq	EDFAD268-9534-4341-96EC-FCF7F7859F79	Ovary	61.0	B469134F-2528-456E-BF69-C5B5A9268145	25C0888A-25B9-4CC0-A02F-6D363A341E8F	TCGA-61-2111-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-61-2111	TCGA-OV		s17476	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa838e4b0c9d6adf70600	58cfa838e4b0c9d6adf70600	UNCID_1966535.83c4827f-742b-42bf-96d0-335b484ee724.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1966535.83c4827f-742b-42bf-96d0-335b484ee724.sorted_genome_alignments	UNCID_1966535.83c4827f-742b-42bf-96d0-335b484ee724.sorted_genome_alignments.bam	38.1	1.94	0.16	58cfa838e4b0c9d6adf70600	UNCID_1966535.83c4827f-742b-42bf-96d0-335b484ee724.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FJ-A3Z9-01A	72FF655F-BB08-40ED-B4C3-E9497D4DA108	Primary Tumor	Illumina HiSeq	9B34571E-4746-4F72-8407-629BA7083CF0	Bladder	72.0	3AC90DDF-5007-4A45-A543-EA942949E030	83C4827F-742B-42BF-96D0-335B484EE724	TCGA-FJ-A3Z9-01A-11R-A26T-07	HG19	TCGA-FJ-A3Z9	TCGA-BLCA		s2988	University of North Carolina	BLN - Baylor	United States	NO	TX	N0	Muscle invasive urothelial carcinoma (pT2 or above)		A26T-07	True
13722.58cfa832e4b0c9d6adf6d328	58cfa832e4b0c9d6adf6d328	TCGA-KN-8432-11A-01D-2311-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8432-11A-01D-2311-10_wgs_Illumina	TCGA-KN-8432-11A-01D-2311-10_wgs_Illumina.bam	211.3		0.05	58cfa832e4b0c9d6adf6d328	TCGA-KN-8432-11A-01D-2311-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8432-11A	AF1111AF-9384-4E37-9B16-227D38007EBD	Solid Tissue Normal	Illumina HiSeq	0044f889-53c7-47d9-815d-84ea35acee63	Kidney	86.0	6A5BAAC8-C270-45F7-8911-592D987E3FBE	7D556F90-8997-4E2F-9F30-23814AA3C222	TCGA-KN-8432-11A-01D-2311-10	GRCh37-lite	TCGA-KN-8432	TCGA-KICH		s16407	Baylor College of Medicine	Harvard	United States	NO	T2b	NX	Kidney Chromophobe	Stage II	2311-10	True
13767.58cfa82ee4b0c9d6adf6b1e8	58cfa82ee4b0c9d6adf6b1e8	TCGA-13-0884-01B-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-13-0884-01B-01R-1565-13_GRCh37-lite_rnaseq	TCGA-13-0884-01B-01R-1565-13_GRCh37-lite_rnaseq.bam	203.0	1.8	0.16	58cfa82ee4b0c9d6adf6b1e8	TCGA-13-0884-01B-01R-1565-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0884-01B	63A75E0B-9241-4F0E-9236-01A2E2C05B7E	Primary Tumor	Illumina HiSeq	6305AC8F-5F02-44E6-8227-8FAB3105C0BD	Ovary	39.0	4AA80346-4292-4863-9891-BB4C218880B3	5339B819-0E19-4B7D-A098-6F58AFC07180	TCGA-13-0884-01B-01R-1565-13	GRCh37-lite	TCGA-13-0884	TCGA-OV	3260.0	s17216	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1565-13	True
13722.58cfa832e4b0c9d6adf6d216	58cfa832e4b0c9d6adf6d216	TCGA-J8-A3YH-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_4_rg.sorted.filtered.	WGS	TCGA-J8-A3YH-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_4_rg.sorted	TCGA-J8-A3YH-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_4_rg.sorted.bam	86.99		0.16	58cfa832e4b0c9d6adf6d216	TCGA-J8-A3YH-10A-01D-A23Q_120927_SN208_0432_AC188LACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE		Thyroid Carcinoma	Aligned reads	TCGA-J8-A3YH-10A	A09B20B5-C187-4632-B996-0D5314A9885C	Blood Derived Normal	Illumina HiSeq	3180bef4-6ed0-4432-af76-0f70becf05c1	Thyroid	39.0	E5E18EDC-042A-4A3B-BF29-D4560D3E3DC2	3B557C96-DD0A-4695-939A-0874237C4827	TCGA-J8-A3YH-10A-01D-A23Q-26	HG19_Broad_variant	TCGA-J8-A3YH	TCGA-THCA		s12124	MD Anderson - Institute for Applied Cancer Science	Mayo Clinic	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23Q-26	True
13722.58cfa830e4b0c9d6adf6be41	58cfa830e4b0c9d6adf6be41	TCGA-BJ-A28R-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BJ-A28R-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_8_rg.sorted	TCGA-BJ-A28R-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_8_rg.sorted.bam	60.26	1.93	0.17	58cfa830e4b0c9d6adf6be41	TCGA-BJ-A28R-10A-01D-A16N_121204_SN208_0442_BC1F7YACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28R-10A	524A39EE-8FA3-418E-98A2-A6A90E9C8064	Blood Derived Normal	Illumina HiSeq	22696c6b-bf53-4670-9518-1526986414a8	Thyroid	38.0	576D5B97-6871-4E32-8A11-14ECAE9D490C	90BB8D84-280A-4E9C-8F10-4003DCDCEF31	TCGA-BJ-A28R-10A-01D-A16N-02	HG19_Broad_variant	TCGA-BJ-A28R	TCGA-THCA		s12355	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	True
13767.58cfa83be4b0c9d6adf721a7	58cfa83be4b0c9d6adf721a7	UNCID_2598659.64351fb2-8e3b-41a0-9764-52f2c7279e63.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2598659.64351fb2-8e3b-41a0-9764-52f2c7279e63.sorted_genome_alignments	UNCID_2598659.64351fb2-8e3b-41a0-9764-52f2c7279e63.sorted_genome_alignments.bam	62.66	1.87	0.17	58cfa83be4b0c9d6adf721a7	UNCID_2598659.64351fb2-8e3b-41a0-9764-52f2c7279e63.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thymoma	Aligned reads	TCGA-ZB-A96O-01A	ACFBA23A-06EB-4FF1-BE60-0452A13A4978	Primary Tumor	Illumina HiSeq	50CE3A9F-98AC-41B7-8D48-318E4C253BC1	Thymus	54.0	0BA45982-1D33-4E3A-BD96-7F737BE58381	64351FB2-8E3B-41A0-9764-52F2C7279E63	TCGA-ZB-A96O-01A-11R-A42S-07	HG19	TCGA-ZB-A96O	TCGA-THYM		s550	University of North Carolina	Thoraxklinik	Germany	NO					A42S-07	True
13722.58cfa82de4b0c9d6adf6a609	58cfa82de4b0c9d6adf6a609	7652d849b685c386a065309525f742d7.filtered.	WGS	7652d849b685c386a065309525f742d7	7652d849b685c386a065309525f742d7.bam	7.14	1.93	0.08	58cfa82de4b0c9d6adf6a609	7652d849b685c386a065309525f742d7.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A0J1-10A	EC7A9D74-8B3F-4747-8926-1739A016AB2B	Blood Derived Normal	Illumina HiSeq	71b29e81-6847-4a7c-9051-48bb0ea4e4b2	Uterus	80.0	7249199D-6E4A-4A4A-9F4C-996E9B7E2D20	8623A4A0-5AE3-4A17-9263-1F78DADE3832	TCGA-AX-A0J1-10A-01D-A066-09	GRCh37-lite	TCGA-AX-A0J1	TCGA-UCEC		s4583	Washington University School of Medicine	Gynecologic Oncology Group	None	NO			Endometrioid endometrial adenocarcinoma		A066-09	True
13722.58cfa831e4b0c9d6adf6c97e	58cfa831e4b0c9d6adf6c97e	TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina	TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina.bam	31.0	1.9	0.08	58cfa831e4b0c9d6adf6c97e	TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5625-10A	53D9A130-4A3A-4491-85CD-9A44415A1632	Blood Derived Normal	Illumina HiSeq	8525b9e2-c05e-4524-ba11-f1673ffc575e	Head and Neck	52.0	F3AD5B44-87B1-41AE-8CC1-42E158BC174C	FDE15753-1874-45DB-9CCF-7C1BD4238D59	TCGA-DQ-5625-10A-01D-A32X-10	GRCh37-lite	TCGA-DQ-5625	TCGA-HNSC		s16059	Baylor College of Medicine	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma		A32X-10	True
13767.58cfa838e4b0c9d6adf70c6a	58cfa838e4b0c9d6adf70c6a	UNCID_2148378.5c99d6ce-742c-427c-a252-e2ce6b7f919c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2148378.5c99d6ce-742c-427c-a252-e2ce6b7f919c.sorted_genome_alignments	UNCID_2148378.5c99d6ce-742c-427c-a252-e2ce6b7f919c.sorted_genome_alignments.bam	28.42	1.9	0.17	58cfa838e4b0c9d6adf70c6a	UNCID_2148378.5c99d6ce-742c-427c-a252-e2ce6b7f919c.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-O2-A5IB-01A	8BE10CE9-220D-4816-A575-8E8E7F041114	Primary Tumor	Illumina HiSeq	6901428A-6A80-413B-92DE-1C6CD050921E	Lung	71.0	803E1D61-0CCD-4A97-917D-34B5FDF290F3	5C99D6CE-742C-427C-A252-E2CE6B7F919C	TCGA-O2-A5IB-01A-11R-A27Q-07	HG19	TCGA-O2-A5IB	TCGA-LUSC	340.0	s10588	University of North Carolina	Washington University - CALGB	United States	NO	T3	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	A27Q-07	True
13767.58cfa837e4b0c9d6adf702dc	58cfa837e4b0c9d6adf702dc	UNCID_1950770.66dc3d95-050b-49df-b8fc-743aec0e9e36.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1950770.66dc3d95-050b-49df-b8fc-743aec0e9e36.sorted_genome_alignments	UNCID_1950770.66dc3d95-050b-49df-b8fc-743aec0e9e36.sorted_genome_alignments.bam	46.64	1.86	0.16	58cfa837e4b0c9d6adf702dc	UNCID_1950770.66dc3d95-050b-49df-b8fc-743aec0e9e36.sorted_genome_alignments.bam	Alive	FEMALE			Pancreatic Adenocarcinoma	Aligned reads	TCGA-M8-A5N4-01A	F0A4944C-D6CF-4163-A1AB-189803464B03	Primary Tumor	Illumina HiSeq	16051630-1352-4A39-B700-C2BE67AFE452	Pancreas	48.0	BD1CFFC7-DC9D-45D0-9EB7-9338132E715F	66DC3D95-050B-49DF-B8FC-743AEC0E9E36	TCGA-M8-A5N4-01A-11R-A26U-07	HG19	TCGA-M8-A5N4	TCGA-PAAD		s776	University of North Carolina	Ontario Institute for Cancer Research (OICR)	Canada	NO	T3	N0	Pancreas-Adenocarcinoma Ductal Type	Stage II	A26U-07	True
13722.58cfa830e4b0c9d6adf6c0a2	58cfa830e4b0c9d6adf6c0a2	TCGA-BJ-A0ZG-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZG-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_7_rg.sorted	TCGA-BJ-A0ZG-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_7_rg.sorted.bam	6.76	1.71	0.13	58cfa830e4b0c9d6adf6c0a2	TCGA-BJ-A0ZG-10A-01D-A10R_120711_SN1120_0174_BD13R2ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZG-10A	A3810F36-D2B4-4A45-AD08-A4DBFB9D27AA	Blood Derived Normal	Illumina HiSeq	ec575768-5714-4488-a113-a87ae6de34f0	Thyroid	80.0	CF6D9496-441B-4ED1-90D0-BDE9F2C8FD61	B66FBD46-CC3B-4881-ADA0-2998BAF442DA	TCGA-BJ-A0ZG-10A-01D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZG	TCGA-THCA		s12098	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10R-02	True
13767.58cfa82fe4b0c9d6adf6b3a4	58cfa82fe4b0c9d6adf6b3a4	TCGA-24-0966-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-0966-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-24-0966-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	684.0	1.8	0.13	58cfa82fe4b0c9d6adf6b3a4	TCGA-24-0966-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-0966-01A	FEF1696C-A8F4-4DB6-8615-E486522BAAAA	Primary Tumor	Illumina HiSeq	FBDFA2D4-9065-425D-B0F3-447779AF10EC	Ovary	78.0	67C7B4CB-5FE3-49CF-9AA3-DF23717553BB	63A8DE0C-927C-4FAF-A596-841871CEB8F9	TCGA-24-0966-01A-01R-1564-13	GRCh37-lite	TCGA-24-0966	TCGA-OV		s17369	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa835e4b0c9d6adf6eee6	58cfa835e4b0c9d6adf6eee6	UNCID_1415444.0c562903-7b09-49f2-b59e-fa697d69f810.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1415444.0c562903-7b09-49f2-b59e-fa697d69f810.sorted_genome_alignments	UNCID_1415444.0c562903-7b09-49f2-b59e-fa697d69f810.sorted_genome_alignments.bam	57.8	1.8	0.15	58cfa835e4b0c9d6adf6eee6	UNCID_1415444.0c562903-7b09-49f2-b59e-fa697d69f810.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6408-01A	14375753-A69F-41E0-B910-2BB8E84CC43A	Primary Tumor	Illumina HiSeq	1E1ABA3A-C251-4606-89F2-19BF69426CA8	Brain	23.0	F68159AD-A0E9-4F9F-AD68-A29D53772982	0C562903-7B09-49F2-B59E-FA697D69F810	TCGA-DU-6408-01A-11R-1708-07	HG19	TCGA-DU-6408	TCGA-LGG	3470.0	s8165	University of North Carolina	Henry Ford Hospital	United States	NO			Oligodendroglioma		1708-07	True
13722.58cfa82de4b0c9d6adf6a762	58cfa82de4b0c9d6adf6a762	G14856.TCGA-05-4432-01A-01D-1931-08.2.filtered.	WGS	G14856.TCGA-05-4432-01A-01D-1931-08.2	G14856.TCGA-05-4432-01A-01D-1931-08.2.bam	306.53	1.9	0.14	58cfa82de4b0c9d6adf6a762	G14856.TCGA-05-4432-01A-01D-1931-08.2.bam	Alive	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4432-01A	E737F650-B72D-44E7-B750-558A56716803	Primary Tumor	Illumina HiSeq	612f40cd-a773-4962-b831-73dc8d9fb669	Lung	66.0	2A675528-1ABC-4220-A61A-25109850CE0D	3FBF4DA2-16C9-49AF-A5B3-3DC6C928E75C	TCGA-05-4432-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4432	TCGA-LUAD		s11425	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage II	1931-08	True
13767.58cfa83be4b0c9d6adf72984	58cfa83be4b0c9d6adf72984	UNCID_2624516.7d32ee7b-77a7-4c50-923f-a870221640e5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2624516.7d32ee7b-77a7-4c50-923f-a870221640e5.sorted_genome_alignments	UNCID_2624516.7d32ee7b-77a7-4c50-923f-a870221640e5.sorted_genome_alignments.bam	20.1	1.78	0.16	58cfa83be4b0c9d6adf72984	UNCID_2624516.7d32ee7b-77a7-4c50-923f-a870221640e5.sorted_genome_alignments.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-5M-AAT4-01A	1136DD50-242A-4659-AAD4-C53F9E759BB3	Primary Tumor	Illumina HiSeq	B2233C30-FDDC-4361-A628-C7E3B11B00F6	Colorectal	74.0	7CE1F7C4-C7B2-4A2F-A3F1-B96BEF4F6B63	7D32EE7B-77A7-4C50-923F-A870221640E5	TCGA-5M-AAT4-01A-11R-A41B-07	HG19	TCGA-5M-AAT4	TCGA-COAD	49.0	s13628	University of North Carolina	University of Sao Paulo	Brazil	NO	T3	N0	Colon Adenocarcinoma	Stage IV	A41B-07	True
13767.58cfa83ce4b0c9d6adf73136	58cfa83ce4b0c9d6adf73136	_1_TCGA-BR-8372-01A-11R-2343-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-8372-01A-11R-2343-13_rnaseq	_1_TCGA-BR-8372-01A-11R-2343-13_rnaseq.bam	323.5		0.17	58cfa83ce4b0c9d6adf73136	_1_TCGA-BR-8372-01A-11R-2343-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8372-01A	5B52F882-DF12-42EC-A000-FF3B428BA05B	Primary Tumor	Illumina HiSeq	166AC33B-DBD0-430F-BF92-CECBC7CBB1B5	Stomach	63.0	FAE10552-1D8A-4970-B733-5AA0F498FBC8	82A70DA7-F6EC-4F02-81EF-A4BDADF258FD	TCGA-BR-8372-01A-11R-2343-13	GRCh37-lite	TCGA-BR-8372	TCGA-STAD		s15275	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T4b	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	2343-13	True
13767.58cfa837e4b0c9d6adf6fcf0	58cfa837e4b0c9d6adf6fcf0	UNCID_1708257.7af273bb-bede-495c-8a07-0a1d5d23a0eb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1708257.7af273bb-bede-495c-8a07-0a1d5d23a0eb.sorted_genome_alignments	UNCID_1708257.7af273bb-bede-495c-8a07-0a1d5d23a0eb.sorted_genome_alignments.bam	143.2		0.15	58cfa837e4b0c9d6adf6fcf0	UNCID_1708257.7af273bb-bede-495c-8a07-0a1d5d23a0eb.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN		Kidney Chromophobe	Aligned reads	TCGA-KL-8329-11A	D542C363-FD6C-447D-B71A-0E94FEC125E4	Solid Tissue Normal	Illumina HiSeq	C5C0FF75-93E5-487A-A08B-CA1239770A89	Kidney	57.0	19892DDC-2C76-4109-A8AE-4B7805F7A69D	7AF273BB-BEDE-495C-8A07-0A1D5D23A0EB	TCGA-KL-8329-11A-01R-2315-07	HG19	TCGA-KL-8329	TCGA-KICH		s16461	University of North Carolina	MSKCC	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2315-07	True
13767.58cfa834e4b0c9d6adf6e9c2	58cfa834e4b0c9d6adf6e9c2	UNCID_1250679.589feea4-d8ea-4c3f-9d63-367ba1488465.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1250679.589feea4-d8ea-4c3f-9d63-367ba1488465.sorted_genome_alignments	UNCID_1250679.589feea4-d8ea-4c3f-9d63-367ba1488465.sorted_genome_alignments.bam	24.85	1.86	0.16	58cfa834e4b0c9d6adf6e9c2	UNCID_1250679.589feea4-d8ea-4c3f-9d63-367ba1488465.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZF-06A	E0D36CC0-652C-4224-BB10-09D15C7BD8F1	Metastatic	Illumina HiSeq	E10CE867-EB21-4164-8D8E-132E08A3530E	Skin	78.0	FE7D6D24-E8DA-4703-BC74-2720363B4C01	589FEEA4-D8EA-4C3F-9D63-367BA1488465	TCGA-FS-A1ZF-06A-12R-A18S-07	HG19	TCGA-FS-A1ZF	TCGA-SKCM	470.0	s8054	University of North Carolina	Essen	Germany	NO	T4b	N0		Stage II	A18S-07	True
13722.58cfa831e4b0c9d6adf6c37e	58cfa831e4b0c9d6adf6c37e	TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted	TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted.bam	46.0	1.9	0.16	58cfa831e4b0c9d6adf6c37e	TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted.bam	Alive	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5719-01A	263F67E0-0A28-42E6-B3F3-1DDD0D397220	Primary Tumor	Illumina HiSeq	e6237df3-92e8-4e8b-92a4-b09d3515f16f	Stomach	54.0	606573EE-ED11-4DB5-ABAF-E842EC575EEE	9008E364-B8F3-4923-B0CC-6ED34AA7BAC3	TCGA-CG-5719-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5719	TCGA-STAD		s15247	Harvard Medical School	Indivumed	Germany	NO	T4	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1598-02	True
13767.58cfa838e4b0c9d6adf70608	58cfa838e4b0c9d6adf70608	UNCID_1912313.eee5c7c2-da4c-4d30-9001-7ca9f25c806a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1912313.eee5c7c2-da4c-4d30-9001-7ca9f25c806a.sorted_genome_alignments	UNCID_1912313.eee5c7c2-da4c-4d30-9001-7ca9f25c806a.sorted_genome_alignments.bam	128.2		0.14	58cfa838e4b0c9d6adf70608	UNCID_1912313.eee5c7c2-da4c-4d30-9001-7ca9f25c806a.sorted_genome_alignments.bam	Dead	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-8133-01A	BECC8BB8-BDBF-426C-B9B6-A23558EB13C1	Primary Tumor	Illumina HiSeq	49A6E5A5-3052-4A46-88B3-497DDD680741	Lung	74.0	26006BE0-D6C5-47B7-BB7B-5CB3F78C1EBD	EEE5C7C2-DA4C-4D30-9001-7CA9F25C806A	TCGA-77-8133-01A-12R-2247-07	HG19	TCGA-77-8133	TCGA-LUSC	1640.0	s10614	University of North Carolina	Prince Charles Hospital	Australia	NO	T1	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	2247-07	True
13722.58cfa831e4b0c9d6adf6c51e	58cfa831e4b0c9d6adf6c51e	TCGA-CM-4746-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CM-4746-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CM-4746-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	87.72	1.9	0.15	58cfa831e4b0c9d6adf6c51e	TCGA-CM-4746-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4746-10A	C0B8C55C-B993-481D-AEEA-9EBFA64EE20E	Blood Derived Normal	Illumina HiSeq	454e7afb-d46f-4230-bbf3-ee5844e29cdc	Colorectal	61.0	3ED6A50C-8AC3-49DB-9DC1-C2F8C49D78A1	850C3F5C-2CB7-465D-9254-BAC172442BAA	TCGA-CM-4746-10A-01D-1405-02	HG18	TCGA-CM-4746	TCGA-COAD		s13846	Harvard Medical School	MSKCC	None	NO	T2	N0	Colon Adenocarcinoma	Stage I	1405-02	True
13767.58cfa82fe4b0c9d6adf6b6ce	58cfa82fe4b0c9d6adf6b6ce	TCGA-30-1718-01A-01R-1567-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-30-1718-01A-01R-1567-13_GRCh37-lite_rnaseq	TCGA-30-1718-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	227.0	1.8	0.15	58cfa82fe4b0c9d6adf6b6ce	TCGA-30-1718-01A-01R-1567-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-30-1718-01A	AD2939E6-B8B8-475A-90E2-6A369C3D3167	Primary Tumor	Illumina HiSeq	52E335FC-4F83-415F-97DA-4EECF3EA4D72	Ovary	44.0	9EA630A2-1412-4F40-897A-38A52600A1CB	5ABCE979-686D-40C4-ACD7-EF9CC5ACF26F	TCGA-30-1718-01A-01R-1567-13	GRCh37-lite	TCGA-30-1718	TCGA-OV	1579.0	s17266	Canada's Michael Smith Genome Sciences Centre	Harvard	None	NO			Serous Cystadenocarcinoma		1567-13	True
13722.58cfa831e4b0c9d6adf6cdd1	58cfa831e4b0c9d6adf6cdd1	TCGA-FD-A3SS-10A-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_2_rg.sorted.filtered.	WGS	TCGA-FD-A3SS-10A-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_2_rg.sorted	TCGA-FD-A3SS-10A-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_2_rg.sorted.bam	53.16		0.17	58cfa831e4b0c9d6adf6cdd1	TCGA-FD-A3SS-10A-01D-A233_120905_SN1120_0187_AD1E4NACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SS-10A	7B98B829-FDC7-4719-BEE9-C83F6154019C	Blood Derived Normal	Illumina HiSeq	275f5d73-157d-4162-a8da-dec4f5f8c299	Bladder	66.0	3CC80B9B-B7B5-42BF-83CC-212A828128EE	72276377-845C-4A0B-872A-4FA4FCE12B91	TCGA-FD-A3SS-10A-01D-A233-26	HG19_Broad_variant	TCGA-FD-A3SS	TCGA-BLCA		s2912	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T4	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	True
13722.58cfa831e4b0c9d6adf6ca8e	58cfa831e4b0c9d6adf6ca8e	TCGA-DK-A1A3-10A-01D-A13U_120921_SN208_0431_BD1D5FACXX_s_8_rg.sorted.filtered.	WGS	TCGA-DK-A1A3-10A-01D-A13U_120921_SN208_0431_BD1D5FACXX_s_8_rg.sorted	TCGA-DK-A1A3-10A-01D-A13U_120921_SN208_0431_BD1D5FACXX_s_8_rg.sorted.bam	58.67	1.93	0.15	58cfa831e4b0c9d6adf6ca8e	TCGA-DK-A1A3-10A-01D-A13U_120921_SN208_0431_BD1D5FACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A3-10A	C5B20CCC-523D-491C-8536-008E05C57212	Blood Derived Normal	Illumina HiSeq	dea57f3e-8079-4c79-9961-51b68eba2dcc	Bladder	60.0	57DE21D1-0917-49B0-9813-7F4B7A94F6EB	CCBC402E-6FAB-4BB8-84CA-314649D26EF0	TCGA-DK-A1A3-10A-01D-A13U-02	HG19_Broad_variant	TCGA-DK-A1A3	TCGA-BLCA		s2702	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13U-02	True
13722.58cfa832e4b0c9d6adf6cfd8	58cfa832e4b0c9d6adf6cfd8	TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted	TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted.bam	59.29		0.15	58cfa832e4b0c9d6adf6cfd8	TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3TQ-01A	7218AA6F-3345-484F-A329-A3B6169A67C7	Primary Tumor	Illumina HiSeq	87ede4e6-17e6-4287-8ee3-cde27de3aa7d	Cervix	55.0	2F3BFFB4-2C85-4B72-9AF5-4DB9DC358AE6	7018744F-49FF-4F47-AEE5-07F0DEA5D7D3	TCGA-FU-A3TQ-01A-11D-A232-26	HG19_Broad_variant	TCGA-FU-A3TQ	TCGA-CESC		s1199	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N1	Cervical Squamous Cell Carcinoma		A232-26	True
13767.58cfa835e4b0c9d6adf6ec60	58cfa835e4b0c9d6adf6ec60	UNCID_1322520.39239ac6-7757-43ca-928a-4885260ecbc7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1322520.39239ac6-7757-43ca-928a-4885260ecbc7.sorted_genome_alignments	UNCID_1322520.39239ac6-7757-43ca-928a-4885260ecbc7.sorted_genome_alignments.bam	224.2		0.15	58cfa835e4b0c9d6adf6ec60	UNCID_1322520.39239ac6-7757-43ca-928a-4885260ecbc7.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-FC-7708-01A	208A75B3-407C-4C5A-8938-3691547B6887	Primary Tumor	Illumina HiSeq	F2F8BAA2-B81A-4901-B167-F349EE588708	Prostate	52.0	0A6801F9-7AAE-4BA1-844B-159B703A20F3	39239AC6-7757-43CA-928A-4885260ECBC7	TCGA-FC-7708-01A-11R-2118-07	HG19	TCGA-FC-7708	TCGA-PRAD		s3831	University of North Carolina	Asterand	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13722.58cfa832e4b0c9d6adf6cec2	58cfa832e4b0c9d6adf6cec2	TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted.filtered.	WGS	TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted	TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted.bam	398.7		0.13	58cfa832e4b0c9d6adf6cec2	TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7080-01A	FD50FF41-EC9D-4DB1-A673-36BA0CA1EAC8	Primary Tumor	Illumina HiSeq	4012de79-f9d8-4ee6-ab04-538482e6a66c	Prostate	66.0	E30730B8-81F1-49A8-8446-547B5C3CC730	CEF3C431-0329-4619-834B-DC57B33399A5	TCGA-HC-7080-01A-11D-1957-02	HG19_Broad_variant	TCGA-HC-7080	TCGA-PRAD		s3807	Harvard Medical School	International Genomics Consortium	United States	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type		1957-02	True
13722.58cfa82ee4b0c9d6adf6a8e8	58cfa82ee4b0c9d6adf6a8e8	G35154.TCGA-DH-A669-10A-01D-A31J-08.3.filtered.	WGS	G35154.TCGA-DH-A669-10A-01D-A31J-08.3	G35154.TCGA-DH-A669-10A-01D-A31J-08.3.bam	56.02		0.07	58cfa82ee4b0c9d6adf6a8e8	G35154.TCGA-DH-A669-10A-01D-A31J-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DH-A669-10A	76E54EF6-1799-4FD9-BEC3-0EA960E8461E	Blood Derived Normal	Illumina HiSeq	958ecf79-2dcd-480b-a65f-d208b59fbf57	Brain	70.0	F61ACBA6-BD08-428B-8D9B-FCCEFE643A36	E849ABEF-B55E-4124-B760-09101A7C4390	TCGA-DH-A669-10A-01D-A31J-08	HG19_Broad_variant	TCGA-DH-A669	TCGA-LGG	919.0	s8322	Broad Institute of MIT and Harvard	University of Florida	United States	NO			Oligodendroglioma		A31J-08	False
13767.58cfa834e4b0c9d6adf6e960	58cfa834e4b0c9d6adf6e960	UNCID_1227357.554a301f-fbc8-41f2-96e9-5da2ee943727.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1227357.554a301f-fbc8-41f2-96e9-5da2ee943727.sorted_genome_alignments	UNCID_1227357.554a301f-fbc8-41f2-96e9-5da2ee943727.sorted_genome_alignments.bam	163.8	1.8	0.14	58cfa834e4b0c9d6adf6e960	UNCID_1227357.554a301f-fbc8-41f2-96e9-5da2ee943727.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5066-01A	3199CFE5-3BE3-43CD-A36B-5CF2C7A9929F	Primary Tumor	Illumina HiSeq	9FB9392F-D2DB-4A9F-B7C7-1DBFC8D3CE3F	Lung	72.0	478CC306-6AEE-4597-8834-1E5CF8B05A59	554A301F-FBC8-41F2-96E9-5DA2EE943727	TCGA-50-5066-01A-01R-1628-07	HG19	TCGA-50-5066	TCGA-LUAD		s11499	University of North Carolina	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage I	1628-07	True
13767.58cfa835e4b0c9d6adf6ebfe	58cfa835e4b0c9d6adf6ebfe	UNCID_1282414.4af17296-dc40-45f6-8bef-0bb5af55406f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1282414.4af17296-dc40-45f6-8bef-0bb5af55406f.sorted_genome_alignments	UNCID_1282414.4af17296-dc40-45f6-8bef-0bb5af55406f.sorted_genome_alignments.bam	61.04	1.73	0.17	58cfa835e4b0c9d6adf6ebfe	UNCID_1282414.4af17296-dc40-45f6-8bef-0bb5af55406f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28R-01A	524A39EE-8FA3-418E-98A2-A6A90E9C8064	Primary Tumor	Illumina HiSeq	8B0AB6A3-D3A2-4B37-83AE-F81AE4B01845	Thyroid	38.0	F4906B86-3971-4ED3-AC3C-69635311FB45	4AF17296-DC40-45F6-8BEF-0BB5AF55406F	TCGA-BJ-A28R-01A-11R-A16R-07	HG19	TCGA-BJ-A28R	TCGA-THCA		s12273	University of North Carolina	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16R-07	True
13722.58cfa832e4b0c9d6adf6cfc8	58cfa832e4b0c9d6adf6cfc8	TCGA-FS-A1ZN-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_6_rg.sorted.filtered.	WGS	TCGA-FS-A1ZN-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_6_rg.sorted	TCGA-FS-A1ZN-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_6_rg.sorted.bam	23.83		0.16	58cfa832e4b0c9d6adf6cfc8	TCGA-FS-A1ZN-10A-01D-A190_120605_SN1222_0112_AC0WJJACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZN-10A	9D86940D-50FB-4D2F-8B1E-539196885F46	Blood Derived Normal	Illumina HiSeq	27bdfcc3-454a-4619-a5db-13e91e2aff16	Skin	43.0	24D3D408-8417-4497-814E-31D407886EE0	A5E22F8F-A2D8-4968-B258-BC67282CB9C0	TCGA-FS-A1ZN-10A-01D-A190-02	HG19_Broad_variant	TCGA-FS-A1ZN	TCGA-SKCM	730.0	s7536	Harvard Medical School	Essen	Germany	NO	T4b	N1a		Stage III	A190-02	True
13767.58cfa83ce4b0c9d6adf731c0	58cfa83ce4b0c9d6adf731c0	_1_TCGA-CG-5724-01A-11R-1602-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-CG-5724-01A-11R-1602-13_rnaseq	_1_TCGA-CG-5724-01A-11R-1602-13_rnaseq.bam	334.8	1.8	0.14	58cfa83ce4b0c9d6adf731c0	_1_TCGA-CG-5724-01A-11R-1602-13_rnaseq.bam	Dead	MALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5724-01A	0B4E8D73-459D-4930-9D1A-ABB8D53E1844	Primary Tumor	Illumina HiSeq	C3450E6A-3C8D-4B36-A7C1-EFC470A52EE9	Stomach	59.0	4D624B21-5AEE-42B8-B192-8AFECB51434D	F5B280AF-A502-4FCF-BC81-53F1111242BE	TCGA-CG-5724-01A-11R-1602-13	GRCh37-lite	TCGA-CG-5724	TCGA-STAD	366.0	s15435	Canada's Michael Smith Genome Sciences Centre	Indivumed	Germany	NO	T3	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	1602-13	True
13767.58cfa837e4b0c9d6adf6ffee	58cfa837e4b0c9d6adf6ffee	UNCID_1815835.3dbb7586-0e8d-41ff-aa57-ab701b892784.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1815835.3dbb7586-0e8d-41ff-aa57-ab701b892784.sorted_genome_alignments	UNCID_1815835.3dbb7586-0e8d-41ff-aa57-ab701b892784.sorted_genome_alignments.bam	28.98	1.84	0.16	58cfa837e4b0c9d6adf6ffee	UNCID_1815835.3dbb7586-0e8d-41ff-aa57-ab701b892784.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A45I-01A	C5D08BE7-B94C-423A-AEA8-BBC635787C63	Primary Tumor	Illumina HiSeq	105BA3FE-CE2F-4BB7-AD10-7159AE323E47	Thyroid	51.0	E6294121-63C4-4736-9A99-9D277D5F3ABD	3DBB7586-0E8D-41FF-AA57-AB701B892784	TCGA-BJ-A45I-01A-11R-A23W-07	HG19	TCGA-BJ-A45I	TCGA-THCA		s12196	University of North Carolina	University of Pittsburgh	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage III	A23W-07	True
13767.58cfa838e4b0c9d6adf70524	58cfa838e4b0c9d6adf70524	UNCID_1902614.8f581126-cf99-41bb-84ce-c9533f2db53a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1902614.8f581126-cf99-41bb-84ce-c9533f2db53a.sorted_genome_alignments	UNCID_1902614.8f581126-cf99-41bb-84ce-c9533f2db53a.sorted_genome_alignments.bam	26.6	1.85	0.18	58cfa838e4b0c9d6adf70524	UNCID_1902614.8f581126-cf99-41bb-84ce-c9533f2db53a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A4K0-01A	08293BF4-727D-45C2-ABBF-1AEC3BA1C8A4	Primary Tumor	Illumina HiSeq	60B0A862-701B-4E10-AE46-0EAD611AFEA4	Thyroid	54.0	2F9B1634-04B5-44AD-8EC2-A23EF4FFB0DD	8F581126-CF99-41BB-84CE-C9533F2DB53A	TCGA-EL-A4K0-01A-11R-A250-07	HG19	TCGA-EL-A4K0	TCGA-THCA		s12839	University of North Carolina	MD Anderson	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A250-07	True
13767.58cfa837e4b0c9d6adf70306	58cfa837e4b0c9d6adf70306	UNCID_1954192.957a2bee-d5ff-4b21-931a-c50c3bc5fcc2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1954192.957a2bee-d5ff-4b21-931a-c50c3bc5fcc2.sorted_genome_alignments	UNCID_1954192.957a2bee-d5ff-4b21-931a-c50c3bc5fcc2.sorted_genome_alignments.bam	15.71	1.79	0.18	58cfa837e4b0c9d6adf70306	UNCID_1954192.957a2bee-d5ff-4b21-931a-c50c3bc5fcc2.sorted_genome_alignments.bam	Dead	MALE	ASIAN		Pancreatic Adenocarcinoma	Aligned reads	TCGA-HV-A5A3-01A	D4F66F06-9289-45C1-B9EB-AAEF991A4BB6	Primary Tumor	Illumina HiSeq	BEDD8E54-6A47-4475-A46E-84FFFA841073	Pancreas	50.0	975BA0D6-92B7-46F8-A564-F852554E706E	957A2BEE-D5FF-4B21-931A-C50C3BC5FCC2	TCGA-HV-A5A3-01A-11R-A26U-07	HG19	TCGA-HV-A5A3	TCGA-PAAD	128.0	s772	University of North Carolina	National Cancer Center Korea	Korea South	NO	T3	NX	Pancreas-Adenocarcinoma Ductal Type	Stage II	A26U-07	True
13722.58cfa831e4b0c9d6adf6cdd0	58cfa831e4b0c9d6adf6cdd0	TCGA-FE-A3PD-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_8_rg.sorted.filtered.	WGS	TCGA-FE-A3PD-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_8_rg.sorted	TCGA-FE-A3PD-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_8_rg.sorted.bam	10.47		0.17	58cfa831e4b0c9d6adf6cdd0	TCGA-FE-A3PD-10A-01D-A221_120611_SN1222_0115_BD141KACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A3PD-10A	39D90499-8549-4DA5-B391-C421F18FACF1	Blood Derived Normal	Illumina HiSeq	15d6d1a8-5bb0-4b4b-9f8a-06c8530be145	Thyroid	17.0	703333E7-A2BA-4601-8F33-D0CD1F587E76	6CDCC877-A657-49EF-BD45-B51124FAE18E	TCGA-FE-A3PD-10A-01D-A221-26	HG19_Broad_variant	TCGA-FE-A3PD	TCGA-THCA		s12254	MD Anderson - Institute for Applied Cancer Science	Ohio State University	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A221-26	True
13767.58cfa833e4b0c9d6adf6dcb9	58cfa833e4b0c9d6adf6dcb9	UNCID_1118498.526c9170-0f25-4374-9287-1fc40acb6555.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1118498.526c9170-0f25-4374-9287-1fc40acb6555.sorted_genome_alignments	UNCID_1118498.526c9170-0f25-4374-9287-1fc40acb6555.sorted_genome_alignments.bam	33.56	1.75	0.17	58cfa833e4b0c9d6adf6dcb9	UNCID_1118498.526c9170-0f25-4374-9287-1fc40acb6555.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LL-01A	2A84997D-CCEE-4F46-BEA2-752534F26416	Primary Tumor	Illumina HiSeq	78E447A5-9C86-456D-9365-2BF1D26814DA	Breast	73.0	E57574E4-7E01-4E61-BD29-EE4EC63DDDD6	526C9170-0F25-4374-9287-1FC40ACB6555	TCGA-E2-A1LL-01A-11R-A144-07	HG19	TCGA-E2-A1LL	TCGA-BRCA		s6298	University of North Carolina	Roswell Park	United States	NO	T3	N2a	Infiltrating Ductal Carcinoma	Stage III	A144-07	True
13767.58cfa83ce4b0c9d6adf72d4a	58cfa83ce4b0c9d6adf72d4a	UNCID_597912.fd27fbf6-ceaf-4eef-9585-a84b7ad60453.111019_UNC14-SN744_0180_AB01RFABXX.6.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_597912.fd27fbf6-ceaf-4eef-9585-a84b7ad60453.111019_UNC14-SN744_0180_AB01RFABXX.6.trimmed.annotated.translated_to_genomic	UNCID_597912.fd27fbf6-ceaf-4eef-9585-a84b7ad60453.111019_UNC14-SN744_0180_AB01RFABXX.6.trimmed.annotated.translated_to_genomic.bam	68.8	1.7	0.15	58cfa83ce4b0c9d6adf72d4a	UNCID_597912.fd27fbf6-ceaf-4eef-9585-a84b7ad60453.111019_UNC14-SN744_0180_AB01RFABXX.6.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5698-01A	D26F3A6B-72F4-4E48-815E-57B8B211112D	Primary Tumor	Illumina HiSeq	83D44090-849D-48CE-A61A-0ECFB0AD846B	Kidney	77.0	E7830CAE-311E-40E0-BA12-AA9D0D8EAA49	FD27FBF6-CEAF-4EEF-9585-A84B7AD60453	TCGA-B0-5698-01A-11R-1672-07	HG19	TCGA-B0-5698	TCGA-KIRC		s8996	University of North Carolina	University of Pittsburgh	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1672-07	True
13767.58cfa82ee4b0c9d6adf6b03e	58cfa82ee4b0c9d6adf6b03e	TCGA-13-0800-01A-01R-1564-13_rnaseq.filtered.	RNA-Seq	TCGA-13-0800-01A-01R-1564-13_rnaseq	TCGA-13-0800-01A-01R-1564-13_rnaseq.bam	385.0	1.8	0.16	58cfa82ee4b0c9d6adf6b03e	TCGA-13-0800-01A-01R-1564-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0800-01A	390EED6B-50AF-48A9-9FD6-3A68A2BBB7F9	Primary Tumor	Illumina HiSeq	878C72B5-147E-4676-91F9-07BD11BB0324	Ovary	52.0	A99995E3-8D0B-453A-B604-206218279B71	CD93531B-4D92-4BE3-95E5-032636DD1AD8	TCGA-13-0800-01A-01R-1564-13	NCBI36_BCCAGSC_variant	TCGA-13-0800	TCGA-OV		s17916	Canada's Michael Smith Genome Sciences Centre	Memorial Sloan Kettering	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa831e4b0c9d6adf6c734	58cfa831e4b0c9d6adf6c734	TCGA-D7-6525-01A-11R-1802-13_rnaseq.filtered.	RNA-Seq	TCGA-D7-6525-01A-11R-1802-13_rnaseq	TCGA-D7-6525-01A-11R-1802-13_rnaseq.bam	166.2	1.8	0.14	58cfa831e4b0c9d6adf6c734	TCGA-D7-6525-01A-11R-1802-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6525-01A	82F9A197-040D-4C5E-89D9-D87A7AA0168D	Primary Tumor	Illumina HiSeq	CAECC7DD-65BB-4B52-B18F-5A83EE95AF1E	Stomach	58.0	C1AC6717-828B-4289-9755-7C56A6FC1392	A012DD75-F1B5-4DCE-B3D9-068039C9AF31	TCGA-D7-6525-01A-11R-1802-13	GRCh37-lite	TCGA-D7-6525	TCGA-STAD		s14909	Canada's Michael Smith Genome Sciences Centre	Greater Poland Cancer Center	Poland	NO	T2	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage III	1802-13	True
13767.58cfa835e4b0c9d6adf6ecec	58cfa835e4b0c9d6adf6ecec	UNCID_1345916.85C4A097-4567-4BDF-879C-96C9A4F48052.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1345916.85C4A097-4567-4BDF-879C-96C9A4F48052.sorted_genome_alignments	UNCID_1345916.85C4A097-4567-4BDF-879C-96C9A4F48052.sorted_genome_alignments.bam	26.77	1.73	0.17	58cfa835e4b0c9d6adf6ecec	UNCID_1345916.85C4A097-4567-4BDF-879C-96C9A4F48052.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A3NY-01A	BD5374C9-7F36-457F-B66B-7CC7FF64224E	Primary Tumor	Illumina HiSeq	FB317067-2672-45CB-A645-ABCAE88ACE28	Breast	72.0	50BD5C91-6557-4456-92D3-AE40CF7A8B9D	85C4A097-4567-4BDF-879C-96C9A4F48052	TCGA-GM-A3NY-01A-11R-A21T-07	HG19	TCGA-GM-A3NY	TCGA-BRCA		s6403	University of North Carolina	MD Anderson	United States	NO	T2	N1a	Infiltrating Lobular Carcinoma	Stage II	A21T-07	True
13767.58cfa834e4b0c9d6adf6e7c8	58cfa834e4b0c9d6adf6e7c8	UNCID_1213133.7bf6ccc1-5c04-4ae6-9f92-af14171cdf89.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1213133.7bf6ccc1-5c04-4ae6-9f92-af14171cdf89.sorted_genome_alignments	UNCID_1213133.7bf6ccc1-5c04-4ae6-9f92-af14171cdf89.sorted_genome_alignments.bam	29.32	1.86	0.17	58cfa834e4b0c9d6adf6e7c8	UNCID_1213133.7bf6ccc1-5c04-4ae6-9f92-af14171cdf89.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A2N9-01A	1E63D4B3-1B49-4BB9-B64F-001273AAE120	Primary Tumor	Illumina HiSeq	DEA16B94-72D8-42B3-B887-F0F0911F6B87	Thyroid	42.0	48171F82-064D-467A-9E04-7B850C5E99C2	7BF6CCC1-5C04-4AE6-9F92-AF14171CDF89	TCGA-BJ-A2N9-01A-11R-A18C-07	HG19	TCGA-BJ-A2N9	TCGA-THCA		s12262	University of North Carolina	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A18C-07	True
13767.58cfa82ee4b0c9d6adf6a920	58cfa82ee4b0c9d6adf6a920	G17470.TCGA-06-2567-01A-01R-1849-01.2.filtered.	RNA-Seq	G17470.TCGA-06-2567-01A-01R-1849-01.2	G17470.TCGA-06-2567-01A-01R-1849-01.2.bam	176.7	1.8	0.14	58cfa82ee4b0c9d6adf6a920	G17470.TCGA-06-2567-01A-01R-1849-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-2567-01A	55A063B0-98AD-4700-B3CE-61BFE364FEC8	Primary Tumor	Illumina HiSeq	EC98A337-8CE6-4721-860A-A27C8B836122	Brain	65.0	87817041-278C-41D8-9C27-BAC80D299903	E99614F9-51D8-4096-83AF-8EFFD5266881	TCGA-06-2567-01A-01R-1849-01	HG19_Broad_variant	TCGA-06-2567	TCGA-GBM	133.0	s14286	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13767.58cfa839e4b0c9d6adf711bb	58cfa839e4b0c9d6adf711bb	UNCID_2283334.ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2283334.ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f.sorted_genome_alignments	UNCID_2283334.ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f.sorted_genome_alignments.bam	169.0	1.8	0.14	58cfa839e4b0c9d6adf711bb	UNCID_2283334.ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-2576-01A	0806923C-2DEE-403D-A2E9-771722873B0D	Primary Tumor	Illumina HiSeq	0682A810-BDDF-49EB-BC3E-CFA2E161180B	Lung	62.0	61646911-1672-45CA-8DEB-4192E1CEED49	AC4077CA-1CC5-4DF5-B621-94E2CB8ECD0F	TCGA-43-2576-01A-01R-A32Z-07	HG19	TCGA-43-2576	TCGA-LUSC		s10151	University of North Carolina	Christiana Healthcare	United States	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage III	A32Z-07	True
13767.58cfa82ee4b0c9d6adf6ae14	58cfa82ee4b0c9d6adf6ae14	TCGA-04-1361-01A-01R-1565-13_rnaseq.filtered.	RNA-Seq	TCGA-04-1361-01A-01R-1565-13_rnaseq	TCGA-04-1361-01A-01R-1565-13_rnaseq.bam	244.0	1.8	0.16	58cfa82ee4b0c9d6adf6ae14	TCGA-04-1361-01A-01R-1565-13_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1361-01A	A6AAD7F9-8444-4C2F-8E4B-B19FD453544F	Primary Tumor	Illumina HiSeq	49D9B64B-DC27-4530-98BC-9781DDCD7C8A	Ovary	57.0	702CC8D9-38F6-474A-BD7E-E56820C5A5B0	746BA0B0-F7A4-4F43-9961-97DCCC756E71	TCGA-04-1361-01A-01R-1565-13	NCBI36_BCCAGSC_variant	TCGA-04-1361	TCGA-OV		s17326	Canada's Michael Smith Genome Sciences Centre	Gynecologic Oncology Group	None	NO			Serous Cystadenocarcinoma		1565-13	True
13722.58cfa831e4b0c9d6adf6cc1f	58cfa831e4b0c9d6adf6cc1f	TCGA-EE-A29R-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EE-A29R-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_8_rg.sorted	TCGA-EE-A29R-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_8_rg.sorted.bam	37.0		0.17	58cfa831e4b0c9d6adf6cc1f	TCGA-EE-A29R-10A-01D-A190_120729_SN1120_0179_AC11G3ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A29R-10A	D73D1B38-9AB4-409E-A360-E93F8C54715C	Blood Derived Normal	Illumina HiSeq	a15d7730-71dc-45c5-b2e1-e431da6b8f38	Skin	48.0	A16B0EA8-3F15-4F42-A709-06B6BAC4AF91	E54FFA2C-E4BB-4048-AF1A-63CE7BA1F45E	TCGA-EE-A29R-10A-01D-A190-02	HG19_Broad_variant	TCGA-EE-A29R	TCGA-SKCM		s8010	Harvard Medical School	University of Sydney	Australia	NO	T3b	N1b		Stage III	A190-02	True
13722.58cfa830e4b0c9d6adf6be98	58cfa830e4b0c9d6adf6be98	TCGA-AG-3896-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3896-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3896-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	44.59	1.9	0.14	58cfa830e4b0c9d6adf6be98	TCGA-AG-3896-10A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3896-10A	9AF35239-FFB9-4D4F-889E-F743DA271EEF	Blood Derived Normal	Illumina HiSeq	5936dd60-e257-4b23-9cd8-a67a0afcbb78	Colorectal	85.0	C8B8CE61-200B-4FD8-B315-CA68823CFBCC	08DEACDA-23DF-416A-8235-E5342322D44F	TCGA-AG-3896-10A-01D-1115-02	HG18	TCGA-AG-3896	TCGA-READ		s2168	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	1115-02	True
13722.58cfa82fe4b0c9d6adf6b98e	58cfa82fe4b0c9d6adf6b98e	TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted	TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted.bam	115.4	1.9	0.14	58cfa82fe4b0c9d6adf6b98e	TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE		Lung Adenocarcinoma	Aligned reads	TCGA-50-5944-01A	1C339545-C08A-4A77-B8E9-A7E49E53853F	Primary Tumor	Illumina HiSeq	c76f3861-5117-4ed7-9ca6-eecc10e949f3	Lung	69.0	BF8FDF82-62B4-4B5D-93E7-CE153576FE49	71CD46A8-30B0-4452-860D-3ED173C461A7	TCGA-50-5944-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5944	TCGA-LUAD		s11348	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Lung Acinar Adenocarcinoma	Stage I	1751-02	True
13767.58cfa838e4b0c9d6adf70a54	58cfa838e4b0c9d6adf70a54	UNCID_2083136.a2367aee-0cd5-473e-b799-77970c0ceea3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2083136.a2367aee-0cd5-473e-b799-77970c0ceea3.sorted_genome_alignments	UNCID_2083136.a2367aee-0cd5-473e-b799-77970c0ceea3.sorted_genome_alignments.bam	52.31	1.77	0.16	58cfa838e4b0c9d6adf70a54	UNCID_2083136.a2367aee-0cd5-473e-b799-77970c0ceea3.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A3A5-01A	D8549D23-37D4-42BD-B472-F49BBEBD09B0	Primary Tumor	Illumina HiSeq	F4396EC2-E0E1-4686-BFDC-8ED067E4FBA0	Liver	66.0	2BE2966F-D7BE-4FB4-BEE9-C00C47F7AB69	A2367AEE-0CD5-473E-B799-77970C0CEEA3	TCGA-DD-A3A5-01A-11R-A22L-07	HG19	TCGA-DD-A3A5	TCGA-LIHC	3125.0	s16624	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T3	N0	Hepatocellular Carcinoma	Stage III	A22L-07	True
13767.58cfa83be4b0c9d6adf72060	58cfa83be4b0c9d6adf72060	UNCID_2560703.2f773549-6729-45df-9d58-485eb019cde9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2560703.2f773549-6729-45df-9d58-485eb019cde9.sorted_genome_alignments	UNCID_2560703.2f773549-6729-45df-9d58-485eb019cde9.sorted_genome_alignments.bam	36.29	1.85	0.17	58cfa83be4b0c9d6adf72060	UNCID_2560703.2f773549-6729-45df-9d58-485eb019cde9.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Mesothelioma	Aligned reads	TCGA-ZN-A9VW-01A	54D21956-25E4-42DF-ADBE-6907721FC4B5	Primary Tumor	Illumina HiSeq	B12F4A76-AA19-4CF4-BB82-CB2A4FBD02FB	Mesothelium	61.0	D9BD04F9-42B6-4DBD-A770-0FA5DA681290	2F773549-6729-45DF-9D58-485EB019CDE9	TCGA-ZN-A9VW-01A-11R-A40A-07	HG19	TCGA-ZN-A9VW	TCGA-MESO	84.0	s443	University of North Carolina	Brigham and Women's Hospital Division of Thoracic Surgery	United States	NO	T4	N0		Stage IV	A40A-07	True
13767.58cfa832e4b0c9d6adf6cdfe	58cfa832e4b0c9d6adf6cdfe	TCGA-FP-7735-11A-01R-2055-13_rnaseq.filtered.	RNA-Seq	TCGA-FP-7735-11A-01R-2055-13_rnaseq	TCGA-FP-7735-11A-01R-2055-13_rnaseq.bam	72.2		0.14	58cfa832e4b0c9d6adf6cdfe	TCGA-FP-7735-11A-01R-2055-13_rnaseq.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-FP-7735-11A	1D43AF3C-4279-4AED-9CED-CE3896A48AE0	Solid Tissue Normal	Illumina HiSeq	D3B800D3-EE3C-4A89-A671-D8FD40AFFF1B	Stomach	77.0	B915A686-C04A-444E-A177-BECF436B844F	04C93226-FEA0-483A-BABF-DA36D34F44BD	TCGA-FP-7735-11A-01R-2055-13	GRCh37-lite	TCGA-FP-7735	TCGA-STAD		s15000	Canada's Michael Smith Genome Sciences Centre	International Genomics Consortium	United States	NO	T2	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	2055-13	True
13722.58cfa830e4b0c9d6adf6c25d	58cfa830e4b0c9d6adf6c25d	TCGA-BJ-A0Z3-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BJ-A0Z3-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_8_rg.sorted	TCGA-BJ-A0Z3-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_8_rg.sorted.bam	24.48	1.95	0.16	58cfa830e4b0c9d6adf6c25d	TCGA-BJ-A0Z3-10A-01D-A13U_120706_SN1120_0170_BD1422ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0Z3-10A	331CAE6E-2868-4C58-9302-709A9FF7D025	Blood Derived Normal	Illumina HiSeq	9033bf3e-9c80-4f03-9bcf-a63c9794ccff	Thyroid	33.0	CE23632D-EA12-422B-AA3A-78874E665E4D	A1FFA620-F821-4652-AF2E-0C629067F9A5	TCGA-BJ-A0Z3-10A-01D-A13U-02	HG19_Broad_variant	TCGA-BJ-A0Z3	TCGA-THCA		s12746	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13U-02	True
13722.58cfa830e4b0c9d6adf6ba5d	58cfa830e4b0c9d6adf6ba5d	TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina.filtered.	WGS	TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina	TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina.bam	205.35	1.73	0.08	58cfa830e4b0c9d6adf6ba5d	TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina.bam	Alive	FEMALE			Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00R-01A	CA22EDD4-EB7C-4677-84AA-6F0354459A19	Primary Tumor	Illumina HiSeq	6182870d-a572-4538-aaa5-06b4adad7bbe	Colorectal	64.0	F72EEAE9-F7F5-4576-A072-5021119117D6	05780D48-80E7-4D70-B00C-081F8A9519F2	TCGA-AA-A00R-01A-01D-A126-10	GRCh37-lite	TCGA-AA-A00R	TCGA-COAD		s13677	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A126-10	False
13767.58cfa83ce4b0c9d6adf72b84	58cfa83ce4b0c9d6adf72b84	UNCID_372571.TCGA-BP-4976-01A-01R-1334-07.110620_UNC14-SN744_0132_AD0CP3ABXX.7.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_372571.TCGA-BP-4976-01A-01R-1334-07.110620_UNC14-SN744_0132_AD0CP3ABXX.7.trimmed.annotated.translated_to_genomic	UNCID_372571.TCGA-BP-4976-01A-01R-1334-07.110620_UNC14-SN744_0132_AD0CP3ABXX.7.trimmed.annotated.translated_to_genomic.bam	86.3	1.7	0.15	58cfa83ce4b0c9d6adf72b84	UNCID_372571.TCGA-BP-4976-01A-01R-1334-07.110620_UNC14-SN744_0132_AD0CP3ABXX.7.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4976-01A	2375EF64-8212-4AD4-97E8-BFA6D1DB430F	Primary Tumor	Illumina HiSeq	DAEB8DA5-6BAA-4F63-8104-929E8021FDD4	Kidney	77.0	1465CE1E-F267-4DAD-A327-3128456A6201	8764F098-42B1-404E-B1DE-93A3A3998A19	TCGA-BP-4976-01A-01R-1334-07	HG19	TCGA-BP-4976	TCGA-KIRC		s9543	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13722.58cfa82ee4b0c9d6adf6aec0	58cfa82ee4b0c9d6adf6aec0	G49537.TCGA-EM-A2CN-10B-01D-A19M-08.2.filtered.	WGS	G49537.TCGA-EM-A2CN-10B-01D-A19M-08.2	G49537.TCGA-EM-A2CN-10B-01D-A19M-08.2.bam	31.78		0.08	58cfa82ee4b0c9d6adf6aec0	G49537.TCGA-EM-A2CN-10B-01D-A19M-08.2.bam	Alive	MALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CN-10B	4AED5116-D27B-4911-B310-05C2248B861F	Blood Derived Normal	Illumina HiSeq	e590d3d8-14d7-4334-b3eb-1daaf338e677	Thyroid	62.0	1580ADDD-2378-4CA5-A1E6-D6C02C1EC053	06DFC16A-CA37-46CA-8ABB-20C1295E8F3A	TCGA-EM-A2CN-10B-01D-A19M-08	HG19_Broad_variant	TCGA-EM-A2CN	TCGA-THCA		s12497	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IV	A19M-08	False
13767.58cfa83be4b0c9d6adf728bc	58cfa83be4b0c9d6adf728bc	UNCID_339393.TCGA-B0-4707-01A-01R-1277-07.110324_UNC9-SN296_0160_AB038BABXX.6.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_339393.TCGA-B0-4707-01A-01R-1277-07.110324_UNC9-SN296_0160_AB038BABXX.6.trimmed.annotated.translated_to_genomic	UNCID_339393.TCGA-B0-4707-01A-01R-1277-07.110324_UNC9-SN296_0160_AB038BABXX.6.trimmed.annotated.translated_to_genomic.bam	100.0	1.8	0.15	58cfa83be4b0c9d6adf728bc	UNCID_339393.TCGA-B0-4707-01A-01R-1277-07.110324_UNC9-SN296_0160_AB038BABXX.6.trimmed.annotated.translated_to_genomic.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4707-01A	4CFE9A35-80F2-422B-82E8-8F4B12DED992	Primary Tumor	Illumina HiSeq	5412DD5C-4B14-411D-8775-9CCF41D65F11	Kidney	63.0	9AACA08A-3E46-4058-B95C-B41900D1887A	912BB19E-3AC4-4F39-BE62-D583D2AF893B	TCGA-B0-4707-01A-01R-1277-07	HG19	TCGA-B0-4707	TCGA-KIRC	600.0	s9084	University of North Carolina	University of Pittsburgh	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	1277-07	True
13767.58cfa82ee4b0c9d6adf6aee4	58cfa82ee4b0c9d6adf6aee4	TCGA-04-1356-01A-01R-1569-13_rnaseq.filtered.	RNA-Seq	TCGA-04-1356-01A-01R-1569-13_rnaseq	TCGA-04-1356-01A-01R-1569-13_rnaseq.bam	312.0	1.8	0.16	58cfa82ee4b0c9d6adf6aee4	TCGA-04-1356-01A-01R-1569-13_rnaseq.bam	Dead	FEMALE	WHITE	HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1356-01A	8652DDEE-98F4-4584-B450-E6F2F5C9D7EC	Primary Tumor	Illumina HiSeq	5AC8823D-C5CC-437E-A3E9-80909BCE24D6	Ovary	62.0	3D1F80F8-1033-48D9-9B97-36F025486B0A	DC4A5C2F-8B96-4D3B-9553-A02510BA445F	TCGA-04-1356-01A-01R-1569-13	NCBI36_BCCAGSC_variant	TCGA-04-1356	TCGA-OV	1499.0	s17325	Canada's Michael Smith Genome Sciences Centre	Gynecologic Oncology Group	None	NO			Serous Cystadenocarcinoma		1569-13	True
13767.58cfa82fe4b0c9d6adf6b917	58cfa82fe4b0c9d6adf6b917	TCGA-36-1576-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-36-1576-01A-01R-1566-13_rnaseq	TCGA-36-1576-01A-01R-1566-13_rnaseq.bam	590.0	1.8	0.15	58cfa82fe4b0c9d6adf6b917	TCGA-36-1576-01A-01R-1566-13_rnaseq.bam	Alive	FEMALE			Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-36-1576-01A	3445C524-5A37-40B6-8614-956D76EED939	Primary Tumor	Illumina HiSeq	B4133110-D999-41B6-8761-FB7FA9EF39D8	Ovary	76.0	24FFA457-5765-43C1-8CDD-B50A31DC5B56	55B6BD7C-E77D-4019-93E9-B5410E4807B2	TCGA-36-1576-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-36-1576	TCGA-OV		s17582	Canada's Michael Smith Genome Sciences Centre	BC Cancer Agency	None	NO			Serous Cystadenocarcinoma		1566-13	True
13722.58cfa82de4b0c9d6adf6a492	58cfa82de4b0c9d6adf6a492	243c10f1efa33520bf06a2abbf747e06.filtered.	WGS	243c10f1efa33520bf06a2abbf747e06	243c10f1efa33520bf06a2abbf747e06.bam	29.88	1.72	0.08	58cfa82de4b0c9d6adf6a492	243c10f1efa33520bf06a2abbf747e06.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A054-10A	D77E4DBC-B239-4742-8CB7-EFD427010D13	Blood Derived Normal	Illumina HiSeq	14a2def0-6613-4a7b-a857-655ccfb48cf9	Uterus	64.0	2A884E50-859A-4269-A604-210562E65E9C	42482DBA-7343-43F6-8E59-185462D53EC6	TCGA-AP-A054-10A-01D-A066-09	GRCh37-lite	TCGA-AP-A054	TCGA-UCEC	709.0	s4235	Washington University School of Medicine	MSKCC	None	NO			Endometrioid endometrial adenocarcinoma		A066-09	True
13722.58cfa830e4b0c9d6adf6c1de	58cfa830e4b0c9d6adf6c1de	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.bam	62.34	1.97	0.15	58cfa830e4b0c9d6adf6c1de	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A0YX-01A	22473AD4-DF39-4716-B558-3C1409D5FA0E	Primary Tumor	Illumina HiSeq	71886c7b-a73b-4c00-9555-5fd61b5e1347	Bladder	70.0	DA614214-F84C-43AB-983C-D9D76CF2D6AE	DC052DFC-26A8-4393-8849-FA954913C622	TCGA-BT-A0YX-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BT-A0YX	TCGA-BLCA		s2867	Harvard Medical School	University of Pittsburgh	None	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A10R-02	True
13722.58cfa832e4b0c9d6adf6d040	58cfa832e4b0c9d6adf6d040	TCGA-FU-A3YQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FU-A3YQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_5_rg.sorted	TCGA-FU-A3YQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_5_rg.sorted.bam	104.06		0.15	58cfa832e4b0c9d6adf6d040	TCGA-FU-A3YQ-10A-01D-A232_140124_SN1120_0292_BD2F1HACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3YQ-10A	6E01248B-C551-4F52-8066-CB2D26EB6394	Blood Derived Normal	Illumina HiSeq	02661caa-7ed3-483f-b1bb-720e65fef5b3	Cervix	35.0	F4FBEDEB-D14D-4189-99AF-0F015CFE5AC7	D6A3F40F-4BD5-4173-A695-CD4837267B21	TCGA-FU-A3YQ-10A-01D-A232-26	HG19_Broad_variant	TCGA-FU-A3YQ	TCGA-CESC		s1207	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma		A232-26	True
13722.58cfa830e4b0c9d6adf6bf9c	58cfa830e4b0c9d6adf6bf9c	TCGA-BR-6453-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BR-6453-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_5_rg.sorted	TCGA-BR-6453-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_5_rg.sorted.bam	263.4	1.9	0.14	58cfa830e4b0c9d6adf6bf9c	TCGA-BR-6453-11A-01D-1798_130115_SN1222_0169_BD1K2PACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6453-11A	AE633E83-303F-4A90-AC3B-34458FD9BEEF	Solid Tissue Normal	Illumina HiSeq	717f3dd6-5471-4f58-b218-01a2ca71eced	Stomach	54.0	B6DFCC18-F388-4486-8D3D-611C5E15FB29	C1402501-D8BA-4AF4-A88E-ABB79009DB18	TCGA-BR-6453-11A-01D-1798-02	HG19_Broad_variant	TCGA-BR-6453	TCGA-STAD		s15306	Harvard Medical School	Asterand	Russia	NO	T2	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1798-02	True
13767.58cfa834e4b0c9d6adf6e8d6	58cfa834e4b0c9d6adf6e8d6	UNCID_1220710.7f8bad33-c92b-48f6-99b1-2165784efd8f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1220710.7f8bad33-c92b-48f6-99b1-2165784efd8f.sorted_genome_alignments	UNCID_1220710.7f8bad33-c92b-48f6-99b1-2165784efd8f.sorted_genome_alignments.bam	12.06	1.76	0.17	58cfa834e4b0c9d6adf6e8d6	UNCID_1220710.7f8bad33-c92b-48f6-99b1-2165784efd8f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A196-01A	A9EB1022-FFD3-42DE-A39D-2126FC7EC0CE	Primary Tumor	Illumina HiSeq	C7DACDDA-0BC4-4039-AE36-6460ED584F1A	Skin	64.0	239F69F7-E78A-4B09-BF00-E521F63A3BB4	7F8BAD33-C92B-48F6-99B1-2165784EFD8F	TCGA-ER-A196-01A-11R-A18T-07	HG19	TCGA-ER-A196	TCGA-SKCM		s7891	University of North Carolina	University of Pittsburgh	United States	NO	T4b	N0		Stage II	A18T-07	True
13722.58cfa82fe4b0c9d6adf6b8c8	58cfa82fe4b0c9d6adf6b8c8	TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina.filtered.	WGS	TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina	TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina.bam	308.0	1.9	0.05	58cfa82fe4b0c9d6adf6b8c8	TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2681-01A	7D8EAB0A-E6C8-4449-9EBF-50C41DB94A06	Primary Tumor	Illumina HiSeq	11d59d80-a10a-4e78-b8a8-64a9569a9e32	Colorectal	73.0	0537BAD8-0E85-4B05-91B3-FD965E96D0D7	D3DAF373-1485-455E-A0A1-8E33D215D623	TCGA-A6-2681-01A-01D-1554-10	GRCh37-lite	TCGA-A6-2681	TCGA-COAD		s13650	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3	N0	Colon Adenocarcinoma	Stage II	1554-10	False
13767.58cfa83ce4b0c9d6adf72e46	58cfa83ce4b0c9d6adf72e46	_1_TCGA-BR-6852-11A-01R-1884-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-6852-11A-01R-1884-13_rnaseq	_1_TCGA-BR-6852-11A-01R-1884-13_rnaseq.bam	694.2	1.8	0.15	58cfa83ce4b0c9d6adf72e46	_1_TCGA-BR-6852-11A-01R-1884-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6852-11A	44799C67-61CD-4F3E-BDBC-423E2E0FD2E8	Solid Tissue Normal	Illumina HiSeq	A1D08CE5-F724-43E5-9F8D-212F26FC09E6	Stomach	64.0	CF0E71E9-4CDC-4458-BBB4-A3A1EDB7ABE4	7D9503D0-3188-44CB-9F84-544883C204B0	TCGA-BR-6852-11A-01R-1884-13	GRCh37-lite	TCGA-BR-6852	TCGA-STAD		s15428	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1884-13	True
13722.58cfa82fe4b0c9d6adf6b9ad	58cfa82fe4b0c9d6adf6b9ad	TCGA-86-6562-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_8_rg.sorted.filtered.	WGS	TCGA-86-6562-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_8_rg.sorted	TCGA-86-6562-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_8_rg.sorted.bam	316.7	1.9	0.14	58cfa82fe4b0c9d6adf6b9ad	TCGA-86-6562-10A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-86-6562-10A	DCD066BA-5894-453E-B1DA-82092858C3DB	Blood Derived Normal	Illumina HiSeq	02776cc1-3edd-49d5-b77e-8a9ec2d68f5a	Lung	52.0	EB924A4A-EC5C-4E4A-856D-F5984B89687C	2DD29997-7D20-4F06-963B-C82274A2FD03	TCGA-86-6562-10A-01D-1751-02	HG19_Broad_variant	TCGA-86-6562	TCGA-LUAD		s11254	Harvard Medical School	Asterand	Russia	NO	T2a	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage II	1751-02	True
13767.58cfa835e4b0c9d6adf6efa3	58cfa835e4b0c9d6adf6efa3	UNCID_1455706.be67f169-2a2c-4938-a141-a839b295b87f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1455706.be67f169-2a2c-4938-a141-a839b295b87f.sorted_genome_alignments	UNCID_1455706.be67f169-2a2c-4938-a141-a839b295b87f.sorted_genome_alignments.bam	60.48	1.81	0.18	58cfa835e4b0c9d6adf6efa3	UNCID_1455706.be67f169-2a2c-4938-a141-a839b295b87f.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3AI-01A	6A87BBC4-6161-4FC6-B4DF-518D7831F4D2	Primary Tumor	Illumina HiSeq	E746781F-7834-41D4-AAA8-AAF06D7081F6	Thyroid	67.0	7C6EBB44-EB6F-4C33-A195-574D00D439B3	BE67F169-2A2C-4938-A141-A839B295B87F	TCGA-EM-A3AI-01A-11R-A206-07	HG19	TCGA-EM-A3AI	TCGA-THCA		s12290	University of North Carolina	University Health Network	Canada	NO	T2	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A206-07	True
13767.58cfa82fe4b0c9d6adf6b3ea	58cfa82fe4b0c9d6adf6b3ea	TCGA-24-1436-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-24-1436-01A-01R-1566-13_rnaseq	TCGA-24-1436-01A-01R-1566-13_rnaseq.bam	220.0	1.8	0.15	58cfa82fe4b0c9d6adf6b3ea	TCGA-24-1436-01A-01R-1566-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1436-01A	6E84E89D-4F35-43B8-B47D-B1343B8C1AB9	Primary Tumor	Illumina HiSeq	BAE4F9EB-833E-4FCB-A3C9-B5ECF168D0D2	Ovary	57.0	E1EDA97E-24FE-4DC8-92EB-080399B1D82D	45FF767A-721A-4D89-B5E9-0C6E7EBA476D	TCGA-24-1436-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-24-1436	TCGA-OV	260.0	s18110	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa837e4b0c9d6adf6fd62	58cfa837e4b0c9d6adf6fd62	UNCID_1724870.88EE3A4F-7688-4247-B03C-73F6E3AF7493.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1724870.88EE3A4F-7688-4247-B03C-73F6E3AF7493.sorted_genome_alignments	UNCID_1724870.88EE3A4F-7688-4247-B03C-73F6E3AF7493.sorted_genome_alignments.bam	42.65	1.79	0.16	58cfa837e4b0c9d6adf6fd62	UNCID_1724870.88EE3A4F-7688-4247-B03C-73F6E3AF7493.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A1QS-01A	6F9D21C0-3B88-450D-A249-3E9BAFBA2DFA	Primary Tumor	Illumina HiSeq	B0BFB26F-881A-4F22-B01C-9A8AC28A4806	Cervix	46.0	8389C79E-164E-4462-ADCD-364DB3AFB463	88EE3A4F-7688-4247-B03C-73F6E3AF7493	TCGA-EA-A1QS-01A-61R-A22U-07	HG19	TCGA-EA-A1QS	TCGA-CESC		s1423	University of North Carolina	Asterand	Russia	NO	T1b1	N0	Cervical Squamous Cell Carcinoma		A22U-07	True
13767.58cfa838e4b0c9d6adf70c3f	58cfa838e4b0c9d6adf70c3f	UNCID_2121126.47964b92-bd93-45b1-97c9-194da4c9dccb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2121126.47964b92-bd93-45b1-97c9-194da4c9dccb.sorted_genome_alignments	UNCID_2121126.47964b92-bd93-45b1-97c9-194da4c9dccb.sorted_genome_alignments.bam	54.58	1.89	0.18	58cfa838e4b0c9d6adf70c3f	UNCID_2121126.47964b92-bd93-45b1-97c9-194da4c9dccb.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-NH-A50T-01A	490EABCA-4575-4BD6-9604-6B6E23D069CE	Primary Tumor	Illumina HiSeq	19AE51B5-6B9E-46A8-BE48-B5D853655A9D	Colorectal	68.0	9F5AD422-C94D-4914-B6F0-071596ECB589	47964B92-BD93-45B1-97C9-194DA4C9DCCB	TCGA-NH-A50T-01A-11R-A28H-07	HG19	TCGA-NH-A50T	TCGA-COAD		s13292	University of North Carolina	Candler	United States	NO	T3	N0	Colon Adenocarcinoma	Stage II	A28H-07	True
13767.58cfa83ae4b0c9d6adf71a6d	58cfa83ae4b0c9d6adf71a6d	UNCID_2439913.cbf842bf-9549-40dd-b83d-9cbda5f361b9.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2439913.cbf842bf-9549-40dd-b83d-9cbda5f361b9.sorted_genome_alignments	UNCID_2439913.cbf842bf-9549-40dd-b83d-9cbda5f361b9.sorted_genome_alignments.bam	56.18	1.89	0.18	58cfa83ae4b0c9d6adf71a6d	UNCID_2439913.cbf842bf-9549-40dd-b83d-9cbda5f361b9.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-Y8-A8RY-01A	A5B3DE4C-F3FA-414C-B809-59C3C1438AA7	Primary Tumor	Illumina HiSeq	93125DDD-89A6-441F-8CBB-B88101234702	Kidney	63.0	61F86B3E-89FD-4F42-9C28-08750B0FDB24	CBF842BF-9549-40DD-B83D-9CBDA5F361B9	TCGA-Y8-A8RY-01A-11R-A37K-07	HG19	TCGA-Y8-A8RY	TCGA-KIRP		s11946	University of North Carolina	Spectrum Health	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A37K-07	True
13767.58cfa835e4b0c9d6adf6ea44	58cfa835e4b0c9d6adf6ea44	UNCID_1217980.cc556dfb-6bd4-4d53-a33b-6dae9407d7c4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1217980.cc556dfb-6bd4-4d53-a33b-6dae9407d7c4.sorted_genome_alignments	UNCID_1217980.cc556dfb-6bd4-4d53-a33b-6dae9407d7c4.sorted_genome_alignments.bam	5.7	1.8	0.15	58cfa835e4b0c9d6adf6ea44	UNCID_1217980.cc556dfb-6bd4-4d53-a33b-6dae9407d7c4.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4625-11A	0EA4920F-F4C8-4590-84B3-EB419824E144	Solid Tissue Normal	Illumina HiSeq	AD1A6903-64F2-4D4C-96A1-AB6F4DB23C38	Lung	66.0	0D76E56D-BC9D-4085-AA3C-C6EDBDB6DD59	CC556DFB-6BD4-4D53-A33B-6DAE9407D7C4	TCGA-38-4625-11A-01R-1758-07	HG19	TCGA-38-4625	TCGA-LUAD		s11386	University of North Carolina	UNC	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1758-07	True
13722.58cfa82ee4b0c9d6adf6a8ea	58cfa82ee4b0c9d6adf6a8ea	G35154.TCGA-DB-5278-10A-01D-1468-08.1.filtered.	WGS	G35154.TCGA-DB-5278-10A-01D-1468-08.1	G35154.TCGA-DB-5278-10A-01D-1468-08.1.bam	78.3	1.9	0.05	58cfa82ee4b0c9d6adf6a8ea	G35154.TCGA-DB-5278-10A-01D-1468-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-5278-10A	010AAC75-3BFE-4BF2-B866-AF0F2D92F125	Blood Derived Normal	Illumina HiSeq	fa6a196d-09f3-47ff-a614-66b54fa20d3c	Brain	17.0	AFDAFC3C-5D20-453E-80CC-AE12494EF693	80B03480-5D28-481E-A447-59140D82F1F8	TCGA-DB-5278-10A-01D-1468-08	HG19_Broad_variant	TCGA-DB-5278	TCGA-LGG		s8097	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO			Oligodendroglioma		1468-08	False
13722.58cfa832e4b0c9d6adf6d194	58cfa832e4b0c9d6adf6d194	TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted.filtered.	WGS	TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted	TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted.bam	95.7	1.9	0.15	58cfa832e4b0c9d6adf6d194	TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6377-01A	007F9081-5093-4323-B4F8-CD510BF20705	Primary Tumor	Illumina HiSeq	126d92ca-d172-491d-9366-11555d88901b	Prostate	61.0	8F105D0D-0630-46FC-8168-DCBA11A5197F	811D74B4-6F98-4B1F-9ADD-CB949E4B5B20	TCGA-G9-6377-01A-11D-1957-02	HG19_Broad_variant	TCGA-G9-6377	TCGA-PRAD		s3977	Harvard Medical School	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		1957-02	True
13767.58cfa834e4b0c9d6adf6e8d2	58cfa834e4b0c9d6adf6e8d2	UNCID_1217745.30e65995-e4e6-40c0-a8af-823cc6fde4a8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1217745.30e65995-e4e6-40c0-a8af-823cc6fde4a8.sorted_genome_alignments	UNCID_1217745.30e65995-e4e6-40c0-a8af-823cc6fde4a8.sorted_genome_alignments.bam	12.47	1.8	0.15	58cfa834e4b0c9d6adf6e8d2	UNCID_1217745.30e65995-e4e6-40c0-a8af-823cc6fde4a8.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A197-06A	3EBB2374-4518-4E19-9B65-9C3E66252C4C	Metastatic	Illumina HiSeq	4A78AE53-6773-4B14-B2B3-9D8DBDF2EBDE	Skin	83.0	A0B189C0-996A-4A35-B8BF-EC1309B05603	30E65995-E4E6-40C0-A8AF-823CC6FDE4A8	TCGA-ER-A197-06A-32R-A18S-07	HG19	TCGA-ER-A197	TCGA-SKCM	424.0	s7552	University of North Carolina	University of Pittsburgh	United States	NO	T4b	N1a		Stage III	A18S-07	True
13767.58cfa834e4b0c9d6adf6e2e0	58cfa834e4b0c9d6adf6e2e0	UNCID_1184140.a62572f8-bd89-491a-9bf4-1877a07da46e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1184140.a62572f8-bd89-491a-9bf4-1877a07da46e.sorted_genome_alignments	UNCID_1184140.a62572f8-bd89-491a-9bf4-1877a07da46e.sorted_genome_alignments.bam	5.0	1.7	0.14	58cfa834e4b0c9d6adf6e2e0	UNCID_1184140.a62572f8-bd89-491a-9bf4-1877a07da46e.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4852-01A	759238F2-0D37-404E-96F1-C26CAE0BA2EA	Primary Tumor	Illumina HiSeq	264A785D-0892-4E92-A1AA-5EFF6E49C8FF	Kidney	78.0	3DB92958-403A-48EB-A006-3CC6F7E9BCBD	A62572F8-BD89-491A-9BF4-1877A07DA46E	TCGA-B0-4852-01A-01R-1503-07	HG19	TCGA-B0-4852	TCGA-KIRC	1121.0	s9203	University of North Carolina	University of Pittsburgh	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage II	1503-07	True
13767.58cfa837e4b0c9d6adf70054	58cfa837e4b0c9d6adf70054	UNCID_1859717.e5e12896-2cf3-4d5d-8f79-00cd964fc132.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1859717.e5e12896-2cf3-4d5d-8f79-00cd964fc132.sorted_genome_alignments	UNCID_1859717.e5e12896-2cf3-4d5d-8f79-00cd964fc132.sorted_genome_alignments.bam	37.45	1.66	0.15	58cfa837e4b0c9d6adf70054	UNCID_1859717.e5e12896-2cf3-4d5d-8f79-00cd964fc132.sorted_genome_alignments.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ES-A2HT-01A	7DD3BDA9-3A0A-46FA-B052-A6D24B847804	Primary Tumor	Illumina HiSeq	4E0A399E-AD53-4AC6-954E-E18B991DB7E2	Liver	54.0	9B68C72D-30D4-4A7A-ADE7-A2BDE50A84F2	E5E12896-2CF3-4D5D-8F79-00CD964FC132	TCGA-ES-A2HT-01A-12R-A180-07	HG19	TCGA-ES-A2HT	TCGA-LIHC	438.0	s16708	University of North Carolina	University of Florida	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A180-07	True
13767.58cfa833e4b0c9d6adf6dc5c	58cfa833e4b0c9d6adf6dc5c	UNCID_1126251.ad602633-fdd7-4bf1-b3ac-e1c8e0a02934.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1126251.ad602633-fdd7-4bf1-b3ac-e1c8e0a02934.sorted_genome_alignments	UNCID_1126251.ad602633-fdd7-4bf1-b3ac-e1c8e0a02934.sorted_genome_alignments.bam	15.63	1.79	0.18	58cfa833e4b0c9d6adf6dc5c	UNCID_1126251.ad602633-fdd7-4bf1-b3ac-e1c8e0a02934.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A1AL-01A	1F99E4D4-4E8B-4CC1-A129-227A2A82780E	Primary Tumor	Illumina HiSeq	33E841A1-093E-42E1-B02D-7E52DB779992	Breast	60.0	A7945D1C-35CA-4C95-98C6-CCB6E6D2B39C	AD602633-FDD7-4BF1-B3AC-E1C8E0A02934	TCGA-AR-A1AL-01A-21R-A12P-07	HG19	TCGA-AR-A1AL	TCGA-BRCA		s5519	University of North Carolina	Mayo	None	NO	T3	N1	Infiltrating Lobular Carcinoma	Stage III	A12P-07	True
13722.58cfa831e4b0c9d6adf6cc11	58cfa831e4b0c9d6adf6cc11	TCGA-EE-A29H-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EE-A29H-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_6_rg.sorted	TCGA-EE-A29H-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_6_rg.sorted.bam	57.71		0.17	58cfa831e4b0c9d6adf6cc11	TCGA-EE-A29H-06A-12D-A18Y_120729_SN1120_0180_BC1176ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A29H-06A	C8BA1856-D055-4DC6-A184-72763C76AAE4	Metastatic	Illumina HiSeq	21070c2b-7503-4c5c-9a66-5e6564c37d01	Skin	59.0	92AE970D-75B4-4D9F-B84F-A2070F0CBE90	F32701EE-123A-4D6C-AE5A-06F52AAD063E	TCGA-EE-A29H-06A-12D-A18Y-02	HG19_Broad_variant	TCGA-EE-A29H	TCGA-SKCM		s7840	Harvard Medical School	University of Sydney	Australia	NO	T1a	N0		Stage I	A18Y-02	True
13767.58cfa837e4b0c9d6adf6fd3e	58cfa837e4b0c9d6adf6fd3e	UNCID_1676597.B045331F-5CB5-4BE4-896F-E4C60D5AAD8F.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1676597.B045331F-5CB5-4BE4-896F-E4C60D5AAD8F.sorted_genome_alignments	UNCID_1676597.B045331F-5CB5-4BE4-896F-E4C60D5AAD8F.sorted_genome_alignments.bam	5.72	1.83	0.15	58cfa837e4b0c9d6adf6fd3e	UNCID_1676597.B045331F-5CB5-4BE4-896F-E4C60D5AAD8F.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A3XD-01A	6FE664CC-E66B-4ABF-A7D2-08BB4CE8EBA3	Primary Tumor	Illumina HiSeq	A250DBC8-D0A7-4C22-83CC-8C9C858FB317	Skin	53.0	8F179CF8-7F97-4373-BE12-9DA06B1E3AF1	B045331F-5CB5-4BE4-896F-E4C60D5AAD8F	TCGA-EB-A3XD-01A-22R-A239-07	HG19	TCGA-EB-A3XD	TCGA-SKCM		s7758	University of North Carolina	Asterand	Ukraine	NO	T4b	NX		Stage II	A239-07	True
13767.58cfa838e4b0c9d6adf7042f	58cfa838e4b0c9d6adf7042f	UNCID_1902210.a8d45785-d6e2-4c38-9625-ee36e2a1017a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1902210.a8d45785-d6e2-4c38-9625-ee36e2a1017a.sorted_genome_alignments	UNCID_1902210.a8d45785-d6e2-4c38-9625-ee36e2a1017a.sorted_genome_alignments.bam	49.97	1.87	0.15	58cfa838e4b0c9d6adf7042f	UNCID_1902210.a8d45785-d6e2-4c38-9625-ee36e2a1017a.sorted_genome_alignments.bam	Alive	FEMALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A4FN-01A	F854CE67-C586-4424-A674-2DD67AD0ED7F	Primary Tumor	Illumina HiSeq	B587F4A4-E040-4548-9A98-85C81BCA6B9A	Thyroid	49.0	551D0A51-C755-43EF-ACF7-88B598F06C9B	A8D45785-D6E2-4C38-9625-EE36E2A1017A	TCGA-EM-A4FN-01A-11R-A250-07	HG19	TCGA-EM-A4FN	TCGA-THCA		s12484	University of North Carolina	University Health Network	Canada	NO	T1b	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A250-07	True
13767.58cfa838e4b0c9d6adf70c13	58cfa838e4b0c9d6adf70c13	UNCID_2121361.0bb6e848-b69a-465d-9039-1aa75d98815f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2121361.0bb6e848-b69a-465d-9039-1aa75d98815f.sorted_genome_alignments	UNCID_2121361.0bb6e848-b69a-465d-9039-1aa75d98815f.sorted_genome_alignments.bam	30.14	1.84	0.18	58cfa838e4b0c9d6adf70c13	UNCID_2121361.0bb6e848-b69a-465d-9039-1aa75d98815f.sorted_genome_alignments.bam	Alive	FEMALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-63-A5MR-01A	A2D7C06B-EFA9-4B7E-9EA6-B47C9AD6EF38	Primary Tumor	Illumina HiSeq	E6A52F58-C1E5-4FF8-B1EA-B7D09A828DCA	Lung	70.0	311B964A-367F-4D05-AE8A-E8100554335A	0BB6E848-B69A-465D-9039-1AA75D98815F	TCGA-63-A5MR-01A-31R-A27Q-07	HG19	TCGA-63-A5MR	TCGA-LUSC		s10482	University of North Carolina	Ontario Institute for Cancer Research	Canada	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	A27Q-07	True
13767.58cfa837e4b0c9d6adf6fce2	58cfa837e4b0c9d6adf6fce2	UNCID_1722734.6c6c44ac-3626-482e-8d33-adbd122f8352.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1722734.6c6c44ac-3626-482e-8d33-adbd122f8352.sorted_genome_alignments	UNCID_1722734.6c6c44ac-3626-482e-8d33-adbd122f8352.sorted_genome_alignments.bam	39.73	1.82	0.18	58cfa837e4b0c9d6adf6fce2	UNCID_1722734.6c6c44ac-3626-482e-8d33-adbd122f8352.sorted_genome_alignments.bam	Alive	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RO-01A	C996CFFB-8132-4973-987D-143274B6A081	Primary Tumor	Illumina HiSeq	D5581A32-7115-44FA-B27D-375F5C907F02	Cervix	59.0	31EA30DA-AB0D-48AF-BB1C-58F99AB033A9	6C6C44AC-3626-482E-8D33-ADBD122F8352	TCGA-EK-A2RO-01A-11R-A18M-07	HG19	TCGA-EK-A2RO	TCGA-CESC		s1257	University of North Carolina	Gynecologic Oncology Group	United States	NO			Cervical Squamous Cell Carcinoma		A18M-07	True
13722.58cfa831e4b0c9d6adf6cd96	58cfa831e4b0c9d6adf6cd96	TCGA-FE-A230-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-FE-A230-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_4_rg.sorted	TCGA-FE-A230-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_4_rg.sorted.bam	53.75	1.88	0.15	58cfa831e4b0c9d6adf6cd96	TCGA-FE-A230-10A-01D-A14U_120629_SN1120_0168_BD1454ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A230-10A	B1D71782-2443-43F3-BD0E-8B7220515CB6	Blood Derived Normal	Illumina HiSeq	95f6440a-f378-4551-859b-3c4c64c419f6	Thyroid	30.0	33613A27-3E77-4ED8-AB5F-A9DE98431149	D31A8255-C4C9-4512-9333-5B97C8A70936	TCGA-FE-A230-10A-01D-A14U-02	HG19_Broad_variant	TCGA-FE-A230	TCGA-THCA		s12529	Harvard Medical School	Ohio State University	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	True
13722.58cfa831e4b0c9d6adf6cb9e	58cfa831e4b0c9d6adf6cb9e	TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted	TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted.bam	282.3		0.16	58cfa831e4b0c9d6adf6cb9e	TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7328-01A	42B7D14F-09E5-4D91-BB98-5FE35907A6A9	Primary Tumor	Illumina HiSeq	09a1120f-21a6-48c2-a9e8-3b229a16fc7f	Prostate	70.0	4539A7C3-CCA2-4ED0-9310-92CD843AA1CD	C4D292D4-D001-4704-94C9-CC1674F6F16E	TCGA-EJ-7328-01A-31D-2111-02	HG19_Broad_variant	TCGA-EJ-7328	TCGA-PRAD		s3960	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		2111-02	True
13767.58cfa83be4b0c9d6adf723a1	58cfa83be4b0c9d6adf723a1	UNCID_2580932.981cc3a0-6ba5-41c1-b823-13047c44058a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2580932.981cc3a0-6ba5-41c1-b823-13047c44058a.sorted_genome_alignments	UNCID_2580932.981cc3a0-6ba5-41c1-b823-13047c44058a.sorted_genome_alignments.bam	21.63	1.78	0.15	58cfa83be4b0c9d6adf723a1	UNCID_2580932.981cc3a0-6ba5-41c1-b823-13047c44058a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thymoma	Aligned reads	TCGA-5U-AB0F-01A	BB9BB553-F304-4D14-A655-5C3BF4720A9B	Primary Tumor	Illumina HiSeq	29C7CF6A-8A97-455C-A158-6576B5BE2CD4	Thymus	58.0	FDCC8130-D177-4430-9A8D-175B91486A68	981CC3A0-6BA5-41C1-B823-13047C44058A	TCGA-5U-AB0F-01A-11R-A42C-07	HG19	TCGA-5U-AB0F	TCGA-THYM		s492	University of North Carolina	Regina Elena National Cancer Institute	Italy	NO					A42C-07	True
13767.58cfa834e4b0c9d6adf6e326	58cfa834e4b0c9d6adf6e326	UNCID_1185376.85344fe3-0087-4c61-b02b-96a311fa8034.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1185376.85344fe3-0087-4c61-b02b-96a311fa8034.sorted_genome_alignments	UNCID_1185376.85344fe3-0087-4c61-b02b-96a311fa8034.sorted_genome_alignments.bam	104.3	1.8	0.14	58cfa834e4b0c9d6adf6e326	UNCID_1185376.85344fe3-0087-4c61-b02b-96a311fa8034.sorted_genome_alignments.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4986-01A	CCD44D97-F0D5-47CD-9C12-AF458C750D23	Primary Tumor	Illumina HiSeq	A46ECBBF-BAB1-47C5-8B88-330FFFB97EB1	Kidney	75.0	1AA58F3B-788E-4224-8887-4AF8EB05F4D4	85344FE3-0087-4C61-B02B-96A311FA8034	TCGA-BP-4986-01A-01R-1334-07	HG19	TCGA-BP-4986	TCGA-KIRC		s9339	University of North Carolina	MSKCC	None	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13722.58cfa830e4b0c9d6adf6c058	58cfa830e4b0c9d6adf6c058	TCGA-AZ-4308-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4308-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4308-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	123.72	1.9	0.16	58cfa830e4b0c9d6adf6c058	TCGA-AZ-4308-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4308-10A	3D8FD9B2-9AA2-4C81-8843-535AE66D6140	Blood Derived Normal	Illumina HiSeq	fc1a3245-0316-493f-b46a-f179c1f6a452	Colorectal	47.0	54F3DCE1-F69B-44BD-BAFB-17A6C937452E	4230CC2F-6B46-4130-A9E8-D7E834E13C4C	TCGA-AZ-4308-10A-01D-1405-02	HG18	TCGA-AZ-4308	TCGA-COAD		s13686	Harvard Medical School	University of Pittsburgh	None	NO	T3	N1	Colon Adenocarcinoma	Stage III	1405-02	True
13722.58cfa83ce4b0c9d6adf73116	58cfa83ce4b0c9d6adf73116	e1fd0963f179515dbd7a5f7018b66fd9.filtered.	WGS	e1fd0963f179515dbd7a5f7018b66fd9	e1fd0963f179515dbd7a5f7018b66fd9.bam	55.79	2.17	0.08	58cfa83ce4b0c9d6adf73116	e1fd0963f179515dbd7a5f7018b66fd9.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BW-11A	5D1D00C6-FCAE-479E-AE1E-DE76EFD41D98	Solid Tissue Normal	Illumina HiSeq	190c051d-e6c9-4898-ae78-5946797b28ff	Breast	71.0	D03B3D7B-3629-4FDE-A47A-3184F67236EB	CA6B4239-5535-4790-A449-4B95E9395ADB	TCGA-BH-A0BW-11A-12D-A314-09	GRCh37-lite	TCGA-BH-A0BW	TCGA-BRCA		s6613	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A314-09	True
13722.58cfa82ee4b0c9d6adf6aae2	58cfa82ee4b0c9d6adf6aae2	G32534.TCGA-DJ-A3US-10A-01D-A22D-08.2.filtered.	WGS	G32534.TCGA-DJ-A3US-10A-01D-A22D-08.2	G32534.TCGA-DJ-A3US-10A-01D-A22D-08.2.bam	14.21		0.08	58cfa82ee4b0c9d6adf6aae2	G32534.TCGA-DJ-A3US-10A-01D-A22D-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A3US-10A	6EE95DC8-2BAC-4691-AFA2-8222E07506AD	Blood Derived Normal	Illumina HiSeq	9f8905dd-43d5-4299-bd1e-57a1e27e7835	Thyroid	37.0	D03234D9-E9FC-4B55-B516-00985999A1B3	23AA8B80-6356-479F-BEAE-D06AA7D895DC	TCGA-DJ-A3US-10A-01D-A22D-08	HG19_Broad_variant	TCGA-DJ-A3US	TCGA-THCA		s12338	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22D-08	True
13722.58cfa830e4b0c9d6adf6bea6	58cfa830e4b0c9d6adf6bea6	TCGA-AZ-4615-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4615-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4615-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	170.72	1.9	0.14	58cfa830e4b0c9d6adf6bea6	TCGA-AZ-4615-10A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4615-10A	BF69A4CE-EC7E-4752-A86D-DCC80E3C9A57	Blood Derived Normal	Illumina HiSeq	90608783-775c-48d4-a0e7-3b07c961c2e6	Colorectal	84.0	ADA35D85-5095-452A-B796-8684F1688500	7FE7E146-7FD2-4C9E-A64B-644543E97DE3	TCGA-AZ-4615-10A-01D-1405-02	HG18	TCGA-AZ-4615	TCGA-COAD		s13035	Harvard Medical School	University of Pittsburgh	None	NO	T3	N1	Colon Adenocarcinoma	Stage III	1405-02	True
13767.58cfa838e4b0c9d6adf70aee	58cfa838e4b0c9d6adf70aee	UNCID_2096352.3f4ab9a7-3a43-4601-a21f-2ee63b10efee.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2096352.3f4ab9a7-3a43-4601-a21f-2ee63b10efee.sorted_genome_alignments	UNCID_2096352.3f4ab9a7-3a43-4601-a21f-2ee63b10efee.sorted_genome_alignments.bam	50.66	1.88	0.17	58cfa838e4b0c9d6adf70aee	UNCID_2096352.3f4ab9a7-3a43-4601-a21f-2ee63b10efee.sorted_genome_alignments.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BC-A110-01A	CF028BCE-D20D-42B8-8507-1EC94A391E85	Primary Tumor	Illumina HiSeq	AF590350-AF63-4A10-BD34-7E8302A0A47B	Liver	51.0	4DB99739-F0D5-4DB9-A5FA-4445C7A61B4B	3F4AB9A7-3A43-4601-A21F-2EE63B10EFEE	TCGA-BC-A110-01A-11R-A131-07	HG19	TCGA-BC-A110	TCGA-LIHC	2116.0	s16725	University of North Carolina	UNC	United States	NO	T1	NX	Hepatocellular Carcinoma		A131-07	True
13722.58cfa82ee4b0c9d6adf6ab28	58cfa82ee4b0c9d6adf6ab28	G26381.TCGA-14-1823-01A-01D-1494-08.1.filtered.	WGS	G26381.TCGA-14-1823-01A-01D-1494-08.1	G26381.TCGA-14-1823-01A-01D-1494-08.1.bam	365.37	1.91	0.05	58cfa82ee4b0c9d6adf6ab28	G26381.TCGA-14-1823-01A-01D-1494-08.1.bam	Dead	FEMALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-14-1823-01A	A515CF2D-E918-4958-9BF6-E611B425A97E	Primary Tumor	Illumina HiSeq	38fe2fc2-ccf1-494b-89f0-54ed8a5a213c	Brain	58.0	7EAD0574-478A-4FE1-AABE-34965101B05D	4A1AD661-F6AE-44E8-B50B-72FF658FF22B	TCGA-14-1823-01A-01D-1494-08	HG19_Broad_variant	TCGA-14-1823	TCGA-GBM	543.0	s13928	Broad Institute of MIT and Harvard	Emory University	None	NO			Untreated primary (de novo) GBM		1494-08	True
13767.58cfa83be4b0c9d6adf72150	58cfa83be4b0c9d6adf72150	UNCID_2575448.abbfb4d1-8cc0-4730-aed0-6cb6659d2bbb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2575448.abbfb4d1-8cc0-4730-aed0-6cb6659d2bbb.sorted_genome_alignments	UNCID_2575448.abbfb4d1-8cc0-4730-aed0-6cb6659d2bbb.sorted_genome_alignments.bam	32.72	1.86	0.16	58cfa83be4b0c9d6adf72150	UNCID_2575448.abbfb4d1-8cc0-4730-aed0-6cb6659d2bbb.sorted_genome_alignments.bam					Testicular Germ Cell Tumors	Aligned reads	TCGA-2G-AALX-01A	8FB406E7-49B1-4662-860C-5A4D32B9D19C	Primary Tumor	Illumina HiSeq	4487DD67-5EA8-4A0D-B1AC-6573F21321A6	Testis		58D0246C-6808-452D-A7D0-2AD23F15ABDF	ABBFB4D1-8CC0-4730-AED0-6CB6659D2BBB	TCGA-2G-AALX-01A-11R-A430-07	HG19	TCGA-2G-AALX	TCGA-TGCT		s597	University of North Carolina	Erasmus MC	None	NO					A430-07	True
13722.58cfa83ce4b0c9d6adf73090	58cfa83ce4b0c9d6adf73090	f6f0bc109f78a22318fcd55e02cd9e0e.filtered.	WGS	f6f0bc109f78a22318fcd55e02cd9e0e	f6f0bc109f78a22318fcd55e02cd9e0e.bam	54.22	1.93	0.08	58cfa83ce4b0c9d6adf73090	f6f0bc109f78a22318fcd55e02cd9e0e.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0G9-01A	45D58088-D3F4-4EB0-B75C-BCB98C0981DC	Primary Tumor	Illumina HiSeq	5394f784-0e1a-4fe2-82e6-a4ba4d7f95b4	Uterus	79.0	117A5B33-42C5-4A52-BABE-D9712F3E7472	EAE45FBE-9F7D-4F59-A0A9-1F0F0D69AFC4	TCGA-A5-A0G9-01A-11D-A066-09	GRCh37-lite	TCGA-A5-A0G9	TCGA-UCEC		s4575	Washington University School of Medicine	Cedars Sinai	None	NO			Endometrioid endometrial adenocarcinoma		A066-09	True
13722.58cfa82ee4b0c9d6adf6ac22	58cfa82ee4b0c9d6adf6ac22	G37566.TCGA-HC-7075-01A-11D-1961-08.2.filtered.	WGS	G37566.TCGA-HC-7075-01A-11D-1961-08.2	G37566.TCGA-HC-7075-01A-11D-1961-08.2.bam	242.7		0.05	58cfa82ee4b0c9d6adf6ac22	G37566.TCGA-HC-7075-01A-11D-1961-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7075-01A	5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA	Primary Tumor	Illumina HiSeq	8f4cf0ab-38b1-49e1-8c15-82f9d02b5f9f	Prostate	63.0	1FA3E5C2-E415-42FA-AEA3-F6C84959522A	DDC422E4-87E2-4FC0-B56B-DDC2D6A92F58	TCGA-HC-7075-01A-11D-1961-08	HG19_Broad_variant	TCGA-HC-7075	TCGA-PRAD		s3406	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2a		Prostate Adenocarcinoma Acinar Type		1961-08	False
13767.58cfa838e4b0c9d6adf70992	58cfa838e4b0c9d6adf70992	UNCID_2084170.22142880-0e1a-4e12-98b1-2597e9d14def.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2084170.22142880-0e1a-4e12-98b1-2597e9d14def.sorted_genome_alignments	UNCID_2084170.22142880-0e1a-4e12-98b1-2597e9d14def.sorted_genome_alignments.bam	21.17	1.75	0.18	58cfa838e4b0c9d6adf70992	UNCID_2084170.22142880-0e1a-4e12-98b1-2597e9d14def.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BD-A3EP-01A	DE302B98-250D-42FE-9945-11E1B2BBD3C6	Primary Tumor	Illumina HiSeq	6FE51ED1-EE46-4255-B735-AE3B866D1886	Liver	75.0	553DFA2D-C496-4982-8BA1-32D5054864BE	22142880-0E1A-4E12-98B1-2597E9D14DEF	TCGA-BD-A3EP-01A-11R-A22L-07	HG19	TCGA-BD-A3EP	TCGA-LIHC		s17080	University of North Carolina	University of Pittsburgh	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A22L-07	True
13767.58cfa838e4b0c9d6adf70822	58cfa838e4b0c9d6adf70822	UNCID_2033716.ba70deb1-e8c2-4f74-9883-46e7095f677d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2033716.ba70deb1-e8c2-4f74-9883-46e7095f677d.sorted_genome_alignments	UNCID_2033716.ba70deb1-e8c2-4f74-9883-46e7095f677d.sorted_genome_alignments.bam	39.04	1.72	0.16	58cfa838e4b0c9d6adf70822	UNCID_2033716.ba70deb1-e8c2-4f74-9883-46e7095f677d.sorted_genome_alignments.bam					Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-FL-A1YH-11A	47C49C54-95F8-42C8-94E4-411280452512	Solid Tissue Normal	Illumina HiSeq	704584B1-0340-4B03-995B-97D9546115C8	Uterus		0E9C603F-5EC6-4FD7-87BB-BCE23CA2C042	BA70DEB1-E8C2-4F74-9883-46E7095F677D	TCGA-FL-A1YH-11A-11R-A16F-07	HG19	TCGA-FL-A1YH	TCGA-UCEC		s4890	University of North Carolina	University of Hawaii - Normal Study	United States	NO					A16F-07	True
13767.58cfa835e4b0c9d6adf6eda9	58cfa835e4b0c9d6adf6eda9	UNCID_1378888.514bfcb2-3eae-436d-aec3-540cab765c3c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1378888.514bfcb2-3eae-436d-aec3-540cab765c3c.sorted_genome_alignments	UNCID_1378888.514bfcb2-3eae-436d-aec3-540cab765c3c.sorted_genome_alignments.bam	80.2		0.16	58cfa835e4b0c9d6adf6eda9	UNCID_1378888.514bfcb2-3eae-436d-aec3-540cab765c3c.sorted_genome_alignments.bam	Dead	MALE			Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-8007-01A	C7B23A5A-C49A-4426-BD4E-B191F4227AC6	Primary Tumor	Illumina HiSeq	25477866-1423-4884-B3A9-296C886319BC	Lung	68.0	3B80A817-1D68-4A68-81F4-F5201339AF88	514BFCB2-3EAE-436D-AEC3-540CAB765C3C	TCGA-77-8007-01A-11R-2187-07	HG19	TCGA-77-8007	TCGA-LUSC	198.0	s10121	University of North Carolina	Prince Charles Hospital	Australia	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	2187-07	True
13767.58cfa83ae4b0c9d6adf71dac	58cfa83ae4b0c9d6adf71dac	UNCID_2501027.acb2a050-f12f-4a83-8c9e-5e69afcfdd66.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2501027.acb2a050-f12f-4a83-8c9e-5e69afcfdd66.sorted_genome_alignments	UNCID_2501027.acb2a050-f12f-4a83-8c9e-5e69afcfdd66.sorted_genome_alignments.bam	29.22	1.82	0.16	58cfa83ae4b0c9d6adf71dac	UNCID_2501027.acb2a050-f12f-4a83-8c9e-5e69afcfdd66.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-XD-AAUL-01A	597A5A56-244B-4218-A55D-5D08217EA28C	Primary Tumor	Illumina HiSeq	B32228A4-47CF-49B3-938A-D8664DBEFF73	Pancreas	56.0	EEFA10E3-1267-41BA-8207-794CE650DCD1	ACB2A050-F12F-4A83-8C9E-5E69AFCFDD66	TCGA-XD-AAUL-01A-21R-A39D-07	HG19	TCGA-XD-AAUL	TCGA-PAAD		s848	University of North Carolina	Providence Portland Medical Center	United States	NO	T3	N0	Pancreas-Adenocarcinoma Ductal Type	Stage II	A39D-07	True
13767.58cfa838e4b0c9d6adf70bdd	58cfa838e4b0c9d6adf70bdd	UNCID_2101091.a6029e8e-f375-4843-989c-745b2bc64f94.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2101091.a6029e8e-f375-4843-989c-745b2bc64f94.sorted_genome_alignments	UNCID_2101091.a6029e8e-f375-4843-989c-745b2bc64f94.sorted_genome_alignments.bam	11.96	1.87	0.17	58cfa838e4b0c9d6adf70bdd	UNCID_2101091.a6029e8e-f375-4843-989c-745b2bc64f94.sorted_genome_alignments.bam	Dead	MALE	WHITE		Lung Squamous Cell Carcinoma	Aligned reads	TCGA-NC-A5HJ-01A	00FD9306-4A68-49AB-A768-E5FED126A765	Primary Tumor	Illumina HiSeq	8CE5C84D-D885-4757-B643-35119189C2AE	Lung	59.0	97163B07-0328-4661-A06E-185F7849E819	A6029E8E-F375-4843-989C-745B2BC64F94	TCGA-NC-A5HJ-01A-11R-A26W-07	HG19	TCGA-NC-A5HJ	TCGA-LUSC	418.0	s10345	University of North Carolina	Washington University - CHUV	Switzerland	NO	T3	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A26W-07	True
13767.58cfa830e4b0c9d6adf6c090	58cfa830e4b0c9d6adf6c090	TCGA-BR-7715-11A-01R-2055-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-7715-11A-01R-2055-13_rnaseq	TCGA-BR-7715-11A-01R-2055-13_rnaseq.bam	145.2		0.15	58cfa830e4b0c9d6adf6c090	TCGA-BR-7715-11A-01R-2055-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7715-11A	69704642-BA65-4A45-8F13-95D847185045	Solid Tissue Normal	Illumina HiSeq	513EE3CB-4670-4E06-A765-5CFC51AA9DB9	Stomach	65.0	23739FB2-3E92-44FA-91AE-B84B69894979	41B5FA1B-3F18-41DE-8A34-2F42F4581724	TCGA-BR-7715-11A-01R-2055-13	GRCh37-lite	TCGA-BR-7715	TCGA-STAD		s15052	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2055-13	True
13767.58cfa837e4b0c9d6adf6fcfe	58cfa837e4b0c9d6adf6fcfe	UNCID_1712330.102bbfea-fb71-41c8-899d-75670fda81e8.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1712330.102bbfea-fb71-41c8-899d-75670fda81e8.sorted_genome_alignments	UNCID_1712330.102bbfea-fb71-41c8-899d-75670fda81e8.sorted_genome_alignments.bam	82.2		0.16	58cfa837e4b0c9d6adf6fcfe	UNCID_1712330.102bbfea-fb71-41c8-899d-75670fda81e8.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Chromophobe	Aligned reads	TCGA-KL-8340-01A	3129E869-BB2F-423A-BD20-D0DAAE33B11A	Primary Tumor	Illumina HiSeq	0FF7D480-0FC2-4452-8952-26C3AB4C1942	Kidney	34.0	07C3C6E6-D297-4D80-9C28-974FA470A132	102BBFEA-FB71-41C8-899D-75670FDA81E8	TCGA-KL-8340-01A-11R-2315-07	HG19	TCGA-KL-8340	TCGA-KICH		s16545	University of North Carolina	MSKCC	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2315-07	True
13722.58cfa831e4b0c9d6adf6cbb2	58cfa831e4b0c9d6adf6cbb2	TCGA-EK-A2RD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EK-A2RD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_6_rg.sorted	TCGA-EK-A2RD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_6_rg.sorted.bam	11.5		0.16	58cfa831e4b0c9d6adf6cbb2	TCGA-EK-A2RD-10A-01D-A20X_140117_SN590_0245_AC371LACXX_s_6_rg.sorted.bam	Alive	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RD-10A	16363EF7-899D-4927-A74B-E7C03B3D8AF1	Blood Derived Normal	Illumina HiSeq	38640bc1-87b3-4a78-9b34-d7ffce7d0cd0	Cervix	47.0	0262E6F4-0B87-4A9F-AF4B-8E1657CAB3C5	F22E0E0E-40F1-46AA-80C7-BBF3310F5413	TCGA-EK-A2RD-10A-01D-A20X-26	HG19_Broad_variant	TCGA-EK-A2RD	TCGA-CESC		s1194	MD Anderson - Institute for Applied Cancer Science	Gynecologic Oncology Group	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma		A20X-26	True
13767.58cfa837e4b0c9d6adf7017d	58cfa837e4b0c9d6adf7017d	UNCID_1841465.e1355ed5-ae8c-47ba-9b60-a72038142b89.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1841465.e1355ed5-ae8c-47ba-9b60-a72038142b89.sorted_genome_alignments	UNCID_1841465.e1355ed5-ae8c-47ba-9b60-a72038142b89.sorted_genome_alignments.bam	66.2	1.7	0.15	58cfa837e4b0c9d6adf7017d	UNCID_1841465.e1355ed5-ae8c-47ba-9b60-a72038142b89.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7014-01A	A776CFD0-DB9F-450A-943C-5A9A80A75FB7	Primary Tumor	Illumina HiSeq	CD3C3413-87C7-4788-B0A5-9C143F4B27BA	Brain	59.0	050F26D9-B105-412A-9E5B-36840A1843E3	E1355ED5-AE8C-47BA-9B60-A72038142B89	TCGA-DU-7014-01A-11R-2027-07	HG19	TCGA-DU-7014	TCGA-LGG	3571.0	s8434	University of North Carolina	Henry Ford Hospital	United States	NO			Oligodendroglioma		2027-07	True
13767.58cfa837e4b0c9d6adf703cd	58cfa837e4b0c9d6adf703cd	UNCID_1821416.cbc4cdac-a504-47ed-96cf-5c459f7febd0.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1821416.cbc4cdac-a504-47ed-96cf-5c459f7febd0.sorted_genome_alignments	UNCID_1821416.cbc4cdac-a504-47ed-96cf-5c459f7febd0.sorted_genome_alignments.bam	52.81	1.8	0.16	58cfa837e4b0c9d6adf703cd	UNCID_1821416.cbc4cdac-a504-47ed-96cf-5c459f7febd0.sorted_genome_alignments.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A47W-01A	122FC134-8915-47DB-96C9-AB1853C3CD18	Primary Tumor	Illumina HiSeq	F588538A-A588-4488-AD5B-B6537AB92CC6	Bladder	42.0	3E3F2238-288D-42F4-95FF-1BB8C1A3373B	CBC4CDAC-A504-47ED-96CF-5C459F7FEBD0	TCGA-CF-A47W-01A-11R-A23W-07	HG19	TCGA-CF-A47W	TCGA-BLCA		s3172	University of North Carolina	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A23W-07	True
13722.58cfa830e4b0c9d6adf6bcf3	58cfa830e4b0c9d6adf6bcf3	TCGA-AG-3574-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3574-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3574-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	41.21	1.8	0.14	58cfa830e4b0c9d6adf6bcf3	TCGA-AG-3574-10A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3574-10A	0EDA7373-8335-455F-B90A-8C3540F28088	Blood Derived Normal	Illumina HiSeq	9211afac-c744-41bb-ac38-56805c35f544	Colorectal	89.0	FC65E77A-760D-49D6-81B3-CD55899C76AB	8BCF4B23-7007-4919-BC51-A71E98E295B4	TCGA-AG-3574-10A-01D-1167-02	HG18	TCGA-AG-3574	TCGA-READ		s1967	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage II	1167-02	True
13767.58cfa832e4b0c9d6adf6d842	58cfa832e4b0c9d6adf6d842	TCGA-L5-A4OR-01A-11R-A260-31_rnaseq.filtered.	RNA-Seq	TCGA-L5-A4OR-01A-11R-A260-31_rnaseq	TCGA-L5-A4OR-01A-11R-A260-31_rnaseq.bam	109.59	1.9	0.17	58cfa832e4b0c9d6adf6d842	TCGA-L5-A4OR-01A-11R-A260-31_rnaseq.bam	Dead	MALE	WHITE		Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OR-01A	09EACBFD-3F4A-4D2B-B7A7-C021535E2981	Primary Tumor	Illumina HiSeq	4B0FB3A5-77D8-4EFC-A1F7-F02CA95AD693	Esophagus	83.0	7DA8E467-C347-4C47-9E2D-AA46840B5CD5	BCB02AE2-2B93-4ED3-B6DF-70D2AF3A8B28	TCGA-L5-A4OR-01A-11R-A260-31	GRCh37-lite	TCGA-L5-A4OR	TCGA-ESCA	96.0	s1663	Canada's Michael Smith Genome Sciences Centre	University of Michigan	United States	NO	T1	N0		Stage I	A260-31	True
13767.58cfa834e4b0c9d6adf6e1b2	58cfa834e4b0c9d6adf6e1b2	UNCID_1157708.bfa78a45-16bf-410a-816d-bd369ded91e5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1157708.bfa78a45-16bf-410a-816d-bd369ded91e5.sorted_genome_alignments	UNCID_1157708.bfa78a45-16bf-410a-816d-bd369ded91e5.sorted_genome_alignments.bam	46.22	1.85	0.17	58cfa834e4b0c9d6adf6e1b2	UNCID_1157708.bfa78a45-16bf-410a-816d-bd369ded91e5.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A24L-01A	DE646F6A-6D50-4BE2-B3CD-F17554B234DF	Primary Tumor	Illumina HiSeq	BD37923B-AB0E-4749-86DD-B46FC4B93A0E	Breast	26.0	F773AE1D-0AD9-42DD-9675-C8B7287FEC85	BFA78A45-16BF-410A-816D-BD369DED91E5	TCGA-AR-A24L-01A-11R-A169-07	HG19	TCGA-AR-A24L	TCGA-BRCA		s6045	University of North Carolina	Mayo	United States	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage II	A169-07	True
13767.58cfa83ce4b0c9d6adf72af4	58cfa83ce4b0c9d6adf72af4	UNCID_373304.TCGA-B2-3924-01A-02R-1325-07.110418_UNC15-SN850_0063_BB07MAABXX.2.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_373304.TCGA-B2-3924-01A-02R-1325-07.110418_UNC15-SN850_0063_BB07MAABXX.2.trimmed.annotated.translated_to_genomic	UNCID_373304.TCGA-B2-3924-01A-02R-1325-07.110418_UNC15-SN850_0063_BB07MAABXX.2.trimmed.annotated.translated_to_genomic.bam	20.33	1.7	0.16	58cfa83ce4b0c9d6adf72af4	UNCID_373304.TCGA-B2-3924-01A-02R-1325-07.110418_UNC15-SN850_0063_BB07MAABXX.2.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B2-3924-01A	424E5C99-3693-4B10-BBF0-FC43E851610C	Primary Tumor	Illumina HiSeq	07EE04CB-0C80-48E7-988F-94B39F8FAAA2	Kidney	73.0	21527594-ED75-4654-9CAF-83D31F248E67	09B4506E-729D-47FD-A08B-FEF5F191B380	TCGA-B2-3924-01A-02R-1325-07	HG19	TCGA-B2-3924	TCGA-KIRC		s9967	University of North Carolina	Christiana Healthcare	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1325-07	True
13767.58cfa82ee4b0c9d6adf6a7c2	58cfa82ee4b0c9d6adf6a7c2	G17812.TCGA-28-5213-01A-01R-1850-01.4.filtered.	RNA-Seq	G17812.TCGA-28-5213-01A-01R-1850-01.4	G17812.TCGA-28-5213-01A-01R-1850-01.4.bam	117.7	1.8	0.15	58cfa82ee4b0c9d6adf6a7c2	G17812.TCGA-28-5213-01A-01R-1850-01.4.bam	Alive	MALE	WHITE		Glioblastoma Multiforme	Aligned reads	TCGA-28-5213-01A	7338E476-10FF-444A-A16F-429D28355F65	Primary Tumor	Illumina HiSeq	CEBC84FB-235C-4E4B-83C1-E675638BE62E	Brain	72.0	B6CA6325-97DF-4790-BE83-71E3579F78DA	FF4D089B-8F65-46F1-B3BC-DAB1271725FB	TCGA-28-5213-01A-01R-1850-01	HG19_Broad_variant	TCGA-28-5213	TCGA-GBM		s14300	Broad Institute of MIT and Harvard	Cedars Sinai	None	NO			Untreated primary (de novo) GBM		1850-01	True
13767.58cfa82fe4b0c9d6adf6b4e4	58cfa82fe4b0c9d6adf6b4e4	TCGA-25-1329-01A-01R-1565-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-25-1329-01A-01R-1565-13_GRCh37-lite_rnaseq	TCGA-25-1329-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	325.0	1.8	0.15	58cfa82fe4b0c9d6adf6b4e4	TCGA-25-1329-01A-01R-1565-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1329-01A	955C80BE-53DF-4565-9303-A7ABF96A2F81	Primary Tumor	Illumina HiSeq	E4B811C3-32C0-452E-B4ED-C17FA8CFDBBE	Ovary	76.0	D7AD6239-B56B-4762-9656-7653F308E01D	5CF09CE6-44B1-4F0E-89AC-3EA302D684D8	TCGA-25-1329-01A-01R-1565-13	GRCh37-lite	TCGA-25-1329	TCGA-OV	457.0	s17188	Canada's Michael Smith Genome Sciences Centre	Mayo Clinic - Rochester	None	NO			Serous Cystadenocarcinoma		1565-13	True
13767.58cfa82fe4b0c9d6adf6b710	58cfa82fe4b0c9d6adf6b710	TCGA-59-2363-01A-01R-1569-13_rnaseq.filtered.	RNA-Seq	TCGA-59-2363-01A-01R-1569-13_rnaseq	TCGA-59-2363-01A-01R-1569-13_rnaseq.bam	577.0	1.8	0.15	58cfa82fe4b0c9d6adf6b710	TCGA-59-2363-01A-01R-1569-13_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-59-2363-01A	F4D95C8E-FB84-46CA-ACC0-827015CC9D0A	Primary Tumor	Illumina HiSeq	14F90ACC-ACCF-4118-B03E-B77502999258	Ovary	40.0	FAF406A4-D3D4-4FF5-8A3B-86ECBC6802AB	1D3F29AC-5F19-452D-99B6-72C0ABF1CE32	TCGA-59-2363-01A-01R-1569-13	NCBI36_BCCAGSC_variant	TCGA-59-2363	TCGA-OV		s17795	Canada's Michael Smith Genome Sciences Centre	Roswell Park	None	NO			Serous Cystadenocarcinoma		1569-13	True
13722.58cfa831e4b0c9d6adf6c3a6	58cfa831e4b0c9d6adf6c3a6	TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina	TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina.bam	75.65	1.95	0.08	58cfa831e4b0c9d6adf6c3a6	TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-A1HT-01A	670C1CBC-4494-45F1-BB8B-18DB82D4F7E0	Primary Tumor	Illumina HiSeq	f7c13bc4-5edc-4964-8267-e7956bf2fdd0	Liver	50.0	96F911ED-2064-4745-AD07-6C47B0A0C7CD	6B25A78F-20DC-4CCC-B4C0-F9885D16725D	TCGA-CC-A1HT-01A-11D-A12Z-10	GRCh37-lite	TCGA-CC-A1HT	TCGA-LIHC		s16850	Baylor College of Medicine	ILSbio	Vietnam	NO	T3	N0	Hepatocellular Carcinoma	Stage III	A12Z-10	True
13767.58cfa82ee4b0c9d6adf6a9b4	58cfa82ee4b0c9d6adf6a9b4	G17676.TCGA-41-2571-01A-01R-1850-01.2.filtered.	RNA-Seq	G17676.TCGA-41-2571-01A-01R-1850-01.2	G17676.TCGA-41-2571-01A-01R-1850-01.2.bam	54.7	1.8	0.15	58cfa82ee4b0c9d6adf6a9b4	G17676.TCGA-41-2571-01A-01R-1850-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-41-2571-01A	722F462D-F939-4BC1-AAE4-8F78B1335A87	Primary Tumor	Illumina HiSeq	304D7D9F-46D7-4908-9957-ACF037DF723F	Brain	89.0	1428C1F2-626C-4017-A651-EA2FA19156BA	A7433808-7FB3-4909-92AE-2D74B32886B0	TCGA-41-2571-01A-01R-1850-01	HG19_Broad_variant	TCGA-41-2571	TCGA-GBM	26.0	s13942	Broad Institute of MIT and Harvard	Christiana Healthcare	None	NO			Untreated primary (de novo) GBM		1850-01	True
13767.58cfa833e4b0c9d6adf6db96	58cfa833e4b0c9d6adf6db96	UNCID_1107907.ace0aace-27ba-42a6-8d6b-3c29095ccbe5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1107907.ace0aace-27ba-42a6-8d6b-3c29095ccbe5.sorted_genome_alignments	UNCID_1107907.ace0aace-27ba-42a6-8d6b-3c29095ccbe5.sorted_genome_alignments.bam	71.7	1.8	0.15	58cfa833e4b0c9d6adf6db96	UNCID_1107907.ace0aace-27ba-42a6-8d6b-3c29095ccbe5.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6593-01A	E10568FE-0436-43F2-9F0F-48F9903868C4	Primary Tumor	Illumina HiSeq	CC275718-ABEC-43A6-A3C6-87D11C327316	Lung	49.0	3B2ED302-D8F1-4078-95F0-3B5C5B322DEB	ACE0AACE-27BA-42A6-8D6B-3C29095CCBE5	TCGA-50-6593-01A-11R-1755-07	HG19	TCGA-50-6593	TCGA-LUAD	336.0	s10694	University of North Carolina	University of Pittsburgh	United States	NO	T1	N2	Lung Adenocarcinoma Mixed Subtype	Stage III	1755-07	True
13722.58cfa830e4b0c9d6adf6c027	58cfa830e4b0c9d6adf6c027	TCGA-BJ-A0ZA-10A-02D-A10R_120616_SN1120_0154_BD142VACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZA-10A-02D-A10R_120616_SN1120_0154_BD142VACXX_s_7_rg.sorted	TCGA-BJ-A0ZA-10A-02D-A10R_120616_SN1120_0154_BD142VACXX_s_7_rg.sorted.bam	7.91	1.97	0.13	58cfa830e4b0c9d6adf6c027	TCGA-BJ-A0ZA-10A-02D-A10R_120616_SN1120_0154_BD142VACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZA-10A	4C513413-263E-4C7B-B997-7B688C47B698	Blood Derived Normal	Illumina HiSeq	b6543b80-1693-4e71-b213-e80b5a7c7e81	Thyroid	67.0	EAD7A19A-AF58-4B53-8091-A52C2221A4A9	6F261862-34AD-4C24-B71F-934B0762F5D8	TCGA-BJ-A0ZA-10A-02D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZA	TCGA-THCA		s12626	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A10R-02	True
13722.58cfa832e4b0c9d6adf6d1e4	58cfa832e4b0c9d6adf6d1e4	TCGA-FG-6688-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FG-6688-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_3_rg.sorted	TCGA-FG-6688-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_3_rg.sorted.bam	107.0	1.9	0.15	58cfa832e4b0c9d6adf6d1e4	TCGA-FG-6688-10A-01D-1891_130919_SN590_0239_BC2N06ACXX_s_3_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-6688-10A	DADD7428-9E4D-4652-9469-AB521B88D529	Blood Derived Normal	Illumina HiSeq	ed5c4e17-1960-4f9e-9152-02db5a6f6ec9	Brain	59.0	845A2B47-F2B9-431C-8E95-B2DDCB1F6DF0	898DE9F3-554F-4445-B365-D8C2F9B85780	TCGA-FG-6688-10A-01D-1891-02	HG19_Broad_variant	TCGA-FG-6688	TCGA-LGG		s8571	Harvard Medical School	Case Western	United States	NO			Astrocytoma		1891-02	True
13767.58cfa838e4b0c9d6adf70425	58cfa838e4b0c9d6adf70425	UNCID_1965403.ba28ba04-d709-48c8-bd20-2b036ef54e2c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1965403.ba28ba04-d709-48c8-bd20-2b036ef54e2c.sorted_genome_alignments	UNCID_1965403.ba28ba04-d709-48c8-bd20-2b036ef54e2c.sorted_genome_alignments.bam	16.2	1.7	0.13	58cfa838e4b0c9d6adf70425	UNCID_1965403.ba28ba04-d709-48c8-bd20-2b036ef54e2c.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-6598-11A	A8B4284D-CBBB-43E3-897B-D04AF4BFBA74	Solid Tissue Normal	Illumina HiSeq	391894A5-7F23-496E-B914-6EF76E8ECC0A	Colorectal	77.0	456CC2DF-F9A7-4F65-8450-A79ED69FA27F	BA28BA04-D709-48C8-BD20-2B036EF54E2C	TCGA-AZ-6598-11A-01R-1774-07	HG19	TCGA-AZ-6598	TCGA-COAD	1503.0	s13463	University of North Carolina	University of Pittsburgh	United States	NO	T3	N0	Colon Adenocarcinoma	Stage II	1774-07	True
13722.58cfa832e4b0c9d6adf6cf70	58cfa832e4b0c9d6adf6cf70	TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted.filtered.	WGS	TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted	TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted.bam	8.9		0.14	58cfa832e4b0c9d6adf6cf70	TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A3OP-11A	31DA07BB-6752-49A3-A7EA-5427C04A9458	Solid Tissue Normal	Illumina HiSeq	cec19b51-29ce-4b48-81a6-7f61054cc053	Bladder	84.0	22340B82-9219-49C6-B511-FDA79F24F36E	120EE6C1-48C4-42BB-97F2-BFFD79B35FF9	TCGA-GD-A3OP-11A-11D-A221-26	HG19_Broad_variant	TCGA-GD-A3OP	TCGA-BLCA		s2921	MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A221-26	True
13767.58cfa833e4b0c9d6adf6df74	58cfa833e4b0c9d6adf6df74	UNCID_1150981.c417152a-d278-4aeb-951e-a7b6ae5654c1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1150981.c417152a-d278-4aeb-951e-a7b6ae5654c1.sorted_genome_alignments	UNCID_1150981.c417152a-d278-4aeb-951e-a7b6ae5654c1.sorted_genome_alignments.bam	13.92	1.78	0.14	58cfa833e4b0c9d6adf6df74	UNCID_1150981.c417152a-d278-4aeb-951e-a7b6ae5654c1.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RN-01A	2199B7A1-BD47-4BB5-B36A-A3E291E3E259	Primary Tumor	Illumina HiSeq	1367C483-C605-4672-8981-D160323D9439	Breast	60.0	3652A456-36EE-4746-B25D-A6303984B77F	C417152A-D278-4AEB-951E-A7B6AE5654C1	TCGA-B6-A0RN-01A-12R-A084-07	HG19	TCGA-B6-A0RN	TCGA-BRCA		s5871	University of North Carolina	Duke	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A084-07	True
13767.58cfa838e4b0c9d6adf70664	58cfa838e4b0c9d6adf70664	UNCID_1961490.d4c11d19-2467-4cb5-a351-d409cb3deea4.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1961490.d4c11d19-2467-4cb5-a351-d409cb3deea4.sorted_genome_alignments	UNCID_1961490.d4c11d19-2467-4cb5-a351-d409cb3deea4.sorted_genome_alignments.bam	261.2		0.17	58cfa838e4b0c9d6adf70664	UNCID_1961490.d4c11d19-2467-4cb5-a351-d409cb3deea4.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-A4-7584-01A	0843841B-AFAB-4831-9084-A850DB85287C	Primary Tumor	Illumina HiSeq	8F7368E2-A03D-451A-A35E-7D73D4BFFD20	Kidney	59.0	4B1F5B01-CC9E-4E49-99FF-E07238B7858F	D4C11D19-2467-4CB5-A351-D409CB3DEEA4	TCGA-A4-7584-01A-11R-2139-07	HG19	TCGA-A4-7584	TCGA-KIRP		s11811	University of North Carolina	International Genomics Consortium	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	2139-07	True
13767.58cfa837e4b0c9d6adf6fc9a	58cfa837e4b0c9d6adf6fc9a	UNCID_1669454.31f32186-f631-434d-9c00-f2bbd4cced40.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1669454.31f32186-f631-434d-9c00-f2bbd4cced40.sorted_genome_alignments	UNCID_1669454.31f32186-f631-434d-9c00-f2bbd4cced40.sorted_genome_alignments.bam	13.2		0.15	58cfa837e4b0c9d6adf6fc9a	UNCID_1669454.31f32186-f631-434d-9c00-f2bbd4cced40.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7470-01A	FEE2114E-F723-4374-91F8-F1DCC6B3EAEE	Primary Tumor	Illumina HiSeq	A60B15FB-724E-4F46-9872-C7B9E0AE0CDE	Brain	37.0	C6171CCF-9675-47C6-A23E-E33D74014080	31F32186-F631-434D-9C00-F2BBD4CCED40	TCGA-HT-7470-01A-12R-2090-07	HG19	TCGA-HT-7470	TCGA-LGG		s8415	University of North Carolina	Case Western - St Joes	United States	NO			Oligodendroglioma		2090-07	True
13767.58cfa83be4b0c9d6adf720a3	58cfa83be4b0c9d6adf720a3	UNCID_2560026.78bff220-61fb-4bcf-9520-6c8f287cdf0e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2560026.78bff220-61fb-4bcf-9520-6c8f287cdf0e.sorted_genome_alignments	UNCID_2560026.78bff220-61fb-4bcf-9520-6c8f287cdf0e.sorted_genome_alignments.bam	28.64	1.82	0.17	58cfa83be4b0c9d6adf720a3	UNCID_2560026.78bff220-61fb-4bcf-9520-6c8f287cdf0e.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-A62T-01A	76618CF5-F6E0-46EF-A1C0-ACC0AD9FDCCB	Primary Tumor	Illumina HiSeq	17874BAA-E657-4C9D-99C7-53161F6D5C47	Lung	78.0	545C9110-4FED-4927-BEB0-47CD8BC17B3B	78BFF220-61FB-4BCF-9520-6C8F287CDF0E	TCGA-56-A62T-01A-11R-A405-07	HG19	TCGA-56-A62T	TCGA-LUSC		s10354	University of North Carolina	International Genomics Consortium	United States	NO	T2b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A405-07	True
13767.58cfa838e4b0c9d6adf708a0	58cfa838e4b0c9d6adf708a0	UNCID_2043497.f73e06ac-aa61-45be-b666-83279a7fb908.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2043497.f73e06ac-aa61-45be-b666-83279a7fb908.sorted_genome_alignments	UNCID_2043497.f73e06ac-aa61-45be-b666-83279a7fb908.sorted_genome_alignments.bam	84.85	1.83	0.15	58cfa838e4b0c9d6adf708a0	UNCID_2043497.f73e06ac-aa61-45be-b666-83279a7fb908.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-J9-A52D-01A	C03AE0F2-DDE3-47E8-A046-CE85C86DD77D	Primary Tumor	Illumina HiSeq	AE657FD1-818C-45BF-A4D2-9CD06ECA8DDF	Prostate	71.0	D2FEDED2-C367-4561-91AF-9D0C7FC6638F	F73E06AC-AA61-45BE-B666-83279A7FB908	TCGA-J9-A52D-01A-11R-A29R-07	HG19	TCGA-J9-A52D	TCGA-PRAD		s3864	University of North Carolina	Melbourne Health	Australia	NO	T3a		Prostate Adenocarcinoma  Other Subtype		A29R-07	True
13767.58cfa83ce4b0c9d6adf73043	58cfa83ce4b0c9d6adf73043	_1_TCGA-BR-A4PE-01A-31R-A251-31_rnaseq.filtered.	RNA-Seq	_1_TCGA-BR-A4PE-01A-31R-A251-31_rnaseq	_1_TCGA-BR-A4PE-01A-31R-A251-31_rnaseq.bam	76.15	1.91	0.15	58cfa83ce4b0c9d6adf73043	_1_TCGA-BR-A4PE-01A-31R-A251-31_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-A4PE-01A	FCE4E670-84BE-4592-AE6C-2B7A59218110	Primary Tumor	Illumina HiSeq	DCDBBBC0-3682-422C-A443-8149CA770F4F	Stomach	68.0	BE4C09EB-4E12-48D4-80E9-059847263E96	F1CBA7EE-3815-41B6-AE63-06803F29097E	TCGA-BR-A4PE-01A-31R-A251-31	GRCh37-lite	TCGA-BR-A4PE	TCGA-STAD		s14941	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T2	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	A251-31	True
13767.58cfa837e4b0c9d6adf6fef4	58cfa837e4b0c9d6adf6fef4	UNCID_1782278.ce5ac357-df4c-4dc3-b899-55328a21dc18.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1782278.ce5ac357-df4c-4dc3-b899-55328a21dc18.sorted_genome_alignments	UNCID_1782278.ce5ac357-df4c-4dc3-b899-55328a21dc18.sorted_genome_alignments.bam	19.8	1.6	0.17	58cfa837e4b0c9d6adf6fef4	UNCID_1782278.ce5ac357-df4c-4dc3-b899-55328a21dc18.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-6167-01A	D42BC7F0-CFB2-4ECE-AE47-521308635633	Primary Tumor	Illumina HiSeq	135ED690-B102-4672-833C-137494C45E82	Colorectal	57.0	E29A1283-3E22-41F6-BC76-BFB244A044AE	CE5AC357-DF4C-4DC3-B899-55328A21DC18	TCGA-CM-6167-01A-11R-1653-07	HG19	TCGA-CM-6167	TCGA-COAD		s13433	University of North Carolina	MSKCC	United States	NO	T3	N2b	Colon Adenocarcinoma	Stage III	1653-07	True
13722.58cfa830e4b0c9d6adf6bb6a	58cfa830e4b0c9d6adf6bb6a	TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted	TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted.bam	267.4	1.9	0.15	58cfa830e4b0c9d6adf6bb6a	TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted.bam	Dead	FEMALE			Lung Adenocarcinoma	Aligned reads	TCGA-75-6205-01A	9A63F744-4ED4-4B4D-AAC6-F9BDA66AA563	Primary Tumor	Illumina HiSeq	ccc090ad-afab-4e7d-b71b-dcd39a87e359	Lung		D845174B-1A04-4D22-B34F-C48D7AE35233	A5D194B2-0A92-49A1-9AC3-FC4C1B6ADE92	TCGA-75-6205-01A-11D-1751-02	HG19_Broad_variant	TCGA-75-6205	TCGA-LUAD		s10666	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1751-02	True
13767.58cfa837e4b0c9d6adf701e9	58cfa837e4b0c9d6adf701e9	UNCID_1811966.64bf47b5-577f-4ce2-a6e3-374a35f9a58f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1811966.64bf47b5-577f-4ce2-a6e3-374a35f9a58f.sorted_genome_alignments	UNCID_1811966.64bf47b5-577f-4ce2-a6e3-374a35f9a58f.sorted_genome_alignments.bam	96.2	1.7	0.15	58cfa837e4b0c9d6adf701e9	UNCID_1811966.64bf47b5-577f-4ce2-a6e3-374a35f9a58f.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-D5-6928-01A	EECAA5CD-0B69-4AF2-A782-035025F207B6	Primary Tumor	Illumina HiSeq	A0FDDCBC-6F86-4CBB-A444-C74D270CF213	Colorectal	80.0	2FCFEBA3-1455-43C1-B10F-1559FD0E03CF	64BF47B5-577F-4CE2-A6E3-374A35F9A58F	TCGA-D5-6928-01A-11R-1928-07	HG19	TCGA-D5-6928	TCGA-COAD		s12946	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage II	1928-07	True
13767.58cfa838e4b0c9d6adf704b1	58cfa838e4b0c9d6adf704b1	UNCID_1931045.cd1148b8-b4a5-4ebc-b1fb-10838677896a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1931045.cd1148b8-b4a5-4ebc-b1fb-10838677896a.sorted_genome_alignments	UNCID_1931045.cd1148b8-b4a5-4ebc-b1fb-10838677896a.sorted_genome_alignments.bam	223.8	1.8	0.15	58cfa838e4b0c9d6adf704b1	UNCID_1931045.cd1148b8-b4a5-4ebc-b1fb-10838677896a.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-EF-5831-01A	4D5437B3-B6A0-4D17-A7AA-4F2B790E4532	Primary Tumor	Illumina HiSeq	744054C4-A16A-4185-A518-8E30D3B96151	Colorectal	72.0	A20F4CC7-2B64-415A-8CDC-26D575A2299F	CD1148B8-B4A5-4EBC-B1FB-10838677896A	TCGA-EF-5831-01A-01R-1660-07	HG19	TCGA-EF-5831	TCGA-READ		s2080	University of North Carolina	Cureline	Russia	NO	T3	N0	Rectal Adenocarcinoma	Stage II	1660-07	True
13722.58cfa832e4b0c9d6adf6d84d	58cfa832e4b0c9d6adf6d84d	TCGA-LN-A4A6-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-LN-A4A6-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_7_rg.sorted	TCGA-LN-A4A6-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_7_rg.sorted.bam	24.13		0.16	58cfa832e4b0c9d6adf6d84d	TCGA-LN-A4A6-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_7_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A4A6-01A	FFCFA005-A04F-458E-9D1D-86143DD823E5	Primary Tumor	Illumina HiSeq	113e1f46-b529-435b-bb5a-879746bc79bb	Esophagus	65.0	14A1D0B5-CA52-4E95-B965-66A9E6BEAE43	B0BB8A76-3BF2-44E3-884A-F94A2D687F53	TCGA-LN-A4A6-01A-11D-A267-26	HG19_Broad_variant	TCGA-LN-A4A6	TCGA-ESCA		s1775	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0		Stage II	A267-26	True
13767.58cfa82ee4b0c9d6adf6b02e	58cfa82ee4b0c9d6adf6b02e	TCGA-10-0938-01A-02R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-10-0938-01A-02R-1564-13_GRCh37-lite_rnaseq	TCGA-10-0938-01A-02R-1564-13_GRCh37-lite_rnaseq.bam	263.0	1.8	0.16	58cfa82ee4b0c9d6adf6b02e	TCGA-10-0938-01A-02R-1564-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-10-0938-01A	7CA97692-0BF5-4BBD-81CE-10A051D04BD5	Primary Tumor	Illumina HiSeq	C26DAF03-5CCF-41AE-8565-B720C1C675C4	Ovary	80.0	C11664E8-8883-4A0F-87C3-6FDC903860D5	F7B5774E-BFB3-4E6D-8A24-009F3C294109	TCGA-10-0938-01A-02R-1564-13	GRCh37-lite	TCGA-10-0938	TCGA-OV	636.0	s17599	Canada's Michael Smith Genome Sciences Centre	MD Anderson Cancer Center	None	NO			Serous Cystadenocarcinoma		1564-13	True
13722.58cfa831e4b0c9d6adf6c55a	58cfa831e4b0c9d6adf6c55a	TCGA-CG-5733-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CG-5733-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_6_rg.sorted	TCGA-CG-5733-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_6_rg.sorted.bam	129.0	1.9	0.16	58cfa831e4b0c9d6adf6c55a	TCGA-CG-5733-11A-01D-1598_121023_SN208_0436_AC1CMBACXX_s_6_rg.sorted.bam	Dead	FEMALE			Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5733-11A	8A9AFA5E-63CE-41EB-AAFB-B0B03653DA5A	Solid Tissue Normal	Illumina HiSeq	f72098d0-5e3e-49e7-a5e9-5bf9f620f2c0	Stomach	83.0	C7134D34-299D-440B-94C5-1A4D59978F01	6521DCC6-77A9-4DBC-A27A-6AF8194CB45A	TCGA-CG-5733-11A-01D-1598-02	HG19_Broad_variant	TCGA-CG-5733	TCGA-STAD	641.0	s14992	Harvard Medical School	Indivumed	Germany	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1598-02	True
13767.58cfa83be4b0c9d6adf71f32	58cfa83be4b0c9d6adf71f32	UNCID_2529016.e819d2ae-9cfb-4256-a15c-23fbb3683ee7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2529016.e819d2ae-9cfb-4256-a15c-23fbb3683ee7.sorted_genome_alignments	UNCID_2529016.e819d2ae-9cfb-4256-a15c-23fbb3683ee7.sorted_genome_alignments.bam	59.85	1.91	0.18	58cfa83be4b0c9d6adf71f32	UNCID_2529016.e819d2ae-9cfb-4256-a15c-23fbb3683ee7.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Cholangiocarcinoma	Aligned reads	TCGA-W5-AA30-11A	B4F7F9E4-5FC5-4461-8E0B-0B6C384863C6	Solid Tissue Normal	Illumina HiSeq	203BA1CC-9BE4-453C-82A1-FE9CD1FED992	Bile Duct	82.0	BE72384D-C424-4553-9A80-0F37E4CED48E	E819D2AE-9CFB-4256-A15C-23FBB3683EE7	TCGA-W5-AA30-11A-11R-A41I-07	HG19	TCGA-W5-AA30	TCGA-CHOL		s21	University of North Carolina	Mayo Clinic Rochester	United States	NO	T1	N0		Stage I	A41I-07	True
13767.58cfa83ae4b0c9d6adf71b56	58cfa83ae4b0c9d6adf71b56	UNCID_2431366.b1b529ee-df72-4e05-b342-eb31a28eaf64.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2431366.b1b529ee-df72-4e05-b342-eb31a28eaf64.sorted_genome_alignments	UNCID_2431366.b1b529ee-df72-4e05-b342-eb31a28eaf64.sorted_genome_alignments.bam	46.23	1.91	0.18	58cfa83ae4b0c9d6adf71b56	UNCID_2431366.b1b529ee-df72-4e05-b342-eb31a28eaf64.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A8GM-06A	44B5453A-3009-43B9-BC34-71A11A6D5E63	Metastatic	Illumina HiSeq	6CC2FD3F-E14D-4081-91C2-6BAB708302D9	Skin	73.0	94A3F542-8321-4631-8F88-7500B6A45EB7	B1B529EE-DF72-4E05-B342-EB31A28EAF64	TCGA-D3-A8GM-06A-11R-A37K-07	HG19	TCGA-D3-A8GM	TCGA-SKCM		s7963	University of North Carolina	MD Anderson	United States	NO	T3b	N0		Stage II	A37K-07	True
13722.58cfa832e4b0c9d6adf6d3f8	58cfa832e4b0c9d6adf6d3f8	TCGA-V4-A9EK-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_8_rg.sorted.filtered.	WGS	TCGA-V4-A9EK-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_8_rg.sorted	TCGA-V4-A9EK-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_8_rg.sorted.bam	14.71		0.15	58cfa832e4b0c9d6adf6d3f8	TCGA-V4-A9EK-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EK-10A	4464418C-EC35-4826-B3D5-152AC2A27A04	Blood Derived Normal	Illumina HiSeq	15b18072-acb9-4966-8fe3-4443bb420700	Eye	37.0	08A866B3-FA9C-47B1-AD86-276BEA2B63FD	50AE90FA-2A06-4F7A-952D-631A766060E1	TCGA-V4-A9EK-10A-01D-A40E-26	HG19_Broad_variant	TCGA-V4-A9EK	TCGA-UVM		s242	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0		Stage II	A40E-26	True
13767.58cfa837e4b0c9d6adf7007a	58cfa837e4b0c9d6adf7007a	UNCID_1805811.976a1b88-ed7a-493a-8ac9-3d504edfbc76.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1805811.976a1b88-ed7a-493a-8ac9-3d504edfbc76.sorted_genome_alignments	UNCID_1805811.976a1b88-ed7a-493a-8ac9-3d504edfbc76.sorted_genome_alignments.bam	16.06	1.78	0.17	58cfa837e4b0c9d6adf7007a	UNCID_1805811.976a1b88-ed7a-493a-8ac9-3d504edfbc76.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A402-01A	75B3FE55-1A63-426E-867E-2EF52F54778D	Primary Tumor	Illumina HiSeq	4A6F97BB-DDC3-4C51-878B-4AC586D7EF9B	Breast	47.0	6961FFFE-50B4-4296-8390-196B6070F739	976A1B88-ED7A-493A-8AC9-3D504EDFBC76	TCGA-B6-A402-01A-11R-A239-07	HG19	TCGA-B6-A402	TCGA-BRCA		s6223	University of North Carolina	Duke	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A239-07	True
13767.58cfa833e4b0c9d6adf6e044	58cfa833e4b0c9d6adf6e044	UNCID_1140646.348a0fd6-eb6b-4550-a26a-3896c4963b3a.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1140646.348a0fd6-eb6b-4550-a26a-3896c4963b3a.sorted_genome_alignments	UNCID_1140646.348a0fd6-eb6b-4550-a26a-3896c4963b3a.sorted_genome_alignments.bam	11.94	1.78	0.13	58cfa833e4b0c9d6adf6e044	UNCID_1140646.348a0fd6-eb6b-4550-a26a-3896c4963b3a.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A12G-01A	58C56D4B-3F85-4AAD-A779-5F9E1791677D	Primary Tumor	Illumina HiSeq	42AA56F0-4922-46FC-829B-54CD388B6131	Breast	75.0	9F48E197-0BFB-430E-A874-D14178485367	348A0FD6-EB6B-4550-A26A-3896C4963B3A	TCGA-AO-A12G-01A-11R-A10J-07	HG19	TCGA-AO-A12G	TCGA-BRCA		s6522	University of North Carolina	MSKCC	None	NO	T2	N0 (i+)	Other  specify	Stage II	A10J-07	True
13722.58cfa831e4b0c9d6adf6cc2d	58cfa831e4b0c9d6adf6cc2d	TCGA-EE-A2A1-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EE-A2A1-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_6_rg.sorted	TCGA-EE-A2A1-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_6_rg.sorted.bam	28.75		0.15	58cfa831e4b0c9d6adf6cc2d	TCGA-EE-A2A1-10A-01D-A190_120726_SN590_0172_BC0WN3ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A2A1-10A	A92E70E1-C57D-45EF-A822-33B361C22291	Blood Derived Normal	Illumina HiSeq	d20d23e7-eda7-44ca-8c01-958309009ef8	Skin	46.0	0933084B-90BA-4105-8989-996F00776A8B	4E250771-0ED3-4FD5-A177-90276344D1FD	TCGA-EE-A2A1-10A-01D-A190-02	HG19_Broad_variant	TCGA-EE-A2A1	TCGA-SKCM		s7678	Harvard Medical School	University of Sydney	Australia	NO	T2a	N0		Stage I	A190-02	True
13767.58cfa836e4b0c9d6adf6fae2	58cfa836e4b0c9d6adf6fae2	UNCID_1657698.aabf5831-8886-4570-9266-00cd858ba17b.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1657698.aabf5831-8886-4570-9266-00cd858ba17b.sorted_genome_alignments	UNCID_1657698.aabf5831-8886-4570-9266-00cd858ba17b.sorted_genome_alignments.bam	89.55	1.81	0.15	58cfa836e4b0c9d6adf6fae2	UNCID_1657698.aabf5831-8886-4570-9266-00cd858ba17b.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-DS-A1OB-01A	29A48C93-BADE-4346-A901-DE35A6537337	Primary Tumor	Illumina HiSeq	82D12F20-CFDC-4D74-AFA0-6612F0D49B95	Cervix	45.0	D664C261-6C5F-454D-B908-334DC2683A2B	AABF5831-8886-4570-9266-00CD858BA17B	TCGA-DS-A1OB-01A-11R-A14Y-07	HG19	TCGA-DS-A1OB	TCGA-CESC	861.0	s1226	University of North Carolina	Cedars Sinai	United States	NO	T1b2	N1	Cervical Squamous Cell Carcinoma		A14Y-07	True
13767.58cfa837e4b0c9d6adf70144	58cfa837e4b0c9d6adf70144	UNCID_1804059.c90eedc2-4b27-479c-b857-9a19267164dc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1804059.c90eedc2-4b27-479c-b857-9a19267164dc.sorted_genome_alignments	UNCID_1804059.c90eedc2-4b27-479c-b857-9a19267164dc.sorted_genome_alignments.bam	48.8	1.8	0.15	58cfa837e4b0c9d6adf70144	UNCID_1804059.c90eedc2-4b27-479c-b857-9a19267164dc.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-5662-11A	960D278C-C87D-42DC-AD28-42E010D8F0F1	Solid Tissue Normal	Illumina HiSeq	23CFBC1B-6F96-4690-B872-9A7EE51983EE	Colorectal	46.0	6C4DBBE4-7F58-4DE2-9AAF-A6D87170870A	C90EEDC2-4B27-479C-B857-9A19267164DC	TCGA-A6-5662-11A-01R-1653-07	HG19	TCGA-A6-5662	TCGA-COAD		s13751	University of North Carolina	Christiana Healthcare	None	NO	T3	N2	Colon Adenocarcinoma	Stage IV	1653-07	True
13767.58cfa835e4b0c9d6adf6ebe6	58cfa835e4b0c9d6adf6ebe6	UNCID_1321723.70a93713-e154-46c8-9360-b873c63f0f05.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1321723.70a93713-e154-46c8-9360-b873c63f0f05.sorted_genome_alignments	UNCID_1321723.70a93713-e154-46c8-9360-b873c63f0f05.sorted_genome_alignments.bam	47.7		0.16	58cfa835e4b0c9d6adf6ebe6	UNCID_1321723.70a93713-e154-46c8-9360-b873c63f0f05.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HI-7169-01A	11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6	Primary Tumor	Illumina HiSeq	CF1BADA5-DFCB-4A23-84FF-F55F39628606	Prostate	55.0	AEEF0836-305C-465C-A9CA-6C1825353AE7	70A93713-E154-46C8-9360-B873C63F0F05	TCGA-HI-7169-01A-11R-2118-07	HG19	TCGA-HI-7169	TCGA-PRAD		s3480	University of North Carolina	Fox Chase	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type		2118-07	True
13722.58cfa830e4b0c9d6adf6c31e	58cfa830e4b0c9d6adf6c31e	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.bam	67.64	2.28	0.18	58cfa830e4b0c9d6adf6c31e	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A27C-01A	7FEE9D6F-C0EA-43C2-89C2-66D965A077A8	Primary Tumor	Illumina HiSeq	ecc65751-9b59-49c3-a142-7a4c61174649	Bladder	52.0	EAD6792B-4E52-4C28-891C-6D8696873A13	1E553EB3-8C42-48A1-87A7-BFA8541CE568	TCGA-CF-A27C-01A-11D-A16N-02	HG19_Broad_variant	TCGA-CF-A27C	TCGA-BLCA		s2873	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A16N-02	True
13767.58cfa838e4b0c9d6adf707f4	58cfa838e4b0c9d6adf707f4	UNCID_2031545.91238210-9f8d-4c09-8016-fd0a7d135023.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2031545.91238210-9f8d-4c09-8016-fd0a7d135023.sorted_genome_alignments	UNCID_2031545.91238210-9f8d-4c09-8016-fd0a7d135023.sorted_genome_alignments.bam	90.0	1.87	0.18	58cfa838e4b0c9d6adf707f4	UNCID_2031545.91238210-9f8d-4c09-8016-fd0a7d135023.sorted_genome_alignments.bam	Alive	FEMALE			Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EO-A3KU-01A	DB67A9CD-65BA-4D6F-A799-031B6B3DF599	Primary Tumor	Illumina HiSeq	B2437DAB-09DA-47D6-8D8F-E5875408CE7B	Uterus	68.0	72940768-0848-4134-8D1D-C81A02F92134	91238210-9F8D-4C09-8016-FD0A7D135023	TCGA-EO-A3KU-01A-11R-A22K-07	HG19	TCGA-EO-A3KU	TCGA-UCEC		s5312	University of North Carolina	University Health Network	Canada	NO			Serous endometrial adenocarcinoma		A22K-07	True
13722.58cfa832e4b0c9d6adf6cf3c	58cfa832e4b0c9d6adf6cf3c	TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted.filtered.	WGS	TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted	TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted.bam	59.4	2.0	0.15	58cfa832e4b0c9d6adf6cf3c	TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6373-01A	C3A509C6-35A6-4D17-A9FD-0AA8884B33A0	Primary Tumor	Illumina HiSeq	b8d1f15f-e927-4a6e-8154-620ccb08e6f5	Prostate	68.0	18365C1F-9BC0-4865-B40D-DEF3EE73331C	A0563516-591D-4FC2-AF37-8BA62A071C58	TCGA-G9-6373-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6373	TCGA-PRAD		s3976	Harvard Medical School	Roswell Park	United States	NO	T3a		Prostate Adenocarcinoma Acinar Type		1784-02	True
13767.58cfa837e4b0c9d6adf6ff58	58cfa837e4b0c9d6adf6ff58	UNCID_1801969.2f31b846-4424-438e-b169-c1989b288920.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1801969.2f31b846-4424-438e-b169-c1989b288920.sorted_genome_alignments	UNCID_1801969.2f31b846-4424-438e-b169-c1989b288920.sorted_genome_alignments.bam	150.0	1.8	0.13	58cfa837e4b0c9d6adf6ff58	UNCID_1801969.2f31b846-4424-438e-b169-c1989b288920.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-5862-01A	A19CD9F8-482B-4B70-B7D7-06D6BB1B0260	Primary Tumor	Illumina HiSeq	17EB67D8-AD54-456A-98F1-D538A9DC310B	Colorectal	80.0	E7390B8C-FC12-43F1-8C94-F5DAF0D186F7	2F31B846-4424-438E-B169-C1989B288920	TCGA-CM-5862-01A-01R-1653-07	HG19	TCGA-CM-5862	TCGA-COAD	153.0	s13085	University of North Carolina	MSKCC	None	NO	T3	N1a	Colon Adenocarcinoma	Stage IV	1653-07	True
13767.58cfa837e4b0c9d6adf6fed4	58cfa837e4b0c9d6adf6fed4	UNCID_1782938.2f165c52-b5b5-4c07-8048-1f1b32faa7c3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1782938.2f165c52-b5b5-4c07-8048-1f1b32faa7c3.sorted_genome_alignments	UNCID_1782938.2f165c52-b5b5-4c07-8048-1f1b32faa7c3.sorted_genome_alignments.bam	77.8	1.8	0.16	58cfa837e4b0c9d6adf6fed4	UNCID_1782938.2f165c52-b5b5-4c07-8048-1f1b32faa7c3.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-D5-6535-01A	A123DC45-E427-461E-8D60-C51307AA498C	Primary Tumor	Illumina HiSeq	D8F19BD4-FC6B-435E-B058-01D75C4C916C	Colorectal	80.0	383F29D6-7DB7-42A3-A2F3-FB69DCA65F83	2F165C52-B5B5-4C07-8048-1F1B32FAA7C3	TCGA-D5-6535-01A-11R-1723-07	HG19	TCGA-D5-6535	TCGA-COAD		s12935	University of North Carolina	Greater Poland Cancer Center	Poland	NO	T3	N1	Colon Adenocarcinoma	Stage III	1723-07	True
13722.58cfa832e4b0c9d6adf6d5bc	58cfa832e4b0c9d6adf6d5bc	TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted	TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted.bam	24.3		0.16	58cfa832e4b0c9d6adf6d5bc	TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A4A4-01A	E89D7900-915D-4936-B1B2-CAC3670EA2F4	Primary Tumor	Illumina HiSeq	8f2d7e64-e129-494b-9068-ad15dcb9457e	Esophagus	36.0	C7A31A25-A496-4D26-A9D2-C42ADB22BB45	655BFF55-E213-442B-8C1F-A1A959E89CDB	TCGA-LN-A4A4-01A-11D-A267-26	HG19_Broad_variant	TCGA-LN-A4A4	TCGA-ESCA		s1778	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N1		Stage III	A267-26	True
13767.58cfa83be4b0c9d6adf729d4	58cfa83be4b0c9d6adf729d4	UNCID_355791.TCGA-B0-5117-01A-01R-1420-07.110525_UNC14-SN744_0118_AD0D60ABXX.3.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_355791.TCGA-B0-5117-01A-01R-1420-07.110525_UNC14-SN744_0118_AD0D60ABXX.3.trimmed.annotated.translated_to_genomic	UNCID_355791.TCGA-B0-5117-01A-01R-1420-07.110525_UNC14-SN744_0118_AD0D60ABXX.3.trimmed.annotated.translated_to_genomic.bam	61.3	1.8	0.15	58cfa83be4b0c9d6adf729d4	UNCID_355791.TCGA-B0-5117-01A-01R-1420-07.110525_UNC14-SN744_0118_AD0D60ABXX.3.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5117-01A	AE55B2D3-62A1-419E-9F9A-5DDFAC356DB4	Primary Tumor	Illumina HiSeq	3AE34E3F-D572-4C8A-B5F0-69119467CF35	Kidney	40.0	09FFF3F4-075E-45FD-BF47-C94A9CCF0E3B	D0BCABDC-B462-49DC-857A-F200CD960C66	TCGA-B0-5117-01A-01R-1420-07	HG19	TCGA-B0-5117	TCGA-KIRC		s9672	University of North Carolina	University of Pittsburgh	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1420-07	True
13767.58cfa838e4b0c9d6adf70d4e	58cfa838e4b0c9d6adf70d4e	UNCID_2166773.eba2b96d-21f8-4091-b8c4-0ef2b9c00075.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2166773.eba2b96d-21f8-4091-b8c4-0ef2b9c00075.sorted_genome_alignments	UNCID_2166773.eba2b96d-21f8-4091-b8c4-0ef2b9c00075.sorted_genome_alignments.bam	19.12	1.9	0.16	58cfa838e4b0c9d6adf70d4e	UNCID_2166773.eba2b96d-21f8-4091-b8c4-0ef2b9c00075.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-A6J3-01A	AE4F0714-3B74-46C0-9C1B-F028C7CF2E62	Primary Tumor	Illumina HiSeq	2379CB99-811A-41DF-9BF3-46318E458E54	Brain	52.0	39B6A86A-CCA1-4636-AAE3-53E4AEF890A0	EBA2B96D-21F8-4091-B8C4-0EF2B9C00075	TCGA-FG-A6J3-01A-11R-A31N-07	HG19	TCGA-FG-A6J3	TCGA-LGG		s8449	University of North Carolina	Case Western	United States	NO			Astrocytoma		A31N-07	True
13767.58cfa833e4b0c9d6adf6e055	58cfa833e4b0c9d6adf6e055	UNCID_1141369.5cd42d4a-5971-4a01-8c10-99321105a864.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1141369.5cd42d4a-5971-4a01-8c10-99321105a864.sorted_genome_alignments	UNCID_1141369.5cd42d4a-5971-4a01-8c10-99321105a864.sorted_genome_alignments.bam	62.21	1.85	0.15	58cfa833e4b0c9d6adf6e055	UNCID_1141369.5cd42d4a-5971-4a01-8c10-99321105a864.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A124-01A	B094E8B2-8ECE-4B36-8025-18073A8B873C	Primary Tumor	Illumina HiSeq	3ABE9F40-E43D-49F9-8079-F46A3AF64476	Breast	38.0	2F4D3CEA-30C8-4CF0-A610-33B3E20241E8	5CD42D4A-5971-4A01-8C10-99321105A864	TCGA-AO-A124-01A-11R-A10J-07	HG19	TCGA-AO-A124	TCGA-BRCA		s6173	University of North Carolina	MSKCC	None	NO	T2	N0 (i-)	Other  specify	Stage II	A10J-07	True
13767.58cfa838e4b0c9d6adf70e9a	58cfa838e4b0c9d6adf70e9a	UNCID_2191863.ac3970c9-575a-4d72-a2b3-45f1ab671bbb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2191863.ac3970c9-575a-4d72-a2b3-45f1ab671bbb.sorted_genome_alignments	UNCID_2191863.ac3970c9-575a-4d72-a2b3-45f1ab671bbb.sorted_genome_alignments.bam	95.64	1.86	0.16	58cfa838e4b0c9d6adf70e9a	UNCID_2191863.ac3970c9-575a-4d72-a2b3-45f1ab671bbb.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K9-01A	4485CC98-5D58-4EB4-8325-7D1A617B6461	Primary Tumor	Illumina HiSeq	A4F375DB-CBC7-4383-98DD-1F0E8B821502	Uterus	88.0	52A96216-708F-43F2-A923-130A1C35922D	AC3970C9-575A-4D72-A2B3-45F1AB671BBB	TCGA-B5-A0K9-01A-21R-A104-07	HG19	TCGA-B5-A0K9	TCGA-UCEC		s4344	University of North Carolina	Duke	United States	NO			Endometrioid endometrial adenocarcinoma		A104-07	False
13722.58cfa832e4b0c9d6adf6d217	58cfa832e4b0c9d6adf6d217	TCGA-IR-A3LF-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-IR-A3LF-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_4_rg.sorted	TCGA-IR-A3LF-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_4_rg.sorted.bam	21.55		0.16	58cfa832e4b0c9d6adf6d217	TCGA-IR-A3LF-10A-01D-A232_140124_SN208_0506_BC2PD5ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LF-10A	785DDEA1-399D-47D8-B2B0-39E95EAA24B5	Blood Derived Normal	Illumina HiSeq	d1073f97-3ce5-4d38-9ccc-813fee28fb63	Cervix	64.0	BACC5092-B6AB-4A28-9D55-FA3AD22C3EEF	757BABBC-9A2D-4BF5-B298-48222FEA7BD8	TCGA-IR-A3LF-10A-01D-A232-26	HG19_Broad_variant	TCGA-IR-A3LF	TCGA-CESC		s1209	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T1b1	N0	Endocervical Adenocarcinoma of the Usual Type		A232-26	True
13722.58cfa831e4b0c9d6adf6c8e6	58cfa831e4b0c9d6adf6c8e6	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.bam	52.73		0.13	58cfa831e4b0c9d6adf6c8e6	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN		Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6960-01A	2C985B30-0F8F-4C8F-A924-CC6AAD7EBF0D	Primary Tumor	Illumina HiSeq	5fdfb781-64fd-48dd-9d26-3de7bfdf5908	Head and Neck	49.0	967F6CC9-95D2-4666-A20A-717D768613A4	F41864FE-49FA-4037-AF02-E3F8E2515614	TCGA-CV-6960-01A-41D-2317-26	HG19_Broad_variant	TCGA-CV-6960	TCGA-HNSC	862.0	s15902	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	2317-26	True
13767.58cfa830e4b0c9d6adf6c06c	58cfa830e4b0c9d6adf6c06c	TCGA-BR-7716-01A-21R-2055-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-7716-01A-21R-2055-13_rnaseq	TCGA-BR-7716-01A-21R-2055-13_rnaseq.bam	244.2		0.14	58cfa830e4b0c9d6adf6c06c	TCGA-BR-7716-01A-21R-2055-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7716-01A	CA21C55F-45A7-42AF-BE07-430990D5445B	Primary Tumor	Illumina HiSeq	7CA8BD75-E825-450C-9F02-94BFF63C8024	Stomach	62.0	849F9CB7-33D0-4B03-BFB3-73EE625B84E0	EB15A3BD-FEA6-4216-904C-5C53DBE9613A	TCGA-BR-7716-01A-21R-2055-13	GRCh37-lite	TCGA-BR-7716	TCGA-STAD		s15385	Canada's Michael Smith Genome Sciences Centre	Asterand	Russia	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	2055-13	True
13767.58cfa837e4b0c9d6adf70088	58cfa837e4b0c9d6adf70088	UNCID_1879332.52cca577-c5d1-4dff-9e3a-4007beb120db.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1879332.52cca577-c5d1-4dff-9e3a-4007beb120db.sorted_genome_alignments	UNCID_1879332.52cca577-c5d1-4dff-9e3a-4007beb120db.sorted_genome_alignments.bam	11.14	1.86	0.17	58cfa837e4b0c9d6adf70088	UNCID_1879332.52cca577-c5d1-4dff-9e3a-4007beb120db.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A2LJ-01A	738E1ACC-1F0C-4A96-9C8A-222727EF5AF8	Primary Tumor	Illumina HiSeq	9A5EADD6-2C3B-4577-950D-42A9D5B11A46	Breast	40.0	FCA8DA49-849B-4790-A956-DB7EE97C39E9	52CCA577-C5D1-4DFF-9E3A-4007BEB120DB	TCGA-AR-A2LJ-01A-12R-A19W-07	HG19	TCGA-AR-A2LJ	TCGA-BRCA		s6417	University of North Carolina	Mayo	United States	NO	T3	N1	Infiltrating Lobular Carcinoma	Stage III	A19W-07	True
13767.58cfa82fe4b0c9d6adf6b366	58cfa82fe4b0c9d6adf6b366	TCGA-24-2261-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-24-2261-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-24-2261-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	648.0	1.8	0.15	58cfa82fe4b0c9d6adf6b366	TCGA-24-2261-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-2261-01A	EEC69EA9-CEB8-456A-AFF4-41FB8A261E36	Primary Tumor	Illumina HiSeq	3C852B87-3F2E-4A33-B588-8A851ABD1A58	Ovary	76.0	7BCD356D-7031-44B1-B1D7-8D8F60F0CAFF	75E9506A-D007-4FB2-8BDD-7E7780653A63	TCGA-24-2261-01A-01R-1568-13	GRCh37-lite	TCGA-24-2261	TCGA-OV	24.0	s17184	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa82ee4b0c9d6adf6b08a	58cfa82ee4b0c9d6adf6b08a	G49837.TCGA-90-7767-10A-01D-A320-08.3.filtered.	WGS	G49837.TCGA-90-7767-10A-01D-A320-08.3	G49837.TCGA-90-7767-10A-01D-A320-08.3.bam	130.3		0.07	58cfa82ee4b0c9d6adf6b08a	G49837.TCGA-90-7767-10A-01D-A320-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-90-7767-10A	9DFF11CD-0784-4A60-9C77-43F8957D3DFA	Blood Derived Normal	Illumina HiSeq	897b33ac-6e52-43d6-856d-e7adcc83770c	Lung	56.0	338EBCB0-4EB5-4094-89C5-3AF9023067DF	E1601870-C2B6-48AF-9697-41B62D967E10	TCGA-90-7767-10A-01D-A320-08	HG19_Broad_variant	TCGA-90-7767	TCGA-LUSC		s10508	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T2b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage II	A320-08	True
13767.58cfa835e4b0c9d6adf6ee4f	58cfa835e4b0c9d6adf6ee4f	UNCID_1380544.a04ad65d-6d83-4e84-8bd8-3cab2a195642.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1380544.a04ad65d-6d83-4e84-8bd8-3cab2a195642.sorted_genome_alignments	UNCID_1380544.a04ad65d-6d83-4e84-8bd8-3cab2a195642.sorted_genome_alignments.bam	22.67	1.89	0.18	58cfa835e4b0c9d6adf6ee4f	UNCID_1380544.a04ad65d-6d83-4e84-8bd8-3cab2a195642.sorted_genome_alignments.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A3M8-01A	C1E704D6-A33B-4891-90BD-992B0040C075	Primary Tumor	Illumina HiSeq	74EA7805-565E-48A0-809D-20F4A66F0002	Breast	68.0	122305ED-CA1E-431F-A332-0AC3409CDED2	A04AD65D-6D83-4E84-8BD8-3CAB2A195642	TCGA-C8-A3M8-01A-11R-A213-07	HG19	TCGA-C8-A3M8	TCGA-BRCA		s6571	University of North Carolina	ILSbio	Vietnam	NO	T1c	N0	Infiltrating Lobular Carcinoma	Stage I	A213-07	True
13767.58cfa839e4b0c9d6adf714b6	58cfa839e4b0c9d6adf714b6	UNCID_2334205.c1132808-3c5c-47d8-90ad-b47f8d2d48c7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2334205.c1132808-3c5c-47d8-90ad-b47f8d2d48c7.sorted_genome_alignments	UNCID_2334205.c1132808-3c5c-47d8-90ad-b47f8d2d48c7.sorted_genome_alignments.bam	33.28	1.87	0.17	58cfa839e4b0c9d6adf714b6	UNCID_2334205.c1132808-3c5c-47d8-90ad-b47f8d2d48c7.sorted_genome_alignments.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TQ-A7RU-01A	B19DCBC2-B0D4-4759-9213-1A5B99DF7E76	Primary Tumor	Illumina HiSeq	CF2C6DFF-8A8D-4555-AC47-4362D1AB1952	Brain	51.0	653A8E06-0CE1-43C0-B624-4FF2721B2E0B	C1132808-3C5C-47D8-90AD-B47F8D2D48C7	TCGA-TQ-A7RU-01A-21R-A34F-07	HG19	TCGA-TQ-A7RU	TCGA-LGG		s8817	University of North Carolina	University of Sao Paulo	Brazil	NO			Oligodendroglioma		A34F-07	True
13767.58cfa83ae4b0c9d6adf71662	58cfa83ae4b0c9d6adf71662	UNCID_2352178.0d5a9a1e-e473-4b9a-bc27-60147dca9fe6.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2352178.0d5a9a1e-e473-4b9a-bc27-60147dca9fe6.sorted_genome_alignments	UNCID_2352178.0d5a9a1e-e473-4b9a-bc27-60147dca9fe6.sorted_genome_alignments.bam	83.21	1.85	0.18	58cfa83ae4b0c9d6adf71662	UNCID_2352178.0d5a9a1e-e473-4b9a-bc27-60147dca9fe6.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-SJ-A6ZI-01A	3C2A6E30-A507-49F6-8B1F-36EB3AA41E60	Primary Tumor	Illumina HiSeq	1BA4F731-D19C-4133-A033-D14AE6DB216E	Uterus	64.0	629770A3-4982-480B-A066-E85C609DFA3F	0D5A9A1E-E473-4B9A-BC27-60147DCA9FE6	TCGA-SJ-A6ZI-01A-12R-A34R-07	HG19	TCGA-SJ-A6ZI	TCGA-UCEC		s4540	University of North Carolina	Albert Einstein Medical Center	United States	NO			Endometrioid endometrial adenocarcinoma		A34R-07	True
13767.58cfa82fe4b0c9d6adf6b2b4	58cfa82fe4b0c9d6adf6b2b4	TCGA-23-1118-01A-01R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-23-1118-01A-01R-1564-13_GRCh37-lite_rnaseq	TCGA-23-1118-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	377.0	1.8	0.15	58cfa82fe4b0c9d6adf6b2b4	TCGA-23-1118-01A-01R-1564-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1118-01A	700E91BB-D675-41B2-BBBD-935767C7B447	Primary Tumor	Illumina HiSeq	06632CB9-B7C0-4EE9-829F-A1684A7C884D	Ovary	45.0	E1BE8AD9-1A52-4677-8436-3DA22AD12E9A	9E73D9F4-DD7C-439F-A8C5-236311E3FACF	TCGA-23-1118-01A-01R-1564-13	GRCh37-lite	TCGA-23-1118	TCGA-OV		s17232	Canada's Michael Smith Genome Sciences Centre	Cedars Sinai	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa835e4b0c9d6adf6eeaa	58cfa835e4b0c9d6adf6eeaa	UNCID_1382553.dbb086b3-17fe-4bc6-9fa7-b3b26a2263ee.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1382553.dbb086b3-17fe-4bc6-9fa7-b3b26a2263ee.sorted_genome_alignments	UNCID_1382553.dbb086b3-17fe-4bc6-9fa7-b3b26a2263ee.sorted_genome_alignments.bam	12.95	1.78	0.15	58cfa835e4b0c9d6adf6eeaa	UNCID_1382553.dbb086b3-17fe-4bc6-9fa7-b3b26a2263ee.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A3MV-06A	F581A9B5-8956-4AC3-9375-370C446CAD29	Metastatic	Illumina HiSeq	9087D5A3-C3F9-45D2-A081-1FFA2379D2C5	Skin	38.0	878EA24C-1732-4ACD-8A7F-71B5E8F5ADF9	DBB086B3-17FE-4BC6-9FA7-B3B26A2263EE	TCGA-D3-A3MV-06A-11R-A21D-07	HG19	TCGA-D3-A3MV	TCGA-SKCM		s7928	University of North Carolina	MD Anderson	United States	NO	T2b	N2a		Stage III	A21D-07	True
13722.58cfa830e4b0c9d6adf6bdfc	58cfa830e4b0c9d6adf6bdfc	TCGA-AG-3582-10A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3582-10A-01D-1989-10_wgs_Illumina	TCGA-AG-3582-10A-01D-1989-10_wgs_Illumina.bam	20.0	1.9	0.17	58cfa830e4b0c9d6adf6bdfc	TCGA-AG-3582-10A-01D-1989-10_wgs_Illumina.bam	Alive	MALE			Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3582-10A	DB1E3104-8BFD-4353-854A-C478BA1F7D07	Blood Derived Normal	Illumina HiSeq	0e0791f1-6e83-4c6d-a329-9d669695606b	Colorectal	75.0	E948F2D0-E1BF-46FA-A0E0-A733036D3DA3	59765F45-8069-486F-8FAF-2E69EA1B99CD	TCGA-AG-3582-10A-01D-1989-10	GRCh37-lite	TCGA-AG-3582	TCGA-READ		s2125	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IV	1989-10	True
13767.58cfa83ce4b0c9d6adf730b6	58cfa83ce4b0c9d6adf730b6	_1_TCGA-CD-5803-01A-11R-1602-13_rnaseq.filtered.	RNA-Seq	_1_TCGA-CD-5803-01A-11R-1602-13_rnaseq	_1_TCGA-CD-5803-01A-11R-1602-13_rnaseq.bam	38.8	1.8	0.16	58cfa83ce4b0c9d6adf730b6	_1_TCGA-CD-5803-01A-11R-1602-13_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5803-01A	33901C6F-9180-4A19-866C-F4AC6BEC76DA	Primary Tumor	Illumina HiSeq	4EAC3246-0877-4459-B530-AA1A4D13F4A0	Stomach	78.0	EB71264D-C896-4910-BF46-D6F129B83941	B7761A24-F5BB-4A76-8B27-0B20038F029A	TCGA-CD-5803-01A-11R-1602-13	GRCh37-lite	TCGA-CD-5803	TCGA-STAD		s14865	Canada's Michael Smith Genome Sciences Centre	ILSbio	Vietnam	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1602-13	True
13767.58cfa83ae4b0c9d6adf717c5	58cfa83ae4b0c9d6adf717c5	UNCID_2366962.e9566249-b898-4da6-ae19-360b3c71aa20.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2366962.e9566249-b898-4da6-ae19-360b3c71aa20.sorted_genome_alignments	UNCID_2366962.e9566249-b898-4da6-ae19-360b3c71aa20.sorted_genome_alignments.bam	34.01	1.86	0.17	58cfa83ae4b0c9d6adf717c5	UNCID_2366962.e9566249-b898-4da6-ae19-360b3c71aa20.sorted_genome_alignments.bam	Alive	FEMALE		HISPANIC OR LATINO	Pheochromocytoma and Paraganglioma	Aligned reads	TCGA-QR-A70V-01A	9D6E8692-AB14-414F-A5FD-556B9D62FE34	Primary Tumor	Illumina HiSeq	C3E2A1DD-29D4-4FA7-ABC2-A6E14D1C96F5	Nervous System	66.0	7E143858-0F6A-4B52-B5DA-E366ABF2E91C	E9566249-B898-4DA6-AE19-360B3C71AA20	TCGA-QR-A70V-01A-11R-A35K-07	HG19	TCGA-QR-A70V	TCGA-PCPG		s1018	University of North Carolina	National Institutes of Health	United States	NO					A35K-07	True
13722.58cfa82fe4b0c9d6adf6b879	58cfa82fe4b0c9d6adf6b879	TCGA-A5-A0RA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-A5-A0RA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_6_rg.sorted	TCGA-A5-A0RA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_6_rg.sorted.bam	7.22	2.16	0.16	58cfa82fe4b0c9d6adf6b879	TCGA-A5-A0RA-10A-01D-A101_120406_SN1120_0131_BD0UK4ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0RA-10A	AFD710B8-D172-4AC4-9973-E969DB1ED231	Blood Derived Normal	Illumina HiSeq	0299a5c4-cb18-4ec1-bbdc-6305aab55198	Uterus	68.0	55E3C47B-0A82-4347-98BD-F4F3B6D0C7C7	DCEB13CD-497F-4206-9055-3D034AD58997	TCGA-A5-A0RA-10A-01D-A101-02	HG19_Broad_variant	TCGA-A5-A0RA	TCGA-UCEC		s5197	Harvard Medical School	Cedars Sinai	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa832e4b0c9d6adf6d10c	58cfa832e4b0c9d6adf6d10c	TCGA-HU-A4H4-01A-21R-A251-31_rnaseq.filtered.	RNA-Seq	TCGA-HU-A4H4-01A-21R-A251-31_rnaseq	TCGA-HU-A4H4-01A-21R-A251-31_rnaseq.bam	59.78	1.79	0.17	58cfa832e4b0c9d6adf6d10c	TCGA-HU-A4H4-01A-21R-A251-31_rnaseq.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4H4-01A	00FDF96D-C48A-47E0-B91D-576C52E6819C	Primary Tumor	Illumina HiSeq	3CFB9C2F-9A22-41B6-B161-EAB14545DE91	Stomach	53.0	F8DF5FD6-BB50-473B-804A-F934DD266866	F0C78332-67DA-4C6F-AE33-7FF78362F02F	TCGA-HU-A4H4-01A-21R-A251-31	GRCh37-lite	TCGA-HU-A4H4	TCGA-STAD		s15142	Canada's Michael Smith Genome Sciences Centre	National Cancer Center Korea	Korea South	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage II	A251-31	True
13767.58cfa838e4b0c9d6adf70799	58cfa838e4b0c9d6adf70799	UNCID_2029205.e2f4f6ea-e643-421e-96ec-3618bb46b91d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2029205.e2f4f6ea-e643-421e-96ec-3618bb46b91d.sorted_genome_alignments	UNCID_2029205.e2f4f6ea-e643-421e-96ec-3618bb46b91d.sorted_genome_alignments.bam	56.04	1.83	0.17	58cfa838e4b0c9d6adf70799	UNCID_2029205.e2f4f6ea-e643-421e-96ec-3618bb46b91d.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-MU-A51Y-01A	77DA506B-E726-409F-B3EB-D41242862982	Primary Tumor	Illumina HiSeq	997263FD-DE4A-4006-AFAA-D82DF98784C6	Cervix	27.0	51B871DF-0B7B-44FE-B9F0-0E39AE6CB3A0	E2F4F6EA-E643-421E-96EC-3618BB46B91D	TCGA-MU-A51Y-01A-11R-A26T-07	HG19	TCGA-MU-A51Y	TCGA-CESC		s1571	University of North Carolina	University of Minnesota	United States	NO	T2a1	N0	Cervical Squamous Cell Carcinoma		A26T-07	True
13722.58cfa832e4b0c9d6adf6d1f2	58cfa832e4b0c9d6adf6d1f2	TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina.filtered.	WGS	TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina	TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina.bam	361.7		0.05	58cfa832e4b0c9d6adf6d1f2	TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FF-8047-01A	F978CB0F-D319-4C01-B4C5-23AE1403A106	Primary Tumor	Illumina HiSeq	59fecb70-aec2-4deb-b598-543c4dd843e1	Lymph Nodes	38.0	A592550C-97B4-4A82-A088-14A5AC6BF084	1B1780D5-06DA-40EE-9E15-02631A68027B	TCGA-FF-8047-01A-11D-2210-10	GRCh37-lite	TCGA-FF-8047	TCGA-DLBC		s1100	Baylor College of Medicine	SingHealth	Singapore	NO			Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)		2210-10	True
13722.58cfa830e4b0c9d6adf6c226	58cfa830e4b0c9d6adf6c226	TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted	TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.bam	96.07	1.92	0.15	58cfa830e4b0c9d6adf6c226	TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0UV-01A	B19425AB-A82F-4C2A-BF58-D1BD30511D74	Primary Tumor	Illumina HiSeq	91fbcf9b-f514-49ff-925b-08d6244293f7	Uterus	55.0	30945527-528A-448E-8DB4-2E0C31C9016D	A0F51177-4C00-4F97-8CD4-2E05B63B00DE	TCGA-BS-A0UV-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0UV	TCGA-UCEC		s5222	Harvard Medical School	University of Hawaii	None	NO			Endometrioid endometrial adenocarcinoma		A101-02	True
13767.58cfa834e4b0c9d6adf6e50c	58cfa834e4b0c9d6adf6e50c	UNCID_1179911.da0f6a1a-6af3-4f05-847a-57fc1981c67e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1179911.da0f6a1a-6af3-4f05-847a-57fc1981c67e.sorted_genome_alignments	UNCID_1179911.da0f6a1a-6af3-4f05-847a-57fc1981c67e.sorted_genome_alignments.bam	75.0	1.8	0.17	58cfa834e4b0c9d6adf6e50c	UNCID_1179911.da0f6a1a-6af3-4f05-847a-57fc1981c67e.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-4714-01A	98FF8A6B-0EAD-4E55-9FB7-6FE5CC69D0F6	Primary Tumor	Illumina HiSeq	81033DB8-5F3F-4014-84B9-11432AF35162	Kidney	81.0	37EBCAEB-7A9C-4E96-ADF2-49AA7E402AFD	DA0F6A1A-6AF3-4F05-847A-57FC1981C67E	TCGA-B0-4714-01A-01R-1277-07	HG19	TCGA-B0-4714	TCGA-KIRC	99.0	s9028	University of North Carolina	University of Pittsburgh	None	NO	T3b	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1277-07	True
13767.58cfa834e4b0c9d6adf6e691	58cfa834e4b0c9d6adf6e691	UNCID_1188990.50b89155-4264-47b0-b883-6c132aee6835.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1188990.50b89155-4264-47b0-b883-6c132aee6835.sorted_genome_alignments	UNCID_1188990.50b89155-4264-47b0-b883-6c132aee6835.sorted_genome_alignments.bam	139.3	1.8	0.14	58cfa834e4b0c9d6adf6e691	UNCID_1188990.50b89155-4264-47b0-b883-6c132aee6835.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5001-01A	D6EA5CEC-97BF-4C0F-85BF-293D463B0586	Primary Tumor	Illumina HiSeq	F7489AE3-D296-42DB-A50A-8D0E6EAC6A99	Kidney	43.0	E863BD35-0382-4979-B599-033A06A1F50B	50B89155-4264-47B0-B883-6C132AEE6835	TCGA-BP-5001-01A-01R-1334-07	HG19	TCGA-BP-5001	TCGA-KIRC		s9621	University of North Carolina	MSKCC	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13722.58cfa831e4b0c9d6adf6cb56	58cfa831e4b0c9d6adf6cb56	TCGA-EE-A20H-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EE-A20H-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_8_rg.sorted	TCGA-EE-A20H-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_8_rg.sorted.bam	55.78		0.16	58cfa831e4b0c9d6adf6cb56	TCGA-EE-A20H-06A-11D-A18Y_120730_SN1222_0141_BC115GACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EE-A20H-06A	267B98E7-708F-458A-82D1-5FAA415B9EE7	Metastatic	Illumina HiSeq	8a9e2a3c-228d-41b2-b1f5-a8242675c6e3	Skin	56.0	79AC8FFC-843B-4F1F-A681-8A507769DB19	609F4177-82C0-4E12-B1E9-291EBB381FF6	TCGA-EE-A20H-06A-11D-A18Y-02	HG19_Broad_variant	TCGA-EE-A20H	TCGA-SKCM	5118.0	s8008	Harvard Medical School	University of Sydney	Australia	NO	T2	N0		Stage I	A18Y-02	True
13767.58cfa830e4b0c9d6adf6c03a	58cfa830e4b0c9d6adf6c03a	TCGA-BR-7196-01A-11R-2055-13_rnaseq.filtered.	RNA-Seq	TCGA-BR-7196-01A-11R-2055-13_rnaseq	TCGA-BR-7196-01A-11R-2055-13_rnaseq.bam	160.2		0.14	58cfa830e4b0c9d6adf6c03a	TCGA-BR-7196-01A-11R-2055-13_rnaseq.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7196-01A	1B641270-18F8-4257-821B-D26179E08E28	Primary Tumor	Illumina HiSeq	B38DFC7C-5334-4A94-B381-5AC5813D3E63	Stomach	64.0	3B7B1D8F-6A84-46FD-9DAA-C5922FC135A1	42B8D3BE-2BCC-4896-9BF4-CB3EE6F93DFF	TCGA-BR-7196-01A-11R-2055-13	GRCh37-lite	TCGA-BR-7196	TCGA-STAD		s14622	Canada's Michael Smith Genome Sciences Centre	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	2055-13	True
13722.58cfa831e4b0c9d6adf6c87d	58cfa831e4b0c9d6adf6c87d	TCGA-D3-A2JD-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D3-A2JD-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_3_rg.sorted	TCGA-D3-A2JD-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_3_rg.sorted.bam	18.0		0.18	58cfa831e4b0c9d6adf6c87d	TCGA-D3-A2JD-10A-01D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-D3-A2JD-10A	A5F95C6C-E25A-4AD8-BD5D-FCFD8A31933C	Blood Derived Normal	Illumina HiSeq	28a73c15-1674-4322-94fc-ecf6ca914d51	Skin	58.0	FC0F052A-C6DE-4AD4-852A-5BF7FE83ABB2	626E455C-5340-4095-8D27-D1D83615D201	TCGA-D3-A2JD-10A-01D-A18Z-02	HG19_Broad_variant	TCGA-D3-A2JD	TCGA-SKCM	361.0	s7321	Harvard Medical School	MD Anderson	United States	NO	T4b	N1b		Stage III	A18Z-02	True
13722.58cfa82de4b0c9d6adf6a6fa	58cfa82de4b0c9d6adf6a6fa	9ae1429cc5f7f8e4692281baf49e4ff5.filtered.	WGS	9ae1429cc5f7f8e4692281baf49e4ff5	9ae1429cc5f7f8e4692281baf49e4ff5.bam	55.4	1.9	0.08	58cfa82de4b0c9d6adf6a6fa	9ae1429cc5f7f8e4692281baf49e4ff5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RT-01A	4BF50455-9AB7-4521-A791-089F66D3B877	Primary Tumor	Illumina HiSeq	0058348e-638c-426a-9fba-b26a3143c45b	Breast	39.0	C2300B5B-43A7-43B8-8CD1-22FF7E89A21A	1BB3A1C7-4D7B-4FB6-B54D-E94CBD0E32AA	TCGA-B6-A0RT-01A-21D-A128-09	GRCh37-lite	TCGA-B6-A0RT	TCGA-BRCA		s5635	Washington University School of Medicine	Duke	United States	NO	T3	N1	Infiltrating Ductal Carcinoma	Stage III	A128-09	True
13767.58cfa82fe4b0c9d6adf6b245	58cfa82fe4b0c9d6adf6b245	TCGA-23-1024-01A-02R-1564-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-23-1024-01A-02R-1564-13_GRCh37-lite_rnaseq	TCGA-23-1024-01A-02R-1564-13_GRCh37-lite_rnaseq.bam	190.0	1.8	0.16	58cfa82fe4b0c9d6adf6b245	TCGA-23-1024-01A-02R-1564-13_GRCh37-lite_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1024-01A	8AC6CE06-AB50-4AB4-A469-9F8BF01BE963	Primary Tumor	Illumina HiSeq	6E72C389-A954-4C45-82C0-322FF2148C40	Ovary	52.0	96430CD1-1F32-4D4E-AE16-E39DF6405739	467CEACE-18C4-436B-A8F6-842794C5DFA5	TCGA-23-1024-01A-02R-1564-13	GRCh37-lite	TCGA-23-1024	TCGA-OV		s18105	Canada's Michael Smith Genome Sciences Centre	Cedars Sinai	None	NO			Serous Cystadenocarcinoma		1564-13	True
13767.58cfa83ae4b0c9d6adf717a4	58cfa83ae4b0c9d6adf717a4	UNCID_2387537.f8fba04c-cd45-4f85-8b75-dcf5426b7637.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2387537.f8fba04c-cd45-4f85-8b75-dcf5426b7637.sorted_genome_alignments	UNCID_2387537.f8fba04c-cd45-4f85-8b75-dcf5426b7637.sorted_genome_alignments.bam	29.4	1.82	0.18	58cfa83ae4b0c9d6adf717a4	UNCID_2387537.f8fba04c-cd45-4f85-8b75-dcf5426b7637.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-VP-A872-01A	7FC65E49-0401-4A36-8800-FD87B7927FC1	Primary Tumor	Illumina HiSeq	D7A2E69B-C23B-4A47-B27C-4D424235990A	Prostate	60.0	8D739C95-CEB7-4411-ACD5-E9CBFC238023	F8FBA04C-CD45-4F85-8B75-DCF5426B7637	TCGA-VP-A872-01A-11R-A352-07	HG19	TCGA-VP-A872	TCGA-PRAD		s3894	University of North Carolina	Washington University	United States	NO	T3a	N0	Prostate Adenocarcinoma  Other Subtype		A352-07	True
13722.58cfa832e4b0c9d6adf6ce42	58cfa832e4b0c9d6adf6ce42	TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted	TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.bam	57.24	2.0	0.17	58cfa832e4b0c9d6adf6ce42	TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A25K-01A	2F9ED09D-2626-4C23-BA47-1850D36F812A	Primary Tumor	Illumina HiSeq	970a6dab-c1e4-4446-968a-4b37d1506eeb	Thyroid	36.0	343311B1-D586-4F92-9984-32AF1AFB1F62	663173D3-A9EE-4E73-8444-52F01727BE6D	TCGA-ET-A25K-01A-11D-A16N-02	HG19_Broad_variant	TCGA-ET-A25K	TCGA-THCA		s12757	Harvard Medical School	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	True
13767.58cfa834e4b0c9d6adf6e8fe	58cfa834e4b0c9d6adf6e8fe	UNCID_1221597.d964a3c5-aa6c-431c-b179-7e0b70e26e2d.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1221597.d964a3c5-aa6c-431c-b179-7e0b70e26e2d.sorted_genome_alignments	UNCID_1221597.d964a3c5-aa6c-431c-b179-7e0b70e26e2d.sorted_genome_alignments.bam	32.2	1.5	0.13	58cfa834e4b0c9d6adf6e8fe	UNCID_1221597.d964a3c5-aa6c-431c-b179-7e0b70e26e2d.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6370-01A	F947B0BC-BDAC-44E8-B5B9-FFAE4147740A	Primary Tumor	Illumina HiSeq	7AAD9BE9-CF36-4E72-96BB-F8A4704CA8FA	Prostate	52.0	644E1E7D-DFD1-4F83-82DC-AE0C7E010F6F	D964A3C5-AA6C-431C-B179-7E0B70E26E2D	TCGA-G9-6370-01A-11R-1789-07	HG19	TCGA-G9-6370	TCGA-PRAD		s3988	University of North Carolina	Roswell Park	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type		1789-07	True
13767.58cfa82fe4b0c9d6adf6b670	58cfa82fe4b0c9d6adf6b670	TCGA-57-1583-01A-01R-1566-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-57-1583-01A-01R-1566-13_GRCh37-lite_rnaseq	TCGA-57-1583-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	527.0	1.8	0.15	58cfa82fe4b0c9d6adf6b670	TCGA-57-1583-01A-01R-1566-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-57-1583-01A	76CC2D21-EEBC-4F09-9BC7-DBF7AF0AAFA8	Primary Tumor	Illumina HiSeq	2BA784FA-6167-4AE7-AF7A-BEDEA279C5E7	Ovary	57.0	04B379AC-220B-4582-84C8-BE370D5AD619	3A37E320-0301-4F2B-BF09-F102C12502B1	TCGA-57-1583-01A-01R-1566-13	GRCh37-lite	TCGA-57-1583	TCGA-OV	346.0	s17855	Canada's Michael Smith Genome Sciences Centre	International Genomics Consortium	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa835e4b0c9d6adf6efb7	58cfa835e4b0c9d6adf6efb7	UNCID_1455528.3b64c3a6-42e7-434d-9ace-221f68e831f2.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1455528.3b64c3a6-42e7-434d-9ace-221f68e831f2.sorted_genome_alignments	UNCID_1455528.3b64c3a6-42e7-434d-9ace-221f68e831f2.sorted_genome_alignments.bam	51.23	1.76	0.18	58cfa835e4b0c9d6adf6efb7	UNCID_1455528.3b64c3a6-42e7-434d-9ace-221f68e831f2.sorted_genome_alignments.bam	Alive	MALE			Thyroid Carcinoma	Aligned reads	TCGA-EM-A3AJ-01A	D8D54C81-7EF5-4B0F-B35B-28FBF8C5198E	Primary Tumor	Illumina HiSeq	190F8854-4495-4AB1-8572-398AA4A5F58A	Thyroid	39.0	1316CFD3-0DF0-4D46-8234-C736608AA9F9	3B64C3A6-42E7-434D-9ACE-221F68E831F2	TCGA-EM-A3AJ-01A-11R-A206-07	HG19	TCGA-EM-A3AJ	TCGA-THCA		s12430	University of North Carolina	University Health Network	Canada	NO	T3	N1a	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A206-07	True
13722.58cfa831e4b0c9d6adf6c7dd	58cfa831e4b0c9d6adf6c7dd	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.bam	361.7	1.9	0.15	58cfa831e4b0c9d6adf6c7dd	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6933-01A	2A749317-0156-4213-8482-B2C2D6E52E9B	Primary Tumor	Illumina HiSeq	76d94513-c228-445e-91f7-474a75422b69	Head and Neck	53.0	8C57C9E6-75BD-442C-984D-3709D2AC4CEC	662EA9EC-86E3-46EE-91C9-6972DA5B5CA1	TCGA-CV-6933-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6933	TCGA-HNSC	2741.0	s15516	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III	1911-02	True
13767.58cfa83be4b0c9d6adf72600	58cfa83be4b0c9d6adf72600	UNCID_2635626.12037b1a-ef64-4ea7-99c8-703132eb2d1e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2635626.12037b1a-ef64-4ea7-99c8-703132eb2d1e.sorted_genome_alignments	UNCID_2635626.12037b1a-ef64-4ea7-99c8-703132eb2d1e.sorted_genome_alignments.bam	29.79	1.86	0.16	58cfa83be4b0c9d6adf72600	UNCID_2635626.12037b1a-ef64-4ea7-99c8-703132eb2d1e.sorted_genome_alignments.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A9RU-01A	6F18F96E-C0C9-4CC4-9FB2-CBA8949D5402	Primary Tumor	Illumina HiSeq	D4E71B65-7F8D-4E13-B7F9-A8EAAB94B20C	Breast	90.0	71CA5ED1-C8D8-4B05-AAA1-C4051976FE1C	12037B1A-EF64-4EA7-99C8-703132EB2D1E	TCGA-E2-A9RU-01A-11R-A41B-07	HG19	TCGA-E2-A9RU	TCGA-BRCA		s6101	University of North Carolina	Roswell Park	United States	NO	T2	N3a	Infiltrating Ductal Carcinoma	Stage III	A41B-07	True
13767.58cfa837e4b0c9d6adf7015d	58cfa837e4b0c9d6adf7015d	UNCID_1863938.7a9961f7-5d9e-47e6-9ccb-7642f01083d5.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1863938.7a9961f7-5d9e-47e6-9ccb-7642f01083d5.sorted_genome_alignments	UNCID_1863938.7a9961f7-5d9e-47e6-9ccb-7642f01083d5.sorted_genome_alignments.bam	104.2	1.7	0.16	58cfa837e4b0c9d6adf7015d	UNCID_1863938.7a9961f7-5d9e-47e6-9ccb-7642f01083d5.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-F4-6461-01A	2900EADD-7E27-4371-94E5-7D58CDFF0138	Primary Tumor	Illumina HiSeq	F16E4935-997F-48A2-B6D0-A3D8BF2C0F81	Colorectal	41.0	115E6BE9-DD9A-4137-8A5C-821FF7860A8F	7A9961F7-5D9E-47E6-9CCB-7642F01083D5	TCGA-F4-6461-01A-11R-1774-07	HG19	TCGA-F4-6461	TCGA-COAD		s13100	University of North Carolina	Asterand	Russia	NO	T4b	N2	Colon Adenocarcinoma	Stage III	1774-07	True
13722.58cfa832e4b0c9d6adf6cffa	58cfa832e4b0c9d6adf6cffa	TCGA-GC-A3WC-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-GC-A3WC-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_3_rg.sorted	TCGA-GC-A3WC-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_3_rg.sorted.bam	79.1		0.16	58cfa832e4b0c9d6adf6cffa	TCGA-GC-A3WC-10A-01D-A233_120904_SN1120_0186_BC1911ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3WC-10A	DB52C68A-ED44-4EC4-9381-D75F9BCBC29A	Blood Derived Normal	Illumina HiSeq	86cc0d9a-1aa0-4d61-9fb9-ea2370c44f9d	Bladder	80.0	9BCD8C28-B397-41D2-A004-2B093EB9A739	9BB2C8B6-EDF9-4258-8938-7D7CB74DCDBF	TCGA-GC-A3WC-10A-01D-A233-26	HG19_Broad_variant	TCGA-GC-A3WC	TCGA-BLCA		s2730	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	True
13767.58cfa835e4b0c9d6adf6f062	58cfa835e4b0c9d6adf6f062	UNCID_1474405.F732F86B-5190-4827-8471-656A43B47681.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1474405.F732F86B-5190-4827-8471-656A43B47681.sorted_genome_alignments	UNCID_1474405.F732F86B-5190-4827-8471-656A43B47681.sorted_genome_alignments.bam	19.28	1.86	0.18	58cfa835e4b0c9d6adf6f062	UNCID_1474405.F732F86B-5190-4827-8471-656A43B47681.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3QF-01A	47990D5E-A0E1-4752-86F5-4F5B84E219DF	Primary Tumor	Illumina HiSeq	4799CAC2-613A-4331-8211-9613C81FE91A	Bladder	79.0	6647C98E-7AA1-49E4-A067-D53AEBACFF9C	F732F86B-5190-4827-8471-656A43B47681	TCGA-GV-A3QF-01A-31R-A22U-07	HG19	TCGA-GV-A3QF	TCGA-BLCA		s2975	University of North Carolina	BLN - Cleveland Clinic	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A22U-07	True
13767.58cfa837e4b0c9d6adf6fe7c	58cfa837e4b0c9d6adf6fe7c	UNCID_1781143.c809549e-bd06-4b47-a3ff-dd2dbb2dfd2c.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1781143.c809549e-bd06-4b47-a3ff-dd2dbb2dfd2c.sorted_genome_alignments	UNCID_1781143.c809549e-bd06-4b47-a3ff-dd2dbb2dfd2c.sorted_genome_alignments.bam	131.8	1.8	0.16	58cfa837e4b0c9d6adf6fe7c	UNCID_1781143.c809549e-bd06-4b47-a3ff-dd2dbb2dfd2c.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-G4-6295-01A	E17959BD-045D-4540-B43A-C3863E8FF3C0	Primary Tumor	Illumina HiSeq	E6D3D0CC-6F78-46F6-A0E2-E73AC832471E	Colorectal	70.0	EC60D3A7-14FF-4171-9D46-A2B6F898C5F1	C809549E-BD06-4B47-A3FF-DD2DBB2DFD2C	TCGA-G4-6295-01A-11R-1723-07	HG19	TCGA-G4-6295	TCGA-COAD		s13737	University of North Carolina	Roswell Park	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1723-07	True
13767.58cfa82fe4b0c9d6adf6b203	58cfa82fe4b0c9d6adf6b203	TCGA-09-1670-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-09-1670-01A-01R-1566-13_rnaseq	TCGA-09-1670-01A-01R-1566-13_rnaseq.bam	447.0	1.8	0.16	58cfa82fe4b0c9d6adf6b203	TCGA-09-1670-01A-01R-1566-13_rnaseq.bam	Alive	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-1670-01A	60014A6E-6A13-4F92-BBFD-EEEEE9632F98	Primary Tumor	Illumina HiSeq	55608E0A-A7EB-4BA1-ADD6-F3EEAFE033D5	Ovary	57.0	1AD76860-B19E-45AC-B81A-BB0BDAC2B5AB	EB2322DD-5A7F-41C0-9BE2-7E1F7DC485B4	TCGA-09-1670-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-09-1670	TCGA-OV		s17900	Canada's Michael Smith Genome Sciences Centre	UCSF	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa83ae4b0c9d6adf7187c	58cfa83ae4b0c9d6adf7187c	UNCID_2408215.b22b56c2-3e66-430b-b1a5-3441b30551c3.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2408215.b22b56c2-3e66-430b-b1a5-3441b30551c3.sorted_genome_alignments	UNCID_2408215.b22b56c2-3e66-430b-b1a5-3441b30551c3.sorted_genome_alignments.bam	26.08	1.69	0.15	58cfa83ae4b0c9d6adf7187c	UNCID_2408215.b22b56c2-3e66-430b-b1a5-3441b30551c3.sorted_genome_alignments.bam	Alive	MALE			Brain Lower Grade Glioma	Aligned reads	TCGA-VM-A8CB-01A	33600812-1894-4471-A365-75AE4D990B72	Primary Tumor	Illumina HiSeq	202A0C35-A41E-4620-8B93-0546C3ECBAA0	Brain	33.0	DA791A2D-D77F-4C48-80AE-B8C3F581F136	B22B56C2-3E66-430B-B1A5-3441B30551C3	TCGA-VM-A8CB-01A-11R-A36H-07	HG19	TCGA-VM-A8CB	TCGA-LGG		s8310	University of North Carolina	Huntsman Cancer Institute	United States	NO			Oligodendroglioma		A36H-07	True
13722.58cfa832e4b0c9d6adf6d4e5	58cfa832e4b0c9d6adf6d4e5	TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted	TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted.bam	51.84		0.17	58cfa832e4b0c9d6adf6d4e5	TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F1-01A	94F3D9B0-0EE4-4F6A-A8FF-CE7A4D8FAB76	Primary Tumor	Illumina HiSeq	83f97de6-ac60-4cc0-bcff-bdecfe40f951	Eye	46.0	6C6A3062-B453-434B-9168-7837CAABC4EF	706721D2-3759-4664-BFB7-8FF7273C2786	TCGA-V4-A9F1-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F1	TCGA-UVM		s226	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0		Stage II	A40D-26	True
13722.58cfa831e4b0c9d6adf6ccee	58cfa831e4b0c9d6adf6ccee	TCGA-EJ-5518-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EJ-5518-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_8_rg.sorted	TCGA-EJ-5518-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_8_rg.sorted.bam	610.4	1.9	0.16	58cfa831e4b0c9d6adf6ccee	TCGA-EJ-5518-10A-01D-1573_130131_SN1120_0235_BD1TAFACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5518-10A	2B35C119-CDC1-49E2-8229-CA5CDE9E63D0	Blood Derived Normal	Illumina HiSeq	048d94f9-66cb-4acc-9246-166201f39dab	Prostate	66.0	DA203181-CD7A-44FD-85D9-9A7E7D8E9778	98CE8C9E-8F01-466B-92B5-EE4FA7E7AFF7	TCGA-EJ-5518-10A-01D-1573-02	HG19_Broad_variant	TCGA-EJ-5518	TCGA-PRAD		s3786	Harvard Medical School	University of Pittsburgh	United States	NO	T4	N0	Prostate Adenocarcinoma Acinar Type		1573-02	True
13767.58cfa839e4b0c9d6adf7112c	58cfa839e4b0c9d6adf7112c	UNCID_2268956.3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2268956.3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee.sorted_genome_alignments	UNCID_2268956.3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee.sorted_genome_alignments.bam	15.13	1.92	0.16	58cfa839e4b0c9d6adf7112c	UNCID_2268956.3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-QH-A6CZ-01A	B4F4C9B5-BC50-4F35-A7DA-FD011C3B2C02	Primary Tumor	Illumina HiSeq	B4FD4F79-57DF-4518-AD5A-0405B6D4CEEB	Brain	38.0	1E73EA08-66AD-4B83-A2C5-048E5F3B7ADB	3D2E42A7-D83F-471B-AC4C-19F3D62EB0EE	TCGA-QH-A6CZ-01A-11R-A32Q-07	HG19	TCGA-QH-A6CZ	TCGA-LGG		s8455	University of North Carolina	Fondazione-Besta	Italy	NO			Oligoastrocytoma		A32Q-07	True
13722.58cfa82ee4b0c9d6adf6ab52	58cfa82ee4b0c9d6adf6ab52	G26401.TCGA-15-1444-10A-01D-1696-08.1.filtered.	WGS	G26401.TCGA-15-1444-10A-01D-1696-08.1	G26401.TCGA-15-1444-10A-01D-1696-08.1.bam	2.0	1.9	0.05	58cfa82ee4b0c9d6adf6ab52	G26401.TCGA-15-1444-10A-01D-1696-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-15-1444-10A	4C42DC4E-66B7-40BF-9FBE-B92543248198	Blood Derived Normal	Illumina HiSeq	89ad7385-8faa-47ff-8b2a-1cf30fa598d6	Brain	21.0	F64D61AC-B8B7-44A8-A5C4-ADFFF2940FF3	41190F35-E3AF-46E3-9B2D-41BC41D5891B	TCGA-15-1444-10A-01D-1696-08	HG19_Broad_variant	TCGA-15-1444	TCGA-GBM	1537.0	s14264	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO			Glioblastoma Multiforme (GBM)		1696-08	False
13767.58cfa835e4b0c9d6adf6ef14	58cfa835e4b0c9d6adf6ef14	UNCID_1474254.D692892D-D63B-4AC2-9627-AE255AB17CAB.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1474254.D692892D-D63B-4AC2-9627-AE255AB17CAB.sorted_genome_alignments	UNCID_1474254.D692892D-D63B-4AC2-9627-AE255AB17CAB.sorted_genome_alignments.bam	21.07	1.79	0.15	58cfa835e4b0c9d6adf6ef14	UNCID_1474254.D692892D-D63B-4AC2-9627-AE255AB17CAB.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SL-01A	4570B6E2-D430-41CA-AAB1-CE4D14C36463	Primary Tumor	Illumina HiSeq	CA7E6222-3162-42B7-BCE0-CDD8F02754DA	Bladder	60.0	0A1E88E0-3593-40BA-86E5-751074885578	D692892D-D63B-4AC2-9627-AE255AB17CAB	TCGA-FD-A3SL-01A-21R-A22U-07	HG19	TCGA-FD-A3SL	TCGA-BLCA		s2978	University of North Carolina	BLN - University Of Chicago	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A22U-07	True
13767.58cfa82fe4b0c9d6adf6b6cc	58cfa82fe4b0c9d6adf6b6cc	TCGA-30-1860-01A-01R-1568-13_GRCh37-lite_rnaseq.filtered.	RNA-Seq	TCGA-30-1860-01A-01R-1568-13_GRCh37-lite_rnaseq	TCGA-30-1860-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	335.0	1.8	0.15	58cfa82fe4b0c9d6adf6b6cc	TCGA-30-1860-01A-01R-1568-13_GRCh37-lite_rnaseq.bam	Dead	FEMALE	WHITE	HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-30-1860-01A	563853A2-9AC2-48BE-ADF3-1E547EE2B274	Primary Tumor	Illumina HiSeq	4E41B8C8-79DA-4307-9ED8-39A3D6C54164	Ovary	58.0	5AE1AE22-B891-472A-B737-E48C73B91798	1B8EED7B-173E-4E38-80A4-A3A0AEA469A1	TCGA-30-1860-01A-01R-1568-13	GRCh37-lite	TCGA-30-1860	TCGA-OV	1366.0	s17851	Canada's Michael Smith Genome Sciences Centre	Harvard	None	NO			Serous Cystadenocarcinoma		1568-13	True
13722.58cfa82ee4b0c9d6adf6aeda	58cfa82ee4b0c9d6adf6aeda	TCGA-05-4397-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_8_rg.sorted.filtered.	WGS	TCGA-05-4397-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_8_rg.sorted	TCGA-05-4397-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_8_rg.sorted.bam	256.93	1.9	0.15	58cfa82ee4b0c9d6adf6aeda	TCGA-05-4397-10A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_8_rg.sorted.bam	Dead	MALE			Lung Adenocarcinoma	Aligned reads	TCGA-05-4397-10A	6DFD47D2-831A-4386-9051-F78199A16BB5	Blood Derived Normal	Illumina HiSeq	6be1b088-22a4-428b-be61-923f6c558318	Lung	65.0	E9F8F56D-E3A6-4F92-807A-99BD857CAD8A	448DEB16-395E-480B-A492-374FFD9579FD	TCGA-05-4397-10A-01D-1203-02	HG19_Broad_variant	TCGA-05-4397	TCGA-LUAD	731.0	s11434	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage II	1203-02	True
13767.58cfa833e4b0c9d6adf6dee8	58cfa833e4b0c9d6adf6dee8	UNCID_1146575.34b7764e-748a-415c-84b5-c45d0932e642.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1146575.34b7764e-748a-415c-84b5-c45d0932e642.sorted_genome_alignments	UNCID_1146575.34b7764e-748a-415c-84b5-c45d0932e642.sorted_genome_alignments.bam	14.11	1.88	0.14	58cfa833e4b0c9d6adf6dee8	UNCID_1146575.34b7764e-748a-415c-84b5-c45d0932e642.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0FW-01A	E112B452-8850-4353-BFED-0DBDC243290B	Primary Tumor	Illumina HiSeq	E40C2BEA-009C-4E00-9E07-E59170B2CA12	Breast	67.0	A4910543-8BFD-4CD9-9EAB-CF16AEAD9537	34B7764E-748A-415C-84B5-C45D0932E642	TCGA-AN-A0FW-01A-11R-A034-07	HG19	TCGA-AN-A0FW	TCGA-BRCA		s5552	University of North Carolina	Cureline	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage III	A034-07	True
13767.58cfa833e4b0c9d6adf6d911	58cfa833e4b0c9d6adf6d911	UNCID_1071695.c806fc33-7a1d-44a8-b67b-7f74363c3f01.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1071695.c806fc33-7a1d-44a8-b67b-7f74363c3f01.sorted_genome_alignments	UNCID_1071695.c806fc33-7a1d-44a8-b67b-7f74363c3f01.sorted_genome_alignments.bam	300.0	1.7	0.14	58cfa833e4b0c9d6adf6d911	UNCID_1071695.c806fc33-7a1d-44a8-b67b-7f74363c3f01.sorted_genome_alignments.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-0944-01A	DF7C9193-0BD2-4FD9-8AE1-1F9D341E92C5	Primary Tumor	Illumina HiSeq	80CB2871-E146-43AF-9B40-E50FA8D321DE	Lung	61.0	3AD22921-3E1A-488E-83DF-5AE8D24DBD06	C806FC33-7A1D-44A8-B67B-7F74363C3F01	TCGA-22-0944-01A-01R-0692-07	HG19	TCGA-22-0944	TCGA-LUSC	223.0	s10534	University of North Carolina	Mayo Clinic - Rochester	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	0692-07	True
13767.58cfa835e4b0c9d6adf6ef22	58cfa835e4b0c9d6adf6ef22	UNCID_1474028.e1a6b655-0a09-4a79-b86b-8ff65b2bbceb.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1474028.e1a6b655-0a09-4a79-b86b-8ff65b2bbceb.sorted_genome_alignments	UNCID_1474028.e1a6b655-0a09-4a79-b86b-8ff65b2bbceb.sorted_genome_alignments.bam	357.3	1.8	0.15	58cfa835e4b0c9d6adf6ef22	UNCID_1474028.e1a6b655-0a09-4a79-b86b-8ff65b2bbceb.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-2657-01A	F40301BA-831E-4AFD-9CE8-5F3C1A05FF7E	Primary Tumor	Illumina HiSeq	87B93442-0D43-4BEE-B455-26EFFB665A35	Lung	74.0	1028D7A9-0AC0-4FD8-A34B-46F3E6E53F79	E1A6B655-0A09-4A79-B86B-8FF65B2BBCEB	TCGA-44-2657-01A-01R-1107-07	HG19	TCGA-44-2657	TCGA-LUAD		s11182	University of North Carolina	Christiana Healthcare	United States	NO	T2	NX	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage I	1107-07	True
13722.58cfa832e4b0c9d6adf6d5f9	58cfa832e4b0c9d6adf6d5f9	TCGA-LN-A49W-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-LN-A49W-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_6_rg.sorted	TCGA-LN-A49W-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_6_rg.sorted.bam	43.58		0.16	58cfa832e4b0c9d6adf6d5f9	TCGA-LN-A49W-10A-01D-A267_131018_SN590_0240_AC2MW5ACXX_s_6_rg.sorted.bam	Alive	MALE	ASIAN		Esophageal Carcinoma	Aligned reads	TCGA-LN-A49W-10A	DAF211F2-941E-4244-8CF5-D31492269443	Blood Derived Normal	Illumina HiSeq	cfd64f86-5534-4ee7-ae0e-a68a622e0be8	Esophagus	73.0	67C9543B-3D37-4762-9FFF-602E7E0B7D93	8F89DE2A-8C40-4F93-BD00-3CB47EFC4876	TCGA-LN-A49W-10A-01D-A267-26	HG19_Broad_variant	TCGA-LN-A49W	TCGA-ESCA		s1878	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N1		Stage III	A267-26	True
13767.58cfa835e4b0c9d6adf6eda4	58cfa835e4b0c9d6adf6eda4	UNCID_1378002.8a224dc6-632b-418b-bd5e-bcefc8ad049e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1378002.8a224dc6-632b-418b-bd5e-bcefc8ad049e.sorted_genome_alignments	UNCID_1378002.8a224dc6-632b-418b-bd5e-bcefc8ad049e.sorted_genome_alignments.bam	16.09	1.77	0.18	58cfa835e4b0c9d6adf6eda4	UNCID_1378002.8a224dc6-632b-418b-bd5e-bcefc8ad049e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3KD-01A	BB026999-0AAB-4232-96D7-2C93B6C9691D	Primary Tumor	Illumina HiSeq	8AFA22E8-C1A7-4BD2-B536-8E947AA944B0	Breast	47.0	401D075C-D443-4592-8C03-E675CAAD2B50	8A224DC6-632B-418B-BD5E-BCEFC8AD049E	TCGA-A2-A3KD-01A-12R-A213-07	HG19	TCGA-A2-A3KD	TCGA-BRCA		s6065	University of North Carolina	Walter Reed	United States	NO	T3	N1mi	Mucinous Carcinoma	Stage III	A213-07	True
13767.58cfa83ce4b0c9d6adf72c05	58cfa83ce4b0c9d6adf72c05	UNCID_402458.0a92ac08-a817-401f-8827-62b419b7afc2.110711_UNC14-SN744_0141_BD0DFHABXX.6.trimmed.annotated.translated_to_genomic.filtered.	RNA-Seq	UNCID_402458.0a92ac08-a817-401f-8827-62b419b7afc2.110711_UNC14-SN744_0141_BD0DFHABXX.6.trimmed.annotated.translated_to_genomic	UNCID_402458.0a92ac08-a817-401f-8827-62b419b7afc2.110711_UNC14-SN744_0141_BD0DFHABXX.6.trimmed.annotated.translated_to_genomic.bam	70.3	1.8	0.15	58cfa83ce4b0c9d6adf72c05	UNCID_402458.0a92ac08-a817-401f-8827-62b419b7afc2.110711_UNC14-SN744_0141_BD0DFHABXX.6.trimmed.annotated.translated_to_genomic.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5201-01A	54C9850C-9B67-42EA-A04B-16A88F786DFA	Primary Tumor	Illumina HiSeq	01A38495-24C2-4435-9B23-3215224D968D	Kidney	63.0	4249CCCF-A338-49F1-A007-8CC003E5FBC0	0A92AC08-A817-401F-8827-62B419B7AFC2	TCGA-BP-5201-01A-01R-1426-07	HG19	TCGA-BP-5201	TCGA-KIRC		s8972	University of North Carolina	MSKCC	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	1426-07	True
13767.58cfa834e4b0c9d6adf6e51b	58cfa834e4b0c9d6adf6e51b	UNCID_1179737.0e959a22-7e2a-4cf8-92cc-ae13baee45b1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1179737.0e959a22-7e2a-4cf8-92cc-ae13baee45b1.sorted_genome_alignments	UNCID_1179737.0e959a22-7e2a-4cf8-92cc-ae13baee45b1.sorted_genome_alignments.bam	68.8	1.7	0.14	58cfa834e4b0c9d6adf6e51b	UNCID_1179737.0e959a22-7e2a-4cf8-92cc-ae13baee45b1.sorted_genome_alignments.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5677-01A	D2664FDE-CE3B-45E6-9A23-4A07980F7BAC	Primary Tumor	Illumina HiSeq	012E2C53-E3FF-46BF-9CF5-5838AD3F246E	Kidney	54.0	2061667F-5253-4933-AA22-E8F7E092DBBF	0E959A22-7E2A-4CF8-92CC-AE13BAEE45B1	TCGA-CJ-5677-01A-11R-1541-07	HG19	TCGA-CJ-5677	TCGA-KIRC	782.0	s9474	University of North Carolina	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1541-07	True
13767.58cfa82fe4b0c9d6adf6b8ba	58cfa82fe4b0c9d6adf6b8ba	TCGA-61-2002-01A-01R-1568-13_rnaseq.filtered.	RNA-Seq	TCGA-61-2002-01A-01R-1568-13_rnaseq	TCGA-61-2002-01A-01R-1568-13_rnaseq.bam	421.0	1.8	0.14	58cfa82fe4b0c9d6adf6b8ba	TCGA-61-2002-01A-01R-1568-13_rnaseq.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2002-01A	85BB4987-51E7-40FE-AD59-2AA56754ECA9	Primary Tumor	Illumina HiSeq	23E4683A-4B10-40EF-87C5-4CBDD1B2DC87	Ovary	46.0	C9AA3E59-A10A-4E4C-B8CB-40D970F43DF7	14CD154A-6EA5-4AD9-92E4-72F53EE5D60B	TCGA-61-2002-01A-01R-1568-13	NCBI36_BCCAGSC_variant	TCGA-61-2002	TCGA-OV		s17648	Canada's Michael Smith Genome Sciences Centre	University of Pittsburgh	None	NO			Serous Cystadenocarcinoma		1568-13	True
13767.58cfa835e4b0c9d6adf6ea48	58cfa835e4b0c9d6adf6ea48	UNCID_1269642.febae3ce-225b-4414-bc02-4538b062d76e.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1269642.febae3ce-225b-4414-bc02-4538b062d76e.sorted_genome_alignments	UNCID_1269642.febae3ce-225b-4414-bc02-4538b062d76e.sorted_genome_alignments.bam	8.21	1.7	0.15	58cfa835e4b0c9d6adf6ea48	UNCID_1269642.febae3ce-225b-4414-bc02-4538b062d76e.sorted_genome_alignments.bam	Alive	FEMALE	WHITE		Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QF-01A	FCA0C7D9-5E6F-4AA7-BA04-5DF2EB8BA398	Primary Tumor	Illumina HiSeq	BCF86C1B-4686-431B-89C5-C0E0F25A634D	Thyroid	61.0	E4B53CA1-D395-4FEA-A962-DFBD2B373A6B	FEBAE3CE-225B-4414-BC02-4538B062D76E	TCGA-DJ-A1QF-01A-12R-A14Y-07	HG19	TCGA-DJ-A1QF	TCGA-THCA		s12410	University of North Carolina	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A14Y-07	True
13767.58cfa834e4b0c9d6adf6e861	58cfa834e4b0c9d6adf6e861	UNCID_1226256.d74355d5-c8f1-4657-ac5c-5f76a4e47467.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1226256.d74355d5-c8f1-4657-ac5c-5f76a4e47467.sorted_genome_alignments	UNCID_1226256.d74355d5-c8f1-4657-ac5c-5f76a4e47467.sorted_genome_alignments.bam	212.2	1.8	0.16	58cfa834e4b0c9d6adf6e861	UNCID_1226256.d74355d5-c8f1-4657-ac5c-5f76a4e47467.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-BQ-7051-11A	A614255D-9F1B-4E9A-8A50-435D4D123B3F	Solid Tissue Normal	Illumina HiSeq	C9F2E2BD-D08E-4839-9CB0-6D2930806DA8	Kidney	74.0	469CAB5C-8376-4E6F-A19C-177999C44458	D74355D5-C8F1-4657-AC5C-5F76A4E47467	TCGA-BQ-7051-11A-02R-1965-07	HG19	TCGA-BQ-7051	TCGA-KIRP		s11879	University of North Carolina	MSKCC	United States	NO	T2	N0	Kidney Papillary Renal Cell Carcinoma	Stage II	1965-07	True
13767.58cfa834e4b0c9d6adf6e350	58cfa834e4b0c9d6adf6e350	UNCID_1187132.baf74825-1139-4fc4-b650-3059a1106a7f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1187132.baf74825-1139-4fc4-b650-3059a1106a7f.sorted_genome_alignments	UNCID_1187132.baf74825-1139-4fc4-b650-3059a1106a7f.sorted_genome_alignments.bam	77.3	1.7	0.15	58cfa834e4b0c9d6adf6e350	UNCID_1187132.baf74825-1139-4fc4-b650-3059a1106a7f.sorted_genome_alignments.bam	Alive	MALE	WHITE		Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4994-01A	82F069C4-7928-4B7B-8A42-114DB7DE0501	Primary Tumor	Illumina HiSeq	9C425B33-F5BA-4C02-8348-519C60FCDF7F	Kidney	54.0	FEA9FE78-CE9B-4C22-B688-7D458997D6FD	BAF74825-1139-4FC4-B650-3059A1106A7F	TCGA-BP-4994-01A-01R-1334-07	HG19	TCGA-BP-4994	TCGA-KIRC		s8893	University of North Carolina	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	1334-07	True
13722.58cfa832e4b0c9d6adf6d4a4	58cfa832e4b0c9d6adf6d4a4	TCGA-V4-A9EE-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-V4-A9EE-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_3_rg.sorted	TCGA-V4-A9EE-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_3_rg.sorted.bam	13.28		0.15	58cfa832e4b0c9d6adf6d4a4	TCGA-V4-A9EE-10A-01D-A40E_140725_SN590_0252_BC41HPACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EE-10A	EDBF6720-467E-4928-B1CB-0E7336358D18	Blood Derived Normal	Illumina HiSeq	13176c9c-7e2e-4835-9a15-75896c085c18	Eye	86.0	0E3BE5E7-04CC-4E29-ACE9-DF3E22701A1A	9B0E05B2-A98F-4BC4-8878-5280F78A1DC5	TCGA-V4-A9EE-10A-01D-A40E-26	HG19_Broad_variant	TCGA-V4-A9EE	TCGA-UVM	398.0	s211	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0		Stage II	A40E-26	True
13722.58cfa82ee4b0c9d6adf6a876	58cfa82ee4b0c9d6adf6a876	G26391.TCGA-26-5135-01A-01D-1486-08.1.filtered.	WGS	G26391.TCGA-26-5135-01A-01D-1486-08.1	G26391.TCGA-26-5135-01A-01D-1486-08.1.bam	443.73	1.9	0.05	58cfa82ee4b0c9d6adf6a876	G26391.TCGA-26-5135-01A-01D-1486-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-26-5135-01A	69D56F2D-6924-409B-9D1E-C8D69B400270	Primary Tumor	Illumina HiSeq	1fec68bf-4fbd-4cbf-bf2e-e540dd2bc143	Brain	72.0	8CFB4C3F-B25F-412C-91C7-997C64EA2D75	2CE48F01-2F61-49D9-A56A-7438BF4A37D7	TCGA-26-5135-01A-01D-1486-08	HG19_Broad_variant	TCGA-26-5135	TCGA-GBM	270.0	s14173	Broad Institute of MIT and Harvard	University of Florida	None	NO			Untreated primary (de novo) GBM		1486-08	False
13767.58cfa83ae4b0c9d6adf715e1	58cfa83ae4b0c9d6adf715e1	UNCID_2386160.8ab941c0-6e1c-403c-901d-03ac81bbb81f.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2386160.8ab941c0-6e1c-403c-901d-03ac81bbb81f.sorted_genome_alignments	UNCID_2386160.8ab941c0-6e1c-403c-901d-03ac81bbb81f.sorted_genome_alignments.bam	10.6	1.84	0.18	58cfa83ae4b0c9d6adf715e1	UNCID_2386160.8ab941c0-6e1c-403c-901d-03ac81bbb81f.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-J4-A83M-01A	D6974DB6-2BD3-4082-B48E-9C60F7FE3A1F	Primary Tumor	Illumina HiSeq	2E82E1A3-5B98-4271-A275-C9FEA41223C1	Prostate	64.0	004BDE0B-224A-48CE-AA33-242BA7385ECC	8AB941C0-6E1C-403C-901D-03AC81BBB81F	TCGA-J4-A83M-01A-11R-A352-07	HG19	TCGA-J4-A83M	TCGA-PRAD		s3709	University of North Carolina	ABS - Lahey Clinic	None	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		A352-07	True
13722.58cfa831e4b0c9d6adf6c9af	58cfa831e4b0c9d6adf6c9af	TCGA-DJ-A13W-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_2_rg.sorted.filtered.	WGS	TCGA-DJ-A13W-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_2_rg.sorted	TCGA-DJ-A13W-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_2_rg.sorted.bam	38.59	1.95	0.14	58cfa831e4b0c9d6adf6c9af	TCGA-DJ-A13W-10A-01D-A10R_120617_SN1222_0116_AC0WMMACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13W-10A	3B48CC5E-3396-4DD5-893D-54B75B98B016	Blood Derived Normal	Illumina HiSeq	8ac86520-440a-4302-b185-5f222e1f75ef	Thyroid	45.0	C6EAF3F8-DD7D-4B38-BF42-8A53AAFAB259	BCB946CF-8A80-41B4-BD03-3A3255FA1C83	TCGA-DJ-A13W-10A-01D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13W	TCGA-THCA		s12107	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10R-02	True
13767.58cfa838e4b0c9d6adf70890	58cfa838e4b0c9d6adf70890	UNCID_2044292.9d16eccb-44fa-4188-9ad2-3a17ed821247.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2044292.9d16eccb-44fa-4188-9ad2-3a17ed821247.sorted_genome_alignments	UNCID_2044292.9d16eccb-44fa-4188-9ad2-3a17ed821247.sorted_genome_alignments.bam	27.8	1.84	0.16	58cfa838e4b0c9d6adf70890	UNCID_2044292.9d16eccb-44fa-4188-9ad2-3a17ed821247.sorted_genome_alignments.bam	Alive	MALE			Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-A65M-01A	D4FF9F1A-1D35-4AD6-9A36-059547081C7E	Primary Tumor	Illumina HiSeq	E3A79C0D-456C-4AFA-96E7-519E89E6CDCB	Prostate	65.0	4761D0F1-E6E9-4D8F-9FCE-014C3F2ED64F	9D16ECCB-44FA-4188-9AD2-3A17ED821247	TCGA-EJ-A65M-01A-11R-A29R-07	HG19	TCGA-EJ-A65M	TCGA-PRAD		s3692	University of North Carolina	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type		A29R-07	True
13767.58cfa834e4b0c9d6adf6e96e	58cfa834e4b0c9d6adf6e96e	UNCID_1243711.9434a419-0eeb-4952-a60c-a8afe98a0347.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1243711.9434a419-0eeb-4952-a60c-a8afe98a0347.sorted_genome_alignments	UNCID_1243711.9434a419-0eeb-4952-a60c-a8afe98a0347.sorted_genome_alignments.bam	63.77	1.86	0.17	58cfa834e4b0c9d6adf6e96e	UNCID_1243711.9434a419-0eeb-4952-a60c-a8afe98a0347.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A0Y2-01A	6AD260AD-769A-4F3C-BD07-927ADF6B2338	Primary Tumor	Illumina HiSeq	D2237632-02F2-4D0B-B2CB-8C7E3FE24269	Thyroid	30.0	EB4FEEBB-293E-43E3-A2ED-344B17D180B3	9434A419-0EEB-4952-A60C-A8AFE98A0347	TCGA-DE-A0Y2-01A-11R-A10U-07	HG19	TCGA-DE-A0Y2	TCGA-THCA		s12405	University of North Carolina	University of North Carolina	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A10U-07	True
13722.58cfa831e4b0c9d6adf6c8f0	58cfa831e4b0c9d6adf6c8f0	TCGA-CV-7180-10A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CV-7180-10A-01D-2266-10_Illumina	TCGA-CV-7180-10A-01D-2266-10_Illumina.bam	36.0		0.05	58cfa831e4b0c9d6adf6c8f0	TCGA-CV-7180-10A-01D-2266-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7180-10A	D2CA9A4D-C14C-40C0-871C-88794A02E4AA	Blood Derived Normal	Illumina HiSeq	7a1bc885-10c7-42e5-9024-c742bde8c9cc	Head and Neck	34.0	406255B7-F269-4DC2-9EC2-E68809B66787	87255DF3-4E17-4CC4-A3CF-EA121E937D8F	TCGA-CV-7180-10A-01D-2266-10	GRCh37-lite	TCGA-CV-7180	TCGA-HNSC	327.0	s15649	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II	2266-10	True
13767.58cfa82ee4b0c9d6adf6a80a	58cfa82ee4b0c9d6adf6a80a	G17195.TCGA-06-0138-01A-02R-1849-01.2.filtered.	RNA-Seq	G17195.TCGA-06-0138-01A-02R-1849-01.2	G17195.TCGA-06-0138-01A-02R-1849-01.2.bam	48.4	1.8	0.15	58cfa82ee4b0c9d6adf6a80a	G17195.TCGA-06-0138-01A-02R-1849-01.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0138-01A	66BD4C9E-2EBD-4092-A2B0-69027E8AF5B8	Primary Tumor	Illumina HiSeq	F1EA4030-06A8-4500-B7EC-0BE20D213E91	Brain	43.0	8761CA7D-DD5E-47B5-956F-B6738C1CE9DC	6F2FEDB4-66E2-48FD-8744-CBD30075BB03	TCGA-06-0138-01A-02R-1849-01	HG19_Broad_variant	TCGA-06-0138	TCGA-GBM	737.0	s14203	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO			Untreated primary (de novo) GBM		1849-01	True
13722.58cfa82ee4b0c9d6adf6ad18	58cfa82ee4b0c9d6adf6ad18	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.filtered.	WGS	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.bam	24.95		0.08	58cfa82ee4b0c9d6adf6ad18	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2OV-01A	55E03FFC-F006-4EC8-8E5D-A738FF091F8A	Primary Tumor	Illumina HiSeq	6c8370c6-102f-4bde-84ce-bf930800ac6a	Thyroid	64.0	1183BCB5-50A7-4CC0-A94C-732636B7EE7D	2DFE70FD-2650-49C0-B6EB-67DF585D063B	TCGA-EM-A2OV-01A-11D-A202-08	HG19_Broad_variant	TCGA-EM-A2OV	TCGA-THCA		s12347	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A202-08	True
13767.58cfa837e4b0c9d6adf700f6	58cfa837e4b0c9d6adf700f6	UNCID_1899267.d36829af-a8cc-41fc-8929-a1979af2facc.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1899267.d36829af-a8cc-41fc-8929-a1979af2facc.sorted_genome_alignments	UNCID_1899267.d36829af-a8cc-41fc-8929-a1979af2facc.sorted_genome_alignments.bam	134.2	1.8	0.14	58cfa837e4b0c9d6adf700f6	UNCID_1899267.d36829af-a8cc-41fc-8929-a1979af2facc.sorted_genome_alignments.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-AF-6672-01A	6221496D-40CC-4071-969F-6FBCBA4F573C	Primary Tumor	Illumina HiSeq	793C0992-6EBF-4122-8E44-A3F82FC648CE	Colorectal	43.0	63291336-7277-4B3C-9CA6-658636BCE3AD	D36829AF-A8CC-41FC-8929-A1979AF2FACC	TCGA-AF-6672-01A-11R-1830-07	HG19	TCGA-AF-6672	TCGA-READ		s2249	University of North Carolina	Christiana Healthcare	United States	NO	T4a	N2b	Rectal Adenocarcinoma	Stage IV	1830-07	True
13767.58cfa82fe4b0c9d6adf6b3c2	58cfa82fe4b0c9d6adf6b3c2	TCGA-24-1545-01A-01R-1566-13_rnaseq.filtered.	RNA-Seq	TCGA-24-1545-01A-01R-1566-13_rnaseq	TCGA-24-1545-01A-01R-1566-13_rnaseq.bam	495.0	1.8	0.14	58cfa82fe4b0c9d6adf6b3c2	TCGA-24-1545-01A-01R-1566-13_rnaseq.bam	Dead	FEMALE	WHITE		Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1545-01A	F2EC64F5-A414-4C34-99C7-D59BC4E831E0	Primary Tumor	Illumina HiSeq	4730309B-00D5-474C-899A-129DA5036803	Ovary	69.0	ED59C414-E594-44C8-B920-159336D45B4F	E2FCBA09-755D-425D-AB4D-CEDE8EF86E48	TCGA-24-1545-01A-01R-1566-13	NCBI36_BCCAGSC_variant	TCGA-24-1545	TCGA-OV	1746.0	s17439	Canada's Michael Smith Genome Sciences Centre	Washington University	None	NO			Serous Cystadenocarcinoma		1566-13	True
13767.58cfa838e4b0c9d6adf70f56	58cfa838e4b0c9d6adf70f56	UNCID_2217308.fdc9171f-a1c4-49e1-9ca3-d95519850187.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_2217308.fdc9171f-a1c4-49e1-9ca3-d95519850187.sorted_genome_alignments	UNCID_2217308.fdc9171f-a1c4-49e1-9ca3-d95519850187.sorted_genome_alignments.bam	46.83	1.91	0.18	58cfa838e4b0c9d6adf70f56	UNCID_2217308.fdc9171f-a1c4-49e1-9ca3-d95519850187.sorted_genome_alignments.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Pancreatic Adenocarcinoma	Aligned reads	TCGA-H6-A45N-11A	758B70F6-8064-4F43-AABE-E5F968FE2955	Solid Tissue Normal	Illumina HiSeq	56B39B8C-6733-46D6-803F-707F543A2FDE	Pancreas	88.0	A00C5AF8-5504-46A0-9ACC-B32190DBAC10	FDC9171F-A1C4-49E1-9CA3-D95519850187	TCGA-H6-A45N-11A-12R-A26U-07	HG19	TCGA-H6-A45N	TCGA-PAAD		s788	University of North Carolina	Christiana Healthcare	United States	NO	T3	N1	Pancreas-Adenocarcinoma-Other Subtype	Stage II	A26U-07	True
13767.58cfa832e4b0c9d6adf6d776	58cfa832e4b0c9d6adf6d776	UNCID_1055311.87fc2c1d-3072-40fb-bc36-5b7a5604d4d7.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1055311.87fc2c1d-3072-40fb-bc36-5b7a5604d4d7.sorted_genome_alignments	UNCID_1055311.87fc2c1d-3072-40fb-bc36-5b7a5604d4d7.sorted_genome_alignments.bam	94.2	1.8	0.15	58cfa832e4b0c9d6adf6d776	UNCID_1055311.87fc2c1d-3072-40fb-bc36-5b7a5604d4d7.sorted_genome_alignments.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2709-01A	4718E180-C166-4826-B5A1-945F4A56EB16	Primary Tumor	Illumina HiSeq	3F8C815A-ED4A-405F-94A1-F1D97E867812	Lung	69.0	A30C673C-9A0B-462A-824D-8B4DB17D4498	87FC2C1D-3072-40FB-BC36-5B7A5604D4D7	TCGA-60-2709-01A-21R-1820-07	HG19	TCGA-60-2709	TCGA-LUSC		s10382	University of North Carolina	Roswell Park	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage I	1820-07	True
13767.58cfa837e4b0c9d6adf6ffb1	58cfa837e4b0c9d6adf6ffb1	UNCID_1805856.4d9bb08c-d954-4e14-aff2-3bec55cdf1c1.sorted_genome_alignments.filtered.	RNA-Seq	UNCID_1805856.4d9bb08c-d954-4e14-aff2-3bec55cdf1c1.sorted_genome_alignments	UNCID_1805856.4d9bb08c-d954-4e14-aff2-3bec55cdf1c1.sorted_genome_alignments.bam	11.19	1.79	0.15	58cfa837e4b0c9d6adf6ffb1	UNCID_1805856.4d9bb08c-d954-4e14-aff2-3bec55cdf1c1.sorted_genome_alignments.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A409-01A	5362CBC4-CD28-4AFD-A8AC-1A4C2C33CAD2	Primary Tumor	Illumina HiSeq	64A95F87-E560-4442-AE44-B3B9B2C5AE8E	Breast	44.0	9E1C48C2-CE8E-4256-8CB2-31B12C523C66	4D9BB08C-D954-4E14-AFF2-3BEC55CDF1C1	TCGA-B6-A409-01A-11R-A24H-07	HG19	TCGA-B6-A409	TCGA-BRCA	573.0	s6953	University of North Carolina	Duke	United States	NO	T1c	N2a	Infiltrating Ductal Carcinoma	Stage III	A24H-07	True
